PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Bell, TM; Vetor, AN; Zarzaur, BL				Bell, Teresa M.; Vetor, Ashley N.; Zarzaur, Ben L.			Prevalence and treatment of depression and posttraumatic stress disorder among trauma patients with non-neurological injuries	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		Posttraumatic stress disorder treatment; depression treatment; posttraumatic stress disorder after injury; depression after injury	QUALITY-OF-LIFE; SYMPTOMS; US	BACKGROUND Psychological impairment among injury survivors is well documented. Little is known about the prevalence of treatment of psychological impairment, however. We aimed to determine the proportion of injury survivors treated for depression and posttraumatic stress disorder (PTSD) in the year after injury as well as to determine potential barriers to treatment. METHODS Adults (18 and older) admitted to a Level I trauma center with an injury severity score greater than 10 but without traumatic brain injury or spinal cord injury were eligible for study inclusion. The Center for Epidemiological StudiesDepression and PTSD CheckListCivilian Versions surveys were administered during the initial hospitalization and repeated at 1, 2, 4, and 12 months after injury. Patients were asked if they received treatment specifically for depression or PTSD at each follow-up. Factors associated with treatment were determined using multivariable logistic regression analysis. RESULTS Five hundred injury survivors were enrolled in this prospective observational study. Of those, 68.4% of patients screened positive for depression at some point in the year after their injury (53.3%, 1 month; 49.9%, 2 months; 49.0%, 4 months; and 50.2%, 12 months). Only 22.2% of depressed patients reported receiving treatment for depression; 44.4% of patients screened positive for PTSD (26.6%, 1 month; 27.8%, 2 months; 29.8%, 4 months; and 30.0%, 12 months), but only 9.8% received treatment for PTSD. After adjusting for other factors, compared to commercial insurance status, self-pay insurance status was negatively associated with treatment for PTSD or depression (odds ratio, 0.44; 95% confidence interval, 0.21-0.95). CONCLUSION Depression and PTSD are common in non-neurotrauma patients in the year following injury. Greater collaboration between those caring for injury survivors and behavioral health experts may help improve psychological outcomes after injury. LEVEL OF EVIDENCE Therapeutic/Care management, level IV.	[Bell, Teresa M.; Vetor, Ashley N.; Zarzaur, Ben L.] Indiana Univ, Sch Med, Dept Surg, Indianapolis, IN 46202 USA		Zarzaur, BL (corresponding author), 720 Eskenazi Ave,H-2 Room 431, Indianapolis, IN 46202 USA.	bzarzaur@iupui.edu	Bell, Teresa Maria/Q-9271-2019; Zarzaur, Ben/S-6572-2019	Zarzaur, Ben/0000-0001-9988-9572; Bell, Teresa/0000-0002-6519-4358	National Institute of General Medical Science of the National Institutes of Health [K23GM084427]; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108, KL2TR001106]; IUPUI Research Support Funds Grant; IU Grand Challenge Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001106, KL2TR002530, UL1TR001108, TL1TR001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM084427] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of General Medical Science of the National Institutes of Health under award number K23GM084427 as well as KL2TR001106, and UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; the IUPUI Research Support Funds Grant; and the IU Grand Challenge Initiative. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	American College of Surgeons, B STATT POSTTR STRES; [Anonymous], WISQARS DAT ONL; Bonnie RJ, 2007, I MED US COMMITTEE I; Bryant-Davis T, 2013, HDB MULTICULTURAL ME, P505; Center for Substance Abuse Treatment (US), 2014, TREATMENT IMPROVEMEN, V57; *COMM TRAUM, 2006, RES OPT CAR INJ PAT; Dicker RA, 2009, J TRAUMA, V67, P1169, DOI 10.1097/TA.0b013e3181bdb78a; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Kiely JM, 2006, J TRAUMA, V61, P791, DOI 10.1097/01.ta.0000239360.29852.1d; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Ruggiero K. J., 2016, INT J EMERGENCY MENT, V18, P25, DOI DOI 10.4172/1522-4821.C1.005; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Taubman-Ben-Ari O, 2001, PSYCHOL MED, V31, P555, DOI 10.1017/S0033291701003658; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021; Weisberg RB, 2007, AM J PSYCHIAT, V164, P276, DOI 10.1176/appi.ajp.164.2.276; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Zarzaur BL, 2016, J SURG RES, V202, P103, DOI 10.1016/j.jss.2015.12.038; Zatzick DF, 2003, PSYCHOSOMATICS, V44, P479, DOI 10.1176/appi.psy.44.6.479; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943; Zatzick DF, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0424-4	22	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					999	1006		10.1097/TA.0000000000001992			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100025	29851909	Green Accepted, Green Submitted			2022-02-06	
J	Gaudet, AD; Fonken, LK; Ayala, MT; Bateman, EM; Schleicher, WE; Smith, EJ; D'Angelo, HM; Maier, SF; Watkins, LR				Gaudet, Andrew D.; Fonken, Laura K.; Ayala, Monica T.; Bateman, Emily M.; Schleicher, Wolfgang E.; Smith, Elana J.; D'Angelo, Heather M.; Maier, Steven F.; Watkins, Linda R.			Spinal Cord Injury in Rats Disrupts the Circadian System	ENEURO			English	Article						biological clock; circadian rhythms; diurnal rhythms; neurotrauma; spinal cord injury	NEUROPATHIC PAIN; NEUROINFLAMMATORY RESPONSE; GENE-EXPRESSION; BODY-MASS; LIGHT; MICROGLIA; RHYTHMS; CLOCK; GLUCOCORTICOIDS; CORTICOSTERONE	Spinal cord injury (SCI) perturbs many physiological systems. The circadian system helps maintain homeostasis throughout the body by synchronizing physiological and behavioral functions to predictable daily events. Whether disruption of these coordinated daily rhythms contributes to SCI-associated pathology remains understudied. Here, we hypothesized that SCI in rats would dysregulate several prominent circadian outputs including glucocorticoids, core temperature, activity, neuroinflammation, and circadian gene networks. Female and male Sprague Dawley rats were subjected to clinically relevant thoracic 9 moderate contusion SCI (or laminectomy sham surgery). Diurnal measures-including rhythms of plasma corticosterone (CORT), body temperature, and activity (using small implanted transmitters), and intraspinal circadian and inflammatory gene expression-were studied prior to and after surgery. SCI caused overall increases and disrupted rhythms of the major rodent glucocorticoid, CORT. Presurgery and sham rats displayed expected rhythms in body temperature and activity, whereas rats with SCI had blunted daily rhythms in body temperature and activity. In parallel, SCI disrupted intraspinal rhythms of circadian clock gene expression. Circadian clock genes can act as transcriptional regulators of inflammatory pathways. Indeed, SCI rats also showed dysregulated rhythms in inflammatory gene expression in both the epicenter and distal spinal cord. Our data show that moderate SCI in rats causes wide-ranging diurnal rhythm dysfunction, which is severe at acute time points and gradually recovers over time. Normalizing post-SCI diurnal rhythms could enhance the recovery of homeostasis and quality of life.	[Gaudet, Andrew D.; Fonken, Laura K.; Ayala, Monica T.; Bateman, Emily M.; Schleicher, Wolfgang E.; Smith, Elana J.; D'Angelo, Heather M.; Maier, Steven F.; Watkins, Linda R.] Univ Colorado, Dept Psychol & Neuroscience, 2860 Wilderness Pl,UCB 603, Boulder, CO 80301 USA; [Gaudet, Andrew D.; Fonken, Laura K.; Ayala, Monica T.; Bateman, Emily M.; Schleicher, Wolfgang E.; Smith, Elana J.; D'Angelo, Heather M.; Maier, Steven F.; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80301 USA; [Gaudet, Andrew D.] Univ Texas Austin, Dept Psychol, Coll Liberal Arts, Austin, TX 78712 USA; [Gaudet, Andrew D.] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA; [Fonken, Laura K.] Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78712 USA		Gaudet, AD (corresponding author), Univ Colorado, Dept Psychol & Neuroscience, 2860 Wilderness Pl,UCB 603, Boulder, CO 80301 USA.	andrew.gaudet@utexas.edu		Gaudet, Andrew/0000-0001-8828-1553; Schleicher, Wolfgang/0000-0001-6054-3435; Smith, Elana/0000-0001-7978-4757	United States Department of DefenseUnited States Department of Defense [W81XWH-13-1-0277/SC120066]; Paralyzed Veterans of America [3004]; Craig H. Neilsen Foundation; Wings for Life Foundation	This work was supported by the United States Department of Defense (Grant W81XWH-13-1-0277/SC120066 to L.R.W.). Additional support was provided by Paralyzed Veterans of America (LRW: Grant 3004 to L.R.W.), the Craig H. Neilsen Foundation (to S.F.M.), and the Wings for Life Foundation (to A.D.G. and L.R.W.).	Alan N, 2010, SPINE J, V10, P1108, DOI 10.1016/j.spinee.2010.09.018; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bedrosian TA, 2016, ANNU REV PHYSIOL, V78, P109, DOI 10.1146/annurev-physiol-021115-105102; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Buijs FN, 2016, PHYSIOLOGY, V31, P170, DOI 10.1152/physiol.00037.2015; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Cho HJ, 2009, NEUROSCIENCE, V162, P453, DOI 10.1016/j.neuroscience.2009.04.063; Craft TKS, 2005, STROKE, V36, P2006, DOI 10.1161/01.STR.0000177538.17687.54; Cragg JJ, 2015, SPINAL CORD, V53, P64, DOI 10.1038/sc.2014.165; DAGOSTINO J, 1982, ACTA ENDOCRINOL-COP, V100, P85, DOI 10.1530/acta.0.1000085; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Ellis A, 2016, BRAIN BEHAV IMMUN, V58, P348, DOI 10.1016/j.bbi.2016.08.004; Engwall M, 2014, CRIT CARE NURS Q, V37, P273, DOI 10.1097/CNQ.0000000000000031; FARR LA, 1988, NURS RES, V37, P170; Fonken LK, 2018, BRAIN BEHAV IMMUN, V70, P257, DOI 10.1016/j.bbi.2018.03.005; Fonken LK, 2016, NEUROBIOL AGING, V47, P102, DOI 10.1016/j.neurobiolaging.2016.07.019; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Fonken LK, 2014, ENDOCR REV, V35, P648, DOI 10.1210/er.2013-1051; Fonken LK, 2012, J BIOL RHYTHM, V27, P319, DOI 10.1177/0748730412448324; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Frank MG, 2013, BRAIN BEHAV IMMUN, V33, P1, DOI 10.1016/j.bbi.2013.02.004; GARTNER K, 1980, LAB ANIM, V14, P267, DOI 10.1258/002367780780937454; Gaudet AD, 2018, NEUROTHERAPEUTICS, V15, P554, DOI 10.1007/s13311-018-0630-7; Gaudet AD, 2018, NEUROSCIENTIST, V24, P221, DOI 10.1177/1073858417721150; Gaudet AD, 2017, EXP NEUROL, V295, P46, DOI 10.1016/j.expneurol.2017.05.011; Gaudet AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22862; Gaudet AD, 2015, MOL CELL NEUROSCI, V64, P84, DOI 10.1016/j.mcn.2014.12.006; Gaudier-Diaz MM, 2017, BRAIN RES, V1673, P86, DOI 10.1016/j.brainres.2017.08.008; Giannoccaro MP, 2013, SLEEP MED REV, V17, P399, DOI 10.1016/j.smrv.2012.12.005; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hook MA, 2017, J NEUROTRAUM, V34, P632, DOI 10.1089/neu.2016.4507; Inskip JA, 2009, SPINAL CORD, V47, P2, DOI 10.1038/sc.2008.61; Inskip JA, 2012, J NEUROTRAUM, V29, P1638, DOI 10.1089/neu.2011.2145; Jones LM, 2003, ARCH PHYS MED REHAB, V84, P1068, DOI 10.1016/S0003-9993(03)00045-5; Karelina K, 2009, P NATL ACAD SCI USA, V106, P5895, DOI 10.1073/pnas.0810737106; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; Li DP, 2016, CELL MOL NEUROBIOL, V36, P1045, DOI 10.1007/s10571-015-0295-2; Li SY, 2011, J CLIN NURS, V20, P396, DOI 10.1111/j.1365-2702.2010.03507.x; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; McCreedy DA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0101-18.2018; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Nicolaides NC, 2014, ANN NY ACAD SCI, V1318, P71, DOI 10.1111/nyas.12464; Noble LJ, 2002, J NEUROSCI, V22, P7526; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Pruss H, 2017, NAT NEUROSCI, V20, P1549, DOI 10.1038/nn.4643; Putatunda R, 2014, BRAIN RES, V1581, P64, DOI 10.1016/j.brainres.2014.05.003; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Roenneberg T, 2016, CURR BIOL, V26, pR432, DOI 10.1016/j.cub.2016.04.011; Sauerbeck AD, 2015, J NEUROTRAUM, V32, P159, DOI 10.1089/neu.2014.3497; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroeder AM, 2012, J PHYSIOL-LONDON, V590, P6213, DOI 10.1113/jphysiol.2012.233676; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Segal JP, 2018, J NEUROSCI RES, V96, P1002, DOI 10.1002/jnr.24150; Stevens RG, 2014, CA-CANCER J CLIN, V64, P207, DOI 10.3322/caac.21218; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tahara Y, 2017, J PHYSIOL SCI, V67, P1, DOI 10.1007/s12576-016-0450-7; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Thijssen DHJ, 2011, CHRONOBIOL INT, V28, P146, DOI 10.3109/07420528.2010.540364; Van Meeteren NLU, 2003, J NEUROTRAUM, V20, P1029, DOI 10.1089/089771503770195876; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; West CR, 2015, J NEUROTRAUM, V32, P922, DOI 10.1089/neu.2014.3722; Westenbroek C, 2005, HORM BEHAV, V47, P620, DOI 10.1016/j.yhbeh.2005.01.004; Woodruff ER, 2016, ENDOCRINOLOGY, V157, P1522, DOI 10.1210/en.2015-1884; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Youngstedt Shawn D., 2016, Journal of Circadian Rhythms, V14, P2, DOI 10.5334/jcr.137	75	11	11	1	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	NOV-DEC	2018	5	6							0328-18.2018	10.1523/ENEURO.0328-18.2018			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HJ1CF	WOS:000456898800027	30627655	gold, Green Published			2022-02-06	
J	Herron, K; Farquharson, L; Wroe, A; Sterr, A				Herron, Katie; Farquharson, Lorna; Wroe, Abigail; Sterr, Annette			Development and Evaluation of a Cognitive Behavioural Intervention for Chronic Post-Stroke Insomnia	BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY			English	Article						stroke; insomnia; cognitive behavioural therapy	TRAUMATIC BRAIN-INJURY; SLEEP-WAKE DISTURBANCES; FATIGUE SEVERITY SCALE; PERSISTENT INSOMNIA; DAYTIME SLEEPINESS; CBT-I; THERAPY; STROKE; PAIN; VALIDATION	Background: Cognitive behavioural therapy for insomnia (CBTI) has been successfully applied to those with chronic illness. However, despite the high prevalence of post-stroke insomnia, the applicability of CBTI for this population has not been substantially researched or routinely used in clinical practice. Aims: The present study developed a 'CBTI+' protocol for those with post-stroke insomnia and tested its efficacy. The protocol also incorporated additional management strategies that considered the consequences of stroke. Method: A single-case experimental design was used with five community-dwelling individuals with post-stroke insomnia. Daily sleep diaries were collected over 11 weeks, including a 2-week baseline, 7-week intervention and 2-week follow-up. The Insomnia Severity Index, Dysfunctional Attitudes and Beliefs About Sleep Scale, Epworth Sleepiness Scale, Fatigue Severity Scale and Stroke Impact Scale were administered pre- and post-treatment, as well as at 2-week follow-up. Results: At post-treatment, three participants no longer met diagnostic criteria for insomnia and all participants showed improvements on two or more sleep parameters, including sleep duration and sleep onset latency. Three participants showed a reduction in daytime sleepiness, increased quality of life and reduction in unhelpful beliefs about sleep. Conclusions: This study provides initial evidence that CBTI+ is a feasible and acceptable intervention for post-stroke insomnia. Furthermore, it indicates that sleep difficulties in community-dwelling stroke populations are at least partly maintained by unhelpful beliefs and behaviours. The development and delivery of the CBTI+ protocol has important clinical implications for managing post-stroke insomnia and highlights directions for future research.	[Herron, Katie] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Pain Management Ctr, London, England; [Herron, Katie; Farquharson, Lorna] Royal Holloway Univ London, Dept Psychol, Surrey, England; [Wroe, Abigail] Berkshire Healthcare NHS Fdn Trust, Clin Hlth Psychol Serv, Reading, Berks, England; [Sterr, Annette] Univ Surrey, Sch Psychol, Guildford, Surrey, England		Herron, K (corresponding author), Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Pain Management Ctr, London, England.	katie.herron@nhs.net	Farquharson, Lorna/AAO-7777-2021	Farquharson, Lorna/0000-0001-7272-4022; Sterr, Annette/0000-0003-4490-985X	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0200128] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0200128] Funding Source: UKRI		American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Anderson C, 2008, SLEEP MED, V9, P184, DOI 10.1016/j.sleep.2007.02.006; Arba F, 2017, ACTA NEUROL SCAND, V135, P603, DOI 10.1111/ane.12637; Bassetti CL, 2006, SLEEP MED CLIN, V1, P139, DOI 10.1016/j.jsmc.2005.11.012; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beaulieu-Bonneau S, 2007, SLEEP, V30, P1739, DOI 10.1093/sleep/30.12.1739; Berger AM, 2009, PSYCHO-ONCOLOGY, V18, P634, DOI 10.1002/pon.1438; Bouchard Sebastien, 2003, Behav Sleep Med, V1, P187, DOI 10.1207/S15402010BSM0104_2; Briones B, 1996, SLEEP, V19, P583, DOI 10.1093/sleep/19.7.583; Campos TF, 2005, BIOL RHYTHM RES, V36, P109, DOI 10.1080/09291010400028799; Carney C. E., 2010, COGNITIVE STRATEGIES; Carney CE, 2006, SLEEP, V29, P444; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Chesson A, 2000, SLEEP, V23, P237; Conley Samantha, 2015, Curr Sleep Med Rep, V1, P157; Currie SR, 2000, J CONSULT CLIN PSYCH, V68, P407, DOI 10.1037//0022-006X.68.3.407; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; Dopke CA, 2004, PSYCHIATR REHABIL J, V27, P235, DOI 10.2975/27.2004.235.242; Duncan PW, 2003, NEUROLOGY, V60, P291, DOI 10.1212/01.WNL.0000041493.65665.D6; Duss Simone B., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P94, DOI 10.1016/j.nbscr.2016.11.003; Eccleston C, 2013, BRIT J ANAESTH, V111, P59, DOI 10.1093/bja/aet207; Edinger JD, 2005, ARCH INTERN MED, V165, P2527, DOI 10.1001/archinte.165.21.2527; Edinger JD, 2005, CLIN PSYCHOL REV, V25, P539, DOI 10.1016/J.CPR.2005.04.003; Edinger JD, 2003, SLEEP, V26, P177, DOI 10.1093/sleep/26.2.177; ESPIE CA, 1989, J BEHAV THER EXP PSY, V20, P143, DOI 10.1016/0005-7916(89)90047-5; Espie CA, 2008, J CLIN ONCOL, V26, P4651, DOI 10.1200/JCO.2007.13.9006; Espie CA, 2009, SLEEP, V32, P1549, DOI 10.1093/sleep/32.12.1549; Evans C, 1998, RELIABLE CHANGE CRIT; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Flowers HL, 2016, ARCH PHYS MED REHAB, V97, P2188, DOI 10.1016/j.apmr.2016.03.006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glozier N, 2017, CEREBROVASC DIS EXTR, V7, P9, DOI 10.1159/000455751; Harrison RA, 2015, CEREBROVASC DIS, V39, P190, DOI 10.1159/000375397; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hermann DM, 2008, STROKE, V39, P62, DOI 10.1161/STROKEAHA.107.494955; Hermann DM, 2016, NEUROLOGY, V87, P1407, DOI 10.1212/WNL.0000000000003037; HOHAGEN F, 1993, EUR ARCH PSY CLIN N, V242, P329, DOI 10.1007/BF02190245; Hossain JL, 2005, J SLEEP RES, V14, P245, DOI 10.1111/j.1365-2869.2005.00466.x; Hyyppa M. T., 1995, INT J REHABILITATION, V1, P1573; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Joa KL, 2017, AM J PHYS MED REHAB, V96, P741, DOI 10.1097/PHM.0000000000000744; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson JA, 2016, SLEEP MED REV, V27, P20, DOI 10.1016/j.smrv.2015.07.001; Jones F, 2006, DISABIL REHABIL, V28, P841, DOI 10.1080/09638280500534952; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kneebone II, 2016, COGN BEHAV PRACT, V23, P99, DOI 10.1016/j.cbpra.2015.02.001; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Kyle SD, 2011, SLEEP MED, V12, P735, DOI 10.1016/j.sleep.2011.03.016; Lacks P., 1987, BEHAV TREATMENT PERS; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Leppavuori A, 2002, CEREBROVASC DIS, V14, P90, DOI 10.1159/000064737; Lichstein KL, 2006, SLEEP, V29, P232; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; Lichstein KL, 2004, EPIDEMIOLOGY OF SLEEP AGE, GENDER, AND ETHNICITY, P1; Lu W, 2016, NEUROREHABILITATION, V38, P59, DOI 10.3233/NRE-151296; Malouff JA, 2008, CLIN PSYCHOL REV, V28, P736, DOI 10.1016/j.cpr.2007.10.004; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Mathiowetz V, 2001, ARCH PHYS MED REHAB, V82, P449, DOI 10.1053/apmr.2001.22192; McGeough E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub2; Means MK, 2003, SLEEP MED, V4, P285, DOI 10.1016/S1389-9457(03)00057-1; Mental Health Task Force, 2016, IMPL 5 YEAR FORW VIE; Mitchell M. D., 2012, BMC FAMILY PRACTICE, V25, P13; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 2004, AM J PSYCHIAT, V161, P332, DOI 10.1176/appi.ajp.161.2.332; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 2003, INSOMNIA CLIN GUIDE; Nair W., 1993, DRUG NEWS PERSPECT, V6, P600; Nguyen S., 2017, DISABIL REHABIL, P1; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Nielson WR, 2013, CLIN J PAIN, V29, P461, DOI 10.1097/AJP.0b013e3182608561; O'Neill D., 2010, CAMBRIDGE HDB FORENS; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ostwald SK, 2014, DISABIL REHABIL, V36, P55, DOI 10.3109/09638288.2013.777806; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Perfect MM, 2010, J CLIN PSYCHOL, V66, P1205, DOI 10.1002/jclp.20732; Perlis ML, 2008, J CLIN SLEEP MED, V4, P11; Perlis ML, 1997, J SLEEP RES, V6, P179, DOI 10.1046/j.1365-2869.1997.00045.x; Perlis ML, 2005, COGNITIVE BEHAV TREA; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Rassafiani M, 2010, INT J THER REHABIL, V17, P285, DOI 10.12968/ijtr.2010.17.6.48151; Reid KJ, 2006, AM J GERIAT PSYCHIAT, V14, P860, DOI 10.1097/01.JGP.0000206164.56404.ba; Sanford SD, 2006, SLEEP MED, V7, P319, DOI 10.1016/j.sleep.2006.01.010; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Schuiling WJ, 2005, STROKE, V36, P578, DOI 10.1161/01.STR.0000154862.33213.73; Shan RSLP, 2004, AM J PHYS MED REHAB, V83, P421, DOI 10.1097/00002060-200406000-00003; Siebern AT, 2011, PSYCHOL RES BEHAV MA, V4, P21, DOI 10.2147/PRBM.S10041; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; Smith SS, 2004, J PSYCHOSOM RES, V56, P245, DOI 10.1016/S0022-3999(03)00545-2; Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246; Sterr A, 2008, BRAIN INJURY, V22, P575, DOI 10.1080/02699050802189727; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Tang NKY, 2015, SLEEP, V38, P1751, DOI 10.5665/sleep.5158; Tate RL, 2016, PHYS THER, V96, P932, DOI 10.1037/arc0000026.supp; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Troxel WM, 2012, BEHAV SLEEP MED, V10, P266, DOI 10.1080/15402002.2011.607200; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; Vincent N, 2008, J CONSULT CLIN PSYCH, V76, P820, DOI 10.1037/0022-006X.76.5.820; Vitiello MV, 2013, J CLIN PSYCHOL, V69, P1013, DOI 10.1002/jclp.21948; Wade AG, 2011, NEUROPSYCH DIS TREAT, V7, P1, DOI 10.2147/NDT.S15123; WELLS A, 1995, BEHAV THER, V26, P153, DOI 10.1016/S0005-7894(05)80088-7; Wessendorf TE, 2000, J NEUROL, V247, P41, DOI 10.1007/PL00007787; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Widar M, 2004, J PAIN SYMPTOM MANAG, V27, P215, DOI 10.1016/j.jpainsymman.2003.07.006; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3; Wilson S. L., 2000, SINGLE CASE EXPT DES; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Wroe AL, 2015, BEHAV COGN PSYCHOTH, V43, P412, DOI 10.1017/S1352465813001227	116	11	11	1	16	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1352-4658	1469-1833		BEHAV COGN PSYCHOTH	Behav. Cognit. Psychther.	NOV	2018	46	6					641	660		10.1017/S1352465818000061			20	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GT7EH	WOS:000444683800001	29478417				2022-02-06	
J	Hsu, IL; Li, CY; Chu, DC; Chien, LC				Hsu, I-Lin; Li, Chung-Yi; Chu, Da-Chen; Chien, Li-Chien			An Epidemiological Analysis of Head Injuries in Taiwan	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						head injury; incidence; national health insurance; population-based study; mortality; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HOSPITAL DISCHARGE; UNITED-STATES; DISABILITY; MORTALITY	Traumatic head injuries occur frequently in Taiwan, having catastrophic consequences for the victims, their families, and society as a whole. However, little is known about the risk factors at the population level in Taiwan. The primary aim of this study was to obtain more information on these variables and their relationships. Another aim was to analyze the effects of independent variables such as sex, age, residency, pre-existing conditions, mechanisms of injury, associated injuries, and severity on the probability of in-hospital death. Using the 2007-2008 total admissions claim dataset from Taiwan's National Health Insurance system, total admissions due to acute head injury were selected for further analysis. The obtained data included patient demographics and trauma hospitalization rate. A total of 99,391 patients were admitted with head injury, 48,792 of which had moderate-to-severe head injury. There were 4935 cases recorded as in-hospital mortality and the standardized in-hospital mortality rate was 10.7 deaths per 100,000 person-years. The mortality rate increased with age. After adjustments, male sex, age older than 54 years, living in a rural area, lower monthly income, a Charlson comorbidity index greater than one, being a pedestrian hit by a motor vehicle, fall from a height, and having significant chest, abdominal, or lower extremity injury increased the risk of death during admission. This population-based analysis provides information about the incidence rate and death rate for admissions in Taiwan due to acute head injury and the factors that affect in-hospital mortality. Our results that highlight the risk factors for adverse outcome can help us prevent or improve rural area trauma care of head injury patients in the future.	[Hsu, I-Lin] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg, Tainan 70403, Taiwan; [Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70403, Taiwan; [Li, Chung-Yi] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung 40402, Taiwan; [Chu, Da-Chen] Taipei City Hosp, Dept Neurosurg, Taipei 10065, Taiwan; [Chien, Li-Chien] Taipei City Hosp, Dept Emergency Med, Taipei 10065, Taiwan		Chien, LC (corresponding author), Taipei City Hosp, Dept Emergency Med, Taipei 10065, Taiwan.	yilinhsu@gmail.com; cyli99@mail.ncku.edu.tw; DAD57@tpech.gov.tw; maxchien@mail2000.com.tw	LI, CHUNG-YI/ABI-1419-2020	LI, CHUNG-YI/0000-0002-0321-8908			Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; American College of Surgeons, 2018, ADV TRAUM LIF SUPP; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Annest Joseph L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Annoni J M, 1992, Disabil Rehabil, V14, P23; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHIU WT, 1995, J CLIN NEUROSCI, V2, P210, DOI 10.1016/S0967-5868(95)80004-2; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Department of Statistics Ministry of Health and Welfare Taiwan, 2011, 2011 STAT CAUS DEATH; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LEE ST, 1990, J TRAUMA, V30, P194, DOI 10.1097/00005373-199002000-00010; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Mullins RJ, 2006, J TRAUMA, V60, P691, DOI 10.1097/01.ta.0000210454.92078.89; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Singh GK, 2013, J URBAN HEALTH, V90, P388, DOI 10.1007/s11524-012-9744-0; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5	32	11	11	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2018	15	11							2457	10.3390/ijerph15112457			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	HC2OB	WOS:000451640500131	30400380	Green Published, Green Submitted, gold			2022-02-06	
J	Jackson, EM; Costabile, PM; Tekes, A; Steffen, KM; Ahn, ES; Scafidi, S; Noje, C				Jackson, Eric M.; Costabile, Philomena M.; Tekes, Aylin; Steffen, Katherine M.; Ahn, Edward S.; Scafidi, Susanna; Noje, Corina			Use of Telemedicine During Interhospital Transport of Children With Operative Intracranial Hemorrhage*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						interhospital transport; intracranial hemorrhage; pediatric; telemedicine	TRAUMATIC BRAIN-INJURY; NEUROSURGICAL PATIENTS; MORTALITY-RATES; TIME; OUTCOMES; SURGERY; IMPACT; CARE	Objectives: To analyze the impact of an intervention of using telemedicine during interhospital transport on time to surgery in children with operative intracranial hemorrhage. Design: We performed a retrospective chart review of children with intracranial hemorrhage transferred for emergent neurosurgical intervention between January 1, 2011 and December 31, 2016. We identified those patients whose neuroimaging was transmitted via telemedicine to the neurosurgical team prior to arrival at our center and then compared the telemedicine and nontelemedicine groups. Mann-Whitney U and Fisher exact tests were used to compare interval variables and categorical data. Setting: Single-center study performed at Johns Hopkins Hospital. Patients: Patients less than or equal to 18 years old transferred for operative intracranial hemorrhage. Interventions: Pediatric transport implemented routine telemedicine use via departmental smart phones to facilitate transfer of information and imaging and reduce time to definitive care by having surgical services available when needed. Measurements and Main Results: Fifteen children (eight in telemedicine group; seven in nontelemedicine group) met inclusion criteria. Most had extraaxial hemorrhage (87.5% telemedicine group; 85.7% nontelemedicine group; p = 1.0), were intubated pre transport (62.5% telemedicine group; 71.4% nontelemedicine group; p = 1.0), and arrived at our center's trauma bay during night shift or weekend (87.5% telemedicine group; 57.1% nontelemedicine group; p = 0.28). Median trauma bay Glasgow Coma Scale scores did not differ (eight in telemedicine group; seven in nontelemedicine group; p = 0.24). Although nonsignificant, when compared with the nontelemedicine group, the telemedicine group had decreased rates of repeat preoperative neuroimaging (37.5% vs 57%; p = 0.62), shorter median times from trauma bay arrival to surgery (33min vs 47min; p = 0.22) and from diagnosis to surgery (146.5min vs 157min; p = 0.45), shorter intensive care stay (2.5 vs 5 d) and hospitalization (4 vs 5 d), and higher home discharge rates (87.5% vs 57.1%; p = 0.28). Conclusions: Telemedicine use during interhospital transport appears to expedite definitive care for children with intracranial hemorrhage requiring emergent neurosurgical intervention, which could contribute to improved patient outcomes.	[Jackson, Eric M.; Ahn, Edward S.] Johns Hopkins Univ, Sch Med, Neurosurg, Baltimore, MD USA; [Costabile, Philomena M.] Johns Hopkins Univ Hosp, Nursing, Baltimore, MD 21287 USA; [Costabile, Philomena M.; Noje, Corina] Johns Hopkins Univ Hosp, Pediat Transport, Baltimore, MD 21287 USA; [Tekes, Aylin; Ahn, Edward S.] Johns Hopkins Univ Hosp, Russell H Morgan Dept Radiol & Radiol Sci, Div Pediat Radiol & Pediat Neuroradiol, Baltimore, MD 21287 USA; [Steffen, Katherine M.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Pediat, Palo Alto, CA 94304 USA; [Scafidi, Susanna; Noje, Corina] Johns Hopkins Univ, Sch Med, Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA		Scafidi, S (corresponding author), Johns Hopkins Univ, Sch Med, Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	sscafid2@jhmi.edu		Scafidi, Susanna/0000-0002-1229-8778; Jackson, Eric/0000-0001-9306-9290	Aesculap	Dr. Ahn received funding from Aesculap. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Belt GH, 2016, STROKE, V47, P2413, DOI 10.1161/STROKEAHA.116.014270; Desai V, 2015, J NEUROSURG-PEDIATR, V16, P726, DOI 10.3171/2015.6.PEDS15184; Fayeye O, 2013, BRIT J NEUROSURG, V27, P326, DOI 10.3109/02688697.2012.743965; Fugok K, 2018, TELEMED E-HEALTH, V24, P367, DOI 10.1089/tmj.2017.0095; Heath B, 2009, PEDIATR CRIT CARE ME, V10, P588, DOI 10.1097/PCC.0b013e3181a63eac; Holland CM, 2017, NEUROSURGERY, V81, P450, DOI 10.1093/neuros/nyw124; Kahn EN, 2016, WORLD NEUROSURG, V89, P133, DOI 10.1016/j.wneu.2016.01.075; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Kim YJ, 2014, INT EMERG NURS, V22, P214, DOI 10.1016/j.ienj.2014.02.005; Klein KE, 2015, CRIT CARE CLIN, V31, P197, DOI 10.1016/j.ccc.2014.12.002; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Marcoux J, 2016, J NEUROSURG, V125, P642, DOI 10.3171/2015.6.JNS15175; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Vedantam A, 2016, J NEUROSURG-PEDIATR, V18, P638, DOI 10.3171/2016.5.PEDS16155	17	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	NOV	2018	19	11					1033	1038		10.1097/PCC.0000000000001706			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	GY9FL	WOS:000448945200012	30134361				2022-02-06	
J	Kuusinen, V; Cesnaite, E; Perakyla, J; Ogawa, KH; Hartikainen, KM				Kuusinen, Venla; Cesnaite, Elena; Perakyla, Jari; Ogawa, Keith H.; Hartikainen, Kaisa M.			Orbitofrontal Lesion Alters Brain Dynamics of Emotion-Attention and Emotion-Cognitive Control Interaction in Humans	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						attention; cognitive control; executive function; emotion; EEG; ERP; orbitofrontal cortex; human studies	CONCUSSION SYMPTOMS QUESTIONNAIRE; ANTERIOR THALAMIC NUCLEI; EXECUTIVE FUNCTIONS; SPATIAL ATTENTION; STIMULI COMPETE; HEAD-INJURY; CORTEX; MODULATION; CONFLICT; CAPTURE	Patients with lesion to the orbitofrontal cortex (OFC) experience challenges in emotional control and emotion-guided behaviors. The OFC is known to participate in executive functions and attentional control of emotion and our previous research suggests OFC lesion alters the balance between voluntary and involuntary attention and cognitive control within the context of emotion. To better understand how OFC lesion affects the dynamics and interaction of these functions, we studied EEG and performance of 12 patients with lesion to the OFC and 11 control subjects with intact OFC in a Go/NoGo visual reaction time (RT) task with neutral targets and intervening threat-related emotional distractors (Executive RT Test). Event-related potentials (ERPs), specifically N2P3 peak-to-peak amplitude and the following late positive potential (LPP), were used to measure allocation of attention and cognitive control to emotional distractors. Task performance and Behavior Rating Inventory of Executive Functions-Adult version (BRIEF-A) scores were used to assess executive functions. As expected, the Control group showed increased N2P3 amplitude in the context of threat-related distractors, particularly over the right hemisphere, while LPP was not modulated by these distractors. In contrast, patients with OFC lesion showed no such impact of threat-related distractors on N2P3 amplitude but exhibited increased and prolonged left-lateralized impact of threat on LPP in the Go-condition. In NoGo-condition, the N2P3 amplitude was increased in both groups due to threat, but the impact was seen earlier, i.e., at the N2 peak in the OFC group and later at the P3 peak in Controls. The OFC group committed more errors in the Executive RT Test and reported more problems in BRIEF-A, thus both objective and subjective evidence for challenges in executive functions was obtained in patients with orbitofrontal lesion. Furthermore, the time-course of attention allocation and cognitive control towards task-irrelevant emotional stimuli was altered as evidenced by ERPs. We conclude that orbitofrontal lesion is associated with altered neural dynamics underlying the interaction of involuntary attention to emotion and cognitive control. These alterations in brain dynamics may underlie some of the challenges patients encounter in everyday life when emotional events interact with cognitive demands.	[Kuusinen, Venla; Cesnaite, Elena; Perakyla, Jari; Hartikainen, Kaisa M.] Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland; [Kuusinen, Venla; Perakyla, Jari; Hartikainen, Kaisa M.] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Cesnaite, Elena] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Ogawa, Keith H.] St Marys Coll Calif, Dept Psychol, Moraga, CA USA		Hartikainen, KM (corresponding author), Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland.; Hartikainen, KM (corresponding author), Univ Tampere, Fac Med & Life Sci, Tampere, Finland.	kaisa.haitikainen@live.com		Hartikainen, Kaisa/0000-0001-7278-9635	Academy of FinlandAcademy of FinlandEuropean Commission; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Finnish Medical Foundation (Suomen Laaketieteen Saatio); Orion Research Foundation (Orionin Tutkimussaatio); Paulo Foundation (Paulon Saatio)	This study was supported by the Academy of Finland, the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital, The Finnish Medical Foundation (Suomen Laaketieteen Saatio), Orion Research Foundation (Orionin Tutkimussaatio) and The Paulo Foundation (Paulon Saatio).	Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brain Injuries. Current Care Guidelines, 2017, WORK GROUP SET FINN; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carretie L, 2014, COGN AFFECT BEHAV NE, V14, P1228, DOI 10.3758/s13415-014-0270-2; Daffner KR, 2000, J COGNITIVE NEUROSCI, V12, P393, DOI 10.1162/089892900562219; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Dennis TA, 2007, BIOL PSYCHOL, V76, P1, DOI 10.1016/j.biopsycho.2007.05.001; Department of Veterans Affairs and Department of Defense, 2016, VA DOD CLIN PRACT GU, P1; Diedrich O, 1997, J PSYCHOPHYSIOL, V11, P71; Diekhof EK, 2011, NEUROPSYCHOLOGIA, V49, P984, DOI 10.1016/j.neuropsychologia.2011.01.032; Diekhof EK, 2009, HUM BRAIN MAPP, V30, P3325, DOI 10.1002/hbm.20754; Dixon P, 2008, J MEM LANG, V59, P447, DOI 10.1016/j.jml.2007.11.004; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; Funderud I, 2013, BRAIN RES, V1527, P174, DOI 10.1016/j.brainres.2013.06.017; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Groom MJ, 2015, BRAIN COGNITION, V97, P1, DOI 10.1016/j.bandc.2015.04.004; Gruber O, 2010, BRAIN RES, V1351, P212, DOI 10.1016/j.brainres.2010.06.056; Hajcak G, 2008, EMOTION, V8, P250, DOI 10.1037/1528-3542.8.2.250; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hartikainen K., 2003, DETECTION CHANGE EVE, P99, DOI DOI 10.1007/978-1-4615-0294-4; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hartikainen KM, 2012, NEUROREPORT, V23, P447, DOI 10.1097/WNR.0b013e3283531e74; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Hodsoll S, 2011, EMOTION, V11, P346, DOI 10.1037/a0022771; Hooker CI, 2006, ORBITOFRONTAL CORTEX, P307, DOI [DOI 10.1093/ACPROF:OSO/9780198565741.003.0012, 10.1093/acprof:oso/9780198565741.001.0001/acprof-9780198565741-chapter-12]; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kam JWY, 2018, CORTEX, V101, P309, DOI 10.1016/j.cortex.2017.12.023; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lawrence M. A., 2016, EZ EASY ANAL VISUALI; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lovstad M, 2012, J COGNITIVE NEUROSCI, V24, P378, DOI 10.1162/jocn_a_00099; Maki-Marttunen V, 2017, J NEUROTRAUM, V34, P400, DOI 10.1089/neu.2015.4390; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Megias A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16657-y; Northoff G, 2000, CEREB CORTEX, V10, P93, DOI 10.1093/cercor/10.1.93; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Paulmann S, 2010, SOC NEUROSCI-UK, V5, P59, DOI 10.1080/17470910903135668; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; R Core Team, 2017, R LANG ENV STAT COMP; Randall WM, 2011, CLIN NEUROPHYSIOL, V122, P2400, DOI 10.1016/j.clinph.2011.05.012; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sun LH, 2017, J CLIN EXP NEUROPSYC, V39, P954, DOI 10.1080/13803395.2017.1285869; Sun LH, 2015, NEUROPSYCHOLOGIA, V78, P88, DOI 10.1016/j.neuropsychologia.2015.10.001; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Winstanley CA, 2010, BEHAV BRAIN RES, V210, P263, DOI 10.1016/j.bbr.2010.02.044; Wright P, 2008, NEUROIMAGE, V39, P894, DOI 10.1016/j.neuroimage.2007.09.014; Xie Y, 2018, ELIFE, V7, DOI 10.7554/eLife.31507; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012	77	11	11	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 1	2018	12								437	10.3389/fnhum.2018.00437			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	GZ0CM	WOS:000449024100001	30443211	Green Published, gold			2022-02-06	
J	Martz, E; Jelleberg, C; Dougherty, DD; Wolters, C; Schneiderman, A				Martz, Erin; Jelleberg, Chennettee; Dougherty, Deborah D.; Wolters, Charles; Schneiderman, Aaron			Tinnitus, Depression, Anxiety, and Suicide in Recent Veterans: A Retrospective Analysis	EAR AND HEARING			English	Article						Anxiety; Depression; Suicide; Tinnitus; Veterans	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ACTIVE-DUTY; ALL-CAUSE; RISK; ASSOCIATION; HEALTH; MORTALITY; INDIVIDUALS	Objectives: The purpose of this project was to investigate whether there is an association between tinnitus diagnosis and suicide and whether depression and anxiety strengthen that association. Given that tinnitus is the top service-connected disability among U.S. Veterans (Veterans Benefits Administration, 2016) and that suicide among Veterans has been occurring at a higher frequency as compared with community suicide rates (Hoffmire et al., 2015), the possible associations between tinnitus and suicide will be explored. Co-occurring physical conditions also will be examined to determine if they increase the risk of suicide in the context of tinnitus. Design: Administrative health care data related to Operations Enduring Freedom/Iraqi Freedom/New Dawn (OEF/OIF/OND) were used to identify Veterans who accessed the Veterans Administration (VA) health care system from January 1, 2002, to December 31, 2011. Veterans who were deceased as of December 2011 were identified using the National Death Index (NDI) files. Tinnitus cases were followed until either they were deceased or to the end of the study period. The International Classification of Diseases 9th Revision Clinical Modification (ICD-9-CM) codes were used to identify all conditions and diseases. As per mortality research standards, International Classification of Diseases 10th Revision (ICD-10) codes were used to identify cause of death. Results: Of 769,934 OEF/OIF/OND Veterans receiving VA care January 2002 to December 2011, 15% (n =116,358) were diagnosed with tinnitus. Of these Veterans diagnosed with tinnitus, 21% were also diagnosed with depression, another 8% with anxiety, and another 17% with both depression and anxiety. Fifty-four percentage were identified as having tinnitus without depression or anxiety. Among individuals with tinnitus, 41.9% had co-occurring hearing loss. Suicide rates were lower among Veterans with tinnitus than Veterans without tinnitus. Co-occurring diagnoses of mental-health conditions did not significantly increase the risk of suicide. Conclusions: The study results do not confirm clinical and anecdotal reports that tinnitus could be related to suicide among Veterans. However, tenets from rehabilitation psychology suggest that the onset of chronic impairment or disability does not predict an individual's subsequent psychological states; other personal attributes may be more influential. Health care professionals, such as audiologists and psychologists, should be cognizant of the associations between tinnitus and mental health issues and be prepared to address the psychological needs of individuals who have tinnitus.	[Martz, Erin] Vet Affairs Portland Healthcare Syst, Rehabil Oregon, Portland, OR USA; [Martz, Erin] Vet Affairs Portland Healthcare Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Jelleberg, Chennettee] Portland State Univ, Portland, OR 97207 USA; [Dougherty, Deborah D.; Wolters, Charles] Intellica Corp, San Antonio, TX USA; [Schneiderman, Aaron] Vet Hlth Adm, Off Patient Care Serv, Post Deployment Hlth Serv, Epidemiol Program, Washington, DC USA		Martz, E (corresponding author), VA Portland Healthcare Syst, Bldg 6,Room 114A,3710 SW,US Vet Hosp Rd, Portland, OR 97239 USA.	rehabilityoregon@gmail.com			VA Portland Healthcare System; VHA Office of Patient Care Services, Post Deployment Health Services	This material is the result of work supported with resources and the use of facilities at the VA Portland Healthcare System and the support of the VHA Office of Patient Care Services, Post Deployment Health Services. The authors acknowledge the help that Dr. Robert Bossarte provided to the first two authors as they were starting this research study.	Bartels H, 2008, EAR HEARING, V29, P947, DOI 10.1097/AUD.0b013e3181888f83; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Department of Veterans Affairs, 2006, HDB COD GUID VERS 6; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Dobscha SK, 2014, J GEN INTERN MED, V29, pS853, DOI 10.1007/s11606-014-3028-1; Erlandsson SI, 2000, BRIT J AUDIOL, V34, P11, DOI 10.3109/03005364000000114; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Geyh S, 2013, SPINAL CORD, V51, P322, DOI 10.1038/sc.2012.128; Granjeiro RC, 2013, OTOLARYNG HEAD NECK, V148, P658, DOI 10.1177/0194599812473554; HARROPGRIFFITHS J, 1987, J PSYCHOSOM RES, V31, P613, DOI 10.1016/0022-3999(87)90040-7; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hoare DJ, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD010151.PUB2; Hobson J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006371.pub3; Hoffmire CA, 2015, PSYCHIAT SERV, V66, P959, DOI 10.1176/appi.ps.201400031; Jacobson G P, 2001, J Am Acad Audiol, V12, P493; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Kanwar A, 2013, DEPRESS ANXIETY, V30, P917, DOI 10.1002/da.22074; Kemp J, 2012, SUICIDE DATA REPORT; Klonsky ED, 2013, J ABNORM PSYCHOL, V122, P231, DOI 10.1037/a0030278; Kochkin S., 2011, HEARING REV, V18, P10; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Lazarus RS, 1984, STRESS COPING ADAPTA; Lewis J E, 2002, J Am Acad Audiol, V13, P339; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; Lewis JE, 1992, J AUDIOLOGICAL MED, V1, P30; Marciano E, 2003, INT J AUDIOL, V42, P4, DOI 10.3109/14992020309056079; Martz E., 2007, COPING CHRONIC ILLNE; Martz E, 2016, J REHABIL RES DEV, V53, P729, DOI 10.1682/JRRD.2015.09.0176; McCormack A, 2015, INT J AUDIOL, V54, P599, DOI 10.3109/14992027.2015.1014577; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; Nondahl DM, 2011, INT J AUDIOL, V50, P313, DOI 10.3109/14992027.2010.551220; Pridmore S, 2012, OTOLARYNG HEAD NECK, V147, P193, DOI 10.1177/0194599812446286; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Rosen CS, 2008, PSYCHIAT SERV, V59, P290, DOI 10.1176/appi.ps.59.3.290; Sampaio A. L., 2013, OTOLARYNGOL HEAD N S, V149, pP222; Schweininger S, 2015, DEPRESS ANXIETY, V32, P64, DOI 10.1002/da.22288; Seo JH, 2016, CLIN OTOLARYNGOL, V41, P222, DOI 10.1111/coa.12500; Shontz F. C, 1977, REHABIL PSYCHOL, V24, P207, DOI DOI 10.1037/H0090933; SULLIVAN M, 1993, ARCH INTERN MED, V153, P2251, DOI 10.1001/archinte.153.19.2251; SULLIVAN MD, 1988, GEN HOSP PSYCHIAT, V10, P285, DOI 10.1016/0163-8343(88)90037-0; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; Veterans Affairs U S D O, 2016, SUIC VET OTH AM; Veterans Benefits Administration, 2016, VBA ANN REP VET BEN; Victor SE, 2014, CLIN PSYCHOL REV, V34, P282, DOI 10.1016/j.cpr.2014.03.005; World Health Organization, 2014, PREVENTING SUICIDE G; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Yurgil KA, 2016, J HEAD TRAUMA REHAB, V31, P30, DOI 10.1097/HTR.0000000000000117; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70; Zeidner M, 1996, HDB COPING THEORY RE, V195; Zivin K, 2015, J PSYCHOSOM RES, V78, P324, DOI 10.1016/j.jpsychores.2015.01.014	56	11	11	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	NOV-DEC	2018	39	6					1046	1056		10.1097/AUD.0000000000000573			11	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	HK0HA	WOS:000457578500002	29624539	Green Published			2022-02-06	
J	Walsh, DR; Ross, AM; Malijauskaite, S; Flanagan, BD; Newport, DT; McGourty, KD; Mulvihill, JJE				Walsh, Darragh R.; Ross, Aisling M.; Malijauskaite, Sigita; Flanagan, Brendan D.; Newport, David T.; McGourty, Kieran D.; Mulvihill, John J. E.			Regional mechanical and biochemical properties of the porcine cortical meninges	ACTA BIOMATERIALIA			English	Article						Dura mater; Cortical tissue; Biochemical characterisation; Mechanical characterisation; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CRANIAL DURA-MATER; EXTRACELLULAR-MATRIX; BRIDGING VEINS; PLAQUE TISSUE; SPINAL-CORD; ENCEPHALOPATHY; SPORT; HEAD; EPIDEMIOLOGY	The meninges are pivotal in protecting the brain against traumatic brain injury (TBI), an ongoing issue in most mainstream sports. Improved understanding of TBI biomechanics and pathophysiology is desirable to improve preventative measures, such as protective helmets, and advance our TBI diagnostic/prognostic capabilities. This study mechanically characterised the porcine meninges by performing uniaxial tensile testing on the dura mater (DM) tissue adjacent to the frontal, parietal, temporal, and occipital lobes of the cerebellum and superior sagittal sinus region of the DM. Mechanical characterisation revealed a significantly higher elastic modulus for the superior sagittal sinus region when compared to other regions in the DM. The superior sagittal sinus and parietal regions of the DM also displayed local mechanical anisotropy. Further, fatigue was noted in the DM following ten preconditioning cycles, which could have important implications in the context of repetitive TBI. To further understand differences in regional mechanical properties, regional variations in protein content (collagen I, collagen III, fibronectin and elastin) were examined by immunoblot analysis. The superior sagittal sinus was found to have significantly higher collagen I, elastin, and fibronectin content. The frontal region was also identified to have significantly higher collagen I and fibronectin content while the temporal region had increased elastin and fibronectin content. Regional differences in the mechanical and biochemical properties along with regional tissue thickness differences within the DM reveal that the tissue is a non-homogeneous structure. In particular, the potentially influential role of the superior sagittal sinus in TBI biomechanics warrants further investigation. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Walsh, Darragh R.; Ross, Aisling M.; Malijauskaite, Sigita; Newport, David T.; McGourty, Kieran D.; Mulvihill, John J. E.] Univ Limerick, Bernal Inst, Limerick, Ireland; [Walsh, Darragh R.; Ross, Aisling M.; Flanagan, Brendan D.; Newport, David T.; Mulvihill, John J. E.] Univ Limerick, Sch Engn, Limerick, Ireland; [Malijauskaite, Sigita; McGourty, Kieran D.] Univ Limerick, Sch Chem Sci, Limerick, Ireland; [McGourty, Kieran D.; Mulvihill, John J. E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland		McGourty, KD; Mulvihill, JJE (corresponding author), Univ Limerick, AD3-027,Analog Devices Bldg, Limerick V94 T9PX, Ireland.	kieran.mcgourty@ul.ie; john.mulvihill@ul.ie	Mulvihill, John/T-8131-2019; Newport, David/D-1867-2010; Ross, Aisling/AAN-9532-2021; Mulvihill, John/AAA-9805-2021	Mulvihill, John/0000-0003-0437-0351; Newport, David/0000-0003-4591-8643; 	Irish Research Council under the Government of Ireland Postgraduate Scholarship Programme [GOIPG/2017/1816]; Faculty of Science and Engineering PhD Scholarship 2016, University of Limerick	Donations of porcine specimens by Rosderra Meats, Nenagh, Co. Tipperary and Fitzgerald's Butchers, Ballylanders, Co. Limerick are gratefully acknowledged. This research was supported by the funding from the Irish Research Council under the Government of Ireland Postgraduate Scholarship Programme (GOIPG/2017/1816) and by the Faculty of Science and Engineering PhD Scholarship 2016, University of Limerick.	Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Constantinides G, 2006, MAT SCI ENG A-STRUCT, V430, P189, DOI 10.1016/j.msea.2006.05.125; Cunnane EM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S1-S7; Davis N. F., 2017, UROLOGY; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Decimo I, 2012, AM J STEM CELLS, V1, P92; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gammons MR, 2013, CURR SPORT MED REP, V12, P377, DOI 10.1249/JSR.0000000000000016; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gu LX, 2012, COMPOS PART B-ENG, V43, P3160, DOI 10.1016/j.compositesb.2012.04.014; Haimann MCJ, 1998, J ANAT, V192, P99; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jarvelainen H., PHARM REV, V61; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Khanafer K, 2013, EUR J VASC ENDOVASC, V45, P332, DOI 10.1016/j.ejvs.2012.12.015; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022; Mulvihill JJ, 2013, ACTA BIOMATER, V9, P9027, DOI 10.1016/j.actbio.2013.07.012; Mulvihill JJ, 2013, BIOMECH MODEL MECHAN, V12, P975, DOI 10.1007/s10237-012-0457-9; O'Leary SA, 2013, J BIOMECH, V46, P1955, DOI 10.1016/j.jbiomech.2013.05.003; Pasquesi SA, 2017, ANN BIOMED ENG, V45, P1877, DOI 10.1007/s10439-017-1833-5; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Protasoni M, 2011, J NEUROSURG, V114, P1723, DOI 10.3171/2010.12.JNS101732; Raykin J, 2017, BIOMECH MODEL MECHAN, V16, P33, DOI 10.1007/s10237-016-0800-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo M. V., 2018, NAT IMMUNOL; Sacks MS, 1998, J BIOMECH ENG-T ASME, V120, P541, DOI 10.1115/1.2798027; Sahler C. S., 2012, REHABILIT RES PRACT, V2012, P10; Sajanti J, 1999, BBA-MOL BASIS DIS, V1454, P209, DOI 10.1016/S0925-4439(99)00016-2; Schneider D. K., 2016, BR J SPORTS MED; SCHWARTZ E, 1988, J INVEST DERMATOL, V91, P158, DOI 10.1111/1523-1747.ep12464405; Scott G., 2015, IEEE T MED IMAG; SHELLSWELL GB, 1979, FEBS LETT, V106, P305, DOI 10.1016/0014-5793(79)80520-7; Shetye SS, 2014, J MECH BEHAV BIOMED, V34, P146, DOI 10.1016/j.jmbbm.2014.02.014; Shi ZD, 2009, BRIT J NEUROSURG, V23, P71, DOI 10.1080/02688690802582638; TRELOAR LRG, 1973, REP PROG PHYS, V36, P755, DOI 10.1088/0034-4885/36/7/001; Tsutsumi S, 2018, NEURORADIOL J, V31, P177, DOI 10.1177/1971400917736929; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Walsh MT, 2014, J BIOMECH, V47, P793, DOI 10.1016/j.jbiomech.2014.01.017; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YEOH OH, 1993, RUBBER CHEM TECHNOL, V66, P754, DOI 10.5254/1.3538343; Yu FB, 2013, FRONT BIOSCI-LANDMRK, V18, P1336, DOI 10.2741/4182; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	65	11	12	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	OCT 15	2018	80						237	246		10.1016/j.actbio.2018.09.004			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GZ1MY	WOS:000449133400019	30208332	Green Submitted			2022-02-06	
J	Brooks, BL; Plourde, V; Beauchamp, MH; Tang, K; Yeates, KO; Keightley, M; Anderson, P; Desire, N; Barrowman, N; Zemek, R				Brooks, Brian L.; Plourde, Vickie; Beauchamp, Miriam H.; Tang, Ken; Yeates, Keith Owen; Keightley, Michelle; Anderson, Peter; Desire, Naddley; Barrowman, Nick; Zemek, Roger		PERC Concussion Team	Predicting Psychological Distress after Pediatric Concussion	JOURNAL OF NEUROTRAUMA			English	Article						adolescents; anxiety; children; depression; mTBI	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; HEAD-INJURY; MILD; CHILDREN; SYMPTOMS; RECOVERY; DEPRESSION; HISTORY; SPORT	A significant proportion of children and adolescents report psychological distress following concussion, but little is known about the predictors of these problems. The purpose of this study was to examine predictive factors of psychological distress following pediatric concussion. It was hypothesized that the presence of pre-injury psychological distress would be the strongest predictor of psychological distress post-concussion, with other demographic and acute injury factors adding incrementally to prediction. This is a prospective, multi-center cohort. Children and adolescents (6-17 years old; n=311) who sustained a concussion and were assessed through four pediatric emergency departments. Participants were reassessed at 4-weeks (n=275) and 12-weeks (n=190) post-injury. Emergency department (ED) assessment documented injury mechanism, acute symptomatology, acute cognitive functioning, and pre-injury functioning. Psychological distress at 4- and 12-weeks follow-up was categorized as present if one or more psychological scores from the parent-completed measures (Child Behavior Checklist, Strengths and Difficulties Questionnaire) exceeded established cutoffs. The presence of psychological distress at each follow-up was predicted using multi-variable logistic regressions. Psychological distress was reported in 23% of youth at both 4- and 12-weeks post-concussion. A pre-injury diagnosis of anxiety and acutely forgetting recent information were significant predictors of psychological distress at 4 weeks, whereas worse acute orientation assessment in the ED predicted psychological distress at 12 weeks. Nearly one of four youth experienced psychological distress after concussion. Clinicians in acute care settings should screen for the factors (pre-injury anxiety, acute mental status) associated with post-injury psychological distress and consider proactively referring patients for further assistance.	[Brooks, Brian L.; Desire, Naddley] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Plourde, Vickie] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Tang, Ken; Barrowman, Nick; Zemek, Roger] Childrens Hosp Eastern Ontario, Clin Res Unit, Res Inst, Ottawa, ON, Canada; [Yeates, Keith Owen] Alberta Childrens Prov Gen Hosp, Res Inst, Hotchkiss Brain Inst, Calgary, AB, Canada; [Keightley, Michelle] Univ Toronto, Bloorview Res Inst, Holland Bloorview Kids Rehabil Hosp, Dept Occupat Sci, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Bloorview Res Inst, Holland Bloorview Kids Rehabil Hosp, Dept Occupat Therapy, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Res Inst, Behav Neurosci & Consultat Liaison Program, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca	Barrowman, Nick/AAL-3166-2020; Barlow, Karen/I-6492-2019; Yeates, Keith/AAJ-4223-2020; Barlow, Karen/C-1323-2014	Barrowman, Nick/0000-0002-4704-9595; Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Plourde, Vickie/0000-0002-0098-5431; Yeates, Keith/0000-0001-7680-2892; Osmond, Martin/0000-0001-8275-8381	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [126197]; Canadian Institutes of Health Research-Ontario Neurotrauma FoundationCanadian Institutes of Health Research (CIHR) [127047]; CIHR Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR)	This study was supported by operating grant 126197 from the Canadian Institutes of Health Research (CIHR) and team grant TM1:#127047 from the Canadian Institutes of Health Research-Ontario Neurotrauma Foundation. Brian Brooks acknowledges salary funding from the CIHR Embedded Clinician Researcher Salary Award.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; [Anonymous], 2013, Br J Sports Med, V47, P263; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; R Development Core Team, 2016, R LANG ENV STAT COMP; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	45	11	11	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					679	685		10.1089/neu.2018.5792		OCT 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000447010500001	30032719				2022-02-06	
J	Bonnette, S; Diekfuss, JA; Kiefer, AW; Riley, MA; Foss, KDB; Thomas, S; DiCesare, CA; Yuan, WH; Dudley, J; Reches, A; Myer, GD				Bonnette, Scott; Diekfuss, Jed A.; Kiefer, Adam W.; Riley, Michael A.; Foss, Kim D. Barber; Thomas, Staci; DiCesare, Christopher A.; Yuan, Weihong; Dudley, Jonathan; Reches, Amit; Myer, Gregory D.			A jugular vein compression collar prevents alterations of endogenous electrocortical dynamics following blast exposure during special weapons and tactical (SWAT) breacher training	EXPERIMENTAL BRAIN RESEARCH			English	Article						Recurrence quantification analysis (RQA); Mild traumatic brain injury (mTBI); Special weapons and tactics (SWAT) team; Electroencephalography (EEG); Spontaneous activity	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; RECURRENCE QUANTIFICATION ANALYSIS; WHITE-MATTER INTEGRITY; US MILITARY PERSONNEL; HIGH-SCHOOL FOOTBALL; NEURAL PLASTICITY; PLOTS; SYSTEMS; EEG	Exposure to explosive blasts places one at risk for traumatic brain injury, especially for special weapons and tactics (SWAT) and military personnel, who may be repeatedly exposed to blasts. In the current study, the effectiveness of a jugular vein compression collar to prevent alterations in resting-state electrocortical activity following a single-SWAT breacher training session was investigated. SWAT team personnel were randomly assigned to wear a compression collar during breacher training and resting state electroencephalography (EEG) was measured within 2 days prior to and two after breacher training. It was hypothesized that significant changes in brain dynamics-indicative of possible underlying neurodegenerative processes-would follow blast exposure for those who did not wear the collar, with ameliorated changes for the collar-wearing group. Using recurrence quantification analysis (RQA) it was found that participants who did not wear the collar displayed longer periods of laminar electrocortical behavior (as indexed by RQA's vertical max line measure) after breacher training. It is proposed that the blast wave exposure for the no-collar group may have reduced the number of pathways, via axonal disruption-for electrical transmission-resulting in the EEG signals becoming trapped in laminar states for longer periods of time. Longer laminar states have been associated with other electrocortical pathologies, such as seizure, and may be important for understanding head trauma and recovery.	[Bonnette, Scott; Diekfuss, Jed A.; Kiefer, Adam W.; Foss, Kim D. Barber; Thomas, Staci; DiCesare, Christopher A.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Kiefer, Adam W.; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kiefer, Adam W.; Riley, Michael A.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Yuan, Weihong; Dudley, Jonathan] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Yuan, Weihong] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Reches, Amit] ElMindA Ltd, Tel Aviv, Israel; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Bonnette, S (corresponding author), Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, Cincinnati, OH 45229 USA.	scott.bonnette@cchmc.org	Diekfuss, Jed/ABD-7372-2020; DiCesare, Christopher/AAA-3327-2021; DiCesare, Christopher/ABH-9573-2020; Myer, Gregory/H-6572-2016	Diekfuss, Jed/0000-0003-3835-363X; DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Dudley, Jonathan/0000-0002-5189-9568	Q30 Sports Innovations, LLC	The authors would like to thank Hamilton County Police Association SWAT. We appreciate their patience with the testing scheduling, follow-ups, and equipment additions. Their enthusiastic support made this study possible. We would like to thank Chief David Schaefer-SWAT Commander, Sheriff Jim Neil-Hamilton County Sheriff and Chief Charles R. Lindsey-HCPA president for their help in obtaining approval for the study and for Interim SWAT Commander Tim Chin for helping to coordinate the entire study protocol. Special acknowledgement goes to SWAT Medical Directors, Dustin J. Calhoun, MD and Edward Otten, MD and Hamilton County Medical Director Lakshmi Kode Sammarco, MD. Without their time, commitment, and passion for the health and well-being of their team members, this study would not have been possible. We also thank Chief Jim Puthoff-Liaison to HCPA who supported and presented the research ideas to the SWAT that allowed for the initial discussions to medical directors. We would also like to thank James P. Bailey, Evans Demolition/Excavation Division who helped secure the bank for explosive breach training. We also thank the Bomb Explosive Ordnance Disposal Technicians Brad Justice and Steve Luensman who coordinated the explosive training and helped to ensure the safety of both SWAT members and the research team. The authors acknowledge funding support from Q30 Sports Innovations, LLC.	Bai Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00471; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bassingthwaighte J.B., 1994, FRACTAL PHYSL, DOI [10.1007/978-1-4614-7572-9_10, DOI 10.1007/978-1-4614-7572-9, 10.1007/978-1-4614-7572-9]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Becker K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008876; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Buzsaki Gyorgy, 2006, RHYTHMS BRAIN; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Carrubba S, 2012, NEUROL RES, V34, P286, DOI 10.1179/1743132812Y.0000000010; Center TDaVBI, 2018, DOD NUMB TRAUM BRAIN; Chandler CDW, 2006, ASHA LEAD, V11, P8, DOI DOI 10.1044/LEADER.FTR4.11092006.8; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Delius M, 2002, EUR SURG RES, V34, P30, DOI 10.1159/000048884; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; FREEMAN WJ, 1994, PROG BRAIN RES, V102, P319; Galarneau M. R, 2008, TRAUMATIC BRAIN INJU; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Gurau O, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00121; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayward EP, 2008, PLANNING TACTICS MIL; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaplan D, 1995, TIME SERIES ANAL UND, P278; Kelso JS, 1995, DYNAMIC PATTERNS SEL; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kiefer AW, 2015, NONLIN DYNAM PSYCHOL, V19, P489; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Myer GD, 2016, BR J SPORTS MED BJSP, V2016; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nicolaou N, 2014, CUREUS, V6, P8; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rizzi M, 2016, RECURRENCE PLOTS THE, DOI [10.1007/978-3-319-29922-8, DOI 10.1007/978-3-319-29922-8]; Rizzi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31129; Rodriguez-Millan M, 2016, MATER DESIGN, V110, P391, DOI 10.1016/j.matdes.2016.08.015; Romano MC, 2005, EUROPHYS LETT, V71, P466, DOI 10.1209/epl/i2005-10095-1; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Schinkel S, 2009, J PHYSIOLOGY-PARIS, V103, P315, DOI 10.1016/j.jphysparis.2009.05.007; Schinkel S, 2007, COGN NEURODYNAMICS, V1, P317, DOI 10.1007/s11571-007-9023-z; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Song IH, 2004, NEUROSCI LETT, V366, P148, DOI 10.1016/j.neulet.2004.05.025; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Takens F, 1981, LECT NOTES MATH DYN, V898, P366, DOI DOI 10.1007/BFB0091924; Thomasson N, 2001, PHYS LETT A, V279, P94, DOI 10.1016/S0375-9601(00)00815-X; Timothy LT, 2017, INT J PSYCHOPHYSIOL, V120, P86, DOI 10.1016/j.ijpsycho.2017.07.006; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Webber C.L., 2005, CONT NONLINEAR METHO, V94, P26; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Wei Zhang, 2008, 5th International Conference on Information Technology and Applications in Biomedicine (ITAB 2008) in conjunction with 2nd International Symposium & Summer School on Biomedical and Health Engineering (IS3BHE 2008), P391, DOI 10.1109/ITAB.2008.4570657; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834; Zaepffel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060060; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M	83	11	11	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	OCT	2018	236	10					2691	2701		10.1007/s00221-018-5328-x			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU3CS	WOS:000445152900015	29987537				2022-02-06	
J	La Fountaine, MF				La Fountaine, Michael F.			An anatomical and physiological basis for the cardiovascular autonomic nervous system consequences of sport-related brain injury	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Sympathetic nervous system; Parasympathetic nervous system; Baroreceptor sensitivity; Mild traumatic brain injury	HEART-RATE-VARIABILITY; CEREBRAL-BLOOD-FLOW; QT INTERVAL VARIABILITY; ASSOCIATION POSITION STATEMENT; PROFESSIONAL FOOTBALL PLAYERS; POWER SPECTRAL-ANALYSIS; INSULAR CORTEX; REPOLARIZATION LABILITY; BAROREFLEX SENSITIVITY; RECURRENT CONCUSSION	Concussion is defined as a complex pathophysiological process affecting the brain that is induced by the application or transmission of traumatic biomechanical forces to the head. The result of the impact is the onset of transient symptoms that may be experienced for approximately 2 weeks in most individuals. However, in some individuals, symptoms may not resolve and persist for a protracted period and a chronic injury ensues. Concussion symptoms are generally characterized by their emergence through changes in affect, cognition, or multi-sensory processes including the visual and vestibular systems. An emerging consequence of concussion is the presence of cardiovascular autonomic nervous system dysfunction that is most apparent through hemodynamic perturbations and provocations. Further interrogation of data that are derived from continuous digital electrocardiograms and/or beat-to-beat blood pressure monitoring often reveal an imbalance of parasympathetic or sympathetic nervous system activity during a provocation after an injury. The disturbance is often greatest early after injury and a resolution of the dysfunction occurs in parallel with other symptoms. The possibility exists that the disturbance may remain if the concussion does not resolve. Unfortunately, there is little evidence in humans to support the etiology for the emergence of this post-injury dysfunction. As such, evidence from experimental models of traumatic brain injury and casual observations from human studies of concussion implicate a transient abnormality of the anatomical structures and functions of the cardiovascular autonomic nervous system. The purpose of this review article is to provide a mechanistic narrative of multi-disciplinary evidence to support the anatomical and physiological basis of cardiovascular autonomic nervous system dysfunction after concussion. The review article will identify the anatomical structures of the autonomic nervous system and propose a theoretical framework to demonstrate the potential effects of concussive head trauma on corresponding outcome measurements. Evidence from experimental models will be used to describe abnormal cellular functions and provide a hypothetical mechanistic basis for the respective responses of the anatomical structures to concussive head trauma. When available, example observations from the human concussion literature will be presented to demonstrate the effects of concussive head trauma that may be related to anomalous activity in the respective anatomical structures of the autonomic nervous system.	[La Fountaine, Michael F.] Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ 07079 USA; [La Fountaine, Michael F.] Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, S Orange, NJ 07079 USA; [La Fountaine, Michael F.] James J Peters Vet Affairs Med Ctr, Dept Vet Affairs, Rehabil Res & Dev Serv, Natl Ctr Med Consequences Spinal Cord Injury, Bronx, NY 10468 USA; [La Fountaine, Michael F.] Seton Hall Univ, Sch Hlth & Med Sci, 400 South Orange Ave, S Orange, NJ 07079 USA		La Fountaine, MF (corresponding author), Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ 07079 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, S Orange, NJ 07079 USA.; La Fountaine, MF (corresponding author), James J Peters Vet Affairs Med Ctr, Dept Vet Affairs, Rehabil Res & Dev Serv, Natl Ctr Med Consequences Spinal Cord Injury, Bronx, NY 10468 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Sch Hlth & Med Sci, 400 South Orange Ave, S Orange, NJ 07079 USA.	lafounmi@shu.edu	La Fountaine, Michael/Q-6769-2019		New Jersey Commission for Brain Injury Research Individual Research Grant [CBIR16IRG025]	Preparation of this manuscript was partially supported by the New Jersey Commission for Brain Injury Research Individual Research Grant #CBIR16IRG025.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; AHNVE S, 1982, CIRCULATION, V65, P435, DOI 10.1161/01.CIR.65.3.435; AKSELROD S, 1985, AM J PHYSIOL, V249, pH867, DOI 10.1152/ajpheart.1985.249.4.H867; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], CIRCULATION, V93, P1043; [Anonymous], 2017, PHYS DESK REFERENCE; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Atiga WL, 1998, J CARDIOVASC ELECTR, V9, P899, DOI 10.1111/j.1540-8167.1998.tb00130.x; Atiga WL, 2000, CIRCULATION, V101, P1237, DOI 10.1161/01.CIR.101.11.1237; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bauer A, 2010, J ELECTROCARDIOL, V43, P649, DOI 10.1016/j.jelectrocard.2010.05.012; Bauer A, 2009, J ELECTROCARDIOL, V42, P602, DOI 10.1016/j.jelectrocard.2009.06.023; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Berkoff D. J, 2008, CLIN J SPORT MED OFF, V18, P197; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; BOYESON MG, 1992, BRAIN RES BULL, V29, P435, DOI 10.1016/0361-9230(92)90080-H; BOYESON MG, 1993, RESTOR NEUROL NEUROS, V5, P283, DOI 10.3233/RNN-1993-5404; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Burnstock G., 2012, PRIMER AUTONOMIC NER; Camm AJ, 1996, CIRCULATION, V93, P1043; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chapleau MW, 2001, ANN NY ACAD SCI, V940, P1; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clarke Donald D., 1999, P637; Clifton G, 1985, MANAGEMENT CARDIOVAS; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; COOTE JH, 1971, J PHYSIOL-LONDON, V215, P789, DOI 10.1113/jphysiol.1971.sp009498; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; DAVIES CTM, 1967, J APPL PHYSIOL, V22, P947, DOI 10.1152/jappl.1967.22.5.947; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; DEKKER AJAM, 1991, NEUROSCI BIOBEHAV R, V15, P299, DOI 10.1016/S0149-7634(05)80008-9; DELIUS W, 1972, ACTA PHYSIOL SCAND, V84, P82, DOI 10.1111/j.1748-1716.1972.tb05158.x; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Duprez DA, 2004, AM J HYPERTENS, V17, P647, DOI 10.1016/j.amjhyper.2004.03.671; ECKBERG DL, 1980, J PHYSIOL-LONDON, V304, P489, DOI 10.1113/jphysiol.1980.sp013338; ELISBERG EI, 1953, AM HEART J, V45, P227, DOI 10.1016/0002-8703(53)90183-5; Ellis M. J, 2016, J NEUROSURG PEDIAT, P1; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Feeney D, 1988, CATECHOLAMINES RECOV; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Foley CM, 2012, SPORTS HEALTH, V4, P139, DOI 10.1177/1941738111434275; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; FURLAN R, 1990, CIRCULATION, V81, P537, DOI 10.1161/01.CIR.81.2.537; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gennarelli T, 1993, GEOMORPHOLOGY SEDIME, V11, P5; Gianaros PJ, 2007, HYPERTENSION, V49, P134, DOI 10.1161/01.HYP.0000250984.14992.64; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hertzman Alrick B, 1937, AM J PHYSIOL, V119, P334; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Ives JC, 2007, J ATHL TRAINING, V42, P431; Jennett B, 1981, CONT NEUROLOGY SERIE; JOANNIDES R, 1995, AM J PHYSIOL-HEART C, V268, pH794, DOI 10.1152/ajpheart.1995.268.2.H794; Katayama Y, 1988, Brain Inj, V2, P51, DOI 10.3109/02699058809150931; KAYAMA Y, 1992, BRAIN RES, V569, P210, DOI 10.1016/0006-8993(92)90632-J; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; KIRCHHEIM HR, 1976, PHYSIOL REV, V56, P100, DOI 10.1152/physrev.1976.56.1.100; Kostyun Regina, 2015, Conn Med, V79, P161; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Krieger EM, 2001, ANN NY ACAD SCI, V940, P338, DOI 10.1111/j.1749-6632.2001.tb03689.x; Kuusela TA, 2002, AM J PHYSIOL-HEART C, V282, pH773, DOI 10.1152/ajpheart.00559.2001; La Fountaine M. F, 2017, AM COLL SPORTS MED A; La Fountaine MF, 2016, J NEUROTRAUM, V33, P904, DOI 10.1089/neu.2015.3968; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; La Fountaine MF, 2014, INT J CARDIOL, V172, pE511, DOI 10.1016/j.ijcard.2014.01.095; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; La Rovere Maria Teresa, 2008, Ann Noninvasive Electrocardiol, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; LANDGREN S, 1952, ACTA PHYSIOL SCAND, V26, P1; LANDGREN S, 1952, ACTA PHYSIOL SCAND, V26, P35, DOI 10.1111/j.1748-1716.1952.tb00890.x; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Langfitt T, 1966, VASCULAR VACTORS HEA; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LIND AR, 1964, CLIN SCI, V27, P229; LIPSITZ LA, 1995, CHAOS, V5, P102, DOI 10.1063/1.166091; LOW PA, 1995, NEUROLOGY, V45, pS19; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Macey PM, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00087; Magnano AR, 2002, J AM COLL CARDIOL, V39, P1820, DOI 10.1016/S0735-1097(02)01852-1; MaisonBlanche P, 1997, PACE, V20, P2614, DOI 10.1111/j.1540-8159.1997.tb06111.x; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MARK AL, 1985, CIRC RES, V57, P461, DOI 10.1161/01.RES.57.3.461; MARTIN LJ, 1993, J NEUROSCI, V13, P2249; MCCLOSKE.DI, 1972, J PHYSIOL-LONDON, V224, P173, DOI 10.1113/jphysiol.1972.sp009887; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Melcher A, 1976, Acta Physiol Scand Suppl, V435, P1; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Mine T, 2008, ANN NONINVAS ELECTRO, V13, P228, DOI 10.1111/j.1542-474X.2008.00225.x; Mitchell J. H, 1983, HDB PHYSL CARDIOVA 2, VIII, P623, DOI DOI 10.1002/CPHY.CP020317; MITCHELL JH, 1977, AM J PHYSIOL, V233, pH374, DOI 10.1152/ajpheart.1977.233.3.H374; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Nagai M, 2009, AM J HYPERTENS, V22, P723, DOI 10.1038/ajh.2009.71; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nieuwenhuys R, 2012, PROG BRAIN RES, V195, P123, DOI 10.1016/B978-0-444-53860-4.00007-6; OPPENHEIMER SM, 1990, BRAIN RES, V533, P66, DOI 10.1016/0006-8993(90)91796-J; OPPENHEIMER SM, 1991, BRAIN RES, V550, P115, DOI 10.1016/0006-8993(91)90412-O; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; OPPENHEIMER SM, 1992, BRAIN RES, V569, P221, DOI 10.1016/0006-8993(92)90633-K; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; PARER WJ, 1985, AM J OBSTET GYNECOL, V153, P402, DOI 10.1016/0002-9378(85)90078-X; Penaz J, 1968, BIOKYBERNETIK, P233; Piccirillo G, 2001, CLIN SCI, V101, P429, DOI 10.1042/CS20000310; Piccirillo G, 2009, J AM COLL CARDIOL, V54, P840, DOI 10.1016/j.jacc.2009.06.008; PIHA SJ, 1995, CLIN PHYSIOL, V15, P339, DOI 10.1111/j.1475-097X.1995.tb00524.x; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rajkowski J, 1992, NEUROSCI ABSTR, V18; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; Rosner M., 1985, SYSTEMATIC RESPONSE; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Sano T, 1968, J Electrocardiol, V1, P147; SAYERS BM, 1973, ERGONOMICS, V16, P17; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schneider RC., 1973, HEAD NECK INJURIES F; SELLER H, 1969, PFLUG ARCH EUR J PHY, V306, P1, DOI 10.1007/BF00586608; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; SLEIGHT P, 1995, CLIN SCI, V88, P103, DOI 10.1042/cs0880103; Smirl JD, 2015, J APPL PHYSIOL, V119, P487, DOI 10.1152/japplphysiol.00264.2015; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Spyer, 1990, CENTRAL REGULATION A, P145; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Tan MP, 2009, MINERVA MED, V100, P329; Tandon A, 2009, ACTA NEUROCHIR, V151, P1411, DOI 10.1007/s00701-009-0444-9; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; TIBES U, 1977, CIRC RES, V41, P332, DOI 10.1161/01.RES.41.3.332; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Torrealba F, 1996, NEUROSCIENCE, V71, P77, DOI 10.1016/0306-4522(95)00426-2; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Velarde F, 1992, J NEUROTRAUM, V9; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Waite J, 1993, NEUROSCI ABSTR, V19; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wilkinson Charles W, 2012, Front Neurol, V3, P11, DOI 10.3389/fneur.2012.00011; Wu JS, 2008, HYPERTENS RES, V31, P897, DOI 10.1291/hypres.31.897; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zhang ZH, 1998, BRAIN RES, V813, P73, DOI 10.1016/S0006-8993(98)00996-2; Zheng P, 2015, J NEUROSURG, V123, P75, DOI 10.3171/2014.12.JNS132308	180	11	11	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		155	166		10.1016/j.ijpsycho.2017.11.016			12	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000019	29197614				2022-02-06	
J	Li, D; Ji, JX; Xu, YT; Ni, HB; Rui, Q; Liu, HX; Jiang, F; Gao, R; Chen, G				Li, Di; Ji, Jia-Xuan; Xu, Yi-Tian; Ni, Hai-Bo; Rui, Qin; Liu, Hui-Xiang; Jiang, Feng; Gao, Rong; Chen, Gang			Inhibition of Lats1/p-YAP1 pathway mitigates neuronal apoptosis and neurological deficits in a rat model of traumatic brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Lats1; neurological deficit; neuronal apoptosis; traumatic brain injury; YAP1	ORGAN SIZE CONTROL; HIPPO PATHWAY; CELL-PROLIFERATION; STROMAL CELLS; TBI; HEMORRHAGE; SECONDARY; RECOVERY; SURVIVAL; GROWTH	AimsTo investigate the roles of Lats1/p-YAP1 pathway in TBI-induced neuronal apoptosis and neurological deficits in rats. ResultsWe found that Lats1 and YAP1 were expressed in cerebral cortex neurons of Sprague-Dawley rats, and the phosphorylation levels of Lats1 and YAP1 in injured regions were significantly increased after TBI. Furthermore, inhibition of Lats1 not only decreased the level of p-YAP1, but also attenuated neuronal apoptosis and neurological impairment. ConclusionsOur work demonstrates that inhibition of Lats1/p-YAP1 pathway mitigates neuronal apoptosis and neurological deficits in a rat model of TBI.	[Li, Di; Ni, Hai-Bo; Liu, Hui-Xiang; Jiang, Feng; Gao, Rong] Soochow Univ, Peoples Hosp Zhangjiagang 1, Dept Neurosurg, Suzhou, Peoples R China; [Li, Di] Soochow Univ, Peoples Hosp Zhangjiagang 1, Translat Med Ctr, Suzhou, Peoples R China; [Ji, Jia-Xuan] Nanjing Univ Chinese Med, Zhangjiagang Hosp Tradit Chinese Med, Dept Neurosurg, Suzhou, Peoples R China; [Xu, Yi-Tian] Nanjing Med Univ, Sch Basic Med Sci, Nanjing, Jiangsu, Peoples R China; [Rui, Qin] Soochow Univ, Peoples Hosp Zhangjiagang 1, Clin Lab, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China		Gao, R (corresponding author), Soochow Univ, Peoples Hosp Zhangjiagang 1, Dept Neurosurg, Suzhou, Peoples R China.	lidi715@163.com	Xu, Yitian/AAH-9794-2019		Zhangjiagang Government [ZJGQNKJ201706]	Zhangjiagang Government, Grant/Award Number: ZJGQNKJ201706	Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Camacho-Soto A, 2017, ANN NEUROL, V82, P744, DOI 10.1002/ana.25074; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chantsoulis M, 2017, ANN AGR ENV MED, V24, P141, DOI [10.5604/12321966.1232770    , 10.5604/12321966.1232770]; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chiyoda T, 2012, J CELL BIOL, V197, P625, DOI 10.1083/jcb.201110110; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gong JB, 2016, J CRANIOFAC SURG, V27, pE159, DOI 10.1097/SCS.0000000000002404; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Iwasa H, 2013, EXP CELL RES, V319, P931, DOI 10.1016/j.yexcr.2013.01.020; Khalafian Andrey, 2015, J Okla State Med Assoc, V108, P358; Lee DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11961; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Matsuda T, 2016, CIRC RES, V119, P596, DOI 10.1161/CIRCRESAHA.116.308586; Menon DK, 2015, NAT REV NEUROL, V11, P71; Pang AL, 2017, CELL TRANSPLANT, V26, P1262, DOI 10.1177/0963689717715168; Robertson A, 2017, STEM CELL RES, V20, P42, DOI 10.1016/j.scr.2017.02.011; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Song Y, 2016, J CLIN ENDOCR METAB, V101, P1552, DOI 10.1210/jc.2016-1120; Steel J, 2017, BRAIN INJURY, V31, P1889, DOI 10.1080/02699052.2017.1373200; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Xu S, 2016, ONCOL LETT, V12, P4999, DOI 10.3892/ol.2016.5376; Ye XY, 2015, J CELL MOL MED, V19, P651, DOI 10.1111/jcmm.12469; Yin C, 2017, NEUROBIOL DIS, V103, P133, DOI 10.1016/j.nbd.2017.04.006; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	33	11	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	OCT	2018	24	10					906	916		10.1111/cns.12833			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	GS9UU	WOS:000444073600006	29488331	Bronze, Green Published			2022-02-06	
J	Linder, SM; Ozinga, SJ; Koop, MM; Dey, T; Figler, R; Cruickshank, J; Alberts, JL				Linder, Susan M.; Ozinga, Sarah J.; Koop, Mandy Miller; Dey, Tanujit; Figler, Richard; Cruickshank, Jason; Alberts, Jay L.			Cleveland Clinic Postural Stability Index Norms for the Balance Error Scoring System	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						POSTURAL STABILITY; CONCUSSION; TRAUMATIC BRAIN INJURY; ACCELEROMETRY; NORMATIVE VALUES; BALANCE	CONCUSSION; SPORT; QUANTIFICATION; ACCELEROMETER; POPULATION; CHILDREN; VALIDITY; DEFICITS; INJURY; STANCE	Introduction Despite the widespread utilization of the Balance Error Scoring System (BESS) in the evaluation of concussion, it has been criticized for its error-based scoring that is susceptible to floor and ceiling effects and substantial inter-rater variability. A biomechanical outcome, Cleveland Clinic Postural Stability Index (CC-PSI), has been developed as an alternative to subjective BESS scoring. The CC-PSI uses inertial sensor data within a mobile device to provide an objective measure of postural sway during the BESS. This project aimed to determine the effect of age and sex on the CC-PSI and report normative values for healthy, active children, adolescents, and young adults. Methods A cross-sectional sample of 6762 student-athletes completed BESS testing. Participants were stratified according to three age groups for each sex. The groups included the following: youth (age, 5-13 yr), males (n = 360), females (n = 246); high school (age, 14-18 yr), males (n = 3743), females (n = 1673); and college (age, 19-23 yr), males (n = 497), females (n = 243). Percentile rankings were determined for each participant to characterize movement of COM in the medial-lateral, anterior-posterior, and trunk rotation directions relative to the entire cohort during the BESS stances. Results Overall, postural stability was worse in youth compared with high school and collegiate athletes. Specifically, the CC-PSI was significantly worse in youth male athletes compared with high school and collegiate male athletes (P < 0.001). Females exhibited significantly better scores compared with males in youth and high school cohorts (P < 0.01). Conclusions The CC-PSI provides a quantitative, objective measure of postural stability, overcoming the limitations associated with conventional BESS scoring. Optimal concussion management should use objective age- and sex-specific values in the evaluation of postural stability. The normative values of the CC-PSI may be used in the absence of a baseline BESS evaluation to aid clinical decision making.	[Linder, Susan M.; Ozinga, Sarah J.; Koop, Mandy Miller; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Linder, Susan M.; Dey, Tanujit; Figler, Richard; Cruickshank, Jason; Alberts, Jay L.] Cleveland Clin, Concuss Ctr, Cleveland, OH 44106 USA; [Dey, Tanujit] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Alberts, Jay L.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA		Alberts, JL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	albertj@ccf.org			Edward F. and Barbara A. Bell Family Endowed Chair; Farmer Foundation	This project was supported the Edward F. and Barbara A. Bell Family Endowed Chair to J.L.A. and by the Farmer Foundation. The authors would like to thank the Cleveland Clinic athletic trainers for their assistance with baseline testing.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Balaban B, 2014, PM&R, V6, P635, DOI 10.1016/j.pmrj.2013.12.017; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Bernstein JP., 2018, APPL NEUROPSYCH-ADUL, V2018, P1, DOI [10.1080/23279095.2017.1416471, DOI 10.1080/23279095.2017.1416471]; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2014, CONCUSSIONS ATHLETIC; Cohen J., 2013, STAT POWER ANAL BEHA; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hayes K C, 1982, Exerc Sport Sci Rev, V10, P363, DOI 10.1249/00003677-198201000-00011; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; KUO AD, 1993, PROG BRAIN RES, V97, P349; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Ozinga SJ, 2017, NEUROREHABILITATION, V41, P211, DOI 10.3233/NRE-171473; Ozinga SJ, 2015, MOVEMENT DISORD, V30, P1214, DOI 10.1002/mds.26214; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Pawlowski B, 2003, AM J HUM BIOL, V15, P144, DOI 10.1002/ajhb.10136; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; TAMHANE AC, 1979, J AM STAT ASSOC, V74, P471, DOI 10.2307/2286358; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Verbecque E, 2016, GAIT POSTURE, V49, P402, DOI 10.1016/j.gaitpost.2016.08.003; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	42	11	11	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	OCT	2018	50	10					1998	2006		10.1249/MSS.0000000000001660			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GT5MO	WOS:000444553300003	29794620				2022-02-06	
J	O'Connor, S; Warrington, G; McGoldrick, A; Cullen, S				O'Connor, Siobhan; Warrington, Giles; McGoldrick, Adrian; Cullen, SarahJane			A 9-Year Epidemiologic Study (2007-2015) on Race-Day Jockey Fall and Injury Incidence in Amateur Irish Horse Racing	JOURNAL OF ATHLETIC TRAINING			English	Article						point-to-point horse racing; qualified riders; injury rate; concussions; fractures	BONE HEALTH; IRELAND; FLAT	Context: Point-to-point racing may place jockeys at risk of serious injuries due to the high incidence of falls as previously reported. Despite many advances in health and safety strategies, the incidence of falls and injuries in point-to-point racing has not been reported since 2006. Objectives: To provide a longitudinal analysis of the fall and injury incidence in point-to-point horse racing jockeys in Ireland from 2007 to 2015 and compare these findings with the previous literature. Design: Descriptive epidemiologic study. Setting: All injuries that occurred due to a fall at every official point-to-point race meeting from 2007 to 2015 were recorded by a medical doctor using a standardized injury report form. Main Outcome Measure(s): Falls and injury rates and their 95% confidence intervals were calculated. Incidence rate ratios (IRRs), 95% confidence intervals and percentage change were compared between point-to-point and professional racing, between previous data and the current results, and from 2007 to 2015. Results: An average of 67.40 injuries/1000 falls and 9.08 injuries/1000 rides occurred in point-to-point racing, and this was reduced compared with the previous analysis. Amateur jockeys sustained an overall mean of 134.77 falls/1000 rides and the yearly means decreased over the 9 years of the study. Amateur jockeys sustained a higher fall rate than professional jockeys (flat: IRR = 35.47 [31.03, 40.54]; jump: IRR = 2.72 [2.63, 2.82]); however, their injuries/1000 falls rate was lower (flat: IRR = 0.19 [0.15, 0.24]; jump: IRR = 0.33 [0.30, 0.63]). Soft tissue injuries were predominant (43.09%), with 26.06 fractures and 9.98 concussions/1000 falls occurring. Conclusions: Although injuries have been reduced since the previous analysis, more serious injuries such as fractures and concussions were more common in point-to-point racing than professional racing, possibly due to their higher fall risk. Thus, identifying strategies to reduce the fall risk in point-to-point racing should be a priority.	[O'Connor, Siobhan] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Warrington, Giles] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland; [Warrington, Giles] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [McGoldrick, Adrian] Turf Club, The Curragh, Kildare, Ireland; [Cullen, SarahJane] Waterford Inst Technol, Dept Hlth Sport & Exercise Sci, Waterford, Ireland		O'Connor, S (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland.	siobhan.oconnor@dcu.ie	O'Connor, Siobhan/Q-8568-2018	O'Connor, Siobhan/0000-0002-2001-0746; Warrington, Giles/0000-0001-6473-3607	Irish Turf Club	This research was supported by the Irish Turf Club. We acknowledge the support of the Turf Club medical officers who gathered the valuable data at the various race meetings.	Balendra G, 2007, BRIT J SPORT MED, V41, P162, DOI 10.1136/bjsm.2006.033894; Hitchens P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000142; Hitchens PL, 2012, INJURY PREV, V18, P385, DOI 10.1136/injuryprev-2011-040255; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; O'Connor S, 2017, J ATHL TRAINING, V52, P1140, DOI 10.4085/1062-6050-52.12.17; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Warrington G, 2009, J SPORT SCI, V27, P543, DOI 10.1080/02640410802702863; Wilson G, 2013, INT J SPORTS MED, V34, P453, DOI 10.1055/s-0032-1321898	8	11	11	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2018	53	10					950	955		10.4085/1062-6050-339-17			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HB9TJ	WOS:000451435400004	30376371	Green Published, gold			2022-02-06	
J	Schreibman, DL; Hong, CM; Keledjian, K; Ivanova, S; Tsymbalyuk, S; Gerzanich, V; Simard, JM				Schreibman, David L.; Hong, Caron M.; Keledjian, Kaspar; Ivanova, Svetlana; Tsymbalyuk, Solomiya; Gerzanich, Volodymyr; Simard, J. Marc			Mannitol and Hypertonic Saline Reduce Swelling and Modulate Inflammatory Markers in a Rat Model of Intracerebral Hemorrhage	NEUROCRITICAL CARE			English	Article						Intracerebral hemorrhage; Mannitol; Hypertonic saline; Microglia; Brain swelling	TRAUMATIC BRAIN-INJURY; ELEVATED INTRACRANIAL-PRESSURE; CELL-ACTIVATION; BLOOD; RESUSCITATION; MICROGLIA; STROKE; EDEMA; POLARIZATION; NEUTROPHIL	Background: Spontaneous intracerebral hemorrhage (ICH) leaves most survivors dependent at follow-up. The importance of promoting M2-like microglial responses is increasingly recognized as a key element to ameliorate brain injury following ICH. The osmotherapeutic agents, mannitol and hypertonic saline (HTS), which are routinely used to reduce intracranial pressure, have been shown to reduce neuroinflammation in experimental ischemic and traumatic brain injury, but anti-inflammatory effects of osmotherapies have not been investigated in ICH. Methods: We studied the effects of iso-osmotic mannitol and HTS in rat models of ICH utilizing high-dose and moderate-dose collagenase injections into the basal ganglia, associated with high and low mortality, respectively. We studied the effects of osmotherapies, first given 5 h after ICH induction, and then administered every 12 h thereafter (4 doses total). Immunohistochemistry was used to quantify microglial activation and polarization. Results: Compared to controls, mannitol and HTS increased plasma osmolarity 1 h after infusion (301 +/- 1.5, 315 +/- 4.2 and 310 +/- 2.0 mOsm/kg, respectively), reduced mortality at 48 h (82, 36 and 53%, respectively), and reduced hemispheric swelling at 48 h (32, 21, and 17%, respectively). In both perihematomal and contralateral tissues, mannitol and HTS reduced activation of microglia/macrophages (abundance and morphology of Iba1 + cells), and in perihematomal tissues, they reduced markers of the microglia/macrophage M1-like phenotype (nuclear p65, TNF, and NOS2), increased markers of the microglia/macrophage M2-like phenotype (arginase, YM1, and pSTAT3), and reduced infiltration of CD45 + cells. Conclusions: Repeated dosing of osmotherapeutics at regular intervals may be a useful adjunct to reduce neuroinflammation following ICH.	[Schreibman, David L.; Hong, Caron M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Keledjian, Kaspar; Ivanova, Svetlana; Tsymbalyuk, Solomiya; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA		Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu			Department of Anesthesia; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL082517]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL082517] Funding Source: NIH RePORTER	This work was supported in part by a grant to DLS from the Department of Anesthesia. JMS is supported by a grant from the National Heart, Lung, and Blood Institute (HL082517).	Altin JG, 1997, IMMUNOL CELL BIOL, V75, P430, DOI 10.1038/icb.1997.68; Bereczki D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001153.pub2; Bereczki D, 2003, STROKE, V34, P1730, DOI 10.1161/01.STR.0000078658.52316.E8; Bermueller C, 2006, J NEUROL SCI, V241, P73, DOI 10.1016/j.jns.2005.10.016; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Gigliuto C M, 1991, N J Med, V88, P48; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Huang LQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-102; Jeong GR, 2016, J NEUROIMMUNOL, V295, P21, DOI 10.1016/j.jneuroim.2016.04.009; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Kalita J, 2004, J NEUROL SCI, V224, P19, DOI 10.1016/j.jns.2004.05.019; Kim H, 1999, PHARMACOLOGY, V59, P201, DOI 10.1159/000028321; Kim JH, 2017, WORLD NEUROSURG, V102, P56, DOI 10.1016/j.wneu.2017.02.105; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; Marks JA, 2012, J TRAUMA ACUTE CARE, V73, P351, DOI 10.1097/TA.0b013e3182592f76; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Misra UK, 2005, J NEUROL SCI, V234, P41, DOI 10.1016/j.jns.2005.03.038; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; OURIEL K, 1985, CIRCULATION, V72, P254; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Shields CJ, 2003, ANN SURG, V238, P249, DOI 10.1097/01.sla.0000080827.77985.fc; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Verdaasdonk JS, 2014, METHOD CELL BIOL, V123, P347, DOI 10.1016/B978-0-12-420138-5.00019-7; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wasserman JK, 2007, EXP NEUROL, V207, P227, DOI 10.1016/j.expneurol.2007.06.025; Wasserman JK, 2007, BRAIN RES, V1136, P208, DOI 10.1016/j.brainres.2006.12.035; Wu J, 2010, ACTA NEUROCHIR SUPPL, V106, P147, DOI 10.1007/978-3-211-98811-4_26; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017	40	11	11	1	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2018	29	2					253	263		10.1007/s12028-018-0535-7			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GY3QG	WOS:000448467900014	29700692	Green Accepted			2022-02-06	
J	Van den Brand, CL; Karger, LB; Nijman, STM; Hunink, MGM; Patka, P; Jellema, K				Van den Brand, Crispijn L.; Karger, Lennard B.; Nijman, Susanne T. M.; Hunink, Myriam G. M.; Patka, Peter; Jellema, Korne			Traumatic brain injury in the Netherlands, trends in emergency department visits, hospitalization and mortality between 1998 and 2012	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						epidemiology; neurotrauma; trauma; traumatic brain injury	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; STATEMENT; DISEASE; RULE	BackgroundTraumatic brain injury (TBI) is a major cause of morbidity and mortality worldwide. The effects of epidemiological changes such as ageing of the population and increased traffic safety on the incidence of TBI are unknown.ObjectiveThe objective of this study was to evaluate trends in TBI-related emergency department (ED) visits, hospitalization and mortality in the Netherlands between 1998 and 2012.DesignThis was a retrospective observational, longitudinal study.Main outcome measuresThe main outcome measures were TBI-related ED visits, hospitalization and mortality.ResultsBetween 1998 and 2012, there were 500000 TBI-related ED visits in the Netherlands. In the same period, there were 222000 TBI-related admissions and 17000 TBI-related deaths. During this period, there was a 75% increase in ED visits for TBI and a 95% increase for TBI-related hospitalization; overall mortality because of TBI did not change significantly. Despite the overall increase in TBI-related ED visits, this increase was not evenly distributed among age groups or trauma mechanisms. In patients younger than 65 years, a declining trend in ED visits for TBI caused by road traffic accidents was observed. Among patients 65 years or older, ED visits for TBI caused by a fall increased markedly. TBI-related mortality shifted from mainly young (67%) and middle-aged individuals (<65 years) to mainly elderly (63%) individuals (65 years) between 1998 and 2012. The conclusions of this study did not change when adjusting for changes in age, sex and overall population growth.ConclusionThe incidence of TBI-related ED visits and hospitalization increased markedly between 1998 and 2012 in the Netherlands. TBI-related mortality occurred at an older age. These observations are probably the result of a change in aetiology of TBI, specifically a decrease in traffic accidents and an increase in falls in the ageing population. This hypothesis is supported by our data. However, ageing of the population is not the only cause of the changes observed; the observed changes remained significant when correcting for age and sex. The higher incidence of TBI with a relatively stable mortality rate highlights the importance of clinical decision rules to identify patients with a high risk of poor outcome after TBI.	[Van den Brand, Crispijn L.] Haaglanden Med Ctr, Dept Emergency Med, POB 432, NL-2501 CK The Hague, Netherlands; [Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands; [Karger, Lennard B.] Haga Hosp, Dept Intens Care Med, The Hague, Netherlands; [Nijman, Susanne T. M.] Consumer Safety Inst VeiligheidNL, Amsterdam, Netherlands; [Patka, Peter] Erasmus MC, Dept Emergency Med, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA		Van den Brand, CL (corresponding author), Haaglanden Med Ctr, Dept Emergency Med, POB 432, NL-2501 CK The Hague, Netherlands.	c.van.den.brand@haaglandenmc.nl			St Jacobus Foundation	C.B. was funded by a grant from the St Jacobus Foundation.	[Anonymous], 2015, DUTCH HOSP DATA KEY; Calonge N, 2009, ANN INTERN MED, V150, P396; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Cigolle CT, 2015, JAMA INTERN MED, V175, P443, DOI 10.1001/jamainternmed.2014.7533; Consumer Safety Institute, 2005, DUTCH BURD INJ MOD; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hageman G, 2010, GUIDELINE ASSESSMENT; Halkes PHA, 2006, LANCET, V367, P1665; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Paas GRA, 2002, RES VALIDITY LMR REP; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; van den Brand Crispijn L, 2014, Ned Tijdschr Geneeskd, V158, pA6973; Veiligheid NL, 2013, TRAUM BRAIN INJ ACC; Winkle RA, 2014, EUROPACE, V16, P195, DOI 10.1093/europace/eut244	22	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	OCT	2018	25	5					355	361		10.1097/MEJ.0000000000000457			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GU8YJ	WOS:000445629800009	28266943				2022-02-06	
J	Vieira, LV; Pedrosa, LAC; Souza, VS; Paula, CA; Rocha, R				Vieira, Luiza Valois; Carvalho Pedrosa, Livia Alves; Souza, Viviane Sahade; Paula, Cristiane Assis; Rocha, Raquel			Incidence of diarrhea and associated risk factors in patients with traumatic brain injury and enteral nutrition	METABOLIC BRAIN DISEASE			English	Article						Diarrhea; Enteral nutrition; Trauma brain injury; Intensive care unit	NOSOCOMIAL DIARRHEA; CRITICALLY-ILL; CLOSTRIDIUM-DIFFICILE; PROKINETIC THERAPY; FEED INTOLERANCE; SEPSIS; METOCLOPRAMIDE	To determine the occurrence of diarrhea and associated factors in critically ill patients with traumatic brain injury (TBI) in use of nutritional therapy. Prospective cohort study conducted in an Intensive Care Unit (ICU) of a General Hospital reference in trauma. We evaluated TBI patients who stayed less than 72 h in the ICU, who were using EN for at least 48 h. Definition of diarrhea it was considered three or more episodes of liquid stools or semi-liquid at 24 h. For analysis were evaluated demographic, epidemiological, clinical and nutritional data. Twenty-three patients were evaluated, being 86.9% male, median 33 years old (IQR = 25-52 years) and 16-day ICU stay (IQR = 10-26 days). Diarrhea occurred in 69.6% of the patients and they had a longer time in the ICU (p = 0.007). All patients who used combination prokinetic therapy (metoclopramide and erythromycin) and used antibiotics for more than 8 days had diarrhea (p = 0.057 and p = 0.007, respectively). The incidence of diarrhea was high in TBI patients with enteral nutrition and was associated with the use of antibiotics for more than one week.	[Vieira, Luiza Valois; Carvalho Pedrosa, Livia Alves; Souza, Viviane Sahade; Rocha, Raquel] Univ Fed Bahia, Escola Nutr, Dept Ciencias Nutr, Ave Araujo Pinho 32, BR-40110150 Salvador, BA, Brazil; [Paula, Cristiane Assis] Hosp Geral Estado Bahia, Unidade Nutr, Salvador, BA, Brazil		Vieira, LV (corresponding author), Univ Fed Bahia, Escola Nutr, Dept Ciencias Nutr, Ave Araujo Pinho 32, BR-40110150 Salvador, BA, Brazil.	luizavvieira@gmail.com	Rocha, Raquel/G-3924-2012	Rocha, Raquel/0000-0002-2687-2080			Alberti C, 2003, AM J RESP CRIT CARE, V168, P77, DOI 10.1164/rccm.200208-785OC; BLISS DZ, 1992, AM J CLIN NUTR, V55, P753, DOI 10.1093/ajcn/55.3.753; Borges Sérvulo Luiz, 2008, Arq. Gastroenterol., V45, P117, DOI 10.1590/S0004-28032008000200005; Campos Brenno Belazi Nery de Souza, 2012, Rev. bras. ter. intensiva, V24, P97, DOI 10.1590/S0103-507X2012000100015; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Fujino V., 2007, ARQ CIENC SAUDE, V14, P220; Guerricagoitia LI, 2011, ENFERM INTENSIV, V22, P65, DOI 10.1016/j.enfi.2010.10.002; Jack Leanne, 2010, Intensive Crit Care Nurs, V26, P327, DOI 10.1016/j.iccn.2010.08.001; Marra AR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-42; Marshall JC, 2005, CRIT CARE MED, V33, P1708, DOI 10.1097/01.CCM.0000174478.70338.03; Nguyen NQ, 2008, INTENS CARE MED, V34, P169, DOI 10.1007/s00134-007-0834-5; Nguyen NQ, 2007, CRIT CARE MED, V35, P2561, DOI 10.1097/01.CCM.0000286397.04815.B1; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Nursal TZ, 2007, J CLIN NEUROSCI, V14, P344, DOI 10.1016/j.jocn.2005.11.011; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, P463; Pinto TF, 2012, BRAIN INJURY, V26, P1113, DOI 10.3109/02699052.2012.666369; Polage CR, 2012, CLIN INFECT DIS, V55, P982, DOI 10.1093/cid/cis551; Saback Lucas Montano Paternostro, 2007, Rev. bras. ter. intensiva, V19, P44, DOI 10.1590/S0103-507X2007000100006; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Trabal J, 2008, NUTR HOSP, V23, P500; Waltzberg DL, 2003, CURR OPIN CLIN NUTR, V6, P531, DOI [10.1097/01.mco.0000087968.83880.de, 10.1097/00075197-200309000-00006]; *WHO, 1989, TREATM PREV AC DIARR; Wierdsma NJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10530; Wiesen P, 2006, CURR OPIN CRIT CARE, V12, P149, DOI 10.1097/01.ccx.0000216583.64804.46	26	11	14	1	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	OCT	2018	33	5					1755	1760		10.1007/s11011-018-0287-2			6	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	GU3DD	WOS:000445154200038	30014176				2022-02-06	
J	Volk, C; Jaramillo, V; Merki, R; Tuura, RO; Huber, R				Volk, Carina; Jaramillo, Valeria; Merki, Renato; Tuura, Ruth O'Gorman; Huber, Reto			Diurnal changes in glutamate plus glutamine levels of healthy young adults assessed by proton magnetic resonance spectroscopy	HUMAN BRAIN MAPPING			English	Article						high-density EEG; MRS; sleep; slow wave activity; synaptic homeostasis	AMINOBUTYRIC-ACID LEVELS; TRAUMATIC BRAIN-INJURY; SLOW-WAVE ACTIVITY; SYNAPTIC PLASTICITY; SLEEP; GLUTAMATE/GLUTAMINE; HOMEOSTASIS; MRS; SCHIZOPHRENIA; DEPRIVATION	The glutamatergic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor is involved in synaptic plasticity processes, and animal studies have demonstrated altered expression across the sleep wake cycle. Accordingly, glutamate levels are reduced during non-rapid eye movement (NREM) sleep and the rate of this decrease is positively correlated with sleep EEG slow wave activity (SWA). Here, we combined proton magnetic resonance spectroscopy (H-1-MRS) and high-density sleep EEG to assess if H-1-MRS is sensitive to diurnal changes of glutamate + glutamine (GLX) in healthy young adults and if potential overnight changes of GLX are correlated to SWA. H-1-MRS was measured in the parietal lobe in the evening and in the subsequent morning. High-density sleep EEG was recorded overnight between the evening and morning scans. Our results revealed a significant overnight reduction in GLX, but no significant changes in other metabolites. The decrease in GLX positively correlated with the decrease of SWA. Our study demonstrates that quantification of diurnal changes in GLX is possible by means of H-1-MRS and indicates that overnight changes in GLX are related to SWA, a marker that is closely linked to the restorative function of sleep. This relationship might be of particular interest in clinical populations in which sleep is disturbed.	[Volk, Carina; Jaramillo, Valeria; Merki, Renato; Tuura, Ruth O'Gorman; Huber, Reto] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Volk, Carina; Jaramillo, Valeria; Merki, Renato; Huber, Reto] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Tuura, Ruth O'Gorman] Univ Childrens Hosp Zurich, MR Ctr, Zurich, Switzerland; [Huber, Reto] Univ Zurich, Psychiat Hosp, Dept Child & Adolescent Psychiat & Psychotherapy, Zurich, Switzerland		Huber, R (corresponding author), Univ Childrens Hosp, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	reto.huber@kispi.uzh.ch		O'Gorman, Ruth/0000-0001-5932-7786; Jaramillo, Valeria/0000-0003-1446-8328; Volk, Carina/0000-0002-6104-626X	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [320030_153387]; Clinical Research Priority Program (CRPP) Sleep and Health of the University of Zurich	Swiss National Science Foundation, Grant/Award Number: 320030_153387; Clinical Research Priority Program (CRPP) Sleep and Health of the University of Zurich	Achermann P., 2005, PRINCIPLES PRACTICE, P405; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Bai X, 2015, J MAGN RESON IMAGING, V41, P1326, DOI 10.1002/jmri.24665; Bollmann S, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.79; Chowdhury FA, 2015, J MAGN RESON IMAGING, V41, P694, DOI 10.1002/jmri.24611; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dlabac-de Lange JJ, 2017, BRAIN STIMUL, V10, P59, DOI 10.1016/j.brs.2016.08.002; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Hallahan BP, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-23; Hanlon EC, 2009, SLEEP, V32, P719, DOI 10.1093/sleep/32.6.719; Huang ZR, 2015, HUM BRAIN MAPP, V36, P3204, DOI 10.1002/hbm.22841; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Iber C., 2007, AASM MANUAL SCORING, P7; Kerkhof GA, 2010, PROG BRAIN RES, V185, P131, DOI 10.1016/B978-0-444-53702-7.00008-7; Krause AJ, 2017, NAT REV NEUROSCI, V18, P404, DOI 10.1038/nrn.2017.55; Lee HK, 2011, SEMIN CELL DEV BIOL, V22, P514, DOI 10.1016/j.semcdb.2011.06.007; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Robertson DMW, 2001, NEUROLOGY, V57, P2114, DOI 10.1212/WNL.57.11.2114; Rowland LM, 2013, SCHIZOPHRENIA BULL, V39, P1096, DOI 10.1093/schbul/sbs092; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; STANLEY BG, 1989, LIFE SCI, V45, P275, DOI 10.1016/0024-3205(89)90136-7; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2013, NAT REV NEUROSCI, V14, P445, DOI 10.1038/nrn3494; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	35	11	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	OCT	2018	39	10					3984	3992		10.1002/hbm.24225			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GS8ER	WOS:000443941200013	29885049	Green Published, Green Submitted			2022-02-06	
J	Bernstein, LJ; Pond, GR; Gan, HK; Tirona, K; Chan, KK; Hope, A; Kim, J; Chen, EX; Siu, LL; Razak, ARA				Bernstein, Lori J.; Pond, Gregory R.; Gan, Hui K.; Tirona, Kattleya; Chan, Kelvin K.; Hope, Andrew; Kim, John; Chen, Eric X.; Siu, Lillian L.; Razak, Albiruni R. Abdul			Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						head and neck cancer; neurocognitive function; patient-reported symptoms; pretreatment; quality of life	QUALITY-OF-LIFE; STEM-CELL TRANSPLANTATION; TRAUMATIC BRAIN-INJURY; BREAST-CANCER; COGNITIVE FUNCTION; ADJUVANT CHEMOTHERAPY; INTRAINDIVIDUAL VARIABILITY; ADULT SURVIVORS; IMPAIRMENT; WOMEN	BackgroundNewly diagnosed patients with head and neck cancer may be at risk for impaired neurocognitive function (NCF) due to disease, treatment, and lifestyle factors. MethodsEighty pretreatment patients with head and neck cancer and 40 control patients without cancer completed assessment of NCF and self-reported cognition, fatigue, and mood. Blood samples to evaluate organ reserves, hormones, and cytokines were collected. ResultsPatients experienced worse symptoms of cognitive dysfunction, fatigue, and anxiety than controls. In contrast, NCF was equivalent for patients and controls. Using published norms as comparison, groups had similar high rates of impairment in performance (9/80 patients and 3/40 controls scored in the abnormal range). ConclusionPretreatment patients with head and neck cancer reported cognitive disturbance. The frequency of impaired performance, albeit high, was consistent with the literature demonstrating false-positive abnormal neuropsychological test performance is not uncommon. Inclusion of a noncancer patient control cohort is essential because using solely normative data as a comparison may foster erroneous interpretation.	[Bernstein, Lori J.; Tirona, Kattleya] Univ Toronto, Dept Support Care, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pond, Gregory R.] McMaster Univ, Dept Biostat, Hamilton, ON, Canada; [Gan, Hui K.; Chan, Kelvin K.; Chen, Eric X.; Siu, Lillian L.; Razak, Albiruni R. Abdul] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Hope, Andrew; Kim, John] Univ Toronto, Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada		Bernstein, LJ (corresponding author), Toronto Gen Hosp, ELLICSR, Hlth Wellness & Canc Survivorship Ctr, 200 Elizabeth St,B-PMB 146, Toronto, ON M5G 2C4, Canada.	Lori.Bernstein@uhn.ca	Razak, Albiruni Abdul/C-4608-2015	Razak, Albiruni Abdul/0000-0001-7657-9950; Bernstein, Lori/0000-0002-2479-3223	CIHRCanadian Institutes of Health Research (CIHR) [RN142313‐261573] Funding Source: Medline		Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Benedict RH, 1997, BVMT R BRIEF VISUOSP; Bernstein LJ, 2017, NEUROSCI BIOBEHAV R, V83, P417, DOI 10.1016/j.neubiorev.2017.10.028; Bernstein LJ, 2014, J INT NEUROPSYCH SOC, V20, P380, DOI 10.1017/S1355617714000125; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Bond SM, 2012, SUPPORT CARE CANCER, V20, P149, DOI 10.1007/s00520-010-1081-9; Brandt J, 2001, HVLT R HOPKINS VERBA; Castellon SA, 2004, J CLIN EXP NEUROPSYC, V26, P955, DOI 10.1080/13803390490510905; Chang G, 2009, CANCER, V115, P4625, DOI 10.1002/cncr.24496; Cheung YT, 2014, J CLIN EPIDEMIOL, V67, P811, DOI 10.1016/j.jclinepi.2013.12.011; Collins B, 2013, PSYCHO-ONCOLOGY, V22, P1517, DOI 10.1002/pon.3163; DAntonio LL, 1996, ARCH OTOLARYNGOL, V122, P482; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC, 2001, DKEFS DELIS KAPLAN E; Edelstein K, 2014, J INT NEUROPSYCH SOC, V20, P351, DOI 10.1017/S1355617714000149; Edelstein K, 2011, J PEDIAT HEMATOL ONC, V33, P450, DOI 10.1097/MPH.0b013e31820d86f2; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ferguson RJ, 2007, J CLIN ONCOL, V25, P3866, DOI 10.1200/JCO.2007.10.8639; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gan HK, 2011, INT J RADIAT ONCOL, V81, P126, DOI 10.1016/j.ijrobp.2010.05.004; Harder H, 2006, J CLIN EXP NEUROPSYC, V28, P283, DOI 10.1080/13803390490918147; Hermelink K, 2007, CANCER, V109, P1905, DOI 10.1002/cncr.22610; Hermelink K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv099; Hosseini SMH, 2014, J INT NEUROPSYCH SOC, V20, P391, DOI 10.1017/S1355617713001173; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Jacobs SR, 2007, CANCER-AM CANCER SOC, V110, P1560, DOI 10.1002/cncr.22962; Jacobs SR, 2007, J PAIN SYMPTOM MANAG, V33, P13, DOI 10.1016/j.jpainsymman.2006.06.011; Kadan-Lottick NS, 2010, JNCI-J NATL CANCER I, V102, P881, DOI 10.1093/jnci/djq156; Klove H., 1963, CLIN NEUROPSYCHOLOGY; Lee KM, 2006, INT IMMUNOPHARMACOL, V6, P1298, DOI 10.1016/j.intimp.2006.03.015; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Meyers CA, 2005, CANCER-AM CANCER SOC, V104, P788, DOI 10.1002/cncr.21234; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Palmer BW, 1998, ARCH CLIN NEUROPSYCH, V13, P503, DOI 10.1016/S0887-6177(97)00037-1; Pomykala KL, 2013, BRAIN IMAGING BEHAV, V7, P511, DOI 10.1007/s11682-013-9243-2; Psychological Corporation, 2002, WAIS 3 WMS 3 UPD TEC; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Reitan R, 1985, HALSTEAD REITAN NEUR; Ringash J, 2001, HEAD NECK-J SCI SPEC, V23, P201, DOI 10.1002/1097-0347(200103)23:3<201::AID-HED1019>3.0.CO;2-M; Ringash J, 2015, HEAD NECK-J SCI SPEC, V37, P425, DOI 10.1002/hed.23561; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schagen SB, 2006, J NATL CANCER I, V98, P1742, DOI 10.1093/jnci/djj470; Schultze-Lutter F, 2007, BRIT J PSYCHIAT, V191, pS43, DOI 10.1192/bjp.191.51.s43; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tchen N, 2003, J CLIN ONCOL, V21, P4175, DOI 10.1200/JCO.2003.01.119; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Vardy J, 2006, SUPPORT CARE CANCER, V14, P1111, DOI 10.1007/s00520-006-0037-6; Vardy J, 2009, CANCER TREAT RES, P387, DOI 10.1007/978-0-387-75115-3_24; Vittadini G, 2001, ALCOHOL ALCOHOLISM, V36, P393, DOI 10.1093/alcalc/36.5.393; Wagner L.I., 2009, SUPPORT ONCOL, V7, pW32, DOI DOI 10.1016/J.JPAINSYMMAN.2014.08.012; Wechsler D., 1997, WAIS 3 WESCHLER ADUL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Yao C, 2017, PSYCHO-ONCOLOGY, V26, P2261, DOI 10.1002/pon.4351; Yao C, 2017, BREAST CANCER RES TR, V166, P15, DOI 10.1007/s10549-017-4376-4; Yao C, 2016, J INT NEUROPSYCH SOC, V22, P530, DOI 10.1017/S1355617716000126; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Zer A, 2018, JAMA OTOLARYNGOL, V144, P71, DOI 10.1001/jamaoto.2017.2235; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zygogianni A, 2011, ASIAN PAC J CANCER P, V12, P339	67	11	11	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	SEP	2018	40	9					2029	2042		10.1002/hed.25198			14	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology; Surgery	GS9VJ	WOS:000444075400019	29667262				2022-02-06	
J	Carlozzi, NE; Lange, RT; French, LM; Sander, AM; Freedman, J; Brickell, TA				Carlozzi, Noelle E.; Lange, Rael T.; French, Louis M.; Sander, Angelle M.; Freedman, Jenna; Brickell, Tracey A.			A Latent Content Analysis of Barriers and Supports to Healthcare: Perspectives From Caregivers of Service Members and Veterans With Military-Related Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregiver; health-related quality of life; outcome assessment (healthcare); quality of life; service members; traumatic brain injury; underserved populations; veterans; wounded warriors	OF-THE-LITERATURE; MENTAL-HEALTH; COGNITIVE REHABILITATION; HELP-SEEKING; ACTIVE-DUTY; FAMILY; STIGMA; LIFE; INDIVIDUALS; PREVALENCE	Objective: To identify barriers and supports that caregivers of individuals with military-related traumatic brain injury (TBI) encounter when navigating the military healthcare system; this information will be used as the foundation of a new patient-reported outcome measure. Setting: Community. Participants: Forty-five caregivers of service members and veterans (SMV) who sustained a medically documented mild, moderate, severe, or penetrating TBI. Design: Latent content analysis. Main Measures: Nine focus group discussions of barriers and supports to navigating the military healthcare system and community resources. Results: Latent content analysis indicated that caregivers discussed barriers (66%) and supports (34%) to obtaining care within the military healthcare system and the community. Caregivers most frequently discussed SMVs' interactions with healthcare, their own interactions with healthcare, family care, and community organizations. Conclusions: Caregivers confront numerous challenges while pursuing healthcare services. Although much of the discussion focused on barriers and perceived unmet needs within the military healthcare system, caregivers also recognized supports within the military healthcare system and general community. Increased attention to accessibility and quality of services, as well as reducing financial burden, can lead to improved health-related quality of life for caregivers and their SMVs.	[Carlozzi, Noelle E.; Freedman, Jenna] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA		Carlozzi, NE (corresponding author), Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01-NR013658]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0028, 90DP0060]; NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000028, U48DP000060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	This study was funded by a grant from the National Institute of Nursing Research (R01-NR013658). This material is also based upon work supported in part by the Defense and Veterans Brain Injury Center. In addition, Dr Sander was partially supported by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant numbers 90DP0028 [PI: Sherer], and 90DP0060 [PI: Arciniegas]); NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, and HHS, and you should not assume endorsement by the Federal Government. In addition, for some authors (T.A.B. and L.M.F.), the views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position, policy, or decision unless so designated by other official documentation. Furthermore, the identification of specific products or scientific instrumentation does not constitute endorsement or implied endorsement on the part of the author, Department of Defense, or any component agency. While we generally excise references to products, companies, manufacturers, organizations, etc., in government-produced works, the article produced and other similarly situated research presents a special circumstance when such product inclusions become an integral part of the scientific endeavor. Finally, the authors acknowledge Dr Anna L. Kratz for her assistance with comoderating focus groups.	BASCH CE, 1987, HEALTH EDUC QUART, V14, P411, DOI 10.1177/109019818701400404; BASCH CE, 1989, HEALTH EDUC QUART, V16, P389, DOI 10.1177/109019818901600307; Blais RK, 2013, J TRAUMA STRESS, V26, P77, DOI 10.1002/jts.21772; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Caregiving NA, 2010, CAR VET SERV HOM REP; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Catanzaro, 1988, NURSING RES THEORY P; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Chapman PL, 2014, MIL MED, V179, P55, DOI 10.7205/MILMED-D-12-00367; Chokshi DA, 2014, NEW ENGL J MED, V371, P297, DOI 10.1056/NEJMp1406868; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cozza Stephen J., 2014, CARE MILITARY SERVIC; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DVBIC, 2015, DOD WORLDW NUMB TBI; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Elnitsky CA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-498; Elnitsky CA, 2013, MIL MED, V178, P775, DOI 10.7205/MILMED-D-13-00012; Fletcher CE, 2017, J ALTERN COMPLEM MED, V23, P26, DOI 10.1089/acm.2016.0236; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; French LM, 2011, SOC WORK HEALTH CARE, V50, P501, DOI 10.1080/00981389.2011.582007; Gorman LA, 2011, PSYCHIAT SERV, V62, P28, DOI 10.1176/ps.62.1.pss6201_0028; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Institute of Medicine, 2008, GULF WAR HLTH, V7; JARRETT RL, 1994, SOC PROBL, V41, P30, DOI 10.1525/sp.1994.41.1.03x0423g; JARRETT RL, 1993, SUCCESSFUL FOCUS GRO, P184; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Lewy CS, 2014, PSYCHIAT SERV, V65, P1170, DOI 10.1176/appi.ps.201300325; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McFarlane AC, 2009, CURR OPIN PSYCHIATR, V22, P369, DOI 10.1097/YCO.0b013e32832c9064; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Misra-Hebert AD, 2015, SOUTH MED J, V108, P488, DOI 10.14423/SMJ.0000000000000326; Mittal D, 2013, PSYCHIATR REHABIL J, V36, P86, DOI 10.1037/h0094976; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parkkinen L, 2005, ANN NEUROL, V57, P82, DOI 10.1002/ana.20321; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; PROMIS, PROMIS INSTR DEV PSY; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Schall Marie W, 2004, Jt Comm J Qual Saf, V30, P415; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Scholten J, 2013, J HEAD TRAUMA REHAB, V28, P219, DOI 10.1097/HTR.0b013e318291daca; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Shamdasani, 1990, FOCUS GROUPS THEORY; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Smith A M, 1998, Rehabil Nurs, V23, P252; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verdeli H, 2011, J FAM PSYCHOL, V25, P488, DOI 10.1037/a0024525; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whyte J, 2005, PHYS MED REHABILITAT; Zemke R., 1985, FIGURING THINGS OUT; Zinzow HM, 2012, CLIN PSYCHOL REV, V32, P741, DOI 10.1016/j.cpr.2012.09.002	77	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					342	353		10.1097/HTR.0000000000000373			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500016	29385014	Green Accepted			2022-02-06	
J	Chen, CY; Hsu, TY; Chen, WK; Muo, CH; Chen, HC; Shih, HM				Chen, Chih-Yu; Hsu, Tai-Yi; Chen, Wei-Kung; Muo, Chih-Hsin; Chen, Hang-Cheng; Shih, Hong-Mo			The use of extracorporeal membrane oxygenation in trauma patients A national case-control study	MEDICINE			English	Article						extracorporeal membrane oxygenation; national health insurance research database; surgery; trauma	LIFE-SUPPORT; MANAGEMENT; INJURIES	Extracorporeal membrane oxygenation (ECMO) has been increasingly applied for the treatment of patients with trauma. Because a common complication of ECMO is bleeding, the use of ECMO support for patients with trauma was limited in the past. Studies have demonstrated a survival benefit from ECMO support in cases of traumatic lung injury, and it is likely that patients with other types of trauma would also benefit from ECMO support. However, the effect of ECMO in patients with other types of trauma is unknown. Using the national insurance data of Taiwan, we identified 810 patients with trauma who received ECMO support from 2000 to 2010. Patients who died or who withdrew from the program within 7 days after discharge were defined as deceased. Logistic regression was used to estimate the odds ratio (OR) of death and 95% confidence intervals (CIs). The overall mortality was 32.8% (266/810). A total of 417 patients received surgery during hospitalization, with an overall mortality of 39.0% (163/417). Patients who underwent thoracic surgery had an OR of 2.23 (95% CI: 1.49-3.34) compared with those who did not. Patients who underwent brain surgery had an OR of 2.86 (95% CI: 1.37-5.98) compared with patients who did not. Patients who received abdominal surgery had an OR of 4.47 (95% CI: 2.63-7.61) compared with patients who did not. All types of surgery had odds of mortality except orthopedic surgery; the use of ECMO with orthopedic surgery had an OR of 1.06 (95% CI: 0.69-1.62) compared with patients who did not receive orthopedic surgery. Except for orthopedic surgery, patients with trauma who received ECMO support and required further surgery during hospitalization exhibited a relatively high mortality rate.	[Chen, Chih-Yu; Hsu, Tai-Yi; Chen, Wei-Kung; Chen, Hang-Cheng; Shih, Hong-Mo] China Med Univ Hosp, Dept Emergency Med, 2 Yuh Der Rd, Taichung 40447, Taiwan; [Chen, Chih-Yu; Hsu, Tai-Yi; Chen, Wei-Kung; Muo, Chih-Hsin; Chen, Hang-Cheng; Shih, Hong-Mo] China Med Univ, Coll Med, Shenyang, Liaoning, Peoples R China; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan		Shih, HM (corresponding author), China Med Univ Hosp, Dept Emergency Med, 2 Yuh Der Rd, Taichung 40447, Taiwan.	homoe042002@hotmail.com		Shih, Hong-Mo/0000-0001-7732-3594	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital [DMR-107-192]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), China Medical University Hospital (DMR-107-192), the Academia Sinica Stroke Biosignature Project (BM10701010021), the MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), the Tseng-Lien Lin Foundation, Taichung, Taiwan, and the Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P219, DOI 10.1097/TA.0000000000000363; Biderman P, 2013, J TRAUMA ACUTE CARE, V75, P907, DOI 10.1097/TA.0b013e3182a8334f; Biscotti M, 2015, PERFUSION-UK, V30, P407, DOI 10.1177/0267659114554327; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Chang CH, 2016, CIRCULATION, V133, P2423, DOI 10.1161/CIRCULATIONAHA.115.019143; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003204; Cirocchi R, 2013, CRIT CARE, V17, DOI 10.1186/cc12868; Cohn SM, 2010, WORLD J SURG, V34, P1959, DOI 10.1007/s00268-010-0599-9; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Dunham CM, 2001, J TRAUMA, V50, P958, DOI 10.1097/00005373-200105000-00037; Jacobs JV, 2015, J TRAUMA ACUTE CARE, V79, P1049, DOI 10.1097/TA.0000000000000790; Karmy-Jones R, 2004, CURR PROB SURG, V41, P223, DOI 10.1016/j.cpsurg.2003.12.004; Lin BC, 2014, INJURY, V45, P122, DOI 10.1016/j.injury.2013.08.022; Muellenbach RM, 2011, ANAESTHESIST, V60, P647, DOI 10.1007/s00101-011-1872-5; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Rixen D, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1162-2; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Terragni P, 2014, CURR OPIN CRIT CARE, V20, P86, DOI 10.1097/MCC.0000000000000053	22	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP	2018	97	36							e12223	10.1097/MD.0000000000012223			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC1PG	WOS:000451572400085	30200143	gold, Green Published			2022-02-06	
J	Dennis, EL; Babikian, T; Alger, J; Rashid, F; Villalon-Reina, JE; Jin, Y; Olsen, A; Mink, R; Babbitt, C; Johnson, J; Giza, CC; Thompson, PM; Asarnow, RF				Dennis, Emily L.; Babikian, Talin; Alger, Jeffry; Rashid, Faisal; Villalon-Reina, Julio E.; Jin, Yan; Olsen, Alexander; Mink, Richard; Babbitt, Christopher; Johnson, Jeffrey; Giza, Christopher C.; Thompson, Paul M.; Asarnow, Robert F.			Magnetic resonance spectroscopy of fiber tracts in children with traumatic brain injury: A combined MRS - Diffusion MRI study	HUMAN BRAIN MAPPING			English	Article						diffusion MRI; longitudinal; MRS; pediatric; traumatic brain injury	CORPUS-CALLOSUM; AXONAL INJURY; MODERATE; TENSOR; TRAJECTORIES; RECOVERY; OUTCOMES; UCLA	Traumatic brain injury can cause extensive damage to the white matter (WM) of the brain. These disruptions can be especially damaging in children, whose brains are still maturing. Diffusion magnetic resonance imaging (dMRI) is the most commonly used method to assess WM organization, but it has limited resolution to differentiate causes of WM disruption. Magnetic resonance spectroscopy (MRS) yields spectra showing the levels of neurometabolites that can indicate neuronal/axonal health, inflammation, membrane proliferation/turnover, and other cellular processes that are on-going post-injury. Previous analyses on this dataset revealed a significant division within the msTBI patient group, based on interhemispheric transfer time (IHTT); one subgroup of patients (TBI-normal) showed evidence of recovery over time, while the other showed continuing degeneration (TBI-slow). We combined dMRI with MRS to better understand WM disruptions in children with moderate-severe traumatic brain injury (msTBI). Tracts with poorer WM organization, as shown by lower FA and higher MD and RD, also showed lower N-acetylaspartate (NAA), a marker of neuronal and axonal health and myelination. We did not find lower NAA in tracts with normal WM organization. Choline, a marker of inflammation, membrane turnover, or gliosis, did not show such associations. We further show that multi-modal imaging can improve outcome prediction over a single modality, as well as over earlier cognitive function measures. Our results suggest that demyelination plays an important role in WM disruption post-injury in a subgroup of msTBI children and indicate the utility of multi-modal imaging.	[Dennis, Emily L.; Rashid, Faisal; Villalon-Reina, Julio E.; Jin, Yan; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, Mary & Mark Stevens Inst Neuroimaging & Informat, Imaging Genet Ctr, Marina Del Rey, CA USA; [Dennis, Emily L.; Babikian, Talin; Olsen, Alexander; Asarnow, Robert F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Alger, Jeffry] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Alger, Jeffry] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA; [Alger, Jeffry] NeuroSpectroScopics LLC, Sherman Oaks, CA USA; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Mink, Richard] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Mink, Richard] Los Angeles BioMed Res Inst, Torrance, CA USA; [Babbitt, Christopher] Miller Childrens Hosp, Long Beach, CA USA; [Johnson, Jeffrey] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Babikian, Talin; Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA USA; [Babikian, Talin; Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Giza, Christopher C.; Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Dennis, EL (corresponding author), Univ Southern Calif, Keck Sch Med, 2025 Zonal Ave, Los Angeles, CA 90033 USA.	emily.dennis@ini.usc.edu	Olsen, Alexander/P-5235-2019; Dennis, Emily/AAD-5223-2021; Thompson, Paul M/C-4194-2018	Olsen, Alexander/0000-0001-8691-3860; Dennis, Emily/0000-0001-7112-4009; Thompson, Paul M/0000-0002-4720-8867; Mink, Richard/0000-0002-7998-4713	NICHDS [R01 HD061504]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99 NS096116]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54 EB020403, R01 EB008432, R01 AG040060, R01 NS080655]; UCLA BIRC, UCLA Faculty Grants Program [R01 NS027544]; Child Neurology Foundation; UCLA Steve Tisch BrainSPORT Program; NCAA; U.S. Dept of DefenseUnited States Department of Defense; Today's and Tomorrow's Children Fund; Staglin IMHRO Center for Cognitive Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504, U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB008432, P41EB015922, U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544, R01NS080655, K99NS096116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060] Funding Source: NIH RePORTER	NICHDS, Grant/Award Number: R01 HD061504; NINDS, Grant/Award Number: K99 NS096116; NIH, Grant/Award Numbers: U54 EB020403, R01 EB008432, R01 AG040060, and R01 NS080655; UCLA BIRC, UCLA Faculty Grants Program, Grant/Award Number: R01 NS027544; Child Neurology Foundation; UCLA Steve Tisch BrainSPORT Program; NCAA; U.S. Dept of Defense; Today's and Tomorrow's Children Fund; Staglin IMHRO Center for Cognitive Neuroscience	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Babikian T, 2018, J NEUROTRAUM, V35, P1637, DOI 10.1089/neu.2017.5366; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis E., 2018, NEUROSCIENTIST; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Ebel A, 2003, MAGN RESON IMAGING, V21, P113, DOI 10.1016/S0730-725X(02)00645-8; Ellis M. U., 2015, J NEUROTRAUMA; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Ghosh N, 2017, DEV NEUROSCI-BASEL, V39, P413, DOI 10.1159/000475545; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jin Y, 2014, NEUROIMAGE, V100, P75, DOI 10.1016/j.neuroimage.2014.04.048; Jin Y, 2011, I S BIOMED IMAGING, P822, DOI 10.1109/ISBI.2011.5872531; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Parry L, 2004, CHILD NEUROPSYCHOL, V10, P248, DOI 10.1080/09297040490909279; Sabati M, 2015, MAGN RESON MED, V74, P1209, DOI 10.1002/mrm.25510; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wechsler D, 2003, WECHSLER INTELLIGENC; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	45	11	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	SEP	2018	39	9					3759	3768		10.1002/hbm.24209			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GQ0AA	WOS:000441276600022	29749094	Bronze, Green Published, Green Accepted			2022-02-06	
J	Gillespie, NA; Neale, MC; Bates, TC; Eyler, LT; Fennema-Notestine, C; Vassileva, J; Lyons, MJ; Prom-Wormley, EC; McMahon, KL; Thompson, PM; deZubicaray, G; Hickie, IB; McGrath, JJ; Strike, LT; Renteria, ME; Panizzon, MS; Martin, NG; Franz, CE; Kremen, WS; Wright, MJ				Gillespie, Nathan A.; Neale, Michael C.; Bates, Timothy C.; Eyler, Lisa T.; Fennema-Notestine, Christine; Vassileva, Jasmin; Lyons, Michael J.; Prom-Wormley, Elizabeth C.; McMahon, Katie L.; Thompson, Paul M.; deZubicaray, Greig; Hickie, Ian B.; McGrath, John J.; Strike, Lachlan T.; Renteria, Miguel E.; Panizzon, Matthew S.; Martin, Nicholas G.; Franz, Carol E.; Kremen, William S.; Wright, Margaret J.			Testing associations between cannabis use and subcortical volumes in two large population-based samples	ADDICTION			English	Article						Brain volume; cannabis use; grey matter; imaging; multi-substance use; subcortical	GRAY-MATTER VOLUME; STRUCTURAL BRAIN ALTERATIONS; VOXEL-BASED MORPHOMETRY; VIETNAM ERA TWIN; SUBSTANCE USE; HIPPOCAMPAL VOLUME; ALCOHOL-USE; HIGH-RISK; ENVIRONMENTAL-INFLUENCES; POLYSUBSTANCE USE	Background and aims Disentangling the putative impact of cannabis on brain morphology from other comorbid substance use is critical. After controlling for the effects of nicotine, alcohol and multi-substance use, this study aimed to determine whether frequent cannabis use is associated with significantly smaller subcortical grey matter volumes. Design Exploratory analyses using mixed linear models, one per region of interest (ROI), were performed whereby individual differences in volume (outcome) at seven subcortical ROIs were regressed onto cannabis and comorbid substance use (predictors). Setting Two large population-based twin samples from the United States and Australia. Participants A total of 622 young Australian adults [66% female; mu(age) = 25.9, standard deviation SD) = 3.6] and 474 middle-aged US males (mu(age) = 56.1(SD) (= 2.6)) of predominately Anglo-Saxon ancestry with complete substance use and imaging data. Subjects with a history of stroke or traumatic brain injury were excluded. Measurements Magnetic resonance imaging (MRI) and volumetric segmentation methods were used to estimate volume in seven subcortical ROIs: thalamus, caudate nucleus, putamen, pallidum, hippocampus, amygdala and nucleus accumbens. Substance use measurements included maximum nicotine and alcohol use, total life-time multi-substance use, maximum cannabis use in the young adults and regular cannabis use in the middle-aged males. Findings After correcting for multiple testing (P = 0.007), cannabis use was unrelated to any subcortical ROI. However, maximum nicotine use was associated with significantly smaller thalamus volumes in middle-aged males. Conclusions In exploratory analyses based on young adult and middle-aged samples, normal variation in cannabis use is unrelated statistically to individual differences in brain morphology as measured by subcortical volume.	[Gillespie, Nathan A.; Neale, Michael C.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Box 980126, Richmond, VA 23298 USA; [Gillespie, Nathan A.; Strike, Lachlan T.; Renteria, Miguel E.; Martin, Nicholas G.; Wright, Margaret J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Bates, Timothy C.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Eyler, Lisa T.] VA San Diego Healthcare Syst, Desert Pacific Mental Illness Res Educ & Clin Ctr, San Diego, CA 92161 USA; [Eyler, Lisa T.; Fennema-Notestine, Christine; Panizzon, Matthew S.; Franz, Carol E.; Kremen, William S.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Vassileva, Jasmin] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA 23284 USA; [Lyons, Michael J.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Prom-Wormley, Elizabeth C.] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Richmond, VA 23284 USA; [McMahon, Katie L.; Thompson, Paul M.; Strike, Lachlan T.; Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [deZubicaray, Greig; Strike, Lachlan T.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [deZubicaray, Greig] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia; [deZubicaray, Greig] Queensland Univ Technol, Inst Biomed Innovat, Brisbane, Qld, Australia; [Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW, Australia; [McGrath, John J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [McGrath, John J.; Kremen, William S.] VA San Diego Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Gillespie, NA (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Box 980126, Richmond, VA 23298 USA.	ngillespie@vcu.edu	de Zubicaray, Greig/ABC-8955-2021; Strike, Lachlan T/R-3902-2018; McGrath, John J/G-5493-2010; Vassileva, Jasmin/AAF-8356-2019; Renteria, Miguel E./M-6671-2017; Thompson, Paul M/C-4194-2018; Neale, Michael/AAD-5056-2020; Wright, Margaret Jane/A-4560-2016; McMahon, Katie L/C-6440-2009; Bates, Timothy C/C-9637-2010; de Zubicaray, Greig I/B-1763-2008; Hickie, Ian B/K-8975-2015; Eyler, Lisa/AAQ-4337-2021	de Zubicaray, Greig/0000-0003-4506-0579; Strike, Lachlan T/0000-0003-2885-5898; McGrath, John J/0000-0002-4792-6068; Vassileva, Jasmin/0000-0003-2397-2657; Renteria, Miguel E./0000-0003-4626-7248; Thompson, Paul M/0000-0002-4720-8867; Wright, Margaret Jane/0000-0001-7133-4970; McMahon, Katie L/0000-0002-6357-615X; Bates, Timothy C/0000-0002-1153-9007; de Zubicaray, Greig I/0000-0003-4506-0579; Hickie, Ian B/0000-0001-8832-9895; Prom-Wormley, Elizabeth/0000-0001-9230-9723; Fennema-Notestine, Christine/0000-0002-6527-6361; Gillespie, Nathan/0000-0001-8655-2823	US National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00DA023549, DA-18673, NIA R01 AG018384, R01 AG018386, R01 AG022381, R01 AG022982, R01 DA025109 05, R01 HD050735, K08 AG047903, R03 AG 046413, U54 EB020403, R01 HD050735-01A2]; Australia National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [496682, 1009064, 49662]; VA San Diego Center of Excellence for Stress and Mental Health; NHMRC John Cade FellowshipNational Health and Medical Research Council of Australia [APP1056929]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG046413, R01AG022381, R01AG018384, R01AG018386, R01AG050595, R01AG022982, K08AG047903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K99DA023549, R37DA018673, R01DA018673, R00DA023549, R01DA025109] Funding Source: NIH RePORTER	This study was supported by US National Institute of Health grants: R00DA023549; DA-18673; NIA R01 AG018384; R01 AG018386; R01 AG022381; R01 AG022982; R01 DA025109 05; R01 HD050735; K08 AG047903; R03 AG 046413; U54 EB020403; and R01 HD050735-01A2. This study was also supported by Australia National Health and Medical Research Council (NHMRC) grants: 496682; 1009064; 1009064; and 49662 and the VA San Diego Center of Excellence for Stress and Mental Health. J.J.McG. was funded by the NHMRC John Cade Fellowship: APP1056929. N.A.G. had full access to all the data in this study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Ashtari M, 2011, J PSYCHIATR RES, V45, P1055, DOI 10.1016/j.jpsychires.2011.01.004; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Battistella G, 2014, NEUROPSYCHOPHARMACOL, V39, P2041, DOI 10.1038/npp.2014.67; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Boker S. M., MULTIPURPOSE SOFTWAR; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chang L, 2005, BIOL PSYCHIAT, V57, P967, DOI 10.1016/j.biopsych.2005.01.039; Churchwell JC, 2012, DEV NEUROSCI-BASEL, V34, P310, DOI 10.1159/000337724; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Couvy-Duchesne B., 2018, BMJ OPEN, V18, P1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Das D, 2012, ADDICT BIOL, V17, P817, DOI 10.1111/j.1369-1600.2010.00301.x; de Win MML, 2008, BRAIN, V131, P2936, DOI 10.1093/brain/awn255; de Zubicaray GI, 2008, BRAIN IMAGING BEHAV, V2, P258, DOI 10.1007/s11682-008-9029-0; Demirakca T, 2011, DRUG ALCOHOL DEPEN, V114, P242, DOI 10.1016/j.drugalcdep.2010.09.020; El Marroun H, 2016, BIOL PSYCHIAT, V79, P971, DOI 10.1016/j.biopsych.2015.08.024; Eyler LT, 2011, HUM BRAIN MAPP, V32, P641, DOI 10.1002/hbm.21054; Fein G, 2013, NEUROIMAGE-CLIN, V3, P47, DOI 10.1016/j.nicl.2013.06.018; Fein G, 2013, PSYCHIAT RES-NEUROIM, V214, P1, DOI 10.1016/j.pscychresns.2013.06.001; Filbey FM, 2015, BEHAV BRAIN RES, V293, P46, DOI 10.1016/j.bbr.2015.07.029; Filbey FM, 2014, P NATL ACAD SCI USA, V111, P16913, DOI 10.1073/pnas.1415297111; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Franklin TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104102; Froeliger B, 2010, PSYCHOPHARMACOLOGY, V210, P577, DOI 10.1007/s00213-010-1862-3; Gillespie NA, 2013, TWIN RES HUM GENET, V16, P21, DOI 10.1017/thg.2012.111; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Hanlon CA, 2016, ADDICT BIOL, V21, P185, DOI 10.1111/adb.12171; Hanson KL, 2010, AM J DRUG ALCOHOL AB, V36, P161, DOI 10.3109/00952991003736397; Hunt D., 2006, METHAMPHETAMINE USE; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; Johnston LD, 2009, J ADOLESCENT HEALTH, V45, P539, DOI 10.1016/j.jadohealth.2009.09.004; Kendler KS, 2005, PSYCHOL MED, V35, P1349, DOI 10.1017/S0033291705004964; Koenders L, 2015, J PSYCHIATR NEUROSCI, V40, P197, DOI 10.1503/jpn.140081; Kremen WS, 2006, TWIN RES HUM GENET, V9, P1009, DOI 10.1375/twin.9.6.1009; Kremen WS, 2013, TWIN RES HUM GENET, V16, P399, DOI 10.1017/thg.2012.86; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Lyons MJ, 2004, PSYCHOL MED, V34, P1239, DOI 10.1017/S0033291704002260; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Medina KL, 2009, ADDICT BIOL, V14, P457, DOI 10.1111/j.1369-1600.2009.00166.x; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Momenan R, 2012, PSYCHIAT RES-NEUROIM, V204, P101, DOI 10.1016/j.pscychresns.2012.05.003; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039830; Morley KI, 2015, DRUG ALCOHOL REV, V34, P427, DOI 10.1111/dar.12263; Nagel BJ, 2005, PSYCHIAT RES-NEUROIM, V139, P181, DOI 10.1016/j.pscychresns.2005.05.008; Neale MC., 1992, METHODOLOGY GENETIC; Noyan CO, 2016, NEUROPSYCH DIS TREAT, V12, P1355, DOI 10.2147/NDT.S107733; Pagliaccio D, 2015, JAMA PSYCHIAT, V72, P994, DOI 10.1001/jamapsychiatry.2015.1054; PICKLES A, 1994, BEHAV GENET, V24, P457, DOI 10.1007/BF01076181; Pinheiro J, NLME LINEAR NONLINEA; Quinn RK, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.144; R Development Core Team, 2008, R LANG ENV STAT COMP; Rando K, 2013, BIOL PSYCHIAT, V74, P482, DOI 10.1016/j.biopsych.2013.04.030; Reid AG, 2008, J PSYCHOPHARMACOL, V22, P7, DOI 10.1177/0269881107080795; Renteria ME, 2014, GENES BRAIN BEHAV, V13, P821, DOI 10.1111/gbb.12177; Rocchetti M, 2013, PSYCHIAT CLIN NEUROS, V67, P483, DOI 10.1111/pcn.12085; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; RUBBOLI F, 1994, NEUROCHEM INT, V25, P69, DOI 10.1016/0197-0186(94)90055-8; Schiffer B, 2011, ARCH GEN PSYCHIAT, V68, P1039, DOI 10.1001/archgenpsychiatry.2011.61; Schiffer B, 2010, BRAIN, V133, P3093, DOI 10.1093/brain/awq153; Schoeneborn C.A., 2009, NATL HLTH STAT REPOR, V16; Silins E, 2014, LANCET PSYCHIAT, V1, P286, DOI 10.1016/S2215-0366(14)70307-4; Squeglia LM, 2009, CLIN EEG NEUROSCI, V40, P31, DOI 10.1177/155005940904000110; Squeglia LM, 2014, DEV COGN NEUROS-NETH, V9, P117, DOI 10.1016/j.dcn.2014.02.005; Stone JM, 2012, EUR NEUROPSYCHOPHARM, V22, P114, DOI 10.1016/j.euroneuro.2011.06.004; Substance Abuse and Mental Health Services Administration, 2012, NSDUH SER H, VH-46; Substance Abuse and Mental Health Services Administration, 2013, HHS PUBL; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Vafaee MS, 2015, J CEREBR BLOOD F MET, V35, P699, DOI 10.1038/jcbfm.2014.246; van Holst RJ, 2012, DRUG ALCOHOL DEPEN, V124, P142, DOI 10.1016/j.drugalcdep.2011.12.025; van Wingen GA, 2013, DRUG ALCOHOL DEPEN, V131, P198, DOI 10.1016/j.drugalcdep.2013.05.007; Verweij KJH, 2010, ADDICTION, V105, P417, DOI 10.1111/j.1360-0443.2009.02831.x; Walter M, 2012, CURR TOP MED CHEM, V12, P2426, DOI 10.2174/156802612805289971; Wang J, 2010, NEUROPSYCHOPHARMACOL, V35, P702, DOI 10.1038/npp.2009.178; Welch KA, 2011, BRIT J PSYCHIAT, V199, P386, DOI 10.1192/bjp.bp.110.090175; Yip SW, 2014, DRUG ALCOHOL DEPEN, V140, P33, DOI 10.1016/j.drugalcdep.2014.03.031; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694	79	11	11	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0965-2140	1360-0443		ADDICTION	Addiction	SEP	2018	113	9					1661	1672		10.1111/add.14252			12	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	GP2GD	WOS:000440644200010	29691937	Green Accepted			2022-02-06	
J	Hadanny, A; Abbott, S; Suzin, G; Bechor, Y; Efrati, S				Hadanny, Amir; Abbott, Stefanie; Suzin, Gil; Bechor, Yair; Efrati, Shai			Effect of hyperbaric oxygen therapy on chronic neurocognitive deficits of post-traumatic brain injury patients: retrospective analysis	BMJ OPEN			English	Article						TBI; HBOT; traumatic brain injury; hyperbaric oxygen; cognitive	POST-CONCUSSION SYNDROME; SYMPTOMS; ANGIOGENESIS; PRESSURE; STROKE; CORTEX; CELLS	Objectives The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) in participants suffering from chronic neurological deficits due to traumatic brain injury (TBI) of all severities in the largest cohort evaluated so far with objective cognitive function tests and metabolic brain imaging. Methods A retrospective analysis was conducted of 154 patients suffering from chronic neurocognitive damage due to TBI, who had undergone computerised cognitive evaluations pre-HBOT and post-HBOT treatment. Results The average age was 42.714.6 years, and 58.4% were men. All patients had documented TBI 0.3-33 years (mean 4.6 +/- 5.8, median 2.75 years) prior to HBOT. HBOT was associated with significant improvement in all of the cognitive domains, with a mean change in global cognitive scores of 4.6 +/- 8.5 (p<0.00001). The most prominent improvements were in memory index and attention, with mean changes of 8.1 +/- 16.9 (p<0.00001) and 6.8 +/- 16.5 (p<0.0001), respectively. The most striking changes observed in brain single photon emission computed tomography images were in the anterior cingulate and the postcentral cortex, in the prefrontal areas and in the temporal areas. Conclusions In the largest published cohort of patients suffering from chronic deficits post-TBI of all severities, HBOT was associated with significant cognitive improvements. The clinical improvements were well correlated with increased activity in the relevant brain areas.	[Hadanny, Amir] Galilee Med Ctr, Neurosurg Dept, Nahariyya, Israel; [Hadanny, Amir; Abbott, Stefanie; Suzin, Gil; Bechor, Yair; Efrati, Shai] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel; [Hadanny, Amir] Bar Ilan Univ, Galilee Fac Med, Ramat Gan, Israel; [Hadanny, Amir; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Efrati, Shai] Assaf Harfoeh Med Ctr, Res & Dev Unit, Zerifin, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Hadanny, A (corresponding author), Galilee Med Ctr, Neurosurg Dept, Nahariyya, Israel.; Hadanny, A (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel.; Hadanny, A (corresponding author), Bar Ilan Univ, Galilee Fac Med, Ramat Gan, Israel.; Hadanny, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	amir.had@gmail.com		Hadanny, Amir/0000-0001-9028-7268			Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Berman S, 2013, NEPHROLOGY, V18, P292, DOI 10.1111/nep.12043; Bhutani S, 2012, INDIAN J PLAST SURG, V45, P316, DOI 10.4103/0970-0358.101309; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Cifu DX, 2014, J REHABIL RES DEV, V51, P1047, DOI 10.1682/JRRD.2014.01.0013; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Doniger GM, GUIDE NORMATIVE DATA; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Etzion Y, 2000, EUR J NEUROSCI, V12, P4007, DOI 10.1046/j.1460-9568.2000.00303.x; Figueroa XA, 2016, NEUROLOGY, V87, P1400, DOI 10.1212/WNL.0000000000003146; Fujita N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115685; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; JASZCZAK RJ, 1979, PHYS MED BIOL, V24, P1123, DOI 10.1088/0031-9155/24/6/003; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kochanek PM, 2007, BRAIN INJURY MED PRI, P81; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Melton JL, 2005, PSYCHOMETRIC EVALUAT; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Schweiger GMD A, 2003, ACTA NEUROPSYCHOLOGI, V1, P407; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sohlberg M., 2001, COGNITIVE REHABILITA; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Takemura A, 2017, J ATHEROSCLER THROMB, V24, P26, DOI 10.5551/jat.34686; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Tal S, 2015, RESTOR NEUROL NEUROS, V33, P943, DOI 10.3233/RNN-150585; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Zur D, 2015, J NEURO-OPHTHALMOL, V35, P26, DOI 10.1097/WNO.0000000000000199	44	11	14	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2018	8	9							e023387	10.1136/bmjopen-2018-023387			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HA6VD	WOS:000450417800139	30269074	Green Published, gold			2022-02-06	
J	Lequerica, AH; Lucca, C; Chiaravalloti, ND; Ward, I; Corrigan, JD				Lequerica, Anthony H.; Lucca, Christian; Chiaravalloti, Nancy D.; Ward, Irene; Corrigan, John D.			Feasibility and Preliminary Validation of an Online Version of the Ohio State University Traumatic Brain Injury Identification Method	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						History; Questionnaires; Rehabilitation; Survey; Traumatic brain injury	POST-CONCUSSION SYMPTOMS; PSYCHIATRIC-DISORDERS; RELIABILITY; QUESTIONNAIRE; VALIDITY; MODERATE; HISTORY; HEALTH	Objective: To test the feasibility and validity of an online version of an established interview designed to determine a lifetime history of traumatic brain injury (TBI). Design: Cross-sectional. Setting: General community. Participants: A volunteer sample of individuals (N= 265) from the general population across the United States. Interventions: Not applicable. Main Outcome Measure(s): Online version of the Ohio State University Traumatic Brain Injury Identification Method, Rivermead Postconcussion Symptoms Questionnaire (RPQ), Patient-Reported Outcomes Measurement Information System Cognitive Concerns Scale. Results: The measure was completed by 89.4% of the sample with most participants completing the measure in <8 minutes. After controlling for age, sex, psychiatric history, drug or alcohol history, and history of developmental disability, worst TBI severity was significantly associated with scores on the RPQ, F(2,230)=4.56, P= .011, and having a TBI within the past 2 years was associated with higher scores on the cognitive factor subscale of the RPQ, F(1,75)=7.7, P= .007. Conclusions: The online administration of the Ohio State University Traumatic Brain Injury Identification Method appears to be feasible in the general population. Preliminary validity was demonstrated for the indices of worst TBI severity and time since most recent TBI. (C) 2018 by the American Congress of Rehabilitation Medicine	[Lequerica, Anthony H.; Lucca, Christian; Chiaravalloti, Nancy D.] Kessler Fdn, Ctr Traumat Brain Injury Rehabil Res, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA; [Lequerica, Anthony H.; Chiaravalloti, Nancy D.] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Ward, Irene] Kessler Inst Rehabil, Brain Injury Program, W Orange, NJ USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Lequerica, AH (corresponding author), Kessler Fdn, Ctr Traumat Brain Injury Rehabil Res, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	alequerica@kesslerfoundation.org	Corrigan, John D./E-2921-2011	Chiaravalloti, Nancy/0000-0003-2943-7567			Becker Heather, 2014, Int J MS Care, V16, P1, DOI 10.7224/1537-2073.2012-047; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Fieo Robert, 2016, Psychol Test Assess Model, V58, P255; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141	22	11	11	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2018	99	9					1811	1817		10.1016/j.apmr.2018.03.023			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GT2YK	WOS:000444366000014	29709522				2022-02-06	
J	Li, QX; Shen, YX; Ahmad, A; Shen, YJ; Zhang, YQ; Xu, PK; Chen, WW; Yu, YQ				Li, Qing-Xin; Shen, Yu-Xian; Ahmad, Akhlaq; Shen, Yu-Jun; Zhang, Yi-Quan; Xu, Pei-Kun; Chen, Wei-Wei; Yu, Yong-Qiang			Mesencephalic Astrocyte-Derived Neurotrophic Factor Prevents Traumatic Brain Injury in Rats by Inhibiting Inflammatory Activation and Protecting the Blood-Brain Barrier	WORLD NEUROSURGERY			English	Article						Blood-brain barrier; Endoplasmic reticulum stress; MANF; MRI; Neuroinflammation; NF-kappa B; Traumatic brain injury	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; KAPPA-B; SUBARACHNOID HEMORRHAGE; VASCULAR INTEGRITY; OXIDATIVE STRESS; NUCLEAR-FACTOR; CELL-DEATH; MODEL; MANF	BACKGROUND: Our previous studies have shown that mesencephalic astrocyte-derived neurotrophic factor (MANF) provides a neuroprotective effect against ischemia/reperfusion injury and is also involved in inflammatory disease models. This study investigates the potential role and mechanism of MANF in acute brain damage after traumatic brain injury (TBI). METHODS: The model of TBI was induced by Feeney free falling methods with male Sprague-Dawley rats. The expression of MANF, 24 hours after TBI, was detected by the immunohistochemistry, immunofluorescence, Western blot, and reverse transcription polymerase chain reaction techniques. After treatment with recombinant human MANF after TBI, assessment was conducted 24 hours later for brain water content, cerebral edema volume in magnetic resonance imaging, neurobehavioral testing, and Evans blue extravasation. Moreover, by the techniques of Western blot and reverse transcription polymerase chain reaction, the expression of inflammatory cytokines (interleukin 1 beta and tumor necrosis factor alpha) and P65 was also analyzed to explore the underlying protective mechanism of MANF. RESULTS: At 24 hours after TBI, we found that endogenous MANF was widely expressed in the rat's brain tissues and different types of cells. Treatment with a high dose of recombinant human MANF (20 mu g/20 mu L) significantly increased the modified Garcia score, and reduced brain water content as well as cerebral edema volume on magnetic resonance imaging. Furthermore, MANF alleviated not only the permeability of the blood-brain barrier (BBB) but also the expressions of interleukin 1 beta and tumor necrosis factor alpha messenger RNA and protein. Besides, the activation of P65 was also inhibited. CONCLUSIONS: These results suggest that MANF provides a neuroprotective effect against acute brain injury after TBI, via attenuating blood-brain barrier disruption and intracranial neuroinflammation; the inhibition of the NF-kappa B signaling pathway might be a potential mechanism.	[Li, Qing-Xin; Zhang, Yi-Quan; Xu, Pei-Kun; Chen, Wei-Wei; Yu, Yong-Qiang] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Shen, Yu-Xian; Shen, Yu-Jun] Anhui Med Univ, Sch Basic Med Sci, Hefei, Anhui, Peoples R China; [Shen, Yu-Xian; Shen, Yu-Jun] Anhui Med Univ, Biopharmaceut Inst, Hefei, Anhui, Peoples R China; [Ahmad, Akhlaq] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Ahmad, Akhlaq] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China		Yu, YQ (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China.	cjr.yuyongqiang@vip.163.com		Shen, Yuxian/0000-0002-0916-0743	Cultured National Natural Science Foundation of China Youth Fund in The First Affiliated Hospital, AMU [2011KJ19]	This work was partly supported by the Cultured National Natural Science Foundation of China Youth Fund in The First Affiliated Hospital, AMU (number2011KJ19 to Q.-X.L.).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Chen YC, 2012, DEV BIOL, V370, P237, DOI 10.1016/j.ydbio.2012.07.030; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; GRAEBER MB, 1989, NEUROSCI LETT, V103, P241, DOI 10.1016/0304-3940(89)90106-7; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mao X, 2016, AM J TRANSL RES, V8, P133; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pamukcu B, 2011, THROMB RES, V128, P117, DOI 10.1016/j.thromres.2011.03.025; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Patel MB, 2015, J NEUROTRAUM, V32, P984, DOI 10.1089/neu.2014.3652; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raji CA, 2015, BRAIN IMAGING BEHAV, V9, P527, DOI 10.1007/s11682-015-9385-5; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang DM, 2010, BIOCHEM BIOPH RES CO, V402, P123, DOI 10.1016/j.bbrc.2010.09.128; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Xu B, 2014, MOL MED REP, V10, P1863, DOI 10.3892/mmr.2014.2462; Yan JH, 2008, EXP NEUROL, V214, P37, DOI 10.1016/j.expneurol.2008.07.006; Yan JH, 2013, STROKE, V44, P1410, DOI 10.1161/STROKEAHA.113.678474; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Zhu W, 2016, IMMUNOPHARM IMMUNOT, V38, P205, DOI 10.3109/08923973.2016.1168433	53	11	11	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2018	117						E117	E129		10.1016/j.wneu.2018.05.202			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GR2UR	WOS:000442440400015	29883817				2022-02-06	
J	Trzepacz, PT; Franco, JG; Meagher, DJ; Lee, Y; Kim, JL; Kishi, Y; Furlanetto, LM; Negreiros, D; Huang, MC; Chen, CH; Kean, J; Leonard, M				Trzepacz, Paula T.; Franco, Jose G.; Meagher, David J.; Lee, Yanghyun; Kim, Jeong-Lan; Kishi, Yasuhiro; Furlanetto, Leticia M.; Negreiros, Daniel; Huang, Ming-Chyi; Chen, Chun-Hsin; Kean, Jacob; Leonard, Maeve			Delirium Phenotype by Age and Sex in a Pooled Data Set of Adult Patients	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							RATING SCALE-REVISED-98 RELIABILITY; ALZHEIMERS-DISEASE; GENDER-DIFFERENCES; SCALE REVISED-98; SYMPTOM PROFILE; DEMENTIA; VERSION; VALIDITY; PHENOMENOLOGY; POPULATION	The authors aimed to evaluate whether the clinical phenotype of delirium differs if dichotomized either by sex or age (cutoff age, 65 years old) in a pooled sample of 406 nondemented adult patients with delirium as defined by DSM-IV criteria. Delirium characteristics were measured with the Delirium Rating Scale-Revised-98 (DRS-R-98). DRS-R-98 items were subgrouped to represent subscores representing the three core domains of delirium (cognitive, higher-order thinking, and circadian), noncore accessory symptoms (psychotic and affective), and diagnostic characteristics (temporal onset, fluctuation, and physical disorder). The authors compared means of the DRS-R-98 subscores and medians of individual items. Exploratory factor analyses evaluated delirium characteristics for each subgroup for each of the four groups-male, female, nongeriatric, and geriatric-while taking into account active medical diagnoses. Mates had higher scores on motor agitation and affective lability (behavioral), whereas females had a higher frequency of hypoactive delirium. Delirium had a two-factor structure that emerged in all four study groups, and all its core domains loaded (i.e., correlated together) onto some of these two factors and with circadian domain correlating with accessory symptoms. Although the influence of a variety of active diagnoses on delirium was small and complex, traumatic brain injury had a clear influence on cognitive domain and abrupt onset. Age had a mild influence over delirium characteristics for both males and females. In conclusion, the authors confirmed a two-factor structure for delirium phenomenology, regardless of age and sex, with few significant differences between etiological groups.	[Trzepacz, Paula T.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Franco, Jose G.] Univ Pontificia Botivariana, Fac Med, GIPE, Medellin, Colombia; [Meagher, David J.; Leonard, Maeve] Univ Limerick, Grad Entry Med Sch, Dept Psychiat, Limerick V94 F858, Ireland; [Meagher, David J.; Leonard, Maeve] Univ Hosp Limerick, Clin Educ & Res Ctr, Limerick V94 F858, Ireland; [Lee, Yanghyun] Mungyeong Jeil Gen Hosp, Dept Psychiat, Mungyeong, South Korea; [Kim, Jeong-Lan] Chungnam Natl Univ, Coll Med, Dept Psychiat, Daejeon, South Korea; [Kishi, Yasuhiro] Musashikosugi Hosp, Nippon Med Sch, Dept Psychiat, Kawasaki, Kanagawa, Japan; [Furlanetto, Leticia M.; Negreiros, Daniel] Univ Fed Santa Catarina, Dept Internal Med, Florianopolis, SC, Brazil; [Huang, Ming-Chyi] Taipei City Hosp, Taipei City Psychiat Ctr, Dept Psychiat, Taipei, Taiwan; [Chen, Chun-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Chun-Hsin] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan; [Kean, Jacob] Univ Utah, VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Hlth Syst Innovat & Res, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Dept Commun Sci & Disorders, Salt Lake City, UT USA		Franco, JG (corresponding author), Univ Pontificia Botivariana, Fac Med, GIPE, Medellin, Colombia.	pttrzepacz@outlook.com; josefranco11@hotmail.com	Franco, Jose G./N-2850-2014; Huang, Ming-Chyi/W-9515-2019; Kishi, Yasuhiro/T-4047-2019; Trzepacz, Paula/AAQ-3330-2021	Franco, Jose G./0000-0001-9255-8084; Kim, Jeong Lan/0000-0002-6554-4637			Londono EMC, 2018, INTENS CRIT CARE NUR, V45, P37, DOI 10.1016/j.iccn.2017.12.010; Cole MG, 2002, J NEUROPSYCH CLIN N, V14, P167, DOI 10.1176/appi.neuropsych.14.2.167; Cortes EP, 2014, DEMENTIA COMPREHENSI; de Negreiros DP, 2008, INT J GERIATR PSYCH, V23, P472, DOI 10.1002/gps.1906; Edlund A, 2007, J GERIATR PSYCH NEUR, V20, P166, DOI 10.1177/0891988707303338; Erol A, 2015, BIPOLAR DISORD, V17, P670, DOI 10.1111/bdi.12329; Franco JG, 2007, ACTAS ESP PSIQUIATRI, V35, P170; Franco JG, 2013, PSYCHOSOMATICS, V54, P227, DOI 10.1016/j.psym.2012.06.010; Franco JG, 2009, PSYCHOSOMATICS, V50, P255, DOI 10.1176/appi.psy.50.3.255; Grover S, 2013, East Asian Arch Psychiatry, V23, P56; Grover S, 2011, J PSYCHOSOM RES, V70, P473, DOI 10.1016/j.jpsychores.2010.11.007; Huang MC, 2009, COMPR PSYCHIAT, V50, P81, DOI 10.1016/j.comppsych.2008.05.011; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Jain G, 2011, GEN HOSP PSYCHIAT, V33, P377, DOI 10.1016/j.genhosppsych.2011.05.001; Kato M, 2010, PSYCHOSOMATICS, V51, P425, DOI 10.1176/appi.psy.51.5.425; Kean J, 2010, BRAIN INJURY, V24, P1222, DOI 10.3109/02699052.2010.498008; Laurila JV, 2004, INT J GERIATR PSYCH, V19, P271, DOI 10.1002/gps.1079; Laws KR, 2016, WORLD J PSYCHIATR, V6, P54, DOI 10.5498/wjp.v6.i1.54; Lee Jun, 2008, [Journal of the Korean Society of Biological Therapies in Psychiatry, 생물치료정신의학], V14, P101; Lee Y, 2011, PSYCHIAT INVEST, V8, P30, DOI 10.4306/pi.2011.8.1.30; Leentjens AFG, 2008, J PSYCHOSOM RES, V64, P219, DOI 10.1016/j.jpsychores.2007.11.003; Leonard M, 2011, J NEUROPSYCH CLIN N, V23, P180, DOI 10.1176/appi.neuropsych.23.2.180; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Lin Katherine A, 2015, Alzheimers Dement (N Y), V1, P103; Lipowski Z J, 1991, Int Psychogeriatr, V3, P115, DOI 10.1017/S1041610291000595; LIPTZIN B, 1993, J NEUROPSYCH CLIN N, V5, P154; Mattoo SK, 2012, J NEUROPSYCH CLIN N, V24, P95, DOI 10.1176/appi.neuropsych.11010009; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Meagher DJ, 2012, J PSYCHOSOM RES, V72, P236, DOI 10.1016/j.jpsychores.2011.11.013; Meagher DJ, 2010, J NEUROL NEUROSUR PS, V81, P876, DOI 10.1136/jnnp.2009.200956; Neumarker KJ, 2001, HIST PSYCHIATR, V12, P213, DOI 10.1177/0957154X0101204605; Ross C A, 1991, Int Psychogeriatr, V3, P135, DOI 10.1017/S1041610291000613; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Sepulveda E, 2015, PSYCHOSOMATICS, V56, P530, DOI 10.1016/j.psym.2015.03.005; Sundermann EE, 2016, NEUROLOGY, V87, P1916, DOI 10.1212/WNL.0000000000003288; Thurber S, 2015, J NEUROPSYCH CLIN N, V27, pE122, DOI 10.1176/appi.neuropsych.13110345; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Trzepacz PT, 1998, J NEUROPSYCH CLIN N, V10, P199, DOI 10.1176/jnp.10.2.199; Trzepacz PT, 2010, ADM MANUAL DELIRIUM; Turkel SB, 2006, PSYCHOSOMATICS, V47, P320, DOI 10.1176/appi.psy.47.4.320; Vest RS, 2013, HORM BEHAV, V63, P301, DOI 10.1016/j.yhbeh.2012.04.006; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Voyer Philippe, 2006, Clin Nurs Res, V15, P46, DOI 10.1177/1054773805282299; Weiss EM, 2005, FORTSCHR NEUROL PSYC, V73, P587, DOI 10.1055/s-2004-830296; Wharton W, 2009, AM J TRANSL RES, V1, P131; 임경옥, 2006, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V45, P518	46	11	11	0	4	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2018	30	4					294	301		10.1176/appi.neuropsych.18020024			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GX8GY	WOS:000448023000006	30045679	Bronze			2022-02-06	
J	Willer, BS; Zivadinov, R; Haider, MN; Miecznikowski, JC; Leddy, JJ				Willer, Barry S.; Zivadinov, Robert; Haider, Mohammad N.; Miecznikowski, Jeffrey C.; Leddy, John J.			A Preliminary Study of Early-Onset Dementia of Former Professional Football and Hockey Players	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; chronic traumatic encephalopathy; concussion; retired athletes	CHRONIC TRAUMATIC ENCEPHALOPATHY; CONCUSSION; INVENTORY	Objective: To provide an overview of 3 studies of the same population of retired professional contact sport athletes compared with age-matched noncontact sport athlete controls on cognition, executive function, behavior, and advanced brain imaging. Setting: University Concussion Management Clinic. Participants: Twenty-two retired professional hockey and football athletes (average age 56 years) and 21 age-matched noncontact sport athlete controls. Design: Case control. Main Measures: Participants were assessed on a broad range of neuropsychological measures that are associated with identification of mild cognitive impairment and executive function. Athletes were also assessed using self-report measures of executive function and personality. Advanced structural and functional imaging techniques were utilized as well. Results: The former National Football League and National Hockey League athletes perceived themselves to have impaired executive function, but this was not confirmed by objective neurocognitive assessment. No significant differences were found when comparing contact-sport athletes with controls on the presence of mild cognitive impairment or brain structural and functional tissue injury. Contact sport athletes were more anxious and more likely to report unusual beliefs and experiences. Conclusion: None of the retired contact sport athletes qualified as having early-onset dementia consistent with chronic traumatic encephalopathy. There were no remarkable differences in imaging, cognition, behavior, or executive function from noncontact sport athletes. The results underscore an apparent disconnect between public perceptions and evidence-based conclusions about the inevitability of chronic traumatic encephalopathy and the potential neurodegenerative effect on former athletes from contact sports.	[Willer, Barry S.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA; [Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY USA; [Haider, Mohammad N.; Leddy, John J.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Orthoped & Sports Med, Buffalo, NY USA; [Miecznikowski, Jeffrey C.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biostat, Buffalo, NY USA		Willer, BS (corresponding author), SUNY Buffalo, Dept Psychiat, G96 Farber Hall,Main St Campus, Buffalo, NY 14214 USA.	bswiller@buffalo.edu	Zivadinov, Robert/Q-2054-2019	Zivadinov, Robert/0000-0002-7799-1485	National Institutes of Health (National Center for Advancing Translational Sciences) [UL1TR001412]; Robert Rich Family Foundation; Ralph and Mary Wilson Foundation; Biogen IdecBiogen; Teva PharmaceuticalsTeva Pharmaceutical Industries; Sanofi-GenzymeSanofi-AventisGenzyme Corporation; NovartisNovartis; Claret Medical; Coherus-Intekrin; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER	We wish to thank the following organizations for financial support: The National Institutes of Health (National Center for Advancing Translational Sciences) award number UL1TR001412; the Robert Rich Family Foundation; and the Ralph and Mary Wilson Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other funding source. We also want to thank the research team at Boston University, in particular Dr Robert Stern, for their willingness to share their protocol for evaluation of neurocognitive performance.; Dr Zivadinov received personal compensation from EMD Serono, Novartis, Celgene, Genentech, Claret Medical, and Sanofi-Genzyme for speaking and consultant fees. Dr Zivadinov received financial support for research activities from Biogen Idec, Teva Pharmaceuticals, Sanofi-Genzyme, Novartis, Claret Medical, and Coherus-Intekrin. Other investigators report no conflicts of interest.	Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Clark LR, 2013, J INT NEUROPSYCH SOC, V19, P635, DOI 10.1017/S1355617713000313; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; De Abajo S, 2001, J SPORT MED PHYS FIT, V41, P479; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Krueger RF, 2014, ANNU REV CLIN PSYCHO, V10, P477, DOI 10.1146/annurev-clinpsy-032813-153732; Mckee A, 2009, J NEUROPATH EXP NEUR, V68, P560; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Riley DO, 2015, BRAIN INJURY, V29, P154, DOI 10.3109/02699052.2014.965215; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stoyanova S, 2016, BJCEM, V4, P41	28	11	11	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E1	E8		10.1097/HTR.0000000000000421			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500001	30080796	Green Accepted			2022-02-06	
J	Zhang, R; Liang, Y; Wei, SX				Zhang, Ran; Liang, Yi; Wei, Shuxiang			M2 macrophages are closely associated with accelerated clavicle fracture healing in patients with traumatic brain injury: a retrospective cohort study	JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH			English	Article						Traumatic brain injury; Clavicle fracture; Fracture healing; Macrophages	BONE; CELLS; MODEL	Background: Mounting evidence indicate patients with traumatic brain injury (TBI) have an accelerated fracture healing. The healing process of bone fractures is greatly dependent on infiltrated macrophages. The macrophages are categorized into M1 or M2 phenotypes with different functions. This study is aimed to address the potential role of subtypes of macrophages in the process of fracture healing in patients with TBI. Methods: Twenty-five cases of clavicle fracture alone (CF group) and 22 cases of clavicle fracture concomitant with TBI (CFT group) were retrospectively analyzed in this study. Callus tissues were harvested during operations. The expressions of COX-2, CD206, and CD68 were measured with immunohistochemistry. Results: The percentages of M2 macrophages in total macrophages increased after bone fracture in both groups, while the percentages of M1-type macrophages are decreased. Interestingly, the increased percentages of M2 macrophages are significantly higher in CFT group than in CF group. Compared to CF group, the fracture callus volume was much larger (21.9 vs 8.5 cm(3)) and the fracture healing time was much shorter (82.2 vs 127.0 days) in CFT group. The percentage of M2 macrophages was negatively correlated with fracture healing time in patients (r = - 0.575, p < 0.01). Conclusions: The findings suggest that the percentages of M2 macrophages in callus tissues increased dramatically during the repairing stage in both CF and CFT group. Percentages of M2 macrophages are associated with accelerated fracture healing in patients with TBI. M2 macrophage polarization during the stage of bone regeneration may play a vital role in promoting bone fracture healing.	[Zhang, Ran; Liang, Yi; Wei, Shuxiang] Liuzhou Gen Hosp, Dept Orthoped, 8 Wenchang Rd, Liuzhou 545006, Guangxi, Peoples R China; [Zhang, Ran] Guangxi Univ Technol, Liuzhou 545006, Guangxi, Peoples R China		Zhang, R (corresponding author), Liuzhou Gen Hosp, Dept Orthoped, 8 Wenchang Rd, Liuzhou 545006, Guangxi, Peoples R China.; Zhang, R (corresponding author), Guangxi Univ Technol, Liuzhou 545006, Guangxi, Peoples R China.	zr7971@126.com	Liang, Yi/ABD-9785-2021	Liang, Yi/0000-0002-6440-6144	Science and Technology Program of Liuzhou [2015 J030524]	The study was supported by the Science and Technology Program of Liuzhou (No. 2015 J030524).	Abdelmagid SM, 2015, LIFE SCI, V123, P25, DOI 10.1016/j.lfs.2014.11.011; Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Annamalai RT, 2018, BIOMATERIALS, V161, P216, DOI 10.1016/j.biomaterials.2018.01.040; Baht GS, 2018, CURR OSTEOPOROS REP, V16, P138, DOI 10.1007/s11914-018-0423-2; Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031; CALANDRIELLO B, 1964, Bull Hosp Joint Dis, V25, P170; Chiossone L, 2016, STEM CELLS, V34, P1909, DOI 10.1002/stem.2369; Cho SW, 2015, J PATHOL TRANSL MED, V49, P102, DOI 10.4132/jptm.2015.02.02; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Juban G, 2017, FEBS LETT, V591, P3007, DOI 10.1002/1873-3468.12703; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Michalski MN, 2017, PHARMACOL THERAPEUT, V174, P43, DOI 10.1016/j.pharmthera.2017.02.017; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakamura Y, 2016, J STROKE CEREBROVASC, V25, P600, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.034; Nunez SY, 2018, J IMMUNOL, V200, P1008, DOI 10.4049/jimmunol.1700737; Pajarinen J, 2019, BIOMATERIALS, V196, P80, DOI 10.1016/j.biomaterials.2017.12.025; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Sang XG, 2017, ANN CLIN BIOCHEM, V54, P584, DOI 10.1177/0004563216673087; Schlundt C, 2018, BONE, V106, P78, DOI 10.1016/j.bone.2015.10.019; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735; Song Y, 2017, EUR REV MED PHARMACO, V21, P1522; Suto Y, 2018, J TRAUMA ACUTE CARE, V85, P275, DOI 10.1097/TA.0000000000001957; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442	31	11	12	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-799X			J ORTHOP SURG RES	J. Orthop. Surg. Res.	AUG 29	2018	13								213	10.1186/s13018-018-0926-7			9	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	GR9SY	WOS:000443113100001	30157885	Green Published, gold			2022-02-06	
J	Bareham, CA; Allanson, J; Roberts, N; Hutchinson, PJA; Pickard, JD; Menon, DK; Chennu, S				Bareham, Corinne A.; Allanson, Judith; Roberts, Neil; Hutchinson, Peter J. A.; Pickard, John D.; Menon, David K.; Chennu, Srivas			Longitudinal Bedside Assessments of Brain Networks in Disorders of Consciousness: Case Reports From the Field	FRONTIERS IN NEUROLOGY			English	Article						consciousness; electroencephalography; brain networks; longitudinal assessment; disorders of consciousness; minimally conscious state; unresponsive wakefulness state	DEFAULT MODE NETWORK; COMA RECOVERY SCALE; FUNCTIONAL CONNECTIVITY; AWARENESS; DYNAMICS; DIAGNOSIS; BASES	Clinicians are regularly faced with the difficult challenge of diagnosing consciousness after severe brain injury. As such, as many as 40% of minimally conscious patients who demonstrate fluctuations in arousal and awareness are known to be misdiagnosed as unresponsive/vegetative based on clinical consensus. Further, a significant minority of patients show evidence of hidden awareness not evident in their behavior. Despite this, clinical assessments of behavior are commonly used as bedside indicators of consciousness. Recent advances in functional high-density electroencephalography (hdEEG) have indicated that specific patterns of resting brain connectivity measured at the bedside are strongly correlated with the re-emergence of consciousness after brain injury. We report case studies of four patients with traumatic brain injury who underwent regular assessments of hdEEG connectivity and Coma Recovery Scale-Revised (CRS-R) at the bedside, as part of an ongoing longitudinal study. The first, a patient in an unresponsive wakefulness state (UWS), progressed to a minimally-conscious state several years after injury. HdEEG measures of alpha network centrality in this patient tracked this behavioral improvement. The second patient, contrasted with patient 1, presented with a persistent UWS diagnosis that paralleled with stability on the same alpha network centrality measure. Patient 3, diagnosed as minimally conscious minus (MCS-), demonstrated a significant late increase in behavioral awareness to minimally conscious plus (MCS+). This patient's hdEEG connectivity across the previous 18 months showed a trajectory consistent with this increase alongside a decrease in delta power. Patient 4 contrasted with patient 3, with a persistent MCS-diagnosis that was similarly tracked by consistently high delta power over time. Across these contrasting cases, hdEEG connectivity captures both stability and recovery of behavioral trajectories both within and between patients. Our preliminary findings highlight the feasibility of bedside hdEEG assessments in the rehabilitation context and suggest that they can complement clinical evaluation with portable, accurate and timely generation of brain-based patient profiles. Further, such hdEEG assessments could be used to estimate the potential utility of complementary neuroimaging assessments, and to evaluate the efficacy of interventions.	[Bareham, Corinne A.; Hutchinson, Peter J. A.; Pickard, John D.; Chennu, Srivas] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Allanson, Judith] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Roberts, Neil] Jacobs & Gardens Neuro Ctr, Sawbridgeworth Med Serv, Sawbridgeworth, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Chennu, Srivas] Univ Kent, Sch Comp, Canterbury, Kent, England		Chennu, S (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Chennu, S (corresponding author), Univ Kent, Sch Comp, Canterbury, Kent, England.	sc785@kent.ac.uk		Hutchinson, Peter/0000-0002-2796-1835; Bareham, Corinne/0000-0003-1814-9527	Evelyn Trust [15/07]; UK Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/P033199/1]; UK National Institute for Health Research (NIHR) as part of the Acute Brain Injury and Repair Theme of the Cambridge Biomedical Research Centre; NIHRNational Institute for Health Research (NIHR); NIHR Cambridge BRC; NIHR Brain Injury Healthcare Technology Cooperative; James S. McDonnell Foundation; Alan Turing Institute (UK Engineering and Physical Sciences Research Council)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N510129/1]; NIHR Senior Investigator award; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/P033199/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025, G0502030, G0600986, G9439390, G0001237, G1002277] Funding Source: UKRI	The authors received funding from the Evelyn Trust [SC, Ref: 15/07], UK Engineering and Physical Sciences Research Council [SC, Ref: EP/P033199/1], the UK National Institute for Health Research (NIHR) as part of the Acute Brain Injury and Repair Theme of the Cambridge Biomedical Research Centre [PJAH], the NIHR Research Professorship [PJAH], the NIHR Cambridge BRC [PJAH and DKM], the NIHR Brain Injury Healthcare Technology Cooperative [JDP], the NIHR Senior Investigator award [DKM] and the James S. McDonnell Foundation [JDP]. This research was undertaken with the support of the Alan Turing Institute (UK Engineering and Physical Sciences Research Council Grant Number EP/N510129/1).	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Bertolero M, 2017, ARXIV170101150, DOI 10.1038/s41467-017-01189-w; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Chennu S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004669; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Comsa IM, 2017, BIORXIV, DOI [10.1101/231464, DOI 10.1101/231464]; Cruse D, 2014, BRAIN INJURY, V28, P1197, DOI 10.3109/02699052.2014.920517; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2012, LANCET, V379, P1702, DOI 10.1016/S0140-6736(12)60715-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; Lant ND, 2016, NEUROIMAGE-CLIN, V10, P27, DOI 10.1016/j.nicl.2015.11.004; Loewy DH, 1996, ELECTROEN CLIN NEURO, V98, P493, DOI 10.1016/0013-4694(96)95553-4; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Peterson A, 2016, NEUROSCI CONSCIOUS, DOI 10.1093/nc/niw011; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schiff ND, 2014, CURR OPIN NEUROBIOL, V25, P7, DOI 10.1016/j.conb.2013.10.007; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thonnard M, 2013, FUNCT NEUROL, V28, P259, DOI 10.11138/FNeur/2013.28.4.259; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157	46	11	12	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 16	2018	9								676	10.3389/fneur.2018.00676			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GR0TJ	WOS:000442235600001	30186220	Green Published, Green Accepted, gold			2022-02-06	
J	Cullum, S; Mullin, K; Zeng, I; Yates, S; Payman, V; Fisher, M; Cheung, G				Cullum, Sarah; Mullin, Katherine; Zeng, Irene; Yates, Susan; Payman, Vahid; Fisher, Mark; Cheung, Gary			Do community-dwelling Maori and Pacific peoples present with dementia at a younger age and at a later stage compared with NZ Europeans?	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						cross-cultural; dementia; epidemiology; Maori; New Zealand; Pacific	TRAUMATIC BRAIN-INJURY; NEW-ZEALAND; ALZHEIMERS-DISEASE; COGNITIVE ASSESSMENT; ETHNIC INEQUALITIES; LEWY BODIES; DIAGNOSIS; PREVALENCE; GUIDELINES; MANAGEMENT	ObjectiveEthnicity may affect presentation to clinical services in people with dementia; however, no studies have examined this in maori or Pacific peoples in New Zealand (NZ). Our objective was to examine the routinely collected clinical data from a memory assessment service in South Auckland to examine the presentation of dementia in the major NZ ethnic groups. MethodsA total of 360 patients presenting to a memory service with a new diagnosis of dementia were included in this study. Demographic data (age, sex, and ethnicity) and dementia sub-type and severity were analyzed. ResultsThere were 142 NZ European (mean age: 79.2, SD 7.4), 43 maori (mean age: 70.2, SD 7.6), 126 Pacific (mean age: 74.3, SD 7.6), and 49 other ethnicities (mean age: 78.0, SD 8.5) presenting with a new diagnosis of dementia. After adjustment for gender and dementia subtype, maori and Pacific patients were 8.5 and 5.3years younger than NZ European patients (P<0.0001). Pacific peoples tended to present with more advanced dementia (OR=1.63, 95% CI: 0.98-2.70, P=0.06) after adjustment for age and gender. There was little difference in the subtypes of dementia between ethnic groups. Conclusionsmaori and Pacific peoples with dementia presented to an NZ memory service at a younger age than NZ Europeans, and Pacific peoples presented with more advanced dementia. A population-based epidemiological study is critical to determine whether maori and Pacific peoples have indeed a higher risk of developing dementia at a younger age.	Univ Auckland, Counties Manukau Hlth, Auckland, New Zealand; Middlemore Hosp, Auckland, New Zealand		Cullum, S (corresponding author), Univ Auckland, Room 12-003,Level 12,Auckland Hosp Support Bldg, Auckland 1142, New Zealand.	sarah.cullum@auckland.ac.nz	Cullum, Sarah/W-5851-2019	Cullum, Sarah/0000-0003-0785-9101; Zeng, Irene Suilan/0000-0001-8100-3120			Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Baxter J, 2006, AUST NZ J PSYCHIAT, V40, P905, DOI 10.1111/j.1440-1614.2006.01910.x; Ben-Shlomo Y, 2016, INT J EPIDEMIOL, V45, P973, DOI 10.1093/ije/dyw096; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Corbett S, 2014, NEW ZEAL MED J, V127, P53; Counties Manukau Health, 2015, CMDHB 2015; Deloitte Access Economics, 2017, UPD DEM EC IMP REP 2; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Ellison-Loschmann L, 2006, AM J PUBLIC HEALTH, V96, P612, DOI 10.2105/AJPH.2005.070680; Feigin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134609; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Hill S, 2010, CANCER-AM CANCER SOC, V116, P3205, DOI 10.1002/cncr.25127; Hsieh S, 2013, DEMENT GERIATR COGN, V36, P242, DOI 10.1159/000351671; Jatrana S, 2008, AUST NZ J PUBL HEAL, V32, P437, DOI 10.1111/j.1753-6405.2008.00276.x; Joshy Grace, 2006, N Z Med J, V119, pU1999; Langley J, 2012, NEW ZEAL MED J, V125; MacPherson L, 2015, NZ PERIOD LIFE TABLE; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKenzie F, 2011, ETHNIC HEALTH, V16, P535, DOI 10.1080/13557858.2011.583638; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Ministry of Health, 2004, ETHN DAT PROT HLTH D; Ministry of Health, 2014, HLTH MOR AD CHILDR 2; Ministry of Health, 2013, HAZ DRINK 2011 12 FI; Ministry of Health, 2013, HLTH PAC AD CHILDR; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Prince M., 2014, DEMENTIA RISK REDUCT; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Simmons D, 1999, NEW ZEAL MED J, V112, P316; Statistics New Zealand, 2013, CENS ETH GROUP PROF; Storey JE, 2004, INT PSYCHOGERIATR, V16, P13, DOI 10.1017/S1041610204000043; Venketasubramanian N., 2011, DEMENTIA GERIATRIC C, V30, P492, DOI DOI 10.1159/000321675; Warren LA, 2015, INT PSYCHOGERIATR, V27, P1959, DOI 10.1017/S1041610215000861; Wiener JM., 2014, RACIAL ETHNIC DISPAR; World Health Organization, 2012, DEM PUBL HLTH PRIOR	40	11	11	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	AUG	2018	33	8					1098	1104		10.1002/gps.4898			7	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	GM3SL	WOS:000438028900011	29766582				2022-02-06	
J	Lippa, SM; Lange, RT; French, LM; Iverson, GL				Lippa, Sara M.; Lange, Rael T.; French, Louis M.; Iverson, Grant L.			Performance Validity, Neurocognitive Disorder, and Post-concussion Symptom Reporting in Service Members with a History of Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Performance validity; Neurocognitive disorder; Postconcussional syndrome; Effort	NEUROPSYCHOLOGICAL STATUS RBANS; STATUS EFFORT INDEX; POSTTRAUMATIC-STRESS-DISORDER; DEFINED MALINGERING GROUPS; REPEATABLE BATTERY; OEF/OIF VETERANS; POOR EFFORT; EVALUATION CONTEXT; CLINICAL UTILITY; CUTOFF SCORES	Objective: To examine the influence of different performance validity test (PVT) cutoffs on neuropsychological performance, postconcussion symptoms, and rates of neurocognitive disorder and postconcussional syndrome following mild traumatic brain injury (MTBI) in active duty service members. Method: Participants were 164 service members (Age: M = 28.1 years [SD = 7.3]) evaluated on average 4.1 months (SD = 5.0) following injury. Participants were divided into three mutually exclusive groups using original and alternative cutoff scores on the Test of Memory Malingering (TOMM) and the Effort Index (El) from the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): (a) PVT-Pass, n = 85; (b) Alternative PVT-Fail, n = 53; and (c) Original PVT-Fail, n = 26. Participants also completed the Neurobehavioral Symptom Inventory. Results: The PVT-Pass group performed better on cognitive testing and reported fewer symptoms than the two PVT-Fail groups. The Original PVT-Fail group performed more poorly on cognitive testing and reported more symptoms than the Alternative PVT-Fail group. Both PVT-Fail groups were more likely to meet DSM-5 Category A criteria for mild and major neurocognitive disorder and symptom reporting criteria for postconcussional syndrome than the PVT-Pass group. When alternative PVT cutoffs were used instead of original PVT cutoffs, the number of participants with valid data meeting cognitive testing criteria for neurocognitive disorder or postconcussional syndrome decreased dramatically. Conclusion: PVT performance is significantly and meaningfully related to overall neuropsychological outcome. By using only original cutoffs, clinicians and researchers may miss people with invalid performances.	[Lippa, Sara M.; Lange, Rael T.; French, Louis M.; Iverson, Grant L.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lippa, Sara M.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 19,Room 6009,8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19,Room 6009,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	sara.lippa.ctr@mail.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Iverson, Grant/0000-0001-7348-9570			Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P725, DOI 10.1093/arclin/acs071; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brooks B. L., 2013, WAIS IV WMS IV ACS A; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carter KR, 2016, CLIN NEUROPSYCHOL, V30, P1118, DOI 10.1080/13854046.2016.1206145; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2016, J HEAD TRAUMA REHAB, V31, P346, DOI 10.1097/HTR.0000000000000183; Cohen J., 2013, STAT POWER ANAL BEHA; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Crighton AH, 2015, ARCH CLIN NEUROPSYCH, V30, P181, DOI 10.1093/arclin/acv002; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dunham KJ, 2014, ARCH CLIN NEUROPSYCH, V29, P633, DOI 10.1093/arclin/acu042; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greve K. W., 2007, ASSESSMENT MALINGERE, P171; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hook JN, 2009, ARCH CLIN NEUROPSYCH, V24, P231, DOI 10.1093/arclin/acp026; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jones A, 2016, ARCH CLIN NEUROPSYCH, V31, P273, DOI 10.1093/arclin/acw006; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lippa SM, 2017, APPL NEUROPSYCH-ADUL, V24, P73, DOI 10.1080/23279095.2015.1100617; Lippa SM, 2014, REHABIL PSYCHOL, V59, P306, DOI 10.1037/a0037217; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Lippa SM, 2013, BRAIN INJURY, V27, P689, DOI 10.3109/02699052.2013.771793; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Moore RC, 2013, J INT NEUROPSYCH SOC, V19, P198, DOI 10.1017/S1355617712001221; Morra LF, 2015, SCHIZOPHR RES, V162, P205, DOI 10.1016/j.schres.2014.12.033; Mossman D, 2018, PSYCHOL ASSESSMENT, V30, P74, DOI 10.1037/pas0000449; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; Pachet AK, 2007, CLIN NEUROPSYCHOL, V21, P286, DOI 10.1080/13854040500376823; Paulson D, 2015, ARCH CLIN NEUROPSYCH, V30, P207, DOI 10.1093/arclin/acv009; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rogers R., 2008, CLIN ASSESSMENT MALI; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sieck BC, 2013, ARCH CLIN NEUROPSYCH, V28, P135, DOI 10.1093/arclin/acs109; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stenclik JH, 2013, APPL NEUROPSYCH-ADUL, V20, P243, DOI 10.1080/09084282.2012.704603; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Walters GD, 2008, PSYCHOL ASSESSMENT, V20, P238, DOI 10.1037/1040-3590.20.3.238; Walters GD, 2009, J CLIN EXP NEUROPSYC, V31, P584, DOI 10.1080/13803390802363728; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Williams JM, 2011, ARCH CLIN NEUROPSYCH, V26, P280, DOI 10.1093/arclin/acr009; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Zimmer A, 2018, APPL NEUROPSYCH-ADUL, V25, P385, DOI 10.1080/23279095.2017.1319835	83	11	11	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2018	33	5					606	618		10.1093/arclin/acx098			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GS3SF	WOS:000443539600009	29069278	hybrid			2022-02-06	
J	Rosenfeldt, Z; Conklen, K; Jones, B; Ferrill, D; Deshpande, M; Siddiqui, FM				Rosenfeldt, Zachary; Conklen, Katelyn; Jones, Breck; Ferrill, Don; Deshpande, Maithili; Siddiqui, Fazeel M.			Comparison of Nicardipine with Clevidipine in the Management of Hypertension in Acute Cerebrovascular Diseases	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebrovascular disease; hypertension; nicardipine; clevidipine; outcomes	HEALTH-CARE PROFESSIONALS; BLOOD-PRESSURE; INTRACEREBRAL HEMORRHAGE; STROKE; GUIDELINES	Background and Purpose: In acute stroke, hypertension worsens outcomes. Guide-lines do not mention a preferred antihypertensive agent. This present study aimed to compare the efficacy and safety of nicardipine and clevidipine in acute stroke. Methods: This retrospective review compared nicardipine with clevidipine for hypertension in acute stroke patients from March 17, 2015 to December 23, 2016. Ischemic and hemorrhagic stroke types were evaluated. Patients were excluded if under 18 years, had traumatic brain injury, had intracranial neoplasm, were on dialysis, had both study drugs during the stroke admission, or the study drug was infused for less than 1 hour. Efficacy outcomes were: time to goal blood pres-sure, percent time in goal, blood pressure range, and need for additional antihypertensive agents during the infusion. A composite of in-hospital death, 30-day readmission, rebleeding, ischemic to hemorrhagic conversion, and hematoma expansion were compared. Other clinical outcomes included length of intensive care unit and hospital stay, hypotension, bradycardia, tachycardia, onset of atrial fibrillation, and acute kidney injury. Results: Mean time to goal blood pressure was 65.5 minutes and 65.8 minutes in the nicardipine and clevidipine group, respectively (P = .83). No efficacy outcome was significantly different between 2 groups after multivariate analysis. Conclusions: Both nicardipine and clevidipine are reasonable antihypertensive agents in stroke, although cost and volume restriction could differentiate preference.	[Rosenfeldt, Zachary] Community Hosp, Dept Pharm Serv, Munster, IN USA; [Conklen, Katelyn; Ferrill, Don] Mem Med Ctr, Dept Pharm Serv, Springfield, IL 62781 USA; [Jones, Breck; Siddiqui, Fazeel M.] Southern Illinois Univ, Sch Med, Dept Neurosurg, Springfield, IL USA; [Deshpande, Maithili] Southern Illinois Univ, Dept Pharm Practice, Edwardsville, IL USA		Siddiqui, FM (corresponding author), Southern Illinois Univ, Sch Med, Dept Neurol, 751 N Rutledge St, Springfield, IL 62702 USA.	fazeelmukhtar@gmail.com					Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; [Anonymous], 2010, CARD PACK INS; [Anonymous], 2011, CLEV PACK INS; Aronson S, 2008, ANESTH ANALG, V107, P1110, DOI 10.1213/ane.0b013e31818240db; Bailie G. R., 2013, DIALYSIS OF DRUGS; Buttner S, 2020, J INTENSIVE CARE MED, V35, P338, DOI 10.1177/0885066617748596; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Erdman MJ, 2017, NEUROHOSPITALIST, V7, P9, DOI 10.1177/1941874416665744; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Finger JR, 2017, NEUROCRIT CARE, V26, P167, DOI 10.1007/s12028-016-0349-4; Frontera JA, 2016, NEW ENGL J MED, V375, DOI 10.1056/NEJMc1613117; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Maisel WH, 2001, ANN INTERN MED, V135, P1061, DOI 10.7326/0003-4819-135-12-200112180-00010; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Ohkuma H, 2001, STROKE, V32, P1176, DOI 10.1161/01.STR.32.5.1176; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Sakamoto Y, 2013, STROKE, V44, P1846, DOI 10.1161/STROKEAHA.113.001212	21	11	11	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2018	27	8					2067	2073		10.1016/j.jstrokecerebrovasdis.2018.03.001			7	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	GM5AS	WOS:000438139600011	29627171				2022-02-06	
J	Wallace, J; Covassin, T; Moran, R; Deitrick, JM				Wallace, Jessica; Covassin, Tracey; Moran, Ryan; Deitrick, Jamie McAllister			Factors Contributing to Disparities in Baseline Neurocognitive Performance and Concussion Symptom Scores Between Black and White Collegiate Athletes	JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES			English	Article						Neurocognitive performance; Collegiate athletes; ImPACT; Racial disparities; Baseline testing	HIGH-SCHOOL; AFRICAN-AMERICANS; ONLINE VERSION; IMPACT; SPORT; SEX; AGE; ASSOCIATION; SPECIFICITY; SENSITIVITY	Background National Collegiate Athletic Association (NCAA) concussion guidelines state that all NCAA athletes must have a concussion baseline test prior to commencing their competitive season. To date, little research has examined potential racial differences on baseline neurocognitive performance among NCAA athletes. The purpose of this study was to investigate differences between Black and White collegiate athletes on baseline neurocognitive performance and self-reported symptoms. Methods A total of 597 collegiate athletes (400 White, 197 Black) participated in this study. Athletes self-reported their race on the demographic section of their pre-participation physical examination and were administered the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) neurocognitive battery in a supervised, quiet room. Controlling for sex, data were analyzed using separate one-way analyses of covariance (ANCOVAs) on symptom score, verbal and visual memory, visual motor processing speed, and reaction time composite scores. Results Results revealed significant differences between White and Black athletes on baseline symptom score (F-(1,F-542) = 5.82, p = .01), visual motor processing speed (F-(1,F- 5 4 2) = 14.89, p < .001), and reaction time (F-(1,F-542) = 11.50, p < .01). White athletes performed better than Black athletes on baseline visual motor processing speed and reaction time. Black athletes reported higher baseline symptom scores compared to Whites. There was no statistical difference between race on verbal memory (p = .08) and that on visual memory (p = .06). Conclusions Black athletes demonstrated disparities on some neurocognitive measures at baseline. These results suggest capturing an individual baseline on each athlete, as normative data comparisons may be inappropriate for athletes of a racial minority.	[Wallace, Jessica] Youngstown State Univ, 1 Univ Plaza,307L Beeghly Ctr, Youngstown, OH 44555 USA; [Covassin, Tracey] Michigan State Univ, 105 IM Circle, E Lansing, MI 48824 USA; [Moran, Ryan] Univ Alabama, Tuscaloosa, AL USA; [Deitrick, Jamie McAllister] Coastal Carolina Univ, Conway, SC 29528 USA		Wallace, J (corresponding author), Youngstown State Univ, 1 Univ Plaza,307L Beeghly Ctr, Youngstown, OH 44555 USA.	jwallace02@ysu.edu; covassin@msu.edu; Moranry3@msu.edu; jdeitrick@coastal.edu					Berry J.W., 1976, HUMAN ECOLOGY COGNIT; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CHEN TH, 1994, PERCEPT MOTOR SKILL, V79, P1683, DOI 10.2466/pms.1994.79.3f.1683; Coakley J., 2007, SPORT SOC ISSUES CON; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fyffe DC, 2011, J INT NEUROPSYCH SOC, V17, P625, DOI 10.1017/S1355617711000476; Holmes L, 2016, SPORTS MED OPEN, V2, P1; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; KATZ I, 1964, AM PSYCHOL, V19, P381, DOI 10.1037/h0040569; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kush JC, 1997, ASSESSMENT, V4, P297, DOI 10.1177/107319119700400309; Lezak MD, 2005, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; LOVELL M, 2001, IMMEDIATE POST CONCU; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Manly JJ, 2002, STUD NEUROPSYCHOL DE, P79; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mehta KM, 2004, J AM GERIATR SOC, V52, P2120, DOI 10.1111/j.1532-5415.2004.52575.x; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; MOYERMAN DR, 1992, HISPANIC J BEHAV SCI, V14, P163, DOI 10.1177/07399863920142001; National Collegiate Athletic Association, 2016, SPORT SPONS PART DEM; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; ROSS TP, 1995, CLIN NEUROPSYCHOL, V9, P321, DOI 10.1080/13854049508400496; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, ARCH CLIN NEUROPSYCH; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Teng EL, 2005, ALZ DIS ASSOC DIS, V19, P267, DOI 10.1097/01.wad.0000190805.13126.8e; Tsushima William T, 2008, Hawaii Med J, V67, P93; Whitfield K. E., 1996, J AGING ETHNICITY, V1, P41; ZUCKERMAN M, 1990, AM PSYCHOL, V45, P1297, DOI 10.1037/0003-066X.45.12.1297; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	48	11	11	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2197-3792	2196-8837		J RACIAL ETHN HEALTH	J. Racial Ethn. Health Disparities	AUG	2018	5	4					894	900		10.1007/s40615-017-0437-y			7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GV9BH	WOS:000446446900023	29098599				2022-02-06	
J	Wang, B; Han, SS				Wang, Bo; Han, Shuangshuang			Inhibition of Inducible Nitric Oxide Synthase Attenuates Deficits in Synaptic Plasticity and Brain Functions Following Traumatic Brain Injury	CEREBELLUM			English	Article						Traumatic brain injury (TBI); Neuroprotection; Inhibitor; Inducible nitric oxide synthase (iNOS); Behaviors	MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; SELECTIVE-INHIBITION; C-REL; RECOGNITION MEMORY; KAPPA-B; EXPRESSION; RATS; BINDING; MICE	Traumatic brain injury (TBI), resulting from external force on the head, usually leads to long-term deficits in motor and cognitive functions. Inducible nitric oxide synthase (iNOS)-mediated excessive inflammation could exacerbate brain damage after TBI. The present study therefore investigated the potential neuroprotective effects of iNOS inhibition after TBI. Male C57BL/6J mice were subjected to controlled cortical impact injury and then treated with high selective iNOS inhibitor 1400W. Expression of iNOS mRNA was determined by quantitative RT-PCR. Western blotting was carried out to determine iNOS protein levels. Motor and cognitive functions, and long-term potentiation (LTP) in the medial prefrontal cortex (mPFC) and hippocampus were examined. Expression of iNOS was induced after TBI in a temporal manner. Treatment with 1400W after TBI improved motor and cognitive functions. TBI mice showed deficits in LTP in both the mPFC and hippocampus, and treatment with 1400W could rescue this impairment. Inhibition of iNOS attenuated deficits in synaptic plasticity and brain functions after TBI. The neuroprotective effect of iNOS inhibition on cognitive function might be via rescuing the TBI-induced LTP impairment.	[Wang, Bo] Cangzhou Cent Hosp, Emergency Dept, 16 Xinhua West Rd, Cangzhou 061001, Hebei, Peoples R China; [Han, Shuangshuang] Cangzhou Med Coll, Higher Educ Area, West Yingbin Ave, Cangzhou 061001, Hebei, Peoples R China		Wang, B (corresponding author), Cangzhou Cent Hosp, Emergency Dept, 16 Xinhua West Rd, Cangzhou 061001, Hebei, Peoples R China.	wangbo6292@126.com					Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; ASSREUY J, 1993, BRIT J PHARMACOL, V108, P833, DOI 10.1111/j.1476-5381.1993.tb12886.x; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; Cockroft KM, 1996, STROKE, V27, P1393, DOI 10.1161/01.STR.27.8.1393; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Grover LM, 2009, LEARN MEMORY, V16, P69, DOI 10.1101/lm.1179109; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Hwang SY, 2013, BRIT J PHARMACOL, V169, P1551, DOI 10.1111/bph.12223; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 1997, J NEUROSCI, V17, P9157; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Katsumoto S, 2003, NITRIC OXIDE-BIOL CH, V8, P149, DOI 10.1016/S1089-8603(02)00118-0; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MARLETTA MA, 1988, CHEM RES TOXICOL, V1, P249, DOI 10.1021/tx00005a001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Schinzel R, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P133, DOI 10.1016/B978-0-12-802686-1.00008-0; Shono Y, 2016, CANCER RES, V76, P377, DOI 10.1158/0008-5472.CAN-14-2814; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Togashi H, 1999, RECENT ADV NITRIC OX, P53; Vitecek J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/318087; Wang ZM, 2008, INT J NEUROPSYCHOPH, V11, P611, DOI 10.1017/S1461145707008334; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781	38	11	13	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	AUG	2018	17	4					477	484		10.1007/s12311-018-0934-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GL4IC	WOS:000437113000010	29556966				2022-02-06	
J	Wang, J; Ma, MW; Dhandapani, KM; Brann, DW				Wang, Jing; Ma, Merry W.; Dhandapani, Krishnan M.; Brann, Darrell W.			NADPH oxidase 2 deletion enhances neurogenesis following traumatic brain injury	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						NADPH oxidase; NOX2; NOX inhibitor; Neurogenesis; Traumatic brain injury	NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; PROLIFERATION; EXPRESSION; DIFFERENTIATION; MECHANISMS; MIGRATION; EPILEPSY; NEURONS	The NADPH oxidase (NOX) enzyme family is a major source of reactive oxygen species (ROS) and contributor to the secondary pathology underlying traumatic brain injury (TBI). However, little is known about how NOX-derived ROS influences the proliferation and cell-fate determination of neural stem/progenitor cells (NSCs/NPCs) following TBI. In the current study, we found that deletion of NOX2 (NOX2-KO) significantly decreases the population of radial glia-like NSCs and neuroblasts but maintains the population of non-radial Sox2 expressing stem cells under physiological (non-injury) conditions. Surprisingly, the brains of NOX2-KO mice demonstrated a robust increase in the number of neuroblasts during the first week after TBI, as compared to the wild-type group. This increase may result from an enhanced proliferation of NPCs in a lower ROS environment after brain injury, as further examination revealed a significant increase of dividing neuroblasts in both NOX2-KO and NOX inhibitor-treated mouse brain during the first week following TBI. Finally, 5-Bromo-2'-deoxyuridine (BrdU) lineage tracing demonstrated a significantly increased number of newborn neurons were present in the perilesional cortex of NOX2-KO mice at 5 weeks post TBI, indicating that deletion of NOX2 promotes longterm neurogenesis in the injured brain following TBI. Altogether, these findings suggest that targeting NOX through genetic deletion or inhibition enhances post-injury neurogenesis, which may be beneficial for recovery following TBI.	[Wang, Jing; Ma, Merry W.; Dhandapani, Krishnan M.; Brann, Darrell W.] Charlie Norwood Med Ctr, One Freedom Way, Augusta, GA 30904 USA; [Wang, Jing; Ma, Merry W.; Brann, Darrell W.] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120 15 St,CA-4004, Augusta, GA 30909 USA; [Dhandapani, Krishnan M.] Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30909 USA		Brann, DW (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120 15 St,CA-4004, Augusta, GA 30909 USA.	dbrann@augusta.edu		Dhandapani, Krishnan/0000-0001-7044-1117	VA Merit Review Award from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development ServiceUS Department of Veterans Affairs [5l101BX001117]; American Heart AssociationAmerican Heart Association [16POST27340004]	This research was supported by a VA Merit Review Award (5l101BX001117) from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service, and an AHA Postdoctoral Fellowship (16POST27340004) from the American Heart Association.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Chandran R., 2017, J CEREB BLOOD FLOW M, DOI DOI 10.1177/0271678X1773870129083257; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Gao HM, 2012, TRENDS PHARMACOL SCI, V33, P295, DOI 10.1016/j.tips.2012.03.008; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lindvall O., 2015, COLD SPRING HARB PER, V7; Ma MW, 2018, FREE RADICAL BIO MED, V117, P66, DOI 10.1016/j.freeradbiomed.2018.01.031; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nayernia Z, 2017, REDOX BIOL, V13, P82, DOI 10.1016/j.redox.2017.04.026; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Wang J, 2014, J NEUROSCI, V34, P13790, DOI 10.1523/JNEUROSCI.2275-14.2014; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	39	11	11	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	AUG	2018	123						62	71		10.1016/j.freeradbiomed.2018.05.069			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	GK8HA	WOS:000436459200007	29782989				2022-02-06	
J	Castranio, EL; Wolfe, CM; Nam, KN; Letronne, F; Fitz, NF; Lefterov, I; Koldamova, R				Castranio, Emilie L.; Wolfe, Cody M.; Nam, Kyong Nyon; Letronne, Florent; Fitz, Nicholas F.; Lefterov, Iliya; Koldamova, Radosveta			ABCA1 haplodeficiency affects the brain transcriptome following traumatic brain injury in mice expressing human APOE isoforms	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Apolipoprotein E; ABCA1; Transcriptome; WGCNA; Microglia sensome	APOLIPOPROTEIN-E; NEUROINFLAMMATION; ACTIVATION; DISEASE; GENE; MODULATION; GENOTYPE; RECOVERY; MODERATE; PROTEIN	Expression of human Apolipoprotein E (APOE) modulates the inflammatory response in an isoform specific manner, with APOE4 isoform eliciting a stionger pro-inflammatory response, suggesting a possible mechanism for worse outcome following traumatic brain injury (TBI). APOE lipidation and stability is modulated by ATP-binding cassette transporter A1 (ABCA1), a transmembrane protein that transports lipids and cholesterol onto APOE. We examined the impact of Abca1 deficiency and APOE isoform expression on the response to TBI using 3-months-old, human APOE3(+/+) (E3/Abca1(+/+)) and APOE4(+/+) (E4/Abca1(+/+)) targeted replacement mice, and APOE3(+/+) and APOE4(+/+) mice with only one functional copy of the Abca1 gene (E3/Abca1(+/-); E4/Abca1(+/-)). TBI-treated mice received a craniotomy followed by a controlled cortical impact (CCI) brain injury in the left hemisphere, sham-treated mice received the same surgical procedure without the impact. We performed RNA-seq using samples from cortices and hippocampi followed by genome-wide differential gene expression analysis. We found that TBI significantly impacted unique transcripts within each group, however, the proportion of unique transcripts was highest in E4/Abca1(+/-) mice. Additionally, we found that Abca1 haplodeficiency increased the expression of microglia sensome genes among only APOE4 injured mice, a response not seen in injured APOE3 mice, nor in either group of sham-treated mice. To identify gene networks, or modules, correlated to TBI, APOE isoform and Abca1 haplodeficiency, we used weighted gene co-expression network analysis (WGCNA). The module that positively correlated to TBI groups was associated with immune response and featured hub genes that were microglia-specific, including Trem2, Tyrobp, Cd68 and Hexb. The modules positively correlated with APOE4 isoform and negatively to Abca1 haplodeficient mice represented "protein translation" and "oxidation-reduction process", respectively. Our results reveal E4/Abca1(+/-) TBI mice have a distinct response to injury, and unique gene networks are associated with APOE isoform, Abca1 insufficiency and injury.	[Castranio, Emilie L.; Wolfe, Cody M.; Nam, Kyong Nyon; Letronne, Florent; Fitz, Nicholas F.; Lefterov, Iliya; Koldamova, Radosveta] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA		Lefterov, I; Koldamova, R (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	iliya@pitt.edu; radak@pitt.edu	Lefterov, Iliya/B-4767-2008	Lefterov, Iliya/0000-0002-0249-0280; Nam, Kyongnyon/0000-0002-5140-6014; Fitz, Nicholas/0000-0001-6938-6536	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ES024233, AG056371, AG057565, K01AG044490]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-13-1-0384]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES024233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG044490, R56AG057565, R01AG037919, RF1AG056371] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (ES024233, AG056371, AG057565 and K01AG044490) and the U.S. Department of Defense (W81XWH-13-1-0384).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Blocquel D, 2017, NUCLEIC ACIDS RES, V45, P8091, DOI 10.1093/nar/gkx455; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Carter AY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172161; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fitz NF, 2012, J NEUROSCI, V32, P13125, DOI 10.1523/JNEUROSCI.1937-12.2012; Ghroubi S, 2016, ANN PHYS REHABIL MED, V59, P87, DOI 10.1016/j.rehab.2016.01.005; Karasinska JM, 2013, NEUROBIOL DIS, V54, P445, DOI 10.1016/j.nbd.2013.01.018; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova R, 2014, NEUROBIOL DIS, V72, P13, DOI 10.1016/j.nbd.2014.05.007; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Li XW, 2015, FASEB J, V29, P1754, DOI 10.1096/fj.14-262683; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Nam KN, 2018, BBA-MOL BASIS DIS, V1864, P152, DOI 10.1016/j.bbadis.2017.10.018; Nam KN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04412-2; Nam KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep24048; Pathania D, 2009, ADV DRUG DELIVER REV, V61, P1250, DOI 10.1016/j.addr.2009.05.010; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; White CR, 2017, ADV EXP MED BIOL, V982, P407, DOI 10.1007/978-3-319-55330-6_22; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Tiveron MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157052; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Wang SL, 2016, CELL REP, V16, P1954, DOI 10.1016/j.celrep.2016.07.030; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yu HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00074; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	48	11	11	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	JUL 26	2018	6								69	10.1186/s40478-018-0569-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO4RW	WOS:000440002300003	30049279	Green Published, gold			2022-02-06	
J	Maruta, J; Spielman, LA; Rajashekar, U; Ghajar, J				Maruta, Jun; Spielman, Lisa A.; Rajashekar, Umesh; Ghajar, Jamshid			Association of Visual Tracking Metrics With Post-concussion Symptomatology	FRONTIERS IN NEUROLOGY			English	Article						closed head injury; mild traumatic brain injury; ocular pursuit; predictive timing; smooth pursuit	TRAUMATIC BRAIN-INJURY; SMOOTH-PURSUIT; NEUROCOGNITIVE PERFORMANCE; REACTION-TIME; ATTENTION; SYMPTOMS; RELIABILITY; SYNCHRONIZATION; SPECIFICITY; STABILITY	Attention impairment may provide a cohesive neurobiological explanation for clusters of clinical symptoms that occur after a concussion; therefore, objective quantification of attention is needed. Visually tracking a moving target is an attention-dependent sensorimotor function, and eye movement can be recorded easily and objectively to quantify performance. Our previous work suggested the utility of gaze-target synchronization metrics of a predictive visual tracking task in concussion screening and recovery monitoring. Another objectively quantifiable performance measure frequently suggested for concussion screening is simple visuo-manual reaction time (simple reaction time, SRT). Here, we used visual tracking and SRT tasks to assess changes between pre- and within-2-week post-concussion performances and explore their relationships to post-concussion symptomatology. Athletes participating in organized competitive sports were recruited. Visual tracking and SRT records were collected from the recruited athlete pool as baseline measures over a 4-year period. When athletes experienced a concussion, they were re-assessed within 2 weeks of their injury. We present the data from a total of 29 concussed athletes. Post-concussion symptom burden was assessed with the Rivermead Post-Concussion Symptoms Questionnaire and subscales of the Brain Injury Screening Questionnaire. Post-concussion changes in visual tracking and SRT performance were examined using a paired t-test. Correlations of changes in visual tracking and SRT performance to symptom burden were examined using Pearson's coefficients. Post-concussion changes in visual tracking performance were not consistent among the athletes. However, changes in several visual tracking metrics had moderate to strong correlations to symptom scales (r up to 0.68). On the other hand, while post-concussion SRT performance was reduced (p < 0.01), the changes in the performance metrics were not meaningfully correlated to symptomatology (r <= 0.33). Results suggest that visual tracking performance metrics reflect clinical symptoms when assessed within 2 weeks of concussion. Evaluation of concussion requires assessments in multiple domains because the clinical profiles are heterogeneous. While most individuals show recovery within a week of injury, others experience prolonged recovery periods. Visual tracking performance metrics may serve as a biomarker of debilitating symptoms of concussion implicating attention as a root cause of such pathologies.	[Maruta, Jun; Spielman, Lisa A.; Rajashekar, Umesh; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY 10004 USA; [Maruta, Jun; Ghajar, Jamshid] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Maruta, Jun] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Maruta, J (corresponding author), Brain Trauma Fdn, New York, NY 10004 USA.; Maruta, J (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.; Maruta, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA.	jun.maruta@mssm.edu	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	U.S. Department of DefenseUnited States Department of Defense [W911QY-12-C-0005, W911QY-14-C-0086]	The authors thank Brain Trauma Foundation's clinical research staff for assistance with data collection and maintenance. This work was supported by U.S. Department of Defense contracts W911QY-12-C-0005 and W911QY-14-C-0086.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bargary G, 2017, VISION RES, V141, P157, DOI 10.1016/j.visres.2017.03.001; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Barthelemy S, 2001, NEUROSCI LETT, V315, P41, DOI 10.1016/S0304-3940(01)02313-8; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chen Y, 2002, PROG BRAIN RES, V140, P255; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dretsch M, 2015, APPL NEUROPSYCH-ADUL, V22, P304, DOI 10.1080/23279095.2014.926454; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gordon WA, 2017, J HEAD TRAUMA REHAB, V32, P393, DOI 10.1097/HTR.0000000000000274; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Heaton KJ, 2014, AVIAT SPACE ENVIR MD, V85, P497, DOI 10.3357/ASEM.3882.2014; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Maruta J, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00640; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2012, PROC SPIE, V8371, DOI 10.1117/12.927790; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ohlendorf S, 2007, EUR J NEUROSCI, V26, P2096, DOI 10.1111/j.1460-9568.2007.05824.x; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; ROYBYRNE P, 1995, BIOL PSYCHIAT, V38, P92, DOI 10.1016/0006-3223(94)00225-R; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Tavassoli A, 2009, J NEUROPHYSIOL, V102, P110, DOI 10.1152/jn.91320.2008; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	47	11	11	2	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 26	2018	9								611	10.3389/fneur.2018.00611			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GO3FQ	WOS:000439875000001	30093880	gold, Green Published			2022-02-06	
J	Brassil, HE; Salvatore, AP				Brassil, Heather E.; Salvatore, Anthony P.			The frequency of post-traumatic stress disorder symptoms in athletes with and without sports related concussion	CLINICAL AND TRANSLATIONAL MEDICINE			English	Article						Sport concussion; mTBI; Post-traumatic stress disorder (PTSD) symptoms	TRAUMATIC BRAIN-INJURY; CLINICAL PRESENTATION; MECHANISMS; SEQUELAE; SCALE; IRAQ	Background: Purpose of this study is to investigate the presence and frequency of post-traumatic stress disorder (PTSD) symptoms in post-concussed (PC) athletes compared to a group of healthy control (HC) athletes. Research design and method: A pre and post-test group design was used to compare a post-concussed group to a matched healthy control group of athletes. An archival database which included PC (n = 62) and HC (n = 62) participants matched on age, years of education and gender who completed a test battery at baseline and post injury, The test battery was comprised of a neurocognitive assessment, self-reported symptom inventory and PTSD symptom questionnaire. Post-concussion assessment was obtained within 0-13 days post-injury. Results: PTSD symptom scores were greater in PC post injury group (Mdn = 0) than for the HC group (Mdn = 0.0), U = 1282.0, p = 0.000, r = 0.34. A Wilcoxon Signed-ranks test indicated that PTSD symptom scores post-injury (Mdn = 0) were significantly higher than pre-injury (Mdn = 0), Z = -2.75, p = 0.000, r = 0.35. Within the PC post injury group athletes having "difficulty sleeping" was the highest reported symptom an average of 25.8% followed by "avoiding similar situations" at an average of 19.4%. "Having trouble keeping thoughts of incident out of your head" was reported at an average of 17.7% and "flashbacks" were reported at an average of 12.9%. "Nightmares" and "feeling numb and detached" were reported at an average of 8.1 and 6.5% respectively. Conclusion: Athletes who reported no PTSD symptoms prior to sports related concussion do exhibit symptoms of PTSD. Providing a PTSD symptom questionnaire may provide a more comprehensive treatment plan for PC post injury athletes who may be at risk of chronic PTSD symptoms.	[Salvatore, Anthony P.] Univ Louisiana, Lafayette, LA 70504 USA; [Brassil, Heather E.] Univ Texas El Paso, El Paso, TX 79968 USA		Salvatore, AP (corresponding author), Univ Louisiana, Lafayette, LA 70504 USA.	salvatore@utep.edu			Department of Health and Human Services, Administration for Community Living, NIDILRR-Advanced Rehabilitation Research and Training Program (ARRT) grant	This investigation was funded in part by a Department of Health and Human Services, Administration for Community Living, NIDILRR-Advanced Rehabilitation Research and Training Program (ARRT) grant, Principle Investigator, Anthony P. Salvatore. Dr. Brassil was funded by this grant as an ARRT Post-Doctoral Research Fellow.	American Psychiatric A, 2013, DIAGN STAT MAN MENT; Appaneal RN, 2007, J CLIN SPORT PSYCHOL, V1, P68, DOI 10.1123/jcsp.1.1.68; Gignac GE, 2016, PERS INDIV DIFFER, V102, P74, DOI 10.1016/j.paid.2016.06.069; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Howlett JR, 2016, POSTTRAUMATIC STRESS; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Manschreck T., 2012, CURR PSYCHIAT, V11, P16; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; MORGAN GA, 2006, UNDERSTANDING EVALUA; Newcomer RR, 2003, J ATHL TRAINING, V38, P163; O'Neill DF, 2008, J CLIN SPORT PSYCHOL, V2, P278, DOI 10.1123/jcsp.2.3.278; Peck DF, 1996, J PSYCHOSOM RES, V41, P55, DOI 10.1016/0022-3999(96)00050-5; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Smith SM, 2016, J PSYCHIATR RES, V82, P16, DOI 10.1016/j.jpsychires.2016.06.022; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	24	11	11	3	15	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2001-1326			CLIN TRANSL MED	Clin. Transl. Med.	JUL 23	2018	7								25	10.1186/s40169-018-0200-y			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GO1XQ	WOS:000439754600001	30039260	Green Published, gold			2022-02-06	
J	Wendel, KM; Lee, JB; Affeldt, BM; Hamer, M; Harahap-Carrillo, IS; Pardo, AC; Obenaus, A				Wendel, Kara M.; Lee, Jeong Bin; Affeldt, Bethann M.; Hamer, Mary; Harahap-Carrillo, Indira S.; Pardo, Andrea C.; Obenaus, Andre			Corpus Callosum Vasculature Predicts White Matter Microstructure Abnormalities after Pediatric Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood vessel; closed-head injury; concussion; diffusion tensor imaging; myelin; oligodendrocytes	RAT-BRAIN; VULNERABILITY; EXPRESSION; DEMYELINATION; ANGIOGENESIS; PLASTICITY; RECOVERY; PROGRAM; PROTEIN; GLIOMAS	Emerging data suggest that pediatric traumatic brain injury (TBI) is associated with impaired developmental plasticity and poorer neuropsychological outcomes than adults with similar head injuries. Unlike adult mild TBI (mTBI), the effects of mTBI on white matter (WM) microstructure and vascular supply are not well understood in the pediatric population. The cerebral vasculature plays an important role providing necessary nutrients and removing waste. To address this critical element, we examined the microstructure of the corpus callosum (CC) following pediatric mTBI using diffusion tensor magnetic resonance imaging (DTI), and investigated myelin, oligodendrocytes, and vasculature of WM with immunohistochemistry (IHC). We hypothesized that pediatric mTBI leads to abnormal WM microstructure and impacts the vasculature within the CC, and that these alterations to WM vasculature contribute to the long-term altered microstructure. We induced in mice a closed-head injury (CHI) mTBI at post-natal day (P) 14; then at 4, 14, and 60 days post-injury (DPI) mice were sacrificed for analysis. We observed persistent changes in apparent diffusion coefficient (ADC) within the ipsilateral CC following mTBI, indicating microstructural changes, but surprisingly changes in myelin and oligodendrocyte densities were minimal. However, vascular features of the ipsilateral CC such as vessel density, length, and number of junctions were persistently altered following mTBI. Correlative analysis showed a strong inverse relationship between ADC and vessel density at 60 DPI, suggesting increased vessel density following mTBI may restrict WM diffusion characteristics. Our findings suggest that WM vasculature contributes to the long-term microstructural changes within the ipsilateral CC following mTBI.	[Wendel, Kara M.; Obenaus, Andre] Univ Calif Irvine, Irvine Sch Med, Dept Anat & Neurobiol, Irvine, CA USA; [Obenaus, Andre] Univ Calif Irvine, Irvine Sch Med, Dept Pediat, Irvine, CA USA; [Lee, Jeong Bin; Affeldt, Bethann M.; Hamer, Mary; Harahap-Carrillo, Indira S.; Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA; [Pardo, Andrea C.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA		Obenaus, A (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Dept Pediat, 1022-1082 Hlth Sci Rd,Hewitt Hall,Room 2066, Irvine, CA 92617 USA.	obenausa@uci.edu	Pardo, Andrea/B-4836-2017	Pardo, Andrea/0000-0001-7767-8539	Loma Linda University	These studies were supported by Loma Linda University Grants to Promote Collaborative and Translation Research (GCAT). We would like to acknowledge Loma Linda University for the support for this study, Dr. Jane Johnson for generously providing the Asc11CreER: ccGFP CD-1 mice, and Mariann Howland for her contributions and assistance with the statistical analysis for this study.	Affeldt BM, 2017, INT J DEV NEUROSCI, V61, P1, DOI 10.1016/j.ijdevneu.2017.05.001; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Akiyama K, 2002, J NEUROSCI RES, V68, P19, DOI 10.1002/jnr.10188; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bernklau I, 2016, FOOD RES INT, V89, P812, DOI 10.1016/j.foodres.2016.10.012; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Centers for Disease Control and Prevention, 2016, REP PED MILD TRAUM B; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Faul M, 2010, TRAUMATIC BRAIN INJU; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Fischer I, 2005, BRAIN PATHOL, V15, P297; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gambardella L., 2012, TXB ANGIOGENESIS LYM, P189; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Giacomini A, 2015, ANGIOGENESIS, V18, P499, DOI 10.1007/s10456-015-9481-6; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Ichkova A, 2017, NEUROCHEM INT, V111, P93, DOI 10.1016/j.neuint.2017.03.022; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; KIMURA M, 1989, P NATL ACAD SCI USA, V86, P5661, DOI 10.1073/pnas.86.14.5661; Kom C, 2015, DEV CELL, V34, P5, DOI 10.1016/j.devcel.2015.06.004; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Kreis T., 1999, GUIDEBOOK EXTRACELLU; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Lumbroso B, 2015, RETINA-J RET VIT DIS, V35, P2242, DOI 10.1097/IAE.0000000000000879; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Muramatsu K, 1997, STROKE, V28, P2281, DOI 10.1161/01.STR.28.11.2281; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Obenaus A, 2007, EPILEPSIA, V48, P11, DOI 10.1111/j.1528-1167.2007.01237.x; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; ROSENBLUTH J, 1966, J CELL BIOL, V28, P73, DOI 10.1083/jcb.28.1.73; Sadeghi N, 2008, AM J NEURORADIOL, V29, P476, DOI 10.3174/ajnr.A0851; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Walchli T, 2015, NAT PROTOC, V10, P53, DOI 10.1038/nprot.2015.002; Wessa P., 2017, BAGPLOT V1 0 3 FREE; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	58	11	12	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					152	164		10.1089/neu.2018.5670		JUL 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439628400001	29739276				2022-02-06	
J	Latchoumane, CFV; Jackson, L; Sendi, MSE; Tehrani, KF; Mortensen, LJ; Stice, SL; Ghovanloo, M; Karumbaiah, L				Latchoumane, Charles-Francois V.; Jackson, LaDonya; Sendi, Mohammad S. Eslampanah; Tehrani, Kayvan F.; Mortensen, Luke J.; Stice, Steven L.; Ghovanloo, Maysam; Karumbaiah, Lohitash			Chronic Electrical Stimulation Promotes the Excitability and Plasticity of ESC-derived Neurons following Glutamate-induced Inhibition In vitro	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; MICROELECTRODE ARRAYS; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; ANODAL POLARIZATION; DECISION-MAKING; NMDA RECEPTORS; NEUROTOXICITY; TDCS	Functional electrical stimulation (FES) is rapidly gaining traction as a therapeutic tool for mediating the repair and recovery of the injured central nervous system (CNS). However, the underlying mechanisms and impact of these stimulation paradigms at a molecular, cellular and network level remain largely unknown. In this study, we used embryonic stem cell (ESC)-derived neuron and glial co-cultures to investigate network maturation following acute administration of L-glutamate, which is a known mediator of excitotoxicity following CNS injury. We then modulated network maturation using chronic low frequency stimulation (LFS) and direct current stimulation (DCS) protocols. We demonstrated that L-glutamate impaired the rate of maturation of ESC-derived neurons and glia immediately and over a week following acute treatment. The administration of chronic LFS and DCS protocols individually following L-glutamate infusion significantly promoted the excitability of neurons as well as network synchrony, while the combination of LFS/DCS did not. qRT-PCR analysis revealed that LFS and DCS alone significantly up-regulated the expression of excitability and plasticity-related transcripts encoding N-methyl-D-aspartate (NMDA) receptor subunit (NR2A), brain-derived neurotrophic factor (BDNF) and Ras-related protein (RAB3A). In contrast, the simultaneous administration of LFS/DCS down-regulated BDNF and RAB3A expression. Our results demonstrate that LFS and DCS stimulation can modulate network maturation excitability and synchrony following the acute administration of an inhibitory dose of L-glutamate, and upregulate NR2A, BDNF and RAB3A gene expression. Our study also provides a novel framework for investigating the effects of electrical stimulation on neuronal responses and network formation and repair after traumatic brain injury.	[Latchoumane, Charles-Francois V.; Jackson, LaDonya; Tehrani, Kayvan F.; Mortensen, Luke J.; Stice, Steven L.; Karumbaiah, Lohitash] Univ Georgia, Regenerat Biosci Ctr, ADS Complex, Athens, GA 30602 USA; [Tehrani, Kayvan F.; Mortensen, Luke J.] Univ Georgia, Coll Engn, Sch Chem Mat & Biomed Engn, Athens, GA 30602 USA; [Sendi, Mohammad S. Eslampanah; Ghovanloo, Maysam] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA		Karumbaiah, L (corresponding author), Univ Georgia, Regenerat Biosci Ctr, ADS Complex, Athens, GA 30602 USA.	lohitash@uga.edu	Ghovanloo, Maysam/O-3468-2019; Mortensen, Luke/N-2640-2018	Ghovanloo, Maysam/0000-0001-9502-3704; Latchoumane, Charles-Francois Vincent/0000-0001-7018-0439; Jackson-Cowan, Ladonya/0000-0002-8723-7240; Mortensen, Luke/0000-0002-4331-4099; Karumbaiah, Lohitash/0000-0001-7969-417X; Eslampanah Sendi, Mohammad Sadegh/0000-0003-2946-1786	National Science Foundation Science and Technology Center for Emergent Behaviors of Integrated Cellular Systems [CBET-0939511]; NIH R01United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS099596-01A1]; Georgia Institute of Technology/Emory University Regenerative Engineering and Medicine Center; UGA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099596] Funding Source: NIH RePORTER	This research was supported by startup funds from UGA, seed grant funding from the Georgia Institute of Technology/Emory University Regenerative Engineering and Medicine Center to Lohitash Karumbaiah and Maysam Ghovanloo, NIH R01(1R01NS099596-01A1) award to Lohitash Karumbaiah and National Science Foundation Science and Technology Center for Emergent Behaviors of Integrated Cellular Systems, Grant CBET-0939511 to Steve Stice.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashley JG, 2018, BRAIN INJURY, V32, P600, DOI 10.1080/02699052.2018.1432896; Bakkum DJ, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00193; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; CHOI DW, 1988, J NEUROSCI, V8, P185; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Demirtas-Tatlidede A, 2012, ALZ DIS ASSOC DIS, V26, P282, DOI 10.1097/WAD.0b013e31823346c6; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Soler MD, 2010, BRAIN, V133, P2565, DOI 10.1093/brain/awq184; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fee MS, 1996, J NEUROPHYSIOL, V76, P3823, DOI 10.1152/jn.1996.76.6.3823; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Frega M, 2012, NEUROTOXICOL TERATOL, V34, P116, DOI 10.1016/j.ntt.2011.08.001; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Fukushima K, 2016, J BIOMOL SCREEN, V21, P54, DOI 10.1177/1087057115610055; Gardner RJ, 2013, J NEUROSCI, V33, P18469, DOI 10.1523/JNEUROSCI.2197-13.2013; GINZBURG I, 1994, PHYS REV E, V50, P3171, DOI 10.1103/PhysRevE.50.3171; Gottlieb DI, 1999, CELLS TISSUES ORGANS, V165, P165, DOI 10.1159/000016696; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Gross GW, 1997, BIOSENS BIOELECTRON, V12, P373, DOI 10.1016/S0956-5663(97)00012-2; GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Hecht D, 2010, J NEUROSCI, V30, P4241, DOI 10.1523/JNEUROSCI.2924-09.2010; Heikkila TJ, 2009, EXP NEUROL, V218, P109, DOI 10.1016/j.expneurol.2009.04.011; Hofmann F, 2006, J PHYSIOL-PARIS, V99, P125, DOI 10.1016/j.jphysparis.2005.12.005; Illes S, 2007, EXP NEUROL, V207, P171, DOI 10.1016/j.expneurol.2007.05.020; Impey D, 2017, J PSYCHOPHARMACOL, V31, P614, DOI 10.1177/0269881116665336; ISLAM N, 1995, EXP NEUROL, V133, P25, DOI 10.1006/exnr.1995.1004; ISLAM N, 1995, BRAIN RES, V684, P206, DOI 10.1016/0006-8993(95)00434-R; Ito D, 2013, BRAIN RES, V1534, P22, DOI 10.1016/j.brainres.2013.08.004; Johnstone AFM, 2010, NEUROTOXICOLOGY, V31, P331, DOI 10.1016/j.neuro.2010.04.001; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Karumbaiah L, 2015, BIOCONJUGATE CHEM, V26, P2336, DOI 10.1021/acs.bioconjchem.5b00397; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Kim SJ, 2010, J KOREAN MED SCI, V25, P1499, DOI 10.3346/jkms.2010.25.10.1499; Krause B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00602; Kreuz T, 2011, J NEUROSCI METH, V195, P92, DOI 10.1016/j.jneumeth.2010.11.020; Laste G, 2012, EXP BRAIN RES, V221, P75, DOI 10.1007/s00221-012-3149-x; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Lefaucheur JP, 2008, BRAIN STIMUL, V1, P337, DOI 10.1016/j.brs.2008.07.003; LeFew WR, 2013, NEUROTOXICOLOGY, V36, P34, DOI 10.1016/j.neuro.2013.02.006; Liu YH, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.045002; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; McConnell ER, 2012, NEUROTOXICOLOGY, V33, P1048, DOI 10.1016/j.neuro.2012.05.001; Mukai Y, 2003, ELECTR ENG JPN, V145, P28, DOI 10.1002/eej.10216; Murphy DN, 2009, CURR OPIN PSYCHIATR, V22, P306, DOI 10.1097/YCO.0b013e32832a133f; Napoli A, 2015, BRAIN RES BULL, V119, P127, DOI 10.1016/j.brainresbull.2015.10.002; Nitsche MA, 2002, NERVENARZT, V73, P332, DOI 10.1007/s00115-002-1272-9; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Notturno F, 2014, J NEUROL SCI, V342, P146, DOI 10.1016/j.jns.2014.05.017; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Odawara A, 2014, BIOCHEM BIOPH RES CO, V443, P1176, DOI 10.1016/j.bbrc.2013.12.142; Palm U, 2016, ENCEPHALE, V42, P39, DOI 10.1016/j.encep.2015.06.003; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Penn Y, 2016, P NATL ACAD SCI USA, V113, P3341, DOI 10.1073/pnas.1515105113; Podda MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep22180; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Pripfl J, 2014, BRAIN STIMUL, V7, P226, DOI 10.1016/j.brs.2013.11.003; Pripfl J, 2013, EUR J NEUROSCI, V38, P3778, DOI 10.1111/ejn.12375; Puri R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00107; Quiroga RQ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041904; RANDALL RD, 1992, J NEUROSCI, V12, P1882; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sinor JD, 2000, J NEUROSCI, V20, P8831; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Thakker-Varia S, 2001, J NEUROSCI, V21, P6782, DOI 10.1523/JNEUROSCI.21-17-06782.2001; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tukker AM, 2016, ALTEX-ALTERN ANIM EX, V33, P261, DOI 10.14573/altex.1510091; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wallace K, 2015, NEUROTOXICOLOGY, V49, P79, DOI 10.1016/j.neuro.2015.05.007; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wichterle Hynek, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01h01s5; Winkler C, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0063-17.2017; Yoon KJ, 2012, BRAIN RES, V1452, P61, DOI 10.1016/j.brainres.2012.02.062; Yu SH, 2014, J PHYS THER SCI, V26, P247, DOI 10.1589/jpts.26.247; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	97	11	11	3	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 19	2018	8								10957	10.1038/s41598-018-29069-3			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5LY	WOS:000439102400013	30026496	Green Submitted, Green Published, gold			2022-02-06	
J	Lu, LY; Wang, ML; Wei, XE; Li, WB				Lu, Liyan; Wang, Mingling; Wei, Xiaoer; Li, Wenbin			20-HETE Inhibition by HET0016 Decreases the Blood-Brain Barrier Permeability and Brain Edema After Traumatic Brain Injury	FRONTIERS IN AGING NEUROSCIENCE			English	Article						HET0016; blood-brain barrier; blood edema; 20-HETE; traumatic brain injury	CEREBRAL ISCHEMIA/REPERFUSION; OXIDATIVE STRESS; ARACHIDONIC-ACID; ISCHEMIA; MATRIX-METALLOPROTEINASE-9; DISRUPTION; FLOW; HEMORRHAGE; PATHWAY; DAMAGE	Recent studies have implicated 20-HETE as a vasoconstrictive mediator in trauma, the purpose of this study was to determine whether administration of HET0016, the 20-HETE inhibitor, could protect neurons from trauma and the effect of HET0016 on the blood-brain barrier (BBB) and brain edema in experimental traumatic brain injury (TBI). Rat models with TBI were established. Brain edema was measured according to the wet and dry weight method at 3, 24, and 72 h after injury. The BBB permeability was quantified by dynamic contrast-enhanced magnetic resonance imaging (DCEMRI). Superoxide production, the activity of superoxide dismutase (SOD) and total antioxidative capability (T-AOC) in traumatic brain tissues were also measured. Western blot analysis was used to analyze the expression of the occludin, ZO-1, Matrix metalloproteinase-9 (MMP-9), and c-Jun N-terminal protein kinase (JNK) pathways. At 24 and 72 h after administration of HET0016 following TBI, the BBB permeability and brain edema decreased. The decrease in superoxide production and the increase in the activity of SOD and T-AOC were measured in this study. Western blot analysis showed that the expression of MMP-9 and JNK pathways was suppressed, but the expression of ZO-1 and occludin was increased. These results suggest that the administration of HET0016 could protect the BBB function and decrease brain edema after experimental traumatic injury by suppressing the expression of MMP-9 and activating the expression of tight junction proteins via suppressing the JNK pathway and oxidative stress.	[Lu, Liyan] Nanjing First Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Mingling; Wei, Xiaoer; Li, Wenbin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai, Peoples R China		Li, WB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.	liwenbin@sjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC81271540]; Nanjing Medical University [2017NJMU123]	This study was supported by the National Natural Science Foundation of China (NSFC81271540) and Nanjing Medical University grant (2017NJMU123).	Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Cai HX, 2015, NEUROSCI BULL, V31, P550, DOI 10.1007/s12264-015-1533-1; Fordsmann JC, 2013, J NEUROSCI, V33, P2562, DOI 10.1523/JNEUROSCI.2308-12.2013; Garcia V, 2015, PROSTAG OTH LIPID M, V116, P124, DOI 10.1016/j.prostaglandins.2014.12.001; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hanrahan F, 2016, TRANSLATIONAL RES TR; Harder David R., 1994, American Journal of Physiology, V266, pH2098; Haris M, 2008, J MAGN RESON IMAGING, V28, P588, DOI 10.1002/jmri.21491; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Kim JY, 2015, NEUROSCIENCE, V304, P355, DOI 10.1016/j.neuroscience.2015.07.065; Lahoud-Rahme MS, 2009, RESUSCITATION, V80, P484, DOI 10.1016/j.resuscitation.2009.01.007; Lapchak PA, 2000, STROKE, V31, P3034, DOI 10.1161/01.STR.31.12.3034; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Liu Y, 2014, BRAIN RES, V1544, P45, DOI 10.1016/j.brainres.2013.11.031; Liu Y, 2012, BRAIN RES, V1445, P73, DOI 10.1016/j.brainres.2012.01.031; Lu LY, 2018, MOL MED REP, V17, P7339, DOI 10.3892/mmr.2018.8780; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Poloyac SM, 2006, J CEREBR BLOOD F MET, V26, P1551, DOI 10.1038/sj.jcbfm.9600309; Renic M, 2012, AM J PHYSIOL-HEART C, V302, pH1285, DOI 10.1152/ajpheart.00340.2011; Renic M, 2009, J CEREBR BLOOD F MET, V29, P629, DOI 10.1038/jcbfm.2008.156; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Toth P, 2013, BRIT J PHARMACOL, V168, P1878, DOI 10.1111/bph.12079; Urrutia A, 2013, NEUROBIOL DIS, V50, P49, DOI 10.1016/j.nbd.2012.10.006; Wang GY, 2015, CELL MOL NEUROBIOL, V35, P1105, DOI 10.1007/s10571-015-0204-8; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wu GF, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0287-3; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yang ZJ, 2012, J NEUROCHEM, V121, P168, DOI 10.1111/j.1471-4159.2012.07666.x; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zhu JC, 2015, DEV NEUROSCI-BASEL, V37, P376, DOI 10.1159/000369007	36	11	12	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JUL 16	2018	10								207	10.3389/fnagi.2018.00207			10	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	GN1BE	WOS:000438717000001	30061822	Green Published, gold			2022-02-06	
J	Liu, XY; Czosnyka, M; Donnelly, J; Cardim, D; Cabeleira, M; Hutchinson, PJ; Hu, X; Smielewski, P; Brady, K				Liu, Xiuyun; Czosnyka, Marek; Donnelly, Joseph; Cardim, Danilo; Cabeleira, Manuel; Hutchinson, Peter J.; Hu, Xiao; Smielewski, Peter; Brady, Ken			Wavelet pressure reactivity index: a validation study	JOURNAL OF PHYSIOLOGY-LONDON			English	Article						cerebral autoregulation; experimental hypotension; low limit of autoregulation; pressure reactivity index; wavelet transform	CEREBRAL PERFUSION-PRESSURE; NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; ARTERIAL-BLOOD PRESSURE; HEART-RATE-VARIABILITY; CEREBROVASCULAR REACTIVITY; COHERENCE ANALYSIS; TIME-SERIES; AUTOREGULATION; FLOW	We present a novel method to monitor cerebral autoregulation (CA) using the wavelet transform (WT). The new method is validated against the pressure reactivity index (PRx) in two piglet experiments with controlled hypotension. The first experiment (n=12) had controlled haemorrhage with artificial stationary arterial blood pressure (ABP) and intracranial pressure (ICP) oscillations induced by sinusoidal slow changes in positive end-expiratory pressure (PEEP group'). The second experiment (n=17) had venous balloon inflation during spontaneous, non-stationary ABP and ICP oscillations (non-PEEP group'). The wavelet transform phase shift (WTP) between ABP and ICP was calculated in the frequency range 0.0067-0.05Hz. Wavelet semblance, the cosine of WTP, was used to make the values comparable to PRx, and the new index was termed wavelet pressure reactivity index (wPRx). The traditional PRx, the running correlation coefficient between ABP and ICP, was calculated. The result showed a significant linear relationship between wPRx and PRx in the PEEP group (R=0.88) and non-PEEP group (R=0.56). In the non-PEEP group, wPRx showed better performance than PRx in distinguishing cerebral perfusion pressure (CPP) above and below the lower limit of autoregulation (LLA). When CPP was decreased below LLA, wPRx increased from 0.43 +/- 0.28 to 0.69 +/- 0.12 (P=0.003) while PRx increased from 0.07 +/- 0.21 to 0.27 +/- 0.37 (P=0.04). Moreover, wPRx provided a more stable result than PRx (SD of PRx was 0.40 +/- 0.07, and SD of wPRx was 0.28 +/- 0.11, P=0.001). Assessment of CA using wavelet-derived phase shift between ABP and ICP is feasible.	[Liu, Xiuyun; Czosnyka, Marek; Donnelly, Joseph; Cabeleira, Manuel; Hutchinson, Peter J.; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg,Brain Phys Lab, Hills Rd, Cambridge CB2 0QQ, England; [Liu, Xiuyun; Hu, Xiao] UCSF, Dept Physiol Nursing, San Francisco, CA USA; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Donnelly, Joseph] Univ Auckland, Dept Anaesthesiol, Auckland, New Zealand; [Cardim, Danilo] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Fac Med, Vancouver, BC, Canada; [Brady, Ken] Baylor Coll Med, Houston, TX 77030 USA		Liu, XY (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg,Brain Phys Lab, Hills Rd, Cambridge CB2 0QQ, England.	xiuyun.liu@ucsf.edu	Donnelly, Joseph/N-6803-2019; Liu, Xiuyun/V-4427-2017; Cardim, Danilo Augusto/B-8447-2012	Donnelly, Joseph/0000-0002-6502-8069; Liu, Xiuyun/0000-0001-9540-4865; Cardim, Danilo Augusto/0000-0002-9261-1321; Hutchinson, Peter/0000-0002-2796-1835; Smielewski, Peter/0000-0001-5096-3938; czosnyka, marek/0000-0003-2446-8006	NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986, G0502030, G1002277, G0601025] Funding Source: UKRI	PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre.	Aaslid R., 1986, INTRACRANIAL PRESSUR, P226; Addison P.S., 2015, IEEE REV BIOMED ENG, V8, P78, DOI DOI 10.1109/RBME.2015.2436978; Addison P.S., 2016, ILLUSTRATED WAVELET, V2nd ed.; Addison PS, 2015, IEEE ENG MED BIO, P5960, DOI 10.1109/EMBC.2015.7319749; Addison PS., 2002, ILLUSTRATED WAVELET; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bishop SM, 2012, ANESTHESIOLOGY, V117, P810, DOI 10.1097/ALN.0b013e31826a4aa2; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Chalak LF, 2017, DEV NEUROSCI-BASEL, V39, P89, DOI 10.1159/000457833; Chalak LF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45958; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Chi NF, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7803426; Cooper GRJ, 2008, COMPUT GEOSCI-UK, V34, P95, DOI 10.1016/j.cageo.2007.03.009; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Davrath LR, 2003, AM J PHYSIOL-HEART C, V285, pH1697, DOI 10.1152/ajpheart.00208.2003; de Jong DLK, 2017, J PHYSIOL-LONDON, V595, P5623, DOI 10.1113/JP274304; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Faes L, 2004, IEEE T BIO-MED ENG, V51, P1156, DOI 10.1109/TBME.2004.827271; Garg A, 2014, AM J PHYSIOL-HEART C, V307, pH259, DOI 10.1152/ajpheart.00171.2014; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Gressens P, 2008, BRAIN PATHOL, V18, P10, DOI 10.1111/j.1750-3639.2007.00095.x; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Grundy D, 2015, EXP PHYSIOL, V100, P755, DOI 10.1113/EP085299; Highton D, 2015, ANESTH ANALG, V121, P198, DOI 10.1213/ANE.0000000000000790; Keissar K, 2009, PHILOS T R SOC A, V367, P1393, DOI 10.1098/rsta.2008.0273; Kenosi M, 2015, ACTA PAEDIATR, V104, P225, DOI 10.1111/apa.12906; Kvandal P, 2013, J CLIN MONIT COMPUT, V27, P375, DOI 10.1007/s10877-013-9484-z; Labrecque L, 2017, PHYSL REP, V5, P21; Lang E W, 1995, New Horiz, V3, P400; Lang EW, 2015, J NEUROSURG, V122, P588, DOI 10.3171/2014.10.JNS14602; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LASSEN NA, 1972, SCAND J CLIN LAB INV, V30, P113, DOI 10.3109/00365517209081099; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Liu J, 2016, J PHYSIOL-LONDON, V594, P3141, DOI 10.1113/JP271068; Liu X, 2017, PLOS MED, V14, P7; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; National Research Council, 2011, GUIDE CARE USE LAB A; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Panerai RB, 2014, MED ENG PHYS, V36, P576, DOI 10.1016/j.medengphy.2013.09.004; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Peng TY, 2010, IEEE T BIO-MED ENG, V57, P960, DOI 10.1109/TBME.2009.2024265; Pichot V, 1999, J APPL PHYSIOL, V86, P1081, DOI 10.1152/jappl.1999.86.3.1081; Placek MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181851; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Schmidt B, 1999, J CEREBR BLOOD F MET, V19, P990, DOI 10.1097/00004647-199909000-00006; SHIGEMORI M, 1989, Neurological Research, V11, P165; Smith M, 2011, PHILOS T R SOC A, V369, P4452, DOI 10.1098/rsta.2011.0242; Tarumi T, 2014, J ALZHEIMERS DIS, V41, P765, DOI 10.3233/JAD-132018; Tian FH, 2016, NEUROIMAGE-CLIN, V11, P124, DOI 10.1016/j.nicl.2016.01.020; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; van der Scheer JW, 2018, SPINAL CORD, V56, P469, DOI 10.1038/s41393-017-0021-7; Wszedybyl-Winklewska M, 2017, PLOS ONE, V12, P2; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	62	11	11	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	JUL 15	2018	596	14					2797	2809		10.1113/JP274708			13	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	GN0NQ	WOS:000438667800019	29665012	Green Published, Bronze			2022-02-06	
J	Born, K; Amsler, F; Gross, T				Born, Konstantin; Amsler, Felix; Gross, Thomas			Prospective evaluation of the Quality of Life after Brain Injury (QOLIBRI) score: minor differences in patients with major versus no or mild traumatic brain injury at one-year follow up	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Quality of life after brain injury (QOLIBRI); Health-related quality of life (HRQoL); Outcome; Traumatic brain injury (TBI); Trauma; Longer-term; euro quality of life group health-related quality of life on five dimensions (EQ-5D); Medical outcomes study short Form-36 (SF-36); Trauma outcome profile (TOP)	GLASGOW COMA SCALE; HEAD-INJURY; MULTIPLE TRAUMA; SEVERITY SCORE; 1ST YEAR; POLYTRAUMA; MULTICENTER; DEFINITION; INSTRUMENT; MODERATE	Background: The Quality of Life after Brain Injury (QOLIBRI) score was developed to assess disease-specific health-related quality of life (HRQoL) after traumatic brain injury (TBI). So far, validation studies on the QOLIBRI were only conducted in cohorts with traumatic brain injury. This study investigated the longer-term residuals in severely injured patients, focusing specifically on the possible impact of major TBI. Methods: In a prospective questionnaire investigation, 199 survivors with an injury severity score (ISS) > 15 participated in one-year follow-up. Patients who had sustained major TBI (abbreviated injury scale, AIS head > 2) were compared with patients who had no or only mild TBI (AIS head <= 2). Univariate analysis (ANOVA, Cohen's kappa, Pearson's r) and stepwise linear regression analysis (B with 95% CI, R, R-2) were used. Results: The total QOLIBRI revealed no differences in one-year outcomes between patients with versus without major TBI (75 and 76, resp.; p = 0.68). With regard to the cognitive subscore, the group with major TBI demonstrated significantly more limitations than the one with no or mild TBI (p < 0.05). The AIS head correlated significantly with the cognitive dimension of the QOLIBRI (r = -0.16; p < 0.05), but not with the mental components of the SF-36 or the TOP. In multivariate analysis, the influence of the severity of head injury (AIS head) on total QOLIBRI was weaker than that of injured extremities (R-2 = 0.02; p < 0.05 vs. R-2 = 0.04; p = 0.001) and equal to the QOLIBRI cognitive subscore (R-2 = 0.03, p < 0.01 each). Conclusions: Given the unexpected result of similar mean QOLIBRI total score values and only minor differences in cognitive deficits following major trauma independently of whether patients sustained major brain injury or not, further studies should investigate whether the QOLIBRI actually has the discriminative capacity to detect specific residuals of major TBI. In effect, the score appears to indicate mental deficits following different types of severe trauma, which should be evaluated in more detail.	[Born, Konstantin; Gross, Thomas] Cantonal Hosp Aarau, Dept Traumatol, Tellstr, CH-5001 Aarau, Switzerland		Gross, T (corresponding author), Cantonal Hosp Aarau, Dept Traumatol, Tellstr, CH-5001 Aarau, Switzerland.	thomas.gross@ksa.ch		Amsler, Felix/0000-0003-4259-7004			American College of Surgeons' Committee on Trauma and the International ATLS working group, 2012, ADV TRAUM LIF SUPP A; Attenberger C, 2012, INJURY, V43, P1566, DOI 10.1016/j.injury.2011.01.002; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gennarelli T, 1990, ABBREVIATED INJURY S; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Gross T, 2010, BRIT J SURG, V97, P118, DOI 10.1002/bjs.6842; Gross T, 2018, CLIN INTERV AGING, V13, P773, DOI 10.2147/CIA.S158344; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hoffman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103082; Hofhuis JGM, 2014, J TRAUMA ACUTE CARE, V76, P549, DOI 10.1097/TA.0b013e3182a9d105; JENNETT B, 1975, LANCET, V1, P480; Kaske S, 2014, INJURY, V45, pS100, DOI 10.1016/j.injury.2014.08.028; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Livny A, 2017, J NEUROTRAUM, V34, P1466, DOI 10.1089/neu.2016.4598; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Neugebauer EAM, 2012, DTSCH ARZTEBL INT, V109, P102, DOI 10.3238/arztebl.2012.0102; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Orwelius L, 2012, J TRAUMA ACUTE CARE, V72, P504, DOI 10.1097/TA.0b013e31821a416a; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Pirente N, 2002, UNFALLCHIRURG, V105, P413; Pirente N, 2001, UNFALLCHIRURG, V104, P57, DOI 10.1007/s001130050688; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Reith FCM, 2016, J NEUROTRAUM, V33, P89, DOI 10.1089/neu.2014.3843; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Soberg HL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0589-9; Stein SC, 1995, NEUROTRAUMA, P31; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Szende A, 2004, MEASURING SELF REPOR; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wustenhagen S., 2009, THESIS; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	56	11	11	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1477-7525			HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	JUL 9	2018	16								136	10.1186/s12955-018-0966-z			14	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GM2NI	WOS:000437923500001	29986710	Green Published, gold			2022-02-06	
J	Gao, LS; Xu, WL; Fan, SB; Li, T; Zhao, TF; Ying, GY; Zheng, JW; Li, JR; Zhang, ZY; Yan, F; Zhu, YJ; Chen, G				Gao, Liansheng; Xu, Weilin; Fan, Shuangbo; Li, Tao; Zhao, Tengfei; Ying, Guangyu; Zheng, Jingwei; Li, Jianru; Zhang, Zhongyuan; Yan, Feng; Zhu, Yongjian; Chen, Gao			MANF attenuates neuronal apoptosis and promotes behavioral recovery via Akt/MDM-2/p53 pathway after traumatic spinal cord injury in rats	BIOFACTORS			English	Article						apoptosis; MANF; traumatic spinal cord injury; neurological function; blood spinal cord barrier	IMPROVES FUNCTIONAL RECOVERY; ENDOPLASMIC-RETICULUM STRESS; 6-OHDA-INDUCED CELL-DAMAGE; NEUROTROPHIC FACTOR MANF; BRAIN-INJURY; BARRIER DISRUPTION; MDM2; INFLAMMATION; ACTIVATION; EXPRESSION	The aim of this study was to investigate the potential effect and mechanism of action of MANF in attenuating neuronal apoptosis following t-SCI. A clip compressive model was used to induce a crush injury of the spinal cord in a total of 230 rats. The Basso, Beattie, and Bresnahan (BBB) score, spinal cord water content, and blood spinal cord barrier (BSCB) permeability were evaluated. The expression levels of MANF and its downstream proteins were examined by western blotting. Immunofluorescence staining of MANF, NeuN, GFAP, Iba-1, cleaved caspase-3, and TUNEL staining were also performed. Cells were counted in six randomly selected fields in the gray matter regions of the sections from two spinal cord sites (2 mm rostral and caudal to the epicenter of the injury) per sample. A cell-based mechanical injury model was also conducted using SH-SY5Y cells. Cell apoptosis and viability were assessed by flow cytometry, an MTT assay, and trypan blue staining. Subcellular structures were observed by transmission electron microscopy. MANF was mainly expressed in neurons. The expression levels of MANF, and its downstream target, p-Akt, were gradually increased and after t-SCI. Treatment with MANF increased Bcl-2 and decreased Bax and CC-3 levels; these effects were reversed on treatment with MK2206. The BBB score, spinal cord water content, and BSCB destruction were also ameliorated by MANF treatment. MANF decreases neuronal apoptosis and improves neurological function through Akt/MDM-2/p53 pathway after t-SCI. Therefore, MANF might be a potential treatment for patients with t-SCI. (c) 2018 BioFactors, 44(4):369-386, 2018	[Gao, Liansheng; Xu, Weilin; Li, Tao; Ying, Guangyu; Zheng, Jingwei; Li, Jianru; Zhang, Zhongyuan; Yan, Feng; Zhu, Yongjian; Chen, Gao] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Fan, Shuangbo] Ningbo Zhenhai Longsai Hosp, Dept Neurosurg, Ningbo, Zhejiang, Peoples R China; [Zhao, Tengfei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China		Zhu, YJ; Chen, G (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	neurosurgery@zju.edu.cn; d-chengao@zju.edu.cn	yongjian, zhu/AAR-5445-2021	yan, feng/0000-0001-8663-6859	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401011, 81601003, 81771264]; Medical Science and Technology Health Research Fund of Zhejiang Province [2017209992]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY15H060004]	This work was supported by the National Natural Science Foundation of China (No. 81401011, No. 81601003, and No. 81771264), Project cosponsored by the Medical Science and Technology Health Research Fund of Zhejiang Province (No. 2017209992) and Natural Science Foundation of Zhejiang Province (No. LY15H060004).	Ahn JY, 2004, EMBO J, V23, P3995, DOI 10.1038/sj.emboj.7600392; Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bharne AP, 2013, NEUROPHARMACOLOGY, V67, P126, DOI 10.1016/j.neuropharm.2012.10.028; Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133; Cheng H, 2002, J NEUROSCI RES, V69, P397, DOI 10.1002/jnr.10303; Chiu LS, 2016, EXPERT REV NEUROTHER, V16, P361, DOI 10.1586/14737175.2016.1150180; Fan ZK, 2013, J NEUROTRAUM, V30, P473, DOI 10.1089/neu.2012.2574; Fang B, 2013, J VASC SURG, V58, P1043, DOI 10.1016/j.jvs.2012.11.087; Fernandez-Lopez B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/350750; Figueroa JD, 2016, J NEUROTRAUM, V33, P1436, DOI 10.1089/neu.2015.4186; Gao GS, 2017, EXP THER MED, V14, P3926, DOI 10.3892/etm.2017.4934; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Goldberg AL, 2010, J SPINAL CORD MED, V33, P105, DOI 10.1080/10790268.2010.11689685; Guercio JR, 2019, J SPINAL CORD MED, V42, P102, DOI 10.1080/10790268.2018.1439803; Hao F, 2017, EXP NEUROL, V291, P120, DOI 10.1016/j.expneurol.2017.01.008; He ZL, 2017, AM J TRANSL RES, V9, P1075; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hodgetts SI, 2017, VITAM HORM, V104, P405, DOI 10.1016/bs.vh.2016.11.007; Hu AM, 2015, SPINAL CORD, V53, P98, DOI 10.1038/sc.2014.209; Hu JZ, 2015, NEUROCHEM RES, V40, P1393, DOI 10.1007/s11064-015-1606-1; Huang JW, 2016, CELL BIOL INT, V40, P803, DOI 10.1002/cbin.10621; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Inuzuka H, 2010, ONCOTARGET, V1, P685; Jiang W, 2016, SPINE, V41, pE330, DOI 10.1097/BRS.0000000000001287; Kim Y, 2017, TRANSL RES, V188, P1, DOI 10.1016/j.trsl.2017.06.010; Kjell J, 2016, SPINAL CORD, V54, P517, DOI 10.1038/sc.2015.208; Ko HR, 2016, ELIFE, V5, DOI 10.7554/eLife.20799; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Lee TT, 1999, J NEUROTRAUM, V16, P347, DOI 10.1089/neu.1999.16.347; Li XQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-62; Liang WB, 2010, BIOMATERIALS, V31, P8634, DOI 10.1016/j.biomaterials.2010.07.084; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lu M, 2013, NEUROSCI LETT, V542, P87, DOI 10.1016/j.neulet.2013.03.004; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Niu CC, 2011, J NEUROPATH EXP NEUR, V70, P634, DOI 10.1097/NEN.0b013e318222b97b; Nomura K, 2017, NAT STRUCT MOL BIOL, V24, P578, DOI 10.1038/nsmb.3414; Norisada J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146923; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rosich K, 2017, J NEUROTRAUM, V34, P3311, DOI 10.1089/neu.2017.5175; Saadatzadeh MR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102216; Samano C, 2019, NEUROCHEM RES, V44, P200, DOI 10.1007/s11064-017-2459-6; Seo JY, 2015, SPINE, V40, P883, DOI 10.1097/BRS.0000000000000845; Sereno Dayane, 2017, Biochem Biophys Rep, V11, P161, DOI 10.1016/j.bbrep.2017.02.009; Sun H, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0082-8; Tollini LA, 2014, CANCER CELL, V26, P235, DOI 10.1016/j.ccr.2014.06.006; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090433; Wang S, 2017, NEUROCHEM RES, V42, P455, DOI 10.1007/s11064-016-2092-9; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; Wang XX, 2014, J NEUROTRAUM, V31, P1955, DOI 10.1089/neu.2014.3355; Weinmann O, 2006, MOL CELL NEUROSCI, V32, P161, DOI 10.1016/j.mcn.2006.03.007; Yan F, 2017, MOL NEUROBIOL, V54, P1808, DOI 10.1007/s12035-016-9790-9; Yang W, 2014, J NEUROL SCI, V344, P129, DOI 10.1016/j.jns.2014.06.042; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Zhang JX, 2017, EXP GERONTOL, V100, P77, DOI 10.1016/j.exger.2017.10.021; Zhang JX, 2017, EXP GERONTOL, V89, P45, DOI 10.1016/j.exger.2017.01.010; Zhao H, 2013, J MOL NEUROSCI, V51, P671, DOI 10.1007/s12031-013-0042-4; Zhou KL, 2016, SPINAL CORD, V54, P510, DOI 10.1038/sc.2015.217; Zhou KL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17130; Zhou YL, 2017, ONCOTARGET, V8, P1688, DOI 10.18632/oncotarget.13777; Zhu LN, 2017, NEUROL SCI, V38, P1741, DOI 10.1007/s10072-017-3042-2	72	11	11	3	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-6433	1872-8081		BIOFACTORS	Biofactors	JUL-AUG	2018	44	4					369	386		10.1002/biof.1433			18	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	GR0LF	WOS:000442207300006	29797541				2022-02-06	
J	Jannesar, S; Allen, M; Mills, S; Gibbons, A; Bresnaha, JC; Salegio, EA; Sparrey, CJ				Jannesar, Shervin; Allen, Mark; Mills, Sarah; Gibbons, Anne; Bresnaha, Jacqueline C.; Salegio, Ernesto A.; Sparrey, Carolyn J.			Compressive mechanical characterization of non-human primate spinal cord white matter	ACTA BIOMATERIALIA			English	Article						Spinal cord injury; Non-human primate; White matter; Tissue characterization; Viscoelastic constitutive model	MAGNETIC-RESONANCE ELASTOGRAPHY; SOFT BIOLOGICAL TISSUES; FINITE-ELEMENT-ANALYSIS; CONTUSION INJURY MODEL; HUMAN BRAIN-TISSUE; IN-VIVO; CERVICAL-SPINE; VISCOELASTIC PROPERTIES; UNCONFINED COMPRESSION; CONSTITUTIVE MODEL	The goal of developing computational models of spinal cord injury (SCI) is to better understand the human injury condition. However, finite element models of human SCI have used rodent spinal cord tissue properties due to a lack of experimental data. Central nervous system tissues in non human primates (NHP) closely resemble that of humans and therefore, it is expected that material constitutive models obtained from NHPs will increase the fidelity and the accuracy of human SCI models. Human SCI most often results from compressive loading and spinal cord white matter properties affect FE predicted patterns of injury; therefore, the objectives of this study were to characterize the unconfined compressive response of NHP spinal cord white matter and present an experimentally derived, finite element tractable constitutive model for the tissue. Cervical spinal cords were harvested from nine male adult NHPs (Macaca mulatto). White matter biopsy samples (3 mm in diameter) were taken from both lateral columns of the spinal cord and were divided into four strain rate groups for unconfined dynamic compression and stress relaxation (post-mortem <1-hour). The NHP spinal cord white matter compressive response was sensitive to strain rate and showed substantial stress relaxation confirming the viscoelastic behavior of the material. An Ogden 1st order model best captured the non-linear behavior of NHP white matter in a quasi-linear viscoelastic material model with 4-term Prony series. This study is the first to characterize NHP spinal cord white matter at high (>10/sec) strain rates typical of traumatic injury. The finite element derived material constitutive model of this study will increase the fidelity of SCI computational models and provide important insights for transferring pre-clinical findings to clinical treatments. Statement of Significance Spinal cord injury (SCI) finite element (FE) models provide an important tool to bridge the gap between animal studies and human injury, assess injury prevention technologies (e.g. helmets, seatbelts), and provide insight into the mechanisms of injury. Although, FE model outcomes depend on the assumed material constitutive model, there is limited experimental data for fresh spinal cords and all was obtained from rodent, porcine or bovine tissues. Central nervous system tissues in non human primates (NHP) more closely resemble humans. This study characterizes fresh NHP spinal cord material properties at high strains rates and large deformations typical of SCI for the first time. A constitutive model was defined that can be readily implemented in finite strain FE analysis of SCI. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Jannesar, Shervin; Sparrey, Carolyn J.] Simon Fraser Univ, Mechatron Syst Engn, Surrey, BC, Canada; [Allen, Mark; Mills, Sarah; Gibbons, Anne; Salegio, Ernesto A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Bresnaha, Jacqueline C.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Sparrey, Carolyn J.] ICORD, Vancouver, BC, Canada; [Jannesar, Shervin; Sparrey, Carolyn J.] Simon Fraser Univ, 250-13450 102 Ave, Surrey, BC V3T 0A3, Canada		Sparrey, CJ (corresponding author), Simon Fraser Univ, 250-13450 102 Ave, Surrey, BC V3T 0A3, Canada.	csparrey@sfu.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [EQPE-Q407572, RGPIN-402007]; Simon Fraser University Community Trust Endowment Fund; VAUS Department of Veterans Affairs; UCSF Department of Neurosurgery; CH Neilsen Foundation	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (EQPE-Q407572, RGPIN-402007), the Simon Fraser University Community Trust Endowment Fund, the VA, the UCSF Department of Neurosurgery and the CH Neilsen Foundation.	[Anonymous], 2016, ABAQUS 6 14 DOCUMENT; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; Bhatnagar T, 2016, ANN BIOMED ENG, V44, P1285, DOI 10.1007/s10439-015-1412-6; Bilston L, 1998, IRCOBI C BIOM; Bilston LE, 1996, ANN BIOMED ENG, V24, P67; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Craven J, 2004, ANAESTH INTENSIVE CA, V5, P144; Estes M., AM SOC MECH ENG E, V345E; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Galford J., 1970, J BIOMECH; Galle B, 2007, J BIOMECH, V40, P3029, DOI 10.1016/j.jbiomech.2007.03.014; Galle B, 2010, J BIOMECH, V43, P2839, DOI 10.1016/j.jbiomech.2010.06.014; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Geissler SA, 2013, J SPINE, DOI [10.4172/2165-7939.S4-001, DOI 10.4172/2165-7939.S4-001]; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; GREEN AE, 1971, LARGE ELASTIC DEFORM; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guertler CA, 2018, J BIOMECH, V69, P10, DOI 10.1016/j.jbiomech.2018.01.016; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Ichihara K, 2003, J NEUROSURG, V99, P278, DOI 10.3171/spi.2003.99.3.0278; Ichihara K, 2001, J NEUROTRAUM, V18, P361, DOI 10.1089/08977150151071053; Imajo Y, 2009, SPINE, V34, pE83, DOI 10.1097/BRS.0b013e31818a2c30; Jannesar S, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034171; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Kruse S. A., 2009, INT SOC MAG RESON ME, P630; Kwon BK, 2012, J NEUROTRAUM, V29, P2367, DOI 10.1089/neu.2012.2479; Lee J.H., 2012, JOVE; Maikos JT, 2008, J NEUROTRAUM, V25, P795, DOI 10.1089/neu.2007.0423; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2001, J BIOMECH, V34, P651, DOI 10.1016/S0021-9290(00)00236-0; Moran R, 2014, J BIOMECH, V47, P3762, DOI 10.1016/j.jbiomech.2014.09.030; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Oakland RJ, 2006, P I MECH ENG H, V220, P489, DOI 10.1243/09544119JETM135; PANJABI MM, 1995, J SPINAL DISORD, V8, P39; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prange M., 2000, STAPP CAR CRASH J; Provenzano P, 2001, ANN BIOMED ENG, V29, P908, DOI 10.1114/1.1408926; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P163, DOI 10.1016/j.jmbbm.2012.05.001; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Russell CM, 2012, J NEUROTRAUM, V29, P1574, DOI 10.1089/neu.2011.2225; Salegio EA, 2016, J NEUROTRAUM, V33, P439, DOI 10.1089/neu.2015.3956; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; SHELLSWELL GB, 1979, FEBS LETT, V106, P305, DOI 10.1016/0014-5793(79)80520-7; Shetye SS, 2014, J MECH BEHAV BIOMED, V34, P146, DOI 10.1016/j.jmbbm.2014.02.014; Shetye SS, 2014, ACTA BIOMATER, V10, P792, DOI 10.1016/j.actbio.2013.10.038; Sparrey C. J., 2004, EFFECT IMPACT VELOCI, DOI [10.14288/1.0080718, DOI 10.14288/1.0080718]; Sparrey CJ, 2008, SPINE, V33, pE812, DOI 10.1097/BRS.0b013e3181894fd3; Sparrey CJ, 2016, J NEUROTRAUM, V33, P1136, DOI 10.1089/neu.2015.3974; Sparrey CJ, 2011, J BIOMECH, V44, P1078, DOI 10.1016/j.jbiomech.2011.01.035; Sparrey CJ, 2009, J NEUROTRAUM, V26, P585, DOI 10.1089/neu.2008.0654; Spencer A.J.M., 1984, CONTINUUM THEORY MEC; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Troyer KL, 2011, ACTA BIOMATER, V7, P700, DOI 10.1016/j.actbio.2010.09.003; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Wilcox RK, 2002, J BIOMECH, V35, P381, DOI 10.1016/S0021-9290(01)00180-4	76	11	11	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUL 1	2018	74						260	269		10.1016/j.actbio.2018.05.002			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GM3IM	WOS:000437998200019	29729417	Green Submitted			2022-02-06	
J	Plourde, V; Yeates, KO; Brooks, BL				Plourde, Vickie; Yeates, Keith Owen; Brooks, Brian L.			Predictors of Long-Term Psychosocial Functioning and Health-Related Quality of Life in Children and Adolescents With Prior Concussions	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Concussion; Pre-existing conditions; Childhood; Adolescence; Pediatric; Long-term functioning	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; DIFFICULTIES QUESTIONNAIRE; POSTCONCUSSIVE SYMPTOMS; PSYCHOMETRIC PROPERTIES; HEAD-INJURY; STRENGTHS; VALIDITY; PEDSQL(TM)-4.0; RELIABILITY	Objectives: Individual differences in long-term psychosocial functioning after concussions in children and adolescents are poorly understood. The aim of the study was to investigate potential predictors of long-term psychosocial functioning and health-related quality of life in youth after prior concussion. Methods: Participants (N= 75; mean age = 14.3 years old; 52% girls) with one prior concussion (n = 24), multiple prior concussions (n = 24), or a prior orthopedic injury and no concussion (n = 27) were seen on average 2.7 years after their most recent injury. Psychosocial functioning was assessed using the self-report versions of the Behavior Assessment System for Children (BASC-2; Anxiety and Depression scales only), the Strengths and Difficulties Questionnaire, and the Pediatric Quality of Life Inventory TM 4.0. Pre-existing conditions (attention problems, learning difficulties, mood concerns, anxiety concerns, and migraines) were reported by parents using a checklist and examined as predictors of long-term functioning. Other potential predictors included age at testing, sex, time between most recent injury and testing, and number of prior concussions. Results: The groups did not differ significantly on long-term psychosocial functioning. Moreover, only pre-existing mood concerns or attention problems significantly predicted psychosocial adjustment. Conclusions: Children's functioning before a concussion is critical to understanding outcome. Pre-injury attention and mood concerns should be assessed in clinical settings to prevent and treat long-term psychosocial problems after concussion.	[Plourde, Vickie] Univ Alberta, Fac St Jean, 8406 Rue Marie Anne Gaboury Northwest, Edmonton, AB T6C 4G9, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada		Plourde, V (corresponding author), Univ Alberta, Fac St Jean, 8406 Rue Marie Anne Gaboury Northwest, Edmonton, AB T6C 4G9, Canada.	plourde@ualberta.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Plourde, Vickie/0000-0002-0098-5431	Shaikh Family Research Award; Ronald and Irene Ward Chair in Pediatric Brain Injury; Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute (University of Calgary); Integrated Concussion Research Program (University of Calgary); Alberta Innovates-Health Solutions	This study was funded by the Shaikh Family Research Award, an endowment held by the Alberta Children's Hospital Foundation and granted to Brian Brooks by the Alberta Children's Hospital Research Institute. Additional support for the study was provided from the Ronald and Irene Ward Chair in Pediatric Brain Injury (awarded to Keith Yeates). Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award. Vickie Plourde acknowledges postdoctoral fellowship funding from the Alberta Children's Hospital Research Institute (University of Calgary), the Integrated Concussion Research Program (University of Calgary), and Alberta Innovates-Health Solutions.	Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Boe T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152202; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Curvis W, 2014, BRIT J CLIN PSYCHOL, V53, P131, DOI 10.1111/bjc.12025; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; IBM Corp, 2013, IBM SPSS STAT MAC; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Muris P, 2004, BRIT J CLIN PSYCHOL, V43, P437, DOI 10.1348/0144665042388982; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Van Roy B, 2008, J CHILD PSYCHOL PSYC, V49, P1304, DOI 10.1111/j.1469-7610.2008.01942.x; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	53	11	11	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2018	24	6					540	548		10.1017/S1355617718000061			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GM3XJ	WOS:000438044700002	29560837	Bronze			2022-02-06	
J	Robles, AJ; Kornblith, LZ; Hendrickson, CM; Howard, BM; Conroy, AS; Moazed, F; Calfee, CS; Cohen, MJ; Callcut, RA				Robles, Anamaria J.; Kornblith, Lucy Z.; Hendrickson, Carolyn M.; Howard, Benjamin M.; Conroy, Amanda S.; Moazed, Farzad; Calfee, Carolyn S.; Cohen, Mitchell J.; Callcut, Rachael A.			Health care utilization and the cost of posttraumatic acute respiratory distress syndrome care	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 09-13, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		ARDS; Berlin criteria; cost; trauma	ACUTE LUNG INJURY; WORK-LOSS COSTS; INTENSIVE-CARE; TRAUMA DEATHS; UNITED-STATES; EPIDEMIOLOGY; OUTCOMES; MORTALITY; SURVIVORS; SERVICES	BACKGROUND Posttraumatic acute respiratory distress syndrome (ARDS) is associated with prolonged mechanical ventilation and longer hospitalizations. The relationship between posttraumatic ARDS severity and financial burden has not been previously studied. We hypothesized that increasing ARDS severity is associated with incrementally higher health care costs. METHODS Adults arriving as the highest level of trauma activation were enrolled in an ongoing prospective cohort study. Patients who survived 6 hours or longer are included in the analysis. Blinded review of chest radiographs was performed by two independent physicians for any intubated patient with Pao(2):FIO2 ratio of 300 mmHg or lower during the first 8 days of admission. The severity of ARDS was classified by the Berlin criteria. Hospital charge data were used to perform standard costing analysis. RESULTS Acute respiratory distress syndrome occurred in 13% (203 of 1,586). The distribution of disease severity was 33% mild, 42% moderate, and 25% severe. Patients with ARDS were older (41 years vs. 35 years, p < 0.01), had higher median Injury Severity Score (30 vs. 10, p < 0.01), more chest injury (Abbreviated Injury Scale score, 3: 51% vs. 21%, p < 0.01), and blunt mechanisms (85% vs. 53%, p < 0.01). By ARDS severity, there was no significant difference in age, mechanism, or rate of traumatic brain injury. Increasing ARDS severity was associated with higher Injury Severity Score and higher mortality rates. Standardized total hospital charges were fourfold higher for patients who developed ARDS compared with those who did not develop ARDS (US $434,000 vs. US $96,000; p < 0.01). Furthermore, the daily hospital charges significantly increased across categories of worsening ARDS severity (mild, US $20,451; moderate, US $23,994; severe, US $33,316; p < 0.01). CONCLUSION The development of posttraumatic ARDS is associated with higher health care costs. Among trauma patients who develop ARDS, total hospital charges per day increase with worsening severity of disease. Prevention, early recognition, and treatment of ARDS after trauma are potentially important objectives for efforts to control health care costs in this population. LEVEL OF EVIDENCE Economic and value-based evaluations, level IV.	[Robles, Anamaria J.; Kornblith, Lucy Z.; Howard, Benjamin M.; Conroy, Amanda S.; Callcut, Rachael A.] San Francisco Gen Hosp, Dept Surg, San Francisco, CA 94110 USA; [Hendrickson, Carolyn M.; Moazed, Farzad; Calfee, Carolyn S.] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cohen, Mitchell J.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; Univ Colorado, Denver, CO 80202 USA		Robles, AJ (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A, 1001 Potrero Ave, San Francisco, CA 94110 USA.	anamaria.robles@ucsf.edu	Callcut, Rachael/ABE-1484-2021	Robles, Anamaria/0000-0002-3693-314X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01ES026834, R01HL110969, K24HL133390]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL110969, K24HL133390, K23HL133495, K23HL136844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER	Funding: R.A.C. is supported by NIH K01ES026834. C.S.C. was supported by NIH R01HL110969 and NIH K24HL133390.	ASHBAUGH DG, 1967, LANCET, V2, P319; BELLAMY PE, 1984, CRIT CARE MED, V12, P622, DOI 10.1097/00003246-198408000-00002; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; BYRICK RJ, 1980, CRIT CARE MED, V8, P332, DOI 10.1097/00003246-198006000-00003; Cameron JI, 2006, CRIT CARE MED, V34, P81, DOI 10.1097/01.CCM.0000190428.71765.31; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Centers for Disease Control and Prevention, 2015, 10 LEAD CAUS DEATH A; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Cooper LM, 2004, CRIT CARE MED, V32, P2247, DOI 10.1097/01.CCM.0000146301.47334.BD; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; Daurat A, 2016, INJURY, V47, P147, DOI 10.1016/j.injury.2015.08.031; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Dodoo-Schittko F, 2017, J THORAC DIS, V9, P818, DOI 10.21037/jtd.2017.03.120; Drummond M., 2005, METHODS EC EVALUATIO; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Ezenduka C, 2012, J MENT HEALTH POLICY, V15, P139; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1078, DOI 10.15585/mmwr.mm6438a5; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1074, DOI 10.15585/mmwr.mm6438a4; Frutos-Vivar F, 2006, SEM RESP CRIT CARE M, V27, P327, DOI 10.1055/s-2006-948287; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Hendrickson CM, 2015, J TRAUMA ACUTE CARE, V79, P417, DOI 10.1097/TA.0000000000000760; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Islam MM, 2013, DRUG ALCOHOL REV, V32, P312, DOI 10.1111/dar.12019; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; Kaplan R, 2011, HARVARD BUSINESS REV; Malangoni MA, 2005, SURGERY, V138, P757; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Pfeifer R, 2017, J TRAUMA ACUTE CARE, V83, P496, DOI 10.1097/TA.0000000000001571; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Wind J, 2007, RESP MED, V101, P2091, DOI 10.1016/j.rmed.2007.05.021; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460	42	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2018	85	1					148	154		10.1097/TA.0000000000001926			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GL8GZ	WOS:000437457000022	29958249	Green Accepted			2022-02-06	
J	Krutsch, W; Krutsch, V; Hilber, F; Pfeifer, C; Baumann, F; Weber, J; Schmitz, P; Kerschbaum, M; Nerlich, M; Angele, P				Krutsch, Werner; Krutsch, Volker; Hilber, Franz; Pfeifer, Christian; Baumann, Florian; Weber, Johannes; Schmitz, Paul; Kerschbaum, Maximilian; Nerlich, Michael; Angele, Peter			11.361 sports injuries in a 15-year survey of a Level I emergency trauma department reveal different severe injury types in the 6 most common team sports	SPORTVERLETZUNG-SPORTSCHADEN			English	Article						injury; team sports; football; emergency department; injury severity; injury prevention	TRAINING-PROGRAM; SOCCER INJURIES; ICE HOCKEY; FOOTBALL; EPIDEMIOLOGY; DEPARTMENTS	Introduction Severe sports-related injuries are a common affliction treated in Level I trauma departments. Detailed knowledge on injury characteristics from different medical settings is essential to improve the development of injury prevention strategies in different team sports. Methods Team sport injuries were retrospectively analysed in a Level I trauma department registry over 15 years. Injury and treatment data were compared with regard to competition and training exposure. Injury data such as time of visitation, type of injury, multiple injured body regions and immediate hospitalisation helped to define the severity level of each team sports injury. Results At the Level I trauma department, 11.361 sports-related injuries were seen over 15 years, of which 34.0% were sustained during team sports. Soccer injuries were the most common injuries of all team sports (71.4%). The lower extremity was the most affected body region overall, followed by the upper extremity. Head injuries were mainly seen in Ice hockey and American football and concussion additionally frequently in team handball. Slight injuries like sprains or contusions occurred most frequently in all team sports. In soccer and team handball, injuries sustained in competition were significantly more severe (p<0.001) than those sustained in practice. Volleyball and basketball had a trend to higher rate of severe injuries sustained during practice sessions. Conclusion Depending on the specific injury profile of each team sports, injury prevention strategies should address competitive as well as training situations, which may need different strategies.	[Krutsch, Werner; Hilber, Franz; Pfeifer, Christian; Baumann, Florian; Weber, Johannes; Schmitz, Paul; Kerschbaum, Maximilian; Nerlich, Michael; Angele, Peter] Univ Med Ctr, Dept Trauma Surg, Regensburg, Germany; [Krutsch, Volker] Klin Nurnberg Nord, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany		Krutsch, V (corresponding author), Klin Nurnberg Nord, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany.	Volker.Krutsch@klinikum-nuernberg.de		Kerschbaum, Maximilian/0000-0003-4996-8808			Adams AL, 2006, ACAD EMERG MED, V13, P571, DOI 10.1197/j.aem.2005.12.015; Agel J, 2010, CAN J SURG, V53, P319; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Brophy RH, 2010, AM J SPORT MED, V38, P1166, DOI 10.1177/0363546509357836; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; DELOES M, 1988, INT J SPORTS MED, V9, P461, DOI 10.1055/s-2007-1025052; Diaz de Leon-Miranda Emmanuel, 2007, Rev Med Inst Mex Seguro Soc, V45, P47; Drawer S, 2001, BRIT J SPORT MED, V35, P402, DOI 10.1136/bjsm.35.6.402; EKSTRAND J, 1989, SPORTS MED, V8, P56, DOI 10.2165/00007256-198908010-00006; EKSTRAND J, 1983, MED SCI SPORT EXER, V15, P267, DOI 10.1249/00005768-198315030-00014; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Fong DTP, 2008, INJURY, V39, P1222, DOI 10.1016/j.injury.2008.02.032; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Kerr ZY, 2011, CLIN J SPORT MED, V21, P101, DOI 10.1097/JSM.0b013e31820bd1b6; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; Koch M, 2016, ARCH ORTHOP TRAUM SU, V136, P353, DOI 10.1007/s00402-015-2350-3; Krutsch W, 2016, KNEE SURG SPORT TR A, V24, P2271, DOI 10.1007/s00167-014-3357-y; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; McLean SG, 2008, J ATHL TRAINING, V43, P538, DOI 10.4085/1062-6050-43.5.538; Petersen W, 2005, ARCH ORTHOP TRAUM SU, V125, P614, DOI 10.1007/s00402-005-0793-7; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Williams JM, 1998, BRIT J SPORT MED, V32, P291, DOI 10.1136/bjsm.32.4.291; Yard EE, 2006, J ATHL TRAINING, V41, P441	28	11	11	1	14	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0932-0555	1439-1236		SPORTVERLETZ SPORTSC	Sportverletz. Sportschaden	JUN	2018	32	2					111	119		10.1055/s-0583-3792			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GI4NA	WOS:000434347200003	29734457				2022-02-06	
J	Malcolm, D				Malcolm, Dominic			Concussion in Sport: Public, Professional and Critical Sociologies	SOCIOLOGY OF SPORT JOURNAL			English	Article							FOOTBALL; INJURIES; MEDICINE; ETHICS	This article explores the emerging agenda in relation to concussion in sport to illustrate the threats and opportunities currently faced by the sociology of sport as an academic sub-discipline. The article begins by delineating aspects of the "crisis" in sociology, Burawoy' s call for an enhanced public sociology as a (part) solution, and responses to these ideas within the sociology of sport. It then identifies how the engagement of sociologists in this terrain must be understood in relation to the recent medicalization of sports-related concussion, and illustrates the impact of this on sociologists of sport through an examination of recent social scientific scholarship in relation to concussion. It argues that a successful public sociology of sport should be predicated on the subdiscipline's distinctive contribution to the production of knowledge. To this end, the article concludes by reporting the findings of an empirical study of concussion in English professional soccer, to outline a framework for sportrelated health research, and thus the basis on which a socially influential sociology of concussion in sport could develop.	[Malcolm, Dominic] Loughborough Univ, Sch Sport & Exercise Sci, Loughborough, Leics, England		Malcolm, D (corresponding author), Loughborough Univ, Sch Sport & Exercise Sci, Loughborough, Leics, England.	D.E.Makolm@lboro.ac.uk					Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Andrews DL, 2008, QUEST, V60, P45, DOI 10.1080/00336297.2008.10483568; Bairner A, 2009, INT REV SOCIOL SPORT, V44, P115, DOI 10.1177/1012690209338439; Burawoy M, 2005, AM SOCIOL REV, V70, P4, DOI 10.1177/000312240507000102; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Conrad P., 2007, MED SOC TRANSFORMATI; Cooky C, 2017, SOCIOL SPORT J, V34, P1, DOI 10.1123/ssj.2016-0156; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Donnelly P., 2015, PLAYING CHANGE CONTI, P361; Dunning E., 2017, SPORT SOC, V7, P1; Dunning E., 2013, NORBERT ELIAS SOCIOL; Fainaru-Wada Mark, 2013, LEAGUE OF DENIAL; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Frias FJL, 2017, SPORT ETHICS PHILOS, V11, P264, DOI 10.1080/17511321.2017.1342688; Furedi F., 2004, HAVE ALL INTELLECTUA; Gans Herbert, 1988, MIDDLE AM INDIVIDUAL; Gibson K., 2018, BANNING TACKLE SCH R; Gouldner A.W., 1970, COMING CRISIS W SOCI; Grey-Thompson T., 2017, DUTY CARE SPORT INDE; Hardes J, 2017, SPORT ETHICS PHILOS, V11, P281, DOI 10.1080/17511321.2017.1281344; Hollands R, 2009, SOCIOLOGICAL RES ONL, DOI [10.5153/sro.1839, DOI 10.5153/SRO.1839]; Jarvie G., 2007, International Review for the Sociology of Sport, V42, P411, DOI 10.1177/1012690208089834; Jutel A, 2009, SOCIOLOGY HLTH ILLNE, V38, P387; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Lupton D, 1995, IMPERATIVE HLTH PUBL; Malcolm D, 2012, SPORT AND SOCIOLOGY; Malcolm D., 2017, SPORT MED HLTH MED S; Malcolm D, 2017, J SCI MED SPORT, V20, P1053, DOI 10.1016/j.jsams.2017.05.004; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Malcolm Dominic, 2014, ASIA PACIFIC J SPORT, V3, P51, DOI DOI 10.1080/21640599.2014.889343; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MCDONALD I, 2002, POWER GAMES CRITICAL; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McNamee M., 2015, KINESIOL REV, V4, P190, DOI [10.1123/kr.2015-0011, DOI 10.1123/KR.2015-0011]; McNamee MJ, 2016, CLIN SPORT MED, V35, P257, DOI 10.1016/j.csm.2015.10.008; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Partridge B, 2015, NEUROETHICS-NETH, V8, P39, DOI 10.1007/s12152-014-9217-0; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Petersen A. R., 1996, NEW PUBLIC HLTH DISC; Piggin J., 2017, NZ J SPORTS MED, V44; Piggin J, 2017, BRIT J SPORT MED, V51, P1108, DOI 10.1136/bjsports-2016-096406; Savage M, 2007, SOCIOLOGY, V41, P885, DOI 10.1177/0038038507080443; Sugden J., 1998, FIFA CONTEST WORLD F, V1st; Sugden J., 1999, GREAT BALLS FIRE BIG; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Timmermans S, 2013, SOC SCI MED, V77, P1, DOI 10.1016/j.socscimed.2012.10.004; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	52	11	11	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0741-1235	1543-2785		SOCIOL SPORT J	Sociol. Sport J.	JUN	2018	35	2					141	148		10.1123/ssj.2017-0113			8	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology; Sport Sciences	GQ9RF	WOS:000442123000007		Green Submitted, Green Accepted			2022-02-06	
J	Martz, E; Livneh, H; Southwick, SM; Pietrzak, RH				Martz, Erin; Livneh, Hanoch; Southwick, Steven M.; Pietrzak, Robert H.			Posttraumatic growth moderates the effect of posttraumatic stress on quality of life in US military veterans with life-threatening illness or injury	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article							SPINAL-CORD-INJURY; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; BREAST-CANCER; PSYCHOSOCIAL ADAPTATION; COMMITMENT THERAPY; NATIONAL-HEALTH; MENTAL-HEALTH; FOLLOW-UP; DISABILITY		[Martz, Erin] Rehabil Oregon, Portland, OR 97207 USA; [Martz, Erin] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA; [Livneh, Hanoch] Portland State Univ, Rehabil Counseling Program, Portland, OR 97207 USA; [Southwick, Steven M.] US Dept Vet Affairs, Natl Ctr Posttraumat Stress Disorder, VA Connecticut Healthcare Syst, West Haven, CT USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA		Martz, E (corresponding author), Rehabil Oregon, Portland, OR 97207 USA.; Martz, E (corresponding author), Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA.	rehabilityoregon@gmail.com					A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson ML, 2014, J TRAUMA STRESS, V27, P182, DOI 10.1002/jts.21894; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bishop M, 2005, J REHABIL, V71, P5; Bishop M., 2009, UNDERSTANDING PSYCHO, P521; Bluvstein I, 2013, J CLIN PSYCHOL MED S, V20, P164, DOI 10.1007/s10880-012-9318-z; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Bose CN, 2016, EUR J CARDIOVASC NUR, V15, P537, DOI 10.1177/1474515115625033; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Calhoun, 1995, TRAUMA TRANSFORMATIO; Calhoun L. G., 2014, HDB POSTTRAUMATIC GR; Cann A, 2010, ANXIETY STRESS COPIN, V23, P127, DOI 10.1080/10615800903094273; Carboon I., 2005, TRAUMATOLOGY, V11, P269, DOI [10.1177/153476560501100406, DOI 10.1177/153476560501100406]; Carlson EB, 2011, PSYCHOL ASSESSMENT, V23, P463, DOI 10.1037/a0022294; Carver CS, 2005, HEALTH PSYCHOL, V24, P508, DOI 10.1037/0278-6133.24.5.508; Chesney M, 1996, INT J STD AIDS, V7, P75, DOI 10.1258/0956462961917690; CHESNEY MA, 1994, PSYCHIAT CLIN N AM, V17, P163; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; CREWE NM, 1980, MINN MED, V63, P586; DePalma Judith A, 2003, AACN Clin Issues, V14, P54; Diener E, 1997, SOC INDIC RES, V40, P189, DOI 10.1023/A:1006859511756; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Dijkers MPJM, 2005, J REHABIL RES DEV, V42, P87, DOI 10.1682/JRRD.2004.08.0100; Dunn DS, 1996, REHABIL PSYCHOL, V41, P285, DOI 10.1037/0090-5550.41.4.285; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Frank A. G., 2010, HDB REHABILITATION P; Garnefski N, 2008, J CLIN PSYCHOL MED S, V15, P270, DOI 10.1007/s10880-008-9136-5; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hayes SC, 2004, BEHAV THER, V35, P639, DOI 10.1016/S0005-7894(04)80013-3; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Henriques G, 2014, REV GEN PSYCHOL, V18, P7, DOI 10.1037/a0036288; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Jansen L, 2011, BRIT J CANCER, V105, P1158, DOI 10.1038/bjc.2011.335; Kennedy P., 2017, PRACTICAL PSYCHOL ME, P423; Kennedy P., 2012, OXFORD HDB REHABILIT; Kortte KB, 2010, REHABIL PSYCHOL, V55, P40, DOI 10.1037/a0018624; Kreuter M, 2005, SPINAL CORD, V43, P123, DOI 10.1038/sj.sc.3101692; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lechner SC, 2006, J CONSULT CLIN PSYCH, V74, P828, DOI 10.1037/0022-006X.74.5.828; Livneh H, 2001, REHABIL COUNS BULL, V44, P151, DOI 10.1177/003435520104400305; Livneh H, 2014, REHABIL PSYCHOL, V59, P329, DOI 10.1037/a0036733; Maercker A, 2004, PSYCHOL INQ, V15, P41; Maki A. R., 2011, PROFESSIONAL PRACTIC; Martz E., 2010, HEALTH, V2, P332, DOI DOI 10.4236/HEALTH.2010.24050; Martz E, 2009, J CLIN PSYCHOL, V65, P94, DOI 10.1002/jclp.20541; Miller DL, 1996, J CLIN PSYCHOL MED S, V3, P115, DOI 10.1007/BF01996132; Morrill EF, 2008, PSYCHO-ONCOLOGY, V17, P948, DOI 10.1002/pon.1313; Mortenson WB, 2010, SPINAL CORD, V48, P73, DOI 10.1038/sc.2009.92; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; O'Donnell ML, 2005, J TRAUMA, V59, P1328, DOI 10.1097/01.ta.0000197621.94561.4e; Pakenham KI, 2005, HEALTH PSYCHOL, V24, P123, DOI 10.1037/0278-6133.24.2.123; Pedhazur, 1997, MULTIPLE REGRESSION; Pietrzak RH, 2013, DEPRESS ANXIETY, V30, P432, DOI 10.1002/da.22083; Pietrzak RH, 2012, J AM GERIATR SOC, V60, P296, DOI 10.1111/j.1532-5415.2011.03788.x; Post Marcel, 2005, J Neurol Phys Ther, V29, P139; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Ramos C., 2017, PSYCHO-ONCOLOGY, P1; Ramos C, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0302-x; RENWICK R, 1996, QUALITY LIFE HLTH PR; Roepke AM, 2015, J CONSULT CLIN PSYCH, V83, P129, DOI 10.1037/a0036872; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Schweininger S, 2015, DEPRESS ANXIETY, V32, P64, DOI 10.1002/da.22288; Sears SR, 2003, HEALTH PSYCHOL, V22, P487, DOI 10.1037/0278-6133.22.5.487; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Stevelink SAM, 2015, OCCUP ENVIRON MED, V72, P243, DOI 10.1136/oemed-2014-102207; Tate DG, 2015, ARCH PHYS MED REHAB, V96, P340, DOI 10.1016/j.apmr.2014.09.036; Taylor SE, 1996, J PERS, V64, P873, DOI 10.1111/j.1467-6494.1996.tb00947.x; Tedeschi R.G., 1998, POSTTRAUMATIC GROWTH; Tedeschi RG, 2004, PSYCHIAT TIMES, V21, P58; Tedeschi RG, 2011, AM PSYCHOL, V66, P19, DOI 10.1037/a0021896; Tomich PL, 2004, HEALTH PSYCHOL, V23, P16, DOI 10.1037/0278-6133.23.1.16; Tsai J, 2015, PSYCHOL MED, V45, P165, DOI 10.1017/S0033291714001202; Tsai J, 2016, DEPRESS ANXIETY, V33, P9, DOI 10.1002/da.22371; Tsai J, 2016, J AFFECT DISORDERS, V189, P269, DOI 10.1016/j.jad.2015.08.076; Wagner AC, 2016, J TRAUMA STRESS, V29, P379, DOI 10.1002/jts.22122; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Weathers F.W., 1993, 9 ANN C ISTSS; Wilson J., 2013, INT HDB TRAUMATIC ST; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015; Zhang CQ, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02350	89	11	11	2	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	JUN	2018	109						1	8		10.1016/j.jpsychores.2018.03.004			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GH2ZS	WOS:000433271100002	29773146	Green Published			2022-02-06	
J	Moon, SL; Parker, R				Moon, Stephanie L.; Parker, Roy			EIF2B2 mutations in vanishing white matter disease hypersuppress translation and delay recovery during the integrated stress response	RNA			English	Article						white matter disease; eIF2B; GADD34; integrated stress response; ISRIB	UNFOLDED PROTEIN RESPONSE; INITIATION-FACTOR 2B; ENDOPLASMIC-RETICULUM STRESS; TRAUMATIC BRAIN-INJURY; ER-STRESS; INTELLECTUAL DISABILITY; CELL-DEATH; EIF2B; INHIBITION; THAPSIGARGIN	Mutations in eIF2B genes cause vanishing white matter disease (VWMD), a fatal leukodystrophy that can manifest following physical trauma or illness, conditions that activate the integrated stress response (ISR). EIF2B is the guanine exchange factor for eIF2, facilitating ternary complex formation and translation initiation. During the ISR, eIF2 alpha is phosphorylated and inhibits eIF2B, causing global translation suppression and stress-induced gene translation, allowing stress adaptation and recovery. We demonstrate that VWMD patient cells hypersuppress translation during the ISR caused by acute ER stress, delaying stress-induced gene expression and interrupting a negative feedback loop that allows translational recovery by GADD34-mediated dephosphorylation of phospho-eIF2 alpha. Thus, cells from VWMD patients undergo a prolonged state of translational hyperrepression and fail to recover from stress. We demonstrate that small molecules targeting eIF2B or the eIF2 alpha kinase PERK rescue translation defects in patient cells. Therefore, defects in the ISR could contribute to white matter loss in VWMD.	[Moon, Stephanie L.; Parker, Roy] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA		Parker, R (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA.; Parker, R (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.	Roy.Parker@colorado.edu		PARKER, ROY/0000-0002-8412-4152; Moon, Stephanie/0000-0002-4989-0150	Anna and John J. Sie Foundation; Howard Hughes Medical InstituteHoward Hughes Medical Institute	We thank Denise Muhlrad and Dr. Anjali Rao for technical assistance, members of the Parker laboratory, especially Dr. Carolyn Decker, for helpful comments and advice, and the Cell Culture Facility at the BioFrontiers Institute. S.L.M. was funded by the Anna and John J. Sie Foundation post-doctoral fellowship award. This work was supported by funds to R.P. from the Howard Hughes Medical Institute.	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bakunts A, 2017, ELIFE, V6, DOI 10.7554/eLife.27518; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Borck G, 2012, MOL CELL, V48, P641, DOI 10.1016/j.molcel.2012.09.005; Bruch J, 2015, J NEUROPATH EXP NEUR, V74, P850, DOI 10.1097/NEN.0000000000000224; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Cabilly Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046715; Cardenas VA, 2007, ARCH NEUROL-CHICAGO, V64, P873, DOI 10.1001/archneur.64.6.873; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Double KL, 1996, NEUROBIOL AGING, V17, P513; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Gat-Viks I, 2015, J NEUROCHEM, V134, P513, DOI 10.1111/jnc.13142; Gordiyenko Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4902; Guan BJ, 2017, MOL CELL, V68, P885, DOI 10.1016/j.molcel.2017.11.007; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kashiwagi K, 2016, NATURE, V531, P122, DOI 10.1038/nature16991; Kernohan KD, 2015, HUM MOL GENET, V24, P6293, DOI 10.1093/hmg/ddv337; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lin YF, 2014, J NEUROSCI, V34, P12182, DOI 10.1523/JNEUROSCI.1373-14.2014; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; McCormick TS, 1997, J BIOL CHEM, V272, P6087, DOI 10.1074/jbc.272.9.6087; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105; Raini G, 2017, J NEUROCHEM, V141, P694, DOI 10.1111/jnc.14024; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sekine Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166278; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; van Kollenburg B, 2006, NEUROBIOL DIS, V21, P496, DOI 10.1016/j.nbd.2005.08.009; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; Volpi VG, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00162; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wong YL, 2018, ELIFE, V7, DOI 10.7554/eLife.32733; Wortham NC, 2015, BIOCHEM SOC T, V43, P1234, DOI 10.1042/BST20150164; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130705	53	11	12	0	3	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	JUN	2018	24	6					841	852		10.1261/rna.066563.118			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK3ZG	WOS:000436090100008	29632131	Green Published, Bronze			2022-02-06	
J	Alanazi, HO; Abdullah, AH; Qureshi, KN; Ismail, AS				Alanazi, H. O.; Abdullah, A. H.; Qureshi, K. N.; Ismail, A. S.			Accurate and dynamic predictive model for better prediction in medicine and healthcare	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Accuracy; Features; Outcomes; Prediction; Predictive models; Sensitivity; Specificity; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CLASSIFIERS; OUTCOMES	Information and communication technologies (ICTs) have changed the trend into new integrated operations and methods in all fields of life. The health sector has also adopted new technologies to improve the systems and provide better services to customers. Predictive models in health care are also influenced from new technologies to predict the different disease outcomes. However, still, existing predictive models have suffered from some limitations in terms of predictive outcomes performance. In order to improve predictive model performance, this paper proposed a predictive model by classifying the disease predictions into different categories. To achieve this model performance, this paper uses traumatic brain injury (TBI) datasets. TBI is one of the serious diseases worldwide and needs more attention due to its seriousness and serious impacts on human life. The proposed predictive model improves the predictive performance of TBI. The TBI data set is developed and approved by neurologists to set its features. The experiment results show that the proposed model has achieved significant results including accuracy, sensitivity, and specificity.	[Alanazi, H. O.; Abdullah, A. H.; Ismail, A. S.] Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia; [Alanazi, H. O.] Majmaah Univ, Fac Appl Med Sci, Dept Med Sci Technol, Al Majmaah, Saudi Arabia; [Qureshi, K. N.] Bahria Univ Islamabad, Dept Comp Sci, Islamabad, Pakistan		Qureshi, KN (corresponding author), Bahria Univ Islamabad, Dept Comp Sci, Islamabad, Pakistan.	kashifnq@gmail.com	Qureshi, Kashif/AAJ-1052-2020; ABDULLAH, ABDUL HANAN/P-9181-2018; Ismail, Abdul Samad/F-5015-2011	Ismail, Abdul Samad/0000-0002-0786-865X; Qureshi, Kashif/0000-0003-3045-8402	Ministry of Education Malaysia (MOE); Research Management Center (RMC) at University Teknologi Malaysia (UTM) [Q.J130000.2628.12J19]	The research is supported by the Ministry of Education Malaysia (MOE) and conducted in collaboration with the Research Management Center (RMC) at University Teknologi Malaysia (UTM) under VOT NUMBER: Q.J130000.2628.12J19.	Alanazi Hamdan O., 2016, Journal of Theoretical and Applied Information Technology, V93, P561; Alanazi HO, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0715-6; Alwedyan J., 2011, P 2011 INT C INT SEM, P18; Awan K, 2016, INDONESIAN J ELECT E, V4, P594, DOI DOI 10.11591/ijeecs.v4.i3.pp594-604; Balvers K, 2015, CRIT CARE, V19, P1; Bhargavi P, 2009, INT J COMPUT SCI NET, V9, P117; Buytendijk F., 2010, PREDICTIVE ANAL BRIN; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Clark GM, 2008, MOL ONCOL, V1, P406, DOI 10.1016/j.molonc.2007.12.001; Ding SF, 2013, ARTIF INTELL REV, V39, P251, DOI 10.1007/s10462-011-9270-6; Gross R., 2002, Pattern Recognition. 24th DAGM Symposium. Proceedings (Lecture Notes in Computr Science Vol.2449), P481; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Hassanzadeh M, 2015, J GUILAN U MED SCI, V24, P52; Ireson G, 2016, IMPERIAL J INTERDISC, V2; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Li XC, 2008, ENG APPL ARTIF INTEL, V21, P785, DOI 10.1016/j.engappai.2007.07.001; Lu HY, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0187-x; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; McLachlan G., 2004, DISCRIMINANT ANAL ST, V544; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Naseer Qureshi Kashif, 2016, International Journal of Distributed Sensor Networks, DOI 10.1155/2016/2617480; Perel P, 2006, BMC MED INFORM DECIS, V6, P1; Qureshi KN, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/1605734; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Siegel Eric, 2013, PREDICTIVE ANAL POWE; Simon J, 2015, J CARD FAIL, V21, pS12, DOI 10.1016/j.cardfail.2015.06.072; Soreide K, 2015, EUR J TRAUMA EMERG S, V41, P91, DOI 10.1007/s00068-014-0417-4; van der Ploeg T, 2016, J CLIN EPIDEMIOL, V78, P83, DOI 10.1016/j.jclinepi.2016.03.002; Witten I., 2005, DATA MINING PRACTICA, Vsecond	30	11	11	0	3	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	MAY	2018	187	2					501	513		10.1007/s11845-017-1655-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE6HA	WOS:000431325400038	28756541				2022-02-06	
J	Bensalah, M; Donaldson, M; Aribi, Y; Iabassen, M; Cherfi, L; Nebbal, M; Medjaher, M; Haffaf, E; Abdennebi, B; Guenane, K; Djermane, A; Kemali, Z; OuldKablia, S				Bensalah, Meriem; Donaldson, Malcolm; Aribi, Yamina; Iabassen, Malek; Cherfi, Lyes; Nebbal, Mustapha; Medjaher, Meriem; Haffaf, ElMehdi; Abdennebi, Benaissa; Guenane, Kamel; Djermane, Adel; Kemali, Zahra; OuldKablia, Samia			Cortisol evaluation during the acute phase of traumatic brain injury-A prospective study	CLINICAL ENDOCRINOLOGY			English	Article						adrenal insufficiency; cortisol; diabetes insipidus; diastolic hypopressure; sedative drugs; skull base fracture; traumatic brain injury	HEAD-INJURY; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; PITUITARY INSUFFICIENCY; CRANIOCEREBRAL TRAUMA; DIABETES-INSIPIDUS; HYPOPITUITARISM; PROGNOSIS; MANAGEMENT; ADULTS	Background: Biochemical diagnosis of adrenal insufficiency (AI) is difficult in the context of traumatic brain injury (TBI). Aim: To assess the frequency and predictive factors of AI in victims of TBI from Algiers. Methods: Between November 2009 and December 2013, TBI victims had a single 8-9 am serum cortisol measurement during the acute postinjury period (0-7 days). AI was defined according to basal cortisol levels of 83, 276 and 414 nmol/L. Variables studied were TBI severity according to Glasgow coma scale, duration of intubation and coma, pupillary status, hypotension, anaemia, brain imaging findings, diabetes insipidus and medication. Insulin tolerance test was performed during the recovery phase, defining AI as peak cortisol <500 nmol/L. Results: Cortisol samples were obtained at median 3 (1-7) days from 277 patients (257M: 20F) aged 32 (18-65) years. Acute AI frequency was 8 (2.8%), 20 (21%) and 35 (37%), respectively using the three cortisol cut-offs. Factors predicting AI were diastolic hypotension, sedative medication, diabetes insipidus, skull base fracture and intraparenchymal haematoma. Mortality was highest in patients with acute cortisol <276 nmol/L (44.6% with OR for death 1.64, 95% CI 0.92-3.0, P = .12). During the recovery phase, AI was present in 3 of 3, 12 of 24, 4 of 16 and 20 of 66 patients with week 1 cortisol <83, 83-276, 277-414 and >414 nmol/L. Conclusion: Hydrocortisone replacement is advised in TBI patients with morning cortisol <276 nmol/L or those < 414 nmol/L with additional risk factors for AI. As acute and subsequent AI are poorly correlated, patients with moderate/severe TBI require adrenal re-evaluation during the recovery phase.	[Bensalah, Meriem; Aribi, Yamina; Iabassen, Malek; Kemali, Zahra; OuldKablia, Samia] Cent Hosp Army, Endocrinol Unit, Algiers, Algeria; [Donaldson, Malcolm] Glasgow Univ, Sch Med, Glasgow, Lanark, Scotland; [Cherfi, Lyes] Cent Hosp Army, Crit Care Unit, Algiers, Algeria; [Nebbal, Mustapha] Cent Hosp Army, Neurosurg Unit, Algiers, Algeria; [Medjaher, Meriem; Haffaf, ElMehdi] Cent Hosp Army, Nucl Med Unit, Algiers, Algeria; [Abdennebi, Benaissa] Salim Zemirli Hosp, Crit Care Unit, Algiers, Algeria; [Guenane, Kamel] Salim Zemirli Hosp, Neurosurg Unit, Algiers, Algeria; [Djermane, Adel] Fac Med Algiers, Algiers, Algeria		Bensalah, M (corresponding author), Cent Hosp Army, Endocrinol Unit, Algiers, Algeria.	meriem_hammoutene@2ic-dz.com		Djermane, Adel/0000-0001-7237-2514			Abdu TAM, 1999, J CLIN ENDOCR METAB, V84, P838, DOI 10.1210/jc.84.3.838; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Beavogui K, 2012, NEUROCHIRURGIE, V58, P287, DOI 10.1016/j.neuchi.2012.05.006; Boughey JC, 2004, AM SURGEON, V70, P500; Carmichael JD, 2011, PITUITARY, 3RD EDITION, P343, DOI 10.1016/B978-0-12-380926-1.10010-0; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Dalwadi Pradip P, 2017, Indian J Endocrinol Metab, V21, P80, DOI 10.4103/2230-8210.196018; Delemer B, 2006, ANN ENDOCRINOL-PARIS, V67, P310, DOI 10.1016/S0003-4266(06)72604-X; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Edwards P, 2005, LANCET, V365, P1957; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; JENNETT B, 1975, LANCET, V1, P480; Kakati A, 2013, INDIAN J NEUROTRAUM, V10, P92, DOI 10.1016/j.ijnt.2013.10.002; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Mujuni E, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-16; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	33	11	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	MAY	2018	88	5					627	636		10.1111/cen.13562			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GD0DR	WOS:000430170300003	29405355	Green Accepted			2022-02-06	
J	George, KL; Quatrara, B				George, Katie L.; Quatrara, Beth			Interprofessional Simulations Promote Knowledge Retention and Enhance Perceptions of Teamwork Skills in a Surgical-Trauma-Burn Intensive Care Unit Setting	DIMENSIONS OF CRITICAL CARE NURSING			English	Article						Critical care; Critical event; Interprofessional; Knowledge; Simulation; Teamwork	IN-SITU SIMULATION; NURSE TURNOVER; PHYSICIAN COLLABORATION; EDUCATION; MULTIDISCIPLINARY; EMERGENCY; RESUSCITATION; IMPACT; IMPLEMENTATION; CONFIDENCE	Background: The current state of health care encompasses highly acute, complex patients, managed with ever-changing technology. The ability to function proficiently in critical care relies on knowledge, technical skills, and interprofessional teamwork. Integration of these factors can improve patient outcomes. Simulation provides "hands-on'' practice and allows for the integration of teamwork into knowledge/skill training. However, simulation can require a significant investment of time, effort, and financial resources. The Institute of Medicine recommendations from 2015 include "strengthening the evidence base for interprofessional education (IPE)'' and "linking IPE with changes in collaborative behavior.'' In one surgical-trauma-burn intensive care unit (STBICU), no IPE existed. The highly acute and diverse nature of the patients served by the unit highlights the importance of appropriate training. This is heightened during critical event situations where patients deteriorate rapidly and the team intervenes swiftly. Purpose: The aims of this study were to (1) evaluate knowledge retention and analyze changes in perceptions of teamwork among nurses and resident physicians in a STBICU setting after completion of an interprofessional critical event simulation and (2) provide insight for future interprofessional simulations (IPSs), including the ideal frequency of such training, associated cost, and potential effect on nursing turnover. Design: A comparison-cohort pilot study was developed to evaluate knowledge retention and analyze changes in perceptions of teamwork. Methods: A 1-hour critical event IPS was held for nurses and resident physicians in a STBICU setting. A traumatic brain injury patient with elevated intracranial pressure, rapid deterioration, and cardiac arrest was utilized for the simulation scenario. The simulation required the team to use interventions to reduce elevated intracranial pressure and then perform cardiac resuscitation according to Advanced Cardiac Life Support guidelines. A semistructured debriefing guided by the TENTS tool highlighted important aspects of teamwork. Participants took knowledge and Teamwork Skills Scale (TSS) pretests, posttests, and 1-month posttests. Mean scores were calculated for each time point (pre, post, and 1-month post), and paired t tests were used to evaluate changes. Results: Mean knowledge test and TSS scores both significantly increased after the simulation and remained significantly elevated at 1-month follow-up. Participants recommended retraining intervals of 3 to 6 months. Cost of each simulation was estimated to be $324.44. Analysis of nursing turnover rates did not demonstrate a statistically significant reduction in turnover; however, confounding factors were not controlled for. Conclusion: Significant improvements on both knowledge test and TSS scores demonstrate the effectiveness of the intervention, and retention of the information gained and teamwork skills learned. Participants valued the intervention and recommended to increase the frequency of training. Future studies should develop a framework for "best practice'' IPS, analyze the relationship with nursing turnover, and ultimately seek correlations between IPS and improved patient outcomes.	[George, Katie L.] Univ Virginia Hlth Syst, Emergency Gen Surg Serv, Charlottesville, VA USA; [George, Katie L.] Amer Assoc Crit Care Nurses AACN, Monticello Chapter, Aliso Viejo, CA USA; [Quatrara, Beth] Univ Virginia UVA, Sch Nursing, Nursing, Charlottesville, VA USA; [Quatrara, Beth] UVA Ctr Acad Strateg Partnerships Interprofess Re, Charlottesville, VA USA		George, KL (corresponding author), Dept Surg, POB 800679, Charlottesville, VA 22908 USA.	klb5an@virginia.edu					Acero NM, 2012, J SURG EDUC, V69, P759, DOI 10.1016/j.jsurg.2012.06.022; Andreatta P, 2011, PEDIATR CRIT CARE ME, V12, P33, DOI 10.1097/PCC.0b013e3181e89270; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P268, DOI 10.1097/HTR.0000000000000053; Boet S, 2014, CAN J ANESTH, V61, P571, DOI 10.1007/s12630-014-0143-8; Boyle DK, 2004, J NURS ADMIN, V34, P60, DOI 10.1097/00005110-200402000-00003; Crofts JF, 2007, BJOG-INT J OBSTET GY, V114, P1534, DOI 10.1111/j.1471-0528.2007.01493.x; Curran VR, 2005, EDUC HEALTH, V18, P32, DOI 10.1080/13576280500042606; Dadiz R, 2013, SIMUL HEALTHC, V8, P279, DOI 10.1097/SIH.0b013e31829543a3; Delac K, 2013, CRIT CARE NURS Q, V36, P244, DOI 10.1097/CNQ.0b013e3182846f1a; Dempsey E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009106.pub2; European Resuscitation Council, 2015, SUMM MAIN CHANG RES; Figueroa MI, 2013, PEDIATR CARDIOL, V34, P612, DOI 10.1007/s00246-012-0506-2; Fischer H, 2012, RESUSCITATION, V83, P227, DOI 10.1016/j.resuscitation.2011.09.014; Flannery AH, 2016, AM J CRIT CARE, V25, P12, DOI 10.4037/ajcc2016190; Galletta M, 2016, RES NURS HEALTH, V39, P375, DOI 10.1002/nur.21733; Greif R, 2015, RESUSCITATION, V95, P288, DOI 10.1016/j.resuscitation.2015.07.032; GRYMONPRE R, 2010, J RES INTERPROF PRAC, V1, P127, DOI DOI 10.22230/jripe.2010v1n2a13; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Harrison CM, 2017, TRENDS CARDIOVAS MED, V27, P163, DOI 10.1016/j.tcm.2016.08.009; Hauck A, 2011, J NURS MANAGE, V19, P269, DOI 10.1111/j.1365-2834.2011.01205.x; Hayward D, 2016, J CLIN NURS, V25, P1336, DOI 10.1111/jocn.13210; Hepburn K., 2002, TEAM PERFORMANCE HLT, P159, DOI 10.1007/978-1-4615-0581-5; Hohenhaus SM, 2008, J EMERG NURS, V34, P142, DOI 10.1016/j.jen.2007.09.019; Ilias A., 2012, J ED VOCATIONAL RES, V3, P387, DOI DOI 10.22610/jevr.v3i12.94; Institute of Medicine, 2015, MEAS IMP INT ED COLL; Interprofessional Education Collaborative, IPEC COR COMP INT CO; Klipfel Janee M, 2014, Urol Nurs, V34, P39; Knowles M. S., 1980, MODERN PRACTICE ADUL, V2nd; Lapkin S, 2011, J CLIN NURS, V20, P3543, DOI 10.1111/j.1365-2702.2011.03843.x; Lighthall GK, 2010, JT COMM J QUAL PATIE, V36, P209, DOI 10.1016/S1553-7250(10)36034-X; Lucas AN, 2014, J CONTIN EDUC NURS, V45, P360, DOI 10.3928/00220124-20140716-02; Lutgendorf MA, 2017, MIL MED, V182, pE1762, DOI 10.7205/MILMED-D-16-00030; Mahramus T, 2013, CLIN NURSE SPEC, V27, P291, DOI 10.1097/NUR.0b013e3182a8729d; Maxson PM, 2011, MAYO CLIN PROC, V86, P31, DOI 10.4065/mcp.2010.0282; McKee SE, 2011, ANDRAGOGICAL METHODS; Mundell WC, 2013, RESUSCITATION, V84, P1174, DOI 10.1016/j.resuscitation.2013.04.016; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; North N, 2013, J NURS MANAGE, V21, P419, DOI 10.1111/j.1365-2834.2012.01371.x; NSI Nursing Solutions Inc, 2016, NAT HEALTHC RET RN S; O'Brien-Pallas L, 2010, J NURS MANAGE, V18, P1073, DOI 10.1111/j.1365-2834.2010.01167.x; Park SH, 2014, HEALTH SERV RES, V49, P1205, DOI 10.1111/1475-6773.12158; Patterson MD, 2013, BMJ QUAL SAF, V22, P383, DOI 10.1136/bmjqs-2012-000951; Robben S, 2012, J CONTIN EDUC HEALTH, V32, P196, DOI 10.1002/chp.21145; Romanow R.J., 2002, BUILDING VALUES FUTU; Rosen MA, 2012, J CONTIN EDUC HEALTH, V32, P243, DOI 10.1002/chp.21152; Russell Sally S, 2006, Urol Nurs, V26, P349; Sawyer T, 2013, NEONATAL NETW, V32, P26, DOI 10.1891/0730-0832.32.1.26; Smith ER, EVALUATION MANAGEMEN; Sorensen JL, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-016-0838-3; Steinemann S, 2011, J SURG EDUC, V68, P472, DOI 10.1016/j.jsurg.2011.05.009; Surcouf JW, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.18726; Teaching Excellence in Adult Literacy, 2011, AD LEARN THEOR; Young JS, 2015, UVA TRAUMA HDB	53	11	11	2	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0730-4625	1538-8646		DIMENS CRIT CARE NUR	Dimens. Crit. Care Nurs.	MAY-JUN	2018	37	3					144	155		10.1097/DCC.0000000000000301			12	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	GE4HX	WOS:000431177500005	29596291				2022-02-06	
J	Heschl, S; Meadley, B; Andrew, E; Butt, W; Bernard, S; Smith, K				Heschl, Stefan; Meadley, Ben; Andrew, Emily; Butt, Warwick; Bernard, Stephen; Smith, Karen			Efficacy of pre-hospital rapid sequence intubation in paediatric traumatic brain injury: A 9-year observational study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Endotracheal intubation; Traumatic brain injury; Paediatrics; Paramedic	ENDOTRACHEAL INTUBATION; TRACHEAL INTUBATION; SUCCESS RATES; CHILDREN; PARAMEDICS; CARE; FIELD; LIFE	Introduction: Prehospital airway management of the paediatric patient with traumatic brain injury (TBI) is controversial. Endotracheal intubation of children in the field requires specific skills and has potential benefits but also carries potentially serious complications. We aimed to compare mortality and functional outcomes after six months between children with TBI who either underwent prehospital rapid sequence intubation (RSI) by trained Intensive Care paramedics (ICP) or received no intubation. Methods: We conducted a retrospective study of patients aged <= 14 years with suspected TBI in Victoria, Australia. Patients were either transported via helicopter and received RSI by an ICP (2005-2013) or via road ambulance and received no intubation (2006-2013). Prehospital data was linked to hospital and 6-month follow-up data to assess mortality and functional outcome. Results: A total of 106 patients were included in the study of which 87 received RSI by paramedics and 19 did not receive intubation. Overall, the intubation success rate was 99% (86/87), with a first-pass success rate of 93% (81/87). In total, 67% of patients (n = 41) receiving RSI had a favourable functional outcome, compared with 54% of non-intubated patients (n = 7) (p = 0.36). In the 75 children with major trauma, prehospital RSI was associated with a significant decrease in length of hospital stay (523 h vs. 1939 h, p = 0.03). In the 53 children in this subgroup with available six months data the difference in favourable functional outcome increased to 66% (n = 31)vs. 17% (n= 1) (p = 0.06). Discussion: Prehospital RSI in paediatric patients with TBI can safely be performed by highly trained paramedics. Overall, we observed more favourable long-term outcomes in patients who received prehospital intubation than those who did not, however our study is not powered to detect a significant difference. Intubation prior to transport might be beneficial for major trauma patients. (C) 2018 Elsevier Ltd. All rights reserved.	[Heschl, Stefan] Med Univ Graz, Graz, Austria; [Heschl, Stefan; Meadley, Ben; Andrew, Emily; Bernard, Stephen; Smith, Karen] Ambulance Victoria, Melbourne, Vic, Australia; [Meadley, Ben; Andrew, Emily; Bernard, Stephen; Smith, Karen] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Butt, Warwick] Royal Childrens Hosp, Melbourne, Vic, Australia; [Bernard, Stephen] Alfred Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Smith, Karen] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Melbourne, Vic, Australia		Heschl, S (corresponding author), Med Univ Graz, Dept Anaesthesiol & Intens Care Med, Auenbruggerpl 29, A-8036 Graz, Austria.	stefan.heschl@medunigraz.at		Meadley, Ben/0000-0002-4228-5919; Smith, Karen/0000-0002-9057-0685			AIJIAN P, 1989, ANN EMERG MED, V18, P489, DOI 10.1016/S0196-0644(89)80830-3; Andrew E, 2015, PREHOSP EMERG CARE, V6, DOI [10.3109/10903127.2014.99584615021711022100, DOI 10.3109/10903127.2014.99584615021711022100]; [Anonymous], 2016, AMBULANCE VICTORIA C; Babl FE, 2001, PEDIATR EMERG CARE, V17, P5, DOI 10.1097/00006565-200102000-00002; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Boswell WC, 2016, AIR MED J, V14; Brownstein D, 1996, ANN EMERG MED, V28, P34, DOI 10.1016/S0196-0644(96)70136-1; Colwell CB, 2009, PREHOSP EMERG CARE, V13, P304, DOI 10.1080/10903120902935280; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Ehrlich PF, 2004, J PEDIATR SURG, V39, P1376, DOI 10.1016/j.jpedsurg.2004.05.010; Eich C, 2009, RESUSCITATION, V80, P1371, DOI 10.1016/j.resuscitation.2009.09.004; Foltin GL, 2010, PEDIATR EMERG CARE, V26, P773, DOI 10.1097/PEC.0b013e3181fc4088; Garza Alex G, 2005, Prehosp Emerg Care, V9, P163, DOI 10.1080/10903120590924654; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gerritse BM, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-6; Gerritse BM, 2008, RESUSCITATION, V79, P225, DOI 10.1016/j.resuscitation.2008.05.016; Harrison TH, 2004, PEDIATR EMERG CARE, V20, P101, DOI 10.1097/01.pec.0000113879.10140.7f; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; LOSEK J D, 1989, Pediatric Emergency Care, V5, P1, DOI 10.1097/00006565-198903000-00001; Martinon C, 2011, PEDIATR CRIT CARE ME, V12, P65, DOI 10.1097/PCC.0b013e3181e2a244; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Suominen P, 2000, Eur J Emerg Med, V7, P3; Taylor A, 2003, INTENS CARE MED, V29, P795, DOI 10.1007/s00134-003-1690-6; Tollefsen WW, 2013, PEDIATR EMERG CARE, V29, P963, DOI 10.1097/PEC.0b013e3182a219ea; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	31	11	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2018	49	5					916	920		10.1016/j.injury.2018.02.013			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	GG0LO	WOS:000432370300006	29452732				2022-02-06	
J	Howell, DR; Berkstresser, B; Wang, F; Buckley, TA; Mannix, R; Stillman, A; Meehan, WP				Howell, David R.; Berkstresser, Brant; Wang, Francis; Buckley, Thomas A.; Mannix, Rebekah; Stillman, Alexandra; Meehan, William P., III			Self-reported sleep duration affects tandem gait, but not steady-state gait outcomes among healthy collegiate athletes	GAIT & POSTURE			English	Article						Sleep; Gait; Tandem gait; Concussion; Mild traumatic brain injury; Locomotion	DUAL-TASK GAIT; SINGLE-TASK; CONCUSSION; MANAGEMENT; MOTOR; ADOLESCENTS; PERFORMANCE; TRAINERS	Background: Sleep deficits are associated with motor and cognitive function deficits, even in the absence of a recent concussion. Research question: Does the amount of self-reported sleep prior to pre-season concussion testing affect single-task and dual-task instrumented steady-state gait and timed tandem gait test performance? Methods: One hundred and fourteen healthy collegiate athletes (mean age 18.8 +/- 0.7 years; 60% female) reported the amount of sleep they received during the prior night and completed a timed tandem gait test and an instrumented assessment of steady-state gait in both single-task and dual-task conditions. Outcome variables included spatio-temporal gait parameters during steady-state gait, best and mean tandem gait times, and cognitive test accuracy. Results: Participants who reported sleeping < 7 h of sleep during the night prior to testing (n = 62) had significantly longer tandem gait times in single-task and dual-task conditions (11.1 +/- 2.2 vs. 10.1 +/- 2.0 s and 14.5 +/- 4.3 vs. 12.3 +/- 2.6 s, respectively; p =. 009) compared to those who reported sleeping >= 7 h (n = 52). No significant differences between groups were observed for spatio-temporal steady-state gait variables or for cognitive test accuracy. Significance: Self-reported sleep duration may be associated with baseline testing tandem gait performance. Thus, as sleep can play a role in motor abilities, clinicians may consider interpreting tandem gait performance in light of sleep duration during the night prior to testing.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Berkstresser, Brant; Wang, Francis] Harvard Univ Hlth Serv, Cambridge, MA USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah; Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Stillman, Alexandra] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Childrens Hosp Colorado,Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu	Mannix, Rebekah/AAD-8702-2020; Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Howell, David/0000-0002-2955-0191			Al-Sharman A, 2013, PHYS THER, V93, P1625, DOI 10.2522/ptj.20120502; Allali G, 2014, RESP PHYSIOL NEUROBI, V201, P31, DOI 10.1016/j.resp.2014.06.012; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Godde B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00139; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hetzler RK, 2008, J STRENGTH COND RES, V22, P1969, DOI 10.1519/JSC.0b013e318185f36c; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hoffer ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146039; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Kaplan J, 2017, AUTON NEUROSCI-BASIC, V202, P86, DOI 10.1016/j.autneu.2016.08.019; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leisman G, 2013, REV NEUROSCIENCE, V24, P9, DOI 10.1515/revneuro-2012-0067; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; McCarthy ME, 1997, SLEEP, V20, P115, DOI 10.1093/sleep/20.2.115; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Oldham J. R., 2018, MED SCI SPORTS EXERC, DOI [10.1249/MSS, DOI 10.1249/MSS]; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649; Zhou XQ, 2017, BRAIN CONNECT, V7, P58, DOI 10.1089/brain.2016.0452	36	11	11	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAY	2018	62						291	296		10.1016/j.gaitpost.2018.03.038			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	GG6WT	WOS:000432840100041	29605797				2022-02-06	
J	Matuseviciene, G; Johansson, J; Moller, M; Godbolt, AK; Pansell, T; Deboussard, CN				Matuseviciene, Giedre; Johansson, Jan; Moller, Marika; Godbolt, Alison K.; Pansell, Tony; Deboussard, Catharina Nygren			Longitudinal changes in oculomotor function in young adults with mild traumatic brain injury in Sweden: an exploratory prospective observational study	BMJ OPEN			English	Article							INSUFFICIENCY SYMPTOM SURVEY; CONVERGENCE INSUFFICIENCY; EYE-MOVEMENTS; HEAD-INJURY; CONCUSSION; DYSFUNCTIONS; RELIABILITY; SCALE; POPULATION; DEPRESSION	Objectives To assess (1) whether visual disturbances can be demonstrated with objective measures more often in patients with mild traumatic brain injury (mTBI) than in orthopaedic controls and non-injured controls, (2) whether such objectively demonstrated disturbances change over time and (3) whether self-reported visual symptoms after mTBI correlate with objectively measurable changes in visuomotor performance. Design A prospective, controlled, observational study, with assessments planned 7-10 and 75-100 days after injury. Setting Emergency department of a general hospital in Sweden. Participants 15 patients with mTBI, 15 patients with minor orthopaedic injury, 15 non-injured controls, aged 18-40 years. Outcome measures Visual examination, including assessment of visual acuity, accommodation, eye alignment, saccades and stereoacuity. Symptom assessment using Convergence Insufficiency Symptoms Survey (CISS) and Rivermead PostConcussion Symptoms Questionnaire. Results Assessments were performed 4-13 and 81-322 days after injury (extended time frames for logistical reasons). No statistically significant difference was found between the mTBI and control groups regarding saccade performance and stereoacuity at any time point. The accommodative amplitude was significantly lower in the mTBI group compared with non-injured controls at baseline. 6 out of 13 patients with mTBI had accommodative insufficiency at follow-up. Near point of convergence in the mTBI group was receded at baseline and improved statistically significantly at follow-up. At baseline, patients with mTBI had significantly higher CISS score than orthopaedic and non-injured controls. For patients with mTBI, the CISS score correlated with fusional vergence. Conclusion There were some transient measurable visual changes regarding convergence in patients with mTBI during the subacute period after the injury. Our findings of persistence of accommodative insufficiency in a considerable proportion of patients with mTBI suggest that this visual function should not be overlooked in clinical assessment.	[Matuseviciene, Giedre; Moller, Marika; Godbolt, Alison K.; Deboussard, Catharina Nygren] Karolinska Inst, Danderyd Hosp, Div Rehabil Med, Dept Clin Sci, Stockholm, Sweden; [Johansson, Jan; Pansell, Tony] Karolinska Inst, Dept Clin Neurosci Eye & Vis, Stockholm, Sweden		Matuseviciene, G (corresponding author), Karolinska Inst, Danderyd Hosp, Div Rehabil Med, Dept Clin Sci, Stockholm, Sweden.	giedre.matuseviciene@sll.se	MAller, Marika C/N-8782-2016; Moller, Marika/S-5427-2019; Pansell, Tony/L-9487-2017	MAller, Marika C/0000-0001-8700-5186; Moller, Marika/0000-0001-8700-5186; Johansson, Jan/0000-0002-1093-4179	AFA insurance [130095]; Lars Hedlund, Karolinska Institutet [2-1582/2016]	This study was supported by grant from AFA insurance (reference no: 130095) and by grant from Lars Hedlund, Karolinska Institutet (reference no: 2-1582/2016).	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hokoda S C, 1985, J Am Optom Assoc, V56, P560; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Porcar E, 1997, OPTOMETRY VISION SCI, V74, P111, DOI 10.1097/00006324-199702000-00023; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Rutstein RP., 1998, ANOMALIES BINOCULAR; Scheiman M., 2014, CLIN MANAGEMENT BINO; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; TEASDALE G, 1974, LANCET, V2, P81; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Von Noorden GK, 2002, BINOCULAR VISION OCU, V6th; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	11	11	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2018	8	2							e018734	10.1136/bmjopen-2017-018734			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH0ZB	WOS:000433129800214	29431132	gold, Green Published			2022-02-06	
J	Miller, LE; Kuo, C; Wu, LC; Urban, JE; Camarillo, DB; Stitzel, JD				Miller, Logan E.; Kuo, Calvin; Wu, Lyndia C.; Urban, Jillian E.; Camarillo, David B.; Stitzel, Joel D.			Validation of a Custom Instrumented Retainer Form Factor for Measuring Linear and Angular Head Impact Kinematics	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						mouthguard; instrumentation; brain injury; concussion; validation; linear acceleration; angular acceleration; angular velocity	ACCELERATION MEASUREMENT; FOOTBALL HELMETS; EXPOSURE; PLAYERS; CONCUSSION; MOUTHGUARD; LOCATION; SENSORS; SYSTEM; INJURY	Head impact exposure in popular contact sports is not well understood, especially in the youth population, despite recent advances in impact-sensing technology which has allowed widespread collection of real-time head impact data. Previous studies indicate that a custom-instrumented mouthpiece is a superior method for collecting accurate head acceleration data. The objective of this study was to evaluate the efficacy of mounting a sensor device inside an acrylic retainer form factor to measure six-degrees-offreedom (6DOF) head kinematic response. This study compares 6DOF mouthpiece kinematics at the head center of gravity (CG) to kinematics measured by an anthropomorphic test device (ATD). This study found that when instrumentation is mounted in the rigid retainer form factor, there is good coupling with the upper dentition and highly accurate kinematic results compared to the ATD. Peak head kinematics were correlated with r(2) > 0.98 for both rotational velocity and linear acceleration and r(2) = 0.93 for rotational acceleration. These results indicate that a rigid retainer-based form factor is an accurate and promising method of collecting head impact data. This device can be used to study head impacts in helmeted contact sports such as football, hockey, and lacrosse as well as nonhelmeted sports such as soccer and basketball. Understanding the magnitude and frequency of impacts sustained in various sports using an accurate head impact sensor, such as the one presented in this study, will improve our understanding of head impact exposure and sports-related concussion.	[Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27106 USA; [Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27106 USA; [Kuo, Calvin] Stanford Univ, Dept Mech Engn, 443 Via Ortega,Room 202, Stanford, CA 94305 USA; [Wu, Lyndia C.; Camarillo, David B.] Stanford Univ, Dept Bioengn, 443 Via Ortega,Room 202, Stanford, CA 94305 USA; [Urban, Jillian E.; Camarillo, David B.] Wake Forest Sch Med, Clin & Translat Sci Inst, Winston Salem, NC 27106 USA		Stitzel, JD (corresponding author), Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27106 USA.; Stitzel, JD (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27106 USA.	logmille@wakehealth.edu; calvink@stanford.edu; lyndiacw@stanford.edu; jurban@wakehealth.edu; dcamarillo@stanford.edu; jstitzel@wakehealth.edu	Wu, Lyndia/AAQ-1106-2020; Kuo, Calvin/AAH-1933-2019; Stitzel, Joel/B-4045-2012	Wu, Lyndia/0000-0002-8236-032X; Kuo, Calvin/0000-0001-8401-9136; Stitzel, Joel/0000-0001-9762-3033	Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center	This study was supported by the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center. The authors thank the Cam Lab at Stanford University for conducting the experimental tests. Special thanks to Hurst Dental Lab and Triad Electronics Services for collaboration and assistance in sensor fabrication. The authors would also like to thank Casey Costa for his work in developing MATLAB code to process and analyze the mouthpiece outputs.	Abramowitz M., 1965, HDB MATH FUNCTIONS F, V55; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Society of Automotive Engineers, 2007, J2111 SAE; Tyson A., 2018, ANN BIOMED ENG UNPUB; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153	28	11	11	0	12	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAY	2018	140	5							054501	10.1115/1.4039165			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	GA9YQ	WOS:000428700000011	29383374				2022-02-06	
J	Rowlands, C; Rooshenas, L; Fairhurst, K; Rees, J; Gamble, C; Blazeby, JM				Rowlands, Ceri; Rooshenas, Leila; Fairhurst, Katherine; Rees, Jonathan; Gamble, Carrol; Blazeby, Jane M.			Detailed systematic analysis of recruitment strategies in randomised controlled trials in patients with an unscheduled admission to hospital	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL-TRIAL; COMMUNITY CONSULTATION; INFORMED-CONSENT; EMERGENCY RESEARCH; MYOCARDIAL-INFARCTION; HEALTH RESEARCH; ENROLLMENT; EXCEPTION; SURROGATE	Objectives To examine the design and findings of recruitment studies in randomised controlled trials (RCTs) involving patients with an unscheduled hospital admission (UHA), to consider how to optimise recruitment in future RCTs of this nature. Design Studies within the ORRCA database (Online Resource for Recruitment Research in Clinical TriAls; www.orrca.org.uk) that reported on recruitment to RCTs involving UHAs in patients > 18 years were included. Extracted data included trial clinical details, and the rationale and main findings of the recruitment study. Results Of 3114 articles populating ORRCA, 39 recruitment studies were eligible, focusing on 68 real and 13 hypothetical host RCTs. Four studies were prospectively planned investigations of recruitment interventions, one of which was a nested RCT. Most recruitment papers were reports of recruitment experiences from one or more 'real' RCTs (n= 24) or studies using hypothetical RCTs (n= 11). Rationales for conducting recruitment studies included limited time for informed consent (IC) and patients being too unwell to provide IC. Methods to optimise recruitment included providing patients with trial information in the prehospital setting, technology to allow recruiters to cover multiple sites, screening logs to uncover recruitment barriers, and verbal rather than written information and consent. Conclusion There is a paucity of high-quality research into recruitment in RCTs involving UHAs with only one nested randomised study evaluating a recruitment intervention. Among the remaining studies, methods to optimise recruitment focused on how to improve information provision in the prehospital setting and use of screening logs. Future research in this setting should focus on the prospective evaluation of the well-developed interventions to optimise recruitment.	[Rowlands, Ceri; Rooshenas, Leila; Fairhurst, Katherine; Blazeby, Jane M.] Univ Bristol, Sch Social & Community Med, MRC ConDuCT Hub Trials Methodol Res 2, Bristol, Avon, England; [Rooshenas, Leila; Fairhurst, Katherine; Rees, Jonathan; Blazeby, Jane M.] Univ Bristol, Sch Populat Hlth Sci, Bristol Med Sch, Bristol, Avon, England; [Rees, Jonathan; Blazeby, Jane M.] Univ Hosp Bristol NHS Fdn Trust, Div Surg Head & Neck, Bristol, Avon, England; [Gamble, Carrol] Univ Liverpool, Inst Translat Med, MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England		Rooshenas, L (corresponding author), Univ Bristol, Sch Social & Community Med, MRC ConDuCT Hub Trials Methodol Res 2, Bristol, Avon, England.; Rooshenas, L (corresponding author), Univ Bristol, Sch Populat Hlth Sci, Bristol Med Sch, Bristol, Avon, England.	Leila.rooshenas@bristol.ac.uk	Gamble, Carrol/AAE-9895-2019	Gamble, Carrol/0000-0002-3021-1955; Blazeby, Jane/0000-0002-3354-3330; Rowlands, Ceri/0000-0002-9497-5532	Medical Research Council (MRC) Hub for Trials Methodology Research NetworkUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Collaboration and Innovation for Difficult Trials in Invasive Procedures (ConDuCT-II) Hub for Trials Methodology Research [MR/K025643/1]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K025643/1, MR/L004933/2, MR/L004933/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0514-10114, CL-2009-25-003] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/L004933/2, MR/L004933/1, MR/K025643/1] Funding Source: UKRI	CR is supported by the Medical Research Council (MRC) Hub for Trials Methodology Research Network and the Collaboration and Innovation for Difficult Trials in Invasive Procedures (ConDuCT-II) Hub for Trials Methodology Research (MR/K025643/1). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abboud PA, 2006, J MED ETHICS, V32, P468, DOI 10.1136/jme.2005.012633; ABRAMSON NS, 1990, ANN EMERG MED, V19, P781, DOI 10.1016/S0196-0644(05)81703-2; Adeoye O, 2012, J STROKE CEREBROVASC, V21, P667, DOI 10.1016/j.jstrokecerebrovasdis.2011.02.016; Agard A, 2001, HEART, V86, P632, DOI 10.1136/heart.86.6.632; Ali K, 2006, STROKE, V37, P865, DOI 10.1161/01.STR.0000204053.36966.80; Annane D, 2004, INTENS CARE MED, V30, P321, DOI 10.1007/s00134-003-2065-8; Auster J, 2009, AUSTRALAS J AGEING, V28, P149, DOI 10.1111/j.1741-6612.2009.00362.x; Authority NHR, 2017, APPL PROP APPR PROC; Bellomo R, 2009, BLOOD PURIFICAT, V27, P199, DOI 10.1159/000195091; Beshansky JR, 2014, CLIN TRIALS, V11, P178, DOI 10.1177/1740774514526476; Boland J, 2015, J PAIN SYMPTOM MANAG, V49, P762, DOI 10.1016/j.jpainsymman.2014.09.018; Bulger EM, 2009, ANN EMERG MED, V53, P341, DOI 10.1016/j.annemergmed.2008.07.021; Burns KEA, 2017, ANN AM THORAC SOC, V14, P238, DOI 10.1513/AnnalsATS.201606-425OC; Burns KEA, 2013, AM J RESP CRIT CARE, V187, P1212, DOI 10.1164/rccm.201208-1537OC; Caldwell PHY, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000368; Chlan L, 2009, AM J CRIT CARE, V18, P410, DOI 10.4037/ajcc2009400; Chow E, 2011, APPL CLIN INFORM, V2, P472, DOI 10.4338/ACI-2011-04-CR-0026; Clark DJ, 2013, ACTA NEUROCHIR, V155, P1329, DOI 10.1007/s00701-013-1748-3; Cofield SS, 2010, ACAD EMERG MED, V17, P1104, DOI 10.1111/j.1553-2712.2010.00866.x; Collins JF, 2003, CONTROL CLIN TRIALS, V24, P71, DOI 10.1016/S0197-2456(02)00265-9; Cook D, 2013, INTENS CARE MED, V39, P2115, DOI 10.1007/s00134-013-3074-x; Costescu DJW, 2013, CLIN TRIALS, V10, P612, DOI 10.1177/1740774513492045; Crowley ST, 2008, CLIN J AM SOC NEPHRO, V3, P955, DOI 10.2215/CJN.05621207; Del Giudice A, 2009, ACAD EMERG MED, V16, P309, DOI 10.1111/j.1553-2712.2009.00367.x; Donovan JL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1391-4; Elkins JS, 2006, STROKE, V37, P123, DOI 10.1161/01.STR.0000195149.44390.aa; Elliott D, 2017, EUR UROL, V72, P789, DOI 10.1016/j.eururo.2017.04.036; Fayter D, 2007, J CLIN EPIDEMIOL, V60, P990, DOI 10.1016/j.jclinepi.2006.12.013; Flaherty ML, 2008, NEUROLOGY, V71, P1566, DOI 10.1212/01.wnl.0000316196.63704.f5; Fletcher B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000496; Fordyce CB, 2017, CLIN TRIALS, V14, P88, DOI 10.1177/1740774516676084; Foster D, 2000, CRIT CARE MED, V28, P867, DOI 10.1097/00003246-200003000-00042; Glassberg AE, 2008, CHEST, V134, P719, DOI 10.1378/chest.08-0633; Goldstein JN, 2010, INT J EMERG MED, V3, P385, DOI 10.1007/s12245-010-0244-2; Hopewell S, 2007, COCHRANE DB SYST REV, V18; Huynh L, 2014, CLIN TRIALS, V11, P576, DOI 10.1177/1740774514540371; Ibrahim S, 2014, J IMMIGR MINOR HEALT, V16, P882, DOI 10.1007/s10903-013-9783-y; Kendall B, 2012, CLIN TRIALS, V9, P358, DOI 10.1177/1740774512440760; Kenyon S, 2006, QUAL SAF HEALTH CARE, V15, P98, DOI 10.1136/qshc.2005.015636; Leira EC, 2009, STROKE, V40, P895, DOI 10.1161/STROKEAHA.108.530204; MAPSTONE J, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.MR000013; Mc Daid C, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-16; Newman JT, 2012, CRIT CARE MED, V40, P2590, DOI 10.1097/CCM.0b013e318258ff19; Ngune Irene, 2012, Qual Prim Care, V20, P115; Provencher V, 2014, ARCH GERONTOL GERIAT, V59, P18, DOI 10.1016/j.archger.2014.03.006; Raftery J, 2008, HEALTH TECHNOL ASSES, V12, P1; Roberts I, 2011, LANCET, V377, P1071, DOI 10.1016/S0140-6736(11)60317-6; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; Sahan Kate M, 1800, Eur J Cardiovasc Med, V4, P506; Schandelmaier S, 2016, CRIT CARE MED, V44, P130, DOI 10.1097/CCM.0000000000001369; Schats R, 2003, J NEUROL NEUROSUR PS, V74, P988, DOI 10.1136/jnnp.74.7.988; Scotton WJ, 2013, BRIT J NEUROSURG, V27, P590, DOI 10.3109/02688697.2013.793291; Shaw L, 2014, EMERG MED J, V31, P994, DOI 10.1136/emermed-2013-202536; Sims CA, 2013, J TRAUMA ACUTE CARE, V74, P157, DOI 10.1097/TA.0b013e318278908a; Smith CT, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-32; Smith OM, 2013, J CRIT CARE, V28, P28, DOI 10.1016/j.jcrc.2012.08.005; Smyth RMD, 2012, MIDWIFERY, V28, pE538, DOI 10.1016/j.midw.2011.08.006; Snowdon C, 2012, MIDWIFERY, V28, P800, DOI 10.1016/j.midw.2011.11.009; Tam VC, 2008, J CLIN ONCOL, V26, P2205, DOI 10.1200/JCO.2007.14.6795; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub4, 10.1002/14651858.MR000013.pub5]; Watson Judith M, 2006, BMC Med Res Methodol, V6, P34, DOI 10.1186/1471-2288-6-34; Whitesides LW, 2017, CLIN TRIALS, V14, P180, DOI 10.1177/1740774516677276; Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0; Yamal JM, 2014, CLIN TRIALS, V11, P187, DOI 10.1177/1740774514522560; Yuval R, 2000, ARCH INTERN MED, V160, P1142, DOI 10.1001/archinte.160.8.1142; Ziai H, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017737	67	11	11	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2018	8	2							e018581	10.1136/bmjopen-2017-018581			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH0ZB	WOS:000433129800211	29420230	Green Published, gold			2022-02-06	
J	Schatz, J; Schlenz, AM; Smith, KE; Roberts, CW				Schatz, Jeffrey; Schlenz, Alyssa M.; Smith, Kelsey E.; Roberts, Carla W.			Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SOCIAL COMPETENCE; SCHOOL-AGE; ANEMIA; TODDLERS; TERM; DEFICITS; OUTCOMES; INFANTS	AimTo assess the predictive validity of developmental screenings in children with sickle cell disease (SCD) for academic outcomes and stroke risk. MethodParent questionnaires and medical record data were collected for a cohort receiving developmental screenings between September 2004 and May 2008 as toddlers or early school age. Screening outcomes were dichotomized (positive, negative) by a priori criteria. Questionnaires assessed school and social functioning, services received, and quality of life. Medical record data assessed general SCD morbidity and stroke risk. ResultsForty-one toddlers (mean age 2y 5mo; 25 males, 16 females) and 49 early school-age children (mean age 6y 5mo; 26 males, 23 females) completed follow-up. The mean follow-up period was 8 years 6 months (range 6.1-10.8y). For toddlers, positive screenings for language delays predicted lower academic performance (p=0.023). For older children, positive screenings for cognitive delays predicted more frequent academic/attentional problems at school (p<0.001), grade retention (p=0.007), and lower academic performance (p=0.001). Positive screenings were associated with an earlier onset of school problems and lower quality of life. Positive screenings for language/cognitive delays predicted increased stroke risk (both p<0.05). InterpretationScreening for language or cognitive development in young children with SCD predicts academic outcomes and stroke risk. What this paper adds Developmental screening predicts academic outcomes in sickle cell disease. Children with concerning language/cognitive screenings have early-onset school difficulties. Developmental screenings may help predict cerebrovascular complications. Resumen Validez predictiva de la pesquisa del desarrollo en ninos pequenos con anemia falciforme: un estudio de seguimiento longitudinal ObjetivoEvaluar la validez predictiva de las pruebas de pesquisa del desarrollo en ninos con Anemia Falciformes (AF) para el aprendizaje academicos y el riesgo de accidente cerebrovascular (ACV). MetodoSe recolectaron datos usando cuestionarios para padres e historias medicas de una cohorte de ninos que recibieron pruebas de pesquisa del desarrollo entre Septiembre del 2004 y Mayo del 2008, a la de edad prescolar o al inicio de la edad escolar. Los resultados de la deteccion fueron dicotomizados (positivos, negativos) segun criterios elegidos a priori. Los cuestionarios evaluaron el funcionamiento escolar y social, los servicios recibidos y la calidad de vida. Datos de registros medicos: morbilidad relacionada con AF y riesgo de ACV. ResultadosCuarenta y un ninos de edad prescolar (edad media de 2 anos, 5 meses, 25 varones, 16 mujeres) y 49 ninos en edad escolar (edad media de 6 anos, 5 meses, 26 varones, 23 mujeres) completaron el seguimiento. El periodo de seguimiento medio fue de 8 anos y 6 meses (rango 6.1-10.8 anos). Para los ninos pequenos, las evaluaciones positivas para retrasos en el lenguaje predijeron un menor rendimiento academico (p = 0.023). En los ninos mayores, las pesquisas positivas para retrasos cognitivos predijeron mayor frecuencia de problemas academicos / atencionales en la escuela (p = 0,0003), retencion de grado (p = 0,007) y un rendimiento academico mas bajo (p = 0,001). Las pesquisas positivas se asociaron con un inicio mas temprano de problemas escolares y una menor calidad de vida. Los examenes positivos para el retraso del lenguaje / cognitivo predijeron un riesgo de ACV mas alto (ambos p <0.05). InterpretacionPruebas de pesquisa de retraso en el lenguaje o desarrollo cognitivo en ninos pequenos con AF pueden predecir problemas academicos o riesgo de ACV. Resumo Validade preditiva do rastreio do desenvolvimento em criancas pequenas com anemia falciforme: estudo longitudinal de seguimento ObjetivoAvaliar a validade preditivo de avaliacoes de rastreio de desenvolvimento em criancas com anemia falciforme (AF) para resultados academicos e para risco de acidente vascular encefalico (AVE). MetodoForam coletados questionarios respondidos pelos pais e dados de registros medicos de uma coorte composta por pre-escolares e por criancas em idade escolar precoce que foram submetidas a avaliacoes de rastreio de desenvolvimento entre setembro de 2004 e maio de 2008. Os resultados da triagem foram dicotomizados (positivos, negativos) por criterios estabelecidos a priori. Os questionarios avaliaram o funcionamento escolar e social, os servicos recebidos e a qualidade de vida. Os dados dos registros medicos avaliaram a morbidade em geral e o risco de AVE. ResultadosQuarenta e um pre-escolares (media de idade de 2 anos e 5 meses; 25 do sexo masculino, 16 do sexo feminino) e 49 criancas com idade escolar precoce (media de idade de 6 anos e 5 meses; 26 do sexo masculino e 23 do sexo feminino) completaram o seguimento. O periodo medio de seguimento foi de 8 anos e 6 meses (6,1-10,8 anos). Para os pre-escolares, avaliacoes positivas para atrasos de linguagem previram menor desempenho academico (p = 0,023). Para criancas mais velhas, avaliacoes positivas para atrasos cognitivos previram problemas academicos / atencionais mais frequentes na escola (p = 0,0003), retencAo de serie (p = 0,007) e menor desempenho academico (p = 0,001). As avaliacoes positivas foram associados com um inicio precoce de problemas escolares e com menor qualidade de vida. As avaliacoes positivas para atrasos linguisticos / cognitivos previram aumento do risco de acidente vascular encefalico (ambos p <0,05). InterpretacAoO rastreio do desenvolvimento linguistico ou cognitivo em criancas pequenas com AF preve resultados academicos e risco de acidente vascular cerebral. What this paper adds Developmental screening predicts academic outcomes in sickle cell disease. Children with concerning language/cognitive screenings have early-onset school difficulties. Developmental screenings may help predict cerebrovascular complications. This article is commented on by King on pages 443-444 of this issue. This article's abstract has been translated into Spanish and Portuguese. Follow the links from the abstract to view the translations.	[Schatz, Jeffrey; Smith, Kelsey E.] Univ South Carolina, Dept Psychol, 1512 Pendleton St, Columbia, SC 29208 USA; [Schlenz, Alyssa M.] Med Univ South Carolina, Dept Pediat, Charleston, SC USA; [Roberts, Carla W.] Univ South Carolina, Dept Pediat, 1512 Pendleton St, Columbia, SC 29208 USA		Schatz, J (corresponding author), Univ South Carolina, Dept Psychol, 1512 Pendleton St, Columbia, SC 29208 USA.	schatz@sc.edu		Schatz, Jeffrey/0000-0002-5129-2344; Schlenz, Alyssa/0000-0002-1106-5016			Anders DG, 2016, AM J PREV MED, V51, pS31, DOI 10.1016/j.amepre.2016.01.001; Armstrong FD, 2013, PEDIATRICS, V131, pE406, DOI 10.1542/peds.2012-0283; Aygun B, 2011, PEDIATR BLOOD CANCER, V56, P620, DOI 10.1002/pbc.22833; Borenstein M., 2009, HDB RES SYNTHESIS ME, V2nd, P221; Cohen J., 2013, STAT POWER ANAL BEHA; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fullerton HJ, 2004, BLOOD, V104, P336, DOI 10.1182/blood-2004-02-0636; Glass P, 2013, J DEV BEHAV PEDIATR, V34, P399, DOI 10.1097/DBP.0b013e31829c3c48; Hermann B, 2006, BRAIN, V129, P2609, DOI 10.1093/brain/awl196; Hogan AM, 2006, BRIT J HAEMATOL, V132, P99, DOI 10.1111/j.1365-2141.2005.05828.x; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; King AA, 2014, AM J HEMATOL, V89, pE188, DOI 10.1002/ajh.23805; McClellan CB, 2008, J PEDIATR PSYCHOL, V33, P1153, DOI 10.1093/jpepsy/jsn036; Meisels S. J., 2000, HDB EARLY CHILDHOOD, P231, DOI DOI 10.1017/CBO9780511529320.013; MULHERN RK, 1989, PEDIATRICS, V83, P18; Puffer E, 2007, CHILD NEUROPSYCHOL, V13, P142, DOI 10.1080/09297040600584626; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Rosen CL, 2014, PEDIATRICS, V134, P273, DOI 10.1542/peds.2013-4223; ROSS G, 1990, PEDIATRICS, V86, P391; Schatz J, 2004, J PEDIATR PSYCHOL, V29, P627, DOI 10.1093/jpepsy/jsh065; Schatz J, 2007, J INT NEUROPSYCH SOC, V13, P933, DOI 10.1017/S1355617707071196; Schatz J, 2006, MENT RETARD DEV D R, V12, P200, DOI 10.1002/mrdd.20115; Schatz J, 2009, DEV NEUROPSYCHOL, V34, P122, DOI 10.1080/87565640802499191; Schatz J, 2008, J CHILD NEUROL, V23, P44, DOI 10.1177/0883073807307982; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	27	11	11	3	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	MAY	2018	60	5					520	526		10.1111/dmcn.13689			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	GC8XX	WOS:000430082900019	29488622	Bronze			2022-02-06	
J	Tobaldini, E; Toschi-Dias, E; Trimarchi, PD; Brena, N; Comanducci, A; Casarotto, S; Montano, N; Devalle, G				Tobaldini, Eleonora; Toschi-Dias, Edgar; Trimarchi, Pietro Davide; Brena, Nicola; Comanducci, Angela; Casarotto, Silvia; Montano, Nicola; Devalle, Guya			Cardiac autonomic responses to nociceptive stimuli in patients with chronic disorders of consciousness	CLINICAL NEUROPHYSIOLOGY			English	Article						Disorders of consciousness; Vegetative state; Minimally conscious state; Cardiac autonomic control; Symbolic analysis; Entropy	HEART-RATE-VARIABILITY; TRAUMATIC BRAIN-INJURY; ITALIAN VERSION; UP TILT; SYSTEM; SCALE; COMA; MODULATION; DEATH; STATE	Objectives: Patients with chronic disorders of consciousness (DOC) may show alterations of autonomic function; however, in this clinical population, no data are available on the specific effects of nociceptive stimuli on cardiac autonomic control. Thus, we aimed at investigating the effects of a noxious stimulation on heart rate variability (HRV) in a population of patients with chronic DOC, taking into account different states of consciousness (vegetative state/unresponsive wakefulness syndrome, VS/UWS and minimally conscious state, MCS). Methods: We enrolled twenty-four DOC patients (VS/UWS, n = 12 and MCS, n = 12). ECG and respiration were recorded during baseline, immediately after the nociceptive stimulus and, finally, during the recovery period. Linear and nonlinear HRV measures were used to evaluate the cardiac autonomic control. Results: In DOC patients, nonlinear HRV analysis showed that nociceptive stimuli are able to elicit a change of autonomic function characterized by an increased sympathetic and a reduced vagal modulation. A significant reduction of autonomic complexity has also been detected. More interestingly, VS/UWS patients showed a less complex dynamics compared to MCS patients. Conclusions: Cardiac autonomic responses are able to significantly differentiate the autonomic function between VS/UWS and MCS patients. Significance: Nonlinear HRV analysis may represent a useful tool to characterize the cardiac autonomic responses to nociceptive stimuli in a chronic DOC population. (C) 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Tobaldini, Eleonora; Toschi-Dias, Edgar; Montano, Nicola] Univ Milan, Dept Internal Med, Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy; [Tobaldini, Eleonora; Toschi-Dias, Edgar; Montano, Nicola] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Toschi-Dias, Edgar] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor, Sao Paulo, Brazil; [Trimarchi, Pietro Davide; Comanducci, Angela; Devalle, Guya] Fdn Don C Gnocchi, IRCCS, Vegetat State Unit, Milan, Italy; [Brena, Nicola] ASST Fatebenefratelli Sacco, Internal Med Unit, Milan, Italy; [Casarotto, Silvia] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy		Montano, N (corresponding author), Univ Milan, Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Via F Sforza 35, I-20122 Milan, Italy.	nicola.montano@unimi.it	Comanducci, Angela/AAB-9917-2019; Casarotto, Silvia/Q-9402-2019; Toschi-Dias, Edgar/C-9685-2013; Toschi-Dias, Edgar/AAP-9528-2020	Casarotto, Silvia/0000-0002-7548-7664; Toschi-Dias, Edgar/0000-0002-5226-2956; Toschi-Dias, Edgar/0000-0002-5226-2956; Comanducci, Angela/0000-0001-6084-019X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07651-7, 2015/17642-0]; Italian Space Agency Grant	Edgar Toschi-Dias was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP # 2013/07651-7 and # 2015/17642-0). Nicola Montano was supported by an Italian Space Agency Grant. The others authors declare no funding.	Baillard C, 2002, CRIT CARE MED, V30, P306, DOI 10.1097/00003246-200202000-00007; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Calabro RS, 2017, CLIN NEUROPHYSIOL, V128, P454, DOI 10.1016/j.clinph.2016.12.011; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Freitas J, 1996, CLIN AUTON RES, V6, P141, DOI 10.1007/BF02281900; Garcia OD, 1995, DEVEL NEUR, V9, P191; Giacino JT, 1997, SEMIN NEUROL, V17, P105, DOI 10.1055/s-2008-1040919; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; JENNETT B, 1972, LANCET, V1, P734; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leo A, 2016, EXP BRAIN RES, V234, P2189, DOI 10.1007/s00221-016-4622-8; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Naro A, 2016, NEUROSCIENCE, V317, P141, DOI 10.1016/j.neuroscience.2016.01.009; Pistoia F, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6040047; Plum F., 2007, DIAGNOSIS STUPOR COM; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2007, AM J PHYSIOL-HEART C, V293, pH702, DOI 10.1152/ajpheart.00006.2007; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Riganello F, 2015, J NEUROTRAUM, V32, P1071, DOI 10.1089/neu.2014.3539; Riganello F, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-164; Riganello F, 2012, J REHABIL MED, V44, P495, DOI 10.2340/16501977-0975; Sattin D, 2013, INT J REHABIL RES, V36, P182, DOI 10.1097/MRR.0b013e3283618d68; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Tobaldini E, 2015, SLEEP MED, V16, P779, DOI 10.1016/j.sleep.2014.12.023; Tobaldini E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00294; Tobaldini E, 2013, INT J CARDIOL, V168, P3267, DOI 10.1016/j.ijcard.2013.04.137; Viola AU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019002; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006	36	11	11	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAY	2018	129	5					1083	1089		10.1016/j.clinph.2018.01.068			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB3GY	WOS:000428945500028	29486984				2022-02-06	
J	Wu, QQ; Ma, L; Liu, QN; Feng, LN; Wang, ZY; Ohrndorf, A; Christ, HJ; Xiong, J				Wu, Qianqian; Ma, Li; Liu, Qiunan; Feng, Lina; Wang, Zhenyu; Ohrndorf, Arne; Christ, Hans-Juergen; Xiong, Jian			Impact response and energy absorption of human skull cellular bones	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Cellular structure; Skull bone; Energy absorption; Failure mechanism; Impact	MECHANICAL-PROPERTIES; BIOLOGICAL-MATERIALS; BEHAVIOR; STRENGTH; FRACTURE; MODEL	A skull fracture, due to a composition of typical lightweight cellular structures, is the most common type of traumatic brain injury. This paper presents a systematic investigation on the failure mechanism and energy absorption of skull cellular bones under low- and medium-velocity impact loadings. Non-destructive three-dimensional micro-computed tomography (Micro-CT) is utilized to scan samples of human skull cellular bones, and relevant structural parameters are obtained to reconstruct a finite element (FE) model of these bones. Microstructures, mechanical properties, and failure process analysis of human skull cellular bones under impact loadings are investigated. The effects of some typical parameters, such as impact velocity and angle, impactor shape and density, and various reconstructed sections on the impact behavior of human skull cellular bones are investigated. Their impact properties and energy absorption are summarized. The present work will be of great significance in understanding the mechanical mystery of human skull cellular bones under impact loading.	[Wu, Qianqian; Ma, Li; Feng, Lina; Xiong, Jian] Harbin Inst Technol, Ctr Composite Mat, Harbin 150001, Heilongjiang, Peoples R China; [Ohrndorf, Arne; Christ, Hans-Juergen; Xiong, Jian] Univ Siegen, Inst Werkstofftech, D-57076 Siegen, Germany; [Liu, Qiunan] Beijing Inst Struct & Environm Engn, Beijing 100076, Peoples R China; [Wang, Zhenyu] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150001, Heilongjiang, Peoples R China		Xiong, J (corresponding author), Harbin Inst Technol, Ctr Composite Mat, Harbin 150001, Heilongjiang, Peoples R China.	jx@hit.edu.cn	Ohrndorf, Arne/F-2996-2010		Program for Interdisciplinary Basic Research of Science-Engineering-Medicine and Outstanding Young Scholars in Harbin Institute of Technology; Alexander von Humboldt FoundationAlexander von Humboldt Foundation [1155520]; Program for Outstanding Young Scholars in Harbin Institute of Technology; Science and Technology on Advanced Composites in Special Environment Laboratory; Young Elite Scientist Sponsorship Program by CAST [YESS20160190]	The present work was supported in part by the Program for Interdisciplinary Basic Research of Science-Engineering-Medicine and Outstanding Young Scholars in Harbin Institute of Technology. JX also acknowledges the support from Alexander von Humboldt Foundation under grant award 1155520 (University of Siegen, Germany). JX also gratefully acknowledges supported by Program for Outstanding Young Scholars in Harbin Institute of Technology, the Science and Technology on Advanced Composites in Special Environment Laboratory and Young Elite Scientist Sponsorship Program by CAST (YESS20160190).	Ashby MF., 1992, MAT SELECTION MECH D; Auperrin A, 2014, J BIOMECH, V47, P1180, DOI 10.1016/j.jbiomech.2013.10.060; Bessho M, 2007, J BIOMECH, V40, P1745, DOI 10.1016/j.jbiomech.2006.08.003; Bevill G, 2009, BONE, V44, P579, DOI 10.1016/j.bone.2008.11.020; Boruah S, 2013, P INT RES COUNC BIOM; Boruah S, 2017, J MECH BEHAV BIOMED, V65, P688, DOI 10.1016/j.jmbbm.2016.09.041; Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001; Colombo P, 2008, SCIENCE, V322, P381, DOI 10.1126/science.1162962; Currey JD, 2009, OPEN BONE J, V1, P38, DOI [DOI 10.2174/1876525400901010038, DOI 10.2174/]; Deck C., 2007, P 5 INT FOR AUT TRAF; Delille R, 2007, INT J CRASHWORTHINES, V12, P101, DOI 10.1080/13588260701433081; Falland-Cheung L, 2017, J MECH BEHAV BIOMED, V68, P303, DOI 10.1016/j.jmbbm.2017.02.023; Fousova M, 2017, J MECH BEHAV BIOMED, V69, P368, DOI 10.1016/j.jmbbm.2017.01.043; Furusu K, 2001, JSAE REV, V22, P195, DOI 10.1016/S0389-4304(01)00084-4; Garcia-Gonzalez D, 2017, J MECH BEHAV BIOMED, V69, P342, DOI 10.1016/j.jmbbm.2017.01.012; Gibson L. J., 2010, CELLULAR MAT NATURE; Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027; Guillen T, 2011, J MECH BEHAV BIOMED, V4, P1452, DOI 10.1016/j.jmbbm.2011.05.015; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Irnbert L, 2015, J MECH BEHAV BIOMED, V46, P261, DOI 10.1016/j.jmbbm.2014.12.020; Kemper Andrew R, 2005, Stapp Car Crash J, V49, P199; Kennedy EB, 2017, J MECH BEHAV BIOMED, V75, P413, DOI 10.1016/j.jmbbm.2017.08.009; [Lu TianJian 卢天健], 2012, [中国材料进展, Materials China], V31, P13; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Motherway J., 2009, LEGAL MED, V11, P220; Murr L. E., 2017, J MECH BEHAV BIOMED; Ngan A.H.W, 2009, ENG MAT PROCESSES DE; NORMAN TL, 1995, J BIOMECH, V28, P309, DOI 10.1016/0021-9290(94)00069-G; Ohrndorf A, 2006, Technol Health Care, V14, P201; POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3; Rahmoun J, 2014, MECH RES COMMUN, V60, P7, DOI 10.1016/j.mechrescom.2014.04.001; Sahoo D, 2013, J MECH BEHAV BIOMED, V28, P340, DOI 10.1016/j.jmbbm.2013.08.010; Swift NB, 2016, J MECH BEHAV BIOMED, V61, P271, DOI 10.1016/j.jmbbm.2016.03.019; Torimitsu S, 2015, FORENSIC SCI INT, V252, DOI 10.1016/j.forsciint.2015.04.029; Verhulp E, 2008, J BIOMECH, V41, P1479, DOI 10.1016/j.jbiomech.2008.02.032; Xiong J, 2015, ADV ENG MATER, V17, P1253, DOI 10.1002/adem.201400471; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878	39	11	11	5	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	MAY	2018	81						106	119		10.1016/j.jmbbm.2018.02.018			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GD8OQ	WOS:000430772200012	29501963				2022-02-06	
J	Liraz-Zaltsman, S; Slusher, B; Atrakchi-Baranes, D; Rosenblatt, K; Levi, YF; Kesner, E; Silva, AJ; Biegon, A; Shohami, E				Liraz-Zaltsman, Sigal; Slusher, Barbara; Atrakchi-Baranes, Dana; Rosenblatt, Kineret; Levi, Yael Friedman; Kesner, Efrat; Silva, Alcino J.; Biegon, Anat; Shohami, Esther			Enhancement of Brain D-Serine Mediates Recovery of Cognitive Function after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						CBIO; cognitive deficits; D-cycloserine; NMDARs; TBI	AMINO-ACID OXIDASE; CLOSED-HEAD INJURY; PERIPHERAL BENZODIAZEPINE-RECEPTORS; D-CYCLOSERINE; NMDA RECEPTORS; SYNAPTIC PLASTICITY; MEMORY DEFICITS; DEMENTIA RISK; MOUSE MODEL; GLUTAMATE	Cognitive deficits, especially memory loss, are common and devastating neuropsychiatric sequelae of traumatic brain injury (TBI). The deficits may persist for years and may be accompanied by increased risk of developing early-onset dementia. Past attempts to reverse the neuropathological effects of brain injury with glutamate-N-methyl-D-aspartate (NMDA) antagonists failed to show any benefits or worsened the outcome, suggesting that activation, rather than blockage, of the NMDA receptor (NMDAR) may be useful in the subacute period after TBI and stroke. Activation of the NMDAR requires occupation of the glycine-modulatory site by co-agonists to achieve its synaptic functions. Glycine and D-serine are endogenous ligands/co-agonists of synaptic NMDARs in many areas of the mature brain. The aim of the present study was to evaluate the effect of 6-chlorobenzo(d)isoxazol-3-ol (CBIO), an inhibitor of D-amino acid oxidase (DAAO), which degrades D-serine, on cognitive outcome in a mouse model of TBI. Because treating TBI animals with CBIO elevates the endogenous levels of D-serine, we compared this novel treatment with treatment by exogenous D-serine alone and combined with CBIO. The results show that a single treatment (24 h post-injury) with CBIO in the mouse model of closed head injury significantly improves cognitive and motor function, and decreases lesion volume and the inflammatory response. Moreover, the compound proved to be neuroprotective, as the hippocampal volume and the number of neurons in hippocampal regions increased. Treatment with CBIO boosted the NR1 and phospho-NR1 subunits of the NMDAR and affected the CREB, phospho-CREB, and brain-derived neurotropic factor (BDNF) pathways. These findings render CBIO a promising, novel treatment for cognitive impairment following TBI.	[Liraz-Zaltsman, Sigal; Atrakchi-Baranes, Dana] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel; [Rosenblatt, Kineret] Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel; [Liraz-Zaltsman, Sigal; Levi, Yael Friedman; Kesner, Efrat; Shohami, Esther] Hebrew Univ Jerusalem, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel; [Slusher, Barbara] Johns Hopkins Sch Med, Johns Hopkin Drug Discovery, Baltimore, MD USA; [Slusher, Barbara] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Silva, Alcino J.] Univ Calif Los Angeles, Integrat Ctr Learning, Los Angeles, CA USA; [Silva, Alcino J.] Univ Calif Los Angeles, Memory Brain Res Inst, Los Angeles, CA USA; [Biegon, Anat] SUNY Stony Brook, Sch Med, Dept Radiol & Neurol, Stony Brook, NY 11794 USA		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Dept Pharmacol, IL-91120 Jerusalem, Israel.	esty.shohami@mail.huji.ac.il	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558	Dr. Miriam and Sheldon Adelson Foundation (AMRF)	This study was supported by a grant from the Dr. Miriam and Sheldon Adelson Foundation (AMRF) to E.S. and A.J.S.	Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Albensi BC, 2007, CURR PHARM DESIGN, V13, P3185, DOI 10.2174/138161207782341321; Alessandri B, 1996, ACT NEUR S, V67, P6; Andersen JM, 2002, BEHAV BRAIN RES, V129, P211, DOI 10.1016/S0166-4328(01)00318-7; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Balu DT, 2015, CURR OPIN PHARMACOL, V20, P109, DOI 10.1016/j.coph.2014.12.004; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Billard JM, 2007, EUR J NEUROSCI, V25, P2260, DOI 10.1111/j.1460-9568.2007.05488.x; Billard JM, 2012, AMINO ACIDS, V43, P1851, DOI 10.1007/s00726-012-1346-3; BOWERY NG, 1987, NATURE, V326, P338, DOI 10.1038/326338a0; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dhawan J, 2011, FUTUR NEUROL, V6, P823, DOI 10.2217/FNL.11.55; Dhawan J, 2010, NEUROIMAGE, V51, P599, DOI 10.1016/j.neuroimage.2010.02.073; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Ferraris D, 2008, J MED CHEM, V51, P3357, DOI 10.1021/jm800200u; Fujihira T, 2007, NEUROCHEM INT, V51, P233, DOI 10.1016/j.neuint.2007.06.003; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gottlieb JD, 2011, SCHIZOPHR RES, V131, P69, DOI 10.1016/j.schres.2011.05.029; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; GUILARTE TR, 1995, NEUROTOXICOLOGY, V16, P441; Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y; Hashimoto K, 2009, BIOL PSYCHIAT, V65, P1103, DOI 10.1016/j.biopsych.2009.01.002; Ho YJ, 2011, BEHAV BRAIN RES, V219, P280, DOI 10.1016/j.bbr.2011.01.028; Huang X, 2012, CNS NEUROSCI THER, V18, P4, DOI 10.1111/j.1755-5949.2011.00276.x; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Klatte K, 2013, J NEUROSCI, V33, P13066, DOI 10.1523/JNEUROSCI.5423-12.2013; Ledgerwood L, 2004, BEHAV NEUROSCI, V118, P505, DOI 10.1037/0735-7044.118.3.505; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lees KR, 1997, NEUROLOGY, V49, pS66, DOI 10.1212/WNL.49.5_Suppl_4.S66; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Liraz-Zaltsman S, 2016, J MOL NEUROSCI, V60, P46, DOI 10.1007/s12031-016-0786-8; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maria NSS, 2017, J NEUROTRAUM, V34, P1692, DOI 10.1089/neu.2016.4747; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; Rojas C, 2016, J PSYCHOPHARMACOL, V30, P887, DOI 10.1177/0269881116652586; Rojas C, 2016, NEUROPSYCHOPHARMACOL, V41, P1610, DOI 10.1038/npp.2015.319; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Rouaud E, 2003, BRIT J PHARMACOL, V140, P1051, DOI 10.1038/sj.bjp.0705541; Sano Y, 2014, CURR BIOL, V24, P2833, DOI 10.1016/j.cub.2014.10.018; Schneider JS, 2000, BRAIN RES, V860, P190, DOI 10.1016/S0006-8993(00)02036-9; Sershen H, 2016, NEUROCHEM RES, V41, P398, DOI 10.1007/s11064-016-1838-8; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Shohami E, 2011, OXID STRESS APPL BAS, P99, DOI 10.1007/978-1-60327-514-9_7; SIMIAND J, 1984, PSYCHOPHARMACOLOGY, V84, P48, DOI 10.1007/BF00432023; Smith Sean M, 2010, Open Med Chem J, V4, P3, DOI 10.2174/1874104501004020003; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Thanos PK, 2011, SYNAPSE, V65, P938, DOI 10.1002/syn.20922; Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2013, BIOCHEM SOC T, V41, P1546, DOI 10.1042/BST20130220; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com	68	11	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1667	1680		10.1089/neu.2017.5561		APR 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000431102800001	29648983				2022-02-06	
J	Dunkley, BT; Urban, K; Da Costa, L; Wong, SM; Pang, EW; Taylor, MJ				Dunkley, Benjamin T.; Urban, Karolina; Da Costa, Leodante; Wong, Simeon M.; Pang, Elizabeth W.; Taylor, Margot J.			Default Mode Network Oscillatory Coupling Is Increased Following Concussion	FRONTIERS IN NEUROLOGY			English	Article						concussion; mild traumatic brain injury; magnetoencephalography; resting-state; functional connectivity; neural oscillations; synchrony	TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; CHILDREN BORN; MILD; MAGNETOENCEPHALOGRAPHY; FREQUENCY; DISRUPTION; DISORDER; ALPHA; SYNCHRONIZATION	Concussion is a common form of mild traumatic brain injury. Despite the descriptor "mild," a single injury can leave long-lasting and sustained alterations to brain function, including changes to localized activity and large-scale interregional communication. Cognitive complaints are thought to arise from such functional deficits. We investigated the impact of injury on neurophysiological and functionally specialized resting networks, known as intrinsic connectivity networks (ICNs), using magnetoencephalography. We assessed neurophysiological connectivity in 40 males, 20 with concussion and 20 without. Regions-of-interest that comprise nodes of ICNs were defined, and their time courses derived using a beamformer approach. Pairwise fluctuations and covariations in band-limited amplitude envelopes were computed reflecting measures of functional connectivity. Intra-network connectivity was compared between groups using permutation testing and correlated with symptoms. We observed increased resting spectral connectivity in the default mode network (DMN) and motor networks (MOTs) in our concussion group when compared with controls, across alpha through gamma ranges. Moreover, these differences were not explained by power spectrum density within the ICNs. Furthermore, this increased coupling was significantly associated with symptoms in the DMN and MOTs-but once accounting for comorbidities (including, depression, anxiety, and ADHD) only the DMN continued to be associated with symptoms. The DMN plays a critical role in shifting between cognitive tasks. These data suggest even a single concussion can perturb the intrinsic coupling of this functionally specialized network in the brain, and may explain persistent and wide-ranging symptomatology.	[Dunkley, Benjamin T.; Wong, Simeon M.; Taylor, Margot J.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada; [Dunkley, Benjamin T.; Pang, Elizabeth W.; Taylor, Margot J.] Sick Kids Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Dunkley, Benjamin T.; Taylor, Margot J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Urban, Karolina] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Da Costa, Leodante] Sunnybrook Med Ctr, Div Neurosurg, Toronto, ON, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON, Canada; [Taylor, Margot J.] Univ Toronto, Dept Psychol, Toronto, ON, Canada		Dunkley, BT (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada.; Dunkley, BT (corresponding author), Sick Kids Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada.; Dunkley, BT (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON, Canada.	ben.dunkley@sickkids.ca	Wong, Simeon/V-8051-2019	Wong, Simeon/0000-0001-9070-0665; Dunkley, Ben/0000-0001-6173-1171; Urban, Karolina/0000-0003-1301-7891	Defence Research and Development Canada (DRDC) [W7719-135182/001/TOR]; Canadian Forces Health Services	Thanks are given to Amanda Robertson, Allison Bethune, and Marc Lalancette for help in the data collection, and Simeon Wong for help with the data pre-processing. This work was supported by funding from Defence Research and Development Canada (DRDC) (Contract #: W7719-135182/001/TOR) and the Canadian Forces Health Services to MT and EP.	Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baillet S, 2017, NAT NEUROSCI, V20, P327, DOI 10.1038/nn.4504; Baker AP, 2014, ELIFE, V3, DOI 10.7554/eLife.01867; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Basar E, 2004, INT J BIFURCAT CHAOS, V14, P453, DOI 10.1142/S0218127404009272; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; Brookes MJ, 2014, NEUROIMAGE, V91, P282, DOI 10.1016/j.neuroimage.2013.12.066; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cheyne D, 2007, CLIN NEUROPHYSIOL, V118, P1691, DOI 10.1016/j.clinph.2007.05.064; Conners CK., 2011, ENCY CLIN NEUROPSYCH, P675, DOI [DOI 10.1007/978-0-387-79948-3_1534, 10.1007/978-0-387-79948-3_1534]; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Doesburg SM, 2011, PEDIATR RES, V70, P171, DOI 10.1203/PDR.0b013e3182225a9e; Doesburg SM, 2011, NEUROIMAGE, V54, P2330, DOI 10.1016/j.neuroimage.2010.10.044; Doesburg SM, 2009, BRAIN RES, V1303, P97, DOI 10.1016/j.brainres.2009.09.069; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Dunkley BT, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00145; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fingelkurts AA, 2004, HUM BRAIN MAPP, V22, P27, DOI 10.1002/hbm.20014; Fingelkurts AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087507; Fingelkurts AA, 2017, CLIN EEG NEUROSCI, V48, P327, DOI 10.1177/1550059417696180; Fingelkurts AA, 2011, BRAIN COGNITION, V75, P79, DOI 10.1016/j.bandc.2010.11.015; Florin E, 2015, NEUROIMAGE, V111, P26, DOI 10.1016/j.neuroimage.2015.01.054; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Hunt BAE, 2016, P NATL ACAD SCI USA, V113, P13510, DOI 10.1073/pnas.1608587113; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Koelewijn L, 2015, HUM BRAIN MAPP, V36, P3935, DOI 10.1002/hbm.22888; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lansbergen MM, 2011, PROG NEURO-PSYCHOPH, V35, P47, DOI 10.1016/j.pnpbp.2010.08.004; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory Paul, 2009, Scand J Med Sci Sports, V19, P452, DOI 10.1111/j.1600-0838.2009.00978.x; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Nugent AC, 2015, NEUROIMAGE, V118, P1, DOI 10.1016/j.neuroimage.2015.05.051; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Shah-Basak PP, 2018, J NEUROTRAUM, V35, P267, DOI 10.1089/neu.2017.5117; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stitt I, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500229; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Voets NL, 2012, BRAIN, V135, P2350, DOI 10.1093/brain/aws137; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wechsler D., 2011, WECHSLER ABBREVIATED; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Ye AX, 2014, HUM BRAIN MAPP, V35, P6049, DOI 10.1002/hbm.22604; Yerys BE, 2015, NEUROIMAGE-CLIN, V9, P223, DOI 10.1016/j.nicl.2015.07.018; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zumer JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001965	94	11	11	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 26	2018	9								280	10.3389/fneur.2018.00280			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE1II	WOS:000430969600002	29755402	Green Published, Green Submitted, gold			2022-02-06	
J	Bespalov, A; Steckler, T				Bespalov, Anton; Steckler, Thomas			Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?	JOURNAL OF NEUROSCIENCE METHODS			English	Article; Proceedings Paper	10th Measuring Behavior Conference	MAY 25-27, 2016	Dublin, IRELAND			CNS drug discovery; Behavioral neuroscience; Reproducibility; Research quality	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PSYCHIATRIC-DISORDERS; REPRODUCIBILITY; INHIBITION; BEXAROTENE; GUIDELINES; DISCOVERY; MEDICINES; FUNDERS	There are many reasons why novel therapeutics fail in clinical trials but these failures are often attributed to lacking quality of preclinical data. These problems are not limited to any specific therapeutic area, academic or industrial research and are due in large part to several generic factors influencing research quality (e.g., related to definition of pre-specified endpoints, principles of study design and analysis, biased reporting, and lack of proper training). Yet, neuroscience drug discovery is often said to be affected more than the other fields. Within neuroscience, behavioral studies are the most blamed for being poorly designed, underpowered and mis-reported and there are indeed several factors that may be rather unique for behavioral research, such as a multitude of environmental conditions that are difficult to control and that are often not reported, ethical concerns about in vivo research and the pressure to reduce animal numbers, contributing to under-powered studies, and the complexity of study design and analysis, creating too much room for post hoc data massaging and selective reporting. Also, the blood-brain barrier as a frequently neglected complicating factor has to be considered in CNS research. The importance of these factors is increasingly recognized and urgent efforts are needed to demonstrate that behavioral methods of preclinical neuroscience research deliver results that can be as robust as with the non-behavioral methods Until this goal is achieved, behavioral neuroscience and neuroscience in general may be losing young talent, CNS drug discovery may lack the needed investment and this field may indeed be amongst the most affected by the current preclinical data quality crisis. (C) 2017 Elsevier B.V. All rights reserved.	[Bespalov, Anton] PAASP, Aukopf 14-1, D-69118 Heidelberg, Germany; [Bespalov, Anton] Pavlov Med Univ, Valdman Inst Pharmacol, St Petersburg, Russia; [Steckler, Thomas] Janssen Res & Dev, Beerse, Belgium		Bespalov, A (corresponding author), PAASP, Aukopf 14-1, D-69118 Heidelberg, Germany.	anton.bespalov@paasp.net	Bespalov, Anton/AAS-1469-2020; Steckler, Thomas/AAF-3975-2020; Bespalov, Anton Y/R-6506-2016	Bespalov, Anton/0000-0003-3730-1395; 			Arnsten AFT, 2015, PHARMACOL REV, V67, P681, DOI 10.1124/pr.115.010512; Balducci C, 2015, J ALZHEIMERS DIS, V46, P471, DOI 10.3233/JAD-150029; Bespalov A, 2016, NAT REV DRUG DISCOV, V15, DOI 10.1038/nrd.2016.88; Buccafusco JJ, 2004, NEUROPHARMACOLOGY, V46, P10, DOI 10.1016/j.neuropharm.2003.07.002; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Cressey D, 2015, NATURE, V520, P271, DOI 10.1038/520271a; Egan K.J., 2015, EVID BASED PRECLIN M, V2, pe00010, DOI 10.1002/ebm2.10; Garner JP, 2014, ILAR J, V55, P438, DOI 10.1093/ilar/ilu047; Harris KD, 2016, NAT NEUROSCI, V19, P1165, DOI 10.1038/nn.4365; Kauffmann A, 2010, GENOMICS, V95, P138, DOI 10.1016/j.ygeno.2010.01.003; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Macleod M. R., 2017, FINDINGS RETROSPECTI, DOI [10.1101/187245, DOI 10.1101/187245]; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Milian MJ, 2015, EUR NEUROPSYCHOPHARM, V25, P599, DOI 10.1016/j.euroneuro.2015.01.016; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; O'Hare E, 2016, NEUROPHARMACOLOGY, V100, P124, DOI 10.1016/j.neuropharm.2015.04.020; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Snyder HM, 2016, ALZHEIMERS DEMENT, V12, P1177, DOI 10.1016/j.jalz.2016.07.001; Steckler T, 2016, PSYCHOPHARMACOLOGY, V233, P1131, DOI 10.1007/s00213-016-4252-7; Thomas D.W, 2016, CLIN DEV SUCCESS RAT; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Voelkl B, 2016, TRENDS PHARMACOL SCI, V37, P509, DOI 10.1016/j.tips.2016.05.003; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Williams M, 2011, J PHARMACOL EXP THER, V336, P3, DOI 10.1124/jpet.110.171751; Witkin JM, 2015, CNS NEUROL DISORD-DR, V14, P4, DOI 10.2174/1871527314666150130154757	32	11	11	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 15	2018	300				SI		4	9		10.1016/j.jneumeth.2017.10.018			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GK5KK	WOS:000436213800002	29107620				2022-02-06	
J	Bodanapally, UK; Shanmuganathan, K; Issa, G; Dreizin, D; Li, G; Sudini, K; Fleiter, TR				Bodanapally, U. K.; Shanmuganathan, K.; Issa, G.; Dreizin, D.; Li, G.; Sudini, K.; Fleiter, T. R.			Dual-Energy CT in Hemorrhagic Progression of Cerebral Contusion: Overestimation of Hematoma Volumes on Standard 120-kV Images and Rectification with Virtual High-Energy Monochromatic Images after Contrast-Enhanced Whole-Body Imaging	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; IODINATED CONTRAST; RISK-FACTORS	BACKGROUND AND PURPOSE: In patients with hemorrhagic contusions, hematoma volumes are overestimated on follow-up standard 120-kV images obtained after contrast-enhanced whole-body CT. We aimed to retrospectively determine hemorrhagic progression of contusion rates on 120-kV and 190-keV images derived from dual-energy CT and the magnitude of hematoma volume overestimation. MATERIALS AND METHODS: We retrospectively analyzed admission and follow-up CT studies in 40 patients with hemorrhagic contusions. After annotating the contusions, we measured volumes from admission and follow-up 120-kV and 190-keV images using semiautomated 3D segmentation. Bland-Altman analysis was used for hematoma volume comparison. RESULTS: On 120-kV images, hemorrhagic progression of contusions was detected in 24 of the 40 patients, while only 17 patients had hemorrhagic progression of contusions on 190-keV images (P = .008). Hematoma volumes were systematically overestimated on follow-up 120-kV images (9.68 versus 8 mm(3); mean difference, 1.68 mm(3); standard error, 0.37; P < .001) compared with 190-keV images. There was no significant difference in volumes between admission 120-kV and 190-keV images. Mean and median percentages of overestimation were 29% (95% CI, 18-39) and 22% (quartile 3 - quartile 1 = 36.8), respectively. CONCLUSIONS: The 120-kV images, which are comparable with single-energy CT images, significantly overestimated the hematoma volumes, hence the rate of hemorrhagic progression of contusions, after contrast-enhanced whole-body CT. Hence, follow-up of hemorrhagic contusions should be performed on dual-energy CT, and 190-keV images should be used for the assessment of hematoma volumes.	[Bodanapally, U. K.; Shanmuganathan, K.; Issa, G.; Li, G.; Fleiter, T. R.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Sudini, K.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA		Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Radiol, 22 S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu		Fleiter, Thorsten/0000-0001-6255-9027			Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Bodanapally UK, 2017, AM J NEURORADIOL, V38, P1946, DOI 10.3174/ajnr.A5318; Bodanapally UK, 2017, AM J NEURORADIOL, V38, P1013, DOI 10.3174/ajnr.A5107; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Gunn ML, 2015, RADIOL CLIN N AM, V53, P639, DOI 10.1016/j.rcl.2015.02.006; Gupta R, 2010, RADIOLOGY, V257, P205, DOI 10.1148/radiol.10091806; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Phan CM, 2012, AM J NEURORADIOL, V33, P1088, DOI 10.3174/ajnr.A2909; Postma Alida A, 2015, Curr Radiol Rep, V3, P16; Potter CA, 2016, RADIOGRAPHICS, V36, P2186, DOI 10.1148/rg.2016160069; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Wu X, 2009, P SOC PHOTO-OPT INS, V7258, P725845, DOI DOI 10.1117/12.811698; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121	25	11	12	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2018	39	4					658	662		10.3174/ajnr.A5558			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GC4HL	WOS:000429745500009	29439124	hybrid, Green Published			2022-02-06	
J	Borland, ML; Dalziel, SR; Phillips, N; Dalton, S; Lyttle, MD; Bressan, S; Oakley, E; Hearps, SJC; Kochar, A; Furyk, J; Cheek, JA; Neutze, J; Babl, FE				Borland, Meredith L.; Dalziel, Stuart R.; Phillips, Natalie; Dalton, Sarah; Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Hearps, Stephen J. C.; Kochar, Amit; Furyk, Jeremy; Cheek, John A.; Neutze, Jocelyn; Babl, Franz E.		Res Emergency Dept Int	Vomiting With Head Trauma and Risk of Traumatic Brain Injury	PEDIATRICS			English	Article							CLINICAL DECISION RULES; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CT SCANS; CHILDREN; CHALICE; CHILDHOOD; VARIABLES; ACCURACY; PECARN	OBJECTIVES:To determine the prevalence of traumatic brain injuries in children who vomit after head injury and identify variables from published clinical decision rules (CDRs) that predict increased risk.METHODS:Secondary analysis of the Australasian Paediatric Head Injury Rule Study. Vomiting characteristics were assessed and correlated with CDR predictors and the presence of clinically important traumatic brain injury (ciTBI) or traumatic brain injury on computed tomography (TBI-CT). Isolated vomiting was defined as vomiting without other CDR predictors.RESULTS:Of the 19920 children enrolled, 3389 (17.0%) had any vomiting, with 2446 (72.2%) >2 years of age. In 172 patients with ciTBI, 76 had vomiting (44.2%; 95% confidence interval [CI] 36.9%-51.7%), and in 285 with TBI-CT, 123 had vomiting (43.2%; 95% CI 37.5%-49.0%). With isolated vomiting, only 1 (0.3%; 95% CI 0.0%-0.9%) had ciTBI and 2 (0.6%; 95% CI 0.0%-1.4%) had TBI-CT. Predictors of increased risk of ciTBI with vomiting by using multivariate regression were as follows: signs of skull fracture (odds ratio [OR] 80.1; 95% CI 43.4-148.0), altered mental status (OR 2.4; 95% CI 1.0-5.5), headache (OR 2.3; 95% CI 1.3-4.1), and acting abnormally (OR 1.86; 95% CI 1.0-3.4). Additional features predicting TBI-CT were as follows: skull fracture (OR 112.96; 95% CI 66.76-191.14), nonaccidental injury concern (OR 6.75; 95% CI 1.54-29.69), headache (OR 2.55; 95% CI 1.52-4.27), and acting abnormally (OR 1.83; 95% CI 1.10-3.06).CONCLUSIONS:TBI-CT and ciTBI are uncommon in children presenting with head injury with isolated vomiting, and a management strategy of observation without immediate computed tomography appears appropriate.	[Borland, Meredith L.] Princess Margaret Hosp Children, GPO D184, Perth, WA 6840, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat & Emergency Med, Crawley, Australia; [Dalziel, Stuart R.] Starship Childrens Hlth, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Phillips, Natalie] Lady Cilento Childrens Hosp, South Brisbane, Australia; [Phillips, Natalie] Univ Queensland, Sch Med, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Sydney, NSW, Australia; [Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Hearps, Stephen J. C.; Cheek, John A.; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Oakley, Ed; Cheek, John A.; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Kochar, Amit] Womens & Childrens Hosp, Adelaide, SA, Australia; [Furyk, Jeremy] Townsville Hosp, Townsville, Qld, Australia; [Neutze, Jocelyn] Kidz First Childrens Hosp, Auckland, New Zealand		Borland, ML (corresponding author), Princess Margaret Hosp Children, GPO D184, Perth, WA 6840, Australia.	meredith.borland@health.wa.gov.au	Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172; Lyttle, Mark/0000-0002-8634-7210	National Health and Medical Research Council (Paediatric Emergency Medicine Centre of Research Excellence; Canberra, Australia) [GNT1046727, GNT1058560]; Murdoch Children's Research Institute (Melbourne, Australia); Emergency Medicine Foundation (Brisbane, Australia) [EMPJ-11162]; Australia's Perpetual Philanthropic Services [2012/1140]; Auckland Medical Research Foundation (Auckland, New Zealand) [3112011]; A+ Trust (Auckland District Health Board; Auckland, New Zealand); Government of Western Australia Department of Health Targeted Research Fund (Perth, Australia); Townsville Hospital and Health Service Private Practice Research and Education Trust Fund (Townsville, Australia); Victorian Government's Infrastructure Support Program (Melbourne, Australia); Royal Children's Hospital Foundation (Melbourne, Australia); Melbourne Children's Clinician Scientist Fellowship (Melbourne, Australia); National Health and Medical Research Council Practitioner Fellowship (Canberra, Australia); Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	Funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Paediatric Emergency Medicine Centre of Research Excellence GNT1058560; Canberra, Australia); the Murdoch Children's Research Institute (Melbourne, Australia); the Emergency Medicine Foundation (EMPJ-11162; Brisbane, Australia); Australia's Perpetual Philanthropic Services (2012/1140); Auckland Medical Research Foundation (3112011) and the A+ Trust (Auckland District Health Board; Auckland, New Zealand); The Government of Western Australia Department of Health Targeted Research Fund 2013 (Perth, Australia); and the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund (Townsville, Australia) and supported by the Victorian Government's Infrastructure Support Program (Melbourne, Australia). Dr Babl was partly funded by a grant from The Royal Children's Hospital Foundation and the Melbourne Children's Clinician Scientist Fellowship (Melbourne, Australia) and a National Health and Medical Research Council Practitioner Fellowship (Canberra, Australia). Dr Dalziel was partly funded by the Health Research Council of New Zealand (HRC13/556).	Babl FE, 2005, J PAEDIATR CHILD H, V41, P614, DOI 10.1111/j.1440-1754.2005.00733_6.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bainbridge J, 2012, BRIT J RADIOL, V85, P183, DOI 10.1259/bjr/56169980; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Fundaro C, 2012, CHILD NERV SYST, V28, P1063, DOI 10.1007/s00381-012-1717-9; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harty E, 2010, EMERG MED J, V27, P750, DOI 10.1136/emj.2009.077644; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kocyigit A, 2014, CLIN IMAG, V38, P236, DOI 10.1016/j.clinimag.2013.12.004; Kuppermann N, 2014, LANCET, V383, P308; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lockie FD, 2013, EMERG MED AUSTRALAS, V25, P75, DOI 10.1111/1742-6723.12019; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Institue For Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335; Van Winkle PJ, 2012, J PEDIATR-US, V161, P547, DOI 10.1016/j.jpeds.2012.03.009; Xiao B, 2013, EMERG MED J, V30, DOI 10.1136/emermed-2011-200525	28	11	12	3	7	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2018	141	4							e20173123	10.1542/peds.2017-3123			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GB7SU	WOS:000429276200028	29599113	Bronze, Green Published			2022-02-06	
J	Campos-Pires, R; Koziakova, M; Yonis, A; Pau, A; Macdonald, W; Harris, K; Edge, CJ; Franks, NP; Mahoney, PF; Dickinson, R				Campos-Pires, Rita; Koziakova, Mariia; Yonis, Amina; Pau, Ashni; Macdonald, Warren; Harris, Katie; Edge, Christopher J.; Franks, Nicholas P.; Mahoney, Peter F.; Dickinson, Robert			Xenon Protects against Blast-Induced Traumatic Brain Injury in an In Vitro Model	JOURNAL OF NEUROTRAUMA			English	Article						blast-induced neurotrauma; blast traumatic brain injury; neuroprotection; primary blast injury; TBI; xenon	D-ASPARTATE RECEPTOR; HIPPOCAMPAL SLICE CULTURES; CENTRAL-NERVOUS-SYSTEM; NITROUS-OXIDE; COMPETITIVE-INHIBITION; HYPOXIA-ISCHEMIA; GLYCINE SITE; ORGANOTYPIC CULTURES; TERM NEUROPROTECTION; CARDIAC-ARREST	The aim of this study was to evaluate the neuroprotective efficacy of the inert gas xenon as a treatment for patients with blast-induced traumatic brain injury in an in vitro laboratory model. We developed a novel blast traumatic brain injury model using C57BL/6N mouse organotypic hippocampal brain-slice cultures exposed to a single shockwave, with the resulting injury quantified using propidium iodide fluorescence. A shock tube blast generator was used to simulate open field explosive blast shockwaves, modeled by the Friedlander waveform. Exposure to blast shockwave resulted in significant (p < 0.01) injury that increased with peak-overpressure and impulse of the shockwave, and which exhibited a secondary injury development up to 72h after trauma. Blast-induced propidium iodide fluorescence overlapped with cleaved caspase-3 immunofluorescence, indicating that shock-wave-induced cell death involves apoptosis. Xenon (50% atm) applied 1h after blast exposure reduced injury 24h (p < 0.01), 48h (p < 0.05), and 72h (p < 0.001) later, compared with untreated control injury. Xenon-treated injured slices were not significantly different from uninjured sham slices at 24h and 72h. We demonstrate for the first time that xenon treatment after blast traumatic brain injury reduces initial injury and prevents subsequent injury development in vitro. Our findings support the idea that xenon may be a potential first-line treatment for those with blast-induced traumatic brain injury.	[Campos-Pires, Rita; Koziakova, Mariia; Yonis, Amina; Pau, Ashni; Harris, Katie; Dickinson, Robert] Imperial Coll London, Dept Surg & Canc, Anaesthet Pain Med & Intens Care Sect, London, England; [Campos-Pires, Rita; Koziakova, Mariia; Macdonald, Warren; Dickinson, Robert] Imperial Coll London, Dept Bioengn, Royal British Leg Ctr Blast Injury Studies, London, England; [Macdonald, Warren] Imperial Coll London, Dept Bioengn, London, England; [Edge, Christopher J.; Franks, Nicholas P.] Imperial Coll London, Dept Life Sci, London, England; [Edge, Christopher J.] Royal Berkshire Hosp NHS Fdn Trust, Dept Anaesthet, Reading, Berks, England; [Mahoney, Peter F.] ICT Ctr, Med Directorate Joint Force Command, Royal Ctr Def Med, Birmingham, W Midlands, England		Dickinson, R (corresponding author), Imperial Coll London, Sir Ernst Chain Bldg, London SW7 2AZ, England.	r.dickinson@imperial.ac.uk		Franks, Nicholas/0000-0003-4874-4212	Royal Centre for Defence Medicine, Birmingham, United Kingdom; Royal British Legion Centre for Blast Injury Studies, Imperial College London, United Kingdom; Medical Research Council, London, United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_13064, MR/N027736/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_13064, MR/N027736/1, G0901892] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_13064, G0901892, MR/N027736/1] Funding Source: researchfish	Study is supported by: Royal Centre for Defence Medicine, Birmingham, United Kingdom, Royal British Legion Centre for Blast Injury Studies, Imperial College London, United Kingdom. Medical Research Council, London, United Kingdom (MC_PC_13064; MR/N027736/1).	Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Campos-Pires R., 2016, BLAST INJURY SCI ENG, P173; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Crain SM, 1998, METHODS, V16, P228, DOI 10.1006/meth.1998.0681; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Faul M, 2010, TRAUMATIC BRAIN INJU; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Giacalone M, 2013, CLIN J PAIN, V29, P639, DOI 10.1097/AJP.0b013e31826b12f5; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Martin JL, 2007, BRIT J ANAESTH, V98, P236, DOI 10.1093/bja/ael340; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Petersen-Felix S, 1998, BRIT J ANAESTH, V81, P742, DOI 10.1093/bja/81.5.742; PITTINGER CB, 1953, ANESTHESIOLOGY, V14, P10, DOI 10.1097/00000542-195301000-00002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shu Y, 2010, ANESTHESIOLOGY, V113, P360, DOI 10.1097/ALN.0b013e3181d960d7; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	50	11	13	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	8					1037	1044		10.1089/neu.2017.5360			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0DM	WOS:000429447100007	29285980	Green Published, Bronze			2022-02-06	
J	Dvorak, D; Shang, A; Abdel-Baki, S; Suzuki, W; Fenton, AA				Dvorak, Dino; Shang, Andrea; Abdel-Baki, Samah; Suzuki, Wendy; Fenton, Andre A.			Cognitive Behavior Classification From Scalp EEG Signals	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Electroencephalography; cognition; synchrony; cognition; muscle artifact	THETA-OSCILLATIONS; WORKING-MEMORY; BRAIN; HZ; SYNCHRONY; NETWORKS; SEARCH; POWER; TASK; LOAD	Electroencephalography (EEG) has become increasingly valuable outside of its traditional use in neurology. EEG is now used for neuropsychiatric diagnosis, neurological evaluation of traumatic brain injury, neurotherapy, gaming, neurofeedback, mindfulness, and cognitive enhancement training. The trend to increase the number of EEG electrodes, the development of novel analytical methods, and the availability of large data sets has created a data analysis challenge to find the "signal of interest" that conveys the most information about ongoing cognitive effort. Accordingly, we compare three common types of neural synchronymeasures that are applied to EEG-power analysis, phase locking, and phase-amplitude coupling to assess which analytical measure provides the best separation between EEG signals that were recorded, while healthy subjects performed eight cognitive tasks-Hopkins Verbal Learning Test and its delayed version, Stroop Test, Symbol Digit Modality Test, Controlled Oral Word Association Test, Trail Marking Test, Digit Span Test, and Benton Visual Retention Test. We find that of the three analytical methods, phase-amplitude coupling, specifically theta (4-7 Hz)-high gamma (70-90 Hz) obtained from frontal and parietal EEG electrodes provides both the largest separation between the EEG during cognitive tasks and also the highest classification accuracy between pairs of tasks. We also find that phase-locking analysis provides the most distinct clustering of tasks based on their utilization of long-term memory. Finally, we show that phase-amplitude coupling is the least sensitive to contamination by intense jaw-clenching muscle artifact.	[Dvorak, Dino; Suzuki, Wendy; Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Shang, Andrea] NYU, New York, NY 10003 USA; [Shang, Andrea] Rutgers State Univ, Dept Psychol Behav & Syst Neurosci, New Brunswick, NJ 08854 USA; [Abdel-Baki, Samah] Biosignal Grp Corp, Acton, MA 01720 USA		Fenton, AA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	dd1348@nyu.edu; andrea.shang@rutgers.edu; sbaki@biosignalgroup.com; ws21@nyu.edu; afenton@nyu.edu		Fenton, Andre/0000-0002-5063-1156; Dvorak, Dino/0000-0003-3884-1393	NYU Dean for Science Funds; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH099128, R01MH084038]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084038, R01MH099128] Funding Source: NIH RePORTER	This work was supported by NYU Dean for Science Funds. The work of A. A. Fenton was supported by NIH under Grant R01MH099128 and Grant R01MH084038.	Akbar N, 2016, J CLIN EXP NEUROPSYC, V38, P393, DOI 10.1080/13803395.2015.1119255; Amin Hafeez Ullah, 2012, 2012 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2012), P950, DOI 10.1109/IECBES.2012.6498189; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Basso JC, 2015, J INT NEUROPSYCH SOC, V21, P791, DOI 10.1017/S135561771500106X; Belkacem AN, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/653639; BENTON AL, 1945, ARCH NEURO PSYCHIATR, V54, P212, DOI 10.1001/archneurpsyc.1945.02300090051008; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brickman AM, 2011, HIPPOCAMPUS, V21, P923, DOI 10.1002/hipo.20840; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cole SR, 2017, TRENDS COGN SCI, V21, P137, DOI 10.1016/j.tics.2016.12.008; Dvorak D, 2014, J NEUROSCI METH, V225, P42, DOI 10.1016/j.jneumeth.2014.01.002; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Fitzgibbon SP, 2004, CLIN NEUROPHYSIOL, V115, P1802, DOI 10.1016/j.clinph.2004.03.009; Forn C, 2013, BRAIN COGNITION, V82, P152, DOI 10.1016/j.bandc.2013.04.003; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Grant AC, 2014, EPILEPSY BEHAV, V34, P81, DOI 10.1016/j.yebeh.2014.03.015; Hamster K., 1983, MULTILINGUAL APHASIA; Harrison RR, 2007, IEEE CUST INTEGR CIR, P115, DOI 10.1109/CICC.2007.4405694; Heusser AC, 2016, NAT NEUROSCI, V19, P1374, DOI 10.1038/nn.4374; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jung TP, 1997, IEEE T BIO-MED ENG, V44, P60, DOI 10.1109/10.553713; Keles HO, 2016, NEUROIMAGE, V138, P76, DOI 10.1016/j.neuroimage.2016.05.058; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2011, NEW IDEAS PSYCHOL, V29, P57, DOI 10.1016/j.newideapsych.2010.11.001; Lee NR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00496; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Makeig S, 1996, ADV NEUR IN, V8, P145; McLoughlin G, 2014, AM J MED GENET B, V165, P111, DOI 10.1002/ajmg.b.32208; Nash JK, 2000, CLIN ELECTROENCEPHAL, V31, P30, DOI 10.1177/155005940003100109; Niedermeyer E, 2011, NIEDERMEYERS ELECTRO; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Omurtag A, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-35; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Poudel GR, 2014, J PSYCHIATR NEUROSCI, V39, P87, DOI 10.1503/jpn.120226; Radwan B, 2016, NEUROBIOL DIS, V88, P125, DOI 10.1016/j.nbd.2016.01.003; Rogers JM, 2016, INT J PSYCHOPHYSIOL, V106, P87, DOI 10.1016/j.ijpsycho.2016.06.006; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tong JJ, 2015, IEEE ENG MED BIO, P566, DOI 10.1109/EMBC.2015.7318425; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Trejo LJ, 2007, LECT NOTES ARTIF INT, V4565, P201; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wechsler D., 1949, WECHSLER INTELLIGENC; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; Wolfson, 1993, HALSTEAD REITAN NEUR; [No title captured]	53	11	11	2	23	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	APR	2018	26	4					729	739		10.1109/TNSRE.2018.2797547			11	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Rehabilitation	GC3OC	WOS:000429692400002	29641377	Green Accepted			2022-02-06	
J	Raj, R; Bendel, S; Reinikainen, M; Hoppu, S; Luoto, T; Ala-Kokko, T; Tetri, S; Laitio, R; Koivisto, T; Rinne, J; Kivisaari, R; Siironen, J; Higgins, A; Skrifvars, MB				Raj, Rahul; Bendel, Stepani; Reinikainen, Matti; Hoppu, Sanna; Luoto, Teemu; Ala-Kokko, Tero; Tetri, Sami; Laitio, Ruut; Koivisto, Timo; Rinne, Jaakko; Kivisaari, Riku; Siironen, Jari; Higgins, Alisa; Skrifvars, Markus B.			Temporal Trends in Healthcare Costs and Outcome Following ICU Admission After Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						cost-effectiveness; intensive care unit; outcome; traumatic brain injury; treatment cost; treatment intensity	RENAL REPLACEMENT THERAPY; INTENSIVE-CARE; BED NUMBERS; POPULATION; MEDICINE; SYSTEM; UNITS	Objective: To assess temporal trends in 1-year healthcare costs and outcome of intensive care for traumatic brain injury in Finland. Design: Retrospective observational cohort study. Setting: Multicenter study including four tertiary ICUs. Patients: Three thousand fifty-one adult patients (>= 18 yr) with significant traumatic brain injury treated in a tertiary ICU during 2003-2013. Intervention: None. Measurements and Main Results: Total 1-year healthcare costs included the index hospitalization costs, rehabilitation unit costs, and social security reimbursements. All costs are reported as 2013 U.S. dollars ($). Outcomes were 1-year mortality and permanent disability. Multivariate regression models, adjusting for case-mix, were used to assess temporal trends in costs and outcome in predefined Glasgow Coma Scale (3-8, 9-12, and 13-15) and age (18-40, 41-64, and >= 65 yr) subgroups. Overall 1-year survival was 76% (n = 2,304), and of 1-year survivors, 37% (n = 850) were permanently disabled. Mean unadjusted 1-year healthcare cost was $39,809 (95% CI, $38,144-$41,473) per patient. Adjusted healthcare costs decreased only in the Glasgow Coma Scale 13-15 and 65 years and older subgroups, due to lower rehabilitation costs. Adjusted 1-year mortality did not change in any subgroup (p < 0.05 for all subgroups). Adjusted risk of permanent disability decreased significantly in all subgroups (p < 0.05). Conclusion: During the last decade, healthcare costs of ICU-admitted traumatic brain injury patients have remained largely the same in Finland. No change in mortality was noted, but the risk for permanent disability decreased significantly. Thus, our results suggest that cost-effectiveness of traumatic brain injury care has improved during the past decade in Finland.	[Raj, Rahul; Kivisaari, Riku; Siironen, Jari] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Raj, Rahul; Kivisaari, Riku; Siironen, Jari; Skrifvars, Markus B.] Univ Helsinki, Helsinki, Finland; [Bendel, Stepani] Kuopio Univ Hosp, Dept Intens Care, Kuopio, Finland; [Bendel, Stepani; Koivisto, Timo] Univ Eastern Finland, Kuopio, Finland; [Reinikainen, Matti] North Karelia Cent Hosp, Dept Intens Care, Joensuu, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Dept Intens Care, Tampere, Finland; [Hoppu, Sanna; Luoto, Teemu] Univ Tampere, Tampere, Finland; [Luoto, Teemu] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Ala-Kokko, Tero] Oulu Univ Hosp, Dept Intens Care, Oulu, Finland; [Ala-Kokko, Tero; Tetri, Sami] Univ Oulu, Oulu, Finland; [Tetri, Sami] Oulu Univ Hosp, Dept Neurosurg, Oulu, Finland; [Laitio, Ruut] Turku Univ Hosp, Dept Intens Care, Turku, Finland; [Laitio, Ruut; Rinne, Jaakko] Univ Turku, Turku, Finland; [Koivisto, Timo] Kuopio Univ Hosp, Dept Neurosurg, Kuopio, Finland; [Rinne, Jaakko] Turku Univ Hosp, Dept Neurosurg, Turku, Finland; [Higgins, Alisa; Skrifvars, Markus B.] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Intens Care, Helsinki, Finland		Raj, R (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland.; Raj, R (corresponding author), Univ Helsinki, Helsinki, Finland.	rahul.raj@hus.fi	Raj, Rahul/K-7693-2012; Higgins, Alisa/AAM-8088-2020; Luoto, Teemu/W-6468-2018	Raj, Rahul/0000-0003-4243-9591; Higgins, Alisa/0000-0001-8295-7559; Luoto, Teemu/0000-0002-7329-3284; Reinikainen, Matti/0000-0001-6878-3740	Helsinki University [H3702 73702705]; Helsinki University Hospital [VTR-TYH2014221]; Svenska Kulturfonden [17/2921]; Medicinska Understodsforeningen Liv and Halsa; Finska Lakaresallskapet; Maud Kuistilan Saatio; Eemil Aaltosen Saatio; Ella and Georg Ehrnroothin Saatio; Suomalais-Norjalainen	Supported by grants from Helsinki University (three-year project grant: H3702 73702705) and Helsinki University Hospital (state funding: VTR-TYH2014221). Dr. Raj received personal research grants from Svenska Kulturfonden (Grant 17/2921), Medicinska Understodsforeningen Liv and Halsa, Finska Lakaresallskapet, Maud Kuistilan Saatio, Eemil Aaltosen Saatio, Ella and Georg Ehrnroothin Saatio, Suomalais-Norjalainen	Ad Hoc Committee on Health Research Relating to Future Intervention Options, 1996, INV HLTH RES DEV REP; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; Efendijev I, 2014, INTENS CARE MED, V40, P1853, DOI 10.1007/s00134-014-3509-z; Graf J, 2008, CRIT CARE, V12, DOI 10.1186/cc6963; Halpern NA, 2004, CRIT CARE MED, V32, P1254, DOI 10.1097/01.CCM.0000128577.31689.4C; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; JENNETT B, 1975, LANCET, V1, P480; Kapiainen S., 2014, TERVEYDEN JA SOSIAAL, V3; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korkeila M, 2000, INTENS CARE MED, V26, P1824, DOI 10.1007/s001340000726; Laukkanen A, 2013, INTENS CARE MED, V39, P406, DOI 10.1007/s00134-012-2760-4; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Official Statistics of Finland (OSF), 2014, CONS PRIC IND; Organisation for Economic Co-operation and Development, PURCH POW PAR PPP; Raj R, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0320-6; Reinikainen M, 2007, ACTA ANAESTH SCAND, V51, P522, DOI 10.1111/j.1399-6576.2007.01274.x; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; REYNOLDS HN, 1988, JAMA-J AM MED ASSOC, V260, P3446, DOI 10.1001/jama.260.23.3446; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SCHAPIRA DV, 1993, JAMA-J AM MED ASSOC, V269, P783, DOI 10.1001/jama.269.6.783; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933	27	11	11	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2018	46	4					E302	E309		10.1097/CCM.0000000000002959			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ7IZ	WOS:000427775500004	29293155	Green Published			2022-02-06	
J	Rittschof, CC; Vekaria, HJ; Palmer, JH; Sullivan, PG				Rittschof, Clare C.; Vekaria, Hemendra J.; Palmer, Joseph H.; Sullivan, Patrick G.			Brain mitochondrial bioenergetics change with rapid and prolonged shifts in aggression in the honey bee, Apis mellifera	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Behavioral plasticity; Genomics; Neural energetics; Alzheimer's disease; Traumatic brain injury	DIVISION-OF-LABOR; OXIDATIVE-METABOLISM; AEROBIC GLYCOLYSIS; JUVENILE-HORMONE; GENE-EXPRESSION; KETOGENIC DIET; CALCIUM; MECHANISMS; RESPONSES; INSULIN	Neuronal function demands high-level energy production, and as such, a decline in mitochondrial respiration characterizes brain injury and disease. A growing number of studies, however, link brain mitochondrial function to behavioral modulation in non-diseased contexts. In the honey bee, we show for the first time that an acute social interaction, which invokes an aggressive response, may also cause a rapid decline in brain mitochondrial bioenergetics. The degree and speed of this decline has only been previously observed in the context of brain injury. Furthermore, in the honey bee, age-related increases in aggressive tendency are associated with increased baseline brain mitochondrial respiration, as well as increased plasticity in response to metabolic fuel type in vitro. Similarly, diet restriction and ketone body feeding, which commonly enhance mammalian brain mitochondrial function in vivo, cause increased aggression. Thus, even in normal behavioral contexts, brain mitochondria show a surprising degree of variation in function over both rapid and prolonged time scales, with age predicting both baseline function and plasticity in function. These results suggest that mitochondrial function is integral to modulating aggression-related neuronal signaling. We hypothesize that variation in function reflects mitochondrial calcium buffering activity, and that shifts in mitochondrial function signal to the neuronal soma to regulate gene expression and neural energetic state. Modulating brain energetic state is emerging as a critical component of the regulation of behavior in non-diseased contexts.	[Rittschof, Clare C.; Palmer, Joseph H.] Univ Kentucky, Dept Entomol, Agr Sci Ctr North S 225, Lexington, KY 40546 USA; [Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, 741 South Limestone St,475 BBSRB, Lexington, KY 40536 USA; [Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, 741 South Limestone St,475 BBSRB, Lexington, KY 40536 USA		Rittschof, CC (corresponding author), Univ Kentucky, Dept Entomol, Agr Sci Ctr North S 225, Lexington, KY 40546 USA.	clare.rittschof@uky.edu	Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235	University of Kentucky Office of the Vice President for Research Support Grant; US Department of Veterans Affairs Biomedical Laboratory Research and Development ProgramUS Department of Veterans Affairs [I01BX003405]; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	This work was supported in part by the University of Kentucky Office of the Vice President for Research Support Grant (C.C.R.) and a Merit Review Award (I01BX003405 to P.G.S.) from the US Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The contents of this paper do not represent the views of the US Department of Veterans Affairs or the United States Government.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Ament SA, 2011, J EXP BIOL, V214, P3808, DOI 10.1242/jeb.060244; Ament SA, 2010, WIRES SYST BIOL MED, V2, P566, DOI 10.1002/wsbm.73; Asahina K, 2017, ANNU REV NEUROSCI, V40, P51, DOI 10.1146/annurev-neuro-072116-031240; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; BREED MD, 1990, BEHAV ECOL SOCIOBIOL, V27, P395, DOI 10.1007/BF00164065; Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Bushman BJ, 2014, P NATL ACAD SCI USA, V111, P6254, DOI 10.1073/pnas.1400619111; Butterfield DA, 2014, BBA-MOL BASIS DIS, V1842, P1693, DOI 10.1016/j.bbadis.2014.06.010; Cervoni MS, 2017, J EXP BIOL, V220, P4035, DOI 10.1242/jeb.161844; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chandrasekaran S, 2015, GENES BRAIN BEHAV, V14, P158, DOI 10.1111/gbb.12201; Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008; Chouhan AK, 2012, J NEUROSCI, V32, P1233, DOI 10.1523/JNEUROSCI.1301-11.2012; COLLINS AM, 1983, J CHEM ECOL, V9, P57, DOI 10.1007/BF00987770; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dong GH, 2015, PROG NEURO-PSYCHOPH, V57, P76, DOI 10.1016/j.pnpbp.2014.10.012; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; GUZMANNOVOA E, 1994, BEHAV ECOL, V5, P91, DOI 10.1093/beheco/5.1.91; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hara Y, 2014, P NATL ACAD SCI USA, V111, P486, DOI 10.1073/pnas.1311310110; Harrison JF, 2002, COMP BIOCHEM PHYS A, V133, P323, DOI 10.1016/S1095-6433(02)00163-0; Hartman AL, 2013, EPILEPSY RES, V104, P275, DOI 10.1016/j.eplepsyres.2012.10.011; Herb BR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4594-0; Hollis F, 2015, P NATL ACAD SCI USA, V112, P15486, DOI 10.1073/pnas.1512653112; Hroudova J, 2013, NEURAL REGEN RES, V8, P363, DOI 10.3969/j.issn.1673-5374.2013.04.009; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Hunt GJ, 2003, ANIM BEHAV, V66, P459, DOI 10.1006/anbe.2003.2253; Jauch-Chara K, 2012, DIABETES, V61, P2261, DOI 10.2337/db12-0025; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kim DY, 2015, ANN NEUROL, V78, P77, DOI 10.1002/ana.24424; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li-Byarlay H, 2014, P NATL ACAD SCI USA, V111, P12533, DOI 10.1073/pnas.1412306111; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Munch D, 2013, JOVE-J VIS EXP, DOI 10.3791/50550; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nouvian M, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2653; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2011, BRAIN RES, V1384, P151, DOI 10.1016/j.brainres.2011.01.102; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Picard M., 2018, FRONT NEUROENDOCRIN; Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112; Picard M, 2014, P NATL ACAD SCI USA, V111, P7, DOI 10.1073/pnas.1321881111; Placais PY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15510; Placais PY, 2013, SCIENCE, V339, P440, DOI 10.1126/science.1226018; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Ray S, 1997, NEUROREPORT, V8, P789, DOI 10.1097/00001756-199702100-00042; Richard FJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-50; Rittschof CC, 2013, GENES BRAIN BEHAV, V12, P802, DOI 10.1111/gbb.12087; Rittschof C. C, 2017, GLIA; Rittschof CC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02971-0; Rittschof CC, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0199-8; Rittschof CC, 2015, CURR OPIN BEHAV SCI, V6, P19, DOI 10.1016/j.cobeha.2015.07.006; Rittschof CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15572; Rittschof CC, 2014, P NATL ACAD SCI USA, V111, P17929, DOI 10.1073/pnas.1420369111; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schippers MP, 2010, J COMP PHYSIOL B, V180, P45, DOI 10.1007/s00360-009-0386-9; Schulz DJ, 2002, BRAIN BEHAV EVOLUT, V60, P350, DOI 10.1159/000067788; Shannon BJ, 2013, J NEUROPHYSIOL, V109, P1444, DOI 10.1152/jn.00651.2012; Shannon BJ, 2016, P NATL ACAD SCI USA, V113, pE3782, DOI 10.1073/pnas.1604977113; Stanley IA, 2014, TRENDS CELL BIOL, V24, P118, DOI 10.1016/j.tcb.2013.07.010; Sullivan JP, 2003, J EXP BIOL, V206, P2287, DOI 10.1242/jeb.00432; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; van der Kooij MA, 2018, MOL PSYCHIATR, V23, P569, DOI 10.1038/mp.2017.135; van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014; Wang SB, 2013, TRENDS CARDIOVAS MED, V23, P14, DOI 10.1016/j.tcm.2012.08.005; Wright CM, 2014, P NATL ACAD SCI USA, V111, P9533, DOI 10.1073/pnas.1400850111; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774; Zayed A, 2012, ANNU REV GENET, V46, P591, DOI 10.1146/annurev-genet-110711-155517	94	11	11	0	7	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	APR	2018	221	8							jeb176917	10.1242/jeb.176917			10	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	GN3MN	WOS:000438909900019	29496782	hybrid			2022-02-06	
J	Schwerin, SC; Chatterjee, M; Imam-Fulani, AO; Radomski, KL; Hutchinson, EB; Pierpaoli, CM; Juliano, SL				Schwerin, Susan C.; Chatterjee, Mitali; Imam-Fulani, Aminat O.; Radomski, Kryslaine L.; Hutchinson, Elizabeth B.; Pierpaoli, Carlo M.; Juliano, Sharon L.			Progression of histopathological and behavioral abnormalities following mild traumatic brain injury in the male ferret	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						astrocytes; astrogliosis; attention; behavior; brain; cerebral cortex; cognitive impairment; GFAP; graymatter; mammals; memory; neuroinflammation; reactivemicroglia; TBI (traumatic brain injury); whitematter	INFLAMMATION; MODEL; ASSOCIATION; EXPRESSION; MICROGLIA; INTEGRITY; SEVERITY; MICE; TIME; MRI	White matter damage is an important consequence of traumatic brain injury (TBI) in humans. Unlike rodents, ferrets have a substantial amount of white matter and a gyrencephalic brain; therefore, they may represent an ideal small mammal model to study human-pertinent consequences of TBI. Here we report immunohistochemical and behavioral results after a controlled cortical impact (CCI) injury to the sensorimotor cortex of adult male ferrets. We assessed inflammation in the neocortex and white matter, and behavior at 1 day post injury and 1, 4, and 16 weeks post injury (WPI). CCI in the ferret produced inflammation that originated in the neocortex near the site of the injury and progressed deep into the white matter with time. The density of microglia and astrocytes increased in the neocortex near the injury, peaking at 4WPI and remaining elevated at 16WPI. Microglial morphology in the neocortex was significantly altered in the first 4 weeks, but showed a return toward normal at 16 weeks. Clusters of microglial cells in the white matter persisted until 16WPI. We assessed motor and cognitive behavior using the open field, novel object recognition, T-maze, and gait tests. A transient deficit in memory occurred at 4WPI, with a reduction of rearing and motor ability at 12 and 16WPI. Behavioral impairments coincide with features of the inflammatory changes in the neocortex revealed by immunohistochemistry. The ferret represents an important animal model to explore ongoing damage in the white matter and cerebral cortex after TBI.	[Schwerin, Susan C.; Radomski, Kryslaine L.; Hutchinson, Elizabeth B.; Pierpaoli, Carlo M.; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Schwerin, Susan C.; Chatterjee, Mitali; Imam-Fulani, Aminat O.; Radomski, Kryslaine L.; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Hutchinson, Elizabeth B.; Pierpaoli, Carlo M.] NIH, Quantitat Med Imaging Sect, Natl Inst Biomed Imaging & Bioengn, Bethesda, MD USA; [Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA		Schwerin, SC (corresponding author), USUHS APG, B2086,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Susan.Schwerin.ctr@usuhs.edu	Juliano, Sharon/AAO-1030-2020; Chatterjee, Mitali/AAV-2129-2021; Pierpaoli, Carlo/E-1672-2011	Pierpaoli, Carlo/0000-0001-8558-4428; Hutchinson, Elizabeth/0000-0002-3374-5469; Radomski, Kryslaine/0000-0001-9624-623X; Schwerin, Susan/0000-0001-5435-2448	Congressionally Directed Medical Research Programs CDMRPUnited States Department of Defense [W81XWH-13-2-0019, W81XWH-13-2-0018]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [ZIAEB000089] Funding Source: NIH RePORTER	This research was supported by the Congressionally Directed Medical Research Programs CDMRP (award numbers W81XWH-13-2-0019 and W81XWH-13-2-0018)	Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fox J. G., 2014, BIOL DIFERRET, DOI [10.1002/9781118782699.ch1, DOI 10.1002/9781118782699.CH1]; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gold JR, 2015, BEHAV NEUROSCI, V129, P473, DOI 10.1037/bne0000065; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lloyd AF, 2017, CURR OPIN NEUROBIOL, V47, P113, DOI 10.1016/j.conb.2017.10.001; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nissen JC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030561; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Sullivan GM, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9342534; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Whitwell HL, 2005, FORENSIC NEUROPATHOL; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zhou ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23568	44	11	12	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		556	572		10.1002/jnr.24218			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300008	29360208				2022-02-06	
J	Slovis, JC; Gupta, N; Li, NY; Kernie, SG; Miles, DK				Slovis, Julia C.; Gupta, Nachi; Li, Natasha Y.; Kernie, Steven G.; Miles, Darryl K.			Assessment of Recovery Following Pediatric Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						critical care outcomes; Glasgow Outcome Scale; pediatric intensive care units; post-traumatic vegetative state; traumatic brain injury	CLOSED HEAD-INJURY; CHILDREN; SURVIVAL; OUTCOMES; MILD	Objectives: We analyzed a prospective database of pediatric traumatic brain injury patients to identify predictors of outcome and describe the change in function over time. We hypothesized that neurologic status at hospital discharge would not reflect the long-term neurologic recovery state. Design: This is a descriptive cohort analysis of a single-center prospective database of pediatric traumatic brain injury patients from 2001 to 2012. Functional outcome was assessed at hospital discharge, and the Glasgow Outcome Scale Extended Pediatrics or Glasgow Outcome Scale was assessed on average at 15.8 months after injury. Setting: Children's Medical Center Dallas, a single-center PICU and Level 1 Trauma Center. Patients: Patients, 0-17 years old, with complicated-mild/moderate or severe accidental traumatic brain injury. Measurements and Main Results: Dichotomized long-term outcome was favorable in 217 of 258 patients (84%), 80 of 82 patients (98%) with complicated-mild/moderate injury and 133 of 172 severe patients (77%). In the bivariate analysis, younger age, motor vehicle collision as a mechanism of injury, intracranial pressure monitor placement, cardiopulmonary resuscitation at scene or emergency department, increased hospital length of stay, increased ventilator days (all with p < 0.01) and occurrence of seizures (p = 0.03) were significantly associated with an unfavorable outcome. In multiple regression analysis, younger age (p = 0.03), motor vehicle collision (p = 0.01), cardiopulmonary resuscitation (p < 0.01), and ventilator days (p < 0.01) remained significant. Remarkably, 28 of 60 children (47%) with an unfavorable Glasgow Outcome Scale at hospital discharge improved to a favorable outcome. In severe patients with an unfavorable outcome at hospital discharge, younger age was identified as a risk factor for remaining in an unfavorable condition (p = 0.1). Conclusions: Despite a poor neurologic status at hospital discharge, many children after traumatic brain injury will significantly improve at long-term assessment. The factors most associated with outcomes were age, cardiopulmonary resuscitation, motor vehicle collision, intracranial pressure placement, days on a ventilator, hospital length of stay, and seizures. The factor most associated with improvement from an unfavorable neurologic status at discharge was being older.	[Slovis, Julia C.; Li, Natasha Y.; Kernie, Steven G.] Columbia Univ, Dept Pediat, Med Ctr, New York Presbyterian Morgan Stanley Childrens Ho, New York, NY 10027 USA; [Gupta, Nachi] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA; [Li, Natasha Y.] Loma Linda Univ, Dept Pediat, Med Ctr, Loma Linda, CA 92350 USA; [Miles, Darryl K.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA		Miles, DK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	darryl.miles@utsouthwestern.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549	Crystal Charity Ball program	We thank a number of people involved in this study over the years. Initial funding came from the Crystal Charity Ball program for pediatric traumatic brain injury in conjunction with Dr. Sandi Chapman from The Center for Brain Health at The University of Texas at Dallas. We also thank Dr. Sam Lehman and Deborah Town of Children's Medical Center Dallas for the initial data collection and Katrina Vandebruinhorst for subsequent data collection and study coordination. In addition, Dr. Todd Maxson started the level 1 trauma center at Children's Medical Center Dallas, and Karen Dowling was the founding administrative coordinator for the Perot Center for Brain and Nerve Injuries. Ana Hernandez acquired the Glasgow Outcome Scale Extended Pediatrics as part of a larger outcomes project. Additional research coordinators participating in this study over the years include Patricia Plumb, Annemarie Jones, Evin Shirley, and Andrew Herbert. Assistance with statistical analysis was provided by Dr. Sekhar Ramkrishnan.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; DeCuypere M, 2016, J NEUROSURG-PEDIATR, V17, P595, DOI 10.3171/2015.7.PEDS15285; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Guerrier G, 2015, AUST NZ J PUBL HEAL, V39, P188, DOI 10.1111/1753-6405.12362; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; Huguenard AL, 2016, J NEUROSURG-PEDIATR, V17, P476, DOI 10.3171/2015.7.PEDS14723; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Ramaiah VK, 2013, CHILD NERV SYST, V29, P629, DOI 10.1007/s00381-012-1984-5; Richard YF, 2015, AM J EPIDEMIOL, V182, P177, DOI 10.1093/aje/kwv014; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	25	11	11	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	APR	2018	19	4					353	360		10.1097/PCC.0000000000001490			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	GK1CA	WOS:000435849300015	29419604				2022-02-06	
J	Wang, B; Han, SS				Wang, Bo; Han, Shuangshuang			Exosome-associated tau exacerbates brain functional impairments induced by traumatic brain injury in mice	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Tau; Phosphorylation; Exosome; Impairments	CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; HEAD-INJURY; PROTEIN; PHOSPHORYLATION; ACCUMULATION; ONSET	Traumatic brain injury (TBI) has been associated with an increased risk for neurodegenerative diseases, and Tau spread and accumulation might be one of the mechanisms underlying this process. Exosomes were speculated to be a vehicle for spreading Tau in neurodegenerative diseases. The present study sought to investigate the effect of exosome associated Tau after TBI. C57BL/6J mice were subjected to controlled cortical impact injury and the levels of total and phosphorylated Tau in exosomes were measured. Then we isolated exosomes from wildtype and Tau-knockout mice after TBI. These exosomes were either added to primary cultured neurons to evaluate the toxicity, or injected into brains of mice subjected to TIM to evaluate the effect on brain functions. The levels of total and phosphorylated Tau in exosomes after TIM were significantly elevated. TBI derived exosomes displayed toxicity in primary neuron cultures, exacerbated TBI induced LTP (long-term potentiation) impairment and exacerbated motor and cognitive impairments after TBI. The exosome-associated Tau pathology was one of the mechanisms underlying the long-term neurodegenerative effect after TBI.	[Wang, Bo] Cangzhou Cent Hosp, Emergency Dept, 16 Xinhua West Rd, Cangzhou 061001, Hebei, Peoples R China; [Han, Shuangshuang] Cangzhou Med Coll, Higher Educ Area, West Yingbin Ave, Cangzhou 061001, Hebei, Peoples R China		Wang, B (corresponding author), Cangzhou Cent Hosp, Emergency Dept, 16 Xinhua West Rd, Cangzhou 061001, Hebei, Peoples R China.	wangbo6292@126.com					Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Tepper K, 2014, J BIOL CHEM, V289, P34389, DOI 10.1074/jbc.M114.611368; Thery C., 2001, CURRENT PROTOCOLS CE; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Zaborowski MP, 2015, BIOSCIENCE, V65, P783, DOI 10.1093/biosci/biv084	29	11	12	1	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	APR	2018	88						158	166		10.1016/j.mcn.2018.02.002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE3ET	WOS:000431097300016	29408549				2022-02-06	
J	Wang, MY; Duan, FL; Wu, JL; Min, Q; Huang, QC; Luo, M; He, ZQ				Wang, Mengyang; Duan, Faliang; Wu, Jinglei; Min, Qiang; Huang, Qiaochun; Luo, Ming; He, Zhuqiang			Effect of cyclooxygenase-2 inhibition on the development of post-traumatic stress disorder in rats	MOLECULAR MEDICINE REPORTS			English	Article						post-traumatic stress disorder; cyclooxygenase-2; tumor necrosis factor; interleukin-6; nitric oxide; prostaglandin E2	ANXIETY-RELATED BEHAVIOR; ELEVATED PLUS-MAZE; QUALITY-OF-LIFE; OXIDATIVE STRESS; COX-2 INHIBITOR; NERVOUS-SYSTEM; MESSENGER-RNA; FAST FEEDBACK; WATER-MAZE; APOPTOSIS	Post-traumatic stress disorder (PTSD) is characterized by re-experiencing of a traumatic event, avoidance of trauma-associated stimulation, general changes in mood and cognition, and hyper arousal symptoms. Cyclooxygenase is involved in the production of prostaglandins and thromboxanes, and its inducible form cyclooxygenase-2(COX-2), an important mediator of cell injury in inflammation, is primarily expressed in leukocytes and brain cells. The present study investigated the expression of COX-2 in the hippocampi of rats with PTSD and evaluated the effect of COX-2 inhibition on PTSD. Adult male Wistar rats were randomly divided into three groups: Control (n=20), PTSD (n=20) and intervention group (PTSD+COX-2 inhibitor treatment, n=20). The expression of COX-2 was detected by immunohistochemistry, reverse transcription-quantitative polymerase chain reaction and western blotting. Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling staining was used to observe the apoptosis of rat hippocampal neurons. Tumor necrosis factor (TNF-), interleukin (IL)-6 and prostaglandin E2 (PGE2) levels were analyzed by ELISA. Nitric oxide (NO) was detected using the Griess test. The behavioral and cognitive function of rats in the PTSD group was significantly decreased compared with the control group, while the behavioral and cognitive function of rats in the intervention group were improved. The COX-2 mRNA and protein expression levels in hippocampi of rats in the PTSD group were higher than in the control and intervention group. The apoptosis of hippocampus in rats with PTSD was significantly increased compared with the control group and following treatment with COX-2 inhibitor, apoptosis was decreased. In addition, compared with the control group and intervention group, the levels of TNF-, IL-6, PGE2 and NO in hippocampi of rats were increased in the PTSD group. The present study indicated that COX-2 may be involved in the pathogenesis of PTSD, and inhibition of its expression serves a neuroprotective role in hippocampi of PTSD rats.	[Wang, Mengyang; Duan, Faliang; Wu, Jinglei; Min, Qiang; Huang, Qiaochun; Luo, Ming; He, Zhuqiang] Wuhan 1 Hosp, Dept Neurosurg, 215 Zhongshan Ave, Wuhan 430022, Hubei, Peoples R China		He, ZQ (corresponding author), Wuhan 1 Hosp, Dept Neurosurg, 215 Zhongshan Ave, Wuhan 430022, Hubei, Peoples R China.	colei@sina.com			Nature Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [2015CFB694]	This study was supported by the grant from Nature Science Foundation of Hubei Province (grant no. 2015CFB694).	Altorki NK, 2003, J CLIN ONCOL, V21, P2645, DOI 10.1200/JCO.2003.07.127; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Bailey JN, 2010, PSYCHIAT RES, V178, P507, DOI 10.1016/j.psychres.2010.04.043; Boals A, 2010, J ANXIETY DISORD, V24, P161, DOI 10.1016/j.janxdis.2009.10.004; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Cisler JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134717; Cohen BE, 2009, ARCH GEN PSYCHIAT, V66, P1214, DOI 10.1001/archgenpsychiatry.2009.149; Cohen H, 2011, EUR NEUROPSYCHOPHARM, V21, P230, DOI 10.1016/j.euroneuro.2010.11.011; Gamble-George JC, 2016, ELIFE, V5, DOI [10.7554/eLife.14137, 10.7754/eLife.14137]; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050402; Hinz B, 2002, J PHARMACOL EXP THER, V300, P367, DOI 10.1124/jpet.300.2.367; Jones KD, 2010, J COUNS DEV, V88, P372, DOI 10.1002/j.1556-6678.2010.tb00036.x; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Karim A, 1999, J RHEUMATOL, V26, P2539; KNIGHT JA, 2004, ASSESSING PSYCHOL TR, P344; Li RJ, 2014, J HUAZHONG U SCI-MED, V34, P234, DOI 10.1007/s11596-014-1264-6; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mills KL, 2006, AM J PSYCHIAT, V163, P652, DOI 10.1176/appi.ajp.163.4.652; Moeller Donald R, 2014, J Spec Oper Med, V14, P64; Morioka N, 2002, NEUROPHARMACOLOGY, V43, P868, DOI 10.1016/S0028-3908(02)00143-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; Nadeem MN, 2016, INT J BASIC CLIN PHA, V5, P1466, DOI [10.18203/2319-2003.ijbcp20162454, DOI 10.18203/2319-2003.IJBCP20162454]; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; Neylan TC, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23938; Nury T, 2014, BIOCHEM BIOPH RES CO, V446, P714, DOI 10.1016/j.bbrc.2013.11.081; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Pietrzak RH, 2012, AM J GERIAT PSYCHIAT, V20, P380, DOI 10.1097/JGP.0b013e31820d92e7; Puetz TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126529; Rauch SAM, 2006, AM J GERIAT PSYCHIAT, V14, P316, DOI 10.1097/01.JGP.0000199382.96115.86; Robinson R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002283; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Said RS, 2014, REPROD TOXICOL, V43, P85, DOI 10.1016/j.reprotox.2013.11.005; Singh DP, 2014, PHARMACOL BIOCHEM BE, V120, P33, DOI 10.1016/j.pbb.2014.02.006; Takadera T, 2002, NEUROSCI LETT, V317, P61, DOI 10.1016/S0304-3940(01)02449-1; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Yagami T, 2016, MOL NEUROBIOL, V53, P4754, DOI 10.1007/s12035-015-9355-3	46	11	11	1	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2018	17	4					4925	4932		10.3892/mmr.2018.8525			8	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GA9PA	WOS:000428672100008	29393449	hybrid, Green Published, Green Submitted			2022-02-06	
J	Zeiler, FA; Donnelly, J; Cardim, D; Menon, DK; Smielewski, P; Czosnyka, M				Zeiler, F. A.; Donnelly, J.; Cardim, D.; Menon, D. K.; Smielewski, P.; Czosnyka, M.			ICP Versus Laser Doppler Cerebrovascular Reactivity Indices to Assess Brain Autoregulatory Capacity	NEUROCRITICAL CARE			English	Article						Cerebrovascular reactivity; Autoregulation; Laser Doppler; ICP index; Covariance; Machine learning	CEREBRAL AUTOREGULATION; BLOOD-FLOW; NEUROCRITICAL CARE; HEAD-INJURY; PRESSURE; FLOWMETRY; PERFUSION	Background To explore the relationship between various autoregulatory indices in order to determine which approximate small vessel/microvascular (MV) autoregulatory capacity most accurately. Methods Utilizing a retrospective cohort of traumatic brain injury patients (N = 41) with: transcranial Doppler (TCD), intracranial pressure (ICP) and cortical laser Doppler flowmetry (LDF), we calculated various continuous indices of autoregulation and cerebrovascular responsiveness: A. ICP derived [pressure reactivity index (PRx)-correlation between ICP and mean arterial pressure (MAP), PAx-correlation between pulse amplitude of ICP (AMP) and MAP, RAC-correlation between AMP and cerebral perfusion pressure (CPP)], B. TCD derived (Mx-correlation between mean flow velocity (FVm) and CPP, Mx_a-correlation between FVm and MAP, Sx-correlation between systolic flow velocity (FVs) and CPP, Sx_acorrelation between FVs and MAP, Dx-correlation between diastolic flow index (FVd) and CPP, Dx_a-correlation between FVd and MAP], and LDF derived (Lx-correlation between LDF cerebral blood flow [CBF] and CPP, Lx_a-correlation between LDF-CBF and MAP). We assessed the relationship between these indices via Pearson correlation, Friedman test, principal component analysis (PCA), agglomerative hierarchal clustering (AHC), and k-means cluster analysis (KMCA). Results LDF-based autoregulatory index (Lx) was most associated with TCD-based Mx/Mx_a and Dx/Dx_a across Pearson correlation, PCA, AHC, and KMCA. Lx was only remotely associated with ICP-based indices (PRx, PAx, RAC). TCD-based Sx/Sx_a was more closely associated with ICP-derived PRx, PAx and RAC. This indicates that vascular-derived indices of autoregulatory capacity (i.e., TCD and LDF based) covary, with Sx/Sx_a being the exception, whereas indices of cerebrovascular reactivity derived from pulsatile CBV (i.e., ICP indices) appear to not be closely related to those of vascular origin. Conclusions Transcranial Doppler Mx is the most closely associated with LDF-based Lx/Lx_a. Both Sx/Sx-a and the ICP-derived indices appear to be dissociated with LDF-based cerebrovascular reactivity, leaving Mx/Mx-a as a better surrogate for the assessment of cortical small vessel/ MV cerebrovascular reactivity. Sx/Sx_a cocluster/covary with ICP-derived indices, as seen in our previous work.	[Zeiler, F. A.; Menon, D. K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Donnelly, J.; Cardim, D.; Smielewski, P.; Czosnyka, M.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Sect Brain Phys,Div Neurosurg, Cambridge CB2 0QQ, England; [Menon, D. K.] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Menon, D. K.] Univ Cambridge, Queens Coll, Cambridge, England; [Menon, D. K.] Natl Inst Hlth Res, Cambridge, England; [Czosnyka, M.] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca; donnellyj87@gmail.com; dac69@cam.ac.uk; dkm13@cam.ac.uk; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk	Donnelly, Joseph/E-9235-2018; Cardim, Danilo Augusto/B-8447-2012; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Cardim, Danilo Augusto/0000-0002-9261-1321; Donnelly, Joseph/0000-0002-6502-8069; czosnyka, marek/0000-0003-2446-8006; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award; European UnionEuropean Commission [602150]; Grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI17C1790]; Woolf Fisher Scholarship (NZ); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund. These studies were supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to DKM. Authors were also supported by a European Union Framework Program 7 Grant (CENTER-TBI; Grant Agreement No. 602150). MC is supported by a Grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (Grant No. HI17C1790). JD is supported by a Woolf Fisher Scholarship (NZ). *Special thanks to Mr. PJ Kirkpatrick, Prof. JD Pickard and their previous research staff/students, for aiding in the collection of this original data set in the early 90's, and their previous publications on LDF in TBI.	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Cardona G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-3; Crawley M.J., 2013, R BOOK, P809; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; KIRKPATRICK PJ, 1994, J NEUROL NEUROSUR PS, V57, P1382, DOI 10.1136/jnnp.57.11.1382; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Pandey M., 2015, BIOSTATISTICS BASIC, P454; RCore-Team, 2013, R LANG ENV STAT COMP; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2010, NEUROL RES, V32, P425, DOI 10.1179/174313209X459165	18	11	12	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2018	28	2					194	202		10.1007/s12028-017-0472-x			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF5GM	WOS:000431994700009	29043544	Green Published, hybrid, Green Submitted			2022-02-06	
J	D'Lauro, C; Johnson, BR; McGinty, G; Allred, CD; Campbell, DE; Jackson, JC				D'Lauro, Christopher; Johnson, Brian R.; McGinty, Gerald; Allred, C. Dain; Campbell, Darren E.; Jackson, Jonathan C.			Reconsidering Return-to-Play Times: A Broader Perspective on Concussion Recovery	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; return to play; elite athletes; sex differences	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; INTERNATIONAL-CONFERENCE; FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; CONSENSUS STATEMENT; EPIDEMIOLOGY; PERFORMANCE	Background: Return-to-play protocols describe stepwise, graduated recoveries for safe return from concussion; however, studies that comprehensively track return-to-play time are expensive to administer and heavily sampled from elite male contact-sport athletes. Purpose: To retrospectively assess probable recovery time for collegiate patients to return to play after concussion, especially for understudied populations, such as women and nonelite athletes. Study Design: Cohort study; Level of evidence, 3. Methods: Medical staff at a military academy logged a total of 512 concussion medical records over 38 months. Of these, 414 records included complete return-to-play protocols with return-to-play time, sex, athletic status, cause, and other data. Results: Overall mean return to play was 29.4 days. Sex and athletic status both affected return-to-play time. Men showed significantly shorter return to play than women, taking 24.7 days (SEM, 1.5 days) versus 35.5 days (SEM, 2.7 days) (P < .001). Intercollegiate athletes also reported quicker return-to-play times than nonintercollegiate athletes: 25.4 days (SEM, 2.6 days) versus 34.7 days (SEM, 1.6 days) (P = .002). These variables did not significantly interact. Conclusion: Mean recovery time across all groups (29.4 days) showed considerably longer return to play than the most commonly cited concussion recovery time window (7-10 days) for collegiate athletes. Understudied groups, such as women and nonelite athletes, demonstrated notably longer recovery times. The diversity of this sample population was associated with longer return-to-play times; it is unclear how other population-specific factors may have contributed. These inclusive return-to-play windows may indicate longer recovery times outside the population of elite athletes.	[D'Lauro, Christopher; Johnson, Brian R.; McGinty, Gerald; Allred, C. Dain; Campbell, Darren E.; Jackson, Jonathan C.] US Air Force Acad, Colorado Springs, CO 80840 USA; [D'Lauro, Christopher; Johnson, Brian R.] US Air Force Acad, Dept Behav Sci & Leadership, 2354 Fairchild Dr,Suite 5L60, Colorado Springs, CO 80840 USA; [McGinty, Gerald] US Air Force Acad, Athlet Dept, Sports Med, Colorado Springs, CO 80840 USA; [Allred, C. Dain; Campbell, Darren E.; Jackson, Jonathan C.] US Air Force Acad, Med Grp 10, Colorado Springs, CO 80840 USA		D'Lauro, C (corresponding author), US Air Force Acad, Dept Behav Sci & Leadership, 2354 Fairchild Dr,Suite 5L60, Colorado Springs, CO 80840 USA.	Christopher.dlauro@gmail.com	D'Lauro, Christopher/V-2587-2019; D'Lauro, Christopher/X-1518-2019	D'Lauro, Christopher/0000-0003-0894-6602	National Collegiate Athletic Association; Department of Defense through the CARE Grand Alliance; Department of Defense through the Mind Matters Award	Partial support for this study was received from the National Collegiate Athletic Association and the Department of Defense through the CARE Grand Alliance and the Mind Matters Award.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Carrell SE, 2011, J PUBLIC ECON, V95, P657, DOI 10.1016/j.jpubeco.2010.12.005; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hainline Brian, 2013, Neurol Clin Pract, V3, P277, DOI 10.1212/CPJ.0b013e3182a1ba46; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Laker SR, 2011, PHYS MED REH CLIN N, V22, P619, DOI 10.1016/j.pmr.2011.08.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; National Collegiate Athletic Association, DIV 1; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	38	11	11	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR 14	2018	6	3							2325967118760854	10.1177/2325967118760854			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FZ5SF	WOS:000427655500001	29568786	Green Published, gold			2022-02-06	
J	Brickell, TA; French, LM; Lippa, SM; Lange, RT				Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.			Characteristics and Health Outcomes of Post-9/11 Caregivers of US Service Members and Veterans Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregiver; polytrauma; posttraumatic stress; service member; traumatic brain injury; Veteran	CENTERED PREVENTIVE INTERVENTION; FAMILY CAREGIVERS; BURDEN; PARENT; BLAST; SYMPTOMS; CHILDREN; IMPACT; SPOUSE; CARE	Objectives: To (a) characterize a sample of post-9/11 caregivers providing help to service members and veterans (SMV) following traumatic brain injury (TBI), (b) examine the level of support provided, and (c) determine caregiver health and well-being outcomes. Setting: Military treatment facility. Participants: Caregivers (N = 278) of SMVs who sustained a mild, moderate, severe, or penetrating TBI (96.0% female; 86.0% spouse/partner; age: M = 38.7 years, SD = 10.4). Participants were divided into 3 groups on the basis of the level of support provided (low, medium, high). Design: Prospective observational. Main Measures: Caregiver Appraisal Scale, SF-36v2 Health Survey, Mayo-Portland Adaptability Inventory-4, Caregiver Questionnaire. Results: The majority of caregivers were helping an SMV with mild TBI and comorbid posttraumatic stress disorder/depression, who was injured in a blast-related incident during combat. Caregivers helped predominantly with activities of daily living and/or instrumental activities of daily living and spent more than 40 hours per week providing care. High-support caregivers were more likely to be caring for an SMV with comorbid posttraumatic stress disorder, report poor physical and mental health outcomes, and have a negative impact on employment and finances. Conclusions: A better understanding of protective factors is required to ensure that burden of care does not exceed the caregiver's health and financial capacity, or undermine the care, well-being, and recovery of the SMV.	[Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Fac Med, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 N Palmer Rd, Bethesda, MD 20889 USA.	tbrickell@dvbic.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This material is based upon work supported by the Defense and Veterans Brain Injury Center. Portions of these data were presented at the North American Brain Injury Association conference, Tampa, Florida.	Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Bayen E, 2017, SUPPORT CARE CANCER, V25, P245, DOI 10.1007/s00520-016-3397-6; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Beardslee W, 2011, PREV SCI, V12, P339, DOI 10.1007/s11121-011-0234-5; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Charlifue SB, 2016, SPINAL CORD, V54, P732, DOI 10.1038/sc.2016.25; Cozza SJ, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P259, DOI 10.1007/978-1-4419-7064-0_13; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Folkman S., 1984, STRESS; French L. M., 2012, NEUROPSYCHOLOGICAL A, P127; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Griffin JM, 2014, MILITARY DEPLOYMENT; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Harding R, 2015, J PAIN SYMPTOM MANAG, V50, P445, DOI 10.1016/j.jpainsymman.2015.04.005; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Kim Y, 2012, PSYCHO-ONCOLOGY, V21, P273, DOI 10.1002/pon.1888; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P, 2016, J AM ACAD CHILD PSY, V55, P14, DOI 10.1016/j.jaac.2015.10.009; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Monk JK, 2017, J MARITAL FAM THER, V43, P448, DOI 10.1111/jmft.12230; National Alliance for Caregiving, 2008, CAR VET SERV HOM; Ramchand R, 2009, HIDDEN HEROES AM MIL; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238; Smeets SM, 2012, ARCH PHYS MED REHAB, V93, P834, DOI 10.1016/j.apmr.2011.10.029; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Teixeira RJ, 2013, PSYCHO-ONCOLOGY, V22, P1587, DOI 10.1002/pon.3173; Turner-Bowker, 2007, USERS MANUAL SF 36V2; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; van Wijnen HGFM, 2017, CLIN REHABIL, V31, P1267, DOI 10.1177/0269215516686155; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024	43	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					133	145		10.1097/HTR.0000000000000384			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200014	29517593				2022-02-06	
J	Brown, M; Baradaran, H; Christos, PJ; Wright, D; Gupta, A; Tsiouris, AJ				Brown, Matthew; Baradaran, Hediyeh; Christos, Paul J.; Wright, Drew; Gupta, Ajay; Tsiouris, Apostolos J.			Magnetic resonance spectroscopy abnormalities in traumatic brain injury: A meta-analysis	JOURNAL OF NEURORADIOLOGY			English	Article						Magnetic resonance spectroscopy; Traumatic brain injury	PROTON MR SPECTROSCOPY; MITOCHONDRIAL IMPAIRMENT; SPORTS CONCUSSIONS; N-ACETYLASPARTATE; AXONAL INJURY; MILD; SEVERITY; DIFFUSION; CHOLINE; AREAS	Background and purpose. - Despite traumatic brain injury (TBI) being common, evaluation with imaging remains challenging. Magnetic resonance spectroscopy (MRS) shows promise in detecting changes of brain metabolite concentrations following TBI; however, currently there are only small studies available without conclusive evidence of the technique's efficacy. The purpose of this systematic review and meta analysis was to evaluate the association between TBI and MRS metabolite changes. Materials & methods. - A comprehensive literature search was performed looking for studies reporting brain metabolite concentrations in both TBI and control subjects. Included studies reported values for both adult TBI and control subjects. Cumulative and subgroup meta-analyses were performed using a random effects model. Results. - The literature search returned an initial 898 manuscripts, of which 36 (which included 748 unique subjects) met study criteria. Cumulatively, NAA/Cr ratios in TBI patients showed a significant decrease as compared to controls (standardized mean deviation [SMD] = 0.88, P < 0.0001). When broken into subgroups by severity, the severe and mixed TBI subgroups showed decreases, but the mild TBI (mTBI) subgroup did not. When stratified by time, a significant decrease was seen in the subacute and chronic phases but not the acute phase. Cumulative post-TBI Cho/Cr levels were increased compared to controls (SMD = 0.69, P = 0.0002). Significant changes were seen in all subgroups except the mild and mixed mTBI subgroups and the acute phase subgroup. Conclusion. - Current evidence shows that MRS is able to detect changes to metabolites following TBI, but not in patients with mTBI or in the acute stage. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Brown, Matthew; Baradaran, Hediyeh; Gupta, Ajay; Tsiouris, Apostolos J.] New York Presbyterian Hosp, Weill Cornell Med, Dept Radiol, 525 East 68th St, New York, NY 10065 USA; [Brown, Matthew; Baradaran, Hediyeh; Gupta, Ajay; Tsiouris, Apostolos J.] New York Presbyterian Hosp, Weill Cornell Med, Dept Healthcare Policy, 525 East 68th St, New York, NY 10065 USA; [Brown, Matthew; Baradaran, Hediyeh; Gupta, Ajay; Tsiouris, Apostolos J.] New York Presbyterian Hosp, Weill Cornell Med, Dept Res, 525 East 68th St, New York, NY 10065 USA; [Christos, Paul J.; Wright, Drew] New York Presbyterian Hosp, Weill Cornell Med, Healthcare Policy & Res, 525 East 68th St, New York, NY 10065 USA; [Gupta, Ajay] Weill Cornell Med, Feil Family Brain & Mind Res Inst, 407 E 61st St, New York, NY 10065 USA		Brown, M (corresponding author), 420 E 70th St, New York, NY 10021 USA.	mfb2003@med.cornell.edu	Baradaran, Hediyeh/S-6115-2019; Wright, Drew/P-1147-2019	Baradaran, Hediyeh/0000-0002-6251-5769; Wright, Drew/0000-0002-1776-5427	Clinical and Translational Science Center at Weill Cornell Medical College [UL1-TR000457-06]	Statistical support for this project was partially funded by the following grant: Clinical and Translational Science Center at Weill Cornell Medical College (UL1-TR000457-06).	Affairs V, 2013, TBI PATHOPHYSIOL JUL, P1; Aygok GA, 2008, ACTA NEUROCHIR SUPPL, V102, P57, DOI 10.1007/978-3-211-85578-2_12; Boulanger Y, 2000, BRAIN RES REV, V33, P380, DOI 10.1016/S0165-0173(00)00037-0; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Capizzano AA, 2010, J NEUROPSYCH CLIN N, V22, P370, DOI 10.1176/appi.neuropsych.22.4.370; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Du YL, 2011, NEUROL INDIA, V59, P31, DOI 10.4103/0028-3886.86540; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Son BC, 2000, ACT NEUR S, V76, P13; Sood S, 2010, SEMIN ROENTGENOL, V45, P137, DOI 10.1053/j.ro.2009.09.008; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wong AMC, 2017, J NEURORADIOLOGY, V44, P281, DOI 10.1016/j.neurad.2017.02.003; Yoon SJ, 2005, CLIN REHABIL, V19, P209, DOI 10.1191/0269215505cr813oa	47	11	12	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	MAR	2018	45	2					123	129		10.1016/j.neurad.2017.09.004			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GE0MA	WOS:000430906700006	28965789				2022-02-06	
J	Dutta, M; Murray, L; Miller, W; Groves, D				Dutta, Manaswita; Murray, Laura; Miller, Wendy; Groves, Doyle			Effects of Epilepsy on Language Functions: Scoping Review and Data Mining Findings	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TEMPORAL-LOBE EPILEPSY; COMPLEX PARTIAL SEIZURES; HIGH-LEVEL LANGUAGE; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; OLDER-ADULTS; PEDIATRIC EPILEPSY; NEUROPSYCHOLOGICAL DEFICITS; COGNITIVE IMPAIRMENT; GENERALIZED EPILEPSY	Purpose: This study involved a scoping review to identify possible gaps in the empirical description of language functioning in epilepsy in adults. With access to social network data, data mining was used to determine if individuals with epilepsy are expressing language-related concerns. Method: For the scoping review, scientific databases were explored to identify pertinent articles. Findings regarding the nature of epilepsy etiologies, patient characteristics, tested language modalities, and language measures were compiled. Data mining focused on social network databases to obtain a set of relevant language-related posts. Results: The search yielded 66 articles. Epilepsy etiologies except temporal lobe epilepsy and older adults were underrepresented. Most studies utilized aphasia tests and primarily assessed single-word productions; few studies included healthy control groups. Data mining revealed several posts regarding epilepsy-related language problems, including word retrieval, reading, writing, verbal memory difficulties, and negative effects of epilepsy treatment on language. Conclusion: Our findings underscore the need for future specification of the integrity of language in epilepsy, particularly with respect to discourse and high-level language abilities. Increased awareness of epilepsyrelated language issues and understanding the patients' perspectives about their language concerns will allow researchers and speech-language pathologists to utilize appropriate assessments and improve quality of care.	[Dutta, Manaswita] Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA; [Murray, Laura] Western Univ, Sch Commun Sci & Disorders, London, ON, Canada; [Miller, Wendy; Groves, Doyle] Indiana Univ, Sch Nursing, Bloomington, IN 47405 USA		Dutta, M (corresponding author), Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA.	mdutta@indiana.edu	Dutta, Manaswita/AAY-4245-2020	Dutta, Manaswita/0000-0001-8371-2246; Murray, Laura/0000-0002-7773-1843			Abou-Khalil B., 2015, PERSPECTIVENEUROPH, V25, P47, DOI DOI 10.1044/NNSLD25.2.47; Alessio A, 2006, EPILEPSY BEHAV, V8, P593, DOI 10.1016/j.yebeh.2006.01.007; Antonsson M, 2016, CLIN LINGUIST PHONET, V30, P944, DOI 10.1080/02699206.2016.1205664; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Austin J., 2012, NURS TIMES, V109, P20; Bartha L, 2005, J NEUROL NEUROSUR PS, V76, P808, DOI 10.1136/jnnp.2004.045385; Bartha L, 2004, EPILEPSY BEHAV, V5, P348, DOI 10.1016/j.yebeh.2004.02.004; Bartha L., 2001, Z NEUROPSYCHOL, V5, P348; Bartha-Doering L, 2014, EPILEPSIA, V55, P1512, DOI 10.1111/epi.12743; Bell B, 2003, J INT NEUROPSYCH SOC, V9, P733, DOI 10.1017/S1355617703950065; Bell BD, 2003, EPILEPSY RES, V55, P29, DOI 10.1016/S0920-1211(03)00110-4; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Benton AL, 1994, MULTILINGUAL APHASIA; Berg E, 2003, CLIN LINGUIST PHONET, V17, P63, DOI 10.1080/0269920021000055540; Beykikhoshk A., 2014, ADV SOCIAL NETWORKS; Blanken G., 1999, AUDITIVES SPRACHVERS; Blanken G., 1996, AUDITIVES SPRACHVERS; Blanken G., 1999, WORTPRODUKTIONSPRUFU; Bonelli SB, 2012, EPILEPSIA, V53, P639, DOI 10.1111/j.1528-1167.2012.03433.x; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Busch RM, 2013, EPILEPSIA, V54, pe37, DOI 10.1111/epi.12088; Caplan R, 2002, J CHILD PSYCHOL PSYC, V43, P245, DOI 10.1111/1469-7610.00017; Caplan R, 2006, EPILEPSY BEHAV, V8, P726, DOI 10.1016/j.yebeh.2006.03.009; Caplan R, 2009, EPILEPSIA, V50, P2397, DOI 10.1111/j.1528-1167.2009.02199.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Condret-Santi V, 2014, EPILEPSY RES, V108, P1825, DOI 10.1016/j.eplepsyres.2014.09.001; Dash D, 2014, ANN INDIAN ACAD NEUR, V17, pS50, DOI 10.4103/0972-2327.128655; Davies KG, 1998, EPILEPSIA, V39, P407, DOI 10.1111/j.1528-1157.1998.tb01393.x; Davies KG, 1997, J EPILEPSY, V10, P122, DOI 10.1016/S0896-6974(97)90003-7; de Haan M, 2006, TRENDS NEUROSCI, V29, P374, DOI 10.1016/j.tins.2006.05.008; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Drane DL, 2008, NEUROPSYCHOLOGIA, V46, P1242, DOI 10.1016/j.neuropsychologia.2007.11.034; Drane DL, 2015, EPILEPSIA, V56, P101, DOI 10.1111/epi.12860; Epilepsy Statistics, 2014, EP FDN; Fargo JD, 2005, NEUROPSYCHOLOGY, V19, P603, DOI 10.1037/0894-4105.19.5.603; Fargo JD, 2004, EPILEPSY BEHAV, V5, P143, DOI 10.1016/j.yebeh.2003.11.023; Fastenau PS, 2004, EPILEPSIA, V45, P1261, DOI 10.1111/j.0013-9580.2004.15204.x; Field SJ, 2000, BRAIN LANG, V74, P213, DOI 10.1006/brln.2000.2335; Folstein M. F., 2001, MINI MENTAL STATE EX; Fritz N, 2005, EPILEPSY BEHAV, V6, P373, DOI 10.1016/j.yebeh.2005.01.002; GABR M, 1989, ANN NEUROL, V25, P82, DOI 10.1002/ana.410250113; Gaillard WD, 2007, NEUROLOGY, V69, P1761, DOI 10.1212/01.wnl.0000289650.48830.1a; Gargaro AC, 2013, EPILEPSY BEHAV, V27, P461, DOI 10.1016/j.yebeh.2013.03.002; Gauffin H, 2013, EPILEPSY BEHAV, V28, P26, DOI 10.1016/j.yebeh.2013.04.001; Giovagnoli AR, 2016, EUR J NEUROL, V23, P1713, DOI 10.1111/ene.13113; Giovagnoli AR, 2009, EPILEPSY RES, V84, P217, DOI 10.1016/j.eplepsyres.2009.02.004; Giovagnoli AR, 1999, ACTA NEUROL SCAND, V99, P334, DOI 10.1111/j.1600-0404.1999.tb07361.x; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Glosser G, 2001, NEUROPSYCHOLOGY, V15, P39, DOI 10.1037/0894-4105.15.1.39; Goodglass H., 1972, ASSESSMENT APHASIA R; Griffith HR, 2006, EPILEPSY BEHAV, V8, P161, DOI 10.1016/j.yebeh.2005.09.004; Guimaraes CA, 2007, J CHILD NEUROL, V22, P836, DOI 10.1177/0883073807304701; Hamberger MJ, 2007, EPILEPSIA, V48, P531, DOI 10.1111/j.1528-1167.2006.00955.x; Hamberger MJ, 2010, NEUROLOGY, V74, P1488, DOI 10.1212/WNL.0b013e3181dd40f0; Hamberger MJ, 2003, J INT NEUROPSYCH SOC, V9, P479, DOI 10.1017/S135561770393013X; Hamberger MJ, 1999, EPILEPSY RES, V35, P229, DOI 10.1016/S0920-1211(99)00023-6; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Helmstaedter C, 1998, NEUROPSYCHOLOGIA, V36, P681, DOI 10.1016/S0028-3932(97)00134-6; Henkin Y, 2003, EPILEPSIA, V44, P1207, DOI 10.1046/j.1528-1157.2003.65402.x; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Hermann BP, 1999, NEUROPSYCHOLOGY, V13, P3, DOI 10.1037/0894-4105.13.1.3; HERMANN BP, 1988, CORTEX, V24, P245, DOI 10.1016/S0010-9452(88)80033-9; HERMANN BP, 1988, ANN NEUROL, V23, P585, DOI 10.1002/ana.410230610; HERMANN BP, 1991, J NEUROSURG, V74, P560, DOI 10.3171/jns.1991.74.4.0560; Hermann BP, 2008, EPILEPSIA, V49, P1847, DOI 10.1111/j.1528-1167.2008.01735.x; HOWELL RA, 1994, CORTEX, V30, P469, DOI 10.1016/S0010-9452(13)80342-5; Howieson D. B., 2010, ESSENTIALS NEUROPSYC, P29; Huber W., 1983, AACHENER APHASIE TES; Jaimes-Bautista Amanda G, 2015, Epilepsy Res Treat, V2015, P746745, DOI 10.1155/2015/746745; Janecek JK, 2013, EPILEPSY BEHAV, V28, P95, DOI 10.1016/j.yebeh.2013.04.006; Jastak S., 1984, WIDE RANGE ACHIEVE M; Kantardzic M., 2011, DATA MINING CONCEPTS; Kaplan E., 2001, BOSTON NAMING TEST; Kemp, 1998, NEPSY DEV NEUROPSYCH; Kertesz A., 1982, W APHASIA BATTERY; Kho KH, 2008, NEUROPSYCHOLOGIA, V46, P1170, DOI 10.1016/j.neuropsychologia.2007.10.014; Kim C. H., 2006, EUR NEUROL, V57, P39; Laakso K, 2000, CLIN LINGUIST PHONET, V14, P329, DOI 10.1080/02699200050051065; Langfitt JT, 1996, ARCH NEUROL-CHICAGO, V53, P72, DOI 10.1001/archneur.1996.00550010090021; Larose Daniel T., 2014, DISCOVERING KNOWLEDG; Lehrl S., 2005, MEHRFACHWAHL WORTSCH; Ljunggren S, 2015, SEIZURE-EUR J EPILEP, V30, P50, DOI 10.1016/j.seizure.2015.05.014; Loddenkemper T, 2004, J NEUROL NEUROSUR PS, V75, P149; Lomlomdjian C, 2011, EPILEPSY RES, V97, P37, DOI 10.1016/j.eplepsyres.2011.06.016; LORING DW, 1994, ARCH CLIN NEUROPSYCH, V9, P229, DOI 10.1016/0887-6177(94)90028-0; MacAllister WS, 2007, NEUROPSYCHOL REV, V17, P427, DOI 10.1007/s11065-007-9048-4; Maeda K, 2011, EPILEPSY BEHAV, V22, P592, DOI 10.1016/j.yebeh.2011.07.037; Mattis S, 1988, DEMENTIA RATING SCAL; Mayer JF, 2003, APHASIOLOGY, V17, P481, DOI 10.1080/02687030344000148; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Miller LA, 2016, EPILEPSY BEHAV, V56, P113, DOI 10.1016/j.yebeh.2016.01.011; Miller WR, 2017, WESTERN J NURS RES, V39, P166, DOI 10.1177/0193945916670363; Minkina I, 2013, AM J SPEECH-LANG PAT, V22, pS250, DOI 10.1044/1058-0360(2012/12-0048); Moore PM, 2002, SEIZURE-EUR J EPILEP, V11, P224, DOI 10.1053/seiz.2001.0668; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Murray L. L., 2015, NEUROGENIC DISORDERS; National Heart Lung and Blood Institute National Institute of Health U. S. Department of Health and Human Services, 2014, QUAL ASS TOOL PREPOS; Newton A. T., 2009, SPEC INT GROUP COMP, DOI [10.2196/jmir.5033, DOI 10.2196/JMIR.5033]; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; OJEMANN GA, 1985, J NEUROSURG, V62, P101, DOI 10.3171/jns.1985.62.1.0101; OShea MF, 1996, J CLIN EXP NEUROPSYC, V18, P98, DOI 10.1080/01688639608408266; Paradiso S, 2001, J NEUROL NEUROSUR PS, V70, P180, DOI 10.1136/jnnp.70.2.180; Patricacou A, 2007, APHASIOLOGY, V21, P1157, DOI 10.1080/02687030600670643; Perrone-Bertolotti M, 2012, EPILEPSY BEHAV, V23, P81, DOI 10.1016/j.yebeh.2011.11.011; Piazzini A, 2006, EPILEPSIA, V47, P82, DOI 10.1111/j.1528-1167.2006.00884.x; Priest C, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5033; PRIVITERA MD, 1991, ANN NEUROL, V30, P391, DOI 10.1002/ana.410300311; Rai VK, 2015, EPILEPSY RES, V109, P72, DOI 10.1016/j.eplepsyres.2014.09.031; Ramirez MJ, 2008, EPILEPSIA, V49, P22, DOI 10.1111/j.1528-1167.2007.01209.x; Ramirez MJ, 2010, EPILEPSY BEHAV, V18, P64, DOI 10.1016/j.yebeh.2010.02.020; Reardon S., 2015, HEALTHIT ANAL; Riva D, 2007, EPILEPSY BEHAV, V10, P278, DOI 10.1016/j.yebeh.2006.12.003; Roach A., 1996, CLIN APHASIOLOGY, V24, P121, DOI DOI 10.1037/t56477-000; Robillard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069861; Sadiq SB, 2012, EPILEPSY BEHAV, V23, P500, DOI 10.1016/j.yebeh.2012.01.024; Sarkis RA, 2013, EPILEPSY BEHAV, V27, P326, DOI 10.1016/j.yebeh.2013.02.015; SAYKIN AJ, 1995, EPILEPSIA, V36, P1071, DOI 10.1111/j.1528-1157.1995.tb00464.x; Schefft BK, 2003, EPILEPSY BEHAV, V4, P161, DOI 10.1016/S1525-5050(03)00026-X; Schneider BA, 2000, PSYCHOL AGING, V15, P110, DOI 10.1037/0882-7974.15.1.110; Schwarz M, 2005, SEIZURE-EUR J EPILEP, V14, P562, DOI 10.1016/j.seizure.2005.09.001; Schwarz M, 2009, EPILEPSY BEHAV, V16, P629, DOI 10.1016/j.yebeh.2009.09.016; Seidenberg M, 1998, NEUROPSYCHOLOGY, V12, P303, DOI 10.1037/0894-4105.12.2.303; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Silvia O, 2003, EPILEPSY BEHAV, V4, P717, DOI 10.1016/j.yebeh.2003.09.008; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Spencer L., 2003, QUALITY QUALITATIVE; SPERLING MR, 1995, NEUROLOGY, V45, P970, DOI 10.1212/WNL.45.5.970; Spreen O, 1991, COMPENDIUM NEUROPSYC; Staden U, 1998, NEUROPEDIATRICS, V29, P242, DOI 10.1055/s-2007-973569; STAFINIAK P, 1990, NEUROLOGY, V40, P1509, DOI 10.1212/WNL.40.10.1509; Stark RE, 1995, BRAIN LANG, V51, P406, DOI 10.1006/brln.1995.1068; Strauss E, 2000, BRAIN COGNITION, V43, P403; Strekas A, 2013, INT J LANG COMM DIS, V48, P207, DOI 10.1111/j.1460-6984.2012.00203.x; Szaflarski JP, 2012, EPILEPSY BEHAV, V24, P74, DOI 10.1016/j.yebeh.2012.02.022; Threats T. T., 2012, PERSPECTIVES NEUROPH, V22, P128; Toledano R, 2013, EPILEPSY BEHAV, V29, P172, DOI 10.1016/j.yebeh.2013.07.017; Trebuchon-Da Fonseca A, 2009, BRAIN, V132, P2772, DOI 10.1093/brain/awp083; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; van Ettinger-Veenstra HM, 2010, NEUROIMAGE, V49, P3481, DOI 10.1016/j.neuroimage.2009.10.041; Van Ettinger-Veenstra H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00110; Wang WH, 2011, EPILEPSY BEHAV, V22, P728, DOI 10.1016/j.yebeh.2011.08.038; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Welch LW, 1996, BRAIN LANG, V53, P260, DOI 10.1006/brln.1996.0047; Whatley AD, 2010, HEALTH EDUC RES, V25, P575, DOI 10.1093/her/cyq001; Wiig E. H., 1989, TEST LANGUAGE COMPET; Williams J, 1998, PEDIATR NEUROL, V19, P189, DOI 10.1016/S0887-8994(98)00053-8; Wingfield A, 2005, CURR DIR PSYCHOL SCI, V14, P144, DOI 10.1111/j.0963-7214.2005.00356.x; Witt JA, 2013, EUR J NEUROL, V20, P130, DOI 10.1111/j.1468-1331.2012.03814.x; World Health Organization, 2016, INT CLASS FUNCT DIS; Worrall LE, 2003, APHASIOLOGY, V17, P329, DOI 10.1080/02687030244000699; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175; Zhang X, 2013, SEIZURE-EUR J EPILEP, V22, P780, DOI 10.1016/j.seizure.2013.06.006; Zhao FQ, 2014, ANN INDIAN ACAD NEUR, V17, P374, DOI 10.4103/0972-2327.144003; [No title captured]	156	11	11	0	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAR	2018	27	1		S	SI		350	378		10.1044/2017_AJSLP-16-0195			29	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GI1TU	WOS:000434154300005	29497749				2022-02-06	
J	Evans, LP; Newell, EA; Mahajan, M; Tsang, SH; Ferguson, PJ; Mahoney, J; Hue, CD; Vogel, EW; Morrison, B; Arancio, O; Nichols, R; Bassuk, AG; Mahajan, VB				Evans, Lucy P.; Newell, Elizabeth A.; Mahajan, MaryAnn; Tsang, Stephen H.; Ferguson, Polly J.; Mahoney, Jolonda; Hue, Christopher D.; Vogel, Edward W., III; Morrison, Barclay, III; Arancio, Ottavio; Nichols, Russell; Bassuk, Alexander G.; Mahajan, Vinit B.			Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							COMBAT OCULAR TRAUMA; MOUSE MODEL; VISUAL OUTCOMES; AXONAL INJURY; UNITED-STATES; OPTIC-NERVE; EYE; DEATH; IRAQI	Objective: Limited attention has been given to ocular injuries associated with traumatic brain injury (TBI). The retina is an extension of the central nervous system and evaluation of ocular damage may offer a less-invasive approach to gauge TBI severity and response to treatment. We aim to characterize acute changes in the mouse eye after exposure to two different models of TBI to assess the utility of eye damage as a surrogate to brain injury. Methods: A model of blast TBI (bTBI) using a shock tube was compared to a lateral fluid percussion injury model (LFPI) using fluid pressure applied directly to the brain. Whole eyes were collected from mice 3 days post LFPI and 24 days post bTBI and were evaluated histologically using a hematoxylin and eosin stain. Results: bTBI mice showed evidence of vitreous detachment in the posterior chamber in addition to vitreous hemorrhage with inflammatory cells. Subretinal hemorrhage, photoreceptor degeneration, and decreased cellularity in the retinal ganglion cell layer was also seen in bTBI mice. In contrast, eyes of LFPI mice showed evidence of anterior uveitis and subcapsular cataracts. Interpretation: We demonstrated that variations in the type of TBI can result in drastically different phenotypic changes within the eye. As such, molecular and phenotypic changes in the eye following TBI may provide valuable information regarding the mechanism, severity, and ongoing pathophysiology of brain injury. Because vitreous samples are easily obtained, molecular changes within the eye could be utilized as biomarkers of TBI in human patients.	[Evans, Lucy P.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Evans, Lucy P.; Newell, Elizabeth A.; Ferguson, Polly J.; Mahoney, Jolonda; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Mahajan, MaryAnn; Mahajan, Vinit B.] Stanford Univ, Omics Lab Dept Ophthalmol, Palo Alto, CA 94304 USA; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Barbara Donald Jonas Lab Regenerat Med, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Edward S Harkness Eye Inst, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Inst Human Nutr, New York, NY 10027 USA; [Tsang, Stephen H.] Columbia Univ, Dept Pathol, Inst Human Nutr, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Dept Cell Biol, Inst Human Nutr, New York, NY USA; [Hue, Christopher D.; Vogel, Edward W., III; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Arancio, Ottavio; Nichols, Russell] Columbia Univ, Taub Inst, Dept Pathol & Cell Biol, New York, NY USA; [Mahajan, Vinit B.] Palo Alto Vet Adm, Palo Alto, CA USA		Mahajan, VB (corresponding author), Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Omics Lab, Palo Alto, CA 94304 USA.	vinit.mahajan@standford.edu	Morrison, Barclay/B-7132-2008; arancio, ottavio/AAB-7959-2019	Morrison, Barclay/0000-0001-7676-0864; Newell, Elizabeth/0000-0002-1476-033X; Mahajan, Muktar/0000-0003-1024-6808; Bassuk, Alexander/0000-0002-4067-2157; Mahajan, Vinit/0000-0003-1886-1741; arancio, ottavio/0000-0001-6335-164X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, R01AR059703]; Research to Prevent Blindness (RPB), New York, NYResearch to Prevent Blindness (RPB); Barbara & Donald Jonas Laboratory of Regenerative Medicine; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY024698, R21AG050437, 5P30EY019007, R01EY018213]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5P30CA013696]; Research to Prevent Blindness (RPB) Physician-Scientist AwardResearch to Prevent Blindness (RPB); RPB, New York, NY, USA; Multi-University Research Initiative from the Army Research Office [W911NF-10-1-0526]; National Defense Science & Engineering Graduate Fellowship from the Department of Defense (EWV); Dept. of the Army - USAMRAA [W81XWH12-1-0579]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA013696] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY018213, R01EY024665, R01EY025225, R01EY024698, R01EY026682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR059703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG050437] Funding Source: NIH RePORTER	VBM and AGB are supported by NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698 and R21AG050437]. VBM is supported by Research to Prevent Blindness (RPB), New York, NY. SHT is supported by the Barbara & Donald Jonas Laboratory of Regenerative Medicine and Bernard & Shirlee Brown Glaucoma Laboratory are supported by the National Institute of Health [5P30EY019007, R01EY018213, R01EY024698, R21AG050437], National Cancer Institute Core [5P30CA013696], the Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB, New York, NY, USA. PJF is supported by NIH R01AR059703. CDH, EWV, and BM were supported by a Multi-University Research Initiative from the Army Research Office (W911NF-10-1-0526). EWV was supported by a National Defense Science & Engineering Graduate Fellowship from the Department of Defense (EWV-2012). OA and RN were supported by the Dept. of the Army - USAMRAA (W81XWH12-1-0579).	Allegri Pia, 2011, J Ophthalmic Vis Res, V6, P284; Berkowitz CD, 2017, NEW ENGL J MED, V376, P1659, DOI 10.1056/NEJMcp1701446; Blanch RJ, 2014, INVEST OPHTH VIS SCI, V55, P6350, DOI 10.1167/iovs.13-13708; Blanch RJ, 2013, OPHTHALMOLOGY, V120, P1588, DOI 10.1016/j.ophtha.2013.01.009; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P7220, DOI 10.1167/iovs.12-9887; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Chalioulias K, 2007, J R Army Med Corps, V153, P124; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Faul M, 2010, TRAUMATIC BRAIN INJU; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Kersten HM, 2014, NAT REV NEUROL, V10, P349, DOI 10.1038/nrneurol.2014.79; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; Mahajan Vinit B, 2011, J Vis Exp, DOI 10.3791/3184; Mahajan VB, 2014, PROTEOM CLIN APPL, V8, P204, DOI 10.1002/prca.201300062; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Pieramici DJ, 1997, AM J OPHTHALMOL, V123, P820, DOI 10.1016/S0002-9394(14)71132-8; SIPPERLEY JO, 1978, ARCH OPHTHALMOL-CHIC, V96, P2267, DOI 10.1001/archopht.1978.03910060563021; Skeie JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127567; Skeie JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082140; Skeie JM, 2012, RETINA-J RET VIT DIS, V32, P2141, DOI 10.1097/IAE.0b013e3182562017; Sosin DM, 1996, BRAIN INJURY, V10, P47; VALENTI WM, 1988, INFECT CONT HOSP EP, V9, P289, DOI 10.1086/645857; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	46	11	12	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	MAR	2018	5	3					240	251		10.1002/acn3.523			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY8KF	WOS:000427112500001	29560370	Green Published, gold			2022-02-06	
J	Foreman, B; Albers, D; Schmidt, JM; Falo, CM; Velasquez, A; Connolly, ES; Claassen, J				Foreman, Brandon; Albers, David; Schmidt, J. Michael; Falo, Cristina Maria; Velasquez, Angela; Connolly, E. Sander; Claassen, Jan			Intracortical electrophysiological correlates of blood flow after severe SAH: A multimodality monitoring study	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Critical care; subarachnoid hemorrhage; delayed cerebral ischemia; cerebral blood flow; electroencephalography	DELAYED CEREBRAL-ISCHEMIA; ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; QUANTITATIVE EEG; PRESSURE REACTIVITY; CT PERFUSION; VASOSPASM; INFARCTION; AUTOREGULATION; TOMOGRAPHY	Subarachnoid hemorrhage (SAH) is a devastating form of stroke. Approximately one in four patients develop progressive neurological deterioration and silent infarction referred to as delayed cerebral ischemia (DCI). DCI is a complex, multifactorial secondary brain injury pattern and its pathogenesis is not fully understood. We aimed to study the relationship between cerebral blood flow (CBF) and neuronal activity at both the cortex and in scalp using electroencephalography (EEG) in poor-grade SAH patients undergoing multimodality intracranial neuromonitoring. Twenty patients were included, of whom half had DCI median 4.7 days (interquartile range (IQR): 4.0-5.6) from SAH bleed. The rate of decline in regional cerebral blood flow (rCBF) was significant in both those with and without DCI and occurred between days 4 and 7 post-SAH. The scalp EEG alpha-delta ratio declined early in those with DCI. In the group without DCI, CBF and cortical EEG alpha-delta ratio were correlated (r = 0.53; p < 0.01) and in the group without DCI, inverse neurovascular coupling was observed at CPP < 80 mmHg. We found preliminary evidence that as patients enter the period of highest risk for the development of DCI, the absence of neurovascular coupling may act as a possible pathomechanism in the development of ischemia following SAH.	[Foreman, Brandon; Schmidt, J. Michael; Falo, Cristina Maria; Velasquez, Angela; Claassen, Jan] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Albers, David] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Connolly, E. Sander; Claassen, Jan] Columbia Univ, Dept Neurosurg, New York, NY 10032 USA		Claassen, J (corresponding author), Columbia Univ, Div Crit Care Neurol, Dept Neurol, Coll Phys & Surg, 177 Ft Washington Ave,MHB 8-300, New York, NY 10032 USA.	jc1439@columbia.edu	Claassen, Jan/AAA-5451-2020	Foreman, Brandon/0000-0002-5418-674X	NIH National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [RO1LM06910]; Mayfield Education and Research Foundation; SAGE Therapeutics	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. Albers reports funding through the NIH National Library of Medicine (RO1LM06910); Brandon Foreman receives funding from the Mayfield Education and Research Foundation and consultant fees from SAGE Therapeutics.	Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Carr D., 2014, HEXBIN HEXAGONAL BIN; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cremers CHP, 2015, NEURORADIOLOGY, V57, P897, DOI 10.1007/s00234-015-1543-3; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Curtis CJ, 2014, ECOL INDIC, V37, P274, DOI 10.1016/j.ecolind.2012.10.023; Dankbaar JW, 2011, CEREBROVASC DIS, V32, P133, DOI 10.1159/000328244; Dankbaar JW, 2010, STROKE, V41, P1927, DOI 10.1161/STROKEAHA.109.574392; Dhar R, 2012, STROKE, V43, P1788, DOI 10.1161/STROKEAHA.111.646836; Dorsch N, 2011, ACTA NEUROCHIR SUPPL, V110, P5, DOI 10.1007/978-3-7091-0353-1_1; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Fisher C M, 1977, Neurosurgery, V1, P245; Foreman B, 2016, J CLIN NEUROPHYSIOL, V33, P174, DOI 10.1097/WNP.0000000000000273; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Gollwitzer S, 2015, CLIN NEUROPHYSIOL, V126, P1514, DOI 10.1016/j.clinph.2014.10.215; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Jabbarli R, 2015, J CEREB BLOOD FLOW M, V35, P157; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Johnson U, 2016, NEUROCRIT CARE, V25, P47, DOI 10.1007/s12028-016-0240-3; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; Labovitz DL, 2006, NEUROEPIDEMIOLOGY, V26, P147, DOI 10.1159/000091655; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; MESSICK JM, 1987, ANESTHESIOLOGY, V66, P344, DOI 10.1097/00000542-198703000-00014; Minhas PS, 2003, NEUROSURGERY, V52, P1017, DOI 10.1227/01.NEU.0000058231.08870.1F; NAGATA K, 1989, ELECTROEN CLIN NEURO, V72, P16, DOI 10.1016/0013-4694(89)90027-8; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NEILDWYER G, 1994, ACTA NEUROCHIR, V131, P137, DOI 10.1007/BF01401464; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; Pappas AC, 2015, J NEUROSCI, V35, P13375, DOI 10.1523/JNEUROSCI.1551-15.2015; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; R Core Team, 2014, R LANG ENV STAT COMP; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00089; Rots ML, 2016, NEUROCRIT CARE, V24, P207, DOI 10.1007/s12028-015-0205-y; Sanelli PC, 2013, AM J NEURORADIOL, V34, P292, DOI 10.3174/ajnr.A3225; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; TOLONEN U, 1981, ELECTROEN CLIN NEURO, V51, P177, DOI 10.1016/0013-4694(81)90007-9; Torchiano M, 2014, EFFSIZE EFFICIENT EF; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; van der Schaaf I, 2006, NEUROLOGY, V66, P1533, DOI 10.1212/01.wnl.0000216272.67895.d3; van Rij J., 2015, ITSADUG INTERPRETING; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Washington CW, 2011, NEUROCRIT CARE, V15, P312, DOI 10.1007/s12028-011-9594-8; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	52	11	11	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2018	38	3					506	517		10.1177/0271678X17700433			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	GC0MR	WOS:000429471900012	28387139	Green Published, Bronze			2022-02-06	
J	Howells, T; Smielewski, P; Donnelly, J; Czosnyka, M; Hutchinson, PJA; Menon, DK; Enblad, P; Aries, MJH				Howells, Tim; Smielewski, Peter; Donnelly, Joseph; Czosnyka, Marek; Hutchinson, Peter J. A.; Menon, David K.; Enblad, Per; Aries, Marcel J. H.			Optimal Cerebral Perfusion Pressure in Centers With Different Treatment Protocols	CRITICAL CARE MEDICINE			English	Article						cerebral blood flow; cerebral perfusion pressure; intracranial pressure; traumatic brain injury; treatment protocols	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; VASOMOTOR REACTIVITY; MONITORING DATA; AUTOREGULATION; VARIABILITY; MANAGEMENT; BEDSIDE	Objectives: The three centers in this study have different policies regarding cerebral perfusion pressure targets and use of vasopressors in traumatic brain injury patients. The aim was to determine if the different policies affected the estimation of cerebral perfusion pressure which optimizes the strength of cerebral autoregulation, termed "optimal cerebral perfusion pressure." Design: Retrospective analysis of prospectively collected data. Setting: Three neurocritical care units at university hospitals in Cambridge, United Kingdom, Groningen, the Netherlands, and Uppsala, Sweden. Patients: A total of 104 traumatic brain injury patients were included: 35 each from Cambridge and Groningen, and 34 from Uppsala. Interventions: None. Measurements and Main Results: In Groningen, the cerebral perfusion pressure target was greater than or equal to 50 and less than 70mm Hg, in Uppsala greater than or equal to 60, and in Cambridge greater than or equal to 60 or preferably greater than or equal to 70. Despite protocol differences, median cerebral perfusion pressure for each center was above 70mm Hg. Optimal cerebral perfusion pressure was calculated as previously published and implemented in the Intensive Care Monitoring+ software by the Cambridge group, now replicated in the Odin software in Uppsala. Periods with cerebral perfusion pressure above and below optimal cerebral perfusion pressure were analyzed, as were absolute difference between cerebral perfusion pressure and optimal cerebral perfusion pressure and percentage of monitoring time with a valid optimal cerebral perfusion pressure. Uppsala had the highest cerebral perfusion pressure/optimal cerebral perfusion pressure difference. Uppsala patients were older than the other centers, and age is positively correlated with cerebral perfusion pressure/optimal cerebral perfusion pressure difference. Optimal cerebral perfusion pressure was significantly lower in Groningen than in Cambridge. There were no significant differences in percentage of monitoring time with valid optimal cerebral perfusion pressure. Summary optimal cerebral perfusion pressure curves were generated for the combined patient data for each center. These summary curves could be generated for Groningen and Cambridge, but not Uppsala. The older age of the Uppsala patient cohort may explain the absence of a summary curve. Conclusions: Differences in optimal cerebral perfusion pressure calculation were found between centers due to demographics (age) and treatment (cerebral perfusion pressure targets). These factors should be considered in the design of trials to determine the efficacy of autoregulation-guided treatment.	[Howells, Tim; Enblad, Per] Uppsala Univ Hosp, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Smielewski, Peter; Donnelly, Joseph; Czosnyka, Marek; Hutchinson, Peter J. A.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit,Div Anaesthesia, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Aries, Marcel J. H.] Maastricht Univ, Med Ctr, Dept Crit Care, Maastricht, Netherlands		Howells, T (corresponding author), Uppsala Univ Hosp, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.	timothy.howells@lul.se	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Hutchinson, Peter/0000-0002-2796-1835; czosnyka, marek/0000-0003-2446-8006	National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); NIHR Cambridge BRC; GlaxoSmithKlineGlaxoSmithKline; PfizerPfizer; NeuroTrauma-Sciences; NIHR, United Kingdom; European UnionEuropean Commission [602150]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0502030, G0601025, G0600986, G1002277] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G0600986, G1002277, G0502030] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, 12/35/57, II-C5-0715-20005, 13/15/02] Funding Source: researchfish	Drs. Smielewski and Czosnyka disclosed that they receive part of the licensing fees of the software Intensive Care Monitoring+ used in data collection and analysis for this article. Dr. Hutchinson is supported by a National Institute for Health Research (NIHR) Research Professorship and the NIHR Cambridge BRC. Dr. Menon's institution received funding from GlaxoSmithKline; he received funding from Pfizer and NeuroTrauma-Sciences; he disclosed that he has or has had collaborative research or consultancy agreements with Ornim Medical, Shire Medical, Calico Inc, Pressura Ltd, Glide Pharma Ltd, and Lantasman AB; and he received support for article research from the NIHR, United Kingdom. Dr. Menon is supported by the NIHR, United Kingdom, through a Senior Investigator Award and funding provided to the NIHR Cambridge Biomedical Centre and by the European Union through a FP-7 grant for the CENTER-TBI Study (Agreement Number: 602150). The remaining authors have declared that they do not have any potential conflicts of interest.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bullock MR, 1996, J NEUROTRAUM, V13, P693; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cicconetti P, 2000, ARCH GERONTOL GERIAT, V30, P225, DOI 10.1016/S0167-4943(00)00052-2; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Imai Y, 1997, AM J HYPERTENS, V10, P1281, DOI 10.1016/S0895-7061(97)00277-X; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Smielewski P, 2005, ACT NEUR S, V95, P43; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P507; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11	19	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAR	2018	46	3					e235	e241		10.1097/CCM.0000000000002930			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX7WE	WOS:000426301500007	29293154	Green Submitted			2022-02-06	
J	Klein, LR; Martel, ML; Driver, BE; Reing, M; Cole, JB				Klein, Lauren R.; Martel, Marc L.; Driver, Brian E.; Reing, Mackenzie; Cole, Jon B.			Emergency Department Frequent Users for Acute Alcohol Intoxication	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							PROMINENT RISK-FACTORS	Introduction: A subset of frequent users of emergency services are those who use the emergency department (ED) for acute alcohol intoxication. This population and their ED encounters have not been previously described. Methods: This was a retrospective, observational, cohort study of patients presenting to the ED for acute alcohol intoxication between 2012 and 2016. We collected all data from the electronic medical record. Frequent users for alcohol intoxication were defined as those with greater than 20 visits for acute intoxication without additional medical chief complaints in the previous 12 months. We used descriptive statistics to evaluate characteristics of frequent users for alcohol intoxication, as well as their ED encounters. Results: We identified 32,121 patient encounters. Of those, 325 patients were defined as frequent users for alcohol intoxication, comprising 11,370 of the encounters during the study period. The median maximum number of encounters per person for alcohol intoxication in a one-year period was 47 encounters (range 20 to 169). Frequent users were older (47 years vs. 39 years), and more commonly male (86% vs. 71%). Frequent users for alcohol intoxication had higher rates of medical and psychiatric comorbidities including liver disease, chronic kidney disease, ischemic vascular disease, dementia, chronic obstructive pulmonary disease, history of traumatic brain injury, schizophrenia, and bipolar disorder. Conclusion: In this study, we identified a group of ED frequent users who use the ED for acute alcohol intoxication. This population had higher rates of medical and psychiatric comorbidities compared to non-frequent users.	[Klein, Lauren R.; Martel, Marc L.; Driver, Brian E.; Reing, Mackenzie; Cole, Jon B.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA		Klein, LR (corresponding author), Hennepin Cty Med Ctr, 701 Pk Ave South, Minneapolis, MN 55415 USA.	lauren.klein@hcmed.org	Cole, Jon B/J-5788-2019	Cole, Jon B/0000-0002-7714-8826			Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Biros MH, 1996, ACAD EMERG MED, V3, P853, DOI 10.1111/j.1553-2712.1996.tb03530.x; Curran GM, 2003, ANN EMERG MED, V41, P659, DOI 10.1067/mem.2003.154; Doupe MB, 2012, ANN EMERG MED, V60, P24, DOI 10.1016/j.annemergmed.2011.11.036; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Leporatti L, 2016, HEALTH POLICY, V120, P462, DOI 10.1016/j.healthpol.2016.03.005; Locker TE, 2007, EMERG MED J, V24, P398, DOI 10.1136/emj.2006.043844; Mullins PM, 2017, ALCOHOL ALCOHOLISM, V52, P119, DOI 10.1093/alcalc/agw074; Pines Jesse M, 2011, Acad Emerg Med, V18, pe64, DOI 10.1111/j.1553-2712.2011.01086.x; Thornquist L, 2002, ACAD EMERG MED, V9, P300, DOI 10.1111/j.1553-2712.2002.tb01323.x; Whiteman PJ, 2000, ACAD EMERG MED, V7, P14, DOI 10.1111/j.1553-2712.2000.tb01884.x	11	11	11	0	3	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	MAR	2018	19	2					398	402		10.5811/westjem.2017.10.35052			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GH2SD	WOS:000433251200027	29560072	gold, Green Published			2022-02-06	
J	Martins, BD; Torres, BBJ; de Oliveira, KM; Lavor, MS; Osorio, CM; Fukushima, FB; Rosado, IR; de Melo, EG				Martins, Bernardo De Caro; Junta Torres, Bruno Benetti; de Oliveira, Karen Maciel; Lavor, Mario Sergio; Osorio, Carla Maria; Fukushima, Fabiola Bono; Rosado, Isabel Rodrigues; de Melo, Eliane Goncalves			Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats	SPINE JOURNAL			English	Article						Clinical recovery; Dantrolene; Excitotoxicity inhibition; Neuron preservation; Riluzole; Spinal cord injury	FOCAL CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; APOPTOSIS IN-VITRO; TRAUMATIC INJURY; RYANODINE RECEPTOR; PHASE-I; CHANNELS; MODEL; NEUROPROTECTION; MOTONEURONS	BACKGROUND CONTEXT: Damage to the spinal cord can result in irreversible impairment or complete loss of motor, sensory, and autonomic functions. Riluzole and dantrolene have been shown to provide neuroprotection by reducing neuronal apoptosis after brain and spinal cord injury (SCI) in several animal models of neurologic disorders. As these drugs protect the injured spinal cord through different mechanisms, we investigated the cumulative effects of riluzole and dantrolene. PURPOSE: This study aimed to investigate the neuroprotective efficacy of the combined administration of riluzole and dantrolene in experimental thoracic SCI. STUDY DESIGN: Twenty-nineWistar rats were laminectomized at T12 and divided in five groups. Rats in GI (n=6) underwent laminectomy alone and were treated with placebo. Rats in GII (n=6) underwent laminectomy followed by SCI and were treated with placebo. Rats in GIII (n=5) underwent laminectomy followed by SCI and were treated with riluzole and placebo 15 minutes and 1 hour after laminectomy, respectively. Rats in GIV (n=6) underwent laminectomy followed by SCI and were treated with placebo and dantrolene 15 minutes and 1 hour after laminectomy, respectively. Rats in GV (n=6) underwent laminectomy followed by SCI and were treated with riluzole and dantrolene 15 minutes and 1 hour after laminectomy, respectively. A compressive trauma was performed to induce SCI. METHODS: Behavioral testing of hind limb function was performed using the Basso Beattie Bresnahan locomotor rating scale, which revealed significant recovery in the group treated with the association of riluzole and dantrolene compared with other groups. After euthanasia, the spinal cord was evaluated using light microscopy and immunochemistry with anti-NeuN and transferase dUTP nick-end-labeling (TUNEL) staining. RESULTS: Animals treated with the association of riluzole and dantrolene showed a larger number of NeuN-positive neurons adjacent to the epicenter of injury (p <=.05). Furthermore, the TUNEL staining was similar between animals treated with riluzole and dantrolene and those that did not receive spinal cord trauma (p>.05). CONCLUSIONS: These results showed that riluzole and dantrolene have a synergistic effect in neuroprotection after traumatic SCI by decreasing apoptotic cell death. (C) 2017 Elsevier Inc. All rights reserved.	[Martins, Bernardo De Caro; Junta Torres, Bruno Benetti; de Oliveira, Karen Maciel; Lavor, Mario Sergio; Osorio, Carla Maria; Fukushima, Fabiola Bono; Rosado, Isabel Rodrigues; de Melo, Eliane Goncalves] Univ Fed Minas Gerais, Vet Hosp, Clin & Surg Dept, Belo Horizonte, MG, Brazil		Martins, BD (corresponding author), Univ Fed Minas Gerais, Vet Hosp, Clin & Surg Dept, Belo Horizonte, MG, Brazil.	bernardodcmartins@hotmail.com	Torres, Bruno Benetti Junta/AAX-9672-2020; DE LAVOR, MARIO SERGIO LIMA/Y-4138-2019; Fukushima, Fabiola Bono/ABG-2548-2020	Torres, Bruno Benetti Junta/0000-0002-6400-046X; DE LAVOR, MARIO SERGIO LIMA/0000-0003-0795-5320; Fukushima, Fabiola Bono/0000-0001-9843-8374			Ahuja CS, 2016, STEM CELL TRANSL MED, V5, P914, DOI 10.5966/sctm.2015-0381; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Aslan A, 2009, EUR SPINE J, V18, P1442, DOI 10.1007/s00586-009-1033-6; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BENAZZOUZ A, 1995, EUR J PHARMACOL, V284, P299, DOI 10.1016/0014-2999(95)00362-O; BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603, DOI 10.1007/BF00370302; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Chow DSL, 2012, J NEUROSURG-SPINE, V17, P129, DOI 10.3171/2012.5.AOSPINE12112; Cifra A, 2013, NEUROSCIENTIST, V19, P137, DOI 10.1177/1073858412444932; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; Fehlings MG, 2012, J NEUROSURG-SPINE, V17, P151, DOI 10.3171/2012.4.AOSPINE1259; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Gwak M, 2008, ANESTH ANALG, V106, P227, DOI 10.1213/01.ane.0000287663.81050.38; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hassanzadeh K, 2011, PHARMACOL REP, V63, P697, DOI 10.1016/S1734-1140(11)70581-3; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; Torres BBJ, 2010, INT J EXP PATHOL, V91, P530, DOI 10.1111/j.1365-2613.2010.00738.x; Kitzman PH, 2009, NEUROSCI LETT, V455, P150, DOI 10.1016/j.neulet.2009.03.016; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Kocogullari CU, 2008, THORAC CARDIOV SURG, V56, P406, DOI 10.1055/s-2008-1038731; Koh JY, 1999, J NEUROCHEM, V72, P716, DOI 10.1046/j.1471-4159.1999.0720716.x; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; Li F, 2005, BRAIN RES, V1048, P59, DOI 10.1016/j.brainres.2005.04.058; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mazzone GL, 2011, NEUROSCIENCE, V190, P318, DOI 10.1016/j.neuroscience.2011.06.013; Meininger V, 2000, J NEUROL, V247, P19; Mu X., 1997, Society for Neuroscience Abstracts, V23, P1384; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nagoshi N, 2015, EXPERT OPIN INV DRUG, V24, P645, DOI 10.1517/13543784.2015.1009629; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Nogradi A, 2007, NEUROSCIENCE, V144, P431, DOI 10.1016/j.neuroscience.2006.09.046; Oliveira KM, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-15; Oliveira KM, 2014, INT J CLIN EXP PATHO, V7, P3524; Popescu BO, 2002, J CELL MOL MED, V6, P555, DOI 10.1111/j.1582-4934.2002.tb00454.x; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; Satkunendrarajah K, 2016, EXP NEUROL, V276, P59, DOI 10.1016/j.expneurol.2015.09.011; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Schwartz G, 2002, PROG BRAIN RES, V137, P177; Shortland PJ, 2006, EUR J NEUROSCI, V24, P3343, DOI 10.1111/j.1460-9568.2006.05218.x; Siniscalchi A, 1999, SYNAPSE, V32, P147, DOI 10.1002/(SICI)1098-2396(19990601)32:3<147::AID-SYN1>3.3.CO;2-G; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Springer JE, 2000, J NEUROSCI, V20, P7246; Stutzmann JM, 1996, NEUROREPORT, V7, P387, DOI 10.1097/00001756-199601310-00003; Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116; Thorell WE, 2002, J NEUROTRAUM, V19, P335, DOI 10.1089/089771502753594909; Torres BBJ, 2010, ARQ BRAS MED VET ZOO, V62, P92, DOI 10.1590/S0102-09352010000100013; Torres B. B. Junta, 2016, SPINE, V4, P1066; Torres B, 2011, PATHOL RES PRACT, V207, P775, DOI 10.1016/j.prp.2011.10.004; Vasconcelos NL, 2016, SPINE J, V16, P1015, DOI 10.1016/j.spinee.2016.04.013; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q; Wei HF, 2000, J NEUROCHEM, V75, P81, DOI 10.1046/j.1471-4159.2000.0750081.x; Wei HF, 1996, J NEUROCHEM, V67, P2390; Wilson JR, 2014, WORLD NEUROSURG, V81, P825, DOI 10.1016/j.wneu.2013.01.001; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; Wu Y, 2014, NEUROSCIENCE, V265, P302, DOI 10.1016/j.neuroscience.2014.01.059; ZHANG L, 1993, NEUROSCI LETT, V158, P105, DOI 10.1016/0304-3940(93)90623-S; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	66	11	12	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	MAR	2018	18	3					532	539		10.1016/j.spinee.2017.10.067			8	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	FZ5FM	WOS:000427617300018	29155254				2022-02-06	
J	Plourde, V; Hrabok, M; Sherman, EMS; Brooks, BL				Plourde, Vickie; Hrabok, Marianne; Sherman, Elisabeth M. S.; Brooks, Brian L.			Validity of a Computerized Cognitive Battery in Children and Adolescents with Neurological Diagnoses	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Childhood neurologic disorders; Assessment; Convergent and divergent validity	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; PROCESSING SPEED; IMPACT	Objective: Little is known about the validity of computerized cognitive batteries, such as CNS Vital Signs (CNSVS), in pediatric patients. The purpose of this study was to examine convergent and divergent validity of the CNSVS in a clinical pediatric sample with neurological diagnoses. Method: Participants included 123 pediatric patients assessed in a tertiary care setting as part of clinical care. CNSVS (Memory, Psychomotor Speed, Reaction Time, Complex Attention, and Cognitive Flexibility domains, and a Neurocognition Index) and paper-and-pencil neuropsychological measures assessing learning, memory, processing speed, reaction time, attention, and executive functioning were administered Results: Most correlations between CNSVS domain scores and neuropsychological measures assessing similar constructs were medium in strength. With the exception of stronger correlations between psychomotor speed tests, correlations between tests of similar constructs were not significantly higher than those between dissimilar constructs. Conclusions: These results provide support for validity of the CNSVS battery, but also caution that many abilities are inter-correlated.	[Plourde, Vickie; Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Plourde, Vickie; Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Paediat, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada; [Hrabok, Marianne] Alberta Hlth Serv, Addict & Mental Hlth, Edmonton, AB, Canada; [Hrabok, Marianne] Univ Alberta, Dept Psychiat, Fac Med & Dent, Edmonton, AB, Canada; [Sherman, Elisabeth M. S.] Copeman Healthcare Ctr, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Brain Injury & Rehabil Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Arts, Dept Psychol, Calgary, AB, Canada		Plourde, V (corresponding author), Univ Calgary, Cumming Sch Med, Dept Paediat, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	vickie.plourde@ucalgary.ca		Plourde, Vickie/0000-0002-0098-5431	Integrated Concussion Research Program at the University of Calgary; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute; Alberta Innovates Health Solutions; Cumming School of Medicine at the University of Calgary; Alberta Innovates [201610079] Funding Source: researchfish	Dr. Brian Brooks acknowledges salary funding from the Canadian Institutes of Health Research (CIHR). Dr. Vickie Plourde was financially supported for her fellowship by the Alberta Children's Hospital Research Institute, the Integrated Concussion Research Program at the University of Calgary, Cumming School of Medicine at the University of Calgary, and Alberta Innovates Health Solutions.	Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Bozkurt H., 2016, APPL NEUROPSYCHOLOGY; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crook T. H., 2009, NEUROPSYCHOLOGICAL A, P84; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; Dede E., 2015, NEUROLOGY PSYCHIAT B, V21, P128, DOI DOI 10.1016/J.NPBR.2015.07.003; Delis D, 1994, MANUAL CALIFORNIA VE; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Korkman M., 2007, NEPSY 2 CLIN INTERPR, V2nd ed ed; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Newman JB, 2013, CLIN NEUROPSYCHOL, V27, P779, DOI 10.1080/13854046.2013.789552; Ozer S., 2015, CHILD NEUROPSYCHOLOG; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Sherman EMS, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P873, DOI 10.1007/978-0-387-76978-3_30; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Wechsler D, 2003, WECHSLER INTELLIGENC	22	11	11	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2018	33	2					247	253		10.1093/arclin/acx067			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY4QD	WOS:000426808700011	28981565	Green Published, Bronze			2022-02-06	
J	Rieger, B; Lewandowski, L; Potts, H; Potter, K; Chin, LS				Rieger, Brian; Lewandowski, Lawrence; Potts, Heather; Potter, Kyle; Chin, Lawrence S.			Parent Knowledge and Perceptions of Concussion Related to Youth Football	CUREUS			English	Article						concussion; pediatric; sport; parent; education; youth football	BRAIN-INJURY; SPORTS; SYMPTOMS; COACHES; SCHOOL	Introduction There is increased concern about concussion in youth athletes, yet there is little research on parent knowledge of concussion. Purpose The purpose of the current study was to investigate attitudes to and knowledge of concussion among parents of youth football players. Methods We surveyed 180 parents/guardians of youth football players, ages 5-12, regarding their knowledge and beliefs concerning concussion. Results We found that the vast majority of respondents (86%) had confidence in their ability to recognize concussions. Yet, a significant number also held misconceptions about concussions, such as 'too much sleep' (48%) or 'eating certain foods' (26%) make concussion symptoms worse. Most (82%) had not heard of the Zurich guidelines, and less than half (44%) were aware that sustained mental activity could worsen symptoms. Parents were concerned about their child sustaining a concussion, but a substantial minority also reported 'serious concern' about their children losing playing time or their position. Discussion Results are somewhat positive in terms of parents' general knowledge of concussions; yet, response variability and misconceptions point to a continued need for concussion education for parents. Medical professionals can play an important role in informing families about concussion symptoms, management, and recovery.	[Rieger, Brian] SUNY Upstate Med Univ, Phys Med & Rehabil, Syracuse, NY 13210 USA; [Lewandowski, Lawrence; Potts, Heather; Potter, Kyle] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA		Rieger, B (corresponding author), SUNY Upstate Med Univ, Phys Med & Rehabil, Syracuse, NY 13210 USA.	riegerb@upstate.edu					[Anonymous], 2014, POLL FINDS 40 WOULD; [Anonymous], 2015, TRAUMATIC BRAIN INJU; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Covassin T, 2013, SPORT PSYCHOL, V27, P372, DOI 10.1123/tsp.27.4.372; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heads up, 2017, HEADS UP; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Limited contact in practice rule, 2013, LTD CONTACT PRACTICE; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Ralph A, 2013, BRAIN INJURY, V27, P1475, DOI 10.3109/02699052.2013.823653; Simon LM, 2016, CURR SPORT MED REP, V15, P161, DOI 10.1249/JSR.0000000000000268; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036	26	11	11	0	5	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAR	2018	10	3							e2268	10.7759/cureus.2268			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HB3FX	WOS:000450937400020	29736353	Green Published, gold, Green Submitted			2022-02-06	
J	Seemann, R; Graef, F; Garbe, A; Keller, J; Huang, F; Duda, G; Schmidt-Bleek, K; Schaser, KD; Tsitsilonis, S				Seemann, R.; Graef, F.; Garbe, A.; Keller, J.; Huang, F.; Duda, G.; Schmidt-Bleek, K.; Schaser, K-D.; Tsitsilonis, S.			Leptin-deficiency eradicates the positive effect of traumatic brain injury on bone healing: histological analyses in a combined trauma mouse model	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						Fracture Healing; Bone; Brain; Mouse	CONTROLLED CORTICAL IMPACT; CALLUS FORMATION; HEAD-INJURY; FEMORAL FRACTURE; OB/OB MICE; DIFFERENTIATION; MINERALIZATION; ABNORMALITIES; GROWTH; UNION	Introduction: The combination of traumatic brain injury (TBI) and long-bone fracture leads to increased formation of callus and mineral density in wild-type (WT) mice. However, this effect was not detected radiologically in leptin-deficient mice. Due to the complex interactions between hormonal and bone metabolism and the important role of leptin in this setting, our aim was to investigate morphologic properties and the tissue composition in the fracture callus comparing WT and leptin-deficient mice. Methods: Female C57/Black6N mice (n=36) and leptin deficient ob/ob mice (n=36) each were assigned to two groups (fracture Fx/combined trauma Fx/TBI). Femoral osteotomy was stabilized with external fixator, TBI was induced with controlled cortical impact injury. After sacrifice of the animals, femora were harvested, cryofixated, and 7 mu m slices were prepared. Staining was performed adhering to Movat's Pentachrome protocol. Histomorphometric analysis, quantifying percentage of mineralized bone area, and a semi-quantitative evaluation of bone bridging were performed. Results: Leptin deficient mice showed a higher rate of non-union after osteotomy, less callus formation in the osteotomy gap, and unexpected bone and cartilage formation independent of the osteotomy region. Discussion: Leptin plays an important role in fracture healing and bone formation. Without Leptin, the positive effect of TBI on fracture healing ceases. The comprehension of the underlying pathophysiological process could sign important for novel strategies in stimulation of fracture healing.	[Seemann, R.; Graef, F.; Garbe, A.; Keller, J.; Huang, F.; Tsitsilonis, S.] Charite, Ctr Musculoskeletal Surg, Augustenburger Pl 1, D-13353 Berlin, Germany; [Duda, G.; Schmidt-Bleek, K.] Charite, Julius Wolff Inst, Augustenburger Pl 1, D-13353 Berlin, Germany; [Keller, J.; Duda, G.; Schmidt-Bleek, K.; Tsitsilonis, S.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany; [Schaser, K-D.] Univ Hosp Carl Gustav Carus Dresden, Univ Ctr Orthoped & Trauma Surg, Fetscherstr 74, D-01307 Dresden, Germany		Seemann, R (corresponding author), Charite, Ctr Musculoskeletal Surg, Augustenburger Pl 1, D-13353 Berlin, Germany.	ricarda.seemann@charite.de	Schmidt-Bleek, Katharina/O-9816-2015; Duda, Georg/H-2085-2016	Seemann, Ricarda/0000-0001-5752-070X; Graef, Frank/0000-0002-0435-9059; Duda, Georg/0000-0001-7605-3908	German Research Society (DFG)German Research Foundation (DFG) [TS 303/1-1]	This study was funded by the German Research Society (DFG, project TS 303/1-1).	Beil FT, 2011, J TRAUMA, V70, P857, DOI 10.1097/TA.0b013e3181de3dd9; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Burguera B, 2001, PHYSIOL BEHAV, V74, P717, DOI 10.1016/S0031-9384(01)00615-1; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CALANDRIELLO B, 1964, Bull Hosp Joint Dis, V25, P170; Cheung KMC, 2003, J ORTHOP RES, V21, P685, DOI 10.1016/S0736-0266(03)00026-3; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ealey KN, 2006, REGUL PEPTIDES, V136, P9, DOI 10.1016/j.regpep.2006.04.013; Friedman J, 2016, J CLIN INVEST, V126, P4727, DOI 10.1172/JCI91578; Garcia P, 2013, EUR CELLS MATER, V26, P1; Gat-Yablonski G, 2008, CURR OPIN CLIN NUTR, V11, P303, DOI 10.1097/MCO.0b013e3282f795cf; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Gordeladze JO, 2002, J CELL BIOCHEM, V85, P825, DOI 10.1002/jcb.10156; Graef F, 2017, J MUSCULOSKEL NEURON, V17, P78; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Iwaniec UT, 2007, PEPTIDES, V28, P1012, DOI 10.1016/j.peptides.2007.02.001; Khan SN, 2013, J ORTHOP TRAUMA; Kishida Y, 2005, BONE, V37, P607, DOI 10.1016/j.bone.2005.05.009; Kooistra BW, 2010, J ORTHOP TRAUMA, V24, pS81, DOI 10.1097/BOT.0b013e3181ca3fd1; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Mehta M, 2010, BONE, V47, P219, DOI 10.1016/j.bone.2010.05.029; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Roszer T, 2014, CELL TISSUE RES, V356, P195, DOI 10.1007/s00441-013-1768-6; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Yan H, 2013, NEUROL RES; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193	39	11	12	0	6	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	MAR	2018	18	1					32	41					10	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	FZ2QD	WOS:000427424400004	29504576				2022-02-06	
J	Tarazi, A; Tator, CH; Wennberg, R; Ebraheem, A; Green, REA; Collela, B; Saverino, C; Khodadadi, M; Misquitta, K; Tartaglia, MC				Tarazi, Apameh; Tator, Charles H.; Wennberg, Richard; Ebraheem, Ahmed; Green, Robin E. A.; Collela, Brenda; Saverino, Christina; Khodadadi, Mozghan; Misquitta, Karen; Tartaglia, Maria Carmela			Motor Function in Former Professional Football Players with History of Multiple Concussions	JOURNAL OF NEUROTRAUMA			English	Article						chronic traumatic encephalopathy; concussion; professional athletes	TRAUMATIC BRAIN-INJURY; DISEASE; SPORT; ENCEPHALOPATHY; STATEMENT; SPECTRUM	The objective of this study was to assess the incidence of motor impairment in former professional Canadian Football League (ex-CFL) players with multiple concussions. We investigated motor symptoms and signs in 45 ex-CFL players with multiple concussions and 25 age- and education-matched healthy controls with no history of concussion. Neurological assessment included items from the SCAT3 (Sport Concussion Assessment Tool 3) and the Unified Parkinson's Disease Rating Scale part III (UPDRS-Part III). A performance-based measurement of manual motor function was undertaken using the Grooved Pegboard test. Cognition was measured with patient-reported outcomes for memory, executive and behavioral symptoms as well as performance-based measures of memory and executive function. Symptoms of anxiety and depression were measured using the Personality Assessment Inventory. There was no significant difference between the ex-CFL players and controls on the UPDRS-Part III scores, and neither group reported clinically significant motor complaints. Ex-CFL players did not perform differently from control subjects on the Grooved Pegboard test. In contrast, with regard to cognitive and mood testing, players were more symptomatic: The ex-CFL players reported significantly more memory (77.8% vs. 16%, respectively, p<0.001), executive (53.3% vs. 8%, respectively, p<0.001), and behavioral symptoms (66.7% vs. 20%, respectively, p<0.001). No significant differences were found when comparing ex-CFL players and controls in performance on memory and executive tests. In summary, in a group of retired CFL players who self-reported declines in memory, executive and behavioral symptoms, no motor symptoms were reported and no motor signs were detected.	[Tarazi, Apameh; Tator, Charles H.; Wennberg, Richard; Ebraheem, Ahmed; Green, Robin E. A.; Collela, Brenda; Khodadadi, Mozghan; Tartaglia, Maria Carmela] Canadian Concuss Ctr, Toronto, ON, Canada; [Tarazi, Apameh; Tator, Charles H.; Wennberg, Richard; Khodadadi, Mozghan; Tartaglia, Maria Carmela] Toronto Western Hosp, Concuss Res Clin, Toronto, ON, Canada; [Tator, Charles H.; Tartaglia, Maria Carmela] Univ Toronto, Krembil Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Krembil Neurosci Ctr, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Wennberg, Richard; Tartaglia, Maria Carmela] Toronto Western Hosp, Krembil Neurosci Ctr, Dept Med, Div Neurol, Toronto, ON, Canada; [Misquitta, Karen; Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Green, Robin E. A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Green, Robin E. A.; Collela, Brenda] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada; [Green, Robin E. A.; Collela, Brenda; Saverino, Christina] Toronto Rehabil Inst, Toronto, ON, Canada		Tartaglia, MC (corresponding author), Toronto Western Hosp, 399 Bathurst St,WW5-449, Toronto, ON M5T 2S8, Canada.	Carmela.tartaglia@uhn.ca		Green, Robin/0000-0001-9451-3963			Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dadar M., 2016, ALZHEIMERS DEMENT, V12, pP71; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Goswami R, 2014, BRAIN INJURY, V28, P592; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Misquitta K., 2016, ALZHEIMERS DEMENT, V12, pP1110; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9	33	11	11	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	8					1003	1007		10.1089/neu.2017.5290		MAR 2018	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0DM	WOS:000426666000001	29256818				2022-02-06	
J	Vasquez, BP; Tomaszczyk, JC; Sharma, B; Colella, B; Green, REA				Vasquez, Brandon P.; Tomaszczyk, Jennifer C.; Sharma, Bhanu; Colella, Brenda; Green, Robin E. A.			Longitudinal Recovery of Executive Control Functions After Moderate-Severe Traumatic Brain Injury: Examining Trajectories of Variability and Ex-Gaussian Parameters	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; variability; ex-Gaussian; recovery; postacute decline; executive control; attention; neurodegeneration	REACTION-TIME; INTRAINDIVIDUAL VARIABILITY; SUSTAINED ATTENTION; PERFORMANCE VARIABILITY; HEAD-INJURY; FOLLOW-UP; COGNITION	Background. Executive control deficits are deleterious and enduring consequences of moderate-severe traumatic brain injury (TBI) that disrupt everyday functioning. Clinically, such impairments can manifest as behavioural inconsistency, measurable experimentally by the degree of variability across trials of a reaction time (RT) task (also known as intraindividual variability [IIV]). Growing research on cognition after TBI points to cognitive deterioration in the chronic stages postinjury. Objective. To examine the longitudinal recovery of RT characteristics (IIV and more detailed ex-Gaussian components, as well as the number of impulsively quick responses) following moderate-severe TBI. Methods. Seventy moderate-severe TBI patients were assessed at 2, 5, 12, and 24+ months postinjury on a go/no-go RT task. RT indices (ex-Gaussian parameters mu and sigma [mean and variability of the normal distribution component], and tau [extremely slow responses]; mean, intraindividual coefficient of variation [ICV], and intraindividual standard deviation [ISD]) were analyzed with repeated-measures multivariate analysis of variance. Results. ICV, ISD, and ex-Gaussian tau significantly decreased (ie, improved) over time in the first year of injury, but worsened from 1 to 2+ years, as did the frequency of extremely fast responses. These quadratic patterns were accentuated by age and shown primarily in tau (extremely slow) and extremely fast (impulsive) responses. Conclusions. The pattern of early recovery followed by decline in executive control function is consistent with growing evidence that moderate-severe TBI is a progressive and degenerative disorder. Given the responsiveness to treatment of executive control deficits, elucidating the trajectory and underpinnings of inconsistent behavioral responding may reveal novel prognostic and clinical management opportunities.	[Vasquez, Brandon P.; Tomaszczyk, Jennifer C.; Sharma, Bhanu; Colella, Brenda; Green, Robin E. A.] Toronto Rehabil Inst, Toronto, ON, Canada; [Sharma, Bhanu] McMaster Univ, Hamilton, ON, Canada; [Green, Robin E. A.] Univ Toronto, Toronto, ON, Canada		Green, REA (corresponding author), Toronto Rehabil Inst, Res Dept, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	robin.green@uhn.ca	Vasquez, Brandon/L-9798-2019	Green, Robin/0000-0001-9451-3963	Canada Research ChairsCanada Research ChairsCGIAR [950-211602, 950-230647]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 86704]; Physicians Services Inc. Foundation [1243]; Ontario Neurotrauma Foundation [2007517]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by grants from Canada Research Chairs (950-211602 & 950-230647), Canadian Institutes of Health Research (MOP 86704), Physicians Services Inc. Foundation (1243), and Ontario Neurotrauma Foundation (2007517).	Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bielak AAM, 2014, DEV PSYCHOL, V50, P143, DOI 10.1037/a0032650; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone K., 2014, HDB NEUROPSYCHOLOGY, P191, DOI [10.1007/978-1-4939-0784-7_10, DOI 10.1007/978-1-4939-0784-7_10]; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dykiert D, 2012, DEV PSYCHOL, V48, P1262, DOI 10.1037/a0027550; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Garrett DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00101; Gmehlin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112298; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Green REA, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00615; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hultsch D. F., 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MacDonald SWS, 2006, J CLIN EXP NEUROPSYC, V28, P655, DOI 10.1080/13803390590954245; MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Sinclair KL, 2013, J CLIN EXP NEUROPSYC, V35, P210, DOI 10.1080/13803395.2012.762340; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Vasquez BP, 2016, J GERONTOL B-PSYCHOL, V71, P189, DOI 10.1093/geronb/gbu140; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Williams BR, 2005, NEUROPSYCHOLOGY, V19, P88, DOI 10.1037/0894-4105.19.1.88	38	11	11	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAR	2018	32	3					191	199		10.1177/1545968318760727			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GD4MW	WOS:000430478300001	29561244	Bronze			2022-02-06	
J	Garg, C; Seo, JH; Ramachandran, J; Loh, JM; Calderon, F; Contreras, JE				Garg, Charu; Seo, Joon Ho; Ramachandran, Jayalakshmi; Loh, Ji Meng; Calderon, Frances; Contreras, Jorge E.			Trovafloxacin attenuates neuroinflammation and improves outcome after traumatic brain injury in mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Brain injury; Neuroinflammation; Microglia; Pannexin; Hemichannel	CONTROLLED CORTICAL IMPACT; BRILLIANT BLUE FCF; PANNEXIN 1; ATP RELEASE; ALPHA AGONIST; CHANNELS; ACTIVATION; MECHANISMS; INFLAMMATION; INHIBITION	Background: Trovafloxacin is a broad-spectrum antibiotic, recently identified as an inhibitor of pannexin-1 (Panx1) channels. Panx1 channels are important conduits for the adenosine triphosphate (ATP) release from live and dying cells that enhances the inflammatory response of immune cells. Elevated extracellular levels ATP released upon injury activate purinergic pathways in inflammatory cells that promote migration, proliferation, phagocytosis, and apoptotic signals. Here, we tested whether trovafloxacin administration attenuates the neuroinflammatory response and improves outcomes after brain trauma. Methods: The murine controlled cortical impact (CCI) model was used to determine whether in vivo delivery of trovafloxacin has anti-inflammatory and neuroprotective actions after brain trauma. Locomotor deficit was assessed using the rotarod test. Levels of tissue damage markers and inflammation were measured using western blot, qPCR, and immunofluorescence. In vitro assays were used to evaluate whether trovafloxacin blocks ATP release and cell migration in a chemotactic-stimulated microglia cell line. Results: Trovafloxacin treatment of CCI-injured mice significantly reduced tissue damage markers and improved locomotor deficits. In addition, trovafloxacin treatment significantly reduced mRNA levels of several pro-inflammatory cytokines (IL-1 beta, IL-6, and TNF-alpha), which correlates with an overall reduction in the accumulation of inflammatory cell types (neutrophils, microglia/macrophages, and astroglia) at the injury zone. To determine whether trovafloxacin exerted these effects by direct action on immune cells, we evaluated its effect on ATP release and cell migration using a chemotactic-stimulated microglial cell line. We found that trovafloxacin significantly inhibited both ATP release and migration of these cells. Conclusion: Our results show that trovafloxacin administration has pronounced anti-inflammatory and neuroprotective effects following brain injury. These findings lay the foundation for future studies to directly test a role for Panx1 channels in pathological inflammation following brain trauma.	[Garg, Charu; Seo, Joon Ho; Ramachandran, Jayalakshmi; Calderon, Frances; Contreras, Jorge E.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave, Newark, NJ 07103 USA; [Loh, Ji Meng] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA		Calderon, F; Contreras, JE (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave, Newark, NJ 07103 USA.	calderfr@njms.rutgers.edu; contrejo@njms.rutgers.edu	Loh, Ji Meng Meng/AAW-6592-2021	Contreras, Jorge Enrique/0000-0001-9203-1602	New Jersey Commission for Brain Injury Research [CBIR14FEL006, CBIR13IRG015, CBIR15IRG018]; Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [D34HP26020]	This research was supported by the New Jersey Commission for Brain Injury Research (Pre-doctoral CBIR14FEL006 to C. Garg, CBIR13IRG015 to F. Calderon, CBIR15IRG018 to J.E. Contreras) and Health Resources and Services Administration through grant D34HP26020 to New Jersey Medical School Hispanic Center of Excellence (to support F. Calderon and J.E. Contreras).	Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Angus JA, 2016, EUR J PHARMACOL, V791, P179, DOI 10.1016/j.ejphar.2016.08.035; Avanzato D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32602; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Bargiotas P, 2012, CHANNELS, V6, P453, DOI 10.4161/chan.22315; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brough D, 2009, EUR J IMMUNOL, V39, P352, DOI 10.1002/eji.200838843; BROWN JP, 1980, FOOD COSMET TOXICOL, V18, P1, DOI 10.1016/0015-6264(80)90002-4; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen J, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00656; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chiu YH, 2014, CHANNELS, V8, P1, DOI 10.4161/chan.27545; Cisneros-Mejorado A, 2015, J CEREBR BLOOD F MET, V35, P843, DOI 10.1038/jcbfm.2014.262; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dahl G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0191; Domercq M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00049; DunnMeynell AA, 1997, J NEUROTRAUM, V14, P43, DOI 10.1089/neu.1997.14.43; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Freitas-Andrade M, 2016, NEUROSCIENCE, V323, P207, DOI 10.1016/j.neuroscience.2015.04.035; Garre JM, 2016, J NEUROSCI, V36, P4785, DOI 10.1523/JNEUROSCI.4195-15.2016; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gootz TD, 1996, ANTIMICROB AGENTS CH, V40, P2691, DOI 10.1128/AAC.40.12.2691; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hall IH, 2003, BIOMED PHARMACOTHER, V57, P359, DOI 10.1016/S0753-3322(03)00054-4; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Jin X, 2012, J SOFTWARE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0041892; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Khan AA, 1998, ANTIMICROB AGENTS CH, V42, P1713, DOI 10.1128/AAC.42.7.1713; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lohman AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8965; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Marques-da-Silva C, 2011, IMMUNOBIOLOGY, V216, P1, DOI 10.1016/j.imbio.2010.03.010; Meaney David F, 2015, Handb Clin Neurol, V127, P105, DOI 10.1016/B978-0-444-52892-6.00007-6; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Ng W, 1999, J ANTIMICROB CHEMOTH, V43, P811, DOI 10.1093/jac/43.6.811; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112655; PHILLIPS JC, 1980, FOOD COSMET TOXICOL, V18, P7, DOI 10.1016/0015-6264(80)90003-6; Poon IKH, 2014, NATURE, V507, P329, DOI 10.1038/nature13147; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; Qiu F, 2011, FEBS LETT, V585, P3430, DOI 10.1016/j.febslet.2011.09.033; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rubin B.K., 2005, ANTIBIOTICS ANTIINFL; Saez PJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah7107; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Shaw PJ, 2007, TOXICOL SCI, V100, P259, DOI 10.1093/toxsci/kfm218; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Stibick DL, 2001, J NEUROTRAUM, V18, P303, DOI 10.1089/08977150151070955; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sun Q, 2007, BIOORG MED CHEM LETT, V17, P6682, DOI 10.1016/j.bmcl.2007.10.070; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Thompson RJ, 2015, J PHYSIOL-LONDON, V593, P3463, DOI 10.1113/jphysiol.2014.282426; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Wang JJ, 2013, J GEN PHYSIOL, V141, P649, DOI 10.1085/jgp.201310966; Wang YC, 2015, MOL MED REP, V12, P2149, DOI 10.3892/mmr.2015.3607; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ya JC, 2015, MOL MED REP, V12, P6591, DOI 10.3892/mmr.2015.4292	81	11	11	2	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	FEB 13	2018	15								42	10.1186/s12974-018-1069-9			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FW2CC	WOS:000425107900003	29439712	Green Published, gold			2022-02-06	
J	Moe, HK; Moen, KG; Skandsen, T; Kvistad, KA; Laureys, S; Haberg, A; Vik, A				Moe, Hans Kristian; Moen, Kent Goran; Skandsen, Toril; Kvistad, Kjell Arne; Laureys, Steven; Haberg, Asta; Vik, Anne			The Influence of Traumatic Axonal Injury in Thalamus and Brainstem on Level of Consciousness at Scene or Admission: A Clinical Magnetic Resonance Imaging Study	JOURNAL OF NEUROTRAUMA			English	Article						basal ganglia; brainstem; craniocerebral trauma; Glasgow Coma Scale; neuroimaging; thalamus	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; PROGNOSTIC VALUE; CLASSIFICATION; SEVERITY; MODERATE; MRI; LESIONS; DIAGNOSIS; DAMAGE	The aim of this study was to investigate how traumatic axonal injury (TAI) lesions in the thalamus, basal ganglia, and brainstem on clinical brain magnetic resonance imaging (MRI) are associated with level of consciousness in the acute phase in patients with moderate to severe traumatic brain injury (TBI). There were 158 patients with moderate to severe TBI (7-70 years) with early 1.5T MRI (median 7 days, range 0-35) without mass lesion included prospectively. Glasgow Coma Scale (GCS) scores were registered before intubation or at admission. The TAI lesions were identified in T2*gradient echo, fluid attenuated inversion recovery, and diffusion weighted imaging scans. In addition to registering TAI lesions in hemispheric white matter and the corpus callosum, TAI lesions in the thalamus, basal ganglia, and brainstem were classified as uni- or bilateral. Twenty percent of patients had TAI lesions in the thalamus (7% bilateral), 18% in basal ganglia (2% bilateral), and 29% in the brainstem (9% bilateral). One of 26 bilateral lesions in the thalamus or brainstem was found on computed tomography. The GCS scores were lower in patients with bilateral lesions in the thalamus (median four) and brainstem (median five) than in those with corresponding unilateral lesions (median six and eight, p=0.002 and 0.022). The TAI locations most associated with low GCS scores in univariable ordinal regression analyses were bilateral TAI lesions in the thalamus (odds ratio [OR] 35.8; confidence interval [CI: 10.5-121.8], p<0.001), followed by bilateral lesions in basal ganglia (OR 13.1 [CI: 2.0-88.2], p=0.008) and bilateral lesions in the brainstem (OR 11.4 [CI: 4.0-32.2], p<0.001). This Trondheim TBI study showed that patients with bilateral TAI lesions in the thalamus, basal ganglia, or brainstem had particularly low consciousness at admission. We suggest these bilateral lesions should be evaluated further as possible biomarkers in a new TAI-MRI classification as a worst grade, because they could explain low consciousness in patients without mass lesions.	[Moe, Hans Kristian; Moen, Kent Goran; Skandsen, Toril; Haberg, Asta; Vik, Anne] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Moen, Kent Goran] Levanger Hosp, Dept Med Imaging, Levanger, Norway; [Skandsen, Toril] St Olavs Univ Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Kvistad, Kjell Arne; Haberg, Asta] St Olavs Univ Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Laureys, Steven] Univ Liege, Univ Hosp Liege, Liege, Belgium; [Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway		Moe, HK (corresponding author), Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Edvard Griegs Gate 8, N-7030 Trondheim, Norway.	hanskristianmoe91@gmail.com	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807; Moe, Hans Kristian/0000-0002-1699-6848	Norwegian Research CouncilResearch Council of NorwayEuropean Commission; Norwegian University of Science and Technology (NTNU); liaison committee; ERA-NET NEURON; Research Council of Norway (TAI-MRI project)Research Council of Norway; NTNU	We thank Mari Folvik, Jana Rydland, and Jian Xu for their contributions in the MRI readings. We would also like to thank Anne-Mari Holte Flusund for her work in examining CT scans for lesions in the thalamus, basal ganglia, and brainstem. HKM received a research scholarship from the Norwegian Research Council and funding from the Norwegian University of Science and Technology (NTNU). KGM and TS have, during the study period, received research grants from the liaison committee between the Central Norway regional health authority and NTNU. This work (AMF) has also been partly funded by ERA-NET NEURON and the Research Council of Norway (TAI-MRI project).	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Matsusue Eiji, 2006, Magn Reson Med Sci, V5, P99, DOI 10.2463/mrms.5.99; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Posner JB, 2007, PLUM POSNERS DIAGNOS; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Schiff ND, 2016, J NEURAL TRANSM, V123, P797, DOI 10.1007/s00702-016-1547-0; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Ward LM, 2011, CONSCIOUS COGN, V20, P464, DOI 10.1016/j.concog.2011.01.007; Zappella N, 2014, NEUROCRIT CARE, V20, P494, DOI 10.1007/s12028-014-9962-2; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	50	11	13	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					975	984		10.1089/neu.2017.5252		FEB 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000424837900001	29334825	Green Published, Bronze, Green Submitted			2022-02-06	
J	Kim, W; Ma, L; Lomoio, S; Willen, R; Lombardo, S; Dong, JH; Haydon, PG; Tesco, G				Kim, WonHee; Ma, Liang; Lomoio, Selene; Willen, Rachel; Lombardo, Sylvia; Dong, Jinghui; Haydon, Philip G.; Tesco, Giuseppina			BACE1 elevation engendered by GGA3 deletion increases beta-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice	MOLECULAR NEURODEGENERATION			English	Article						Alzheimer disease; Amyloid-beta (A beta); Beta-secretase 1 (BACE1); Golgi-localized.-ear-containing ARF binding protein 3 (GGA3); Amyloid precursor protein (APP); Cell adhesion molecule L1 like protein (CHL1); Down syndrome	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE PATHOGENESIS; PROTEIN-CLEAVING ENZYME-1; ADHESION MOLECULE L1; PRECURSOR PROTEIN; SECRETASE ACTIVITY; CLOSE HOMOLOG; OXIDATIVE STRESS; TRANSGENIC MICE; CELL-ADHESION	Background: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in the production of amyloid beta (A beta), the toxic peptide that accumulates in the brains of Alzheimer's disease (AD) patients. Our previous studies have shown that the clathrin adaptor Golgi-localized.-ear-containing ARF binding protein 3 (GGA3) plays a key role in the trafficking of BACE1 to lysosomes, where it is normally degraded. GGA3 depletion results in BACE1 stabilization both in vitro and in vivo. Moreover, levels of GGA3 are reduced and inversely related to BACE1 levels in post-mortem brains of AD patients. Method: In order to assess the effect of GGA3 deletion on AD-like phenotypes, we crossed GGA3 -/- mice with 5XFAD mice. BACE1-mediated processing of APP and the cell adhesion molecule L1 like protein (CHL1) was measured as well as levels of A beta 42 and amyloid burden. Results: In 5XFAD mice, we found that hippocampal and cortical levels of GGA3 decreased while BACE1 levels increased with age, similar to what is observed in human AD brains. GGA3 deletion prevented age-dependent elevation of BACE1 in GGA3KO;5XFAD mice. We also found that GGA3 deletion resulted in increased hippocampal levels of A beta 42 and amyloid burden in 5XFAD mice at 12 months of age. While levels of BACE1 did not change with age and gender in GGAKO;5XFAD mice, amyloid precursor protein (APP) levels increased with age and were higher in female mice. Moreover, elevation of APP was associated with a decreased BACE1-mediated processing of CHL1 not only in 12 months old 5XFAD mice but also in human brains from subjects affected by Down syndrome, most likely due to substrate competition. Conclusion: This study demonstrates that GGA3 depletion is a leading candidate mechanism underlying elevation of BACE1 in AD. Furthermore, our findings suggest that BACE1 inhibition could exacerbate mechanism-based side effects in conditions associated with APP elevation (e.g. Down syndrome) owing to impairment of BACE1-mediated processing of CHL1. Therefore, therapeutic approaches aimed to restore GGA3 function and to prevent the down stream effects of its depletion (e.g. BACE1 elevation) represent an attractive alternative to BACE inhibition for the prevention/treatment of AD.	[Kim, WonHee; Ma, Liang; Lomoio, Selene; Willen, Rachel; Lombardo, Sylvia; Tesco, Giuseppina] Tufts Univ, Alzheimers Dis Res Lab, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA; [Kim, WonHee; Ma, Liang; Lomoio, Selene; Willen, Rachel; Lombardo, Sylvia; Dong, Jinghui; Haydon, Philip G.; Tesco, Giuseppina] Tufts Univ, Dept Neurosci, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA		Tesco, G (corresponding author), Tufts Univ, Alzheimers Dis Res Lab, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.; Tesco, G (corresponding author), Tufts Univ, Dept Neurosci, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	Giuseppina.Tesco@Tufts.edu		Kim, WonHee/0000-0001-5530-7606	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS092497, R01AG025952]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS047243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092497, P30NS047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG025952] Funding Source: NIH RePORTER	This work was supported by Award Number R01NS092497 (to GT) and R01AG025952 (to GT) from National Institute of Health (NIH). The Imaging Core Facility is part of "Tufts Center for Neuroscience Research", supported by NIH Award Number P30 NS047243 (Jackson).	Arnst JL, 2013, ANAL BIOCHEM, V440, P71, DOI 10.1016/j.ab.2013.05.017; Barao S, 2016, TRENDS NEUROSCI, V39, P158, DOI 10.1016/j.tins.2016.01.003; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Cai Y, 2010, EUR J NEUROSCI, V32, P1223, DOI 10.1111/j.1460-9568.2010.07376.x; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; CUMMINGS BJ, 1992, NEUROSCIENCE, V48, P763, DOI 10.1016/0306-4522(92)90265-4; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Dislich B, 2015, MOL CELL PROTEOMICS, V14, P2550, DOI 10.1074/mcp.M114.041533; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Guglielmotto M, 2011, J ALZHEIMERS DIS, V27, P871, DOI 10.3233/JAD-2011-110884; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hardy J, 2017, FEBS J, V284, P1040, DOI 10.1111/febs.14004; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Heyden A, 2008, NEUROSCIENCE, V155, P221, DOI 10.1016/j.neuroscience.2008.04.080; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Irintchev A, 2012, NEUROSCIENTIST, V18, P452, DOI 10.1177/1073858411419047; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; LeBlanc AC, 2014, CELL DEATH DIFFER, V21, P696, DOI 10.1038/cdd.2013.194; LeBlanc AC, 2013, EUR J NEUROSCI, V37, P2005, DOI 10.1111/ejn.12250; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li XL, 2015, NEUROTHERAPEUTICS, V12, P862, DOI 10.1007/s13311-015-0378-2; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mamada N, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0163-5; Masuda A, 2016, NEUROBIOL LEARN MEM, V135, P73, DOI 10.1016/j.nlm.2016.07.001; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Melnikova T, 2016, NEUROBIOL DIS, V96, P171, DOI 10.1016/j.nbd.2016.08.009; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Sadleir KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101643; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tamagno E, 2003, NEUROBIOL DIS, V14, P291, DOI 10.1016/S0969-9961(03)00131-1; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Weinstock J, 2012, ACS MED CHEM LETT, V3, P789, DOI 10.1021/ml200276j; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	87	11	11	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1750-1326			MOL NEURODEGENER	Mol. Neurodegener.	FEB 2	2018	13								6	10.1186/s13024-018-0239-7			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FU8YI	WOS:000424142100001	29391027	Green Published, gold			2022-02-06	
J	Cole, WR; Gregory, E; Arrieux, JP; Haran, FJ				Cole, Wesley R.; Gregory, Emma; Arrieux, Jacques P.; Haran, F. Jay			RETRACTED: Intraindividual Cognitive Variability: An Examination of ANAM4 TBI-MIL Simple Reaction Time Data from Service Members with and without Mild Traumatic Brain Injury(Retracted article. See vol. 24, pg. 212, 2018)	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Retracted Publication						Concussion; Military; Computerized assessment; Intraindividual variability cognitive function; Reaction time; Neuropsychology	CONCUSSION; SPORT; AGE; ASSOCIATION; PERFORMANCE; CONSISTENCY; MANAGEMENT; VALIDITY; INJURY; IMPACT	Objectives: The Automated Neuropsychological Assessment Metrics 4 TBI-MIL (ANAM4) is a computerized cognitive test often used in post-concussion assessments with U.S. service members (SMs). However, existing evidence remains mixed regarding ANAM4's ability to identify cognitive issues following mild traumatic brain injury (mTBI). Studies typically examine ANAM4 using standardized scores and/or comparisons to a baseline. A more fine-grained approach involves examining inconsistency within an individual's performance (i.e., intraindividual variability). Methods: Data from 237 healthy control SMs and 105 SMs within seven days of mTBI who took the ANAM4 were included in analyses. Using each individual's raw scores on a simple reaction time (RT) subtest (SRT1) that is repeated at the end of the battery (SRT2), we calculated mean raw RT and the intraindividual standard deviation (ISD) of trial-by-trial RT. Analyses investigated differences between groups in mean RT, RT variability (i.e., ISD), and change in ISD from SRT1 and SRT2. Results: Using regression residuals to control for demographic variables, analysis of variance, and pairwise comparisons revealed the control group had faster mean RT and smaller ISD compared to the mTBI group. Furthermore, the mTBI group had a significant increase in ISD from SRT1 to SRT2, with effect sizes exceeding the minimum practical effect for comparisons of ISD in SRT2 and change in ISD from SRT1 to SRT2. Conclusions: While inconsistencies in performance are often viewed as test error, the results suggest intraindividual cognitive variability may be more sensitive than traditional metrics in detecting changes in cognitive function after mTBI. Additionally, the findings highlight the utility of the ANAM4's repeating a RT subtest at two points in the same session for exploring within-subject differences in performance variability.	[Cole, Wesley R.; Gregory, Emma; Arrieux, Jacques P.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Cole, Wesley R.; Gregory, Emma; Arrieux, Jacques P.] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Cole, Wesley R.; Arrieux, Jacques P.] Womack Army Med Ctr, Ft Bragg, NC 28310 USA; [Cole, Wesley R.; Gregory, Emma; Arrieux, Jacques P.] Gen Dynam Hlth Solut, Fairfax, VA USA; [Haran, F. Jay] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Cole, WR (corresponding author), Womack Army Med Ctr, Intrepid Spirit, Ft Bragg, NC 28310 USA.	wesley.r.cole.ctr@mail.mil			General Dynamics Information Technology for the U.S. Defense Health Agency [W91YTZ-13-C-0015]	The authors thank Karen Schwab, Brian Ivins, Felicia Qashu, Mary Alice Dale, James Wes McGee, Katie Toll, and Alex Fender for their contributions to this research. This material is published by permission of the Defense and Veterans Brain Injury Center, operated by General Dynamics Information Technology for the U.S. Defense Health Agency under Contract No. W91YTZ-13-C-0015. The authors have no financial interests to disclose. The views expressed in this manuscript are those of the author(s) and do not necessarily reflect the official policy or position of the Department of the Navy, Department of the Army, Department of Defense, or the U.S. Government.	[Anonymous], 2013, COMPR POL TRAUM BRAI; Arrieux J.P., 2017, REV VALIDITY COMPUTE; Batterham PJ, 2014, AGE AGEING, V43, P84, DOI 10.1093/ageing/aft116; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Cognitive Science Research Center CSRC, 2014, ANAM MIL BATT ADM MA; Cole WR, 2018, ARCH CLIN NEUROPSYCH, V33, P102, DOI 10.1093/arclin/acx036; Cole WR, 2017, J CLIN EXP NEUROPSYC, V39, P35, DOI 10.1080/13803395.2016.1198470; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Defense Health Board, 2016, REP PREP UND PERS RE; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fjell AM, 2009, NEUROBIOL AGING, V30, P2065, DOI 10.1016/j.neurobiolaging.2008.01.015; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Garrett D. D., 2012, FRONT HUM NEUROSCI, V6, P1, DOI DOI 10.3389/FNHUM.2012.00101; HALE S, 1988, PSYCHOL AGING, V3, P407, DOI 10.1037/0882-7974.3.4.407; Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Hultsch D. F., 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lovden M, 2007, NEUROPSYCHOLOGIA, V45, P2827, DOI 10.1016/j.neuropsychologia.2007.05.005; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742	35	11	11	1	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2018	24	2					156	162		10.1017/S1355617717001187			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	FT3XL	WOS:000423081900005	29168451				2022-02-06	
J	Donnell, Z; Hoffman, R; Sarmiento, K; Hays, C				Donnell, Zoe; Hoffman, Rosanne; Sarmiento, Kelly; Hays, Cameron			Concussion attitudes, behaviors, and education among youth ages 12-17: Results from the 2014 YouthStyles survey	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Knowledge; Attitude; Behavior; Adolescent	TRAUMATIC BRAIN-INJURY; SCHOOL SOCCER PLAYERS; KNOWLEDGE; COACHES; PARENTS	Introduction: This study assessed young athletes' (ages 12 to 17) concussion attitudes and behaviors, particularly their self-reported experience learning about concussion and intentions to report a concussion and disparities in these experiences. Methods: We used data from Porter Novelli's 2014 YouthStyles survey that is conducted each year to gather insights about American consumers. Results: Of the 1,005 respondents, 57% reported sports participation. Fourteen percent reported they may have had a previous concussion, and among them 41% reported having a concussion more than once while playing sports. Males (17.7%) were significantly more likely to report having a concussion than females (10.0%; chi(2) (1) = 7.01, p = 0.008). Fifty-five percent of respondents reported having learned about what to do if they think they may have a concussion, and 92% reported that they would tell their coach if they thought they sustained a concussion while playing youth or high school sports. Youth from higher income families ($75,000-$124,999) were significantly more likely than youth from lower income families (less than $35,000) to report that they learned about what do if they suspected that they had a concussion. Conclusion: Age of athlete, parental income level, athlete's sex, and living in a metro versus non-metro area led to disparities in athletes' concussion education. There is a need for increased access to concussion education and an emphasis on customizing concussion education efforts to meet the needs of different groups. Practical application: We identified athletes' self-reported previously sustained concussions and predictors of education related to concussion. Further research is needed to explore the age, gender and income gaps in concussion education among athletes. Published by Elsevier Ltd.	[Donnell, Zoe; Hoffman, Rosanne; Hays, Cameron] ICF, 530 Gaither Rd, Rockville, MD 20850 USA; [Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA		Donnell, Z (corresponding author), ICF, 530 Gaither Rd, Rockville, MD 20850 USA.	zoe.donnell@icf.com			Intramural CDC HHS [CC999999] Funding Source: Medline		Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention National Center for Injury Prevention and Control & Division of Unintentional Injury Prevention (d), WHAT IS A CONC; Centers for Disease Control and Prevention National Center for Injury Prevention and Control & Division of Unintentional Injury Prevention (d), REC CONC; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Manschreck T., 2012, CURR PSYCHIAT, V11, P16; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Probst J. C., 2016, J RURAL HLTH; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; The Association Between School-based Physical Activity, 2010, INCL PHYS ED AC PERF; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; UMASS Lowell, ATT SPORTS CONC; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	22	11	11	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	FEB	2018	64						163	169		10.1016/j.jsr.2017.12.001			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	GD8TN	WOS:000430785100018	29636165	Green Accepted			2022-02-06	
J	Klainbart, S; Bibring, U; Strich, D; Chai, O; Bdolah-Abram, T; Aroch, I; Kelmer, E				Klainbart, Sigal; Bibring, Uri; Strich, Dalia; Chai, Orit; Bdolah-Abram, Tali; Aroch, Itamar; Kelmer, Efrat			Retrospective evaluation of 140 dogs involved in road traffic accidents	VETERINARY RECORD			English	Article							MOTOR-VEHICLE ACCIDENTS; TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE SYNDROME; BLUNT TRAUMA; POSTPRANDIAL HYPOTENSION; ADMISSION HYPERGLYCEMIA; PULMONARY CONTUSION; FOCUSED ASSESSMENT; VEHICULAR TRAUMA; ABDOMINAL FLUID	This study has retrospectively reviewed the medical records of 140 dogs sustaining road traffic accident (RTA), and has examined the population characteristics, medical history, injury type, physical examination, emergency laboratory tests and radiography findings, the animal trauma triage (ATT) score, the length of hospitalisation, the complications and the outcome. The survival rate was 83.2 per cent. Younger dogs sustained more frequently lung contusions and limb fractures, while larger dogs more frequently suffered limb fractures, and smaller dogs and older ones sustained more frequently pelvic fractures and sacroiliac luxation (P<0.05 for all). Dogs sustaining orthopaedic injuries required longer hospitalisation (P<0.001). The survival rates of non-ambulatory dogs (P<0.001) and those with neurological abnormalities (P<0.001), abnormal body temperature (P=0.001), hyperglycaemia (P=0.026) or hypoproteinaemia (P=0.04) at presentation were lower compared with those in which these were absent. The number of injured body systems was significantly (P<0.001) and positively associated with death. Dogs surviving RTA to presentation to the hospital have a good prognosis for survival to discharge. Older age, and high ATT score, abnormal body temperature, neurological deficits, hyperglycaemia and hypoproteinaemia at presentation, and occurrence of multiorgan trauma are negative prognostic indicators in such dogs.	[Klainbart, Sigal; Strich, Dalia; Kelmer, Efrat] Hebrew Univ Jerusalem, Vet Teaching Hosp, Dept Small Anim Emergency & Crit Care, Rehovot, Israel; [Klainbart, Sigal; Bibring, Uri; Strich, Dalia; Chai, Orit; Aroch, Itamar; Kelmer, Efrat] Hebrew Univ Jerusalem, Koret Sch Vet Med, Rehovot, Israel; [Bibring, Uri] Hebrew Univ Jerusalem, Vet Teaching Hosp, Dept Radiol, Rehovot, Israel; [Chai, Orit] Hebrew Univ Jerusalem, Vet Teaching Hosp, Dept Neurol, Rehovot, Israel; [Bdolah-Abram, Tali] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel; [Aroch, Itamar] Hebrew Univ Jerusalem, Vet Teaching Hosp, Small Anim Internal Med, Rehovot, Israel		Klainbart, S (corresponding author), Hebrew Univ Jerusalem, Vet Teaching Hosp, Dept Small Anim Emergency & Crit Care, Rehovot, Israel.; Klainbart, S (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Rehovot, Israel.	klainbart@gmail.com	chaimizrahi, orit/W-6283-2019				Akinrinmade J. F., 2014, Nigerian Veterinary Journal, V35, P1007; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazar KA, 2004, MED HYPOTHESES, V63, P778, DOI 10.1016/j.mehy.2004.04.015; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Boysen SR, 2004, JAVMA-J AM VET MED A, V225, P1198, DOI 10.2460/javma.2004.225.1198; BROWN M, 2014, LAVINS RADIOGRAPHY V, P197; Bruce CW, 2008, VET COMP ORTHOPAED, V21, P280; Chow RS, 2004, J VET EMERG CRIT CAR, V14, P100, DOI 10.1111/j.1534-6935.2004.04001.x; Cook JL, 1997, J AM ANIM HOSP ASSOC, V33, P528, DOI 10.5326/15473317-33-6-528; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; Demetriades D, 2003, J TRAUMA, V54, P1146, DOI 10.1097/01.TA.0000044352.00377.8F; Eicke BM, 2003, J NEUROIMAGING, V13, P352, DOI 10.1177/1051228403258080; FRASER CM., 2010, MERCK VET MANUAL HDB; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Goldfarb MG, 1996, HEALTH SERV RES, V31, P71; Hall KE, 2014, JAVMA-J AM VET MED A, V244, P300, DOI 10.2460/javma.244.3.300; Harruff RC, 1998, ACCIDENT ANAL PREV, V30, P11, DOI 10.1016/S0001-4575(97)00057-2; Hayes G, 2010, J VET INTERN MED, V24, P457, DOI 10.1111/j.1939-1676.2010.0483.x; HOFF SJ, 1994, AM SURGEON, V60, P138; Hoover L, 2006, J TRAUMA, V61, P310, DOI 10.1097/01.ta.0000229052.75460.c2; Hosgood G, 1998, J VET EMERG CRIT CAR, V8, P222, DOI DOI 10.1111/J.1476-4431.1998.TB00128.X; Intarapanich NP, 2016, J FORENSIC SCI, V61, P993, DOI 10.1111/1556-4029.13074; JANSEN RWMM, 1995, ANN INTERN MED, V122, P286, DOI 10.7326/0003-4819-122-4-199502150-00009; KOLATA RJ, 1975, J AM VET MED ASSOC, V167, P938; KOLATA RJ, 1974, J AM VET MED ASSOC, V164, P499; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; Landstrom Ulf, 2001, Nutrition and Health (Bicester), V15, P87; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lisciandro GR, 2009, J VET EMERG CRIT CAR, V19, P426, DOI 10.1111/j.1476-4431.2009.00459.x; Malone DL, 2001, J TRAUMA, V51, P458, DOI 10.1097/00005373-200109000-00006; Markogiannakis H, 2006, EMERG MED J, V23, P27, DOI 10.1136/emj.2004.022392; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; MELDON SW, 2000, ACAD EMERG MED, V7, P79; Peden M., 2004, WORLD REPORT ROAD TR; Peters T., 1996, ALL ALBUMIN BIOCH GE; Powell L. L., 1999, Journal of Veterinary Emergency and Critical Care, V9, P127, DOI 10.1111/j.1476-4431.1999.tb00074.x; Rockar R. A., 1994, Journal of Veterinary Emergency & Critical Care, V4, P77, DOI 10.1111/j.1476-4431.1994.tb00118.x; RUTLEDGE R, 1995, SURG CLIN N AM, V75, P305, DOI 10.1016/S0039-6109(16)46590-4; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SATOMI N, 1985, J NATL CANCER I, V74, P1255; Schulman AM, 2002, AM SURGEON, V68, P942; SELCER BA, 1987, J SMALL ANIM PRACT, V28, P21, DOI 10.1111/j.1748-5827.1987.tb05967.x; SEVITT S, 1973, INJURY, V4, P281, DOI 10.1016/0020-1383(73)90001-6; Sigrist NE, 2004, J VET EMERG CRIT CAR, V14, P259, DOI 10.1111/j.1476-4431.2004.04024.x; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Siram SM, 2011, J SURG RES, V167, P14, DOI 10.1016/j.jss.2010.10.007; Son JT, 2015, J CLIN NURS, V24, P2277, DOI 10.1111/jocn.12864; SPACKMAN CJA, 1984, J AM VET MED ASSOC, V185, P975; STELLIN G, 1991, AM SURGEON, V57, P780; Stillion JR, 2012, J VET EMERG CRIT CAR, V22, P588, DOI 10.1111/j.1476-4431.2012.00798.x; Streeter EM, 2009, JAVMA-J AM VET MED A, V235, P405, DOI 10.2460/javma.235.4.405; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; TAMAS PM, 1985, J AM ANIM HOSP ASSOC, V21, P161; TONGE JI, 1972, MED J AUSTRALIA, V2, P5; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; Toro K, 2005, FORENSIC SCI INT, V151, P151, DOI 10.1016/j.forsciint.2005.01.014; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Yukl RL, 2003, J EMERG MED, V25, P1, DOI 10.1016/S0736-4679(03)00105-7	66	11	11	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0042-4900	2042-7670		VET REC	Vet. Rec.	FEB	2018	182	7								10.1136/vr.104293			8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	FW3NE	WOS:000425213400018	29259067				2022-02-06	
J	Marwitz, JH; Sima, AP; Kreutzer, JS; Dreer, LE; Bergquist, TF; Zafonte, R; Johnson-Greene, D; Felix, ER				Marwitz, Jennifer H.; Sima, Adam P.; Kreutzer, Jeffrey S.; Dreer, Laura E.; Bergquist, Thomas F.; Zafonte, Ross; Johnson-Greene, Douglas; Felix, Elizabeth R.			Longitudinal Examination of Resilience After Traumatic Brain Injury: A Traumatic Brain Injury Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Psychological; Rehabilitation; Resilience; psychological	DISABILITY RATING-SCALE; CONNOR-DAVIDSON RESILIENCE; MILITARY SERVICE MEMBERS; LIFE SATISFACTION; CD-RISC; TBI-QOL; PREDICTORS; OUTCOMES; REHABILITATION; TRAJECTORIES	Objectives: To evaluate (1) the trajectory of resilience during the first year after a moderate-severe traumatic brain injury (TBI); (2) factors associated with resilience at 3, 6, and 12 months postinjury; and (3) changing relationships over time between resilience and other factors. Design: Longitudinal analysis of an observational cohort. Setting: Five inpatient rehabilitation centers. Participants: Patients with TBI (N=195) enrolled in the resilience module of the TBI Model Systems study with data collected at 3-, 6-, and 12 month follow-up. Interventions: Not applicable. Main Outcome Measure: Connor-Davidson Resilience Scale. Results: Initially, resilience levels appeared to be stable during the first year postinjury. Individual growth curve models were used to examine resilience over time in relation to demographic, psychosocial, and injury characteristics. After adjusting for these characteristics, resilience actually declined over time. Higher levels of resilience were related to nonminority status, absence of preinjury substance abuse, lower anxiety and disability level, and greater life satisfaction. Conclusions: Resilience is a construct that is relevant to understanding brain injury outcomes and has potential value in planning clinical interventions. (C) 2017 by the American Congress of Rehabilitation Medicine	[Marwitz, Jennifer H.; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med, Dept Phys Med & Rehabil, Rochester, MN USA; [Zafonte, Ross] Harvard Med Sch, Massachusetts Gen Hosp, Brigham & Womens Hosp, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Johnson-Greene, Douglas] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA		Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Box 980542, Richmond, VA 23298 USA.	jennifer.marwitz@vcuhealth.org	Felix, Elizabeth/AAD-6356-2021	Sima, Adam/0000-0001-8426-9987; Felix, Elizabeth/0000-0002-6239-715X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0030, 90DP0033, 90DP0034, 90DP0039, 90DP0044, 90DP0046]	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant nos. 90DP0030, 90DP0033, 90DP0034, 90DP0039, 90DP0044, 90DP0046). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Bertisch H, 2014, NEUROREHABILITATION, V34, P573, DOI 10.3233/NRE-141059; Brown SA, 2001, AM J PHYS MED REHAB, V80, P196, DOI 10.1097/00002060-200103000-00009; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pooley JA, 2010, AUST COMMUNITY PSYCH, V22, P30; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Wagnild G M, 1993, J Nurs Meas, V1, P165; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; [No title captured]	37	11	11	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2					264	271		10.1016/j.apmr.2017.06.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YX	WOS:000424069800007	28734937				2022-02-06	
J	Moffet, EW; Zens, TJ; Haines, KL; Beems, MV; McQuistion, KM; Leverson, GE; Agarwal, SK				Moffet, Eric W.; Zens, Tiffany J.; Haines, Krista L.; Beems, Megan V.; McQuistion, Kaitlyn M.; Leverson, Glen E.; Agarwal, Suresh K.			Race, insurance status, and traumatic brain injury outcomes before and after enactment of the Affordable Care Act	SURGERY			English	Article; Proceedings Paper	Association-for-Academic-Surgery/Society-of-University-Surgeons 12th Annual Meeting of the Academic-Surgical-Congress (ASC)	FEB 07-09, 2017	Las Vegas, NV	Acad Surg Congress, Assoc Acad Surg, Soc Univ Surg			UNITED-STATES; RACIAL/ETHNIC DISPARITIES; ETHNIC DISPARITIES; CENTER DESIGNATION; HELMET LAWS; DATA-BANK; LEVEL I; IMPACT; MORTALITY; HYPERTENSION	Background. The Affordable Care Act aims to improve patient outcomes. Race/ethnicity and insurance status impact outcomes after traumatic brain injury. We sought to gauge the Affordable Care Act's effect on outcomes after traumatic brain injury, as graded by race/ethnicity and insurance status. Methods. The National Trauma Data Bank was utilized to identify traumatic brain injury patients before and after the Affordable Care Act. Patient outcomes comprised of hospital duration of stay, in-hospital mortality, discharge to rehabilitation, and surgical procedures. Using regression analysis, we evaluated the impact of race/ethnicity and insurance status on traumatic brain injury outcomes, then compared them before and after the Affordable Care Act. Results. Mortality decreased for blacks (odds ratio =0.96 [confidence interval 0.83-1.10] to odds ratio =0.79 [confidence interval = 0.70-0.89], and Hispanics (odds ratio = 1.03 [confidence interval = 0.90-1.17] to odds ratio = 0.79 [confidence interval = 0.70-0.89]). Mortality increased for the uninsured (odds ratio = 1.28 [confidence interval =1.11-1.47] to odds ratio = 1.40 [confidence interval = 1.24-1.58]). Medicaid patients underwent decreased duration of stay, (coefficient = 2.75 [confidence interval = 2.49-3.02] to coefficient = 2.17, [confidence interval =1.98-2.37]), discharge to rehabilitation (odds ratio = 1.15, [confidence interval = 1.04-1.26] to odds ratio = 0.95 [confidence interval = 0.87-1.03]), and surgical procedures (odds ratio = 1.28 [confidence interval = 1.13-1.45] to odds ratio = 1.18, [confidence interval = 1.07-1.30]), while mortality remained unchanged. Conclusion. After the Affordable Care Act traumatic brain injury mortality decreased for blacks and Hispanics, but increased for the uninsured. Decreasing trends in resource consumption were also evident, especially for Medicaid patients. These results may illustrate altered delivery of care. (C) 2017 Elsevier Inc. All rights reserved.	[Moffet, Eric W.; Zens, Tiffany J.; Haines, Krista L.; Beems, Megan V.; McQuistion, Kaitlyn M.; Leverson, Glen E.; Agarwal, Suresh K.] Univ Wisconsin, Dept Surg, Div Trauma & Acute Care Surg, Sch Med & Publ Hlth, 600 Highland Ave G5-335, Madison, WI 53792 USA		Agarwal, SK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, 600 Highland Ave G5-335, Madison, WI 53792 USA.	emoffet@wisc.edu		Haines, Krista/0000-0002-2056-1820	University of Wisconsin Shapiro Summer Research Program	We thank the University of Wisconsin Shapiro Summer Research Program for supporting this research.	Abrams Melinda, 2015, Issue Brief (Commonw Fund), V12, P1; Agency for Healthcare Research and Quality, 2014, AGENCY HEALTHCARE RE; Alban RF, 2010, AM SURGEON, V76, P1108; [Anonymous], 2016, KEY FACTS UN POP; [Anonymous], 2013, HLTH REF IMPL TIM; [Anonymous], 2010, HLTH REF COMM COL IM; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Blumenthal D, 2015, NEW ENGL J MED, V372, P2451, DOI 10.1056/NEJMhpr1503614; Brasel KJ, 2002, J SURG RES, V107, P223, DOI 10.1006/jsre.2002.6512; Chen J, 2016, MED CARE, V54, P140, DOI 10.1097/MLR.0000000000000467; Cheslik TG, 2016, J TRAUMA ACUTE CARE, V80, P1010, DOI 10.1097/TA.0000000000001052; Collins Sara R, 2016, Issue Brief (Commonw Fund), V24, P1; Damberg C L., 2007, ENV SCAN PAY PERFORM; Dao H, 2012, J TRAUMA ACUTE CARE, V72, P638, DOI 10.1097/TA.0b013e318243d9ca; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Duane TM, 2012, J TRAUMA ACUTE CARE, V72, P641; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2015, WEST J EMERG MED, V16, P98, DOI 10.5811/westjem.2014.10.22837; Ferdinand KC, 2015, CURR MED RES OPIN, V31, P913, DOI 10.1185/03007995.2015.1029894; Galewitz P., 2012, BOOM TRAUMA CTR CAN; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hwabejire JO, 2013, JAMA SURG, V148, P956, DOI 10.1001/jamasurg.2013.2148; James J, 2012, HEALTH AFFAIR; Joseph B, 2016, J TRAUMA ACUTE CARE, V81, P427, DOI 10.1097/TA.0000000000001082; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Meehan WP, 2013, J PEDIATR-US, V163, P726, DOI 10.1016/j.jpeds.2013.03.073; Mueller M, 2015, AM J HYPERTENS, V28, P699, DOI 10.1093/ajh/hpu233; Nott MT, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12151; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Rosenstock S, 2014, J URBAN HEALTH, V91, P873, DOI 10.1007/s11524-013-9861-4; Scott JW, 2016, MED CARE, V54, P818, DOI 10.1097/MLR.0000000000000586; Scott JW, 2015, J AM COLL SURGEONS, V221, P495, DOI 10.1016/j.jamcollsurg.2015.03.032; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sood N, 2012, HEALTH AFFAIR, V31, P2043, DOI 10.1377/hlthaff.2012.0382; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Uninsurance loMUCotCo, 2001, COV MATT INS HLTH CA; Valderrama AL, 2013, MMWR-MORBID MORTAL W, V62, P351; Waters TM, 2015, JAMA INTERN MED, V175, P347, DOI 10.1001/jamainternmed.2014.5486; Zogg CK, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.3609; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	49	11	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2018	163	2					251	258		10.1016/j.surg.2017.09.006			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	FV1JL	WOS:000424317300002	29146230				2022-02-06	
J	Wu, SH; Lu, IC; Lee, SS; Kwan, AL; Chai, CY; Huang, SH				Wu, Sheng-Hua; Lu, I-Cheng; Lee, Su-Shin; Kwan, Aij-Lie; Chai, Chee-Yin; Huang, Shu-Hung			Erythropoietin attenuates motor neuron programmed cell death in a burn animal model	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; SKELETAL-MUSCLE APOPTOSIS; ALZHEIMERS-DISEASE; RAT MODEL; NEUROINFLAMMATION; ACTIVATION; IMPROVES; INFLAMMATION; MICROGLIA	Burn-induced neuromuscular dysfunction may contribute to long-term morbidity; therefore, it is imperative to develop novel treatments. The present study investigated whether erythropoietin (EPO) administration attenuates burn-induced motor neuron apoptosis and neuro-inflammatory response. To validate our hypothesis, a third-degree hind paw burn rat model was developed by bringing the paw into contact with a metal surface at 75 degrees C for 10 s. A total of 24 male Sprague-Dawley rats were randomly assigned to four groups: Group A, sham-control; Group B, burn-induced; Group C, burn + single EPO dose (5000 IU/kg i.p. at D0); and Group D, burn + daily EPO dosage (3000 IU/kg/day i.p. at D0-D6). Two treatment regimens were used to evaluate single versus multiple doses treatment effects. Before sacrifice, blood samples were collected for hematological parameter examination. The histological analyses of microglia activation, iNOS, and COX-2 in the spinal cord ventral horn were performed at week 1 post-burn. In addition, we examined autophagy changes by biomarkers of LC3B and ATG5. The expression of BCL-2, BAX, cleaved caspase-3, phospho-AKT, and mTOR was assessed simultaneously through Western blotting. EPO administration after burn injury attenuated neuroinflammation through various mechanisms, including the reduction of microglia activity as well as iNOS and COX-2 expression in the spinal cord ventral horn. In addition, the expression of phospho-AKT, mTOR and apoptotic indicators, such as BAX, BCL-2, and cleaved caspase-3, was modulated. Furthermore, the activity of burn-induced autophagy in the spinal cord ventral horn characterized by the expression of autophagic biomarkers, LC3B and ATG5, was reduced after EPO administration. The present results indicate that EPO inhibits the AKT-mTOR pathway to attenuate burn-induced motor neuron programmed cell death and microglia activation. EPO can modulate neuroinflammation and programmed cell death and may be a therapeutic candidate for neuroprotection.	[Wu, Sheng-Hua; Lu, I-Cheng] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Kaohsiung, Taiwan; [Wu, Sheng-Hua; Lu, I-Cheng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Wu, Sheng-Hua; Lu, I-Cheng] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Lee, Su-Shin; Kwan, Aij-Lie; Huang, Shu-Hung] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan; [Lee, Su-Shin; Huang, Shu-Hung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Plast Surg, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Sch Med, Dept Pathol, Kaohsiung, Taiwan		Huang, SH (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan.; Huang, SH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Plast Surg, Kaohsiung, Taiwan.; Huang, SH (corresponding author), Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan.; Huang, SH (corresponding author), Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan.	huangsh63@gmail.com	Huang, Shu-Hung/AAA-3445-2021	Huang, Shu-Hung/0000-0002-2903-1703; Chai, Chee-Yin/0000-0003-0486-9742	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2314-B-037-061-MY3, MOST106-2314-B-037-028]; Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University [Kmhk-105-022]; Center for Stem Cell Research, Kaohsiung Medical University [KMU-TP105G00, KMU-TP105G02]; Aim for the Top Universities Grant [KMU-TP105B07]; Kaohsiung Medical University Hospital [KMUH105-5R69, 106-6R81]; Childhood Burn Foundation of the Republic Of China	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-037-061-MY3, MOST106-2314-B-037-028); Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University (Kmhk-105-022), Center for Stem Cell Research, Kaohsiung Medical University (KMU-TP105G00, KMU-TP105G02), Aim for the Top Universities Grant (KMU-TP105B07), Kaohsiung Medical University Hospital (KMUH105-5R69, 106-6R81), and Childhood Burn Foundation of the Republic Of China. The funders had no role in the study design, data collection and analysis, publication decision, or manuscript preparation.	Alnaeeli Mawadda, 2012, Anat Res Int, V2012, P953264, DOI 10.1155/2012/953264; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bagyinszky E, 2017, J NEUROL SCI, V376, P242, DOI 10.1016/j.jns.2017.03.031; Bahcekapili N, 2014, INT J NEUROSCI, V124, P762, DOI 10.3109/00207454.2013.878935; Bakan V, 2016, ULUS TRAVMA ACIL CER, V22, P322, DOI 10.5505/tjtes.2015.09483; Barranco Caroline, 2015, Nat Rev Rheumatol, V11, P127, DOI 10.1038/nrrheum.2015.12; Basrai HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153418; Bianchi R, 2007, EUR J CANCER, V43, P710, DOI 10.1016/j.ejca.2006.09.028; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Carelli S, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/453179; Carraway MS, 2010, CIRC RES, V106, P1722, DOI 10.1161/CIRCRESAHA.109.214353; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chan KY, 2017, DEV NEUROSCI; Chauhan AK, 2017, MOL NEUROBIOL, V287; Chung H, 2009, J NEUROSCI RES, V87, P2365, DOI 10.1002/jnr.22046; Ciardiello F, 2002, ANN ONCOL, V13, P501, DOI 10.1093/annonc/mdf191; Dauber A, 2002, PAIN MED, V3, P6, DOI 10.1046/j.1526-4637.2002.02004.x; Duan HJ, 2009, APOPTOSIS, V14, P52, DOI 10.1007/s10495-008-0277-7; Ebid AA, 2014, BURNS, V40, P97, DOI 10.1016/j.burns.2013.05.022; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Fry CS, 2016, J PHYSIOL-LONDON, V594, P5223, DOI 10.1113/JP272520; Frymoyer A, 2017, PEDIAT RES; Gantner DC, 2017, ANN SURG; Gonzalez FF, 2013, STROKE, V44, P753, DOI 10.1161/STROKEAHA.111.000104; Gunst J, 2013, CRIT CARE MED, V41, P182, DOI 10.1097/CCM.0b013e3182676657; Hart DW, 2000, SURGERY, V128, P312, DOI 10.1067/msy.2000.108059; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Holavanahalli RK, 2016, J BURN CARE RES, V37, P243, DOI 10.1097/BCR.0000000000000257; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Jiang CJ, 2016, NEURAL REGEN RES, V11, P1450, DOI 10.4103/1673-5374.191219; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Kristal B, 2008, ISR MED ASSOC J, V10, P266; Li XQ, 2005, GLIA, V51, P254, DOI 10.1002/glia.20202; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Lopez E, 2015, ARCH PEDIATRIE, V22, P1092, DOI 10.1016/j.arcped.2015.07.001; Maggioni D, 2010, J NEUROSCI RES, V88, P3171, DOI 10.1002/jnr.22465; McPherson RJ, 2010, CURR OPIN PEDIATR, V22, P139, DOI 10.1097/MOP.0b013e328336eb57; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Merelli A, 2015, INT J NEUROSCI, V125, P793, DOI 10.3109/00207454.2014.989321; Merritt EK, 2012, J BURN CARE RES, V33, P291, DOI 10.1097/BCR.0b013e3182331e4b; Messier AM, 2014, CURR OPIN PEDIATR, V26, P139, DOI 10.1097/MOP.0000000000000077; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Nakazawa H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170391; Neelakantan S, 2009, PEDIATR INT, V51, P25, DOI 10.1111/j.1442-200X.2008.02648.x; Ning B, 2011, NEUROSCI LETT, V490, P57, DOI 10.1016/j.neulet.2010.12.025; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Ojha S, 2016, NEUROTOX RES, V29, P275, DOI 10.1007/s12640-015-9579-z; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Porter C, 2013, J TRAUMA ACUTE CARE, V74, P1480, DOI 10.1097/TA.0b013e3182921651; Punnonen J, 2015, CURR TOP MED CHEM, V15, P955, DOI 10.2174/156802661510150328224527; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Robinson S, 2016, J NEUROSURG-PEDIATR, V17, P739, DOI 10.3171/2015.10.PEDS15554; Sawikr Y, 2017, ADV PROTEIN CHEM STR, V108, P33, DOI 10.1016/bs.apcsb.2017.02.001; Shapiro IM, 2014, AUTOPHAGY, V10, P7, DOI 10.4161/auto.26679; Shefa U, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1689341; Song JQ, 2014, J SURG RES, V187, P128, DOI 10.1016/j.jss.2013.09.042; STREAT SJ, 1987, J TRAUMA, V27, P262, DOI 10.1097/00005373-198703000-00006; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Tahamtan M, 2016, FUND CLIN PHARMACOL, V30, P502, DOI 10.1111/fcp.12226; Tamura T, 2017, BRAIN RES; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Tsai TH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0761-8; Vairano M, 2002, EUR J NEUROSCI, V16, P584, DOI 10.1046/j.1460-9568.2002.02125.x; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Vetrichevvel TP, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012668; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; White JPM, 2011, EUR J PAIN, V15, P683, DOI 10.1016/j.ejpain.2010.12.006; Williams PA, 2017, EXP EYE RES, V157, P20, DOI 10.1016/j.exer.2017.02.014; Wu SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/372819; Wu YW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0191; Wustenberg T, 2011, MOL PSYCHIATR, V16, P26, DOI 10.1038/mp.2010.51; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Xiao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039488; Xie Z, 2012, EYE, V26, P144, DOI 10.1038/eye.2011.254; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yasuhara S, 1999, J BURN CARE REHABIL, V20, P462, DOI 10.1097/00004630-199920060-00007; Yasuhara S, 2000, AM J PHYSIOL-ENDOC M, V279, pE1114, DOI 10.1152/ajpendo.2000.279.5.E1114; Yoshimura, 1996, Oncologist, V1, P337; Zhang DX, 2017, BIOMED PHARMACOTHER, V87, P332, DOI 10.1016/j.biopha.2016.12.115; Zheng HH, 2013, NEUROREPORT, V24, P335, DOI 10.1097/WNR.0b013e32835ffe03	88	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2018	13	1							e0190039	10.1371/journal.pone.0190039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU2GT	WOS:000423668400013	29385149	gold, Green Published, Green Submitted			2022-02-06	
J	Al-Jehani, H; Angle, M; Marcoux, J; Teitelbaum, J				Al-Jehani, Hosam; Angle, Mark; Marcoux, Judith; Teitelbaum, Jeanne			Early abnormal transient hyperemic response test can predict delayed ischemic neurologic deficit in subarachnoid hemorrhage	CRITICAL ULTRASOUND JOURNAL			English	Article						Transient hyperemic response test (THRT); Delayed ischemic neurologic deficit (DIND); Vasospasm (VS); Subarachnoid hemorrhage (SAH)	CEREBRAL AUTOREGULATION; CEREBROVASCULAR AUTOREGULATION; COMPUTED-TOMOGRAPHY; BLOOD-FLOW; VASOSPASM	Background: Early detection of vasospasm is crucial to prevent significant delayed ischemic neurological deficit post subarachnoid hemorrhage. The standard methods of detection, including cerebral angiogram and computed tomography are invasive and not safe to be repeated, as is very often indicated clinically. Transient hyperemic response test has been previously used to predict autoregulation failure in traumatic brain injury and subarachnoid hemorrhage. Aims: We investigate the usability of transient hyperemic response test as a predictor of clinical vasospasm in a cohort of patients with aneurismal subarachnoid hemorrhage. Methods: A retrospective review of all THRT examinations done between January 2011 and July 2012 conducted at Montreal Neurological Institute and Hospital and the Montreal General Hospital. Patients diagnosed with aSAH in which the THRT was performed within the first 24-48 h of admission were included in the study. Two-dimensional transcranial Doppler images were obtained and velocities were recorded. A positive response was one in which the velocity was increased by more than 9% of the baseline systolic velocity, indicating an intact cerebral autoregulation. Lindegaard ratio > 3 is considered abnormal and in the context of elevated systolic velocity of the MCA, is highly suggestive of DIND. Results: Fifteen patients met the inclusion criteria. A total of 6 patients developed clinical and radiological vasospasm. Out of these 6 patients, 5 (83%) had an abnormal THRT in the initial TCD assessment (p = 0.0406). We found that abnormal transient hyperemic response test readings are predictive of subsequent vasospasm development. Conclusions: The results of this small retrospective study support the notion that transient hyperemic response test has predictive value in vasospasm development and may prove useful in patient monitoring and successful clinical management.	[Al-Jehani, Hosam; Angle, Mark; Teitelbaum, Jeanne] McGill Univ, Montreal Neurol Inst & Hosp, Neurocrit Care Unit, Montreal, PQ, Canada; [Al-Jehani, Hosam] King Fahad Univ Hosp, Imam Abdulrahman Bin Faisal Univ, Dept Neurosurg & Crit Care Med, Dammam, Saudi Arabia; [Al-Jehani, Hosam; Marcoux, Judith] McGill Univ, Montreal Neurol Inst & Hosp, Montreal Gen Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Al-Jehani, Hosam] King Fahad Specialist Hosp Dammam, Dept Neurosurg, Dammam, Saudi Arabia		Al-Jehani, H (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Neurocrit Care Unit, Montreal, PQ, Canada.	hjehani@iau.edu.sa					Brown RJ, 2013, NEUROSURGERY, V72, P702, DOI 10.1227/NEU.0b013e318285c3db; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; Lam JM, 2000, NEUROSURGERY, V47, P25; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Mills JN, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415960; Modi NJ, 2016, NEUROL INDIA, V64, P8, DOI 10.4103/0028-3886.178030; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Perrein A, 2015, MINERVA ANESTESIOL, V81, P1219; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Rathakrishnan R, 2011, NEUROCRIT CARE, V14, P152, DOI 10.1007/s12028-010-9495-2; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Schatlo B, 2007, REV RECENT CLIN TRIA, V2, P49, DOI 10.2174/157488707779318125; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wintermark M, 2002, ANN NEUROL, V51, P417, DOI 10.1002/ana.10136	23	11	11	0	0	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2036-3176	2036-7902		CRIT ULTRASOUND J	Crit. Ultrasound J.	JAN 4	2018	10								1	10.1186/s13089-017-0079-7			6	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	FT5WV	WOS:000423224900001	29302799	gold, Green Published			2022-02-06	
J	Al-Nuaimi, S; Aldandashi, S; Easa, AKS; Saqqur, M				Al-Nuaimi, Saleem; Aldandashi, Samer; Easa, Abdul Kadir Saed; Saqqur, Maher			Psychiatric morbidity among physically injured Syrian refugees in Turkey	COMPREHENSIVE PSYCHIATRY			English	Article							SOUTHEAST-ASIAN REFUGEES; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; FOLLOW-UP; POPULATION; SURVIVORS; TORTURE; IMPACT	Objective: To the best of our knowledge, the mental health status of physically injured Syrian refugees has not yet been investigated. The aim of this study was to examine the prevalence of psychiatric morbidity among physically injured Syrian refugees in Turkey receiving treatment at the main rehabilitation centre near the Syrian border. Method: This is a cross sectional study. Information was collected from consenting injured Syrian refugees at Dar-el-Shefa'a Hospital in Reyhanli (Turkey) during a one week period in December 2012 and another one week period in August 2013. A clinical psychiatric interview was conducted to determine a diagnosis according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR. Results: A total of 40 refugees consented and completed a clinical psychiatric interview. All refugees in this study did not have a significant past psychiatric history. The most prevalent cuiient diagnosis was major depressive disorder (22.5%), adjustment disorder (20%), and post-traumatic stress disorder (15%). Five (12.5%) patients had no evidence of a psychiatric disorder. Conclusion: The prevalence of psychiatric morbidity among injured Syrian refugees in our study was extremely high. This may help guide the treatment and management of this select population. Limitations: This study had a low number of participants. The method of assessment was not standardized with a validated tool. C Clinical implications: This study may help guide the treatment and management of this select population, both in neighbouring countries and as resettled refugees in Western host countries. (C) 2017 Elsevier Inc. All rights reserved.	[Al-Nuaimi, Saleem; Aldandashi, Samer] Univ Alberta, Walter Mackenzie Ctr, Dept Psychiat, 8440 112th St, Edmonton, AB T6G 2B7, Canada; [Easa, Abdul Kadir Saed] Dar El Shefaa Hosp, Reyhanli, Turkey; [Saqqur, Maher] Univ Alberta, Walter Mackenzie Ctr, Dept Med, Div Neurol, 8440 112th St, Edmonton, AB T6G 2B7, Canada		Al-Nuaimi, S (corresponding author), Walter Mackenzie Ctr, Dept Psychiat, 8440 112th St, Edmonton, AB T6G 2B7, Canada.	sa@ualberta.ca					Ager A., 1993, MENTAL HLTH REFUGEE; Banal R, 2010, INDIAN J PSYCHIAT, V52; Beiser M, 2001, SOC SCI MED, V53, P1321, DOI 10.1016/S0277-9536(00)00412-3; Bisson J.I., 2006, PSYCHIATRY, V5, P240, DOI DOI 10.1053/J.MPPSY.2006.04.004; Boehnlein J. K., 1995, TRANSCULT PSYCHIATRY, V32, P223; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; CHAKRABORTY A, 1991, LANCET, V337, P1204, DOI 10.1016/0140-6736(91)92869-4; CHUNG RCY, 1993, SOC SCI MED, V36, P631, DOI 10.1016/0277-9536(93)90060-H; Deb S, 1999, AM J PSYCHIAT, V156, P374; DEGIROLAMO G, 1996, ETHNOCULTURAL ASPECT, P33, DOI DOI 10.1037/10555-002; DESJARALAIS R, 1995, WORLD MENTAL HLTH PR; Ditlevsen DN, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-26; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Hermansson AC, 2002, J NERV MENT DIS, V190, P374, DOI 10.1097/00005053-200206000-00005; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Javidi H, 2012, INT J OCCUP ENV MED, V3, P2; Johnson D., 2016, SYRIA ENVOY CLAIMS 4; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lavik NJ, 1996, BRIT J PSYCHIAT, V169, P726, DOI 10.1192/bjp.169.6.726; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P1567; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Naeem Farooq, 2005, J Ayub Med Coll Abbottabad, V17, P23; Ommeren M, 2001, ARCH GEN PSYCHIAT, V58, P475; Orley J., 1994, AMIDST PERIL PAIN ME, P193; RAMSAY R, 1993, BRIT J PSYCHIAT, V162, P55, DOI 10.1192/bjp.162.1.55; Roberts K, 2000, DISABIL SOC, V15, P943, DOI 10.1080/713662008; Shakespeare-Finch J, 2010, J LOSS TRAUMA, V15, P69, DOI 10.1080/15325020903373151; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; UNHCR, SYR REG REF RESP	29	11	11	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	JAN	2018	80						34	38		10.1016/j.comppsych.2017.08.002			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FP5QC	WOS:000417673000004	28972916				2022-02-06	
J	Ashley, JG; Ashley, MJ; Masel, BE; Randle, K; Kreber, LA; Singh, C; Harrington, D; Griesbach, GS				Ashley, Jessica G.; Ashley, Mark J.; Masel, Brent E.; Randle, Kevin; Kreber, Lisa A.; Singh, Charan; Harrington, David; Griesbach, Grace S.			The influence of post-acute rehabilitation length of stay on traumatic brain injury outcome: a retrospective exploratory study	BRAIN INJURY			English	Article						Rehabilitation; traumatic brain injury; length of stay	RATING-SCALE	Objective: Data regarding length of stay (LOS) in a rehabilitation programme after traumatic brain injury (TBI) are limited. The goal of this study was to examine the effect of LOS and disability on outcome following TBI.Methods: Records from patients in a multidisciplinary rehabilitation programme at least 3months after TBI were analysed retrospectively to study the influence of LOS on functional outcome at different levels of disability. Functional status was determined by the Mayo-Portland Adaptability Inventory (MPAI) and the Community Integration Questionnaire (CIQ). Patients were further grouped by time since injury of 3-12months or over 1year.Results: Those with a mild and moderate disabilities and over 1 year chronicity showed improvements after 90days of rehabilitation. Patients with a severe disability and over 1year chronicity required at least 180days to show improvements. Moderately and severely disabled patients with an injury chronicity of 3-12months showed improvements in the MPAI after 90days. However, further improvement was observed after 180days in the severely disabled group.Conclusions: Results suggest that both, level of disability and injury chronicity, should be considered when determining LOS. Data also show an association between LOS and changes in the MPAI and CIQ.	[Ashley, Jessica G.; Ashley, Mark J.; Masel, Brent E.; Randle, Kevin; Kreber, Lisa A.; Singh, Charan; Harrington, David; Griesbach, Grace S.] Ctr Neuro Skills, Res Dept, Bakersfield, CA USA; [Griesbach, Grace S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Masel, Brent E.] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Ashley, Mark J.] Southern Illinois Univ, Inst Rehabil, Coll Educ, Carbondale, IL USA		Ashley, JG (corresponding author), Ctr Neuro Skills, 5215 Ashe Rd, Bakersfield, CA 93313 USA.	jashley@neuroskills.com					Avesani R, 2012, EUR J PHYS REHAB MED, V48, P433; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Lamontagne ME, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-59; Livingston-Thomas J, 2016, NEUROTHERAPEUTICS, V13, P395, DOI 10.1007/s13311-016-0423-9; Lu HY, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0187-x; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilt, 2012, AGENCY HEALTHC RES Q; Winardi W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129796	22	11	11	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					600	607		10.1080/02699052.2018.1432896			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200011	29388849				2022-02-06	
J	Baldry, E; Briggs, DB; Goldson, B; Russell, S				Baldry, Eileen; Briggs, Damon B.; Goldson, Barry; Russell, Sophie			'Cruel and unusual punishment': an inter-jurisdictional study of the criminalisation of young people with complex support needs	JOURNAL OF YOUTH STUDIES			English	Article						Cognitive disabilities; comparative analysis; complex support needs; criminalisation; mental health disorders; youth justice	TRAUMATIC BRAIN-INJURY; JUVENILE-OFFENDERS; MENTAL-HEALTH; PREVALENCE; JUSTICE; DISABILITY	Although several criminologists and social scientists have drawn attention to the high rates of mental and cognitive disability amongst populations of young people embroiled in youth justice systems, less attention has been paid to the ways in which young people with disability are disproportionately exposed to processes of criminalisation and how the same processes serve to further disable them. In this paper, we aim to make a contribution towards filling this gap by drawing upon qualitative findings from the Comparative Youth Penality Project - an empirical inter-jurisdictional study of youth justice and penality in England and Wales and in four Australian states. We build on, integrate and extend theoretical perspectives from critical disability studies and from critical criminology to examine the presence of, and responses to, socio-economically disadvantaged young people with multiple disabilities (complex support needs) in youth justice systems in our selected jurisdictions. Four key findings emerge from our research pertaining to: (i) the criminalisation of disability and disadvantage; (ii) the management of children and young people with disabilities by youth justice agencies; (iii) the significance of early and holistic responses for children and young people with complex support needs; and (iv) the inadequate nature of community based support.	[Baldry, Eileen; Russell, Sophie] Univ New South Wales, Sch Social Sci, Sydney, NSW, Australia; [Goldson, Barry] Univ Liverpool, Sch Law & Social Justice, Dept Sociol Social Policy & Criminol, Liverpool, Merseyside, England; [Briggs, Damon B.] Univ Roehampton, Dept Social Sci, London, England		Russell, S (corresponding author), Univ New South Wales, Sch Social Sci, Sydney, NSW, Australia.	sophie.russell@unsw.edu.au		Baldry, Eileen/0000-0001-5599-5592	Australian Research CouncilAustralian Research Council [DP 130100184]; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/J500094/1]; Howard League for Penal Reform	This work was supported by Australian Research Council: [grant number: DP 130100184]; Economic and Social Research Council: [grant number: ES/J500094/1]; Howard League for Penal Reform.	ABS (Australian Bureau of Statistics), 2016, DIS AG CAR AUSTR SUM; AIFS (Australian Institute of Family Studies), 2015, CHILDR CAR CFCA RES; AIHW (Australian Institute of Health and Welfare), 2016, YOUNG PEOPL CHILD PR; Allerton M., 2003, 2003 NSW YOUNG PEOPL; Anderson SAS, 2016, CHILD YOUTH SERV REV, V65, P195, DOI 10.1016/j.childyouth.2016.04.004; Baldry E., 2011, PEOPLE MENTAL COGNIT; Baldry E., 2016, OCKHAMS RAZOR R 0418; Baldry E., 2017, LAW POVERTY 40 YEARS, P103; Baldry E, 2014, GRIFFITH LAW REV, V23, P370, DOI 10.1080/10383441.2014.1000218; Baldry E, 2013, ADV POLIC THEOR PRAC, P219; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; British Medical Association, 2014, YOUNG LIV BARS; Calma T., 2008, PREVENTING CRIME PRO; Chitsabesan P, 2007, J CHILD SERV, V2, P4, DOI 10.1108/17466660200700032; Commonwealth of Australia, 2011, DOING TIM TIM DOING; Commonwealth of Australia, 2016, IND DET PEOPL COGN P; Crane L, 2016, J AUTISM DEV DISORD, V46, P2028, DOI 10.1007/s10803-016-2729-1; Department of Family and Community Services, 2014, LEAD CLIN PRACT SUPP; DOWSE L, 2009, AUSTR J HUMAN RIGHTS, V15, P29, DOI DOI 10.1080/1323238X.2009.11910860; Dowse L, 2014, RES PRACT INTELLECT, V1, P174, DOI 10.1080/23297018.2014.953671; Education and Health Standing Committee, 2012, FOET ALC SPECTR DIS FOET ALC SPECTR DIS; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Fernandez E., 2014, STUDY CHILDRENS COUR; Fitzpatrick C., 2016, CRIMINOLOGY CRIMINAL; Goldson B, 2005, CARE STATE CHILD DEA; Goldson B., 2002, VULNERABLE INSIDE CH; Goldson Barry., 2006, HOWARD J CRIM JUST, V45, P449, DOI [10.1111/j.1468-2311.2006.00437.x, DOI 10.1111/J.1468-2311.2006.00437.X]; Gray J., 2002, AUST EDUC RES, V29, P27; Gyateng, 2010, PUNISHING DISADVANTA; Gyateng T, 2013, YOUNG PEOPLE SECURE; Haines A., 2012, EVALUATION YOUTH JUS; Harrington R., 2005, MENTAL HLTH NEEDS EF; Haysom L, 2014, J INTELL DISABIL RES, V58, P1004, DOI 10.1111/jir.12109; Holman Barry., 2006, DANGERS DETENTION; IDRS (Intellectual Disability Rights Service), 2008, EN JUST; Indig D, 2011, 2009 NSW YOUNG PEOPL; Kenny D., 2006, NSW YOUNG PEOPLE COM; Kenny DT, 2008, YOUNG OFFENDERS ON COMMUNITY ORDERS: HEALTH, WELFARE AND CRIMINOGENIC NEEDS, P1; Kenny DT, 2007, CONT ISSUES CRIME JU, V107, P1; Maddocks T., 2016, ABC NEWS; Mccausland, 2015, PREDICTABLE PREVENTA; Medhora S., 2016, TRIPLE J HACK   1211; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Mounce L., 2012, NOBODY MADE CONNECTI; Newbury-Birch D, 2016, INT J PRISON HEALTH, V12, P57, DOI 10.1108/IJPH-08-2015-0024; Noetic, 2010, STRAT REV NEW S WAL; NSW Health and NSW Juvenile Justice, 2016, 2015 YOUNG PEOPL CUS; NSWLRC (NSW Law Reform Commission), 2013, PEOPL COGN MENT HLTH; NSWLRC (NSW Law Reform Commission), 2012, PEOPL COGN MENT HLTH; Oliver M., 1996, UNDERSTANDING DISABI; Perpitch N., 2014, ABC NEWS; Prichard J, 2005, ALCOHOL DRUGS CRIME; Prison Reform Trust, 2016, CAR OUT TROUBL; Redmond A., 2015, CHILDREN CUSTODY 201; Schnittker J, 2007, J HEALTH SOC BEHAV, V48, P115, DOI 10.1177/002214650704800202; Shaw J, 2016, YOUTH JUSTICE, V16, P147, DOI 10.1177/1473225415617858; Simpson J., 2001, THE FRAMEWORK REPORT; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P20, DOI 10.3109/17549507.2015.1081291; Staines J, 2017, SAFER COMMUNITIES, V16, P102, DOI 10.1108/SC-01-2017-0005; Standing Committee on Social Policy and Legal Affairs, 2012, FASD HIDD HARM; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Taylor Charlie, 2016, REV YOUTH JUSTICE SY; To WT, 2014, RES DEV DISABIL, V35, P1, DOI 10.1016/j.ridd.2013.10.015; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Victoria Legal Aid, 2016, CAR NOT CUST; Vinson T., 2007, DROPPING EDGE; Vinson T., 2015, DROPPING EDGE; Ward S, 2015, J EMPIR LEGAL STUD, V12, P716, DOI 10.1111/jels.12090; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Young Minds, 2013, SAM OLD EXP YOUNG OF; Young S, 2015, PSYCHOL MED, V45, P247, DOI 10.1017/S0033291714000762	71	11	11	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1367-6261	1469-9680		J YOUTH STUD	J. Youth Stud.		2018	21	5					636	652		10.1080/13676261.2017.1406072			17	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	GB4MT	WOS:000429035000005		Green Accepted			2022-02-06	
J	Caron, JG; Rathwell, S; Delaney, JS; Johnston, KM; Ptito, A; Bloom, GA				Caron, Jeffrey G.; Rathwell, Scott; Delaney, J. Scott; Johnston, Karen M.; Ptito, Alain; Bloom, Gordon A.			Development, implementation and assessment of a concussion education programme for high school student-athletes	JOURNAL OF SPORTS SCIENCES			English	Article						Concussion education; intervention; adolescent; mixed method; knowledge translation; injury prevention	TRAUMATIC BRAIN-INJURY; KNOWLEDGE TRANSLATION; SPORTS CONCUSSION; TIME; EPIDEMIOLOGY; PLAYERS; HOCKEY; ONLINE; VIDEO	Although experts have noted that adolescent athletes should be educated about concussions to improve their safety, there is no agreement on the most effective strategy to disseminate concussion education. The purpose of this study was to develop, implement and assess a concussion education programme. More precisely, four interactive oral presentations were delivered to high school student-athletes (N=35, M-age=15.94, SD=0.34) in a large urban centre. Participants completed a questionnaire at three time-points during the season to measure changes in their knowledge (CK) and attitudes (CA) of concussions, and focus group interviews were conducted following the concussion education programme. Questionnaire data revealed participants' post-intervention CK scores were higher than their pre-intervention scores. During the focus groups, the student-athletes said they acquired CK about the role of protective equipment and symptom variability, and in terms of CA, they intended to avoid dangerous in-game collisions in the future. Our study was the first to create and deliver a concussion education intervention across multiple time-points, and to use mixed-methods in its assessment. These findings may be of interest to researchers, practitioners and stakeholders in sport who are invested in making the sport environment safer through concussion education and awareness.	[Caron, Jeffrey G.; Bloom, Gordon A.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Rathwell, Scott] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Delaney, J. Scott] McGill Univ, Dept Emergency Med, Hlth Ctr, Montreal, PQ, Canada; [Delaney, J. Scott] McGill Sports Med Clin, Montreal, PQ, Canada; [Johnston, Karen M.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Johnston, Karen M.] Athlet Edge Sports Med, Toronto, ON, Canada; [Ptito, Alain] McGill Univ, Dept Psychol, Hlth Ctr, Montreal, PQ, Canada; [Ptito, Alain] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Ptito, Alain] Montreal Neurol Inst, Montreal, PQ, Canada		Caron, JG (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.	jeffrey.caron@mail.mcgill.ca			Bloomberg-Manulife Doctoral Fellowship	This work was supported by the Bloomberg-Manulife Doctoral Fellowship.	Ahmed OH, 2016, PHYS THER SPORT, V21, P82, DOI 10.1016/j.ptsp.2016.03.001; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Braun V., 2013, SUCCESSFUL QUALITATI; Canadian Heritage, 2013, CAN SPORT PART 2010; Caron JG, 2015, INT SPORT COACH J, V2, P285, DOI 10.1123/iscj.2015-0022; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cote J., 2010, SPORT COACHING PROFE, P63; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Kipping RR, 2012, J PUBLIC HEALTH-UK, V34, P236, DOI 10.1093/pubmed/fdr076; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; Marshall S, 2015, INJURY EPIDEMIOLOGY, V2, P1; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Morse J, 2010, SAGE HDB MIXED METHO, P339; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Podlog L, 2011, PHYS THER SPORT, V12, P36, DOI 10.1016/j.ptsp.2010.07.005; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; REGISTERMIHALIK. J, 2013, JOURNAL OF ATHLETIC, V48, P645, DOI DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rubin IS, 2012, QUALITATIVE INTERVIE; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Sniehotta FF, 2014, HEALTH PSYCHOL REV, V8, P1, DOI 10.1080/17437199.2013.869710; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Straus SE, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P1, DOI 10.1002/9781118413555; Straus SE, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P227; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; Tachakkori A., 2010, HDB MIXED METHODS RE; Tavory I., 2014, ABDUCTIVE ANAL THEOR; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	43	11	11	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2018	36	1					48	55		10.1080/02640414.2017.1280180			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FQ9TP	WOS:000418704900007	28094682	Green Submitted			2022-02-06	
J	Cheng, SX; Xu, ZW; Yi, TL; Sun, HT; Yang, C; Yu, ZQ; Yang, XS; Jin, XH; Tu, Y; Zhang, S				Cheng, Shi-Xiang; Xu, Zhong-Wei; Yi, Tai-Long; Sun, Hong-Tao; Yang, Cheng; Yu, Ze-Qi; Yang, Xiao-Sa; Jin, Xiao-Han; Tu, Yue; Zhang, Sai			iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management	NEUROTHERAPEUTICS			English	Article						Targeted temperature management; Traumatic brain injury; Proteomics; Isobaric tags for relative and absolute quantitation; Cerebrospinal fluid	PHARMACOLOGICALLY INDUCED HYPOTHERMIA; LARGE GENE LISTS; MILD HYPOTHERMIA; RODENT MODELS; POSTTRAUMATIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; RATS; MECHANISMS; EXPRESSION	This study aimed to investigate the effects of targeted temperature management (TTM) modulation on traumatic brain injury (TBI) and the involved mechanisms using quantitative proteomics technology. SH-SY5Y and HT-22 cells were subjected to moderate stretch injury using the cell injury controller (CIC), followed by incubation at TTM (mild hypothermia, 32 degrees C), or normothermia (37 degrees C). The real-time morphological changes, cell cycle phase distribution, death, and cell viability were evaluated. Moderate TBI was produced by the controlled cortical impactor (CCI), and the effects of TTM on the neurological damage, neurodegeneration, cerebrovascular histopathology, and behavioral outcome were determined in vivo. Results showed that TTM treatment prevented TBI-induced neuronal necrosis in the brain, achieved a substantial reduction in neuronal death both in vitro and in vivo, reduced cortical lesion volume and neuronal loss, attenuated cerebrovascular histopathological damage, brain edema, and improved behavioral outcome. Using an iTRAQ proteomics approach, proteins that were significantly associated with TTM in experimental TBI were identified. Importantly, changes in four candidate molecules (plasminogen [PLG], antithrombin III [AT III], fibrinogen gamma chain [FGG], transthyretin [TTR]) were verified using TBI rat brain tissues and TBI human cerebrospinal fluid (CSF) samples. This study is one of the first to investigate the neuroprotective effects of TTM on the proteome of human and experimental models of TBI, providing an overall landscape of the TBI brain proteome and a scientific foundation for further assessment of candidate molecules associated with TTM for the promotion of reparative strategies post-TBI.	[Cheng, Shi-Xiang; Yi, Tai-Long; Sun, Hong-Tao; Yang, Cheng; Yu, Ze-Qi; Yang, Xiao-Sa; Tu, Yue; Zhang, Sai] Logist Univ Chinese Peoples Armed Police Force PA, Tianjin Key Lab Neurotrauma Repair, Inst Traumat Brain Injury & Neurosci, Ctr Neurol & Neurosurg,Affiliated Hosp, Tianjin, Peoples R China; [Xu, Zhong-Wei; Jin, Xiao-Han] Logist Univ Chinese Peoples Armed Police Force PA, Cent Lab, Tianjin, Peoples R China		Cheng, SX; Tu, Y; Zhang, S (corresponding author), Logist Univ Chinese Peoples Armed Police Force PA, Tianjin Key Lab Neurotrauma Repair, Inst Traumat Brain Injury & Neurosci, Ctr Neurol & Neurosurg,Affiliated Hosp, Tianjin, Peoples R China.	shixiangcheng@vip.126.com; ytumail@vip.126.com; zhangsai718@vip.126.com		yi, tailong/0000-0002-7092-2444	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31200809]; Science & Technology Program of Tianjin, China [15ZXLCSY00040];  [AWS15J001]	This work was supported by grants from the National Natural Science Foundation of China (31200809), Science & Technology Program of Tianjin, China (15ZXLCSY00040), and Technology Research Projects (AWS15J001).	Anderson KJ, 2003, J NEUROTRAUM, V20, P1223, DOI 10.1089/089771503770802899; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Benoit CE, 2011, TRENDS PHARMACOL SCI, V32, P43, DOI 10.1016/j.tips.2010.10.002; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Chahrour O, 2015, J PHARMACEUT BIOMED, V113, P2, DOI 10.1016/j.jpba.2015.04.013; Cheng SX, 2013, THER HYPOTHERMIA TEM, V3, P132, DOI 10.1089/ther.2013.0005; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Doll H, 2010, J NEUROTRAUM, V27, P2245, DOI 10.1089/neu.2010.1505; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Fujita M, 2017, J NEUROTRAUMA, V19; Fujita M, 2012, J NEUROTRAUM, V29, P1491, DOI 10.1089/neu.2011.2278; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Jin XH, 2017, BBA-PROTEINS PROTEOM, V1865, P1207, DOI 10.1016/j.bbapap.2017.07.003; Jin YC, 2016, WORLD NEUROSURG, V88, P433, DOI 10.1016/j.wneu.2015.10.055; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lei J, 2015, CONTEMP CLIN TRIALS, V40, P9, DOI 10.1016/j.cct.2014.11.008; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Loov C, 2015, J NEUROTRAUM, V32, P244, DOI 10.1089/neu.2014.3517; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Miyauchi T, 2014, J NEUROTRAUM, V31, P773, DOI 10.1089/neu.2013.3181; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Ottens AK, 2010, J NEUROTRAUM, V27, P1837, DOI 10.1089/neu.2010.1374; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Silasi G, 2011, THER HYPOTHERMIA TEM, V1, P87, DOI 10.1089/ther.2011.0005; Szczygielski J, 2017, J NEUROTRAUM, V34, P1623, DOI 10.1089/neu.2016.4615; Thelin E. P., 2016, BRAIN INJURY FRONT N, V7, P23, DOI [10.3389/fneur.2016.0002327014178, DOI 10.3389/FNEUR.2016.0002327014178]; Thelin EP, 2016, BEHAV BRAIN RES; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Ul Amin F, 2017, SCI REP-UK, V7, DOI 10.1038/srep40753; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Zhai LH, 2013, PROTEOMICS, V13, P2229, DOI 10.1002/pmic.201200591; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984; Zhao CC, 2017, J NEUROTRAUM, V34, P1636, DOI 10.1089/neu.2016.4759; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858	60	11	14	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	JAN	2018	15	1					216	232		10.1007/s13311-017-0591-2			17	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	FU8CV	WOS:000424080900020	29247448	Green Published, Bronze			2022-02-06	
J	Corwin, DJ; Zonfrillo, MR; Wiebe, DJ; Master, CL; Grady, MF; Arbogast, KB				Corwin, Daniel J.; Zonfrillo, Mark R.; Wiebe, Douglas J.; Master, Christina L.; Grady, Matthew F.; Arbogast, Kristy B.			Vestibular and oculomotor findings in neurologically-normal, non-concussed children	BRAIN INJURY			English	Article						Concussion; Pediatric; Vestibular and oculomotor examination	ASSOCIATIONS; COMMON	Objective: To determine the proportion of non-concussed, neurologically normal children with failures on a vestibular and oculomotor examination for concussion performed in an acute setting.Design: This was a cross-sectional study of subjects 6-18years old presenting to a paediatric emergency department with non-neurologic chief complaints. The examination was administered by a paediatric emergency medicine physician, and includes assessments of dysmetria, nystagmus, smooth pursuits, saccades, gaze stability, near-point of convergence, and gait/balance testing.Results: Of the 295 subjects enrolled, 24% failed at least one element of testing. About 13% had >1 failed element and 5% had >2 failed elements. About 29% of females and 19% of males had failed examinations. By age, 15% of subjects 6-8years old, 32% 9-11years, 32% 12-14years, and 26% 15-18years had failed examinations. Overall, 10% were unable to complete the exam due to developmental age.Conclusions: The provider should be aware that a proportion of non-concussed children may demonstrate failure on a single element of the vestibular and oculomotor exam. While this testing is of benefit to the acute care provider in diagnosing paediatric concussion, its utility is greatest in the context of an injury history with acute onset of concussion symptoms.	[Corwin, Daniel J.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA; [Wiebe, Douglas J.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Master, Christina L.; Grady, Matthew F.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Wiebe, Douglas J.; Master, Christina L.; Grady, Matthew F.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Corwin, DJ (corresponding author), Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	corwind@email.chop.edu	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563; Master, Christina/0000-0002-6717-4270; Arbogast, Kristy/0000-0002-1694-4562	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS061779] Funding Source: Medline; ACL HHS [R49CE002474] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS061779] Funding Source: NIH RePORTER		Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Gilboy N, 2012, EMERGENCY SEVERITY I; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hussaindeen JR, 2017, CLIN EXP OPTOM, V100, P642, DOI 10.1111/cxo.12496; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jang Jung Un, 2015, Taiwan J Ophthalmol, V5, P177, DOI 10.1016/j.tjo.2015.07.005; Lavrich JB, 2010, CURR OPIN OPHTHALMOL, V21, P356, DOI 10.1097/ICU.0b013e32833cf03a; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nieto, 2014, EPIDEMIOLOGY BASICS; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Scheiman M, 1996, J Am Optom Assoc, V67, P193; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	22	11	11	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					794	799		10.1080/02699052.2018.1458150			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200014	29584455	Green Accepted			2022-02-06	
J	Cranmer, GA; Sanderson, J				Cranmer, Gregory A.; Sanderson, Jimmy			"Rough Week for Testosterone": Public Commentary around the Ivy League's Decision to Restrict Tackle Football in Practice	WESTERN JOURNAL OF COMMUNICATION			English	Article						Concussion; Football; Ivy League; Social Media and Sport; Sport and Health; Sport and Masculinity	CONCUSSION; TWITTER; MASCULINITY; PROTEST; INJURY; SPORTS	This research examines public dialogue about the decision of the Ivy League schools to restrict full-contact tackling during football practice. Data from Twitter and online news comments were subjected to interpretive analysis, which revealed that participants framed the policy as evidence of social progress while others critiqued its effectiveness and positioned it as evidence of the decline of masculinity and American identity. The results indicate that public discourse around health and safety issues within sport are more complex and varied than those in the media. Additionally, sport organizations should anticipate resistance to policies and strategically craft communication to address these barriers.	[Cranmer, Gregory A.] Clemson Univ, Dept Commun, Sports Commun, Clemson, SC USA		Cranmer, GA (corresponding author), Clemson Univ, Dept Commun, 305B Daniel Hall, Clemson, SC 29634 USA.	Gcranme@clemson.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Angelini JR, 2014, J LANG SOC PSYCHOL, V33, P226, DOI 10.1177/0261927X13508559; Battista J., 2016, NFL             0329; Bell T. R., 2016, International Journal of Sport Communication, V9, P499, DOI 10.1123/IJSC.2016-0075; Billings A, 2014, COMMUN SPORT, V2, P107, DOI 10.1177/2167479514527427; Billings AC, 2014, J MASS COMMUN Q, V91, P38, DOI 10.1177/1077699013514416; Blazska M., 2016, GLOBAL SPORT BUSINES, V4, P1; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Burch LM, 2015, J BROADCAST ELECTRON, V59, P399, DOI 10.1080/08838151.2015.1054999; Butterworth M.L., 2014, NFL CRITICAL CULTURA, P205; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Connell R.W., 1990, SOCIOLOGICAL PERSPEC, P141; Cranmer G. A., 2016, International Journal of Sport Communication, V9, P209, DOI 10.1123/IJSC.2015-0126; Daly M., 2016, ASS PRESS; Depoe S., 1994, AM SCHLESINGER IDEOL; Eagleman AM, 2011, J SPORT MANAGE, V25, P156, DOI 10.1123/jsm.25.2.156; Endres KL, 2004, J MASS COMMUN Q, V81, P7, DOI 10.1177/107769900408100102; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Foote JG, 2017, COMMUN Q, V65, P268, DOI 10.1080/01463373.2016.1227347; Frederick E, 2016, ONLINE INFORM REV, V40, P798, DOI 10.1108/OIR-02-2016-0038; Frederick EL, 2016, SPORT SOC, V19, P1460, DOI 10.1080/17430437.2015.1133598; Freelon D, 2014, J BROADCAST ELECTRON, V58, P59, DOI 10.1080/08838151.2013.875018; Gladwell M., 2009, NEW YORKER; Guarino B., 2016, TRUMP KNOCKS SOFTER; Huang Y, 2013, MEDIA WAR CONFL, V6, P191, DOI 10.1177/1750635213495601; Kassing J. W., 2011, DISSENT ORG; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kian E. M., 2015, International Journal of Sport Communication, V8, P500, DOI 10.1123/IJSC.2015-0094; Kirk M., 2013, LEAGUE OF DENIAL; Ksiazek TB, 2015, J BROADCAST ELECTRON, V59, P556, DOI 10.1080/08838151.2015.1093487; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Messner Michael A., 1992, POWER PLAY SPORTS PR; Nadesan M., 2016, CRISIS COMMUNICATION; Nisbet MatthewC., 2010, DOING NEWS FRAMING A, P43; Reese SD, 2001, LEA COMMUN SER, P7; Reimer Alex, 2016, FORBES; Roderick M., 2000, International Review for the Sociology of Sport, V35, P165, DOI 10.1177/101269000035002003; Saldana J, 2013, CODING MANUAL QUALIT; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sanderson J, 2016, SOCIOL SPORT J, V33, P113, DOI 10.1123/ssj.2015-0048; Scheufele DA, 1999, J COMMUN, V49, P103, DOI 10.1111/j.1460-2466.1999.tb02784.x; Scott R., 2015, CONCUSSION; Sheridan B., 2012, HEAD GAMES; Solomon J., 2016, CBS SPORTS      0303; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; TRUJILLO N, 1995, SOCIOL SPORT J, V12, P403, DOI 10.1123/ssj.12.4.403; TRUJILLO N, 1991, CRIT STUD MASS COMM, V8, P290, DOI 10.1080/15295039109366799; van Luijk N, 2012, INT J SPORT POLICY P, V4, P343, DOI 10.1080/19406940.2012.656686; Wagner-McGough S., 2016, CBS SPORTS      0512; Waldron Travis, 2013, THINK PROGR; Weight EA, 2015, J APPL SPORT MANAG, V7, P57, DOI 10.18666/JASM-2015-V7-I4-5982; Young, 2004, SPORTING BODIES DAMA, P59; Zaharopoulos Thimios, 2007, MASS COMMUNICATION S, V10, P235, DOI DOI 10.1080/15205430701265752	60	11	11	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1057-0314	1745-1027		WESTERN J COMM	West. J. Commun.		2018	82	5					631	647		10.1080/10570314.2018.1441431			17	Communication	Emerging Sources Citation Index (ESCI)	Communication	GU6ET	WOS:000445400800007					2022-02-06	
J	Delaney, JS; Caron, JG; Correa, JA; Bloom, GA				Delaney, Jeffrey Scott; Caron, Jeffrey G.; Correa, Jose A.; Bloom, Gordon A.			Why Professional Football Players Chose Not to Reveal Their Concussion Symptoms During a Practice or Game	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; symptoms; professional; football; reasons	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; SOCCER PLAYERS; EDUCATION; MANAGEMENT; DIAGNOSIS; IMPACT; HOCKEY	Objective: To determine why professional football players in Canada decided not to seek medical attention during a game or practice when they believed they had suffered a concussion. Design: Retrospective survey. Setting: Preseason Canadian Football League training camps. Participants: Four hundred fifty-four male professional football players. Main Outcome Measures: Reasons athletes did not seek medical attention for a presumed concussion during the previous season, how often this occurred and how important these reasons were in the decision process. Results: One hundred six of the 454 respondents (23.4%) believed they had suffered a concussion during their previous football season and 87 of the 106 (82.1%) did not seek medical attention for a concussion at least once during that season. The response "Did not feel the concussion was serious/severe and felt you could still continue to play with little danger to yourself" was the most commonly listed reason (49/106) for not seeking medical attention for a presumed concussion. Many players answered that they did not seek medical attention because they did not want to be removed from a game (42/106) and/or they did not want to risk missing future games (41/106) by being diagnosed with a concussion. Conclusions: Some professional football players who believed they had suffered a concussion chose not to seek medical attention at the time of injury. Players seemed educated about the concussion evaluation process and possible treatment guidelines, but this knowledge did not necessarily translate into safe and appropriate behavior at the time of injury.	[Delaney, Jeffrey Scott] McGill Sport Med Clin, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada; [Delaney, Jeffrey Scott] McGill Univ, Hlth Ctr, Dept Emergency Med, Montreal, PQ, Canada; [Caron, Jeffrey G.; Correa, Jose A.; Bloom, Gordon A.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Correa, Jose A.] McGill Univ, Dept Math, Montreal, PQ, Canada		Delaney, JS (corresponding author), McGill Sport Med Clin, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada.	j.delaney@mcgill.ca			Canadian Football League Players Association (CFLPA)	The authors would like to thank the players and team therapists of the Canadian Football League (CFL) for their help in collecting data. We would also like to thank the CFL league management and the Canadian Football League Players Association (CFLPA) for their assistance and support in completing this study.	Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Caron JG, 2017, J SPORTS SCI, P1; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McDonald K., 2017, COMMUNICATION; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Seravalli F., 2016, NHL USE CONCUSSION S; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Wagner-McGough S., 2016, NEW NFL RULE GIVES C; Warren WL, 1998, CLIN SPORT MED, V17, P99, DOI 10.1016/S0278-5919(05)70064-8; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	39	11	13	4	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2018	28	1					1	12		10.1097/JSM.0000000000000495			12	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	GB0JM	WOS:000428732000003	29064867				2022-02-06	
J	Fuller, CW; Taylor, A; Raftery, M				Fuller, Colin W.; Taylor, Aileen; Raftery, Martin			Eight-season epidemiological study of injuries in men's international Under-20 rugby tournaments	JOURNAL OF SPORTS SCIENCES			English	Article						Risk factors; injury causation; injury burden	WORLD CUP 2015; MATCH INJURIES; UNION; SURVEILLANCE; MECHANISMS; PLAYERS; EVENTS	The aim of this study was to define the incidence and nature of match injuries sustained in men's international under-20 rugby. The study comprised an 8-season prospective study of 16 international under-20 rugby tournaments. Procedures complied with the consensus statement for epidemiological studies in rugby. Outputs included players' mean age, stature and body mass and incidence, severity, location, type and cause of match injuries. The overall incidence of injury was 49.7 injuries/1000 player-match-hours (backs: 48.3; forwards: 50.9) with a mean severity of 32.2days-absence (backs: 29.4; forwards: 34.4). There were no significant changes in incidence or severity of injury over the study period. Shoulder/clavicle (18.3%), head/face (16.4%), knee (13.7%) and ankle (13.7%) were the most common injury locations and ligament sprain (35.4%), haematoma/bruise (15.9%), concussion (12.5%) and muscle strain (11.2%) the most common types of injury. Being-tackled (29.2%), tackling (24.0%) and collisions (14.3%) were the most common events leading to injury. The results confirm that international under-20 rugby has a high incidence and severity of injury but the incidence is half that reported for senior international players. There was no significant change in the overall incidence of injury at the Under-20 level in the period 2008 to 2016.	[Fuller, Colin W.] Colin Fuller Consultancy Ltd, Loughborough, England; [Fuller, Colin W.; Taylor, Aileen; Raftery, Martin] World Rugby, Dublin, Ireland		Fuller, CW (corresponding author), Colin Fuller Consultancy Ltd, Loughborough, England.	ColinFullerConsultancy@gmail.com			World Rugby	This work was supported by the World Rugby.	Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Burger N, 2017, AM J SPORT MED, V45, P278, DOI 10.1177/0363546516677548; Crichton J, 2012, BRIT J SPORT MED, V46, P538, DOI 10.1136/bjsports-2011-090688; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Fuller CW, 2009, SAMJ S AFR MED J, V99, P232; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P207, DOI 10.2147/OAJSM.S7715; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Sterne, 2003, ESSENTIAL MED STAT; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; World Rugby, 2017, U20 CHAMP OV	21	11	12	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2018	36	15					1776	1783		10.1080/02640414.2017.1418193			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GB5IS	WOS:000429098400014	29252097				2022-02-06	
J	Greene, NH; Kernic, MA; Vavilala, MS; Rivara, FP				Greene, Nathaniel H.; Kernic, Mary A.; Vavilala, Monica S.; Rivara, Frederick P.			Variation in Adult Traumatic Brain Injury Outcomes in the United States	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						epidemiology; healthcare disparities; outcomes; rehabilitation; traumatic brain injury	HEAD-INJURIES; ACUTE REHABILITATION; FUNCTIONAL OUTCOMES; INSURANCE STATUS; CARE; CHILDREN; MORTALITY	Objective: To ascertain the degree of variation, by state of acute care hospitalization, in outcomes associated with traumatic brain injury (TBI) in an adult population. Setting: All acute care hospitals in 21 states in the United States in the year 2010. Participants: Adult (> 18 years) patients (N = 95 546) admitted to a hospital with a moderate or severe TBI. Design: Retrospective cohort study using data from State Inpatient Databases from Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project. Main Measures: Inpatient mortality and discharge to inpatient rehabilitation. Results: The adjusted risk of inpatient mortality varied between states by as much as 40%, with age, severity of injury, and insurance status as significant factors in both outcomes. The adjusted risk of discharge to inpatient rehabilitation varied between by more than 100% among the states measured. Conclusions: There was clinically significant variation between states in inpatient mortality and rehabilitation discharge after adjusting for variables known to affect each outcome. Future efforts should be focused on identifying the causes of this state-to-state variation, how these causes affect patient outcomes, and may serve as a guide to further standardization of treatment for traumatic brain injury across the United States.	[Greene, Nathaniel H.; Vavilala, Monica S.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Kernic, Mary A.; Rivara, Frederick P.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Greene, Nathaniel H.; Kernic, Mary A.; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Greene, Nathaniel H.] Duke Univ, Durham, NC USA		Greene, NH (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27710 USA.	nathaniel.greene@dm.duke.edu	Greene, Nathaniel/J-3450-2014	Greene, Nathaniel/0000-0003-0230-0499	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822] Funding Source: Medline; NCIPC CDC HHS [U01 CE002196] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196] Funding Source: NIH RePORTER		Agrawal M, 2014, BRAIN INJURY, V28, P292, DOI 10.3109/02699052.2013.865266; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clark DE., ICDPIC STATA MODULE; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hamlat CA, 2012, ANN SURG, V255, P165, DOI 10.1097/SLA.0b013e31823840ca; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jamieson LM, 2007, INJURY PREV, V13, P243, DOI 10.1136/ip.2007.015354; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Rice-Townsend S, 2013, J PEDIATR SURG, V48, P104, DOI 10.1016/j.jpedsurg.2012.10.025; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Scales CD, 2011, J UROLOGY, V186, P146, DOI 10.1016/j.juro.2011.03.018; Sears JM, 2014, INJURY, V45, P16, DOI 10.1016/j.injury.2012.12.024; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stallion A, 2007, J TRAUMA, V62, P1262; Svenson JE, 2001, AM J EMERG MED, V19, P19, DOI 10.1053/ajem.2001.18041; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	11	11	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					E1	E8		10.1097/HTR.0000000000000306			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300001	28422899	Green Accepted			2022-02-06	
J	Haarbauer-Krupa, JK; Comstock, RD; Lionbarger, M; Hirsch, S; Kavee, A; Lowe, B				Haarbauer-Krupa, Juliet K.; Comstock, R. Dawn; Lionbarger, Michael; Hirsch, Shawn; Kavee, Andrew; Lowe, Brooks			Healthcare professional involvement and RTP compliance in high school athletes with concussion	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; return to play; high school athletes; healthcare professional; concussion management; athletic trainer	UNITED-STATES; INJURIES; SPORTS; MANAGEMENT; TRAINERS; SERVICES; POLICIES; TRENDS; RETURN	Objectives: To describe concussion rates in high school athletes and involvement of healthcare professionals in concussion diagnosis, management and compliance with return to play (RTP) guidelines. Methods: Data were analysed from injury reports in the National High School Sports-Related Injury Surveillance System between 2009/2010 and 2012/2013 to identify student athletes with concussion and determine compliance with RTP guidelines. Compliance with RTP guidelines was examined using logistic regression, adjusting for sport and injury-related variables. Results: There were 5611 concussions recorded during 15 712 475 athlete exposures (AEs), a rate of 3.6 concussions per 10000 AEs. Rates were higher during competition and among girls compared to boys in gender equitable sports. Healthcare professionals were less likely to be present at the time of concussion for girls' sports, lower competition levels and practices. Compliance with RTP guidelines was higher for athletes with recurrent concussions, those sustained in collision sports, for athletes reporting more symptoms and when a physician made the RTP decision. Conclusions: Presence of healthcare professionals and compliance with RTP guidelines varied by sport, gender, level of play and exposure type. High school athletes with concussion are best served by assessment teams with athletic trainers and physicians working together to manage concussions and contribute to RTP decisions.	[Haarbauer-Krupa, Juliet K.; Lionbarger, Michael] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Aurora, CO USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Aurora, CO USA; [Hirsch, Shawn; Kavee, Andrew; Lowe, Brooks] SciMetrika LLC, Res Triangle Pk, NC USA		Haarbauer-Krupa, JK (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway,MS F-62, Atlanta, GA 30341 USA.	JHaarbauerKrupa@cdc.gov		Hirsch, Shawn/0000-0001-6280-9559	Centers of Disease Control and Prevention, Atlanta, GA, USA [200-2012-M-53715]	This project was funded by the Centers of Disease Control and Prevention, Atlanta, GA, USA, contracted to SciMetrika LLC, contract number 200-2012-M-53715. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. There are no conflicts of interest to disclose.	American Academy of Pediatrics Committee on Sport Medicine and Fitness, 2001, PEDIATRICS, V107, P1205, DOI DOI 10.1542/PEDS.107.5.1221; Brener ND, 2007, J SCHOOL HEALTH, V77, P464, DOI 10.1111/j.1746-1561.2007.00230.x; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Centers for Disease Control and Prevention, 2016, IMPL RET PLAY LEARN; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Comstock D, 2016, HIGH SCH RIO REPORTI; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lombardi NJ, 2016, ORTHOPEDICS, V39, pE944, DOI 10.3928/01477447-20160623-10; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	21	11	11	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1337	1344		10.1080/02699052.2018.1482426			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000004	29953252	Green Accepted			2022-02-06	
J	Hoopsick, RA; Vest, BM; Homish, DL; Homish, GG				Hoopsick, R. A.; Vest, B. M.; Homish, D. L.; Homish, G. G.			Combat exposure, emotional and physical role limitations, and substance use among male United States Army Reserve and National Guard soldiers	QUALITY OF LIFE RESEARCH			English	Article						Military; Quality of life; Substance use; Frequent heavy drinking; Non-medical use of prescription drugs; Combat	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; INTIMATE PARTNER VIOLENCE; MILITARY PERSONNEL; HEALTH-PROBLEMS; NORMATIVE DATA; ALCOHOL-ABUSE; DRUG-USE; IRAQ	Combat-exposed soldiers are at an increased risk for health problems that diminish quality of life (QOL) and substance use. We explored the cross-sectional associations between combat exposure and two measures of QOL, and the effect of substance use on those associations. Data are from the baseline wave of Operation: SAFETY, an ongoing survey-based study of United States Army Reserve/National Guard (USAR/NG) soldiers and their partners. Our sample consisted of male USAR/NG soldiers with a history of deployment (N = 248). Limitations in usual activity due to physical and emotional problems were assessed using the 36-Item Short-Form Health Survey (SF-36). Greater combat exposure was independently associated with limitations in usual activity due to physical (regression coefficient = -0.35, 95% CI -0.55 to -0.16, R (2) = 0.09; p < 0.01) and emotional (regression coefficient = -0.32, 95% CI -0.56 to -0.09, R (2) = 0.09; p < 0.01) problems. Combat exposure had a significant interaction with frequent heavy drinking on physical role limitations (regression coefficient = -0.65, 95% CI -1.18 to -0.12, R (2) = 0.12; p < 0.05) and emotional role limitations (regression coefficient = -0.83, 95% CI -1.46 to -0.19, R (2) = 0.12; p < 0.05). Combat exposure also had a significant interaction with lifetime non-medical use of prescription drugs on physical role limitations (regression coefficient = 0.81, 95% CI 0.18-1.45, R (2) = 0.11; p < 0.05). Combat is an unmodifiable risk factor for poor QOL among soldiers; however, frequent heavy drinking and non-medical use of prescription drugs modifies the relationship between combat exposure and QOL. Therefore, substance use is a potential point of intervention to improve QOL among soldiers.	[Hoopsick, R. A.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, 3435 Main St,335 Kimball Tower, Buffalo, NY 14214 USA; [Vest, B. M.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Family Med, 77 Goodell St Suite 220, Buffalo, NY 14203 USA; [Homish, D. L.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, 3435 Main St,194 Farber Hall, Buffalo, NY 14214 USA; [Homish, G. G.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, 3435 Main St,325 Kimball Tower, Buffalo, NY 14214 USA		Hoopsick, RA (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, 3435 Main St,335 Kimball Tower, Buffalo, NY 14214 USA.	rachelh@buffalo.edu	Homish, Gregory G/A-9576-2009; Hoopsick, Rachel A./ABH-7046-2020	Hoopsick, Rachel A./0000-0001-5992-9007; Homish, Gregory/0000-0003-2601-3283; Vest, Bonnie/0000-0002-3401-7367	United States Department of Health and Human Services National Institute on Drug Abuse [R01-DA034072]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA034072] Funding Source: NIH RePORTER	This work was supported by the United States Department of Health and Human Services National Institute on Drug Abuse under Grant: R01-DA034072.	Adams RS, 2016, J TRAUMA STRESS, V29, P356, DOI 10.1002/jts.22121; Ali R, 2002, ADDICTION, V97, P1183; Bennett AS, 2013, SUBST USE MISUSE, V48, P894, DOI 10.3109/10826084.2013.796991; Bertakis KD, 2007, J HEALTH COMMUN, V12, P513, DOI 10.1080/10810730701508187; Betthauser K, 2015, AM J HEALTH-SYST PH, V72, P1279, DOI 10.2146/ajhp140523; Black Donald W, 2004, Ann Clin Psychiatry, V16, P53, DOI 10.1080/10401230490452645; BRAY RM, 1991, AM J PUBLIC HEALTH, V81, P865, DOI 10.2105/AJPH.81.7.865; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Brown JL, 2012, JAMA-J AM MED ASSOC, V308, P1869, DOI 10.1001/jama.2012.14254; Burholt V, 2011, J PUBLIC HEALTH-UK, V33, P587, DOI 10.1093/pubmed/fdr006; Dello Buono M, 1998, AGE AGEING, V27, P207; Der-Martirosian C, 2010, QUAL LIFE RES, V19, P1333, DOI 10.1007/s11136-010-9700-y; Friedmann PD, 2000, J GEN INTERN MED, V15, P84, DOI 10.1046/j.1525-1497.2000.03379.x; Homish GG, 2007, J CONSULT CLIN PSYCH, V75, P43, DOI 10.1037/0022-006X.75.1.43; Gharibi Maliheh, 2015, Glob J Health Sci, V8, P178, DOI 10.5539/gjhs.v8n2p178; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Gonzales R, 2011, AM J ADDICTION, V20, P366, DOI 10.1111/j.1521-0391.2011.00142.x; Griffin ML, 2015, AM J ADDICTION, V24, P308, DOI 10.1111/ajad.12188; Griffith J, 2010, MIL PSYCHOL, V22, P176, DOI 10.1080/08995601003638967; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Hayes, 2018, INTRO MEDIATION MODE; Heavey SC, 2017, STRESS HEALTH, V33, P617, DOI 10.1002/smi.2748; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hopman WM, 2009, CAN J PUBLIC HEALTH, V100, P449, DOI 10.1007/BF03404342; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kaczmarek M, 2017, HOMO, V68, P42, DOI 10.1016/j.jchb.2016.11.004; Kelsall HL, 2014, PAIN, V155, P685, DOI 10.1016/j.pain.2013.12.025; Kilpatrick DG., 2011, SERVING THOSE WHO HA; Koblinsky Sally A, 2014, Mil Behav Health, V2, P162; Kozlowski Lynn T, 2017, Prev Med Rep, V6, P111, DOI 10.1016/j.pmedr.2017.02.026; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; Leonard KE, 2014, PSYCHOL VIOLENCE, V4, P384, DOI 10.1037/a0037483; LOCKE HJ, 1959, MARRIAGE FAM LIVING, V21, P251, DOI 10.2307/348022; Lowe SR, 2017, SUBST USE MISUSE, V52, P1348, DOI 10.1080/10826084.2017.1280832; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Maoz H, 2016, J TRAUMA STRESS, V29, P556, DOI 10.1002/jts.22135; Marshall BDL, 2012, DRUG ALCOHOL DEPEN, V124, P193, DOI 10.1016/j.drugalcdep.2011.12.027; Martins SS, 2015, AM J PUBLIC HEALTH, V105, P2373, DOI 10.2105/AJPH.2015.302843a; McCarthy WJ, 2002, J ADDICT DIS, V21, P35, DOI 10.1300/J069v21n02_04; Noel PH, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-79; Park J, 2015, PAIN MANAG NURS, V16, P733, DOI 10.1016/j.pmn.2015.04.002; Pietrzak RH, 2014, AM J GERIAT PSYCHIAT, V22, P551, DOI 10.1016/j.jagp.2012.11.018; Polak K, 2001, Psychiatr Pol, V35, P1057; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2010, DRUG ALCOHOL DEPEN, V108, P37, DOI 10.1016/j.drugalcdep.2009.11.014; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Sheffler JL, 2016, AGING MENT HEALTH, V20, P1202, DOI 10.1080/13607863.2015.1072797; Smith TC, 2009, PUBLIC HEALTH REP, V124, P90, DOI 10.1177/003335490912400112; Source M. O., 2012, DEMOGRAPHICS PROFILE; StataCorp, 2017, STAT REF MAN REL 15; Stevelink SAM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2455-1; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tracy EM, 2012, DRUG ALCOHOL DEPEN, V124, P242, DOI 10.1016/j.drugalcdep.2012.01.010; Trautmann S, 2016, EPIDEMIOL PSYCHIAT S, V18, P1, DOI DOI 10.1017/S204579601600024X; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; VA, 2012, SUMM VA BEN NAT GUAR; VA, 2012, AN VA HLTH CAR UT OP; Vest Bonnie M, 2017, Mil Behav Health, V5, P313, DOI 10.1080/21635781.2017.1343694; Voelker MD, 2002, AM J EPIDEMIOL, V155, P899, DOI 10.1093/aje/155.10.899; Vogt D., 2012, MANUAL DEPLOYMENT RI; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wetterling T, 1999, ALCOHOL ALCOHOLISM, V34, P330, DOI 10.1093/alcalc/34.3.330; Wojcik BE, 2015, MIL MED, V180, P216, DOI 10.7205/MILMED-D-14-00061; Wojcik BE, 2009, MIL MED, V174, P1010, DOI 10.7205/MILMED-D-01-6108	64	11	11	0	11	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	JAN	2018	27	1					137	147		10.1007/s11136-017-1706-2			11	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	FT0EI	WOS:000422793600014	28921407	Green Accepted			2022-02-06	
J	Hoot, MR; Levin, HS; Smith, AN; Goldberg, G; Wilde, EA; Walker, WC; Eapen, BC; Nolen, T; Pugh, NL				Hoot, Michelle R.; Levin, Harvey S.; Smith, Austin N.; Goldberg, Gary; Wilde, Elisabeth A.; Walker, William C.; Eapen, Blessen C.; Nolen, T.; Pugh, N. L.			Pain and chronic mild traumatic brain injury in the US military population: a Chronic Effects of Neurotrauma Consortium study	BRAIN INJURY			English	Article						Anxiety; concussion; depression; post-traumatic stress disorder; sleep disturbance; structural equation modelling	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYNDROME; POSTCONCUSSIVE SYMPTOMS; OEF/OIF/OND VETERANS; AFGHANISTAN VETERANS; BLAST EXPOSURE; SLEEP QUALITY; IRAQ; TBI; INTENSITY	Primary objectives: To describe the association between mild traumatic brain injury (mTBI) and pain intensity and pain interference outcomes while accounting for potential confounders and mediators including environmental factors and comorbidities in a cohort of US Veterans of the Iraq and Afghanistan wars.Research design:Cross-sectional snapshot of baseline data from a prospective, longitudinal study.Methods: Effects of mTBI on pain intensity and pain interference were compared between participants with or without mTBI exposure. Data were analysed using covariate-adjusted regression analyses as well as structural equation modelling (SEM) methods to assess the robustness of findings across different modelling assumptions. As results of the two approaches were consistent with respect to the overall association between mTBI exposure and pain, the results focus primarily on the SEM findings.Results: The mTBI exposed group reported significantly greater indices of post-traumatic stress disorder (PTSD), depression, anxiety and sleep disturbance. After accounting for other factors, mTBI exposure was significantly, but indirectly associated with the pain interference and pain intensity outcomes.Conclusions: mTBI is strongly associated with pain intensity and pain interference in this sample. However, the effect appears to be mediated by other common mTBI comorbidities: PTSD, depression, anxiety and sleep disturbance.	[Hoot, Michelle R.; Smith, Austin N.; Goldberg, Gary; Walker, William C.] Hunter Holmes McGuire Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Richmond, VA USA; [Hoot, Michelle R.; Smith, Austin N.; Walker, William C.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Levin, Harvey S.; Goldberg, Gary] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Res Serv Line, Houston, TX USA; [Goldberg, Gary; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Phys Med & Rehabil Serv, San Antonio, TX USA; [Nolen, T.; Pugh, N. L.] RTI Int, Biostat & Epidemiol Div, Res Triangle Pk, NC USA		Hoot, MR (corresponding author), Hunter Holmes McGuire VAMC, 1201 Broad Rock Blvd 151, Richmond, VA 23249 USA.	Michelle.hoot@va.gov		Hoot, Michelle/0000-0002-3273-0484; Pugh, Norma/0000-0003-3052-2232; Nolen, Tracy/0000-0003-2512-343X	US Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX001135]	This work was supported by the US Department of Defense [W81XWH-13-2-0095]; US Department of Veterans Affairs [I01 CX001135].	[Anonymous], 2011, PRINCIPLES PRACTICE; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Centers for Disease Control & Prevention (US), 2012, DOD VA COD PROP FIN; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ganzel BL, 2010, PSYCHOL REV, V117, P134, DOI 10.1037/a0017773; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hsiao FJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0799-x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lee CJ, 2018, BRIT J OPHTHALMOL, V102, P667, DOI 10.1136/bjophthalmol-2017-310509; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; MacKinnon DP., 2008, ERLBAUM, DOI [DOI 10.1007/978-1-4842-0043-8_5, DOI 10.4324/9780203809556]; Mohan Akansha, 2016, Yale Journal of Biology and Medicine, V89, P49; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nathan DE, 2017, BRAIN CONNECT, V7, P236, DOI 10.1089/brain.2016.0433; Powell MA, 2015, J TRAUMA STRESS, V28, P322, DOI 10.1002/jts.22027; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; SAS/STAT<(R)>, 2013, SAS STAT 13 1 US GUI, P1154; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwarzer R, 2000, HEALTH PSYCHOL, V19, P487, DOI 10.1037/0278-6133.19.5.487; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vachon-Presseau E, 2013, BRAIN, V136, P815, DOI 10.1093/brain/aws371; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433	41	11	11	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1169	1177		10.1080/02699052.2018.1482427			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200003	29883191				2022-02-06	
J	Hu, W; Tung, YC; Zhang, YC; Liu, F; Iqbal, K				Hu, Wen; Tung, Yunn Chyn; Zhang, Yanchong; Liu, Fei; Iqbal, Khalid			Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury	JOURNAL OF ALZHEIMERS DISEASE			English	Article						3xTg-AD mice; asparaginyl endopeptidase; chronic traumatic encephalopathy; tau hyperphosphorylation; traumatic brain injury	PROTEIN PHOSPHATASE 2A; ALZHEIMERS-DISEASE; MOUSE MODEL; ABNORMAL HYPERPHOSPHORYLATION; CALPAIN ACTIVATION; IMPACT MODEL; HEAD-INJURY; MU-CALPAIN; PATHOLOGY; SET	Traumatic brain injury (TBI) is an established risk factor for the development of neurodegeneration and dementia late in life. Repetitive mild TBI (r-mTBI) is directly associated with chronic traumatic encephalopathy (CTE), a progressive neurodegenerative disorder characterized by focal perivascular to widespread Alzheimer-type neurofibrillary pathology of hyperphosphorylated tau. Studies in animal models have shown hyperphosphorylation of tau after TBI. However, the molecular mechanisms by which TBI leads to tau pathology are not understood. In this study, we employed western blots and immunohistochemistry to test, in triple-transgenic mouse model of Alzheimer's disease (3xTg-AD), the effect of r-mTBI on tau hyperphosphorylation and activation of asparaginyl endopeptidase (AEP), a cysteine proteinase which is known to be involved in tau hyperphosphorylation. We found that the level of active AEP was increased and correlated with the level of tau hyperphosphorylation following r-mTBI, and that fimbria showed increased immunoreactivity to phospho-tau. In addition, inhibitor 2 of protein phosphatase 2A (I-2(PP2A)) was translocated from neuronal nucleus to the cytoplasm and colocalized with hyperphosphorylated tau. These data suggest the involvement of AEP-I-2(PP2A)-PP2A-ptau pathway in tau pathology in TBI.	[Hu, Wen; Tung, Yunn Chyn; Zhang, Yanchong; Liu, Fei; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA; [Hu, Wen; Zhang, Yanchong; Liu, Fei] Nantong Univ, Key Lab Neuroregenerat, Minist Educ, Nantong, Jiangsu, Peoples R China; [Hu, Wen; Zhang, Yanchong; Liu, Fei] Nantong Univ, Coinnovat Ctr Neuroregenerat Jiangsu Prov, Nantong, Jiangsu, Peoples R China		Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com			New York State Office for People with Developmental Disabilities (OPWDD); Alzheimer's Association, USAAlzheimer's Association [ZEN-120241433, DSAD-15-363172, 2016-NIRG-397030]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31671046, 81773713]	We are grateful to Dr. Peter Davies from The Feinstein Institute for Medical Research, Manhasset, NY, USA for generously providing antibody PHF-1. This work was funded in part by the New York State Office for People with Developmental Disabilities (OPWDD) and by grants from the Alzheimer's Association, USA (ZEN-120241433, DSAD-15-363172 and 2016-NIRG-397030) and from National Natural Science Foundation of China (31671046 and 81773713).	ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Arif M, 2014, J BIOL CHEM, V289, P27677, DOI 10.1074/jbc.M114.565358; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Castejon O. J., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P263; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Dai CL, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0341-7; Dall E, 2016, BIOCHIMIE, V122, P126, DOI 10.1016/j.biochi.2015.09.022; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Halfon S, 1998, FEBS LETT, V438, P114, DOI 10.1016/S0014-5793(98)01281-2; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hu W, 2016, ALZHEIMERS DEMENT, V12, P1066, DOI 10.1016/j.jalz.2016.01.014; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Ishizaki T, 2010, J CEREBR BLOOD F MET, V30, P1756, DOI 10.1038/jcbfm.2010.39; Jin NN, 2015, J BIOL CHEM, V290, P15219, DOI 10.1074/jbc.M115.645507; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08187; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Takashima A, 2008, J ALZHEIMERS DIS, V14, P371; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; US Department of Health and Human Sevice Centers for Disease Control and Prevention National Center for Injury Prevention and Control, TRAUMATIC BRAIN INJU; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15709; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072379; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	78	11	12	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2018	64	3					709	722		10.3233/JAD-180177			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GL6AE	WOS:000437257500003	29889065	Green Published, hybrid			2022-02-06	
J	Kellar, D; Newman, S; Pestilli, F; Cheng, H; Port, NL				Kellar, Derek; Newman, Sharlene; Pestilli, Franco; Cheng, Hu; Port, Nicholas L.			Comparing fMRI activation during smooth pursuit eye movements among contact sport athletes, non-contact sport athletes, and non-athletes	NEUROIMAGE-CLINICAL			English	Article						Smooth pursuit; fMRI; Collegiate athletics	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; PROFESSIONAL SOCCER PLAYERS; WHITE-MATTER INTEGRITY; HEAD IMPACT SEVERITY; POSTURAL CONTROL; PUNCH-DRUNK; HIGH-SCHOOL; NEUROPSYCHOLOGICAL IMPAIRMENT; MICROSTRUCTURAL DAMAGE	Objectives: Though sub-concussive impacts are common during contact sports, there is little consensus whether repeat blows affect brain function. Using a "lifetime exposure" rather than acute exposure approach, we examined oculomotor performance and brain activation among collegiate football players and two control groups. Our analysis examined whether there are group differences in eye movement behavioral performance and in brain activation during smooth pursuit. Methods: Data from 21 off-season Division I football "starters" were compared with a) 19 collegiate cross-country runners, and b) 11 non-athlete college students who were SES matched to the football player group (total N = 51). Visual smooth pursuit was performed while undergoing fMRI imaging via a 3 Tesla scanner. Smooth pursuit eye movements to three stimulus difficulty levels were measured with regard to RMS error, gain, and lag. Results: No meaningful differences were found for any of the standard analyses used to assess smooth pursuit eye movements. For fMRI, greater activation was seen in the oculomotor region of the cerebellar vermis and areas of the FEF for football players as compared to either control group, who did not differ on any measure. Conclusion: Greater cerebellar activity among football players while performing an oculomotor task could indicate that they are working harder to compensate for some subtle, long-term subconcussive deficits. Alternatively, top athletes in a sport requiring high visual motor skill could have more of their cerebellum and FEF devoted to oculomotor task performance regardless of subconcussive history. Overall, these results provide little firm support for an effect of accumulated subconcussion exposure on brain function.	[Kellar, Derek; Newman, Sharlene; Pestilli, Franco; Cheng, Hu; Port, Nicholas L.] Indiana Univ, Dept Psychol & Brain Sci, 1101 E 10th St, Bloomington, IN USA		Port, NL (corresponding author), Indiana Univ, Sch Optometry, 800 E Atwater Ave, Bloomington, IN 47405 USA.	nport@indiana.edu	Cheng, Hu/AAS-3076-2021	Pestilli, Franco/0000-0002-2469-0494	Indiana Spinal Cord and Brain Injury Research Fund; Indiana Spinal Cord and Brain Injury Research Fund, NIH [R21DC013974]; NSFNational Science Foundation (NSF) [IIS-1636893, BCS-1734853]; NIH NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ULTTR001108]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R21DC013974] Funding Source: NIH RePORTER	Indiana Spinal Cord and Brain Injury Research Fund, NIH R21DC013974. This research was partially supported by NSF IIS-1636893, BCS-1734853 and NIH NIMH ULTTR001108 to FP. The Indiana University Imaging Research Facility partially supported data acquisition and preprocessing.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; Adams J, 2007, CLIN J SPORT MED, V17, P304, DOI 10.1097/JSM.0b013e31803202c8; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carroll EJ, 1936, AM J MED SCI, V191, P706, DOI 10.1097/00000441-193619150-00014; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kemp S, 2016, BRAIN INJURY, V30, P1068, DOI 10.3109/02699052.2016.1148776; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Landau SM, 2006, COGN AFFECT BEHAV NE, V6, P246, DOI 10.3758/CABN.6.3.246; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Liston DB, 2017, OPTOMETRY VISION SCI, V94, P51, DOI 10.1097/OPX.0000000000000918; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Mangus Brent C, 2004, Sports Biomech, V3, P209, DOI 10.1080/14763140408522841; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maruta J, 2017, MIL MED, V182, P120, DOI 10.7205/MILMED-D-16-00093; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Meyer OL, 2014, AM J PUBLIC HEALTH, V104, P1734, DOI 10.2105/AJPH.2014.302003; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Millspaugh J., 1937, US NAVAL MED B, V35, pe303; Miyashita T. L., 2017, SPORTS HEALTH; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tedeschi CG, 1944, P SOC EXP BIOL MED, V57, P264; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Ursache A, 2015, BEHAV MED, V41, P145, DOI 10.1080/08964289.2015.1024604; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Woollett K, 2009, PHILOS T R SOC B, V364, P1407, DOI 10.1098/rstb.2008.0288; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zuckerman SL, 2015, INT J SPORTS MED, V36, P419, DOI 10.1055/s-0034-1395587	115	11	11	4	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						413	424		10.1016/j.nicl.2018.01.025			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH1NG	WOS:000433169000042	29541575	Green Published, gold			2022-02-06	
J	Lilley, EJ; Scott, J; Weissman, JS; Krasnova, A; Salim, A; Haider, AH; Cooper, Z				Lilley, Elizabeth J.; Scott, Johnw.; Weissman, Joel S.; Krasnova, Anna; Salim, Ali; Haider, Adil H.; Cooper, Zara			End-of-Life Care in Older Patients After Serious or Severe Traumatic Brain Injury in Low-Mortality Hospitals Compared With All Other Hospitals	JAMA SURGERY			English	Article							PALLIATIVE CARE; AMERICAN-COLLEGE; GERIATRIC TRAUMA; QUALITY; DEATH; ASSOCIATION; HOSPICE; CANCER; SURVIVAL; BENEFIT	IMPORTANCE More than 80% of older patients die or are seriously impaired within 1 year after severe traumatic brain injury (TBI). Given their poor survival, information about end-of-life care is a relevant marker of high-value trauma care for these patients. In-hospital mortality is commonly used to measure quality of trauma care; however, it is not known what type of end-of-life care hospitals with the best survival outcomes provide to those who die. OBJECTIVE To determine whether end-of-life care for older patients with TBI is correlated with in-hospital mortality. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort study using 2005-2011 national Medicare claims from acute care hospitals was conducted. Medicare beneficiaries aged 65 years or older who were admitted with serious or severe TBI were included. Transferred patients, those treated at low-volume hospitals, and those who died on the date of admission were excluded. Low-mortality hospitals were those in the lowest quartile for in-hospital mortality using standardized mortality rates adjusting for age, sex, race/ethnicity, comorbidity, and injury severity. Patients at low-mortality hospitals were compared with patients at all other hospitals. The study was conducted from January 2005 to December 2011. Data analysis was conducted between August 2016 and February 2017. MAIN OUTCOMES AND MEASURES End-of-life care outcomes for patients who died in hospital or 30 days or less after discharge included gastrostomy and tracheostomy placement during the TBI admission and enrollment in hospice. RESULTS Of 363 hospitals included in the analysis, 91 (25.1%) were designated as low-mortality. The cohort included 34 691 patients (median age, 79 years; interquartile range, 72-84 years; 40.8% women). Of these patients, 55.8% of those at low-mortality hospitals and 62.5% at all other hospitals died in the hospital or 30 days or less after discharge (P < .01). Among patients who died in the hospital (n = 16 994), end-of-life care was similar at low-mortality hospitals and all other hospitals. For patients who survived the TBI admission and died 30 days or less after discharge (n = 4027), those at low-mortality hospitals underwent fewer gastrostomy (15.9% vs 24.0%; adjusted OR, 0.61; 95% CI, 0.52-0.72) or tracheostomy (18.2% vs 24.9%; adjusted OR, 0.71; 95% CI, 0.60-0.83) procedures and received more hospice care (66.3% vs 52.5%; adjusted OR, 1.72; 95% CI, 1.50-1.96). CONCLUSIONS AND RELEVANCE For older patients with serious or severe TBI, hospitals with the lowest in-hospital mortality perform fewer high-intensity treatments at the end of life and enroll more patients in hospice without increasing cumulative mortality 30 days or less after discharge.	[Lilley, Elizabeth J.; Scott, Johnw.; Weissman, Joel S.; Krasnova, Anna; Salim, Ali; Haider, Adil H.; Cooper, Zara] Ctr Surg & Publ Hlth, 1620 Tremont St,4-020, Boston, MA 02120 USA; [Lilley, Elizabeth J.] Univ Med & Dent New Jersey, Dept Surg, New Brunswick, NJ USA; [Scott, Johnw.; Salim, Ali; Haider, Adil H.; Cooper, Zara] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA		Lilley, EJ (corresponding author), Ctr Surg & Publ Hlth, 1620 Tremont St,4-020, Boston, MA 02120 USA.	elilley@partners.org		Scott, John/0000-0002-9916-6523; Krasnova, Anna/0000-0001-7119-308X	Johns Hopkins UniversityJohns Hopkins University; Paul B. Beeson Emerging Leaders Career Development Award in Aging [1K76AG054859-01]; Cambia Foundation; Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI; American Geriatrics Society Geriatrics for Specialists Initiative; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)	Dr Haider is a cofounder and equity holder of a start-up supported by The Johns Hopkins University known as Patient Doctor Technologies, which owns and operates the Doctella website (https://www.doctella.com). Dr Cooper is supported by the Paul B. Beeson Emerging Leaders Career Development Award in Aging (1K76AG054859-01) and the Cambia Foundation. Dr Cooper also received funding during this time-but not for support of this project-from Patient-Centered Outcomes Research Institute, the American Geriatrics Society Geriatrics for Specialists Initiative, National Cancer Institute, and the National Institute on Aging. No other conflicts were reported.	Austin JM, 2015, HEALTH AFFAIR, V34, P423, DOI 10.1377/hlthaff.2014.0201; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, P1086, DOI 10.1097/TA.0b013e31826fc7a0; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Chiang JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138773; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Hales S, 2014, J PAIN SYMPTOM MANAG, V48, P839, DOI 10.1016/j.jpainsymman.2013.12.240; Hales S, 2012, J PAIN SYMPTOM MANAG, V43, P195, DOI 10.1016/j.jpainsymman.2011.03.018; Hashmi ZG, 2014, J TRAUMA ACUTE CARE, V76, P1184, DOI 10.1097/TA.0000000000000215; Institute of Medicine Committee on Approaching Death, 2014, DYING AM ADDR KEY EN; Karlekar M, 2014, PALLIATIVE MED, V28, P1062, DOI 10.1177/0269216314534514; Kleinman JC, 1976, STAT NOTES HLTH PLAN; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Luta X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123764; MacDorman Marian F, 2015, Natl Vital Stat Rep, V64, P1; MACKENZIE EJ, 1990, J PEDIATR SURG, V25, P970, DOI 10.1016/0022-3468(90)90240-A; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; MOORE FA, 1992, J TRAUMA, V33, P435, DOI 10.1097/00005373-199209000-00017; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Mosenthal AC, 2012, CRIT CARE MED, V40, P1199, DOI 10.1097/CCM.0b013e31823bc8e7; Nathens AB, 2012, SURG CLIN N AM, V92, P441, DOI 10.1016/j.suc.2012.01.003; Obermeyer Z, 2014, JAMA, V312, P1888; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Rodriguez R, 2015, ANN PALLIAT MED, V4, P194, DOI 10.3978/j.issn.2224-5820.2015.09.03; Rubin EB, 2016, JAMA INTERN MED, V176, P1557, DOI 10.1001/jamainternmed.2016.4362; Saito AM, 2011, J PALLIAT MED, V14, P929, DOI 10.1089/jpm.2010.0522; Santry HP, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.01.003; Schwarze ML, 2014, JAMA SURG, V149, P631, DOI 10.1001/jamasurg.2013.5143; Shafi S, 2009, J AM COLL SURGEONS, V209; Toevs CC, 2014, J AM COLL SURGEONS, V219, pS49, DOI 10.1016/j.jamcollsurg.2014.07.108; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wright AA, 2016, JAMA-J AM MED ASSOC, V315, P284, DOI 10.1001/jama.2015.18604; Wright AA, 2010, CANCER-AM CANCER SOC, V116, P4656, DOI 10.1002/cncr.25217	41	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	JAN	2018	153	1					44	50		10.1001/jamasurg.2017.3148			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FT3EL	WOS:000423029900016	28975244	Bronze, Green Published			2022-02-06	
J	Lopez-Garcia, I; Gero, D; Szczesny, B; Szoleczky, P; Olah, G; Modis, K; Zhang, KL; Gao, JL; Wu, P; Sowers, LC; DeWitt, D; Prough, DS; Szabo, C				Lopez-Garcia, Isabel; Gero, Domokos; Szczesny, Bartosz; Szoleczky, Petra; Olah, Gabor; Modis, Katalin; Zhang, Kangling; Gao, Jungling; Wu, Ping; Sowers, Lawrence C.; DeWitt, Doug; Prough, Donald S.; Szabo, Csaba			Development of a stretch-induced neurotrauma model for medium-throughput screening in vitro: identification of rifampicin as a neuroprotectant	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; NEUROBLASTOMA-CELLS; OXIDATIVE STRESS; CELLULAR INJURY; DAMAGE; INHIBITION; APOPTOSIS; ISCHEMIA; DIFFERENTIATION	Background and PurposeWe hypothesized that an in vitro, stretch-based model of neural injury may be useful to identify compounds that decrease the cellular damage in neurotrauma. Experimental ApproachWe screened three neural cell lines (B35, RN33B and SH-SY5Y) subjected to two differentiation methods and selected all-trans-retinoic acid-differentiated B35 rat neuroblastoma cells subjected to rapid stretch injury, coupled with a subthreshold concentration of H2O2, for the screen. The model induced marked alterations in gene expression and proteomic signature of the cells and culminated in delayed cell death (LDH release) and mitochondrial dysfunction [reduced 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) conversion]. Follow-up studies utilized human stem cell-derived neurons subjected to rapid stretch injury. Key ResultsFrom screening of a composite library of 3500 drugs, five drugs (when applied in a post-treatment regimen relative to stretch injury) improved both LDH and MTT responses. The effects of rifampicin were investigated in further detail. Rifampicin reduced cell necrosis and apoptosis and improved cellular bioenergetics. In a second model (stretch injury in human stem cell-derived neurons), rifampicin pretreatment attenuated LDH release, protected against the loss of neurite length and maintained neuron-specific class III -tubulin immunoreactivity. Conclusions and ImplicationsWe conclude that the current model is suitable for medium-throughput screening to identify compounds with neuroprotective potential. Rifampicin, when applied either in pre- or post-treatment, improves the viability of neurons subjected to stretch injury and protects against neurite loss. Rifampicin may be a candidate for repurposing for the therapy of traumatic brain injury.	[Lopez-Garcia, Isabel; Gero, Domokos; Szczesny, Bartosz; Szoleczky, Petra; Olah, Gabor; Modis, Katalin; DeWitt, Doug; Prough, Donald S.; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, 601 Harborside Dr,Bldg 21,Room 4-202J, Galveston, TX 77555 USA; [Zhang, Kangling; Sowers, Lawrence C.] Univ Texas Med Branch, Dept Pharmacol, Galveston, TX 77555 USA; [Gao, Jungling; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA		Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 601 Harborside Dr,Bldg 21,Room 4-202J, Galveston, TX 77555 USA.	szabocsaba@aol.com	Gero, Domokos/F-7853-2017	Gero, Domokos/0000-0002-3132-3465	Moody Endowment (Galveston, TX, USA)	This work was supported by a grant from the Moody Endowment (Galveston, TX, USA).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Biagini G, 1997, CLIN SCI, V93, P401, DOI 10.1042/cs0930401; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brouwer MC, 2013, LANCET INFECT DIS, V13, P2, DOI 10.1016/S1473-3099(12)70274-8; Chao C, 2016, MOL MED, DOI [10.2119/molmed.2016.00102<original-structure ref = info:doi/10.2119/molmed.2016.00102></original-structure>, DOI 10.2119/M0LMED.2016.00102]; Chazotte B., 2011, LABELING NUCL DNA HO, V1; Chong WS, 2012, KOREAN J ANESTHESIOL, V62, P166, DOI 10.4097/kjae.2012.62.2.166; Croslan DR, 2008, BRAIN RES, V1210, P39, DOI 10.1016/j.brainres.2008.02.059; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Dailey L, 2001, J CELL PHYSIOL, V186, P315, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; DeWitt D S, 1995, New Horiz, V3, P376; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Engel DC, 2005, NEUROPHARMACOLOGY, V49, P985, DOI 10.1016/j.neuropharm.2005.05.021; Fukuda K, 2010, INVEST OPHTH VIS SCI, V51, P3629, DOI 10.1167/iovs.09-4107; Gero D, 2015, BRIT J PHARMACOL, V172, P4817, DOI 10.1111/bph.13252; Gero D, 2013, DIABETES, V62, P953, DOI 10.2337/db12-0789; Glass TF, 2004, NEUROBIOL DIS, V17, P378, DOI 10.1016/j.nbd.2004.07.017; Gollapudi S, 2003, J CLIN IMMUNOL, V23, P11, DOI 10.1023/A:1021944113833; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hoffman SW, 2000, J NEUROTRAUM, V17, P415, DOI 10.1089/neu.2000.17.415; Kilic U, 2004, ACTA NEUROPATHOL, V108, P65, DOI 10.1007/s00401-004-0867-6; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Lamprecht MR, 2016, J NEUROTRAUMA; Laskowitz D., 2016, TRANSLATIONAL RES TR; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Morrison SJ, 2001, CURR BIOL, V11, pR349, DOI 10.1016/S0960-9822(01)00191-9; Muramoto M, 2003, NEUROPHARMACOLOGY, V45, P394, DOI 10.1016/S0028-3908(03)00168-0; Nicholas D, 2015, MOL CELL PROTEOMICS, V14, P15, DOI 10.1074/mcp.M113.035089; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Park IH, 2008, IMMUNOPHARM IMMUNOT, V30, P837, DOI [10.1080/08923970802135732, 10.1080/08923970802135732 ]; Pearn ML, 2016, CELL MOL NEUROBIOL; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rodrigues CMP, 2000, J NEUROCHEM, V75, P2368, DOI 10.1046/j.1471-4159.2000.0752368.x; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Smeda JS, 2011, J CEREBR BLOOD F MET, V31, P476, DOI 10.1038/jcbfm.2010.110; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Szabo C, 2005, CRIT CARE MED, V33, pS530, DOI 10.1097/01.CCM.0000187002.88999.CF; Tang K, 2015, DEV GROWTH DIFFER, V57, P109, DOI 10.1111/dgd.12204; te Brake L, 2015, INT J ANTIMICROB AG, V45, P496, DOI 10.1016/j.ijantimicag.2014.12.027; Tomiyama T, 1996, J BIOL CHEM, V271, P6839, DOI 10.1074/jbc.271.12.6839; TYNDALE RF, 1994, J NEUROSCI, V14, P5417; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wang N, 2010, ANAL CHEM, V82, P2262, DOI 10.1021/ac9023022; WASIL M, 1988, BIOCHEM PHARMACOL, V37, P775, DOI 10.1016/0006-2952(88)90159-1; WERNER C, 1991, STROKE, V22, P910, DOI 10.1161/01.STR.22.7.910; WHITE LA, 1994, J NEUROIMMUNOL, V49, P135, DOI 10.1016/0165-5728(94)90189-9; WHITTEMORE SR, 1993, BRAIN RES, V615, P27, DOI 10.1016/0006-8993(93)91111-5; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yerramasetti R, 2002, J CLIN IMMUNOL, V22, P37, DOI 10.1023/A:1014256603539; Yuan LQ, 2014, ARCH BIOCHEM BIOPHYS, V558, P10, DOI 10.1016/j.abb.2014.05.028; Yulug B, 2004, BRAIN RES, V996, P76, DOI 10.1016/j.brainres.2003.10.012; Yulug B, 2014, BRAIN RES BULL, V107, P37, DOI 10.1016/j.brainresbull.2014.05.007	62	11	11	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JAN	2018	175	2			SI		284	300		10.1111/bph.13642			17	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FS2HR	WOS:000419599900010	27723079	Bronze, Green Published			2022-02-06	
J	Miarka, B; Dal Bello, F; Brito, CJ; Tabben, M; Oguma, A; Amtmann, J; Moreira, DIG; Pocecco, E; Del Vecchio, FB; Chamari, K				Miarka, Bianca; Dal Bello, Fabio; Brito, Ciro Jose; Tabben, Montassar; Oguma, Andrea; Amtmann, John; Moreira, Dan Ilo Gomes; Pocecco, Elena; Del Vecchio, Fabricio Boscolo; Chamari, Karim			Injuries during a World Judo Championship: differences between sex, weight category and competition phase	INTERNATIONAL JOURNAL OF PERFORMANCE ANALYSIS IN SPORT			English	Article						Performance analysis; injury and prevention; martial arts; combat Sports	TIME-MOTION ANALYSIS; SPORTS INJURIES; COMBAT SPORTS; NECK INJURIES; AGE-GROUPS; PREVENTION; METAANALYSIS; FIGHTERS; MATCHES; PLAYERS	This study analyses the injury incidence and related factors during the World Judo Championship of 2013. For this purpose, 673 athletes (258 females and 415 males) of all weight categories have been evaluated concerning factors related to occurred injuries (severity, body area, situation, type and mechanism) in an epidemiological observational study. Concussions were identified and analysed separately for injury risk and incidence rate per 1000 A-E (athlete-exposures). ANOVA, Tukey, Chi-squared and a Logistic Regression Analysis were performed, p <=.05. The overall incidence rate was of 47.2 injuries. The incidence rate separated by sex was 38.0 and 52.9 for males and females, respectively. There was a higher prevalence of soft-tissue injuries (58.8%) characterised as stress injuries (36.8%) and miscellaneous traumas (42.6%), mostly occurring during being thrown (29.4%) and gripping fight (32.4%). Concerning the phases of the competition, there was a higher prevalence of injuries in the Eliminatory (54.4%) followed by the Final (20.6%). Male athletes had a prevalence of injury mechanism contact with mat, while an increase in the weight division was negatively associated with the incidence of miscellaneous traumas, musculoskeletal injuries and neck chokes. These risks in competitions could be minimised with prevention systems.	[Miarka, Bianca; Brito, Ciro Jose] Univ Fed Juiz de Fora, Phys Educ Dept, Juiz Fora, Juiz De Fora, Brazil; [Dal Bello, Fabio] Univ Santo Tomas, Phys Act & Sports Sci Master Program, Santiago, Chile; [Tabben, Montassar; Chamari, Karim] Qatar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, ASPETAR, Doha, Qatar; [Oguma, Andrea] UniSt Anna, Phys Educ Dept, Santana, Brazil; [Amtmann, John] Univ Montana, Safety Hlth & Ind Hyg Dept, Montana Tech, Butte, MT USA; [Moreira, Dan Ilo Gomes] Fed Inst Minas Gerais, Phys Educ Dept, Belo Horizonte, MG, Brazil; [Pocecco, Elena] Univ Innsbruck, Dept Sport Sci, Innsbruck, Austria; [Del Vecchio, Fabricio Boscolo] Univ Fed Pelotas, Phys Educ Sch, Pelotas, Brazil		Miarka, B (corresponding author), Univ Fed Juiz de Fora, Phys Educ Dept, Juiz Fora, Juiz De Fora, Brazil.	bianca.miarka@ufjf.edu.br	Brito, Ciro Jose/ABH-2245-2020; Brito, Ciro/AAC-9104-2019; CHAMARI, Karim/AAJ-7938-2021; Boscolo, Fabricio/AAU-9456-2020	Brito, Ciro Jose/0000-0002-9678-1977; CHAMARI, Karim/0000-0001-9178-7678; Boscolo, Fabricio/0000-0003-3771-9660			Agel J, 2007, J ATHL TRAINING, V42, P303; Arriaza R, 2017, BRIT J SPORT MED, V51, P226, DOI 10.1136/bjsports-2016-096574; Barsottini Daniel, 2006, Rev Bras Med Esporte, V12, P56; Bengtsson H, 2013, BRIT J SPORT MED, V47, P743, DOI 10.1136/bjsports-2013-092383; Branco Braulio H M, 2013, Asian J Sports Med, V4, P125; Brito C. J., 2017, J HUMAN KINECTICS, V22; Cierna D, 2018, BRIT J SPORT MED, V52, P730, DOI 10.1136/bjsports-2017-097756; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Frey A, 2004, J TRAUMATOLOGIE SPOR, V21, P100, DOI DOI 10.1016/S0762-915X(04)97390-1; Garatachea N, 2012, J SPORT MED PHYS FIT, V52, P1; Ghrairi Mourad, 2014, Muscles Ligaments Tendons J, V4, P149; Green CM, 2007, SCAND J MED SCI SPOR, V17, P205, DOI 10.1111/j.1600-0838.2006.00552.x; Hanna WA, 2015, UNFALLCHIRURG, V118, P507, DOI 10.1007/s00113-015-0014-y; International Judo Federation, 2017, IJF JUD REF RUL; International Judo Federation, 2013, DISC CID IJF; James G, 2003, BIOL SPORT, V20, P25; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kamitani T, 2017, BRIT J SPORT MED, V51, P1581, DOI 10.1136/bjsports-2017-097681; Kamitani T, 2013, AM J SPORT MED, V41, P1915, DOI 10.1177/0363546513490662; Kim KS, 2015, BRIT J SPORT MED, V49, P1144, DOI 10.1136/bjsports-2014-094365; Kreiswirth EM, 2014, J ATHL TRAINING, V49, P89, DOI 10.4085/1062-6050-49.1.11; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; Kuvacic G, 2017, J HUM KINET, V56, P207, DOI 10.1515/hukin-2017-0038; Malliaropoulos N, 2013, BRIT J SPORT MED, V47, P1137, DOI 10.1136/bjsports-2013-093161; Malliaropoulos Nikos G, 2014, Muscles Ligaments Tendons J, V4, P262; Miarka B, 2017, MOTOR CONTROL, V21, P390, DOI 10.1123/mc.2016-0007; Miarka B, 2016, INT J PERF ANAL SPOR, V16, P442, DOI 10.1080/24748668.2016.11868900; Miarka B, 2016, INT J PERF ANAL SPOR, V16, P133, DOI 10.1080/24748668.2016.11868876; Miarka B, 2016, INT J PERF ANAL SPOR, V16, P30, DOI 10.1080/24748668.2016.11868868; Miarka B, 2015, INT J PERF ANAL SPOR, V15, P315, DOI 10.1080/24748668.2015.11868795; Miarka B, 2014, J SPORT SCI, V32, P1529, DOI 10.1080/02640414.2014.903335; Miarka B, 2011, INT J PERF ANAL SPOR, V11, P254, DOI 10.1080/24748668.2011.11868546; Miarka B, 2012, J SPORT SCI, V30, P899, DOI 10.1080/02640414.2012.679675; Miarka B, 2011, INT J HIST SPORT, V28, P1016, DOI 10.1080/09523367.2011.563633; Nagahiro Shinji, 2011, No Shinkei Geka, V39, P1139; Noh JW, 2015, J PHYS THER SCI, V27, P2425, DOI 10.1589/jpts.27.2425; Pierantozzi E, 2009, MEDIT J MUSC SURV, V17, P26; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Rossler R, 2014, SPORTS MED, V44, P1733, DOI 10.1007/s40279-014-0234-2; San Juan R., 2014, BRIT J SPORT MED, V48, P656; Scoggin J. F., 2014, ORTHOPAEDIC J SPORTS, V2, P1, DOI [10.1177/2325967114522184, DOI 10.1177/2325967114522184]; Souza M, 2006, SCI SPORT, V21, P280, DOI 10.1016/j.scispo.2006.06.002; Sterkowicz-Przybycien K, 2017, J STRENGTH COND RES, V31, P817, DOI 10.1519/JSC.0000000000001597; Sterkowicz-Przybycien K, 2013, ARCH BUDO, V9, P149; Sterkowicz-Przybycien KL, 2014, J STRENGTH COND RES, V28, P3585, DOI 10.1519/JSC.0000000000000561	47	11	11	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2474-8668	1474-8185		INT J PERF ANAL SPOR	Int. J. Perform Anal. Sport		2018	18	2					229	244		10.1080/24748668.2018.1463777			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GJ2QU	WOS:000435117600003					2022-02-06	
S	Napoli, E; Lippert, T; Borlongan, CV		Turksen, K		Napoli, Eleonora; Lippert, Trenton; Borlongan, Cesar V.			Stem Cell Therapy: Repurposing Cell-Based Regenerative Medicine Beyond Cell Replacement	CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 1: STEM CELLS IN REGENERATIVE MEDICINE: ADVANCES AND CHALLENGES	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Cell transplantation; Neurological disorders; Endogenous brain repair; Neurogenic niches	TRAUMATIC BRAIN-INJURY; FETAL DOPAMINE NEURONS; PARKINSONS-DISEASE; BONE-MARROW; TRANSPLANTATION; SURVIVAL; GRAFTS; MODEL; MOTOR; IMPROVEMENT	Stem cells exhibit simple and naive cellular features, yet their exact purpose for regenerative medicine continues to elude even the most elegantly designed research paradigms from developmental biology to clinical therapeutics. Based on their capacity to divide indefinitely and their dynamic differentiation into any type of tissue, the advent of transplantable stem cells has offered a potential treatment for aging-related and injury-mediated diseases. Recent laboratory evidence has demonstrated that transplanted human neural stem cells facilitate endogenous reparative mechanisms by initiating multiple regenerative processes in the brain neurogenic areas. Within these highly proliferative niches reside a myriad of potent regenerative molecules, including antiinflammatory cytokines, proteomes, and neurotrophic factors, altogether representing a biochemical cocktail vital for restoring brain function in the aging and diseased brain. Here, we advance the concept of therapeutically repurposing stem cells not towards cell replacement per se, but rather exploiting the cells' intrinsic properties to serve as the host brain regenerative catalysts.	[Napoli, Eleonora] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Lippert, Trenton; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA		Napoli, E (corresponding author), Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.; Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	enapoli@ucdavis.edu; cborlong@health.usf.edu	Napoli, Eleonora/AAQ-6079-2021	Napoli, Eleonora/0000-0001-8808-4242			Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; Bagetta V, 2011, J NEUROSCI, V31, P12513, DOI 10.1523/JNEUROSCI.2236-11.2011; Borlongan CV, 2016, MOL THER, V24, P1710, DOI 10.1038/mt.2016.186; Borlongan CV, 2016, LANCET, V388, P736, DOI 10.1016/S0140-6736(16)31259-4; Borlongan CV, 2000, EXPERT OPIN INV DRUG, V9, P2319, DOI 10.1517/13543784.9.10.2319; Borlongan CV, 1999, LANCET, V353, pSL29; Brundin P, 1998, NAT NEUROSCI, V1, P537, DOI 10.1038/2773; Calabresi P, 2013, LANCET NEUROL, V12, P811, DOI 10.1016/S1474-4422(13)70118-2; Costa C, 2012, BRAIN, V135, P1884, DOI 10.1093/brain/aws101; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Crowley MG, 2017, J NEUROSURG SCI, V61, P291, DOI 10.23736/S0390-5616.16.03921-7; Dunnett SB, 2001, NAT REV NEUROSCI, V2, P365, DOI 10.1038/35072572; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; FREEMAN TB, 1995, ANN NEUROL, V38, P379, DOI 10.1002/ana.410380307; Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863; Hall H, 2014, BRAIN, V137, P2493, DOI 10.1093/brain/awu193; Herrera-Marschitz M, 2010, PROG NEUROBIOL, V90, P176, DOI 10.1016/j.pneurobio.2009.01.005; Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Li W, 2016, P NATL ACAD SCI USA, V113, P6544, DOI 10.1073/pnas.1605245113; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; Napoli E, 2017, STEM CELLS, V35, P1443, DOI 10.1002/stem.2636; Napoli E, 2017, STEM CELL REV REP, V13, P192, DOI 10.1007/s12015-016-9716-y; Napoli E, 2016, TRANSL STROKE RES, V7, P452, DOI 10.1007/s12975-016-0490-6; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Tajiri N, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00116; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074857; Ungerstedt U, 1974, Adv Neurol, V5, P421; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Wenning GK, 1997, ANN NEUROL, V42, P95, DOI 10.1002/ana.410420115; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Zuo FX, 2017, STEM CELLS, V35, P1519, DOI 10.1002/stem.2616	44	11	11	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-93867-7; 978-3-319-93866-0	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1079						87	91		10.1007/5584_2018_174	10.1007/978-3-319-93867-7		5	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	BL8ZZ	WOS:000457208000007	29480446				2022-02-06	
J	Nguyen, TP; Schaffert, J; LoBue, C; Womack, KB; Hart, J; Cullum, CM				Nguyen, Trung P.; Schaffert, Jeff; LoBue, Christian; Womack, Kyle B.; Hart, John; Cullum, C. Munro			Traumatic Brain Injury and Age of Onset of Dementia with Lewy Bodies	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Age of onset; dementia; dementia with Lewy bodies; traumatic brain injury	ENVIRONMENTAL RISK-FACTORS; HEAD-INJURY; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; EARLIER AGE; FRONTOTEMPORAL DEMENTIA; DIAGNOSIS; MANAGEMENT; HISTORY	Background: Traumatic brain injury (TBI) with loss of consciousness (LOC) has been associated with earlier onset of mild cognitive impairment, frontotemporal dementia, Parkinson's disease, and Alzheimer's disease (AD), but has not been examined as a risk factor for earlier onset of dementia with Lewy bodies (DLB). Objective: The purpose of this study was to assess the association between a history of TBI and the age of onset of DLB. Method: Data from 576 subjects with a clinical diagnosis of DLB were obtained from the National Alzheimer's Coordinating Center (NACC). Analyses of Covariance examined whether self-reported history of remote TBI with LOC (i.e., >1 year prior to the first Alzheimer's Disease Center visit) was associated with earlier DLB symptom onset. Results: Controlling for sex, those with a history of remote TBI had an approximately 1.5-year earlier clinician-estimated age of onset (F = 0.87, p = 0.35) and 0.75-years earlier age of diagnosis (F = 0.14, p = 0.71) of DLB compared to those without a history of TBI, though the differences did not reach statistical significance. Analysis of subjects with autopsy-confirmed diagnoses was underpowered due to the low number of TBI+ subjects. Conclusions: Remote TBI with LOC was not significantly associated with DLB onset, despite being a significant risk factor for cognitive decline and earlier age of onset in other neurodegenerative conditions. Replication of these results using a larger cohort of DLB subjects with and without a TBI history who have undergone autopsy is indicated, as our TBI+ subjects did show a slightly earlier onset of about 1.5 years. Further investigations into other potential DLB risk factors are also warranted.	[Nguyen, Trung P.; Womack, Kyle B.; Hart, John; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Schaffert, Jeff; LoBue, Christian; Womack, Kyle B.; Hart, John; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hart, John] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX USA		Nguyen, TP (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	trungp.nguyen@utsouthwestern.edu	Cullum, C. Munro/AAC-2496-2019; Womack, Kyle/O-5422-2018	Cullum, C. Munro/0000-0001-9706-5465; Womack, Kyle/0000-0002-6060-9075; Schaffert, Jeff/0000-0002-8842-980X	University of Texas Southwestern Alzheimer's disease Center (NIH/NIA) [P3012300-19]; Texas Alzheimer's Research and Care Consortium (TARCC); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P50 AG047366, P30 AG010129, P50 AG016573, P50 AG005131]; NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG053760];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P30 AG049638];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG053760, P30AG012300, U01AG016976, P50AG033514, P30AG010129, P50AG016574, P50AG005131, P50AG005133, P50AG005681, P50AG005138, P30AG019610, P50AG005134, P30AG010133, P50AG016573, P30AG049638, P50AG023501, P50AG025688, P50AG005146, P50AG047366, P30AG010161, P50AG008702, P50AG047266, P30AG008017, P50AG005142, P50AG047270, P30AG013854, P30AG008051, P30AG035982, P30AG010124, P30AG013846, P30AG028383, P50AG005136] Funding Source: NIH RePORTER	This work was supported in part by the University of Texas Southwestern Alzheimer's disease Center (NIH/NIA grant number P3012300-19) and the Texas Alzheimer's Research and Care Consortium (TARCC). The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Boot BP, 2013, NEUROLOGY, V81, P833, DOI 10.1212/WNL.0b013e3182a2cbd1; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Fang F, 2012, MOVEMENT DISORD, V27, P1632, DOI 10.1002/mds.25143; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Maher NE, 2002, NEUROLOGY, V58, P79, DOI 10.1212/WNL.58.1.79; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Skogseth R, 2017, J ALZHEIMERS DIS, V59, P1139, DOI 10.3233/JAD-170274; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548	35	11	11	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2018	66	2					717	723		10.3233/JAD-180586			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB6ZU	WOS:000451224700024	30320582	Green Accepted			2022-02-06	
J	Ngwenya, LB; Gardner, RC; Yue, JK; Burke, JF; Ferguson, AR; Huang, MC; Winkler, EA; Pirracchio, R; Satris, GG; Yuh, EL; Mukherjee, P; Valadka, AB; Okonkwo, DO; Manley, GT				Ngwenya, Laura B.; Gardner, Raquel C.; Yue, John K.; Burke, John F.; Ferguson, Adam R.; Huang, Michael C.; Winkler, Ethan A.; Pirracchio, Romain; Satris, Gabriela G.; Yuh, Esther L.; Mukherjee, Pratik; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.			Concordance of common data elements for assessment of subjective cognitive complaints after mild-traumatic brain injury: a TRACK-TBI Pilot Study	BRAIN INJURY			English	Article						Traumatic brain injury; brain concussion; cognitive complaints; common data elements	CONCUSSION SYMPTOMS QUESTIONNAIRE; GLASGOW COMA SCALE; MINOR HEAD-INJURY; EMERGENCY-DEPARTMENT; MISERABLE MINORITY; RISK-FACTORS; FOLLOW-UP; RELIABILITY; PERFORMANCE; IDENTIFICATION	Objective: To determine characteristics and concordance of subjective cognitive complaints (SCCs) 6months following mild-traumatic brain injury (mTBI) as assessed by two different TBI common data elements (CDEs).Research design: The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot Study was a prospective observational study that utilized the NIH TBI CDEs, Version 1.0. We examined variables associated with SCC, performance on objective cognitive tests (Wechsler Adult Intelligence Scale, California Verbal Learning Test, and Trail Making Tests A and B), and agreement on self-report of SCCs as assessed by the acute concussion evaluation (ACE) versus the Rivermead Post Concussion Symptoms Questionnaire (RPQ).Results: In total, 68% of 227 participants endorsed SCCs at 6months. Factors associated with SCC included less education, psychiatric history, and being assaulted. Compared to participants without SCC, those with SCC defined by RPQ performed significantly worse on all cognitive tests. There was moderate agreement between the two measures of SCCs (kappa=0.567 to 0.680).Conclusion: We show that the symptom questionnaires ACE and RPQ show good, but not excellent, agreement for SCCs in an mTBI study population. Our results support the retention of RPQ as a basic CDE for mTBI research.Abbreviations: BSI-18: Brief Symptom Inventory; 18CDEs: common data elements; CT: computed tomography; CVLT: California Verbal Learning Test; ED: emergency department; GCS: Glasgow coma scale; LOC: loss of consciousnessm; TBI: mild-traumatic brain injury; PTA: post-traumatic amnesia; SCC: subjective cognitive complaints; TBI: traumatic brain injury; TRACK-TBI: Transforming Research and Clinical Knowledge in Traumatic Brain Injury; TMT: Trail Making Test; WAIS-PSI: Wechsler Adult Intelligence Scale, Fourth Edition, Processing Speed Index	[Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Gardner, Raquel C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Gardner, Raquel C.] San Francisco Vet Adm Med Ctr, Dept Neurosurg, San Francisco, CA USA; [Yue, John K.; Burke, John F.; Ferguson, Adam R.; Huang, Michael C.; Winkler, Ethan A.; Satris, Gabriela G.; Yuh, Esther L.; Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Yue, John K.; Burke, John F.; Ferguson, Adam R.; Huang, Michael C.; Winkler, Ethan A.; Satris, Gabriela G.; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Pirracchio, Romain] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Ferguson, Adam/0000-0001-7102-1608; Ngwenya, Laura/0000-0001-7103-971X; Burke, John/0000-0002-6190-5116	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069409-02S1]	This work was supported by NIH/NINDS [grant number NS069409-02S1 to GTM].	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Delis D.C., 2000, CALIFORNIA VERBAL LE; Derogatis LR, 2001, BSI18; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Erro R, 2014, J GERIATR PSYCH NEUR, V27, P276, DOI 10.1177/0891988714532015; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Galioto R, 2015, EPILEPSY BEHAV, V51, P48, DOI 10.1016/j.yebeh.2015.06.035; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; GRONWALL D, 1974, LANCET, V2, P605; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kania K, 2016, J NEUROSURG-PEDIATR, V18, P224, DOI 10.3171/2016.1.PEDS15511; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; National Institute of Health, NINDS COMM DAT EL; Prouteau A, 2004, SCHIZOPHR RES, V69, P85, DOI 10.1016/j.schres.2003.08.011; Rabinowitz AR, 2016, J CLIN EXP NEUROPSYC, V38, P599, DOI 10.1080/13803395.2015.1123224; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; van Rijsbergen MWA, 2017, EUR J NEUROL, V24, P475, DOI 10.1111/ene.13227; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	52	11	11	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	9					1071	1078		10.1080/02699052.2018.1481527			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL0ZJ	WOS:000436823600002	29863894				2022-02-06	
J	O'Reilly, K; Wilson, N; Peters, K				O'Reilly, Kate; Wilson, Nathan; Peters, Kath			Narrative literature review: Health, activity and participation issues for women following traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; women; gender; social participation; identity; employment; sexuality; physical complications	LIFE SATISFACTION; SEX-DIFFERENCES; DEPRESSION; SYMPTOMS; OUTCOMES; GENDER; SEVERITY; IMPACT; MEN	Objective: This narrative review will draw attention to the current limitations within the literature related to women following traumatic brain injury in order to stimulate discussion and inform future directions for research.Background: There is a wide-ranging body of research about traumatic brain injury with the higher incidence of brain injury among males reflected in this body of work. As a result, the specific gendered issues facing women with traumatic brain injury are not as well understood.Method: A search of electronic databases was conducted using the terms traumatic brain injury, brain injury, women, participation, concussion and outcomes.Results: The 36 papers revealed the following five themes (1) Relationships and life satisfaction; (2) Perception of self and body image; (3) Meaningful occupation; (4) Sexuality and sexual health; and (5) Physical function.Conclusions: Without research, which focuses specifically on the experience of women and girls with traumatic brain injury there is a risk that clinical care, policy development and advocacy services will not effectively accommodate them.Implications for rehabilitationExploring the gendered issues women may experience following traumatic brain injury will enhance clinicians understanding of the unique challenges they face. Such information has the potential to guide future directions for research, policy, and practice.Screening women for hormonal imbalances such as hypopituitarism following traumatic brain injury is recommended as this may assist clinicians in addressing the far reaching implications in regard to disability, quality of life and mood.The growing literature regarding the cumulative effect of repeat concussions following domestic violence and women's increased risk of sport-related concussion may assist clinicians in advocating for appropriate rehabilitation and community support services.	[O'Reilly, Kate; Wilson, Nathan; Peters, Kath] Western Sydney Univ, Sch Nursing & Midwifery, Locked Bag 1797, Penrith, NSW 2751, Australia		O'Reilly, K (corresponding author), Western Sydney Univ, Sch Nursing & Midwifery, Locked Bag 1797, Penrith, NSW 2751, Australia.	Kate.Oreilly@westernsydney.edu.au	Wilson, Nathan/ABF-9708-2020; Peters, Kath/ABF-9495-2020	Wilson, Nathan/0000-0002-6979-2099; O'Reilly, Kate/0000-0001-8644-3803; Peters, Kath/0000-0001-5299-2863			Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Andelic N, 2015, J NEUROL, V262, P523, DOI 10.1007/s00415-014-7595-1; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arslanian-Engoren C, 2011, JOGNN-J OBST GYN NEO, V40, P337, DOI 10.1111/j.1552-6909.2011.01234.x; Australian Institute of Health and Welfare, 2007, BULLETIN, V55; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brain Injury Association of Queensland, 2007, ACQ BRAIN INJ FACTS; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cassidy D, 2014, ARCH PHYS MED REH S2, V9532, P278; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan JD, 2001, CLIN J WOMENS HLTH, V1, P184; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Helps Y, 2008, INJURY RES STAT SERI, V45; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Howes HFR, 2005, BRAIN INJURY, V19, P403, DOI 10.1080/02699050400025158; Jacobsson L, 2013, J REHABIL MED, V45, P1010, DOI 10.2340/16501977-1204; Kalpinski RJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/102570; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; McLean LL, 2016, QUAL REP, V21, P1118; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Nalder E, 2016, ARCH PHYS MED REHAB, V97, pS46, DOI 10.1016/j.apmr.2014.07.428; O'Reilly K., 2015, J AUSTRALASIAN REHAB, V18, P18; Paquette M, 2014, SOC SCI MED, V59, P1047; Paquette MC, 2002, J NUTR EDUC BEHAV, V34, P172, DOI 10.1016/S1499-4046(06)60087-0; Parks Jennifer K, 2010, Proc (Bayl Univ Med Cent), V23, P355; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Puscheck E., 2015, CLIN GYNECOLOGY; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saban KL, 2011, J WOMENS HEALTH, V20, P179, DOI 10.1089/jwh.2010.2334; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Stewart AL, 1992, MEASURING FUNCTIONIN; Strizzi J, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/247479; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Vokes T., 2015, CLIN GYNECOLOGY; Wilson NJ, 2012, INTELLECT DEV DISAB, V50, P261, DOI 10.1352/1934-9556-50.3.261; World Health Organisation, 2002, DISABIL HLTH; Xiong C, 2016, DISABIL HEALTH J, V9, P439, DOI 10.1016/j.dhjo.2015.12.002	59	11	12	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	19					2331	2342		10.1080/09638288.2017.1334838			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GO4ZI	WOS:000440026500015	28585486				2022-02-06	
J	Persinger, VC; Whiteside, DM; Bobova, L; Saigal, SD; Vannucci, MJ; Basso, MR				Persinger, Virginia C.; Whiteside, Douglas M.; Bobova, Lyuba; Saigal, Seema D.; Vannucci, Marla J.; Basso, Michael R.			Using the California Verbal Learning Test, Second Edition as an embedded performance validity measure among individuals with TBI and individuals with psychiatric disorders	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity tests; California Verbal Learning Test-II; traumatic brain injury; psychiatric disorders	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; FORCED-CHOICE RECOGNITION; CARD SORTING TEST; SUSPECT EFFORT; TEST-II; CLASSIFICATION ACCURACY; INSUFFICIENT EFFORT; INCOMPLETE EFFORT; CVLT-II	Objective: Among embedded performance validity tests (PVTs), little research addresses the use of Total Hits and Total False Positives from the California Verbal Learning Test, Second Edition (CVLT-II) in spite of low sensitivity, particularly in psychiatric samples. Method: This study examined the classification accuracy of these two measures in individuals with psychiatric disorders or mild traumatic brain injury (MTBI). These samples were separated into two groups using the criteria of passing all PVTs versus failing 2 or more PVTs. They were also compared to a criterion group of moderate to severe traumatic brain injury (M-STBI) patients who passed all PVTs. The sample included 176 individuals consecutively referred for neuropsychological testing (mean age = 46.31, SD = 15.30; mean education = 13.07, SD = 2.50, 52.3% males; 91.2% Caucasian) who met study criteria. Results: For classification accuracy, Total Hits in the psychiatric group had excellent classification accuracy (Area Under the Curve [AUC] = .82; Sensitivity = .47; Specificity = .90), whereas Total False Positives (AUC = .49) demonstrated poor classification accuracy. The MTBI group had similar results, with Total Hits having excellent classification accuracy (AUC = .88; Sensitivity = .60; Specificity = .90), whereas Total False Positive (AUC = .62) did not. Conclusions: Results provide preliminary support for using Total Hits; however, Total False Positives were ineffective in identifying non-credible patients with psychiatric disorders or MTBI. Total Hits also compared favorably to other embedded CVLT measures.	[Persinger, Virginia C.] Methodist Rehabil Ctr, Dept Neuropsychol, Jackson, MS USA; [Persinger, Virginia C.; Bobova, Lyuba; Saigal, Seema D.; Vannucci, Marla J.] Adler Univ, Dept Clin Psychol, Chicago, IL USA; [Whiteside, Douglas M.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Basso, Michael R.] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA		Whiteside, DM (corresponding author), Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA.	douglas-whiteside@uiowa.edu	Whiteside, Douglas/AAK-6396-2020; Basso, Michael/S-9587-2019	Basso, Michael/0000-0002-0217-662X; Whiteside, Douglas/0000-0002-8454-4413			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Boone K.B., 2013, CLIN PRACTICE FORENS; Bush, 2012, MILD TRAUMATIC BRAIN; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Goldberg H.E., 2007, ASSESSMENT FEIGNED C, P281; Green P, 1996, MANUAL COMPUTERIZED; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hosmer D.W., 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Larrabee, 2005, FORENSIC NEUROPSYCHO, P209; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P14; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; O'Jile JR, 2005, ARCH CLIN NEUROPSYCH, V20, P547, DOI 10.1016/j.acn.2004.12.001; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	43	11	11	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	6					1039	1053		10.1080/13854046.2017.1419507			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GO3SJ	WOS:000439914700001	29283307				2022-02-06	
J	Requejo, C; Ruiz-Ortega, JA; Cepeda, H; Sharma, A; Sharma, HS; Ozkizilcik, A; Tian, R; Moessler, H; Ugedo, L; Lafuente, JV				Requejo, C.; Ruiz-Ortega, J. A.; Cepeda, H.; Sharma, A.; Sharma, H. S.; Ozkizilcik, A.; Tian, R.; Moessler, H.; Ugedo, L.; Lafuente, J. V.			Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease	MOLECULAR NEUROBIOLOGY			English	Article						Parkinson'sdisease; 6-OHDA; Preclinical stage; Nanowired cerebrolysin; Enriched environment; Neuroprotection	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; APP TRANSGENIC MODEL; MOTOR FUNCTION; 6-OHDA LESIONS; ANIMAL-MODELS; HEAT-STRESS; LIMB-USE; DOPAMINE; GDNF	Rearing in enriched environment (EE) improves the recuperation in animal models of Parkinson's disease (PD). Administration of TiO2-nanowired cerebrolysin (CBL) could represent an additional strategy to protect or repair the nigrostriatal system. This study aims to explore morphofunctional and biochemical changes in a preclinical stage of PD testing the synergistic efficiency of combining both strategies, housing in EE, and nanodelivery of CBL. Sprague-Dawley male rats receiving intrastriatally 6-hydroxydopamine after a short evolution time were segregated into CBL group (rats receiving nanowired CBL), EE group (rats housed in EE), CBL + EE group (rats housed in EE and receiving nanowired CBL), and control group (rats without additional treatment). Prodromic stage and treatment effects were characterized by the presence of motor symptoms (amphetamine-induced rotational behavior test). Tyrosine hydroxylase (TH) immunohistochemistry and Western blot (p-Akt/Akt and p-ERK/ERK 1/2 as survival markers and caspase-3 as apoptotic marker) were performed in striatum and SN. A decrease in motor symptoms was shown by rats receiving CBL. EE monitoring cages revealed that rats from CBL + EE group showed more significant number of laps in the wheel than EE group. In SN, CBL + EE group also presented the highest neuronal density. Moreover, p-Akt/Akt and p-ERK/ERK 1/2 ratio was significant higher and caspase-3 expression was lower in CBL + EE group. In conclusion, the combination of CBL and EE provided evidence of neuoprotective-neurorestorative mechanisms by which this combined strategy promoted morphofunctional improvement by activation of survival pathways after dopamine depletion in a preclinical model of PD.	[Requejo, C.; Cepeda, H.; Sharma, H. S.; Lafuente, J. V.] Univ Basque Country UPV EHU, Dept Neurosci, LaNCE, Leioa, Vizcaya, Spain; [Ruiz-Ortega, J. A.; Ugedo, L.] Univ Basque Country UPV EHU, Dept Pharmacol, Leioa, Vizcaya, Spain; [Sharma, A.; Sharma, H. S.] Uppsala Univ, Int Expt CNS Injury & Repair, Uppsala, Sweden; [Sharma, H. S.] Uppsala Univ, Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, SE-75185 Uppsala, Sweden; [Ozkizilcik, A.; Tian, R.] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA; [Tian, R.] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Moessler, H.] Ever Neuro Pharma, Drug Discovery & Develop, Oberburgau, Austria; [Lafuente, J. V.] BioCruces Hlth Res Inst, Nanoneurosurg Grp, Baracaldo 48903, Vizcaya, Spain; [Lafuente, J. V.] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile		Requejo, C (corresponding author), Univ Basque Country UPV EHU, Dept Neurosci, LaNCE, Leioa, Vizcaya, Spain.	catalina.requejo@ehu.eus	Ruiz-Ortega, Jose Angel/F-2465-2016; Lafuente, Jose-Vicente/O-6395-2014; Tian, Z. Ryan/R-6671-2016; Requejo, Catalina/O-4094-2016; Ugedo, Luisa/H-4244-2015	Ruiz-Ortega, Jose Angel/0000-0003-2246-4378; Lafuente, Jose-Vicente/0000-0001-7246-0987; Tian, Z. Ryan/0000-0002-5644-8483; Requejo, Catalina/0000-0002-5440-5455; Ozkizilcik, Asya/0000-0002-6261-9533; Ugedo, Luisa/0000-0001-5993-0606	University of the Basque Country (UPV/EHU) [PPG 17/51, UFI 11/32]; Basque GovernmentBasque Government [Saiotek SA-2010/00028, GIC IT 901/16, IT747-13]; Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission [SAF2010-20375 SAF2016 77756 R]; FEDER fundsEuropean Commission; SGIker (UPV/EHU); USAF [FA8655-05-1-3065]; UPV/EHU	The authors thank the support of the University of the Basque Country (UPV/EHU) PPG 17/51 (UFI 11/32), the Basque Government (Saiotek SA-2010/00028, GIC IT 901/16 and IT747-13), "Ministerio de Ciencia e Innovacion" (SAF2010-20375 SAF2016 77756 R), FEDER funds, and SGIker (UPV/EHU). C. Requejo appreciates the UPV/EHU for a fellowship subvention. HS Sharma to Air Force Material Command, USAF, under grant number FA8655-05-1-3065.	Alcantara-Gonzalez F, 2012, SYNAPSE, V66, P938, DOI 10.1002/syn.21588; Anastasia A, 2009, J NEUROCHEM, V109, P755, DOI 10.1111/j.1471-4159.2009.06001.x; Bengoetxea H, 2008, EFFECTS VISUAL EXPER; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bez F, 2016, NEUROBIOL DIS, V94, P213, DOI 10.1016/j.nbd.2016.06.005; Bezard E, 2003, J NEUROSCI, V23, P10999; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Blesa J, 2014, PARKINSONS DIS ANIMA, V8, P1; Burke RE, 2010, PROG BRAIN RES, V183, P79, DOI 10.1016/S0079-6123(10)83005-5; Chang WH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0553-z; Cheng BH, 2007, AUTON NEUROSCI-BASIC, V134, P38, DOI 10.1016/j.autneu.2007.02.002; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Cohen AD, 2003, J NEUROCHEM, V85, P299, DOI 10.1046/j.1471-4159.2003.01657.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eagle AL, 2015, NEUROSCI RES, V92, P71, DOI 10.1016/j.neures.2014.11.002; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Feng LR, 2010, EUR J NEUROSCI, V32, P10, DOI 10.1111/j.1460-9568.2010.07266.x; Francardo V, PHARM STIMULATION SI; Fuqua JL, 2014, PEPTIDES, V54, P1, DOI 10.1016/j.peptides.2013.12.007; Hartmann A, 2001, J NEUROCHEM, V76, P1785, DOI 10.1046/j.1471-4159.2001.00160.x; Herran E, 2014, INT J NANOMED, V9, P2677, DOI 10.2147/IJN.S61940; Herring A, 2010, BRAIN PATHOL, V20, P166, DOI 10.1111/j.1750-3639.2008.00257.x; Hp D, 2015, PUBMED COMMONS, V9, P2; Jadavji NM, 2006, NEUROSCIENCE, V140, P1127, DOI 10.1016/j.neuroscience.2006.03.027; Jain V, 2012, CELL MOL NEUROBIOL, V32, P599, DOI 10.1007/s10571-012-9807-5; Johansson BB, 1999, ACT NEUR S, V73, P51; Jollivet C, 2004, BIOMATERIALS, V25, P933, DOI 10.1016/S0142-9612(03)00601-X; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Laganiere J, 2010, J NEUROSCI, V30, P16469, DOI 10.1523/JNEUROSCI.2440-10.2010; LaHue SC, 2016, MOVEMENT DISORD, V31, P1444, DOI 10.1002/mds.26728; Lindgren N, 2012, J PARKINSON DIS, V2, P333, DOI 10.3233/JPD-012146; Lukhanina EP, 2004, ZH NEVROPATOL PSIKH, V104, P54; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Mo C, 2015, NEUROSCI BIOBEHAV R, V52, P178, DOI 10.1016/j.neubiorev.2015.03.003; Morera-Herreras T, 2011, PSYCHOPHARMACOLOGY, V214, P379, DOI 10.1007/s00213-010-2043-0; Morin N, 2014, EXP NEUROL, V256, P105, DOI 10.1016/j.expneurol.2013.01.024; Muresanu DF, 2015, MOL NEUROBIOL, V52, P837, DOI 10.1007/s12035-015-9298-8; Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P327, DOI 10.1007/978-3-211-98811-4_61; Noor NA, 2016, LIFE SCI, V155, P174, DOI 10.1016/j.lfs.2016.05.022; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Olanow CW, 2012, MOVEMENT DISORD, V27, P666, DOI 10.1002/mds.25019; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; Ortuzar N, 2013, BEHAV BRAIN RES, V246, P36, DOI 10.1016/j.bbr.2013.02.036; Palma Jose-Alberto, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS94, DOI 10.1016/S1353-8020(13)70024-5; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609; Rahmeier FL, 2016, NEUROSCI LETT, V630, P84, DOI 10.1016/j.neulet.2016.07.032; Requejo C, 2015, MOL NEUROBIOL, V52, P846, DOI 10.1007/s12035-015-9234-y; Requejo C, 2016, MOL NEUROBIOL, P1, DOI DOI 10.1007/S12035016-02441; Requejo C, MOL NEUROBIOL UNPUB; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rockenstein E, 2015, STEM CELL RES, V15, P54, DOI 10.1016/j.scr.2015.04.008; ROSE FD, 1993, BEHAV BRAIN RES, V56, P93, DOI 10.1016/0166-4328(93)90025-L; Sharma A, 2012, CNS NEUROL DISORD-DR, V11, P7, DOI 10.2174/187152712799960790; Sharma HS, 2011, J NANOSCI NANOTECHNO, V11, P7549, DOI 10.1166/jnn.2011.5114; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P138, DOI 10.1111/j.1749-6632.2009.05330.x; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Steiner B, 2006, EXP NEUROL, V199, P291, DOI 10.1016/j.expneurol.2005.11.004; Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035; Tian ZR, 2012, CNS NEUROL DISORD-DR, V11, P86; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Tsui A, 2011, J NEUROL, V258, P1393, DOI 10.1007/s00415-011-6061-6; Vela L, 2016, J NEUROL SCI, V368, P150, DOI 10.1016/j.jns.2016.07.003; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495	74	11	11	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					286	299		10.1007/s12035-017-0741-x			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV6PC	WOS:000424702600029	28840482				2022-02-06	
J	Romani, C; MacDonald, A; De Felice, S; Palermo, L				Romani, Cristina; MacDonald, Anita; De Felice, Sara; Palermo, Liana			Speed of processing and executive functions in adults with phenylketonuria: Quick in finding the word, but not the ladybird	COGNITIVE NEUROPSYCHOLOGY			English	Article						Phenylketonuria; speed of processing; executive functions; ageing; serial vs. parallel search; feature vs. conjunction search	EARLY-TREATED PHENYLKETONURIA; WHITE-MATTER ABNORMALITIES; AGE-RELATED DIFFERENCES; CLOSED-HEAD INJURY; VISUAL-SEARCH; LIFE-SPAN; DEVELOPMENTAL DYSLEXIA; PARKINSONS-DISEASE; PHENYLALANINE CONCENTRATIONS; COGNITIVE PERFORMANCE	A reduction in processing speed is widely reported in phenylketonuria (PKU), possibly due to white matter pathology. We investigated possible deficits and their relationships with executive functions in a sample of 37 early-treated adults with PKU (AwPKUs). AwPKUs were not characterized by a generalized speed deficit, but instead their performance could be explained by two more specific impairments: (a) a deficit in the allocation of visuo-spatial attention that reduced speed in visual search tasks, in some reading conditions and visuo-motor coordination tasks; and (b) a more conservative decision mechanism that slowed down returning an answer across domains. These results suggest that the impairments in executive functions seen in AwPKUs are not the consequence of a generalized speed deficit. They also suggest that processing speed is linked to the efficiency of a particular cognitive component and cannot be considered a general function spanning domains. Similarities with patterns in ageing are discussed.	[Romani, Cristina; De Felice, Sara; Palermo, Liana] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [MacDonald, Anita] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Palermo, Liana] Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Palermo, Liana] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy		Palermo, L (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England.; Palermo, L (corresponding author), Queen Elizabeth Hosp, Birmingham, W Midlands, England.; Palermo, L (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	Liana.palermo@unicz.it	Palermo, Liana/ABG-2726-2021	Palermo, Liana/0000-0001-8047-7201; Romani, Cristina/0000-0002-5693-4131	Marie Curie Intra European Fellowship within the 7th European Community Framework Programme [329423]	This research was supported by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme granted to Liana Palermo under the supervision of Cristina Romani (TREPAPHEN; Project ID: 329423).	Adler-Abramovich L, 2012, NAT CHEM BIOL, V8, P701, DOI [10.1038/NCHEMBIO.1002, 10.1038/nchembio.1002]; Albinet CT, 2012, BRAIN COGNITION, V79, P1, DOI 10.1016/j.bandc.2012.02.001; Albrecht J, 2009, NEUROSCI BIOBEHAV R, V33, P414, DOI 10.1016/j.neubiorev.2008.11.001; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson PJ, 2007, DEV NEUROPSYCHOL, V32, P645, DOI 10.1080/87565640701375963; Anderson PJ, 2010, MOL GENET METAB, V99, pS3, DOI 10.1016/j.ymgme.2009.10.005; Anderson PJ, 2004, DEV MED CHILD NEUROL, V46, P230, DOI [10.1017/S0012162204000386, 10.1017/S001212204000386]; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Banerjee P, 2011, CHILD NEUROPSYCHOL, V17, P105, DOI 10.1080/09297049.2010.525502; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brinley JF, 1965, BEHAV AGING NERVOUS, P114; Brumm VL, 2004, J INHERIT METAB DIS, V27, P549, DOI 10.1023/B:BOLI.0000042985.02049.ff; Burlina AB, 2000, J INHERIT METAB DIS, V23, P313, DOI 10.1023/A:1005694122277; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Channon S, 2005, NEUROPSYCHOLOGY, V19, P679, DOI 10.1037/0894-4105.19.5.679; Channon S, 2004, NEUROPSYCHOLOGY, V18, P613, DOI 10.1037/0894-4105.18.4.613; Channon S, 2007, ARCH DIS CHILD, V92, P213, DOI 10.1136/adc.2006.104786; Christ SE, 2001, DEV NEUROPSYCHOL, V20, P653, DOI 10.1207/875656401753549852; Christ SE, 2016, MOL GENET METAB, V118, P3, DOI 10.1016/j.ymgme.2016.02.004; Christ SE, 2010, MOL GENET METAB, V99, pS22, DOI 10.1016/j.ymgme.2009.10.007; Cormack F, 2004, INT J GERIATR PSYCH, V19, P763, DOI 10.1002/gps.1159; Corsi P. M., 1972, THESIS MCGILL U MONT; DeRoche K, 2008, DEV NEUROPSYCHOL, V33, P474, DOI 10.1080/87565640802101482; Dyer CA, 2000, EUR J PEDIATR, V159, pS107, DOI 10.1007/PL00014369; Erixon-Lindroth N, 2005, PSYCHIAT RES-NEUROIM, V138, P1, DOI 10.1016/j.pscychresns.2004.09.005; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Feldmann R, 2005, J INHERIT METAB DIS, V28, P445, DOI 10.1007/s10545-005-0445-7; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Folk CL, 1996, EXP AGING RES, V22, P99, DOI 10.1080/03610739608254000; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; HALE S, 1994, PSYCHOL SCI, V5, P384, DOI 10.1111/j.1467-9280.1994.tb00290.x; Hale S, 1996, AGING NEUROPSYCHOL C, V3, P154, DOI 10.1080/13825589608256621; Hartas D, 2011, BRIT EDUC RES J, V37, P893, DOI 10.1080/01411926.2010.506945; Hommel B, 2004, DEV PSYCHOL, V40, P545, DOI 10.1037/0012-1649.40.4.545; Howard D, 2006, COGNITION, V100, P464, DOI 10.1016/j.cognition.2005.02.006; HUMPHREYS GW, 1992, CAN J PSYCHOL, V46, P377, DOI 10.1037/h0084329; Janos AL, 2012, NEUROPSYCHOLOGY, V26, P735, DOI 10.1037/a0029419; Janzen D, 2010, MOL GENET METAB, V99, pS47, DOI 10.1016/j.ymgme.2009.10.009; Jenkins L, 2000, PSYCHOL AGING, V15, P157, DOI 10.1037//0882-7974.15.1.157; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kaasinen V, 2002, NEUROSCI BIOBEHAV R, V26, P785, DOI 10.1016/S0149-7634(02)00065-9; KAIL R, 1991, DEV PSYCHOL, V27, P259, DOI 10.1037/0012-1649.27.2.259; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Kongs S. K., 2000, WCST 64 WISCONSIN CA; Landerl K, 2000, APPL PSYCHOLINGUIST, V21, P243, DOI 10.1017/S0142716400002058; Landvogt C, 2008, J CEREBR BLOOD F MET, V28, P824, DOI 10.1038/sj.jcbfm.9600571; Landy KM, 2015, CORTEX, V73, P228, DOI 10.1016/j.cortex.2015.08.020; Lawrence B, 1998, AGING NEUROPSYCHOL C, V5, P129, DOI 10.1076/anec.5.2.129.600; Leuzzi V, 2007, J INHERIT METAB DIS, V30, P209, DOI 10.1007/s10545-006-0399-4; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; LYKKELUND C, 1988, EUR J PEDIATR, V148, P238, DOI 10.1007/BF00441411; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; MCKEAN CM, 1972, BRAIN RES, V47, P469, DOI 10.1016/0006-8993(72)90653-1; Moyle JJ, 2007, NEUROPSYCHOL REV, V17, P91, DOI 10.1007/s11065-007-9021-2; Moyle JJ, 2007, J CLIN EXP NEUROPSYC, V29, P436, DOI 10.1080/13803390600745829; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; Myerson J, 2003, PSYCHON B REV, V10, P262, DOI 10.3758/BF03196491; Nardecchia F, 2015, MOL GENET METAB, V115, P84, DOI 10.1016/j.ymgme.2015.04.003; Nettelbeck T, 2010, PERS INDIV DIFFER, V48, P379, DOI 10.1016/j.paid.2009.10.032; Oppenheim GM, 2007, BRAIN LANG, V103, P175, DOI 10.1016/j.bandl.2007.07.102; Palermo L, 2017, NEUROPSYCHOLOGY, V31, P255, DOI 10.1037/neu0000337; Pascucci T, 2012, J INHERIT METAB DIS, V35, P1001, DOI 10.1007/s10545-012-9473-2; PLUDE DJ, 1989, PSYCHOL AGING, V4, P98, DOI 10.1037/0882-7974.4.1.98; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Poon, 1980, AGING 1980S PSYCHOL, P332, DOI [10.1037/10050-024, DOI 10.1037/10050-024]; Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042; Puopolo C, 2013, NEUROSCI BIOBEHAV R, V37, P2638, DOI 10.1016/j.neubiorev.2013.08.013; Reitan R, 1985, HALSTEAD REITAN NEUR; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; Romani C, 2017, NEUROPSYCHOLOGY, V31, P242, DOI 10.1037/neu0000336; Romani C, 2015, Q J EXP PSYCHOL, V68, P99, DOI 10.1080/17470218.2014.938666; Romani C, 2011, CORTEX, V47, P715, DOI 10.1016/j.cortex.2010.05.008; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; RUSKIN EM, 1990, J EXP CHILD PSYCHOL, V50, P1, DOI 10.1016/0022-0965(90)90029-8; SAHAKIAN B, 1989, BRIT J PSYCHIAT, V154, P797, DOI 10.1192/bjp.154.6.797; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Scarabino T, 2009, RADIOL MED, V114, P461, DOI 10.1007/s11547-009-0365-y; Scriber C, 2001, METABOLIC MOL BASES, P1667; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Shafto MA, 2014, SCIENCE, V346, P583, DOI 10.1126/science.1254404; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; SMITH GA, 1995, PSYCHOL AGING, V10, P238, DOI 10.1037/0882-7974.10.2.238; Smith ML, 1996, DEV NEUROPSYCHOL, V12, P327, DOI 10.1080/87565649609540656; Soloway AH, 2013, MED HYPOTHESES, V81, P690, DOI 10.1016/j.mehy.2013.07.028; Starns JJ, 2012, PSYCHON B REV, V19, P139, DOI 10.3758/s13423-011-0189-3; Starns JJ, 2010, PSYCHOL AGING, V25, P377, DOI 10.1037/a0018022; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Trites R., 1977, GROOVED PEGBOARD TES; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1981, WECHSLER ADULT INTEL; WELFORD AT, 1965, BEHAV AGING NERVOUS, P3; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	107	11	11	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0264-3294	1464-0627		COGN NEUROPSYCHOL	Cogn. Neuropsychol.		2018	35	3-4			SI		171	198		10.1080/02643294.2017.1320278			28	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GF7MJ	WOS:000432152000004	28632427	Green Accepted			2022-02-06	
J	Sawyer, TW; Josey, T; Wang, Y; Villanueva, M; Ritzel, DV; Nelson, P; Lee, JJ				Sawyer, T. W.; Josey, T.; Wang, Y.; Villanueva, M.; Ritzel, D. V.; Nelson, P.; Lee, J. J.			Investigations of primary blast-induced traumatic brain injury	SHOCK WAVES			English	Article						Advanced blast simulator; Primary blast; Tissue culture; Traumatic brain injury (TBI); Underwater blast	FIBRILLARY ACIDIC PROTEIN; ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; PI3K/AKT/MTOR PATHWAY; SHELL SHOCK; UP-REGULATION; MOUSE MODEL; RAT-BRAIN; EXPOSURE	The development of an advanced blast simulator (ABS) has enabled the reproducible generation of single-pulse shock waves that simulate free-field blast with high fidelity. Studies with rodents in the ABS demonstrated the necessity of head restraint during head-only exposures. When the head was not restrained, violent global head motion was induced by pressures that would not produce similar movement of a target the size and mass of a human head. This scaling artefact produced changes in brain function that were reminiscent of traumatic brain injury (TBI) due to impact-acceleration effects. Restraint of the rodent head eliminated these, but still produced subtle changes in brain biochemistry, showing that blast-induced pressure waves do cause brain deficits. Further experiments were carried out with rat brain cell aggregate cultures that enabled the conduct of studies without the gross movement encountered when using rodents. The suspension nature of this model was also exploited to minimize the boundary effects that complicate the interpretation of primary blast studies using surface cultures. Using this system, brain tissue was found not only to be sensitive to pressure changes, but also able to discriminate between the highly defined single-pulse shock waves produced by underwater blast and the complex pressure history exposures experienced by aggregates encased within a sphere and subjected to simulated air blast. The nature of blast-induced primary TBI requires a multidisciplinary research approach that addresses the fidelity of the blast insult, its accurate measurement and characterization, as well as the limitations of the biological models used.	[Sawyer, T. W.; Josey, T.; Wang, Y.; Villanueva, M.; Nelson, P.; Lee, J. J.] Def Res & Dev Canada, Suffield Res Ctr, Box 4000, Medicine Hat, AB T1A 8K6, Canada; [Ritzel, D. V.] Dyn FX Consulting Ltd, 19 Laird Ave North, Amherstburg, ON N9V 2T5, Canada		Sawyer, TW (corresponding author), Def Res & Dev Canada, Suffield Res Ctr, Box 4000, Medicine Hat, AB T1A 8K6, Canada.	thomas.sawyer@drdc-rddc.gc.ca					Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Alphonse Vanessa D, 2014, Biomed Sci Instrum, V50, P248; ZUCKERMAN S., 1941, Proceedings of the Royal Society of Medicine, V31, P171; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; CASSEN B, 1952, J Aviat Med, V23, P120; Cernak I, 2010, MED DATA REV, V2, P297; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Clark S. L., 1943, SURG GYNECOL OBSTET, V77, P403; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; COPPEL DL, 1976, BRIT J SURG, V63, P735, DOI 10.1002/bjs.1800631003; Courtney MW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3518970; Cudahy E., 2001, 1162 NSMRL, P1; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Eulion JF, 1942, NEW ENGL J MED, V226, P1; Evans Ian, 2015, Methods Mol Biol, V1332, P91, DOI 10.1007/978-1-4939-2917-7_7; Freidell M. T., 1943, US NAV MED B, V41, P353; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gean A. D., 2014, BRAIN INJURY APPL WA; Guy R J, 2000, J R Nav Med Serv, V86, P27; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hohman TJ, 2015, JAMA NEUROL, V72, P520, DOI 10.1001/jamaneurol.2014.4761; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Honegger P, 2011, METHODS MOL BIOL, V758, P81, DOI 10.1007/978-1-61779-170-3_6; Honegger Paul, 2003, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1209s15; Hooker DR, 1924, AM J PHYSIOL, V67, P219; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Josey T., 2016, P 24 MIL ASP BLAST S; Josey T., 2016, P PERS ARM SYST S PA; Kane MJ, 2012, NEUROSCI LETT, V522, P47, DOI 10.1016/j.neulet.2012.06.012; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kobeissy F. H., 2016, BRAIN NEUROTRAUMA MO; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lange C, 2016, NAT REV NEUROL, V12, P439, DOI 10.1038/nrneurol.2016.88; Lee J. J, 2016, P PERS ARM SYST S PA; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li T, 2014, INT J MOL SCI, V15, P18856, DOI 10.3390/ijms151018856; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Mott F W, 1917, Br Med J, V2, P612; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Mott FW, 1916, LANCET, V1, P545; Mott FW, 1917, BRIT MED J, V1917, P39, DOI 10.1136/bmj.2.2950.39; Myers CS, 1915, LANCET, V1, P316; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Palma J., 1943, U S NAVAL MED BULL, V41, P3; Palma J., 1942, HAWAII MED J, V10, P42; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Pugh H. L., 1943, US NAVAL MED B, V41, P9; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Reid F, 2014, ENDEAVOUR, V38, P91, DOI 10.1016/j.endeavour.2014.05.002; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ritzel D. V., 2011, P NATO HFM 207 HAL; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Santos SS, 2007, J NEUROSCI RES, V85, P3386, DOI 10.1002/jnr.21409; Sawyer TW, 2018, J NEUROTRAUM, V35, P174, DOI 10.1089/neu.2016.4961; Sawyer TW, 2017, J NEUROTRAUM, V34, P517, DOI 10.1089/neu.2016.4430; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smith GA, 2015, J INHERIT METAB DIS, V38, P753, DOI 10.1007/s10545-015-9838-4; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Yaguda A, 1945, US NAV M B, V44, P232; Yang ZH, 1996, J TRAUMA, V40, pS81, DOI 10.1097/00005373-199603001-00019; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014; Zander NE, 2016, ANAL BIOCHEM, V504, P4, DOI 10.1016/j.ab.2016.03.009; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594; Zuckerman S, 1940, LANCET, V2, P219	102	11	11	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JAN	2018	28	1					85	99		10.1007/s00193-017-0756-2			15	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FU0TF	WOS:000423562600007					2022-02-06	
J	Saykally, JN; Ratliff, WA; Keeley, KL; Pick, CG; Mervis, RF; Citron, BA				Saykally, Jessica N.; Ratliff, Whitney A.; Keeley, Kristen L.; Pick, Chaim G.; Mervis, Ronald F.; Citron, Bruce A.			Repetitive Mild Closed Head Injury Alters Protein Expression and Dendritic Complexity in a Mouse Model	JOURNAL OF NEUROTRAUMA			English	Article						autophagy; dendritic complexity; repetitive injury; transcription factors; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; COGNITIVE DEFICITS; FOOTBALL PLAYERS; TDP-43; DISEASE; MICE; AUTOPHAGY; ENCEPHALOPATHY; ACCUMULATION	Worldwide head injuries are a growing problem. In the United States alone, 1.7 million people suffer a head injury each year. While most of these injuries are mild, head injury sufferers still sustain symptoms that can have major medical and economical impacts. Moreover, repetitive mild head injuries, like those observed in active military personnel and athletes, have demonstrated a more severe and long-term set of consequences. In an effort to better understand the delayed pathological changes following multiple mild head injuries, we used a mouse model of mild closed head injury (with no motor deficits observed by rotarod testing) and measured dendritic complexity at 30 days after injury and potentially related factors up to 60 days post-injury. We found an increase in TDP-43 protein at 60 days post-injury in the hippocampus and a decrease in autophagy factors three days post-injury. Alterations in dendritic complexity were neuronal subtype and location specific. Measurements of neurotropic factors suggest that an increase in complexity in the cortex may be a consequence of neuronal loss of the less connected neurons.	[Saykally, Jessica N.; Ratliff, Whitney A.; Keeley, Kristen L.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Lab Mol Biol Res & Dev 151, Bldg 22,Room 123,POB 4125, Bay Pines, FL 33744 USA; [Saykally, Jessica N.; Ratliff, Whitney A.; Keeley, Kristen L.; Citron, Bruce A.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA; [Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Mervis, Ronald F.] NeuroStruct Res Labs Inc, Tampa, FL USA; [Mervis, Ronald F.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Aging & Brain Repair, Tampa, FL USA		Citron, BA (corresponding author), Bay Pines VA Healthcare Syst, Lab Mol Biol Res & Dev 151, Bldg 22,Room 123,POB 4125, Bay Pines, FL 33744 USA.	bcitron@health.usf.edu			Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development)US Department of Veterans Affairs [I01RX001520]; Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program [W81XWH-16-1-0626]; Florida Department of Health James and Esther King Biomedical Research Program [4KB14]; Bay Pines Foundation; Veterans AffairsUS Department of Veterans Affairs [I01RX001520] Funding Source: NIH RePORTER	We thank Andrea Smith for expert animal assistance and Sonya Bhaskar for expert technical assistance. This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development (I01RX001520)), the Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program (W81XWH-16-1-0626), the Florida Department of Health James and Esther King Biomedical Research Program (4KB14), and The Bay Pines Foundation.	Bose JK, 2011, J BIOL CHEM, V286, P44441, DOI 10.1074/jbc.M111.237115; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Dallasen RM, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-27; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Franklin K.B.J, 2012, MOUSE BRAIN STEREOTA; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Heim L.R., 2017, J NEUROTRAUMA; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jinwal UK, 2012, J BIOL CHEM, V287, P24814, DOI 10.1074/jbc.M112.367268; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Garcia-Segura LM, 2014, J NEUROSCI METH, V226, P103, DOI 10.1016/j.jneumeth.2014.01.016; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; SHOLL DA, 1953, J ANAT, V87, P387; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tremblay C, 2011, J NEUROPATH EXP NEUR, V70, P788, DOI 10.1097/NEN.0b013e31822c62cf; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wilson RS, 2013, JAMA NEUROL, V70, P1418, DOI 10.1001/jamaneurol.2013.3961; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	44	11	11	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					139	148		10.1089/neu.2017.5070			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700016	28701108				2022-02-06	
J	Swan, AA; Nelson, JT; Pogoda, TK; Amuan, ME; Akin, FW; Pugh, MJ				Swan, Alicia A.; Nelson, Jeremy T.; Pogoda, Terri K.; Amuan, Megan E.; Akin, Faith W.; Pugh, Mary Jo			Sensory dysfunction and traumatic brain injury severity among deployed post-9/11 veterans: a chronic effects of neurotrauma consortium study	BRAIN INJURY			English	Article						Brain injury; sensory; Iraq and Afghanistan Wars; Veteran; health care	EVOKED MYOGENIC POTENTIALS; HEARING-LOSS; OLDER-ADULTS; VISUAL IMPAIRMENT; NOISE EXPOSURE; UNITED-STATES; SEX-DIFFERENCES; BLAST EXPOSURE; HEAD-INJURY; US ADULTS	Objectives: To describe the prevalence of sensory dysfunction (i.e. auditory, visual, vestibular, chemosensory and multiple sensory problems) and explore associations with traumatic brain injury (TBI) severity and injury mechanism among deployed Post-9/11 Veterans.Methods: This retrospective cohort analysis used Departments of Defense and Veterans Affairs diagnostic codes and administrative data.Results: Among the 570,248 Veterans in this cohort, almost 23% had at least one diagnosis of sensory dysfunction. In the multinomial regression analysis, the odds of all types of sensory dysfunction were greater among those with any TBI relative to those with no TBI. The odds for auditory or multisensory problems were higher among those that indicated exposure to blast. In particular, exposure to quaternary blast injury (e.g. crush, respiratory and burn injuries) was associated with increased odds for auditory, visual, vestibular and multisensory problems.Conclusions: Sensory problems affect a substantial number of deployed Post-9/11 Veterans and are more common among those with TBI or with exposure to deployment-related blast exposure. Because sensory problems profoundly impact quality of life, their identification and enhanced education and therapy are vital tools to improve prognosis for these relatively young Veterans.	[Swan, Alicia A.; Pugh, Mary Jo] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Nelson, Jeremy T.] Dept Def Hearing Ctr Excellence, San Antonio, TX USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Amuan, Megan E.] Edith Nourse Rogers VA Med Ctr, Ctr Hlth Care Org & Implementat Res, Bedford, MA USA; [Akin, Faith W.] James H Quillen VA Med Ctr, Mountain Home, TN USA; [Akin, Faith W.] East Tennessee State Univ, Dept Audiol & Speech Language Pathol, Johnson City, TN 37614 USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Pugh, Mary Jo] Univ Utah, VA Salt Lake City Hlth Care Syst, Decis Enhancement & Analyt Sci Ctr IDEAS 20, Informat, Salt Lake City, UT 84112 USA; [Pugh, Mary Jo] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA		Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, IDEAS Ctr Innovat 20, Salt Lake City, UT 84148 USA.	maryjo.pugh@hsc.utah.edu	Pugh, Mary Jo/K-5336-2019; Swan, Alicia A/O-3536-2018; Pogoda, Terri/F-6243-2012	Pugh, Mary Jo/0000-0003-4196-7763; Swan, Alicia A/0000-0003-2412-0499; Pogoda, Terri/0000-0003-1397-8780	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA Health Services Research and Development Service, South Texas Veterans Healthcare System/Audie L. Murphy Division; Edith Nourse Rogers VA Memorial Hospital; Joint Trauma System	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA Health Services Research and Development Service, South Texas Veterans Healthcare System/Audie L. Murphy Division, the Edith Nourse Rogers VA Memorial Hospital, and the Joint Trauma System.	Akin FW, 2012, EAR HEARING, V33, P458, DOI 10.1097/AUD.0b013e3182498c5f; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Bainbridge KE, 2014, ANNU REV PUBL HEALTH, V35, P139, DOI 10.1146/annurev-publhealth-032013-182510; Bird JC, 1998, BRIT J GEN PRACT, V48, P1828; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brennan M, 2006, J REHABIL RES DEV, V43, P777, DOI 10.1682/JRRD.2005.06.0109; BRUINS WR, 1991, J LARYNGOL OTOL, V105, P890, DOI 10.1017/S002221510011775X; Caban AJ, 2005, AM J PUBLIC HEALTH, V95, P1940, DOI 10.2105/AJPH.2004.056671; Campbell V A, 1999, MMWR CDC Surveill Summ, V48, P131; Capo-Aponte JE, 2015, J REHABIL RES DEV, V52, P273, DOI 10.1682/JRRD.2014.09.0204; Chandler D W, 1997, J Am Acad Audiol, V8, P81; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Cruickshanks KJ, 2010, HEARING RES, V264, P3, DOI 10.1016/j.heares.2009.10.008; Defense and Veterans Brain Injury Center [Internet], 2000, WORLDW NUMB TBI; Department of Veterans Affairs and Department of Defense, 2018, VA DOD CLIN PRACT GU; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eapen BC, 2013, CURR PHYS MED REHABI, V1, P151, DOI DOI 10.1007/S40141-013-0023-0; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Goman AM, 2016, AM J PUBLIC HEALTH, V106, P1820, DOI 10.2105/AJPH.2016.303299; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; Karatas M, 2008, NEUROLOGIST, V14, P355, DOI 10.1097/NRL.0b013e31817533a3; Killion MC, 2011, INT J AUDIOL, V50, pS38, DOI 10.3109/14992027.2010.540581; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P253, DOI 10.1007/s10654-011-9563-8; Koo JW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008224; Lam BL, 2009, OPHTHAL EPIDEMIOL, V16, P144, DOI 10.1080/09286580902863007; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lin FR, 2012, JARO-J ASSOC RES OTO, V13, P109, DOI 10.1007/s10162-011-0298-8; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Liu G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013246; Lupsakko TA, 2002, J AM GERIATR SOC, V50, P1748, DOI 10.1046/j.1532-5415.2002.50476.x; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; MANGABEIRA-ALBERNAZ P L, 1959, Laryngoscope, V69, P1478; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McCABE B F, 1958, Acta Otolaryngol, V49, P147; Mick P, 2016, EAR HEARING, V37, pE194, DOI 10.1097/AUD.0000000000000267; Military Health System, 2018, SURV CAS DEF 13 0 NE; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Nelson JT, 2017, HEARING RES, V349, P13, DOI 10.1016/j.heares.2016.10.005; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Park YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150783; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; SUMNER D, 1967, BRAIN, V90, P187, DOI 10.1093/brain/90.1.187; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; TIBBLIN G, 1990, Scandinavian Journal of Primary Health Care, V8, P9, DOI 10.3109/02813439008994923; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Veterans Benefits Administration US Department of Veterans Affairs, ANN BEN REP FISC YEA; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Wang YP, 2007, OTOLARYNG HEAD NECK, V137, P607, DOI 10.1016/j.otohns.2007.05.005; Wang YP, 2006, OTOL NEUROTOL, V27, P956, DOI 10.1097/01.mao.0000231590.57348.4b; Wells TS, 2015, NOISE HEALTH, V17, P34, DOI 10.4103/1463-1741.149574; WICKENS T. D., 1989, MULTIWAY CONTINGENCY; Wu CC, 2009, INT J AUDIOL, V48, P655, DOI 10.1080/14992020903012481; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; Yamada M, 2012, J AM GERIATR SOC, V60, P1304, DOI 10.1111/j.1532-5415.2012.04039.x; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131; YETISER S, 1993, MIL MED, V158, P803, DOI 10.1093/milmed/158.12.803	75	11	11	3	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1197	1207		10.1080/02699052.2018.1495340			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200006	30024786				2022-02-06	
J	Thompson, EC; Krizman, J; White-Schwoch, T; Nicol, T; LaBella, CR; Kraus, N				Thompson, Elaine C.; Krizman, Jennifer; White-Schwoch, Travis; Nicol, Trent; LaBella, Cynthia R.; Kraus, Nina			Difficulty hearing in noise: a sequela of concussion in children	BRAIN INJURY			English	Article						Concussion; post-concussion syndrome; auditory processing; speech-in-noise perception; mild traumatic brain injury	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; COMPLAINTS; SYMPTOMS; VETERANS	Objective: Concussions can result in auditory processing deficits even in the absence of hearing loss. In children and adolescents, the extent to which these impairments have functional consequences for everyday listening, such as the ability to understand speech in noisy environments, is unknown.Research design: Case-control study.Subjects and methods: Forty youth comprised the participants: 20 had sustained a concussion and were recovering from their injury, and 20 controls had sustained non-concussive orthopaedic (e.g. musculoskeletal) injuries. All were evaluated on the Hearing in Noise Test, an audiologic index of the ability to hear sentences in adverse listening conditions.Results: Children and adolescents recovering from concussions demonstrated an overall impaired ability to perceive speech in noisy backgrounds compared to a peer control group. This deficit also emerged across trials in the most taxing listening condition, and with respect to published, age-normative values.Conclusions: Functional listening skillssuch as the ability to understand speech in noise, and the ability to sustain performance over time in taxing auditory conditionsmay be compromised in children with concussions. These impairments may exacerbate cognitive and academic challenges associated with concussion injuries, and should be considered in return-to-learn and return-to-play decisions.	[Thompson, Elaine C.; Krizman, Jennifer; White-Schwoch, Travis; Nicol, Trent; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL USA; [Thompson, Elaine C.; Krizman, Jennifer; White-Schwoch, Travis; Nicol, Trent; Kraus, Nina] Northwestern Univ, Dept Commun Sci, Chicago, IL 60611 USA; [Kraus, Nina] Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Evanston, IL USA; [LaBella, Cynthia R.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Orthopaed & Sports Med, Chicago, IL 60611 USA; [LaBella, Cynthia R.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA		Kraus, N (corresponding author), Auditory Neurosci Lab, 2240 Campus Dr, Evanston, IL 60208 USA.	nkraus@northwestern.edu			Knowles Hearing Center at Northwestern University	Many thanks to the members of the Auditory Neuroscience Laboratory for their thoughtful feedback on the manuscript, to the members of the Sports Medicine Research Group for their assistance with recruitment, and to the patients and their families for participating in the study. This work is supported by the Knowles Hearing Center at Northwestern University.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; ALLEN P, 1995, J SPEECH HEAR RES, V38, P503, DOI 10.1044/jshr.3802.503; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Barry J. G., 2010, J VISUALIZED EXPT, V44, P2139, DOI [10.3791/2139, DOI 10.3791/2139]; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Boets B, 2011, RES DEV DISABIL, V32, P560, DOI 10.1016/j.ridd.2010.12.020; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); COCKRELL J L, 1992, Brain Injury, V6, P261, DOI 10.3109/02699059209029667; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gathercole S.E., 2006, WORKING MEMORY ED, P33, DOI DOI 10.1016/B978-012554465-8/50010-7; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kraus N, 2017, NEUROSCI LETT, V646, P21, DOI 10.1016/j.neulet.2017.03.008; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meltzer L, 2010, PROMOTING EXECUTIVE; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Piontkowski D., 1979, ATTENTION COGNITIVE, P297, DOI 10.1007/978-1-4613-2985-5_11; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sato H, 2008, J ACOUST SOC AM, V123, P2064, DOI 10.1121/1.2839283; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Sharma M, 2009, J SPEECH LANG HEAR R, V52, P706, DOI 10.1044/1092-4388(2008/07-0226); Shield BM, 2008, J ACOUST SOC AM, V123, P133, DOI 10.1121/1.2812596; Soli SD, 2008, INT J AUDIOL, V47, P356, DOI 10.1080/14992020801895136; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	42	11	11	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					763	769		10.1080/02699052.2018.1447686			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200010	29517389				2022-02-06	
J	Tousignant, B; Jackson, PL; Massicotte, E; Beauchamp, MH; Achim, AM; Vera-Estay, E; Bedell, G; Sirois, K				Tousignant, Beatrice; Jackson, Philip L.; Massicotte, Elsa; Beauchamp, Miriam H.; Achim, Amelie M.; Vera-Estay, Evelyn; Bedell, Gary; Sirois, Katia			Impact of traumatic brain injury on social cognition in adolescents and contribution of other higher order cognitive functions	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; adolescence; social cognition; mentalising; perspective taking; empathy	IMPAIRED SELF-AWARENESS; EMOTION RECOGNITION; CHILDREN; EMPATHY; CHILDHOOD; MIND; DEFICITS; PARTICIPATION; COMPREHENSION; SCHIZOPHRENIA	Social cognition impairments can contribute to social participation difficulties following traumatic brain injury (TBI). However, little attention has been given to these impairments during adolescence, a period of life when peer relationships are central. The aim of the current study was to examine the impact of a moderate to severe TBI sustained in adolescence on multiple facets of social cognition. Twentythree adolescents who had sustained a moderate-to-severe TBI were compared with a group of 23 typically developing peers. The Integrated Social Cognition Battery (mentalising, social knowledge, emotion recognition) and the Interpersonal Reactivity Index were administered, along with non-social cognition tests (selective attention, working memory, executive functions), IQ estimation, and a socio-demographic questionnaire. Adolescents with TBI reported having a significantly lower ability to take other people's perspectives versus controls. They also presented significantly lower levels of mentalising. After controlling for non-social higher-order cognitive variables, the group effect on mentalising remained marginally significant, whereas the effect on perspective taking remained significant. Our findings suggest the presence of primary deficits in social cognition following TBI in adolescence. These deficits could partially underlie the social reintegration difficulties encountered following TBI. A systematic assessment of social cognition in clinical practice is necessary.	[Tousignant, Beatrice; Jackson, Philip L.; Massicotte, Elsa; Sirois, Katia] Univ Laval, Ecole Psychol, Pavillon Felix Antoine Savard 2325, Quebec City, PQ G1V 0A6, Canada; [Tousignant, Beatrice; Jackson, Philip L.; Massicotte, Elsa; Sirois, Katia] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Jackson, Philip L.; Achim, Amelie M.] Ctr Rech Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Beauchamp, Miriam H.; Vera-Estay, Evelyn] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ctr Rech Hop Ste Justine, Montreal, PQ, Canada; [Bedell, Gary] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA		Sirois, K (corresponding author), Univ Laval, Ecole Psychol, Pavillon Felix Antoine Savard 2325, Quebec City, PQ G1V 0A6, Canada.	katia.sirois@psy.ulaval.ca		Bedell, Gary/0000-0002-9555-8861; Tousignant, Beatrice/0000-0003-1328-0139; Jackson, Philip/0000-0001-8991-3217	REPAR-FRQS [11-12- 6]; FRQS [29157]; CIHRCanadian Institutes of Health Research (CIHR) [MSH-87688]	This work was supported by REPAR-FRQS under grant number [11-12-#6] to K. Sirois; FRQS under salary grant number [29157] to P.L. Jackson; and CIHR under salary grant number [MSH-87688] to P.L. Jackson.	Achim AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00823; Achim AM, 2012, PSYCHIAT RES, V196, P207, DOI 10.1016/j.psychres.2011.10.011; Achim AM, 2011, PSYCHIAT RES, V190, P3, DOI 10.1016/j.psychres.2010.10.030; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Allemand M, 2015, J PERS, V83, P229, DOI 10.1111/jopy.12098; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Balaban T, 2009, PHYS OCCUP THER PEDI, V29, P367, DOI 10.3109/01942630903245333; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P931, DOI 10.1111/j.1469-7610.1989.tb00296.x; Bates ME, 2004, J INT NEUROPSYCH SOC, V10, P392, DOI 10.1017/S135561770410307X; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Ciaramelli E, 2006, BRAIN COGNITION, V60, P198; Cooper JM, 2014, J NEUROTRAUM, V31, P713, DOI 10.1089/neu.2013.3101; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Eisenberg N, 2005, J RES ADOLESCENCE, V15, P235, DOI 10.1111/j.1532-7795.2005.00095.x; Ekman P., 1976, PICTURES FACIAL AFFE; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; FUNDER DC, 1980, J PERS, V48, P473, DOI 10.1111/j.1467-6494.1980.tb02380.x; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Katia S., 2014, OPEN J THERAPY REHAB, V2, P11, DOI [10.4236/ojtr.2014.21009, DOI 10.4236/OJTR.2014.21009]; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; LARSON R, 1991, CHILD DEV, V62, P284, DOI 10.2307/1131003; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Pinkham AE, 2014, SCHIZOPHRENIA BULL, V40, P813, DOI 10.1093/schbul/sbt081; Powell J., 2000, COGNITIVE NEUROPSYCH, V5, P175, DOI [DOI 10.1080/13546800050083520, 10.1080/13546800050083520]; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ross KA, 2011, BRAIN INJURY, V25, P1206, DOI 10.3109/02699052.2011.609519; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Townsend J.T., 1983, STOCHASTIC MODELING; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Van der Graaff J, 2014, DEV PSYCHOL, V50, P881, DOI 10.1037/a0034325; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940	98	11	11	6	31	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	3					429	447		10.1080/09602011.2016.1158114			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA4BY	WOS:000428275800007	26963905	Green Accepted			2022-02-06	
J	Townshend, J; Norman, A				Townshend, Jane; Norman, Alyson			The Secondary Impact of Traumatic Brain Injury: An Interpretative Phenomenological Analysis of the Experiences of Family and Friends	FAMILY JOURNAL			English	Article						IPA; traumatic brain injury; family	SEVERE HEAD-INJURY; ADULTS; REHABILITATION; DISABILITY; RELATIVES; FATIGUE; CARERS; PEOPLE	This study seeks to contribute to our understanding of the lived experiences of family members and friends of individuals with traumatic brain injury (TBI). The study employed an interpretative phenomenological approach, enabling family members and friends to identify and reflect upon the factors they themselves considered most significant about the impact of TBI on someone close to them, and how this experience has affected their own lives and their relationship with the TBI survivor. Eleven participants, two males and nine females aged 22-79, were from the United Kingdom. Several strong and interconnected themes emerged from the interviews, clustering into four superordinate themes: "continuity and discontinuity"; "damage, loss, and grief"; "roles and responsibility"; and "coping and not coping." The study findings identify the importance of support and information provision for family members and friends of those with TBI to help them manage the long-term impact of TBI.	[Townshend, Jane; Norman, Alyson] Univ Plymouth, Sch Psychol, A212A Portland Sq, Plymouth PL4 8AA, Devon, England		Norman, A (corresponding author), Univ Plymouth, Sch Psychol, A212A Portland Sq, Plymouth PL4 8AA, Devon, England.	alyson.norman@plymouth.ac.uk					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Bay EH, 2012, J MARITAL FAM THER, V38, P556, DOI 10.1111/j.1752-0606.2011.00231.x; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bessell A., 2007, J INT NEUROPSYCH SOC, V13, P1; Bright R, 1996, GRIEF POWERLESSNESS; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Coyle A., 2007, ANAL QUALITATIVE DAT, P9; Duff Diane, 2006, Axone, V27, P9; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; Gainotti G., 2003, HDB CLIN NEUROPSYCHO, P368; Headway, 2014, TICK TIM BOMB FALS E; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; King NS, 2003, HDB CLIN NEUROPSYCHO, P487; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Lezak M., 1985, REHABIL PSYCHOL, V31, P241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Niemeier JP, 2001, DISABIL REHABIL, V23, P645, DOI 10.1080/09638280110049324; Norman A, 2016, J ADULT PROT, V18, P341, DOI 10.1108/JAP-08-2016-0017; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P1; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Smith J.A., 2008, QUALITATIVE PSYCHOL, V2nd ed., P53, DOI [DOI 10.4135/9781848607927.N11, 10.1002/9780470776278.ch10, DOI 10.1002/9780470776278.CH10]; Smith J.A., 2009, INTERPRETATIVE PHENO; Smith J.A., 2004, QUALITATIVE RES PSYC, V1, P39, DOI DOI 10.1191/1478088704QP0040A; Stebbins P, 2001, REHABIL PSYCHOL, V46, P178, DOI 10.1037/0090-5550.46.2.178; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432	37	11	11	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1066-4807	1552-3950		FAM J	Fam. J.	JAN	2018	26	1					77	85		10.1177/1066480717752905			9	Family Studies	Emerging Sources Citation Index (ESCI)	Family Studies	GB8CB	WOS:000429300800010		Green Submitted			2022-02-06	
J	Wang, GX; Zhang, YP; Gao, ZW; Shields, LBE; Li, F; Chu, TC; Lv, HY; Moriarty, T; Xu, XM; Yang, XY; Shields, CB; Cai, J				Wang, Guoxiang; Zhang, Yi Ping; Gao, Zhongwen; Shields, Lisa B. E.; Li, Fang; Chu, Tianci; Lv, Huayi; Moriarty, Thomas; Xu, Xiao-Ming; Yang, Xiaoyu; Shields, Christopher B.; Cai, Jun			Pathophysiological and behavioral deficits in developing mice following rotational acceleration-deceleration traumatic brain injury	DISEASE MODELS & MECHANISMS			English	Article						Abusive head trauma; Shaken baby syndrome; Rotational acceleration-deceleration injury; Ischemia; Hemorrhage; Neuronal degeneration	NONACCIDENTAL HEAD-INJURY; SHAKEN BABY SYNDROME; NEURON-SPECIFIC ENOLASE; DIFFUSE AXONAL INJURY; INFANT RAT MODEL; CEREBROSPINAL-FLUID; RETINAL HEMORRHAGE; OVINE MODEL; CHILDREN; YOUNG	Abusive head trauma (AHT) is the leading cause of death from trauma in infants and young children. An AHT animal model was developed on 12-day-old mice subjected to 90 degrees head extension-flexion sagittal shaking repeated 30, 60, 80 and 100 times. The mortality and time until return of consciousness were dependent on the number of repeats and severity of the injury. Following 60 episodes of repeated head shakings, the pups demonstrated apnea and/or bradycardia immediately after injury. Acute oxygen desaturation was observed by pulse oximetry during respiratory and cardiac suppression. The cerebral blood perfusion was assessed by laser speckle contrast analysis (LASCA) using a PeriCam PSI system. There was a severe reduction in cerebral blood perfusion immediately after the trauma that did not significantly improve within 24 h. The injured mice began to experience reversible sensorimotor function at 9 days postinjury (dpi), which had completely recovered at 28 dpi. However, cognitive deficits and anxiety-like behavior remained. Subdural/subarachnoid hemorrhage, damage to the brain-blood barrier and parenchymal edema were found in all pups subjected to 60 insults. Proinflammatory response and reactive gliosis were upregulated at 3 dpi. Degenerated neurons were found in the cerebral cortex and olfactory tubercles at 30 dpi. This mouse model of repetitive brain injury by rotational head acceleration-deceleration partially mimics the major pathophysiological and behavioral events that occur in children with AHT. The resultant hypoxia/ischemia suggests a potential mechanism underlying the secondary rotational acceleration-deceleration-induced brain injury in developing mice.	[Wang, Guoxiang; Yang, Xiaoyu; Cai, Jun] Jilin Univ, Orthoped Hosp, Dept Spine Surg, Bethune Hosp 2, Changchun 130041, Jilin, Peoples R China; [Wang, Guoxiang; Gao, Zhongwen; Li, Fang; Chu, Tianci; Cai, Jun] Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40202 USA; [Zhang, Yi Ping; Shields, Lisa B. E.; Moriarty, Thomas; Shields, Christopher B.] Norton Healthcare, Norton Neurosci Inst, Louisville, KY 40202 USA; [Gao, Zhongwen] Jilin Univ, Dept Orthoped, China Japan Union Hosp, Changchun 130033, Jilin, Peoples R China; [Li, Fang] China Japan Friendship Hosp, Dept Neurol Surg, Beijing 100029, Peoples R China; [Lv, Huayi] Jilin Univ, Bethune Hosp 2, Eye Ctr, Changchun 130041, Jilin, Peoples R China; [Xu, Xiao-Ming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Shields, Christopher B.] Univ Louisville, Dept Neurol Surg, Sch Med, Louisville, KY 40202 USA; [Cai, Jun] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA		Yang, XY; Cai, J (corresponding author), Jilin Univ, Orthoped Hosp, Dept Spine Surg, Bethune Hosp 2, Changchun 130041, Jilin, Peoples R China.; Cai, J (corresponding author), Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40202 USA.; Shields, CB (corresponding author), Norton Healthcare, Norton Neurosci Inst, Louisville, KY 40202 USA.; Shields, CB (corresponding author), Univ Louisville, Dept Neurol Surg, Sch Med, Louisville, KY 40202 USA.; Cai, J (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA.	yangxiaoyu88@sina.com; cbshields1@gmail.com; j0cai002@louisville.edu	chu, tianci/AAG-8393-2020	/0000-0003-1721-7786; Li, Fang/0000-0003-1636-8662	NeuroCures Foundation; Kentucky Spinal Cord and Head Injury Research Board Research Grant; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81350013, 31572217, 81400998, 81300769]; China Scholarship CouncilChina Scholarship Council	This work was supported by the NeuroCures Foundation (J.C.), by a Kentucky Spinal Cord and Head Injury Research Board Research Grant (J.C. and C.B.S.), and partially by the National Natural Science Foundation of China (81350013, 31572217 to X.Y.; 81400998 to Z.G.; 81300769 to H.L.) and the China Scholarship Council (G.W.).	Anderson RWG, 2014, J BIOMECH, V47, P2578, DOI 10.1016/j.jbiomech.2014.06.002; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barnhart CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124521; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Bonnier C, 2002, BRAIN PATHOL, V12, P320; Bonnier Christine, 2004, Pediatr Rehabil, V7, P165, DOI 10.1080/13638490410001703325; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Cai J, 2012, J PATHOL, V226, P495, DOI 10.1002/path.2980; Cai J, 2011, RESP PHYSIOL NEUROBI, V178, P210, DOI 10.1016/j.resp.2011.06.003; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clevenger AC, 2015, J NEUROTRAUM, V32, P120, DOI 10.1089/neu.2014.3570; Coats B, 2017, J NEUROTRAUM, V34, P235, DOI 10.1089/neu.2015.4352; Curristin SM, 2002, P NATL ACAD SCI USA, V99, P15729, DOI 10.1073/pnas.232568799; de Souza SL, 2004, PHYSIOL BEHAV, V82, P375, DOI 10.1016/j.physbeh.2004.04.007; DEFELIPE J, 2011, FRONT NEUROANAT, V5, P46445; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Dierssen M, 2002, PHARMACOL BIOCHEM BE, V73, P19, DOI 10.1016/S0091-3057(02)00792-X; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Finnie JW, 2012, J CLIN NEUROSCI, V19, P1159, DOI 10.1016/j.jocn.2011.12.019; Finnie JW, 2010, J CLIN NEUROSCI, V17, P237, DOI 10.1016/j.jocn.2009.07.001; Fiske Elizabeth A, 2008, ANS Adv Nurs Sci, V31, pE1, DOI 10.1097/01.ANS.0000319567.14503.e5; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Geddes JF, 2004, FORENSIC SCI INT, V146, P83, DOI 10.1016/S0379-0738(03)00283-4; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Guida F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00095; Halliday D., 2013, FUNDAMENTALS PHYS EX, V10th; Hammelrath L, 2016, NEUROIMAGE, V125, P144, DOI 10.1016/j.neuroimage.2015.10.009; Heather NL, 2012, CLIN ENDOCRINOL, V77, P357, DOI 10.1111/j.1365-2265.2012.04376.x; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Izzy S., 2013, CURR TREAT OPTION NE, V16, P1; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Le Isabelle R, 2001, BEHAV BRAIN RES, V125, P57, DOI 10.1016/S0166-4328(01)00279-0; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Li Q, 2009, AM J PATHOL, V175, P2133, DOI 10.2353/ajpath.2009.090354; Lind K, 2013, ARCH PEDIATRIE, V20, P446, DOI 10.1016/j.arcped.2012.04.019; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Margulies S. S., 2010, PEDIAT TRAUMATIC BRA; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Minns RA, 2012, PEDIATRICS, V130, pE1227, DOI 10.1542/peds.2011-3274; Morad Y, 2010, CLIN EXP OPHTHALMOL, V38, P514, DOI 10.1111/j.1442-9071.2010.02291.x; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Pierce MC, 2008, ANNU REV BIOMED ENG, V10, P85, DOI 10.1146/annurev.bioeng.9.060906.151907; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Sandoz B, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P293; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Serbanescu I, 2008, EYE, V22, P715, DOI 10.1038/eye.2008.6; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Smith SL, 1998, J NEUROTRAUM, V15, P707, DOI 10.1089/neu.1998.15.707; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang HX, 2016, J NEUROPATH EXP NEUR, V75, P183, DOI 10.1093/jnen/nlv019; Wang YY, 2016, MOL NEUROBIOL, V53, P3448, DOI 10.1007/s12035-015-9263-6; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; Yamagata K, 2004, NEUROBIOL DIS, V17, P491, DOI 10.1016/j.nbd.2004.08.001; Yu AN, 2012, CHILD ABUSE NEGLECT, V36, P333, DOI 10.1016/j.chiabu.2011.11.009; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	98	11	11	3	11	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	JAN	2018	11	1							dmm030387	10.1242/dmm.030387			10	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	FU4EA	WOS:000423805100005	29208736	Green Published, gold			2022-02-06	
J	Williams, TS; Roberts, SD; Coppens, AM; Crosbie, J; Dlamini, N; Westmacott, R				Williams, Tricia S.; Roberts, Samantha D.; Coppens, Andrea M.; Crosbie, Jennifer; Dlamini, Nomazulu; Westmacott, Robyn			Secondary attention-deficit/hyperactivity disorder following perinatal and childhood stroke: impact on cognitive and academic outcomes	CHILD NEUROPSYCHOLOGY			English	Article						Pediatric stroke; developmental ADHD; secondary ADHD; cognitive outcomes; academic outcomes	DEFICIT-HYPERACTIVITY DISORDER; ARTERIAL ISCHEMIC-STROKE; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; QUALITY-OF-LIFE; WORKING-MEMORY; INTELLIGENCE SCALE; EXECUTIVE FUNCTION; CHILDREN; ADHD	This cross-sectional retrospective clinical research study examines a large group of children followed within a pediatric stroke program and a developmental attention-deficit/hyperactivity disorder (ADHD) clinic at the Hospital for Sick Children, between May 2004 and June 2016. All children with a history of stroke who participated in a neuropsychological assessment between the ages of 4 and 18years were considered for inclusion. From a sample of 275 participants with a history of stroke, 36 children (13.1%) received a diagnosis of secondary ADHD. Children with secondary ADHD were younger at the time of stroke and more likely to be identified as having a presumed perinatal stroke and persistent seizures than children without secondary ADHD diagnoses. There were no differences in pattern of lesion, size, or laterality between children who developed secondary ADHD and those who did not. Children with secondary ADHD had the lowest scores across all cognitive and academic measures compared to children with stroke-only and developmental ADHD. Findings highlight the added risk of receiving a diagnosis of secondary ADHD following pediatric stroke. Implications for future research and directed intervention are discussed.	[Williams, Tricia S.; Roberts, Samantha D.; Crosbie, Jennifer; Dlamini, Nomazulu; Westmacott, Robyn] Hosp Sick Children, Div Neurol, Dept Psychol & Psychiat, Toronto, ON, Canada; [Coppens, Andrea M.] Nationwide Childrens Hosp, Dept Pediat Psychol & Neuropsychol, Columbus, OH USA		Williams, TS (corresponding author), Hosp Sick Children, Dept Psychol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	tricia.williams@sickkids.ca			Medical Psychiatry Alliance; Centre for Addiction and Mental Health; Hospital for Sick ChildrenUniversity of Toronto; Ontario Ministry of health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; University of TorontoUniversity of Toronto; Trillium Health PartnersUniversity of Toronto	This work is supported by the Medical Psychiatry Alliance, a collaborative health partnership of the University of Toronto, the Centre for Addiction and Mental Health, the Hospital for Sick Children, Trillium Health Partners, the Ontario Ministry of health and Long-Term Care and an anonymous donor.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson V, 2006, J INT NEUROPSYCH SOC, V12, P519, DOI 10.1017/S135561770606067X; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Bates EA, 2004, BRAIN LANG, V88, P248, DOI 10.1016/S0093-934X(03)00102-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Brosseau L, 2006, TOP STROKE REHABIL, V13, P1, DOI 10.1310/3TKX-7XEC-2DTG-XQKH; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Burns Thomas G, 2010, Appl Neuropsychol, V17, P234, DOI 10.1080/09084282.2010.499803; Cardenas JF, 2011, CHILD NERV SYST, V27, P1375, DOI 10.1007/s00381-010-1366-9; Carmichael JA, 2015, APPL NEUROPSYCH-CHIL, V4, P97, DOI 10.1080/21622965.2015.1005481; Chilosi AM, 2005, DEV MED CHILD NEUROL, V47, P725, DOI 10.1017/S0012162205001532; Chilosi AM, 2001, J CHILD NEUROL, V16, P309, DOI 10.1177/088307380101600502; De La Fuente A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00192; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Desu M, 1990, SAMPLE SIZE METHODOL; Dimitropoulos A, 2013, NEUROLOGY, V81, P241, DOI 10.1212/WNL.0b013e31829bfdcf; Dunn DW, 2009, DEV MED CHILD NEUROL, V51, P364, DOI 10.1111/j.1469-8749.2008.03172.x; Eve M, 2016, APPL NEUROPSYCH-CHIL, V5, P273, DOI 10.1080/21622965.2015.1055563; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fleiss J.L., 1986, RELIABILITY MEASUREM; Fuentes A, 2016, CHILD NEUROPSYCHOL, V22, P1, DOI 10.1080/09297049.2014.969694; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Ghotra SK, 2015, DEV MED CHILD NEUROL, V57, P1027, DOI 10.1111/dmcn.12870; Gomes A, 2014, DEV NEUROPSYCHOL, V39, P9, DOI 10.1080/87565641.2013.827197; Graham AR, 2016, APPL NEUROPSYCH-CHIL, V5, P173, DOI 10.1080/21622965.2016.1167505; Gray SA, 2012, J CHILD PSYCHOL PSYC, V53, P1277, DOI 10.1111/j.1469-7610.2012.02592.x; Hale JB, 2011, J LEARN DISABIL-US, V44, P196, DOI 10.1177/0022219410391191; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hobson WL, 2011, PEDIATRICS, V128, P1, DOI 10.1542/peds.2011-0662; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P255, DOI 10.1080/09297049.2010.535654; Kirk R. E., 1982, EXPT DESIGN PROCEDUR, DOI [10.1002/0471264385.wei0201, DOI 10.1002/0471264385.WEI0201]; Kirton A, 2008, ANN NEUROL, V63, P436, DOI 10.1002/ana.21334; Kirton A, 2007, NEUROREHABILITATION, V22, P371; Koziol LF, 2015, APPL NEUROPSYCH-CHIL, V4, P123, DOI 10.1080/21622965.2015.1005482; Law N, 2015, EPILEPSIA, V56, P1605, DOI 10.1111/epi.13126; Liotti M, 2007, PSYCHOPHYSIOLOGY, V44, P936, DOI 10.1111/j.1469-8986.2007.00568.x; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Mawjee K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137173; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2003, J INT NEUROPSYCH SOC, V9, P815, DOI 10.1017/S1355617703960012; Max JE, 2002, J AM ACAD CHILD PSY, V41, P555, DOI 10.1097/00004583-200205000-00013; Mayes SD, 2007, SCHOOL PSYCHOL QUART, V22, P234, DOI 10.1037/1045-3830.22.2.234; McAuley T, 2014, J CHILD PSYCHOL PSYC, V55, P292, DOI 10.1111/jcpp.12160; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Murias K, 2014, DEV NEUROPSYCHOL, V39, P131, DOI 10.1080/87565641.2013.870178; National Institute of Mental Health, ATT DEF HYP DIS ADHD; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; O'Keeffe F, 2014, CHILD NEUROPSYCHOL, V20, P557, DOI 10.1080/09297049.2013.832740; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Pliszka SR, 2006, AM J PSYCHIAT, V163, P1052, DOI 10.1176/appi.ajp.163.6.1052; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rothbart M. K., 2001, HDB DEV COGNITIVE NE; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Ryan JJ, 2009, PSYCHOL REP, V104, P874, DOI 10.2466/PR0.104.3.874-878; Schachar RJ, 2004, J ABNORM CHILD PSYCH, V32, P285, DOI 10.1023/B:JACP.0000026142.11217.f2; Shillingford AJ, 2008, PEDIATRICS, V121, pE759, DOI 10.1542/peds.2007-1066; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Smith DR, 2001, HDB PSYCHOEDUCATIONA, P169, DOI DOI 10.1016/B978-012058570-0/50008-2; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Torres AR, 2008, EPILEPSY BEHAV, V12, P217, DOI 10.1016/j.yebeh.2007.08.001; Wechsler D., 2012, WECHSLER PRESCHOOL P; Wechsler D., 2002, WPPSI 3 ADM SCORING; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Westmacott R, 2009, STROKE, V40, P2012, DOI 10.1161/STROKEAHA.108.533976; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	86	11	11	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	6					763	783		10.1080/09297049.2017.1333091			21	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GH3JW	WOS:000433299700003	28554265				2022-02-06	
J	Shah-Basak, PP; Urbain, C; Wong, S; da Costa, L; Pang, EW; Dunkley, BT; Taylor, MJ				Shah-Basak, Priyanka P.; Urbain, Charline; Wong, Simeon; da Costa, Leodante; Pang, Elizabeth W.; Dunkley, Benjamin T.; Taylor, Margot J.			Concussion Alters the Functional Brain Processes of Visual Attention and Working Memory	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; cognitive function; electrophysiology; traumatic brain injury	NEURAL SOURCES; INJURY; DEFICITS; PARIETAL; MAGNETOENCEPHALOGRAPHY; CONNECTIVITY; DYSFUNCTION; ACTIVATION; FMRI; ABNORMALITIES	Millions of North Americans sustain a concussion or a mild traumatic brain injury annually, and are at risk of cognitive, emotional, and physical sequelae. Although functional MRI (fMRI) studies have provided an initial framework for examining functional deficits induced by concussion, particularly working memory and attention, the temporal dynamics underlying these deficits are not well understood. We used magnetoencephalography (MEG), a modality with millisecond temporal resolution, in conjunction with a 1-back visual working memory (VWM) paradigm using scenes from everyday life to characterize spatiotemporal functional differences at specific VWM stages, in adults had had or had not had a recent concussion. MEG source-level differences between groups were determined by whole-brain analyses during encoding and recognition phases. Despite comparable behavioral performance, abnormal hypo- and hyperactivation patterns were found in brain areas involving frontoparietal, ventral occipitotemporal, temporal, and subcortical areas in concussed patients. These patterns and their timing varied as a function of VWM stagewise processing, linked to early attentional control, visuoperceptual scene processing, and VWM maintenance and retrieval processes. Parietal hypoactivation, starting at 60ms during encoding, was correlated with symptom severity, possibly linked to impaired top-down attentional processing. Hyperactivation in the scene-selective occipitotemporal areas, the medial temporal complex, specifically the right hippocampus and orbitofrontal areas during encoding and/or recognition, lead us to posit inefficient but compensatory visuoperceptual, relational, and retrieval processing. Although injuries sustained after the concussion were considered mild, these data suggest that they can have prolonged effects on early attentional and VWM processes.	[Shah-Basak, Priyanka P.; Urbain, Charline; Wong, Simeon; Dunkley, Benjamin T.; Taylor, Margot J.] Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON, Canada; [Shah-Basak, Priyanka P.] Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada; [Urbain, Charline] ULB Bruxelles, Erasme Hosp, Lab Cartog Fonct Cerveau, Brussels, Belgium; [da Costa, Leodante] Univ Toronto, Sunnybrook Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Dunkley, Benjamin T.; Taylor, Margot J.] Univ Toronto, Sunnybrook Hosp, Dept Med Imaging, Toronto, ON, Canada; [Taylor, Margot J.] Univ Toronto, Sunnybrook Hosp, Dept Psychol, Toronto, ON, Canada; [Pang, Elizabeth W.; Dunkley, Benjamin T.] SickKids Res Inst, Program Neurosci & Mental Hlth, Toronto, ON, Canada		Shah-Basak, PP (corresponding author), Hosp Sick Children, Diagnost Imaging, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada.	priyanka.shah@sickkids.ca	Wong, Simeon/V-8051-2019	Wong, Simeon/0000-0001-9070-0665; Dunkley, Ben/0000-0001-6173-1171	Defence Research and Development Canada (DRDC); Canadian Forces Health Services [W7719-135182/001/TOR]; Ontasian Imaging Lab	We thank Amanda Robertson and Allison Bethune who recruited the patients and conducted the testing. We are also grateful to Anne Keller and Marc Lalancette for their valuable advice on MEG processing and analyses during the early stages of this study. This work was supported by Defence Research and Development Canada (DRDC), the Canadian Forces Health Services awarded to authors M.J.T. and E.W.P. (contract #W7719-135182/001/TOR), and the Ontasian Imaging Lab which supported P.P.S. (Dr. Manohar Shroff, Director Ontasian Imaging Lab) at The Hospital for Sick Children.	Agam Y, 2007, NEUROIMAGE, V36, P933, DOI 10.1016/j.neuroimage.2007.04.014; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Barth JT, 2001, J ATHL TRAINING, V36, P253; Becke A, 2015, NEUROIMAGE, V110, P78, DOI 10.1016/j.neuroimage.2015.01.059; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Berti S., 2013, NEUROSCI J, V2013; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BottariC, 2015, NEUROPSYCHOL REHABIL, P1, DOI [DOI 10.1080/09602011.2015.1110528., 10.1080/09602011.2015.1110528]; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Centers for Disease Control and Prevention, 2010, PERC DISTR TBI REL H; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Conners C., 2001, CONNERS RATING SCALE; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hancock P, 2009, INT J PSYCHIAT CLIN, V13, P188, DOI 10.1080/13651500802684500; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Hung J, 2005, J NEUROSCI, V25, P9602, DOI 10.1523/JNEUROSCI.0879-05.2005; Hung YW, 2013, CORTEX, V49, P961, DOI 10.1016/j.cortex.2012.05.014; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Kovacevic N, 2007, NEUROIMAGE, V35, P1103, DOI 10.1016/j.neuroimage.2007.01.016; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lee ACH, 2010, J COGNITIVE NEUROSCI, V22, P2823, DOI 10.1162/jocn.2009.21396; Levine Z, 2010, CAN FAM PHYSICIAN, V56, P346; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Martin VC, 2011, P NATL ACAD SCI USA, V108, P13858, DOI 10.1073/pnas.1105816108; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Park DC, 2003, J COGNITIVE NEUROSCI, V15, P1122, DOI 10.1162/089892903322598094; Perry G, 2014, EUR J NEUROSCI, V39, P1517, DOI 10.1111/ejn.12520; Pihlajamaki M, 2003, HIPPOCAMPUS, V13, P67, DOI 10.1002/hipo.10049; Plomp G, 2015, SCI REP-UK, V5, DOI 10.1038/srep18733; Poghosyan V, 2005, EUR J NEUROSCI, V22, P225, DOI 10.1111/j.1460-9568.2005.04181.x; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rahm B, 2014, NEUROIMAGE, V90, P413, DOI 10.1016/j.neuroimage.2013.12.017; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCAT, 2001, BRIT J SPORT MED, V43, P85; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Sewards TV, 2011, NEUROPSYCHOLOGIA, V49, P277, DOI 10.1016/j.neuropsychologia.2010.11.018; Shomstein S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00038; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Terry DP, 2015, ARCH CLIN NEUROPSYCH, V30, P341, DOI 10.1093/arclin/acv020; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; van de Nieuwenhuijzen ME, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00042; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wechsler D., 2011, WECHSLER ABBREVIATED; Zeidman P, 2015, CEREB CORTEX, V25, P3836, DOI 10.1093/cercor/bhu266	83	11	11	2	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					267	277		10.1089/neu.2017.5117		DEC 2017	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000418128100001	29020848				2022-02-06	
J	Kay, MC; Register-Mihalik, JK; Ford, CB; Williams, RM; Valovich McLeod, TC				Kay, Melissa C.; Register-Mihalik, Johna K.; Ford, Cassie B.; Williams, Richelle M.; Valovich McLeod, Tamara C.			Parents' and Child's Concussion History as Predictors of Parental Attitudes and Knowledge of Concussion Recognition and Response	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; knowledge; attitudes; symptom clusters; education	SYMPTOM SCALE; HELP-SEEKING; HEALTH; CONSCIOUSNESS; DISCREPANCIES; METAANALYSIS; FOOTBALL; PLAYERS; LEVEL	Background: Parents' knowledge of and attitudes toward concussions are often vital factors that affect care for injured adolescent athletes. It is important to understand the role that parents' personal experiences with concussions play with regard to current concussion knowledge and attitudes so that clinicians may tailor their educational approaches. Purpose/Hypothesis: The purpose of this study was to determine an association between parents' personal experiences and their child's experiences with concussions as well as parental concussion knowledge and attitudes. We hypothesized that parents who have personally experienced symptoms or have a child who has experienced symptoms would have better knowledge and more favorable attitudes toward concussions. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Parents of youth sport athletes (N = 234 [82 male, 144 female, 8 unreported]; mean age, 44.0 +/- 6.3 years) completed a prevalidated survey for concussion knowledge (maximum score possible, 29) and attitudes (maximum score possible, 49). Higher scores indicated better knowledge and more favorable attitudes toward concussive injuries. Parents reported the frequency of concussion diagnoses and/or experiences of concussion-related symptoms and whether their child had suffered a diagnosed concussion or experienced concussion symptoms (yes/no). Spearman rank correlation and multivariable regression were used to examine the association between experience of symptom clusters (self or child) and concussion knowledge and attitudes. Results: Knowledge was moderate (mean, 23.3 +/- 2.5 of 29), while attitudes prioritized disclosure (mean, 46.3 +/- 3.7 of 49). Parents' experience of the sleep-arousal symptom cluster was positively associated with concussion attitudes (r = 0.22, P = .002; beta = -3.301, P = .011). Parents with children who experienced sleep-arousal and vestibular-somatic symptom clusters were weakly associated with parental concussion knowledge (sleep-arousal: r = 0.15, P = .041; vestibular-somatic: r = 0.17, P = .020; beta = 0.540, P = .012). Conclusion: Our findings suggest that parents' personal experiences with concussion-related symptoms have little effect on parental knowledge and attitudes as a whole. However, clinicians should consider particular symptom clusters that may provide insight into targets for future concussion education. According to these findings, parents of youth sport participants would benefit from increased concussion education focusing on the types of symptoms as well as the consequences of suffering a concussion.	[Kay, Melissa C.; Register-Mihalik, Johna K.; Ford, Cassie B.] Univ N Carolina, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA; [Williams, Richelle M.; Valovich McLeod, Tamara C.] AT Still Univ, Mesa, AZ 85202 USA		Register-Mihalik, JK (corresponding author), Univ N Carolina, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	johnakay@email.unc.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Williams, Richelle/0000-0003-4728-7443	National Operating Committee on Standards for Athletic Equipment	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was funded in part by a grant from the National Operating Committee on Standards for Athletic Equipment.	Al Khatib HK, 2017, EUR J CLIN NUTR, V71, P614, DOI 10.1038/ejcn.2016.201; Brudvik C, 2017, EMERG MED J, V34, P138, DOI 10.1136/emermed-2016-205825; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Elbin RJ, 2016, APPL NEUROPSYCH-CHIL, V5, P294, DOI 10.1080/21622965.2015.1077334; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Itani O, 2017, SLEEP MED, V32, P246, DOI 10.1016/j.sleep.2016.08.006; Janicke DM, 2001, MED CARE, V39, P990, DOI 10.1097/00005650-200109000-00009; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Neill SJ, 2016, J CHILD HEALTH CARE, V20, P77, DOI 10.1177/1367493514551309; Petsios K, 2011, J ASTHMA, V48, P286, DOI 10.3109/02770903.2011.555031; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stevens PK, 2010, J TRAUMA NURS, V17, P183; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Varni JW, 2015, QUAL LIFE RES, V24, P1921, DOI 10.1007/s11136-014-0914-2; Wahlin T, 2012, AUST NZ J PSYCHIAT, V46, P553, DOI 10.1177/0004867412441929	28	11	11	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC 8	2017	5	12							2325967117742370	10.1177/2325967117742370			11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FP5UY	WOS:000417689600001	29242807	gold, Green Published			2022-02-06	
J	Trofa, DP; Park, CN; Noticewala, MS; Lynch, TS; Ahmad, CS; Popkin, CA				Trofa, David P.; Park, Caroline N.; Noticewala, Manish S.; Lynch, T. Sean; Ahmad, Christopher S.; Popkin, Charles A.			The Impact of Body Checking on Youth Ice Hockey Injuries	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						hockey; injuries; concussion; body checking	EMERGENCY-DEPARTMENTS; RISK-FACTORS; PLAYERS; POLICY	Background: Body checking is a common cause of youth ice hockey injuries. Consequently, USA Hockey raised the minimum age at which body checking is permitted from the Pee Wee level (11-12 years old) to the Bantam level (13-14 years old) in 2011. Purpose/Hypothesis: The purpose of this investigation was to determine the impact of body checking on the distribution of injuries reported in youth ice hockey players. We hypothesized that the elimination of body checking at the Pee Wee level would lower the frequency of serious injuries, particularly concussions. Study Design: Descriptive epidemiology study. Methods: Injury data from the National Electronic Injury Surveillance System (NEISS), a United States Consumer Product Safety Commission database, were analyzed for Pee Wee and Bantam players between January 1, 2008 and December 31, 2010 and again between January 1, 2013 and December 31, 2015. Data on the location of injury, diagnosis, and mechanism of injury were collected. The location of injury was categorized into 4 groups: head and neck, upper extremity, lower extremity, and core. Diagnoses investigated included concussions, fractures, lacerations, strains or sprains, internal organ injuries, and other. The mechanism of injury was broken down into 2 categories: checking and other. Results: Between the 2008-2010 and 2013-2015 seasons, overall injuries decreased by 16.6% among Pee Wee players, with injuries caused by body checking decreasing by 38.2% (P = .012). There was a significant change in the distribution of diagnoses in the Pee Wee age group during this time frame (P = .007): strains or sprains, internal organ injuries, and fractures decreased in frequency, while the number of concussions increased by 50.0%. In the Bantam age group, recorded injuries decreased by 6.8%, and there was no change in the distribution of the location of injury, diagnosis, or mechanism of injury (P > .05). Conclusion: There was an observed reduction in the total number, mechanism, and type of injuries when body checking was eliminated from the Pee Wee level. There was, however, an unexpected increase in the number of concussions.	[Trofa, David P.; Park, Caroline N.; Noticewala, Manish S.; Lynch, T. Sean; Ahmad, Christopher S.; Popkin, Charles A.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Dept Orthoped Surg, 622 West 168th St,PH 11-1130, New York, NY USA; Columbia Univ, Med Ctr, Ctr Shoulder Elbow & Sports Med, New York, NY USA		Popkin, CA (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, Dept Orthoped Surg, 622 West 168th St,PH 11-1130, New York, NY USA.	cp2654@cumc.columbia.edu		Ahmad, Christopher S./0000-0001-9235-5228	Arthrex; Stryker; Major League Baseball	One or more of the authors has declared the following potential conflict of interest or source of funding: C.S.A. is a consultant for Arthrex and Acumed and receives research support from Arthrex, Stryker, and Major League Baseball.	Black AM, BRIT J SPORT MED, DOI [10. 1136/bjsports-2016-097392, DOI 10.1136/BJSP0RTS-2016-097392]; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Hockey Canada, HOCK CAN ANN REP 201; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Le Menestrel Suzanne, 2007, New Dir Youth Dev, P13; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Molsa J, 2000, AM J SPORT MED, V28, P322; Popkin CA, 2016, OPEN ACCESS J SPORTS, V7, P167, DOI 10.2147/OAJSM.S118595; USA Hockey, 2015, US HOCK ANN REP 2015; USA Hockey, MEMB STAT; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Westermann RW, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116654651; Yard EE, 2006, J ATHL TRAINING, V41, P441; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	19	11	11	1	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC 5	2017	5	12							2325967117741647	10.1177/2325967117741647			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FO9NA	WOS:000417213000001	29238733	Green Published, gold			2022-02-06	
J	Currie, DW; Kraeutler, MJ; Schrock, JB; McCarty, EC; Comstock, RD				Currie, Dustin W.; Kraeutler, Matthew J.; Schrock, John B.; McCarty, Eric C.; Comstock, R. Dawn			Time Trends in Concussion Symptom Presentation and Assessment Methods in High School Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article; Proceedings Paper	43rd Annual Meeting of the American-Orthopaedic-Society-for-Sports-Medicine (AOSSM)	JUL, 2017	Toronto, CANADA	Amer Orthopaed Soc Sports Med		concussion; imaging; symptomatology	SPORT-RELATED CONCUSSION; UNITED-STATES; BASE-LINE; EPIDEMIOLOGY; MEDICINE	Background: Concussion rates have increased significantly over the past decade. This may reflect an increase in the knowledge and diagnosis of the symptoms of a concussion rather than a true increase in the incidence. Assessing trends in the way that concussions are presenting to and being identified by clinicians over the same period may provide additional insight into the apparent rise in concussions. Purpose: To evaluate patterns of change in concussion symptom presentation, diagnostic/evaluation methods, and symptom resolution time reported for United States high school athletes from the 2007-2008 through 2014-2015 academic years. Study Design: Descriptive epidemiology study. Methods: This study is a retrospective analysis of a web-based longitudinal high school sports injury surveillance database (High School RIO [Reporting Information Online]) collected from 2007-2008 through 2014-2015. For each concussion, athletic trainers entered data regarding symptom presentation, resolution time, and diagnostic/evaluation tools utilized. Academic year was the primary exposure in assessing each aim. Time trends were then assessed using linear regression or the Cochran-Armitage test for trends, depending on the outcome distribution. Results: The proportion of concussed athletes presenting with amnesia, loss of consciousness (LOC), and tinnitus significantly decreased from 2007-2008 through 2014-2015, while the proportion presenting with drowsiness, irritability, light sensitivity, and noise sensitivity increased significantly. The use of diagnostic radiography, magnetic resonance imaging, and computed tomography all significantly decreased during the study period, while the use of computerized neurocognitive tests increased. Concussion symptoms took significantly longer to resolve in more recent years. Conclusion: The decrease in what have traditionally been considered severe symptoms (LOC, amnesia) and the increase in what were traditionally considered minor symptoms (drowsiness, irritability, light sensitivity) suggest that clinicians may have a lower threshold in diagnosing sports-related concussions in more recent years. The significant reduction in the use of all forms of diagnostic head imaging demonstrates an increased recognition of concussions as functional disturbances rather than structural abnormalities. Improved concussion education and the nationwide passage of state-level concussion legislation have likely led to the increased recognition of lingering symptoms in athletes with a diagnosed concussion, thereby leading to a longer symptom resolution time.	[Currie, Dustin W.; Kraeutler, Matthew J.; Schrock, John B.; McCarty, Eric C.; Comstock, R. Dawn] Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA; [Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Anschutz Med Campus,13123 East 16th Ave, Aurora, CO 80045 USA; [Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado, Colorado Sch Publ Hlth, Program Injury Prevent Educ & Res, Anschutz Med Campus, Aurora, CO 80045 USA; [Kraeutler, Matthew J.] Seton Hall Hackensack Meridian Sch Med, Dept Orthoped Surg, S Orange, NJ USA; [Schrock, John B.; McCarty, Eric C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA		Currie, DW (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Anschutz Med Campus,13123 East 16th Ave, Aurora, CO 80045 USA.	dustin.currie@ucdenver.edu	mccarty, eric/AAA-1821-2019	mccarty, eric/0000-0002-8948-5862			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, HEADS UP SCH SPORTS; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Honce JM, 2016, PHYS MED REH CLIN N, V27, P411, DOI 10.1016/j.pmr.2016.01.002; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lombardi NJ, 2016, ORTHOPEDICS, V39, pE944, DOI 10.3928/01477447-20160623-10; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan W., 2011, KIDS SPORTS CONCUSSI; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; NFL Players Association, 2016, NFL HEAD NECK SPIN C; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	25	11	11	1	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2017	45	14					3368	3373		10.1177/0363546517725068			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Orthopedics; Sport Sciences	FO4OH	WOS:000416823600022	28930492				2022-02-06	
J	Frisoli, FA; Shinseki, M; Nwabuobi, L; Zeng, XPL; Adrados, M; Kanter, C; Frangos, SG; Huang, PP				Frisoli, Fabio A.; Shinseki, Matthew; Nwabuobi, Lynda; Zeng, Xiaopei L.; Adrados, Murillo; Kanter, Carolyn; Frangos, Spiros G.; Huang, Paul P.			Early Venous Thromboembolism Chemoprophylaxis After Traumatic Intracranial Hemorrhage	NEUROSURGERY			English	Article						Chemoprophylaxis; Traumatic brain injury; Venous thromboembolism	MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; BRAIN-INJURY; ENOXAPARIN PROPHYLAXIS; SAFETY; EFFICACY; ANTICOAGULATION; PROTOCOL	BACKGROUND: Venous thromboembolism is a common complication of traumatic brain injury with an estimated incidence of 25% when chemoprophylaxis is delayed. The timing of initiating prophylaxis is controversial given the concern for hemorrhage expansion. OBJECTIVE: To determine the safety of initiating venous thromboembolic event (VTE) chemoprophylaxis within 24 h of presentation. METHODS: We performed a retrospective analysis of patients with traumatic intracranial hemorrhage presenting to a level I trauma center. Patients receiving early chemoprophylaxis (<24 h) were compared to the matched cohort of patients who received heparin in a delayed fashion (> 48 h). The primary outcome of the study was radiographic expansion of the intracranial hemorrhage. Secondary outcomes included VTE, use of intracranial pressure (ICP) monitoring, delayed decompressive surgery, and all-cause mortality. RESULTS: Of 282 patients, 94 (33%) received chemoprophylaxis within 24 h of admission. The cohorts were evenly matched across all variables. The primary outcome occurred in 18% of patients in the early cohort compared to 17% in the delayed cohort (P=.83). Fifteen patients (16%) in the early cohort underwent an invasive procedure in a delayed fashion; this compares to 35 patients (19%) in the delayed cohort (P=. 38). Five patients (1.7%) in our study had a VTE during their hospitalization; 2 of these patients received early chemoprophylaxis (P=.75). The rate of mortality from all causes was similar in both groups. CONCLUSION: Early (<24 h) initiation of VTE chemoprophylaxis in patients with traumatic intracranial hemorrhage appears to be safe. Further prospective studies are needed to validate this finding.	[Frisoli, Fabio A.; Shinseki, Matthew] NYU, Sch Med, Dept Neurosurg, 462 1st Ave,Suite 7S, New York, NY 10016 USA; [Nwabuobi, Lynda; Adrados, Murillo; Kanter, Carolyn] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Zeng, Xiaopei L.; Frangos, Spiros G.] Bellevue Hosp Ctr, Div Trauma & Acute Care Surg, Dept Surg, New York, NY 10016 USA; [Huang, Paul P.] Bellevue Hosp Ctr, Dept Neurosurg, New York, NY 10016 USA		Frisoli, FA (corresponding author), NYU, Sch Med, Dept Neurosurg, 462 1st Ave,Suite 7S, New York, NY 10016 USA.	Fabio.frisoli@nyumc.org		Frangos, Spiros/0000-0003-2860-8969; Nwabuobi, Lynda/0000-0002-5289-6174; Huang, Paul/0000-0003-0563-921X			Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Foreman PM, 2014, CLIN NEUROL NEUROSUR, V123, P109, DOI 10.1016/j.clineuro.2014.05.017; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Nickele CM, 2013, NEUROCRIT CARE, V18, P184, DOI 10.1007/s12028-012-9786-x; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027	21	11	11	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2017	81	6					1016	1020		10.1093/neuros/nyx164			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR0NO	WOS:000418758900026	28973510				2022-02-06	
J	Hides, JA; Smith, MMF; Mendis, MD; Treleaven, J; Rotstein, AH; Sexton, CT; Choy, NL; Mccrory, P				Hides, Julie A.; Smith, Melinda M. Franettovich; Mendis, M. Dilani; Treleaven, Julia; Rotstein, Andrew H.; Sexton, Christopher T.; Choy, Nancy Low; Mccrory, Paul			Self-reported Concussion History and Sensorimotor Tests Predict Head/Neck Injuries	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						RISK FACTORS; PROPRIOCEPTION; TRUNK MUSCLES; FOOTBALL; RUGBY	LUMBAR MULTIFIDUS MUSCLE; TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; MOTOR CONTROL; NECK-PAIN; HEAD; EPIDEMIOLOGY; POSITION; SIZE; RELIABILITY	Purpose Sport-related concussion (SRC) is a risk for players involved in high-impact, collision sports. A history of SRC is a risk factor for future concussions, but the mechanisms underlying this are unknown. Despite evidence that most visible signs and symptoms associated with sports concussion resolve within 7-10 d, it has been proposed that subclinical loss of neuromuscular control and impaired motor functioning may persist and be associated with further injury. Alternatively, indicators of poor sensorimotor performance could be independent risk factors. This study investigated if a history of SRC and/or preseason sensorimotor performance predicted season head/neck injuries. Methods A total of 190 male rugby league, rugby union, and Australian Football League players participated. Preseason assessments included self-report of SRC within the previous 12 months and a suite of measures of sensorimotor function (balance, vestibular function, cervical proprioception, and trunk muscle function). Head/neck injury data were collected in the playing season. Results Forty-seven players (25%) reported a history of SRC. A history of concussion was related to changes in size and contraction of trunk muscles. Twenty-two (11.6%) players sustained a head/neck injury during the playing season, of which, 14 (63.6%) players had a history of SRC. Predictors of in-season head/neck injuries included history of SRC, trunk muscle function, and cervical proprioceptive errors. Five risk factors were identified, and players with three or more of these had 14 times greater risk of sustaining a season neck/head injury (sensitivity of 75% and specificity of 82.5%) than did players with two or fewer risk factors. Conclusions The modifiable risk factors identified could be used to screen football players in the preseason and guide the development of exercise programs aimed at injury reduction.	[Hides, Julie A.; Smith, Melinda M. Franettovich; Mendis, M. Dilani; Sexton, Christopher T.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Musculoskeletal Res, Woolloongabba, Qld, Australia; [Hides, Julie A.] Mater Hlth Serv, Mater Back Stabil Res Clin, South Brisbane, Qld, Australia; [Mendis, M. Dilani] Mater Hlth Serv, Physiotherapy Dept, South Brisbane, Qld, Australia; [Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld, Australia; [Rotstein, Andrew H.] Victoria House Med Imaging, Prahran, Vic, Australia; [Choy, Nancy Low] Australian Catholic Univ, Sch Physiotherapy, Banyo, Qld, Australia; [Mccrory, Paul] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia		Hides, JA (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Nathan Campus,170 Kessels Rd, Nathan, Qld 4111, Australia.	j.hides@griffith.edu.au	Treleaven, Julia/N-1379-2019; Sexton, Christopher/AAC-7533-2020; Sexton, Christopher/O-7843-2018; McCrory, Paul/Q-8688-2019; Hides, Julie Anne/F-2141-2011; Smith, Melinda Franettovich/AAK-1568-2021	Treleaven, Julia/0000-0002-6258-3972; Sexton, Christopher/0000-0002-0826-804X; Sexton, Christopher/0000-0002-0826-804X; Hides, Julie Anne/0000-0002-1830-8121; Smith, Melinda Franettovich/0000-0002-0098-7656; McCrory, Paul/0000-0003-4850-0568	Collaborative Research Network/Australian Catholic University Research Fund; Collaborative Research Network; Australian Catholic University [2013000523]	The authors would like to acknowledge the players and medical staff from the participating football teams; funding by the Collaborative Research Network/Australian Catholic University Research Fund; Professor Jennifer Peat for statistical advice; Sue Lewandowski, Ann Rahmann, Andrew Cooper, Felix Leung, and Margot Sexton for assistance with data collection; Nigel Smith for assistance with this manuscript and Hugh Seward for advice. This work was supported by a Collaborative Research Network and Australian Catholic University research fund (Grant No. 2013000523).	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Barker PJ, 2006, SPINE, V31, P397, DOI 10.1097/01.brs.0000195869.18844.56; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BOGDUK N, 1992, SPINE, V17, P897, DOI 10.1097/00007632-199208000-00007; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Hain TC, 2011, NEUROREHABILITATION, V29, P127, DOI 10.3233/NRE-2011-0687; Hides JA, 2017, SCAND J MED SCI SPOR, V27, P440, DOI 10.1111/sms.12643; HIDES JA, 1995, SPINE, V20, P54, DOI 10.1097/00007632-199501000-00010; Hides JA, 2007, J ORTHOP SPORT PHYS, V37, P480, DOI 10.2519/jospt.2007.2416; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hides JA, 2016, MANUAL THER, V24, P46, DOI 10.1016/j.math.2016.05.001; Hides JA, 2012, MED SCI SPORT EXER, V44, P1141, DOI 10.1249/MSS.0b013e318244a321; Hodges P, 2003, SPINE, V28, P2594, DOI 10.1097/01.BRS.0000096676.14323.25; Hootman JM, 2007, J ATHL TRAINING, V42, P311; L'Heureux-Lebeau B, 2014, OTOL NEUROTOL, V35, P1858, DOI 10.1097/MAO.0000000000000506; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lemeshow S, 2000, APPL LOGISTIC REGRES; Mannion AF, 2008, J ANAT, V213, P173, DOI 10.1111/j.1469-7580.2008.00946.x; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Merritt E, 2016, J SPORT REHABIL, P1; Mossman B, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0081-7; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Pinsault N, 2010, PHYS THER SPORT, V11, P66, DOI 10.1016/j.ptsp.2010.02.004; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Roijezon U, 2015, MANUAL THER, V20, P368, DOI 10.1016/j.math.2015.01.008; Roren A, 2009, MANUAL THER, V14, P270, DOI 10.1016/j.math.2008.03.002; Rugby NZ, NZ ACC SPORTSM; Seminati E, 2017, SPORT BIOMECH, V16, P58, DOI 10.1080/14763141.2016.1194453; Swait G, 2007, SPINE, V32, pE692, DOI 10.1097/BRS.0b013e31815a5a1b; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Viel S, 2009, MOTOR CONTROL, V13, P25, DOI 10.1123/mcj.13.1.25; Wallwork TL, 2007, J ORTHOP SPORT PHYS, V37, P608, DOI 10.2519/jospt.2007.2418; Williams RM, 2017, J SPECTROSC, V2017, P1, DOI 10.1155/2017/6867507; Yang CJ, 2016, CLIN OTOLARYNGOL, V41, P532, DOI 10.1111/coa.12558	40	11	11	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	DEC	2017	49	12					2385	2393		10.1249/MSS.0000000000001372			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FN7PF	WOS:000416209900003	28708701	Bronze			2022-02-06	
J	Keller, MS; Park, HJ; Cunningham, ME; Fouladian, JE; Chen, M; Spiegel, BMR				Keller, Michelle Sophie; Park, Hannah J.; Cunningham, Maria Elena; Fouladian, Joshua Eleazar; Chen, Michelle; Spiegel, Brennan Mason Ross			Public Perceptions Regarding Use of Virtual Reality in Health Care: A Social Media Content Analysis Using Facebook	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						social media; virtual reality; qualitative research	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; GENDER-DIFFERENCES; PAIN-CONTROL; FEASIBILITY; DISTRACTION; REHABILITATION; DIRECTIONS; MANAGEMENT; BEHAVIOR	Background: Virtual reality (VR) technology provides an immersive environment that enables users to have modified experiences of reality. VR is increasingly used to manage patients with pain, disability, obesity, neurologic dysfunction, anxiety, and depression. However, public opinion regarding the use of VR in health care has not been explored. Understanding public opinion of VR is critical to ensuring effective implementation of this emerging technology. Objective: This study aimed to examine public opinion about health care VR using social listening, a method that allows for the exploration of unfiltered views of topics discussed on social media and online forums. Methods: In March 2016, NBC News produced a video depicting the use of VR for patient care. The video was repackaged by NowThis, a social media news website, and distributed on Facebook by Upworthy, a news aggregator, yielding 4.3 million views and 2401 comments. We used Microsoft Excel Power Query and ATLAS. ti software (version 7.5, Scientific Software Development) to analyze the comments using content analysis and categorized the comments around first-, second-, and third-order concepts. We determined self-identified gender from the user's Facebook page and performed sentiment analysis of the language to analyze whether the perception of VR differed by gender using a Pearson's chi-square test. Results: Out of the 1614 analyzable comments, 1021 (63.26%) were attributed to female Facebook users, 572 (35.44%) to male users, and 21 (1.30%) to users of unknown gender. There were 1197 comments coded as expressing a positive perception about VR (74.16%), 251 coded as expressing a negative perception and/or concern (15.56%), and 560 coded as neutral (34.70%). Informants identified 20 use cases for VR in health care, including the use of VR for pain and stress reduction; bed-bound individuals; women during labor; and patients undergoing chemotherapy, dialysis, radiation, or imaging procedures. Negative comments expressed concerns about radiation, infection risk, motion sickness, and the ubiquity of and overall dependence on technology. There was a statistically significant association between the language valence of the Facebook post and the gender of the Facebook user; men were more likely to post negative perceptions about the use of VR for health care, whereas women were more likely to post positive perceptions (P<.001). Conclusions: Most informants expressed positive perceptions about the use of VR in a wide range of health care settings. However, many expressed concerns that should be acknowledged and addressed as health care VR continues to evolve. Our results provide guidance in determining where further research on the use of VR in patient care is needed, and offer a formal opportunity for public opinion to shape the VR research agenda.	[Keller, Michelle Sophie; Park, Hannah J.; Cunningham, Maria Elena; Fouladian, Joshua Eleazar; Chen, Michelle; Spiegel, Brennan Mason Ross] Cedars Sinai Med Ctr, Cedars Sinai Ctr Outcomes Res & Educ, 116 N Robertson Blvd,Suite 800, Los Angeles, CA 90048 USA; [Keller, Michelle Sophie] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Informat, Los Angeles, CA 90048 USA; [Keller, Michelle Sophie] Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA USA		Keller, MS (corresponding author), Cedars Sinai Med Ctr, Cedars Sinai Ctr Outcomes Res & Educ, 116 N Robertson Blvd,Suite 800, Los Angeles, CA 90048 USA.	michelle.keller@cshs.org		Chen, Michelle/0000-0003-2538-6790; Keller, Michelle S./0000-0002-8157-7586; Fouladian, Joshua/0000-0003-3871-1054			Akhtar K, 2015, PATIENT SAF SURG, V9, DOI 10.1186/s13037-015-0058-5; AlQarni ZA, 2016, J INFECT PUBLIC HEAL, V9, P708, DOI 10.1016/j.jiph.2016.08.015; Anderson M., 2015, MEN CATCH WOMEN OVER; Benetoli A, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5702; Bordnick PS, 2012, RES SOCIAL WORK PRAC, V22, P293, DOI 10.1177/1049731511426880; Bowler GM, 2010, QUAL REP, V15, P1270; Carrougher GJ, 2009, J BURN CARE RES, V30, P785, DOI 10.1097/BCR.0b013e3181b485d3; Constantine J, 2017, FACEBOOK NOW HAS 2 B; Dascal Julieta, 2017, Innov Clin Neurosci, V14, P14; Farrow S., 2004, TECHNOL DISABIL, V16, P69, DOI [10.3233/TAD-2004-16201, DOI 10.3233/TAD-2004-16201]; Funk C, 2016, US PUBLIC WARY BIOME; Furman E, 2009, J AM DENT ASSOC, V140, P1508, DOI 10.14219/jada.archive.2009.0102; Garrett B, 2014, CLIN J PAIN, V30, P1089, DOI 10.1097/AJP.0000000000000064; Gershon J, 2004, J AM ACAD CHILD PSY, V43, P1243, DOI 10.1097/01.chi.0000135621.23145.05; Gold JI, 2006, CYBERPSYCHOL BEHAV, V9, P207, DOI 10.1089/cpb.2006.9.207; Goncalves R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048469; Hoffman HG, 2000, PAIN, V85, P305, DOI 10.1016/S0304-3959(99)00275-4; Hoffman HG, 2001, CYBERPSYCHOL BEHAV, V4, P527, DOI 10.1089/109493101750527088; KATZ JN, 1995, J HAND SURG-AM, V20A, P549, DOI 10.1016/S0363-5023(05)80265-5; Kent EE, 2016, J CANCER EDUC, V31, P453, DOI 10.1007/s13187-015-0824-1; Kramer TL, 2010, PSYCHIAT SERV, V61, P1153, DOI 10.1176/ps.2010.61.11.1153; Lenhart A., 2010, SOCIAL MEDIA MOBILE; Lewis GN, 2011, DISABIL REHABIL-ASSI, V6, P453, DOI 10.3109/17483107.2011.574310; Lewis GN, 2012, DISABIL REHABIL, V34, P1880, DOI 10.3109/09638288.2012.670036; Li A, 2011, PAIN MANAG, V1, P147, DOI 10.2217/PMT.10.15; Liao YY, 2015, NEUROREHAB NEURAL RE, V29, P658, DOI 10.1177/1545968314562111; Lucas K, 2004, COMMUN RES, V31, P499, DOI 10.1177/0093650204267930; Malloy KM, 2010, CLIN PSYCHOL REV, V30, P1011, DOI 10.1016/j.cpr.2010.07.001; Matar E, 2013, PARKINSONISM RELAT D, V19, P937, DOI 10.1016/j.parkreldis.2013.06.002; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; McEvenue G, 2016, AESTHET SURG J, V36, P1079, DOI 10.1093/asj/sjw069; Morris LD, 2010, BURNS, V36, P659, DOI 10.1016/j.burns.2009.09.005; Mosadeghi S, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.5801; Nysveen H, 2005, J CONSUM MARK, V22, P247, DOI 10.1108/07363760510611671; Park G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155885; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Riquelme HE, 2010, INT J BANK MARK, V28, P328, DOI 10.1108/02652321011064872; Robles-Garcia V, 2016, PARKINSONISM RELAT D, V26, P17, DOI 10.1016/j.parkreldis.2016.02.022; Schuster-Amft C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-350; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Shih P.C., 2015, USE ADOPTION CHALLEN; Sullivan C, 2000, J DENT CHILD, V67, P193; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P190, DOI 10.1002/asi.21180; Thomas JS, 2016, J PAIN, V17, P1302, DOI 10.1016/j.jpain.2016.08.011; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Venkatesh V, 2000, MIS QUART, V24, P115, DOI 10.2307/3250981; Venkatesh V, 2000, ORGAN BEHAV HUM DEC, V83, P33, DOI 10.1006/obhd.2000.2896; WEBER RP, 1990, SAGE U PAPER SERIES; Weiser EB, 2000, CYBERPSYCHOL BEHAV, V3, P167, DOI 10.1089/109493100316012	49	11	12	2	30	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	DEC	2017	19	12							e419	10.2196/jmir.7467			11	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	FR5YR	WOS:000419143000004	29258975	gold, Green Published			2022-02-06	
J	Lee, HI; Lee, SW; Kim, NG; Park, KJ; Choi, BT; Shin, YI; Shin, HK				Lee, Hae In; Lee, Sae-Won; Kim, Nam Gyun; Park, Kyoung-Jun; Choi, Byung Tae; Shin, Yong-Il; Shin, Hwa Kyoung			Low-level light emitting diode therapy promotes long-term functional recovery after experimental stroke in mice	JOURNAL OF BIOPHOTONICS			English	Article						Functional recovery; focal cerebral ischemia; post-stroke; BDNF; neurotrophic factor; photostimulation	TRAUMATIC BRAIN-INJURY; ISCHEMIC BRAIN; LASER THERAPY; PLASTICITY; RATS; REPERFUSION; ASTROCYTES; BARRIER; IMPACT; BDNF	We aimed to investigate the effects of low-level light emitting diode therapy (LED-T) on the long-term functional outcomes after cerebral ischemia, and the optimal timing of LED-T initiation for achieving suitable functional recovery. Focal cerebral ischemia was induced in mice via photothrombosis. These mice were assigned to a sham-operated (control), ischemic (vehicle), or LEDT group [initiation immediately (acute), 4 days (subacute) or 10 days (delayed) after ischemia, followed by once-daily treatment for 7 days]. Behavioral outcomes were assessed 21 and 28 days post-ischemia, and histopathological analysis was performed 28 days post-ischemia. The acute and subacute LED-T groups showed a significant improvement in motor function up to 28 days post-ischemia, although no brain atrophy recovery was noted. We observed proliferating cells (BrdU(+)) in the ischemic brain, and significant increases in BrdU(+) /GFAP(+), BrdU(+)/DCX+, BrdU(+)/NeuN(+), and CD31(+) cells in the subacute LED-T group. However, the BrdU(+)/Iba-1(+) cell count was reduced in the subacute LED-T group. Furthermore, the brain-derived neuro-trophic factor (BDNF) was significantly upregulated in the subacute LED-T group. We concluded that LED-T administered during the subacute stage had a positive impact on the long-term functional outcome, probably via neuron and astrocyte proliferation, blood vessel reconstruction, and increased BDNF expression. Picture: The rotarod test for motor coordination showed that acute and subacute LED-T improves long-term functional recovery after cerebral ischemia. [GRAPHICS] .	[Lee, Hae In; Shin, Yong-Il] Pusan Natl Univ, Dept Rehabil Med, Sch Med, Yangsan 50612, Gyeongnam, South Korea; [Lee, Hae In; Shin, Yong-Il] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan 50612, Gyeongnam, South Korea; [Lee, Sae-Won; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Dept Korean Med Sci, Sch Korean Med, Yangsan 50612, Gyeongnam, South Korea; [Lee, Sae-Won; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Grad Training Program Korean Med Hlth Aging, Yangsan 50612, Gyeongnam, South Korea; [Lee, Sae-Won; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Korean Med Sci Res Ctr Hlth Aging, Yangsan 50612, Gyeongnam, South Korea; [Kim, Nam Gyun; Park, Kyoung-Jun] Med Res Ctr Color Seven, Seoul 06719, South Korea		Shin, YI (corresponding author), Pusan Natl Univ, Dept Rehabil Med, Sch Med, Yangsan 50612, Gyeongnam, South Korea.; Shin, YI (corresponding author), Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan 50612, Gyeongnam, South Korea.; Shin, HK (corresponding author), Pusan Natl Univ, Dept Korean Med Sci, Sch Korean Med, Yangsan 50612, Gyeongnam, South Korea.; Shin, HK (corresponding author), Pusan Natl Univ, Grad Training Program Korean Med Hlth Aging, Yangsan 50612, Gyeongnam, South Korea.; Shin, HK (corresponding author), Pusan Natl Univ, Korean Med Sci Res Ctr Hlth Aging, Yangsan 50612, Gyeongnam, South Korea.	rmshin01@gmail.com; julie@pusan.ac.kr	Choi, Byung Tae/P-4659-2019	Choi, Byung Tae/0000-0002-5965-4346	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2013R1 A2 A2 A03067417, NRF-2016R1 A2B2007862]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2013R1 A2 A2 A03067417 and NRF-2016R1 A2B2007862).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Chen JL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00382; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Lapi D, 2015, J VASC RES, V52, P22, DOI 10.1159/000381096; Lee H. I., 2017, J BIOPHOTONICS; Lee HI, 2016, RESTOR NEUROL NEUROS, V34, P201, DOI 10.3233/RNN-150559; Li MS, 2017, P NATL ACAD SCI USA, V114, pE396, DOI 10.1073/pnas.1612930114; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Ramos-Cejudo J, 2015, STROKE, V46, P221, DOI 10.1161/STROKEAHA.114.006692; Spitler R, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.051022; Tao J, 2016, BRAIN RES BULL, V120, P14, DOI 10.1016/j.brainresbull.2015.10.011; Wagner VP, 2016, LASER MED SCI, V31, P665, DOI 10.1007/s10103-016-1904-0; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Zhang J, 2014, STROKE, V45, P788, DOI 10.1161/STROKEAHA.113.003425	31	11	11	0	7	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	DEC	2017	10	12			SI		1761	1771		10.1002/jbio.201700038			11	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	FO9CW	WOS:000417186600021	28464523				2022-02-06	
J	Puchert, M; Pelkner, F; Stein, G; Angelov, DN; Boltze, J; Wagner, DC; Odoardi, F; Flugel, A; Streit, WJ; Engele, J				Puchert, Malte; Pelkner, Fabian; Stein, Gregor; Angelov, Doychin N.; Boltze, Johannes; Wagner, Daniel-Christoph; Odoardi, Francesca; Fluegel, Alexander; Streit, Wolfgang J.; Engele, Juergen			Astrocytic expression of the CXCL12 receptor, CXCR7/ACKR3 is a hallmark of the diseased, but not developing CNS	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						CXCR7; CXCR4; Astrocytes; Glia limitans; MCAO; EAE; Spinal cord compression; Cerebral infarction; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMPROVES FUNCTIONAL RECOVERY; NEURAL PROGENITOR CELLS; EPIDERMAL-GROWTH-FACTOR; SPINAL-CORD-INJURY; HUMAN GLIOMA-CELLS; CHEMOKINE RECEPTOR; REACTIVE ASTROGLIOSIS	Based on our previous demonstration of CXCR7 as the major mediator of CXCL12 signaling in cultured astrocytes, we have now compared astrocytic expression of the CXCL12 receptors, CXCR7 and CXCR4, during CNS development and disease. In addition, we asked whether disease-associated conditions/factors affect expression of CXCL12 receptors in astrocytes. In the late embryonic rat brain, CXCR7(+)/GFAP(+) cells were restricted to the ventricular/subventricular zone while CXCR4 was widely absent from GFAP-positive cells. In the early postnatal and adult brain, CXCR7 and CXCR4 were almost exclusively expressed by GFAP-immunoreactive astrocytes forming the superficial glia limitans. Contrasting the situation in the intact CNS, a striking increase in astrocytic CXCR7 expression was detectable in the cortex of rats with experimental brain infarcts, in the spinal cord of rats with experimental autoimmune encephalomyelitis (EAE) and after mechanical compression, as well as in the in infarcted human cerebral cortex and in the hippocampus of Alzheimer's disease patients. None of these pathologies was associated with substantial increases in astrocytic CXCR4 expression. Screening of various disease-associated factors/conditions further revealed that CXCR7 expression of cultured cortical astrocytes increases with IFN gamma as well as under hypoxic conditions whereas CXCR7 expression is attenuated following treatment with IFN beta. Again, none of the treatments affected CXCR4 expression in cultured astrocytes. Together, these findings support the hypothesis of a crucial role of astrocytic CXCR7 in the progression of various CNS pathologies.	[Puchert, Malte; Pelkner, Fabian; Engele, Juergen] Univ Leipzig, Inst Anat, Liebigstr 13, D-04103 Leipzig, Germany; [Stein, Gregor] Cologne Univ Hosp, Uniklin Koln, Dept Orthoped & Trauma Surg, D-50924 Cologne, Germany; [Angelov, Doychin N.] Univ Cologne, Inst Anat 1, Joseph Stelzrnann Str 9, D-50924 Cologne, Germany; [Boltze, Johannes] Univ Lubeck, Fraunhofer Res Inst Marine Biotechnol, Dept Med Cell Technol, Monkhofer Weg 239a, D-23562 Lubeck, Germany; [Boltze, Johannes] Univ Lubeck, Inst Med & Marine Biotechnol, Monkhofer Weg 239a, D-23562 Lubeck, Germany; [Wagner, Daniel-Christoph] Inst Pathol, Bldg 706,Langenbeckstr 1, D-55131 Mainz, Germany; [Odoardi, Francesca; Fluegel, Alexander] Univ Med Ctr Gottingen, Dept Neuroimmunol, Inst Multiple Sclerosis Res, Waldweg 33, D-37073 Gottingen, Germany; [Streit, Wolfgang J.] Univ Florida, Dept Neurosci, 1149 Newell Dr, Gainesville, FL 32610 USA		Engele, J (corresponding author), Univ Leipzig, Inst Anat, Liebigstr 13, D-04103 Leipzig, Germany.	engj@medizin.uni-leipzig.de		Boltze, Johannes/0000-0003-3956-4164; Angelov, Doychin/0000-0003-1436-9119			Abe P, 2014, DEVELOPMENT, V141, P1857, DOI 10.1242/dev.104224; Alvarez JI, 2007, J NEUROIMMUNOL, V187, P102, DOI 10.1016/j.jneuroim.2007.05.005; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Arthur V.A.a.B., 2013, GLIAL PHYSL PATHOPHY, P105, DOI [10.1002/9781118402061.ch4, DOI 10.1002/9781118402061.CH4]; Banisadr G, 2016, J NEUROIMMUNE PHARM, V11, P26, DOI 10.1007/s11481-015-9616-y; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berahovich RD, 2010, IMMUNOL LETT, V133, P112, DOI 10.1016/j.imlet.2010.06.010; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; Bonavia R, 2003, TOXICOL LETT, V139, P181, DOI 10.1016/S0378-4274(02)00432-0; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chen Q, 2015, STEM CELLS, V33, P2574, DOI 10.1002/stem.2022; Chen TJ, 2016, CLIN CHIM ACTA, V454, P6, DOI 10.1016/j.cca.2015.12.033; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Doll DN, 2014, AGING DIS, V5, P294, DOI 10.14336/AD.2014.0500294; Ehtesham M, 2013, J NEURO-ONCOL, V113, P153, DOI 10.1007/s11060-013-1108-4; Esencay M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-347; Filous A.R., 2016, PROG NEUROBIOL; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/S1074-7613(01)00143-1; Gu XL, 2016, MOL NEUROBIOL, V53, P2807, DOI 10.1007/s12035-015-9151-0; Guo MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090518; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; ISSAZADEH S, 1995, J NEUROIMMUNOL, V61, P205, DOI 10.1016/0165-5728(95)00100-G; Kieseier BC, 2011, CNS DRUGS, V25, P491, DOI 10.2165/11591110-000000000-00000; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Laske C, 2008, J ALZHEIMERS DIS, V15, P451; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Li MZ, 2011, GLIA, V59, P108, DOI 10.1002/glia.21080; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lin RH, 2015, BRAIN RES, V1628, P327, DOI 10.1016/j.brainres.2015.04.029; Lipfert J, 2013, NEUROPATH APPL NEURO, V39, P667, DOI 10.1111/nan.12015; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059750; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Liu SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055290; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103938; Liu Z., 2015, PROG NEUROBIOL; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Ma JH, 2015, NEUROL RES, V37, P50, DOI 10.1179/1743132814Y.0000000399; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MacVicar BA, 2015, COLD SPRING HARB PER, V7; Manthou M, 2017, RESTOR NEUROL NEUROS, V35, P185, DOI 10.3233/RNN-160691; McColl SR, 2004, LAB INVEST, V84, P1418, DOI 10.1038/labinvest.3700155; Molofsky AV, 2015, GLIA, V63, P1320, DOI 10.1002/glia.22836; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Ottum PA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00539; Ozsoy O, 2012, RESTOR NEUROL NEUROS, V30, P363, DOI 10.3233/RNN-2012-110203; Parachikova A, 2007, NEUROBIOL DIS, V28, P143, DOI 10.1016/j.nbd.2007.07.001; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; PIKE CJ, 1994, NEUROSCIENCE, V63, P517, DOI 10.1016/0306-4522(94)90547-9; Platel JC, 2016, NEUROSCIENCE, V323, P20, DOI 10.1016/j.neuroscience.2015.10.053; Puchert M, 2014, CELL TISSUE RES, V355, P239, DOI 10.1007/s00441-013-1747-y; Pugazhenthi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069585; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Romain B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-58; Ruscher K, 2013, J CEREBR BLOOD F MET, V33, P1225, DOI 10.1038/jcbfm.2013.71; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Semler J, 2011, J NEUROTRAUM, V28, P1247, DOI 10.1089/neu.2010.1737; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sin WX, 2012, IMMUNOL RES, V53, P25, DOI 10.1007/s12026-012-8293-7; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Tanabe S, 1997, J IMMUNOL, V159, P905; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tissir F, 2004, DEV BRAIN RES, V149, P63, DOI 10.1016/j.devbrainres.2004.01.002; Tiveron MC, 2010, J NEUROIMMUNOL, V224, P72, DOI 10.1016/j.jneuroim.2010.05.011; Walters MJ, 2014, BRIT J CANCER, V110, P1179, DOI 10.1038/bjc.2013.830; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wirth F, 2013, J NEUROTRAUM, V30, P453, DOI 10.1089/neu.2012.2653; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	86	11	12	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	DEC	2017	85						105	118		10.1016/j.mcn.2017.09.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO8FE	WOS:000417117400010	28889992				2022-02-06	
J	Thotakura, AK; Marabathina, NR; Danaboyina, AR; Mareddy, RR				Thotakura, A. K.; Marabathina, N. R.; Danaboyina, A. R.; Mareddy, R. R.			Role of serial ultrasonic optic nerve sheath diameter monitoring in head injury	NEUROCHIRURGIE			English	Article						Optic nerve sheath diameter; Intracranial pressure; ICP monitoring; ICP in head injury; Non-invasive ICP monitoring; Orbital ultrasound, ONSD measurement	RAISED INTRACRANIAL-PRESSURE; TRANSORBITAL SONOGRAPHIC EVALUATION; TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; ULTRASONOGRAPHY; CHILDREN; HYPERTENSION; CLASSIFICATION; TOMOGRAPHY	Objectives. - To compare optic nerve sheath diameter (ONSD) measurements in head injury patients with a group of normal subjects and investigate the significance of serial ONSD monitoring in head injury patients. Methods. - All patients with a head injury admitted to our hospital with a program of conservative management at the time of admission were included in this prospective study. On admission, the patient was assessed using the Glasgow Coma Scale (GCS), orbital ultrasound for optic nerve sheath diameter (ONSD), and CT brain scan. CT scan findings were tabulated with Marshall and Rotterdam scores. The patient was serially assessed with ONSD every 24 to 48 hours. If the patient deteriorated, repeat CT and ONSD measurements were performed. A control group consisting of normal subjects was used for comparison. Results. - The case group consisted of 40 patients and the control group included 16 volunteers. The mean age of the case group was 38.9 years and the control group 36.3 years. The mean ONSD was 4.8 mm in the case group as compared to 3.4 mm in control group (P < 0.0001). In the case group, we found a significant correlation between GCS and ONSD, GCS and radiological scores and ONSD and radiological scores. The change in serial recordings of ONSD measurements were termed ascending, descending or static. All the patients with descending trend in serial ONSD values had good outcome and required no surgical intervention. Conclusions. - Ultrasound ONSD measurement is a useful investigation tool in a setting where invasive ICP monitoring is not available. Serial recording of ONSD is valuable and provides valuable information regarding decision making. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Thotakura, A. K.; Marabathina, N. R.; Mareddy, R. R.] NRI Med Coll & Gen Hosp, Dept Neurosurg, Guntur 522503, Andhra Pradesh, India; [Danaboyina, A. R.] NRI Med Coll & Gen Hosp, Dept Radiol, Guntur 522503, Andhra Pradesh, India		Thotakura, AK (corresponding author), NRI Med Coll & Gen Hosp, Dept Neurosurg, Guntur 522503, Andhra Pradesh, India.	doctoramitkumar@gmail.com	Thotakura, Amit/AAV-5756-2021				Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Anas I, 2014, MALAYS J MED SCI, V21, P24; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Beare NAV, 2008, TROP MED INT HEALTH, V13, P1400, DOI 10.1111/j.1365-3156.2008.02153.x; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Chan PYN, 2008, HONG KONG J EMERG ME, V15, P197, DOI 10.1177/102490790801500402; Chen H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0361-x; Garcia JPS, 2004, OPHTHALMOLOGY, V111, P1238, DOI 10.1016/j.ophtha.2003.10.026; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Goel RS, 2008, INJURY, V39, P519, DOI 10.1016/j.injury.2007.09.029; HANSEN HC, 1994, NEURO-OPHTHALMOLOGY, V14, P345, DOI 10.3109/01658109409024061; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Le A, 2009, ANN EMERG MED, V53, P785, DOI 10.1016/j.annemergmed.2008.11.025; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Major R, 2011, EMERG MED J, V28, P679, DOI 10.1136/emj.2009.087353; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Mehrpour M, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/146059; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Qayyum H, 2013, EUR J EMERG MED, V20, P91, DOI 10.1097/MEJ.0b013e32835105c8; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; ROTHMAN MI, 2003, TXB RADIOLOGY IMAGIN, P1573; Sahoo SS, 2013, INDIAN J NEUROTRAUM, V10, P9, DOI 10.1016/j.ijnt.2013.05.010; Shirodkar CG, 2014, INDIAN J CRIT CARE M, V18, P728, DOI 10.4103/0972-5229.144015; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040	31	11	13	0	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	DEC	2017	63	6					444	448		10.1016/j.neuchi.2017.06.001			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FZ7UW	WOS:000427810600002	29122307				2022-02-06	
J	Widerstrom-Noga, E; Loeser, JD; Jensen, TS; Finnerup, NB				Widerstrom-Noga, Eva; Loeser, John D.; Jensen, Troels Staehelin; Finnerup, Nanna Brix			AAPT Diagnostic Criteria for Central Neuropathic Pain	JOURNAL OF PAIN			English	Article						Neuropathic pain; central pain; spinal cord injury; stroke; multiple sclerosis	SPINAL-CORD-INJURY; CENTRAL POSTSTROKE PAIN; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; ABDOMINAL-PAIN; GRADING SYSTEM; CLASSIFICATION; PREVALENCE; STROKE; INDIVIDUALS	Central neuropathic pain, which is pain caused by a lesion or disease of the central somatosensory nervous system, is a serious consequence of spinal cord injury, stroke, multiple sclerosis, and other conditions affecting the central nervous system. A collaborative effort between the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks public-private partnership and the American Pain Society, the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks-American Pain Society Pain Taxonomy (AAPT) initiative, invited a working group to develop diagnostic criteria for central neuropathic pain. The criteria for central neuropathic pain that were developed expand upon existing criteria for neuropathic pain and the International Classification of Diseases 11th Revision draft criteria to ensure consistency. This article focuses on central neuropathic pain associated with spinal cord injury, stroke, and multiple sclerosis, but the AAPT framework can be extended to central pain due to other causes such as traumatic brain injury. The classification of central neuropathic pain is organized according to the AAPT multidimensional framework, specifically: 1) core diagnostic criteria, 2) common features, 3) common medical and psychiatric comorbidities, 4) neurobiological, psychosocial, and functional consequences, and 5) putative neurobiological and psychosocial mechanisms, risk factors, and protective factors. Perspective: The AAPT chronic central neuropathic pain taxonomy provides a classification for central pain associated with spinal cord injury, stroke, and multiple sclerosis. The diagnostic criteria are organized according to the AAPT multidimensional framework, specifically: 1) core diagnostic criteria, 2) common features, 3) common medical and psychiatric comorbidities, 4) neurobiological, psychosocial, and functional consequences, and 5) putative neurobiological and psychosocial mechanisms, risk factors, and protective factors. (C) 2017 by the American Pain Society	[Widerstrom-Noga, Eva] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Widerstrom-Noga, Eva] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Loeser, John D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Jensen, Troels Staehelin; Finnerup, Nanna Brix] Aarhus Univ, Danish Pain Res Ctr, Dept Clin Med, Aarhus, Denmark; [Jensen, Troels Staehelin; Finnerup, Nanna Brix] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark		Widerstrom-Noga, E (corresponding author), Miami Project Cure Paralysis R 48, 1095 NW 14th Terrace, Miami, FL 33136 USA.	EWiderstrom-Noga@med.miami.edu	Finnerup, Nanna Brix/ABA-8219-2020; Jensen, Troels Staehelin/A-3418-2009	Finnerup, Nanna Brix/0000-0001-5541-0240; Jensen, Troels Staehelin/0000-0002-3487-6380; Widerstrom-Noga, Eva/0000-0003-0208-3658	FDAUnited States Department of Health & Human Services	Support was provided by the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks public-private partnership with the FDA, which has received contracts, grants, and other revenue for its activities from the FDA, multiple pharmaceutical and device companies, and other sources. A complete list of current Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks sponsors is available at: http://www.acttion.org/partners.	ANDERSEN G, 1995, PAIN, V61, P187, DOI 10.1016/0304-3959(94)00144-4; Andresen SR, 2016, SPINAL CORD, V54, P973, DOI 10.1038/sc.2016.46; de Oliveira RAA, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-89; Bennett GJ, 2012, J PAIN, V13, P921, DOI 10.1016/j.jpain.2012.05.008; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Boneschi FM, 2008, MULT SCLER, V14, P514, DOI 10.1177/1352458507085551; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bowsher D, 1996, J NEUROL NEUROSUR PS, V61, P62, DOI 10.1136/jnnp.61.1.62; Bruehl S, 2016, J PAIN, V17, pT118, DOI 10.1016/j.jpain.2015.10.014; Bryce TN, 2014, SPINAL CORD, V52, P407, DOI 10.1038/sc.2014.21; Bryce TN, 2012, SPINAL CORD, V50, P413, DOI 10.1038/sc.2011.156; Bryce TN, 2012, SPINAL CORD, V50, P404, DOI 10.1038/sc.2012.2; Burke D, 2017, EUR J PAIN, V21, P29, DOI 10.1002/ejp.905; Burns AS, 2015, ARCH PHYS MED REHAB, V96, P49, DOI 10.1016/j.apmr.2014.07.417; Cardenas DA, 2002, ARCH PHYS MED REHAB, V83, P1708, DOI 10.1053/apmr.2002.35651; Creutzfeldt CJ, 2012, J GEN INTERN MED, V27, P853, DOI 10.1007/s11606-011-1966-4; Cruccu G, 2016, NEUROLOGY, V87, P220, DOI 10.1212/WNL.0000000000002840; Cruz-Almeida Y, 2012, J NEUROTRAUM, V29, P2706, DOI 10.1089/neu.2012.2343; Day MA, 2016, CLIN J PAIN, V32, P155, DOI 10.1097/AJP.0000000000000240; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Douglas C, 2008, ARCH PHYS MED REHAB, V89, P1923, DOI 10.1016/j.apmr.2008.03.022; Dworkin RH, 2016, J PAIN, V17, pT1, DOI 10.1016/j.jpain.2016.02.010; Edwards RR, 2016, J PAIN, V17, pT70, DOI 10.1016/j.jpain.2016.01.001; Fillingim RB, 2016, J PAIN, V17, pT10, DOI 10.1016/j.jpain.2015.08.010; Fillingim RB, 2014, J PAIN, V15, P241, DOI 10.1016/j.jpain.2014.01.004; Finnerup NB, 2008, SPINAL CORD, V46, P198, DOI 10.1038/sj.sc.3102097; Finnerup NB, 2016, SPINAL CORD, V54, P816, DOI 10.1038/sc.2015.236; Finnerup NB, 2013, EUR J PAIN, V17, P953, DOI 10.1002/j.1532-2149.2012.00282.x; Finnerup NB, 2007, EXP NEUROL, V207, P139, DOI 10.1016/j.expneurol.2007.06.001; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Finnerup NB, 2014, J PAIN, V15, P40, DOI 10.1016/j.jpain.2013.09.008; Finnerup NB, 2012, CURR PAIN HEADACHE R, V16, P207, DOI 10.1007/s11916-012-0259-x; Freeman R, 2014, PAIN, V155, P367, DOI 10.1016/j.pain.2013.10.023; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Gustin SM, 2014, PAIN, V155, P1027, DOI 10.1016/j.pain.2014.02.008; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hallstrom H, 2011, PAIN, V152, P772, DOI 10.1016/j.pain.2010.11.019; Hansen AP, 2012, EUR J PAIN, V16, P1128, DOI 10.1002/j.1532-2149.2012.00123.x; Harno H, 2014, NEUROLOGY, V83, P1147, DOI 10.1212/WNL.0000000000000818; Hong JH, 2012, EUR NEUROL, V67, P12, DOI 10.1159/000333012; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Kishimoto Y, 2016, ENVIRON HEALTH PREV, V21, P295, DOI 10.1007/s12199-016-0529-z; Klit H, 2014, PAIN, V155, P2699, DOI 10.1016/j.pain.2014.09.037; Klit H, 2011, PAIN, V152, P818, DOI 10.1016/j.pain.2010.12.030; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Krause SJ, 2003, CLIN J PAIN, V19, P306, DOI 10.1097/00002508-200309000-00004; LEIJON G, 1989, PAIN, V36, P13, DOI 10.1016/0304-3959(89)90107-3; MacGowan DJL, 1997, NEUROLOGY, V49, P120, DOI 10.1212/WNL.49.1.120; Maixner W, 2016, J PAIN, V17, pT93, DOI 10.1016/j.jpain.2016.06.002; Mehta S, 2016, SPINAL CORD, V54, pS7, DOI 10.1038/sc.2016.89; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nielsen SD, 2017, SPINAL CORD, V55, P290, DOI 10.1038/sc.2016.124; Nurmikko TJ, 2010, CURR PAIN HEADACHE R, V14, P189, DOI 10.1007/s11916-010-0108-8; O'Connor AB, 2008, PAIN, V137, P96, DOI 10.1016/j.pain.2007.08.024; O'Donnell MJ, 2013, STROKE, V44, P1238, DOI 10.1161/STROKEAHA.111.671008; Osborne TL, 2007, PAIN, V127, P52, DOI 10.1016/j.pain.2006.07.017; Osterberg A, 2005, EUR J PAIN, V9, P531, DOI 10.1016/j.ejpain.2004.11.005; Osterberg A, 2005, THESIS; Pattany PM, 2002, AM J NEURORADIOL, V23, P901; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ronning OM, 2017, ACTA NEUROL SCAND, V135, P529, DOI 10.1111/ane.12631; Roosink M, 2012, NEUROREHABILITATION, V30, P153, DOI 10.3233/NRE-2012-0739; Rubinelli S, 2016, J REHABIL MED, V48, P235, DOI 10.2340/16501977-2060; Schestatsky P, 2007, NEUROLOGY, V69, P2162, DOI 10.1212/01.wnl.0000295669.12443.d3; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Siddall PJ, 1999, J NEUROL NEUROSUR PS, V66, P617, DOI 10.1136/jnnp.66.5.617; Svendsen KB, 2005, PAIN, V114, P473, DOI 10.1016/j.pain.2005.01.015; Svendsen KB, 2003, ARCH NEUROL-CHICAGO, V60, P1089, DOI 10.1001/archneur.60.8.1089; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Truini A, 2013, J NEUROL, V260, P351, DOI 10.1007/s00415-012-6579-2; Truini A, 2012, PAIN, V153, P2048, DOI 10.1016/j.pain.2012.05.024; Turk DC, 2016, J PAIN, V17, pT21, DOI 10.1016/j.jpain.2016.02.006; Turner AP, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0706-x; Vardeh D, 2016, J PAIN, V17, pT50, DOI 10.1016/j.jpain.2016.03.001; VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A; Wasner G, 2008, BRAIN, V131, P2387, DOI 10.1093/brain/awn169; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P482, DOI 10.1089/neu.2015.4040; Widerstrom-Noga E, 2015, PAIN, V156, P166, DOI 10.1016/j.pain.0000000000000019; Widerstrom-Noga E, 2013, PAIN, V154, P204, DOI 10.1016/j.pain.2012.07.022; Widerstrom-Noga EG, 2007, ARCH PHYS MED REHAB, V88, P1628, DOI 10.1016/j.apmr.2007.09.013; Widerstrom-Noga EG, 2004, J NEUROTRAUM, V21, P1384, DOI 10.1089/neu.2004.21.1384; Widerstrom-Noga EG, 2004, CLIN J PAIN, V20, P261, DOI 10.1097/00002508-200407000-00008; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P43, DOI 10.1682/JRRD.2008.05.0065; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; World Health Organization, SPIN CORD INJ; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007; Zeilig G, 2013, PAIN, V154, P263, DOI 10.1016/j.pain.2012.10.026; Zeilig G, 2012, BRAIN, V135, P418, DOI 10.1093/brain/awr270; Zhang T, 2016, BRAIN RES BULL, V124, P231, DOI 10.1016/j.brainresbull.2016.05.012; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007; Zwibel Howard L, 2011, Am J Manag Care, V17 Suppl 5 Improving, pS139	97	11	13	1	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	DEC	2017	18	12					1417	1426		10.1016/j.jpain.2017.06.003			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ2SP	WOS:000418208600001	28666966				2022-02-06	
J	Marin, C; Laxe, S; Langdon, C; Berenguer, J; Lehrer, E; Marino-Sanchez, F; Alobid, I; Bernabeu, M; Mullol, J				Marin, Concepcio; Laxe, Sara; Langdon, Cristobal; Berenguer, Joan; Lehrer, Eduardo; Marino-Sanchez, Franklin; Alobid, Isam; Bernabeu, Montserrat; Mullol, Joaquim			OLFACTORY FUNCTION IN AN EXCITOTOXIC MODEL FOR SECONDARY NEURONAL DEGENERATION: ROLE OF DOPAMINERGIC INTERNEURONS	NEUROSCIENCE			English	Article						excitotoxicity; traumatic brain injury; olfaction; secondary neuronal degeneration; dopamine; neurogenesis	TRAUMATIC BRAIN-INJURY; ADULT SUBVENTRICULAR ZONE; EXCITATORY AMINO-ACIDS; IDIOPATHIC PARKINSONS-DISEASE; GENE-RELATED PEPTIDE; SPINAL-CORD-INJURY; ERK5 MAP KINASE; BULB VOLUME; RETINAL DAMAGE; BORN NEURONS	Secondary neuronal degeneration (SND) occurring in Traumatic brain injury (TBI) consists in downstream destructive events affecting cells that were not or only marginally affected by the initial wound, further increasing the effects of the primary injury. Glutamate excitotoxicity is hypothesized to play an important role in SND. TBI is a common cause of olfactory dysfunction that may be spontaneous and partially recovered. The role of the glutamate excitotoxicity in the TBI-induced olfactory dysfunction is still unknown. We investigated the effects of excitotoxicity induced by bilateral N-Methyl-D-Aspartate (NMDA) OB administration in the olfactory function, OB volumes, and subventricular zone (SVZ) and OB neurogenesis in rats. NMDA OB administration induced a decrease in the number of correct choices in the olfactory discrimination tests one week after lesions (p < 0.01), and a spontaneous recovery of the olfactory deficit two weeks after lesions (p < 0.05). A lack of correlation between OB volumes and olfactory function was observed. An increase in SVZ neurogenesis Ki67+ cells, PSANCAM+ cells (p < 0.01) associated with an increase in OB glomerular dopaminergic immunostaining (p < 0.05) were related to olfactory function recovery. The present results show that changes in OB volumes cannot explain the recovery of the olfactory function and suggest a relevant role for dopaminergic OB interneurons in the pathophysiology of recovery of loss of smell in TBI. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Marin, Concepcio; Mullol, Joaquim] Inst Invest Biomed August Pi i Sunyer IDIBAPS, IRCE, INGENIO, Barcelona, Catalonia, Spain; [Laxe, Sara; Bernabeu, Montserrat] UAB, Guttmann Inst, Hosp Neurorehabil Adscript, Brain Injury Unit, Barcelona, Spain; [Langdon, Cristobal; Lehrer, Eduardo; Marino-Sanchez, Franklin; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Lehrer, Eduardo; Marino-Sanchez, Franklin; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Neuroradiol Dept, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Marino-Sanchez, Franklin; Alobid, Isam; Mullol, Joaquim] Ctr Biomed Invest Resp Dis CIBERES, Madrid, Spain; [Marino-Sanchez, Franklin] Ramon y Cajal Univ Hosp, ENT Dept, Rhinol Unit, Madrid, Spain		Marin, C (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, IRCE, INGENIO, Barcelona, Catalonia, Spain.	cmarin@clinic.cat	Lehrer, Eduardo/AAE-9945-2021; Marino-Sanchez, Franklin/L-9210-2018	Lehrer, Eduardo/0000-0002-4591-2607; Marino-Sanchez, Franklin/0000-0002-4328-0925	Fundacio La Marato TV3 [110610]	This work was supported by a research grant (110610) from Fundacio La Marato TV3.	Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Alonso M, 2012, NAT NEUROSCI, V15, P897, DOI 10.1038/nn.3108; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ardiles Y, 2007, EXP NEUROL, V207, P275, DOI 10.1016/j.expneurol.2007.06.022; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bastien-Dionne PO, 2010, J COMP NEUROL, V518, P1847, DOI 10.1002/cne.22307; Bonzano S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00189; Bonzano S, 2014, EUR J NEUROSCI, V40, P3450, DOI 10.1111/ejn.12724; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Breton-Provencher V, 2012, BEHAV BRAIN RES, V227, P480, DOI 10.1016/j.bbr.2011.08.001; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brodoehl S, 2012, MOVEMENT DISORD, V27, P1019, DOI 10.1002/mds.25087; Brushfield AM, 2008, BEHAV NEUROSCI, V122, P54, DOI 10.1037/0735-7044.122.1.54; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Butti E, 2012, BRAIN, V135, P3320, DOI 10.1093/brain/aws194; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Carvalho LA, 2013, J NEUROSCI RES, V91, P1572, DOI 10.1002/jnr.23285; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Choi JH, 2010, J COMP PATHOL, V142, P147, DOI 10.1016/j.jcpa.2009.10.013; Costanzo D, 2003, HDB OLFACTION GESTAT, P1038; Daiber P, 2013, EUR J NEUROSCI, V37, P572, DOI 10.1111/ejn.12066; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; DOTY RL, 1975, PHYSIOL BEHAV, V14, P855, DOI 10.1016/0031-9384(75)90081-5; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1989, PSYCHOPHARMACOLOGY, V98, P310, DOI 10.1007/BF00451680; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Escanilla O, 2009, BEHAV NEUROSCI, V123, P828, DOI 10.1037/a0015855; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FINGER TE, 1993, J COMP NEUROL, V334, P117, DOI 10.1002/cne.903340110; FINGER TE, 1992, NEUROSCI LETT, V143, P15, DOI 10.1016/0304-3940(92)90222-S; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frasnelli J, 2007, INT J PSYCHOPHYSIOL, V65, P177, DOI 10.1016/j.ijpsycho.2007.03.007; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Frasnelli J, 2010, NEUROSCI LETT, V468, P259, DOI 10.1016/j.neulet.2009.11.008; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Gengatharan A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00149; Genovese F, 2017, EUR J NEUROSCI, V45, P587, DOI 10.1111/ejn.13490; Ghatpande AS, 2009, J NEUROPHYSIOL, V101, P2052, DOI 10.1152/jn.90734.2008; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gotthard GH, 2010, NEUROBIOL LEARN MEM, V93, P127, DOI 10.1016/j.nlm.2009.09.002; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol H, 2001, ORL J OTO-RHINO-LARY, V63, P72, DOI 10.1159/000055713; Gudziol V, 2009, BRAIN, V132, P3096, DOI 10.1093/brain/awp243; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Gutierrez-Mecinas M, 2005, EUR J NEUROSCI, V22, P1357, DOI 10.1111/j.1460-9568.2005.04328.x; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hoglinger GU, 2015, ACTA NEUROPATHOL, V130, P333, DOI 10.1007/s00401-015-1451-y; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Huart C, 2013, MOLECULES, V18, P11586, DOI 10.3390/molecules180911586; Hummel T, 1996, CHEM SENSES, V21, P75, DOI 10.1093/chemse/21.1.75; Hummel T, 2013, NEUROSCIENCE, V237, P51, DOI [10.1016/J.neuroscience.2013.01.044, 10.1016/j.neuroscience.2013.01.044]; Hummel T, 2011, EXP BRAIN RES, V214, P285, DOI 10.1007/s00221-011-2832-7; Ito Y, 2008, CNS NEUROSCI THER, V14, P192, DOI 10.1111/j.1755-5949.2008.00050.x; Ito Y, 2008, BRAIN RES, V1212, P89, DOI 10.1016/j.brainres.2008.03.021; Ito Y, 2010, CNS NEUROSCI THER, V16, P103, DOI 10.1111/j.1755-5949.2009.00081.x; Jacquot L, 2004, CR BIOL, V327, P305, DOI 10.1016/j.crvi.2004.02.004; Kaneko N, 2017, J NEUROCHEM, V141, P835, DOI 10.1111/jnc.14002; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kiyokage E, 2017, J COMP NEUROL, V525, P1059, DOI 10.1002/cne.24147; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Kratskin I, 2000, NEUROREPORT, V11, P2195, DOI 10.1097/00001756-200007140-00026; Kruzich PJ, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-12; Kueh JLL, 2011, GLIA, V59, P1658, DOI 10.1002/glia.21213; Laska M, 1997, CHEM SENSES, V22, P447, DOI 10.1093/chemse/22.4.447; Lazarini F, 2014, J NEUROSCI, V34, P14430, DOI 10.1523/JNEUROSCI.5366-13.2014; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lee JH, 2016, BRAIN STRUCT FUNCT, V221, P3259, DOI 10.1007/s00429-015-1099-3; Lethbridge R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035024; Liu HA, 2011, EXP NEUROL, V228, P270, DOI 10.1016/j.expneurol.2011.01.021; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Malvaut S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1614329; Mandairon N, 2008, EUR J NEUROSCI, V27, P1210, DOI 10.1111/j.1460-9568.2008.06101.x; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Marin C, 2015, NEUROPHARMACOLOGY, V97, P365, DOI 10.1016/j.neuropharm.2015.06.004; Marin C, 2014, NEUROBIOL DIS, V64, P36, DOI 10.1016/j.nbd.2013.12.009; Mazal PP, 2016, EUR ARCH OTO-RHINO-L, V273, P1, DOI 10.1007/s00405-014-3325-7; McBride K, 2006, J NEUROSCI, V26, P9892, DOI 10.1523/JNEUROSCI.0504-06.2006; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Najac M, 2011, J NEUROSCI, V31, P8722, DOI 10.1523/JNEUROSCI.0527-11.2011; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Paschen L, 2015, EUR J NEUROL, V22, P1068, DOI 10.1111/ene.12709; Patel DA, 2012, INT J DEV NEUROSCI, V30, P1, DOI 10.1016/j.ijdevneu.2011.11.001; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Pavlis M, 2006, PHYSIOL BEHAV, V87, P109, DOI 10.1016/j.physbeh.2005.09.011; Pignatelli A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00007; Poplawsky AJ, 2014, NEUROIMAGE, V91, P237, DOI 10.1016/j.neuroimage.2013.12.067; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Radomski KL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-142; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rombaux P, 2006, LARYNGOSCOPE, V116, P436, DOI 10.1097/01.MLG.0000195291.36641.1E; Rombaux P, 2009, RHINOLOGY, V47, P3; Rombaux P, 2012, OTOLARYNG HEAD NECK, V147, P1136, DOI 10.1177/0194599812459704; Saar G, 2015, NEUROIMAGE, V118, P183, DOI 10.1016/j.neuroimage.2015.05.045; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Sawada M, 2011, J NEUROSCI, V31, P11587, DOI 10.1523/JNEUROSCI.0614-11.2011; Schaefer ML, 2002, J COMP NEUROL, V444, P221, DOI 10.1002/cne.10143; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sohrabji F, 2000, J NEUROBIOL, V45, P61, DOI 10.1002/1097-4695(20001105)45:2<61::AID-NEU1>3.0.CO;2-L; Soria G, 2011, EUR J NEUROSCI, V33, P1551, DOI 10.1111/j.1460-9568.2011.07639.x; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Sui Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031549; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; Tatti R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4791; Thomann PA, 2009, J ALZHEIMERS DIS, V17, P213, DOI 10.3233/JAD-2009-1036; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; Toida K, 2000, NEUROSCIENCE, V101, P11, DOI 10.1016/S0306-4522(00)00356-0; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Wang WB, 2015, J NEUROSCI, V35, P7833, DOI 10.1523/JNEUROSCI.3745-14.2015; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Wysocki CJ, 2003, PERCEPT PSYCHOPHYS, V65, P115, DOI 10.3758/BF03194788; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zak JD, 2015, J NEUROPHYSIOL, V113, P1907, DOI 10.1152/jn.00222.2014; Zhang H, 2001, CLIN CHEM, V47, P1458; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	149	11	11	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 19	2017	364						28	44		10.1016/j.neuroscience.2017.09.008			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK9IX	WOS:000413825900003	28918258				2022-02-06	
J	Papa, L; Robicsek, SA; Brophy, GM; Wang, KKW; Hannay, HJ; Heaton, S; Schmalfuss, I; Gabrielli, A; Hayes, RL; Robertson, CS				Papa, Linda; Robicsek, Steven A.; Brophy, Gretchen M.; Wang, Kevin K. W.; Hannay, H. Julia; Heaton, Shelley; Schmalfuss, Ilona; Gabrielli, Andrea; Hayes, Ronald L.; Robertson, Claudia S.			Temporal Profile of Microtubule-Associated Protein 2: A Novel Indicator of Diffuse Brain Injury Severity and Early Mortality after Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; diffuse axonal injury; microtubule-associated protein; mortality; neuronal injury; outcome; severe traumatic brain injury; traumatic brain injury	CEREBROSPINAL-FLUID; HIPPOCAMPUS; COMA	This study compared cerebrospinal fluid (CSF) levels of microtubule-associated protein 2 (MAP-2) from adult patients with severe traumatic brain injury (TBI) with uninjured controls over 10 days, and examined the relationship between MAP-2 concentrations and acute clinical and radiologic measures of injury severity along with mortality at 2 weeks and over 6 months. This prospective study, conducted at two Level 1 trauma centers, enrolled adults with severe TBI (Glasgow Coma Scale [GCS] score 8) requiring a ventriculostomy, as well as controls. Ventricular CSF was sampled from each patient at 6, 12, 24, 48, 72, 96, 120, 144, 168, 192, 216, and 240h following TBI and analyzed via enzyme-linked immunosorbent assay for MAP-2 (ng/mL). Injury severity was assessed by the GCS score, Marshall Classification on computed tomography (CT), Rotterdam CT score, and mortality. There were 151 patients enrolled130 TBI and 21 control patients. MAP-2 was detectable within 6h of injury and was significantly elevated compared with controls (p < 0.001) at each time-point. MAP-2 was highest within 72h of injury and decreased gradually over 10 days. The area under the receiver operating characteristic curve for deciphering TBI versus controls at the earliest time-point CSF was obtained was 0.96 (95% CI 0.93-0.99) and for the maximal 24-h level was 0.98 (95% CI 0.97-1.00). The area under the curve for initial MAP-2 levels predicting 2-week mortality was 0.80 at 6h, 0.81 at 12h, 0.75 at 18h, 0.75 at 24h, and 0.80 at 48h. Those with Diffuse Injury III-IV had much higher initial (p = 0.033) and maximal (p = 0.003) MAP-2 levels than those with Diffuse Injury I-II. There was a graded increase in the overall levels and peaks of MAP-2 as the degree of diffuse injury increased within the first 120h post-injury. These data suggest that early levels of MAP-2 reflect severity of diffuse brain injury and predict 2-week mortality in TBI patients. These findings have implications for counseling families and improving clinical decision making early after injury and guiding multidisciplinary care. Further studies are needed to validate these findings in a larger sample.	[Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 W Underwood S-200, Orlando, FL 32806 USA; [Robicsek, Steven A.; Gabrielli, Andrea] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Heaton, Shelley] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Schmalfuss, Ilona] Univ Florida, Dept Radiol, Gainesville, FL 32610 USA; [Brophy, Gretchen M.] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci & Neurosurg, Richmond, VA USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Schmalfuss, Ilona] North Florida South Georgia Vet Hlth Syst, Gainesville, FL USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Banyan Labs, Alachua, FL USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 W Underwood S-200, Orlando, FL 32806 USA.	lpstat@aol.com		Brophy, Gretchen/0000-0002-4749-2693; Wang, Kevin/0000-0002-9343-6473	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS052831]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	This study was funded by NIH RO1 NS052831, "Biochemical Markers of Severe Traumatic Brain Injury.''	Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Faul M, 2010, TRAUMATIC BRAIN INJU; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Khan SH, 1998, ACT NEUR S, V71, P50; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Papa L., 2012, PROTEOMICSHUMAN DIS; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81	22	11	11	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					32	40		10.1089/neu.2017.4994		NOV 2017	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000414583000001	28895474	Green Published			2022-02-06	
J	Albert, AF; Kirkman, MA				Albert, Angelique F.; Kirkman, Matthew A.			Clinical and Radiological Predictors of Malignant Middle Cerebral Artery Infarction Development and Outcomes	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Functional outcomes; intracranial hypertension; intracranial pressure; malignant MCA infarction; middle cerebral artery stroke; optic nerve sheath diameter	INTENSIVE-CARE MANAGEMENT; TRAUMATIC BRAIN-INJURY; NERVE SHEATH DIAMETER; ACUTE ISCHEMIC-STROKE; INTRACRANIAL-PRESSURE; HEMORRHAGE; ABC/2	Background: Optic nerve sheath diameter (ONSD) can predict intracranial hypertension and outcomes in severe traumatic brain injury. Its utility in middle cerebral artery (MCA) stroke is unknown. Aims: We reviewed serial radiological measurements, including ONSD, in patients with MCA stroke undergoing decompressive craniectomy (DC) for malignant MCA syndrome and compared demographic, clinical, and radiological data with an age-and gender-matched group of nonmalignant MCA stroke patients. Methods: Patients admitted to a large tertiary hospital in London, UK, between April 2012 and October 2016 with MCA infarction were identified through 2 data sources. We quantified ONSD, eyeball transverse diameter (ETD), ONSD/ETD ratio, midline shift (MLS), and infarct volume on computed tomography (CT). Results: We identified 19 patients (mean age = 49.8 years [standard deviation = 12.5]) with malignant MCA stroke and 19 patients (47.8 years [16.0]) with nonmalignant MCA stroke. Mean ONSD, ONSD/ETD ratio, MLS, and infarct volume on initial CT all significantly increased after developing malignant MCA syndrome and decreased (except infarct volume, which increased) following DC (all Ps <.05). ONSD and ONSD/ETD ratios in the malignant group did not correlate with functional outcomes but were significantly higher on initial CT compared with the nonmalignant group (mean ONSD: 5.66mm [.6] versus 4.97 mm [.5], P = .001; mean ONSD/ETD ratio: .25 [.03] versus .22 [.02], P = .002). Conclusions: ONSD, ONSD/ETD ratio, MLS, and infarct volume change dynamically in patients with malignant MCA infarction who undergo DC. An ONSD of more than 5.25 mm and an ONSD/ETD ratio of more than .232 on initial CT may identify MCA stroke patients at high risk of developing malignant MCA syndrome.	[Albert, Angelique F.] Great Ormond St Hosp Sick Children, London, England; [Kirkman, Matthew A.] Barts Heath NHS Trust, Royal London Hosp, Dept Neurosurg, London, England; [Kirkman, Matthew A.] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Queen Sq, London, England		Kirkman, MA (corresponding author), Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England.	matthew.kirkman@gmail.com	Kirkman, Matthew Anthony/D-4096-2012	Kirkman, Matthew Anthony/0000-0002-0320-6907			Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Bekerman I, 2016, AM J EMERG MED, V34, P2336, DOI 10.1016/j.ajem.2016.08.045; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Chae MK, 2016, RESUSCITATION, V104, P40, DOI 10.1016/j.resuscitation.2016.04.001; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Kirkman MA, 2016, J NEUROSURG ANESTH, V28, P214, DOI 10.1097/ANA.0000000000000225; Kirkman MA, 2014, INTENS CARE MED, V40, P640, DOI 10.1007/s00134-014-3266-z; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Luby M, 2013, AM J NEURORADIOL, V34, P1901, DOI 10.3174/ajnr.A3476; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Sauvigny T, 2016, WORLD NEUROSURG, V88, P519, DOI 10.1016/j.wneu.2015.10.072; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vaiman M, 2016, J CLIN NEUROSCI, V34, P177, DOI 10.1016/j.jocn.2016.06.008; Wang D, 2004, J TRAUMA, V56, P972	19	11	12	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	NOV	2017	26	11					2671	2679		10.1016/j.jstrokecerebrovasdis.2017.06.041			9	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	FL8YV	WOS:000414538100031	28736129				2022-02-06	
J	Hammer, LB; Wan, WH; Brockwood, KJ; Mohr, CD; Carlson, KF				Hammer, Leslie B.; Wan, Wylie H.; Brockwood, Krista J.; Mohr, Cynthia D.; Carlson, Kathleen F.			Military, Work, and Health Characteristics of Separated and Active Service Members From the Study for Employment Retention of Veterans (SERVe)	MILITARY PSYCHOLOGY			English	Article						health; military; support; work; workplace intervention	AFGHANISTAN WAR VETERANS; TRAUMATIC BRAIN-INJURY; SUPPORTIVE SUPERVISOR BEHAVIORS; FAMILY CONFLICT; SOCIAL SUPPORT; ORGANIZATIONAL SUPPORT; FUNCTIONAL IMPAIRMENT; PERCEIVED STRESS; IRAQ; VALIDATION	The Study for Employment Retention of Veterans (SERVe) is focused on improving the health, well-being, and employment retention of military service members who are now civilian employees. The SERVe sample was comprised of employed post 9/11 service members who represent 3 categories of service members: (a) separated active duty service members (n = 235), (b) separated National Guard/Reservists (NG/R; n = 171), and (c) actively drilling NG/R (n = 87). We did not include currently serving full-time active duty military because they are not represented in the current civilian workforce, which is the focus of SERVe. Survey responses reflecting a description of military, work, and support characteristics, as well as physical and psychological health indicators, were collected from a total of 493 employed service members from 35 organizations. Separated and active service members had similar military backgrounds and reported similar work characteristics. However, there were significant differences in social support and health indices, such that separated veterans reported less support and worse physical and psychological health on many indicators compared to active NG/R. This study of employed service members is among the first to examine and show significant health and well-being differences between those who separated from military service and those still serving in the NG/R.	[Hammer, Leslie B.; Wan, Wylie H.; Brockwood, Krista J.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, 3181 Southwest Sam Jackson Pk Rd L606, Portland, OR 97239 USA; [Mohr, Cynthia D.] Portland State Univ, Dept Psychol, Portland, OR 97207 USA; [Carlson, Kathleen F.] VA Portland Healthcare Syst R&D 66, Ctr Improve Vet Involvement Care, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA		Hammer, LB (corresponding author), Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, 3181 Southwest Sam Jackson Pk Rd L606, Portland, OR 97239 USA.	hammerl@ohsu.edu			U.S. Army Medical Research Acquisition Activity, Fort Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs, through the USAMRMC Broad Agency Announcement [W81XWH-13-2-0020]	The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the USAMRMC Broad Agency Announcement under Award W81XWH-13-2-0020. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Adler A. B., 2011, DEPLOYMENT PSYCHOL E, P153, DOI [10.1037/12300-006, DOI 10.1037/12300-006]; Adler AB, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0484-6; Babor TF, 2001, AUDIT ALCOHOL USE DI; Barnett RC, 2001, AM PSYCHOL, V56, P781, DOI 10.1037//0003-066X.56.10.781; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; BLIESE PD, 2003, PSYCHOL PEACEKEEPING, V2003, P185; Boroff KE, 1997, IND LABOR RELAT REV, V51, P50, DOI 10.2307/2525034; Burnett-Zeigler I, 2011, MIL MED, V176, P639, DOI 10.7205/MILMED-D-10-00450; Cammann C., 1983, ASSESSING ORG CHANGE, P71; CAPLAN RD, 1975, HEW PUBLICATION NIOS, V75; Carlson KF, 2016, NEUROREHABILITATION, V39, P351, DOI 10.3233/NRE-161367; Carlson KF, 2013, HEADACHE, V53, P1573, DOI 10.1111/head.12216; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dapprich, 2011, NEW DIRECTIONS ADULT, V2011, P63, DOI [10.1002/ace.432, DOI 10.1002/ACE.432]; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Elbogen EB, 2012, MIL MED, V177, P669, DOI 10.7205/MILMED-D-11-00388; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gunia BC, 2015, MIL PSYCHOL, V27, P197, DOI 10.1037/mil0000078; Hammer L. B., 2005, MILITARY LIFE PSYCHO; Hammer L.B., 2011, APA HDB IND ORG PSYC, V3, P399, DOI [10.1037/12171-011, DOI 10.1037/12171-011]; Hammer LB, 2013, J OCCUP HEALTH PSYCH, V18, P285, DOI 10.1037/a0032612; Hammer LB, 2011, J APPL PSYCHOL, V96, P134, DOI 10.1037/a0020927; Hammer LB, 2009, J MANAGE, V35, P837, DOI 10.1177/0149206308328510; Hammer Leslie B., 2007, RES OCCUPATIONAL STR, V6, P171; Herrell RK, 2014, PSYCHOL SERV, V11, P254, DOI 10.1037/a0037347; Hobfoll SE, 2012, INT J STRESS MANAGE, V19, P217, DOI 10.1037/a0029247; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horton J. L., 2013, OCCUPATIONAL ENV MED; House JS., 1981, WORK STRESS SOCIAL S; Ingersoll-Dayton B, 2001, FAM RELAT, V50, P262, DOI 10.1111/j.1741-3729.2001.00262.x; Institute of Medicine, 2010, RET HOM IR AFGH PREL; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kossek EE, 2011, PERS PSYCHOL, V64, P289, DOI 10.1111/j.1744-6570.2011.01211.x; Lane ME, 2012, AM J PUBLIC HEALTH, V102, P1213, DOI 10.2105/AJPH.2011.300280; Mattacola CG, 1997, J SPORT REHABIL, V6, P38, DOI 10.1123/jsr.6.1.38; Matthews RA, 2010, J OCCUP HEALTH PSYCH, V15, P75, DOI 10.1037/a0017443; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Oregon Department of Veterans' Affairs, 2016, 2016 ODVA ANN REP; PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416; Reed MB, 2007, ADDICT BEHAV, V32, P449, DOI 10.1016/j.addbeh.2006.05.016; Ribeiro JD, 2011, J PERS ASSESS, V93, P597, DOI 10.1080/00223891.2011.608758; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Sahibzada K, 2005, J FAM ISSUES, V26, P820, DOI 10.1177/0192513X05277546; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Schwab KA, 2006, NEUROLOGY, V66, pA235; SOLLINGER JM, 2008, INVISIBLE WOUNDS WAR, P19; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; U.S. Department of Veteran Affairs, 2015, AN VA HLTH CAR UT OP; U.S. Department of Veterans Affairs Veterans Benefits Administration, 2015, DIS COMP; U.S. Department of Veterans Affairs Veterans Health Administration, 2007, VHA DIR 2007 013 SCR; US Department of Veterans Affairs, 2010, NAT SURV VET ACT DUT; Wallen J., 2002, BALANCING WORK FAMIL; Yoon J, 1999, HUM RELAT, V52, P923, DOI 10.1177/001872679905200704	57	11	11	0	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	NOV	2017	29	6					491	512		10.1037/mil0000196			22	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FM8DU	WOS:000415316600002					2022-02-06	
J	Haniff, S; Taylor, PA				Haniff, S.; Taylor, P. A.			In silico investigation of blast-induced intracranial fluid cavitation as it potentially leads to traumatic brain injury	SHOCK WAVES			English	Article						Traumatic brain injury (TBI); Microscale model; Cavitation; Virtual simulation	WHITE-MATTER; DAMAGE; MODEL	We conducted computational macroscale simulations predicting blast-induced intracranial fluid cavitation possibly leading to brain injury. To further understanding of this problem, we developed microscale models investigating the effects of blast-induced cavitation bubble collapse within white matter axonal fiber bundles of the brain. We model fiber tracks of myelinated axons whose diameters are statistically representative of white matter. Nodes of Ranvier are modeled as unmyelinated sections of axon. Extracellular matrix envelops the axon fiber bundle, and gray matter is placed adjacent to the bundle. Cavitation bubbles are initially placed assuming an intracranial wave has already produced them. Pressure pulses, of varied strengths, are applied to the upper boundary of the gray matter and propagate through the model, inducing bubble collapse. Simulations, conducted using the shock wave physics code CTH, predict an increase in pressure and von Mises stress in axons downstream of the bubbles after collapse. This appears to be the result of hydrodynamic jetting produced during bubble collapse. Interestingly, results predict axon cores suffer significantly lower shear stresses from proximal bubble collapse than does their myelin sheathing. Simulations also predict damage to myelin sheathing, which, if true, degrades axonal electrical transmissibility and general health of the white matter structures in the brain.	[Haniff, S.; Taylor, P. A.] Sandia Natl Labs, POB 5800,MS 1160, Albuquerque, NM 87185 USA		Haniff, S (corresponding author), Sandia Natl Labs, POB 5800,MS 1160, Albuquerque, NM 87185 USA.	shaniff@sandia.gov; pataylo@sandia.gov			US Office of Naval ResearchOffice of Naval Research [N0001414IP20020]; US Department of Energy's National Nuclear Security AdministrationNational Nuclear Security Administration [DE-NA-0003525]	This work funded through the US Office of Naval Research, T. Bentley, Project funding manager, under Contract No. N0001414IP20020. Sandia National Laboratories is a multimission laboratory managed and operated by National Technology and Engineering Solutions of Sandia, LLC, a wholly owned subsidiary of Honeywell International, Inc., for the US Department of Energy's National Nuclear Security Administration under contract DE-NA-0003525.	Brennen C. E., 2003, P 5 INT S CAV OS; Brundage A, 2014, J PHYS CONF SER, V500, DOI 10.1088/1742-6596/500/10/102002; Brundage A. L., 2014, COMMUNICATION; Brundage AL, 2013, PROCEDIA ENGINEER, V58, P461, DOI 10.1016/j.proeng.2013.05.053; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; FRIEDLANDER FG, 1947, MATH P CAMBRIDGE PHI, V43, P360; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Gu LX, 2012, COMPOS PART B-ENG, V43, P3160, DOI 10.1016/j.compositesb.2012.04.014; Haniff S, 2016, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2015, VOL 3; Hertel E. S., 1993, P 19 INT S SHOCK WAV, P377, DOI DOI 10.1007/978-3-642-78829-1_61; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Kerley G., 1998, SAND980947 SAND NAT; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Marieb E., 2007, HUMAN ANATOMY PHYSL; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; Snaidero N, 2014, J CELL SCI, V127, P2999, DOI 10.1242/jcs.151043; SWANSON SR, 1985, J ENG MATER-T ASME, V107, P110, DOI 10.1115/1.3225782; Taylor P. A., 2014, IBIA NEUROTRAUMA LET, V35; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tillotson J. H., 1962, GA3216 METALLIC EQUATIONS S; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van der Knaap MS, 2005, MAGNETIC RESONANCE M, P1, DOI DOI 10.1007/3-540-27660-2_1; Virchow, 1854, VIRCHOWS ARCH PATHOL, V6, P562, DOI DOI 10.1007/BF02116709	35	11	11	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	NOV	2017	27	6					929	945		10.1007/s00193-017-0765-1			17	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FN4BE	WOS:000415946600010		Green Submitted			2022-02-06	
J	Parsons, TD; McMahan, T				Parsons, Thomas D.; McMahan, Timothy			An initial validation of the Virtual Environment Grocery Store	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Episodic memory; Prospective memory; Multitasking; Neuropsychological tests; Virtual reality	TRAUMATIC BRAIN-INJURY; ACTION PLANNING-SUPERMARKET; MILD COGNITIVE IMPAIRMENT; ECOLOGICAL VALIDITY; PROSPECTIVE MEMORY; EXECUTIVE FUNCTIONS; EPISODIC MEMORY; OLDER-ADULTS; REALITY; TASK	Background: Virtual reality-based neuropsychological assessments proffer the potential to address the limited ecological validity of pen-and-paper measures of memory. New method: To investigate the construct validity of a newly developed virtual reality-based multiple errands task, the Virtual Environment Grocery Store (VEGS), two studies were performed. Comparison with existing method(s): In Study 1, we explored construct validity via comparison of traditional neuropsychological measures of memory and executive functioning with a low distraction condition of the VEGS. In Study 2, a new sample was used to compare traditional neuropsychological measures of memory and executive functioning with a high distraction condition of the VEGS. Results: Performances on the VEGS memory tasks (in Study 1: low distraction condition) and the traditional neuropsychological assessments of memory were positively correlated, indicating that memory for VEGS content was similar to memory for traditional paper-and-pencil measures. Again, in Study 2, performances on the VEGS memory tasks correlated with the traditional neuropsychological assessments of memory, indicating that memory for VEGS content was similar to memory for traditional paper-and pencil measures. As expected, though, the addition of distractors into the virtual environment resulted in significant correlations with traditional measures of inhibitory control. Conclusions: The VEGS has the advantage over traditional measures of providing objective measurement of individual components of memory in simulations of everyday activities. (C) 2017 Elsevier B.V. All rights reserved.	[Parsons, Thomas D.; McMahan, Timothy] Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA		Parsons, TD (corresponding author), Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA.	Thomas.Parsons@unt.edu		Parsons, Thomas/0000-0003-0331-5019			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Allain P, 2014, J INT NEUROPSYCH SOC, V20, P468, DOI 10.1017/S1355617714000344; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Besnard J, 2016, APPL NEUROPSYCH-ADUL, V23, P223, DOI 10.1080/23279095.2015.1048514; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Burgess P. W., 2000, COGNITIVE PSYCHOL PL, P199; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Canty AL, 2014, NEUROPSYCHOL REHABIL, V24, P238, DOI 10.1080/09602011.2014.881746; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dubreuil P, 2007, ARCH CLIN NEUROPSYCH, V22, P979, DOI 10.1016/j.acn.2007.08.002; Einstein G. O., 2004, MEMORY FITNESS GUIDE; Grewe P, 2014, EPILEPSY BEHAV, V31, P57, DOI 10.1016/j.yebeh.2013.11.014; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hahn EA, 2015, AGING NEUROPSYCHOL C, V22, P25, DOI 10.1080/13825585.2014.888391; Holdnack H.A., 2001, WECHSLER TEST ADULT; Jebara Najate, 2014, Front Aging Neurosci, V6, P338, DOI 10.3389/fnagi.2014.00338; Josman N, 2006, 2006 INT WORKSH VIRT; Josman N, 2014, J STROKE CEREBROVASC, V23, P879, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.013; Josman N, 2009, SCHIZOPHR RES, V115, P270, DOI 10.1016/j.schres.2009.09.015; Kinsella GJ, 2009, BRAIN IMPAIR, V10, P45, DOI 10.1375/brim.10.1.45; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Logie RH, 2011, MEM COGNITION, V39, P1561, DOI 10.3758/s13421-011-0120-1; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2017, NEUROPSYCHOL REHABIL, V27, P777, DOI 10.1080/09602011.2015.1109524; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Pearman A, 2004, J GERONTOL B-PSYCHOL, V59, pP4, DOI 10.1093/geronb/59.1.P4; Plancher G, 2012, NEUROPSYCHOLOGIA, V50, P592, DOI 10.1016/j.neuropsychologia.2011.12.013; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; POLLINA LK, 1992, BRIT J PSYCHOL, V83, P305, DOI 10.1111/j.2044-8295.1992.tb02443.x; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; ROM DM, 1990, BIOMETRIKA, V77, P663, DOI 10.2307/2337008; Sauzeon H, 2012, EXP PSYCHOL, V59, P99, DOI 10.1027/1618-3169/a000131; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Uttl B., 2008, PLOS ONE, V3; Werner P, 2009, DEMENT GERIATR COGN, V27, P301, DOI 10.1159/000204915; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263	45	11	13	2	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	NOV 1	2017	291						13	19		10.1016/j.jneumeth.2017.07.027			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FJ9AP	WOS:000413060100002	28782630				2022-02-06	
J	Rochefort, C; Walters-Stewart, C; Aglipay, M; Barrowman, N; Zemek, R; Sveistrup, H				Rochefort, Coralie; Walters-Stewart, Coren; Aglipay, Mary; Barrowman, Nick; Zemek, Roger; Sveistrup, Heidi			Self-reported balance status is not a reliable indicator of balance performance in adolescents at one-month post-concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain injury; Adolescent; Postural balance; Cognitive function; Injury management	SPORTS-RELATED CONCUSSION; SYMPTOMS; RELIABILITY; STABILITY; RECOVERY; CHILDREN; BOARD	Objectives: To determine if self-reported balance symptoms can be used as a proxy for measures of the center of pressure (COP) to identify balance deficits in a group of concussed adolescents. Design: Case-control. Methods: Thirteen adolescents 1-month post-concussion who reported ongoing balance problems (Bak ance+), 20 adolescent 1-month post-concussion who reported no balance problems (Balance-), and 30 non-injured adolescents (control) completed a series of balance tests. Participants completed two 2-min trials standing on a Nintendo Wii Balance Board (TM) during which the COP under their feet was recorded: i) double-leg stance, eyes open; ii) double-leg stance, eyes closed. Participants also completed a dual-task condition combining a double-leg stance and a Stroop Colour-word test. Results: Participants in both the Balance+ and Balance-group swayed over a larger ellipse area compared to the control group while completing the Eyes Closed (Balance+, p = 0.002: Balance-, p = 0.002) and Dual Task (Balance+, p=0.001; Balance-, p=0.004) conditions and performed the Dual-Task condition with faster medio-lateral velocity (Balance+, p=0.003; Balance-, p = 0.009). The participants in the Balance group also swayed over a larger ellipse area compared to the control group while completing the Eyes Open condition (p=0.005). No significant differences were identified between the Balance+ and Balance-groups. Conclusions: At 1-month post-concussion, adolescents demonstrated balance deficits compared to non-injured adolescents regardless of whether they reported balance problems. These results suggest that self-reported balance status might not be an accurate reflection of balance performance following a concussion in adolescents (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Rochefort, Coralie; Walters-Stewart, Coren; Sveistrup, Heidi] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada; [Aglipay, Mary; Barrowman, Nick; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Sveistrup, Heidi] Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, Ottawa, ON, Canada; [Sveistrup, Heidi] Bruyere Res Inst, Ottawa, ON, Canada		Sveistrup, H (corresponding author), Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada.; Sveistrup, H (corresponding author), Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, Ottawa, ON, Canada.; Sveistrup, H (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.	Heidi.Sveistrup@uottawa.ca	Zemek, Roger/H-1039-2018; Barrowman, Nick/AAL-3166-2020	Barrowman, Nick/0000-0002-4704-9595	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [126197]; CIHR-Ontario Neurotrauma Foundation [127047]; CIHRCanadian Institutes of Health Research (CIHR) [119829]	This project is a sub-study of a larger prospective concussion study funded by a Canadian Institutes of Health Research (CIHR) Operating Grant (MOP: #126197); a CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team Grant (TM1: #127047); and a CIHR planning grant (MRP: #119829).	[Anonymous], 1995, GAIT POSTURE; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Covassin T, 2005, J ATHL TRAINING, V44, P400; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Rhine TD, 2016, CLIN J SPORT MED, V26, P221, DOI 10.1097/JSM.0000000000000234; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Yim-Chiplis P K, 2000, Biol Res Nurs, V1, P321; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	24	11	11	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	NOV	2017	20	11					970	975		10.1016/j.jsams.2017.04.008			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FL4YS	WOS:000414238100004	28495201				2022-02-06	
J	Sarvghad-Moghaddam, H; Rezaei, A; Ziejewski, M; Karami, G				Sarvghad-Moghaddam, H.; Rezaei, A.; Ziejewski, M.; Karami, G.			Correlative analysis of head kinematics and brain's tissue response: a computational approach toward understanding the mechanisms of blast TBI	SHOCK WAVES			English	Article						Blast TBI; Shock waves; Blast overpressure; Correlation; Head kinematics; Brain's tissue responses	IMPACT BIOMECHANICS; INJURY; DEFORMATION; MODEL	Upon impingement of blast waves on the head, stress waves generated at the interface of the skull are transferred into the cranium and the brain tissue and may cause mild to severe blast traumatic brain injury. The intensity of the shock front, defined by the blast overpressure (BoP), that is, the blast-induced peak static overpressure, significantly affects head kinematics as well as the tissue responses of the brain. While evaluation of global linear and rotational accelerations may be feasible, an experimental determination of dynamic responses of the brain in terms of intracranial pressure (ICP), maximum shear stress (MSS), and maximum principal strain (MPS) is almost impossible. The main objective of this study is to investigate possible correlations between head accelerations and the brain's ICP, MSS, and MPS. To this end, three different blasts were simulated by modeling the detonation of 70, 200, and 500 g of TNT at a fixed distance from the head, corresponding to peak BoPs of 0.52, 1.2, and 2 MPa, respectively. A nonlinear multi-material finite element algorithm was implemented in the LS-DYNA explicit solver. Fluid-solid interaction between the blast waves and head was modeled using a penalty-based method. Strong correlations were found between the brain's dynamic responses and both global linear and rotational accelerations at different blast intensities ( 98%), implying that global kinematic parameters of the head might be strong predictors of brain tissue biomechanical parameters.	[Sarvghad-Moghaddam, H.] Harvey Mudd Coll, Engn Dept, Claremont, CA 91711 USA; [Rezaei, A.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Ziejewski, M.; Karami, G.] North Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA		Sarvghad-Moghaddam, H (corresponding author), Harvey Mudd Coll, Engn Dept, Claremont, CA 91711 USA.	hmoghaddam@hmc.edu					[Anonymous], HYPERMESH A; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi M.S., 2009, THESIS; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Hallquist J.O, 2007, LS DYNA KEYWORD USER, V970; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jazi MS, 2016, COMPUT METHOD BIOMEC, V19, P1019, DOI 10.1080/10255842.2015.1088525; King A. I., 2003, IRCOBI C LISB PORT; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Moghaddam HS, 2014, J NEUROTRAUM, V31, pA123; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sarvghad-Moghaddam H., 2014, ASME 2014 INT MECH E, P3, DOI [10.1115/IMECE2014-39338, DOI 10.1115/IMECE2014-39338]; Sarvghad-Moghaddam H., 2015, THESIS; Sarvghad-Moghaddam H., 2014, 17 US NAT C THEOR AP; Sarvghad-Moghaddam Hesam, 2017, Int J Numer Method Biomed Eng, V33, DOI 10.1002/cnm.2782; Sarvghad-Moghaddam H, 2015, J HEAD TRAUMA REHAB, V30, pE67; Sarvghad-Moghaddam H, 2015, J HEAD TRAUMA REHAB, V30, pE66; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	32	11	11	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	NOV	2017	27	6					919	927		10.1007/s00193-017-0749-1			9	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FN4BE	WOS:000415946600009					2022-02-06	
J	Strong, EB; Gary, C				Strong, E. Bradley; Gary, Celeste			Management of Zygomaticomaxillary Complex Fractures	FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA			English	Article						Maxillofacial trauma; Zygoma; Fracture; Zygomaticomaxillary; Intra-operative imaging; Navigation; Pre-surgical planning	INTRAOPERATIVE COMPUTED-TOMOGRAPHY; ZYGOMATIC FRACTURES; MAXILLOFACIAL SURGERY; ORBITAL FRACTURES; FACIAL FRACTURES; TRIPOD FRACTURES; 1-POINT FIXATION; PEDIATRIC CT; CANCER-RISKS; CLASSIFICATION	Zygomaticomaxillary fractures account for approximately 25% of all facial fractures. They can be grouped into high-velocity and low-velocity injuries. A complete head and neck examination is critical for accurate clinical diagnosis. A thin-cut axial computed tomographic scan with sagittal, coronal, and 3-D reconstruction is important for accurate diagnosis and treatment planning. A thorough understanding of the bony tetrapod anatomy and fracture mechanics is critical to treatment planning. Treatment options include closed and open reduction with internal fixation. Computer-aided applications can reduce the need for open reduction and improve the accuracy of both closed and open repairs.	[Strong, E. Bradley] Univ Calif Davis, Sch Med, Dept Otolaryngol, 2521 Stockton Blvd,Suite 5200, Sacramento, CA 95817 USA; [Gary, Celeste] LSU Hlth New Orleans, Dept Otolaryngol, 533 Bolivar St,Suite 566, New Orleans, LA 70112 USA		Strong, EB (corresponding author), Univ Calif Davis, Sch Med, Dept Otolaryngol, 2521 Stockton Blvd,Suite 5200, Sacramento, CA 95817 USA.	ebstrong@ucdavis.edu					Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Czerwinski M, 2005, PLAST RECONSTR SURG, V115, P1858, DOI 10.1097/01.PRS.0000165077.40778.00; ELLIS E, 1985, J ORAL MAXIL SURG, V43, P417, DOI 10.1016/S0278-2391(85)80049-5; Ellis E, 1996, J ORAL MAXIL SURG, V54, P386, DOI 10.1016/S0278-2391(96)90107-X; Ellis E, 2014, J ORAL MAXIL SURG, V72, P1975, DOI 10.1016/j.joms.2014.04.015; Ellis III E, 1996, J ORAL MAXILLOFAC SU, V54, P400; Evans GRD, 2011, PLAST RECONSTR SURG, V127, P891, DOI 10.1097/PRS.0b013e31820456e5; FUJII N, 1983, J ORAL MAXIL SURG, V41, P562, DOI 10.1016/0278-2391(83)90158-1; Fujioka M, 2002, PLAST RECONSTR SURG, V109, P817, DOI 10.1097/00006534-200202000-00069; Fuller Scott C, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P233, DOI 10.1097/MOO.0b013e3281df2c5f; Hoelzle F, 2001, INT J ORAL MAX SURG, V30, P26, DOI 10.1054/ijom.2000.0014; Hollier LH, 2003, PLAST RECONSTR SURG, V111, P2386, DOI 10.1097/01.PRS.0000061010.42215.23; Hwang K, 2010, J CRANIOFAC SURG, V21, P1042, DOI 10.1097/SCS.0b013e3181e48607; Jamal BT, 2009, J ORAL MAXIL SURG, V67, P986, DOI 10.1016/j.joms.2008.12.035; Kelley P, 2007, PLAST RECONSTR SURG, V120, p5S, DOI 10.1097/01.prs.0000260720.73370.d7; Kim JH, 2012, ARCH OTOLARYNGOL, V138, P828, DOI 10.1001/archoto.2012.1815; Kim ST, 2011, J ORAL MAXIL SURG, V69, P2848, DOI 10.1016/j.joms.2011.02.073; KNIGHT J S, 1961, Br J Plast Surg, V13, P325; Kostakis G, 2012, OR SURG OR MED OR PA, V114, pS69, DOI 10.1016/j.tripleo.2011.08.029; Kovacs AF, 2001, INT J ORAL MAX SURG, V30, P380, DOI 10.1054/ijom.2001.0131; Laine F J, 1993, Curr Probl Diagn Radiol, V22, P145; Marinho ROM, 2013, ORAL MAXIL SURG CLIN, V25, P617, DOI 10.1016/j.coms.2013.07.011; O'Sullivan ST, 1998, INJURY, V29, P413, DOI 10.1016/S0020-1383(98)00063-1; Pham AM, 2007, OTOLARYNG HEAD NECK, V137, P624, DOI 10.1016/j.otohns.2007.06.719; Rana M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-36; Roth FS, 2005, J CRANIOFAC SURG, V16, P394, DOI 10.1097/01.scs.0000171964.01616.a8; Shaye DA, 2015, JAMA FACIAL PLAST SU, V17, P113, DOI 10.1001/jamafacial.2014.1343; Shumrick KA, 1997, ARCH OTOLARYNGOL, V123, P378; Shuryak I, 2014, RADIAT RES, V181, P584, DOI 10.1667/RR13622.1; Stanley R B Jr, 1999, Arch Facial Plast Surg, V1, P19, DOI 10.1001/archfaci.1.1.19; Strong EB, 2008, ARCH OTOLARYNGOL, V134, P1080, DOI 10.1001/archotol.134.10.1080; Strong EB, 2013, OTOLARYNG CLIN N AM, V46, P719, DOI 10.1016/j.otc.2013.07.003; Strong EB, 2012, ARCH FACIAL PLAST S, V14, P159, DOI 10.1001/archfacial.2011.1397; Tanrikulu R, 2001, DENTOMAXILLOFAC RAD, V30, P141, DOI 10.1038/sj.dmfr.4600593; Timashpolsky A, 2016, PLAST SURG-CHIR PLAS, V24, P73, DOI 10.1177/229255031602400203; Wilde F, 2013, J ORAL MAXIL SURG, V71, P894, DOI 10.1016/j.joms.2012.10.031; Yonehara Y, 2005, J CRANIOFAC SURG, V16, P481, DOI 10.1097/01.SCS.0000157308.39420.74; ZINGG M, 1991, ARCH OTOLARYNGOL, V117, P611; ZINGG M, 1992, J ORAL MAXIL SURG, V50, P778, DOI 10.1016/0278-2391(92)90266-3	40	11	11	3	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-7406			FACIAL PLAST SURG CL	Facial Plast. Surg. Clin. N. Am.	NOV	2017	25	4					547	+		10.1016/j.fsc.2017.06.006			17	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FK4WX	WOS:000413498600007	28941507				2022-02-06	
J	Yue, JK; Ngwenya, LB; Upadhyayula, PS; Deng, HS; Winkler, EA; Burke, JF; Lee, YM; Robinson, CK; Ferguson, AR; Lingsma, HF; Cnossen, MC; Pirracchio, R; Korley, FK; Vassar, MJ; Yuh, EL; Mukherjee, P; Gordon, WA; Valadka, AB; Okonkwo, DO; Manley, GT				Yue, John K.; Ngwenya, Laura B.; Upadhyayula, Pavan S.; Deng, Hansen; Winkler, Ethan A.; Burke, John F.; Lee, Young M.; Robinson, Caitlin K.; Ferguson, Adam R.; Lingsma, Hester F.; Cnossen, Maryse C.; Pirracchio, Romain; Korley, Frederick K.; Vassar, Mary J.; Yuh, Esther L.; Mukherjee, Pratik; Gordon, Wayne A.; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	Emergency department blood alcohol level associates with injury factors and six-month outcome after uncomplicated mild traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Blood alcohol level; Functional outcome; Injury factors; Mild traumatic brain injury; Nonverbal processing speed	SUBSTANCE-ABUSE; ETHANOL; MORTALITY; SCALE; INTERVENTION; INTOXICATION; MODERATE; HISTORY	The relationship between blood alcohol level (BAL) and mild traumatic brain injury (mTBI) remains in need of improved characterization. Adult patients suffering mTBI without intracranial pathology on computed tomography (CT) from the prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot study with emergency department (ED) Glasgow Coma Scale (GCS) 13-15 and recorded blood alcohol level (BAL) were extracted. BAL >= 80-mg/dl was set as proxy for excessive use. Multivariable regression was performed for patients with six-month Glasgow Outcome Scale Extended (GOSE; functional recovery) and Wechsler Adult Intelligence Scale Processing Speed Index Composite Score (WAIS-PSI; nonverbal processing speed), using BAL >= 80-mg/dl and < 80-mg/dl cohorts, adjusting for demographic/injury factors. Overall, 107 patients were aged 42.7 +/- 16.8-years, 67.3%-male, and 80.4%-Caucasian; 65.4% had BAL = 0-mg/dl, 4.6% BAL < 80-mg/dl, and 30.0% BAL >= 80-mg/dl (range 100-440-mg/dl). BAL differed across loss of consciousness (LOC; none: median 0-mg/dl [interquartile range (IQR) 0-0], < 30-min: 0-mg/d1 [0-43], >= 30-min: 224-mg/dl [50-269], unknown: 108-mg/dl [0232]; p = 0.002). GCS < 15 associated with higher BAL (19-mg/dl [0-204] vs. 0-mg/dl [0-20]; p = 0.013). On univariate analysis, BAL >= 80-mg/c11 associated with less-than-full functional recovery (GOSE < 7; 38.1% vs. 11.5%; p = 0.025) and lower WAIS-PSI (92.4 12.7, 30th-percentile vs. 105.1 11.7, 63rd percentile; p < 0.001). On multivariable regression BAL >= 80-mg/dl demonstrated an odds ratio of 8.05 (95% CI [1.35-47.92]; p = 0.022) for GOSE < 7 and an adjusted mean decrease of 8.88-points (95% CI [0.67-17.09]; p = 0.035) on WAIS-PSI. Day-of-injury BAL >= 80-mg/dl after uncomplicated mTBI was associated with decreased GCS score and prolongation of reported LOC. BAL may be a biomarker for impaired return to baseline function and decreased nonverbal processing speed at six-months postinjury. Future confirmatory studies are needed. Published by Elsevier Ltd.	[Yue, John K.; Deng, Hansen; Winkler, Ethan A.; Burke, John F.; Lee, Young M.; Robinson, Caitlin K.; Ferguson, Adam R.; Vassar, Mary J.; Yuh, Esther L.; Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Yue, John K.; Deng, Hansen; Winkler, Ethan A.; Burke, John F.; Lee, Young M.; Robinson, Caitlin K.; Ferguson, Adam R.; Vassar, Mary J.; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurol Surg, Cincinnati, OH USA; [Upadhyayula, Pavan S.] Univ Calif San Diego, Dept Neurol Surg, La Jolla, CA 92093 USA; [Lingsma, Hester F.; Cnossen, Maryse C.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Pirracchio, Romain] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94110 USA; [Pirracchio, Romain] Univ Calif Berkeley, Div Biostat, Berkeley, CA USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94110 USA; [Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Burke, John/0000-0002-6190-5116; Ferguson, Adam/0000-0001-7102-1608; Ngwenya, Laura/0000-0001-7103-971X; Upadhyayula, Pavan/0000-0003-2071-6965	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US DODUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03; US DOD W81XWH-13-1-0441, US DOD W81XWH-14-2-0176 (to G. T. M.)	Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Gentilello LM, 2005, ANN SURG, V241, P541, DOI 10.1097/01.sla.0000157133.80396.1c; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Hanson KL, 2016, J CLIN EXP NEUROPSYC, V38, P1115, DOI 10.1080/13803395.2016.1198468; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Howell D. C., 2012, STAT METHODS PSYCHOL, V8 th; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; Mohseni S, 2016, BRAIN LNJ, P1; Neighbors CJ, 2010, J STUD ALCOHOL DRUGS, V71, P384, DOI 10.15288/jsad.2010.71.384; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor AN, 2015, BRAIN NEUROTRAUMA MO; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	34	11	11	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2017	45						293	298		10.1016/j.jocn.2017.07.022			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL3GQ	WOS:000414111300062	28789959				2022-02-06	
J	Zuj, DV; Felmingham, KL; Palmer, MA; Lawrence-Wood, E; Van Hooff, M; Lawrence, AJ; Bryant, RA; McFarlane, AC				Zuj, Daniel V.; Felmingham, Kim L.; Palmer, Matthew A.; Lawrence-Wood, Ellie; Van Hooff, Miranda; Lawrence, Andrew J.; Bryant, Richard A.; McFarlane, Alexander C.			Neural activity and emotional processing following military deployment: Effects of mild traumatic brain injury and posttraumatic stress disorder	BRAIN AND COGNITION			English	Article						Traumatic brain injury; PTSD; ERP; Attention bias; Emotion	EVENT-RELATED POTENTIALS; FUNCTIONAL CONNECTIVITY; COMBAT VETERANS; TBI EXHIBIT; TIME-COURSE; PTSD; FACES; ERP; ABNORMALITIES; METAANALYSIS	Posttraumatic Stress Disorder (PTSD) and mild traumatic brain injury (mTBI) are common comorbidities during military deployment that affect emotional brain processing, yet few studies have examined the independent effects of mTBI and PTSD. The purpose of this study was to examine distinct differences in neural responses to emotional faces in mTBI and PTSD. Twenty-one soldiers reporting high PTSD symptoms were compared to 21 soldiers with low symptoms, and 16 soldiers who reported mTBI-consistent injury and symptoms were compared with 16 soldiers who did not sustain an mTBI. Participants viewed emotional face expressions while their neural activity was recorded (via event-related potentials) prior to and following deployment. The high-PTSD group displayed increased 21 and P2 amplitudes to threatening faces at post-deployment compared to the low-PTSD group. In contrast, the mTBI group displayed reduced face-specific processing (N170 amplitude) to all facial expressions compared to the no-mTBI group. Here, we identified distinctive neural patterns of emotional face processing, with attentional biases towards threatening faces in PTSD, and reduced emotional face processing in mTBI.	[Zuj, Daniel V.; Palmer, Matthew A.] Univ Tasmania, Sch Med, Div Psychol, Hobart, Tas, Australia; [Felmingham, Kim L.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Lawrence-Wood, Ellie; Van Hooff, Miranda; Lawrence, Andrew J.; McFarlane, Alexander C.] Univ Adelaide, Sch Med, Ctr Traumat Stress Studies, Adelaide, SA, Australia; [Bryant, Richard A.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia		Zuj, DV (corresponding author), Univ Tasmania, Div Psychol, Locked Bag 1342, Launceston, Tas 7250, Australia.	Daniel.Zuj@utas.edu.au	Bryant, Richard/AAA-6479-2019; Zuj, Daniel/AAF-5494-2019	Bryant, Richard/0000-0002-9607-819X; Zuj, Daniel/0000-0002-6376-8354; Van Hooff, Miranda/0000-0002-9376-3714	Department of Defence through the Middle East Area of Operations Study; Defence Health Foundation; NHMRC Program GrantNational Health and Medical Research Council of Australia [APP1073041]	This project was funded by the Department of Defence through the Middle East Area of Operations Study, the Defence Health Foundation, and an NHMRC Program Grant APP1073041.	Attias J, 1996, BIOL PSYCHIAT, V40, P373, DOI 10.1016/0006-3223(95)00419-X; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00119; Elting JW, 2008, BRAIN INJURY, V22, P870, DOI 10.1080/02699050802403581; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Felmingham KL, 2011, J ANXIETY DISORD, V25, P668, DOI 10.1016/j.janxdis.2011.02.010; Felmingham KL, 2003, NEUROREPORT, V14, P777, DOI 10.1097/00001756-200304150-00024; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, LANCET, V368, P837, DOI 10.1016/S0140-6736(06)69315-X; JEFFREYS DA, 1992, EXP BRAIN RES, V91, P340; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kimble MO, 2010, PSYCHIAT RES, V178, P501, DOI 10.1016/j.psychres.2009.10.009; King D. W., 2008, MANUAL DEV RISK RESI; Klimova A, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.20430; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Olatunji BO, 2013, J ABNORM PSYCHOL, V122, P397, DOI 10.1037/a0030440; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; U.S.G.A. Office, 2008, VA HLTH CAR MILD TRA, P42; Utama NP, 2009, NEUROSCI RES, V64, P30, DOI 10.1016/j.neures.2009.01.009; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	43	11	11	1	23	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	NOV	2017	118						19	26		10.1016/j.bandc.2017.07.001			8	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FI7CY	WOS:000412154900002	28738210				2022-02-06	
J	Rajesh, A; Cooke, GE; Monti, JM; Jahn, A; Daugherty, AM; Cohen, NJ; Kramer, AF				Rajesh, Aishwarya; Cooke, Gillian E.; Monti, Jim M.; Jahn, Andrew; Daugherty, Ana M.; Cohen, Neal J.; Kramer, Arthur F.			Differences in Brain Architecture in Remote Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						DTI; frontal pole; long-term; mild TBI; resting state	IMPACT; NETWORKS	Mild traumatic brain injury (mTBI) is brain trauma from an external impact with a loss of consciousness less than 30min. Mild TBI results in several biopsychosocial impairments, with pronounced cognitive deficits thought to resolve within 3 months of injury. Previous research suggests that these impairments are due to a temporary inability to appropriately allocate neural resources in response to cognitive demands. Our study questioned this assumption and instead hypothesized that mTBI was associated with long-term neural disruptions and compromised brain structure integrity. By extension, we investigated the likelihood that functional restitution and cognitive resolution following mTBI may be due to some form of neurofunctional reorganization. To this end, we examined abnormalities in resting state functional connectivity and structure (volume, thickness, and fractional anisotropy) in two groups of mTBIthose with 1-10 years time post-injury (mTBI(1-10)), and those with 20-65 years time post-injury, relative to age-, sex-, and education-matched controls. We observed abnormalities in brain architecture only in the mTBI(1-10) group, characterized by functional hypo-activation in the right frontal pole, smaller frontal pole volume, and lesser fractional anisotropy in the genu of the corpus callosum that extended near the right frontal pole. This frontal region is laterally specialized to regulate function specific to socio-emotional processes. Collectively, neural disruptions and structural insult in mTBI may persist up to 10 years following injury, but injury-related pathology may resolve with longer recovery time. Disruption to frontal-dependent function that supports socio-emotional processes also may interfere with cognitive functioning, as in the case of chronic mTBI.	[Rajesh, Aishwarya; Cooke, Gillian E.; Monti, Jim M.; Daugherty, Ana M.; Cohen, Neal J.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Champaign, IL USA; [Jahn, Andrew] Haskins Labs Inc, 270 Crown St, New Haven, CT 06511 USA; [Kramer, Arthur F.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Kramer, Arthur F.] Northeastern Univ, Dept Engn, Boston, MA 02115 USA		Rajesh, A (corresponding author), 3414 Beckman Inst,405 N Mathews Ave, Urbana, IL 61801 USA.	aishwar2@illinois.edu	Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD073288] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD073288] Funding Source: NIH RePORTER		Astafiev SV, 2016, NEUROIMAGE-CLIN, V11, P10, DOI 10.1016/j.nicl.2016.01.004; Baek MJ, 2016, PLOS ONE, V11, pe0163792; Carlson MC, 2009, J GERONTOL A-BIOL, V64, P1275, DOI 10.1093/gerona/glp117; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dixon ML, 2014, NEUROPSYCHOLOGIA, V62, P321, DOI 10.1016/j.neuropsychologia.2014.05.024; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Grossman R. I., 2016, RADIOLOGY, V279, P693; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; LEMAY M, 1976, ANN NY ACAD SCI, V280, P349, DOI 10.1111/j.1749-6632.1976.tb25499.x; Levan A, 2016, BRAIN IMAGING BEHAV, V10, P1090, DOI 10.1007/s11682-015-9472-7; Losoi H, 2015, RESILIENCE RECOVERY; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Miller B. L., 2007, HUMAN FRONTAL LOBES, P354; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morgan J. E., 2016, TXB CLIN NEUROPSYCHO; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Orr JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124797; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pow S, 2014, J NEUROL, V261, P1049, DOI 10.1007/s00415-013-7020-1; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rubinov Mikail, 1800, Dialogues Clin Neurosci, V15, P339; Salloway SP, 2008, FRONTAL LOBES NEUROP; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Strauss S. B., 2016, AM J NEURORADIOL; Trefler A, 2016, NEUROIMAGE, V133, P41, DOI 10.1016/j.neuroimage.2016.02.034; Voss MW, 2016, NEUROIMAGE, V131, P113, DOI 10.1016/j.neuroimage.2015.10.044; YORK GK, 1995, NEUROLOGY, V45, P834, DOI 10.1212/WNL.45.4.834	39	11	12	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3280	3287		10.1089/neu.2017.5047		OCT 2017	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000414460600001	28726543	Green Published			2022-02-06	
J	Ghayour, MB; Abdolmaleki, A; Rassouli, MB				Ghayour, Mohammad B.; Abdolmaleki, Arash; Rassouli, Morteza B.			Neuroprotective effect of Lovastatin on motor deficit induced by sciatic nerve crush in the rat	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Lovastatin; Motoneuron; Peripheral nerve injury; Regeneration; Sciatic functional index; Sciatic nerve	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; WALLERIAN DEGENERATION; OXIDATIVE STRESS; WISTAR RATS; STATINS; ATORVASTATIN; SIMVASTATIN	Following severe peripheral nerve injury (PNI), regeneration is often insufficient and functional recovery is incomplete. Any agents that limit the spread of neural tissue damage may enhance the nerve regeneration. In this regard, statins have been shown to have neuroprotective properties. We investigated the effects of Lovastatin against sciatic nerve crush injury in male Wistar Rats. Lovastatin or vehicle was given parenteraly to rats for 7 days postoperative. In Lovastatin treatment groups, a single dose of agent (2 and 5 mg/kg) was administered daily. The control group was given vehicle in the same manner. The rats were subjected to crush injury in the left sciatic nerve with non-serrated clamp for 30 s. Behavioral, electrophysiological and morphological alterations were evaluated during the experimental period. Results showed that Lovastatin in a dose of 5 mg/kg could significantly (P < 0.05) accelerate regeneration process and functional recovery. Also results demonstrated that morphometric parameters such as mean axonal number and myelin thickness were significantly higher in Lovastatin (5 mg/kg) treatment groups compared to controls (P < 0.05). These findings suggest that a short-term course treatment with Lovastatin can protect against sciatic nerve injury. Findings indicate that postoperative administration of Lovastatin led to accelerate regeneration process and motor function recovery in nerve crush model in rats. This effect might be due to the anti-inflammatory, immunomodulatory or anti-oxidative properties of Lovastatin. It is clear that more research is needed to confirm these findings.	[Ghayour, Mohammad B.; Abdolmaleki, Arash; Rassouli, Morteza B.] Ferdowsi Univ Mashhad, Dept Biol, Fac Sci, Mashhad, Iran		Abdolmaleki, A (corresponding author), Ferdowsi Univ Mashhad, Dept Biol, Azadi Sq, Mashhad 9177948974, Iran.	Abdolmaleki.arash@mail.um.ac.ir	Behnam-Rassouli, Morteza/AAH-2407-2019	Behnam-Rassouli, Morteza/0000-0003-4734-9886			Aguirre-Vidal Y, 2015, NEUROTOXICOLOGY, V48, P166, DOI 10.1016/j.neuro.2015.03.012; Arnaud C, 2005, TRENDS CARDIOVAS MED, V15, P202, DOI 10.1016/j.tcm.2005.07.002; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Black AE, 1998, DRUG METAB DISPOS, V26, P755; Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; BOTTI RE, 1991, CLIN NEUROPHARMACOL, V14, P256, DOI 10.1097/00002826-199106000-00010; Chalasani N, 2005, HEPATOLOGY, V41, P690, DOI 10.1002/hep.20671; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Ciurleo R, 2014, PHARMACOL RES, V87, P133, DOI 10.1016/j.phrs.2014.03.004; Daglioglu E, 2010, FOLIA NEUROPATHOL, V48, P49; Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0; Dolga AM, 2009, J ALZHEIMERS DIS, V17, P327, DOI 10.3233/JAD-2009-1052; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Feldman EL, 2003, J CLIN INVEST, V111, P431, DOI 10.1172/JCI200317863; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Hayashi T, 2005, BRAIN RES, V1037, P52, DOI 10.1016/j.brainres.2004.12.051; Huseyinoglu N, 2012, KAFKAS UNIV VET FAK, V18, P917, DOI 10.9775/kvfd.2012.6373; Kim HJ, 2004, LIFE SCI, V74, P1621, DOI 10.1016/j.lfs.2003.08.026; Kim TH, 2011, J ETHNOPHARMACOL, V136, P297, DOI 10.1016/j.jep.2011.04.037; Lewin SL, 1997, LARYNGOSCOPE, V107, P992, DOI 10.1097/00005537-199707000-00029; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Oguzhanoglu A, 2010, INT J NEUROSCI, V120, P76, DOI 10.3109/00207450903389370; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Paintlia AS, 2006, AM J PATHOL, V169, P1012, DOI 10.2353/ajpath.2006.051309; Paintlia AS, 2008, EXP NEUROL, V214, P168, DOI 10.1016/j.expneurol.2008.07.024; Pan HC, 2010, NEUROSURGERY, V67, P376, DOI 10.1227/01.NEU.0000371729.47895.A0; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pathak NN, 2014, NEUROCHEM INT, V68, P1, DOI 10.1016/j.neuint.2014.01.014; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Pooler AM, 2006, J NEUROCHEM, V97, P716, DOI 10.1111/j.1471-4159.2006.03763.x; Raimondo S, 2009, INT REV NEUROBIOL, V87, P81, DOI 10.1016/S0074-7742(09)87005-0; Stern RH, 2000, J CLIN PHARMACOL, V40, P616, DOI 10.1177/00912700022009396; Stoll LL, 2004, DRUG TODAY, V40, P975, DOI 10.1358/dot.2004.40.12.872573; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Terenghi G, 2011, J HAND SURG-EUR VOL, V36E, P730, DOI 10.1177/1753193411422202; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; Umebayashi D, 2014, J NEUROTRAUM, V31, P1967, DOI 10.1089/neu.2013.3223; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Wolthers M, 2005, MICROSURG, V25, P508, DOI 10.1002/micr.20156; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xavier AM, 2012, INJURY, V43, P284, DOI 10.1016/j.injury.2011.05.036; Zamrini E, 2004, NEUROEPIDEMIOLOGY, V23, P94, DOI 10.1159/000073981	50	11	11	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	OCT 5	2017	812						121	127		10.1016/j.ejphar.2017.07.018			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FH1EL	WOS:000410882400015	28688913				2022-02-06	
J	Anthonymuthu, TS; Kenny, EM; Amoscato, AA; Lewis, J; Kochanek, PM; Kagan, VE; Bayir, H				Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Amoscato, Andrew A.; Lewis, Jesse; Kochanek, Patrick M.; Kagan, Valerian E.; Bayir, Hulya			Global assessment of oxidized free fatty acids in brain reveals an enzymatic predominance to oxidative signaling after trauma	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Lipid peroxidation; Docosanoids; Eicosanoids; Octadecanoids; Cardiolipin; Pro-resolving mediators	LIPID-PEROXIDATION; HYDROXYOCTADECADIENOIC ACIDS; EPOXYEICOSATRIENOIC ACIDS; IMMATURE BRAIN; UNITED-STATES; SMOOTH-MUSCLE; NITRIC-OXIDE; HEAD-INJURY; BLOOD-FLOW; RAT-BRAIN	Traumatic brain injury (TBI) is a major health problem associated with significant morbidity and mortality. The pathophysiology of TBI is complex involving signaling through multiple cascades, including lipid peroxidation. Oxidized free fatty acids, a prominent product of lipid peroxidation, are potent cellular mediators involved in induction and resolution of inflammation and modulation of vasomotor tone. While previous studies have assessed lipid peroxidation after TBI, to our knowledge no studies have used a systematic approach to quantify the global oxidative changes in free fatty acids. In this study, we identified and quantified 244 free fatty acid oxidation products using a newly developed global liquid chromatography tandem-mass spectrometry (LC MS/MS) method. This methodology was used to follow the time course of these lipid species in the contusional cortex of our pediatric rat model of TBI. We show that oxidation peaked at 1 h after controlled cortical impact and was progressively attenuated at 4 and 24 h time points. While enzymatic and non-enzymatic pathways were activated at 1 h post-TBI, enzymatic lipid peroxidation was the predominant mechanism with 15-lipoxygenase (LOX) contributing to the majority of total oxidized fatty acid content. Pro-inflammatory lipid mediators were significantly increased at 1 and 4 h after TBI with return to basal levels by 24 h. Anti-inflammatory lipid mediators remained significantly increased across all three time points, indicating an elevated and sustained anti-inflammatory response following TBI.	[Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Lewis, Jesse; Kochanek, Patrick M.; Bayir, Hulya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA; [Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Lewis, Jesse; Kochanek, Patrick M.; Bayir, Hulya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Lewis, Jesse; Kagan, Valerian E.; Bayir, Hulya] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Amoscato, Andrew A.; Kagan, Valerian E.; Bayir, Hulya] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Kochanek, Patrick M.; Bayir, Hulya] Univ Pittsburgh, Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA 15224 USA		Bayir, H (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Dept Crit Care Med,Pediat Crit Care Med, Ctr Free Rad & Antioxidant Hlth,Safar Ctr Resusci, Pittsburgh, PA 15260 USA.	bayihx@ccm.upmc.edu	Anthonymuthu, Tamil/I-5534-2019	Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS061817, U19AIO68021, NS076511, NS084604]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061817, R01NS076511, R01NS084604] Funding Source: NIH RePORTER	The authors acknowledge Henry Alexander for technical assistance in performing CCI experiments. The work is supported, in part, by grants from the NIH (NS061817, U19AIO68021, NS076511 and NS084604).	Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; C. f. D. C. a. Prevention N. C. f. I. P. a. C. D. o. U. I. Prevention, 2015, C TRAUM BRAIN INJ US; CHAN PH, 1980, J NEUROCHEM, V35, P1004, DOI 10.1111/j.1471-4159.1980.tb07100.x; Chen C, 2010, NAT CHEM BIOL, V6, P401, DOI 10.1038/nchembio.375; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dasilva G, 2014, ANAL BIOANAL CHEM, V406, P2827, DOI 10.1007/s00216-014-7701-3; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANKEL EN, 1987, CHEM PHYS LIPIDS, V44, P73, DOI 10.1016/0009-3084(87)90045-4; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; Giles TD, 2012, J CLIN HYPERTENS, V14, P198, DOI 10.1111/j.1751-7176.2012.00606.x; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; HARIRI RJ, 1989, J TRAUMA, V29, P1203, DOI 10.1097/00005373-198909000-00003; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hill R, 2016, J NEUROTRAUM, V33, pA117; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Khan JY, 2003, PEDIATR RES, V54, P77, DOI 10.1203/01.PDR.0000065736.69214.20; Lange A, 1997, J BIOL CHEM, V272, P27345, DOI 10.1074/jbc.272.43.27345; Liu XG, 2008, AM J PHYSIOL-HEART C, V295, pH619, DOI 10.1152/ajpheart.01211.2007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Norris Paul C., 2014, Advances in Biological Regulation, V54, P99, DOI 10.1016/j.jbior.2013.09.009; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, V3rd, P183, DOI [10.1007/b139087, DOI 10.1007/0-387-27447-2_6]; PARKER CW, 1987, ANNU REV IMMUNOL, V5, P65, DOI 10.1146/annurev.iy.05.040187.000433; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Pomposiello SI, 1998, HYPERTENSION, V31, P615, DOI 10.1161/01.HYP.31.2.615; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rimaniol AC, 1995, NEUROREPORT, V7, P133, DOI 10.1097/00001756-199512290-00032; ROBINSON BS, 1990, BIOCHEM J, V265, P763, DOI 10.1042/bj2650763; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Subramanian A., 2012, BRAIN INJURY PATHOGE, P139; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; Vangaveti VN, 2014, LIPIDS, V49, P1181, DOI 10.1007/s11745-014-3954-z; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WILLIAMS KI, 1988, J PATHOL, V156, P101, DOI 10.1002/path.1711560204; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yoshida T, 1998, NEUROREPORT, V9, P1929, DOI 10.1097/00001756-199806220-00003; Yue HF, 2007, J PHARMACEUT BIOMED, V43, P1122, DOI 10.1016/j.jpba.2006.10.009; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	83	11	12	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	OCT	2017	1863	10	B		SI		2601	2613		10.1016/j.bbadis.2017.03.015			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FN1VK	WOS:000415779100010	28347845	Green Accepted, Bronze			2022-02-06	
J	Bai, RJ; Gao, HB; Han, ZL; Huang, S; Ge, XT; Chen, FL; Lei, P				Bai, Ruojing; Gao, Huabin; Han, Zhaoli; Huang, Shan; Ge, Xintong; Chen, Fanglian; Lei, Ping			Flow Cytometric Characterization of T Cell Subsets and Microglia After Repetitive Mild Traumatic Brain Injury in Rats	NEUROCHEMICAL RESEARCH			English	Article						Repetitive mild traumatic brain injury; T cell subsets; Microglia	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; STROKE; DAMAGE; HMGB1; ENCEPHALOPATHY; MACROPHAGES; ISCHEMIA; S100B	Although, there is growing awareness in the progressive neurodegeneration of chronic traumatic encephalopathy, changes of immune reactions remain equivocal at best. Thus, in a clinically relevant rat repetitive mild traumatic brain injury (rmTBI) model, some immunologic cells (T cell subsets, microglia) in the injured brain and peripheral blood were analyzed by flow cytometry and immunofluorescence. In the injured brain, CD3(+) T cells showed a bimodal increase during 42 days post-injury (dpi). CD3(+)CD4(+) T cells firstly increased and then decreased, while CD3(+)CD8(+) T cells had reversed tendency. CD86(+)/CD11b(+) M1-like microglia increased at 42 dpi and CD206(+)/CD11b(+) M2-like microglia peaked at 7 dpi. In addition, peripheral immune suppression was implicated in the chronic phase after rmTBI. Taken together, the study provided useful information on long-term dynamic changes of some immune cells after rmTBI in rats.	[Bai, Ruojing; Gao, Huabin; Han, Zhaoli; Huang, Shan; Lei, Ping] Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Anshan Rd 154, Tianjin 300052, Peoples R China; [Bai, Ruojing; Gao, Huabin; Han, Zhaoli; Huang, Shan; Lei, Ping] Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorder, Tianjin 300052, Peoples R China; [Bai, Ruojing; Gao, Huabin; Huang, Shan; Ge, Xintong; Chen, Fanglian] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Bai, Ruojing; Gao, Huabin; Huang, Shan; Ge, Xintong; Chen, Fanglian] Key Lab Injury Variat & Regenerat Nervous Syst, Tianjin 300052, Peoples R China; [Bai, Ruojing; Gao, Huabin; Huang, Shan; Ge, Xintong; Chen, Fanglian] Tianjin Neurol Inst, Lab Neurotrauma, Tianjin 300052, Peoples R China; [Ge, Xintong] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Anshan Rd 154, Tianjin 300052, Peoples R China.; Lei, P (corresponding author), Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorder, Tianjin 300052, Peoples R China.	leiping1974@163.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	Tianjin Municipal Science and Technology Commission Natural Fund Project [13JCYBJC23700]; National Clinical Key Subject Construction Project of NHFPC Fund [81471252]; Natural Science Foundation for the YouthNational Natural Science Foundation of China (NSFC) [81501055]	The research was supported by grants from Tianjin Municipal Science and Technology Commission Natural Fund Project (13JCYBJC23700) and National Clinical Key Subject Construction Project of NHFPC Fund (81471252) and Natural Science Foundation for the Youth (81501055).	Ajmo CT, 2009, EXP NEUROL, V218, P47, DOI 10.1016/j.expneurol.2009.03.044; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cruse JM, 2000, EXP MOL PATHOL, V68, P38, DOI 10.1006/exmp.1999.2292; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Foerch C, 2005, ARCH NEUROL-CHICAGO, V62, P1130, DOI 10.1001/archneur.62.7.1130; FORD AL, 1995, J IMMUNOL, V154, P4309; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Juranyi Z, 1999, BRAIN RES, V823, P183, DOI 10.1016/S0006-8993(99)01169-5; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matt SM, 2016, CURR OPIN PHARMACOL, V26, P96, DOI 10.1016/j.coph.2015.10.009; Monahan R, 2015, IMMUNOL RES, V63, P3, DOI 10.1007/s12026-015-8698-1; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Rawji KS, 2016, BRAIN, V139, P653, DOI 10.1093/brain/awv395; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Wang J, 2008, WORLD J PEDIATR, V4, P140, DOI 10.1007/s12519-008-0028-4; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Zha J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-65; Zhang M, 2013, J CEREB BLOOD FLOW M, V33, P1	29	11	12	1	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2017	42	10					2892	2901		10.1007/s11064-017-2310-0			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FI9LN	WOS:000412329400020	28620825	Green Published			2022-02-06	
J	de Haan, S; de Groot, JC; Jacobs, B; van der Naalt, J				de Haan, S.; de Groot, J. C.; Jacobs, B.; van der Naalt, J.			The association between microhaemorrhages and post - traumatic functional outcome in the chronic phase after mild traumatic brain injury	NEURORADIOLOGY			English	Article						Mild traumatic brain injury; MRI; Microhaemorrhages; Functional outcome; SWI and T2*GRE	DIFFUSE AXONAL INJURY; CEREBRAL MICROBLEEDS; LESIONS; MRI; COMPLAINTS; SUBACUTE	In the chronic phase after mild traumatic brain injury (mTBI), microhaemorrhages are frequently detected on magnetic resonance imaging (MRI). It is however unclear whether microhaemorrhages are associated with functional outcome and which MRI sequence is most appropriate to address this association. We aimed to determine the association between microhaemorrhages and functional outcome in the chronic posttraumatic phase after injury with the most suitable MRI sequence to address this association. One hundred twenty-seven patients classified with mTBI admitted to the outpatient clinic from 2008 to 2015 for persisting posttraumatic complaints were stratified according to the presence of MRI abnormalities (n = 63 (MRI+ group) and n = 64 without abnormalities (MRI- group)). For the detection of microhaemorrhages, susceptibility-weighted imaging (SWI) and T2* gradient recalled echo (T2*GRE) were used. The relation between the functional outcome (dichotomized Glasgow Outcome Scale Extended scores) and the number and localization of microhaemorrhages was analysed using binary logistic regression. SWI detected twice as many microhaemorrhages compared to T2*GRE: 341 vs. 179. Lesions were predominantly present in the frontal and temporal lobes. Unfavourable outcome was present in 67% of the MRI+ group with a significant association of total number of microhaemorrhages in the temporal cortical area on SWI (OR 0.43 (0.21-0.90) p = 0.02), with an explained variance of 44%. The number of microhaemorrhages was not correlated with the number of posttraumatic complaints. An unfavourable outcome in the chronic posttraumatic phase is associated with the presence and number of microhaemorrhages in the temporal cortical area. SWI is preferably used to detect these microhaemorrhages.	[de Haan, S.; de Groot, J. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Jacobs, B.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	j.van.der.naalt@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chung SW, 2012, J KOREAN NEUROSURG S, V52, P377, DOI 10.3340/jkns.2012.52.4.377; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2017, BEHAV BRAIN RES; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Van der Horn HJ, 2017, CLIN RELEVANCE MICRO; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	33	11	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	OCT	2017	59	10					963	969		10.1007/s00234-017-1898-8			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FG8OU	WOS:000410694400004	28785801				2022-02-06	
J	Dominguez-Duran, E; Domenech-Vadillo, E; de Sande, MGAM; Gonzalez-Aguado, R; Guerra-Jimenez, G; Ramos-Macias, A; Morales-Angulo, C; Martin-Mateos, AJ; Figuerola-Massana, E; Galera-Ruiz, H				Dominguez-Duran, E.; Domenech-Vadillo, E.; Alvarez-Morujo de Sande, M. G.; Gonzalez-Aguado, R.; Guerra-Jimenez, G.; Ramos-Macias, A.; Morales-Angulo, C.; Martin-Mateos, A. J.; Figuerola-Massana, E.; Galera-Ruiz, H.			Analysis of risk factors influencing the outcome of the Epley maneuver	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						BPPV; Epley maneuver; Prognosis; Sex; Age; Hypertension; Diabetes mellitus; Hyperlipidemia; Smoking; Alcohol-related disorders; Migraine disorders; Osteoporosis; Labyrinth diseases; Traumatic brain injury; Whiplash injuries; Time-to-treatment; Sulpiride; Betahistine; Signs and symptoms; Head impulse test; Lateralization; Cervical extension; Nystagmus; Orthotropic nystagmus	PAROXYSMAL POSITIONAL VERTIGO; PARTICLE REPOSITIONING MANEUVER; OTOCONIA; NYSTAGMUS; BPPV	Benign paroxysmal positional vertigo (BPPV) is the most frequent type of vertigo. The treatment of canalithiasis of the posterior semicircular canal consists in performing a particle-repositioning maneuver, such as the Epley maneuver (EM). However, the EM is not effective in all cases. The objective of this study is to identify risk factors, which predict the EM failure, among the clinical variables recorded in anamnesis and patient examination. This is an observational prospective multicentric study. All patients presenting with BPPV were recruited and applied the EM and appointed for a follow-up visit 7 days later. The following variables were recorded: sex, age, arterial hypertension, diabetes, hyperlipidemia, smoking habit, alcohol consumption, migraine, osteoporosis, diseases of the inner ear, previous ipsilateral BPPV, previous traumatic brain injury, previous sudden head deceleration, time of evolution, sulpiride or betahistine treatment, experienced symptoms, outcome of the Halmagyi maneuver, laterality, cephalic hyperextension of the neck, intensity of nystagmus, intensity of vertigo, duration of nystagmus, occurrence of orthotropic nystagmus, symptoms immediately after the EM, postural restrictions, and symptoms 7 days after the EM. Significant differences in the rate of loss of nystagmus were found for six variables: hyperlipidemia, previous ipsilateral BPPV, intensity of nystagmus, duration of nystagmus, post-maneuver sweating, and subjective status. The most useful significant variables in the clinical practice to predict the success of the EM are previous BPPV and intensity of nystagmus. In the other significant variables, no physiopathological hypothesis can be formulated or differences between groups are too small.	[Dominguez-Duran, E.; Galera-Ruiz, H.] Hosp Infanta Luisa, Calle San Jacinto 87, Seville 41010, Spain; [Domenech-Vadillo, E.; Figuerola-Massana, E.] Hosp Univ Joan XXIII, Tarragona, Spain; [Alvarez-Morujo de Sande, M. G.; Martin-Mateos, A. J.] Hosp Univ Puerta Mar, Cadiz, Spain; [Gonzalez-Aguado, R.; Morales-Angulo, C.] Hosp Univ Marques De Valdecilla, Santander, Spain; [Guerra-Jimenez, G.; Ramos-Macias, A.] Complejo Hosp Univ Insular Maternoinfantil, Las Palmas Gran Canaria, Spain		Dominguez-Duran, E (corresponding author), Hosp Infanta Luisa, Calle San Jacinto 87, Seville 41010, Spain.	emiliodominguezorl@gmail.com	Macias, Angel Ramos/AAA-9219-2019; Martin Mateos, Antonio Jesus/AAA-8702-2022; Dominguez-Duran, Emilio/AAZ-2733-2021; Galera-Ruiz, Hugo/G-6125-2016	Martin Mateos, Antonio Jesus/0000-0002-5639-1595; Dominguez-Duran, Emilio/0000-0003-0088-5817; Galera-Ruiz, Hugo/0000-0002-1205-6795; GONZALEZ-AGUADO, ROCIO/0000-0002-4407-287X; Morales-Angulo, Carmelo/0000-0002-4268-2762			Aron M, 2015, OTOLARYNG HEAD NECK, V153, P721, DOI 10.1177/0194599815594384; Babac S, 2014, OTOL NEUROTOL, V35, P1105, DOI 10.1097/MAO.0000000000000417; Balatsouras DG, 2015, B-ENT, V11, P199; BRANDT T, 1990, J NEUROL SCI, V95, P3, DOI 10.1016/0022-510X(90)90113-2; Cavaliere M, 2005, Acta Otorhinolaryngol Ital, V25, P107; Choi SJ, 2012, OTOLARYNG HEAD NECK, V147, P919, DOI 10.1177/0194599812454642; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; DIX MR, 1952, ANN OTO RHINOL LARYN, V61, P987, DOI 10.1177/000348945206100403; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; Faralli M, 2014, B-ENT, V10, P133; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Fyrmpas G, 2009, AURIS NASUS LARYNX, V36, P637, DOI 10.1016/j.anl.2009.04.004; Guneri EA, 2012, OTOLARYNG HEAD NECK, V146, P104, DOI 10.1177/0194599811419093; HALL SF, 1979, J OTOLARYNGOL, V8, P151; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HARVEY SA, 1994, LARYNGOSCOPE, V104, P1206; Jang YS, 2006, LARYNGOSCOPE, V116, P996, DOI 10.1097/01.mlg.0000217238.84401.03; Korkmaz M, 2016, BRAZ J OTORHINOLAR, V82, P452, DOI 10.1016/j.bjorl.2015.08.018; Korres S, 2006, J LARYNGOL OTOL, V120, P528, DOI 10.1017/S0022215106000958; Lee NH, 2010, OTOLARYNG HEAD NECK, V143, P413, DOI 10.1016/j.otohns.2010.06.905; Lee SH, 2010, J CLIN NEUROL, V6, P51, DOI 10.3988/jcn.2010.6.2.51; Marques PS, 2014, ACTA OTO-LARYNGOL, V134, P491, DOI 10.3109/00016489.2013.872291; MCCLURE JA, 1985, J OTOLARYNGOL, V14, P30; Oh HJ, 2007, NEUROLOGY, V68, P1219, DOI 10.1212/01.wnl.0000259037.76469.e4; PAGNINI P, 1989, ORL J OTO-RHINO-LARY, V51, P161, DOI 10.1159/000276052; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Pollak L, 2002, OTOL NEUROTOL, V23, P79, DOI 10.1097/00129492-200201000-00018; ROSS MD, 1976, ANN OTO RHINOL LARYN, V85, P310, DOI 10.1177/000348947608500302; SCHUKNECHT HF, 1969, ARCH OTOLARYNGOL, V90, P765; Soto-Varela A, 2011, OTOL NEUROTOL, V32, P1008, DOI 10.1097/MAO.0b013e3182267f02; Squires TM, 2004, J BIOMECH, V37, P1137, DOI 10.1016/j.jbiomech.2003.12.014; Sridbar S, 2005, J OTOLARYNGOL, V34, P41, DOI 10.2310/7070.2005.00041; Sunami K, 2006, ACTA OTO-LARYNGOL, V126, P834, DOI 10.1080/00016480500527474; Vibert D, 2008, AUDIOL NEURO-OTOL, V13, P293, DOI 10.1159/000124277; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; von Brevern M, 2015, J VESTIBUL RES-EQUIL, V25, P105, DOI 10.3233/VES-150553; Yetiser Sertac, 2015, Int Tinnitus J, V19, P64, DOI 10.5935/0946-5448.20150011; Yu SD, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-110; Zhang H, 2012, CLIN J OTORHINOLARYN, V26, P750	39	11	12	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	OCT	2017	274	10					3567	3576		10.1007/s00405-017-4674-9			10	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	FG2CZ	WOS:000409888700002	28725982				2022-02-06	
J	Farzanegan, GR; Derakhshan, N; Khalili, H; Ghaffarpasand, F; Paydar, S				Farzanegan, Gholam Reza; Derakhshan, Nima; Khalili, Hosseinali; Ghaffarpasand, Fariborz; Paydar, Shahram			Effects of atorvastatin on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injury; a randomized double-blind placebo-controlled clinical trial	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article							NEURONAL SURVIVAL; UNITED-STATES; RATS; SIMVASTATIN; PATHOPHYSIOLOGY; ROSUVASTATIN; REDUCTION; HEMATOMA; IRAN	The aim of the current study was to investigate the effects of atorvastatin on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injury (TBI). The study was conducted as a randomized clinical trial during a 16-month period from May 2015 and August 2016 in a level I trauma center in Shiraz, Southern Iran. We included 65 patients with moderate (GCS: 9-13) to severe (GCS: 5-8) TBI who had brain contusions of less than 30 cc volume. We excluded those who required surgical intervention. Patients were randomly assigned to receive daily 20 mg atorvastatin for 10 days (n = 21) or placebo in the same dosage (n = 23). The brain contusion volumetry was performed on days 0, 3 and 7 utilizing spiral thin-cut brain CT-Scan (1-mm thickness). The outcome measured included modified Rankin scale (MRS), Glasgow Outcome Scale (GOS) and Disability rating Scale (DRS) which were all evaluated 3 months post-injury. There was no significant difference between two study group regarding the baseline, 3rd day and 7th day of the contusion volume and the rate of contusion expansion. However, functional outcome scales of GOS, MRS and DRS at 3-months post-injury were significantly better in atorvastatin arm of the study compared to placebo (p values of 0.043, 0.039 and 0.030 respectively). Even though atorvastatin was not found to be more effective than placebo in reducing contusion expansion rate, it was associated with improved functional outcomes at 3-months following moderate to severe TBI. (C) 2017 Elsevier Ltd. All rights reserved.	[Farzanegan, Gholam Reza; Derakhshan, Nima] Baqiyatallah Univ Med Sci, Trauma Res Ctr, Molla Sadra St, Tehran, Iran; [Derakhshan, Nima; Khalili, Hosseinali; Ghaffarpasand, Fariborz; Paydar, Shahram] Shiraz Univ Med Sci, Shahid Rajaee Emtiaz Trauma Hosp, Trauma Res Ctr, Shiraz, Iran		Derakhshan, N (corresponding author), Baqiyatallah Univ Med Sci, Trauma Res Ctr, Molla Sadra St, Tehran, Iran.	nima_med83@yahoo.com	Khalili, Hosseinali/I-1087-2016; paydar, shahram/U-3074-2018; Ghaffarpasand, Fariborz/I-4204-2019; Derakhshan, Nima/Q-2454-2019	Khalili, Hosseinali/0000-0002-3390-4212; paydar, shahram/0000-0002-6980-2576; Ghaffarpasand, Fariborz/0000-0002-1721-9987; Derakhshan, Nima/0000-0001-7142-3404			Akcay MN, 2005, INT J CLIN PHARM RES, V25, P65; Cheng Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-156; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Heydari ST, 2013, PUBLIC HEALTH, V127, P704, DOI 10.1016/j.puhe.2013.05.003; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; Khalili H, 2016, WORLD NEUROSURG, V94, P120, DOI 10.1016/j.wneu.2016.06.122; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li T, 2014, J NEUROL SCI, V341, P88, DOI 10.1016/j.jns.2014.04.009; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Mountney A, 2016, J NEUROTRAUM, V33, P1492, DOI 10.1089/neu.2015.4139; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Neilson SJ, 2016, BRAIN INJURY, V30, P993, DOI 10.3109/02699052.2016.1147599; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Ozay R, 2016, WORLD NEUROSURG; Patil S, 2009, J ORTHOP RES, V27, P281, DOI 10.1002/jor.20572; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Peymani P, 2012, CHIN J TRAUMATOL, V15, P279, DOI 10.3760/cma.j.issn.1008-1275.2012.05.004; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Vandresen S, 2013, NEUROCHEM INT, V62, P948, DOI 10.1016/j.neuint.2013.03.002; Volbers B, 2011, EUR J NEUROL, V18, P1323, DOI 10.1111/j.1468-1331.2011.03395.x; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031	32	11	11	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2017	44						143	147		10.1016/j.jocn.2017.06.010			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FJ3CW	WOS:000412609100023	28688622				2022-02-06	
J	Gros, DF; Lancaster, CL; Homer, MD; Szafranski, DD; Back, SE				Gros, Daniel F.; Lancaster, Cynthia L.; Homer, Michael David; Szafranski, Derek D.; Back, Sudie E.			The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans	COMPREHENSIVE PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MILD TBI; COMBAT VETERANS; ALCOHOL-USE; THERAPY; IRAQ; METAANALYSIS; PERSONNEL; HISTORY; ILLNESS	Background: The co-occurrence of posttraumatic stress disorder (PTSD), substance use disorders (SUD), and traumatic brain injury (TBI) in veterans of Operations Enduring/Iraqi Freedom and New Dawn has received much attention in the literature. Although hypotheses have been presented and disseminated that TBI history will negatively influence treatment response, little data exist to support these claims. The present study investigates the influence of TBI history on response to COPE (Concurrent Treatment of PTSD and SUD Using Prolonged Exposure), a 12 -session, integrated psychotherapy designed to address co-occurring PTSD and SUD. Method: Participants were 51 veterans with current PTSD and SUD enrolled in a clinical trial examining COPE. Assessments of PTSD symptoms, substance use, and depression were collected at baseline and each treatment session. A TBI measure was used to dichotomize veterans into groups with and without a history of TBI (ns = 30 and 21, respectively). Results: Participants with and without TBI history demonstrated significant improvements in PTSD and depression symptoms during the course of treatment. However, participants with TBI history experienced less improvement relative to participants without TBI history. Conclusions: The present findings suggest that, although patients with a TBI history respond to treatment, their response to treatment was less so than that observed in patients without a TBI history. As such, identification, symptom monitoring, and treatment practices may require alteration and further special consideration in individuals with PTSD, SUD and TBI. Published by Elsevier Inc.	[Gros, Daniel F.] Ralph H Johnson Vet Affairs Med Ctr, Mental Hlth Serv 116,109 Bee St, Charleston, SC 29401 USA; Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA		Gros, DF (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Mental Hlth Serv 116,109 Bee St, Charleston, SC 29401 USA.	grosd@musc.edu			NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [ROI DA030143, K02 DA039229]; Department of Veteran Affairs CSR&D Career Development Award [CX000845]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA030143, K02DA039229] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000845] Funding Source: NIH RePORTER	This research was supported by NIDA grants ROI DA030143 and K02 DA039229 (PI: Back) and Department of Veteran Affairs CSR&D Career Development Award CX000845 (PI: Gros). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of NIDA, Department of Veterans Affairs, or the United States government. There are no conflicts of interest to disclose.	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Back SE, 2012, AM J PSYCHIAT, V169, P688, DOI 10.1176/appi.ajp.2011.11091433; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Beck A., 1996, BECK DEPRESSION INVE; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brady K.T., 2014, CONCURRENT TREATMENT; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Bryant RA, 2006, COGN BEHAV PRACT, V13, P17, DOI 10.1016/j.cbpra.2005.03.002; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Corrigan J.D., 2005, REHABILITATION TRAUM, P133; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Foa E.B., 2007, PROLONGED EXPOSURE T; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gros DF, 2016, J PSYCHOPATHOL BEHAV, V38, P266, DOI 10.1007/s10862-015-9513-y; Gros DF, 2014, PSYCHIAT RES, V220, P275, DOI 10.1016/j.psychres.2014.08.018; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Maas, 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-1881.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; McAllister T, 2016, BRAIN INJURY, V30, P714; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roth RS, 2013, J PALLIAT CARE MED, V1, P105, DOI DOI 10.4172/2329-9096.1000105; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Sobell LC, 1992, MEASURING ALCOHOL CO, V1992, P41, DOI DOI 10.1007/978-1-4612-0357-5_; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Weathers F.W., 1993, ANN CONV INT SOC TRA; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029	40	11	11	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	OCT	2017	78						48	53		10.1016/j.comppsych.2017.07.004			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FH9LG	WOS:000411532300007	28803041	Green Accepted			2022-02-06	
J	Manfiotto, M; Mottolese, C; Szathmari, A; Beuriat, PA; Klein, O; Vinchon, M; Gimbert, E; Roujeau, T; Scavarda, D; Zerah, M; Di Rocco, F				Manfiotto, Marie; Mottolese, Carmine; Szathmari, Alexandru; Beuriat, Pierre-Aurelien; Klein, Olivier; Vinchon, Matthieu; Gimbert, Edouard; Roujeau, Thomas; Scavarda, Didier; Zerah, Michel; Di Rocco, Federico			Decompressive craniectomy and CSF disorders in children	CHILDS NERVOUS SYSTEM			English	Article						CSF disorder; Post-traumatic; Decompressive craniectomy; Cranioplasty; Children	POSTTRAUMATIC HYDROCEPHALUS; CLINICAL ARTICLE; HEAD-INJURY; SURGICAL COMPLICATIONS; COMPUTED-TOMOGRAPHY; FLAP RESORPTION; CRANIOPLASTY; HEMICRANIECTOMY; PREDICTION; INFARCTION	Decompressive craniectomy (DC) is a lifesaving procedure but is associated to several post-operative complications, namely cerebrospinal fluid (CSF) dynamics impairment. The aim of this multicentric study was to evaluate the incidence of such CSF alterations after DC and review their impact on the overall outcome. We performed a retrospective multicentric study to analyze the CSF disorders occurring in children aged from 0 to 17 years who had undergone a DC for traumatic brain injury (TBI) in the major Departments of Pediatric Neurosurgery of France between January 2006 and August 2016. Out of 150 children, ranging in age between 7 months and 17 years, mean 10.75 years, who underwent a DC for TBI in 10 French pediatric neurosurgical centers. Sixteen (6 males, 10 females) (10.67%) developed CSF disorders following the surgical procedure and required an extrathecal CSF shunting. External ventricular drainage increased the risk of further complications, especially cranioplasty infection (p = 0.008). CSF disorders affect a minority of children after DC for TBI. They may develop early after the DC but they may develop several months after the cranioplasty (8 months), consequently indicating the necessity of clinical and radiological close follow-up after discharge from the neurosurgical unit. External ventricular drainage and permanent CSF shunt placement increase significantly the risk of cranioplasty infection.	[Manfiotto, Marie] Ctr Hosp Univ Nice, Nice, France; [Mottolese, Carmine; Szathmari, Alexandru; Beuriat, Pierre-Aurelien; Di Rocco, Federico] Hosp Civils Lyon, Hop Femme Mere Enfant, 59 Bd Pinel, F-69677 Bron, France; [Mottolese, Carmine; Szathmari, Alexandru; Beuriat, Pierre-Aurelien; Di Rocco, Federico] Univ Claude Bernard Lyon 1, 59 Bd Pinel, F-69677 Bron, France; [Klein, Olivier] Ctr Hosp Univ Nancy, Nancy, France; [Vinchon, Matthieu] Ctr Hosp Univ Lille, Lille, France; [Gimbert, Edouard] Ctr Hosp Univ Bordeaux, Bordeaux, France; [Roujeau, Thomas] Ctr Hosp Univ Montpellier, Montpellier, France; [Scavarda, Didier] Ctr Hosp Univ Marseille, Marseille, France; [Zerah, Michel] Hop Necker Enfants Malad, Paris, France		Di Rocco, F (corresponding author), Hosp Civils Lyon, Hop Femme Mere Enfant, 59 Bd Pinel, F-69677 Bron, France.; Di Rocco, F (corresponding author), Univ Claude Bernard Lyon 1, 59 Bd Pinel, F-69677 Bron, France.	federico.dirocco@chu-lyon.fr	Vinchon, Matthieu/AAH-6845-2021	Vinchon, Matthieu/0000-0002-9122-6165; Di Rocco, Federico/0000-0003-2145-5533			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Anile C, 2009, CHILD NERV SYST, V25, P325, DOI 10.1007/s00381-008-0749-7; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Lee MH, 2012, CLIN NEUROL NEUROSUR, V114, P555, DOI 10.1016/j.clineuro.2011.11.027; LEMAY M, 1979, NEURORADIOLOGY, V17, P191, DOI 10.1007/BF00342746; Low CYD, 2013, J CLIN NEUROSCI, V20, P867, DOI 10.1016/j.jocn.2012.06.007; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Mustroph CM, 2017, WORLD NEUROSURG, V18; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P281, DOI 10.1007/978-3-7091-1434-6_54; Takeuchi S, 2013, J CLIN NEUROSCI, V20, P377, DOI 10.1016/j.jocn.2012.03.035; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	44	11	12	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1751	1757		10.1007/s00381-017-3542-7			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900019	29149390				2022-02-06	
J	Petkau, TL; Blanco, J; Leavitt, BR				Petkau, Terri L.; Blanco, Jake; Leavitt, Blair R.			Conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice	NEUROBIOLOGY OF DISEASE			English	Article						Frontotemporal lobar degeneration; Neuronal ceroid lipofuscinosis; Progranulin; Conditional knockout mice; Neuropathology; Nestin	TRAUMATIC BRAIN-INJURY; DEFICIENT MICE; KNOCKOUT MICE; ACTIVATED MICROGLIA; NEUROINFLAMMATION; MUTATIONS; RESPONSES; CULTURES; DISEASE	Progranulin deficiency due to heterozygous null mutations in the GRN gene is a common cause of familial frontotemporal lobar degeneration (FTLD), while homozygous loss-of-function GRN mutations cause neuronal ceroid lipofuscinosis (NCL). Aged progranulin-knockout mice display highly exaggerated lipofuscinosis, microgliosis, and astrogliosis, as well as mild cell loss in specific brain regions. Progranulin is a secreted glycoprotein expressed in both neurons and microglia, but not astrocytes, in the brain. We generated conditional progranulin-knockout mice that lack progranulin in nestin-expressing cells (Nes-cKO mice), which include most neurons as well as astrocytes. We confirmed near complete knockout of progranulin in neurons in Nes-cKO mice, while microglia) progranulin levels remained similar to that of wild-type animals. Overall brain progranulin levels were reduced by about 50% in Nes-cKO, and no Gm was detected in primary Nes-cKO neurons. Nes-cKO mice aged to 12 months did not display any increase in lipofuscin deposition, microgliosis, or astrogliosis in the four brain regions examined, though increases were observed for most of these measures in Gm-null animals. We conclude that neuron-specific loss of progranulin is not sufficient to cause similar neuropathological changes to those seen in constitutive Gm-null animals. Our results suggest that increased lipofuscinosis and gliosis in Grn-null animals are not caused by intrinsic progranulin deficiency in neurons, and that microglia-derived progranulin may be sufficient to maintain neuronal health and homeostasis in the brain. (C) 2017 Elsevier Inc. All rights reserved.	[Petkau, Terri L.; Blanco, Jake; Leavitt, Blair R.] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, 980 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Petkau, Terri L.; Blanco, Jake; Leavitt, Blair R.] Childrens & Womens Hosp, 980 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Leavitt, Blair R.] Univ British Columbia Hosp, Div Neurol, Dept Med, S 192-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada; [Leavitt, Blair R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada		Leavitt, BR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, 980 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.; Leavitt, BR (corresponding author), Childrens & Womens Hosp, 980 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	bleavitt@cmmt.ubc.ca	Leavitt, Blair R/G-1934-2012	leavitt, Blair/0000-0002-4532-766X	Alzheimer Society of Canada; Canadian Institute for Health Research (BRL) [97857]	This work was supported by the Alzheimer Society of Canada (doctoral trainee award to TP), and by the Canadian Institute for Health Research (BRL operating grant #97857).	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Connolly C, 2016, NEUROSCIENCE, V325, P74, DOI 10.1016/j.neuroscience.2016.03.031; Cruts Marc, 2006, Current Alzheimer Research, V3, P485, DOI 10.2174/156720506779025251; De Muynck L, 2013, NEUROBIOL AGING, V34, P2541, DOI 10.1016/j.neurobiolaging.2013.04.022; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kleinberger G, 2010, J NEUROCHEM, V115, P735, DOI 10.1111/j.1471-4159.2010.06961.x; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Naphade SB, 2010, ACTA NEUROPATHOL, V119, P123, DOI 10.1007/s00401-009-0616-y; Petkau TL, 2016, NEUROSCIENCE, V315, P175, DOI 10.1016/j.neuroscience.2015.12.006; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Petkau TL, 2013, NEUROBIOL AGING, V34, P2548, DOI 10.1016/j.neurobiolaging.2013.04.019; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tanaka Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0078-x; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	32	11	12	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2017	106						14	22		10.1016/j.nbd.2017.06.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE5ZW	WOS:000408290800002	28647554				2022-02-06	
J	Tunthanathip, T; Phuenpathom, N				Tunthanathip, Thara; Phuenpathom, Nakornchai			Impact of Road Traffic Injury to Pediatric Traumatic Brain Injury in Southern Thailand	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Mechanism of injury; motorcycle accident; outcome; pediatric head injury; traffic injury; traumatic brain injury	HEAD-INJURY; CHILDREN; OUTCOMES; MECHANISM; INFANTS; PATTERN; SCALE; COMA	Background: Motor vehicle is a major transportation in Southern Thailand as the result of road traffic injury and death. Consequently, severe disability and mortality in pediatric traumatic brain injury (TBI) were observed from traffic accident, particularly motorcycle accident. To identify the risk of intracranial injury in children, the association of treatment outcome with various factors including mechanisms of injury, clinical characteristics, and intracranial pathology can be assessed. Materials and Methods: This was a retrospective study conducted on children, who were younger than 15 years old with TBI and were enrolled from 2004 to 2015. Several clinically relevant issues were reviewed and statistically analyzed. Results: A total of 948 casualties were enrolled. Compared with falling down, the motorcycle accident was significantly associated with intracranial injury (odds ratio 1.73, 95% confidence interval [CI] 1.08-2.76). Other factors associated with intracranial injury were hemiparesis (odds ratio 5.69, 95% CI 1.44-22.36), positive of basal skull fracture signs (odds ratio 15.66, 95% CI 3.44-71.28), and fixed reaction to light of both pupils (odds ratio 5.74, 95% CI 1.71-19.23). Mortality found in thirty cases (3.2%). Furthermore, the risk of death correlated with motorcycle accident (P = 0.02) and severe head injury (P < 0.001). Neurosurgical intervention was not associated with outcome, but severe head injury, hemorrhagic shock, epidural, and subdural hematoma were impact factors. Conclusion: The findings demonstrate road traffic injury, especially motorcycle accident leading to brain injury and death. Prevention program is a necessary key to decrease mortality and disability in pediatric TBI.	[Tunthanathip, Thara; Phuenpathom, Nakornchai] Prince Songkla Univ, Songklanagarind Hosp, Fac Med, Dept Surg,Div Neurosurg, Hat Yai, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand.	tsus4@hotmail.com		Tunthanathip, Thara/0000-0002-6303-836X			Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Al-Sarraj S, 2012, J FORENSIC LEG MED, V19, P144, DOI 10.1016/j.jflm.2011.12.015; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Marlow R, 2015, ARCH DIS CHILD, V100, P1136, DOI 10.1136/archdischild-2015-308615; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Peden M, 2008, WORLD REPORT CHILD I; Phuenpathom N, 2000, J CLIN NEUROSCI, V7, P223, DOI 10.1054/jocn.1999.0203; Pontarelli EM, 2014, PEDIATR EMERG CARE, V30, P677, DOI 10.1097/PEC.0000000000000226; Reith G, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0137-8; TEASDALE G, 1974, LANCET, V2, P81; Thailand Transport Portal, 2015, THAILAND TRANSPORT P; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; World Health Organization, 2016, VIOL INJ PREV	22	11	11	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT-DEC	2017	8	4					601	608		10.4103/jnrp.jnrp_381_17			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FN5AW	WOS:000416019800020	29204022	gold, Green Published			2022-02-06	
J	Yu, J; Yuan, Q; Sun, YR; Wu, X; Du, ZY; Li, ZQ; Wu, XH; Zhou, LF; Wu, G; Hu, J				Yu, Jian; Yuan, Qiang; Sun, Yi-rui; Wu, Xing; Du, Zhuo-ying; Li, Zhi-qi; Wu, Xue-hai; Zhou, Liang-fu; Wu, Gang; Hu, Jin			Effects of Deferoxamine Mesylate on Hematoma and Perihematoma Edema after Traumatic Intracerebral Hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; deferoxamine mesylate; hematoma; perihematoma edema; traumatic intracerebral hemorrhage	LONG-TERM DISABILITY; BRAIN-INJURY; UNITED-STATES	Deferoxamine mesylate can cross the blood-brain barrier and reduce iron accumulation in nervous tissue; moreover, it has a variety of neuroprotective functions in addition to complexing with iron ions. Such iron chelators are expected to become a new treatment option for intracerebral hemorrhage. This study evaluated the effects of deferoxamine mesylate on hematoma and edema absorption after traumatic intracerebral hemorrhage (TICH), and it provides clinical evidence for TICH treatment with deferoxamine mesylate. Patients with isolated TICH, confirmed by head computed tomography, were enrolled prospectively from January 2013 to December 2016. Patients were divided non-randomly into an experimental or control group as decided by the attending neurosurgeon. Patients in the experimental group received intravenous deferoxamine mesylate (20 mg/kg daily) from the day of admission for 5 consecutive days. We evaluated the impact of deferoxamine mesylate on the change in edema volume and the absorption of hematoma volume using a propensity score-matched analysis. In total, 190 patients were included. After matching, 94 patients were included in the final analysis (47 per group); no variable differed significantly between the two groups. The hematoma volume on the 7th day in the control group was higher than that at the same time-point in the experimental group (9.4 +/- 7.2 vs. 5.2 +/- 4.8mL; p = 0.001). There was no difference in hematoma volume on Day 1 (12.6 +/- 7.8 vs. 12.8 +/- 6.4mL; p = 0.896), Day 3 (12.4 +/- 7.4 vs. 11.4 +/- 4.9mL; p = 0.442), and Day 14 (3.2 +/- 3.0 vs. 2.5 +/- 2.6mL; p = 0.215) between the groups. The absorption of hematoma volume between the 1st and 3rd days and the 1st and 7th days in the experimental group was higher than that during the same periods in the control group. The edema volumes on the 3rd, 7th, and 14th days in the control group were higher than those at the same time-points in the experimental group. There was no difference in edema volume on the 1st day. The changes in edema volume between the 1st and 3rd days, the 1st and 7th days, and the 1st and 14th days in the control group were higher than those during the same periods in the experimental group. Deferoxamine mesylate may accelerate hematoma absorption and inhibit edema after TICH; however, further investigation is required to reach definitive conclusions.	[Yu, Jian; Yuan, Qiang; Sun, Yi-rui; Wu, Xing; Du, Zhuo-ying; Li, Zhi-qi; Wu, Xue-hai; Zhou, Liang-fu; Wu, Gang; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China		Wu, G; Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	yq123abc20148@163.com; 277089712@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471241, 81301339, 81671200, 81271374]	This work was supported by the National Natural Science Foundation of China (grants 81471241, 81301339, 81671200 and 81271374). No competing financial interests exist.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Berger RP, 2011, PEDIATR CRIT CARE ME, V12, P362, DOI 10.1097/PCC.0b013e3181f4d5f5; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cepeda S, 2016, J NEUROTRAUM, V33, P1034, DOI 10.1089/neu.2015.4153; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chen QW, 2015, STROKE, V46, P2902, DOI 10.1161/STROKEAHA.115.009713; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Freeman WD, 2008, NEUROCRIT CARE, V9, P307, DOI 10.1007/s12028-008-9089-4; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; Hatakeyama T, 2013, TRANSL STROKE RES, V4, P546, DOI 10.1007/s12975-013-0270-5; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; HURN PD, 1995, STROKE, V26, P688, DOI 10.1161/01.STR.26.4.688; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lou M, 2009, CEREBROVASC DIS, V27, P266, DOI 10.1159/000199464; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; PALMER C, 1994, STROKE, V25, P1039, DOI 10.1161/01.STR.25.5.1039; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sansing LH, 2011, NEUROCRIT CARE, V14, P395, DOI 10.1007/s12028-010-9498-z; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selim M, 2011, STROKE, V42, P3067, DOI 10.1161/STROKEAHA.111.617589; Selim M, 2009, STROKE, V40, pS90, DOI 10.1161/STROKEAHA.108.533125; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Venkatasubramanian C, 2011, STROKE, V42, P73, DOI 10.1161/STROKEAHA.110.590646; Yu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122371; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	28	11	11	4	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2753	2759		10.1089/neu.2017.5033			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700010	28462672				2022-02-06	
J	Low, E; Crewther, SG; Ong, B; Perre, D; Wijeratne, T				Low, Essie; Crewther, Sheila Gillard; Ong, Ben; Perre, Diana; Wijeratne, Tissa			Compromised Motor Dexterity Confounds Processing Speed Task Outcomes in Stroke Patients	FRONTIERS IN NEUROLOGY			English	Article						processing speed; motor speed; cognitive speed; stroke; transient ischemic attack; motor impairment	DIGIT SYMBOL SUBSTITUTION; TRAUMATIC BRAIN-INJURY; ADULT AGE-DIFFERENCES; INSPECTION-TIME; COGNITIVE IMPAIRMENT; INDIVIDUAL-DIFFERENCES; MULTIPLE-SCLEROSIS; WORKING-MEMORY; WAIS-III; INTELLIGENCE	Most conventional measures of information processing speed require motor responses to facilitate performance. However, although not often addressed clinically, motor impairment, whether due to age or acquired brain injury, would be expected to confound the outcome measure of such tasks. The current study recruited 29 patients (20 stroke and 9 transient ischemic attack) with documented reduction in dexterity of the dominant hand, and 29 controls, to investigate the extent to which 3 commonly used processing speed measures with varying motor demands (a Visuo-Motor Reaction Time task, and the Wechsler Adult Intelligence Scale-IV Symbol Search and Coding subtests) may be measuring motor-related speed more so than cognitive speed. Analyses include correlations between indices of cognitive and motor speed obtained from two other tasks (Inspection Time and Pegboard task, respectively) with the three speed measures, followed by hierarchical regressions to determine the relative contribution of cognitive and motor speed indices toward task performance. Results revealed that speed outcomes on tasks with relatively high motor demands, such as Coding, were largely reflecting motor speed in individuals with reduced dominant hand dexterity. Thus, findings indicate the importance of employing measures with minimal motor requirements, especially when the assessment of speed is aimed at understanding cognitive rather than physical function.	[Low, Essie; Crewther, Sheila Gillard; Wijeratne, Tissa] Western Hlth, Sunshine Hosp, Dept Neurol, Melbourne, Vic, Australia; [Low, Essie; Crewther, Sheila Gillard; Ong, Ben; Wijeratne, Tissa] La Trobe Univ, Sch Psychol & Publ Hlth, Dept Psychol & Counselling, Bundoora, Vic, Australia; [Perre, Diana] Western Hlth, Sunshine Hosp, Dept Psychol, Melbourne, Vic, Australia; [Wijeratne, Tissa] Univ Melbourne, Western Hlth Sunshine Hosp, Melbourne Med Sch, Dept Med, St Albans, Vic, Australia; [Wijeratne, Tissa] Univ Rajarata, Dept Med, Anuradhapura, Sri Lanka		Low, E; Wijeratne, T (corresponding author), Western Hlth, Sunshine Hosp, Dept Neurol, Melbourne, Vic, Australia.; Low, E; Wijeratne, T (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Dept Psychol & Counselling, Bundoora, Vic, Australia.; Wijeratne, T (corresponding author), Univ Melbourne, Western Hlth Sunshine Hosp, Melbourne Med Sch, Dept Med, St Albans, Vic, Australia.; Wijeratne, T (corresponding author), Univ Rajarata, Dept Med, Anuradhapura, Sri Lanka.	essie.low@wh.org.au; tissa.wijeratne@wh.org.au	Crewther, Sheila G/A-2165-2008; FRACP, Tissa Wijeratne MD PhD/I-2086-2019	FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111			Ackerman PL, 2000, J EXP PSYCHOL-APPL, V6, P259, DOI 10.1037//1076-898X.6.4.259; Alexander LD, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-6; Arauz A, 2013, J NEUROL NEUROSUR PS, V84, P240, DOI 10.1136/jnnp-2012-303328; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; BERES CA, 1981, J GERONTOL, V36, P591, DOI 10.1093/geronj/36.5.591; Buetefisch CM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00214; Burns NR, 1998, PERS INDIV DIFFER, V24, P25, DOI 10.1016/S0191-8869(97)00142-6; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 10.1017/CBO9780511571312; Carvalho JO, 2016, J CLIN EXP NEUROPSYC, V38, P217, DOI 10.1080/13803395.2015.1101054; Chiaravalloti ND, 2003, J CLIN EXP NEUROPSYC, V25, P489, DOI 10.1076/jcen.25.4.489.13878; Crowe SF, 1999, AUST PSYCHOL, V34, P204, DOI 10.1080/00050069908257455; Cunningham DA, 2015, ARCH PHYS MED REHAB, V96, pS94, DOI 10.1016/j.apmr.2014.07.419; DEARY IJ, 1993, PERCEPTION, V22, P1245, DOI 10.1068/p221245; Deary IJ, 1996, AM PSYCHOL, V51, P599; Dik MG, 2000, STROKE, V31, P2431, DOI 10.1161/01.STR.31.10.2431; Ebaid D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00062; Fong KNK, 2009, NEUROREHABILITATION, V24, P165, DOI 10.3233/NRE-2009-0465; Garaas TW, 2008, VISION RES, V48, P523, DOI 10.1016/j.visres.2007.11.011; Moreno MJG, 2013, PSICOTHEMA, V25, P452, DOI 10.7334/psicothema2012.308; Gillebert CR, 2013, NEUROSCIENTIST, V19, P509, DOI 10.1177/1073858412463168; Gregory T, 2008, INTELLIGENCE, V36, P664, DOI 10.1016/j.intell.2008.03.005; Grudnik JL, 2001, INTELLIGENCE, V29, P523, DOI 10.1016/S0160-2896(01)00078-2; HARVEY LO, 1986, BEHAV RES METH INSTR, V18, P623, DOI 10.3758/BF03201438; Hurford R, 2013, J NEUROL, V260, P237, DOI 10.1007/s00415-012-6625-0; Kenworthy L, 2013, NEUROPSYCHOLOGY, V27, P529, DOI 10.1037/a0033599; Knowles EEM, 2012, SCHIZOPHR RES, V142, P129, DOI 10.1016/j.schres.2012.08.020; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kreiner DS, 2001, CLIN NEUROPSYCHOL, V15, P109, DOI 10.1076/clin.15.1.109.1906; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lichtenberger ElizabethO., 2009, ESSENTIALS WAIS 4 AS; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Low E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22598; Luxton J, 2014, J CLIN EXP NEUROPSYC, V36, P944, DOI 10.1080/13803395.2014.957168; Mehrabian S, 2015, NEUROPSYCH DIS TREAT, V11, P2711, DOI 10.2147/NDT.S86366; Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parmenter BA, 2007, J INT NEUROPSYCH SOC, V13, P417, DOI 10.1017/S1355617707070580; Petrill SA, 2001, INTELLIGENCE, V29, P487, DOI 10.1016/S0160-2896(01)00074-5; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; Roberts RD, 1999, LEARN INDIVID DIFFER, V11, P1, DOI 10.1016/S1041-6080(00)80007-2; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SALTHOUSE TA, 1992, J GERONTOL, V47, pP121, DOI 10.1093/geronj/47.3.P121; Sankarasubramanian V, 2017, CLIN NEUROPHYSIOL, V128, P892, DOI 10.1016/j.clinph.2017.03.030; Schear J M, 1989, Arch Clin Neuropsychol, V4, P25, DOI 10.1016/0887-6177(89)90004-8; Schneider LA, 2017, CHILD NEUROPSYCHOL, V23, P300, DOI 10.1080/09297049.2015.1102215; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Strober LB, 2014, MULT SCLER RELAT DIS, V3, P473, DOI 10.1016/j.msard.2014.03.004; Su CY, 2015, ARCH CLIN NEUROPSYCH, V30, P148, DOI 10.1093/arclin/acu057; Takeuchi H, 2011, J NEUROSCI, V31, P12139, DOI 10.1523/JNEUROSCI.2948-11.2011; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Turunen KEA, 2013, EUR J NEUROL, V20, P286, DOI 10.1111/j.1468-1331.2012.03844.x; Vickers D, 1972, Perception, V1, P263, DOI 10.1068/p010263; Wagle J, 2011, DEMENT GERIATR COGN, V31, P379, DOI 10.1159/000328970; Wechsler D., 2008, WECHSLER ADULT INTEL; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P389, DOI 10.1093/arclin/acs041; Zbinden L, 2006, BRIT J NEUROSURG, V20, P203, DOI 10.1080/02688690600852258	60	11	11	0	0	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 21	2017	8								484	10.3389/fneur.2017.00484			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FH6BL	WOS:000411257100002	28983276	Green Published, gold			2022-02-06	
J	Servatius, RJ; Handy, JD; Doria, MJ; Myers, CE; Marx, CE; Lipsky, R; Ko, N; Avcu, P; Wright, WG; Tsao, JW				Servatius, Richard J.; Handy, Justin D.; Doria, Michael J.; Myers, Catherine E.; Marx, Christine E.; Lipsky, Robert; Ko, Nora; Avcu, Pelin; Wright, W. Geoffrey; Tsao, Jack W.			Stress-Related Mental Health Symptoms in Coast Guard: Incidence, Vulnerability, and Neurocognitive Performance	FRONTIERS IN PSYCHOLOGY			English	Article						PTSD; depression; military personnel; temperament; personality	TRAUMATIC BRAIN-INJURY; POST-CONCUSSIVE SYMPTOMS; BEHAVIORALLY INHIBITED TEMPERAMENT; US MILITARY PERSONNEL; GENDER-DIFFERENCES; SERVICE MEMBERS; ARMY SOLDIERS; HURRICANE-KATRINA; COMBAT EXPOSURE; POLICE OFFICERS	U.S. Coast Guard (CG) personnel face occupational stressors (e.g., search and rescue) which compound daily life stressors encountered by civilians. However, the degree CG personnel express stress-related mental health symptoms of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) is understudied as a military branch, and little is known concerning the interplay of vulnerabilities and neurocognitive outcomes in CG personnel. The current study addressed this knowledge gap, recruiting 241 active duty CG personnel (22% female) to assess mental health, personality, and neurocognitive function. Participants completed a battery of scales: PTSD Checklist with military and non-military prompts to screen for PTSD, Psychological Health Questionnaire 8 for MDD, and scales for behaviorally inhibited (BI) temperament, and distressed (Type D) personality. Neurocognitive performance was assessed with the Defense Automated Neurobehavioral Assessment (DANA) battery. Cluster scoring yielded an overall rate of PTSD of 15% (95% CI: 11-20%) and 8% (95% CI: 3-9%) for MDD. Non-military trauma was endorsed twice that of military trauma in those meeting criteria for PTSD. Individual vulnerabilities were predictive of stress-related mental health symptoms in active duty military personnel; specifically, BI temperament predicted PTSD whereas gender and Type D personality predicted MDD. Stress-related mental health symptoms were also associated with poorer reaction time and response inhibition. These results suggest rates of PTSD and MDD are comparable among CG personnel serving Boat Stations to those of larger military services after combat deployment. Further, vulnerabilities distinguished between PTSD and MDD, which have a high degree of co-occurrence in military samples. To what degree stress-related mental healthy symptoms and attendant neurocognitive deficits affect operational effectiveness remains unknown and warrant future study.	[Servatius, Richard J.; Handy, Justin D.] Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, Syracuse, NY 13210 USA; [Servatius, Richard J.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Servatius, Richard J.; Handy, Justin D.; Ko, Nora; Avcu, Pelin] Rutgers State Univ, Stress & Motivated Behav Inst, Rutgers Biomed Hlth Sci, Newark, NJ 07102 USA; [Doria, Michael J.] US Coast Guard, Washington, DC USA; [Myers, Catherine E.] VA New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA; [Marx, Christine E.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Rutgers Biomed Hlth Sci, Newark, NJ USA; [Marx, Christine E.] Durham Vet Affairs Med Ctr, Vet Affairs Midatlantic Mental Illness Res Educ &, Durham, NC USA; [Marx, Christine E.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Lipsky, Robert] INOVA Hlth Syst, Dept Neurosci, Fairfax, VA USA; [Ko, Nora; Avcu, Pelin] Rutgers State Univ, Grad Sch Biomed Sci, Program Neurosci, Newark, NJ USA; [Wright, W. Geoffrey] Temple Univ, Neuromotor Sci Program, Philadelphia, PA 19122 USA; [Tsao, Jack W.] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN USA; [Tsao, Jack W.] Memphis Vet Affairs Adm, Med Ctr, Dept Neurol, Memphis, TN USA; [Tsao, Jack W.] Le Bonheur Children Hosp, Childrens Fdn Res Inst, Memphis, TN USA		Servatius, RJ (corresponding author), Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, Syracuse, NY 13210 USA.; Servatius, RJ (corresponding author), SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA.; Servatius, RJ (corresponding author), Rutgers State Univ, Stress & Motivated Behav Inst, Rutgers Biomed Hlth Sci, Newark, NJ 07102 USA.	richard.servatius@va.gov		Servatius, Richard/0000-0002-7023-4895	Department of Veterans Affairs, Medical Research fundsUS Department of Veterans Affairs; Stress & Motivated Behavior Institute	The research team is indebted for immeasurable support in conducting the research study to Admirals Dollymoore and Schwartz and CAPT Harnon as well as onsite access and support from: CWO Thomas Moore (CG Station Golden Gate), BMCS Eamon McCormak and BMC Jeremy Jarvis (Station St. Petersburg), LCDR William (Bill) Walsh and LT Leo Danaher (Station New York), BMCM Devin Spencer (Station San Francisco), LT Ben Crowell and LT Alexandria Richardson (Station Seattle), CWO Eric (Bee) Perry (Station Port Canaveral), CWO4 Mark Helmers (Station, New Orleans), and LTJG Anthony Ippolito (Station Fort Lauderdale). Financial support was provided by Department of Veterans Affairs, Medical Research funds and the Stress & Motivated Behavior Institute.	Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P4; Biggs QM, 2010, AM J ORTHOPSYCHIAT, V80, P586, DOI 10.1111/j.1939-0025.2010.01063.x; Bowler RM, 2010, AM J IND MED, V53, P1186, DOI 10.1002/ajim.20876; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Crum-Cianflone NF, 2014, EPIDEMIOL REV, V36, P5, DOI 10.1093/epirev/mxt005; Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Emons WHM, 2007, J PSYCHOSOM RES, V63, P27, DOI 10.1016/j.jpsychores.2007.03.010; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; Gladstone G, 2005, PSYCHIAT RES, V135, P133, DOI 10.1016/j.psychres.2005.03.005; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Harbertson J, 2016, BJPSYCH OPEN, V2, P314, DOI 10.1192/bjpo.bp.116.003038; Harris R.J, 2001, PRIMER MULTIVARIATE; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Honzel N, 2014, COGN AFFECT BEHAV NE, V14, P792, DOI 10.3758/s13415-013-0219-x; Iversen AC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-31; Jacobson IG, 2015, J PSYCHIATR RES, V68, P30, DOI 10.1016/j.jpsychires.2015.05.015; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Lee DJ, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0467-7; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Luxton DD, 2010, DEPRESS ANXIETY, V27, P1027, DOI 10.1002/da.20730; Maia DB, 2008, J AFFECT DISORDERS, V107, P259, DOI 10.1016/j.jad.2007.08.013; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; Mayo JA, 2013, MIL MED, V178, P945, DOI 10.7205/MILMED-D-12-00527; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Mustillo SA, 2015, MIL MED, V180, P419, DOI 10.7205/MILMED-D-14-00335; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Myers CE, 2012, STRESS, V15, P31, DOI 10.3109/10253890.2011.578184; Naismith SL, 2003, J CLIN EXP NEUROPSYC, V25, P866, DOI 10.1076/jcen.25.6.866.16472; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Pole N, 2001, J NERV MENT DIS, V189, P442, DOI 10.1097/00005053-200107000-00005; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Searle AK, 2015, INT J METH PSYCH RES, V24, P32, DOI 10.1002/mpr.1460; Shen YC, 2010, MIL MED, V175, P763, DOI 10.7205/MILMED-D-10-00086; Skogstad L, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0104-4; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Sundin J, 2014, BRIT J PSYCHIAT, V204, P202, DOI 10.1192/bjp.bp.113.129569; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tak S, 2007, J URBAN HEALTH, V84, P153, DOI 10.1007/s11524-006-9155-1; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Thomas P, 1999, EUR ARCH PSY CLIN N, V249, P79, DOI 10.1007/s004060050070; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052; West C, 2008, J OCCUP ENVIRON MED, V50, P689, DOI 10.1097/JOM.0b013e3181638685; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson SH, 2016, UNDERSEA HYPERBAR M, V43, P585	55	11	11	0	13	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	SEP 14	2017	8								1513	10.3389/fpsyg.2017.01513			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FG7WM	WOS:000410635900001	28959220	gold, Green Published			2022-02-06	
J	Breedlove, KM; Breedlove, E; Nauman, E; Bowman, TG; Lininger, MR				Breedlove, Katherine M.; Breedlove, Evan; Nauman, Eric; Bowman, Thomas G.; Lininger, Monica R.			The Ability of an Aftermarket Helmet Add-On Device to Reduce Impact-Force Accelerations During Drop Tests	JOURNAL OF ATHLETIC TRAINING			English	Article						Guardian Cap; peak acceleration; Gadd Severity Index; traumatic brain injuries	AMERICAN FOOTBALL; LACROSSE HELMETS; HIGH-SCHOOL; CONCUSSIONS; YOUTH	Context: The Guardian Cap provides a soft covering intended to mitigate energy transfer to the head during football contact. Yet how well it attenuates impacts remains unknown. Objective: To evaluate the changes in the Gadd Severity Index (GSI) and linear acceleration during drop tests on helmeted headforms with or without Guardian Caps. Design: Crossover study. Setting: Laboratory. Patients or Other Participants: Nine new football helmets sent directly from the manufacturer. Intervention(s): We dropped the helmets at 3 velocities on 6 helmet locations (front, side, right front boss, top, rear right boss, and rear) as prescribed by the National Operating Committee on Standards for Athletic Equipment. Helmets were tested with facemasks in place but no Guardian Cap and then retested with the facemasks in place and the Guardian Cap affixed. Main Outcome Measure(s): The GSI scores and linear accelerations measured in g forces. Results: For the GSI, we found a significant interaction among drop location, Guardian Cap presence, and helmet brand at the high velocity (F-10,F-50 = 3.01, P = .005) but not at the low (F-3.23,F-16.15 = 0.84, P = .50) or medium (F-10,F-50 = 1.29, P = .26) velocities. Similarly for linear accelerations, we found a significant interaction among drop location, Guardian Cap presence, and helmet brand at the high velocity (F-10,F-50 = 3.01, P = .002, omega(2) = 0.05) but not at the low (F-10,F-50 = 0.49, P = .89, omega(2) < 0.01, 1-beta = 0.16) or medium (F-5.20,F-26.01 = 2.43, P = .06, omega(2), 0.01, 1-beta = 0.68) velocities. Conclusions: The Guardian Cap failed to significantly improve the helmets' ability to mitigate impact forces at most locations. Limited evidence indicates how a reduction in GSI would provide clinically relevant benefits beyond reducing the risk of skull fracture or a similar catastrophic event.	[Breedlove, Katherine M.] Univ Delaware, 541 South Coll Ave, Newark, DE 19716 USA; [Breedlove, Katherine M.; Breedlove, Evan; Nauman, Eric] Purdue Univ, W Lafayette, IN 47907 USA; [Bowman, Thomas G.] Lynchburg Coll, Lynchburg, VA 24501 USA; [Lininger, Monica R.] No Arizona Univ, Flagstaff, AZ 86011 USA		Breedlove, KM (corresponding author), Univ Delaware, 541 South Coll Ave, Newark, DE 19716 USA.	kbreedlo@udel.edu	Bowman, Tom/AAU-6473-2020; Bowman, Thomas/AAA-3036-2020	Bowman, Thomas/0000-0002-0034-2946			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; [Anonymous], STAND TEST METH EQ U; [Anonymous], LAB PROC GUID CERT N; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bowman TG, 2014, J ATHL TRAIN S3, V49, pS128; Bowman TG, 2015, J BIOMECH, V48, P3782, DOI 10.1016/j.jbiomech.2015.08.026; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM, 2016, J BIOMECH, V49, P2838, DOI 10.1016/j.jbiomech.2016.06.030; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Fan XT, 2001, J EDUC RES, V94, P275, DOI 10.1080/00220670109598763; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hutchinson TP, 2014, EUR J SPORT SCI, V14, pS377, DOI 10.1080/17461391.2012.705334; McGaw, 2010, INT ENCY ED, P444, DOI DOI 10.1016/B978-0-08-044894-7.01368-3; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; *NAT OP COMM STAND, STAND PERF SPEC NEWL; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; NEWMAN JA, 1993, ACCIDENTAL INJURY BI, P292; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tinard V, 2011, MATER DESIGN, V32, P3112, DOI 10.1016/j.matdes.2010.12.019	24	11	11	0	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2017	52	9					802	808		10.4085/1062-6050-52.6.01			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FN2LO	WOS:000415824000001	28771033	Green Published, Bronze			2022-02-06	
J	Butler, CR; Boychuk, JA; Smith, BN				Butler, Corwin R.; Boychuk, Jeffery A.; Smith, Bret N.			Brain Injury-Induced Synaptic Reorganization in Hilar Inhibitory Neurons Is Differentially Suppressed by Rapamycin	ENEURO			English	Article						dentate gyrus; epilepsy; interneuron; mossy fiber; mTOR; photostimulation	CONTROLLED CORTICAL IMPACT; DENTATE GRANULE CELLS; CA3 PYRAMIDAL CELLS; MOUSE MODEL; MOSSY CELLS; SOMATOSTATIN INTERNEURONS; POSTTRAUMATIC EPILEPSY; MAMMALIAN TARGET; GYRUS; SEIZURES	Following traumatic brain injury (TBI), treatment with rapamycin suppresses mammalian (mechanistic) target of rapamycin (mTOR) activity and specific components of hippocampal synaptic reorganization associated with altered cortical excitability and seizure susceptibility. Reemergence of seizures after cessation of rapamycin treatment suggests, however, an incomplete suppression of epileptogenesis. Hilar inhibitory interneurons regulate dentate granule cell (DGC) activity, and de novo synaptic input from both DGCs and CA3 pyramidal cells after TBI increases their excitability but effects of rapamycin treatment on the injuryinduced plasticity of interneurons is only partially described. Using transgenic mice in which enhanced green fluorescent protein (eGFP) is expressed in the somatostatinergic subset of hilar inhibitory interneurons, we tested the effect of daily systemic rapamycin treatment (3 mg/kg) on the excitability of hilar inhibitory interneurons after controlled cortical impact (CCI)-induced focal brain injury. Rapamycin treatment reduced, but did not normalize, the injury-induced increase in excitability of surviving eGFP+ hilar interneurons. The injury-induced increase in response to selective glutamate photostimulation of DGCs was reduced to normal levels after mTOR inhibition, but the postinjury increase in synaptic excitation arising from CA3 pyramidal cell activity was unaffected by rapamycin treatment. The incomplete suppression of synaptic reorganization in inhibitory circuits after brain injury could contribute to hippocampal hyperexcitability and the eventual reemergence of the epileptogenic process upon cessation of mTOR inhibition. Further, the cell-selective effect of mTOR inhibition on synaptic reorganization after CCI suggests possible mechanisms by which rapamycin treatment modifies epileptogenesis in some models but not others.	[Butler, Corwin R.; Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA; [Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Epilepsy Ctr, Lexington, KY 40536 USA; [Smith, Bret N.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA		Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA.	bret.smith@uky.edu		Boychuk, Jeffery A/0000-0002-7003-1553; Butler, Corwin/0000-0001-5134-4151	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS088608]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088608] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health Grant R21 NS088608 (to B.N.S.).	Bhaskaran MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010683; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Boychuk JA, 2016, EXP NEUROL, V277, P178, DOI 10.1016/j.expneurol.2016.01.005; BROWN TH, 1979, BRAIN RES, V177, P194, DOI 10.1016/0006-8993(79)90931-4; Buckmaster PS, 2011, EPILEPSIA, V52, P2057, DOI 10.1111/j.1528-1167.2011.03253.x; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; BURKE RE, 1967, J NEUROPHYSIOL, V30, P1114, DOI 10.1152/jn.1967.30.5.1114; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Deng P, 2011, J NEUROTRAUM, V28, P1173, DOI 10.1089/neu.2010.1683; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Drew LJ, 2016, HIPPOCAMPUS, V26, P763, DOI 10.1002/hipo.22557; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Halabisky B, 2010, J NEUROPHYSIOL, V104, P2214, DOI 10.1152/jn.00147.2010; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hebert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093691; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Heng K, 2013, EPILEPSIA, V54, P1535, DOI 10.1111/epi.12246; Hester MS, 2016, EXP NEUROL, V280, P1, DOI 10.1016/j.expneurol.2016.03.015; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hsieh LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11753; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Larimer P, 2008, J NEUROSCI, V28, P12212, DOI 10.1523/JNEUROSCI.3612-08.2008; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Parent JM, 1997, J NEUROSCI, V17, P3727; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; SCHARFMAN HE, 1994, J NEUROSCI, V14, P6041; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; SCHARFMAN HE, 1994, NEUROSCIENCE, V59, P245, DOI 10.1016/0306-4522(94)90593-2; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shiri Z, 2017, J NEUROSCI, V37, P2999, DOI 10.1523/JNEUROSCI.2244-16.2017; Staats KA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-31; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442; Yamawaki R, 2015, J COMP NEUROL, V523, P281, DOI 10.1002/cne.23681; Yekhlef L, 2015, J NEUROPHYSIOL, V113, P1616, DOI 10.1152/jn.00841.2014; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang W, 2015, HIPPOCAMPUS, V25, P594, DOI 10.1002/hipo.22396	49	11	11	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2017	4	5							0134-17.2017	10.1523/ENEURO.0134-17.2017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS1FJ	WOS:000419519800010	29085896	Green Published, gold			2022-02-06	
J	Curvello, V; Hekierski, H; Pastor, P; Vavilala, MS; Armstead, WM				Curvello, Victor; Hekierski, Hugh; Pastor, Philip; Vavilala, Monica S.; Armstead, William M.			Dopamine protects cerebral autoregulation and prevents hippocampal necrosis after traumatic brain injury via block of ERK MAPK in juvenile pigs	BRAIN RESEARCH			English	Article						Cerebral autoregulation; Signal transduction; Age; Sex; Brain injury; Histopathology; Vasopressor	TRANSIENT HYPEREMIC RESPONSE; UP-REGULATION; NITROUS-OXIDE; HYPOTENSION; NOREPINEPHRINE; IMPAIRMENT; CHILDREN; NEWBORN; PHENYLEPHRINE; INHIBITION	Traumatic brain injury (TBI) contributes to morbidity in children, and more boys experience TBI. Cerebral autoregulation is impaired after TBI, contributing to poor outcome. Cerebral Perfusion Pressure (CPP) is often normalized by use of vasoactive agents to increase mean arterial pressure (MAP). In prior studies of newborn and juvenile pigs, vasoactive agent choice influenced outcome after TBI as a function of age and sex, with none protecting cerebral autoregulation in both ages and sexes. Dopamine (DA) prevents impairment of cerebral autoregulation in male and female newborn pigs via inhibition of upregulation of ERK mitogen activated protein kinase (MAPK) after fluid percussion injury (FPI). We investigated whether DA protects autoregulation and limits histopathology after FPI in juvenile pigs and the role of ERK in that outcome. Results show that DA protects autoregulation in both male and female juvenile pigs after FPI. Papaverine induced dilation was unchanged by FPI and DA. DA blunted ERK MAPK and prevented loss of neurons in CA1 and CA3 hippocampus of males and females after FPI. These data indicate that DA protects autoregulation and limits hippocampal neuronal cell necrosis via block of ERK after FPI in male and female juvenile pigs. Of the vasoactive agents prior investigated, including norepinephrine, epinephrine, and phenylephrine, DA is the only one demonstrated to improve outcome after TBI in both sexes and ages. These data suggest that DA should be considered as a first line treatment to protect cerebral autoregulation and promote cerebral outcomes in pediatric TBI irrespective of age and sex. (C) 2017 Elsevier B.V. All rights reserved.	[Curvello, Victor; Hekierski, Hugh; Pastor, Philip; Armstead, William M.] Univ Penn, Dept Anesthesiol, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Curvello, Victor; Hekierski, Hugh; Pastor, Philip; Armstead, William M.] Univ Penn, Dept Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.; Armstead, WM (corresponding author), Univ Penn, Dept Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS090998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090998] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health, Grant No. R01 NS090998.	Armstead W.M., 2013, VASCULAR MECH CNS TR, P269; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Curvello V., 2017, PED RES; Czonsyka M., 2014, NEUROCRIT CARE, V21, pS95; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Girling KJ, 1999, ANESTH ANALG, V89, P175, DOI 10.1097/00000539-199907000-00031; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Sharma D, 2010, J NEUROSURG ANESTH, V22, P132, DOI 10.1097/ANA.0b013e3181c9fbf1; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Tibble RK, 2001, ANESTH ANALG, V93, P171	29	11	12	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2017	1670						118	124		10.1016/j.brainres.2017.06.010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD6VM	WOS:000407666000013	28625390	Green Accepted			2022-02-06	
J	Devonish, JA; Homish, DL; Vest, BM; Daws, RC; Hoopsick, RA; Homish, GG				Devonish, J. A.; Homish, D. L.; Vest, B. M.; Daws, R. C.; Hoopsick, R. A.; Homish, G. G.			The impact of military service and traumatic brain injury on the substance use norms of Army Reserve and National Guard Soldiers and their spouses	ADDICTIVE BEHAVIORS			English	Article						Substance use; Military; Traumatic brain injury; Marriage	MENTAL-HEALTH PROBLEMS; POSTTRAUMATIC-STRESS-DISORDER; MARIJUANA USE; OEF/OIF VETERANS; COMMUNITY SAMPLE; PROBLEM DRINKING; IRAQ; ALCOHOL; AFGHANISTAN; PREDICTORS	Introduction: Traumatic brain injury (TBI) and substance use are highly prevalent conditions among military populations. There is a significant body of evidence that suggests greater approval of substance use (i.e., norms) is related to increased substance use. The objective of this work is to understand the impact of TBI and military service on substance use norms of soldiers and their partners. Data are from the baseline assessment of Operation: SAFETY, an ongoing, longitudinal study of US Army Reserve/National Guard (USAR/NG) soldiers and their partners. Methods: Multiple regression models examined associations between alcohol, tobacco, illicit drug use, and non-medical use of prescription drug (NMUPD) norms within and across partners based on current military status (CMS) and TBI. Results: Male USAR/NG soldiers disapproved of NMUPD, illicit drug use and tobacco use. There was no relation between military status and alcohol use. Among females, there was no relation between CMS and norms. The NMUPD norms of wives were more likely to be approving if their husbands reported TBI symptoms and had separated from the military. Husbands of soldiers who separated from the military with TBI had greater approval of the use of tobacco, NMUPD, and illicit drugs. Conclusion: Overall, there is evidence to suggest that, while generally disapproving of substance use, soldiers and partners become more accepting of use if they also experience TBI and separate from the military. Future research should examine the longitudinal influence of TBI on substance use norms and subsequent changes in substance use over time.	[Devonish, J. A.; Homish, D. L.; Daws, R. C.; Hoopsick, R. A.; Homish, G. G.] SUNY Buffalo, Dept Community Hlth & Hlth Behav, 325 Kimball Tower, Buffalo, NY 14214 USA; [Devonish, J. A.] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, 285 Kapoor Hall, Buffalo, NY 14214 USA; [Vest, B. M.] SUNY Buffalo, Dept Family Med, 77 Goodell St,Suite 220, Buffalo, NY 14203 USA		Homish, GG (corresponding author), SUNY Buffalo, Dept Community Hlth & Hlth Behav, 325 Kimball Tower, Buffalo, NY 14214 USA.	ghomish@buffalo.edu	Hoopsick, Rachel A./ABH-7046-2020; Homish, Gregory G/A-9576-2009	Hoopsick, Rachel A./0000-0001-5992-9007; Vest, Bonnie/0000-0002-3401-7367; Homish, Gregory/0000-0003-2601-3283	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-DA034072]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA034072] Funding Source: NIH RePORTER	Funding for this study was provided by the NIH Grant R01-DA034072. The NIH was not involved in the creation of the study design, data collection, analysis, or interpretation, manuscript preparation, or decisions to submit for publication purposes.	Andrews JA, 2002, HEALTH PSYCHOL, V21, P349, DOI 10.1037//0278-6133.21.4.349; [Anonymous], 2014, DOD POL DRUG ALC AB; Armitage CJ, 1999, BASIC APPL SOC PSYCH, V21, P301, DOI 10.1207/S15324834BASP2104_4; Bailey JA, 2016, J ADOLESCENT HEALTH, V59, P262, DOI 10.1016/j.jadohealth.2016.04.010; Bennett AS, 2013, SUBST USE MISUSE, V48, P894, DOI 10.3109/10826084.2013.796991; Bondurant S., 2009, COMBATING TOBACCO US, P380; BRAY RM, 1991, AM J PUBLIC HEALTH, V81, P865, DOI 10.2105/AJPH.81.7.865; Bray RM., 2008, DEP DEFENSE SURVEY H; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Bush DM, 2008, FORENSIC SCI INT, V174, P111, DOI 10.1016/j.forsciint.2007.03.008; Castenada L. W., 2009, DEPLOYMENT EXPERIENC; DeFulio A, 2009, ADDICTION, V104, P1530, DOI 10.1111/j.1360-0443.2009.02657.x; Delucchi KL, 2008, ADDICT BEHAV, V33, P134, DOI 10.1016/j.addbeh.2007.04.027; Department of Defense, 2012, DEP DEF ANN REP C DE; Derrick JL, 2013, NICOTINE TOB RES, V15, P1528, DOI 10.1093/ntr/ntt011; Dollar KM, 2009, AM J PUBLIC HEALTH, V99, P231, DOI 10.2105/AJPH.2008.140459; Eisen SA, 2004, MIL MED, V169, P896, DOI 10.7205/MILMED.169.11.896; Golub A, 2014, ADDICT BEHAV, V39, P449, DOI 10.1016/j.addbeh.2013.06.020; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Homish GG, 2005, SOC SCI MED, V61, P2557, DOI 10.1016/j.socscimed.2005.05.005; Homish GG, 2005, J STUD ALCOHOL, V66, P488, DOI 10.15288/jsa.2005.66.488; Homish GG, 2008, J STUD ALCOHOL DRUGS, V69, P906, DOI 10.15288/jsad.2008.69.906; Homish GG, 2008, AM J HEALTH BEHAV, V32, P754, DOI 10.5555/ajhb.2008.32.6.754; Homish GG, 2007, DRUG ALCOHOL DEPEN, V91, P121, DOI 10.1016/j.drugalcdep.2007.05.014; Homish GG, 2010, ADDICTION, V105, P1457, DOI 10.1111/j.1360-0443.2010.02986.x; Hourani LL, 2006, MIL MED, V171, P849, DOI 10.7205/MILMED.171.9.849; Ilakkuvan V, 2017, HEALTH EDUC BEHAV, V44, P216, DOI 10.1177/1090198116643964; Institute of Medicine, 2008, GULF WAR ON HLTH, V7; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kilmer JR, 2015, ADDICT BEHAV, V42, P51, DOI 10.1016/j.addbeh.2014.11.005; Kulesza Magdalena, 2015, Mil Behav Health, V3, P230; Leonard KE, 2000, J STUD ALCOHOL, V61, P669, DOI 10.15288/jsa.2000.61.669; Leonard KE, 2005, J DRUG ISSUES, V35, P409, DOI 10.1177/002204260503500209; Leonard KE, 2008, PSYCHOL ADDICT BEHAV, V22, P25, DOI 10.1037/0893-164X.22.1.25; Lipperman-Kreda S, 2014, PREV SCI, V15, P738, DOI 10.1007/s11121-013-0442-2; McLaughlin I, 2010, TOBACCO CONTROL LEGA; MEASHAM F, 1994, BRIT J SOCIOL, V45, P287, DOI 10.2307/591497; Mental Health Advisory Team (MHAT-V), 2008, OP IR FREED 06 08 IR; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Neighbors C., 2014, MILITARY BEHAV HLTH, V2, P203, DOI [10.1080/21635781.2014.890883, DOI 10.1080/21635781.2014.890883]; Norman SB, 2014, J STUD ALCOHOL DRUGS, V75, P557, DOI 10.15288/jsad.2014.75.557; Normand J, 1994, INFLUENCE DRUGS AM W; Phillips JA, 2015, WORKPLACE HEALTH SAF, V63, P139, DOI 10.1177/2165079915581983; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Schleicher NC, 2016, PREV MED, V91, P287, DOI 10.1016/j.ypmed.2016.08.027; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Smith PH, 2012, ADDICTION, V107, P1453, DOI 10.1111/j.1360-0443.2012.03840.x; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Williams J, 2009, DRUG ALCOHOL DEPEN, V100, P248, DOI 10.1016/j.drugalcdep.2008.10.007	56	11	11	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4603	1873-6327		ADDICT BEHAV	Addict. Behav.	SEP	2017	72						51	56		10.1016/j.addbeh.2017.03.012			6	Psychology, Clinical; Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Substance Abuse	EY3GJ	WOS:000403859300009	28388492	Green Accepted			2022-02-06	
J	Eaton, J; Hanif, AB; Mulima, G; Kajombo, C; Charles, A				Eaton, Jessica; Hanif, Asma Bilal; Mulima, Gift; Kajombo, Chifundo; Charles, Anthony			Outcomes Following Exploratory Burr Holes for Traumatic Brain Injury in a Resource Poor Setting	WORLD NEUROSURGERY			English	Article						Global neurosurgery; Low-and middle-income countries; sub-Saharan Africa; Trauma; Traumatic brain injury	TERTIARY REFERRAL CENTER; ACUTE SUBDURAL-HEMATOMA; MANAGEMENT; EXPERIENCE; MORTALITY; MWANZA	BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. The incidence of TBI in low-and middle-income countries (LMICs) is disproportionately high, with an associated increased risk of mortality from TBI relative to high-income countries. Although computed tomography is the diagnostic method of choice, this is often unavailable in LMICs. Exploratory burr holes may provide a suitable choice for diagnosis and treatment of TBI. METHODS: We performed a retrospective review of prospectively collected data at KCH, a tertiary care center in Lilongwe, Malawi. All trauma patients presenting between June 2012 and July 2015 with a deteriorating level of consciousness and localizing signs and who underwent exploratory burr holes were included. Additionally, we included all patients admitted with TBI, requiring higherlevel care during 2011. No patients underwent exploratory burr hole during this time. We performed logistic regression to identify predictors of mortality in the total population of TBI patients. RESULTS: Among the 241 patients who presented to KCH with TBI requiring higher-level care, the total mortality was 16.4%. More than half (163, or 68%) underwent exploratory burr hole with a mortality of 6.8%. Mortality in patients who did not undergo exploratory burr hole was 43.9%. Upon adjusted logistic regression, not undergoing exploratory burr hole significantly increased the odds of mortality (odds ratio 12.0, P 0.000, 95% confidence interval 4.48e31.9). CONCLUSION: Exploratory burr holes remain an important diagnostic and therapeutic procedure for TBI in LMICs. Exploratory burr hole technique should be integrated into general surgery education to attenuate TBI-related mortality.	[Eaton, Jessica; Charles, Anthony] UNC Project Malawi, Lilongwe, Malawi; [Hanif, Asma Bilal; Mulima, Gift; Kajombo, Chifundo; Charles, Anthony] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi; [Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA		Charles, A (corresponding author), UNC Project Malawi, Lilongwe, Malawi.; Charles, A (corresponding author), Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi.; Charles, A (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA.	anthchar@med.unc.edu	Mulima, Gift/ABF-9034-2020	Mulima, Gift/0000-0001-8367-0779	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC); Office of AIDS ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Cancer Center; National Heart, Blood, and Lung InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium [R25TW009340]; Fulbright Program; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R25TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008450] Funding Source: NIH RePORTER	This work was supported by the Fulbright Program and the National Institutes of Health (NIH) Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Heart, Blood, and Lung Institute; and the NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium composed of the University of North Carolina, John Hopkins, Morehouse and Tulane (R25TW009340). The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this paper.	ANDREWS BT, 1986, NEUROSURGERY, V19, P408, DOI 10.1227/00006123-198609000-00012; [Anonymous], 2000, INJURY, P1; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burton C, 1965, J Trauma, V5, P643, DOI 10.1097/00005373-196509000-00008; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P74, DOI 10.1111/nyas.12482; Coburger J, 2014, WORLD NEUROSURG, V82, pE1, DOI 10.1016/j.wneu.2012.09.019; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; El-Fiki M, 2014, WORLD NEUROSURG, V82, pE155, DOI 10.1016/j.wneu.2012.10.065; Fatigba HO, 2013, ISRN SURG, V2013; Greenberg MS, 2010, HDB NEUROSURGERY, V7, P850; Gunnarsson T, 2003, CURR OPIN NEUROL, V16, P717, DOI 10.1097/00019052-200312000-00012; Houseman C, 2012, PRINCIPLES NEUROLOGI, P325; JENNETT B, 1975, LANCET, V1, P480; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Nagabhand Arlai, 1993, Journal of the Medical Association of Thailand, V76, P399; Natarajan M, 1989, J Indian Med Assoc, V87, P256; ORTLER M, 1993, UNFALLCHIRURG, V96, P628; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Saraceno BAJ, 2004, ATLAS COUNTRY RESOUR; SCHECTER WP, 1985, ARCH SURG-CHICAGO, V120, P1163; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2010, GLOB FOR IMPR DEV CO	27	11	11	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105						257	264		10.1016/j.wneu.2017.05.153			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600035	28583456	Green Published, Green Accepted			2022-02-06	
J	Goedemans, T; Verbaan, D; Coert, BA; Kerklaan, BJ; van den Berg, R; Coutinho, JM; van Middelaar, T; Nederkoorn, PJ; Vandertop, WP; van den Munckhof, P				Goedemans, Taco; Verbaan, Dagmar; Coert, Bert A.; Kerklaan, Bertjan J.; van den Berg, Rene; Coutinho, Jonathan M.; van Middelaar, Tessa; Nederkoorn, Paul J.; Vandertop, William Peter; van den Munckhof, Pepijn			Neurologic Outcome After Decompressive Craniectomy: Predictors of Outcome in Different Pathologic Conditions	WORLD NEUROSURGERY			English	Article						Aneurysmal subarachnoid hemorrhage; Cerebral venous thrombosis; Decompressive craniectomy; Intracerebral hemorrhage; Ischemic stroke; Outcome; Traumatic brain injury	CEREBRAL VENOUS THROMBOSIS; SUBARACHNOID HEMORRHAGE; INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; HEMICRANIECTOMY; ARTERY; TRIAL; EVACUATION; MANAGEMENT; INFARCTION	OBJECTIVE: Decompressive craniectomy (DC) has been proposed as a lifesaving treatment in patients with elevated intracranial pressure, but its effectiveness on reaching a favorable neurologic outcome remains unclear. We identified predictors of outcome in a large, single-center cohort of patients undergoing DC for different pathologic conditions. METHODS: This retrospective study included all patients undergoing DC from 2006 to 2014. The 1-year outcome, assessed using the Glasgow Outcome Scale (GOS), was dichotomized into favorable (GOS 4e5) and unfavorable (GOS 1e3) outcome. Predictors of outcome were identified by analyzing patient characteristics. RESULTS: DC was performed in 204 patients for ischemic stroke (n [57), traumatic brain injury (n [50), aneurysmal subarachnoid hemorrhage (aSAH) (n [44), intracerebral hemorrhage (ICH) (n [29), cerebral venous thrombosis (CVT) (n [14), or other indications (n [10). Overall, 69 (34%) patients survived favorably, 39 (19%) survived unfavorably, and 96 (47%) died. Higher age, poor Glasgow Coma Scale score, intubated status before DC, bilateral absence of pupillary light reflexes, DC for aSAH, and additional surgeries after DC (excluding cranioplasty) were significant predictors of unfavorable outcome. When patients were sorted for pathologic conditions and predictors of outcome, favorable outcome rates differed remarkably, ranging from 91% for CVT patients undergoing uncomplicated DC to 0% for aSAH patients undergoing DC for secondary infarction or ICH patients with unilateral or bilateral abnormal pupillary light reflexes upon admission. CONCLUSIONS: Long-term neurologic outcome after DC differed remarkably among subpopulations of patients, with favorable outcome rates ranging from 0% to >90%.	[Goedemans, Taco; Verbaan, Dagmar; Coert, Bert A.; Vandertop, William Peter; van den Munckhof, Pepijn] Acad Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [van den Berg, Rene] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Coutinho, Jonathan M.; van Middelaar, Tessa; Nederkoorn, Paul J.] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Kerklaan, Bertjan J.] Onze Lieve Vrouw Hosp, Dept Neurol, Amsterdam, Netherlands; [Kerklaan, Bertjan J.] Zaans Med Ctr, Zaandam, Netherlands		van den Munckhof, P (corresponding author), Acad Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands.	p.vandenmunckhof@amc.nl	Vandertop, William P./K-9288-2018; van den Munckhof, Pepijn/AAY-9259-2020; Coutinho, Jonathan/AAN-4546-2020	Coutinho, Jonathan/0000-0002-8284-982X; Verbaan, Dagmar/0000-0002-9212-5470; Vandertop, William/0000-0001-5417-0265; van den Munckhof, Pepijn/0000-0001-5044-3705			Aaron S, 2013, J NEUROL NEUROSUR PS, V84, P995, DOI 10.1136/jnnp-2012-303356; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dorfer C, 2010, WORLD NEUROSURG, V74, P465, DOI 10.1016/j.wneu.2010.08.001; Esquenazi Y, 2015, CLIN NEUROL NEUROSUR, V128, P117, DOI 10.1016/j.clineuro.2014.11.015; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jabbarli R, 2017, WORLD NEUROSURG, V98, P689, DOI 10.1016/j.wneu.2016.12.012; Kapapa T, 2016, WORLD NEUROSURG, V93, P389, DOI 10.1016/j.wneu.2016.06.075; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Li Q, 2013, BRIT J NEUROSURG, V27, P617, DOI 10.3109/02688697.2013.765938; Moussa WMM, 2017, NEUROSURG REV, V40, P115, DOI 10.1007/s10143-016-0743-6; Stam J, 2008, STROKE, V39, P1487, DOI 10.1161/STROKEAHA.107.502658; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van Middelaar T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0407-0; Vivakaran TTR, 2012, J NEUROSURG, V117, P738, DOI 10.3171/2012.6.JNS11102; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zhang S, 2016, J NEUROSURG, V21, P1; Zuurbier SM, 2012, J NEUROL, V259, P1099, DOI 10.1007/s00415-011-6307-3	23	11	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105						765	774		10.1016/j.wneu.2017.06.069			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600100	28642178				2022-02-06	
J	Jourdan, C; Bayen, E; Vallat-Azouvi, C; Ghout, I; Darnoux, E; Azerad, S; Charanton, J; Aegerter, P; Pradat-Diehl, P; Ruet, A; Azouvi, P				Jourdan, Claire; Bayen, E.; Vallat-Azouvi, C.; Ghout, I.; Darnoux, E.; Azerad, S.; Charanton, J.; Aegerter, P.; Pradat-Diehl, P.; Ruet, A.; Azouvi, P.			Late Functional Changes Post-Severe Traumatic Brain Injury Are Related to Community Reentry Support: Results From the PariS-TBI Cohort	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; brain injuries; community integration; GOSE; longitudinal studies; outcome	GLASGOW OUTCOME SCALE; FOLLOW-UP; HEAD-INJURY; REHABILITATION; PREDICTORS; DISABILITY; ADULTS; EPIDEMIOLOGY; PATTERNS; RECOVERY	Objectives: To explore late functional changes after a traumatic brain injury and their relation to patients' characteristics and reentry support. Design: Prospective follow-up of an inception cohort of adults with severe traumatic brain injury recruited in 2005-2007 in the Parisian area, France. One and 4-year assessments were performed by trained neuropsychologists. One-to-4-year change in the Glasgow Outcome Scale-Extended defined 3 groups: "improvement," "stability," and "worsening." Relationships between these groups and patients' characteristics were analyzed. Results: Among 504 recruited patients and 245 four-year survivors, 93 participated in both evaluations. Overall Glasgow Outcome Scale-Extended improved by 0.4. Forty percent of the sample improved, 44% were stable, and 16% worsened. Being in a more unfavorable group was related to preinjury alcohol abuse and to higher anxiety and depression at 4 years. Attendance to a specialized community reentry unit was related to higher chances of being in the "improvement" group in univariate analyses and after adjustment for age, time to follow command, preinjury alcohol and occupation, and mood disorders (adjusted odds ratio [OR] = 4.6 [1.1-20]). Conclusion: Late functional changes were related to psychosocial variables and to reentry support. The effect of reentry support on late recovery needs to be confirmed by further investigations.	[Jourdan, Claire; Vallat-Azouvi, C.; Azouvi, P.] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Jourdan, Claire; Vallat-Azouvi, C.; Azouvi, P.] Univ Versailles St Quentin, HANDIReSP EA 4047, Montigny Le Bretonneux, France; [Bayen, E.; Pradat-Diehl, P.] Univ Paris 06, Paris, France; [Bayen, E.; Pradat-Diehl, P.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Serv Med Phys & Readaptat, Paris, France; [Vallat-Azouvi, C.] Univ Paris VIII, EA 2027, St Denis, France; [Vallat-Azouvi, C.] Hop Raymond Poincare, Antenne UEROS UGECAM IDF SAMSAH92, Garches, France; [Ghout, I.; Darnoux, E.; Azerad, S.; Aegerter, P.] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Charanton, J.] CRFTC, Paris, France; [Aegerter, P.] Univ Versailles St Quentin, UFR Sci Sante Simone Veil, UMR S 1168, Montigny Le Bretonneux, France		Jourdan, C (corresponding author), CHRU Montpellier, Serv Med Phys & Readaptat, Site Lapeyronie,371 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France.	cl-jourdan@chu-montpellier.fr	RUET, Alexis/L-8726-2015; AEGERTER, Philippe/AAY-6003-2021	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health [AOM04084]; Institut de Recherche en Sante Publique (IRESP)	The first part of this study was funded by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004, AOM04084) and completed with the help of AP-HP (Departement de la Recherche Clinique et du Developpement). The second part of this study was funded by a grant from the Institut de Recherche en Sante Publique (IRESP).	Azouvi P., 2014, NEUROPSYCHOL REHABIL, V25, P864, DOI DOI 10.1080/09602011; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crane PK, 2016, ALZHEIMERS DEMENT, V12, P419, DOI 10.1016/j.jalz.2015.10.007; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hamonet-Torny J., 2013, Annals of Physical and Rehabilitation Medicine, V56, P174, DOI 10.1016/j.rehab.2013.01.007; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Le Gall C., 2007, Annales de Readaptation et de Medecine Physique, V50, P5, DOI 10.1016/j.annrmp.2006.06.007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; R Core Team R, 2013, LANG ENV STAT COMP; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					E26	E34		10.1097/HTR.0000000000000276			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800003	28060204				2022-02-06	
J	Osthoff, M; Walder, B; Delhumeau, C; Trendelenburg, M; Turck, N				Osthoff, Michael; Walder, Bernhard; Delhumeau, Cecile; Trendelenburg, Marten; Turck, Natacha			Association of Lectin Pathway Protein Levels and Genetic Variants Early after Injury with Outcomes after Severe Traumatic Brain Injury: A Prospective Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						complement system; ficolins; inflammation; MBL; TBI	MANNOSE-BINDING LECTIN; SERINE PROTEASES MASPS; COMPLEMENT ACTIVATION; APOPTOTIC CELLS; C1 INHIBITOR; H-FICOLIN; DEFICIENCY; ISCHEMIA; MBL; C1-INHIBITOR	The lectin pathway of the complement system has been implicated in secondary ischemic/inflammatory injury after traumatic brain injury (TBI). However, previous experimental studies have yielded conflicting results, and human studies are scarce. In this exploratory study, we investigated associations of several lectin pathway proteins early after injury and single-nucleotide polymorphisms (SNP) with outcomes after severe TBI (mortality at 14 days [primary outcome] and consciousness assessed with the Glasgow Coma Scale [GCS] at 14 days, disability assessed with the Glasgow Outcome Scale Extended [GOSE] at 90 days). Forty-four patients with severe TBI were included. Plasma levels of lectin pathway proteins were sampled at 6, 12, 24, and 48 h after injury and eight mannose-binding lectin (MBL) and ficolin (FCN) 2 SNPs were analyzed by enzyme-linked immunosorbent assay (ELISA) and genotyping, respectively. Plasma protein levels were stable with only a slight increase in mannose-binding protein-associated serine protease (MASP)-2 and FCN2 levels after 48 h (p < 0.05), respectively. Neither lectin protein plasma levels (6 h or mean levels) nor MBL2 genotypes or FCN2 variant alleles were associated with 14 day mortality or 14 day consciousness. However, FCN2, FCN3, and MASP-2 levels were higher in patients with an unfavorable outcome (GOSE 1-4) at 90 days (p < 0.05), whereas there was no difference in MBL2 genotypes or FCN2 variant alleles. In particular, higher mean MASP-2 levels over 48 h were independently associated with a GOSE score < 4 at 90 days after adjustment (odds ratio 3.46 [95% confidence interval 1.12-10.68] per 100 ng/mL increase, p = 0.03). No association was observed between the lectin pathway of the complement system and 14 day mortality or 14 day consciousness. However, higher plasma FCN2, FCN3, and, in particular, MASP-2 levels early after injury were associated with an unfavorable outcome at 90 days (death, vegetative state, and severe disability) which may be related to an increased activation of the lectin pathway.	[Osthoff, Michael; Trendelenburg, Marten] Univ Hosp Basel, Div Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Osthoff, Michael; Trendelenburg, Marten] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Walder, Bernhard; Delhumeau, Cecile] Univ Hosp Geneva, Dept Anaesthesiol Intens Care & Clin Pharmacol, Div Anaesthesiol, Geneva, Switzerland; [Turck, Natacha] Univ Geneva, Dept Human Prot Sci, OPT Grp, Geneva, Switzerland		Osthoff, M (corresponding author), Univ Hosp Basel, Div Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland.	michael.osthoff@usb.ch	Trendelenburg, Marten/AAM-1626-2020	Trendelenburg, Marten/0000-0001-7036-8386; Osthoff, Michael/0000-0001-5439-957X	Fondation Machaon, Switzerland	This substudy was funded by a research grant from the Fondation Machaon, Switzerland (a not-for-profit private foundation) to the corresponding author. The funding source had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Beinrohr L, 2008, TRENDS MOL MED, V14, P511, DOI 10.1016/j.molmed.2008.09.009; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Cai SH, 2005, J IMMUNOL, V174, P6462, DOI 10.4049/jimmunol.174.10.6462; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Eisen DP, 2014, CLIN EXP IMMUNOL, V176, P165, DOI 10.1111/cei.12241; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Eisen DP, 2006, FEMS IMMUNOL MED MIC, V48, P274, DOI 10.1111/j.1574-695X.2006.00144.x; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Frauenknecht V, 2013, CLIN EXP IMMUNOL, V173, P112, DOI 10.1111/cei.12093; Fust G, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-185; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Kilpatrick DC, 2013, HUM IMMUNOL, V74, P867, DOI 10.1016/j.humimm.2013.04.011; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Kozarcanin H, 2016, J THROMB HAEMOST, V14, P531, DOI 10.1111/jth.13208; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Osthoff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134107; Osthoff M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0480-6; Osthoff M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076218; Osthoff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021338; Pan JW, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0444-z; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Trendelenburg M, 2010, EUR HEART J, V31, P1181, DOI 10.1093/eurheartj/ehp597; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yu W, 2015, CLIN CHIM ACTA, V451, P111, DOI 10.1016/j.cca.2015.10.017; Zangari R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0481-2; Zanier ER, 2014, NEUROLOGY, V82, P126, DOI 10.1212/WNL.0000000000000020	53	11	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2560	2566		10.1089/neu.2016.4941			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200009	28482760				2022-02-06	
J	Sagarkar, S; Mahajan, S; Choudhary, AG; Borkar, CD; Kokare, DM; Sakharkar, AJ				Sagarkar, S.; Mahajan, S.; Choudhary, A. G.; Borkar, C. D.; Kokare, D. M.; Sakharkar, A. J.			Traumatic stress-induced persistent changes in DNA methylation regulate neuropeptide Y expression in rat jejunum	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						DNA methylation; GADD45; gut motility; neuropeptide Y; trauma	INFLAMMATORY-BOWEL-DISEASE; ENTERIC NERVOUS-SYSTEM; BRAIN-INJURY; IMMUNE-SYSTEM; ANXIETY-LIKE; PEPTIDE-YY; EPIGENETICS; MODEL; GENE; NPY	Background: Stress-induced chronic neuropsychiatric conditions such as anxiety are often co-morbid with gastrointestinal malfunctions. While we find enduring anxiety-like symptoms following minimal traumatic brain injury (MTBI) in rats, gastrointestinal consequences of MTBI remain elusive. Methods: In this study, we examined the effects of MTBI on a major gut peptide, neuropeptide Y (NPY) and gut motility. DNA methylation was studied as a possible epigenetic mechanism operative in the regulation of NPY expression in the gut. Key Results: Minimal traumatic brain injury reduced the gut motility 48hours and 30days after trauma. The expression of DNA methyltransferase isoforms (DNMT1, DNMT3a, and DNMT3b) was altered in the jejunum 48hours and 30days after MTBI. However, the mRNA levels of growth arrest and DNA damage 45 (GADD45) isoforms, GADD45a, and GADD45b, which are believed to be involved in active DNA demethylation, initially decreased at 48hours but subsequently increased after 30days of trauma. Similarly, DNA hypomethylation at the NPY promoter region in the jejunum was correlated with the increase in NPY mRNA and protein levels 30days post-trauma. On the other hand, DNA hypomethylation at 48hours was associated with a decline in NPY expression. Treatment with 5-azacytidine (5-AzaC), a DNMT inhibitor, retarded DNA methylation and restored the NPY mRNA levels in the jejunum of MTBI-induced rats. Conclusions & Inferences: These results suggest that DNA demethylation could be operative as an epigenetic mechanism in the long-term regulation of NPY gene expression to alter the gut motility during traumatic stress.	[Sagarkar, S.; Mahajan, S.; Sakharkar, A. J.] Savitribai Phule Pune Univ, Dept Biotechnol, Pune, Maharashtra, India; [Choudhary, A. G.; Borkar, C. D.; Kokare, D. M.] Rashtrasant Tukadoji Maharaj Nagpur Univ, Dept Pharmaceut Sci, Nagpur, Maharashtra, India		Sakharkar, AJ (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune, Maharashtra, India.	amul.sakharkar@unipune.ac.in	Borkar, Chandrashekhar D/E-5722-2015	Borkar, Chandrashekhar D/0000-0003-3636-2356	University Grants Commission (UGC), Government of IndiaUniversity Grants Commission, India [(F.4-5/151-FRP)/2014(BSR)]; Board of College and University Development (BCUD); Savitribai Phule Pune University, Pune; Department Research and Development Program (DRDP) of the Department of Biotechnology, Savitribai Phule Pune University, Pune, India; Department of Biotechnology, Government of IndiaDepartment of Biotechnology (DBT) India [BT/PR6325/GBD/27/402/2012]	This work was supported by grants from the University Grants Commission (UGC), Government of India (F.4-5/151-FRP)/2014(BSR) and Board of College and University Development (BCUD), Savitribai Phule Pune University, Pune to AJS. AJS and SS also acknowledge funds received through the Department Research and Development Program (DRDP) of the Department of Biotechnology, Savitribai Phule Pune University, Pune, India. DMK thanks the Department of Biotechnology, Government of India, for research funds (BT/PR6325/GBD/27/402/2012).	Arciszewski MB, 2009, VET MED-CZECH, V54, P589, DOI 10.17221/66/2009-VETMED; Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; Bannaga AS, 2015, CLIN EXP GASTROENTER, V8, P111, DOI 10.2147/CEG.S57982; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bharne AP, 2015, BEHAV BRAIN RES, V291, P219, DOI 10.1016/j.bbr.2015.05.030; Chen CH, 1997, NEUROGASTROENT MOTIL, V9, P109, DOI 10.1046/j.1365-2982.1997.d01-26.x; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Cifani C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00187; Cox HM, 2007, AUTON NEUROSCI-BASIC, V133, P76, DOI 10.1016/j.autneu.2006.10.005; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00071, 10.3339/fnbeh.2015.00071]; Dimitrijevic M, 2013, AMINO ACIDS, V45, P41, DOI 10.1007/s00726-011-1185-7; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Duan HB, 2013, J SURG RES, V184, P1006, DOI 10.1016/j.jss.2013.03.096; DUMONT Y, 1992, PROG NEUROBIOL, V38, P125, DOI 10.1016/0301-0082(92)90038-G; Gavin DP, 2013, NEUROPHARMACOLOGY, V75, P233, DOI 10.1016/j.neuropharm.2013.07.036; Genton L, 2003, AM J SURG, V186, P253, DOI 10.1016/S0002-9610(03)00210-1; Ghia JE, 2009, GASTROENTEROLOGY, V136, P2280, DOI 10.1053/j.gastro.2009.02.069; Haghighi F, 2014, DIALOGUES CLIN NEURO, V16, P430; HOLZER P, 1987, GASTROENTEROLOGY, V92, P1944, DOI 10.1016/0016-5085(87)90628-7; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; HUBEL KA, 1986, J PHARMACOL EXP THER, V238, P167; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Karpova NN, 2014, NEUROPHARMACOLOGY, V76, P709, DOI 10.1016/j.neuropharm.2013.04.002; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Leach PT, 2012, LEARN MEMORY, V19, P319, DOI 10.1101/lm.024984.111; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; Lin HC, 2004, JAMA-J AM MED ASSOC, V292, P852, DOI 10.1001/jama.292.7.852; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Qihui, 2015, Sheng Wu Gong Cheng Xue Bao, V31, P1175; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer EA, 2000, GUT, V47, P861, DOI 10.1136/gut.47.6.861; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mittelstadt S. W., 2005, Journal of Pharmacological and Toxicological Methods, V52, P154, DOI 10.1016/j.vascn.2005.04.017; Mittermaier C, 2004, PSYCHOSOM MED, V66, P79, DOI 10.1097/01.PSY.0000106907.24881.F2; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Roperch JP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-566; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sakharkar AJ, 2014, INT J NEUROPSYCHOPH, V17, P2057, DOI 10.1017/S1461145714001047; Sakharkar AJ, 2014, INT J NEUROPSYCHOPH, V17, P1207, DOI 10.1017/S1461145714000054; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; SARIA A, 1985, EUR J PHARMACOL, V119, P47, DOI 10.1016/0014-2999(85)90320-6; Schmeltzer SN, 2016, EXP NEUROL, V284, P196, DOI 10.1016/j.expneurol.2016.06.020; Seidl H, 2012, NEUROGASTROENT MOTIL, V24, pe373, DOI 10.1111/j.1365-2982.2012.01955.x; Stankiewicz AM, 2013, BRAIN RES BULL, V98, P76, DOI 10.1016/j.brainresbull.2013.07.003; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Thorsell A, 2010, EXP BIOL MED, V235, P1163, DOI 10.1258/ebm.2010.009331; Torroglosa A, 2014, GENET MED, V16, P703, DOI 10.1038/gim.2014.17; Zhang HJ, 2008, DIGESTION, V78, P72, DOI 10.1159/000165352	56	11	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	SEP	2017	29	9							e13074	10.1111/nmo.13074			11	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Neurosciences & Neurology	FD0SO	WOS:000407249200003	28418087				2022-02-06	
J	Wang, AM; Zhu, GB; Qian, P; Zhu, T				Wang, Aimin; Zhu, Guangbin; Qian, Ping; Zhu, Tao			Tetramethylpyrazine reduces blood-brain barrier permeability associated with enhancement of peripheral cholinergic anti-inflammatory effects for treating traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						tetramethylpyrazine; traumatic brain injury; blood-brain barrier; anti-inflammation	FOCAL CEREBRAL-ISCHEMIA; DYSFUNCTION; ACTIVATION; IMPACT; MODEL	Traumatic brain injury (TBI) is a diverse group of intracranial injuries resulting from external mechanical insults to the brain. While basic and clinical research for TBI has been conducted for decades, it has not identified cost-effective medical interventions for treating TBI. Tetramethylpyrazine (TMP), which is derived from the Chinese herb, Ligusticum chuanxiong Hort (Chuan Xiong), has been clinically used for treating ischemic brain injury for years. However, whether TMP could provide effective benefits for improving the outcomes following TBI is unknown. In the present study, using controlled cortical impact (CCI) injury to create an animal model of TBI, the potential effects of TMP on improving blood-brain barrier (BBB) permeability in the early phase of the secondary injury, as well as the splenic anti-inflammatory activities, were evaluated. Cognitive functions were also assessed by Morris water maze trials following TBI. Results demonstrated that, at 24 h after CCI injury, BBB permeability was significantly reduced (P<0.05) by the application of TMP. In addition, within 24 h after CCI injury, the plasma levels of interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha, and protein and mRNA expression levels of IL-1 beta and TNF-alpha in the spleen were significantly lowered by TMP (P<0.05). Furthermore, within 24 h after CCI injury, the activation of the splenic anti-inflammatory effects mediated by nicotinic acetylcholine receptor alpha 7 (nAChRa7) stimulation were significantly enhanced by TMP (P<0.05). Additionally, impaired spatial memory acquisition and consolidation were significantly improved by TMP after CCI injury (P<0.05). Together, in light of these data, in the treatment of TBI, TMP could effectively reduce BBB permeability, which may be closely associated with the enhanced splenic anti-inflammatory effects activated by nAChRa7 stimulation, and potentially improve cognitive recovery concerning spatial learning and memory.	[Wang, Aimin; Zhu, Guangbin; Qian, Ping; Zhu, Tao] Soochow Univ, Dept Intens Care Unit, Taicang Affiliated Hosp, 58 South Changsheng Rd, Taicang 215006, Jiangsu, Peoples R China		Zhu, T (corresponding author), Soochow Univ, Dept Intens Care Unit, Taicang Affiliated Hosp, 58 South Changsheng Rd, Taicang 215006, Jiangsu, Peoples R China.	zhutao0512@hotmail.com					Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Baumann G, 2013, EXP BIOL MED, V238, P830, DOI 10.1177/1535370213494558; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; BROWN MA, 1995, HIPPOCAMPUS, V5, P171, DOI 10.1002/hipo.450050304; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Chang CY, 2015, BIOCHEM BIOPH RES CO, V463, P421, DOI 10.1016/j.bbrc.2015.05.088; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jia J, 2009, THROMB RES, V123, P727, DOI 10.1016/j.thromres.2008.11.004; Kao TK, 2013, EXP NEUROL, V247, P188, DOI 10.1016/j.expneurol.2013.04.010; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim M, 2014, EUR J PHARMACOL, V740, P504, DOI 10.1016/j.ejphar.2014.06.037; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li WX, 2012, MOLECULES, V17, P10614, DOI 10.3390/molecules170910614; Lin JB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/394926; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Palma E, 2012, CURR DRUG TARGETS, V13, P579, DOI 10.2174/138945012800398838; Ran X, 2011, PHARM BIOL, V49, P1180, DOI 10.3109/13880209.2011.576346; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Shang YH, 2013, CHIN J NAT MEDICINES, V11, P588, DOI [10.1016/S1875-5364(13)60068-0, 10.3724/SP.J.1009.2013.00588]; Sun YW, 2012, J NEUROSCI RES, V90, P1662, DOI 10.1002/jnr.23034; Tan F, 2015, EXP THER MED, V9, P1757, DOI 10.3892/etm.2015.2365; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Westerlund A, 2013, NEUROSCI LETT, V553, P191, DOI 10.1016/j.neulet.2013.08.038; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zhang Chun, 2004, Chinese Medical Sciences Journal, V19, P180; Zhang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113673; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	37	11	13	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2017	14	3	A				2392	2400		10.3892/etm.2017.4754			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FF0MW	WOS:000408596800080	28962173	Green Published, gold			2022-02-06	
J	Yamakawa, GR; Salberg, S; Barlow, KM; Brooks, BL; Esser, MJ; Yeates, KO; Mychasiuk, R				Yamakawa, Glenn R.; Salberg, Sabrina; Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen; Mychasiuk, Richelle			Manipulating cognitive reserve: Pre-injury environmental conditions influence the severity of concussion symptomology, gene expression, and response to melatonin treatment in rats	EXPERIMENTAL NEUROLOGY			English	Article						Mild traumatic brain injury; Epigenetic; Animal model; Telomere length; qRT-PCR	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; TELOMERE LENGTH; PROFESSIONAL FOOTBALL; SOCIOECONOMIC-STATUS; POSSIBLE INVOLVEMENT; NEUROTROPHIC FACTOR; DNA METHYLATION; PLASTICITY; RECEPTOR	In an effort to understand the factors that contribute to heterogeneity in outcomes often associated with mTBI in youth, this study examined the role of premorbid differences in cognitive reserve on post-concussive symptoms (PCS), molecular markers, and treatment response. Male and female rats matured in one of three environmental conditions (Stress, Enrichment, Control), received a mTBI in adolescence, and were randomized to melatonin or placebo treatment. All animals underwent a behavioural test battery designed to examine PCS. Using prefrontal cortex and hippocampus tissue, expression of 9 genes was assessed in an effort to determine how the brain's epi-genome was influenced by cognitive reserve, mTBI, and melatonin. Enrichment increased cognitive reserve (CR) and prevented lingering symptoms. Conversely, stress was associated with progressive worsening and manifestation of PCS in the longer-term. Melatonin was able to restore baseline function for control and enriched animals, but was ineffective for the stress condition. Epigenetic change in the prefrontal cortex was largely driven by the injury, while gene expression changes in the hippocampus were dependent upon cognitive reserve. The occurrence and severity of PCS is dependent upon a complex and multifaceted array of factors that modify behavioural and epigenetic responses to mTBI and its treatment. (C) 2017 Elsevier Inc. All rights reserved.	[Yamakawa, Glenn R.; Salberg, Sabrina; Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen; Mychasiuk, Richelle] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Mychasiuk, Richelle] Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol,Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB, Canada.	rmmychas@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Yeates, Keith/0000-0001-7680-2892; Yamakawa, Glenn/0000-0003-3079-6532; Mychasiuk, Richelle/0000-0001-5291-5083	Alberta Children's Hospital Research Foundation; O'Brien Continuing Scholarship Research Fund; Integrated Concussion Research Program	The authors would like to thank the Alberta Children's Hospital Research Foundation, the O'Brien Continuing Scholarship Research Fund, and the Integrated Concussion Research Program for their financial assistance.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ceanga M, 2010, NEUROSCI LETT, V477, P15, DOI 10.1016/j.neulet.2010.04.024; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Entringer S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003580; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epstein HT, 1999, BRAIN DEV-JPN, V21, P535, DOI 10.1016/S0387-7604(99)00066-2; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Galan A., 2012, J PINEAL RES, V24; Garcia R, 2008, NEUROBIOL LEARN MEM, V89, P560, DOI 10.1016/j.nlm.2007.10.005; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Johnson NF, 2013, AGE, V35, P2045, DOI 10.1007/s11357-012-9493-8; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Mattson MP, 2000, EXP GERONTOL, V35, P489, DOI 10.1016/S0531-5565(00)00115-7; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Noguchi T, 2010, ENDOCRINOLOGY, V151, P4344, DOI 10.1210/en.2010-0266; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ostrowski NL, 1998, PSYCHONEUROENDOCRINO, V23, P989, DOI 10.1016/S0306-4530(98)00070-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Volmar CH., 2015, NEUROEPIGENETICS, V1, P20, DOI DOI 10.1016/J.NEPIG.2014.10.002; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Xu J, 2008, BRIT J CLIN PHARMACO, V66, P901, DOI 10.1111/j.1365-2125.2008.03300.x; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	85	11	11	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						55	65		10.1016/j.expneurol.2017.06.001			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OS	WOS:000406820900006	28579327				2022-02-06	
J	Yang, T; Liu, YWY; Zhao, L; Wang, H; Yang, N; Dai, SS; He, FT				Yang, Ting; Liu, Yang-Wuyue; Zhao, Li; Wang, Hao; Yang, Nan; Dai, Shuang-Shuang; He, Fengtian			Metabotropic glutamate receptor 5 deficiency inhibits neutrophil infiltration after traumatic brain injury in mice	SCIENTIFIC REPORTS			English	Article							IMPROVES FUNCTIONAL RECOVERY; T-CELL-ACTIVATION; IN-VITRO; BARRIER MODEL; MGLUR5; INFLAMMATION; EXPRESSION; MODULATOR; DISEASE; NEUROINFLAMMATION	Both brain native inflammatory cells and infiltrated peripheral white blood cells (WBCs) are primary participants in the brain inflammatory damage post-TBI. Metabotropic glutamate receptor 5 (mGluR5) has been reported to regulate microglias and astrocytes to affect inflammation after TBI, but its effect on modulating infiltrated peripheral WBCs remains unclear. In a mouse moderate TBI model, we found that mGluR5 knockout (KO) significantly reduced neutrophil infiltration and inflammatory cytokine expression in the brain at 24 hours post TBI, which was accompanied by improved neurological dysfunction. Further investigation indicated that mGluR5 KO reduced the permeability of blood-brain barrier (BBB), the entrance for neutrophils to enter brain, and markedly decreased the mRNA levels of neutrophil-associated chemokines in brain tissue, including CXCL1, CXCL2, CCL2, CCL4 and CCL5. Using brain microvascular endothelial cells (BMECs), neutrophils and a BBB model in vitro, we confirmed the inhibitory effect of mGluR5 deficiency on neutrophil infiltration and demonstrated that blockade of protein kinase C (PKC) signaling was involved in it. These results provide insight into the role of mGluR5 in the regulation of inflammation in the acute phase of TBI, which may provide novel clues for TBI therapy.	[Yang, Ting; Liu, Yang-Wuyue; Zhao, Li; Dai, Shuang-Shuang; He, Fengtian] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China; [Wang, Hao] Third Mil Med Univ, Res Inst Surg, Dept Neurosurg, Chongqing 400042, Peoples R China; [Wang, Hao] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Yang, Nan; Dai, Shuang-Shuang] Third Mil Med Univ, Daping Hosp, Mol Biol Ctr, State Key Lab Trauma Burn & Combined Injury, Chongqing 400042, Peoples R China		Dai, SS; He, FT (corresponding author), Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China.; Dai, SS (corresponding author), Third Mil Med Univ, Daping Hosp, Mol Biol Ctr, State Key Lab Trauma Burn & Combined Injury, Chongqing 400042, Peoples R China.	tmmubiodss@aliyun.com; hefengtian06@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31370913, 81322044]	This work was supported by the National Natural Science Foundation of China (No. 31370913, No. 81322044).	Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bittner S, 2013, NAT MED, V19, P1161, DOI 10.1038/nm.3303; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chaudhuri V, 2006, IN VITRO CELL DEV-AN, V42, P314; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Coisne C, 2005, LAB INVEST, V85, P734, DOI 10.1038/labinvest.3700281; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fallarino F, 2010, NAT MED, V16, P897, DOI 10.1038/nm.2183; Garcia-Bonilla L, 2015, J NEUROSCI, V35, P14783, DOI 10.1523/JNEUROSCI.2980-15.2015; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gillard SE, 2003, J COMP NEUROL, V461, P317, DOI 10.1002/cne.10671; Gupta R, 2013, AMINO ACIDS, V44, P757, DOI 10.1007/s00726-012-1400-1; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Herz J, 2015, STROKE, V46, P2916, DOI 10.1161/STROKEAHA.115.010620; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar V, 2012, J BIOL CHEM, V287, P5412, DOI 10.1074/jbc.M111.301366; Liu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33614; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu YM, 1997, J NEUROSCI, V17, P5196; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Moreland JG, 2006, AM J PHYSIOL-LUNG C, V290, pL833, DOI 10.1152/ajplung.00333.2005; Movsesyan VA, 2001, J PHARMACOL EXP THER, V296, P41; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Storto M, 2000, J NEUROIMMUNOL, V109, P112, DOI 10.1016/S0165-5728(00)00269-1; Tison F, 2016, MOVEMENT DISORD, V31, P1373, DOI 10.1002/mds.26659; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang Y, 2010, TRANSGENIC RES, V19, P775, DOI 10.1007/s11248-009-9355-z; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675	47	11	12	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 30	2017	7								9998	10.1038/s41598-017-10201-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF0WS	WOS:000408622400092	28855570	Green Published, gold			2022-02-06	
J	Carrick, FR; Clark, JF; Pagnacco, G; Antonucci, MM; Hankir, A; Zaman, R; Oggero, E				Carrick, Frederick Robert; Clark, Joseph F.; Pagnacco, Guido; Antonucci, Matthew M.; Hankir, Ahmed; Zaman, Rashid; Oggero, Elena			Head-Eye Vestibular Motion Therapy Affects the Mental and Physical Health of Severe Chronic Postconcussion Patients	FRONTIERS IN NEUROLOGY			English	Article						neuro-otology; head movement; eye movement; vestibular; concussion; mTBI; postconcussion syndrome; C3 Logix	TRAUMATIC BRAIN-INJURY; VERTICAL AXIS ROTATION; VESTIBULOCOLLIC REFLEX; DECEREBRATE CATS; VESTIBULOSPINAL REFLEXES; SPATIAL COORDINATION; CONCUSSION SYMPTOMS; RESPONSE PROPERTIES; MOVEMENTS; NEURONS	Context: Approximately 1.8-3.6 million annual traumatic brain injuries occur in the United States. An evidence-based treatment for concussions that is reliable and effective has not been available. Objective: The objective of this study is to test whether head-eye vestibular motion (HEVM) therapy is associated with decreased symptoms and increased function in postconcussive syndrome (PCS) patients that have been severely impaired for greater than 6 months after a mild traumatic brain injury. Design: Retrospective clinical chart review. Setting and participants: Tertiary Specialist Brain Rehabilitation Center. Interventions: All subjects underwent comprehensive neurological examinations including measurement of eye and head movement. The seven modules of the C3 Logix Comprehensive Concussion Management System were used for pre- and postmeasurements of outcome of HEVM therapy. Materials and methods: We utilized an objective validated measurement of physical and mental health characteristics of our patients before and after a 1-week HEVM rehabilitation program. We included only PCS patients that were disabled from work or school for a period of time exceeding 6 months after suffering a sports concussion. These subjects all were enrolled in a 5-day HEVM rehabilitation program at our Institutional Brain Center with pre- and post-C3 Logix testing outcomes. Results: There were statistical and substantive significant decreases in PCS symptom severity after treatment and statistical and substantive significant increases in standardized assessment of concussion scores. The outcomes were associated with positive changes in mental and physical health issues. This is a retrospective review and no control group has been included in this study. These are major limitations with retrospective reviews and further investigations with prospective designs including a randomized controlled study are necessary to further our understanding. Conclusion: Head eye vestibular motion therapy of 5 days duration is associated with statistical and substantive significant decreases of symptom severity associated with chronic PCS.	[Carrick, Frederick Robert; Hankir, Ahmed; Zaman, Rashid] Univ Cambridge, Bedfordshire Ctr Mental Hlth Res, Cambridge, England; [Carrick, Frederick Robert; Pagnacco, Guido; Antonucci, Matthew M.; Oggero, Elena] Carrick Inst, Neurol, Cape Canaveral, FL 32920 USA; [Carrick, Frederick Robert] Harvard Macy Inst, Boston, MA 02114 USA; [Carrick, Frederick Robert] MGH Inst Hlth Profess, Boston, MA 02129 USA; [Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Pagnacco, Guido; Oggero, Elena] Univ Wyoming, Elect & Comp Engn Dept, Laramie, WY 82071 USA; [Antonucci, Matthew M.] Plast Brain Ctr, Neurol, Orlando, FL USA; [Hankir, Ahmed] Carrick Inst, Psychiat, Cape Canaveral, FL USA; [Zaman, Rashid] Univ Cambridge, Dept Psychiat, Cambridge, England		Carrick, FR (corresponding author), Univ Cambridge, Bedfordshire Ctr Mental Hlth Res, Cambridge, England.; Carrick, FR (corresponding author), Carrick Inst, Neurol, Cape Canaveral, FL 32920 USA.; Carrick, FR (corresponding author), Harvard Macy Inst, Boston, MA 02114 USA.; Carrick, FR (corresponding author), MGH Inst Hlth Profess, Boston, MA 02129 USA.	drfrcarrick@post.harvard.edu	Carrick, Frederick/V-3132-2019	Carrick, Frederick/0000-0002-2818-6551; Oggero, Elena/0000-0002-7223-5613; Pagnacco, Guido/0000-0002-4844-1636			Allum JHJ, 1997, J VESTIBUL RES-EQUIL, V7, P189; Amanou L, 2000, Ann Otolaryngol Chir Cervicofac, V117, P161; Anastasopoulos D, 1998, BRAIN, V121, P1497, DOI 10.1093/brain/121.8.1497; Anastasopoulos D, 2009, EXP NEUROL, V217, P336, DOI 10.1016/j.expneurol.2009.03.010; Andre P, 2005, NEUROSCIENCE, V132, P811, DOI 10.1016/j.neuroscience.2004.11.060; ANGELAKI DE, 1992, BIOL CYBERN, V67, P523, DOI 10.1007/BF00198759; [Anonymous], 2017, JAZZ NOVO MULTISENSO; Baizer JS, 2010, BRAIN RES, V1351, P64, DOI 10.1016/j.brainres.2010.05.087; BAKER J, 1985, J NEUROPHYSIOL, V54, P735, DOI 10.1152/jn.1985.54.3.735; BANOVETZ JM, 1995, EXP BRAIN RES, V105, P345; Barresi M, 2012, NEUROSCIENCE, V224, P48, DOI 10.1016/j.neuroscience.2012.08.011; Bertolini G, 2008, IEEE ENG MED BIO, P1060, DOI 10.1109/IEMBS.2008.4649342; BOLTON PS, 1992, J NEUROPHYSIOL, V67, P639, DOI 10.1152/jn.1992.67.3.639; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; C3 Logix, 2017, C3 LOG COMPR CONC CA; Carrick Frederick R, 2015, Biomed Sci Instrum, V51, P9; Carrick FR, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00015; Carrick FR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00003; Carrick FR, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00151; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clement G, 2013, J VESTIBUL RES-EQUIL, V23, P13, DOI 10.3233/VES-130471; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Dynavision D2 Visual, 2017, NEUROCOGNITIVE PHYS; ENDO K, 1994, J NEUROPHYSIOL, V71, P11, DOI 10.1152/jn.1994.71.1.11; Eron JN, 2008, PROG BRAIN RES, V171, P313, DOI 10.1016/S0079-6123(08)00645-6; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FUKUSHIMA K, 1987, BRAIN BEHAV EVOLUT, V30, P200, DOI 10.1159/000118646; Garrick-Bethell I, 2008, J VESTIBUL RES-EQUIL, V18, P25; Gdowski GT, 1999, J NEUROPHYSIOL, V82, P436, DOI 10.1152/jn.1999.82.1.436; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Holzl M, 2008, HNO, V56, P1013, DOI 10.1007/s00106-008-1739-5; Holly JE, 2011, J VESTIBUL RES-EQUIL, V21, P193, DOI 10.3233/VES-2011-0416; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iwamoto Y, 1996, EXP BRAIN RES, V108, P85; Keshner EA, 2004, EXP BRAIN RES, V158, P213, DOI 10.1007/s00221-004-1893-2; Keshner EA, 1999, J VESTIBUL RES-EQUIL, V9, P423; KESHNER EA, 1992, EXP BRAIN RES, V88, P361, DOI 10.1007/BF02259112; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Manzoni D, 1998, J VESTIBUL RES-EQUIL, V8, P283; Manzoni D, 1998, PFLUG ARCH EUR J PHY, V435, P617, DOI 10.1007/s004240050562; Marti S, 2008, PROG BRAIN RES, V171, P211, DOI 10.1016/S0079-6123(08)00629-8; McCandless CH, 2010, EXP BRAIN RES, V202, P271, DOI 10.1007/s00221-009-2130-9; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; MERGNER T, 1983, EXP BRAIN RES, V49, P198; Michels TC, 2010, AM FAM PHYSICIAN, V82, P495; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Nag S, 1999, NEUROL INDIA, V47, P32; Nooij SAE, 2008, J VESTIBUL RES-EQUIL, V18, P97; Pang EW, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00170; Parizek A, 2016, CURR SPORT MED REP, V15, P23, DOI 10.1249/JSR.0000000000000209; Perlmutter SI, 1999, J NEUROPHYSIOL, V82, P855, DOI 10.1152/jn.1999.82.2.855; Peterson B. W., 1989, PROG BRAIN RES, V80, P347, DOI DOI 10.1016/S0079-6123(08)62231-1; PETERSON BW, 1985, J NEUROPHYSIOL, V54, P90, DOI 10.1152/jn.1985.54.1.90; Pollak L, 2009, NEUROPHYSIOL CLIN, V39, P235, DOI 10.1016/j.neucli.2009.07.001; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Reynolds JS, 2008, J NEUROPHYSIOL, V99, P2369, DOI 10.1152/jn.00320.2007; Rivera RG, 2015, MCN-AM J MATERN-CHIL, V40, P76, DOI 10.1097/NMC.0000000000000114; Sadeghi SG, 2009, EXP BRAIN RES, V195, P45, DOI 10.1007/s00221-009-1751-3; Sato H, 2002, EXP BRAIN RES, V145, P351, DOI 10.1007/s00221-002-1119-4; Schlindwein P, 2008, NEUROIMAGE, V39, P19, DOI 10.1016/j.neuroimage.2007.08.016; Sinha N, 2008, PROG BRAIN RES, V171, P277, DOI 10.1016/S0079-6123(08)00639-0; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Takemura K, 2005, EXP BRAIN RES, V167, P103, DOI 10.1007/s00221-005-0030-1; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; Uchino Y, 2000, ARCH ITAL BIOL, V138, P3; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wada Y, 2008, EXP BRAIN RES, V185, P75, DOI 10.1007/s00221-007-1137-3; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walker MF, 2005, ANN NY ACAD SCI, V1039, P349, DOI 10.1196/annals.1325.033; WILSON VJ, 1993, PROG BRAIN RES, V97, P211; WILSON VJ, 1995, J VESTIBUL RES-EQUIL, V5, P147; Wilson VJ, 1999, EXP BRAIN RES, V129, P483, DOI 10.1007/s002210050918; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	80	11	11	2	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 22	2017	8								414	10.3389/fneur.2017.00414			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FE6ML	WOS:000408323500001	28878731	Green Published, gold			2022-02-06	
J	Harrold, GK; Hasanaj, L; Moehringer, N; Zhang, I; Nolan, R; Serrano, L; Raynowska, J; Rucker, JC; Flanagan, SR; Cardone, D; Galetta, SL; Balcer, LJ				Harrold, G. Kyle; Hasanaj, Lisena; Moehringer, Nicholas; Zhang, Isis; Nolan, Rachel; Serrano, Liliana; Raynowska, Jenelle; Rucker, Janet C.; Flanagan, Steven R.; Cardone, Dennis; Galetta, Steven L.; Balcer, Laura J.			Rapid sideline performance meets outpatient clinic: Results from a multidisciplinary concussion center registry	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Symptoms; Rapid number naming; King-Devick test; SCAT3; Standardized Assessment of Concussion (SAC); Timed tandem gait	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; KING-DEVICK TEST; VISUAL SCREENING TOOL; AMATEUR RUGBY UNION; EYE-MOVEMENTS; UNITED-STATES; RECOVERY; BALANCE; RELIABILITY	Objective: This study investigated the utility of sideline concussion tests, including components of the Sports Concussion Assessment Tool, 3rd Edition (SCAT3) and the King-Devick (K-D), a vision-based test of rapid number naming, in an outpatient, multidisciplinary concussion center treating patients with both sports-related and non-sports related concussions. The ability of these tests to predict clinical outcomes based on the scores at the initial visit was evaluated. Methods: Scores for components of the SCAT3 and the K-D were fit into regression models accounting for age, gender, and sport/non-sport etiology in order to predict clinical outcome measures including total number of visits to the concussion center, whether the patient reached a SCAT3 symptom severity score 7, and the total types of referrals each patient received over their course. Patient characteristics, differences between those with sport and non-sport etiologies, and correlations between the tests were also analyzed. Results: Among 426 patients with concussion, SCAT3 total symptom score and symptom severity score at the initial visit predicted each of the clinical outcome variables. K-D score at the initial visit predicted the total number of visits and the total number of referrals. Those with sports-related concussions were younger, had less severely affected test scores, had fewer visits and types of referrals, and were more likely to have clinical resolution of their concussion and to reach a symptom severity score <= 7. Conclusions: This large-scale study of concussion patients supports the use of sideline concussion tests as part of outpatient concussion assessment, especially the total symptom and symptom severity score portions of the SCAT3 and the K-D. Women in this cohort had higher total symptom and symptom severity scores compared to men. Our data also suggest that those with non-sports-related concussions have longer lasting symptoms than those with sports-related concussions, and that these two groups should perhaps be regarded separately when assessing outcomes and needs in a multidisciplinary setting. (C) 2017 Elsevier B.V. All rights reserved.	[Harrold, G. Kyle; Hasanaj, Lisena; Moehringer, Nicholas; Zhang, Isis; Nolan, Rachel; Serrano, Liliana; Raynowska, Jenelle; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Flanagan, Steven R.] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Cardone, Dennis] NYU, Sch Med, Dept Primary Care Sports Med Orthopaed, New York, NY USA		Balcer, LJ (corresponding author), NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA.	laura.balcer@nyumc.org		Flanagan, Steven/0000-0001-9005-5897; Rucker, Janet/0000-0002-0397-0999; Harrold, G/0000-0001-6166-188X	NYU School of Medicine	This study was supported in part by the NYU School of Medicine.	Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Brooks A, 2014, BR J SPORTS MED, V48, P573, DOI DOI 10.1136/BJSPORTS-2014-093494.38; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Faul M, 2010, TRAUMATIC BRAIN INJU; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gardner R. O, 2015, MOL CELL NEUROSCI, P6675; Gerberding J.L., 2003, C MILD TRAUM BRAIN I; Gorman M, 2016, APPL NEUROPSYCH-CHIL, P1; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Meehan W. P., 2015, J SCI MED SPORT; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; White OB, 2012, J NEURO-OPHTHALMOL, V32, P266, DOI 10.1097/WNO.0b013e3182688230; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	38	11	11	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	AUG 15	2017	379						312	317		10.1016/j.jns.2017.06.038			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC9TR	WOS:000407184500070	28716270				2022-02-06	
J	Hou, JM; Nelson, R; Wilkie, Z; Mustafa, G; Tsuda, S; Thompson, FJ; Bose, P				Hou, Jiamei; Nelson, Rachel; Wilkie, Zachary; Mustafa, Golam; Tsuda, Shigeharu; Thompson, Floyd J.; Bose, Prodip			Mild and Mild-to-Moderate Traumatic Brain Injury-Induced Significant Progressive and Enduring Multiple Comorbidities	JOURNAL OF NEUROTRAUMA			English	Article						anxiety; balance impairment; cognitive deficit; H-reflex; mild traumatic brain injury	IMPACT-ACCELERATION MODEL; DIFFUSE AXONAL INJURY; SPINAL-CORD-INJURY; REFLEX EXCITABILITY; ALTERED PATTERNS; CONTUSION INJURY; LOCUS-CERULEUS; HEAD-INJURY; RATS; SEVERITY	Traumatic brain injury (TBI) can produce life-long disabilities, including anxiety, cognitive, balance, and motor deficits. The experimental model of closed head TBI (cTBI) induced by weight drop/impact acceleration is known to produce hallmark TBI injuries. However, comprehensive long-term characterization of comorbidities induced by graded mild-to-mild/moderate intensities using this experimental cTBI model has not been reported. The present study used two intensities of weight drop (1.0m and 1.25 m/450 g) to produce cTBI in a rat model to investigate initial and long-term disability of four comorbidities: anxiety, cognitive, vestibulomotor, and spinal reflex that related to spasticity. TBI and sham injuries were produced under general anesthesia. Time for righting recoveries post-TBI recorded to estimate duration of unconsciousness, revealed that the TBI mild/moderate group required a mean of 1 min 27 sec longer than the values observed for noninjured sham animals. Screening magnetic resonance imaging images revealed no anatomical changes, mid-line shifts, or hemorrhagic volumes. However, compared to sham injuries, significant long-term anxiety, cognitive, balance, and physiological changes in motor reflex related to spasticity were observed post-TBI for both TBI intensities. The longitudinal trajectory of anxiety and balance disabilities tested at 2, 4, 8, and 18 weeks revealed progressively worsening disabilities. In general, disability magnitudes were proportional to injury intensity for three of the four measures. A natural hypothesis would pose that all disabilities would increase incrementally relative to injury severity. Surprisingly, anxiety disability progressed over time to be greater in the mildest injury. Collectively, translational implications of these observations suggest that patients with mild TBI should be evaluated longitudinally at multiple time points, and that anxiety disorder could potentially have a particularly low threshold for appearance and progressively worsen post-injury.	[Hou, Jiamei; Mustafa, Golam; Tsuda, Shigeharu; Thompson, Floyd J.; Bose, Prodip] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Hou, Jiamei; Nelson, Rachel; Wilkie, Zachary; Mustafa, Golam; Tsuda, Shigeharu; Thompson, Floyd J.; Bose, Prodip] North Florida South Georgia Vet Hlth Syst, BRRC, Gainesville, FL USA; [Thompson, Floyd J.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bose, Prodip] Univ Florida, Dept Neurol, Gainesville, FL USA		Bose, P (corresponding author), BRRC, Malcolm Randall VA Med Ctr, 1601 SW Archer Rd, Gainesville, FL 32606 USA.	pkbose@ufl.edu			Office of Research and Development, Rehabilitation Research and Development Service, Department of Veterans AffairsUS Department of Veterans Affairs [B6570R, B78071, B1005-R]; Veterans AffairsUS Department of Veterans Affairs [I01RX001005] Funding Source: NIH RePORTER	This work was supported by the Office of Research and Development, Rehabilitation Research and Development Service, Department of Veterans Affairs Merit Review grant nos. B6570R, B78071, and B1005-R. The authors thank Joel John and Johnathan Joseph for their assistance in EPM, MWM data acquisition, and processing.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Balaban CD, 2000, NEUROSCIENCE, V99, P669, DOI 10.1016/S0306-4522(00)00232-3; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Bose PK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00258; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; CDC, 2016, GET STATS TRAUM BRAI; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hou J., 2015, 45 ANN M SOC NEUR CH; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Ljung C., 1980, P 5 INT IRCOBI C BIO, P209; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; McLean A. J., 1997, HEAD INJURY; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Ommaya A. K., 1967, 11 STAPP CAR CRASH C; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Patrick L., 1963, 7 STAPP CAR CRASH C, P470; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; POMPEIANO O, 1990, NEUROSCIENCE, V35, P227, DOI 10.1016/0306-4522(90)90078-I; POMPEIANO O, 1989, PROG BRAIN RES, V80, P329; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; SCHUERGER RJ, 1993, EXP BRAIN RES, V92, P351; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Thompson FJ, 1998, J NEUROTRAUM, V15, P495, DOI 10.1089/neu.1998.15.495; THOMPSON FJ, 1992, J NEUROPHYSIOL, V68, P1473, DOI 10.1152/jn.1992.68.5.1473; Thompson FJ, 2001, J NEUROTRAUM, V18, P931, DOI 10.1089/089771501750451848; THOMPSON FJ, 1993, ADV NEUROL, V59, P175; Thompson FJ, 2016, METHODS MOL BIOL, V1462, P521, DOI 10.1007/978-1-4939-3816-2_28; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Tsuda S., 2015, 45 ANN M SOC NEUR CH; Tsuda S, 2016, NEUROREPORT, V27, P724, DOI 10.1097/WNR.0000000000000598; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	59	11	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2456	2466		10.1089/neu.2016.4851			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400008	28376701				2022-02-06	
J	Xin, YC; Liu, HY; Zhang, P; Chang, LH; Xie, KL				Xin, Yuchang; Liu, Huiying; Zhang, Peng; Chang, Liuhui; Xie, Keliang			Molecular hydrogen inhalation attenuates postoperative cognitive impairment in rats	NEUROREPORT			English	Article						caspase-3 activity; molecular hydrogen; postoperative cognitive impairment; proinflammatory cytokines	REDUCING OXIDATIVE STRESS; ISCHEMIA-REPERFUSION INJURY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; RICH SALINE; CARDIAC-SURGERY; INFLAMMATION; DYSFUNCTION; NEUROINFLAMMATION; MODEL	Postoperative cognitive decline is a major clinical problem with high morbidity and mortality after surgery. Many studies have found that molecular hydrogen ( H-2) has significant neuroprotection against acute and chronic neurological injury by regulating inflammation and apoptosis. In this study, we hypothesized that H-2 treatment could ameliorate the development of cognitive impairment following surgery. Adult male rats were subjected to stabilized tibial fracture operation under anesthesia. Two percent of H-2 was inhaled for 3 h beginning at 1 h after surgery. Separate cohorts of rats were tested for cognitive function with fear conditioning and the Y-maze test, or euthanized to assess blood-brain barrier integrity, and systemic and hippocampal proinflammatory cytokine and caspase-3 activity. Surgery-challenged animals showed significant cognitive impairment evidenced by a decreased percentage of freezing time and an increased number of learning trials on days 1, 3, and 7 after operation, which were significantly improved by H-2 treatment. Furthermore, H2 treatment significantly ameliorated the increase in serum and hippocampal proinflammatory cytokines tumor necrosis factor-a, interleukin-1 beta, interleukin-6, and highmobility group protein 1 in surgery-challenged animals. Moreover, H-2 treatment markedly improved blood-brain barrier integrity and reduced caspase-3 activity in the hippocampus of surgery-challenged animals. These findings suggest that H-2 treatment could significantly mitigate surgery-induced cognitive impairment by regulating inflammation and apoptosis. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Xin, Yuchang; Chang, Liuhui] Soochow Univ, Affiliated Hosp 2, Dept Anesthesiol, Suzhou, Peoples R China; [Zhang, Peng] Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou 215004, Peoples R China; [Liu, Huiying] PLA, Hosp 307, Dept Resp & Crit Care Dis, Beijing, Peoples R China; [Xie, Keliang] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin Inst Anesthesiol, Tianjin 300052, Peoples R China		Zhang, P (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou 215004, Peoples R China.; Xie, KL (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin Inst Anesthesiol, Tianjin 300052, Peoples R China.	tougaozy2011@126.com; xiekeliang2009@hotmail.com					Barber PA, 2009, ANN THORAC SURG, V87, P672, DOI 10.1016/j.athoracsur.2008.05.021; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cui J, 2016, NEUROSCIENCE, V335, P232, DOI 10.1016/j.neuroscience.2016.08.021; Cui YM, 2014, J SURG RES, V192, P564, DOI 10.1016/j.jss.2014.05.060; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Green D, 2015, BRIT J ANAESTH, V114, P343, DOI 10.1093/bja/aeu471; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hovens IB, 2016, BRAIN BEHAV IMMUN, V54, P178, DOI 10.1016/j.bbi.2016.02.003; Ji Q, 2011, SURG RES, V168, P95; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Jin WJ, 2014, NEUROREPORT, V25, P1, DOI 10.1097/WNR.0000000000000082; Kim J, 2016, ANESTH ANALG, V123, P436, DOI 10.1213/ANE.0000000000001352; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Li JJ, 2012, BRAIN RES, V1486, P103, DOI 10.1016/j.brainres.2012.09.031; Liu LL, 2014, BRAIN RES, V1589, P78, DOI 10.1016/j.brainres.2014.09.030; Liu Y, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-15; Sun L, 2014, NEUROREPORT, V25, P718, DOI 10.1097/WNR.0000000000000181; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Tian Y, 2017, MOL NEUROBIOL, V54, P2579, DOI 10.1007/s12035-016-9825-2; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Xie KL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807635; Xie KL, 2012, SHOCK, V37, P548, DOI 10.1097/SHK.0b013e31824ddc81; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xie ZC, 2013, ANN SURG, V258, P364, DOI 10.1097/SLA.0b013e318298b077; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d	31	11	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 2	2017	28	11					694	700		10.1097/WNR.0000000000000824			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EZ4BN	WOS:000404656000013	28614179				2022-02-06	
J	Araujo, GC; Antonini, TN; Anderson, V; Vannatta, KA; Salley, CG; Bigler, ED; Taylor, HG; Gerhardt, C; Rubin, K; Dennis, M; Lo, W; Mackay, MT; Gordon, A; Koterba, CH; Gomes, A; Greenham, M; Yeates, KO				Araujo, Gabriel C.; Antonini, Tanya N.; Anderson, Vicki; Vannatta, Kathryn A.; Salley, Christina G.; Bigler, Erin D.; Taylor, H. Gerry; Gerhardt, Cynthia; Rubin, Kenneth; Dennis, Maureen; Lo, Warren; Mackay, Mark T.; Gordon, Anne; Koterba, Christine Hajek; Gomes, Alison; Greenham, Mardee; Yeates, Keith Owen			Profiles of Executive Function Across Children with Distinct Brain Disorders: Traumatic Brain Injury, Stroke, and Brain Tumor	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Executive functions; Shifting; Inhibition; Working memory; Pediatric brain disorders; TEA-Ch	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ARTERIAL ISCHEMIC-STROKE; LATENT-VARIABLE ANALYSIS; GLASGOW COMA SCALE; WORKING-MEMORY; FUNCTION DEFICITS; CONTROLLED-TRIAL; FRONTAL LOBES; CHILDHOOD; ADHD	Objectives: This study examined whether children with distinct brain disorders show different profiles of strengths and weaknesses in executive functions, and differ from children without brain disorder. Methods: Participants were children with traumatic brain injury (N = 82; 8-13 years of age), arterial ischemic stroke (N = 36; 6-16 years of age), and brain tumor (N = 74; 9-18 years of age), each with a corresponding matched comparison group consisting of children with orthopedic injury (N = 61), asthma (N = 15), and classmates without medical illness (N = 68), respectively. Shifting, inhibition, and working memory were assessed, respectively, using three Test of Everyday Attention: Children's Version (TEA-Ch) subtests: Creature Counting, Walk-Don't-Walk, and Code Transmission. Comparison groups did not differ in TEA-Ch performance and were merged into a single control group. Profile analysis was used to examine group differences in TEA-Ch subtest scaled scores after controlling for maternal education and age. Results: As a whole, children with brain disorder performed more poorly than controls on measures of executive function. Relative to controls, the three brain injury groups showed significantly different profiles of executive functions. Importantly, post hoc tests revealed that performance on TEA-Ch subtests differed among the brain disorder groups. Conclusions: Results suggest that different childhood brain disorders result in distinct patterns of executive function deficits that differ from children without brain disorder. Implications for clinical practice and future research are discussed.	[Araujo, Gabriel C.] St Louis Childrens Hosp, Dept Psychol, St Louis, MO 63178 USA; [Antonini, Tanya N.] Texas Childrens Hosp, Baylor Coll Med, Psychol Sect, Houston, TX 77030 USA; [Anderson, Vicki] Univ Melbourne, Murdoch Childrens Res Inst, Dept Psychol, Royal Childrens Hosp,Sch Psychol Sci, Parkville, Vic, Australia; [Vannatta, Kathryn A.; Gerhardt, Cynthia] Ohio State Univ, Dept Pediat, Res Inst, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Salley, Christina G.] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol Sci, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Rubin, Kenneth] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Lo, Warren] Ohio State Univ, Dept Pediat, Div Neurol, Columbus, OH 43210 USA; [Lo, Warren] Nationwide Childrens Hosp, Columbus, OH USA; [Mackay, Mark T.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Mackay, Mark T.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Gordon, Anne] Kings Coll London, Paediat Neurol, Evelina London Childrens Hosp, London, England; [Gordon, Anne] Kings Coll London, Inst Psychol Psychiat & Neurosci, London, England; [Koterba, Christine Hajek] Nationwide Childrens Hosp, Pediat Psychol & Neuropsychol, Columbus, OH USA; [Gomes, Alison] Monash Univ, Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Gomes, Alison] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Greenham, Mardee] Univ Melbourne, Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Greenham, Mardee] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Araujo, GC (corresponding author), One Childrens Pl, St Louis, MO 63110 USA.	gabriel.araujo@bjc.org	Yeates, Keith/AAJ-4223-2020; Greenham, Mardee/AAR-1711-2020; Rubin, Kenneth H/M-5276-2018; Koterba, Christine/AAS-9518-2021	Rubin, Kenneth H/0000-0002-2608-2484; Salley, Christina/0000-0002-2698-0946; Yeates, Keith/0000-0001-7680-2892; Mackay, Mark/0000-0002-3787-1112	National Institute of Child Health and Human Development at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 R01 HD048946]; American Cancer SocietyAmerican Cancer Society [RSGPB-03-098-01-PBP]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R03 CA138122-02]; Australian National Health & Medical Research CouncilNational Health and Medical Research Council of Australia; Victorian Government [RINCH 231308]; Victorian Government Operational Infrastructure Scheme; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R03CA138122] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development at the National Institutes of Health (K.O.Y., grant number 5 R01 HD048946); American Cancer Society, (K.V., grant number RSGPB-03-098-01-PBP); National Cancer Institute (K.V., grant number R03 CA138122-02); Australian National Health & Medical Research Council Senior Practitioner Fellowship (V.A.); Victorian Government Operational Infrastructure Fund (V.A., M.G., grant number RINCH 231308); and by the Victorian Government Operational Infrastructure Scheme. We have no conflicts of interest to disclose.	Aarsen FK, 2009, J CLIN ONCOL, V27, P3526, DOI 10.1200/JCO.2008.19.6303; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bayless S, 2007, EARLY HUM DEV, V83, P247, DOI 10.1016/j.earlhumdev.2006.05.021; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brocki K, 2008, ANN NY ACAD SCI, V1129, P246, DOI 10.1196/annals.1417.025; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Conklin HM, 2015, J CLIN ONCOL, V33, P3894, DOI 10.1200/JCO.2015.61.6672; Conklin HM, 2013, J NEURO-ONCOL, V113, P333, DOI 10.1007/s11060-013-1123-5; Conklin HM, 2012, J INT NEUROPSYCH SOC, V18, P996, DOI 10.1017/S1355617712000793; Corbett BA, 2009, PSYCHIAT RES, V166, P210, DOI 10.1016/j.psychres.2008.02.005; De Ruiter MA, 2013, DEV MED CHILD NEUROL, V55, P408, DOI 10.1111/dmcn.12020; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; FLETCHER JM, 1988, J CLIN EXP NEUROPSYC, V10, P495, DOI 10.1080/01688638808408255; Fournier-Vicente S, 2008, ACTA PSYCHOL, V129, P32, DOI 10.1016/j.actpsy.2008.04.004; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Goldberg MC, 2005, J AUTISM DEV DISORD, V35, P279, DOI 10.1007/s10803-005-3291-4; Grunewaldt KH, 2013, PEDIATRICS, V131, pE747, DOI 10.1542/peds.2012-1965; Hajek CA, 2014, J CHILD NEUROL, V29, P887, DOI 10.1177/0883073813491828; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; Hobson P., 2001, REV CLIN GERONTOLOGY, V11, P361, DOI DOI 10.1017/S0959259801011479; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Law N, 2011, NEUROIMAGE, V56, P2238, DOI 10.1016/j.neuroimage.2011.03.065; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Mahone EM, 2001, J INT NEUROPSYCH SOC, V7, P102, DOI 10.1017/S1355617701711101; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1999, TEST EVERYDAY ATTENT; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Middleton FA, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P44; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Salley CG, 2015, J PEDIATR PSYCHOL, V40, P297, DOI 10.1093/jpepsy/jsu083; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Verte S, 2006, J NEUROSCI METH, V151, P5, DOI 10.1016/j.jneumeth.2005.08.023; Wechsler D., 2011, WECHSLER ABBREVIATED; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734	61	11	11	1	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2017	23	7					529	538		10.1017/S1355617717000364			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	FD3VM	WOS:000407460500001	28502261				2022-02-06	
J	Clark, J; Hasselfeld, K; Bigsby, K; Divine, J				Clark, Joseph; Hasselfeld, Kimberly; Bigsby, Kathryn; Divine, Jon			Colored Glasses to Mitigate Photophobia Symptoms Posttraumatic Brain Injury	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; photosensitivity; rehabilitation; therapy; light; cones; rods; opsins	VISUALLY SENSITIVE MIGRAINE; POSTCONCUSSION SYNDROME; TINTED SPECTACLES; CONCUSSION	Context: After a concussion or mild traumatic brain injury (mTBI), patients often suffer from light sensitivity, or photophobia, which contributes to decreased quality of life post-mTBI. Whereas sunglasses may provide some relief from photophobia, they are not practical indoors or in low light. A light-mitigation strategy can be easily used indoors as needed to optimize the relief. We have found that many photophobic patients experience relief using colored sunglasses. Objective: To provide the athletic trainer with a means and method to assess whether an athlete is suffering from photophobia after concussion and to determine if colored glasses provide relief. Design: Cross-sectional study. Setting: Rehabilitation clinic. Patients or Other Participants: Fifty-one patients being treated after concussion. Intervention(s): We assessed postconcussion patients for visual symptoms including photophobia and photosensitivity. Off-the-shelf glasses were used to determine whether specific colors provided relief from photophobia. Screening was done using a penlight and multiple pairs of colored glasses. Main Outcome Measure(s): Self-reported mitigation of photophobia symptoms and the specific color frequency that reduced symptoms in each individual. Results: Of the 39 patients studied who had visual symptoms, 76% complained of photophobia. Using glasses of 1 or more colors, symptoms were relieved in 85% of patients reporting photophobia. The colors that provided the most relief were blue, green, red, and purple. No adverse events were reported. Conclusions: An empirical assessment of frequency-specific photophobia is easy to perform. A traditional penlight is used to elicit photophobia and then the colored glasses are tested for optimal relief. Frequency-specific photophobia can be reduced with a strategy of light-mitigation therapy, including colored glasses, sunglasses, hats, and light avoidance. This, we believe, helps to improve the patient's quality of life and may aid in the recovery process. More work is needed to identify the best colors and methods of mitigating frequency-specific photophobia.	[Clark, Joseph] Univ Cincinnati, Dept Neurol, ML 525,231 Bethesda Ave, Cincinnati, OH 45267 USA; [Hasselfeld, Kimberly; Divine, Jon] Univ Cincinnati, Dept Orthopaed Surg, Div Sports Med, Cincinnati, OH 45267 USA; [Bigsby, Kathryn] NovaCare Rehabil, Cincinnati, OH USA		Clark, J (corresponding author), Univ Cincinnati, Dept Neurol, ML 525,231 Bethesda Ave, Cincinnati, OH 45267 USA.	joseph.clark@uc.edu					ADELSON EH, 1982, VISION RES, V22, P1299, DOI 10.1016/0042-6989(82)90143-2; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Augustine G., 2001, NEUROSCIENCE; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Evans BJW, 2002, OPHTHAL PHYSL OPT, V22, P130, DOI 10.1046/j.1475-1313.2002.00017.x; Faul M, TRAUMATIC BRAIN INJU; Fimreite Vanessa, 2016, J Optom, V9, P231, DOI 10.1016/j.optom.2016.04.004; Green SS., 2015, CURR RES CONCUSSION, V2, P61; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kolb H., 2007, WEBVISION ORG RETINA; Laker SR, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0510-3; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; Lynch JM, 2015, J ATHL TRAINING, V50, P270, DOI 10.4085/1062-6050-49.3.78; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2014, ANN INTERN MED, V160, DOI 10.7326/0003-4819-160-3-201402040-01002; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Takahashi Y, 2001, NEUROLOGY, V57, P1767, DOI 10.1212/WNL.57.10.1767; Tessier-Lavigne M., 2000, PRINCIPL NEURAL SCI, P507; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wilkins AJ, 2002, CEPHALALGIA, V22, P711, DOI 10.1046/j.1468-2982.2002.00362.x; Wilkins AJ, 1999, SEIZURE-EUR J EPILEP, V8, P444, DOI 10.1053/seiz.1999.0337; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	22	11	11	0	10	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2017	52	8					725	729		10.4085/1062-6050-52.4.04			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FF5ZN	WOS:000409081500001	28650685	Green Published, Bronze			2022-02-06	
J	da Costa, LGV; Carmona, MJC; Malbouisson, LM; Rizoli, S; Rocha, JA; Cardoso, RG; Auler, JOC				da Costa, Luiz Guilherme V.; Carmona, Maria Jose C.; Malbouisson, Luiz M.; Rizoli, Sandro; Rocha-Filho, Joel Avancini; Cardoso, Ricardo Galesso; Auler-Junior, Jose Otavio C.			Independent early predictors of mortality in polytrauma patients: a prospective, observational, longitudinal study	CLINICS			English	Article						Multiple Trauma; Indicators; Mortality; Shock; Brain Injuries; Anoxia	TRAUMATIC BRAIN-INJURY; FLUID RESUSCITATION; HOSPITAL MORTALITY; LACTATE; HYPOTENSION; CARE; EPIDEMIOLOGY; SEVERITY; ISCHEMIA; SURVIVAL	OBJECTIVES: Trauma is an important public health issue and associated with substantial socioeconomic impacts and major adverse clinical outcomes. No single study has previously investigated the predictors of mortality across all stages of care (pre-hospital, emergency room, surgical center and intensive care unit) in a general trauma population. This study was designed to identify early predictors of mortality in severely injured polytrauma patients across all stages of care to provide a better understanding of the physiologic changes and mechanisms by which to improve care in this population. METHODS: A longitudinal, prospective, observational study was conducted between 2010 and 2013 in Sao Paulo, Brazil. Patients submitted to high-energy trauma were included. Exclusion criteria were as follows: injury severity score <16, <18 years old or insufficient data. Clinical and laboratory data were collected at four time points: pre-hospital, emergency room, and 3 and 24 hours after hospital admission. The primary outcome assessed was mortality within 30 days. Data were analyzed using tests of association as appropriate, nonparametric analysis of variance and generalized estimating equation analysis (p<0.05). ClinicalTrials.gov: NCT01669577. RESULTS: Two hundred patients were included. Independent early predictors of mortality were as follows: arterial hemoglobin oxygen saturation (p<0.001), diastolic blood pressure (p<0.001), lactate level (p<0.001), Glasgow Coma Scale score (p<0.001), infused crystalloid volume (p<0.015) and presence of traumatic brain injury (p<0.001). CONCLUSION: Our results suggest that arterial hemoglobin oxygen saturation, diastolic blood pressure, lactate level, Glasgow Coma Scale, infused crystalloid volume and presence of traumatic brain injury are independent early mortality predictors.	[da Costa, Luiz Guilherme V.; Carmona, Maria Jose C.; Malbouisson, Luiz M.; Rocha-Filho, Joel Avancini; Auler-Junior, Jose Otavio C.] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Div Anestesiol, Sao Paulo, SP, Brazil; [da Costa, Luiz Guilherme V.; Cardoso, Ricardo Galesso] Secretaria Estado Saude Sao Paulo, GRAU, Sao Paulo, SP, Brazil; [Rizoli, Sandro] Univ Toronto, Trauma & Acute Care Serv, St Michaels Hosp, Toronto, ON, Canada		da Costa, LGV (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Div Anestesiol, Sao Paulo, SP, Brazil.; da Costa, LGV (corresponding author), Secretaria Estado Saude Sao Paulo, GRAU, Sao Paulo, SP, Brazil.	lgvc76@yahoo.com.br	Auler, Jose Otavio Costa/C-4492-2017; CARMONA, MARIA JOSE CARVALHO/G-3653-2014; Costa, Luiz/AAU-6031-2020; Sa Malbouisson, Luiz Marcelo/F-4819-2012	Auler, Jose Otavio Costa/0000-0002-3919-1743; CARMONA, MARIA JOSE CARVALHO/0000-0002-3031-2924; Sa Malbouisson, Luiz Marcelo/0000-0002-3261-5603	Sao Paulo State Research Foundation (Fundacao de Amparo Pesquisa do Estado de Sao Paulo - FAPESP); Sao Paulo State Research Foundation (Fundacao de Amparoa Pesquisa do Estado de Sao Paulo - FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/03315-4]	We thank Sao Paulo State Research Foundation (Fundacao de Amparo Pesquisa do Estado de Sao Paulo - FAPESP) for providing financial support to acquire all the devices used in the study. Financial support was received from the Sao Paulo State Research Foundation (Fundacao de Amparoa Pesquisa do Estado de Sao Paulo - FAPESP) under grant no. 2010/03315-4.	Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arroyo W, 2013, INJURY, V44, P1745, DOI 10.1016/j.injury.2013.08.007; Barfod C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-28; Barmparas G, 2014, J CRIT CARE, V29, P936, DOI 10.1016/j.jcrc.2014.06.023; Battle CE, 2014, CRIT CARE, V18, DOI 10.1186/cc13873; Belzunegui T, 2013, AM J EMERG MED, V31, P1382, DOI 10.1016/j.ajem.2013.06.026; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Borthwick HA, 2012, ANN CLIN BIOCHEM, V49, P391, DOI 10.1258/acb.2011.011227; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Brown JB, 2013, J TRAUMA ACUTE CARE, V74, P1207, DOI 10.1097/TA.0b013e31828c44fd; Cherkas David, 2011, Emerg Med Pract, V13, P1; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark DE, 2007, J TRAUMA, V62, P592, DOI 10.1097/01.ta.0000257239.15436.29; Cudworth M, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-59; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Dziura James D., 2013, Yale Journal of Biology and Medicine, V86, P343; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Gourgiotis S, 2013, CRIT CARE NURSE, V33, P18, DOI 10.4037/ccn2013395; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hampton DA, 2014, AM J SURG, V207, P642, DOI 10.1016/j.amjsurg.2013.12.009; Hampton DA, 2013, J TRAUMA ACUTE CARE, V75, pS9, DOI 10.1097/TA.0b013e318290cd52; Hefny AF, 2013, AFR HEALTH SCI, V13, P731, DOI 10.4314/ahs.v13i3.30; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Holstein JH, 2012, CLIN ORTHOP RELAT R, V470, P2090, DOI 10.1007/s11999-012-2276-9; Hung KKC, 2009, EMERG MED J, V26, P118, DOI 10.1136/emj.2008.070797; Karpati PCJ, 2004, ANESTHESIOLOGY, V100, P30, DOI 10.1097/00000542-200401000-00009; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Kruse O, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-74; Ley EJ, 2012, J TRAUMA ACUTE CARE, V72, P943, DOI 10.1097/TA.0b013e3182465527; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Myburgh JA, 2015, J INTERN MED, V277, P58, DOI 10.1111/joim.12326; O'Reilly GM, 2013, INJURY, V44, P713, DOI 10.1016/j.injury.2013.02.003; Odom SR, 2013, J TRAUMA ACUTE CARE, V74, P999, DOI 10.1097/TA.0b013e3182858a3e; Peden M., 2002, INJURY CHART BOOK GR; Perel P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5166; Rahbar E, 2013, J TRAUMA ACUTE CARE, V75, pS16, DOI 10.1097/TA.0b013e31828fa535; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Tobias AZ, 2014, PREHOSP EMERG CARE, V18, P321, DOI 10.3109/10903127.2013.869645; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	49	11	11	1	9	HOSPITAL CLINICAS, UNIV SAO PAULO	SAO PAULO	FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL	1807-5932	1980-5322		CLINICS	Clinics	AUG	2017	72	8					461	468		10.6061/clinics/2017(08)02			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI2VB	WOS:000411803900002	28954004	Green Submitted, Green Published, gold			2022-02-06	
J	Liu, J; Li, CY; Peng, HW; Yu, KQ; Tao, J; Lin, RH; Chen, LD				Liu, Jiao; Li, Chunyan; Peng, Hongwei; Yu, Kunqiang; Tao, Jing; Lin, Ruhui; Chen, Lidian			Electroacupuncture attenuates learning and memory impairment via activation of alpha 7nAChR-mediated anti-inflammatory activity in focal cerebral ischemia/reperfusion injured rats	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						electroacupuncture; cerebral ischemia/reperfusion; alpha 7 nicotinic acetylcholine receptor; cholinergic anti-inflammatory pathway	NICOTINIC ACETYLCHOLINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; ISCHEMIA-REPERFUSION; MEDIATED INHIBITION; ARTERY OCCLUSION	Studies have reported that electroacupuncture (EA) may reduce learning and memory impairment following cerebral ischemic injury. However, the precise mechanism of action remains unclear. In the present study, the attenuation of focal cerebral ischemia/reperfusion injury by EA in rats was investigated. EA at the Baihui (DU 20) and Shenting (DU 24) acupoints was demonstrated to significantly improve performance in the Morris water maze task, with shortened latency time and increased frequency of passing the platform. Molecular analysis revealed that EA activated the expression of alpha 7 nicotinic acetylcholine receptors (alpha 7nAChR) in the hippocampus. In addition, EA led to a decreased expression of the microglia/macrophage marker Iba1 and the astrocyte marker glial fibrillary acidic protein in the hippocampus. EA treatment also led to decreased production of the inflammatory cytokines tumor necrosis factor-alpha and interleukin-1 beta. Treatment with methyllycaconitine, an alpha 7nAChR antagonist, attenuated the improvement of learning and memory following EA treatment and the inhibitory effects of EA on glial cell activation and inflammatory cytokine production. In conclusion, the findings of the present study demonstrate that EA is able to improve learning and memory function following cerebral ischemic injury via activation of alpha 7nAChR, which significantly decreases the neuroinflammatory response.	[Liu, Jiao; Li, Chunyan; Peng, Hongwei; Yu, Kunqiang; Tao, Jing; Lin, Ruhui; Chen, Lidian] Fujian Univ Tradit Chinese Med, Coll Rehabil Med, 1 Huatuo Rd, Fuzhou 350108, Fujian, Peoples R China; [Lin, Ruhui] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou 350122, Fujian, Peoples R China; [Liu, Jiao] Fujian Univ Tradit Chinese Med, Fujian Rehabil Tech Coinnovat Ctr, Fuzhou 350122, Fujian, Peoples R China		Lin, RH; Chen, LD (corresponding author), Fujian Univ Tradit Chinese Med, Coll Rehabil Med, 1 Huatuo Rd, Fuzhou 350108, Fujian, Peoples R China.	linruhui_2004@sina.com; cld@fjtcm.edu.cn			Fujian Rehabilitation Technology of Collaborative Innovation Center Support Project [X2012004]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81403462]; Fujian Natural Science Foundation of China [2015J01335]; Fujian Key Laboratory of Rehabilitation Technology	This study was supported by the Fujian Rehabilitation Technology of Collaborative Innovation Center Support Project (grant no. X2012004), the Natural Science Foundation of China (grant no. 81403462), the Fujian Natural Science Foundation of China (grant no. 2015J01335) and the Fujian Key Laboratory of Rehabilitation Technology.	Acheson DT, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00103; Aggarwal Neelum T, 2012, Int J Alzheimers Dis, V2012, P171327, DOI 10.1155/2012/171327; Bae CYJ, 2013, ACTA PHARMACOL SIN, V34, P10, DOI 10.1038/aps.2012.94; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Boccia MM, 2010, NEUROSCIENCE, V171, P531, DOI 10.1016/j.neuroscience.2010.08.027; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buchanan JB, 2008, PSYCHONEUROENDOCRINO, V33, P755, DOI 10.1016/j.psyneuen.2008.02.013; Carey L.M., 1995, CRIT REV PHYS REHABI, V7, P51, DOI [DOI 10.1615/CRITREVPHYSREHABILMED.V7.I1.40, 10.1615/CritRevPhysRehabilMed.v7.i1.40]; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen LP, 2011, J TRADIT CHIN MED, V31, P178, DOI 10.1016/S0254-6272(11)60036-8; Chen Y, 2012, BRAIN RES, V1432, P36, DOI 10.1016/j.brainres.2011.11.002; Chin Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-95; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Fan W, 2012, J NEUROINFLAMM, V9, P98; Fan XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122087; Feng XD, 2013, MOL MED REP, V7, P1516, DOI 10.3892/mmr.2013.1392; Guan YZ, 2015, MOL NEUROBIOL, V51, P1480, DOI 10.1007/s12035-014-8825-3; Han XH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/156489; Huang M, 2014, PSYCHOPHARMACOLOGY, V231, P2199, DOI 10.1007/s00213-013-3373-5; Jin Ya-Ping, 2006, Alzheimers Dement, V2, P171, DOI 10.1016/j.jalz.2006.03.006; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Kelly A, 2003, J BIOL CHEM, V278, P19453, DOI 10.1074/jbc.M301938200; Lee ST, 2010, BRAIN RES, V1309, P164, DOI 10.1016/j.brainres.2009.10.076; Liu F, 2014, ACUPUNCT MED, V32, P340, DOI 10.1136/acupmed-2013-010460; Liu F, 2014, J ALTERN COMPLEM MED, V20, P535, DOI 10.1089/acm.2013.0364; Liu XY, 2004, EXP NEUROL, V189, P189, DOI 10.1016/j.expneurol.2004.05.028; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; Norman GJ, 2011, J NEUROSCI, V31, P3446, DOI 10.1523/JNEUROSCI.4558-10.2011; Ondrejcak T, 2012, EUR J PHARMACOL, V677, P63, DOI 10.1016/j.ejphar.2011.12.008; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Pendlebury ST, 2009, CEREBROVASC DIS, V27, pS1; Pohjasvaara T, 1997, STROKE, V28, P785, DOI 10.1161/01.STR.28.4.785; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Tyagi E, 2010, NEUROCHEM INT, V56, P135, DOI 10.1016/j.neuint.2009.09.011; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Q, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-24; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Wu J N, 1996, J Altern Complement Med, V2, P19, DOI 10.1089/acm.1996.2.19; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Zhang C, 2015, NEURAL REGEN RES, V10, P159, DOI 10.4103/1673-5374.150727; Zhou H, 2013, BRAIN RES, V1529, P154, DOI 10.1016/j.brainres.2013.07.006	48	11	13	0	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	AUG	2017	14	2					939	946		10.3892/etm.2017.4622			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FB7BY	WOS:000406297300007	28810545	Green Submitted, Green Published, gold			2022-02-06	
J	Simmons, MM; Swedler, DI; Kerr, ZY				Simmons, Molly MacMhathan; Swedler, David I.; Kerr, Zachary Y.			Injury Surveillance of Head, Neck, and Facial Injuries in Collegiate Ice Hockey Players, 2009-2010 Through 2013-2014 Academic Years	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; lacerations; sex disparities	SPORTS-RELATED CONCUSSION; FOOTBALL PLAYERS; DESCRIPTIVE EPIDEMIOLOGY; GENDER-DIFFERENCES; UNITED-STATES; SYSTEM; RATES; NCAA; PREVENTION; IMPACTS	Context: Ice hockey is a high-speed, full-contact sport with a high risk of head/face/neck (HFN) injuries. However, men's and women's ice hockey differ; checking is allowed only among men. Objectives: To describe the epidemiology of HFN injuries in collegiate men's and women's ice hockey during the 2009-2010 through 2013-2014 academic years. Design: Descriptive epidemiology study. Setting: Ice hockey data from the National Collegiate Athletic Association (NCAA) Injury Surveillance Program during the 2009-2010 through 2013-2014 academic years. Patients or Other Participants: Fifty-seven men's and 26 women's collegiate ice hockey programs from all NCAA divisions provided 106 and 51 team-seasons of data, respectively. Main Outcome Measure(s): Injury rates per 1000 athlete-exposures and rate ratios with 95% confidence intervals (CIs). Results: The NCAA Injury Surveillance Program reported 496 and 131 HFN injuries in men's and women's ice hockey, respectively. The HFN injury rate was higher in men than in women (1.75 versus 1.16/1000 athlete-exposures; incidence rate ratio = 1.51; 95% CI = 1.25, 1.84). The proportion of HFN injuries from checking was higher in men than in women for competitions (38.5% versus 13.6%; injury proportion ratio = 2.82; 95% CI = 1.64, 4.85) and practices (21.9% versus 2.3%; injury proportion ratio = 9.41; 95% CI = 1.31, 67.69). The most common HFN injury diagnosis was concussion; most concussions occurred in men's competitions from player contact while checking (25.9%). Player contact during general play comprised the largest proportion of concussions in men's practices (25.9%), women's competitions (25.0%), and women's practices (24.0%). While 166 lacerations were reported in men, none were reported in women. In men, most lacerations occurred from player contact during checking in competitions (41.8%) and player contact during general play in practices (15.0%). Conclusions: A larger proportion of HFN injuries in ice hockey occurred during checking in men versus women. Concussion was the most common HFN injury and was most often due to player contact. Lacerations were reported only among men and were mostly due to checking. Injury-prevention programs should aim to reduce checking-related injuries.	[Simmons, Molly MacMhathan] VA Ctr Hlth Org & Implementat Res, 200 Springs Rd,Bldg 70, Bedford, MA 01730 USA; [Simmons, Molly MacMhathan] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Swedler, David I.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Simmons, MM (corresponding author), VA Ctr Hlth Org & Implementat Res, 200 Springs Rd,Bldg 70, Bedford, MA 01730 USA.	msimmons@post.harvard.edu		Swedler, David/0000-0001-9257-0665	NCAA	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The ISP was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCAA. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick R, 2007, J ATHL TRAINING, V42, P173; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HADDON W, 1980, ISRAEL J MED SCI, V16, P45; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Irick E, 2014, NCAA SPORTS SPONSORS; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; MURRAY TM, 1995, PEDIATRICS, V95, P419; Runyan CW, 2015, INJURY PREV, V21, P126, DOI 10.1136/ip.4.4.302rep; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Theberge N, 1997, GENDER SOC, V11, P69, DOI 10.1177/089124397011001005; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	38	11	11	2	10	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2017	52	8					776	784		10.4085/1062-6050-52.4.03			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FF5ZN	WOS:000409081500008	28662349	Bronze, Green Published			2022-02-06	
J	Sun, DB; Xu, MJ; Chen, QM; Hu, HT				Sun, De-Biao; Xu, Meng-Jun; Chen, Qing-Meng; Hu, Hai-Tao			Significant elevation of serum caspase-3 levels in patients with intracerebral hemorrhage	CLINICA CHIMICA ACTA			English	Article						Intracerebral hemorrhage; Outcome; Stroke; Caspapse-3; Biomarker; Prognosis	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; APOPTOSIS; EXPRESSION; GROWTH; ACTIVATION; MORTALITY; STRESS; CANCER; BCL-2	Background: Caspase-3 is a potential marker of apoptosis. We investigated whether serum caspase-3 concentrations were increased and its association with severity and prognosis after intracerebral hemorrhage (ICH). Methods: This prospective clinical study recruited 112 ICH patients and 112 healthy individuals. Serum was assayed for caspase-3 using enzyme-linked immunosorbent assay. Stroke severity was quantified by National Institute of Health Stroke Scale (NIHSS) and hematoma volume. Six-month outcome was measured by modified Rankin Scale. Analyses were performed using univariate and multivariate analyses. Results: Patients had significantly higher serum caspase-3 concentrations than controls. Capase-3 concentrations correlated with NIHSS score and hematoma volume. Serum caspase-3 emerged as an independent predictor for 6-month mortality and bad prognosis (modified Rankin scale score > 2). Based on receiver operating characteristic curve, caspase-3 concentrations showed similar prognostic value when compared with NIHSS score and hematoma volume. Conclusion: Serum caspase-3 concentrations are increased in ICH patients as well as correlate with clinical severity and prognosis.	[Sun, De-Biao; Xu, Meng-Jun; Chen, Qing-Meng; Hu, Hai-Tao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China		Hu, HT (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	jinhujinhu@yeah.net			Zhejiang Province Science and Technology Plan Project [2014C33186]	The authors thank all staffs in Department of Neurology, The second Affiliated Hospital, School of Medicine, Zhejiang University for their technical support. This study was supported financially by Zhejiang Province Science and Technology Plan Project (No. 2014C33186).	An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Chen H, 2015, INT J CLIN EXP MED, V8, P10225; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Ekshyyan O, 2004, FRONT BIOSCI-LANDMRK, V9, P1567, DOI 10.2741/1357; Fodor R. S., 2016, ROM J MORPHOL EMBRYO, V57, P951; Juraver-Geslin HA, 2015, GENESIS, V53, P203, DOI 10.1002/dvg.22844; Kim JY, 2017, J STROKE, V19, P28, DOI 10.5853/jos.2016.01935; Kobayashi T, 2007, CLIN CANCER RES, V13, P3868, DOI 10.1158/1078-0432.CCR-06-2730; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Li WH, 2016, BIOMED PHARMACOTHER, V80, P8, DOI 10.1016/j.biopha.2016.03.001; Liu HC, 2015, EUR REV MED PHARMACO, V19, P3459; Loh Kok Poh, 2006, Current Alzheimer Research, V3, P327; Lorente L, 2016, J CRIT CARE, V34, P103, DOI 10.1016/j.jcrc.2016.04.008; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; Lou M, 2016, BIOMED PHARMACOTHER, V84, P1, DOI 10.1016/j.biopha.2016.08.055; Mazumder Suparna, 2008, V414, P13; Morotti A, 2016, EMERG MED CLIN N AM, V34, P883, DOI 10.1016/j.emc.2016.06.010; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pu X, 2017, APOPTOSIS, V22, P357, DOI 10.1007/s10495-016-1323-5; Rosell A, 2008, NEUROSCI LETT, V430, P1, DOI 10.1016/j.neulet.2007.05.006; Thabet AM, 2017, HAND CLINIC, V140, P177, DOI 10.1016/B978-0-444-63600-3.00011-8; Veeravarmal Veeran, 2016, J Oral Maxillofac Pathol, V20, P445; Wang JW, 2014, WORLD J UROL, V32, P1477, DOI 10.1007/s00345-014-1246-0; Wang J, 2016, CLIN CHIM ACTA, V460, P196, DOI 10.1016/j.cca.2016.07.001; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yuksel S, 2012, TURK NEUROSURG, V22, P529, DOI 10.5137/1019-5149.JTN.5731-12.1	27	11	12	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2017	471						62	67		10.1016/j.cca.2017.05.021			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FD2ZK	WOS:000407403100010	28526532				2022-02-06	
J	Zhou, YX				Zhou, Yongxia			Small world properties changes in mild traumatic brain injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						mild traumatic brain injury; small-world property; graph theory; diffusion tensor imaging; functional connectivity; postconcussive symptom	DIFFUSE AXONAL INJURY; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; GRAPH-THEORY; STRUCTURAL NETWORKS; TENSOR; DISRUPTION; DYNAMICS; METRICS	PurposeTo investigate local and global efficiency changes characterized by small-world properties based on resting-state functional MRI, such as centrality and clustering coefficient, in mild traumatic brain injury (MTBI) patients; and to associate these findings with axonal injury as measured by diffusion tensor imaging (DTI) as well as with post-concussive symptom (PCS). Materials and MethodsThirty patients (mean age 3513 years) with clinically defined MTBI and 45 age-matched healthy controls (mean age 3710 years) participated in the experiments. Resting-state functional MRI was performed using gradient echo planar imaging sequence with 3 Tesla MRI scanner to obtain functional small-world networks. Out of all participants, 20 MTBI patients and 20 controls had available DTI data with three b-values (0, 500, 1000) s/mm(2) and 30 directions for diffuse axonal injury analyses. ResultsCompared with controls, MTBI patients showed lower relative betweenness centrality (P=0.01), but significantly higher clustering coefficient (P=0.04), and these two metrics correlated negatively in patients (r=-0.77; P<0.001). Regions with lower betweenness centrality (e.g., frontal and occipital) corresponded with the regions of reduced FA in patients, while global FA reduction correlated with betweenness centrality (r=0.48; P=0.03) and clustering coefficient (r=-0.46; P=0.04) in MTBI patients. In addition, there was significantly higher thalamocortical connectivity that correlated with clustering coefficient (r=0.39; P=0.03) in patients. Also, patients with higher clustering coefficient tended to have less PCS score with negative correlation (r=-0.4; P=0.04). ConclusionOur results demonstrated significant functional small-world properties changes in patients with MTBI, and suggest decreased global efficiency, possibly due to diffuse axonal injury and local network upregulation including increased thalamo-cortical connectivity. Level of Evidence: 2 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:518-527	[Zhou, Yongxia] NYU, Dept Radiol, Ctr Biomed Imaging, Langone Med Ctr, 560 1St Ave, New York, NY 10016 USA		Zhou, YX (corresponding author), NYU, Dept Radiol, Ctr Biomed Imaging, Langone Med Ctr, 560 1St Ave, New York, NY 10016 USA.	yongxiazhou@gmail.com		Zhou, Yongxia (Sharon)/0000-0002-4931-2318	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-RO1 NS039135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER	Contract grant sponsor: National Institute of Health (NIH); contract grant number: NIH-RO1 NS039135.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Drzezga A, 2011, BRAIN, V134, P1635, DOI 10.1093/brain/awr066; Gong YC, 2009, ANN NY ACAD SCI, V1158, P82, DOI 10.1111/j.1749-6632.2008.03752.x; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Hilgetag CC, 2016, BRAIN STRUCT FUNCT, V221, P2361, DOI 10.1007/s00429-015-1035-6; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Min YS, 2015, ANN REHABIL MED-ARM, V39, P374, DOI 10.5535/arm.2015.39.3.374; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Peeters SCT, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.508; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Smith CJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4411; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Voets NL, 2015, CEREB CORTEX, V25, P4584, DOI 10.1093/cercor/bhv109; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitlow CT, 2011, RADIOLOGY, V259, P516, DOI 10.1148/radiol.11101708; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Zavaglia M, 2016, BRAIN STRUCT FUNCT, V221, P2553, DOI 10.1007/s00429-015-1058-z; Zhou Y., 2013, ISRN GERIATRICS, V2013, DOI [10.1155/2013/542080, DOI 10.1155/2013/542080]; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	44	11	12	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	AUG	2017	46	2					518	527		10.1002/jmri.25548			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	FA7PG	WOS:000405638200021	27902865	Green Accepted			2022-02-06	
J	Lorente, L; Martin, MM; Abreu-Gonzalez, P; Perez-Cejas, A; Ramos, L; Argueso, M; Sole-Violan, J; Caceres, JJ; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Abreu-Gonzalez, Pedro; Perez-Cejas, Antonia; Ramos, Luis; Argueso, Monica; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Garcia-Marin, Victor			Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury	BMC NEUROLOGY			English	Article						Melatonin; Brain trauma; Patients; Mortality; Injury	TOTAL ANTIOXIDANT CAPACITY; OXIDATIVE STRESS; HEAD-INJURY; POSSIBLE INVOLVEMENT; DAMAGE; DISTURBANCE; MORTALITY; SEVERITY; EDEMA	Background: Circulating levels of melatonin in patients with traumatic brain injury (TBI) have been determined in a little number of studies with small sample size (highest sample size of 37 patients) and only were reported the comparison of serum melatonin levels between TBI patients and healthy controls. As to we know, the possible association between circulating levels of melatonin levels and mortality of patients with TBI have not been explored; thus, the objective of our current study was to determine whether this association actually exists. Methods: This multicenter study included 118 severe TBI (Glasgow Coma Scale < 9) patients. We measured serum levels of melatonin, malondialdehyde (to assess lipid peroxidation) and total antioxidant capacity (TAC) at day 1 of severe TBI. We used mortality at 30 days as endpoint. Results: We found that non-survivor (n = 33) compared to survivor (n = 85) TBI patients showed higher circulating levels of melatonin (p < 0.001), TAC (p < 0.001) and MDA (p < 0.001). We found that serum melatonin levels predicted 30-day mortality (Odds ratio = 1.334; 95% confidence interval = 1.094-1.627; p = 0.004), after to control for GCS, CT findings and age. We found a correlation between serum levels of melatonin levels and serum levels of TAC (rho = 0.37; p < 0.001) and serum levels of MDA (rho = 0.24; p = 0.008). Conclusions: As to we know, our study is the largest series providing circulating melatonin levels in patients with severe TBI. The main findings were that non-survivors had higher serum melatonin levels than survivors, and the association between serum levels of melatonin levels and mortality, peroxidation state and antioxidant state.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Dept Physiol, Fac Med, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain; [Perez-Cejas, Antonia] Hosp Univ Canarias, Lab Dept, Ofra S-N La Laguna, Tenerife 38320, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista Arriba S-N, Brena Alta, La Palma, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Avda Blasco Ibanez 17-19, Valencia 46004, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Barranco Ballena S-N, Las Palmas Gran Canaria 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N La Laguna, Santa Cruz De Tenerife 38320, Spain.	lorentemartin@msn.com	Abreu-Gonzalez, Pedro/AAC-7790-2020	Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Argueso, Monica/0000-0001-5917-1056	Grupo de Expertos Neurologicos de Canarias (GEN-Canarias. Santa Cruz de Tenerife. Spain); Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [INT16/00165]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported by a grant from Grupo de Expertos Neurologicos de Canarias (GEN-Canarias. Santa Cruz de Tenerife. Spain), and by a grant from Instituto de Salud Carlos III (INT16/00165) (Madrid, Spain) and cofinanced with Fondo Europeo de Desarrollo Regional (FEDER). Fundings influenced no in the study design, the collection, analysis, and interpretation of data, the manuscript writing, and the decision to submit it for publication.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; Kabadi SV, 2010, ANN NY ACAD SCI, V1199, P105, DOI 10.1111/j.1749-6632.2009.05352.x; Kavakli HS, 2010, SCI RES ESSAYS, V5, P2832; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0378-1; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Samantaray S, 2009, J PINEAL RES, V47, P134, DOI 10.1111/j.1600-079X.2009.00703.x; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; TEASDALE G, 1974, LANCET, V2, P81; Tsai MC, 2011, J PINEAL RES, V51, P233, DOI 10.1111/j.1600-079X.2011.00885.x; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3	33	11	12	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUL 19	2017	17								138	10.1186/s12883-017-0922-2			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB3PS	WOS:000406055400001	28724361	gold, Green Published			2022-02-06	
J	Mahmood, A; Roberts, I; Shakur, H				Mahmood, Abda; Roberts, Ian; Shakur, Haleema			A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])	TRIALS			English	Article						Tranexamic acid; Intracranial haemorrhage; Cerebral ischaemia; Traumatic brain injury	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ASSISTED VOLUMETRIC-ANALYSIS; ABC/2 ESTIMATION TECHNIQUE; SUBARACHNOID HEMORRHAGE; EXPLORATORY ANALYSIS; HEMATOMA VOLUME; PROGRESSION; COAGULATION; STROKE; VASOSPASM	Background: Tranexamic acid prevents blood clots from breaking down and reduces bleeding. However, it is uncertain whether tranexamic acid is effective in traumatic brain injury. The CRASH-3 trial is a randomised controlled trial that will examine the effect of tranexamic acid (versus placebo) on death and disability in 13,000 patients with traumatic brain injury. The CRASH-3 trial hypothesizes that tranexamic acid will reduce intracranial haemorrhage, which will reduce the risk of death. Although it is possible that tranexamic acid will reduce intracranial bleeding, there is also a potential for harm. In particular, tranexamic acid may increase the risk of cerebral thrombosis and ischaemia. The protocol detailed here is for a mechanistic sub-study nested within the CRASH-3 trial. This mechanistic sub-study aims to examine the effect of tranexamic acid (versus placebo) on intracranial bleeding and cerebral ischaemia. Methods: The CRASH-3 Intracranial Bleeding Mechanistic Sub-Study (CRASH-3 IBMS) is nested within a prospective, double-blind, multi-centre, parallel-arm randomised trial called the CRASH-3 trial. The CRASH-3 IBMS will be conducted in a cohort of approximately 1000 isolated traumatic brain injury patients enrolled in the CRASH-3 trial. In the CRASH-3 IBMS, brain scans acquired before and after randomisation are examined, using validated methods, for evidence of intracranial bleeding and cerebral ischaemia. The primary outcome is the total volume of intracranial bleeding measured on computed tomography after randomisation, adjusting for baseline bleeding volume. Secondary outcomes include progression of intracranial haemorrhage (from pre-to post-randomisation scans), new intracranial haemorrhage (seen on post-but not pre-randomisation scans), intracranial haemorrhage following neurosurgery, and new focal ischaemic lesions (seen on post-but not pre-randomisation scans). A linear regression model will examine whether receipt of the trial treatment can predict haemorrhage volume. Bleeding volumes and new ischaemic lesions will be compared across treatment groups using relative risks and 95% confidence intervals. Discussion: The CRASH-3 IBMS will provide an insight into the mechanism of action of tranexamic acid in traumatic brain injury, as well as information about the risks and benefits. Evidence from this trial could inform the management of patients with traumatic brain injury.	[Mahmood, Abda; Roberts, Ian; Shakur, Haleema] Univ London, London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England		Mahmood, A (corresponding author), Univ London, London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England.	abda.mahmood@lshtm.ac.uk		Shakur-Still, Haleema/0000-0002-6511-109X; Mahmood, Abda/0000-0002-3267-4590	JP Moulton Charitable Trust (United Kingdom); United Kingdom Department for International Development/Medical Research Council/Wellcome Trust through the Joint Global Health Trials Scheme in low-middle income countries [MR/M009211/1]; National Institute for Health Research, Health Technology Assessment programme for the United Kingdom [14/190/01]; London School of Hygiene and Tropical Medicine [EPNPBH61, EPAA6020]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M009211/1] Funding Source: UKRI	The JP Moulton Charitable Trust (United Kingdom) is funding the run-in costs for the CRASH- 3 trial and the recruitment of up to 500 patients (Additional file 4). Full funding for the main trial is provided through joint funding by the United Kingdom Department for International Development/Medical Research Council/Wellcome Trust through the Joint Global Health Trials Scheme in low- middle income countries (Grant number MR/M009211/1; Additional file 5) and by the National Institute for Health Research, Health Technology Assessment programme for the United Kingdom (Grant number 14/190/01; Additional file 6).; Funding for recruitment in the European Union and North America is provided by the London School of Hygiene and Tropical Medicine (Grant reference EPNPBH61; Additional file 7). The CRASH-3 IBMS is fully funded by the London School of Hygiene and Tropical Medicine (Grant reference EPAA6020; Additional file 7). The design, management and interpretation of the CRASH-3 trial and CRASH-3 IBMS are entirely independent of the manufacturers of tranexamic acid or the funders.	Baharoglu MI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001245.pub2; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Berkner J, 2016, METHODS MOL BIOL, V1462, P11, DOI 10.1007/978-1-4939-3816-2_2; Bingham EC., 1940, RHEOLOGICAL MEMOIRS, V1; Boudokhane S, 2016, ANN PHYS REHABIL M S, V59S, pe134, DOI DOI 10.1016/j.rehab.2016.07.301; Britain G., 1998, DATA PROTECTION ACT; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bunch J, 2000, INFORM RESOURCES COL, V4; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Edwards P, 2005, LANCET, V365, P1957; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Freeman WD, 2008, NEUROCRIT CARE, V9, P307, DOI 10.1007/s12028-008-9089-4; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Ghroubi S, 2016, ANN PHYS REHABIL M S, V59S, pe135; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Hu TT, 2016, BIOL RES NURS, V18, P5, DOI 10.1177/1099800415577634; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2016, ICH HARM GUID INT AD; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193; Ker K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub4; Khan M, 2017, J NEUROIMAGING, V27, P144, DOI 10.1111/jon.12370; Kirsch T, 2004, EMERGENCY MED COMPRE; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Krishnan K, 2015, J NEUROL NEUROSUR PS, V86, P1258, DOI 10.1136/jnnp-2014-309845; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Maeda AK, 2013, ARQ NEURO-PSIQUIAT, V71, P540, DOI 10.1590/0004-282X20130084; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; Mirsky DM, 2013, ANN NEUROL, V74, pS176; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pedraza S, 2012, J NEUROIMAGING, V22, P155, DOI 10.1111/j.1552-6569.2011.00588.x; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Roberts I, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0685-8; Roberts I, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0056-1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roos YB, 2003, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD001245, 10.1002/14651858.CD001245]; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Sa de Camargo Erica C, 2005, NeuroRx, V2, P265; Schwinn DA, 2012, J CLIN INVEST, V122, P4339, DOI 10.1172/JCI66724; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Smajlovic Dzevdet, 2004, Med Arh, V58, P282; Su Z, 2006, PRELIMINARY RESULT 2; Tao HY, 2012, J NEUROINTERV SURG, V4, P256, DOI 10.1136/neurintsurg-2011-010062; Tsair TJ, 2010, RADIOGRAPHY, V16, P209, DOI 10.1016/j.radi.2010.04.004; Wang CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102326; Wang CW, 2009, ACTA RADIOL, V50, P306, DOI 10.1080/02841850802647039; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; World Health Organization, 2013, GLOB STAT REP ROAD S; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Xu XH, 2014, STROKE, V45, P3433, DOI 10.1161/STROKEAHA.114.007095; Yan J, 2013, NEUROL RES, V35, P382, DOI 10.1179/1743132812Y.0000000141; Yan PF, 2016, PEERJ, V4, DOI 10.7717/peerj.1921; Yang W, 2013, NAT MATER, V12, P792, DOI [10.1038/NMAT3695, 10.1038/nmat3695]; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	77	11	12	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 17	2017	18								330	10.1186/s13063-017-2073-6			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FA8ZV	WOS:000405736400004	28716153	gold, Green Published, Green Accepted			2022-02-06	
J	Murphy, S; Thomas, NJ; Gertz, SJ; Beca, J; Luther, JF; Bell, MJ; Wisniewski, SR; Hartman, AL; Tasker, RC				Murphy, Sarah; Thomas, Neal J.; Gertz, Shira J.; Beca, John; Luther, James F.; Bell, Michael J.; Wisniewski, Stephen R.; Hartman, Adam L.; Tasker, Robert C.		Investigators Approaches Decisions	Tripartite Stratification of the Glasgow Coma Scale in Children with Severe Traumatic Brain Injury and Mortality: An Analysis from a Multi-Center Comparative Effectiveness Study	JOURNAL OF NEUROTRAUMA			English	Article						comparative effectiveness research; Glasgow Coma Scale (GCS) score; pediatric neurocritical care; pediatric traumatic brain injury; secondary injuries	RANDOMIZED CONTROLLED-TRIAL; CLINICAL-ASSESSMENT; PEDIATRIC TRAUMA; COAGULOPATHY; CONSCIOUSNESS; HYPOTHERMIA; LEVEL; SCORE; RISK	The Glasgow Coma Scale (GCS) score has not been validated in children younger than 5 years and the clinical circumstances at the time of assignment can limit its applicability. This study describes the distribution of GCS scores in the population, the relationship between injury characteristics with the GCS score, and the association between the tripartite stratification of the GCS on mortality in children with severe traumatic brain injury (TBI). The first 200 children from a multi-center comparative effectiveness study in severe TBI (inclusion criteria: age 0-18 years, GCS 8 at the time of intracranial pressure [ICP] monitoring) were analyzed. After tripartite stratification of GCS scores (Group A, GCS 3; Group B, GCS 4 - 5; and Group C, GCS 6 - 8), analyses of variance and chi-square testing were performed. Mean age was 7.61 years +/- 5.33 and mortality was 19.1%. There was no difference in etiology or type/mechanism of injury between groups. However, groups demonstrated differences in neuromuscular blockade, endotracheal intubation, pre-hospital events (cardiac arrest and apnea), coagulopathy, and pupil response. Mortality between groups was different (42.2% Group A, 22.6% Group B, and 3.8% Group C; p<0.001), and adding pupil response improved mortality associations. In children younger than 5 years of age, a similar relationship between GCS and mortality was observed. Overall, GCS score at the time of ICP monitor placement is strongly associated with mortality across the pediatric age range. Development of models with GCS and other factors may allow identification of subtypes of children after severe TBI for future studies.	[Murphy, Sarah] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Thomas, Neal J.] Penn State Univ, Dept Pediat, Coll Med, Hershey, PA USA; [Gertz, Shira J.] Hackensack Univ Med Ctr, Dept Pediat, Hackensack, NJ USA; [Beca, John] Starship Childrens Hosp, Dept Pediat, Auckland, New Zealand; [Luther, James F.; Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Hartman, Adam L.] NINDS, Off Clin Res, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Tasker, Robert C.] Harvard Med Sch, Dept Anesthesia Pediat, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Dept Neurol, Boston, MA USA		Bell, MJ (corresponding author), Univ Pittsburgh, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Hartman, Adam/W-9782-2019; Gertz, Shira J/AAT-2711-2020; Tasker, Robert C/R-5837-2019	Hartman, Adam/0000-0001-5672-3409; Tasker, Robert/0000-0003-3647-8113	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS081041]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number U01 NS081041. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL UPD 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bell MJ, 2016, INTENS CARE MED, V42, P1618, DOI 10.1007/s00134-016-4401-9; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Emami P, 2016, J NEUROSURG, P1; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Gemke RJBJ, 1998, LANCET, V351, P926; GORDON NS, 1983, NEUROPEDIATRICS, V14, P3, DOI 10.1055/s-2008-1059545; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Peiniger S, 2012, PEDIATR CRIT CARE ME, V13, P455, DOI 10.1097/PCC.0b013e31823893c5; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SIMPSON D, 1982, LANCET, V2, P450; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007	33	11	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2220	2229		10.1089/neu.2016.4793			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000004	28052716	Green Published			2022-02-06	
J	Brook, EM; Kroshus, E; Hu, CH; Gedman, M; Collins, JE; Matzkin, EG				Brook, Emily M.; Kroshus, Emily; Hu, Caroline H.; Gedman, Marissa; Collins, Jamie E.; Matzkin, Elizabeth G.			Incidence of Sports-Related Concussion Among NCAA Women's Ice Hockey Athletes	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						sports-related concussion; concussion in sport; ice hockey; NCAA athletics; female athlete	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; IMPACT; MECHANISMS; SYMPTOMS; MENS	Background: There are limited data on the incidence of concussion and concussion symptom nondisclosure among collegiate women's ice hockey athletes. Purpose: To determine the incidence of sports-related concussion (SRC) in National Collegiate Athletic Association (NCAA) women's ice hockey athletes. Study Design: Descriptive epidemiology study. Methods: An anonymous online survey was completed by 459 NCAA women's ice hockey athletes. Players reported diagnosed concussions as well as incidents where they experienced an impact or blow to the head followed by symptoms associated with a concussion; reports spanned the duration of the 2014-2015 season and throughout players' organized hockey career. Results: About half (n = 219, 47.7%) of respondents reported at least 1 diagnosed concussion over the duration of their entire organized ice hockey career. A total of 13.3% (n = 61) of respondents reported a diagnosed concussion during the 2014-2015 season. The incidence rate was 1.18 (95% CI, 0.92-1.51) per 1000 athlete-exposures to a game or practice and 0.58 (95% CI, 0.45-0.74) per 1000 hours of ice time. One-third (34.2%, n = 157) of players reported at least 1 impact where they experienced concussion-like symptoms during the 2014-2015 season; 82.8% of these players reported that they continued to play after at least 1 of these impacts, and 66.8% of players reported at least 1 impact where they never disclosed any symptoms. Conclusion:There is a high incidence of SRC in collegiate women's ice hockey and a concerning level of symptom nondisclosure. Additional research is needed to understand the causes of concussion and reasons for the lack of symptom disclosure, including factors specific to female athletes and contextual issues specific to women's collegiate ice hockey.	[Brook, Emily M.; Kroshus, Emily; Hu, Caroline H.; Gedman, Marissa; Collins, Jamie E.; Matzkin, Elizabeth G.] Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Hu, Caroline H.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Matzkin, Elizabeth G.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA		Matzkin, EG (corresponding author), Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA.	ematzkin@partners.org		Hu, Caroline/0000-0001-7620-6951			Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; [Anonymous], STAND PLAY RUL EMPH; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Irick E., 2015, STUDENT ATHLETE PART; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; National Federation of State High School Associations, PART SURV HIST BOOK; National Federation of State High School Assosciations, 2014, 2014 2015 HIGH SCH A; Piotroswski S, 2014, NCAA ICE HOCKEY 2014; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	38	11	11	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JUL 11	2017	5	7							2325967117714445	10.1177/2325967117714445			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FA5TO	WOS:000405506800001	28812036	gold, Green Submitted, Green Published			2022-02-06	
J	Hill, LJ; Di Pietro, V; Hazeldine, J; Davies, D; Tomman, E; Logan, A; Belli, A				Hill, Lisa J.; Di Pietro, Valentina; Hazeldine, Jon; Davies, David; Tomman, Emma; Logan, Ann; Belli, Antonio			Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury	SCIENTIFIC REPORTS			English	Article							FIBRILLARY ACIDIC PROTEIN; NF-KAPPA-B; OXIDATIVE STRESS; HEAD-INJURY; DIAGNOSIS; SEVERITY; TRANSCRIPTION; MARKERS; SERUM; GENE	Traumatic brain injury (TBI) is set to become the leading cause of neurological disability across all age groups. Currently, no reliable biomarkers exist to help diagnose the severity of TBI to identify patients who are at risk of developing secondary injuries. Thus, the discovery of reliable biomarkers for the management of TBI would improve clinical interventions. Inflammatory markers are particularly suited for biomarker discovery as TBI leads to very early alterations in inflammatory proteins. Using the Proseek Multiplex Inflammation assay, we measured in patients that had suffered mild TBI (n = 10) or severe TBI (n = 10) with extra-cranial injury or extracranial injury only (EC) (n = 10), 92 inflammation-associated proteins in serum obtained: <1 hr (within 1-hour), 4-12 hr and 48-72 hr post injury. Changes were compared to healthy volunteers (HV). Our results identified CST5, AXIN1 and TRAIL as novel early biomarkers of TBI. CST5 identified patients with severe TBI from all other cohorts and importantly was able to do so within the first hour of injury. AXIN1 and TRAIL were able to discriminate between TBI and HV at <1 hr. We conclude that CST5, AXIN1 and TRAIL are worthy of further study in the context of a pre-hospital or pitch-side test to detect brain injury.	[Hill, Lisa J.; Di Pietro, Valentina; Logan, Ann; Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Neurosci & Ophthalmol Res Grp, Birmingham B15 2TT, W Midlands, England; [Hill, Lisa J.; Di Pietro, Valentina; Hazeldine, Jon; Davies, David; Tomman, Emma; Logan, Ann; Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England		Hill, LJ (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Neurosci & Ophthalmol Res Grp, Birmingham B15 2TT, W Midlands, England.; Hill, LJ (corresponding author), Queen Elizabeth Hosp, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England.	l.j.hill@bham.ac.uk	Hazeldine, Jon/T-5725-2019; Hill, Lisa J/AAO-1560-2021; Belli, Antonio/I-3799-2015	Hill, Lisa J/0000-0001-8431-7029; Belli, Antonio/0000-0002-3211-9933; Toman, Emma/0000-0003-2142-1923	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N019016/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [G18986] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/J011584/1, MR/N019016/1] Funding Source: Medline		Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Carr ME, 2009, MIL MED, V174, P622, DOI 10.7205/MILMED-D-02-4708; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Collins AR, 1998, ORAL MICROBIOL IMMUN, V13, P59, DOI 10.1111/j.1399-302X.1998.tb00753.x; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Ferrer-Mayorga G, 2015, J BIOL CHEM, V290, P26533, DOI 10.1074/jbc.M115.660175; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; PALFREYMAN JW, 1978, CLIN CHIM ACTA, V82, P259, DOI 10.1016/0009-8981(78)90008-6; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Seol DW, 2001, CANCER RES, V61, P1138; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; STUSS DT, 1995, NEUROLOGY, V45, P1251, DOI 10.1212/WNL.45.7.1251; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	34	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 10	2017	7								5002	10.1038/s41598-017-04722-5			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA1EA	WOS:000405180900075	28694499	Green Accepted, Green Published, gold			2022-02-06	
J	Bailey, EK; Nakase-Richardson, R; Patel, N; Dillahunt-Aspillaga, C; Ropacki, SA; Sander, AM; Stevens, L; Tang, X				Bailey, Erin K.; Nakase-Richardson, Risa; Patel, Nitin; Dillahunt-Aspillaga, Christina; Ropacki, Susan A.; Sander, Angelle M.; Stevens, Lillian; Tang, Xinyu			Supervision Needs Following Veteran and Service Member Moderate to Severe Traumatic Brain Injury: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; outcomes research; rehabilitation	POSTTRAUMATIC AMNESIA; GALVESTON ORIENTATION; REHABILITATION; 1-YEAR; OUTCOMES; SCALE; CONSCIOUSNESS; DISCHARGE; DURATION; VALIDITY	Objective: To characterize supervision levels across residential settings at 1 year post-TBI and explore predictors of supervision in a Veteran and Service-member population. Setting: Five VA Polytrauma Rehabilitation Centers. Participants: A total of 302 individuals enrolled in the VA TBI Model Systems (TBIMS) research program. Design: Prospective, longitudinal, multisite. Main Measures: Primary residence and supervision levels measured via scores on the Supervision Rating Scale. For predictive modeling, scores were dichotomized into 2 groups: those that were fully independent/living alone or required only some supervision during the day (independent group, n = 195) and those that required overnight supervision, full-time indirect supervision, and full-time direct supervision (dependent group, n = 107). Results: Thirty-five percent were receiving supervision at 1 year post-TBI across residential settings and 28% were living in alternative settings. Multivariate modeling indicated that older age and longer posttraumatic amnesia (PTA) were predictive of having a need for supervision at 1 year postinjury. Conclusions: Supervision needs are long-term features of moderate and severe TBI. Results of this study lend support to the shift toward conceptualizing TBI as a chronic disease.	[Bailey, Erin K.; Nakase-Richardson, Risa; Dillahunt-Aspillaga, Christina] James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Nakase-Richardson, Risa; Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Internal Med, Tampa, FL USA; [Nakase-Richardson, Risa; Patel, Nitin; Dillahunt-Aspillaga, Christina] HSR&D Innovat Disability& Rehabil Res CINDRR, Tampa, FL USA; [Nakase-Richardson, Risa] DVBIC, Tampa, FL USA; [Ropacki, Susan A.] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; [Ropacki, Susan A.] Vet Affairs Palo Alto Hlth Care Syst, Polytrauma Syst Care, Palo Alto, CA USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sander, Angelle M.] Harris Hlth Syst, Dept Phys Med & Rehabil, Houston, TX USA; [Stevens, Lillian] Hunter Holmes McGuire VA Med Ctr, Dept Mental Hlth, Richmond, VA USA; [Stevens, Lillian] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Stevens, Lillian] DVBIC, Richmond, VA USA; [Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, MH BS, Dept Mental Hlth & Behav Sci, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Bailey, Erin K/V-6432-2019	Bailey, Erin/0000-0002-9390-0678	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015]; US Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans AffairsUS Department of Veterans Affairs [1 I50 HX001233-01, W81XWH-13-2-0095]; U.S. Department of Defense Congressionally Directed Medical Research Programs; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90RT5007, 90DP0028, 90DP0060]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs.; The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant numbers 90RT5007 [PI: Sander], 90DP0028 [PI: Sherer], and 90DP0060 [PI: Arciniegas]). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, and HHS, and you should not assume endorsement by the Federal Government.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; >Centers for Disease Control and Prevention (CDC) the National Institutes of Health (NIH) the Department of Defense (DoD) & the Department of Veterans Affairs (VA) Leadership Panel, 2013, C TRAUM BRAIN INJ US; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Dawodu ST, TRAUMATIC BRAIN INJU; Department of Veterans Affairs, 2013, VHA HDB; Eibner C., 2008, INVISIBLE WOUNDS WAR, P169, DOI 10.7249/mg720ccf; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Sherer M, 1999, BRAIN INJURY, V13, P973; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	41	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					245	254		10.1097/HTR.0000000000000317			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200012	28520667				2022-02-06	
J	Huang, LK; Wang, HH; Tu, HF; Fu, CY				Huang, Li-Kuo; Wang, Hsueh Han; Tu, Hsi-Feng; Fu, Chih-Yuan			Simultaneous head and facial computed tomography scans for assessing facial fractures in patients with traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Computed tomography; Facial fracture; Traumatic brain injury	EPIDEMIOLOGY; CT; MULTIDETECTOR; MANAGEMENT	Introduction: Patients with traumatic brain injury (TBI) may have concomitant facial fractures. While most head injury patients receive head computed tomography (CT) scans for initial evaluation, the objective of our study was to investigate the value of simultaneous facial CT scans in assessing facial fractures in patients with TBI. Methods: From January 1, 2015 to December 31, 2015, 1649 consecutive patients presenting to our emergency department (ED) with a TBI who received CT scans using the protocol for head and facial bones were enrolled. The clinical data and CT images were reviewed via a standardized format. Results: In our cohort, 200 patients (12.1%) had at least one facial fracture shown on the CT scans. Patients with facial fractures were more likely to have initial loss of consciousness (ILOC; p < 0.001), a Glasgow coma scale of 8 or less (p < 0.001), moderate or severe degrees of head injury severity scale (p < 0.001), positive physical examination findings (p < 0.001), and positive CT cranial abnormalities (p < 0.001). A total of 166 (83.0%) patients with facial fractures required further facial CT scans instead of conventional head CT scans alone. Surgical intervention was mandatory in 73 (44.0%) of the 166 patients, who more frequently exhibited fractures of the lower third of the face (p < 0.001) and orbital fractures (p = 0.019). Conclusions: TBI patients with risk factors may have a higher probability of concomitant facial fractures. Fractures of the lower third of the face and orbit are easily overlooked in routine head CT scans but often require surgical intervention. Therefore, simultaneous head and facial CT scans are suggested in selected TBI patients. (C) 2017 Elsevier Ltd. All rights reserved.	[Huang, Li-Kuo; Wang, Hsueh Han] Natl Yang Ming Univ Hosp, Dept Radiol, Yi Lan, Taiwan; [Tu, Hsi-Feng] Natl Yang Ming Univ Hosp, Dept Dent, Yi Lan, Taiwan; [Huang, Li-Kuo] Natl Yang Ming Univ, Sch Med, Dept Radiol, Taipei, Taiwan; [Tu, Hsi-Feng] Natl Yang Ming Univ, Dent Sch, Dept Dent, Taipei, Taiwan; [Fu, Chih-Yuan] Chang Gung Mem Hosp, Dept Trauma & Emergency Surg, 5 Fu Hsing St, Taoyuan, Taiwan; [Fu, Chih-Yuan] Chang Gung Univ, Taoyuan, Taiwan		Fu, CY (corresponding author), Chang Gung Mem Hosp, Dept Trauma & Emergency Surg, 5 Fu Hsing St, Taoyuan, Taiwan.	drfu5564@yahoo.com.tw		Fu, Chih-Yuan/0000-0003-1536-1549			Allareddy V, 2011, J ORAL MAXIL SURG, V69, P2613, DOI 10.1016/j.joms.2011.02.057; Avery LL, 2011, RADIOL CLIN N AM, V49, P183, DOI 10.1016/j.rcl.2010.07.014; Betts AM, 2014, EMERG RADIOL, V21, P511, DOI 10.1007/s10140-014-1221-5; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; Dreizin D, 2016, RADIOGRAPHICS, V36, P1539, DOI 10.1148/rg.2016150218; Erdmann D, 2008, ANN PLAS SURG, V60, P398, DOI 10.1097/SAP.0b013e318133a87b; Gelesko S, 2013, ORAL MAXIL SURG CLIN, V25, P545, DOI 10.1016/j.coms.2013.07.001; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holmgren EP, 2004, J ORAL MAXIL SURG, V62, P913, DOI 10.1016/j.joms.2003.12.026; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Sitzman TJ, 2011, PLAST RECONSTR SURG, V127, P1270, DOI 10.1097/PRS.0b013e3182043ad8; Smith HL, 2013, DENT TRAUMATOL, V29, P313, DOI 10.1111/edt.12006; TEASDALE G, 1974, LANCET, V2, P81; Tse KM, 2015, ACCIDENT ANAL PREV, V79, P13, DOI 10.1016/j.aap.2015.03.012; Whitesell RT, 2015, AM J ROENTGENOL, V205, pW4, DOI 10.2214/AJR.14.13589; Winegar BA, 2013, RADIOGRAPHICS, V33, P3, DOI 10.1148/rg.331125080; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	27	11	11	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2017	48	7					1417	1422		10.1016/j.injury.2017.04.046			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FB2TW	WOS:000405997100022	28455003				2022-02-06	
J	Park, H; Park, KW; Park, KB; Kim, HW; Eom, NK; Lee, DH				Park, Hoon; Park, Kwang-Won; Park, Kun Bo; Kim, Hyun Woo; Eom, Nam Kyu; Lee, Dong Hoon			Impact of Open Reduction on Surgical Strategies for Missed Monteggia Fracture in Children	YONSEI MEDICAL JOURNAL			English	Article						Missed Monteggia fracture; open reduction; ulnar osteotomy; ulnar bow	RADIAL-HEAD DISLOCATION; ANNULAR LIGAMENT RECONSTRUCTION; ULNAR OSTEOTOMY; EXTERNAL FIXATION; ANTERIOR DISLOCATION; CLOSED REDUCTION; LESIONS; MANAGEMENT; INJURIES; DEFORMATION	Purpose: The aims of this study were to review our cases of missed Monteggia fracture treated by open reduction of the radial head with or without ulnar osteotomy and to investigate the indications for open reduction alone in surgical treatment of missed Monteggia fracture. Materials and Methods: We retrospectively reviewed 22 patients who presented with missed Monteggia fracture. The patients' mean age at the time of surgery was 7.6 years. The mean interval from injury to surgery was 16.1 months. The surgical procedure consisted of open reduction of the radiocapitellar joint followed by ulnar osteotomy without reconstruction of the annular ligament. The mean period of follow-up was 3.8 years. Radiographic assessment was performed for the maximum ulnar bow (MUB) and the location of the MUB. Clinical results were evaluated with the Mayo Elbow Performance Index and Kim's scores. Results: Five patients underwent open reduction alone, and 17 patients underwent open reduction and ulnar osteotomy. When the MUB was less than 4 mm and the location of the MUB was in the distal 40% of the ulna, we could achieve reduction of the radial head without ulnar osteotomy. The radial head was maintained in a completely reduced position in 21 patients and was dislocated in one patient at final follow-up. Conclusion: Open reduction alone can be an attractive surgical option in select patients with missed Monteggia fracture with minimal bowing of the distal ulna. However, ulnar osteotomy should be considered in patients with a definite ulnar deformity.	[Park, Hoon; Eom, Nam Kyu] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Orthoped Surg, Seoul, South Korea; [Park, Kwang-Won] Korea Univ, Med Ctr, Guro Hosp, Inst Rare Dis, Seoul, South Korea; [Park, Kwang-Won] Korea Univ, Med Ctr, Guro Hosp, Dept Orthoped Surg, Seoul, South Korea; [Park, Kun Bo; Kim, Hyun Woo; Lee, Dong Hoon] Yonsei Univ, Coll Med, Severance Childrens Hosp, Div Orthoped Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea		Lee, DH (corresponding author), Yonsei Univ, Coll Med, Severance Childrens Hosp, Div Orthoped Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea.	orthopaedee@naver.com	PARK, HOON/O-8387-2018	PARK, HOON/0000-0002-8063-3742; Park, Kun-Bo/0000-0002-8839-4870; Kim, Hyun Woo/0000-0001-8576-1877			Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Bae, 2016, INSTR COURSE LECT, V65, P399; Bae DS, 2016, J PEDIATR ORTHOPED, V36, pS67, DOI 10.1097/BPO.0000000000000765; Belangero WD, 2007, INT ORTHOP, V31, P151, DOI 10.1007/s00264-006-0153-4; BEST TN, 1994, J PEDIATR ORTHOPED, V14, P193, DOI 10.1097/01241398-199403000-00012; Bhaskar A, 2009, INDIAN J ORTHOP, V43, P389, DOI 10.4103/0019-5413.55978; Bor N, 2015, J PEDIATR ORTHOPED, V35, P7, DOI 10.1097/BPO.0000000000000203; Cappellino A, 1998, J PEDIATR ORTHOPED, V18, P410, DOI 10.1097/00004694-199805000-00026; David-West KS, 2005, INJURY, V36, P1206, DOI 10.1016/j.injury.2004.12.033; De Boeck H, 2000, CLIN ORTHOP RELAT R, P215; DeBoeck H, 1997, CLIN ORTHOP RELAT R, P94; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Delpont M, 2014, ORTHOP TRAUMATOL-SUR, V100, P803, DOI 10.1016/j.otsr.2014.06.022; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Di Gennaro Giovanni L, 2015, Musculoskelet Surg, V99 Suppl 1, pS75, DOI 10.1007/s12306-015-0362-3; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; FOWLES JV, 1983, J BONE JOINT SURG AM, V65, P1276, DOI 10.2106/00004623-198365090-00008; Gyr BM, 2004, J PEDIATR ORTHOP B, V13, P402, DOI 10.1097/01202412-200411000-00011; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88, DOI 10.1302/0301-620X.87B1.14669; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; Horii E, 2002, J BONE JOINT SURG AM, V84A, P1183, DOI 10.2106/00004623-200207000-00014; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; Inoue G, 1998, ACTA ORTHOP SCAND, V69, P73, DOI 10.3109/17453679809002361; Jeong WK, 2012, J PEDIATR ORTHOPED, V32, P48, DOI 10.1097/BPO.0b013e31823db04a; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; LINCOLN TL, 1994, J PEDIATR ORTHOPED, V14, P454, DOI 10.1097/01241398-199407000-00006; Lu XM, 2017, J PEDIATR ORTHOPED, V37, P20, DOI 10.1097/BPO.0000000000000584; Lu XM, 2013, J PEDIATR ORTHOPED, V33, P398, DOI 10.1097/BPO.0b013e3182812762; MORREY BF, 1993, ELBOW ITS DISORDERS, V2, P86; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; ONER FC, 1993, J BONE JOINT SURG BR, V75, P577, DOI 10.1302/0301-620X.75B4.8331112; Rahbek O, 2011, J CHILD ORTHOP, V5, P449, DOI 10.1007/s11832-011-0372-0; Rajasekaran S, 2014, INT ORTHOP, V38, P2519, DOI 10.1007/s00264-014-2514-8; Ray R, 2014, J PEDIATR ORTHOP B, V23, P472, DOI 10.1097/BPB.0000000000000062; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; Sano S, 2008, J SHOULDER ELB SURG, V17, P768, DOI 10.1016/j.jse.2008.03.007; Seel MJ, 1999, J PEDIATR ORTHOPED, V19, P306, DOI 10.1097/00004694-199905000-00006; Song KS, 2012, J ORTHOP TRAUMA, V26, P597, DOI 10.1097/BOT.0b013e3182548981; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; Wang MN, 2006, J ORTHOP TRAUMA, V20, P1, DOI 10.1097/01.bot.0000189881.75421.92	42	11	12	0	4	YONSEI UNIV COLL MEDICINE	SEOUL	50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA	0513-5796	1976-2437		YONSEI MED J	Yonsei Med. J.	JUL	2017	58	4					829	836		10.3349/ymj.2017.58.4.829			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8AL	WOS:000407747400021	28540998	gold, Green Published, Green Submitted			2022-02-06	
J	Poltavski, D; Lederer, P; Cox, LK				Poltavski, Dmitri; Lederer, Paul; Cox, Laurie Kopko			Visually Evoked Potential Markers of Concussion History in Patients with Convergence Insufficiency	OPTOMETRY AND VISION SCIENCE			English	Article						concussion; convergence insufficiency; magnocellular pathway; VEP	TRAUMATIC BRAIN-INJURY; LATERAL GENICULATE-NUCLEUS; CRITICAL FLICKER FREQUENCY; MACAQUE MONKEYS; VEP; MTBI; IMPAIRMENT; RESPONSES; SYMPTOMS; NEURONS	Purpose We investigated whether differences in the pattern visual evoked potentials exist between patients with convergence insufficiency and those with convergence insufficiency and a history of concussion using stimuli designed to differentiate between magnocellular (transient) and parvocellular (sustained) neural pathways. Methods Sustained stimuli included 2-rev/s, 85% contrast checkerboard patterns of 1- and 2-degree check sizes, whereas transient stimuli comprised 4-rev/s, 10% contrast vertical sinusoidal gratings with column width of 0.25 and 0.50 cycles/degree. We tested two models: an a priori clinical model based on an assumption of at least a minimal (beyond instrumentation's margin of error) 2-millisecond lag of transient response latencies behind sustained response latencies in concussed patients and a statistical model derived from the sample data. Results Both models discriminated between concussed and nonconcussed groups significantly above chance (with 76% and 86% accuracy, respectively). In the statistical model, patients with mean vertical sinusoidal grating response latencies greater than 119 milliseconds to 0.25-cycle/degree stimuli (or mean vertical sinusoidal latencies >113 milliseconds to 0.50-cycle/degree stimuli) and mean vertical sinusoidal grating amplitudes of less than 14.75 mV to 0.50-cycle/degree stimuli were classified as having had a history of concussion. The resultant receiver operating characteristic curve for this model had excellent discrimination between the concussed and nonconcussed (area under the curve = 0.857; P < .01) groups with sensitivity of 0.92 and specificity of 0.80. Conclusions The results suggest a promising electrophysiological approach to identifying individuals with convergence insufficiency and a history of concussion.	[Poltavski, Dmitri] Univ North Dakota, Dept Psychol, 319 Harvard St,Stop 8380, Grand Forks, ND 58202 USA; [Cox, Laurie Kopko] Diopsys Inc, Pine Brook, NJ USA		Poltavski, D (corresponding author), Univ North Dakota, Dept Psychol, 319 Harvard St,Stop 8380, Grand Forks, ND 58202 USA.	dmitri.poltavski@und.edu					Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Bullier J, 1996, J PHYSIOLOGY-PARIS, V90, P217, DOI 10.1016/S0928-4257(97)81426-X; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2012, VISUAL DIAGNOSIS CAR; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Cooper J, 2012, OPTOMETRY, V83, P20; Covassin T, 2010, OPEN ACCESS J SPORTS, V1, P55; Derr Peter H., 2002, Documenta Ophthalmologica, V104, P37, DOI 10.1023/A:1014474026114; DEVALOIS KK, 1979, J PHYSIOL-LONDON, V291, P483, DOI 10.1113/jphysiol.1979.sp012827; Fimreite V, 2015, BRAIN INJURY, V29, P1199, DOI 10.3109/02699052.2015.1035329; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; HICKS TP, 1983, J PHYSIOL-LONDON, V337, P183, DOI 10.1113/jphysiol.1983.sp014619; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; JACKOWSKI MM, 2001, VISUAL VESTIBULAR CO, P145; KAPLAN E, 1982, J PHYSIOL-LONDON, V330, P125, DOI 10.1113/jphysiol.1982.sp014333; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Klistorner A, 1997, VISION RES, V37, P2161, DOI 10.1016/S0042-6989(97)00003-5; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Laycock R, 2007, NEUROSCI BIOBEHAV R, V31, P363, DOI 10.1016/j.neubiorev.2006.10.003; Lederer P, 2015, VIS DEV REHAB, V1, P46; Levitt JB, 2001, J NEUROPHYSIOL, V85, P2111, DOI 10.1152/jn.2001.85.5.2111; Maunsell JHR, 1999, VISUAL NEUROSCI, V16, P1, DOI 10.1017/S0952523899156177; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Osborne J. W., 2010, PRACTICAL ASSESSMENT, V15, P1, DOI DOI 10.7275/QBPC-GK17; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rouse MW, 1998, OPTOMETRY VISION SCI, V75, P88, DOI 10.1097/00006324-199802000-00012; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; SCHILLER PH, 1990, TRENDS NEUROSCI, V13, P392, DOI 10.1016/0166-2236(90)90117-S; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Tello C, 2010, DOC OPHTHALMOL, V120, P219, DOI 10.1007/s10633-010-9216-3; Thiagarajan P, 2014, OPTOM VISUAL PERFORM, V2, P281; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yadav NK, 2015, BRAIN INJURY, V29, P352, DOI 10.3109/02699052.2014.979229; Yadav NK, 2013, BRAIN INJURY, V27, P1631, DOI 10.3109/02699052.2013.844856	43	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JUL	2017	94	7					742	750		10.1097/OPX.0000000000001094			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EZ9XM	WOS:000405083400004	28609417	Green Published			2022-02-06	
J	Rai, VRH; Phang, LF; Sia, SF; Amir, A; Veerakumaran, JS; Kassim, MKA; Othman, R; Tah, PC; Loh, PS; Jailani, MIO; Ong, G				Rai, Vineya Rai Hakumat; Phang, Lee Fern; Sia, Sheau Fung; Amir, Amirah; Veerakumaran, Jeyaganesh S.; Kassim, Mustafa Abdulazez Kassim; Othman, Rafidah; Tah, Pei Chien; Loh, Pui San; Jailani, Mohamad Irfan Othman; Ong, Gracie			Effects of immunonutrition on biomarkers in traumatic brain injury patients in Malaysia: a prospective randomized controlled trial	BMC ANESTHESIOLOGY			English	Article						Biomarkers; Immunonutrition; Traumatic brain injury; Neomune; Enteral nutrition; Cytokines	CRITICALLY-ILL PATIENTS; HEAD-INJURY; INFLAMMATORY RESPONSE; ENTERAL NUTRITION; GLUTAMINE; IMMUNE; REQUIREMENTS; THERAPY; DIET; INTERLEUKIN-6	Background: Head injury is one of the top three diagnosis leading to intensive care unit (ICU) admission in Malaysia. There has been growing interest in using immunonutrition as a mode of modulating the inflammatory response to injury or infection with the aim of improving clinical outcome. The aim of the present study was to evaluate the effect of an immunonutrition on biomarkers (IL-6, glutathione, CRP, total protein and albumin) in traumatic brain injury patients. Methods: Thirty six patients with head injury admitted to neurosurgical ICU in University Malaya Medical Centre were recruited for this study, over a 6-month period from July 2014 to January 2015. Patients were randomized to receive either an immunonutrition (Group A) or a standard (Group B) enteral feed. Levels of biomarkers were measured at day 1, 5 and 7 of enteral feeding. Results: Patients in Group A showed significant reduction of IL-6 at day 5 (p < 0.001) with concurrent rise in glutathione levels (p = 0.049). Patients in Group A also demonstrated a significant increase of total protein level at the end of the study (day 7). Conclusion: These findings indicate the potential of immunonutrition reducing cytokines and increasing antioxidant indices in patients with TBI. However, further studies incorporating patient outcomes are needed to determine its overall clinical benefits.	[Rai, Vineya Rai Hakumat] Taylors Univ, Sch Med, Lakeside Campus, Subang Jaya 47500, Malaysia; [Rai, Vineya Rai Hakumat] KPJ Tawakkal Specialist Hosp, Jalan Pahang Barat, Kuala Lumpur 53000, Malaysia; [Phang, Lee Fern] Hosp Umum Sarawak, Dept Anaesthesiol, Jalan Hosp, Kuching 93586, Sarawak, Malaysia; [Sia, Sheau Fung] Univ Malaya, Div Neurosurg, Fac Med, Kuala Lumpur 50603, Malaysia; [Amir, Amirah] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur 50603, Malaysia; [Veerakumaran, Jeyaganesh S.; Kassim, Mustafa Abdulazez Kassim; Loh, Pui San; Jailani, Mohamad Irfan Othman; Ong, Gracie] Univ Malaya, Dept Anaesthesiol, Fac Med, Kuala Lumpur 50603, Malaysia; [Othman, Rafidah; Tah, Pei Chien] Univ Malaya, Dept Dietet, Med Ctr, Kuala Lumpur 50603, Malaysia		Amir, A (corresponding author), Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur 50603, Malaysia.	amirahamir@ummc.edu.my	Veerakumaran, Jeyaganesh/A-9802-2012; Sia, Sheau/F-6224-2015; Amir, Amirah/AAB-9628-2021; amir, amirah/D-3624-2016; Loh, PS/AAS-6500-2021; Kassim, Mustafa K.A/E-1308-2012; San Loh, Pui/C-5324-2016	Sia, Sheau/0000-0002-5042-1829; amir, amirah/0000-0001-9189-8925; Loh, PS/0000-0002-3819-1602; Kassim, Mustafa K.A/0000-0003-4204-9905; San Loh, Pui/0000-0002-3819-1602	University of Malaya Research Grant [P00102014A]; Fundamental Research Grant Scheme initiative [FP019-2013B]	This work was supported by the University of Malaya Research Grant (P00102014A) and Fundamental Research Grant Scheme initiative (FP019-2013B).	Adesanya TA, 2014, NUTR TRAUMATIC BRAIN; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Aussel C, 2013, NUTR CLIN METAB, V27, P28, DOI 10.1016/j.nupar.2012.12.003; Beale RJ, 1999, CRIT CARE MED, V27, P2799, DOI 10.1097/00003246-199912000-00032; Bracken MB, 2005, NEUROSURGERY, V57, P1300, DOI 10.1227/01.NEU.0000187320.71967.59; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chen QH, 2014, CRIT CARE, V18, DOI 10.1186/cc13185; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Cohen J, 1999, BRIT MED BULL, V55, P212, DOI 10.1258/0007142991902222; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; Dellinger R P, 1999, Minerva Anestesiol, V65, P340; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Flaring UB, 2003, CLIN SCI, V104, P275, DOI 10.1042/CS20020198; Forget P, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.546; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; FRUIN AH, 1986, SURG NEUROL, V25, P25, DOI 10.1016/0090-3019(86)90109-6; Grimble RF, 2001, P NUTR SOC, V60, P389, DOI 10.1079/PNS2001102; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Heyland D, 2005, INTENS CARE MED, V31, P501, DOI 10.1007/s00134-005-2590-8; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; HOUDIJK APJ, 1994, AM J PHYSIOL-GASTR L, V267, pG1035, DOI 10.1152/ajpgi.1994.267.6.G1035; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jones NE, 2008, CURR OPIN GASTROEN, V24, P215, DOI 10.1097/MOG.0b013e3282f4cdd8; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Khorana Jiraporn, 2009, Journal of the Medical Association of Thailand, V92, P188; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Li PA, 1999, FREE RADICAL BIO MED, V27, P1033, DOI 10.1016/S0891-5849(99)00152-5; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; Marik PE, 2006, CRIT CARE MED, V34, P2844, DOI 10.1097/01.CCM.0000242922.42660.91; Marik PE, 2010, JPEN-PARENTER ENTER, V34, P378, DOI 10.1177/0148607110362692; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; McCowen KC, 2003, AM J CLIN NUTR, V77, P764, DOI 10.1093/ajcn/77.4.764; MOH, 2013, MAL REG INT CAR REP; MOH, 2011, NAT TRAUM DAT JAN 20; Montejo JC, 2003, CLIN NUTR, V22, P221, DOI 10.1016/S0261-5614(03)00007-4; ODWYER ST, 1989, JPEN-PARENTER ENTER, V13, P579, DOI 10.1177/0148607189013006579; Painter TJ, 2015, INT J SURG, V21, P70, DOI 10.1016/j.ijsu.2015.07.008; Peterik A, 2009, CRIT CARE, V13, DOI 10.1186/cc7899; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; Rathmacher JA, 2004, JPEN-PARENTER ENTER, V28, P65, DOI 10.1177/014860710402800265; Roehl K, 2016, PRACT GASTROENTEROL, V40, P27; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Sparo M., 2012, CLIN EXPT PHARM, V2, pe106; Uno H, 2016, SURGERY; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vincent JL, 1998, LANCET, V351, P922; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wu GH, 2001, WORLD J GASTROENTERO, V7, P357; Yang De-lin, 2007, Chin J Traumatol, V10, P145; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021	66	11	13	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	JUN 15	2017	17								81	10.1186/s12871-017-0369-4			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EX9SI	WOS:000403597900003	28619005	Green Published, gold			2022-02-06	
J	Kim, BW; Kim, TU; Hyun, JK				Kim, Byung Wook; Kim, Tae Uk; Hyun, Jung Keun			Effects of Early Cranioplasty on the Restoration of Cognitive and Functional Impairments	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Decompressive craniectomy; Stroke; Traumatic brain injuries; Cognition; Recovery of function	TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CEREBRAL-ARTERY INFARCTION; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; POSTOPERATIVE COMPLICATIONS; BLOOD-FLOW; MULTICENTER; HEMICRANIECTOMY; HEMODYNAMICS; IMPROVEMENT	Objective To delineate the effect of early cranioplasty on the recovery of cognitive and functional impairments in patients who received decompressive craniectomy after traumatic brain injury or spontaneous cerebral hemorrhage. Methods Twenty-four patients who had received cranioplasty were selected and divided according to the period from decompressive craniectomy to cranioplasty into early (<= 90 days) and late (>90 days) groups. The Korean version of the Mini-Mental State Examination (K-MMSE), Korean version of the Modified Barthel Index (K-MBI), and Functional Independence Measure (FIM) were evaluated at admission just after decompressive craniectomy and during the follow-up period after cranioplasty. Results Twelve patients were included in the early group, and another 13 patients were included in the late group. The age, gender, type of lesion, and initial K-MMSE, K-MBI, and FIM did not significantly differ between two groups. However, the total gain scores of the K-MMSE and FIM in the early group (4.50 +/- 7.49 and 9.42 +/- 15.96, respectively) increased more than those in the late group (-1.08 +/- 3.65 and -0.17 +/- 17.86, respectively), and some of K-MMSE subscores (orientation and language) and FIM subcategories (self-care and transfer-locomotion) in the early group increased significantly when compared to those in the late group without any serious complications. We also found that the time to perform a cranioplasty was weakly, negatively correlated with the K-MMSE gain score (r=-0.560). Conclusion Early cranioplasty might be helpful in restoring cognitive and functional impairments, especially orientation, language ability, self-care ability, and mobility in patients with traumatic brain injury or spontaneous cerebral hemorrhage.	[Kim, Byung Wook; Kim, Tae Uk; Hyun, Jung Keun] Dankook Univ, Coll Med, Dept Rehabil Med, 201 Manghyang Ro, Cheonan 31116, South Korea; [Hyun, Jung Keun] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Hyun, Jung Keun] Dankook Univ, WCU Res Ctr, Cheonan, South Korea; [Hyun, Jung Keun] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea		Hyun, JK (corresponding author), Dankook Univ, Coll Med, Dept Rehabil Med, 201 Manghyang Ro, Cheonan 31116, South Korea.	rhhyun@dankook.ac.kr	Hyun, Jung Keun/ABB-2173-2020	Hyun, Jung Keun/0000-0001-9254-4424; KIM, BYUNGWOOK/0000-0002-9456-9294	'Co-operative Research Program for Agriculture Science & Technology Development' Rural Development Administration, Republic of KoreaRural Development Administration (RDA) [PJ010244032015]	This work was carried out with the support of the 'Co-operative Research Program for Agriculture Science & Technology Development (Project No. PJ010244032015)' Rural Development Administration, Republic of Korea.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Borger V, 2016, WORLD NEUROSURG, V92, P83, DOI 10.1016/j.wneu.2016.04.113; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Cho KC, 2011, J KOREAN NEUROTRAUMA, V7, P74; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Corallo F, 2014, FUNCT NEUROL, V29, P273, DOI 10.11138/FNeur/2014.29.4.273; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Erdogan E, 2003, NEUROL INDIA, V51, P479; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huang YH, 2013, INT J SURG, V11, P886, DOI 10.1016/j.ijsu.2013.07.013; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jelcic N, 2013, BRAIN INJURY, V27, P1723, DOI 10.3109/02699052.2013.844857; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Paredes I, 2016, J NEUROTRAUM, V33, P1586, DOI 10.1089/neu.2015.4261; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Song J, 2014, ACTA NEUROCHIR, V156, P193, DOI 10.1007/s00701-013-1908-5; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	36	11	12	0	1	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	JUN	2017	41	3					354	361		10.5535/arm.2017.41.3.354			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FH0BV	WOS:000410805100003	28758072	Green Published, gold, Green Submitted			2022-02-06	
J	Venegoni, W; Shen, QH; Thimmesch, AR; Bell, M; Hiebert, JB; Pierce, JD				Venegoni, Whitney; Shen, Qiuhua; Thimmesch, Amanda R.; Bell, Meredith; Hiebert, John B.; Pierce, Janet D.			The use of antioxidants in the treatment of traumatic brain injury	JOURNAL OF ADVANCED NURSING			English	Article						antioxidant; mitochondria; nursing; oxidative stress; secondary injury; traumatic brain injury	MITOCHONDRIAL DYSFUNCTION; THERAPEUTIC STRATEGIES; OXIDATIVE STRESS; CELL-DEATH; NEUROPROTECTION; BIOENERGETICS; INFLAMMATION; INHIBITION; APOPTOSIS; OUTCOMES	Aims. The aim of this study was to discuss secondary traumatic brain injury, the mitochondria and the use of antioxidants as a treatment. Background. One of the leading causes of death globally is traumatic brain injury, affecting individuals in all demographics. Traumatic brain injury is produced by an external blunt force or penetration resulting in alterations in brain function or pathology. Often, with a traumatic brain injury, secondary injury causes additional damage to the brain tissue that can have further impact on recovery and the quality of life. Secondary injury occurs when metabolic and physiologic processes alter after initial injury and includes increased release of toxic free radicals that cause damage to adjacent tissues and can eventually lead to neuronal necrosis. Although antioxidants in the tissues can reduce free radical damage, the magnitude of increased free radicals overwhelms the body's reduced defence mechanisms. Supplementing the body's natural supply of antioxidants, such as coenzyme Q10, can attenuate oxidative damage caused by reactive oxygen species. Design. Discussion paper. Data sources. Research literature published from 2011-2016 in PubMed, CINAHL and Cochrane. Implications for nursing. Prompt and accurate assessment of patients with traumatic brain injury by nurses is important to ensure optimal recovery and reduced lasting disability. Thus, it is imperative that nurses be knowledgeable about the secondary injury that occurs after a traumatic brain injury and aware of possible antioxidant treatments. Conclusion. The use of antioxidants has potential to reduce the magnitude of secondary injury in patients who experience a traumatic brain injury.	[Venegoni, Whitney] Prairie Star Med, Internal Med, Lenexa, KS USA; [Shen, Qiuhua; Thimmesch, Amanda R.; Bell, Meredith; Hiebert, John B.] Univ Kansas, Sch Nursing, Lawrence, KS 66045 USA; [Pierce, Janet D.] Univ Kansas, Sch Nursing, Nursing, Lawrence, KS 66045 USA		Thimmesch, AR (corresponding author), Univ Kansas, Sch Nursing, Lawrence, KS 66045 USA.	athimmesch@kumc.edu		Shen, Qiuhua/0000-0002-1236-0244	Uniformed Services University of the Health Sciences (USU), Bethesda, MD [HU0001-14-1-TS03]; TriService Nursing Research Program, Uniformed Services University of the Health Sciences	The Uniformed Services University of the Health Sciences (USU), 4301 Jones Bridge Rd., Bethesda, MD 20814-4799 is the awarding (grant number: HU0001-14-1-TS03) and administering office. This research was sponsored by the TriService Nursing Research Program, Uniformed Services University of the Health Sciences; however, the information or content and conclusions do not necessarily represent the official position or policy of, nor should any official endorsement be inferred by, the TriService Nursing Research Program, Uniformed Services University of the Health Sciences, the Department of Defense, or the U.S. Government.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Agrawal Shruti, 2016, World J Crit Care Med, V5, P36, DOI 10.5492/wjccm.v5.i1.36; Akbar M, 2016, BRAIN RES, V1637, P34, DOI 10.1016/j.brainres.2016.02.016; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Ata MT, 2016, WORLD NEUROSURG, V89, P355, DOI 10.1016/j.wneu.2016.01.040; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bennett MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004609.pub3; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bullon P, 2015, PHARMACOL RES, V91, P1, DOI 10.1016/j.phrs.2014.10.007; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; de Roos B, 2015, MOL NUTR FOOD RES, V59, P1229, DOI 10.1002/mnfr.201400568; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Hanrahan F, 2016, TRANSLATIONAL RES TR; Harris T, 2012, POSTGRAD MED J, V88, P588, DOI 10.1136/postgradmedj-2010-74245; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jing L, 2015, INT J BIOL SCI, V11, P59, DOI 10.7150/ijbs.10174; Khormi YH, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0140-1; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Olivieri F, 2013, FREE RADICAL BIO MED, V63, P410, DOI 10.1016/j.freeradbiomed.2013.05.033; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schmelzer C, 2012, MUTAT RES-FUND MOL M, V733, P61, DOI 10.1016/j.mrfmmm.2011.09.004; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Tsang KKT, 2012, BRIT J ORAL MAX SURG, V50, P298, DOI 10.1016/j.bjoms.2011.03.004; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Wong V., 2012, COCHRANE DB SYST REV, V12; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zaki NM, 2016, DRUG DELIV, V23, P1868, DOI 10.3109/10717544.2014.993747; [No title captured]; [No title captured]	43	11	11	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	JUN	2017	73	6					1331	1338		10.1111/jan.13259			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	EX3DC	WOS:000403111200008	28103389	Bronze			2022-02-06	
J	Lesniak, A; Leszczynski, P; Bujalska-Zadrozny, M; Pick, CG; Sacharczuk, M				Lesniak, Anna; Leszczynski, Pawel; Bujalska-Zadrozny, Magdalena; Pick, Chaim G.; Sacharczuk, Mariusz			Naloxone exacerbates memory impairments and depressive-like behavior after mild traumatic brain injury (mTBI) in mice with upregulated opioid system activity	BEHAVIOURAL BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Opioid system; HA/LA mice; Memory impairments; Depressive-like behavior	STRESS-INDUCED ANALGESIA; COGNITIVE DEFICITS; ENDOGENOUS OPIOIDS; MOUSE LINES; RECEPTOR ACTIVATION; DOPAMINE RELEASE; ETHANOL DRINKING; SWIM ANALGESIA; MORPHINE; ISCHEMIA	The neuroprotective role of the endogenous opioid system in the pathophysiological sequelae of brain injury remains largely ambiguous. Noteworthy, almost no data is available on how its genetically determined activity influences the outcome of mild traumatic brain injury. Thus, the aim of our study was to examine the effect of opioid receptor blockage on cognitive impairments produced by mild traumatic brain injury in mice selectively bred for high (HA) and low (LA) swim-stress induced analgesia that show innate divergence in opioid system activity. Mild traumatic brain injury was induced with a weight drop device on anaesthetized mice. Naloxone (5 mg/kg) was intraperitoneally delivered twice a day for 7 days to non-selectively block opioid receptors. Spatial memory performance and manifestations of depressive-like behavior were assessed using the Morris Water Maze and tail suspension tests, respectively. Mild traumatic brain injury resulted in a significant deterioration of spatial memory performance and severity of depressive-like behavior in the LA mouse line as opposed to HA mice. Opioid receptor blockage with naloxone unmasked cognitive deficits in HA mice but was without effect in the LA line. The results suggest a protective role of genetically predetermined enhanced opioid system activity in suppression of mild brain trauma-induced cognitive impairments. Mice selected for high and low swim stress-induced analgesia might therefore be a useful model to study the involvement of the opioid system in the pathophysiology and neurological outcome of traumatic brain injury. (C) 2017 Elsevier B.V. All rights reserved.	[Lesniak, Anna; Bujalska-Zadrozny, Magdalena; Sacharczuk, Mariusz] Med Univ Warsaw, Fac Pharm, Dept Pharmacodynam, Ctr Preclin Res & Technol CePT, Banacha 1B, PL-02097 Warsaw, Poland; [Sacharczuk, Mariusz] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Banacha 1A, PL-02097 Warsaw, Poland; [Leszczynski, Pawel; Sacharczuk, Mariusz] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Genom, Postepu 36A, PL-05552 Magdalenka, Poland; [Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Sacharczuk, M (corresponding author), Med Univ Warsaw, Fac Pharm, Dept Pharmacodynam, Ctr Preclin Res & Technol CePT, Banacha 1B, PL-02097 Warsaw, Poland.	msacharczuk@wum.edu.pl	Leszczynski, Pawel/AAO-6119-2021	Leszczynski, Pawel/0000-0002-4794-248X; Bujalska-Zadrozny, Magdalena/0000-0002-4270-6373; Sacharczuk, Mariusz/0000-0002-6309-5292; Lesniak, Anna/0000-0002-6014-9208	Polish National Science Centre [2011/03/N/NZ4/02021]; Leading National Research Center [KNOW/IGHZ/RPB/WEW/2016/07];  [STAT/MARSAC/2015/01]	This study was financially supported by the Polish National Science Centre, grant no. 2011/03/N/NZ4/02021, Leading National Research Center grant no. KNOW/IGHZ/RPB/WEW/2016/07 and statutory grant no. STAT/MARSAC/2015/01.	ADAMS HP, 1986, STROKE, V17, P404, DOI 10.1161/01.STR.17.3.404; BASKIN DS, 1984, BRAIN RES, V290, P289, DOI 10.1016/0006-8993(84)90946-6; Berrocoso E, 2009, INT J NEUROPSYCHOPH, V12, P1033, DOI 10.1017/S1461145709000236; Blaszczyki JW, 2010, ACTA NEUROBIOL EXP, V70, P398; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Cordonnier L, 2005, NEUROSCIENCE, V135, P1, DOI 10.1016/j.neuroscience.2005.06.006; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DOURMAP N, 1990, BRAIN RES, V524, P153, DOI 10.1016/0006-8993(90)90505-6; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; Feng Y, 2008, LIFE SCI, V82, P752, DOI 10.1016/j.lfs.2008.01.004; Gajkowska B, 2011, FOLIA NEUROPATHOL, V49, P311; Gerra G, 2004, DRUG ALCOHOL DEPEN, V75, P37, DOI 10.1016/j.drugalcdep.2003.11.017; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; Hsu DT, 2015, MOL PSYCHIATR, V20, P193, DOI 10.1038/mp.2014.185; Husain S, 2012, CURR PHARM DESIGN, V18, P6101, DOI 10.2174/138161212803582441; Jang CG, 2003, MOL BRAIN RES, V117, P68, DOI 10.1016/S0169-328X(03)00291-2; Jia KQ, 2014, MOL MED REP, V10, P839, DOI 10.3892/mmr.2014.2301; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kabli N, 2014, MOL PSYCHIATR, V19, P986, DOI 10.1038/mp.2013.115; Karp JF, 2014, J CLIN PSYCHIAT, V75, pE785, DOI 10.4088/JCP.13m08725; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawalec M, 2011, NEUROCHEM RES, V36, P2091, DOI 10.1007/s11064-011-0568-1; Kest B, 1993, Proc West Pharmacol Soc, V36, P249; Kolada Ireneusz, 1994, Polish Journal of Pharmacology, V46, P139; Kosson D, 2005, PHARMACOL REP, V57, P545; Kunihara T, 2004, J VASC SURG, V40, P681, DOI 10.1016/j.jvs.2004.07.005; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; Lesniak A, 2016, NEUROPHARMACOLOGY, V101, P506, DOI 10.1016/j.neuropharm.2015.10.014; LIPKOWSKI AW, 1987, LIFE SCI, V40, P2283, DOI 10.1016/0024-3205(87)90065-8; Lisowski P, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-144; LUTFY K, 1994, EUR J PHARMACOL, V265, P171; LYETH BG, 1995, NEUROPEPTIDES, V29, P11, DOI 10.1016/0143-4179(95)90051-9; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; MAREK P, 1993, BRAIN RES, V608, P353, DOI 10.1016/0006-8993(93)91479-C; MAREK P, 1992, BRAIN RES, V578, P197, DOI 10.1016/0006-8993(92)90248-8; Mathieu-Kia AM, 2001, BRAIN RES, V893, P121, DOI 10.1016/S0006-8993(00)03302-3; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; Meilandt WJ, 2004, J NEUROSCI, V24, P2953, DOI 10.1523/JNEUROSCI.5569-03.2004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mogil Jefrey S., 1996, Physiology and Behavior, V59, P123, DOI 10.1016/0031-9384(95)02073-X; MOGIL JS, 1994, BRAIN RES, V653, P16, DOI 10.1016/0006-8993(94)90366-2; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Ostermeier AM, 2000, ANESTHESIOLOGY, V93, P1053, DOI 10.1097/00000542-200010000-00029; Padula WV, 2016, J NEUROL SCI, V370, P303, DOI 10.1016/j.jns.2016.09.015; PANOCKA I, 1986, BRAIN RES, V397, P156, DOI 10.1016/0006-8993(86)91380-6; PANOCKA I, 1986, BRAIN RES, V397, P152, DOI 10.1016/0006-8993(86)91379-X; PRZEWLOCKI R, 1985, NEUROPEPTIDES, V5, P575, DOI 10.1016/0143-4179(85)90083-6; Ragan AR, 2013, STRESS, V16, P571, DOI 10.3109/10253890.2013.807244; RINNE JO, 1993, NEUROSCI LETT, V161, P77, DOI 10.1016/0304-3940(93)90144-A; Robinson SA, 2017, BEHAV BRAIN RES, V319, P96, DOI 10.1016/j.bbr.2016.10.050; Sacharczuk M, 2003, BEHAV GENET, V33, P435, DOI 10.1023/A:1025373626833; Sacharczuk M, 2008, ALCOHOL, V42, P487, DOI 10.1016/j.alcohol.2008.05.006; Sacharczuk M, 2014, ADDICT BIOL, V19, P643, DOI 10.1111/adb.12030; Sacharczuk M, 2010, PHYSIOL BEHAV, V99, P627, DOI 10.1016/j.physbeh.2010.01.023; Sacharczuk M, 2009, ACTA NEUROBIOL EXP, V69, P459; SADOWSKI B, 1993, PHARMACOL BIOCHEM BE, V45, P527, DOI 10.1016/0091-3057(93)90501-J; SANDOR P, 1986, J CEREBR BLOOD F MET, V6, P553, DOI 10.1038/jcbfm.1986.101; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Slaninova J, 1998, LIFE SCI, V62, pPL199, DOI 10.1016/S0024-3205(98)00058-7; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; SPANAGEL R, 1990, J NEUROCHEM, V55, P1734, DOI 10.1111/j.1471-4159.1990.tb04963.x; STOKES BT, 1984, BRAIN RES, V290, P187, DOI 10.1016/0006-8993(84)90753-4; Tian XS, 2013, INT J MOL SCI, V14, P15959, DOI 10.3390/ijms140815959; Yang L, 2011, J PHARMACOL EXP THER, V339, P499, DOI 10.1124/jpet.111.184127; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; YOUNG W, 1981, J NEUROSURG, V55, P209, DOI 10.3171/jns.1981.55.2.0209; Zhang HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113093; Zhang JH, 2002, AM J PHYSIOL-CELL PH, V282, pC1225, DOI 10.1152/ajpcell.00226.2001; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhao P, 2006, J NEUROPATH EXP NEUR, V65, P945, DOI 10.1097/01.jnen.0000235123.05677.4b; Zheng YJ, 2012, CNS NEUROSCI THER, V18, P762, DOI 10.1111/j.1755-5949.2012.00360.x; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	81	11	11	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 30	2017	326						209	216		10.1016/j.bbr.2017.03.015			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EV3SB	WOS:000401678300023	28284950				2022-02-06	
J	Liu, H; Rose, ME; Ma, XC; Culver, S; Dixon, CE; Graham, SH				Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward; Graham, Steven H.			In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury	PLOS ONE			English	Article							TERMINAL HYDROLASE L1; SPINAL-CORD-INJURY; DYSTROPHY GAD MOUSE; NEURODEGENERATIVE DISEASE; NERVOUS-SYSTEM; MUTANT UCH-L1; UBIQUITIN; UCHL1; AUTOPHAGY; AXONS	Many mechanisms or pathways are involved in secondary post-traumatic brain injury, such as the ubiquitin-proteasome pathway (UPP), axonal degeneration and neuronal cell apoptosis. UCH-L1 is a protein that is expressed in high levels in neurons and may have important roles in the UPP, autophagy and axonal integrity. The current study aims to evaluate the role of UCH-L1 in post-traumatic brain injury (TBI) and its potential therapeutic effects. A novel protein was constructed that fused the protein transduction domain (PTD) of transactivating transduction (TAT) protein with UCH-L1 (TAT-UCH-L1) in order to promote neuronal transduction. The TAT-UCH-L1 protein was readily detected in brain by immunoblotting and immunohistochemistry after i.p. administration in mice. TBI was induced in mice using the controlled cortical impact (CCI) model. TAT-UCH-L1 treatment significantly attenuated K48-linkage polyubiquitin (polyUb)-protein accumulation in hippocampus after CCI compared to vehicle controls, but had no effects on K65-linkage polyUb-protein. TAT-UCH-L1 treatment also attenuated expression of Beclin-1 and LC3BII after CCI. TAT-UCH-L1-treated mice had significantly increased spared tissue volumes and increased survival of CA3 neurons 21 d after CCI compared to control vehicle-treated mice. Axonal injury, detected by APP immunohistochemistry, was reduced in thalamus 24 h and 21 d after CCI in TAT-UCH-L1-treated mice. These results suggest that TAT-UCH-L1 treatment improves function of the UPP and decreases activation of autophagy after CCI. Furthermore, TATUCH- -L1 treatment also attenuates axonal injury and increases hippocampal neuronal survival after CCI. Taken together these results suggest that UCH-L1 may play an important role in the pathogenesis of cell death and axonal injury after TBI.	[Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward; Graham, Steven H.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15219 USA; [Liu, Hao; Rose, Marie E.; Graham, Steven H.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA; [Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA		Graham, SH (corresponding author), VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15219 USA.; Graham, SH (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA.	Steven.Graham@va.gov			Department of Veterans Affairs Rehabilitation Research & Development ServiceUS Department of Veterans Affairs [1I01RX000310-01]; National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS37459]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037459] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000310] Funding Source: NIH RePORTER	Support was provided by the Department of Veterans Affairs Rehabilitation Research & Development Service [http://www.rehab.research.va.gov/]; 1I01RX000310-01 (SHG); and National Institutes of Health National Institute of Neurological Disorders and Stroke [http://www. ninds.nih.gov/]; R01NS37459 (SHG).	Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Castegna A, 2004, J NEUROCHEM, V88, P1540, DOI 10.1046/j.1471-4159.2003.02288.x; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Costes S, 2014, AUTOPHAGY, V10, P1004, DOI 10.4161/auto.28478; Coulombe J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00129; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Goto A, 2009, NEUROCHEM INT, V54, P330, DOI 10.1016/j.neuint.2008.12.012; Graham SH, 2017, AGEING RES REV, V34, P30, DOI 10.1016/j.arr.2016.09.011; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Huang WL, 2007, EUR J NEUROSCI, V25, P362, DOI 10.1111/j.1460-9568.2006.05284.x; Jara JH, 2015, CEREB CORTEX, V25, P4259, DOI 10.1093/cercor/bhu318; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kim H, 2014, 2014 EIGHTH IEEE/ACM INTERNATIONAL SYMPOSIUM ON NETWORKS-ON-CHIP (NOCS), P9, DOI 10.1109/NOCS.2014.7008756; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Liu H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.323; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Noor NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062120; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Poon WW, 2013, J BIOL CHEM, V288, P16937, DOI 10.1074/jbc.M113.463711; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; SWANSON RA, 1990, STROKE, V21, P322, DOI 10.1161/01.STR.21.2.322; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tramutola A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2756068; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093334	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178049	10.1371/journal.pone.0178049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	WOS:000402061500058	28542502	gold, Green Published, Green Submitted			2022-02-06	
J	Zhu, LH; Huang, L; Wen, Q; Wang, T; Qiao, LX; Jiang, L				Zhu, Lihua; Huang, Li; Wen, Quan; Wang, Ting; Qiao, Lixing; Jiang, Li			Recombinant human erythropoietin offers neuroprotection through inducing endogenous erythropoietin receptor and neuroglobin in a neonatal rat model of periventricular white matter damage	NEUROSCIENCE LETTERS			English	Article						Erythropoietin; Premature; Hypoxia-ischemia; Erythropoietin receptor; Neuroglobin	TRAUMATIC BRAIN-INJURY; HYPOXIA-ISCHEMIA; NERVOUS-SYSTEM; EXPRESSION; HIPPOCAMPUS; PROTECTION; APOPTOSIS; OUTCOMES; INFANTS; STROKE	Recombinant human erythropoietin (rh-EPO) has been reported to have protective effects against brain injury. The purpose of this study was to evaluate the levels of erythropoietin receptor (EPOR) and neuroglobin (Ngb) in a neonatal rat model of periventricular white matter damage (PWMD), and to identify the relationship between the two proteins. On postnatal day 3 (P3), rats underwent permanent ligation of the right common carotid artery followed by 6% O-2 for 4 h (HI) or sham operation and normoxic exposure (sham). Immediately after HI, rats received a single intraperitoneal injection of rh-EPO (5 U/g) or saline. We assessed the expression level of Ngb and EPOR on postnatal days 5, 7,10 and 14. EPOR in the HI rats was initially increased as compared to the sham rats at P5. Subsequently, EPOR expression decreased, but was maintained at a higher level than in sham rats from P7 to P14. In rh-EPO treated rats, the increase in EPOR was greater than in HI rats at P5. However, EPOR levels decreased sharply from P7 to P14. In HI rats, Ngb was increased compared to the sham rats from P5 to P14. Ngb levels were further upregulated after rh-EPO administration from P5 to P10 compared to HI rats. However, this upregulation decreased at P14. In conclusion, this study shows that EPOR and Ngb were upregulated, and both of them act as important coordinated neuroprotectors in rh-EPO treatment of PWMD. However, the two proteins exhibit different expression patterns. (C) 2017 Elsevier B.V. All rights reserved.	[Zhu, Lihua] Jiangsu Jiankang Vocat Coll, Inst Clin & Nursing, 69 Huangshan Ling Rd, Nanjing 211800, Jiangsu, Peoples R China; [Huang, Li; Wen, Quan; Qiao, Lixing; Jiang, Li] Southeast Univ, Zhongda Hosp, Dept Pediat, 87 Dingjia Qiao, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Ting] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, 2 Sipai Lou, Nanjing 210096, Jiangsu, Peoples R China		Qiao, LX; Jiang, L (corresponding author), Southeast Univ, Zhongda Hosp, Dept Pediat, 87 Dingjia Qiao, Nanjing 210009, Jiangsu, Peoples R China.	qiaolixing@aliyun.com; familyjiang77777@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601355]	This work was supported by grants from the National Natural Science Foundation of China (81601355).	Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, NEWS PHYSIOL SCI, V19, P110, DOI 10.1152/nips.01513.2003; Campanille V, 2015, BRAIN RES BULL, V116, P57, DOI 10.1016/j.brainresbull.2015.06.003; Chen HJ, 2013, WORLD J PEDIATR, V9, P17, DOI 10.1007/s12519-012-0395-8; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Fisher JW, 2010, EXP BIOL MED, V235, P1398, DOI 10.1258/ebm.2010.010137; Gao Y, 2011, J HISTOCHEM CYTOCHEM, V59, P214, DOI 10.1369/0022155410390323; Guglielmotto M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00147; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Johnson S, 2009, J PEDIATR-US, V154, P478, DOI 10.1016/j.jpeds.2008.11.028; Joshi D, 2014, J VASC SURG, V60, P191, DOI 10.1016/j.jvs.2013.06.054; Kamal A, 2011, BRAIN RES, V1410, P33, DOI 10.1016/j.brainres.2011.06.059; Khankin EV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009246; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Li RC, 2010, J CEREBR BLOOD F MET, V30, P1874, DOI 10.1038/jcbfm.2010.90; Lu JJ, 2014, J NANOSCI NANOTECHNO, V14, P5614, DOI 10.1166/jnn.2014.8728; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Nedjat MR, 2013, NEUROSCIENCE, V238, P125, DOI 10.1016/j.neuroscience.2013.01.067; Nguyen AQ, 2014, EXP BIOL MED, V239, P1461, DOI 10.1177/1535370214523703; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Raida Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076565; Rees S, 2010, J NEUROPATH EXP NEUR, V69, P306, DOI 10.1097/NEN.0b013e3181d27138; Sanchez PE, 2009, J COMP NEUROL, V514, P403, DOI 10.1002/cne.22020; Schubert S, 2010, BRAIN RES, V1356, P1, DOI 10.1016/j.brainres.2010.08.005; Shen Y, 2012, J NEUROSCI RES, V90, P105, DOI 10.1002/jnr.22722; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang T, 2012, INT J PHARMACEUT, V422, P462, DOI 10.1016/j.ijpharm.2011.10.058; Wiedenmann T, 2015, MOL IMMUNOL, V65, P68, DOI 10.1016/j.molimm.2015.01.011; Xu F, 2012, EXP THER MED, V4, P977, DOI 10.3892/etm.2012.723; Zhu LH, 2014, NEONATOLOGY, V106, P143, DOI 10.1159/000362262	35	11	12	1	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 22	2017	650						12	17		10.1016/j.neulet.2017.03.024			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EW2XK	WOS:000402359100003	28359933				2022-02-06	
J	De Oliveira, PA; Ben, J; Matheus, FC; Schwarzbold, ML; Moreira, ELG; Rial, D; Walz, R; Prediger, RD				De Oliveira, Paulo Alexandre; Ben, Juliana; Matheus, Filipe Carvalho; Schwarzbold, Marcelo Liborio; Moreira, Eduardo Luiz Gasnhar; Rial, Daniel; Walz, Roger; Prediger, Rui Daniel			Moderate traumatic brain injury increases the vulnerability to neurotoxicity induced by systemic administration of 6-hydroxydopamine in mice	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Parkinson's disease (PD); Blood-brain barrier (BBB); 6-Hydroxydopamine (6-OHDA)	CLOSED-HEAD INJURY; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; CELL-DEATH; DOPAMINE; RISK; DAMAGE; MODEL; RAT; CONSEQUENCES	Moderate traumatic brain injury (TBI) might increase the vulnerability to neuronal neurodegeneration, but the basis of such selective neuronal susceptibility has remained elusive. In keeping with the disruption of the blood-brain barrier (BBB) caused by TBI, changes in BBB permeability following brain injury could facilitate the access of xenobiotics into the brain. To test this hypothesis, here we evaluated whether TBI would increase the susceptibility of nigrostriatal dopaminergic fibers to the systemic administration of 6-hydroxydopamine (6-OHDA), a classic neurotoxin used to trigger a PD-like phenotype in mice, but that in normal conditions is unable to cross the BBB. Adult Swiss mice were submitted to a moderate TBI using a free weight-drop device and, 5 h later, they were injected intraperitoneally with a single dose of 6-OHDA (100 mg/kg). Afterwards, during a period of 4 weeks, the mice were submitted to a battery of behavioral tests, including the neurological severity score (NSS), the open field and the rotarod. Animals from the TBI plus 6-OHDA group displayed significant motor and neurological impairments that were improved by acute L-DOPA administration (25 mg/kg, i.p.). Moreover, the observation of the motor deficits correlates with (i) a significant decrease in the tyrosine hydroxylase levels mainly in the rostral striatum and (ii) a significant increase in the levels of striatal glial fibrillary acidic protein (GFAP) levels. On the whole, the present findings demonstrate that a previous moderate TBI event increases the susceptibility to motor, neurological and neurochemical alterations induced by systemic administration of the dopaminergic neurotoxin 6-OHDA in mice. (C) 2017 Elsevier B.V. All rights reserved.	[De Oliveira, Paulo Alexandre; Ben, Juliana; Matheus, Filipe Carvalho; Rial, Daniel; Prediger, Rui Daniel] Univ Fed Santa Catarina, Dept Farmacol, Campus Univ, BR-88049900 Florianopolis, SC, Brazil; [Ben, Juliana; Schwarzbold, Marcelo Liborio; Moreira, Eduardo Luiz Gasnhar; Walz, Roger; Prediger, Rui Daniel] Univ Fed Santa Catarina, Programa Posgrad Neurociencias, BR-88049900 Florianopolis, SC, Brazil; [Schwarzbold, Marcelo Liborio; Walz, Roger] Univ Fed Santa Catarina, Dept Clin Med, Ctr Neurociencias Aplicadas CeNAp, BR-88049900 Florianopolis, SC, Brazil; [Moreira, Eduardo Luiz Gasnhar] Univ Fed Santa Catarina, Dept Ciencias Fisiol, BR-88049900 Florianopolis, SC, Brazil		Prediger, RD (corresponding author), Univ Fed Santa Catarina, Dept Farmacol, Campus Univ, BR-88049900 Florianopolis, SC, Brazil.	ruidsp@hotmail.com	Prediger, Rui Daniel/AAV-3419-2020; Prediger, Rui D/C-4036-2013; Moreira, Eduardo/S-6205-2016; Walz, Roger/K-9096-2013; Matheus, Filipe Carvalho/AAB-9747-2020; Rial, Daniel/D-3219-2009; Rial, Daniel/C-3595-2013	Prediger, Rui Daniel/0000-0002-7547-6463; Prediger, Rui D/0000-0002-7547-6463; Moreira, Eduardo/0000-0003-2306-2207; Walz, Roger/0000-0002-9875-6687; Rial, Daniel/0000-0002-2079-7331	Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Council for Scientific and Technological Development - Brazil (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPES-FCTCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Portuguese Foundation for Science and Technology; PRONEX-FAPESC/CNPq (NENASC Project)	This work was supported by grants from Brazilian agencies, Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) and National Council for Scientific and Technological Development - Brazil (CNPq) and CAPES-FCT. Work supported by PRONEX-FAPESC/CNPq (NENASC Project).	Aguiar AS, 2013, NEUROSCIENCE, V243, P46, DOI 10.1016/j.neuroscience.2013.03.039; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Blandini F, 2007, EUR J NEUROSCI, V25, P397, DOI 10.1111/j.1460-9568.2006.05285.x; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CLARK DWJ, 1972, BRIT J PHARMACOL, V44, P233, DOI 10.1111/j.1476-5381.1972.tb07259.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Day HEW, 2002, BRAIN RES, V945, P151, DOI 10.1016/S0006-8993(02)02747-6; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Graybiel A M, 1991, Curr Opin Neurobiol, V1, P644, DOI 10.1016/S0959-4388(05)80043-1; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Haddad D, 2015, FEBS LETT, V589, P3702, DOI 10.1016/j.febslet.2015.10.021; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matheus FC, 2015, MOL NEUROBIOL; Matheus FC, 2012, BEHAV BRAIN RES, V235, P263, DOI 10.1016/j.bbr.2012.08.017; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Nikolaus S, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00352; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; PISA M, 1988, PROG NEURO-PSYCHOPH, V12, P217, DOI 10.1016/0278-5846(88)90038-3; Prediger RDS, 2010, NEUROTOX RES, V17, P114, DOI 10.1007/s12640-009-9087-0; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x	57	11	12	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2017	1663						78	86		10.1016/j.brainres.2017.03.002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU5BL	WOS:000401046500009	28288867				2022-02-06	
J	Crawford, C; Teo, L; Yang, E; Isbister, C; Berry, K				Crawford, Cindy; Teo, Lynn; Yang, EunMee; Isbister, Caitlin; Berry, Kevin			Is Hyperbaric Oxygen Therapy Effective for Traumatic Brain Injury? A Rapid Evidence Assessment of the Literature and Recommendations for the Field	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						hyperbaric oxygen therapy; placebo; sham; systematic review; traumatic brain injury	POST-CONCUSSION SYNDROME; PROSPECTIVE RANDOMIZED TRIAL; CEREBRAL METABOLISM; INTRACRANIAL-PRESSURE; CLINICAL-TRIAL; HEAD; PLACEBO; MANAGEMENT; SYMPTOMS	Objective: This systematic review examines the efficacy of hyperbaric oxygen (HBO2) for traumatic brain injury (TBI) to make evidence-based recommendations for its application and future research. Methods: A comprehensive search was conducted to identify studies through 2014. Methodological quality was assessed and synthesis and interpretation of relevant data was performed. Results: Twelve randomized trials were included. All mild TBI studies demonstrated minimal bias and no statistically significant differences between HBO2 and sham arms. Statistically significant improvement occurred over time within both groups. Moderate-to-severe TBI studies were of mixed quality, with majority of results favoring HBO2 compared with standard care. The placebo analysis conducted was limited by lack of details. Conclusions: For mild TBI, results indicate HBO2 is no better than sham treatment. Improvements within both HBO2 and sham groups cannot be ignored. For acute treatment of moderate-to-severe TBI, although methodology appears flawed across some studies, because of the complexity of brain injury, HBO2 may be beneficial as a relatively safe adjunctive therapy if feasible. Further research should be considered to resolve the controversy surrounding this field, but only if methodological flaws are avoided and bias minimized.	[Crawford, Cindy; Teo, Lynn; Yang, EunMee; Isbister, Caitlin; Berry, Kevin] Samueli Inst, 1737 King St,Ste 600, Alexandria, VA 22314 USA		Crawford, C (corresponding author), Samueli Inst, 1737 King St,Ste 600, Alexandria, VA 22314 USA.	ccrawford@siib.org	Crawford, Cindy/AAI-3891-2021		Hyperbaric Oxygen Research Program, Army Medical Research and Materiel Command [W911QY-14-P-0187]	The Hyperbaric Oxygen Research Program, Army Medical Research and Materiel Command, funded this project through contract W911QY-14-P-0187 administered by the US Army Medical Research Acquisition Activity. The project was conducted by Samueli Institute independent of the funder. This report does not necessarily reflect the opinions or policies of the US Army or any other federal agency. No official endorsement is implied and none should be inferred. Although this article was reviewed and approved for release by Department of Army officials, the manuscript was written and prepared by Samueli Institute. The diverse stakeholders making up the steering committee and subject matter experts contributed to the systematic review protocol development and provided input throughout all phases of the project. Samueli Institute conducted the systematic review independent of the funder, steering committee, and empaneled experts for the purpose of identifying, minimizing, and controlling bias. The recommendations set forth in this report were made collectively by a working group that included the members of the steering committee, empaneled subject matter experts, and Samueli Institute staff during an expert roundtable meeting. The working group was tasked to evaluate for research gaps and to make recommendations for the future based on the systematic review.	ARTRU F, 1976, EUR NEUROL, V14, P351, DOI 10.1159/000114759; ARTRU F, 1976, EUR NEUROL, V14, P310, DOI 10.1159/000114753; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; BERGMANN JF, 1994, CLIN TRIAL META-ANAL, V29, P41; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; BROWN JA, 1988, PEDIATR NEUROSCI, V14, P286, DOI 10.1159/000120406; Buckenmaier CC, 2014, PAIN MED, V15, P1, DOI 10.1111/pme.12371; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cifu DX, 2014, J REHABIL RES DEV, V51, P1047, DOI 10.1682/JRRD.2014.01.0013; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Costello RB, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-106; Davidson JRT, 2011, J CLIN PSYCHIAT, V72, P795, DOI 10.4088/JCP.10r06580; Food and Drug Administration, HYP OX THER DONT BE; GIEBFRIED JW, 1986, OTOLARYNG HEAD NECK, V94, P508, DOI 10.1177/019459988609400418; Gossett WA, 2010, UNDERSEA HYPERBAR M, V37, P35; Harch PG, 2013, J NEUROTRAUM, V30, P1995, DOI 10.1089/neu.2012.2799; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HAYAKAWA T, 1971, J NEUROL NEUROSUR PS, V34, P580, DOI 10.1136/jnnp.34.5.580; HOLBACH KH, 1972, EUR NEUROL, V8, P158, DOI 10.1159/000114570; HOLBACH KH, 1977, J NEUROL, V217, P17, DOI 10.1007/BF00316313; HOLBACH KH, 1970, J NEUROL NEUROSUR PS, V33, P717, DOI 10.1136/jnnp.33.5.717-b; HOLLIN SA, 1968, J NEUROSURG, V29, P229, DOI 10.3171/jns.1968.29.3.0229; Jonas WB, 2011, PHILOS T R SOC B, V366, P1896, DOI 10.1098/rstb.2010.0405; Khorsan R, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/694804; Lee CH, 2009, AM J EMERG MED, V27; Lee C, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-46; Lee LC, 2012, AM J PHYS MED REHAB, V91, P528, DOI 10.1097/PHM.0b013e31824ad556; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Lv LQ, 2011, ARCH PHYS MED REHAB, V92, P1515, DOI 10.1016/j.apmr.2011.01.014; MacPherson H, 2010, J EVID BASED MED, V3, P140, DOI DOI 10.1111/J.1756-5391.2010.01086.X; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Mitani M, 2004, UNDERSEA HYPERBAR M, V31, P163; MOGAMI H, 1969, J NEUROSURG, V31, P636, DOI 10.3171/jns.1969.31.6.0636; MYERS RAM, 1982, AM SURGEON, V48, P487; Nakamura T, 2008, ACTA NEUROCHIR SUPPL, V102, P21, DOI 10.1007/978-3-211-85578-2_4; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Oppel L, 2003, BRAIN INJURY, V17, P225, DOI 10.1080/0269905021000030814; Ren H, 2001, Chin J Traumatol, V4, P239; Ren HJ, 2001, CHINESE MED J-PEKING, V114, P387; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; ROCKSWOLD GL, 1985, MINN MED, V68, P533; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Sahni T, 2012, BRIT J NEUROSURG, V26, P202, DOI 10.3109/02688697.2011.626879; Scottish Intercollegiate Guidelines Network (SIGN), GUID DEV HDB; Shi XY, 2006, CHINESE MED J-PEKING, V119, P1978, DOI 10.1097/00029330-200612010-00007; Shi Xiao-yan, 2003, Chin J Traumatol, V6, P346; SUKOFF MH, 1982, NEUROSURGERY, V10, P29, DOI 10.1227/00006123-198201000-00006; Undersea and Hyperbaric Medical Society, IND HYP OX THER SEC; Viera AJ, 2005, FAM MED, V37, P360; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Weaver LK, 2014, HYPERBARIC OXYGEN TH; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Woolley S M, 1999, Pediatr Rehabil, V3, P81; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391; Zeyu Xie, 2007, Neural Regeneration Research, V2, P314	63	11	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					E27	E37		10.1097/HTR.0000000000000256			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900010	27603765	Green Published			2022-02-06	
J	Eum, RS; Brown, AW; Watanabe, TK; Zasler, ND; Goldstein, R; Seel, RT; Roth, EJ; Zafonte, RD; Glenn, MB				Eum, Regina S.; Brown, Allen W.; Watanabe, Thomas K.; Zasler, Nathan D.; Goldstein, Richard; Seel, Ronald T.; Roth, Elliot J.; Zafonte, Ross D.; Glenn, Mel B.			Risk Factors for Institutionalization After Traumatic Brain Injury Inpatient Rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cross-sectional studies; institutionalization; rehabilitation; risk factors; traumatic brain injury	DISCHARGE DESTINATION; ACUTE-CARE; MODEL; PREDICTORS; REPRESENTATIVENESS; HOSPITALIZATION; ADMISSION	Objective: To create a profile of individuals with traumatic brain injury (TBI) who received inpatient rehabilitation and were discharged to an institutional setting using characteristics measured at rehabilitation discharge. Methods: The Traumatic Brain Injury Model Systems National Database is a prospective, multicenter, longitudinal database for people with moderate to severe TBI. We analyzed data for participants enrolled from January 2002 to June 2012 who had lived in a private residence before TBI. This cross-sectional study used logistic regression analyses to identify sociodemographic factors, lengths of stay, and cognitive and physical functioning levels that differentiated patients discharged to institutional versus private settings. Results: Older age, living alone before TBI, and lower levels of function at rehabilitation discharge (independence in locomotion, bladder management, comprehension, and social interaction) were significantly associated with higher institutionalization rates and provided the best models identifying factors associated with institutionalization. Institutionalization was also associated with decreased independence in bed-chair-wheelchair transfers and increased duration of posttraumatic amnesia. Conclusions: Individuals institutionalized after inpatient rehabilitation for TBI were older, lived alone before injury, had longer posttraumatic amnesia durations, and were less independent in specific functional characteristics. Research evaluating the effect of increasing postdischarge support and improving treatment effectiveness in these functional areas is recommended.	[Eum, Regina S.] West Haven Med Grp, 689 Campbell Ave, West Haven, CT 06516 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Watanabe, Thomas K.] Albert Einstein Healthcare Network, Drucker Brain Injury Ctr, MossRehab, Philadelphia, PA USA; [Watanabe, Thomas K.] Temple Univ, Sch Med, Philadelphia, PA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Int Brain Injury Assoc, Alexandria, VA USA; [Goldstein, Richard] Harvard Med Sch, Dept Phys Med & Rehabil, Brighton, MA USA; [Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Roth, Elliot J.] Northwestern Univ, Northwestern Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Roth, Elliot J.] Northwestern Univ, Rehabil Inst Chicago, Patient Recovery Unit, Chicago, IL 60611 USA; [Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Glenn, Mel B.] Harvard Med Sch, Spaulding Rehabil Hosp Boston, Charlestown, MA USA; [Glenn, Mel B.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Glenn, Mel B.] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA		Eum, RS (corresponding author), West Haven Med Grp, 689 Campbell Ave, West Haven, CT 06516 USA.	regina.eum@gmail.com		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research; Office of Special Education Services; Department of Education to Spaulding Rehabilitation Hospital [H133A120085]; Shepherd Center-Georgia Model Brain Injury System [H133A110006]; Mayo Clinic [H133A120026]; MossRehab [H133A120037]; Virginia Commonwealth University [H133A120031]; Rehabilitation Institute of Chicago [H133A080045]; Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital/Harvard Medical School	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education to Spaulding Rehabilitation Hospital (H133A120085), Shepherd Center-Georgia Model Brain Injury System (H133A110006), Mayo Clinic (H133A120026), MossRehab (H133A120037), Virginia Commonwealth University (H133A120031), and Rehabilitation Institute of Chicago (H133A080045). However, the contents of this article do not necessarily represent the policy of the Department of Education and endorsement by the Federal Government should not be assumed. This work was also supported, in part, by a grant from the Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital/Harvard Medical School.	Allison, 2001, MISSING DATA, V07; [Anonymous], EMPL PROJ; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Cai Q, 2009, SOC WORK HEALTH CARE, V48, P154, DOI 10.1080/00981380802580588; Cameron AC, 2011, HDB EMPIRICAL EC; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Goodwin JS, 2011, J GERONTOL A-BIOL, V66, P1321, DOI 10.1093/gerona/glr171; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Groenwold RHH, 2012, CAN MED ASSOC J, V184, P1265, DOI 10.1503/cmaj.110977; Grunkemeier GL, 2004, ANN THORAC SURG, V77, P1142, DOI 10.1016/j.athoracsur.2004.01.005; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Harrell FE Jr, 2017, REGRESSION MODELING; Hendrickson L, 2008, DETERMINING MEDICAID; Ihrke DK, 2012, GEOGRAPHICAL MOBILIT, P20; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Kochhar R., 2011, FIGHTING POVERTY TOU; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Medicare Payment Advisory Commission, 2013, REH FAC INP PAYM SYS; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Pregibon D, 1980, APPL STAT, V29, P15, DOI DOI 10.2307/2346405; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rozzini L, 2006, J AM MED DIR ASSOC, V7, P345, DOI 10.1016/j.jamda.2005.11.008; STUKEL TA, 1988, J AM STAT ASSOC, V83, P426, DOI 10.2307/2288858; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Taylor P., 2008, AM MOBILITY WHO MOVE; Traumatic Brain Injury Model Systems, TRAUM BRAIN INJ MOD; Unsworth C, 1996, AM J OCCUP THER, V50, P207, DOI 10.5014/ajot.50.3.207; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Wright J, 2000, THE FIM TM; Zhu CW, 2006, CLIN INTERV AGING, V1, P143, DOI 10.2147/ciia.2006.1.2.143	41	11	11	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					158	167		10.1097/HTR.0000000000000246			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900002	27455433				2022-02-06	
J	Finkel, AG; Ivins, BJ; Yerry, JA; Klaric, JS; Scher, A; Choi, YS				Finkel, Alan G.; Ivins, Brian J.; Yerry, Juanita A.; Klaric, John S.; Scher, Ann; Choi, Y. Sammy			Which Matters More? A Retrospective Cohort Study of Headache Characteristics and Diagnosis Type in Soldiers with mTBI/Concussion	HEADACHE			English	Article						post-traumatic headache; concussion; traumatic brain injury; continuous headache; migraine; outcomes	PLACEBO-CONTROLLED PHASE; TRAUMATIC BRAIN-INJURY; CHRONIC MIGRAINE; DOUBLE-BLIND; POSTTRAUMATIC MIGRAINE; ONABOTULINUMTOXINA; INDIVIDUALS; TOPIRAMATE; PREVALENCE; HISTORY	ObjectiveTo describe the diagnostic types and characteristics of headaches in soldiers with mild traumatic brain injury during the wars in Afghanistan and Iraq. BackgroundPersistent post-traumatic headache interferes with returns to activity or duty. The most commonly cited headache diagnosis after concussion is migraine. We hypothesize that headache diagnosis type, eg, migraine, is not sufficient to predict relationships with occupational outcomes after concussion. MethodsThe study sample consisted of all new patients referred for headache evaluation at the Brain Injury Center at Womack Army Medical Center over a 1-year time period. The design was retrospective and observational. Clinical data reported included demographics, causes of injury, headache characteristics, and headache diagnosis type. After reviewing records for retention or severance from military service, the primary occupational outcome measure was departure from service due to medical cause as determined by a Medical Evaluation Board (MEB). The primary outcome measure was to test the strength of association between leaving service for MEB and headache characteristics or diagnosis. ResultsA total of 95 patients (94% male) with concussion described 166 distinct headache types, the most common being migraine (60%) and trigeminal autonomic cephalalgia (24%). A total of 25% of all patients remained on active duty. A continuous headache of any type was present in 75% of patients and of these, 23% remained on active duty. Of the 51% of patients who had both a continuous and non-continuous headache, 17% remained on active duty (P<.001). Therefore, we report that a continuous headache, regardless of diagnosis type was associated with negative occupational outcomes. Regardless of headache duration, headache diagnosis type alone was not associated with soldiers' separations from service. ConclusionsPersistent post-traumatic headache is most likely to present with continuous pain. Migraine is the most common primary diagnosis type. The presence of a continuous headache was strongly associated with negative occupational outcomes. Primary headache diagnosis type was not. Headache characteristics, therefore, may be more important than diagnosis type when determining active duty status. Further prospective research is indicated.	[Finkel, Alan G.; Klaric, John S.; Choi, Y. Sammy] Womack Army Med Ctr WAMC, Ft Bragg, NC USA; [Finkel, Alan G.; Ivins, Brian J.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Finkel, Alan G.] Carolina Headache Inst, Durham, NC USA; [Finkel, Alan G.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Yerry, Juanita A.] Vet Adm Hosp, Fayetteville, NC USA; [Scher, Ann] Uniform Serv Univ, Bethesda, MD USA		Finkel, AG (corresponding author), 6114 Fayetteville Rd,Suite 109, Durham, NC 27713 USA.	finkela@chi09.com		Scher, Ann/0000-0003-4599-9834	Defense and Veteran Brain Injury Center and General Dynamics Information Technology	The views expressed herein are those of the authors and do not reflect the official policy of the Defense and Veteran Brain Injury Center, US Army Medical Department, Department of the Army, Department of Defense, or the U.S. Government. One of the authors (AF) received salary support from the Defense and Veteran Brain Injury Center and General Dynamics Information Technology for work associated with this study.	Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Bair E, 2015, CLIN J PAIN, V31, P73, DOI 10.1097/AJP.0000000000000087; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Erickson Jay C, 2010, Continuum (Minneap Minn), V16, P55, DOI 10.1212/01.CON.0000391453.37923.83; Eross EJ, 2005, HEADACHE, V45, P308, DOI 10.1111/j.1526-4610.2005.05067.x; Finkel AG, 2016, CEPHALALGIA; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mild Traumatic Brain Injury Pocket Guide. (CONUS), DEF CTR EXC PSYCH HL; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Robbins MS, 2012, HEADACHE, V52, P1579, DOI 10.1111/j.1526-4610.2012.02280.x; Scher AI, 2011, 63 ANN M AM AC NEUR; Scher AI, 2014, CEPHALALGIA, V34, P83, DOI 10.1177/0333102413499644; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2007, HEADACHE, V47, P170, DOI 10.1111/j.1526-4610.2006.00684.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495	26	11	11	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAY	2017	57	5					719	728		10.1111/head.13056			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET3LC	WOS:000400179100005	28239838				2022-02-06	
J	Litim, N; Morissette, M; Di Paolo, T				Litim, Nadhir; Morissette, Marc; Di Paolo, Therese			Effects of progesterone administered after MPTP on dopaminergic neurons of male mice	NEUROPHARMACOLOGY			English	Article						Parkinson's disease; Progesterone; GFAP; Neuroinflammation; BDNF; Striatum	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR EXPRESSION; RAT GLIAL-CELLS; PARKINSONS-DISEASE; SPINAL-CORD; NEURODEGENERATIVE DISEASE; SUBSTANTIA-NIGRA; PRIMARY CULTURES; CLINICAL-TRIAL; SEX STEROIDS	Progesterone neuroprotection of striatal dopamine (DA) in male mice lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was previously reported when administered before MPTP or an hour after. A dose of MPTP to induce a partial lesion was used to model early stages or prodromal Parkinson. We hypothesized that brain DA can be restored by progesterone administered early (24 h) or later (5 days) after MPTP. Male mice received 4 injections of MPTP (8 mg/kg) and progesterone (8 mg/kg) once daily for 5 days started 24 h or 5 days after MPTP. The lesion decreased striatal DA and its metabolites but not serotonin contents. MPTP mice treated with progesterone starting 24 h but not 5 days after MPTP had higher striatal DA and its metabolites content than vehicle-treated MPTP mice. Striatal DA transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) specific binding decreased in lesioned mice and were corrected with progesterone treatment starting 24 h but not 5 days after MPTP. Striatal glial fibrillary acidic protein (GFAP) levels, a marker of activated astrocytes, were elevated by the MPTP lesion and were corrected with progesterone treatment starting 24 h after MPTP. Striatal brain derived neurotrophic factor (BDNF) levels were decreased by the MPTP lesion and were prevented by progesterone treatments whereas no change of Akt, GSK313, ERK1 and 2 and their phosphorylated forms were observed. Thus, progesterone administered after MPTP in mice protected dopaminergic neurons through modulation of neuroinflammation and BDNF. In humans, progesterone could possibly be used as a disease modifying drug in prodromal Parkinson. (C) 2017 Elsevier Ltd. All rights reserved.	[Litim, Nadhir; Morissette, Marc; Di Paolo, Therese] CHUL, Ctr Hosp Univ Quebec, Neurosci Res Unit, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada; [Litim, Nadhir; Di Paolo, Therese] Laval Univ, Fac Pharm, Quebec City, PQ, Canada		Di Paolo, T (corresponding author), CHUL, Ctr Hosp Univ Quebec, Neurosci Res Unit, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	Therese.Dipaolo@crchul.ulaval.ca			Canadian Institutes of Health Research (CHIR - Canada) [MOP-82692]; Faculty of Pharmacy of Laval University (Canada); Parkinson Society Canada (Canada)	This research was supported by a grant from the Canadian Institutes of Health Research (CHIR-grant number MOP-82692 - Canada) to TDP, a PhD scholarship from the Faculty of Pharmacy of Laval University (Canada) and a Graduate Student Award from the Parkinson Society Canada (Canada) to NL.	Ankeny DP, 2001, EXP NEUROL, V170, P85, DOI 10.1006/exnr.2001.7699; Arbo BD, 2016, PROG NEUROBIOL, V144, P27, DOI 10.1016/j.pneurobio.2016.03.010; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bourque M, 2016, NEUROENDOCRINOLOGY, V103, P300, DOI 10.1159/000438789; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; Callier S, 2000, SYNAPSE, V37, P245, DOI 10.1002/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Casas S, 2013, NEUROL RES, V35, P719, DOI 10.1179/1743132812Y.0000000142; Casas S, 2011, PHARMACOL BIOCHEM BE, V99, P614, DOI 10.1016/j.pbb.2011.06.012; Chao OY, 2011, NEUROSCIENCE, V196, P228, DOI 10.1016/j.neuroscience.2011.08.043; Chesik D, 2010, NEUROSCI LETT, V468, P178, DOI 10.1016/j.neulet.2009.10.051; Ciesielska A, 2009, INFLAMM RES, V58, P747, DOI 10.1007/s00011-009-0026-6; Costa A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00253; D'Astous M, 2003, SYNAPSE, V47, P10, DOI 10.1002/syn.10145; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; di Michele F, 2013, FRONT NEUROENDOCRIN, V34, P132, DOI 10.1016/j.yfrne.2013.03.001; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; FRASER DD, 1994, GLIA, V11, P83, DOI 10.1002/glia.440110203; FRIM DM, 1994, P NATL ACAD SCI USA, V91, P5104, DOI 10.1073/pnas.91.11.5104; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Giatti S, 2012, J NEUROENDOCRINOL, V24, P851, DOI 10.1111/j.1365-2826.2012.02284.x; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Guerra-Araiza C, 2009, J NEUROSCI RES, V87, P470, DOI 10.1002/jnr.21848; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HORNYKIEWICZ O, 1989, PROG NEURO-PSYCHOPH, V13, P319, DOI 10.1016/0278-5846(89)90121-8; IRWIN I, 1989, NEUROSCI LETT, V101, P83, DOI 10.1016/0304-3940(89)90445-X; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jha MK, 2013, BBA-PROTEINS PROTEOM, V1834, P2418, DOI 10.1016/j.bbapap.2012.12.006; Jiang C., 2016, MOL NEUROBIOL; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; JUNGTESTAS I, 1991, EXP CELL RES, V193, P12, DOI 10.1016/0014-4827(91)90532-Y; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Kieburtz K, 2016, LANCET NEUROL, V15, P540, DOI 10.1016/S1474-4422(16)30001-1; Kilbourn MR, 1996, NUCL MED BIOL, V23, P467, DOI 10.1016/0969-8051(96)00023-6; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Litim N, 2015, NEUROPHARMACOLOGY, V97, P86, DOI 10.1016/j.neuropharm.2015.05.015; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Melcangi RC, 2012, J MOL NEUROSCI, V46, P177, DOI 10.1007/s12031-011-9570-y; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Meyer M, 2013, J NEUROENDOCRINOL, V25, P235, DOI 10.1111/jne.12004; Meyer M, 2010, CELL MOL NEUROBIOL, V30, P123, DOI 10.1007/s10571-009-9437-8; Miller DB, 1998, ANN NY ACAD SCI, V844, P153, DOI 10.1111/j.1749-6632.1998.tb08230.x; Morale MC, 2006, NEUROSCIENCE, V138, P869, DOI 10.1016/j.neuroscience.2005.07.060; Morales I, 2016, J NEUROCHEM, V139, P81, DOI 10.1111/jnc.13684; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nilsen J, 2002, NEUROREPORT, V13, P825, DOI 10.1097/00001756-200205070-00018; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Pardridge WM, 1998, PHARMACEUT RES, V15, P576, DOI 10.1023/A:1011981927620; Ragonese P, 2004, NEUROLOGY, V62, P2010, DOI 10.1212/WNL.62.11.2010; Rodrigues RWP, 2001, INT J NEUROSCI, V109, P91, DOI 10.3109/00207450108986528; Salat D, 2016, LANCET NEUROL, V15, P637, DOI 10.1016/S1474-4422(16)00060-0; Saunders-Pullman R, 1999, NEUROLOGY, V52, P1417, DOI 10.1212/WNL.52.7.1417; Scalzo P, 2010, J NEUROL, V257, P540, DOI 10.1007/s00415-009-5357-2; Schauwecker PE, 1998, EXP NEUROL, V149, P87, DOI 10.1006/exnr.1997.6679; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Shulman LM, 2002, PARKINSONISM RELAT D, V8, P289, DOI 10.1016/S1353-8020(02)00014-7; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spark MJ, 2012, MATURITAS, V72, P192, DOI 10.1016/j.maturitas.2012.03.015; Sridharan S, 2015, NEUROTOXICOLOGY, V51, P172, DOI 10.1016/j.neuro.2015.10.012; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Thomas P, 2012, NEUROENDOCRINOLOGY, V96, P162, DOI 10.1159/000339822; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Ventriglia M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/901082; Waters EM, 2008, J COMP NEUROL, V511, P34, DOI 10.1002/cne.21826; Weissmiller AM, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-14; Wellmer A, 2001, J PERIPHER NERV SYST, V6, P204, DOI 10.1046/j.1529-8027.2001.01019.x; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	88	11	11	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAY 1	2017	117						209	218		10.1016/j.neuropharm.2017.02.007			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	ET8FG	WOS:000400533800020	28192111				2022-02-06	
J	Marcoux, J; Alkutbi, M; Lamoureux, J; Feyz, M; Saluja, RS; de Guise, E				Marcoux, Judith; Alkutbi, Mohammad; Lamoureux, Julie; Feyz, Mitra; Saluja, Rajeet S.; de Guise, Elaine			Discharge Against Medical Advice in Traumatic Brain Injury: Follow-Up and Readmission Rate	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; doctor-patient relationship; head trauma; patient safety; quality of care; follow-up visits; readmission; discharge against medical advice; Level 1 trauma centre; outcome	HOSPITALIZED-PATIENTS; OUTCOMES; LEAVE; RISK; PATHOLOGY; MORTALITY; DISEASE; AMA	Background: Patients who leave hospital against medical advice (AMA) may be at risk of adverse health outcomes, medical complications, and readmission. In this study, we examined the characteristics of patients who left AMA after traumatic brain injury (TBI), their rates of follow-up visits, and readmission. Methods: We retrospectively studied 106 consecutive patients who left the tertiary trauma center AMA (1.8% of all admitted patients with a TBI). Preinjury health and social issues, mechanism of injury, computed tomography findings, and injury markers were collected. They were correlated to compliance with follow-up visits and unplanned emergency room (ER) visits and readmission rates. Results: The most prevalent premorbid health or social-related issues were alcohol abuse (33%) and assault as a mechanism of trauma (33%). Only 15 (14.2%) subjects came to follow-up visit for their TBI. Sixteen (15.1%) of the 106 subjects had multiple readmissions and/or ER visits related to substance abuse. Seven (6.6%) had multiple readmissions or ER visits with psychiatric reasons. Those patients with multiple readmissions and ER visits showed in higher proportion preexisting neurological condition (p=0.027), homelessness (p=0.012), previous neurosurgery (p=0.014), preexisting encephalomalacia (p=0.011), and had a higher ISS score (p=0.014) than those who were not readmitted multiple times. Conclusions: The significantly increased risks of multiple follow-up visits and readmission among TBI patients who leave hospital AMA are related to a premorbid vulnerability and psychosocial issues. Clinicians should target AMA TBI patients with premorbid vulnerability for discharge transition interventions.	[Marcoux, Judith; Saluja, Rajeet S.] McGill Univ, Ctr Hlth, McGill Univ Ctr, Dept Neurosurg,Neurol & Neurosurg Dept, Montreal, PQ, Canada; [Alkutbi, Mohammad] Western Univ, Clin Neurol Sci, London, ON, Canada; [Lamoureux, Julie] Baptist Hlth South Florida, South Miami, FL USA; [Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ, Canada; [de Guise, Elaine] Univ Montreal, McGill Univ, Hlth Ctr, Dept Psychol,Ctr Rech Interdisciplinaire Readapta, Montreal, PQ, Canada		Marcoux, J (corresponding author), McGill Univ, Hlth Ctr, Montreal Gen Hosp, Dept Neurosurg, 1650 Cedar Ave,Room L7-516, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; Aliyu Z, 2002, INT J CLIN PRACT, V56, P325; Anis AH, 2002, CAN MED ASSOC J, V167, P633; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baptist AP, 2007, J ALLERGY CLIN IMMUN, V119, P924, DOI 10.1016/j.jaci.2006.11.695; Berger JT, 2008, J HOSP MED, V3, P403, DOI 10.1002/jhm.362; Brook M, 2006, PSYCHIAT SERV, V57, P1192, DOI 10.1176/appi.ps.57.8.1192; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Canadian Institute for Health Information (CIHI), 2013, REP CIHI; Choi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024459; Corrigan J, PROBLEMATIC SUBSTANC; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; de Guise E, 2014, BRAIN INJURY, V2, P1; Devitt PJ, 2000, J FAM PRACTICE, V49, P224; Duno R, 2003, GEN HOSP PSYCHIAT, V25, P46, DOI 10.1016/S0163-8343(02)00253-0; Fiscella K, 2007, AM J MED, V120, P1047, DOI 10.1016/j.amjmed.2007.08.024; Gerbasi JB, 2003, HARVARD REV PSYCHIAT, V11, P333, DOI 10.1080/714044395; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hwang SW, 2003, CAN MED ASSOC J, V168, P417; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jerrard DA, 2011, J EMERG MED, V41, P412, DOI 10.1016/j.jemermed.2009.10.022; Kim H, 2013, BRAIN INJURY, V27, P325, DOI 10.3109/02699052.2012.750741; Kim H, 2011, J TRAUMA, V71, P1219, DOI 10.1097/TA.0b013e3182190fa6; Meunier M, 2013, REV NEUROL-FRANCE, V169, P459, DOI 10.1016/j.neurol.2013.01.623; Post LF, 2006, HDB HLTH CARE ETHICS, V2nd; Roman G, 2012, ARCH MED RES, V43, P671, DOI 10.1016/j.arcmed.2012.10.018; Southern WN, 2012, AM J MED, V125, P594, DOI 10.1016/j.amjmed.2011.12.017; Wilson B G, RADIOL TECHNOL, V73, P424; Wilson B G., RADIOL TECHNOL, V73, P438; Windish DM, 2008, J GEN INTERN MED, V23, P1698, DOI 10.1007/s11606-008-0728-4; Yong TY, 2013, INTERN MED J, V43, P798, DOI 10.1111/imj.12109	34	11	11	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2017	44	3					311	317		10.1017/cjn.2016.241			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU8KJ	WOS:000401287500012	27226130	Bronze			2022-02-06	
J	Marseglia, L; D'Angelo, G; Manti, S; Rulli, I; Salvo, V; Buonocore, G; Reiter, RJ; Gitto, E				Marseglia, Lucia; D'Angelo, Gabriella; Manti, Sara; Rulli, Immacolata; Salvo, Vincenzo; Buonocore, Giuseppe; Reiter, Russel J.; Gitto, Eloisa			Melatonin Secretion Is Increased in Children with Severe Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; melatonin; pediatric intensive care; oxidative stress; antioxidant	INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; OXIDATIVE STRESS; CIRCADIAN-RHYTHM; VERTEBRATE RETINA; SERUM MELATONIN; HEAD-INJURY; DOPAMINE; RADICALS; SYSTEM	Background: Traumatic brain injury (TBI) is a leading cause of death and disability in children. Oxidative stress plays a significant role in brain damage and melatonin exhibits both direct and indirect antioxidant effects. The primary aim of the present study was to evaluate serum melatonin levels in children with severe TBI in comparison to critically ill children admitted to the Pediatric Intensive Care Unit for conditions other than TBI. Methods: Twenty-four children were evaluated, equally divided into severe TBI and no-TBI. Blood samples for serum melatonin analysis were collected at 22:00, 01:00, 03:00, 05:00, 08:00, and 12:00. Results: Mean serum melatonin peaks in children of the TBI group were higher compared to the values of no-TBI critically ill children (495 +/- 102 vs. 294 +/- 119 pg/mL, p = 0.0002). Furthermore, the difference was even more significant in comparison to values reported in literature for healthy age-matched children (495 +/- 102 vs. 197 +/- 71 pg/mL, p < 0.0001). Conclusion: This study has shown that endogenous serum melatonin levels dramatically increase in children after severe TBI. This elevation is likely to represent a response to oxidative stress and/or inflammation due to severe head injury.	[Marseglia, Lucia; D'Angelo, Gabriella; Manti, Sara; Rulli, Immacolata; Salvo, Vincenzo; Gitto, Eloisa] Univ Messina, Dept Human Pathol Adult & Dev Age, I-98125 Messina, Italy; [Buonocore, Giuseppe] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Reiter, Russel J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA		Marseglia, L (corresponding author), Univ Messina, Dept Human Pathol Adult & Dev Age, I-98125 Messina, Italy.	lmarseglia@unime.it; gabdangelo@unime.it; saramanti@hotmail.it; rulli.imma@tiscali.it; salvovincenzo@virgilio.it; giuseppe.buonocore@unisi.it; reiter@uthscsa.edu; egitto@unime.it	Buonocore, Giuseppe/U-3873-2019; gitto, eloisa/AAC-3956-2022	Buonocore, Giuseppe/0000-0002-7921-7485; D'Angelo, Gabriella/0000-0003-3038-1759; Gitto, Eloisa/0000-0001-7442-8630; Salvo, Vincenzo/0000-0002-9878-9227; Manti, Sara/0000-0002-7664-3083			Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; AMBUEL B, 1992, J PEDIATR PSYCHOL, V17, P95, DOI 10.1093/jpepsy/17.1.95; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; DJAMGOZ MBA, 1992, NEUROCHEM INT, V20, P139, DOI 10.1016/0197-0186(92)90166-O; Easton AS, 1998, J PHYSIOL-LONDON, V507, P541, DOI 10.1111/j.1469-7793.1998.541bt.x; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Frisk U, 2004, CLIN SCI, V107, P47, DOI 10.1042/CS20030374; Gitto E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/980374; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; KONTOS HA, 1983, ADV EXP MED BIOL, V161, P365; Kramer B, 2016, J CRIT CARE, V36, P111, DOI 10.1016/j.jcrc.2016.06.029; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Marseglia L, 2013, J PEDIATR-US, V162, P357, DOI 10.1016/j.jpeds.2012.07.019; Mistraletti G, 2010, J PINEAL RES, V48, P142, DOI 10.1111/j.1600-079X.2009.00737.x; Mundigler G, 2002, CRIT CARE MED, V30, P536, DOI 10.1097/00003246-200203000-00007; NOWAK JZ, 1989, NEUROCHEM INT, V14, P397, DOI 10.1016/0197-0186(89)90027-2; Olofsson K, 2004, ACTA ANAESTH SCAND, V48, P679, DOI 10.1111/j.0001-5172.2004.00401.x; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Reiter RJ, 2007, ACTA BIOCHIM POL, V54, P1; Reiter RJ, 2014, BRAIN STRUCT FUNCT, V219, P1873, DOI 10.1007/s00429-014-0719-7; Samantaray S, 2009, J PINEAL RES, V47, P134, DOI 10.1111/j.1600-079X.2009.00703.x; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Shilo L, 1999, AM J MED SCI, V317, P278, DOI 10.1097/00000441-199905000-00002; Skene DJ, 2006, ANN CLIN BIOCHEM, V43, P344, DOI 10.1258/000456306778520142; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tosini G, 2000, NEUROSCI LETT, V286, P119, DOI 10.1016/S0304-3940(00)01117-4; Vural H, 2001, J PINEAL RES, V31, P193, DOI 10.1034/j.1600-079X.2001.310301.x; WALDHAUSER F, 1984, LANCET, V1, P362; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5	39	11	12	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	MAY	2017	18	5							1053	10.3390/ijms18051053			10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	EY6SQ	WOS:000404113900159	28505079	Green Submitted, Green Published, gold			2022-02-06	
J	Martini, DN; Eckner, JT; Meehan, SK; Broglio, SP				Martini, Douglas N.; Eckner, James T.; Meehan, Sean K.; Broglio, Steven P.			Long-term Effects of Adolescent Sport Concussion Across the Age Spectrum	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						chronic; high school; force control; neurocognitive test; concussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; MEASURED REACTION-TIME; COGNITIVE IMPAIRMENT; INTERNATIONAL-CONFERENCE; NEUROCOGNITIVE FUNCTION; RECURRENT CONCUSSION; CONSENSUS STATEMENT; ALZHEIMERS-DISEASE; NORMATIVE DATA; SYMPTOMS	Background: Research in sport concussion has increased greatly over the previous decade due to increased scientific interest as well as the media and political spotlight that has been cast on this injury. However, a dearth of literature is available regarding the long-term (>1 year after concussion) effects of adolescent concussion on cognitive and motor performance of high school athletes. Purpose: To evaluate the potential for long-term effects of concussion sustained during high school on cognitive and motor performance across the lifespan. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Adults with (n = 30) and without (n = 53) a concussion history were recruited in 3 age groups: younger (18-30 years; n = 43), middle-aged (40-50 years; n = 18), and older (60 years; n = 22). Each participant completed a computerized neurocognitive assessment and continuous tracking and discrete temporal auditory tasks with the hand and foot. Root mean squared error and timing variability were derived from the tracking and temporal auditory tasks, respectively. Data were analyzed by regression analyses for each recorded variable. Results: The analysis revealed significant age effects on neurocognitive task, continuous tracking task, and discrete auditory timing task performance (P values < .05). No concussion history or interaction (concussion history by age) effects were found for performance on any task (P values > .05). Conclusion: While longitudinal investigations are still needed, this cross-sectional study failed to identify any observable effect of adolescent concussion history on cognition or motor performance with age.	[Martini, Douglas N.; Eckner, James T.; Meehan, Sean K.; Broglio, Steven P.] Univ Michigan, Ann Arbor, MI 48109 USA; [Martini, Douglas N.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Meehan, Sean K.] Univ Michigan, Sch Kinesiol, Human Sensorimotor Lab, Ann Arbor, MI 48109 USA		Martini, DN (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,OP32, Portland, OR 97239 USA.	martidou@ohsu.edu	Meehan, Sean K/N-6237-2018	Meehan, Sean K/0000-0002-9848-8803	National Athletic Trainers' Association-Research and Education Foundation (NATA-REF); Rackham Graduate School-University of MichiganUniversity of Michigan System; University of Michigan Injury Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: This project was funded by the National Athletic Trainers' Association-Research and Education Foundation (NATA-REF), The Rackham Graduate School-University of Michigan, and the University of Michigan Injury Center.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bangert AS, 2012, J INT NEUROPSYCH SOC, V18, P1052, DOI 10.1017/S1355617712000860; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Borotikar BS, 2008, CLIN BIOMECH, V23, P81, DOI 10.1016/j.clinbiomech.2007.08.008; Boyd LA, 2001, NEUROSCI LETT, V298, P65, DOI 10.1016/S0304-3940(00)01734-1; Boyd Lara, 2006, J Neurol Phys Ther, V30, P46; Boyd LA, 2007, NEUROREHAB NEURAL RE, V21, P444, DOI 10.1177/1545968307300438; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cohen J, 1977, STAT POWER ANAL BEHA; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HARY D, 1987, BIOL CYBERN, V56, P305, DOI 10.1007/BF00319511; HARY D, 1987, BRIT J MATH STAT PSY, V40, P109, DOI 10.1111/j.2044-8317.1987.tb00872.x; Hill H, 2005, HUM MOVEMENT SCI, V24, P1, DOI 10.1016/j.humov.2004.11.002; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; JAGACINSKI RJ, 1995, PSYCHOL AGING, V10, P8, DOI 10.1037/0882-7974.10.1.8; Judge JO, 1996, CLIN GERIATR MED, V12, P659; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martini DN, 2016, GAIT POSTURE, V49, P264, DOI 10.1016/j.gaitpost.2016.06.028; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; McAuley E, 2004, BRAIN BEHAV IMMUN, V18, P214, DOI 10.1016/j.bbi.2003.12.007; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan SK, 2011, CLIN NEUROPHYSIOL, V122, P1637, DOI 10.1016/j.clinph.2011.01.002; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Ofori E, 2010, EXP BRAIN RES, V203, P299, DOI 10.1007/s00221-010-2229-z; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; van Halteren-van Tilborg IADA, 2007, NEUROPSYCHOL REV, V17, P203, DOI 10.1007/s11065-007-9030-1; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987	58	11	11	2	24	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2017	45	6					1420	1428		10.1177/0363546516686785			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	ET8SB	WOS:000400570100034	28298054	Green Accepted			2022-02-06	
J	Thiessen, A; Brown, J; Beukelman, D; Hux, K; Myersc, A				Thiessen, Amber; Brown, Jessica; Beukelman, David; Hux, Karen; Myersc, Angela			Effect of Message Type on the Visual Attention of Adults With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							EYE-TRACKING; EXECUTIVE FUNCTION; SCENE PERCEPTION; COMMUNICATION; PEOPLE; MEMORY; AAC; MOVEMENTS; FIXATION; PATTERNS	Purpose: The purpose of this investigation was to measure the effect of message type (i.e., action, naming) on the visual attention patterns of individuals with and without traumatic brain injury (TBI) when viewing grids composed of 3 types of images (i.e., icons, decontextualized photographs, and contextualized photographs). Method: Fourteen adults with TBI and 14 without TBI-assigned either to an action or naming message condition-viewed grids composed of 3 different image types. Participants' task was to select/sustain visual fixation on the image they felt best represented a stated message (i.e., action or naming). Results: With final fixation location serving as a proxy for selection, participants in the naming message condition more often than the other 2 image types. Participants in the action message condition selected contextualized photographs significantly more frequently than the other 2 image types. Minimal differences were noted between participant groups. Conclusions: This investigation provides preliminary evidence of the relationship between image and message type. Clinicians involved in the selection of images used for message representation should consider the message being represented when designing supports for people with TBI. Further research is necessary to fully understand the relationship between images and message type.	[Thiessen, Amber] Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77004 USA; [Brown, Jessica] Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN USA; [Beukelman, David; Hux, Karen; Myersc, Angela] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA		Thiessen, A (corresponding author), Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77004 USA.	althiess@central.uh.edu	Hux, Karen/AAQ-2078-2020		Rehabilitation Engineering Research Center from the National Institute on Disability and Rehabilitation Research in the U.S. Department of Education's Office of Special Education and Rehabilitative Services [H133E080011, H133E140026]; National Institute on Disability, Independent Living and Rehabilitation Research in the Department of Health and Human Services [90RE5017-02-01]; Tobii Technologies	This project was supported in part by the Rehabilitation Engineering Research Center for AAC under Grants H133E080011 and H133E140026 from the National Institute on Disability and Rehabilitation Research in the U.S. Department of Education's Office of Special Education and Rehabilitative Services and under Grant 90RE5017-02-01 from the National Institute on Disability, Independent Living and Rehabilitation Research in the Department of Health and Human Services. The project was also supported in part by Tobii Technologies. The authors wish to thank the residents and the staff at QLI in Omaha, Nebraska, for their participation in the research activities. The authors report no conflicts of interest and are solely responsible for the content and writing of the article.	ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Ball LJ, 2010, J MED SPEECH-LANG PA, V18, P11; Beukelman D. R., 2013, SUPPORTING COMMUNICA, P325; Beukelman DR., 2013, AUGMENTATIVE ALTERNA, V4th ed; BLOOMBERG K, 1990, J SPEECH HEAR RES, V33, P717, DOI 10.1044/jshr.3304.717; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brown J, 2015, AUGMENT ALTERN COMM, V31, P15, DOI 10.3109/07434618.2014.995224; Brown JA, 2016, J HEAD TRAUMA REHAB, V31, pE32, DOI 10.1097/HTR.0000000000000148; Brown JA, 2015, DISABIL REHABIL-ASSI, V10, P378, DOI 10.3109/17483107.2014.921250; Campbell L, 2002, ADV SPEECH LANG PATH, V4, P89; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dietz A., 2006, PERSPECTIVES AUGMENT, V15, P13, DOI 10.1044/aac15.1.13; Duchowski A., 2007, EYE TRACKING METHODO; Engebretsen K, 2014, PERSPECT AUGMENTATIV, V23, P55, DOI [10.1044/aac23.1.55, DOI 10.1044/AAC23.1.55]; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Fujisawa K, 2011, AUGMENT ALTERN COMM, V27, P53, DOI 10.3109/07434618.2011.553245; Gibbons C., 2010, PERSPECT AUGMENTATIV, V19, P64, DOI [DOI 10.1044/AAC19.3.64, 10.1044/aac19.3.64]; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gosnell J., 2011, PERSPECTIVES, V20, P7, DOI [10.1044/aac20.1.7, DOI 10.1044/AAC20.1.7]; Hallowell B., 2002, APHASIOLOGY, V16, P587, DOI [10.1080/02687030244000121, DOI 10.1080/02687030244000121]; Henderson JM, 1999, J EXP PSYCHOL HUMAN, V25, P210, DOI 10.1037/0096-1523.25.1.210; Heuer S, 2009, APHASIOLOGY, V23, P351, DOI 10.1080/02687030701770474; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; Holmqvist K., 2011, EYE TRACKING COMPREH; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; Hux K, 2010, APHASIOLOGY, V24, P643, DOI 10.1080/02687030902869299; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Ivanova MV, 2012, APHASIOLOGY, V26, P556, DOI 10.1080/02687038.2011.618219; Jacob RJK, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P573, DOI 10.1016/B978-044451020-4/50031-1; Jagaroo V, 2008, AUGMENT ALTERN COMM, V24, P29, DOI 10.1080/07434610701390673; Johnson JM, 2006, AUGMENT ALTERN COMM, V22, P85, DOI 10.1080/07434610500483588; Koul R., 1998, AUGMENTATIVE ALTERNA, V14, DOI [10.1080/07434619812331278166, DOI 10.1080/07434619812331278166]; Kunka B, 2012, ARCH ACOUST, V37, P63, DOI 10.2478/v10168-012-0009-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; LEVINE SP, 1992, J HEAD TRAUMA REHAB, V7, P46, DOI DOI 10.1097/00001199-199209000-00007; Lezak, 2008, MANUAL MAYO PORTLAND; Light J., 1988, AUGMENT ALTERN COMM, V4, P66, DOI [10.1080/07434618812331274657, DOI 10.1080/07434618812331274657]; Manor BR, 2003, J NEUROSCI METH, V128, P85, DOI 10.1016/S0165-0270(03)00151-1; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mineo BA, 2008, AUGMENT ALTERN COMM, V24, P162, DOI 10.1080/07434610802109915; Mizuko M., 1987, AUGMENT ALTERN COMM, V3, P129, DOI [DOI 10.1080/07434618712331274409, 10.1080/07434618712331274409]; Mohd Razali N., 2011, J STAT MODEL ANAL, V2, P21; Ozcelik E, 2009, COMPUT EDUC, V53, P445, DOI 10.1016/j.compedu.2009.03.002; Rayner K, 2008, APPL COGNITIVE PSYCH, V22, P697, DOI 10.1002/acp.1389; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Scherer M.J., 2002, TECHNOL DISABIL, V14, P125, DOI [DOI 10.3233/TAD-2002-14308, 10.3233/tad-2002-14308]; Scherer M. J., 1994, WOMEN THER, V14, P117; Scherer MJ, 1996, DISABIL REHABIL, V18, P439, DOI 10.3109/09638289609165907; Schietecatte I, 2012, BRIT J DEV PSYCHOL, V30, P267, DOI 10.1111/j.2044-835X.2011.02039.x; Schlosser R. W., 2002, AUGMENT ALTERN COMM, V18, P102, DOI [DOI 10.1080/07434610212331281201, 10.1080/07434610212331281201]; Shane H., 1994, ANN CONV AM SPEECH A; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Snyder C, 2000, J MED SPEECH-LANG PA, V8, P187; Spataro R, 2014, ACTA NEUROL SCAND, V130, P40, DOI 10.1111/ane.12214; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Thiessen A., 2016, COMP VISUAL AT UNPUB; Thiessen A, 2016, J SPEECH LANG HEAR R, V59, P290, DOI 10.1044/2015_JSLHR-L-14-0115; Thiessen A, 2014, AUGMENT ALTERN COMM, V30, P120, DOI 10.3109/07434618.2014.905798; Tobii Technology, 2011, TOB TECHN ACC PREC T; Trojano L, 2012, J NEUROL, V259, P1888, DOI 10.1007/s00415-012-6435-4; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van Dijck J, 2008, VISUAL COMMUN-US, V7, P57, DOI 10.1177/1470357207084865; van Gog T, 2010, LEARN INSTR, V20, P95, DOI 10.1016/j.learninstruc.2009.02.009; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wagner JB, 2013, J AUTISM DEV DISORD, V43, P188, DOI 10.1007/s10803-012-1565-1; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace SE, 2010, PERSPECT AUGMENT ALT, V19, P79; Waller A., 2005, P 2005 INT C ACC DES, P23; Wedel M, 2008, J EXP PSYCHOL-APPL, V14, P129, DOI 10.1037/1076-898X.14.2.129; Wilkinson KM, 2014, AUGMENT ALTERN COMM, V30, P106, DOI 10.3109/07434618.2014.904435; Wilkinson KM, 2014, AUGMENT ALTERN COMM, V30, P130, DOI 10.3109/07434618.2014.904434	81	11	11	0	9	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2017	26	2					428	442		10.1044/2016_AJSLP-16-0024			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FC7NR	WOS:000407028800021	28475661				2022-02-06	
J	Won, SY; Dubinski, D; Herrmann, E; Cuca, C; Strzelczyk, A; Seifert, V; Konczalla, J; Freiman, TM				Won, Sae-Yeon; Dubinski, Daniel; Herrmann, Eva; Cuca, Colleen; Strzelczyk, Adam; Seifert, Volker; Konczalla, Juergen; Freiman, Thomas M.			Epileptic Seizures in Patients Following Surgical Treatment of Acute Subdural Hematoma-Incidence, Risk Factors, Patient Outcome, and Development of New Scoring System for Prophylactic Antiepileptic Treatment (GATE-24 score)	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Epilepsy; Functional outcome; Post-traumatic seizures; Prophylactic antiepileptic treatment; Risk factors	TRAUMATIC BRAIN-INJURY; ADULT PATIENTS; MORTALITY; LEVETIRACETAM; PHENYTOIN; EPIDEMIOLOGY; THERAPY; IMPACT	OBJECT: Clinically evident or subclinical seizures are common manifestations in acute subdural hematoma (aSDH); however, there is a paucity of research investigating the relationship between seizures and aSDH. The purpose of this study is 2-fold: determine incidence and predictors of seizures and then establish a guideline in patients with aSDH to standardize the decision for prophylactic antiepileptic treatment. METHOD: The author analyzed 139 patients with aSDH treated from 2007 until 2015. Baseline characteristics and clinical findings including Glasgow Coma Scale (GCS) at admission, 24 hours after operation, timing of operation, anticoagulation, and Glasgow Outcome Scale at hospital discharge and after 3 months were analyzed. Multivariate logistic regression analysis was performed to detect independent predictors of seizures, and a scoring system was developed. RESULTS: Of 139 patients, overall incidence of seizures was 38%, preoperatively 16% and postoperatively 24%. Ninety percent of patients with preoperative seizures were seizure free after operation for 3 months. Independent predictors of seizures were GCS <9 (odds ratio [OR] 3.3), operation after 24 hours (OR 2.0), and anticoagulation (OR 2.2). Patients with seizures had a significantly higher rate of unfavorable outcome at hospital discharge (P = 0.001) and in 3-month follow-up (P = 0.002). Furthermore, a score system (GATE-24) was developed. In patients with GCS <14, anticoagulation, or surgical treatment 24 hours after onset, a prophylactic antiepileptic treatment is recommended. CONCLUSION: Occurrence of seizures affected severity and outcomes after surgical treatment of aSDH. Therefore seizure prophylaxis should be considered in high-risk patients on the basis of the GATE-24 score to promote better clinical outcome.	[Won, Sae-Yeon; Dubinski, Daniel; Seifert, Volker; Konczalla, Juergen; Freiman, Thomas M.] Goethe Univ, Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ, Univ Hosp, Dept Med, Inst Biostat & Math Modelling, Frankfurt, Germany; [Cuca, Colleen] Goethe Univ, Univ Hosp, Dept Anesthesiol, Intens Care Med & Pain Therapy, Frankfurt, Germany; [Strzelczyk, Adam] Goethe Univ, Univ Hosp, Dept Anesthesiol, Neurol & Epilepsy Ctr Frankfurt Rhine Main, Frankfurt, Germany		Won, SY (corresponding author), Goethe Univ, Univ Hosp, Dept Neurosurg, Frankfurt, Germany.	sae-yeon.won@kgu.de	Dubinski, Daniel/AAH-2910-2021; Won, Sae-Yeon/AAK-3408-2020; Freiman, Thomas/AAV-8494-2021; Konczalla, Juergen/AAJ-8528-2021	Dubinski, Daniel/0000-0001-5568-8429; Freiman, Thomas/0000-0002-2591-2829; Konczalla, Juergen/0000-0001-9771-7806; Strzelczyk, Adam/0000-0001-6288-9915			Aguilar MI, 2007, MAYO CLIN PROC, V82, P82, DOI 10.1016/s0025-6196(11)60970-1; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cervera A, 2012, J NEUROL, V259, P212, DOI 10.1007/s00415-011-6153-3; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Ertl J, 2016, SEIZURE-EUR J EPILEP, V41, P9, DOI 10.1016/j.seizure.2016.07.001; FOY PM, 1992, J NEUROL NEUROSUR PS, V55, P753, DOI 10.1136/jnnp.55.9.753; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gollwitzer S, 2016, NEUROLOGY, V87, P466, DOI 10.1212/WNL.0000000000002791; Grebel JM, 1998, STROKE, V29, P1799; Hamasaki T, 2013, CLIN NEUROL NEUROSUR, V115, P2336, DOI 10.1016/j.clineuro.2013.08.016; Hedegard E, 2014, J NEUROL NEUROSUR PS, V85, P716, DOI 10.1136/jnnp-2013-306465; Hirakawa K, 1972, Neurol Med Chir (Tokyo), V12, P71, DOI 10.2176/nmc.12.71; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Huang KT, 2016, NEUROCRIT CARE, V24, P294, DOI 10.1007/s12028-015-0194-x; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Rudzinski LA, 2011, J CLIN NEUROPHYSIOL, V28, P633, DOI 10.1097/WNP.0b013e31823cc494; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Ryvlin P, 2006, NEUROLOGY, V67, pS3, DOI 10.1212/WNL.67.12_suppl_4.S3; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Strzelczyk A, 2010, J NEUROL, V257, P1322, DOI 10.1007/s00415-010-5520-9; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPISA S10, V44, P1820; Weston J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007286.pub3; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017; Zangaladze A, 2008, EPILEPSIA, V49, P2016, DOI 10.1111/j.1528-1167.2008.01672.x	38	11	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2017	101						416	424		10.1016/j.wneu.2017.02.024			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7CR	WOS:000401932500054	28213197				2022-02-06	
J	Kundu, S; Mazumdar, M; Ferket, B				Kundu, Suman; Mazumdar, Madhu; Ferket, Bart			Impact of correlation of predictors on discrimination of risk models in development and external populations	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						AUC; Correlation; External validation; Risk prediction; Simulation study	TRAUMATIC BRAIN-INJURY; INTERNATIONAL MISSION; CLINICAL-TRIALS; VALIDATION; CANCER; FRAMEWORK; PROGNOSIS; SCORE	Background: The area under the ROC curve (AUC) of risk models is known to be influenced by differences in case-mix and effect size of predictors. The impact of heterogeneity in correlation among predictors has however been under investigated. We sought to evaluate how correlation among predictors affects the AUC in development and external populations. Methods: We simulated hypothetical populations using two different methods based on means, standard deviations, and correlation of two continuous predictors. In the first approach, the distribution and correlation of predictors were assumed for the total population. In the second approach, these parameters were modeled conditional on disease status. In both approaches, multivariable logistic regression models were fitted to predict disease risk in individuals. Each risk model developed in a population was validated in the remaining populations to investigate external validity. Results: For both approaches, we observed that the magnitude of the AUC in the development and external populations depends on the correlation among predictors. Lower AUCs were estimated in scenarios of both strong positive and negative correlation, depending on the direction of predictor effects and the simulation method. However, when adjusted effect sizes of predictors were specified in the opposite directions, increasingly negative correlation consistently improved the AUC. AUCs in external validation populations were higher or lower than in the derivation cohort, even in the presence of similar predictor effects. Conclusions: Discrimination of risk prediction models should be assessed in various external populations with different correlation structures to make better inferences about model generalizability.	[Kundu, Suman] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, 2525 West End,Ste 300 A, Nashville, TN 37203 USA; [Mazumdar, Madhu; Ferket, Bart] Icahn Sch Med Mt Sinai, Inst Healthcare Delivery Sci, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA		Kundu, S (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, 2525 West End,Ste 300 A, Nashville, TN 37203 USA.	suman.kundu@vanderbilt.edu	Kundu, Suman/I-2603-2019	Kundu, Suman/0000-0002-6305-2559; Ferket, Bart/0000-0003-2754-545X	NCI Cancer Center Support GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA196521-01]; American Heart AssociationAmerican Heart Association [16MCPRP31030016]	This work was supported by an NCI Cancer Center Support Grant P30 CA196521-01 (Mazumdar and Ferket) and American Heart Association Grant # 16MCPRP31030016 (Ferket). The funding sources had no role in study design, analysis, interpretation of data, writing of the report, and in the decision to submit the paper for publication.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Demler OV, 2013, STAT MED, V32, P4196, DOI 10.1002/sim.5824; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gray EP, 2016, CLIN LUNG CANCER, V17, P95, DOI 10.1016/j.cllc.2015.11.007; Kluth LA, 2015, EUR UROL, V68, P238, DOI 10.1016/j.eururo.2015.01.032; Lamain-de Ruiter M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4338; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Lumley T, 2002, J CLIN EPIDEMIOL, V55, P129, DOI 10.1016/S0895-4356(01)00434-6; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Siontis GCM, 2015, J CLIN EPIDEMIOL, V68, P25, DOI 10.1016/j.jclinepi.2014.09.007; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Soedamah-Muthu SS, 2014, DIABETOLOGIA, V57, P2304, DOI 10.1007/s00125-014-3358-x; Steyerberg EW, 2008, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Tuomilehto J, 2010, DIABETES RES CLIN PR, V87, P267, DOI 10.1016/j.diabres.2009.11.011; Usher-Smith JA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3139; Usher-Smith JA, 2016, CANCER PREV RES, V9, P13, DOI 10.1158/1940-6207.CAPR-15-0274; Van Calster B, 2015, MED DECIS MAKING, V35, P162, DOI 10.1177/0272989X14547233; Venkatapathy R, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/742724; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Willis BH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000746; Zaroukian S, 2005, BREAST, V14, P209, DOI 10.1016/j.breast.2005.01.001	28	11	11	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	APR 19	2017	17								63	10.1186/s12874-017-0345-1			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	ES6EL	WOS:000399639100003	28420342	gold, Green Published			2022-02-06	
J	Darabi, S; Tiraihi, T; Delshad, A; Sadeghizadeh, M; Khalil, W; Taheri, T				Darabi, Shahram; Tiraihi, Taki; Delshad, AliReza; Sadeghizadeh, Majid; Khalil, Wisam; Taheri, Taher			In vitro non-viral murine pro-neurotrophin 3 gene transfer into rat bone marrow stromal cells	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						NT-3; Transfection; BMSCs; Secretory vector; Non-viral transfection	SPINAL-CORD-INJURY; MESENCHYMAL STEM-CELLS; DEVELOPING NERVOUS-SYSTEM; NEURAL PRECURSOR CELLS; ISCHEMIC BRAIN-INJURY; TRANSIENT TRANSFECTION; NEURONAL DIFFERENTIATION; OXIDATIVE STRESS; MOTOR-NEURONS; EXPRESSION	Neurotrophin 3 (NT-3) is an important factor for promoting prenatal neural development, as well as regeneration, axogenesis and plasticity in postnatal life. Therapy with NT-3 was reported to improve the condition of patients suffering from degenerative diseases and traumatic injuries, however, the disadvantage of NT-3 protein delivery is its short half-life, thus our alternative approach is the use of NT-3 gene therapy. In this study, the bone marrow stromal cells (BMSCs) were isolated from adult rats, cultured for 4 passages and transfected with either pEGFP-N1 or a constructed vector containing murine proNT-3 (pSecTag2/HygroB-murine proNT-3) using Lipofectamine 2000 followed by Hygromycin B (200 mg/kg). The transfection efficiency of the transiently transfected BMSCs was evaluated using the green fluorescence protein containing vector (pEGFP-N1). A quantitative evaluation of the NT-3 expression of mRNA using real time qRT-PCR shows that there was double fold increase in NT-3 gene expression compared with non-transfected BMSCs, also, the culture supernatant yielded double fold increase in NT-3 using ELISA technique, the data were supported by immunoblotting technique. This suggests that the use of this transfection technique can be useful for gene therapy in different neurological disorders with neurodegenerative or traumatic origins. (C) 2017 Elsevier B.V. All rights reserved.	[Darabi, Shahram] Qazvin Univ Med Sci, Cellular & Mol Res Ctr, Qazvin, Iran; [Tiraihi, Taki] Tarbiat Modares Univ, Sch Med Sci, Dept Anat Sci, Tehran, Iran; [Delshad, AliReza] Shahed Univ, Dept Anat, Tehran, Iran; [Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Basic Sci, Dept Genet, Tehran, Iran; [Khalil, Wisam] Tarbiat Modares Univ, Sch Med Sci, Dept Anat Sci, POB 14155-4838, Tehran, Iran; [Taheri, Taher] Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran		Tiraihi, T (corresponding author), Tarbiat Modares Univ, Sch Med Sci, Dept Anat Sci, POB 14155-4838, Tehran, Iran.	takialtr@modares.ac.ir		darabi, shahram/0000-0002-9405-6640	Shefa Neuroscience Research Center at Khatam Al-Anbia Hospital, Tehran, Iran [86-N-105]; Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	The project was funded by Shefa Neuroscience Research Center at Khatam Al-Anbia Hospital, Tehran, Iran (Grant # 86-N-105). We are also grateful for the support of the Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.	Abbaszadeh HA, 2015, CYTOTHERAPY, V17, P912, DOI 10.1016/j.jcyt.2015.03.689; Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Arnhold S, 2006, EUR J CELL BIOL, V85, P551, DOI 10.1016/j.ejcb.2006.01.015; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Bialas M, 2011, J PHYSIOL PHARMACOL, V62, P219; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Castellanos DA, 2002, CELL TRANSPLANT, V11, P297; Chalazonitis A, 1996, MOL NEUROBIOL, V12, P39, DOI 10.1007/BF02740746; Chalazonitis A, 2004, PROG BRAIN RES, V146, P243, DOI 10.1016/S0079-6123(03)46016-0; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen HH, 1999, CURR OPIN NEUROBIOL, V9, P405, DOI 10.1016/S0959-4388(99)80061-0; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Curtis KM, 2012, MOL CELL NEUROSCI, V49, P138, DOI 10.1016/j.mcn.2011.10.008; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; de Munter Johannes P J M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS150, DOI 10.1016/S1353-8020(13)70036-1; Delcroix GJR, 2010, DIFFERENTIATION, V80, P213, DOI 10.1016/j.diff.2010.07.001; Derouazi M, 2004, BIOTECHNOL BIOENG, V87, P537, DOI 10.1002/bit.20161; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Fatima G, 2015, SPINAL CORD, V53, P3, DOI 10.1038/sc.2014.178; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Fowler SC, 2002, INT J DEV NEUROSCI, V20, P303, DOI 10.1016/S0736-5748(02)00010-2; Garcia-Alias G, 2011, J NEUROSCI, V31, P17788, DOI 10.1523/JNEUROSCI.4308-11.2011; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Green SH, 2012, ANAT REC, V295, P1877, DOI 10.1002/ar.22587; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hastings NB, 1999, J COMP NEUROL, V415, P144; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P432, DOI 10.1089/scd.2011.0242; Hossain WA, 2008, J NEUROSCI RES, V86, P2376, DOI 10.1002/jnr.21685; Hossain WA, 2006, J NEUROBIOL, V66, P897, DOI 10.1002/neu.20264; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu XH, 2004, J NEUROCHEM, V90, P1339, DOI 10.1111/j.1471-4159.2004.02594.x; Kearns MD, 2008, MOL PHARMACEUT, V5, P128, DOI 10.1021/mp700131c; Kumar S, 2007, NEUROCHEM RES, V32, P783, DOI 10.1007/s11064-006-9208-6; Lachyankar MB, 1997, EXP NEUROL, V144, P350, DOI 10.1006/exnr.1997.6434; Lee H, 2001, ANAL CHEM, V73, P837, DOI 10.1021/ac000831n; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liu CT, 2008, MOL BIOTECHNOL, V39, P141, DOI 10.1007/s12033-008-9051-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martyn JC, 2007, ARCH VIROL, V152, P329, DOI 10.1007/s00705-006-0845-5; Moradi F, 2012, CELL J, V13, P243; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Noori-Zadeh A, 2014, J NEUROL SCI, V339, P81, DOI 10.1016/j.jns.2014.01.025; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Ohtsuka M, 2009, J NEUROSCI RES, V87, P301, DOI 10.1002/jnr.21855; Ringstedt T, 1997, DEVELOPMENT, V124, P2603; Risbud RM, 2011, BRAIN RES, V1424, P53, DOI 10.1016/j.brainres.2011.09.039; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P366, DOI 10.1007/s12311-009-0105-9; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Scuri Mario, 2010, Inflammation & Allergy Drug Targets, V9, P173; Sieber-Blum M, 1998, BIOCHEM CELL BIOL, V76, P1039, DOI 10.1139/bcb-76-6-1039; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Tender GC, 2011, NEUROSURGERY, V68, P1048, DOI 10.1227/NEU.0b013e318208f9c4; Tinsley R, 2004, ACTA NEUROL SCAND, V109, P1, DOI 10.1046/j.1600-0404.2003.00240.x; Tseng HC, 2006, NEUROBIOL DIS, V22, P88, DOI 10.1016/j.nbd.2005.10.007; Wang LJ, 2014, ACTA NEUROCHIR, V156, P1409, DOI 10.1007/s00701-014-2089-6; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yaghoobi MM, 2006, NEUROSCI LETT, V397, P149, DOI 10.1016/j.neulet.2005.12.009; Yin WX, 2005, ANAL BIOCHEM, V346, P289, DOI 10.1016/j.ab.2005.08.029; Yoo MJ, 2007, J MICROBIOL BIOTECHN, V17, P2033; Zhang J, 2012, NEUROSCIENCE, V222, P1, DOI 10.1016/j.neuroscience.2012.07.023; Zhou XF, 1996, MOL NEUROBIOL, V13, P185, DOI 10.1007/BF02740622; Zhu TQ, 2015, CELL MOL NEUROBIOL, V35, P255, DOI 10.1007/s10571-014-0120-3	68	11	12	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	APR 15	2017	375						137	145		10.1016/j.jns.2017.01.058			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER4EN	WOS:000398752000025	28320116				2022-02-06	
J	Alali, AS; Gomez, D; McCredie, V; Mainprize, TG; Nathens, AB				Alali, Aziz S.; Gomez, David; McCredie, Victoria; Mainprize, Todd G.; Nathens, Avery B.			Understanding Hospital Volume-Outcome Relationship in Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Complications; Multilevel analysis; Quality improvement; Traumatic brain injury	MORTALITY; QUALITY; CARE	BACKGROUND: The hospital volume-outcome relationship in severe traumatic brain injury (TBI) population remains unclear. OBJECTIVE: To examine the relationship between volume of patients with severe TBI per hospital and in-hospital mortality, major complications, and mortality following a major complication (ie, failure to rescue). METHODS: In a multicenter cohort study, data on 9255 adults with severe TBI were derived from 111 hospitals participating in the American College of Surgeons Trauma Quality Improvement Program over 2009-2011. Hospitals were ranked into quartiles based on their volume of severe TBI during the study period. Random-intercept multilevel models were used to examine the association between hospital quartile of severe TBI volume and in-hospital mortality, major complications, and mortality following a major complication after adjusting for patient and hospital characteristics. In sensitivity analyses, we examined these associations after excluding transferred cases. RESULTS: Overall mortality was 37.2% (n = 3447). Two thousand ninety-eight patients (22.7%) suffered from 1 or more major complication. Among patients with major complications, 27.8% (n = 583) died. Higher-volume hospitals were associated with lower mortality; the adjusted odds ratio of death was 0.50 (95% confidence interval: 0.29-0.85) in the highest volume quartile compared to the lowest. There was no significant association between hospital-volume quartile and the odds of a major complication or the odds of death following a major complication. After excluding transferred cases, similar results were found. CONCLUSION: High-volume hospitals might be associated with lower in-hospital mortality following severe TBI. However, this mortality reduction was not associated with lower risk of major complications or death following a major complication.	[Alali, Aziz S.; Gomez, David; McCredie, Victoria; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Alali, Aziz S.] Univ Toronto, Interdept Div Crit Care, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Gomez, David] Univ Toronto, Dept Surg, Toronto, ON, Canada; [McCredie, Victoria] Sunnybrook Hlth Sci Ctr, Dept Crit Care, Toronto, ON, Canada; [McCredie, Victoria; Nathens, Avery B.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mainprize, Todd G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Neurosurg, Toronto, ON, Canada; [Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada		Alali, AS (corresponding author), Univ Toronto, Interdept Div Crit Care, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	aziz.alali@mail.utoronto.ca		Gomez, David/0000-0002-0926-2547	De Souza Chair in Trauma Research	This work was supported in part by funds from De Souza Chair in Trauma Research (to Dr. Nathens). Dr. Nathens is the Director of the American College of Surgeons Trauma Quality Improvement Program, the source of data contained within the manuscript. He is a consultant to the American College of Surgeons in this regard. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Dimick JB, 2005, WORLD J SURG, V29, P1217, DOI 10.1007/s00268-005-7989-4; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Donabedian A., 2003, INTRO QUALITY ASSURA; Gonzalez AA, 2014, JAMA SURG, V149, P119, DOI 10.1001/jamasurg.2013.3649; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hox J.J., 2010, QUANTITATIVE METHODO, V2; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Kozar RA, 2014, J TRAUMA ACUTE CARE, V76, P634, DOI 10.1097/TA.0000000000000130; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Oyetunji TA, 2011, J SURG RES, V165, pE37, DOI 10.1016/j.jss.2010.09.025; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	17	11	11	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2017	80	4					534	541		10.1093/neuros/nyw098			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EZ2BO	WOS:000404515000015	28362914				2022-02-06	
J	de la Tremblaye, PB; Bondi, CO; Lajud, N; Cheng, JP; Radabaugh, HL; Kline, AE				de la Tremblaye, Patricia B.; Bondi, Corina O.; Lajud, Naima; Cheng, Jeffrey P.; Radabaugh, Hannah L.; Kline, Anthony E.			Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined	JOURNAL OF NEUROTRAUMA			English	Article						acetylcholinesterase inhibitors (AChEIs); beam-walking; behavior; controlled cortical impact (CCI); functional recovery; galantamine; hippocampus; learning and memory; Morris water maze; traumatic brain injury	CORTICAL IMPACT INJURY; SPATIAL-LEARNING DEFICITS; NEUROPROTECTION AND/OR ENHANCEMENT; MUSCARINIC ACETYLCHOLINE-RECEPTORS; ALPHA-7 NICOTINIC ACETYLCHOLINE; MEDIATED FUNCTIONAL IMPROVEMENT; MODERATE ALZHEIMERS-DISEASE; REDUCED EVOKED RELEASE; CHOLINESTERASE-INHIBITORS; CHOLINERGIC SYSTEM	Environmental enrichment (EE) enhances cognition after traumatic brain injury (TBI). Galantamine (GAL) is an acetylcholinesterase inhibitor that also may promote benefits. Hence, the aims of this study were to assess the efficacy of GAL alone (standard [STD] housing) and in combination with EE in adult male rats after TBI. The hypothesis was that both therapies would confer motor, cognitive, and histological benefits when provided singly, but that their combination would be more efficacious. Anesthetized rats received a controlled cortical impact or sham injury, then were randomly assigned to receive GAL (1, 2, or 3 mg/kg; intraperitoneally [i.p.]) or saline vehicle (VEH; 1 mL/kg; i.p.) beginning 24 h after surgery and once daily for 21 days (experiment 1). Motor (beam-balance/walk) and cognitive (Morris water maze [MWM]) assessments were conducted on post-operative Days 1-5 and 14-19, respectively. Cortical lesion volumes were quantified on Day 21. Sham controls were better versus all TBI groups. No differences in motor function or lesion volumes were observed among the TBI groups (p > 0.05). In contrast, GAL (2 mg/kg) enhanced MWM performance versus VEH and GAL (1 and 3 mg/kg; p < 0.05). In experiment 2, GAL (2 mg/kg) or VEH was combined with EE and the data were compared with the STD-housed groups from experiment 1. EE alone enhanced motor performance over the VEH-treated and GAL-treated (2 mg/kg) STD-housed groups (p < 0.05). Moreover, both EE groups (VEH or GAL) facilitated spatial learning and reduced lesion size versus STD + VEH controls (p < 0.05). No additional benefits were observed with the combination paradigm, which does not support the hypothesis. Overall, the data demonstrate that EE and once daily GAL (2 mg/kg) promote cognitive recovery after TBI. Importantly, the combined therapies did not negatively affect outcome and thus this therapeutic protocol may have clinical utility.	[de la Tremblaye, Patricia B.; Bondi, Corina O.; Lajud, Naima; Cheng, Jeffrey P.; Radabaugh, Hannah L.; Kline, Anthony E.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [de la Tremblaye, Patricia B.; Bondi, Corina O.; Lajud, Naima; Cheng, Jeffrey P.; Radabaugh, Hannah L.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Lajud, Naima] Mexican Social Secur Inst, Biomed Res Ctr Michoacan, Div Neurosci, Morelia, Michoacan, Mexico		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Phys Med & Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X; Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620, HD069620-S1, NS084967, NS094950]; University of Pittsburgh Physicians /UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS086749, R01NS084967, R01NS060005, R03NS094950] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants NS060005, HD069620, HD069620-S1, NS084967 (AEK), and NS094950 (COB), and the University of Pittsburgh Physicians /UPMC Academic Foundation (COB).	Ago Y, 2010, INT J NEUROPSYCHOPH, V13, P58; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; Benetti F, 2009, INT J DEV NEUROSCI, V27, P59, DOI 10.1016/j.ijdevneu.2008.09.200; Bentley P, 2011, PROG NEUROBIOL, V94, P360, DOI 10.1016/j.pneurobio.2011.06.002; BICKEL U, 1991, NEUROPHARMACOLOGY, V30, P447, DOI 10.1016/0028-3908(91)90005-V; Blesa R, 2003, DEMENT GERIATR COGN, V15, P79, DOI 10.1159/000067974; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Bruel-Jungerman E, 2011, BEHAV BRAIN RES, V221, P379, DOI 10.1016/j.bbr.2011.01.021; Buendia I, 2016, MOL NEUROBIOL, V53, P3338, DOI 10.1007/s12035-015-9272-5; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Coyle J, 2001, BIOL PSYCHIAT, V49, P289, DOI 10.1016/S0006-3223(00)01101-X; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; de Bruin N, 2006, PHARMACOL BIOCHEM BE, V85, P253, DOI 10.1016/j.pbb.2006.08.007; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dimitrova DS, 2006, J PHARMACOL SCI, V101, P199, DOI 10.1254/jphs.FPE05006X; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Emre M, 2002, INT J CLIN PRACT, P64; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Farlow MR, 2001, CLIN THER, V23, pA13, DOI 10.1016/S0149-2918(01)80164-8; Fayuk D, 2004, MOL PHARMACOL, V66, P658, DOI 10.1124/mol.104.000042; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Gould TJ, 2005, BEHAV BRAIN RES, V165, P160, DOI 10.1016/j.bbr.2005.06.040; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Huber KBG, 2016, CURR PHARM DESIGN, V22, P2072, DOI 10.2174/1381612822666160127113631; Hwang TY, 2016, PSYCHIAT INVEST, V13, P341, DOI 10.4306/pi.2016.13.3.341; Iliev AI, 2000, J PHARM PHARMACOL, V52, P1151, DOI 10.1211/0022357001774921; Ji XH, 2007, NEUROSCI LETT, V416, P92, DOI 10.1016/j.neulet.2007.01.053; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kelso ML, 2011, PROG MOL BIOL TRANSL, V98, P85, DOI 10.1016/B978-0-12-385506-0.00003-X; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kumar A, 2011, BRAIN RES BULL, V85, P158, DOI 10.1016/j.brainresbull.2011.03.010; Leary J., 2016, J NEUROTRAUMA; Lorrio S, 2007, J PHARMACOL EXP THER, V322, P591, DOI 10.1124/jpet.107.122747; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maelicke A, 2001, CLIN THER, V23, pA8, DOI 10.1016/S0149-2918(01)80163-6; Maelicke A, 2000, BEHAV BRAIN RES, V113, P199, DOI 10.1016/S0166-4328(00)00214-X; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; Mintzer JE, 2003, INT J GERIATR PSYCH, V18, P292, DOI 10.1002/gps.826; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Muthuraju S, 2011, EUR J PHARMACOL, V672, P96, DOI 10.1016/j.ejphar.2011.08.023; Muthuraju S, 2011, INT J NEUROSCI, V121, P279, DOI 10.3109/00207454.2011.556279; Muthuraju S, 2010, EXP BRAIN RES, V203, P583, DOI 10.1007/s00221-010-2266-7; Muthuraju S, 2009, BEHAV BRAIN RES, V203, P1, DOI 10.1016/j.bbr.2009.03.026; Narimatsu N, 2009, J PHARMACOL EXP THER, V330, P2, DOI 10.1124/jpet.108.147280; Nikiforuk A, 2016, BEHAV BRAIN RES, V313, P214, DOI 10.1016/j.bbr.2016.07.023; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; Raskind MA, 2004, ARCH NEUROL-CHICAGO, V61, P252, DOI 10.1001/archneur.61.2.252; Raskind MA, 2003, NEUROLOGIST, V9, P235, DOI 10.1097/01.nrl.0000087722.46430.c4; Reid RT, 2008, J NEURAL TRANSM, V115, P1437, DOI 10.1007/s00702-008-0107-7; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Seltzer Ben, 2005, Expert Opin Drug Metab Toxicol, V1, P527, DOI 10.1517/17425255.1.3.527; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shin SS, 2015, NEURAL REGEN RES, V10, P1552, DOI 10.4103/1673-5374.165309; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Svoboda Z, 2006, NEUROENDOCRINOL LETT, V27, P183; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomassoni D, 2012, CURR ALZHEIMER RES, V9, P120, DOI 10.2174/156720512799015118; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Wilkinson DG, 2004, DRUG AGING, V21, P453, DOI 10.2165/00002512-200421070-00004; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Woodruff-Pak DS, 2002, CNS DRUG REV, V8, P405; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	106	11	11	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1610	1622		10.1089/neu.2016.4790			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500013	27806662	Green Published			2022-02-06	
J	Howells, T; Johnson, U; McKelvey, T; Ronne-Engstrom, E; Enblad, P				Howells, Tim; Johnson, Ulf; McKelvey, Tomas; Ronne-Engstrom, Elisabeth; Enblad, Per			The effects of ventricular drainage on the intracranial pressure signal and the pressure reactivity index	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Intracranial pressure; Subarachnoid hemorrhage; Cerebral autoregulation; Vascular pressure reactivity; Clinical monitoring	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ISCHEMIA	In subarachnoid hemorrhage (SAH) patients intracranial pressure (ICP) is usually monitored via an extraventricular drain (EVD), which can produce false readings when the drain is open. It is established that both the ICP cardiac pulse frequency and long term trends over several hours are often seriously corrupted. The aim of this study was to establish whether or not the intermediate frequency bands [respiratory, Mayer wave and very low frequency (VLF)] were also corrupted. The VLF range is of special interest because it is important in cerebral autoregulation studies. Using a pattern recognition algorithm we retrospectively identified 718 cases of EVD opening in 80 SAH patients. An analysis of differences between closed and open-drain periods showed that ICP amplitude decreased significantly in all of the three lower frequency bands when the EVD was open. A similar analysis of systemic arterial pressure signal revealed similar changes in the same frequency bands that were positively correlated with the ICP changes. Therefore we concluded that the changes in the ICP signal represented real, physiological changes and not artifact. Pressure reactivity index (PRx) values were also computed during closed and open-drain periods. We found a small but statistically significant decrease during open-drain periods. Based on analysis of the change in the PRx distribution during open drainage we concluded that this decrease also represented physiological changes rather than artifact. In summary the ICP respiratory, Mayer wave, and VLF frequency bands are not corrupted when the EVD is open, and it safe to use these for autoregulation studies.	[Howells, Tim; Johnson, Ulf; Ronne-Engstrom, Elisabeth; Enblad, Per] Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden; [McKelvey, Tomas] Chalmers, Dept Signals & Syst, Gothenburg, Sweden		Howells, T (corresponding author), Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden.	timothy.howells@lul.se	McKelvey, Tomas/R-7193-2019	McKelvey, Tomas/0000-0003-2982-5535; Johnson, Ulf/0000-0002-3879-6476	Swedish Research Foundation	The research described in this paper was supported in part by Grants from the Swedish Research Foundation.	Aries MJH, 2015, NEUROCRIT CARE, V23, P347, DOI 10.1007/s12028-015-0107-z; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brathwaite S, 2014, TRANSL STROKE RES, V5, P207, DOI 10.1007/s12975-013-0316-8; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Fontana J, 2015, NEUROCRIT CARE, V23, P355, DOI 10.1007/s12028-014-0104-7; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Greensted AJ, 2010, FINITE IMPULSE RESPO; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Morgalla MH, 1999, J INTENSIVE CARE MED, V14, P243; Piek J, 1996, NEUROSURGERY, V38, P216, DOI 10.1097/00006123-199601000-00051; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Sakowitz OW, 2006, CURR OPIN CRIT CARE, V12, P103, DOI 10.1097/01.ccx.0000216575.03815.ee; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Soehle M, 2007, ACTA NEUROCHIR, V149, P575, DOI 10.1007/s00701-007-1149-6; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	25	11	11	0	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	APR	2017	31	2					469	478		10.1007/s10877-016-9863-3			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EN9VX	WOS:000396348800028	26987656				2022-02-06	
J	Kim, GH; Byeon, JH; Eun, BL				Kim, Gun-Ha; Byeon, Jung Hye; Eun, Baik-Lin			Neuroprotective Effect of Lacosamide on Hypoxic-Ischemic Brain Injury in Neonatal Rats	JOURNAL OF CLINICAL NEUROLOGY			English	Article						brain; hypoxia-ischemia; lacosamide; neuroprotection; newborn; rat	ANTIEPILEPTIC DRUGS; CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; GERBIL MODEL; TOPIRAMATE; NEURODEGENERATION; MECHANISMS; CHANNELS; DAMAGE	Background and Purpose Lacosamide (LCM) is an antiepileptic drug that enhances the slow inactivation of sodium channels and modulates collapsin response mediator protein -2. LCM was recently demonstrated to exert a neuroprotective effect in a murine model of traumatic brain injury and status epilepticus. Assuming the same underlying excitotoxicity-related brain injury mechanism, we hypothesized that LCM would have a neuroprotective effect in hypoxic-ischemic brain injury. Methods We divided rats into three groups at each testing session: pre-or postfed with LCM, fed with normal saline, and sham. A hypoxic-ischemic brain injury was induced by subjecting 7-day-old rats to right carotid artery coagulation followed by 2.5 h of exposure to 8% oxygen. The animals were killed on postnatal day 12 to evaluate the severity of brain damage. Open field testing was also performed between week 2 and week 6, and the Morris water maze test was performed in week 7 after hypoxia-ischemia. Results The incidence of liquefactive cerebral infarction was lower in rats prefed with LCM at 100 mg/kg/dose, with the mortality rate being higher at higher doses (200 and 300 mg/kg/dose). The infarct areas were smaller in LCM-prefed rats in several brain regions including the hemisphere, hippocampus, cortex, and striatum. Spatial learning and memory function were better in LCM-prefed rats (p<0.05). No effect was observed in postfed rats. Conclusions This study suggests that LCM pretreatment exerts a neuroprotective effect on hypoxia-ischemia in neonatal rats. The obtained results suggest that LCM pretreatment could be used as an effective neuroprotective method for neonates under hypoxic-ischemic conditions including heart surgery.	[Kim, Gun-Ha; Byeon, Jung Hye; Eun, Baik-Lin] Korea Univ, Coll Med, Dept Pediat, 148 Gurodong Ro, Seoul 08308, South Korea		Eun, BL (corresponding author), Korea Univ, Coll Med, Dept Pediat, 148 Gurodong Ro, Seoul 08308, South Korea.	bleun@korea.ac.kr		BYEON, JUNGHYE/0000-0001-5479-2451	Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0810]	This research was supported by a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0810).	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Beydoun A, 2009, EXPERT REV NEUROTHER, V9, P33, DOI 10.1586/14737175.9.1.33; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Calabresi P, 2000, NEUROLOGY, V55, P1249, DOI 10.1212/WNL.55.9.1249; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Chan SA, 1998, ACTA NEUROCHIR, V140, P175, DOI 10.1007/s007010050080; Edmonds HL, 2001, LIFE SCI, V69, P2265, DOI 10.1016/S0024-3205(01)01306-6; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Halford JJ, 2009, EPILEPSY CURR, V9, P1, DOI 10.1111/j.1535-7511.2008.01273.x; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Licko T, 2013, EPILEPSIA, V54, P1176, DOI 10.1111/epi.12196; Liu YQ, 2004, STROKE, V35, P1460, DOI 10.1161/01.STR.0000128029.50221.fa; Meldrum BS, 1996, EPILEPSIA, V37, pS4, DOI 10.1111/j.1528-1157.1996.tb06038.x; Noh MR, 2006, EXP NEUROL, V201, P470, DOI 10.1016/j.expneurol.2006.04.038; Owen AJ, 1997, BRAIN RES, V770, P115, DOI 10.1016/S0006-8993(97)00789-0; Patsalos PN, 2012, EXPERT OPIN PHARMACO, V13, P699, DOI 10.1517/14656566.2012.667803; Schubert S, 2005, BRAIN RES, V1058, P129, DOI 10.1016/j.brainres.2005.07.061; Thomas D, 2006, EPILEPSIA, V47, P200; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; Vartanian MG, 1996, DEV BRAIN RES, V95, P169, DOI 10.1016/0165-3806(96)00073-9; Wang B, 2013, NEUROCRIT CARE, V19, P125, DOI 10.1007/s12028-012-9808-8; WIARD RP, 1995, STROKE, V26, P466, DOI 10.1161/01.STR.26.3.466; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang Y, 1998, BRAIN RES, V804, P169, DOI 10.1016/S0006-8993(98)00410-7	26	11	11	0	4	KOREAN NEUROLOGICAL ASSOC	SEOUL	1111 DAEIL BLD, 43 INSA-DONG, JONGNO-GU, SEOUL, 110-741, SOUTH KOREA	1738-6586	2005-5013		J CLIN NEUROL	J. Clin. Neurol.	APR	2017	13	2					138	143		10.3988/jcn.2017.13.2.138			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER7IC	WOS:000398984100003	28271640	Green Published, Green Submitted			2022-02-06	
J	Korley, FK; Diaz-Arrastia, R; Falk, HJ; Peters, ME; Leoutsakos, JMS; Roy, D; Rao, V; Sair, HI; Ofoche, U; Hall, AJ; Akbari, F; Van Meter, TE; Everett, AD; Van Eyk, JE; Bechtold, KT				Korley, Frederick K.; Diaz-Arrastia, Ramon; Falk, Hayley J.; Peters, Matthew E.; Leoutsakos, Jeannie-Marie S.; Roy, Durga; Rao, Vani; Sair, Haris Iqbal; Ofoche, Uju; Hall, Anna J.; Akbari, Freshta; Van Meter, Timothy E.; Everett, Allen D.; Van Eyk, Jennifer E.; Bechtold, Kathleen T.			Prevalence of Incomplete Functional and Symptomatic Recovery among Patients with Head Injury but Brain Injury Debatable	JOURNAL OF NEUROTRAUMA			English	Article						head trauma; human studies; outcomes; prospective study; traumatic brain injury	POST-CONCUSSION SYMPTOMS; COMMON DATA ELEMENTS; COMPUTED-TOMOGRAPHY; TRAUMA PATIENTS; CONSCIOUSNESS; BIOMARKERS; BLOOD; PREDICTION; ADULT; TBI	Head injury patients not meeting the American Congress of Rehabilitation Medicine (ACRM)'s criteria for mild traumatic brain injury (mTBI), referred to hereafter as HIBRID (Head Injury BRain Injury Debatable), are often excluded from studies. The prognostic importance of HIBRID is unclear. We investigated the differences in functional and symptomatic recovery at 1 month post-injury among TBI patients classified as: HIBRID, ACRM+ cranial computed tomography (CT)-, and cranial CT+; and trauma and healthy controls. Subjects were enrolled in an ongoing prospective cohort (Head Injury Serum Markers for Assessing Response to Trauma; HeadSMART). Outcomes measured at 1 month post-injury include: incomplete functional recovery (Glasgow Outcome Scale Extended < 8); moderate/severe post-concussive symptoms (PCS), defined according to the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision definition; and moderate/severe depressive symptoms (Patient Health Questionnaire 9 >= 10). Between April 2014 and May 2016, 500 TBI and 100 control subjects were enrolled and 376 TBI and 78 control subjects completed outcome assessment. The HIBRID group, constituting 23.9% of study population, had a lower incidence of incomplete functional recovery (36.7% [33 of 90]) than ACRM+, CT-(60.7% [125 of 206]; p < 0.01) and CT+ (78.8% [63 of 80]; p < 0.01) groups. However, the incidence of delayed functional recovery within the HIBRID group was higher than in trauma (9.3% [5 of 54]; p < 0.01) and healthy controls (0% [0 of 24]; p < 0.01). Compared to trauma/healthy controls, the HIBRID group had a higher incidence of moderate/severe depressive symptoms and a similar incidence of moderate/severe PCS. Subjects in the HIBRID group are at high risk for adverse outcomes following head injury and warrant further investigation.	[Korley, Frederick K.] Univ Michigan, Sch Med, Dept Emergency Med, North Campus Res Bldg 026-333N,2800 Plymouth Rd, Ann Arbor, MI 48105 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA; [Falk, Hayley J.; Ofoche, Uju; Hall, Anna J.; Akbari, Freshta] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Peters, Matthew E.; Leoutsakos, Jeannie-Marie S.; Roy, Durga; Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Sair, Haris Iqbal] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Van Meter, Timothy E.] ImmunArray Inc, Program Neurol Dis, Richmond, VA USA; [Everett, Allen D.] Johns Hopkins Univ, Sch Med, Dept Pediat, Bloomberg Childrens Ctr, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Cedar Sinai Med Ctr, Dept Med, Inst Heart, Adv Clin Biosyst Res, Los Angeles, CA USA; [Bechtold, Kathleen T.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA		Korley, FK (corresponding author), Univ Michigan, Sch Med, Dept Emergency Med, North Campus Res Bldg 026-333N,2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	korley@med.umich.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	ImmunArray	HeadSMART was funded by ImmunArray.	Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 2001, J ATHL TRAINING, V36, P249; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Peters M. E., 2016, BRAIN INJ IN PRESS; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; World Health Organization, ICD 10 CLASS MENT BE; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	34	11	11	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1531	1538		10.1089/neu.2016.4723			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500004	27784200				2022-02-06	
J	Logsdon, AF; Lucke-Wold, BP; Turner, RC; Li, XL; Adkins, CE; Mohammad, AS; Huber, JD; Rosen, CL; Lockman, PR				Logsdon, Aric F.; Lucke-Wold, Brandon P.; Turner, Ryan C.; Li, Xinlan; Adkins, Chris E.; Mohammad, Afroz S.; Huber, Jason D.; Rosen, Charles L.; Lockman, Paul R.			A Mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior	ARCHIVES OF NEUROSCIENCE			English	Article						Traumatic Brain Injury; Blood-Brain Barrier Disruption; Astrocyte Reactivity; Tauopathy; Neuropsychiatric Behavior	TRAUMATIC BRAIN-INJURY; BARRIER DISRUPTION; OXIDATIVE STRESS; RAT MODEL; NEUROINFLAMMATION; ENCEPHALOPATHY; NEUROPATHOLOGY; IDENTIFICATION; INFLAMMATION; DEFICITS	Neuropsychiatric symptom development has become more prevalent with 270,000 blast exposures occurring in the past 10 years in the United States. How blast injury leads to neuropsychiatric symptomology is currently unknown. Preclinical models of blast-induced traumatic brain injury have been used to demonstrate blood-brain barrier disruption, degenerative pathophysiology, and behavioral deficits. Vascular injury is a primary effect of neurotrauma that can trigger secondary injury cascades and neurodegeneration. Here we present data from a novel scaled and clinically relevant mouse blast model that was specifically developed to assess the outcome of vascular injury. We look at the biochemical effects and behavioral changes associated with blast injury in young-adult male BALB/c mice. We report that blast exposure causes focal vascular injury in the Somatosensory Barrel Field cortex, which leads to perivascular astrocyte reactivity, as well as acute aberrant behavior. Biochemical analysis revealed that mild blast exposure also invokes tauopathy, neuroinflammation, and oxidative stress. Overall, we propose our model to be used to evaluate focal blood-brain barrier disruption and to discover novel therapies for human neuropsychiatric symptoms.	[Logsdon, Aric F.; Adkins, Chris E.; Mohammad, Afroz S.; Huber, Jason D.; Lockman, Paul R.] West Virginia Univ, Sch Med, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; [Lucke-Wold, Brandon P.; Turner, Ryan C.; Li, Xinlan; Rosen, Charles L.] West Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA		Lockman, PR (corresponding author), West Virginia Univ, Sch Med, Dept Pharmaceut Sci, Morgantown, WV 26506 USA.	prlockman@hsc.wvu.edu	Lucke-Wold, Brandon/AAW-1881-2021; Lucke-Wold, Brandon/AAW-3525-2021	Lucke-Wold, Brandon/0000-0001-6577-4080; Turner, Ryan/0000-0001-5523-0645	NIH grant (WVU HSC)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; American Foundation for pharmaceutical education; Sigma Xi; American medical association foundation; American Association of Pharmaceutical Scientists; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099918] Funding Source: NIH RePORTER	Paul Lockman provided funding and support for this project with an NIH grant (WVU HSC). Aric Logsdon and Brandon Lucke-Wold received funding and support from the American Foundation for pharmaceutical education pre-doctoral fellowship. Brandon Lucke-Wold also received support from Sigma Xi grants in aid of research, the American medical association foundation seed grant, American Association of Pharmaceutical Scientists Pre-doctoral Fellowship, and the neurosurgery research and education foundation medical student summer research fellowship. We would like to acknowledge the generous gift of the T22 antibody from Dr. Rakez Kayed. We would also like to thank Matt Robson PhD, and his father James Robson for help creating the model.	Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Adkins CE, 2016, CLIN EXP METASTAS, V33, P373, DOI 10.1007/s10585-016-9784-z; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Eisenmenger LB, 2016, SEMIN NUCL MED, V46, P57, DOI 10.1053/j.semnuclmed.2015.09.003; Eldawlatly S, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00155; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lucke-Wold B. P., 2015, TRANSL RES, V166, pe1, DOI DOI 10.1016/J.TRSL.2015.08.005.[; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Miremami JD, 2014, SOMATOSENS MOT RES, V31, P127, DOI 10.3109/08990220.2014.897602; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Nguyen NK, 2009, SYNAPSE, V63, P236, DOI 10.1002/syn.20597; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Prochnow N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00031; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Toklu HZ, 2015, FRONTIERS NEUROENGIN; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423	41	11	11	0	1	KOWSAR CORP	TEHRAN	PO BOX 14155-3651, TEHRAN, 14155, IRAN	2322-3944	2322-5769		ARCH NEUROSCI	Arch. Neurosci.	APR	2017	4	2							e44254	10.5812/archneurosci.44254			11	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FF7RD	WOS:000409212800010		gold, Green Submitted, Green Accepted			2022-02-06	
J	Sindelar, B; Bailes, J; Sherman, S; Finan, J; Stone, J; Lee, J; Ahmadian, S; Zhou, Y; Patel, V; Smith, D				Sindelar, Brian; Bailes, Julian; Sherman, Sydney; Finan, John; Stone, James; Lee, John; Ahmadian, Saman; Zhou, Ying; Patel, Vimal; Smith, David			Effect of Internal Jugular Vein Compression on Intracranial Hemorrhage in a Porcine Controlled Cortical Impact Model	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; CCI; head trauma; SAH; TBI	SUPERIOR SAGITTAL SINUS; CEREBRAL VENOUS OUTFLOW; TRAUMATIC BRAIN-INJURY; PRESSURE; RESUSCITATION; SWINE	Internal jugular vein (IJV) compression has been shown to reduce axonal injury in pre-clinical traumatic brain injury (TBI) models and clinical concussion studies. However, this novel approach to prophylactically mitigating TBI through venous congestion raises concerns of increasing the propensity for hemorrhage and hemorrhagic propagation. This study aims to test the safety of IJV compression in a large animal controlled cortical impact (CCI) injury model and the resultant effects on hemorrhage. Twelve swine were randomized to placement of a bilateral IJV compression collar (CCI+collar) or control/no collar (CCI) prior to CCI injury. A histological grading of the extent of hemorrhage, both subarachnoid (SAH) and intraparenchymal (IPH), was conducted in a blinded manner by two neuropathologists. Other various measures of TBI histology were also analyzed including: beta-amyloid precursor protein (beta-APP) expression, presence of degenerating neurons, extent of cerebral edema, and inflammatory infiltrates. Euthanized 5 h after injury, the CCI+collar animals exhibited a significant reduction in total SAH (p = 0.024-0.026) and IPH scores (p = 0.03-0.05) compared with the CCI animals. There was no statistically significant difference in scoring for the other markers of TBI (beta-APP, neuronal degeneration, cerebral edema, or inflammatory infiltration). In conclusion, IJV compression was shown to reduce hemorrhage (SAH and IPH) in the porcine CCI model when applied prior to injury. These results suggest the role of IJV compression for mitigation of not only axonal, but also hemorrhagic injury following TBI.	[Sindelar, Brian; Bailes, Julian; Sherman, Sydney; Finan, John; Stone, James; Patel, Vimal] NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL USA; [Lee, John; Ahmadian, Saman] NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Evanston, IL USA; [Zhou, Ying] NorthShore Univ HealthSyst, Res Inst, Evanston, IL USA; [Sindelar, Brian] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Smith, David] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA		Bailes, J (corresponding author), NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL USA.; Bailes, J (corresponding author), Northshore Univ HealthSyst, Evanston Hosp, Dept Neurosurg, 3rd Floor Kellogg Bldg, Evanston, IL 60201 USA.	jbailes@northshore.org		Finan, John/0000-0003-4626-9702	Q30 Sports Science, LLC; NorthShore University Health System	Funding for this research was provided by Q30 Sports Science, LLC and NorthShore University Health System.	ATTINGER EO, 1969, IEEE T BIO-MED ENG, VBM16, P253, DOI 10.1109/TBME.1969.4502657; Bosnjak R, 2002, MED BIOL ENG COMPUT, V40, P423, DOI 10.1007/BF02345075; Forbes JA, 2014, CHILD NERV SYST, V30, P197, DOI 10.1007/s00381-013-2318-y; FRIES G, 1992, J NEUROSURG, V77, P127, DOI 10.3171/jns.1992.77.1.0127; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; GRADY MS, 1986, J NEUROSURG, V65, P199, DOI 10.3171/jns.1986.65.2.0199; Greiner R, 1998, THIN WALL STRUCT, V31, P159, DOI 10.1016/S0263-8231(98)00011-1; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; KAWAJIRI H, 1983, J MAXILLOFAC SURG, V11, P42, DOI 10.1016/S0301-0503(83)80010-1; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee Avione Y, 2010, Cardiovasc Eng, V1, P282, DOI 10.1007/s13239-010-0024-4; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Martinez R, 2010, ANN BIOMED ENG, V38, P1345, DOI 10.1007/s10439-010-9929-1; Mead R, 1990, DESIGN EXPT STAT PRI; Miyamoto K, 2001, J CLIN NEUROSCI, V8, P97, DOI 10.1054/jocn.2001.0887; Myer GD, 2016, BR J SPORTS MED; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; Nathoo N, 2011, NEUROSURGERY, V69, P1007, DOI 10.1227/NEU.0b013e3182274865; National Center for Catastrophic Sport Injury Research, 2014, ANN SURV FOOTB INJ R; Nusbaum DM, 2013, AVIAT SPACE ENVIR MD, V84, P946, DOI 10.3357/ASEM.3486.2013; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; REKATE HL, 1992, PEDIATR NEUROSURG, V18, P257, DOI 10.1159/000120672; Shah QH, 2011, J ENG SCI TECHNOL, V6, P506; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; WAGNER EM, 1983, AM J PHYSIOL, V244, pH505, DOI 10.1152/ajpheart.1983.244.4.H505; WEI EP, 1984, CIRC RES, V55, P249, DOI 10.1161/01.RES.55.2.249	31	11	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1703	1709		10.1089/neu.2016.4648			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500021	27573472				2022-02-06	
J	Vega, RA; Valadka, AB				Vega, Rafael A.; Valadka, Alex B.			Natural History of Acute Subdural Hematoma	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Acute subdural hematoma; Anticoagulation; Computed tomography; Glasgow coma scale; MRI; Nonoperative management; Traumatic brain injury	INTRACRANIAL HEMORRHAGE; NONSURGICAL MANAGEMENT; RISK-FACTORS; HEAD-INJURY; TRAUMA; RESOLUTION; MORTALITY; OUTCOMES	Because published guidelines for surgical decision-making in patients with acute subdural hematomas (ASDHs) are based largely on case series and other weak evidence, management often must be individualized. Nonoperative management is a viable option in many cases. The literature is divided about the effects of anticoagulant and antiplatelet medications on rapid growth of ASDHs and on their likelihood of progression to large chronic subdural hematomas. Close clinical and radiologic follow-up is needed, both acutely to detect rapid expansion of an ASDH, and sub acutely to detect formation of a large subacute or chronic subdural hematoma.	[Vega, Rafael A.; Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, 417 North 11th St,6th Floor,POB 980631, Richmond, VA 23298 USA		Valadka, AB (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, 417 North 11th St,6th Floor,POB 980631, Richmond, VA 23298 USA.	avaladka@gmail.com					Ahmed Ehtisham, 2012, J Ayub Med Coll Abbottabad, V24, P71; AVIS SP, 1993, AM J FOREN MED PATH, V14, P130, DOI 10.1097/00000433-199306000-00005; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; Feliciano CE, 2008, P R HEALTH SCI J, V27, P27; Fujimoto K, 2014, CLIN NEUROL NEUROSUR, V118, P94, DOI 10.1016/j.clineuro.2013.11.030; Hayes Jackson, 2012, J Med Case Rep, V6, P393, DOI 10.1186/1752-1947-6-393; Howard BM, 2016, J NEUROTRAUMA; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Kim BJ, 2014, ACTA NEUROCHIR, V156, P1605, DOI 10.1007/s00701-014-2151-4; Laviv Y, 2014, BRIT J NEUROSURG, V28, P733, DOI 10.3109/02688697.2014.918578; Lee Jong Joo, 2015, Korean J Neurotrauma, V11, P52, DOI 10.13004/kjnt.2015.11.2.52; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Morris NA, 2016, NEUROCRIT CARE, V24, P226, DOI 10.1007/s12028-015-0178-x; de Amorim RLO, 2014, ACTA NEUROCHIR, V156, P199, DOI 10.1007/s00701-013-1850-6; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Takeuchi S, 2012, J TRAUMA ACUTE CARE, V72, P480, DOI 10.1097/TA.0b013e31823c89b3; Wen L, 2009, IRISH J MED SCI, V178, P367, DOI 10.1007/s11845-008-0168-5; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	24	11	11	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2017	28	2					247	+		10.1016/j.nec.2016.11.007			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ES1AJ	WOS:000399260000008	28325459	Green Published			2022-02-06	
J	Weiss, N; Rosselli, M; Mouri, S; Galanaud, D; Puybasset, L; Agarwal, B; Thabut, D; Jalan, R				Weiss, Nicolas; Rosselli, Matteo; Mouri, Sarah; Galanaud, Damien; Puybasset, Louis; Agarwal, Banwari; Thabut, Dominique; Jalan, Rajiv			Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis	METABOLIC BRAIN DISEASE			English	Article						Hepatic encephalopathy; Brain edema; Blood-brain barrier; Blood-cerebrospinal fluid-barrier; CT scan	TRAUMATIC BRAIN-INJURY; HEPATIC-ENCEPHALOPATHY; CEREBRAL EDEMA; MORTALITY; AMMONIA; ACID; HYPERAMMONEMIA; SPECTROSCOPY; TRYPTOPHAN; ENDOTOXIN	Although hepatic encephalopathy (HE) on the background of acute on chronic liver failure (ACLF) is associated with high mortality rates, it is unknown whether this is due to increased blood-brain barrier permeability. Specific gravity of cerebrospinal fluid measured by CT is able to estimate blood-cerebrospinal fluid-barrier permeability. This study aimed to assess cerebrospinal fluid specific gravity in acutely decompensated cirrhosis and to compare it in patients with or without ACLF and with or without hepatic encephalopathy. We identified all the patients admitted for acute decompensation of cirrhosis who underwent a brain CT-scan. Those patients could present acute decompensation with or without ACLF. The presence of hepatic encephalopathy was noted. They were compared to a group of stable cirrhotic patients and healthy controls. Quantitative brain CT analysis used the Brainview software that gives the weight, the volume and the specific gravity of each determined brain regions. Results are given as median and interquartile ranges and as relative variation compared to the control/baseline group. 36 patients presented an acute decompensation of cirrhosis. Among them, 25 presented with ACLF and 11 without ACLF; 20 presented with hepatic encephalopathy grade >= 2. They were compared to 31 stable cirrhosis patients and 61 healthy controls. Cirrhotic patients had increased cerebrospinal fluid specific gravity (CSF-SG) compared to healthy controls (+0.4 %, p < 0.0001). Cirrhotic patients with ACLF have decreased CSF-SG as compared to cirrhotic patients without ACLF (-0.2 %, p = 0.0030) that remained higher than in healthy controls. The presence of hepatic encephalopathy did not modify CSF-SG (-0.09 %, p = 0.1757). Specific gravity did not differ between different brain regions according to the presence or absence of either ACLF or HE. In patients with acute decompensation of cirrhosis, and those with ACLF, CSF specific gravity is modified compared to both stable cirrhotic patients and healthy controls. This pattern is observed even in the absence of hepatic encephalopathy suggesting that blood-CSF barrier impairment is manifest even in absence of overt hepatic encephalopathy.	[Weiss, Nicolas; Mouri, Sarah; Thabut, Dominique] Hop La Pitie Salpetriere, Brain Liver Pitie Salpetriere Study Grp BLIPS, Paris, France; [Weiss, Nicolas; Thabut, Dominique] AP HP, CDR St Antoine, INSERM UMR S 938, Paris, France; [Weiss, Nicolas] Hop La Pitie Salpetriere, AP HP, Unite Reanimat Neurol, Federat Neurol,Pole Malad Syst Nerveux, Paris, France; [Weiss, Nicolas] IHU A ICM, Inst Neurosci Translat Paris, Paris, France; [Rosselli, Matteo; Agarwal, Banwari; Jalan, Rajiv] Royal Free Hosp, UCL Med Sch, UCL Inst Liver & Digest Hlth, Liver Failure Grp, London, England; [Mouri, Sarah; Thabut, Dominique] Hop La Pitie Salpetriere, AP HP, Serv Hepatogastroenterol, Soins Intensifs Hepatol, Paris, France; [Galanaud, Damien] Hop La Pitie Salpetriere, AP HP, Serv Neuroradiol, Paris, France; [Puybasset, Louis] Hop La Pitie Salpetriere, AP HP, Dept Anesthesie Reanimat, Neuroreanimat Chirurg, Paris, France; [Puybasset, Louis] Univ Paris 06, Paris, France		Weiss, N (corresponding author), Hop La Pitie Salpetriere, Brain Liver Pitie Salpetriere Study Grp BLIPS, Paris, France.; Weiss, N (corresponding author), AP HP, CDR St Antoine, INSERM UMR S 938, Paris, France.; Weiss, N (corresponding author), Hop La Pitie Salpetriere, AP HP, Unite Reanimat Neurol, Federat Neurol,Pole Malad Syst Nerveux, Paris, France.; Weiss, N (corresponding author), IHU A ICM, Inst Neurosci Translat Paris, Paris, France.	nicolas.weiss@aphp.fr	Weiss, Nicolas/E-7345-2011	Weiss, Nicolas/0000-0001-5155-196X; Agarwal, Banwari/0000-0001-5508-2590			Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015; Chavarria L, 2013, J CEREBR BLOOD F MET, V33, P272, DOI 10.1038/jcbfm.2012.173; Cordoba J, 2014, J HEPATOL, V60, P275, DOI 10.1016/j.jhep.2013.10.004; Degos V, 2006, ANESTH ANALG, V103, P1229, DOI 10.1213/01.ane.0000237401.22688.22; Degos V, 2012, ANESTH ANALG, V114, P1026, DOI 10.1213/ANE.0b013e318249fe7a; Ghersi-Egea JF, 2002, J DRUG TARGET, V10, P353, DOI 10.1080/10611860290031859; GhersiEgea JF, 1995, TOXICOL LETT, V82-3, P645, DOI 10.1016/0378-4274(95)03510-9; Gove CD, 1997, HEPATOLOGY, V25, P295; Jalan R, 2007, J HEPATOL, V47, P168, DOI 10.1016/j.jhep.2007.05.003; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; JAMES JH, 1978, SCIENCE, V200, P1395, DOI 10.1126/science.663619; JELLINGER K, 1978, J NEURAL TRANSM, P103; Joshi D, 2014, LIVER INT, V34, P362, DOI 10.1111/liv.12257; Lescot T, 2008, EUR J ANAESTH, V25, P110, DOI 10.1017/S0265021507003304; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; MATTSON LR, 1995, AM J MED GENET, V60, P210, DOI 10.1002/ajmg.1320600308; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; NITSCH C, 1984, J NEUROL SCI, V64, P119, DOI 10.1016/0022-510X(84)90030-3; Ong JP, 2003, AM J MED, V114, P188, DOI 10.1016/S0002-9343(02)01477-8; ONO J, 1978, GASTROENTEROLOGY, V74, P196; Orr JG, 2014, J HEPATOL, V61, P1158, DOI 10.1016/j.jhep.2014.06.034; Puybasset L, 1998, AM J RESP CRIT CARE, V158, P1644, DOI 10.1164/ajrccm.158.5.9802003; Romero-Gomez M, 2005, METAB BRAIN DIS, V20, P319, DOI 10.1007/s11011-005-7913-5; Ropper A.H., 2014, ADAMS VICTORS PRINCI, V10th ed.; Rose C, 1999, GASTROENTEROLOGY, V117, P640, DOI 10.1016/S0016-5085(99)70457-9; Rovira A, 2001, AM J NEURORADIOL, V22, P1137; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Stepanova M, 2012, CLIN GASTROENTEROL H, V10, P1034, DOI 10.1016/j.cgh.2012.05.016; TOMINAGA S, 1991, METAB BRAIN DIS, V6, P93, DOI 10.1007/BF00999907; Vieira SRR, 1998, AM J RESP CRIT CARE, V158, P1571, DOI 10.1164/ajrccm.158.5.9802101; Weiss N, 2016, J HEPATOL, V65, P1120, DOI 10.1016/j.jhep.2016.07.046; Weiss N, 2016, LIVER INT, V36, P1233, DOI 10.1111/liv.13061; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wright G, 2007, HEPATOLOGY, V45, P1517, DOI 10.1002/hep.21599; YOUNG SN, 1975, J NEUROL NEUROSUR PS, V38, P322, DOI 10.1136/jnnp.38.4.322	37	11	11	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	APR	2017	32	2					369	376		10.1007/s11011-016-9916-9			8	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	EP6FX	WOS:000397474900013	27730496	Green Submitted			2022-02-06	
J	Hashim, E; Caverzasi, E; Papinutto, N; Lewis, CE; Jing, RW; Charles, O; Zhang, SD; Lin, A; Graham, SJ; Schweizer, TA; Bharatha, A; Cusimano, MD				Hashim, Eyesha; Caverzasi, Eduardo; Papinutto, Nico; Lewis, Caroline E.; Jing, Ruiwei; Charles, Onella; Zhang, Shudong; Lin, Amy; Graham, Simon J.; Schweizer, Tom A.; Bharatha, Aditya; Cusimano, Michael D.			Investigating Microstructural Abnormalities and Neurocognition in Sub-Acute and Chronic Traumatic Brain Injury Patients with Normal-Appearing White Matter: A Preliminary Diffusion Tensor Imaging Study	FRONTIERS IN NEUROLOGY			English	Article						diffusion tensor imaging; chronic traumatic brain injury; white matter microstructure; human; voxel-based analysis; sub-acute traumatic brain injury; normal-appearing white matter	AXONAL INJURY; CORPUS-CALLOSUM; COGNITIVE IMPAIRMENT; MILD; MEMORY; MODERATE; NEUROANATOMY; DYSFUNCTION; INTEGRITY; FORNIX	For a significant percentage of subjects, with chronic traumatic brain injury (TBI), who report persisting cognitive impairment and functional loss, the diagnosis is often impeded by the fact that routine neuroimaging often does not reveal any abnormalities. In this paper, we used diffusion tensor imaging (DTI) to investigate the apparently normal white matter (as assessed by routine magnetic resonance imaging) in the brains of 19 subjects with sub-acute (9) and chronic (10) TBI. We also assessed memory, executive function, and visual-motor coordination in these subjects. Using a voxel-wise approach, we investigated if parameters of diffusion were significantly different between TBI subjects and 17 healthy controls (HC), who were demographically matched to the TBI group. We also investigated if changes in DTI parameters were associated with neuropsychological performance in either group. Our results indicate significantly increased mean and axial diffusivity (MD and AD, respectively) values in widespread brain locations in TBI subjects, while controlling for age, sex, and time since injury. HC performed significantly better than the TBI subjects on tests of memory and executive function, indicating the persisting functional loss in chronic TBI. We found no correlation between diffusion parameters and performance on test of executive function in either group. We found negative correlation between FA and composite memory scores, and positive correlation between RD and visuomotor coordination test scores, in various tracts in both groups. Our study suggests that changes in MD and AD can indicate persisting micro-structure abnormalities in normal-appearing white matter in the brains of subjects with chronic TBI. Our results also suggest that FA in major white matter tracts is correlated with memory in health and in disease, alike; larger and longitudinal studies are needed to discern potential differences in these correlations in the two groups.	[Hashim, Eyesha; Lewis, Caroline E.; Jing, Ruiwei; Charles, Onella; Zhang, Shudong; Schweizer, Tom A.; Cusimano, Michael D.] St Michaels Hosp, Dept Neurosurg, Toronto, ON, Canada; [Caverzasi, Eduardo; Papinutto, Nico] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Caverzasi, Eduardo] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Lin, Amy] St Michaels Hosp, Dept Radiol, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Sunnybrook Res Inst, Toronto, ON, Canada; [Bharatha, Aditya] Univ Toronto, St Michaels Hosp, Dept Med Imaging, Toronto, ON, Canada; [Bharatha, Aditya] Univ Toronto, Dept Med Imaging & Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurgery, Dept Surg, Fac Med, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Dept Neurosurg, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Div Neurosurgery, Dept Surg, Fac Med, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Caverzasi, Eduardo/P-1707-2019	Caverzasi, Eduardo/0000-0002-0350-0460	Canadian Institutes of Health Research Strategic Team [TIR-103946]; Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946, and the Ontario Neurotrauma Foundation (www.onf.org). The authors are grateful to Dr. Amy W. Lin (Boardcertified radiologist) for screening the MRI scans of all subjects for gross abnormalities in the central white matter of the brain.	Andersson J.L.R., 2007, TR07JA2 FMRIB AN GRO; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Burton DB, 2002, ARCH CLIN NEUROPSYCH, V17, P371, DOI 10.1016/S0887-6177(01)00121-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; GAFFAN EA, 1991, BRAIN, V114, P1297, DOI 10.1093/brain/114.3.1297; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Gould Thomas J, 2010, Addict Sci Clin Pract, V5, P4; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kamali A, 2014, BRAIN STRUCT FUNCT, V219, P269, DOI 10.1007/s00429-012-0498-y; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Mori S, 1995, MRI ATLAS HUMAN WHIT; Murphy ML, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-3; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neter J., 1993, APPL STAT, V4th ed.; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Renzi E D, 1975, Riv Patol Nerv Ment, V96, P252; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schear J M, 1989, Arch Clin Neuropsychol, V4, P25, DOI 10.1016/0887-6177(89)90004-8; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; TATEMICHI TK, 1992, NEUROLOGY, V42, P1966, DOI 10.1212/WNL.42.10.1966; TEASDALE G, 1974, LANCET, V2, P81; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	73	11	11	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 20	2017	8								97	10.3389/fneur.2017.00097			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EO8JH	WOS:000396934900001	28373856	Green Published, gold			2022-02-06	
J	Baker, FA; Tamplin, J; MacDonald, RAR; Ponsford, J; Roddy, C; Lee, C; Rickard, N				Baker, Felicity A.; Tamplin, Jeanette; MacDonald, Raymond A. R.; Ponsford, Jennie; Roddy, Chantal; Lee, Claire; Rickard, Nikki			Exploring the Self through Songwriting: An Analysis of Songs Composed by People with Acquired Neurodisability in an Inpatient Rehabilitation Program	JOURNAL OF MUSIC THERAPY			English	Article						brain injury; spinal cord injury; self-concept; songwriting; adjustment to disability	TRAUMATIC BRAIN-INJURY; IDENTITY; MUSIC; RECONSTRUCTION; IMPACT	Background: Neurological trauma is associated with significant damage to people's pre-injury self-concept. Therapeutic songwriting has been linked with changes in self-concept and improved psychological well-being. Objective: This study analyzed the lyrics of songs composed by inpatients with neurological injuries who participated in a targeted songwriting program. The aim of this study was to understand which of the subdomains of the self-concept were the most frequently expressed in songs. Methods: An independent, deductive content analysis of 36 songs composed by 12 adults with spinal cord injury or brain injury (11 males, mean age 41 years +/-13) were undertaken by authors 1 and 2. Results: Deductive analysis indicated that when writing about the past self, people created songs that reflected a strong focus on family and descriptions of their personality. In contrast, there is a clear preoccupation with the physical self, on the personal self, and a tendency for spiritual and moral reflections to emerge during the active phase of rehabilitation (song about the present self). Statistical analyses confirmed a significant self-concept subdomain by song interaction, F(10, 110) = 5.98, p <.001, eta(2)(p) =.35), which was primarily due to an increased focus on physical self-concept and a reduced focus on family self-concept in the present song, more than in either past or future songs. Conclusions: The analysis process confirmed that songwriting is a vehicle that allows for exploration of self-concept in individuals with neurological impairments. Songwriting may serve as a therapeutic tool to target the most prevalent areas of self-concept challenges for clients undergoing inpatient neurological rehabilitation programs.	[Baker, Felicity A.; Tamplin, Jeanette; Lee, Claire] Univ Melbourne, Melbourne, Vic 3010, Australia; [MacDonald, Raymond A. R.] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Ponsford, Jennie; Roddy, Chantal; Rickard, Nikki] Monash Univ, Clayton, Vic 3800, Australia		Baker, FA (corresponding author), Univ Melbourne, Melbourne Conservatorium Mus, Parkville, Vic 3010, Australia.	Felicity.baker@unimelb.edu.au	Tamplin, Jeanette/AAR-2855-2021; Roddy, Chantal/Q-1558-2017	Tamplin, Jeanette/0000-0002-3623-033X; Roddy, Chantal/0000-0001-5220-9226; MacDonald, Raymond/0000-0002-9748-4480	Australia Research CouncilAustralian Research Council [FT100100022, DP150100201]	This project was supported by Australia Research Council Future Fellowship FT100100022, Australia Research Council Discovery Project DP150100201.	Amiot CE, 2007, PERS SOC PSYCHOL REV, V11, P364, DOI 10.1177/1088868307304091; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Baird A, 2014, NEUROPSYCHOL REHABIL, V24, P125, DOI 10.1080/09602011.2013.858642; Baker F, 2005, J MUSIC THER, V42, P111, DOI 10.1093/jmt/42.2.111; Baker F., 2005, AUSTR J MUSIC THERAP, V16, P25; Baker FA, 2015, THERAPEUTIC SONGWRITING: DEVELOPMENTS IN THEORY, METHODS, AND PRACTICE, P1, DOI 10.1057/9781137499233; Baker F. A., 2016, OXFORD HDB MUSICAL I, P436; Baker FA, 2015, PSYCHOL MUSIC, V43, P122, DOI 10.1177/0305735613498919; Baker FA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00299; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Biderman D, 2006, INT J PSYCHOL, V41, P355, DOI 10.1080/00207590500345963; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Davis CG, 2013, REHABIL PSYCHOL, V58, P166, DOI 10.1037/a0031554; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Fitts WH., 1996, TENNESSEE SELF CONCE; Fraas MR, 2015, TOP LANG DISORD, V35, P210, DOI 10.1097/TLD.0000000000000063; Gendreau A, 2014, DISABIL REHABIL, V36, P1608, DOI 10.3109/09638288.2013.859749; Kelly A, 2013, NEUROPSYCHOL REHABIL, V23, P563, DOI 10.1080/09602011.2013.795903; Krippendorf K., 2013, CONTENT ANAL INTRO I; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; MacDonald R. A. R., 2016, HDB MUSICAL IDENTITI; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Ownsworth T., 2014, BRAIN INJURY; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Riffe D, 2014, ANAL MEDIA MESSAGES; Tamplin J, 2016, NORD J MUSIC THER, V25, P111, DOI 10.1080/08098131.2015.1011208; YOSHIDA KK, 1993, SOCIOL HEALTH ILL, V15, P217, DOI 10.1111/1467-9566.ep11346888	28	11	11	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	SPR	2017	54	1					35	54		10.1093/jmt/thw018			20	Music; Rehabilitation	Social Science Citation Index (SSCI)	Music; Rehabilitation	ES0TR	WOS:000399240200002	28391303	Green Submitted			2022-02-06	
J	Erlbeck, H; Real, RGL; Kotchoubey, B; Mattia, D; Bargak, J; Kubler, A				Erlbeck, Helena; Real, Ruben G. L.; Kotchoubey, Boris; Mattia, Donatella; Bargak, Jakob; Kuebler, Andrea			Basic discriminative and semantic processing in patients in the vegetative and minimally conscious state	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Event-related potentials; Disorders of consciousness; Vegetative state; Minimally conscious state; Mismatch negativity; N400	EVENT-RELATED POTENTIALS; CLOSED-HEAD INJURY; LOCKED-IN SYNDROME; BRAIN POTENTIALS; MISMATCH NEGATIVITY; EVOKED-POTENTIALS; PREDICTS RECOVERY; APALLIC SYNDROME; DISORDERS; REHABILITATION	Patients who survive injuries to the brain following accidents or diseases often acquire a disorder of consciousness (DOC). Assessment of the state of consciousness in these patients is difficult since they are usually incapable of reproducible motor movements. The application of event-related potentials (ERP) recorded via EEG constitutes one promising approach to complement the assessment of cognitive functions in DOC patients. For these assessments, a hierarchical approach was suggested which means that paradigms aiming at higher order ERPs are only presented if early responses were found. In this study, 19 behaviorally unresponsive or low-responsive DOC patients were presented with three auditory paradigms using passive instructions. The paradigms aimed at eliciting the Mismatch Negativity (MMN) and N400 and were applied at two time points. One oddball paradigm (MMN) and two semantic paradigms (word-pairs: N400 Words; sentences: N400 Sentences) were included. The majority of patients (n = 15) did not show any response to the stimulation. In the MMN paradigm, an MMN was identified in two patients, in the N400 Words paradigm, only an N1 was identified in one patient, and in the N400 Sentences paradigm, a late positive complex (LPC) was identified in two patients. These data contradict the hierarchical approach since the LPC was identified in patients who did not exhibit an MMN. They further support the notion that even higher information processing as addressed with the N400 paradigms is preserved in a minority of DOC patients. Thus, in this sample, around 10% of the DOC patients exhibited indicators of preserved consciousness. (C) 2017 Elsevier B.V. All rights reserved.	[Erlbeck, Helena; Real, Ruben G. L.; Kuebler, Andrea] Univ Wurzburg, Inst Psychol, Marcusstr 9-11, D-97070 Wurzburg, Germany; [Kotchoubey, Boris] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Otfried Muller Str 25, D-72076 Tubingen, Germany; [Mattia, Donatella] Fdn Santa Lucia, IRCCS, Neuroelect Imaging & BCI Lab, Via Ardeatina 306, I-00142 Rome, Italy; [Bargak, Jakob] Clin Intens Care, Wieseneckstr 24, D-90571 Schwaig, Germany; [Real, Ruben G. L.] Georg August Univ, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany		Kubler, A (corresponding author), Univ Wurzburg, Inst Psychol, Marcusstr 9-11, D-97070 Wurzburg, Germany.	Helena.erlbeck@uni-wuerzburg.de; ruben.real@med.uni-goettingen.de; boris.kotchoubey@uni-tuebingen.de; d.mattia@hsantalucia.it; j.bargak@intensivpflegeklinik.de; andrea.kuebler@uni-wuerzburg.de	Mattia, Donatella/D-7569-2012	Mattia, Donatella/0000-0002-3092-2511; Kubler, Andrea/0000-0003-4876-0415	European ICT Programme Project [FP7-247919]	This work was supported by the European ICT Programme Project FP7-247919. The text reflects solely the views of its authors. The European Commission is not liable for any use that may be made of the information contained therein.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; Chennu S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00065; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cruse D, 2014, BRAIN INJURY, V28, P1197, DOI 10.3109/02699052.2014.920517; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Daltrozzo J., 2006, THESIS; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Erlbeck H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00654; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Ganis G, 1996, J COGNITIVE NEUROSCI, V8, P89, DOI 10.1162/jocn.1996.8.2.89; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Girden E.R., 1992, QUANTITATIVE APPL SO; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hagoort P, 1996, BRAIN, V119, P627, DOI 10.1093/brain/119.2.627; JENNETT B, 1972, LANCET, V1, P734; Jones SJ, 2000, BRAIN, V123, P1007, DOI 10.1093/brain/123.5.1007; Knuepffer C, 2012, BRAIN LANG, V123, P52, DOI 10.1016/j.bandl.2012.06.009; Kotchoubey B, 2005, NEUROPSYCHOL REHABIL, V15, P333, DOI 10.1080/09602010443000416; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2015, CLIN NEUROPHYSIOL, P107; Kotchoubey B, 2014, CURR PHARM DESIGN, V20, P4239; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Kuebler A, 2007, CURR OPIN NEUROL, V20, P643, DOI 10.1097/WCO.0b013e3282f14782; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; Kutas M, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P406; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Muller-Gass A, 2005, CLIN NEUROPHYSIOL, V116, P2142, DOI 10.1016/j.clinph.2005.05.012; MUNTE TF, 1994, ARCH NEUROL-CHICAGO, V51, P482, DOI 10.1001/archneur.1994.00540170058017; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/s0028-3932(97)00119-x; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Neumann N, 2004, BRAIN RES PROTOC, V14, P25, DOI 10.1016/j.brainresprot.2004.09.001; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2005, PROG BRAIN RES, V150, P457, DOI 10.1016/S0079-6123(05)50032-3; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Pokorny C, 2013, ARTIF INTELL MED, V59, P81, DOI 10.1016/j.artmed.2013.07.003; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Real R.G.L., 2015, CLIN NEUROPHYSIOL; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Rohaut B, 2015, NEUROPSYCHOLOGIA, V66, P279, DOI 10.1016/j.neuropsychologia.2014.10.014; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schoenle PW, 2004, NEUROREHABILITATION, V19, P329; Sitnikova T, 2003, PSYCHOPHYSIOLOGY, V40, P160, DOI 10.1111/1469-8986.00016; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tirschwell D.L., 2006, CONTINUUM LIFELONG L, V12, P46; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020	67	11	12	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	MAR	2017	113						8	16		10.1016/j.ijpsycho.2016.12.012			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	EL1QV	WOS:000394397000002	28041983				2022-02-06	
J	Jimenez, N; Quistberg, A; Vavilala, MS; Jaffe, KM; Rivara, FP				Jimenez, Nathalia; Quistberg, Alex; Vavilala, Monica S.; Jaffe, Kenneth M.; Rivara, Frederick P.			Utilization of Mental Health Services After Mild Pediatric Traumatic Brain Injury	PEDIATRICS			English	Article							INSURANCE STATUS; UNMET NEED; CHILDREN; CONCUSSION; ADOLESCENTS; MEDICAID; REHABILITATION; CARE	BACKGROUND: Mild traumatic brain injury injuries (mTBIs), including concussions, represent >2 million US pediatric emergency department visits annually. Post-mTBI mental health symptoms are prominent and often attributed to the mTBI. This study examined whether individuals seeking post-mTBI mental health care had previous mental health diagnoses or a new onset of such disorders, and determined if mental health care utilization differed by race/ethnicity. METHODS: Retrospective cohort study, using the Medicaid Marketscan claims national dataset (2007-2012). Utilization of mental health services 1 year before and 1 year after mTBI was compared between children with and without mental health diagnoses before injury. Primary outcome was receipt of post-mTBI outpatient mental health care. RESULTS: A total of 31 272 children 20 years or younger were included, 8577 (27%) with mental health diagnoses before their mTBI and 22 695 without one. After injury, children without previous mental health disorders increased mental health services utilization; however, most (86%) postinjury mental health care was received by children with previous mental health disorders. Having a mental health diagnosis pre-mTBI was the most important risk factor for receiving post-mTBI mental health care (odds ratio 7.93, 95% confidence interval 7.40-8.50). Hispanic children were less likely to receive post-mTBI mental health care. CONCLUSIONS: mTBI was associated with increased utilization of mental health services but most of these services were received by children with previous mental health disorders. Our documentation of racial/ethnic disparities in mental health care utilization reemphasize the importance of providing individualized, culturally, and linguistically competent care to improve outcomes after mTBI for all children.	[Jimenez, Nathalia; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Box 9824,4800 Sand Point Way NE, Seattle, WA 98105 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Jimenez, Nathalia; Quistberg, Alex; Vavilala, Monica S.; Jaffe, Kenneth M.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Jimenez, N (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Box 9824,4800 Sand Point Way NE, Seattle, WA 98105 USA.	njimen@uw.edu		Jimenez, Nathalia/0000-0002-6785-8330	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD078453-02]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1U01CE002196]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development (1K23HD078453-02 to Dr Jimenez), and the Centers for Disease Control and Prevention (1U01CE002196 to Dr Jaffe). Funded by the National Institutes of Health (NIH).	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cataife G, 2015, PSYCHIAT SERV, V66, P946, DOI 10.1176/appi.ps.201400045; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clark DE, 2009, ICDPIC STATA MODULE; Graham R, 2013, SPORTS RELATED CONCU; Hacker KA, 2014, PEDIATRICS, V134, P737, DOI 10.1542/peds.2014-0453; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Jaffe KM, 2015, ARCH PHYS MED REHAB, V96, P1371, DOI 10.1016/j.apmr.2015.04.017; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kataoka SH, 2002, AM J PSYCHIAT, V159, P1548, DOI 10.1176/appi.ajp.159.9.1548; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merikangas KR, 2011, J AM ACAD CHILD PSY, V50, P32, DOI 10.1016/j.jaac.2010.10.006; Mitchell JM, 2004, PEDIATRICS, V114, P196, DOI 10.1542/peds.114.1.196; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Popescu I, 2015, PSYCHIAT SERV, V66, P242, DOI 10.1176/appi.ps.201300055; Tang MH, 2008, HEALTH SERV RES, V43, P882, DOI 10.1111/j.1475-6773.2007.00811.x; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	25	11	11	0	7	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAR	2017	139	3							e20162462	10.1542/peds.2016-2462			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	EM0IY	WOS:000395003200027	28159872	Green Published, Bronze			2022-02-06	
J	Liu, SW; Huang, LC; Chung, WF; Chang, HK; Wu, JC; Chen, LF; Chen, YC; Huang, WC; Cheng, H; Lo, SS				Liu, Shih-Wei; Huang, Liang-Chung; Chung, Wu-Fu; Chang, Hsuan-Kan; Wu, Jau-Ching; Chen, Li-Fu; Chen, Yu-Chun; Huang, Wen-Cheng; Cheng, Henrich; Lo, Su-Shun			Increased Risk of Stroke in Patients of Concussion: A Nationwide Cohort Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						concussion; hemorrhagic stroke; ischemic stroke; cohort; and traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; CEREBRAL AUTOREGULATION; ISCHEMIC-STROKE; UNITED-STATES; EPIDEMIOLOGY	Long-term morbidities can develop after traumatic brain injury (TBI). Some studies have suggested that the risk of stroke is higher after TBI, but the association between concussion and stroke remains unclear. Using a national cohort, the authors analyzed the incidence of both hemorrhagic and ischemic strokes in patients with previous concussion. A representative cohort of approximately one million people was followed up for four years. Patients with new-onset concussion were identified (n = 13,652) as the concussion group. Subsequently, the incidence rates of later stroke events in the concussion group were compared to a sex-, age- and propensity score-matched comparison group (n = 13,652). The overall incidence rate of stroke in the concussion group was higher than that of the comparison group (9.63 versus 6.52 per 1000 person-years, p < 0.001). Significantly higher stroke risk was observed in the concussion group than in the comparison group (crude hazard ratio 1.48, p < 0.001; adjusted HR 1.65, p < 0.001). In the concussion group, the cumulative incidence rates of both ischemic stroke and hemorrhagic stroke were higher than those of the comparison group (8.9% vs. 5.8% and 2.7% vs. 1.6%, respectively, both p < 0.001). Concussion is an independent risk factor for both ischemic and hemorrhagic strokes. Prevention and monitoring strategies of stroke are therefore suggested for patients who have experienced concussion.	[Liu, Shih-Wei; Huang, Liang-Chung; Chung, Wu-Fu; Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency Med, Ilan 260, Taiwan; [Chang, Hsuan-Kan; Wu, Jau-Ching; Huang, Wen-Cheng; Cheng, Henrich] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei 112, Taiwan; [Wu, Jau-Ching; Chen, Li-Fu; Chen, Yu-Chun; Huang, Wen-Cheng; Lo, Su-Shun] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Ilan 260, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ, Inst Hosp, Taipei 112, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ, Hlth Care Adm, Taipei 112, Taiwan; [Cheng, Henrich] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan		Chen, LF (corresponding author), Natl Yang Ming Univ Hosp, Dept Emergency Med, Ilan 260, Taiwan.; Wu, JC (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei 112, Taiwan.; Wu, JC; Chen, LF (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	shihweiliu123@gmail.com; horus7855@yahoo.com.tw; wolfchung2001@yahoo.com.tw; hsuankanchang@gmail.com; jauching@gmail.com; 12206@ymuh.ym.edu.tw; hc_cheng@vghtpe.gov.tw; wchuang@vghtpe.gov.tw; hc_cheng@vghtpe.gov.tw; sslo@ymuh.ym.edu.tw	Wu, Jau-Ching/AAU-4009-2021; Chen, Yu Chun/K-6635-2019; Chen, YuChun/L-1052-2019	Wu, Jau-Ching/0000-0002-6996-3409; Chen, YuChun/0000-0002-4124-1949; Huang, Wen-Cheng/0000-0003-4249-710X			Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Borsheim E, 2007, ARCH PHYS MED REHAB, V88, P234, DOI 10.1016/j.apmr.2006.11.003; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Buompadre MC, 2009, J CHILD NEUROL, V24, P685, DOI 10.1177/0883073808330163; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Falkstedt D, 2017, STROKE, V48, P265, DOI 10.1161/STROKEAHA.116.015565; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; Landi A, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	40	11	11	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2017	14	3							230	10.3390/ijerph14030230			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	ER1BN	WOS:000398524100013	28245607	Green Published, Green Submitted, gold			2022-02-06	
J	Martinez, RN; Hogan, TP; Lones, K; Balbale, S; Scholten, J; Bidelspach, D; Musson, N; Smith, BM				Martinez, Rachael N.; Hogan, Timothy P.; Lones, Keshonna; Balbale, Salva; Scholten, Joel; Bidelspach, Douglas; Musson, Nan; Smith, Bridget M.			Evaluation and Treatment of Mild Traumatic Brain Injury Through the Implementation of Clinical Video Telehealth: Provider Perspectives From the Veterans Health Administration	PM&R			English	Article							OPERATION ENDURING FREEDOM; IRAQ; TELEMEDICINE; AFGHANISTAN; CARE; TELEREHABILITATION; DEPLOYMENT; SYMPTOMS; THERAPY; PROGRAM	Background: Substantial numbers of U.S. military veterans who served in recent conflicts experience mild traumatic brain injury. Data suggest that as many as 25% of veterans do not have a comprehensive traumatic brain injury evaluation to determine a diagnosis and develop a plan to treat symptoms. Technologies like clinical video telehealth offer a potential means to overcome travel distance and other barriers that can impact veteran receipt of a comprehensive traumatic brain injury evaluation after a positive screening; however, little is known about implementing clinical video telehealth in this context. Objective: To examine the perspectives of Veterans Health Administration health care providers on implementing clinical video telehealth technology for the assessment and treatment of mild traumatic brain injury among veterans of Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn. Design: Qualitative; semistructured interviews. Setting: Veterans Health Administration Polytrauma System of Care. Participants: Twenty-six providers who participated in a Veterans Health Administration Rehabilitation and Prosthetic Services Teleconsultation Pilot Project for administering comprehensive traumatic brain injury evaluations over clinical video telehealth. Methods: Semistructured interviews that used content-analytic techniques to assess provider experiences implementing clinical video telehealth for veterans with traumatic brain injury, including inhibiting factors and best practices to administer comprehensive traumatic brain injury evaluations. Results: The most commonly reported inhibiting factors to implementing clinical video telehealth for traumatic brain injury evaluation and treatment included scheduling, setting up the clinic, and conducting physical examinations over a virtual modality. To enhance clinical video telehealth implementation, participants described best practices including establishing solid communication and relationships with staff, building rapport with patients, and recognizing the unique needs of patients with traumatic brain injury. Conclusions: Implementing clinical video telehealth programs involves coordinating multiple steps with providers at different sites, highlighting the need for effective communication. Provider-patient communication also emerged as vital to successful clinical video telehealth implementation. These findings suggest that providers would benefit from efforts to build communication competencies.	[Martinez, Rachael N.; Lones, Keshonna; Balbale, Salva; Smith, Bridget M.] Hines VA Hosp, Ctr Innovat Complex Chron Healthcare CINCCH, 5000 South 5th Ave,151H,Bldg 1 D304, Hines, IL 60141 USA; [Hogan, Timothy P.] Edith Nourse Rogers Mem Vet Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Hogan, Timothy P.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Div Hlth Informat & Implementat Sci, Worcester, MA USA; [Balbale, Salva] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Scholten, Joel; Bidelspach, Douglas] VA Cent Off, Rehabil & Prosthet Serv, Phys Med & Rehabil, Washington, DC USA; [Musson, Nan] Gainesville VAMC, VHA Rehabil & Prosthet Serv, Gainesville, FL USA; [Smith, Bridget M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Martinez, RN (corresponding author), Hines VA Hosp, Ctr Innovat Complex Chron Healthcare CINCCH, 5000 South 5th Ave,151H,Bldg 1 D304, Hines, IL 60141 USA.	rachael.n.martinez@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs; Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service Quality Enhancement Research InitiativeUS Department of Veterans Affairs [RRP 11-418]	Disclosures related to this publication: grant, Department of Veterans Affairs; This study was supported by the Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service Quality Enhancement Research Initiative as grant RRP 11-418. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brennan DM, 2004, TELEMED J E-HEALTH, V10, P147, DOI 10.1089/1530562041641237; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Comprehensive TBI Evaluation User Guide, 2011, COMPR TBI EV US GUID; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Gagnon MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-18; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Jarvis-Selinger S, 2008, TELEMED J E-HEALTH, V14, P720, DOI 10.1089/tmj.2007.0108; Kairy D, 2014, REV PANAM SALUD PUBL, V35, P337; Lindlof R, 1995, QUALITATIVE COMMUNIC; Mishkind MC, 2013, MIL MED, V178, P1322, DOI 10.7205/MILMED-D-13-00278; Mitchell JE, 2003, EUR EAT DISORD REV, V11, P222, DOI 10.1002/erv.517; Moehr JR, 2006, INT J MED INFORM, V75, P755, DOI 10.1016/j.ijmedinf.2005.11.001; Moehr JR, 2005, METHOD INFORM MED, V44, P334; Onor ML, 2005, TELEMED J E-HEALTH, V11, P102, DOI 10.1089/tmj.2005.11.102; Rogers TJ, 2014, BRAIN INJURY, V28, P1406, DOI 10.3109/02699052.2014.919537; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shore P, 2014, INT J PSYCHIAT MED, V48, P5, DOI 10.2190/PM.48.1.b; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; TANELIAN T, 2008, INVISIBLE WOUNDS MEN; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	30	11	11	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	MAR	2017	9	3					231	240		10.1016/j.pmrj.2016.07.002			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EP7JT	WOS:000397554800002	27423365				2022-02-06	
J	Vogel, EW; Rwema, SH; Meaney, DF; Bass, CR; Morrison, B				Vogel, Edward; Rwema, Steve; Meaney, David; Bass, Cameron; Morrison, Barclay			Primary Blast Injury Depressed Hippocampal Long-Term Potentiation through Disruption of Synaptic Proteins	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; in vitro studies; learning and memory; military injury; TBI	TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION MODEL; IN-VITRO; AMPA RECEPTORS; GLUTAMATE-RECEPTOR; SLICE CULTURES; RAT MODEL; LTP; ACTIVATION; PHOSPHORYLATION	Blast-induced traumatic brain injury (bTBI) is a major threat to United States service members in military conflicts worldwide. The effects of primary blast, caused by the supersonic shockwave interacting with the skull and brain, remain unclear. Our group has previously reported that in vitro primary blast exposure can reduce long-term potentiation (LTP), the electrophysiological correlate of learning and memory, in rat organotypic hippocampal slice cultures (OHSCs) without significant changes to cell viability or basal, evoked neuronal function. We investigated the time course of primary blast-induced deficits in LTP and the molecular mechanisms that could underlie these deficits. We found that pure primary blast exposure induced LTP deficits in a delayed manner, requiring longer than 1 hour to develop, and that these deficits spontaneously recovered by 10 days following exposure depending on blast intensity. Additionally, we observed that primary blast exposure reduced total -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor 1 (GluR1) subunit expression and phosphorylation of the GluR1 subunit at the serine-831 site. Blast also reduced the expression of postsynaptic density protein-95 (PSD-95) and phosphorylation of stargazin protein at the serine-239/240 site. Finally, we found that modulation of the cyclic adenosine monophosphate (cAMP) pathway ameliorated electrophysiological and protein-expression changes caused by blast. These findings could inform the development of novel therapies to treat blast-induced loss of neuronal function.	[Vogel, Edward; Rwema, Steve; Morrison, Barclay] Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA; [Meaney, David] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bass, Cameron] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA.	bm@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122	Multidisciplinary University Research Initiative from the Army Research Office [W911NF-10-1-0526]; National Defense Science & Engineering Graduate Fellowship from the Department of Defense [EWV-2012]	This work was supported in part by a Multidisciplinary University Research Initiative from the Army Research Office (W911NF-10-1-0526) and by a National Defense Science & Engineering Graduate Fellowship from the Department of Defense (EWV-2012). The authors thank John Brady and Fatima Nathalia Morales for their dedicated assistance with tissue culture maintenance and execution of blast injury.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DAVIS S, 1992, J NEUROSCI, V12, P21; Defense and Veterans Brain Injury Center, 2016, DEP DEF NUMB TRAUM B; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Effgen G. B., 2012, FRONT NEUROL, V3, P1; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jabaris SGSL, 2015, EUR J PHARMACOL, V746, P138, DOI 10.1016/j.ejphar.2014.10.039; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Panzer M. B., 2012, FRONT NEUROL, V3, P1; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Park Y, 2013, J CEREBR BLOOD F MET, V33, P1642, DOI 10.1038/jcbfm.2013.121; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Swant J, 2006, LEARN MEMORY, V13, P161, DOI 10.1101/lm.63806; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009	63	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1063	1073		10.1089/neu.2016.4578			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200011	27573357				2022-02-06	
J	Limbrick, DD; Baksh, B; Morgan, CD; Habiyaremye, G; McAllister, JP; Inder, TE; Mercer, D; Holtzman, DM; Strahle, J; Wallendorf, MJ; Morales, DM				Limbrick, David D., Jr.; Baksh, Brandon; Morgan, Clinton D.; Habiyaremye, Gakwaya; McAllister, James P., II; Inder, Terrie E.; Mercer, Deanna; Holtzman, David M.; Strahle, Jennifer; Wallendorf, Michael J.; Morales, Diego M.			Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; AMYLOID PRECURSOR PROTEIN; KAOLIN-INDUCED HYDROCEPHALUS; WHITE-MATTER DAMAGE; CELL JUNCTION PATHOLOGY; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; POSTHEMORRHAGIC HYDROCEPHALUS; NEUROLOGICAL DISEASES	Introduction Hydrocephalus is a complex neurological disorder with a pervasive impact on the central nervous system. Previous work has demonstrated derangements in the biochemical profile of cerebrospinal fluid ( CSF) in hydrocephalus, particularly in infants and children, in whom neurodevelopment is progressing in parallel with concomitant neurological injury. The objective of this study was to examine the CSF of children with congenital hydrocephalus ( CHC) to gain insight into the pathophysiology of hydrocephalus and identify candidate biomarkers of CHC with potential diagnostic and therapeutic value. Methods CSF levels of amyloid precursor protein ( APP) and derivative isoforms ( sAPP alpha, sAPP beta, A beta(42)), tau, phosphorylated tau ( pTau), L1CAM, NCAM-1, aquaporin 4 ( AQP4), and total protein ( TP) were measured by ELISA in 20 children with CHC. Two comparative groups were included: age-matched controls and children with other neurological diseases. Demographic parameters, ventricular frontal-occipital horn ratio, associated brain malformations, genetic alterations, and surgical treatments were recorded. Logistic regression analysis and receiver operating characteristic curves were used to examine the association of each CSF protein with CHC. Results CSF levels of APP, sAPP alpha, sAPP beta, A beta(42), tau, pTau, L1CAM, and NCAM-1 but not AQP4 or TP were increased in untreated CHC. CSF TP and normalized L1CAM levels were associated with FOR in CHC subjects, while normalized CSF tau levels were associated with FOR in control subjects. Predictive ability for CHC was strongest for sAPPa, especially in subjects <= 12 months of age ( p<0.0001 and AUC = 0.99), followed by normalized sAPP beta ( p = 0.0001, AUC = 0.95), tau, APP, and L1CAM. Among subjects <= 12 months, a normalized CSF sAPP alpha cut-point of 0.41 provided the best prediction of CHC ( odds ratio = 528, sensitivity = 0.94, specificity = 0.97); these infants were 32 times more likely to have CHC. Conclusions CSF proteins such as sAPPa and related proteins hold promise as biomarkers of CHC in infants and young children, and provide insight into the pathophysiology of CHC during this critical period in neurodevelopment.	[Limbrick, David D., Jr.; Baksh, Brandon; Habiyaremye, Gakwaya; McAllister, James P., II; Mercer, Deanna; Strahle, Jennifer; Morales, Diego M.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Limbrick, David D., Jr.; Strahle, Jennifer] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Morgan, Clinton D.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Inder, Terrie E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pediat, Boston, MA USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wallendorf, Michael J.] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA		Morales, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA.	moralesd@wudosis.wustl.edu	McAllister, James P./N-9657-2019	Morgan, Clinton/0000-0002-7511-0488; Morales, Diego/0000-0001-6672-9046	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T34 GM083914] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS075151] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T34GM083914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS075151] Funding Source: NIH RePORTER		Agren-Wilsson A, 2007, ACTA NEUROL SCAND, V116, P333, DOI 10.1111/j.1600-0404.2007.00890.x; Aojula A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0033-2; Blennow K, 2016, MOVEMENT DISORD, V31, P836, DOI 10.1002/mds.26656; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Del Bigio MR, 2012, J NEUROPATH EXP NEUR, V71, P274, DOI 10.1097/NEN.0b013e31824c1b44; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; Di Curzio DL, 2013, EXP NEUROL, V248, P112, DOI 10.1016/j.expneurol.2013.06.004; Douglas MR, 2009, J NEUROL NEUROSUR PS, V80, P545, DOI 10.1136/jnnp.2008.155671; Eskandari R, 2004, J NEUROSURG, V101, P196, DOI 10.3171/ped.2004.101.2.0196; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; GONZALEZDARDER J, 1984, J NEUROSURG, V61, P918, DOI 10.3171/jns.1984.61.5.0918; Gopal SC, 2008, CHILD NERV SYST, V24, P713, DOI 10.1007/s00381-007-0546-8; Gopal SC, 2007, PEDIATR SURG INT, V23, P571, DOI 10.1007/s00383-006-1689-5; Heep A, 2006, CHILD NERV SYST, V22, P1249, DOI 10.1007/s00381-006-0102-y; Herukka SK, 2015, J ALZHEIMERS DIS, V46, P261, DOI 10.3233/JAD-142862; Huang H, 2016, NEUROCHEM RES, V41, P1713, DOI 10.1007/s11064-016-1887-z; Iliff JJ, 2015, LANCET NEUROL, V14, P977, DOI 10.1016/S1474-4422(15)00221-5; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Jimenez AJ, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28426; Jingami N, 2015, J ALZHEIMERS DIS, V45, P109, DOI 10.3233/JAD-142622; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang K, 2014, J CLIN NEUROSCI, V21, P1398, DOI 10.1016/j.jocn.2013.11.039; Klarica M, 2013, NEUROSCIENCE, V248, P278, DOI 10.1016/j.neuroscience.2013.06.022; Kondziella D, 2002, BRAIN RES, V927, P35, DOI 10.1016/S0006-8993(01)03320-0; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Krishnamurthy S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-13; Krishnamurthy S, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-16; Kudo T, 2000, PSYCHIAT CLIN NEUROS, V54, P199, DOI 10.1046/j.1440-1819.2000.00658.x; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Leinonen Ville, 2011, Int J Alzheimers Dis, V2011, P312526, DOI 10.4061/2011/312526; Lewczuk P, 2004, J MOL NEUROSCI, V23, P115, DOI 10.1385/JMN:23:1-2:115; Li XF, 2007, NEUROSCI LETT, V413, P141, DOI 10.1016/j.neulet.2006.11.039; Lim TS, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-66; McAllister JP, 2015, J NEUROSURG, V123, P1427, DOI 10.3171/2014.12.JNS132352; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Merhar S, 2012, NEONATOLOGY, V101, P1, DOI 10.1159/000323498; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203; Morales DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115045; Morales DM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011973; Morales DM SS, NEUROSURGER IN PRESS; Murlidharan G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88034; Nakajima M, 2015, J NEUROL SCI, V357, P88, DOI 10.1016/j.jns.2015.07.001; Nakajima Madoka, 2010, Rinsho Shinkeigaku, V50, P973; Narita K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00039; Naureen I, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-34; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Ohata S, 2016, TRENDS NEUROSCI; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Pyykko OT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091974; Ray B, 2011, J PSYCHIATR RES, V45, P539, DOI 10.1016/j.jpsychires.2010.07.011; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rodriguez EM, 2012, BIOL RES, V45, P231, DOI 10.4067/S0716-97602012000300005; Savman K, 2002, ACTA PAEDIATR, V91, P1357; Schirinzi T, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00086; Schmitz T, 2007, PEDIATR RES, V61, P722, DOI 10.1203/pdr.0b013e31805341f1; Schmitz T, 2011, J PERINAT MED, V39, P83, DOI [10.1515/JPM.2010.125, 10.1515/jpm.2010.125]; Schob S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160680; Sendrowski K, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P236; Sival Deborah A, 2008, Cerebrospinal Fluid Res, V5, P21, DOI 10.1186/1743-8454-5-21; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Tarnaris A, 2011, J NEUROSURG, V115, P145, DOI 10.3171/2011.2.JNS101316; Tarnaris A, 2009, BIOMARK MED, V3, P787, DOI 10.2217/BMM.09.37; Tullberg M, 2007, EUR J NEUROL, V14, P248, DOI 10.1111/j.1468-1331.2006.01553.x; Tullberg M, 2008, CEREBROSPINAL FLUID, V5, P9, DOI DOI 10.1186/1743-8454-5-9; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Waybright T, 2010, J PROTEOMICS, V73, P1156, DOI 10.1016/j.jprot.2010.02.004; Zhang SL, 2013, INT J NEUROSCI, V123, P392, DOI 10.3109/00207454.2012.762363	81	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172353	10.1371/journal.pone.0172353			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	WOS:000394424700037	28212403	gold, Green Published, Green Submitted			2022-02-06	
J	Effgen, GB; Morrison, B				Effgen, Gwen B.; Morrison, Barclay, III			Memantine Reduced Cell Death, Astrogliosis, and Functional Deficits in an in vitro Model of Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; cell death; electrophysiology; memantine; neuron	LONG-TERM POTENTIATION; NMDA RECEPTOR; RECURRENT CONCUSSION; HIPPOCAMPAL CELLS; FOOTBALL PLAYERS; TEMPORAL WINDOW; NEUROPROTECTION; VULNERABILITY; RISK; DYSFUNCTION	Clinical studies suggest that athletes with a history of concussion may be at risk for additional mild traumatic brain injury (mTBI), and repetitive exposure to mTBI acutely increases risk for more significant and persistent symptoms and increases future risk for developing neurodegenerative diseases. Currently, symptoms of mTBI are managed with rest and pain medication; there are no drugs approved by the Food and Drug Administration (FDA) that target the biochemical pathology underlying mTBI to treat or prevent acute and long-term effects of repetitive mTBI. Memantine is an FDA-approved drug for treating Alzheimer's disease, and also was shown to be neuroprotective in rodents following a single, moderate to severe TBI. Therefore, we investigated the potential for memantine to mitigate negative outcomes from repetitive mild stretch injury in organotypical hippocampal slice cultures. Samples received two injuries 24 h apart; injury resulted in significant cell death, loss of long-term potentiation (LTP), and astrogliosis compared with naive, uninjured samples. Delivery of 1.5 mu M memantine 1 h following each stretch significantly reduced the effect of injury for all outcome measures, and did not alter those outcome measures that were unaffected by the injury. Therefore, memantine warrants further pre-clinical and clinical investigation for its therapeutic efficacy to prevent cognitive deficits and neuropathology from multiple mTBIs.	[Effgen, Gwen B.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Center for Injury Prevention and Control of the Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1 R49 CE002096]; Army Research Office [W911NF-10-1-05026]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002096] Funding Source: NIH RePORTER	The authors acknowledge the technical assistance of Elise Gill, Kimberly A. Lynch, and Shruthi Nammalwar. This research was funded in part by Grant 1 R49 CE002096 from the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention to the Center for Injury Epidemiology and Prevention at Columbia University Medical Center, and a multi-disciplinary university research initiative from the Army Research Office (W911NF-10-1-05026). The contents of this manuscript are the sole responsibility of the authors and do not necessarily reflect the official views of the funding agencies.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Beconi Maria G, 2011, PLoS Curr, V3, pRRN1291, DOI 10.1371/currents.RRN1291; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; Chen ZZ, 2016, LIFE SCI, V150, P8, DOI 10.1016/j.lfs.2016.02.081; Comstock R., 2014, EPIDEMIOLOGY; Effgen GB., 2016, J NEUROTRAU IN PRESS; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Frankiewicz T, 1999, NEUROPHARMACOLOGY, V38, P1253, DOI 10.1016/S0028-3908(99)00060-X; Garcia-Munoz M, 2015, NEUROPHARMACOLOGY, V89, P54, DOI 10.1016/j.neuropharm.2014.09.013; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kane MJ, 2011, BRAIN RES, V1425, P123, DOI 10.1016/j.brainres.2011.09.047; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Lamprecht MR, 2015, J NEUROTRAUM, V32, P1361, DOI 10.1089/neu.2015.3912; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; PELLEGRINI JW, 1993, ANN NEUROL, V33, P403, DOI 10.1002/ana.410330414; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rao VLR, 2001, BRAIN RES, V911, P96; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Teasdale TW, 1997, BRIT MED J, V315, P569; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yu Z, 2009, IEEE ENG MED BIO, P1135	44	11	12	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					934	942		10.1089/neu.2016.4528			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200021	27450515				2022-02-06	
J	Wu, CY; Eck, B; Zhang, S; Zhu, JQ; Tiwari, AD; Zhang, YF; Zhu, YJ; Zhang, JM; Wang, B; Wang, XZ; Wang, X; You, JQ; Wang, J; Guan, YH; Liu, XD; Yu, X; Trapp, BD; Miller, R; Silver, J; Wilson, D; Wang, YM				Wu, Chunying; Eck, Brendan; Zhang, Sheng; Zhu, Junqing; Tiwari, Anand Dev; Zhang, Yifan; Zhu, Yunjie; Zhang, Jinming; Wang, Bin; Wang, Xizhen; Wang, Xu; You, Jingqiang; Wang, Jian; Guan, Yihui; Liu, Xingdang; Yu, Xiu; Trapp, Bruce D.; Miller, Robert; Silver, Jerry; Wilson, David; Wang, Yanming			Discovery of 1,2,3-Triazole Derivatives for Multimodality PET/CT/Cryoimaging of Myelination in the Central Nervous System	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							AZIDE-ALKYNE CYCLOADDITION; IN-VIVO QUANTIFICATION; MULTIPLE-SCLEROSIS; CLICK CHEMISTRY; SOLID-PHASE; RADIOTRACERS; INHIBITORS; EVOLUTION; MONITOR; ANALOGS	Myelin pathology is present in many neurological conditions such as multiple sclerosis (MS) and traumatic spinal cord injury (SCI): To. facilitate development of novel therapies aimed at myelin repair, we set out to develop imaging agents that permit direct quantification of myelination in vivo. In this work, we designed and synthesized a series of fluorescent fluorinated myelin imaging agents that can be used for in vivo positron emission tomography (PET) imaging combined with subsequent post-mortem fluorescent cryoimaging. Structure-activity relationship (SAR) studies of the newly developed myelin imaging agents led us to identify a lead compound (TAFDAS, 21) that readily enters the brain and spinal cord and selectively binds to myelin. By conducting sequential PET and 3D cryoimaging in an SCI rat model, we demonstrated for the first time that PET and cryoimaging can be combined as a novel technique to image the spinal cord with high sensitivity and spatial resolution.	[Wu, Chunying; Zhang, Sheng; Zhu, Junqing; Tiwari, Anand Dev; Zhu, Yunjie; Wang, Yanming] Case Western Reserve Univ, Dept Radiol, 11100 Euclid Ave, Cleveland, OH 44106 USA; [You, Jingqiang; Silver, Jerry] Case Western Reserve Univ, Dept Neurosci, 11100 Euclid Ave, Cleveland, OH 44106 USA; [Eck, Brendan; Zhang, Yifan; Yu, Xiu; Wilson, David] Case Western Reserve Univ, Dept Biomed Engn, 11100 Euclid Ave, Cleveland, OH 44106 USA; [Zhang, Jinming] Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing 100853, Peoples R China; [Wang, Bin; Wang, Xizhen; Wang, Xu; Wang, Yanming] Bingzhou Med Univ, Dept Radiol, Binzhou 256603, Shandong, Peoples R China; [Wang, Jian] Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China; [Guan, Yihui; Liu, Xingdang] Huashan Hosp, Dept Nucl Med, Shanghai 200040, Peoples R China; [Miller, Robert] George Washington Univ, Dept Anat & Regenerat Biol, Washington, DC 20037 USA; [Trapp, Bruce D.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44195 USA; [Zhu, Yunjie] Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA		Wu, CY; Wang, YM (corresponding author), Case Western Reserve Univ, Dept Radiol, 11100 Euclid Ave, Cleveland, OH 44106 USA.; Wang, YM (corresponding author), Bingzhou Med Univ, Dept Radiol, Binzhou 256603, Shandong, Peoples R China.	cxw130@case.edu; yxw91@case.edu	Tiwari, Anand Dev/ABD-8241-2021	Tiwari, Anand Dev/0000-0002-2038-5919; Yu, Xin/0000-0001-8996-0267	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG5174-A-4]; Genzyme CorporationSanofi-AventisGenzyme Corporation; Bryon Riesch Paralysis Foundation	This work is supported in part by the National Multiple Sclerosis Society (RG5174-A-4), Genzyme Corporation, and the Bryon Riesch Paralysis Foundation.	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Bodini B, 2016, ANN NEUROL, V80, P166, DOI 10.1002/ana.24667; Burden-Gulley SM, 2011, CANCER RES, V71, P5932, DOI 10.1158/0008-5472.CAN-11-1553; Burley GA, 2006, J AM CHEM SOC, V128, P1398, DOI 10.1021/ja055517v; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Ding YS, 2005, J NEUROCHEM, V94, P337, DOI 10.1111/j.1471-4159.2005.03202.x; DISCHINO DD, 1983, J NUCL MED, V24, P1030; Filippi M, 2003, LANCET NEUROL, V2, P337, DOI 10.1016/S1474-4422(03)00408-3; Frullano L, 2013, J MED CHEM, V56, P1629, DOI 10.1021/jm301435z; Frullano L, 2012, J MED CHEM, V55, P94, DOI 10.1021/jm201010e; Frullano L, 2011, J AM CHEM SOC, V133, P1611, DOI 10.1021/ja1040896; Glaser M, 2009, J LABELLED COMPD RAD, V52, P407, DOI 10.1002/jlcr.1656; HAUW JJ, 1992, J NEUROIMMUNOL, V40, P139, DOI 10.1016/0165-5728(92)90128-8; Hermelinda S.-C., 1998, BRAIN RES, V782, P126; Krasinski A, 2005, J AM CHEM SOC, V127, P6686, DOI 10.1021/ja043031t; Leist TP, 2010, NEUROLOGY, V74, pS54, DOI 10.1212/WNL.0b013e3181c98011; Matias-Guiu JA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0502-2; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Ozturk A, 2010, MULT SCLER J, V16, P166, DOI 10.1177/1352458509353649; Pagliai F, 2006, J MED CHEM, V49, P467, DOI 10.1021/jm051118z; Rovaris M, 1999, CURR OPIN NEUROL, V12, P337, DOI 10.1097/00019052-199906000-00012; Tiwari AD, 2016, J MED CHEM, V59, P3705, DOI 10.1021/acs.jmedchem.5b01858; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tron GC, 2008, MED RES REV, V28, P278, DOI 10.1002/med.20107; Wang CN, 2011, J NEUROSCI, V31, P2382, DOI 10.1523/JNEUROSCI.2698-10.2011; Wang CN, 2010, J HISTOCHEM CYTOCHEM, V58, P611, DOI 10.1369/jhc.2010.954842; Wang YM, 2009, J NEUROSCI, V29, P14663, DOI 10.1523/JNEUROSCI.4082-08.2009; Whiting M, 2006, ANGEW CHEM INT EDIT, V45, P1435, DOI 10.1002/anie.200502161; Wilson D., 2008, P SOC PHOTO-OPT INS, V6916; Wu CY, 2006, J HISTOCHEM CYTOCHEM, V54, P997, DOI 10.1369/jhc.5A6901.2006; Wu CY, 2013, ANN NEUROL, V74, P688, DOI 10.1002/ana.23965; Wu CY, 2010, BIOORGAN MED CHEM, V18, P8592, DOI 10.1016/j.bmc.2010.10.018; Zhou D, 2015, TETRAHEDRON LETT, V56, P952, DOI 10.1016/j.tetlet.2014.10.126	35	11	12	0	20	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-2623	1520-4804		J MED CHEM	J. Med. Chem.	FEB 9	2017	60	3					987	999		10.1021/acs.jmedchem.6b01328			13	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy	EK4WM	WOS:000393928300010	28107629				2022-02-06	
J	Crawford, EF; Wolf, GK; Kretzmer, T; Dillon, KH; Thors, C; Vanderploeg, RD				Crawford, Eric Floyd; Wolf, Gregory K.; Kretzmer, Tracy; Dillon, Kirsten H.; Thors, Christina; Vanderploeg, Rodney D.			Patient, Therapist, and System Factors Influencing the Effectiveness of Prolonged Exposure for Veterans With Comorbid Posttraumatic Stress Disorder and Traumatic Brain Injury	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Iraq-Afghanistan veterans; posttraumatic stress disorder; traumatic brain injury; prolonged exposure; clinically significant change; service connection; therapist training	PTSD CHECKLIST PCL; COMPENSATION-SEEKING; DISABILITY COMPENSATION; PSYCHOMETRIC PROPERTIES; AFGHANISTAN; IRAQ; OUTCOMES; CLINICS; IMPLEMENTATION; SYMPTOMS	In contrast to concerns that cognitive limitations and neurobehavioral symptoms (NBS) associated with traumatic brain injury (TBI) may inhibit treatment effectiveness, a recent study found prolonged exposure (PE) led to large reductions in posttraumatic stress disorder (PTSD) symptoms among Iraq-Afghanistan veterans with a range of TBI severity (article by Wolf, Kretzmer, Crawford, Thors, Wagner, Strom, Eftekhari, Klenk, Hayward, and Vanderploeg [J Trauma Stress 28:339-347, 2015]). We further examined this sample of 69 veterans to determine whether system, veteran, and therapist factors predicted clinically significant responses. Results of hierarchical, logistic regressions revealed that therapist training in PE and lower service connection were associated with increased odds of large decreases in PTSD symptoms after adjusting for the robust effect of PE sessions completed. Other patient-level factors including age, time since injury, and baseline NBS were unrelated to significant improvements. Findings emphasized the impact of PE dosage, indicated greater mastery of the protocol was beneficial, and showed that service connection could impede self-reported, clinically significant change during PE in this important cohort.	[Crawford, Eric Floyd] VA Midatlantic Reg Mental Illness Res Educ & Clin, Durham, NC USA; [Crawford, Eric Floyd; Dillon, Kirsten H.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Wolf, Gregory K.; Kretzmer, Tracy; Thors, Christina; Vanderploeg, Rodney D.] James A Haley Vet Affairs Med Ctr, Mental Hlth & Behav Sci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Crawford, Eric Floyd] Sheridan Vet Affairs Hlth Care Syst, Sheridan, WY USA		Crawford, EF (corresponding author), Sheridan Vet Affairs Hlth Care Syst 118J SNU, 1898 Ft Rd, Sheridan, WY 82801 USA.	eric.crawford@va.gov			James A. Haley Veterans' HospitalUS Department of Veterans Affairs; Durham VAMC	This manuscript is the result of work supported with resources and the use of facilities at the James A. Haley Veterans' Hospital and the Durham VAMC. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Veteran Affairs, Department of Defense, or U.S. Government.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2009, VA DOD CLIN PRACT GU; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cook JM, 2013, PSYCHIATRY, V76, P18, DOI 10.1521/psyc.2013.76.1.18; Crits-Christoph P., 1991, PSYCHOTHER RES, V1, P81, DOI DOI 10.1080/10503309112331335511; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Eftekhari A, 2015, J TRAUMA STRESS, V28, P65, DOI 10.1002/jts.21980; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Foa EB, 2002, J CONSULT CLIN PSYCH, V70, P1022, DOI 10.1037//0022-006X.70.4.1022; Fontana A, 1998, J NERV MENT DIS, V186, P223, DOI 10.1097/00005053-199804000-00004; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Frueh BC, 2003, PSYCHIATR SERV, V54, P84, DOI 10.1176/appi.ps.54.1.84; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Garcia HA, 2014, PSYCHOL SERV, V11, P50, DOI 10.1037/a0035643; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Gros DF, 2011, BEHAV THER, V42, P276, DOI 10.1016/j.beth.2010.07.005; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Laffaye C, 2007, MIL MED, V172, P1039, DOI 10.7205/MILMED.172.10.1039; Laska KM, 2013, J COUNS PSYCHOL, V60, P31, DOI 10.1037/a0031294; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Murdoch M, 2011, ARCH GEN PSYCHIAT, V68, P1072, DOI 10.1001/archgenpsychiatry.2011.105; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Resick PA, 2014, COGNITIVE PROCESSING; Rizvi SL, 2009, BEHAV RES THER, V47, P737, DOI 10.1016/j.brat.2009.06.003; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Strom TQ, 2016, COGN BEHAV PRACT, V23, P148, DOI 10.1016/j.cbpra.2015.03.003; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; US Department of Defense, 2012, US MIL CAS STAT OP N; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Watts BV, 2014, PSYCHIAT SERV, V65, P648, DOI 10.1176/appi.ps.201300176; Weathers F.W., 1993, 9 ANN C ISTSS; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029	47	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	FEB	2017	205	2					140	146		10.1097/NMD.0000000000000594			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	EK5FJ	WOS:000393952000012	27668355				2022-02-06	
J	Jayakumar, AR; Tong, XY; Shamaladevi, N; Barcelona, S; Gaidosh, G; Agarwal, A; Norenberg, MD				Jayakumar, Arumugam Radhakrishnan; Tong, Xiao Y.; Shamaladevi, Nagarajarao; Barcelona, Stephanie; Gaidosh, Gabriel; Agarwal, Apeksha; Norenberg, Michael D.			Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocytes; chronic traumatic encephalopathy; neurons; p-tau; TDP-43 proteinopathy; thrombospondin-1	NF-KAPPA-B; POSTTRAUMATIC-STRESS-DISORDER; K-CL COTRANSPORTER-1; BRAIN-INJURY; ABNORMAL PHOSPHORYLATION; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; AMMONIA; IDENTIFICATION; MECHANISM	Transactivating DNA-binding protein-43 (TDP-43) inclusions and the accumulation of phosphorylated and ubiquitinated tau proteins (p-tau) have been identified in postmortem brain specimens from patients with chronic traumatic encephalopathy (CTE). To examine whether these proteins contribute to the development of CTE, we utilized an in vitro trauma system known to reproduce many of the findings observed in humans and experimental animals with traumatic brain injury. Accordingly, we examined the role of TDP-43 and Tau in an in vitro model of trauma, and determined whether these proteins contribute to the defective neuronal integrity associated with CNS trauma. Single or multiple episodes of trauma to cultured neurons resulted in a time-dependent increase in cytosolic levels of phosphorylated TDP-43 (p-TDP-43). Trauma to cultured neurons also caused an increase in levels of casein kinase 1 epsilon (CK1 epsilon), and ubiquitinated p-TDP-43, along with a decrease in importin-beta (all factors known to mediate the TDP-43 proteinopathy"). Defective neuronal integrity, as evidenced by a reduction in levels of the NR1 subunit of the NMDA receptor, and in PSD95, along with increased levels of phosphorylated tau were also observed. Additionally, increased levels of intra-and extracellular thrombospondin-1 (TSP-1) (a factor known to regulate neuronal integrity) were observed in cultured astrocytes at early stages of trauma, while at later stages decreased levels were identified. The addition of recombinant TSP-1, conditioned media from cultured astrocytes at early stages of trauma, or the CK1 epsilon. inhibitor PF4800567 hydrochloride to traumatized cultured neurons reduced levels of p-TDP-43, and reversed the trauma induced decline in NR1 subunit of the NMDA receptor and PSD95 levels. These findings suggest that a trauma-induced increase in TDP-43 phosphorylation contributes to defective neuronal integrity, and that increasing TSP-1 levels may represent a useful therapeutic approach for the prevention of the neuronal TDP-43 proteinopathy associated with CTE.	[Jayakumar, Arumugam Radhakrishnan; Norenberg, Michael D.] Vet Affairs Med Ctr, Neuropathol Lab, Miami, FL 33125 USA; [Tong, Xiao Y.; Barcelona, Stephanie; Agarwal, Apeksha; Norenberg, Michael D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL USA; [Shamaladevi, Nagarajarao] Univ Miami, Sch Med, Urol, Miami, FL USA; [Gaidosh, Gabriel] Univ Miami, Sch Med, Ophthalmol, Miami, FL USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Biochem & Mol Biol, Miami, FL USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Neuro, Miami, FL USA		Norenberg, MD (corresponding author), Univ Miami, Sch Med, Dept Pathol D 33, POB 016960, Miami, FL 33101 USA.	mnorenbe@med.miami.edu	Agarwal, Apeksha/AAO-2787-2021	Agarwal, Apeksha/0000-0001-6075-8137	Department of Veterans AffairsUS Department of Veterans Affairs; Veterans AffairsUS Department of Veterans Affairs [I01BX000416] Funding Source: NIH RePORTER	This work was supported by a Merit Review from the Department of Veterans Affairs. The authors thank Alina Fernandez-Revuelta for the preparation of cell cultures. The authors declare no competing financial interests.	Ampuero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049279; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Ayala V, 2011, ACTA NEUROPATHOL, V122, P259, DOI 10.1007/s00401-011-0850-y; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; BUEE L, 1992, AM J PATHOL, V141, P783; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clippinger AK, 2013, ACTA NEUROPATHOL, V126, P39, DOI 10.1007/s00401-013-1123-8; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; DE MICHELIS F, 1953, Nova Acta Stomatol, V5, P21; DUCIS I, 1990, BRAIN RES, V514, P349, DOI 10.1016/0006-8993(90)91431-F; Ehlers MD, 2005, CURR BIOL, V15, pR134, DOI 10.1016/j.cub.2005.02.013; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Haber B., 1989, DISSECTION TISSUE CU, P203; Huang Y, 2013, NEURAL REGEN RES, V8, P869, DOI 10.3969/j.issn.1673-5374.2013.10.001; Iguchi Y, 2012, NEUROBIOL DIS, V45, P862, DOI 10.1016/j.nbd.2011.12.002; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; JAFFE E, 1990, GENOMICS, V7, P123, DOI 10.1016/0888-7543(90)90528-3; Jayakumar AR, 2016, NEUROCHEM RES, V41, P307, DOI 10.1007/s11064-015-1801-0; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Jayakumar AR, 2004, NEUROCHEM RES, V29, P2051, DOI 10.1007/s11064-004-6878-9; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROCHEM, V131, P333, DOI 10.1111/jnc.12810; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; JUURLINK BHJ, 1985, DEV NEUROSCI-BASEL, V7, P263, DOI 10.1159/000112295; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Li JL, 2003, NEUROPSYCHOPHARMACOL, V28, P1017, DOI 10.1038/sj.npp.1300112; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Lo FS, 2011, J NEUROPHYSIOL, V106, P2876, DOI 10.1152/jn.00312.2011; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Norenberg M. D., 1998, NEUROSCI INTELL UNIT, P41; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Rick FG, 2013, P NATL ACAD SCI USA, V110, P2617, DOI 10.1073/pnas.1222355110; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Shindo A, 2013, BRAIN RES, V1533, P131, DOI 10.1016/j.brainres.2013.08.007; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Slezak M, 2006, J PHYSIOLOGY-PARIS, V99, P84, DOI 10.1016/j.jphysparis.2005.12.082; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Suzuki H, 2013, MOL CELL BIOCHEM, V372, P241, DOI 10.1007/s11010-012-1465-x; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tan BK, 2009, CARDIOVASC RES, V83, P566, DOI 10.1093/cvr/cvp131; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; WOLF FW, 1990, GENOMICS, V6, P685, DOI 10.1016/0888-7543(90)90505-O; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	81	11	11	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	FEB	2017	140	4					645	661		10.1111/jnc.13867			17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EM8QV	WOS:000395577000010	27735996	Bronze			2022-02-06	
J	Lazaridis, C				Lazaridis, Christos			Cerebral oxidative metabolism failure in traumatic brain injury: "Brain shock"	JOURNAL OF CRITICAL CARE			English	Article						Hypoxia; Blood flow; Intracranial pressure; Oxygen metabolic rate; Mitochondria; Tissue oxygen tension	SEVERE HEAD-INJURY; PERFUSION-PRESSURE; CIRCULATORY SHOCK; OXYGEN DELIVERY; SEVERE TBI; HYPERTENSION; CONTRIBUTE; HYPEROXIA; DIFFUSION; ISCHEMIA	Shock is a systemic form of acute circulatory failure leading to cellular dysoxia and death. Such a state of aerobic metabolism failure also underlies neuronal cell death in severe traumatic brain injury. It is becoming increasingly recognized that ischemic hypoxia is not the sole mechanism and that multiple alternate cooperating mechanisms may be responsible for compromising neuronal oxidative metabolism. These different mechanisms can be usefully understood via analysis of the classic subdivisions of tissue hypoxia. This approach could lead to an alternative treatment paradigm toward cerebral oxygen metabolic rate targeting instead of the traditional targets of intracranial and perfusion pressures. (C) 2016 Elsevier Inc. All rights reserved.	[Lazaridis, Christos] Baylor Coll Med, Div Neurocrit Care & Vasc Neurol, Houston, TX 77030 USA		Lazaridis, C (corresponding author), Baylor Coll Med, Med Ctr, McNair Campus,7200 Cambridge St,9th Floor, Houston, TX 77030 USA.	lazaridi@bcm.edu					Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2016, JAMA NEUROL; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Diringer MN, 2011, TRANSL STROKE RES, V2, P517, DOI 10.1007/s12975-011-0119-8; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Lazaridis C., 2016, JAMA NEUROL; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P635, DOI 10.1038/jcbfm.2013.18; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Struck AF, 2016, NEUROCRIT CARE, V24, P324, DOI 10.1007/s12028-016-0245-y; Varsos GV, 2013, NEUROCRIT CARE, V18, P341, DOI 10.1007/s12028-013-9830-5; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2008, CRIT CARE MED, V36, P363, DOI 10.1097/01.CCM.0000297946.34037.31; Vincent JL, 2014, NEW ENGL J MED, V370, P583, DOI 10.1056/NEJMc1314999; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165	31	11	11	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2017	37						230	233		10.1016/j.jcrc.2016.09.027			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9UW	WOS:000397034600039	27773372				2022-02-06	
J	Tuominen, M; Hanninen, T; Parkkari, J; Stuart, MJ; Luoto, T; Kannus, P; Aubry, M				Tuominen, Markku; Hanninen, Timo; Parkkari, Jari; Stuart, Michael J.; Luoto, Teemu; Kannus, Pekka; Aubry, Mark			Concussion in the international ice hockey World Championships and Olympic Winter Games between 2006 and 2015	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							STATES HIGH-SCHOOL; INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; VIDEO ANALYSIS; HEAD IMPACTS; LEAGUE NHL; MENS; SPORT; RATES; TIME	Background Concussions in sports are a growing concern. This study describes the incidence, injury characteristics and time trends of concussions in international ice hockey. Methods All concussions in the International Ice Hockey Federation (IIHF) World Championships (WC) and Olympic Winter Games were analysed over 9 ice hockey seasons between 2006 and 2015 using a standardised injury reporting system and diagnoses made by the team physicians. Results A total of 3293 games were played (169 tournaments, 1212 teams, 26 130 players) comprising 142 244 athletic game exposures. The average injury rate (IR) for concussion was 1.1 per 1000 ice hockey player-games for all IIHF WC tournaments. The IR was the highest in the men's WC A-pool tournaments and Olympic Games (IR 1.6). However, the annual IR for concussion in the men's tournaments has been lower than that in the World Junior tournaments since 2012. When a concussion occurred with contact to a flexible board, the IR was 0.2 per 1000 player games. In contrast, the IR was 1.1, if the board and glass were traditional (for the latter, RR 6.44 (95% CI 1.50 to 27.61)). In the men's tournaments, the trend of concussions caused by illegal hits decreased over the study period. After the 4th Consensus Statement on Concussion in Sport was published (2013), none of the concussed players in the men's WC returned to play on the day of injury. Conclusions The annual risk of concussion in the men's WC has decreased during the study period. This was most likely due to a reduction in illegal hits. The risk of concussion was significantly lower if games were played on rinks with flexible boards and glass. Rink modifications, improved education and strict rule enforcement should be considered by policymakers in international ice hockey.	[Tuominen, Markku] Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland; [Hanninen, Timo; Parkkari, Jari] UKK Inst, Tampere Res Ctr Sports Med, Tampere, Finland; [Stuart, Michael J.] Mayo Clin, Dept Orthoped, Rochester, MN USA; [Luoto, Teemu] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Kannus, Pekka] UKK Inst, Injury & Osteoporosis Res Ctr, Tampere, Finland; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada		Tuominen, M (corresponding author), Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland.	markku.tuominen@medisport.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284	International Ice Hockey Federation; Finnish Ministry of Education and Culture	This study was financially supported by The International Ice Hockey Federation and the Finnish Ministry of Education and Culture.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2010, CAN J SURG, V53, P319; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT, 2001, J ATHL TRAINING, V36, P253; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P194; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner EC, 2015, AM J SPORT MED, V43, P2027, DOI 10.1177/0363546515588175; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Keightley M, 2013, INT J SPORTS MED, V34, P756, DOI 10.1055/s-0032-1327574; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matic GT, 2015, PHYSICIAN SPORTSMED, V43, P119, DOI 10.1080/00913847.2015.1035210; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Poutiainen P, 2014, EUR J SPORT SCI, V14, P11, DOI 10.1080/17461391.2012.725106; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Stovitz SD, 2016, BR J SPORTS MED; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; Tuominen M, 2017, BRIT J SPORT MED, V51, P36, DOI 10.1136/bjsports-2016-095992; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	41	11	11	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2017	51	4					244	252		10.1136/bjsports-2016-097119			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EL3ST	WOS:000394540300006	28148512	hybrid, Green Published			2022-02-06	
J	Waltzman, D; Soman, S; Hantke, NC; Fairchild, JK; Kinoshita, LM; Wintermark, M; Ashford, JW; Yesavage, J; Williams, L; Adamson, MM; Furst, AJ				Waltzman, Dana; Soman, Salil; Hantke, Nathan C.; Fairchild, J. Kaci; Kinoshita, Lisa M.; Wintermark, Max; Ashford, J. Wesson; Yesavage, Jerome; Williams, Leanne; Adamson, Maheen M.; Furst, Ansgar J.			Altered Microstructural Caudate Integrity in Posttraumatic Stress Disorder but Not Traumatic Brain Injury	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; REDUCED CORTICAL THICKNESS; MILD COGNITIVE IMPAIRMENT; DIFFUSION TENSOR; HIPPOCAMPAL VOLUME; MEMORY PERFORMANCE; BLOOD-FLOW; PTSD; ROBUST; MRI	Objective Given the high prevalence and comorbidity of combat-related PTSD and TBI in Veterans, it is often difficult to disentangle the contributions of each disorder. Examining these pathologies separately may help to understand the neurobiological basis of memory impairment in PTSD and TBI independently of each other. Thus, we investigated whether a) PTSD and TBI are characterized by subcortical structural abnormalities by examining diffusion tensor imaging (DTI) metrics and volume and b) if these abnormalities were specific to PTSD versus TBI. Method We investigated whether individuals with PTSD or TBI display subcortical structural abnormalities in memory regions by examining DTI metrics and volume of the hippocampus and caudate in three groups of Veterans: Veterans with PTSD, Veterans with TBI, and Veterans with neither PTSD nor TBI (Veteran controls). Results While our results demonstrated no macrostructural differences among the groups in these regions, there were significant alterations in microstructural DTI indices in the caudate for the PTSD group but not the TBI group compared to Veteran controls. Conclusions The result of increased mean, radial, and axial diffusivity, and decreased fractional anisotropy in the caudate in absence of significant volume atrophy in the PTSD group suggests the presence of subtle abnormalities evident only at a microstructural level. The caudate is thought to play a role in the physiopathology of PTSD, and the habit-like behavioral features of the disorder could be due to striatal-dependent habit learning mechanisms. Thus, DTI appears to be a vital tool to investigate subcortical pathology, greatly enhancing the ability to detect subtle brain changes in complex disorders.	[Waltzman, Dana; Hantke, Nathan C.; Fairchild, J. Kaci; Ashford, J. Wesson; Yesavage, Jerome; Williams, Leanne; Furst, Ansgar J.] VAPAHCS, WRIISC, Palo Alto, CA 94304 USA; [Waltzman, Dana; Hantke, Nathan C.; Fairchild, J. Kaci; Kinoshita, Lisa M.; Ashford, J. Wesson; Yesavage, Jerome; Williams, Leanne; Adamson, Maheen M.; Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Soman, Salil] Harvard Univ, Dept Radiol, Cambridge, MA 02138 USA; [Hantke, Nathan C.; Fairchild, J. Kaci] VAPAHCS, Sierra Pacific Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Kinoshita, Lisa M.] VAPAHCS, Psychol Serv, Palo Alto, CA USA; [Wintermark, Max] Stanford Univ, Sch Med, Dept Radiol, Palo Alto, CA 94304 USA; [Wintermark, Max; Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Adamson, Maheen M.] VAPAHCS, DVBIC, Palo Alto, CA USA; [Waltzman, Dana] Vet Affairs Palo Alto Hlth Care Syst, MC 151Y, Palo Alto, CA 94304 USA		Waltzman, D (corresponding author), VAPAHCS, WRIISC, Palo Alto, CA 94304 USA.; Waltzman, D (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.; Waltzman, D (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, MC 151Y, Palo Alto, CA 94304 USA.	dana2@stanford.edu	Ashford, J. Wesson/D-3929-2009	Soman, Salil/0000-0002-5887-0717; Adamson, Maheen/0000-0002-1534-4063	Department of Veterans Affairs, Office of Public Health, WRIISC Fellowship programUS Department of Veterans Affairs	Work for this article was supported by the Department of Veterans Affairs, Office of Public Health, WRIISC Fellowship program.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, TRO7JA2 FMRIB; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Bremner JD, 2006, ANN NY ACAD SCI, V1071, P80, DOI 10.1196/annals.1364.008; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cavallari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101199; Caverzasi E, 2014, NEUROIMAGE-CLIN, V4, P426, DOI 10.1016/j.nicl.2014.01.011; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Dickerson KC, 2011, NEUROIMAGE, V55, P266, DOI 10.1016/j.neuroimage.2010.10.080; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fjell AM, 2016, CEREB CORTEX, V26, P1272, DOI 10.1093/cercor/bhv102; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Golier JA, 2005, PSYCHIAT RES-NEUROIM, V139, P53, DOI 10.1016/j.pscychresns.2005.02.007; Goodman J, 2012, REV NEUROSCIENCE, V23, P627, DOI 10.1515/revneuro-2012-0049; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hasan KM, 2012, J NEUROL SCI, V313, P99, DOI 10.1016/j.jns.2011.09.015; Hasan KM, 2011, J NEUROSCI, V31, P16826, DOI 10.1523/JNEUROSCI.4184-11.2011; Hasan KM, 2009, J MAGN RESON IMAGING, V29, P70, DOI 10.1002/jmri.21648; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Layton B, 2002, J NEUROPSYCH CLIN N, V14, P254, DOI 10.1176/jnp.14.3.254; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Linnman C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-8; Lucey JV, 1997, BRIT J PSYCHIAT, V171, P346, DOI 10.1192/bjp.171.4.346; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mueller SG, 2007, PSYCHIAT RES, V234, P194; Nardo D, 2011, PSYCHOL MED, V41, P2549, DOI 10.1017/S0033291711000912; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pederson CL, 2004, J TRAUMA STRESS, V17, P37, DOI 10.1023/B:JOTS.0000014674.84517.46; Piras F, 2010, NEUROSCIENCE, V171, P496, DOI 10.1016/j.neuroscience.2010.09.006; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Primus EA, 1997, BRAIN INJURY, V11, P577; Randolph C., 1998, REPEATABLE BATTERY A; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reitan R, 1985, HALSTEAD REITAN NEUR; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vrenken H, 2006, J MAGN RESON IMAGING, V23, P628, DOI 10.1002/jmri.20564; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 2008, WECHSLER ADULTS INTE; WechslerD, 2001, WECHSLER TEST ADULT; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Ziyan U, 2008, LECT NOTES COMPUT SC, V5241, P279, DOI 10.1007/978-3-540-85988-8_34	84	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170564	10.1371/journal.pone.0170564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QR	WOS:000396129000069	28114393	Green Published, Green Submitted, gold			2022-02-06	
J	Kallakuri, S; Desai, A; Feng, K; Tummala, S; Saif, T; Chen, CY; Zhang, LY; Cavanaugh, JM; King, AI				Kallakuri, Srinivasu; Desai, Alok; Feng, Ke; Tummala, Sharvani; Saif, Tal; Chen, Chaoyang; Zhang, Liying; Cavanaugh, John M.; King, Albert I.			Neuronal Injury and Glial Changes Are Hallmarks of Open Field Blast Exposure in Swine Frontal Lobe	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRAAXONAL NEUROFILAMENT COMPACTION; IMPAIRED AXONAL-TRANSPORT; TIME-DEPENDENT CHANGES; EXPLOSIVE BLAST; ASTROCYTE ACTIVATION; INDUCED NEUROTRAUMA; BIOMARKER LEVELS; SERVICE MEMBERS; MOUSE MODEL	With the rapid increase in the number of blast induced traumatic brain injuries and associated neuropsychological consequences in veterans returning from the operations in Iraq and Afghanistan, the need to better understand the neuropathological sequelae following exposure to an open field blast exposure is still critical. Although a large body of experimental studies have attempted to address these pathological changes using shock tube models of blast injury, studies directed at understanding changes in a gyrencephalic brain exposed to a true open field blast are limited and thus forms the focus of this study. Anesthetized, male Yucatan swine were subjected to forward facing medium blast overpressure (peak side on overpressure 224-332 kPa; n = 7) or high blast overpressure (peak side on overpressure 350-403 kPa; n = 5) by detonating 3.6 kg of composition-4 charge. Sham animals (n = 5) were subjected to all the conditions without blast exposure. After a 3-day survival period, the brain was harvested and sections from the frontal lobes were processed for histological assessment of neuronal injury and glial reactivity changes. Significant neuronal injury in the form of beta amyloid precursor protein immunoreactive zones in the gray and white matter was observed in the frontal lobe sections from both the blast exposure groups. A significant increase in the number of astrocytes and microglia was also observed in the blast exposed sections compared to sham sections. We postulate that the observed acute injury changes may progress to chronic periods after blast and may contribute to short and long-term neuronal degeneration and glial mediated inflammation.	[Kallakuri, Srinivasu; Desai, Alok; Feng, Ke; Tummala, Sharvani; Saif, Tal; Chen, Chaoyang; Zhang, Liying; Cavanaugh, John M.; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA		Kallakuri, S (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	skallakuri@wayne.edu	Chen, Chaoyang/H-3605-2012	Chen, Chaoyang/0000-0003-0838-2245	United States Army through a Medical Research and Materials Command [W81XWH-12-2-0038]; US Army through an MRMC [W81XWH-12-2-0038]	This research was supported by the United States Army through a Medical Research and Materials Command Cooperative Agreement, Award No. W81XWH-12-2-0038 (AIK).; This research was supported by the US Army through an MRMC Cooperative Agreement, Award No. W81XWH-12-2-0038. The authors would like to extend their sincere thanks Dr. Elizabeth Dawe, DVM and Ms. Janine Mattei, from Surgical Research Services, School of Medicine, Wayne State University for their invaluable technical help in preparing the swine for blast procedures. Our special thanks to Team Wendy LLC, Cleveland, OH and ARES, Inc., Port Clinton, OH. We also wish to thank Dr. Chengpeng Zhou, Ms. Heena Purkait, Mrs. Tong Shi, Ms. Natasha Gupta, Ms. Leena Penumalee and Ms. Ramya Maramraju for their valuable technical assistance during the course of this work. We also thank Dr. Scott Millis for his valuable assistance with statistical analyses.	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Burda JE, 2015, EXP NEUROL; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen LLK, 2014, MIL MED, V179, P492, DOI 10.7205/MILMED-D-13-00413; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Garman RH, 2011, JOURNAL OF NEUROTRAU; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kane MJ, 2012, NEUROSCI LETT, V522, P47, DOI 10.1016/j.neulet.2012.06.012; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; Vandevord PJ, 2011, ANNALS OF BIOMEDICAL; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	65	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169239	10.1371/journal.pone.0169239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	WOS:000392405300022	28107370	Green Published, gold, Green Submitted			2022-02-06	
J	Soberg, HL; Roe, C; Brunborg, C; von Steinbuchel, N; Andelic, N				Soberg, Helene Lundgaard; Roe, Cecilie; Brunborg, Cathrine; von Steinbuechel, Nicole; Andelic, Nada			The Norwegian version of the QOLIBRI - a study of metric properties based on a 12 month follow-up of persons with traumatic brain injury	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Disability; Metric properties; Outcome measure; Quality of life; Traumatic brain injury; QOLIBRI; GOSE	QUALITY-OF-LIFE; POST-CONCUSSION SYMPTOMS; IMPAIRED SELF-AWARENESS; RASCH MEASUREMENT MODEL; STRUCTURED INTERVIEWS; PHYSICAL HEALTH; SCALE; MODERATE; REHABILITATION; SEVERITY	Background: Consequences after Traumatic brain injury (TBI) affect the injured person's self-image and quality of life. The purpose was to assess the health related quality of life (HRQoL) at 12 months after a TBI in patients admitted to regional trauma centres, and to evaluate the metric properties of the Norwegian version of the Quality of Life After Brain Injury (QOLIBRI) questionnaire. Methods: Two hundred four patients with TBI of all severities were included. HRQoL at 12 months post-injury was measured by the QOLIBRI. It has a total scale and 6 subscales (satisfied with Cognition, Self, Daily Life and Autonomy and Social Relationships, and bothered by Emotions and Physical Problems). Demographic and injury related data were registered. Disability was registered by Glasgow Outcome Scale Extended (GOSE) and Rivermead Post-Concussion Questionnaire, and mental health by Hospital Anxiety and Depression Scale. Descriptive statistics, internal consistency by Cronbach's alpha and Corrected Item-Total Correlations were calculated. Rasch analysis, Principal Component Analysis (PCA) and Structural Equation Modelling (SEM) were applied. Results: Mean age was 37.6 (SD 15.4) years; 72% were men, and 41% had higher education. Over 60% were severely injured. Mean Glasgow Coma Scale score was 9.3 (SD 4.5). According to the GOSE 5.9% had severe disability, 45.5% had moderate disability, and 48.5% had good recovery at 12 months post-injury. The QOLIBRI scales had a high internal consistency (a = 0.75-0.96), and only Physical Problems had an a < 0.85. In the Rasch analysis all subscales and their items fit the Rasch model, except for the depression item in the Emotion subscale. PCA and SEM analyses supported a six-factor structure in a second-order latent model. The QOLIBRI supports an underlying unidimensional HRQoL model. The SEM model fit statistics of the second-order model indicated a moderate fit to the observed data (CFI = 0.86, TLI = 0.85, RMSEA = 0.076, SRMR = 0.061, chi(2) = 1315.76, df = 623, p-value < 0.001). Conclusion: The Norwegian QOLIBRI has favourable psychometric properties, but there were some weaknesses related to its measurement properties of the total score when tested on a TBI population where many had severe TBI, and many had good recovery.	[Soberg, Helene Lundgaard; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Postbox 4950, N-0424 Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany		Soberg, HL (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Postbox 4950, N-0424 Oslo, Norway.	h.l.soberg@medisin.uio.no		Andelic, Nada/0000-0002-3719-4406	Research Council of NorwayResearch Council of Norway [8744/SFP1108-13]	This study was in part funded by the Research Council of Norway grant number 8744/SFP1108-13. The funding was related to the national multicentre study of people with severe traumatic brain injury and concerned the design of the study and data collection. The collection of data from people with mild traumatic brain injury, and the analysis, interpretation of the whole data set, and writing of the manuscript was performed within the Trauma research group at the Department of Physical Medicine and Rehabilitation at Oslo University Hospital with no additional funding. All authors have contributed with writing the manuscript within their research positions at Oslo University Hospital, Oslo Norway (Soberg, Roe, Brunborg and Andelic) and Institute of Medical Psychology and Medical Sociology, University Medical Centre Gottingen, Germany (von Steinbuchel) with no additional funding.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2015, J NEUROL, V262, P523, DOI 10.1007/s00415-014-7595-1; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; [Anonymous], 2013, ULL TRAUM REG; Association for the Advancement of Automotive medicine, 2008, ABBR INJ SCAL AIS 20; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Finger RP, 2012, OPHTHALMOLOGY, V119, P2351, DOI 10.1016/j.ophtha.2012.05.031; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; GUYATT GH, 1989, CAN MED ASSOC J, V140, P1441; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; TEASDALE G, 1974, LANCET, V2, P81; Tennant A, 2000, BRIT MED BULL, V56, P287, DOI 10.1258/0007142001903210; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	11	11	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1477-7525			HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	JAN 19	2017	15								14	10.1186/s12955-017-0589-9			13	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	EL7RW	WOS:000394819300003	28103876	gold, Green Published			2022-02-06	
J	Harmon, JL; Gibbs, WS; Whitaker, RM; Schnellmann, RG; Adkins, DL				Harmon, Jennifer L.; Gibbs, Whitney S.; Whitaker, Ryan M.; Schnellmann, Rick G.; Adkins, DeAnna L.			Striatal Mitochondrial Disruption following Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; mitochondria; oxidative stress; traumatic brain injury	INFLAMMATION; MICRORNA-21; DAMAGE; RAT; DYSFUNCTION; IMPACT; CORTEX; ROLES	Traumatic brain injury (TBI) results in oxidative stress and calcium dysregulation in mitochondria. However, little work has examined perturbations of mitochondrial homeostasis in peri-injury tissue. We examined mitochondrial homeostasis after a unilateral controlled cortical impact over the sensorimotor cortex in adult male rats. There was a significant reduction in peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) messenger RNA (mRNA) at post-injury days 3 and 6 and a transient reduction in mitochondrial DNA copy number at 3 days post-injury that recovered by 6 days in the ipsi-injury striatum. In ipsilateral cortex, PGC-1a mRNA was reduced only at 6 days post-injury. Additionally, expression of mitochondrial-encoded mRNAs, cytochrome c oxidase subunit 1 and NADH dehydrogenase subunit 1, was decreased at 3 and 6 days post-injury in ipsilesional striatum and at 6 days post-injury in ipsilesional cortex. There was no observable decrease in nuclear-encoded mRNAs mitochondrial transcription factor A or NADH dehydrogenase (ubiquinone) Fe-S protein 1. We detected an acute increase in superoxide dismutase 2 mRNA expression, as well as an induction of microRNA (miR)-21 and miR-155, which have been previously demonstrated to disrupt mitochondrial homeostasis. Behaviorally, rats with TBI exhibited marked error rates in contrainjury forelimb performance on the ladder test. These findings reveal that there may be differential susceptibilities of various peri-injury brain structures to mitochondrial dysfunction and associated behavioral deficits, and that molecular pathways demonstrated to interfere with mitochondrial homeostasis and function are activated subacutely post-TBI.	[Harmon, Jennifer L.; Gibbs, Whitney S.; Whitaker, Ryan M.; Schnellmann, Rick G.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Schnellmann, Rick G.] Ralph H Johnson Vet Adm Med Ctr, Charleston, SC USA; [Adkins, DeAnna L.] Med Univ South Carolina, Dept Neurosci, 173 Ashley Ave,404D MSC510, Charleston, SC 29425 USA; [Adkins, DeAnna L.] Med Univ South Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Adkins, DeAnna L.] Med Univ South Carolina, Ctr Biomed Imaging, Charleston, SC 29425 USA		Adkins, DL (corresponding author), Med Univ South Carolina, Dept Neurosci, 173 Ashley Ave,404D MSC510, Charleston, SC 29425 USA.	adkinsdl@musc.edu		Adkins, DeAnna L/0000-0002-3063-5731	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS065866]; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [F30 DK091107, T32 DK083262]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM084147, P20GM103542]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1-RR029882, C06-RR015455]; Biomedical Laboratory Research and Development Program of the Department of Veterans AffairsUS Department of Veterans Affairs [5I01 BX-000851]; South Carolina Clinical and Translational Research Institute at the Medical University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK083262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109040, T32GM008716] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institute of Neurological Disorders and Stroke (R01 NS065866; to D.L.A.), National Institute of Diabetes and Digestive and Kidney Diseases (F30 DK091107 and T32 DK083262; to J.L.H.), and National Institute of General Medical Sciences (GM084147 [to R.G.S.] and P20GM103542 [to South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling]); National Center for Research Resources (UL1-RR029882); the Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs (5I01 BX-000851; to R.G.S.); and the South Carolina Clinical and Translational Research Institute at the Medical University of South Carolina. Animal facilities were funded by the National Center for Research Resources (C06-RR015455).	ADAMS FS, 1994, PHYSIOL BEHAV, V55, P947, DOI 10.1016/0031-9384(94)90084-1; Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Berardi MJ, 2014, CELL METAB, V20, P541, DOI 10.1016/j.cmet.2014.07.004; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002; Gibbs WS, 2016, LIFE SCI, V166, P139, DOI 10.1016/j.lfs.2016.09.021; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Jaburek M, 2004, J BIOL CHEM, V279, P53097, DOI 10.1074/jbc.M405339200; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wills LP, 2012, J PHARMACOL EXP THER, V342, P106, DOI 10.1124/jpet.112.191528; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639	38	11	11	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					487	+		10.1089/neu.2015.4395			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800024	27321815	Green Published			2022-02-06	
J	Ahl, R; Sjolin, G; Mohseni, S				Ahl, Rebecka; Sjolin, Gabriel; Mohseni, Shahin			Does early beta-blockade in isolated severe traumatic brain injury reduce the risk of post traumatic depression?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Beta-blockade; Depression	POSTTRAUMATIC-STRESS-DISORDER; BLOCKERS; PTSD; ANXIETY; MEMORY	Introduction: Depressive symptoms occur in approximately half of trauma patients, negatively impacting on functional outcome and quality of life following severe head injury. Pontine noradrenaline has been shown to increase upon trauma and associated beta-adrenergic receptor activation appears to consolidate memory formation of traumatic events. Blocking adrenergic activity reduces physiological stress responses during recall of traumatic memories and impairs memory, implying a potential therapeutic role of beta-blockers. This study examines the effect of pre-admission beta-blockade on post-traumatic depression. Methods: All adult trauma patients (>= 18 years) with severe, isolated traumatic brain injury (intracranial Abbreviated Injury Scale score (AIS) >= 3 and extracranial AIS <3) were recruited from the trauma registry of an urban university hospital between 2007 and 2011. Exclusion criteria were in-hospital deaths and prescription of antidepressants up to one year prior to admission. Pre- and post-admission beta-blocker and antidepressant therapy data was requested from the national drugs registry. Post-traumatic depression was defined as the prescription of antidepressants within one year of trauma. Patients with and without pre-admission beta-blockers were matched 1: 1 by age, gender, Glasgow Coma Scale, Injury Severity Score and head AIS. Analysis was carried out using McNemar's and Student's t-test for categorical and continuous data, respectively. Results: A total of 545 patients met the study criteria. Of these, 15% (n = 80) were prescribed beta-blockers. After propensity matching, 80 matched pairs were analyzed. 33% (n = 26) of non beta-blocked patients developed post-traumatic depression, compared to only 18% (n = 14) in the beta-blocked group (p = 0.04). There were no significant differences in ICU (mean days: 5.8 (SD 10.5) vs. 5.6 (SD 7.2), p = 0.85) or hospital length of stay (mean days: 21 (SD 21) vs. 21 (SD 20), p = 0.94) between cohorts. Conclusion: beta-blockade appears to act prophylactically and significantly reduces the risk of posttraumatic depression in patients suffering from isolated severe traumatic brain injuries. Further prospective randomized studies are warranted to validate this finding. (C) 2016 Elsevier Ltd. All rights reserved.	[Ahl, Rebecka; Mohseni, Shahin] Karolinska Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-17176 Stockholm, Sweden; [Sjolin, Gabriel; Mohseni, Shahin] Orebro Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-70185 Orebro, Sweden; [Ahl, Rebecka; Mohseni, Shahin] Univ Orebro, Sch Med Sci, Fakultetsgatan 1, S-70281 Orebro, Sweden		Mohseni, S (corresponding author), Orebro Univ Hosp, Dept Surg, S-70185 Orebro, Sweden.	rebecka.ahl@cantab.net; gabriel.sjolin@regionorebrolan.se; mohsenishahin@yahoo.com	Ahl, Rebecka/AAG-4162-2020	Ahl, Rebecka/0000-0001-7930-3845			Bhuvaneswar CG, 2014, NEUROBIOL LEARN MEM, V112, P248, DOI 10.1016/j.nlm.2013.12.013; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Chamberlain SR, 2006, PSYCHOPHARMACOLOGY, V188, P397, DOI 10.1007/s00213-006-0391-6; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Elhai JD, 2008, J CLIN PSYCHIAT, V69, P597, DOI 10.4088/JCP.v69n0411; Elwood LS, 2009, CLIN PSYCHOL REV, V29, P87, DOI 10.1016/j.cpr.2008.10.002; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Feldner MT, 2006, J COGN PSYCHOTHER, V20, P201, DOI 10.1891/jcop.20.2.201; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hoge EA, 2012, CNS NEUROSCI THER, V18, P21, DOI 10.1111/j.1755-5949.2010.00227.x; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lindgren ME, 2013, PSYCHO-ONCOLOGY, V22, P1889, DOI 10.1002/pon.3233; Mohseni S, 2014, J TRAUMA ACUTE CARE, V76, P804, DOI 10.1097/TA.0000000000000139; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; Poundja J, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.15470; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Suliman S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0391-3; Terzioglu B, 2013, NEUROCHEM RES, V38, P1726, DOI 10.1007/s11064-013-1076-2; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; van Melle JP, 2006, J AM COLL CARDIOL, V48, P2209, DOI 10.1016/j.jacc.2006.07.056; Whale R, 2010, J PSYCHOPHARMACOL, V24, P513, DOI 10.1177/0269881108097714; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	11	11	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2017	48	1					101	105		10.1016/j.injury.2016.10.041			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EF7YF	WOS:000390544600018	27817882				2022-02-06	
J	Baum, CM; Wolf, TJ; Wong, AWK; Chen, CH; Walker, K; Young, AC; Carlozzi, NE; Tulsky, DS; Heaton, RK; Heinemann, AW				Baum, C. M.; Wolf, T. J.; Wong, A. W. K.; Chen, C. H.; Walker, K.; Young, A. C.; Carlozzi, N. E.; Tulsky, D. S.; Heaton, R. K.; Heinemann, A. W.			Validation and clinical utility of the executive function performance test in persons with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive function; NIH Toolbox; traumatic brain injury; performance-based testing	MULTIPLE ERRANDS TEST; ECOLOGICAL VALIDITY; DYSEXECUTIVE SYNDROME; SIMPLIFIED VERSION; ALZHEIMER-TYPE; PROCESS SKILLS; NIH TOOLBOX; RELIABILITY; MOTOR; REHABILITATION	This study examined the relationships between the Executive Function Performance Test (EFPT), the NIH Toolbox Cognitive Function tests, and neuropsychological executive function measures in 182 persons with traumatic brain injury (TBI) and 46 controls to evaluate construct, discriminant, and predictive validity. Construct validity: There were moderate correlations between the EFPT and the NIH Toolbox Crystallized (r=-.479), Fluid Tests (r=-.420), and Total Composite Scores (r=-.496). Discriminant validity: Significant differences were found in the EFPT total and sequence scores across control, complicated mild/moderate, and severe TBI groups. We found differences in the organisation score between control and severe, and between mild and severe TBI groups. Both TBI groups had significantly lower scores in safety and judgement than controls. Compared to the controls, the severe TBI group demonstrated significantly lower performance on all instrumental activities of daily living (IADL) tasks. Compared to the mild TBI group, the controls performed better on the medication task, the severe TBI group performed worse in the cooking and telephone tasks. Predictive validity: The EFPT predicted the self-perception of independence measured by the TBI-QOL (beta = -0.49, p<.001) for the severe TBI group. Overall, these data support the validity of the EFPT for use in individuals with TBI.	[Baum, C. M.; Wolf, T. J.; Wong, A. W. K.; Walker, K.; Young, A. C.] Washington Univ, Sch Med, Occupat Therapy, 4444 Forest Pk Ave,Campus Box 8505, St Louis, MO 63108 USA; [Chen, C. H.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Carlozzi, N. E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Tulsky, D. S.] Univ Delaware, Coll Hlth Sci, Dept Phys Therapy, Newark, DE USA; [Heaton, R. K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA USA; [Heinemann, A. W.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Baum, CM (corresponding author), Washington Univ, Sch Med, Occupat Therapy, 4444 Forest Pk Ave,Campus Box 8505, St Louis, MO 63108 USA.	baumc@wusm.wustl.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133B090024]; Craig H. Neilsen Foundation [290474]; James. S. McDonnell Foundation [JSMF 220020087]	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) was formerly known as National Institute on Disability and Rehabilitation Research (NIDRR) [grant number H133B090024, Allen Heinemann, PI]; the Craig H. Neilsen Foundation [grant number 290474, Alex Wong, PI]; and the James. S. McDonnell Foundation [JSMF 220020087, Carolyn M. Baum, PI].	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Baum C, 1996, ARCH CLIN NEUROPSYCH, V11, P69, DOI 10.1016/0887-6177(95)00009-7; Baum C. M., 1993, THESIS; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Baum CM, 2003, ALZHEIMERS CARE Q, V4, P108; BRUNSWIK E, 1955, PSYCHOL REV, V62, P193, DOI 10.1037/h0047470; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis DC., 2001, DELIS KAPLAN EXECUTI; Edwards, 2003, TEST MANUAL EXECUTIV; Enderby PM, 1986, DISABIL REHABIL, V8, P166, DOI DOI 10.3109/03790798709166209; FISHER AG, 1993, AM J OCCUP THER, V47, P319, DOI 10.5014/ajot.47.4.319; Fitzpatrick SM, 2012, STROKE REHABILITATIO, P208; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; Hartman-Maeir A, 2009, AM J OCCUP THER, V63, P592, DOI 10.5014/ajot.63.5.592; Heaton R., 2000, WISCONSIN CARD SORTI; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Katz N., 2007, OCCUPATIONAL THERAPY, V27, P1; Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260, DOI 10.1097/00001199-200605000-00006; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Linden A, 2005, ACTA NEUROL SCAND, V111, P48, DOI 10.1111/j.1600-0404.2004.00356.x; Lysack CL, 2003, AM J OCCUP THER, V57, P298, DOI 10.5014/ajot.57.3.298; Marcotte K, 2012, NEUROPSYCHOLOGIA, V50, P1776, DOI 10.1016/j.neuropsychologia.2012.04.001; Mercier L, 2001, STROKE, V32, P2602, DOI 10.1161/hs1101.098154; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; PARK S, 1994, AM J OCCUP THER, V48, P697, DOI 10.5014/ajot.48.8.697; PROMIS Validity Standards Committee on behalf of the PROMIS Network of investigators, 2012, PROMIS INSTR DEV PSY; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Voelbel GT, 2011, OTJR-OCCUP PART HEAL, V31, pS30, DOI 10.3928/15394492-20101108-06; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilkinson GaryS, 2006, WRAT4 WIDE RANGE ACH; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolf TJ, 2008, WORK, V31, P221	43	11	12	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	5			SI		603	617		10.1080/09602011.2016.1176934			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EU3IT	WOS:000400923300002	27150506				2022-02-06	
J	Brown, J; Hux, K; Hey, M; Murphy, M				Brown, Jessica; Hux, Karen; Hey, Morgan; Murphy, Madeline			Exploring cognitive support use and preference by college students with TBI: A mixed-methods study	NEUROREHABILITATION			English	Article						Traumatic brain injury; student survivors; cognitive deficits; external supports	TRAUMATIC BRAIN-INJURY; IMPAIRED SELF-AWARENESS; OF-THE-LITERATURE; ASSISTIVE TECHNOLOGY; POSTSECONDARY STUDENTS; EMPLOYMENT SUCCESS; SKILLS; REHABILITATION; OUTCOMES; INDIVIDUALS	PURPOSE: Many college students with TBI rely on external strategies and supports to compensate for persistent memory, organization, and planning deficits that interfere with recalling and executing daily tasks. Practitioners know little, however, about the supports students with TBI choose for this purpose, the reasoning behind their choice, or preferred features of selected supports. The purpose of this study was to explore these issues. METHOD: We collected and analyzed quantitative and qualitative data from eight college students with TBI for completion of a concurrent triangulation mixed-methods design. Data analysis included evaluation and triangulation of participant demo graphic information, survey responses about persistent post-injury symptoms, transcripts from semi-structured interviews about cognitive support devices and strategies, and ranking results about specific compensatory tools. RESULTS: Results suggest that college students with TBI prefer high-tech external supports-sometimes with the addition of low-tech, paper supports- to assist them in managing daily tasks. This preference related to features of portability, accessibility, and automatic reminders. An electronic calendar was the most-preferred high-tech support, and a paper checklist was the most-preferred low-tech support. CONCLUSIONS: Rehabilitation professionals should consider implementing high-tech supports with preferred character istics during treatment given the preferences of students with TBI and the consequent likelihood of their continued long-term use following reintegration to community settings.	[Brown, Jessica; Murphy, Madeline] Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN USA; [Hux, Karen; Hey, Morgan] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA		Brown, J (corresponding author), 164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	brow4565@umn.edu	Hux, Karen/AAQ-2078-2020				Ackerman R., 2009, NEW DIRECTIONS STUDE, V126, P5, DOI [https://doi.org/10.1002/ss.311, DOI 10.1002/SS.311]; Aldrich EM, 2012, CAN J SCH PSYCHOL, V27, P291, DOI 10.1177/0829573512455016; Anderson P., 2010, EXECUTIVE FUNCTIONS, P1; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beigel AR, 2000, INTERV SCH CLIN, V35, P237, DOI 10.1177/105345120003500407; Benedict, 2001, HOPKINS VERBAL LEARN; Bogdan R., 2007, QUALITATIVE RES ED I; Brown J., 2015, COLL STUDENT HLTH AC; Brown J. A., 2016, NEUROREHABILITATION, P1; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Creswell J. W., 2016, QUAL INQ; Creswell J.W ., 2007, QUAL INQ; Cushman L, 1995, PSYCHOL ASSESSMENT M; De Joode EA, 2013, NEUROPSYCHOL REHABIL, V23, P133, DOI 10.1080/09602011.2012.726632; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Dowds MM, 2011, J HEAD TRAUMA REHAB, V26, P339, DOI 10.1097/HTR.0b013e3181f2bf1d; Doyle L, 2009, J RES NURS, V14, P175, DOI 10.1177/1744987108093962; Edwards A. D., 2015, COLL U, V90, P47; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Gioia GA IP, 2000, BEHAV RATING INVENTO; Glang A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P602; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Grajzel K, 2015, ARCH CLIN NEUROPSYCH, V30, P514; Harper M., 2012, QUALITATIVE REPORT, V17, P510; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Head Injury Hotline, 1998, BRAIN INJ CHECKL; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hendricks DJ, 2015, NEUROREHABILITATION, V37, P449, DOI 10.3233/NRE-151273; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kertesz A., 2006, W APHASIA BATTERY RE; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Martella R. C., 2013, UNDERSTANDING INTERP; Martinez S, 2016, J AM COLL HEALTH, V64, P390, DOI 10.1080/07448481.2016.1167057; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Perna R, 2012, APPL NEUROPSYCH-ADUL, V19, P263, DOI 10.1080/09084282.2012.670147; Reitan R, 1985, HALSTEAD REITAN NEUR; Rumrill P, 2016, J VOCAT REHABIL, V45, P53, DOI 10.3233/JVR-160810; Scherer M., 2004, CONNECTING LEARN ED; Scherer M. J., 2003, BRIDGING GAPS REFINI, P165; Scherer M.J., 2002, TECHNOL DISABIL, V14, P125, DOI [DOI 10.3233/TAD-2002-14308, 10.3233/tad-2002-14308]; Scherer Marcia J, 2002, ASSISTIVE TECHNOLOGY; Scherer MJ, 2005, DISABIL REHABIL, V27, P731, DOI 10.1080/09638280400014816; SCHERER MJ, 1993, LIVING STATE STUCK T; Shanahan L, 2011, BRAIN INJURY, V25, P1080, DOI 10.3109/02699052.2011.607781; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sohlberg MM, 2014, AM J SPEECH-LANG PAT, V23, P160, DOI 10.1044/2013_AJSLP-12-0005; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Tate R., 2011, SCH SUPPORT ADOLESCE; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wallace T, 2011, NEUROREHABILITATION, V28, P199, DOI 10.3233/NRE-2011-0649; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; Ylvisaker Mark, 1996, Seminars in Speech and Language, V17, P217, DOI 10.1055/s-2008-1064100	76	11	11	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	41	2					483	499		10.3233/NRE-162065			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK2DU	WOS:000413293600019	28946573				2022-02-06	
J	Carlson, AP; Shuttleworth, CW; Mead, B; Burlbaw, B; Krasberg, M; Yonas, H				Carlson, Andrew P.; Shuttleworth, C. William; Mead, Brittany; Burlbaw, Brittany; Krasberg, Mark; Yonas, Howard			Cortical spreading depression occurs during elective neurosurgical procedures	JOURNAL OF NEUROSURGERY			English	Article						neurosurgical procedures; intraoperative monitoring; cortical spreading depolarization; cortical spreading depression; diagnostic and operative techniques	BRAIN-INJURY; HEMORRHAGE; MIGRAINE	OBJECTIVE Cortical spreading depression (CSD) has been observed with relatively high frequency in the period following human brain injury, including traumatic brain injury and ischemic/hemorrhagic stroke. These events are characterized by loss of ionic gradients through massive cellular depolarization, neuronal dysfunction (depression of electrocorticographic [ECoG] activity) and slow spread (2-5 mm/min) across the cortical surface. Previous data obtained in animals have suggested that even in the absence of underlying injury, neurosurgical manipulation can induce CSD and could potentially be a modifiable factor in neurosurgical injury. The authors report their initial experience with direct intraoperative ECoG monitoring for CSD. METHODS The authors prospectively enrolled patients undergoing elective craniotomy for supratentorial lesions in cases in which the surgical procedure was expected to last > 2 hours. These patients were monitored for CSD from the time of dural opening through the time of dural closure, using a standard 1 x 6 platinum electrode coupled with an AC or full-spectrum DC amplifier. The data were processed using standard techniques to evaluate for slow potential changes coupled with suppression of high-frequency ECoG propagating across the electrodes. Data were compared with CSD validated in previous intensive care unit (ICU) studies, to evaluate recording conditions most likely to permit CSD detection, and identify likely events during the course of neurosurgical procedures using standard criteria. RESULTS Eleven patients underwent ECoG monitoring during elective neurosurgical procedures. During the periods of monitoring, 2 definite CSDs were observed to occur in 1 patient and 8 suspicious events were detected in 4 patients. In other patients, either no events were observed or artifact limited interpretation of the data. The DC-coupled amplifier system represented an improvement in stability of data compared with AC-coupled systems. Compared with more widely used postoperative ICU monitoring, there were additional challenges with artifact from saturation during bipolar cautery as well as additional noise peaks detected. CONCLUSIONS CSD can occur during elective neurosurgical procedures even in brain regions distant from the immediate operative site. ECoG monitoring with a DC-coupled full-spectrum amplifier seemed to provide the most stable signal despite significant challenges to the operating room environment. CSD may be responsible for some cases of secondary surgical injury. Though further studies on outcome related to the occurrence of these events is needed, efforts to decrease the occurrence of CSD by modification of anesthetic regimen may represent a novel target for study to increase the safety of neurosurgical procedures.	[Carlson, Andrew P.; Mead, Brittany; Burlbaw, Brittany; Krasberg, Mark; Yonas, Howard] Univ New Mexico, Sch Med, Dept Neurol Surg, MSC10 5615, Albuquerque, NM 87131 USA; [Shuttleworth, C. William] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA		Carlson, AP (corresponding author), Univ New Mexico, Sch Med, Dept Neurol Surg, MSC10 5615, Albuquerque, NM 87131 USA.	andrewcarlson@salud.unm.edu	Carlson, Andrew P/B-4369-2012	Carlson, Andrew P/0000-0003-2189-3699	Department of Neurosurgery at the University of New Mexico	This study was supported through internal funding from the Department of Neurosurgery at the University of New Mexico.	ANDREWS RJ, 1993, NEUROSURGERY, V33, P1052; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Carlson AP, 2012, NEUROL RES, V34, P223, DOI 10.1179/1743132811Y.0000000077; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2002, NEUROSURGERY, V51, P1457, DOI 10.1097/00006123-200212000-00017; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROPHYSIOL, V102, P2563, DOI 10.1152/jn.00345.2009; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932	18	11	11	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2017	126	1					266	273		10.3171/2015.11.JNS151871			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EG0LY	WOS:000390725500036	26967779	Bronze			2022-02-06	
J	Clark, AJ; Anderson, ND; Nalder, E; Arshad, S; Dawson, DR				Clark, Amanda J.; Anderson, Nicole D.; Nalder, Emily; Arshad, Sidrah; Dawson, Deirdre R.			Reliability and construct validity of a revised Baycrest Multiple Errands Test	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Cognition; Executive function; Traumatic brain injury; Stroke; Multiple Errands Test	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DAMAGE; EXECUTIVE FUNCTION; ECOLOGICAL VALIDITY; CLINICAL NEUROPSYCHOLOGY; DYSEXECUTIVE SYNDROME; COGNITIVE IMPAIRMENT; SIMPLIFIED VERSION; DYSFUNCTION; DEFICITS	Surprisingly few ecologically-valid assessments of executive function exist, but the Baycrest Multiple Errands Test (BMET) shows promise in identifying executive impairment. The goal of the present study was to develop both a revised version of the assessment (BMET-R), to improve the test's ability to discriminate between patients and healthy participants, and an alternate form of the BMET-R to permit repeat testing. Sixteen individuals with acquired brain injury (ABI) due to stroke or trauma and 16 healthy participants completed a series of neuropsychological assessments, questionnaires, the BMET-R and its alternate form (in counterbalanced order). The results of the study indicated that participants with ABI omitted more tasks, broke more rules, and were less efficient than healthy participants on both the revised BMET-R and its alternate form. Moreover, significant correlations were found between the two versions of the BMET-R for task completions, omissions, errors, rule breaks and inefficiencies but few significant correlations were observed between the BMET-R versions and measures of executive dysfunction in everyday life. These results indicate that the two versions of the BMET-R are able to dissociate the performance of participants with ABI from that of healthy participants. However, despite overlaps in performance and correlations between the two versions of the BMET-R, they did not identically assess executive deficits. This suggests that caution should be used when constructing and validating alternate versions of performance-based assessments.	[Clark, Amanda J.] Univ Tennessee, Dept Psychol, Chattanooga, TN 37403 USA; [Anderson, Nicole D.; Nalder, Emily; Arshad, Sidrah; Dawson, Deirdre R.] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Nalder, Emily; Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Anderson, Nicole D.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Anderson, Nicole D.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Nalder, Emily] Univ Toronto, Toronto, ON, Canada		Clark, AJ (corresponding author), Univ Tennessee, Dept Psychol, Chattanooga, TN 37403 USA.	Amanda-Clark@utc.edu	Anderson, Nicole D/E-9101-2011; Dawson, Deirdre/I-8882-2014	Anderson, Nicole D/0000-0002-5979-2220; Dawson, Deirdre/0000-0001-7517-6121	Heart and Stroke Foundation's Center for Stroke Recovery; Ontario Research Coalition; Ontario Neurotrauma Foundation [2011-ONF-REPAR2-879]	This work was supported by the Heart and Stroke Foundation's Center for Stroke Recovery; Ontario Research Coalition and the Ontario Neurotrauma Foundation under Grant [2011-ONF-REPAR2-879]. In addition, the work would not have been possible without the help of Yael Bar, Lydia Beck, Katharina Haag or R. Christopher Branson.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Anderson P. J., 2008, EXECUTIVE FUNCTIONS, P3; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1996, BEHAV ASSESSMENT DYS, P18; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P209, DOI 10.1080/713755574; Damasio AR, 1995, NEUROSCIENTIST, V1, P19, DOI DOI 10.1177/107385849500100104; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Edwards, 2003, TEST MANUAL EXECUTIV; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fisher A. G., 2010, ASSESSMENT MOTOR PRO, V1; Fisher A. G, 2006, ASSESSMENT MOTOR PRO, V6th; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Heaton, 2010, NEUROPSYCHOLOGY EVER, P5; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P207, DOI 10.1080/09084282.2011.643956; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levine B., 2008, COGNITIVE NEUROREHAB, V2nd, P464, DOI [10.1017/CBO9781316529898.033, DOI 10.1017/CBO9781316529898.033]; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maeir A, 2011, OTJR-OCCUP PART HEAL, V31, pS38, DOI 10.3928/15394492-20101108-07; Malec JF, 2003, MANUAL MAYOPORTLAND; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Poole JH, 1999, PSYCHIAT RES, V85, P161, DOI 10.1016/S0165-1781(98)00146-2; Poulin V, 2013, AUST OCCUP THER J, V60, P3, DOI 10.1111/1440-1630.12024; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raspelli S, 2012, PRESENCE-TELEOP VIRT, V21, P31, DOI 10.1162/PRES_a_00077; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D. T., 2009, REHABILITATION EXECU, P3; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tranel D, 2007, J CLIN EXP NEUROPSYC, V29, P319, DOI 10.1080/13803390600701376; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Wechsler D., 1958, MEASUREMENT APPRAISA; Wolf TJ, 2008, WORK, V31, P221; Zachary R. A., 1986, SHIPLEY I LIVING SCA; Zillmer E., 2008, PRINCIPLES NEUROPSYC; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015	58	11	11	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	5			SI		667	684		10.1080/09602011.2015.1117981			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EU3IT	WOS:000400923300004	26670475				2022-02-06	
J	Colledge, F; Brand, S; Zimmerer, S; Puhse, U; Holsboer-Trachsler, E; Gerber, M				Colledge, Flora; Brand, Serge; Zimmerer, Stefan; Puhse, Uwe; Holsboer-Trachsler, Edith; Gerber, Markus			In Individuals Following Aneurysmal Subarachnoid Haemorrhage, Hair Cortisol Concentrations Are Higher and More Strongly Associated with Psychological Functioning and Sleep Complaints than in Healthy Controls	NEUROPSYCHOBIOLOGY			English	Article						Aneurysm; Depression; Neuroendocrinology; Health-related quality of life; Sleep	TRAUMATIC BRAIN-INJURY; CORONARY-ARTERY-DISEASE; QUALITY-OF-LIFE; PITUITARY DYSFUNCTION; FUTURE-DIRECTIONS; RUPTURED ANEURYSM; HIGH-RISK; DEPRESSION; STRESS; HYPOPITUITARISM	Background: Following an aneurysmal subarachnoid haemorrhage (aSAH), many patients report persistent deficits in psychological functioning, characterised by high levels of stress and symptoms of depression, low life satisfaction, along with poor sleep. Such deficits have been associated with altered saliva and serum cortisol levels due to a dysregulation of hypothalamic-pituitary-adrenal axis activity (HPA-AA). However, hair cortisol concentrations (HCCs) have not been assessed in this population, although this method allows a long-term insight into cortisol values. Therefore, the objective of this study was to compare HCCs in aSAH patients and healthy controls and to examine how HCCs are associated with perceived stress, psychological functioning, and sleep complaints. Methods: In this cross-sectional study, data on depressive symptoms, hypochondriacal beliefs, life satisfaction, and sleep complaints were gathered in 15 aSAH patients and 17 healthy controls. HCCs of the previous 3 months were assessed. Results: aSAH patients had significantly higher HCCs than healthy controls. In aSAH patients, higher HCCs were significantly associated with increased depressive symptoms, hypochondriacal beliefs, lower life satisfaction, and increased sleep complaints. Such significant associations were not found in healthy controls. Conclusions: Our findings indicate that a dysregulation of HPA-AA is associated with some of the long-term impairments in psychological functioning and sleep in aSAH survivors. While the direction of association remained unclear, a dysregulated HPA-AA may be causally linked with the maintenance of poor psychological functioning and poor sleep. The overall findings should be considered in the planning of long-term treatment aimed at improving psychological functioning and sleep in aSAH patients. (C) 2017 S. Karger AG, Basel	[Colledge, Flora; Brand, Serge; Puhse, Uwe; Gerber, Markus] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Brand, Serge; Holsboer-Trachsler, Edith] Univ Basel, Ctr Affect Stress & Sleep Disorders, Psychiat Clin, Basel, Switzerland; [Zimmerer, Stefan] Karl Franzens Univ Graz, Univ Hosp Neurosurg, Graz, Austria		Gerber, M (corresponding author), Univ Basel, Dept Sport Exercise & Hlth, Sport Sci Sect, Div Sport & Psychosocial Hlth, Birsstr 320B, CH-4052 Basel, Switzerland.	markus.gerber@unibas.ch	Brand, Serge/H-7159-2019; Gerber, Markus/H-8654-2014	Brand, Serge/0000-0003-2175-2765; Gerber, Markus/0000-0001-6140-8948	Freiwillige Akademische Gesellschaft, Basel, Switzerland	This study was funded by the Freiwillige Akademische Gesellschaft, Basel, Switzerland. The funding source had no involvement in study design, data collection, analysis, and interpretation, article preparation, or the decision to submit the article for publication.	Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bosse S, 2015, PSYCHONEUROENDOCRINO, V61, P36, DOI 10.1016/j.psyneuen.2015.07.488; Brand S, 2015, WORLD J BIOL PSYCHIA, V16, P96, DOI 10.3109/15622975.2014.888093; Brand S, 2010, INT J STRESS MANAGE, V17, P114, DOI 10.1037/a0019090; Buchanan TW, 2004, BIOL PSYCHIAT, V56, P651, DOI 10.1016/j.biopsych.2004.08.014; Chrousos G., 2016, ENDOTEXT; Cohen J., 2013, STAT POWER ANAL BEHA; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2012.654479, 10.3109/10253890.2011.619239]; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Edwards KM, 2008, MATURITAS, V61, P330, DOI 10.1016/j.maturitas.2008.09.024; Fruehwald-Schultes B, 2001, J CLIN ENDOCR METAB, V86, P4187, DOI 10.1210/jc.86.9.4187; Gerber M, 2016, NEUROPSYCHOBIOLOGY, V73, P148, DOI 10.1159/000444492; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; Hadjivassiliou M, 2001, NEUROLOGY, V56, P1672, DOI 10.1212/WNL.56.12.1672; Haugen BR, 2009, BEST PRACT RES CL EN, V23, P793, DOI 10.1016/j.beem.2009.08.003; Hutter BO, 2014, J NEUROSURG, V120, P923, DOI 10.3171/2013.11.JNS121552; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Krysiak R, 2014, BASIC CLIN PHARMACOL, V114, P330, DOI 10.1111/bcpt.12169; Kutlubaev MA, 2012, J PSYCHOSOM RES, V72, P305, DOI 10.1016/j.jpsychores.2011.12.008; Laakmann G, 2003, NEUROPSYCHOBIOLOGY, V47, P31, DOI 10.1159/000068873; Lenze EJ, 2011, AM J GERIAT PSYCHIAT, V19, P482, DOI 10.1097/JGP.0b013e3181ec806c; Manenschijn L, 2013, J CLIN ENDOCR METAB, V98, P2078, DOI 10.1210/jc.2012-3663; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Maurer N, 2016, PSYCHONEUROENDOCRINO, V72, P166, DOI 10.1016/j.psyneuen.2016.07.003; Passier PECA, 2013, QUAL LIFE RES, V22, P1027, DOI 10.1007/s11136-012-0236-1; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; PILOWSKY I, 1967, BRIT J PSYCHIAT, V113, P89, DOI 10.1192/bjp.113.494.89; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Robba C, 2016, PITUITARY, V19, P522, DOI 10.1007/s11102-016-0733-2; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shin IY, 2011, STRESS, V14, P156, DOI 10.3109/10253890.2010.522630; Skoluda N, 2012, PSYCHONEUROENDOCRINO, V37, P611, DOI 10.1016/j.psyneuen.2011.09.001; Stalder T, 2013, J CLIN ENDOCR METAB, V98, P2573, DOI 10.1210/jc.2013-1056; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Stalder T, 2012, PSYCHONEUROENDOCRINO, V37, P602, DOI 10.1016/j.psyneuen.2011.08.007; Steiger A, 2013, PHARMACOPSYCHIATRY, V46, pS30, DOI 10.1055/s-0033-1337921; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Su HC, 2013, CUAJ-CAN UROL ASSOC, V7, pE594, DOI 10.5489/cuaj.420; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Wani TA, 2010, AAPS PHARMSCITECH, V11, P425, DOI 10.1208/s12249-010-9394-z; World Health Organization (WHO), 2005, INT STAT CLASS DIS R, V2nd	53	11	11	1	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0302-282X	1423-0224		NEUROPSYCHOBIOLOGY	Neuropsychobiology		2017	75	1					12	20		10.1159/000477966			9	Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	FL6LQ	WOS:000414356600002	28750407	Green Accepted			2022-02-06	
J	Corallo, F; De Cola, MC; Lo Buono, V; Marra, A; De Luca, R; Trinchera, A; Bramanti, P; Calabro, RS				Corallo, Francesco; De Cola, Maria Cristina; Lo Buono, Viviana; Marra, Angela; De Luca, Rosaria; Trinchera, Antonia; Bramanti, Placido; Calabro, Rocco Salvatore			Early vs late cranioplasty: what is better?	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						cranioplasty; neuropsychological improvement; severe brain injury; surgical timing; rehabilitation	SEVERE HEAD-INJURY; SKIN FLAP SYNDROME; DECOMPRESSIVE CRANIECTOMY; PROSPECTIVE MULTICENTER; CASE SERIES; BLOOD-FLOW; IMPACT; HEMICRANIECTOMY; IMPROVEMENT; SCALE	Aim of the study: Cranioplasty is the surgical repair of skull defects, which commonly is performed after traumatic skull injuries due to tumor removal or decompressive craniectomy. Several studies reported improvement in cognitive functions following cranioplasty in patients with severe brain damage. The reasons why exist such clinical improvement is not completely understood, although the increase in cerebrospinal fluid hydrodynamics with the potential improvement of local and global cerebral hemodynamics, blood flow, and metabolism may play a pivotal role. We investigated whether the cranioplasty improved neurological recovery and the whole array of cognitive functions or just some specific domains. Materials and methods: A total of 30 consecutive brain-injured subjects with craniectomy were enrolled and underwent a structured neuropsychological assessment immediately before the cranioplasty, 1 month after the cranioplasty and 1 year after the surgical procedure. Results: Our results showed that cranioplasty may facilitate the cognitive recovery, independently from the surgical timing. Particularly, we observed an important cognitive recovery in the period immediately after cranioplasty, while the improvement trend settles after a lapse of time, and the recovery starts to slow down. Conclusions: Cranioplasty seems to significantly improve neuropsychological and motor status in the patients with skull defects, independently from cranioplasty timing and patient's clinical status.	[Corallo, Francesco; De Cola, Maria Cristina; Lo Buono, Viviana; Marra, Angela; De Luca, Rosaria; Trinchera, Antonia; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	Bramanti, Placido/K-5117-2016; De Cola, Maria C/B-7714-2017; Lo Buono, Viviana/K-5778-2016; calabro, rocco salvatore/L-9570-2019; marra, angela/AAB-7802-2020; Calabro, Rocco S/K-7520-2016; corallo, francesco/K-5932-2016	De Cola, Maria C/0000-0002-7509-3833; Lo Buono, Viviana/0000-0001-8027-6098; calabro, rocco salvatore/0000-0002-8566-3166; corallo, francesco/0000-0003-4862-3832			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Aydin S, 2011, J NEUROSCI RURAL PRA, V22, P203; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Coelho F, 2014, NEUROPSYCH DIS TREAT, V10, P695, DOI 10.2147/NDT.S52875; Corallo F, 2016, NEUROL SCI, V37, P833, DOI 10.1007/s10072-016-2488-y; Corallo F, 2014, FUNCT NEUROL, V29, P273, DOI 10.11138/FNeur/2014.29.4.273; Corallo F, 2015, TURK NEUROSURG, V25, P193, DOI 10.5137/1019-5149.JTN.10618-14.2; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Doyle DJ, 1989, GLASGOW COMA SCALE G; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HENLEY NM, 1969, J VERB LEARN VERB BE, V8, P176, DOI 10.1016/S0022-5371(69)80058-7; Honeybul Stephen, 2014, Surg Neurol Int, V5, P83, DOI 10.4103/2152-7806.133886; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Huang YH, 2013, INT J SURG, V11, P886, DOI 10.1016/j.ijsu.2013.07.013; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; Mah Jon Kooi, 2016, Asian J Neurosurg, V11, P15, DOI 10.4103/1793-5482.172593; McMinn MR., 1988, CLIN NEUROPSYCHOL, V2, P67, DOI DOI 10.1080/13854048808520087; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Romero FR, 2013, INT J SURG CASE REP, V4, P1007, DOI 10.1016/j.ijscr.2013.08.013; Sander A, LEVEL COGNITIVE FUNC; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Servadei F, 2015, WORLD NEUROSURG, V83, P133, DOI 10.1016/j.wneu.2014.08.031; Stefano CD, 2015, BRAIN INJURY, V30, P164; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; Tuzgen S, 2012, J NEUROSCI RURAL PRA, V3, P251, DOI 10.4103/0976-3147.102598; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053	42	11	13	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2017	127	8					688	693		10.1080/00207454.2016.1235045			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU4FA	WOS:000400984000006	27609482				2022-02-06	
S	Cummings, L		Cummings, L		Cummings, Louise			Cognitive Aspects of Pragmatic Disorders	RESEARCH IN CLINICAL PRAGMATICS	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter						Cognitive-communication disorder; Cognitive pragmatics; Executive function; Mental state attribution; Modular pragmatics; Relevance theory; Theory of mind; Utterance interpretation	TRAUMATIC BRAIN-INJURY; NON-LITERAL LANGUAGE; EXECUTIVE FUNCTIONS; ASPERGER-SYNDROME; WORKING-MEMORY; YOUNG-CHILDREN; MIND DEFICITS; EMOTION RECOGNITION; IRONY COMPREHENSION; ALZHEIMERS-DISEASE	The study of the cognitive substrates of pragmatic disorders is a relatively recent development in clinical pragmatics. This development has been ushered in by calls from researchers and clinicians on two fronts. First, it has been urged that the field of pragmatics should undergo a cognitive turn, such that a cognitive examination of pragmatic concepts is afforded equal significance to societal, philosophical and linguistic approaches to the discipline. Second, clinicians have increasingly acknowledged that it is not possible to assess and treat clients with pragmatic disorders in isolation from cognitive concerns. The chapter begins with an examination of the various cognitive processes that play a role in a standard communicative exchange. From this examination the two main components of any cognitive treatment of pragmatic disorders - executive functions and theory of mind - are established. The findings of clinical studies of clients with pragmatic disorders are discussed. These studies suggest an association between cognitive processes such as theory of mind on the one hand and a range of pragmatic impairments on the other hand. Conversational data from clients with pragmatic disorders are used to illustrate these cognitive-based pragmatic impairments. Finally, three theoretical frameworks with the potential to explain the cognitive basis of pragmatic disorders are examined.	[Cummings, Louise] Nottingham Trent Univ, Sch Arts & Humanities, Clifton Lane, Nottingham NG11 8NS, England		Cummings, L (corresponding author), Nottingham Trent Univ, Sch Arts & Humanities, Clifton Lane, Nottingham NG11 8NS, England.	louise.cummings@ntu.ac.uk		Cummings, Louise/0000-0002-8947-8195			Abbeduto L, 2001, Downs Syndr Res Pract, V7, P9, DOI 10.3104/reports.109; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Bara BG, 2000, BRAIN COGNITION, V43, P21; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 2001, BRAIN LANG, V77, P216, DOI 10.1006/brln.2000.2429; Bara Bruno, 2010, COGNITIVE PRAGMATICS; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bishop DVM, 2005, AUTISM, V9, P7, DOI 10.1177/1362361305049027; Body R., 1999, BRAIN DAM B; Bosco FM, 2006, J PRAGMATICS, V38, P1398, DOI 10.1016/j.pragma.2005.06.011; Bosco FM, 2014, CONSCIOUS COGN, V24, P84, DOI 10.1016/j.concog.2014.01.003; Bozikas VP, 2011, SCHIZOPHR RES, V130, P130, DOI 10.1016/j.schres.2011.04.025; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Bucciarelli M, 2003, J PRAGMATICS, V35, P207, DOI 10.1016/S0378-2166(02)00099-1; Bueno V. F., 2014, J ATTENTION IN PRESS; Caillies S, 2012, RES DEV DISABIL, V33, P1380, DOI 10.1016/j.ridd.2012.03.012; Carlson SM, 2004, J EXP CHILD PSYCHOL, V87, P299, DOI 10.1016/j.jecp.2004.01.002; Carruthers P., 2000, EVOLUTION HUMAN MIND; Castelli I, 2011, AGING MENT HEALTH, V15, P157, DOI 10.1080/13607863.2010.513038; Cavallini E, 2013, INT J AGING HUM DEV, V76, P181, DOI 10.2190/AG.76.3.a; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; Cohen DJ., 2000, UNDERSTANDING OTHER, P21; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Cornish K, 2005, J INTELL DISABIL RES, V49, P372, DOI 10.1111/j.1365-2788.2005.00678.x; Crone EA, 2006, J EXP CHILD PSYCHOL, V95, P99, DOI 10.1016/j.jecp.2006.03.007; Cuerva AG, 2001, NEUROPSY NEUROPSY BE, V14, P153; Cummings L., 2013, INT J LANGUAGE STUDI, V7, P1; Cummings L., 2014, CAMBRIDGE HDB COMMUN, P559; Cummings L., 2012, HDB PRAGMATICS, V4, P291; Cummings L., 2015, OXFORD HDB PRAGMATIC, P346; CUMMINGS L, 2005, PRAGMATICS MULTIDISC; Cummings L., 2012, LODZ PAPERS PRAGMATI, V8, P61; Cummings L., 2009, CLIN PRAGMATICS; Cummings L., 2014, COMMUNICATION DISORD; Cummings L., 2012, WHAT IS CONTEXT LING, P55, DOI DOI 10.1075/LA.196.06CUM; Cummings L., 2014, PRAGMATIC DISORDERS; Cummings L, 2007, LANG COMMUN, V27, P396, DOI 10.1016/j.langcom.2007.06.001; Cummings L, 2017, ROUT HANDB APPL, P419; Cummings L, 2016, PERSP PRAGMAT PHILO, V5, P31, DOI 10.1007/978-3-319-21395-8_3; Cummings L, 2016, PERSP PRAGMAT PHILO, V4, P179, DOI 10.1007/978-3-319-12616-6_6; Cummings L, 2013, PERSP PRAGMAT PHILO, V2, P23, DOI 10.1007/978-3-319-01014-4_2; Cummings L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01286; Cummings L, 2011, PRAGMAT SOC, V2, P17, DOI 10.1075/ps.2.1.02cum; Cummings Louise, 2007, SEMINARS SPEECH LANG, V28, P98; Cummings Louise, 2010, PRAGMATICS ENCY, P292; Cummings Louise, 2008, CLIN LINGUISTICS; Cutica I, 2006, BRAIN LANG, V98, P12, DOI 10.1016/j.bandl.2006.01.001; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; Daunhauer LA, 2014, AJIDD-AM J INTELLECT, V119, P303, DOI 10.1352/1944-7558-119.4.303; David N, 2010, J AUTISM DEV DISORD, V40, P290, DOI 10.1007/s10803-009-0867-4; Diamond A, 2002, DEV PSYCHOL, V38, P352, DOI 10.1037/0012-1649.38.3.352; Dipper LT, 1997, CLIN LINGUIST PHONET, V11, P213, DOI 10.3109/02699209708985192; Donno R, 2010, BRIT J PSYCHIAT, V196, P282, DOI 10.1192/bjp.bp.108.061341; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Eddy CM, 2010, COGN BEHAV NEUROL, V23, P178, DOI 10.1097/WNN.0b013e3181e61cb7; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Fernandez-Duque D, 2009, J CLIN EXP NEUROPSYC, V31, P489, DOI 10.1080/13803390802282688; Fernandez-Gonzalo S, 2014, J NERV MENT DIS, V202, P576, DOI 10.1097/NMD.0000000000000164; Forman H, 2011, J EXP CHILD PSYCHOL, V108, P170, DOI 10.1016/j.jecp.2010.07.004; Godefroy O, 2014, J ALZHEIMERS DIS, V42, P1203, DOI 10.3233/JAD-140585; Golan O, 2008, J AUTISM DEV DISORD, V38, P1534, DOI 10.1007/s10803-007-0533-7; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Grant CM, 2007, J ABNORM CHILD PSYCH, V35, P17, DOI 10.1007/s10802-006-9077-0; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Griffin R, 2006, LATERALITY, V11, P195, DOI 10.1080/13576500500450552; Hale CM, 2005, J AUTISM DEV DISORD, V35, P519, DOI 10.1007/s10803-005-5065-4; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Huizinga M, 2007, DEV NEUROPSYCHOL, V31, P193, DOI 10.1080/87565640701190817; Ikeda Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00227; Irish M, 2014, BRAIN, V137, P1241, DOI 10.1093/brain/awu003; John AE, 2009, AJIDD-AM J INTELLECT, V114, P85, DOI 10.1352/2009.114.85-99; Kamradt JM, 2014, PSYCHOL ASSESSMENT, V26, P1095, DOI 10.1037/pas0000006; KASHER A, 1991, J PRAGMATICS, V16, P381, DOI 10.1016/0378-2166(91)90132-H; Kasher A, 1999, BRAIN LANG, V68, P566, DOI 10.1006/brln.1999.2129; KASHER A, 1984, J PRAGMATICS, V8, P539, DOI 10.1016/0378-2166(84)90041-9; Kasher A., 1991, PRAGMATICS, P567; Kasher A., 1994, FDN SPEECH ACT THEOR, P312; Kleinman J, 2001, J AUTISM DEV DISORD, V31, P29, DOI 10.1023/A:1005657512379; Krachun C, 2010, INT J COMP PSYCHOL, V23, P145; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; Lewis P, 2006, J INTELL DISABIL RES, V50, P532, DOI 10.1111/j.1365-2788.2006.00803.x; Liddle B., 2006, J CULTURAL EVOLUTION, V4, P231, DOI [10.1556/jcep.4.2006.3-4.3, DOI 10.1556/JCEP.4.2006.3-4.3]; Lincoln TM, 2011, SCHIZOPHRENIA BULL, V37, pS23, DOI 10.1093/schbul/sbr066; Lind SE, 2010, J AUTISM DEV DISORD, V40, P479, DOI 10.1007/s10803-009-0889-y; Losh M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00266; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Loukusa S, 2007, J COMMUN DISORD, V40, P357, DOI 10.1016/j.jcomdis.2006.10.001; Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2; Mantyla T, 2007, J EXP CHILD PSYCHOL, V96, P1, DOI 10.1016/j.jecp.2006.08.003; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; Maylor EA, 2002, BRIT J PSYCHOL, V93, P465, DOI 10.1348/000712602761381358; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; McCabe PJ, 2008, J COMMUN DISORD, V41, P203, DOI 10.1016/j.jcomdis.2007.11.002; McDonald S, 2000, BRAIN LANG, V75, P82, DOI 10.1006/brln.2000.2342; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Mehta UM, 2014, PSYCHIAT RES, V219, P268, DOI 10.1016/j.psychres.2014.05.055; Meilijson SR, 2004, J SPEECH LANG HEAR R, V47, P695, DOI 10.1044/1092-4388(2004/053); Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Monetta L, 2009, CORTEX, V45, P972, DOI 10.1016/j.cortex.2009.02.021; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Pijnacker J, 2012, J AUTISM DEV DISORD, V42, P2440, DOI 10.1007/s10803-012-1500-5; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Pulsipher DT, 2013, CLIN NEUROPSYCHOL, V27, P924, DOI 10.1080/13854046.2013.799714; Rasmussen C., 2009, CANADIAN J CLIN PHAR, V16, P370; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Rvachew S., 2014, CAMBRIDGE HDB COMMUN, P61; Santos A, 2009, J AUTISM DEV DISORD, V39, P651, DOI 10.1007/s10803-008-0669-0; Schelletter C, 2003, CLIN LINGUIST PHONET, V17, P335, DOI 10.1080/0269920031000080000; Schoemaker K, 2014, DEV NEUROPSYCHOL, V39, P302, DOI 10.1080/87565641.2014.911875; Segal Gabriel, 1996, THEORIES THEORIES MI, P141; Soroker Nachum, 2005, Brain Cogn, V57, P214, DOI 10.1016/j.bandc.2004.08.047; Sperber D., 1995, RELEVANCE COMMUNICAT; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan K, 1999, AM J MENT RETARD, V104, P523, DOI 10.1352/0895-8017(1999)104<0523:SBAIWS>2.0.CO;2; Tan EJ, 2014, SCHIZOPHR RES, V152, P242, DOI 10.1016/j.schres.2013.11.001; Tannock R., 2005, CONVERGENCE INTERDIS, P45; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Urben S, 2011, BRIT J DEV PSYCHOL, V29, P981, DOI 10.1111/j.2044-835X.2011.02037.x; van den Bergh SFWM, 2014, J AUTISM DEV DISORD, V44, P1959, DOI 10.1007/s10803-014-2071-4; Van Herwegen J, 2013, J COMMUN DISORD, V46, P440, DOI 10.1016/j.jcomdis.2013.10.002; Vugs B, 2014, RES DEV DISABIL, V35, P62, DOI 10.1016/j.ridd.2013.10.022; Weed E, 2010, BRAIN LANG, V113, P65, DOI 10.1016/j.bandl.2010.01.009; Weed E, 2008, INT J SPEECH-LANG PA, V10, P414, DOI 10.1080/17549500802455429; Weismer S. E., 2014, CAMBRIDGE HDB COMMUN, P73, DOI [10.1017/CBO9781139108683.007, DOI 10.1017/CBO9781139108683.007]; Whitely C, 2013, J SPEECH LANG HEAR R, V56, P1625, DOI 10.1044/1092-4388(2013/12-0176); Wiebe SA, 2011, J EXP CHILD PSYCHOL, V108, P436, DOI 10.1016/j.jecp.2010.08.008; Williams D, 2010, DEVELOPMENTAL SCI, V13, P307, DOI 10.1111/j.1467-7687.2009.00885.x; Wilson D, 2005, LINGUA, V115, P1129, DOI 10.1016/j.lingua.2004.02.005; Xu F., 2013, PLOS ONE, V8; Yeh ZT, 2014, PSYCHIAT CLIN NEUROS, V68, P612, DOI 10.1111/pcn.12173; Yirmiya N, 1996, J CHILD PSYCHOL PSYC, V37, P1003, DOI 10.1111/j.1469-7610.1996.tb01497.x	142	11	11	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-47489-2; 978-3-319-47487-8	PERSP PRAGMAT PHILO			2017	11						587	616		10.1007/978-3-319-47489-2_22	10.1007/978-3-319-47489-2		30	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	BI8BR	WOS:000414965000023					2022-02-06	
J	Driver, S; Reynolds, M; Kramer, K				Driver, Simon; Reynolds, Megan; Kramer, Kaye			Modifying an evidence-based lifestyle programme for individuals with traumatic brain injury	BRAIN INJURY			English	Article						Physical activity; exercise; diet; self-management; weight loss	DIABETES-PREVENTION-PROGRAM; PHYSICAL-ACTIVITY; WEIGHT-LOSS; HEALTH; ADULTS; RISK; CARE; INTERVENTION; AQUATICS; MODERATE	Objective: Individuals with traumatic brain injury (TBI) are at a risk of obesity-related chronic diseases; yet, no evidence-based strategies exist to support weight management in this population. The purpose of this study was to use participatory action research to modify the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) programme for overweight/obese people with TBI. The DPP-GLB programme provides education and self-management skills for individuals to reach their lifestyle goals through healthy eating and physical activity. Methods: A committee of 10 stakeholders including clinicians, patients and caregivers reviewed and modified the DPP-GLB for overweight/obese individuals with TBI. Stakeholders suggested modifications to the content, layout, format, language, behaviour-changing strategies and delivery approaches. The group also provided input on research applications of the modified DPP-GLB including recruitment strategies, study design and patient-centred outcome measures. Results: Strategies for successful implementation in this population focused on determining (1) eligibility criteria for programme inclusion and (2) adaptations to the DPP-GLB curriculum including caregiver involvement, TBI-specific physical activity and nutrition recommendations and tracking and presentation of the content. Conclusions: If it is shown to be effective in this population, the modified DPP-GLB for TBI will provide a model for implementation in a variety of community settings.	[Driver, Simon; Reynolds, Megan] Baylor Univ, Med Ctr, Baylor Inst Rehabil, Dept Phys Med & Rehabil, Dallas, TX USA; [Kramer, Kaye] Innovat Wellness Solut LLC, Pittsburgh, PA USA		Driver, S (corresponding author), Baylor Inst Rehabil, Dept Phys Med & Rehabil, 909N Washington Ave, Dallas, TX 75246 USA.	simon.driver@BSWHealth.org		driver, simon/0000-0003-2356-432X			Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Driver S, 2016, ARCH PHYS MED REHAB, V97, pS194, DOI 10.1016/j.apmr.2015.06.023; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Drum CE, 2009, AM J HLTH PROMOT, V2493, P101; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kramer MK, 2015, J OCCUP ENVIRON MED, V57, P284, DOI 10.1097/JOM.0000000000000350; Kramer MK, 2011, DIABETES EDUCATOR, V37, P659, DOI 10.1177/0145721711411930; Kramer MK, 2010, DIABETES RES CLIN PR, V90, pE60, DOI 10.1016/j.diabres.2010.08.013; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Kriska A, 2003, EXERC SPORT SCI REV, V31, P132, DOI 10.1097/00003677-200307000-00006; Kriska AM, 2006, MED SCI SPORT EXER, V38, P826, DOI 10.1249/01.mss.0000218138.91812.f9; Lustenberger T, 2013, BRAIN INJURY, V27, P281, DOI 10.3109/02699052.2012.743178; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; McDermott S., 2007, PRIM HEALTH CARE RES, V8, P36, DOI [DOI 10.1017/S1463423607000059, 10.1017/S1463423607000059]; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Palmer-McLean K, 2009, ACSMS EXERCISE MANAG; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Rieger E, 2014, CLIN OBES, V4, P77, DOI 10.1111/cob.12042; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Venditti EM, 2013, AM J PREV MED, V44, pS339, DOI 10.1016/j.amepre.2012.12.014; Warren AM, 2016, REHABIL PSYCHOL, V61, P179, DOI 10.1037/rep0000080; White G. W., 2001, J PREVENTION INTERVE, V21, P15; Wing RR, 2004, OBES RES, V12, P1426; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	36	11	11	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1612	1616		10.1080/02699052.2017.1346286			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200007	28750178				2022-02-06	
J	Gagnon, KL; DePrince, AP				Gagnon, Kerry L.; DePrince, Anne P.			Head injury screening and intimate partner violence: A brief report	JOURNAL OF TRAUMA & DISSOCIATION			English	Article						Health impact of trauma; intimate partner violence	TRAUMATIC BRAIN-INJURY; ABUSE; WOMEN; PREVALENCE; OUTREACH; OUTCOMES; IMPACT	Objective: Although the importance of traumatic brain injury has gained public attention in recent years, relatively little attention has been paid to head injuries among women who have experienced intimate partner violence (IPV). The present study screened for lifetime exposure to mild traumatic brain injuries (mTBIs) among a sample of women who had experienced recent IPV (median days since target incident=26). Method: Participants included ethnically diverse women whose IPV experiences were reported to law enforcement. Women (n=225) were asked about injuries to the head sustained during the target IPV incident as well as over the lifetime, and related symptoms. Results: The vast majority of women (80%) reported a lifetime head injury. More than half (56%) screened positive for mTBI, defined as at least one instance in which they experienced a change in consciousness or a period of being dazed and confused as a result of a head injury. A minority of women (13%) reported injuries to the head during the target IPV incident. Most women who had experienced a lifetime head injury reported frequent and current cognitive difficulties. Conclusion: These findings highlight the importance of assessing head injuries and related symptoms among women who have experienced IPV, pointing to important implications for policy and practice.	[Gagnon, Kerry L.; DePrince, Anne P.] Univ Denver, Dept Psychol, 2155 South Race St, Denver, CO 80208 USA		Gagnon, KL (corresponding author), Univ Denver, Dept Psychol, 2155 South Race St, Denver, CO 80208 USA.	Kerry.Gagnon@du.edu			National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2007-WG-BX-0002]	This project was funded by Award No. 2007-WG-BX-0002 awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this report are our own and do not necessarily reflect those of the Department of Justice. The views expressed in this report do not necessarily represent those of the National Institute of Justice.	Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; De Prince AP, 2012, J CONSULT CLIN PSYCH, V80, P211, DOI 10.1037/a0027224; DePrince AP, 2013, COGN BEHAV PRACT, V20, P189, DOI 10.1016/j.cbpra.2012.07.001; DePrince AP, 2012, VIOLENCE AGAINST WOM, V18, P861, DOI 10.1177/1077801212456523; Faul M, 2010, TRAUMATIC BRAIN INJU; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lee M. S., 2016, IMPACT EXECUTIVE FUN; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; New York State Office for the Prevention of Domestic Violence, 2006, TRAUM BRAIN INJ DOM; Perna R., 2005, J COGNITIVE REHABILI, V23, P5; Phelan MB, 2007, TRAUMA VIOLENCE ABUS, V8, P199, DOI 10.1177/1524838007301221; Picard N., 1999, HELPS; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333	25	11	11	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1529-9732	1529-9740		J TRAUMA DISSOCIATIO	J. Trauma Dissociation		2017	18	4					635	644		10.1080/15299732.2016.1252001			10	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	EZ2ED	WOS:000404521700011	27775489				2022-02-06	
J	Gonzalez, P; Rodriguez, FJ				Gonzalez, Pau; Javier Rodriguez, Francisco			Analysis of the expression of the Wnt family of proteins and its modulatory role on cytokine expression in non activated and activated astroglial cells	NEUROSCIENCE RESEARCH			English	Article						Astrocyte; Wnt ligand; Wnt receptor; Wnt regulator; Wnt signaling; In vitro; Cytokine expression	AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; WNT/BETA-CATENIN; BETA-CATENIN; SIGNALING PATHWAY; TRANSGENIC MICE; REACTIVE ASTROGLIOSIS; STEM-CELLS; ALVEOLAR MACROPHAGES	Despite the essential functions of astrocytes and the emerging relevance of the Wnt family of proteins in the CNS under physiological and pathological conditions, the astroglial expression of this family of proteins and its potential modulatory role on astroglial activation is almost unknown. Thus, we have evaluated the expression of all Wnt ligands, receptors and regulators, and the activation state of Wnt-related signaling pathways in non-activated and differentially activated astroglial cultures. We found that numerous Wnt ligands, receptors and regulators were expressed in non-activated astrocytes, while the Wnt-dependent pathways were constitutively active. Moreover, the expression of most detectable Wnt-related molecules and the activity of the Wnt-dependent pathways suffered post-activation variations which frequently depended on the activation system. Finally, the analysis of the effects exerted by Wnt1 and 5a on the astroglial expression of prototypical genes related to astroglial activation showed that both Wnt ligands increased the astroglial expression of interleukin 1 beta depending on the experimental context, while did not modulate tumor necrosis factor alpha, interleukin 6, transforming growth factor beta 1 and glial fibrillary acidic protein expression. These results strongly suggest that the Wnt family of proteins is involved in how astrocytes modulate and respond to the physiological and pathological CNS. (C) 2016 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.	[Gonzalez, Pau; Javier Rodriguez, Francisco] Natl Hosp Parapleg, Lab Mol Neurol, Finca la Peraleda S-N, Toledo 45071, Spain		Gonzalez, P; Rodriguez, FJ (corresponding author), Natl Hosp Parapleg, Lab Mol Neurol, Finca la Peraleda S-N, Toledo 45071, Spain.	paug@sescam.jccm.es; fjrodriguez@sescam.jccm.es	Sanchez, Pau Gonzalez/J-2530-2019	Sanchez, Pau Gonzalez/0000-0002-8871-8054; Rodriguez, Javier/0000-0001-5902-7556	Fondo de Investigaciones Sanitarias (FIS)Instituto de Salud Carlos III [PI12-2895]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	We thank Sandra Vazquez, Virginia Perez and Marta Medrano for their outstanding technical assistance. This research was supported by the Fondo de Investigaciones Sanitarias (FIS) (Grant PI12-2895, co-funded by Fondo Europeo de Desarrollo Regional (FEDER)).	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Chen YC, 2012, NEUROL RES, V34, P390, DOI 10.1179/1743132812Y.0000000027; Chen YC, 2012, BIOCHEM BIOPH RES CO, V420, P397, DOI 10.1016/j.bbrc.2012.03.006; Clark MA, 2012, NEUROCHEM RES, V37, P1475, DOI 10.1007/s11064-012-0738-9; Colangelo AM, 2014, NEUROSCI LETT, V565, P59, DOI 10.1016/j.neulet.2014.01.014; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Gao YJ, 2008, NEUROSCI LETT, V437, P180, DOI 10.1016/j.neulet.2008.03.017; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gong K, 2012, PROTEIN CELL, V3, P762, DOI 10.1007/s13238-012-2058-x; Gonzalez P, 2013, J NEUROTRAUM, V30, P806, DOI 10.1089/neu.2012.2613; Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050793; Gonzalez-Fernandez C, 2014, J NEUROTRAUM, V31, P565, DOI 10.1089/neu.2013.3067; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Halleskog C, 2013, J NEUROCHEM, V125, P803, DOI 10.1111/jnc.12250; Halleskog C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-111; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Henderson LJ, 2012, J NEUROSCI, V32, P16306, DOI 10.1523/JNEUROSCI.3145-12.2012; Hirota Y, 2016, NEUROCHEM RES, V41, P222, DOI 10.1007/s11064-015-1766-z; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Jurewicz E, 2013, NEUROCHEM RES, V38, P1941, DOI 10.1007/s11064-013-1100-6; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Ko HM, 2013, BIOCHEM BIOPH RES CO, V438, P420, DOI 10.1016/j.bbrc.2013.07.089; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; L'Episcopo F, 2014, STEM CELLS, V32, P2147, DOI 10.1002/stem.1708; L'Episcopo F, 2014, J MOL CELL BIOL, V6, P13, DOI 10.1093/jmcb/mjt053; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Li B, 2015, CELL BIOL INT, V39, P192, DOI 10.1002/cbin.10359; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Li XJ, 2013, INT J CLIN EXP PATHO, V6, P1245; Li Y, 2014, MOL IMMUNOL, V59, P128, DOI 10.1016/j.molimm.2014.02.002; Liao CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079350; Liu G, 2013, CELL MOL NEUROBIOL, V33, P543, DOI 10.1007/s10571-013-9920-0; Liu S, 2015, PAIN, V156, P2572, DOI 10.1097/j.pain.0000000000000366; Liu Z., 2015, PROG NEUROBIOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchetti B, 2013, TRENDS MOL MED, V19, P144, DOI 10.1016/j.molmed.2012.12.001; Fernandez-Martos CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027000; Meister M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00078; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Moreno-Estelles M, 2012, STEM CELLS, V30, P2796, DOI 10.1002/stem.1243; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Nie XK, 2015, J APPL TOXICOL, V35, P851, DOI 10.1002/jat.3084; Niu LJ, 2012, NEUROSCIENCE, V213, P19, DOI 10.1016/j.neuroscience.2012.03.057; Ohnishi M, 2015, BIOCHEM BIOPH RES CO, V467, P367, DOI 10.1016/j.bbrc.2015.09.151; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Onishi K, 2014, CURR OPIN NEUROBIOL, V27, P232, DOI 10.1016/j.conb.2014.05.005; Paganoni S, 2004, GLIA, V46, P456, DOI 10.1002/glia.20023; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Ransom BR, 2012, METHODS MOL BIOL, V814, P3, DOI 10.1007/978-1-61779-452-0_1; Redondo-Castro E, 2013, EUR J NEUROSCI, V38, P3786, DOI 10.1111/ejn.12382; Richards MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092159; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Satoh J, 2000, NEUROPATHOLOGY, V20, P113, DOI 10.1046/j.1440-1789.2000.00293.x; Shin T, 2003, J NEUROIMMUNOL, V140, P118, DOI 10.1016/S0165-5728(03)00174-7; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tanaka T, 2008, NEUROSCI LETT, V431, P262, DOI 10.1016/j.neulet.2007.11.051; Tang Y, 2014, J DENT RES, V93, P175, DOI 10.1177/0022034513512507; Thiele A, 2001, J IMMUNOL, V167, P6786, DOI 10.4049/jimmunol.167.12.6786; Verkhratsky A., 2015, PROG NEUROBIOL; Wang HH, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-84; Wang J, 2013, INFLAMMATION, V36, P1393, DOI 10.1007/s10753-013-9679-y; Wang JT, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-117; Wang SS, 2013, BIOTECHNOL LETT, V35, P1199, DOI 10.1007/s10529-013-1199-1; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Wu DC, 2000, J CEREBR BLOOD F MET, V20, P1320, DOI 10.1097/00004647-200009000-00007; Xie C, 2014, MOL NEUROBIOL, V49, P1117, DOI 10.1007/s12035-013-8584-6; Yang JL, 2016, GLIA, V64, P1083, DOI 10.1002/glia.22984; YANO S, 1994, J BIOL CHEM, V269, P5428; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036560; Yu L, 2013, NEUROCHEM RES, V38, P1904, DOI 10.1007/s11064-013-1096-y; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang KL, 2012, J NEUROIMMUNE PHARM, V7, P740, DOI 10.1007/s11481-012-9359-y; Zhang L, 2016, LIFE SCI, V153, P132, DOI 10.1016/j.lfs.2016.04.021; Zhang PS, 1996, J NEUROSCI RES, V46, P114, DOI 10.1002/(SICI)1097-4547(19961001)46:1<114::AID-JNR14>3.0.CO;2-5; Zhang XB, 2014, INFLAMMATION, V37, P942, DOI 10.1007/s10753-014-9814-4; Zhang YK, 2013, J CLIN INVEST, V123, P2268, DOI 10.1172/JCI65364	88	11	11	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JAN	2017	114						16	29		10.1016/j.neures.2016.08.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ9GE	WOS:000393533800004	27562517				2022-02-06	
J	Hicks, AJ; Gould, KR; Hopwood, M; Kenardy, J; Krivonos, I; Ponsford, JL				Hicks, A. J.; Gould, K. R.; Hopwood, M.; Kenardy, J.; Krivonos, I.; Ponsford, J. L.			Behaviours of concern following moderate to severe traumatic brain injury in individuals living in the community	BRAIN INJURY			English	Article						Traumatic brain injury; behaviours of concern; behaviour	CHALLENGING BEHAVIORS; AGGRESSIVE-BEHAVIOR; DWELLING ADULTS; SCALE OBS; REHABILITATION; MULTICENTER; EXPERIENCE; CAREGIVER; RELATIVES; OUTCOMES	Primary Objective: Behaviours of Concern (BoC) following traumatic brain injury (TBI) have a significant negative impact on the daily functioning and quality of life for the individual and their family. However, there has been limited research examining the nature and severity of BoC beyond the acute recovery period, including the perspective of the individual with TBI as well as close others (COs).Methods and Procedure: Eighty-nine individuals with predominantly severe TBI, at a mean of 11.4 years' post-injury, were identified through a no-fault accident compensation system database. Structured interviews were completed with 65 individuals with TBI, and 62 COs. Current BoC were documented using the Overt Behaviour Scale (OBS).Main Outcomes and Results: 70.5% of participants exhibited BoC on the OBS, with an average of 3 behaviours. Verbal aggression and socially inappropriate behaviour were the most common BoC. Self-report of behaviour change was endorsed by 81% of the sample. There was generally poor concordance between the perspectives of the individual with the TBI and their CO.Conclusion: Severe BoC, across multiple behaviour types, may be evident many years following predominantly severe TBI. There is a need to provide long-term behaviour support for these individuals.	[Hicks, A. J.; Gould, K. R.; Ponsford, J. L.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Hopwood, M.; Krivonos, I.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Kenardy, J.] Univ Queensland, Recover Injury Res Ctr, Brisbane, Qld, Australia; [Kenardy, J.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia		Hicks, AJ (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	amelia.hicks@monash.edu	Hicks, Amelia/AAQ-7743-2020; Gould, Kate Rachel/AAA-5511-2020; Kenardy, Justin/F-2085-2010; Kenardy, Justin A/H-6603-2014; Ponsford, Jennie/H-8341-2014	Gould, Kate Rachel/0000-0002-3564-7408; Kenardy, Justin A/0000-0001-9475-8450; Hicks, Amelia/0000-0002-1152-0576; Ponsford, Jennie/0000-0003-0430-125X			Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Brooks D N, 1979, Int Rehabil Med, V1, P160; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; Coy AE, 2013, ARCH PHYS MED REHAB, V94, P362, DOI 10.1016/j.apmr.2012.08.210; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Erosa NA, 2010, EPIDEMIOL BIOSTAT PU, V7, P76; Feeney TJ, 2014, NEUROREHABILITATION, V34, P709, DOI 10.3233/NRE-141088; Feeney Timothy J., 2010, Seminars in Speech and Language, V31, P145, DOI 10.1055/s-0030-1257531; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Gagnon J, 2016, BRAIN INJURY, V30, P1019, DOI 10.3109/02699052.2016.1148197; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hammond FM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000136; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kim E, 2002, NEUROREHABILITATION, V17, P297; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rahman B, 2010, NEUROPSYCHOL REHABIL, V20, P212, DOI 10.1080/09602010903021097; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	56	11	11	2	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1312	1319		10.1080/02699052.2017.1317361			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800008	28686065				2022-02-06	
J	Jacoba, L; Bohlken, J; Kostev, K				Jacoba, Louis; Bohlken, Jens; Kostev, Karel			Risk Factors for Mild Cognitive Impairment in German Primary Care Practices	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Germany; mild cognitive impairment; primary practices; risk factors	TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; ALCOHOL-CONSUMPTION; DEMENTIA; PROGRESSION; MEN; AGE; PREVALENCE; DATABASE; STROKE	Background: Mild cognitive impairment (MCI) is a common mental disorder affecting around 16% of elderly people without dementia. MCI is considered an intermediate state between normal cognition and dementia. Objective: To analyze risk factors for the development of MCI in German primary care practices. Methods: In total, 3,604 MCI patients and 3,604 controls without MCI were included between January 2010 and December 2015. Several disorders potentially associated with MCI were determined. Multivariate logistic regression models were fitted with MCI as a dependent variable and other disorders as potential predictors. Results: The mean age was 75.2 years and 45.3% of patients were men. MCI development was found to be associated with 12 disorders: intracranial injury, anxiety disorder, depression, mental and behavioral disorders due to alcohol use, stroke, hyperlipidemia, obesity, hypertension, Parkinson's disease, sleep disorder, coronary heart disease, and diabetes with odds ratios ranging from 1.13 (diabetes) to 2.27 (intracranial injury). Conclusion: Intracranial injury, anxiety, and depression showed the strongest association with MCI. Further analyses are needed to gain a better understanding of the MCI risk factors.	[Jacoba, Louis] Ecole Normale Super Lyon, Dept Biol, Lyon, France; [Bohlken, Jens] Praxis Bohlken, Berlin, Germany; [Kostev, Karel] IMS Hlth, Epidemiol, Darmstadter Landstr 108, D-60598 Frankfurt, Germany		Kostev, K (corresponding author), IMS Hlth, Epidemiol, Darmstadter Landstr 108, D-60598 Frankfurt, Germany.	kkostev@de.imshealth.com	Kostev, Karel/S-4755-2019; Jacob, Louis/AAL-3956-2020	Kostev, Karel/0000-0002-2124-7227; Jacob, Louis/0000-0003-1071-1239			Aarsland D, 2004, ARCH NEUROL-CHICAGO, V61, P1906, DOI 10.1001/archneur.61.12.1906; Anttila T, 2004, BMJ-BRIT MED J, V329, P539, DOI 10.1136/bmj.38181.418958.BE; Becher H, 2009, INT J CLIN PHARM TH, V47, P617; Becker JT, 2009, AM J GERIAT PSYCHIAT, V17, P653, DOI 10.1097/JGP.0b013e3181aad1fe; Bohlken J, 2017, DEMENTIA-LONDON, V16, P853, DOI 10.1177/1471301215621854; Booker A, 2016, INT PSYCHOGERIATR, V28, P1059, DOI 10.1017/S1041610215002082; Booker A, 2016, INT J CLIN PHARM TH, V54, P323, DOI 10.5414/CP202572; Briggs R, 2016, CLIN MED, V16, P247, DOI 10.7861/clinmedicine.16-3-247; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Kaduszkiewicz H, 2014, ANN FAM MED, V12, P158, DOI 10.1370/afm.1596; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Knopman DS, 2009, ARCH NEUROL-CHICAGO, V66, P614, DOI 10.1001/archneurol.2009.30; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Li X, 2013, J AM GERIATR SOC, V61, P2111, DOI 10.1111/jgs.12552; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; Luck T, 2010, ACTA PSYCHIAT SCAND, V121, P260, DOI 10.1111/j.1600-0447.2009.01481.x; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Ng TP, 2016, JAMA NEUROL, V73, P456, DOI 10.1001/jamaneurol.2015.4899; Ng TP, 2009, J AM GERIATR SOC, V57, P1058, DOI 10.1111/j.1532-5415.2009.02262.x; O'Bryant SE, 2013, ALZHEIMERS DEMENT, V9, P622, DOI 10.1016/j.jalz.2012.12.007; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Roberts RO, 2012, NEUROLOGY, V78, P342, DOI 10.1212/WNL.0b013e3182452862; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Solfrizzi V, 2007, NEUROLOGY, V68, P1790, DOI 10.1212/01.wnl.0000262035.87304.89; Vanoh D, 2017, AGING CLIN EXP RES, V29, P173, DOI 10.1007/s40520-016-0553-2; Xu GL, 2009, PSYCHIAT CLIN NEUROS, V63, P43, DOI 10.1111/j.1440-1819.2008.01904.x; Xu WL, 2010, DIABETES, V59, P2928, DOI 10.2337/db10-0539	32	11	12	1	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	56	1					379	384		10.3233/JAD-160875			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK4GW	WOS:000393886100031	27911316				2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Severe and extensive traumatic axonal injury following minor and indirect head trauma	BRAIN INJURY			English	Article						Mild traumatic brain injury; traumatic axonal injury; diffusion tensor imaging; tremor; myoclonus	DIFFUSION TENSOR TRACTOGRAPHY; DEEP BRAIN-STIMULATION; TRACT; TREMOR; PATIENT; LESIONS; HUMANS	Objectives: This study reports on a patient with mild traumatic brain injury (TBI) who showed severe and extensive traumatic axonal injury (TAI) of various neural tracts following minor and indirect head trauma, which was demonstrated by diffusion tensor tractography (DTT). Case description: A 26-year-old female patient suffered from indirect head trauma resulting from flexion-hyperextension injury after being hit from behind by a slowly moving, car. At the time of head trauma, she felt tingling sensation on her four extremities; however, she did not experience loss of consciousness. At 5-day after onset, she began to experience tremor on the right leg and, subsequently, tremor had also developed in the left leg. At 8-days after onset, she could not even stand due to tremor of both legs and began to feel a tingling sensation on both legs. Since similar to 2 weeks after head trauma, myoclonus had developed mainly in the trunk. After 10-weeks after head trauma, when she started rehabilitation, she showed mild quadriparesis (4(+)/4(+)) with severe weakness of the proximal joint (shoulder/hip, 4(-)/4(-), severe resting and intentional tremor, ataxic gait and severe myoclonus. Conclusions: Severe and extensive TAI of various neural tracts was demonstrated in a patient with mild TBI following minor and indirect head trauma, using DTT.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea		Lee, HD (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	Ihd890221@hanmail.net			National Research Foundation (NRF) of Korea - Korean Government (MSIP) [2015R1A2A2A01004073]	The authors report no conflicts of interest. This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP) (2015R1A2A2A01004073).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Bonnard M, 2007, EUR J NEUROSCI, V25, P872, DOI 10.1111/j.1460-9568.2007.05320.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Coenen VA, 2014, NEUROSURGERY, V75, P657, DOI 10.1227/NEU.0000000000000540; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE26, DOI 10.1097/PHM.0000000000000397; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; Lehericy S, 2001, NEUROLOGY, V57, P1055, DOI 10.1212/WNL.57.6.1055; Marek M, 2015, J NEUROL, V262, P54, DOI 10.1007/s00415-014-7503-8; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Miller M D, 1993, Fam Pract Res J, V13, P15; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Schlaier J, 2015, NEUROMODULATION, V18, P105, DOI 10.1111/ner.12238; Seo JP, 2015, BRAIN INJURY, V29, P110, DOI 10.3109/02699052.2014.973447; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783	19	11	11	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					416	419		10.1080/02699052.2016.1239274			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900020	28095027				2022-02-06	
J	Jiang, L; Hu, Y; He, X; Lv, Q; Wang, TH; Xia, QJ				Jiang, Ling; Hu, Yue; He, Xiang; Lv, Qiang; Wang, Ting-hua; Xia, Qing-jie			Breviscapine reduces neuronal injury caused by traumatic brain injury insult: partly associated with suppression of interleukin-6 expression	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; breviscapine; traumatic brain injury; neuroprotective effect; interleukin-6; neural regeneration	TRANSGENIC MICE; MESSENGER-RNA; INHIBITION; OVEREXPRESSION; CYTOKINE; CHILDREN; THERAPY; RELEASE; CELLS	Breviscapine, extracted from the herb Erigeron breviscapus, is widely used for the treatment of cardiovascular diseases, cerebral infarct, and stroke, but its mechanism of action remains unclear. This study established a rat model of traumatic brain injury induced by controlled cortical impact, and injected 75 mg breviscapine via the right lateral ventricle. We found that breviscapine significantly improved neurobehavioral dysfunction at 6 and 9 days after injection. Meanwhile, interleukin-6 expression was markedly down-regulated following breviscapine treatment. Our results suggest that breviscapine is effective in promoting neurological behavior after traumatic brain injury and the underlying molecular mechanism may be associated with the suppression of interleukin-6.	[Xia, Qing-jie] Sichuan Univ, West China Hosp, Dept Anesthesiol, Inst Neurol Dis, Chengdu, Sichuan Provinc, Peoples R China; Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu, Sichuan Provinc, Peoples R China		Xia, QJ (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Inst Neurol Dis, Chengdu, Sichuan Provinc, Peoples R China.	xiaqj2005@126.com					Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; DiSanto E, 1996, BRAIN RES, V740, P239, DOI 10.1016/S0006-8993(96)00865-7; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Guo C, 2014, J ETHNOPHARMACOL, V151, P660, DOI 10.1016/j.jep.2013.11.026; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kukreti V, 2014, J PEDIATR NEUROSCI, V9, P207, DOI 10.4103/1817-1745.147572; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Li YX, 2014, J SEX MED, V11, P2143, DOI 10.1111/jsm.12614; Lou XY, 2015, ASIAN PAC J TROP MED, V8, P853, DOI 10.1016/j.apjtm.2015.09.017; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Penkowa M, 1999, GLIA, V25, P343; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Stoller KP, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0028-0; Tian Li-Hua, 2014, Zhongguo Zhong Yao Za Zhi, V39, P3719; Wang M, 2010, ACTA DIABETOL, V47, pS209, DOI 10.1007/s00592-009-0164-x; Wang S, 2011, NEUROSCIENCE, V185, P150, DOI 10.1016/j.neuroscience.2011.04.005; Wang XY, 2015, NEUROCHEM RES, V40, P1671, DOI 10.1007/s11064-015-1634-x; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Xu B, 2014, MOL MED REP, V10, P1863, DOI 10.3892/mmr.2014.2462; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95; Zhang SJ, 2007, HEPATOB PANCREAT DIS, V6, P604; Zheng CJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/680756; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	39	11	14	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2017	12	1					90	95		10.4103/1673-5374.198990			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EM9VW	WOS:000395660400025	28250753	Green Published, gold			2022-02-06	
J	Johansson, B; Ronnback, L				Johansson, Birgitta; Ronnback, Lars			Assessment and treatment of mental fatigue after a traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Mental fatigue; TBI; assessment; treatment	EXCESSIVE DAYTIME SLEEPINESS; NEUROLOGICAL DISORDERS; MULTIPLE-SCLEROSIS; TEST SCORE; FOLLOW-UP; MILD; INDIVIDUALS; SYMPTOMS; METHYLPHENIDATE; POPULATION	Mental fatigue is a frequently occurring symptom after mild, moderate or severe traumatic brain injury (TBI). Such mental fatigue may become a long-lasting problem, irrespective of severity and even after recovery from other neurological or psychiatric symptoms. Two characteristics of this mental fatigue are that patients easily become exhausted and there is generally a long recovery time. There is a need to increase knowledge and awareness of mental fatigue as it interferes considerably with work, studies, and social activities. Assessment is difficult and few treatment studies have been carried out. For the purposes of assessment, the development of the Mental Fatigue Scale is described here, and we also summarise the few treatment studies found for fatigue after TBI. Symptom alleviation is reported through Mindfulness-Based Stress Reduction (MBSR), light therapy and for the psychostimulant methylphenidate and the dopamine stabiliser (-)-OSU6162. However, more knowledge of the origin of mental fatigue and its underlying mechanisms is needed for development of more efficient therapeutic methods. Prospective randomised trials focusing on long-term outcomes are warranted and should include both pharmacological and non-pharmacological treatments.	[Johansson, Birgitta; Ronnback, Lars] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Inst Neurosci & Physiol,Dept Clin Neurosci & Reha, Bla Straket 7, SE-41345 Gothenburg, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Inst Neurosci & Physiol,Dept Clin Neurosci & Reha, Bla Straket 7, SE-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142			Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Burstein ES, 2011, J NEURAL TRANSM, V118, P1523, DOI 10.1007/s00702-011-0701-y; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Friedman JH, 2007, MOVEMENT DISORD, V22, P297, DOI 10.1002/mds.21240; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2015, MINDFULNESS, V6, P1356, DOI 10.1007/s12671-015-0406-7; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kabat-Zinn J., 2001, FULL FULL CATASTROPH; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Phillips G. E., 1920, MENTAL FATIGUE; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Shah A, 2009, PHYS MED REH CLIN N, V20, P363, DOI 10.1016/j.pmr.2008.12.003; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sullivan M, 1998, J CLIN EPIDEMIOL, V51, P1105, DOI 10.1016/S0895-4356(98)00102-4; Thorndike E. L., 1921, MENTAL WORK FATIGUE; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468	45	11	11	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	7					1047	1055		10.1080/09602011.2017.1292921			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FB4WK	WOS:000406142500005	28278589				2022-02-06	
J	Joseph, B; Hadeed, S; Haider, AA; Ditillo, M; Joseph, A; Pandit, V; Kulvatunyou, N; Tang, A; Latifi, R; Rhee, P				Joseph, Bellal; Hadeed, Steven; Haider, Ansab A.; Ditillo, Michael; Joseph, Aly; Pandit, Viraj; Kulvatunyou, Narong; Tang, Andrew; Latifi, Rifat; Rhee, Peter			Obesity and trauma mortality: Sizing up the risks in motor vehicle crashes	OBESITY RESEARCH & CLINICAL PRACTICE			English	Article						Obesity; Motor vehicle collision; Mortality	BLUNT TRAUMA; OUTCOMES; INJURY; IMPACT; COMPLICATIONS	Background: Protective effects of safety devices in obese motorists in motor vehicle collisions (MVC) remain unclear. Aim of our study is to assess the association between morbid obesity and mortality in MVC, and to determine the efficacy of protective devices. We hypothesised that patients with morbid obesity will be at greater risk of death after MVC. Methods: A retrospective analysis of MVC patients (age >= 16 y.o.) was performed using the National Trauma Data Bank from 2007 to 2010. Patients with recorded comorbidity of morbid obesity (BMI >= 40) were identified. Patients dead on arrival, with isolated traumatic brain injury, or incomplete data were excluded. The primary outcome was in-hospital mortality. Multivariate logistic regression was performed. Results: Our sample of 214,306 MVC occupants included 10,260 (4.8%) morbidly obese patients. Mortality risk was greatest among occupants with morbid obesity (ORcrude 1.74 [1.54-1.98]). After adjusting for patient demographics, safety device and physiological severity, odds of death was 1.52 [1.33-1.74] times greater in motorists with morbid obesity. Motorists with morbid obesity were at greater risk of death if no restraint (OR 1.84 [1.47-2.]1]), seatbelt only (OR 1.48 [1.17-1.86]), or both seatbelt and airbag were present (OR 1.49 [1.13-1.97]). No significant differences in the odds of death exist between drivers with morbid obesity and non-morbidly obese drivers with only airbag deployment (OR 0.99 [0.65-1.51]). Conclusions: Motorists with morbid obesity are at greater risk of MVC. Regardless of safety device use, occupants with morbid obesity remained at greater risk of death. Further research examining the effectiveness of vehicle restraints in drivers with morbid obesity is warranted. (C) 2016 Published by Elsevier Ltd on behalf of Asia Oceania Association for the Study of Obesity.	[Joseph, Bellal; Hadeed, Steven; Haider, Ansab A.; Joseph, Aly; Pandit, Viraj; Kulvatunyou, Narong; Tang, Andrew; Latifi, Rifat; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA; [Ditillo, Michael] Allegheny Hlth Network, Allegheny Gen Hosp, Dept Surg, Pittsburgh, PA USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Ditillo, Michael/AAI-6259-2020	Latifi, Rifat/0000-0003-1091-3682; Ditillo, Michael/0000-0002-1251-4207			[Anonymous], 2015, OCCUPANT PROTECTION; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Desapriya E, 2014, ASIA-PAC J PUBLIC HE, V26, P447, DOI 10.1177/1010539511430720; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Forman Jason, 2009, Ann Adv Automot Med, V53, P25; Galuska DA, 2010, CHRONIC DIS EPIDEMIO; Glance LG, 2014, ANN SURG, V259, P576, DOI 10.1097/SLA.0000000000000330; Hemmila MR, 2007, SURGERY, V142, P439, DOI 10.1016/j.surg.2007.07.002; Jehle D, 2012, AM J EMERG MED, V30, P191, DOI 10.1016/j.ajem.2010.10.017; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rice TM, 2014, EMERG MED J, V31, P9, DOI 10.1136/emermed-2012-201859; Viano DC, 2008, TRAFFIC INJ PREV, V9, P59, DOI 10.1080/15389580701737645; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Winfield RD, 2010, J TRAUMA, V68, P317, DOI 10.1097/TA.0b013e3181caab6c; Zarzaur BL, 2008, J TRAUMA, V64, P412, DOI 10.1097/TA.0b013e3180f61c33	21	11	13	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-403X	1878-0318		OBES RES CLIN PRACT	Obes. Res. Clin. Pract.	JAN-FEB	2017	11	1					72	78		10.1016/j.orcp.2016.03.003			7	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	EO0PJ	WOS:000396400000009	26996285				2022-02-06	
J	Kahveci, K; Dincer, M; Doger, C; Yarici, AK				Kahveci, Kadriye; Dincer, Metin; Doger, Cihan; Yarici, Ayse Karhan			Traumatic brain injury and palliative care: a retrospective analysis of 49 patients receiving palliative care during 2013-2016 in Turkey	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; trauma; palliative care; brain injury; retrospective study; neural regeneration	HEAD-INJURY; ICU; OUTCOMES; COSTS; NEEDS	Traumatic brain injury (TBI), which is seen more in young adults, affects both patients and their families. The need for palliative care in TBI and the limits of the care requirement are not clear. The aim of this study was to investigate the length of stay in the palliative care center (PCC), Turkey, the status of patients at discharge, and the need for palliative care in patients with TBI. The medical records of 49 patients with TBI receiving palliative care in PCC during 2013-2016 were retrospectively collected, including age and gender of patients, the length of stay in PCC, the cause of TBI, diagnosis, Glasgow Coma Scale score, Glasgow Outcome Scale score, Karnofsky Performance Status score, mobilization status, nutrition route (oral, percutaneous endoscopic gastrostomy), pressure ulcers, and discharge status. These patients were aged 45.4 +/- 20.2 years. The median length of stay in the PCC was 34.0 days. These included TBI patients had a Glasgow Coma Scale score % 8, were not mobilized, received tracheostomy and percutaneous endoscopic gastrostomy nutrition, and had pressure ulcers. No difference was found between those who were discharged to their home or other places (rehabilitation centre, intensive care unit and death) in respect of mobilization, percutaneous endoscopic gastrostomy, tracheostomy and pressure ulcers. TBI patients who were followed up in PCC were determined to be relatively young patients (45.4 +/- 20.2 years) with mobilization and nutrition problems and pressure ulcer formation. As TBI patients have complex health conditions that require palliative care from the time of admittance to intensive care unit, provision of palliative care services should be integrated with clinical applications.	[Kahveci, Kadriye; Yarici, Ayse Karhan] Ankara Ulus State Hosp, Dept Anesthesiol & Reanimat, Ankara, Turkey; [Dincer, Metin] Yildirim Beyazit Univ, Hlth Inst Management, Fac Hlth Sci, Ankara, Turkey; [Dincer, Metin] Ankara Ulus State Hosp, Ankara, Turkey; [Doger, Cihan] Ankara Ataturk Training & Res Hosp, Dept Anesthesiol & Reanimat, Ankara, Turkey		Kahveci, K (corresponding author), Ankara Ulus State Hosp, Dept Anesthesiol & Reanimat, Ankara, Turkey.	kahvecikadriye@gmail.com	Dincer, Metin/W-2998-2017	Dincer, Metin/0000-0003-4598-945X			Abernethy AP, 2005, BMC PALLIAT CARE, V4, P7, DOI DOI 10.1186/1472-684X-4-7; Aslakson RA, 2014, CRIT CARE MED, V42, P2418, DOI 10.1097/CCM.0000000000000573; Baltazar GA, 2015, BRAIN INJURY, V29, P607, DOI 10.3109/02699052.2015.1004558; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Brennan F, 2007, J PAIN SYMPTOM MANAG, V33, P494, DOI 10.1016/j.jpainsymman.2007.02.022; Buccheri G, 1996, EUR J CANCER, V32A, P1135, DOI 10.1016/0959-8049(95)00664-8; Chahine LM, 2008, EUR J NEUROL, V15, P1265, DOI 10.1111/j.1468-1331.2008.02319.x; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creutzfeldt CJ, 2015, CRIT CARE MED, V43, P1677, DOI 10.1097/CCM.0000000000001018; Curtis JR, 2001, CRIT CARE MED, V29, pN26, DOI 10.1097/00003246-200102001-00006; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Hall R, 2015, CRIT CARE MED, V43, P2033, DOI 10.1097/CCM.0000000000001176; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; Lynch T, 2013, J PAIN SYMPTOM MANAG, V45, P1094, DOI 10.1016/j.jpainsymman.2012.05.011; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Montalcini T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0660-4; Mosenthal AC, 2003, J AM COLL SURGEONS, V197, P509, DOI 10.1016/S1072-7515(03)00651-3; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Owens D, 2005, AACN ADV CRIT CARE, V16, P542, DOI 10.1097/00044067-200510000-00010; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Simmons BB, 2008, J PALLIAT MED, V11, P1336, DOI 10.1089/jpm.2008.0169; World Health Organization, 2020, WHO DEF PALL CAR	31	11	11	1	6	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2017	12	1					77	+		10.4103/1673-5374.198987			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EM9VW	WOS:000395660400023	28250751	gold, Green Published			2022-02-06	
J	Kleffelgaard, I; Langhammer, B; Hellstrom, T; Sandhaug, M; Tamber, AL; Soberg, HL				Kleffelgaard, I.; Langhammer, B.; Hellstrom, T.; Sandhaug, M.; Tamber, A. L.; Soberg, H. L.			Dizziness-related disability following mild-moderate traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; ICF; dizziness; balance	MOBILITY ASSESSMENT-TOOL; CONCUSSION SYMPTOMS QUESTIONNAIRE; GLASGOW OUTCOME SCALE; LEVEL MOBILITY; VESTIBULAR REHABILITATION; POSTTRAUMATIC VERTIGO; HANDICAP INVENTORY; DEPRESSION SCALE; HOSPITAL ANXIETY; POPULATION	Objective: To investigate the associations between dizziness-related disability after mild- moderate Traumatic Brain Injury (TBI) and personal factors, injury-related factors and post-injury functioning using the International Classification of Functioning, Disability and Health (ICF) as a framework.Methods: Baseline assessments for a Randomised Controlled Trial (RCT) were obtained for 65 patients (mean age 39.2years; SD 12.9years; 70.8% women) who had dizziness and reduced balance 2-6months after injury. The severity of the brain injury, physical and psychological self-reported symptoms and results from the performance based tests were used as independent variables. The main outcome measure (dependent variable) was the Dizziness Handicap Inventory (DHI).Results: Multivariate analyses showed that, the dizziness-related disability was predicted by pre-injury comorbidities (p0.05) and was associated with self-reported vertigo symptoms (p<0.001), reduced performance-based balance (p0.05) and psychological distress (p0.05). These factors accounted for 62% of the variance in DHI.Conclusion: Dizziness and balance problems after mild-moderate TBI appear to be complex biopsychosocial phenomena. Assessments linked to the ICF domains of functioning might contribute to a broader understanding of the needs of these patients. Further, prospective clinical studies with non-dizzy control groups are needed to investigate dizziness-related disability after TBI.	[Kleffelgaard, I.; Hellstrom, T.; Soberg, H. L.] Oslo Univ Hosp HF, Dept Phys Med & Rehabil, Oslo, Norway; [Kleffelgaard, I.; Langhammer, B.; Tamber, A. L.; Soberg, H. L.] Univ Oslo, Coll Appl Sci, Fac Hlth Sci, Oslo, Norway; [Kleffelgaard, I.; Soberg, H. L.] Univ Oslo, Fac Med, Oslo, Norway; [Sandhaug, M.] Statped Head Off Oslo, Oslo, Norway		Kleffelgaard, I (corresponding author), Oslo & Akershus Univ, Coll Appl Sci, Postboks 4, N-0130 Oslo, Norway.	Ingerid.Kleffelgard@hioa.no	Hellstrom, Torgeir/AAY-6043-2021; Hellstrom, Torgeir/AAW-4301-2021; Langhammer, Birgitta/P-1765-2019	Hellstrom, Torgeir/0000-0003-0831-3274; Langhammer, Birgitta/0000-0002-9639-0570			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bisdorff A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00029; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Herdman SJ, 2013, CURR OPIN NEUROL, V26, P96, DOI 10.1097/WCO.0b013e32835c5ec4; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KIRKWOOD BR, 2003, ESSENTIAL MED STAT, P501; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kleffelgaard I, 2013, PHYS THER, V93, P900, DOI 10.2522/ptj.20120381; Kurre A, 2012, BMC EAR NOSE THROAT, V12, DOI 10.1186/1472-6815-12-2; Kurre A, 2010, BMC EAR NOSE THROAT, V10, DOI 10.1186/1472-6815-10-3; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Morris L, 2014, CLENDANIEL VESTIBULA, P504; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peterson MD, 2010, J HEAD TRAUMA REHAB, V25, P193, DOI 10.1097/HTR.0b013e3181dc82fa; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Shumway-Cook A, 2007, VESTIBULAR REHABILIT, P444; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tamber AL, 2014, EUR J PHYSIOTHER, V16, P93, DOI 10.3109/21679169.2014.886721; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; Tinetti ME, 2000, ANN INTERN MED, V132, P337, DOI 10.7326/0003-4819-132-5-200003070-00002; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Whitney SL, 2014, VESTIBULAR REHABILIT, P480; Wilhelmsen K, 2008, BMC EAR NOSE THROAT, V8, DOI 10.1186/1472-6815-8-2; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2009, INT J THER REHABIL, V16, P370, DOI 10.12968/ijtr.2009.16.7.43046; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS; Yardley L, 2004, ANN INTERN MED, V141, P598, DOI 10.7326/0003-4819-141-8-200410190-00007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	11	11	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1436	1444		10.1080/02699052.2017.1377348			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200005	28972411				2022-02-06	
J	Knox, L; Douglas, JM; Bigby, C				Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine			''I've never been a yes person": Decision-making participation and self-conceptualization after severe traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Decision making; self-concept; identity; brain injury	QUALITY-OF-LIFE; REHABILITATION; PEOPLE; AUTONOMY; IDENTITY; ADULTS; EXPERIENCES; POPULATION; NARRATIVES; CONSTRUCTION	Purpose: Although adults who sustain a severe traumatic brain injury (TBI) require support to make decisions in their lives, little is known about their experience of this process. The aim of this study was to explore how participation in decision making contributes to self-conceptualization in adults with severe TBI. Method: We used constructivist grounded theory methods. Data included 20 in-depth interviews with adults with severe TBI. Through a process of constant comparison, analysis involved open and focused coding until clear categories emerged and data saturation was achieved. Results: Self-conceptualization emerged as a complex and multifaceted process, as individuals with TBI aimed to reestablish a sense of autonomy. We describe a recursive relationship in which decision-making participation assists the dynamic construction of self, and self-concept contributes to the experience of making decisions. The role of an individual's social support network in acting as a bridge between participation and self-conceptualization is presented. Conclusions: Findings emphasize that contributing to decisions about one's own goals across a range of life areas can reinforce a positive self-concept. It is vital that supporters understand that participation in decision making provides a pathway to conceptualizing self and aim to maximize the person's participation in the decision-making process.	[Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine] La Trobe Univ, Living Disabil Res Ctr, Bundoora, Vic, Australia; [Knox, Lucy; Douglas, Jacinta M.] Summer Fdn, Box Hill, Vic, Australia		Knox, L (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Dept Community & Clin Allied Hlth, Bundoora, Vic 3086, Australia.	L.Knox@latrobe.edu.au	Knox, Lucy/E-8642-2013; bigby, Christine/I-8526-2015	Knox, Lucy/0000-0001-8331-6032; bigby, Christine/0000-0001-7001-8976; Douglas, Jacinta/0000-0003-0940-6624	University postgraduate scholarship; Victorian Brain Injury Recovery Association & East Kew Branch of the Community Bendigo Bank Research Scholarship	The authors would like to acknowledge the generosity of the participants of this study. This research was supported by a University postgraduate scholarship and Victorian Brain Injury Recovery Association & East Kew Branch of the Community Bendigo Bank Research Scholarship awarded to the first author.	Amado A. N., 2013, FRIENDS CONNECTING P; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA, V6th; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Bigby C., 2015, SUPPORTING PEOPLE CO; Blumer H., 1969, SYMB INTERACT; Brown I, 2009, J POLICY PRACT INTEL, V6, P11, DOI 10.1111/j.1741-1130.2008.00198.x; CAMPBELL JD, 1990, J PERS SOC PSYCHOL, V59, P538, DOI 10.1037/0022-3514.59.3.538; Cardol M, 2002, DISABIL REHABIL, V24, P970, DOI 10.1080/09638280210151996; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Charmaz K., 2007, HDB CONSTRUCTIONIST, P397; Charmaz K., 2002, OCCUP THER J RES, V22, P31; Charmaz K., 2008, HDB EMERGENT METHODS, P155; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Clapton J, 2002, DISABIL REHABIL, V24, P987, DOI 10.1080/09638280210152058; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Deci EL, 2008, CAN PSYCHOL, V49, P14, DOI 10.1037/0708-5591.49.1.14; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P42, DOI 10.1080/09602011.2010.525947; Douglas J, 2015, RETHINKING REHABILIT, DOI DOI 10.1201/B18118; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Draucker CB, 2007, QUAL HEALTH RES, V17, P1137, DOI 10.1177/1049732307308450; Ells C, 2001, SOCIAL THEORY PRACTI, V27, P599; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fellows L. K., 2010, SELF CONTROL SOC MIN, P27; Fellows LK, 2012, J INT NEUROPSYCH SOC, V18, P937, DOI 10.1017/S1355617712001294; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Garro Linda C., 1992, PAIN HUMAN EXPERIENC, P100; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Glaser B., 1967, DISCOVERY GROUNDED T; Glen K.B., 2015, INCLUSION, V3, P2, DOI [10.1352/2326-6988-3.1.2, DOI 10.1352/2326-6988-3.1.2]; Gooding P, 2015, PSYCHIAT PSYCHOL LAW, V22, P701, DOI 10.1080/13218719.2014.983217; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Guba EG, 1994, HDB QUALITATIVE RES, P105; Harris S, 2003, PAIN, V105, P363, DOI 10.1016/S0304-3959(03)00251-3; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Haslam S.A., 2012, SOCIAL CURE IDENTITY, P157; Hunt MR, 2011, DISABIL REHABIL, V33, P961, DOI 10.3109/09638288.2010.515703; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jenkinson J., 1993, DISABILITY HANDICAP, V8, P361, DOI DOI 10.1080/02674649366780351; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kendall E, 2007, DISABIL REHABIL, V29, P817, DOI 10.1080/09638280600919731; Kendall E, 2006, DISABIL REHABIL, V28, P1097, DOI 10.1080/09638280500531784; Kendall J, 1999, WESTERN J NURS RES, V21, P743, DOI 10.1177/01939459922044162; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Knox L, 2016, NEUROPSYCHOL REHABIL, V26, P236, DOI 10.1080/09602011.2015.1019519; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Lawson S, 2008, THER RECREAT J, V42, P236; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Liu C, 2004, CLIN REHABIL, V18, P398, DOI 10.1191/0269215504cr741oa; MARKUS H, 1987, ANNU REV PSYCHOL, V38, P299, DOI 10.1146/annurev.ps.38.020187.001503; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; McCluskey A, 2007, BRAIN IMPAIR, V8, P293, DOI DOI 10.1375/brim.8.3.293; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mills J., 2006, INT J QUAL METH, DOI [DOI 10.1177/160940690600500103, 10.1177/160940690600500103]; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nair KPS, 2003, CLIN REHABIL, V17, P192, DOI 10.1191/0269215503cr599oa; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Nota L, 2007, J INTELL DISABIL RES, V51, P850, DOI 10.1111/j.1365-2788.2006.00939.x; NURIUS P, 1991, SELF SOC DYNAMIC COG, P239; OCONNOR P, 2002, HOSP DUE TRAUMATIC B; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Reindal SM, 1999, DISABIL SOC, V14, P353, DOI 10.1080/09687599926190; ROBERTS BW, 1994, J PERS, V62, P199, DOI 10.1111/j.1467-6494.1994.tb00291.x; RYAN RM, 1991, SELF : INTERDISCIPLINARY APPROACHES, P208; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Schipper K, 2011, NURS ETHICS, V18, P526, DOI 10.1177/0969733011403554; Schwandt T, 2007, SAGE DICT QUALITATIV; Sim J, 1998, CLIN REHABIL, V12, P3, DOI 10.1191/026921598670782549; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Strauss A., 1990, BASICS QUALITATIVE R; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Tweed A., 2012, QUALITATIVE RES METH, P131; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler D, 2015, BRAIN IMPAIR, V16, P221, DOI 10.1017/BrImp.2015.32; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zuscak SJ, 2016, DISABIL REHABIL, V38, P1107, DOI 10.3109/09638288.2015.1092176	101	11	11	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	22					2250	2260		10.1080/09638288.2016.1219925			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FF8HL	WOS:000409257400002	27547914	hybrid			2022-02-06	
J	Lippa, SM; Lange, RT; Bhagwat, A; French, LM				Lippa, Sara M.; Lange, Rael T.; Bhagwat, Aditya; French, Louis M.			Clinical utility of embedded performance validity tests on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) following mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Effort; mild traumatic brain injury; performance validity; repeatable battery for the assessment of neuropsychological status; response bias	STATUS EFFORT INDEX; WORD MEMORY TEST; EVALUATION CONTEXT; EFFORT SCALE; POOR EFFORT; VALIDATION; VETERANS; SCORES; ISSUES; RATES	This study evaluated the clinical utility of two embedded performance validity tests (PVTs) developed for the Repeatable Battery for the Assessment of Neuropsychological Status: the Effort Index (EI) and the Effort Scale (ES) in mild traumatic brain injury (TBI) patients. Participants were 250 military service members (94.0% male; Age: M=28.4, SD=7.6) evaluated following mild TBI on average 7.4 months (SD=15.6) post-injury. Participants were divided into two groups based on their performance on the Test of Memory Malingering: PVT-Pass, n=193; PVT-Fail, n=57. For the EI, recommended cut-offs for extremely probable, highly probable, and probable poor effort were established. A cut-off score of >3 resulted in low sensitivity (.14), high specificity (.99) and positive predictive power (.94), and moderate negative predictive power (.68) and is recommended for identifying highly probable poor effort. For both the EI and ES, cut-offs for probable poor effort were identified; however, classification accuracy was not much improved relative to simply using the sum of the List Recognition and Digit Span raw scores to classify poor effort. It is acknowledged that the use of a different criterion would likely have resulted in different findings. Nevertheless, findings support the use of the EI and the ES as a red flag for possible poor effort in mild TBI patients, but suggest that, in most cases, additional PVTs would be required to accurately rule poor effort in or out.	[Lippa, Sara M.; Lange, Rael T.; French, Louis M.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lippa, Sara M.; Lange, Rael T.; French, Louis M.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lippa, Sara M.; Lange, Rael T.; Bhagwat, Aditya; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Bhagwat, Aditya] United States Publ Hlth Serv, Rockville, MD USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [French, Louis M.] Univ Hlth Sci, Uniformed Serv, Bethesda, MD USA		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19,Room 6009,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	sara.lippa.ctr@mail.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			Armistead-Jehle P, 2013, ARCH CLIN NEUROPSYCH, V28, P297, DOI 10.1093/arclin/act017; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Burton RL, 2015, ARCH CLIN NEUROPSYCH, V30, P1, DOI 10.1093/arclin/acu070; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Crighton AH, 2015, ARCH CLIN NEUROPSYCH, V30, P181, DOI 10.1093/arclin/acv002; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Duff K, 2011, APPL NEUROPSYCHOL, V18, P11, DOI 10.1080/09084282.2010.523354; Dunham KJ, 2014, ARCH CLIN NEUROPSYCH, V29, P633, DOI 10.1093/arclin/acu042; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hook JN, 2009, ARCH CLIN NEUROPSYCH, V24, P231, DOI 10.1093/arclin/acp026; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Lippa SM, 2013, BRAIN INJURY, V27, P689, DOI 10.3109/02699052.2013.771793; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Pachet AK, 2007, CLIN NEUROPSYCHOL, V21, P286, DOI 10.1080/13854040500376823; Peck C, 2014, ARCH CLIN NEUROPSYCH, V29; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Randolph C., 1998, RBANS REPEATABLE BAT; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sieck BC, 2013, ARCH CLIN NEUROPSYCH, V28, P135, DOI 10.1093/arclin/acs109; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	50	11	11	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	1					73	80		10.1080/23279095.2015.1100617			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EC3KW	WOS:000388026000008	27077512				2022-02-06	
J	Mbakile-Mahlanza, L; Manderson, L; Downing, M; Ponsford, J				Mbakile-Mahlanza, Lingani; Manderson, Lenore; Downing, Marina; Ponsford, Jennie			Family caregiving of individuals with traumatic brain injury in Botswana	DISABILITY AND REHABILITATION			English	Article						Anxiety; depression; family caregiving; traumatic brain injury	PSYCHOLOGICAL DISTRESS; SOCIAL SUPPORT; MENTAL-HEALTH; PEOPLE; TBI; DEPRESSION; COMMUNITY; CHILDREN; CARERS; BURDEN	Background The impairments that affect survivors of TBI impact the person's independence, and family members frequently have to take on a caregiver role. This study examined the experience of caregiving for individuals with TBI in Botswana and its impact on psychological distress in caregivers. Methods Using a mixed methods study design, qualitative data from semi-structured interviews were thematically analyzed and triangulated with data regarding functional status from the Structured Head Injury Outcome Questionnaire and the Hospital Anxiety and Depression Scale (HADS). Results The study included 26 participants with moderate to severe TBI, and a total of 18 caregivers were recruited. Caregivers commonly reported receiving limited information regarding their relatives' injuries and management methods. Heavy caregiving demands were placed on them, with little support from the healthcare system. A significant proportion of caregivers experienced anxiety and depression, which was associated with lower functional independence in their injured relative. Somewhat more spouses than parents reported clinically significant anxiety levels. Other consequences of caregiving included social isolation and limited support from the wider community as well as financial difficulties. Despite these stresses caregivers tended to accept their caregiving role. Cultural factors such devotion to their families and faith and belief in God moderated burden and distress. Conclusions Carers of individuals with TBI in Botswana face significant challenges. Rehabilitation efforts need to take these into account. Specifically, more information and support needs to be provided to survivors and their families. Psychological, economic and health needs of the care providers also should be addressed in the planning of rehabilitation interventions.	[Mbakile-Mahlanza, Lingani; Manderson, Lenore; Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Manderson, Lenore] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Downing, Marina; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632; Manderson, Lenore/0000-0002-7883-1790; Mbakile-Mahlanza, Lingani/0000-0002-1285-3276	Australian Psychological Society (APS) Grant; Epworth Healthcare	This work was partly supported by Australian Psychological Society (APS) Grant for Intercultural/International Projects and a travel grant from Epworth Healthcare.	Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Calvete E, 2012, BRAIN INJURY, V26, P834, DOI 10.3109/02699052.2012.655363; Central Statistics Office (now Statistics Botswana), BOTSW HOUS INC EXP S; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Figueiras MJ, 2003, PSYCHOL HEALTH, V18, P201, DOI 10.1080/0887044021000057266; Geere JL, 2013, CHILD CARE HLTH DEV, V39, P381, DOI 10.1111/j.1365-2214.2012.01398.x; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Heymann J, 2007, AIDS CARE, V19, P337, DOI 10.1080/09540120600763225; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingstad B, 1995, DISABILITY CULTURE, P246; Kang'ethe SM, 2009, SAHARA J-J SOC ASP H, V6, P24, DOI 10.1080/17290376.2009.9724926; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Maundeni T, 2013, CHILD FAM SOC WORK, V18, P107, DOI 10.1111/j.1365-2206.2011.00820.x; Mavundla TR, 2009, INT J MENT HEALTH NU, V18, P357, DOI 10.1111/j.1447-0349.2009.00624.x; Minnes P, 2000, BRAIN INJURY, V14, P737; Mokhosi MT, 2004, S AFR J PSYCHOL, V34, P301, DOI 10.1177/008124630403400208; Ndaba-Mbata R D, 2000, Int Nurs Rev, V47, P218, DOI 10.1046/j.1466-7657.2000.00023.x; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Paget A, 2016, DISABIL REHABIL, V38, P223, DOI 10.3109/09638288.2015.1035458; Phaladze NA, 2001, BOTSWANA NOTES RECOR, V33, P73; Plano Clark, 2018, DESIGNING CONDUCTING; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Rajaraman D, 2006, AIDS CARE, V18, P656, DOI 10.1080/09540120500287010; Rajaraman D, 2008, COMMIMITY WORK FAM, V11, P1, DOI 10.1080/13668800701785296; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Seloilwe ES, 2006, J NURS SCHOLARSHIP, V38, P262, DOI 10.1111/j.1547-5069.2006.00112.x; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Stebbins P, 2001, REHABIL PSYCHOL, V46, P178, DOI 10.1037/0090-5550.46.2.178; Strauss A., 1990, BASICS QUALITATIVE R; Tashakkori A., 2010, HDB MIXED METHODS SO; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whitney J, 2007, BRIT J CLIN PSYCHOL, V46, P413, DOI 10.1348/014466507X173781; World Health Organization, 2006, WORLD HLTH REPORT 20; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	11	12	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	6					559	567		10.3109/09638288.2016.1152605			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EK4AR	WOS:000393870000005	26972548				2022-02-06	
J	McKinlay, A; Horwood, LJ				McKinlay, Audrey; Horwood, L. John			The accuracy of adult recall for early mild traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Adult recall; childhood; traumatic brain injury	EARLY-CHILDHOOD; HEAD-INJURY; BIRTH COHORT; OUTCOMES; CHILDREN; ADOLESCENTS; AMNESIA; MEMORY; SKILLS	Background: Childhood mild traumatic brain injury (mTBI) has been associated with negative adult outcomes. Effective interventions require identification of the injury event. There is currently little information regarding the accuracy of adult recall of childhood mTBI. Method: Prospectively collected information from a large birth cohort was used to examine adult recall accuracy at age 25 for 161 childhood mTBI events occurring before age 10. Results: At age 25 cohort members recalled 11 outpatient injuries and 16 inpatient injuries. Recall accuracy increased with age. Logistic regression analysis distinguished between respondents who reported and did not report a childhood mTBI event correctly classifying 84.5% of cases. Age at injury, injury severity and loss of consciousness (LoC) made a unique statistically significant contribution to the model. Conclusions: Most childhood mTBI events are not recalled in adulthood. Age at injury, injury severity and LoC significantly increase likelihood of recall and should be used in measures that evaluate whether injury has occurred.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Horwood, L. John] Univ Otago, Christchurch Hlth & Dev Study, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514; Horwood, L./0000-0003-4881-1956			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2006, J INT NEUROPSYCH SOC, V12, P519, DOI 10.1017/S135561770606067X; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Bauer PJ, 2015, PSYCHOL REV, V122, P204, DOI 10.1037/a0038939; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cordon IM, 2004, DEV REV, V24, P101, DOI 10.1016/j.dr.2003.09.003; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A., 2012, MILD TRAUMATIC BRAIN, P361; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Peterson C, 2012, DEV REV, V32, P287, DOI 10.1016/j.dr.2012.06.002; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127	20	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	13					1296	1299		10.1080/09638288.2016.1193905			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EQ9WM	WOS:000398437000006	27346060	Green Submitted			2022-02-06	
J	Mohammadian, M; Roine, T; Hirvonen, J; Kurki, T; Ala-Seppala, H; Frantzen, J; Katila, A; Kyllonen, A; Maanpaa, HR; Posti, J; Takala, R; Tallus, J; Tenovuo, O				Mohammadian, Mehrbod; Roine, Timo; Hirvonen, Jussi; Kurki, Timo; Ala-Seppala, Henna; Frantzen, Janek; Katila, Ari; Kyllonen, Anna; Maanpaa, Henna-Riikka; Posti, Jussi; Takala, Riikka; Tallus, Jussi; Tenovuo, Olli			High angular resolution diffusion-weighted imaging in mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Magnetic resonance imaging; Diffusion-weighted magnetic resonance imaging; Probabilistic tractography; Global approach	WHITE-MATTER; AXONAL INJURY; SPHERICAL DECONVOLUTION; SPATIAL STATISTICS; CORPUS-CALLOSUM; NERVOUS-SYSTEM; TENSOR; MRI; TRACTOGRAPHY; ORGANIZATION	We sought to investigate white matter abnormalities in mild traumatic brain injury (mTBI) using diffusion-weighted magnetic resonance imaging (DW-MRI). We applied a global approach based on tract-based spatial statistics skeleton as well as constrained spherical deconvolution tractography. DW-MRI was performed on 102 patients with mTBI within two months post-injury and 30 control subjects. A robust global approach considering only the voxels with a single-fiber configuration was used in addition to global analysis of the tract skeleton and probabilistic whole-brain tractography. In addition, we assessed whether the microstructural parameters correlated with age, time from injury, patient's outcome and white matter MRI hyperintensities. We found that whole-brain global approach restricted to single-fiber voxels showed significantly decreased fractional anisotropy (FA) (p = 0.002) and increased radial diffusivity (p = 0.011) in patients with mTBI compared with controls. The results restricted to single-fiber voxels were more significant and reproducible than those with the complete tract skeleton or the whole-brain tractography. FA correlated with patient outcomes, white matter hyperintensities and age. No correlation was observed between FA and time of scan post-injury. In conclusion, the global approach could be a promising imaging biomarker to detect white matter abnormalities following traumatic brain injury. (C) 2016 The Authors. Published by Elsevier Inc.	[Mohammadian, Mehrbod; Hirvonen, Jussi; Kurki, Timo; Ala-Seppala, Henna; Frantzen, Janek; Kyllonen, Anna; Maanpaa, Henna-Riikka; Posti, Jussi; Tallus, Jussi; Tenovuo, Olli] Univ Turku, Dept Neurol, Hameentie 11, Turku 20521, Finland; [Mohammadian, Mehrbod; Hirvonen, Jussi; Kurki, Timo; Posti, Jussi; Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, Turku, Finland; [Roine, Timo] Univ Antwerp, Dept Phys, IMinds Vis Lab, Antwerp, Belgium; [Hirvonen, Jussi; Kurki, Timo] Turku Univ Hosp, Dept Radiol, Turku, Finland; [Frantzen, Janek; Posti, Jussi] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Katila, Ari; Takala, Riikka] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Katila, Ari; Takala, Riikka] Univ Turku, Turku, Finland		Mohammadian, M (corresponding author), Univ Turku, Dept Neurol, Hameentie 11, Turku 20521, Finland.	mehmoh@utu.fi	Hirvonen, Jussi/AAC-1864-2020; Hirvonen, Jussi/H-2521-2012; Mohammadian, Mehrbod/AAH-1018-2019; Posti, Jussi P./Y-2908-2019; Roine, Timo/M-5865-2013	Mohammadian, Mehrbod/0000-0002-6851-7511; Posti, Jussi P./0000-0002-5925-5193; Roine, Timo/0000-0002-3104-9734; Ala-Seppala, Henna/0000-0002-1577-3028	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7-270259-TBIcare]; University of Turku; Instrumentarium Scientific Foundation, Finland; Maud Kuistila Memorial Foundation, Finland	This study was partly funded by the European Commission under the 7th Framework Programme (FP7-270259-TBIcare). M.M received funding from University of Turku and T.R received support from the Instrumentarium Scientific Foundation, Finland and Maud Kuistila Memorial Foundation, Finland.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Annen J., 2016, HUM BRAIN MAPP; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Bammer R, 2003, EUR J RADIOL, V45, P223, DOI 10.1016/S0720-048X(02)00311-X; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Descoteaux M., 2015, HDB BIOMEDICAL IMAGI, P455; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fazekas F., 1987, AM J NEURORADIOL; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Hsu JL, 2012, NEUROIMAGE, V59, P1098, DOI 10.1016/j.neuroimage.2011.09.041; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iffland PH, 2014, VASCULAR MECH CNS TR, P29, DOI DOI 10.1007/978-1-4614-8690-9_2; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lin M., 2015, MAGN RESON; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Narayana P. A., 2014, NEUROIMAGE CLIN; Owen JP, 2013, BRAIN CONNECT, V3, P160, DOI 10.1089/brain.2012.0121; Roine T, 2015, MED IMAGE ANAL, V24, P269, DOI 10.1016/j.media.2015.01.001; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; Roine U, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0058-4; Roine U, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-4; Roine U, 2013, AUTISM RES, V6, P642, DOI 10.1002/aur.1332; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shetty T, 2016, SPORTS HEALTH, V8, P26, DOI 10.1177/1941738115588745; Shrout P., 1979, PSYCHOL B; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Takala RSK, 2015, WORLD NEUROSURG; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; van der Horn H.J., 2016, J NEUROTRAUM; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yoon B, 2008, ARCH GERONTOL GERIAT, V47, P129, DOI 10.1016/j.archger.2007.07.004; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	73	11	14	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	13						174	180		10.1016/j.nicl.2016.11.016			7	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV0FK	WOS:000401413700021	27981032	Green Published, gold			2022-02-06	
J	Murray, LL				Murray, Laura L.			Design fluency subsequent to onset of aphasia: a distinct pattern of executive function difficulties?	APHASIOLOGY			English	Article						Aphasia; executive functioning; design fluency	NETWORK STRENGTHENING TREATMENT; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE LESIONS; FIGURAL FLUENCY; WORKING-MEMORY; NORMATIVE DATA; LANGUAGE; COMMUNICATION; PERFORMANCE; IMPAIRMENT	Background: Executive function problems commonly co-occur with aphasia and influence language and communication performance as well as aphasia treatment outcomes and prognosis. Prior research, however, has focused on a restricted set of executive skills. Aims: This study examined further the integrity of executive functioning and its relationship to language performance in individuals with aphasia by utilising a design fluency measure, which assesses executive skills like initiation, planning, and cognitive flexibility. To examine domain-general versus domain-specific executive problems and determine the distinctiveness of the aphasic group's performance pattern, adults with right hemisphere brain damage (RHD) were included. The hypotheses examined were: (a) compared to adults with no brain damage, the aphasic and RHD groups would display design fluency impairments; (b) the design fluency performances of aphasic and RHD groups would be quantitatively but not qualitatively similar; and (c) the design fluency performances of the aphasic and RHD groups would be related to their language abilities, as well as their performance of other executive and cognitive measures. Methods and Procedures: Participants with aphasia, RHD, or no brain damage completed the Ruff Figural Fluency Test (RFFT; Ruff, 1996), the results of which were quantitatively (i.e., number of unique designs, a perseverative error ratio) and qualitatively analysed (i.e., number and maximum length of orderly patterns, design complexity, number, and types of non-repetition errors), along with a formal cognitive-linguistic test battery and a verbal fluency task. Outcomes and Results: The traditional, quantitative RFFT scores of the aphasia, and RHD groups were significantly lower than those of the control group. Only the RHD group significantly differed from the control group when qualitative RFFT variables were analysed. RFFT performances correlated with language and other cognitive test scores, with some differences in the number and nature of these associations across the aphasic and RHD groups. Conclusions: The current design fluency findings indicated that executive function deficits involving initiation, planning, self-monitoring, and cognitive flexibility commonly co-occur with aphasia. These results supported previous research by identifying executive function impairments in many, however, not all individuals with aphasia, and by confirming influential associations between executive function and language, and communication measures. Inclusion of individuals with RHD indicated that such executive function difficulties and a potent relationship between executive functioning and language skills are not only unique to those with aphasia but also prevalent in other patient populations and consistent with the contribution of domain-general factors in acquired cognitive impairments.	[Murray, Laura L.] Western Univ, Sch Commun Sci & Disorders, London, ON, Canada		Murray, LL (corresponding author), Western Univ, Sch Commun Sci & Disorders, London, ON, Canada.	lmurray@indiana.edu			NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [RO1-DC03886]	This work was supported by the [RO1-DC03886]; NIDCD; National Institute on Deafness and Other Communication Disorders [RO1-DC03886].	Alexander MP, 2006, J INT NEUROPSYCH SOC, V12, P236, DOI 10.1017/S1355617706060309; Baldo JV, 2010, BRAIN LANG, V113, P59, DOI 10.1016/j.bandl.2010.01.004; Baldo JV, 2005, BRAIN LANG, V92, P240, DOI 10.1016/j.bandl.2004.06.103; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Beldo JV, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01523; Berning LC, 1998, ASSESSMENT, V5, P181, DOI 10.1177/107319119800500208; Breier J I, 1996, J Int Neuropsychol Soc, V2, P535; Brown L., 2010, TEST NONVERBAL INTEL; Brownsett SLE, 2014, BRAIN, V137, P242, DOI 10.1093/brain/awt289; Cahana-Amitay D., 2015, REDEFINING RECOVERY; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; Chesneau S, 2015, APHASIOLOGY, V29, P237, DOI 10.1080/02687038.2014.971098; Cohen J., 1983, APPL MULTIPLE REGRES; Crawford JR, 2007, COGN NEUROPSYCHOL, V24, P343, DOI 10.1080/02643290701290146; Dabul B. L., 2000, APRAXIA BATTERY ADUL; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Edmonds LA, 2015, APHASIOLOGY, V29, P1312, DOI 10.1080/02687038.2014.975180; Edmonds LA, 2011, AM J SPEECH-LANG PAT, V20, P131, DOI 10.1044/1058-0360(2011/10-0036); El Hachioui H, 2014, NEUROREHAB NEURAL RE, V28, P273, DOI 10.1177/1545968313508467; Enright J, 2015, APPL NEUROPSYCH-ADUL, V22, P459, DOI 10.1080/23279095.2014.992070; Ferre P, 2011, REHABIL RES PRACT, V2011, DOI 10.1155/2011/131820; Fillingham JK, 2006, NEUROPSYCHOL REHABIL, V16, P129, DOI 10.1080/09602010443000254; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankel T, 2007, APHASIOLOGY, V21, P814, DOI 10.1080/02687030701192448; Frattali C. M., 1995, AM SPEECH LANGUAGE H; Fridriksson J, 2006, CLIN LINGUIST PHONET, V20, P401, DOI 10.1080/02699200500075781; Fucetola R, 2009, APHASIOLOGY, V23, P1418, DOI 10.1080/02687030802514938; Gardner E, 2013, CLIN NEUROPSYCHOL, V27, P470, DOI 10.1080/13854046.2013.771216; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Goebel S, 2013, NEUROL SCI, V34, P1383, DOI 10.1007/s10072-012-1245-0; Goebel S, 2013, PSYCHO-ONCOLOGY, V22, P1319, DOI 10.1002/pon.3142; Goebel S, 2009, CLIN NEUROPSYCHOL, V23, P675, DOI 10.1080/13854040802389185; Golden CJ., 2002, STROOP COLOR WORD TE; Goldstein S., 2014, HDB EXECUTIVE FUNCTI; Goral M, 2011, EXP AGING RES, V37, P516, DOI 10.1080/0361073X.2011.619858; Grant D. A., 1993, WISCONSIN CARD SORTI; GUTBROD K, 1989, J CLIN EXP NEUROPSYC, V11, P821, DOI 10.1080/01688638908400938; Harley TA, 2011, APHASIOLOGY, V25, P123, DOI 10.1080/02687031003798262; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Helm-Estabrooks N, 1992, APHASIA DIAGNOSTIC P; Hinckley J, 2007, BRAIN LANG, V103, P195, DOI 10.1016/j.bandl.2007.07.112; Hula WD, 2007, BRAIN LANG, V103, P240, DOI 10.1016/j.bandl.2007.07.023; Humphreys GF, 2015, CEREB CORTEX, V25, P3547, DOI 10.1093/cercor/bhu198; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Kalbe E, 2005, J CLIN EXP NEUROPSYC, V27, P779, DOI 10.1080/13803390490918273; Kaplan E., 2001, BOSTON NAMING TEST; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Keppel G., 1991, DESIGN ANAL RES HDB; Kiran S, 2015, APHASIOLOGY, V29, P1289, DOI 10.1080/02687038.2014.997182; Kong APH, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/527951; Koziol LF, 2015, APPL NEUROPSYCH-CHIL, V4, P123, DOI 10.1080/21622965.2015.1005482; Kraybill ML, 2008, J CLIN EXP NEUROPSYC, V30, P903, DOI 10.1080/13803390701874361; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Logie RH, 2016, Q J EXP PSYCHOL, V69, P2093, DOI 10.1080/17470218.2015.1136657; Martin Randi C., 2008, Seminars in Speech and Language, V29, P201, DOI 10.1055/s-0028-1082884; MASON CH, 1991, J MARKETING RES, V28, P268, DOI 10.2307/3172863; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mayer JF, 2012, J COMMUN DISORD, V45, P325, DOI 10.1016/j.jcomdis.2012.06.002; Meteyard L, 2015, APHASIOLOGY, V29, P1, DOI 10.1080/02687038.2014.955388; Murray LL, 2012, AM J SPEECH-LANG PAT, V21, pS51, DOI 10.1044/1058-0360(2012/11-0067); Murray LL, 2000, BRAIN LANG, V72, P40, DOI 10.1006/brln.1999.2281; Ng VWK, 2000, HUM BRAIN MAPP, V10, P80, DOI 10.1002/(SICI)1097-0193(200006)10:2<80::AID-HBM40>3.0.CO;2-2; Nicholas M., APHASIOLOGY IN PRESS; Nicholas M, 2017, APHASIOLOGY, V31, P688, DOI 10.1080/02687038.2015.1076927; Nicholas M, 2011, NEUROPSYCHOL REHABIL, V21, P322, DOI 10.1080/09602011.2011.559051; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Oksala NKJ, 2009, J NEUROL NEUROSUR PS, V80, P1230, DOI 10.1136/jnnp.2009.174573; Penn C., APHASIOLOGY IN PRESS; Penn C, 2015, APHASIOLOGY, V29, P291, DOI 10.1080/02687038.2014.986632; Penn C, 2010, APHASIOLOGY, V24, P288, DOI 10.1080/02687030902958399; Pimental P.A, 2000, MINI INVENTORY RIGHT, V2; Pompon RH, 2015, J SPEECH LANG HEAR R, V58, P767, DOI 10.1044/2015_JSLHR-L-14-0063; Possin KL, 2012, J INT NEUROPSYCH SOC, V18, P834, DOI 10.1017/S1355617712000604; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Pulsipher DT, 2013, CLIN NEUROPSYCHOL, V27, P924, DOI 10.1080/13854046.2013.799714; Radanovic M, 2003, ARQ NEURO-PSIQUIAT, V61, P34, DOI 10.1590/S0004-282X2003000100006; Ralph MAL, 2010, NEUROPSYCHOL REHABIL, V20, P289, DOI 10.1080/09602010903237875; Raven J, 2003, RAVENS PROGR MATRICE; Robertson I., 1994, TEST EVERYDAY ATTENT; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P879, DOI 10.1016/S0887-6177(02)00163-4; Rowe F, 2009, STRABISMUS, V17, P24, DOI 10.1080/09273970802678537; Ruff R. M, 1996, RUFF FIGURAL FLUENCY; RUFF RM, 1994, ARCH CLIN NEUROPSYCH, V9, P41, DOI 10.1016/0887-6177(94)90013-2; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Russell KC, 2012, BRAIN INJURY, V26, P984, DOI 10.3109/02699052.2012.660513; Savundranayagam MY, 2011, INT PSYCHOGERIATR, V23, P1470, DOI 10.1017/S1041610211000408; Schultheis MT, 2000, CLIN NEUROPSYCHOL, V14, P196, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT196; Sebkova L, 2015, SABIED INTEGR IZGL, P215, DOI 10.17770/sie2015vol3.385; Seniow J, 2009, J NEUROL SCI, V285, pS281, DOI 10.1016/S0022-510X(09)71071-8; Skidmore ER, 2010, ARCH PHYS MED REHAB, V91, P203, DOI 10.1016/j.apmr.2009.10.026; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Turunen KEA, 2016, J INT NEUROPSYCH SOC, V22, P551, DOI 10.1017/S1355617716000205; Vallila-Rohter S, 2015, J SPEECH LANG HEAR R, V58, P1195, DOI 10.1044/2015_JSLHR-L-14-0257; Varney NR, 2004, APPL NEUROPSYCHOL, V11, P229; VERRAN JA, 1987, NURS RES, V36, P127; Wechsler D, 1987, MEMORY SCALE REVISED; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Yeung O, 2010, INT J SPEECH-LANG PA, V12, P529, DOI 10.3109/17549507.2011.516840; Zakarias L, 2013, APHASIOLOGY, V27, P1426, DOI 10.1080/02687038.2013.835783; Zimmermann Nicolle, 2011, Dement. neuropsychol., V5, P337, DOI 10.1590/S1980-57642011DN05040013	103	11	11	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2017	31	7			SI		793	818		10.1080/02687038.2016.1261248			26	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	EV0VY	WOS:000401465700005					2022-02-06	
J	Narayanan, R; Taylor, SC; Nayaka, A; Deshpande, R; St Aubin, D; Hrisomalos, FN; Hu, J; Rajagopal, R; Tewari, A; Apte, RS				Narayanan, Raja; Taylor, Stanford C.; Nayaka, Ashraya; Deshpande, Riddhima; St Aubin, Daniel; Hrisomalos, Frank N.; Hu, Jonathan; Rajagopal, Rithwick; Tewari, Asheesh; Apte, Rajendra S.			Visual Outcomes after Vitrectomy for Terson Syndrome Secondary to Traumatic Brain Injury	OPHTHALMOLOGY			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; NONDIABETIC VITREOUS HEMORRHAGE; 60 CONSECUTIVE PATIENTS	Purpose: To evaluate visual outcomes after vitrectomy for intraocular hemorrhages secondary to traumatic brain injury. Design: Retrospective, observational case series. Participants: A total of 28 eyes in 20 patients undergoing vitrectomy for Terson syndrome secondary to traumatic brain injury between 1997 and 2015. Methods: We reviewed the records of patients undergoing a standard 20-gauge or 23-gauge pars plana vitrectomy for intraocular hemorrhages secondary to traumatic brain injury, and the timing of vitrectomy in relation to the inciting intracranial event was recorded. Main Outcome Measures: The primary outcome measure was the change in the preoperative visual acuity score at postoperative month 1 and at the last noted clinic appointment. Results: A total of 28 eyes in 20 patients (all male) underwent pars plana vitrectomy for intraocular hemorrhages secondary to traumatic brain injury. The mean preoperative baseline logarithm of the minimum angle of resolution (logMAR) (Snellen) best-corrected visual acuity (BCVA) was 1.81 +/- 0.56 (20/1290). At 1-month postoperative follow-up, the mean BCVA was 0.30 +/- 0.33 (20/40). At the date of the last follow-up, the mean BCVA was 0.15 +/- 0.24 (20/30) and the median BCVA was 0.00 (20/20). Although the difference between preoperative and postoperative BVCA was significantly different at 1 month and the final postoperative clinic visits (P < 0.001), there was not a correlation between preoperative visual acuity as a predictor of final postoperative visual acuity outcome (r = -0.32; P = 0.09; 95% confidence interval [CI] = 0.62 - 0.06). At the date of the last follow-up, the differences in visual outcomes between the individuals undergoing vitrectomy within 3 months of the inciting event, 0.08 +/- 0.15 (20/25), were not significantly different than those undergoing surgical intervention after 3 months, 0.18 +/- 0.27 (20/30) (P = 0.28). Three cases among those undergoing vitrectomy after 3 months were complicated by retinal detachment, none of which resulted in a BCVA worse than when the patient originally presented preoperatively. Conclusions: In this retrospective series of patients without other ocular pathology, surgical intervention effectively provided rapid visual recovery in the majority of individuals with intraocular hemorrhages secondary to traumatic brain injury, irrespective of the timing of vitrectomy or of preoperative visual acuity. (C) 2016 by the American Academy of Ophthalmology	[Narayanan, Raja; Nayaka, Ashraya; Deshpande, Riddhima] LV Prasad Eye Inst, Hyderabad, Andhra Prades, India; [Taylor, Stanford C.; Hrisomalos, Frank N.; Rajagopal, Rithwick; Apte, Rajendra S.] Washington Univ, Dept Ophthalmol & Visual Sci, McMillan Bldg,660 South Euclid Aveue,Box 8096, St Louis, MO 63110 USA; [St Aubin, Daniel; Hu, Jonathan; Tewari, Asheesh] Wayne State Univ, Sch Med, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA		Apte, RS (corresponding author), Washington Univ, Dept Ophthalmol & Visual Sci, McMillan Bldg,660 South Euclid Aveue,Box 8096, St Louis, MO 63110 USA.	Apte@vision.wustl.edu	Narayanan, Raja/AAT-3098-2021	Narayanan, Raja/0000-0001-9688-5859	Research to Prevent Blindness Physician Scientist AwardResearch to Prevent Blindness (RPB); Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Jeffrey Fort Innovation Fund	Supported by a Research to Prevent Blindness Physician Scientist Award (to R.S.A.); an unrestricted grant from Research to Prevent Blindness to the Washington University Department of Ophthalmology, Washington University in St. Louis School of Medicine; and the Jeffrey Fort Innovation Fund.	BELL RA, 1993, ARCH OPHTHALMOL-CHIC, V111, P938, DOI 10.1001/archopht.1993.01090070056019; CASTREN JA, 1963, ACTA OPHTHALMOL, V41, P430; Czorlich P, 2015, NEUROSURG REV, V38, P129, DOI 10.1007/s10143-014-0564-4; Fountas KN, 2008, J NEUROSURG, V109, P439, DOI 10.3171/JNS/2008/109/9/0439; GARFINKLE AM, 1992, J NEUROSURG, V76, P766, DOI 10.3171/jns.1992.76.5.0766; Garweg JG, 2009, ACTA OPHTHALMOL, V87, P222, DOI 10.1111/j.1755-3768.2008.01200.x; Gnanaraj L, 2000, RETINA-J RET VIT DIS, V20, P374, DOI 10.1097/00006982-200007000-00009; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; ISERNHAGEN RD, 1988, RETINA-J RET VIT DIS, V8, P81, DOI 10.1097/00006982-198808020-00001; Ko F, 2010, OPHTHALMOLOGY, V117, P1423, DOI 10.1016/j.ophtha.2009.11.028; Kuhn F, 1998, OPHTHALMOLOGY, V105, P472, DOI 10.1016/S0161-6420(98)93030-5; Litten M., 1881, BERL KLIN WOCHENSCHR, V18, P23; McCarron MO, 2004, J NEUROL NEUROSUR PS, V75, P491, DOI 10.1136/jnnp.2003.016816; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; OYAKAWA RT, 1983, AM J OPHTHALMOL, V96, P517, DOI 10.1016/S0002-9394(14)77916-4; Paunoff F, 1962, KLIN MONATSBL AUGENH, V141, P625; Pfausler B, 1996, J NEUROSURG, V85, P392, DOI 10.3171/jns.1996.85.3.0392; Ritland JS, 2002, ACTA OPHTHALMOL SCAN, V80, P172, DOI 10.1034/j.1600-0420.2002.800210.x; SCHULTZ PN, 1991, OPHTHALMOLOGY, V98, P1814; Seif GI, 2014, CAN J NEUROL SCI, V41, P572, DOI 10.1017/cjn.2014.7; Sharma T, 2002, OPHTHALMIC SURG LAS, V33, P195; Stiebel-Kalish H, 2004, RETINA-J RET VIT DIS, V24, P36, DOI 10.1097/00006982-200402000-00006; Stienen MN, 2012, CLIN NEUROL NEUROSUR, V114, P535, DOI 10.1016/j.clineuro.2011.10.034; Sung W, 2011, ACTA OPHTHALMOL, V89, P544, DOI 10.1111/j.1755-3768.2009.01735.x; Terson A, 1900, CLIN OPHTHALMOL, V6, P309; VANRENS GH, 1983, DOC OPHTHALMOL, V56, P155, DOI 10.1007/BF00154723; Yokoi M, 1997, JPN J OPHTHALMOL, V41, P168, DOI 10.1016/S0021-5155(97)00025-7	27	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JAN	2017	124	1					118	122		10.1016/j.ophtha.2016.09.009			5	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EK4KZ	WOS:000393896900030	27817917				2022-02-06	
J	Nekludov, M; Bellander, BM; Gryth, D; Wallen, H; Mobarrez, F				Nekludov, M.; Bellander, B. -M.; Gryth, D.; Wallen, H.; Mobarrez, F.			Brain-Derived Microparticles in Patients with Severe Isolated TBI	BRAIN INJURY			English	Article						traumatic brain injury; microparticles; clinical study; cerebrovenous blood	ACIDIC PROTEIN GFAP; TISSUE FACTOR; WHOLE-BLOOD; COAGULATION; PLASMA; MICROVESICLES; MESSENGER	Primary Objective: to Investigate the presence of circulating microparticles (MPs) of brain tissue origin In the systemic and cerebrovenous blood of patients with severe traumatic brain Injury (TBI).& para;& para;Research Design: Prospective observational study in 15 consecutive patients with severe isolated TBI.& para;& para;Methods and Procedures: We repeatedly measured concentrations of MPs expressing glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE) and aquaporin-4 (AQP4), in arterial and cerebrovenous blood at admittance to hospital and up to 72 hours after the injury.& para;& para;Main Outcomes and Results: Concentrations of MPs expressing GFAP and AQP4 were significantly higher In the TBI group compared with healthy controls: GFAP 2.0 [1.1-7.9] vs. 1.3 [1-2.1] x 10(6)/mL, p < 0.001; AQP4 0.1 [0.07-0.22] vs. 0.08 [0.06-0.11] x 10(6)/mL, p < 0.001 (median, range). No transcranial gradients were found. Levels of NSE-expressing MPs were also higher in the TBI group compared with healthy controls: 0.4 [0.25-2.1] vs. 0.26 [0.13-0.98] x 10(6)/mL, p < 0.05; however, regarding NSE-posItive non-platelet MPs, there were no differences between patients and controls.& para;& para;Conclusions: Patients with TBI have higher numbers of brain-derived MPs. Further studies are needed, however, to Identify specific and sensitive MP markers of brain Injury.	[Nekludov, M.; Gryth, D.] Karolinska Univ Hosp Solna, Sect Anesthesiol & Intens Care, Dept Physiol & Pharmacol, Karolinska Inst, Stockholm, Sweden; [Bellander, B. -M.] Karolinska Univ Hosp Solna, Sect Neurosurg, Dept Clin Neurosci, Karolinska Inst, Stockholm, Sweden; [Wallen, H.; Mobarrez, F.] Danderyd Hosp, Div Cardiovasc Med, Dept Clin Sci, Karolinska Inst, Stockholm, Sweden; [Mobarrez, F.] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden		Nekludov, M (corresponding author), Karolinska Univ Hosp, Dept Anesthesiol PMI, S-17176 Stockholm, Sweden.	Michael.Nekludov@karolinska.se	Mobarrez, Fariborz/AAK-8929-2020	Mobarrez, Fariborz/0000-0002-7106-6248	Karolinska Institute fund 245; Carnegie Foundation	We thank the Carnegie Foundation and Karolinska Institute fund 245 for financial support. The authors report no conflicts of interest.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Engstrom M, 2006, BLOOD COAGUL FIBRIN, V17, P661, DOI 10.1097/MBC.0b013e32801010b7; Hainfellner JA, 2001, J NEUROPATH EXP NEUR, V60, P449, DOI 10.1093/jnen/60.5.449; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Kerr Zachary Y, 2014, N C Med J, V75, P8; Key NS, 2010, SEMIN THROMB HEMOST, V36, P865, DOI 10.1055/s-0030-1267040; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x; MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Mobarrez F, 2015, PLATELETS, V26, P486, DOI 10.3109/09537104.2014.932339; Mobarrez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090314; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Porro C, 2015, J NEUROIMMUNOL, V288, P70, DOI 10.1016/j.jneuroim.2015.09.006; Riol H, 1997, J NEUROSCI RES, V48, P53; Soop A, 2013, SCAND J IMMUNOL, V78, P205, DOI 10.1111/sji.12076; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Yukutake Y, 2010, NEUROSCIENCE, V168, P885, DOI 10.1016/j.neuroscience.2009.10.029	29	11	13	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1856	1862		10.1080/02699052.2017.1358395			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500018	28972406				2022-02-06	
J	O'Neil-Pirozzi, TM; Doruk, D; Thomson, JM; Fregni, F				O'Neil-Pirozzi, Therese M.; Doruk, Deniz; Thomson, Jennifer M.; Fregni, Felipe			Immediate memory and electrophysiologic effects of prefrontal cortex transcranial direct current stimulation on neurotypical individuals and individuals with chronic traumatic brain injury: a pilot study	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						tDCS; memory; neuroplasticity; rehabilitation; traumatic brain injury	WORKING-MEMORY; TDCS; REHABILITATION; OSCILLATIONS; PERFORMANCE; STRATEGIES; EFFICACY; STROKE	Purpose/aim: Memory impairment post-TBI is common, frequently persistent, and functionally debilitating. The purposes of this pilot study were to assess and to compare immediate behavioral auditory working memory and electrophysiologic effects of three different, randomized, conditions of left dorsolateral prefrontal cortex (LDLPFC) transcranial direct current stimulation (tDCS) applied to four neurotypical adults and four adults with chronic traumatic brain injury (TBI). Materials/methods: Pre- and post-anodal, cathodal, and sham tDCS auditory memory performance, auditory event-related potentials (P300 amplitude and latency) and power of alpha and theta EEG bands were measured across individuals in each group. Results: Post-anodal tDCS only, the neurotypical and TBI groups both demonstrated significantly improved immediate auditory memory function. Also post-anodal tDCS, the TBI group demonstrated significantly increased P300 amplitude versus post-sham tDCS. The neurotypical group demonstrated no pre- post-tDCS electrophysiologic changes across conditions. Conclusions: These findings are consistent with findings of other studies of immediate tDCS effects on other types of memory in neurotypical individuals and in individuals with Parkinson's disease, Alzheimer's disease and stroke and suggest that individuals with memory impairments second to chronic TBI may benefit from LDLPFC anodal tDCS. Pairing tDCS with traditional behavioral memory interventions may facilitate TBI rehabilitation outcomes and warrants continued investigation.	[O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Doruk, Deniz] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Thomson, Jennifer M.] Harvard Med Sch, Spaulding Rehabil Hosp, Lab Neuromodulat, Charlestown, MA USA; [Thomson, Jennifer M.] Univ Sheffield, Western Bank, Cognit Psychol, Dev Psychol, Sheffield, S Yorkshire, England		O'Neil-Pirozzi, TM (corresponding author), Brigham & Womens Hosp, 360 Huntington Ave,70 Forsyth Bldg,Room 103, Boston, MA 02115 USA.; O'Neil-Pirozzi, TM (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, 360 Huntington Ave,70 Forsyth Bldg,Room 103, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu		Thomson, Jenny/0000-0002-4293-4851; Fregni, Felipe/0000-0001-9359-8643			Benedict, 2001, HOPKINS VERBAL LEARN; Bikson M, 2012, CLIN EEG NEUROSCI, V43, P176, DOI 10.1177/1550059412445138; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Datta A, 2011, BRAIN STIMUL, V4, P169, DOI 10.1016/j.brs.2010.11.001; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Holland R, 2012, APHASIOLOGY, V26, P1169, DOI 10.1080/02687038.2011.616925; Jenicek M., 2003, FDN EVIDENCE BASED M; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Khedr EM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00275; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Li LM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00181; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Miotto EC, 2013, CLIN NEUROL NEUROSUR, V115, P309, DOI 10.1016/j.clineuro.2012.05.024; Monte-Silva K, 2010, J NEUROPHYSIOL, V103, P1735, DOI 10.1152/jn.00924.2009; Nakamura-Palacios EM, 2012, INT J NEUROPSYCHOPH, V15, P601, DOI 10.1017/S1461145711001040; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; O'Neil-Pirozzi T, 2015, INT J PHYS MED REHAB, V3, P1; O'Neil-Pirozzi TM, 2012, BRAIN INJURY, V26, P1425, DOI 10.3109/02699052.2012.694561; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; O'Neil-Pirozzi TM, 2015, J HEAD TRAUMA REHAB, V15, P32; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Pena-Gomez C, 2012, BRAIN STIMUL, V5, P252, DOI 10.1016/j.brs.2011.08.006; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Rossi C, 2013, EUR J NEUROL, V20, P202, DOI 10.1111/j.1468-1331.2012.03703.x; ROUX F, 2014, SCI ENG ETHICS, V18, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; TEASDALE G, 1974, LANCET, V2, P81; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027	47	11	12	2	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2017	127	7					592	600		10.1080/00207454.2016.1216415			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET3MD	WOS:000400182200006	27453334	Green Accepted			2022-02-06	
J	Pabian, PS; Oliveira, L; Tucker, J; Beato, M; Gual, C				Pabian, Patrick S.; Oliveira, Leonardo; Tucker, Jennifer; Beato, Morris; Gual, Carlos			Interprofessional management of concussion in sport	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Interdisciplinary management; Interprofessional healthcare	TRAUMATIC BRAIN-INJURY; ASSOCIATION POSITION STATEMENT; HIGH-SCHOOL; EMERGENCY-DEPARTMENT; VESTIBULAR REHABILITATION; POSTCONCUSSION SYNDROME; FOOTBALL PLAYERS; CERVICAL-SPINE; TASK-FORCE; EPIDEMIOLOGY	Due to the high incidence of sports concussion, various health and medical providers are likely to encounter athletes who have sustained such an injury. Management of concussion necessitates coordinated care by the members of the sports medicine team due to its pathophysiology and complexity of management during recovery. All members of the sports medicine team must possess contemporary knowledge of concussion management as well as strong interprofessional communication skills to ensure effective care and safe return to sports participation. Therefore, the aim of this manuscript is to review the current best practices in interdisciplinary management of sports concussion with a special emphasis on the required interprofessional communication among the sports medicine team. (C) 2016 Elsevier Ltd. All rights reserved.	[Pabian, Patrick S.; Tucker, Jennifer; Beato, Morris] Univ Cent Florida, Dept Hlth Profess, Doctor Phys Therapy Program, Orlando, FL 32816 USA; [Oliveira, Leonardo] Univ Cent Florida, Dept Internal Med, Coll Med, Orlando, FL 32816 USA; [Gual, Carlos] Univ Cent Florida, Dept Hlth Profess, Athlet Training Program, Orlando, FL 32816 USA		Pabian, PS (corresponding author), Univ Cent Florida, Dept Hlth Profess, Doctor Phys Therapy Program, Orlando, FL 32816 USA.	Patrick.pabian@ucf.edu; Leonardo.oliveira@ucf.edu; Jennifer.tucker@ucf.edu; Morris.beato@ucf.edu; Carlos.gual@ucf.edu	Pabian, Patrick/Y-9783-2018	Oliveira, Leonardo/0000-0003-4098-1272; Beato, Morris/0000-0002-1073-2411			Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Almasi Stephen J, 2012, WMJ, V111, P21; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Andersen JC, 2002, J ATHL TRAINING, V37, P99; [Anonymous], 2013, MED SCI SPORT EXER, V45, P1618, DOI 10.1249/MSS.0b013e31829ba437; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Baker JG, 2014, INT J CLIN PRACT, V68, P1286, DOI 10.1111/ijcp.12517; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Brock D, 2013, BMJ QUAL SAF, V22, P414, DOI [10.1136/postgradmedj-2012-000952rep, 10.1136/bmjqs-2012-000952]; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carroll Linda, 2012, CONCUSSION CRISIS AN; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; CDC, 2015, INJ PREV CONTR TRAUM; CDC, 2015, SPORTS CONC POL LAWS; Conley KM, 2014, J ATHL TRAINING, V49, P102, DOI 10.4085/1062-6050-48.6.05; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Deering S, 2011, JT COMM J QUAL PATIE, V37, P350, DOI 10.1016/S1553-7250(11)37045-6; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Drezner JA, 2007, CLIN J SPORT MED, V17, P87, DOI 10.1097/JSM.0b013e3180415466; Ellis MJ, 2015, CURR SPORT MED REP, V14, P20, DOI 10.1249/JSR.0000000000000108; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2011, PHYS MED REH CLIN N, V22, P603, DOI 10.1016/j.pmr.2011.08.003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haran H. P., 2015, J SCI MED SPORT; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey EM, 2014, CLIN SIMUL NURS, V10, pE57, DOI 10.1016/j.ecns.2013.08.006; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Institute of Medicine (IOM), 2015, MEAS IMP INT ED COLL; Interprofessional Education Collaborative, 2016, COR COMP INT COLL PR; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Liaw SY, 2014, NURS EDUC TODAY, V34, P259, DOI 10.1016/j.nedt.2013.02.019; Lisbon D, 2016, AM J MED QUAL, V31, P86, DOI 10.1177/1062860614545123; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006338; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; National Collegiate Athletics Association, 2014, 2014 2015 NCAA SPORT; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pabian PS, 2013, STRENGTH COND J, V35, P72; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; Roberts WO, 2014, CURR SPORT MED REP, V13, P395, DOI 10.1249/JSR.0000000000000100; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Salas E, 2008, HUM FACTORS, V50, P540, DOI 10.1518/001872008X288457; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sawyer T, 2013, NEONATAL NETW, V32, P26, DOI 10.1891/0730-0832.32.1.26; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Seifert T, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0513-0; SPITZER WO, 1995, SPINE, V20, pS1; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization (WHO), 2010, FRAM ACT INT ED COLL; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3	98	11	11	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2017	23						123	132		10.1016/j.ptsp.2016.09.006			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EJ5ML	WOS:000393262200019	27654807				2022-02-06	
J	Scholten, J; Vasterling, JJ; Grimes, JB				Scholten, Joel; Vasterling, Jennifer J.; Grimes, Jamie B.			Traumatic brain injury clinical practice guidelines and best practices from the VA state of the art conference	BRAIN INJURY			English	Article						Clinical practice recommendations; clinical practice guidelines; mild traumatic brain injury; concussion; post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PROLONGED EXPOSURE THERAPY; NEUROPSYCHOLOGICAL OUTCOMES; AFGHANISTAN VETERANS; MENTAL-HEALTH; IRAQ; PTSD; SYMPTOMS	Management of symptoms following traumatic brain injury (TBI) can be complex and remains a high priority for Department of Defense (DoD) and Department of Veteran Affairs (VA). Concurrently, awareness of TBI in the public has increased. VA convened a State of the Art (SOTA) Conference to identify priorities for future research and promote best practices for TBI care. Scientific evidence of effective management of symptoms following TBI is expanding, and this evidence has been synthesized into Clinical Practice Guidelines (CPGs) and Clinical Practice Recommendations (CPRs). Knowledge gaps still exist and research efforts to address these gaps should include leveraging large administrative data sets and existing registries to determine effective treatments, investigate compliance of existing clinical care with CPGs and study limitations to determine modifiable vs. non-modifiable core tenants of the evidence-based treatments.	[Scholten, Joel] US Dept Vet Affairs Phys Med & Rehabil, Vet Hlth Adm, 810 Vermont Ave, Washington, DC 20420 USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Dept Vet Affairs, Boston, MA USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA USA; [Vasterling, Jennifer J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Grimes, Jamie B.] Neurol Dept, Bethesda, MD USA; [Grimes, Jamie B.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Scholten, J (corresponding author), US Dept Vet Affairs Phys Med & Rehabil, Vet Hlth Adm, 810 Vermont Ave, Washington, DC 20420 USA.	joel.scholten@va.gov					Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; CDC, 2016, BAS INF TRAUM BRAIN; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Department of Veteran Affairs, 2010, MAN POSTTR STRESS DI; Department of Veterans Affairs, 2016, MAN CONC MILD TRAUM; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Engelhard IM, 2008, MEMORY, V16, P3, DOI 10.1080/09658210701334022; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Koucky EM, 2013, CNS SPECTRUMS, V18, P73, DOI 10.1017/S1092852912000995; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000095; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	35	11	11	2	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1246	1251		10.1080/02699052.2016.1274780			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600010	28981348	hybrid			2022-02-06	
J	Snell, DL; Martin, R; Surgenor, LJ; Siegert, RJ; Hay-Smith, EJC				Snell, Deborah L.; Martin, Rachelle; Surgenor, Lois J.; Siegert, Richard J.; Hay-Smith, E. Jean C.			What's wrong with me? seeking a coherent understanding of recovery after mild traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						MTBI; qualitative analysis; sense of coherence; validation	QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; ILLNESS PERCEPTIONS; HEAD-INJURY; CONCUSSION; SENSE; SYMPTOMS; ASSOCIATIONS; EXPERIENCE; IMPACT	Purpose: Qualitative research examining experiences of recovering from mild traumatic brain injury (MTBI) is limited. Findings from quantitative studies regarding predictors of persisting symptoms are inconsistent with limited attention directed to capturing broad perspectives and priorities of the wider stakeholders. More flexible research approaches may help advance the field. We used a mixed method design to generate patient perspectives of MTBI recovery, integrating these with quantitative investigation to isolate factors that might contribute to divergent MTBI outcomes. Methods: The qualitative component reported here involved semi-structured interviews with selected participants (n = 10) from the quantitative study cohort, sampling both recovered and non-recovered adult MTBI participants. Interviews focused on participants' general description and understandings of their recovery and perceptions of what helped or hindered this. Data were analyzed using general thematic analysis. Results and conclusion: Participants regardless of recovery status identified the importance of having a coherent understanding of their injury and recovery. Factors facilitating coherence included social support, validation, reassurance, accessing credible evidence-based information and having a pathway to wellness. Findings suggested that coherence could be a helpful umbrella construct worthy of examination in future MTBI research. This construct appears broad and able to cope with the complexity of individual experiences after injury.	[Snell, Deborah L.] Burwood Hosp, Concuss Clin, Christchurch, New Zealand; [Snell, Deborah L.] Univ Otago Christchurch, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand; [Martin, Rachelle; Hay-Smith, E. Jean C.] Univ Otago Wellington, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Surgenor, Lois J.] Univ Otago Christchurch, Dept Psychol Med, Christchurch, New Zealand; [Siegert, Richard J.] AUT Univ, Fac Hlth & Environm Studies, Auckland, New Zealand		Snell, DL (corresponding author), Univ Otago Christchurch, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand.	debbie.snell@burwood.org.nz	Martin, R/R-9971-2019; Siegert, Richard J./K-2030-2019	Martin, R/0000-0002-9533-3195; Siegert, Richard/0000-0002-3074-0929	Emerging Researcher First Grant from the Health Research Council of New Zealand [13/702]	This research has been support by an Emerging Researcher First Grant from the Health Research Council of New Zealand [Grant no13/702].	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Antonovsky A., 1987, UNRAVELING MYSTERY H; Arvidsdotter T, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0654-z; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brunger H, 2014, BRAIN INJURY, V28, P71, DOI 10.3109/02699052.2013.857788; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cresswell J., 2003, RES DESIGN QUANTITAT; Fernando AT, 2014, J PAIN SYMPTOM MANAG, V48, P289, DOI 10.1016/j.jpainsymman.2013.09.014; Ferreira PH, 2013, PHYS THER, V93, P470, DOI 10.2522/ptj.20120137; Freitas TH, 2015, WORLD J GASTROENTERO, V21, P6713, DOI 10.3748/wjg.v21.i21.6713; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Letts L., 2007, GUIDELINES CRITICAL; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Matsuzawa YK, 2014, PSYCHOL INJ LAW, V7, P388, DOI 10.1007/s12207-014-9204-0; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; NZGG, 2006, TRAUM BRAIN INJ DIAG; O'Cathain A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-85; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; TEASDALE G, 1974, LANCET, V2, P81; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; World Health Organization, 1992, ICD 10 CLASSIFICATIO	50	11	11	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	19					1968	1975		10.1080/09638288.2016.1213895			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EX7JT	WOS:000403425200009	27626509				2022-02-06	
J	Stenberg, M; Koskinen, LOD; Jonasson, P; Levi, R; Stainacke, BM				Stenberg, Maud; Koskinen, Lars-Owe D.; Jonasson, Per; Levi, Richard; Stainacke, Britt-Marie			Computed tomography and clinical outcome in patients with severe traumatic brain injury	BRAIN INJURY			English	Article						Computed tomography; severe traumatic brain injury; outcome	NONPENETRATING HEAD-INJURY; GLASGOW COMA SCALE; SUBARACHNOID HEMORRHAGE; PROGNOSTIC VALUE; IMPACT; REHABILITATION; CONSCIOUSNESS; POPULATION; MORTALITY; ALCOHOL	Objective: To study: (i) acute computed tomography (CT) characteristics and clinical' outcome; (ii) clinical course and (iii) Corticosteroid Randomisation after Significant Head Injury acute calculator protocol (CRASH) model and clinical outcome in patients with severe traumatic brain injury (sTBI). Methods: Initial CT (CT;) and CT 24 hours post-trauma (CT24) were evaluated according to Marshall and Rotterdam classifications. Rancho Los Amigos Cognitive Scale-Revised (RLAS-R) and Glasgow Outcome Scale Extended (GOSE) were assessed at three months and one year post-trauma. The prognostic value of the CRASH model was evaluated. Results: Thirty-seven patients were included. Marshall CT; and CT24 were significantly correlated with RLAS-R at three months. Rotterdam CT24 was significantly correlated with GOSE at three months. RLAS-R and the GOSE improved significantly from three months to one year. CRASH predicted unfavourable outcome at six months for 81% of patients with bad outcome and for 85% of patients with favourable outcome according to GOSE at one year. Conclusion: Neither CT nor CRASH yielded clinically useful predictions of outcome at one year post injury. The study showed encouragingly many instances of significant recovery in this population of sTBI. The combination of lack of reliable prognostic indicators and favourable outcomes supports the case for intensive acute management and rehabilitation as the default protocol in the cases of sTBI.	[Stenberg, Maud; Stainacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Rehabil Med, Umea, Sweden; [Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, Neurosurg, Umea, Sweden; [Jonasson, Per] Umea Univ, Dept Radiat Sci, Diagnost Radiol, Umea, Sweden; [Levi, Richard] Linkoping Univ, Dept Rehabil Med, Linkoping, Sweden; [Stainacke, Britt-Marie] Karolinska Inst, Danderyd Univ Hosp, Div Rehabil Med, Dept Clin Sci, Stockholm, Sweden; [Stainacke, Britt-Marie] Danderyd Hosp, Dept Rehabil Med, Stockholm, Sweden		Stenberg, M (corresponding author), Umea Univ, Umea Univ Hosp, Dept Community Med & Rehabil, Rehabil Med, Bldg 9A, SE-90185 Umea, Sweden.	maud.stenberg@rehabmed.umu.se	Stenberg, Maud/AAX-4366-2021; Koskinen, Lars-Owe/AAQ-8957-2020	Levi, Richard/0000-0001-7994-372X	Vasterbotten County Council	This study was supported by grants from Vasterbotten County Council.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Eker C, 2000, BRAIN INJURY, V14, P605; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Hagen C, 1987, REHABILITATION HEAD; JENNETT B, 1975, LANCET, V1, P480; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Lubillo S, 1999, J NEUROSURG, V91, P581, DOI 10.3171/jns.1999.91.4.0581; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Vestri A, 2014, BRAIN INJURY, V28, P1102, DOI 10.3109/02699052.2014.910698; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	41	11	15	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					351	358		10.1080/02699052.2016.1261303			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900010	28296529				2022-02-06	
J	Tyerman, E; Eccles, FJR; Gray, V				Tyerman, Emma; Eccles, Fiona J. R.; Gray, Victoria			The experiences of parenting a child with an acquired brain injury: A meta-synthesis of the qualitative literature	BRAIN INJURY			English	Article							TERM BEHAVIOR PROBLEMS; CLOSED-HEAD-INJURY; PSYCHIATRIC-DISORDERS; CHRONICALLY ILL; FAMILY; ADOLESCENTS; STRESS; NEEDS; INFORMATION; PREDICTORS	Objective. To systematically review and then synthesize the qualitative literature on the experience of parenting a child with an acquired brain injury (ABI).Design. Systematic literature review and meta-synthesisMethods. A systematic search of the literature was conducted in four databases. Papers which met the inclusion criterion were assessed for quality using the Critical Skills Appraisal Programme (CASP) tool and then synthesized according to Noblit and Hare's (1988) guidelines for meta-ethnography.Results. Of the 4855 papers retrieved, 17 met the inclusion criteria. Synthesis resulted in three themes: (1) Disconnection: Cut off from internal emotions and isolated from others; (2) Seeking understanding and support to manage in an insecure world; and (3) New parent to a different child.Conclusions. Having a child with an ABI leads to many challenges for parents. These include feeling insecure, isolated from others and struggling to adapt to the different roles required to parent their different child. Clinical implications highlight the need for specialist support that is ongoing after discharge, including specialist knowledge and understanding of ABI and opportunities for peer support.	[Tyerman, Emma; Eccles, Fiona J. R.] Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Lancaster LA1 4YG, England; [Gray, Victoria] Alder Hey Childrens NHS Fdn Trust, Psychol Serv Paediat, Liverpool, Merseyside, England		Eccles, FJR (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Lancaster LA1 4YG, England.	f.eccles@lancaster.ac.uk	Eccles, Fiona/AAR-9468-2020	Eccles, Fiona/0000-0003-1484-2703			Anderson T, 2011, J EVID-INFORM SOC WO, V8, P416, DOI 10.1080/15433710903269172; Andersson K, 2016, BRAIN INJURY, V30, P829, DOI 10.3109/02699052.2016.1146963; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Brown FL, 2014, J CHILD PSYCHOL PSYC, V55, P1172, DOI 10.1111/jcpp.12227; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Caunt BS, 2013, J HAPPINESS STUD, V14, P475, DOI 10.1007/s10902-012-9339-1; Chisholm J, 2001, Axone, V23, P12; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Coffey Jean Sheerin, 2006, Pediatr Nurs, V32, P51; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Crnic KA, 2005, INFANT CHILD DEV, V14, P117, DOI 10.1002/icd.384; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; du Toit Christine, 2013, S. Afr. j. occup. ther., V43, P17; Duggleby W, 2010, QUAL HEALTH RES, V20, P148, DOI 10.1177/1049732309358329; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Falk AC, 2008, PATIENT EDUC COUNS, V70, P251, DOI 10.1016/j.pec.2007.10.001; Fisher HR, 2001, J ADV NURS, V36, P600, DOI 10.1046/j.1365-2648.2001.02013.x; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Forinder U, 2010, SUPPORT CARE CANCER, V18, P543, DOI 10.1007/s00520-009-0678-3; Gebhardt MC, 2011, REHABIL NURS, V36, P3, DOI 10.1002/j.2048-7940.2011.tb00059.x; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; Guerriere D, 1997, J Soc Pediatr Nurs, V2, P105, DOI 10.1111/j.1744-6155.1997.tb00067.x; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hummelinck A, 2006, PATIENT EDUC COUNS, V62, P228, DOI 10.1016/j.pec.2005.07.006; Jackson AC, 2007, J PEDIATR ONCOL NURS, V24, P95, DOI 10.1177/1043454206296030; Jones M., 2010, NZ J OCCUPATIONAL TH, V57, P4; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kazak AE, 2006, FAM SYST HEALTH, V24, P381, DOI DOI 10.1037/1091-7527.24.4.381; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Mednick L, 2009, J UROLOGY, V181, P1312, DOI 10.1016/j.juro.2008.10.051; Meehan Diane Ryder, 2005, J Neurosci Nurs, V37, P265; Menezes AM, 1998, HEART, V80, P286, DOI 10.1136/hrt.80.3.286; Morawska A, 2015, J CHILD HEALTH CARE, V19, P5, DOI 10.1177/1367493513496664; Neurological Alliance, 2016, BRIEF REV NUMB PEOPL; Noblit GW, 1988, META ETHNOGRAPHY SYN; Norberg AL, 2009, EUR J CANCER CARE, V18, P371, DOI 10.1111/j.1365-2354.2008.00976.x; Norberg AL, 2005, ACTA ONCOL, V44, P382, DOI 10.1080/02841860510029789; Office for National Statistics, 2014, 2014 FAM HOUS; Oyserman D, 2000, AM J ORTHOPSYCHIAT, V70, P296, DOI 10.1037/h0087733; Patistea Evangelia, 2003, Eur J Oncol Nurs, V7, P172, DOI 10.1016/S1462-3889(03)00023-1; Petersen H, 2015, HEALTH SOC WORK, V40, P325, DOI 10.1093/hsw/hlv063; Ramritu PL, 1999, INT J NURS STUD, V36, P209, DOI 10.1016/S0020-7489(99)00016-4; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Robson T., 2005, BRAIN IMPAIR, V6, P45, DOI [10.1375/brim.6.1.45.65477, DOI 10.1375/BRIM.6.1.45.65477]; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Sandelowski M., 2007, HDB SYNTHESIZING QUA; Sandelowski M, 2015, QUAL HEALTH RES, V13, P905; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schutz A., 1964, COLLECTED PAPERS; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shortman RI, 2013, CHILD CARE HLTH DEV, V39, P743, DOI 10.1111/cch.12005; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Silva FQB, 2013, ELECT COMPUT ENG, V9, P152; Thorne S, 2004, QUAL HEALTH RES, V14, P1342, DOI 10.1177/1049732304269888; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WALLANDER JL, 1989, J PEDIATR PSYCHOL, V14, P157, DOI 10.1093/jpepsy/14.2.157; Wang M, 2014, J HAPPINESS STUD, V15, P85, DOI 10.1007/s10902-013-9417-z; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	72	11	11	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1553	1563		10.1080/02699052.2017.1341999			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200001	28750173	Green Accepted			2022-02-06	
J	Vlodavsky, E; Palzur, E; Shehadeh, M; Soustiel, JF				Vlodavsky, Eugene; Palzur, Eilam; Shehadeh, Mona; Soustiel, Jean F.			Post-traumatic cytotoxic edema is directly related to mitochondrial function	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral metabolism; cytotoxic edema; mitochondria; mitochondrial permeability transition; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; K+-CL-COTRANSPORTER; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; CYCLOSPORINE-A; EAA RELEASE; METABOLISM; MORTALITY	Cerebral edema represents a major threat following traumatic brain injury. However, therapeutic measures for control of intracranial pressure alone have failed to restore cerebral metabolism and improve neurological outcome. Since mitochondrial damage results in ATP depletion and deactivation of membrane ionic pumps, we hypothesized that modulation of ATP bioavailability may directly affect cytotoxic edema. Intracranial pressure measurements were performed in Sprague-Dawley rats treated by intraperitoneal injection of dimethylsulfoxide (vehicle), cyclosporine A (CsA), or Oligomycin B (OligB) following cortical contusion and further correlated with water content, mitochondrial damage, and electron microscopic assessment of neuronal and axonal edema. As hypothesized, ultra-structural figures of edema closely correlated with intracranial pressure elevation, increased water content and mitochondrial membrane permeabilization expressed by loss of transmembrane mitochondrial potential. Further, mitochondrial damage evidenced ultrastructurally by figures of swollen mitochondria with severely distorted cristae correlated with both cytotoxic edema and mitochondrial dysfunction. Importantly, cerebral edema and mitochondrial impairment were significantly worsened by treatment with OligB, whereas a noticeable improvement could be observed in animals that received injections of CsA. Since OligB and CsA are responsible for symmetrical and opposite effects on oxidative metabolism, these findings support the hypothesis of a causative relationship between edema and mitochondrial function.	[Vlodavsky, Eugene] Rambam Med Ctr, Inst Pathol, Haifa, Israel; [Vlodavsky, Eugene; Shehadeh, Mona] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Palzur, Eilam; Soustiel, Jean F.] Bar Ilan Univ, Eliachar Res Lab, Galilee Med Ctr, Fac Med Galilee, Nahariyya, Israel; [Soustiel, Jean F.] Bar Ilan Univ, Dept Neurosurg, Galilee Med Ctr, Fac Med Galilee, Nahariyya, Israel		Soustiel, JF (corresponding author), Galilee Med Ctr, Dept Neurosurg, POB 21, IL-2210001 Nahariyya, Israel.	jean.soustiel@naharia.health.gov.il		Palzur, Eilam/0000-0003-2032-2974			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Fukui S, 2003, ACT NEUR S, V86, P301; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; KRAMAR R, 1984, AGENTS ACTIONS, V15, P660, DOI 10.1007/BF01966788; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; REILLY PL, 1975, LANCET, V2, P375; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Soustiel JF, 2011, PHARM RES-DORDR, V28, P2945, DOI 10.1007/s11095-011-0463-0; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1147, DOI 10.1152/ajpcell.00538.2001; Szabo C, 2005, CRIT CARE MED, V33, pS530, DOI 10.1097/01.CCM.0000187002.88999.CF; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	39	11	11	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2017	37	1					166	177		10.1177/0271678X15621068			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EE5MY	WOS:000389653500012	26672111	Green Published, Bronze			2022-02-06	
J	Wang, RL; Zhao, HP; Li, JC; Duan, YX; Fan, ZB; Tao, Z; Ju, F; Yan, F; Luo, YM				Wang, Rongliang; Zhao, Haiping; Li, Jincheng; Duan, Yunxia; Fan, Zhibin; Tao, Zhen; Ju, Fei; Yan, Feng; Luo, Yumin			Erythropoietin attenuates axonal injury after middle cerebral artery occlusion in mice	NEUROLOGICAL RESEARCH			English	Article						Erythropoietin; Axonal injury; Demyelination; beta-amyloid precursor protein; Neurite growth inhibitor-A	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; WHITE-MATTER; REACTIVE ASTROCYTES; EXPRESSION; ISCHEMIA; BETA; NEUROGENESIS; RECOVERY; SYSTEM	Objective: Erythropoietin (EPO) confers potent neuroprotection against ischemic injury through a variety of mechanisms. However, the protective effect of EPO on axons after cerebral ischemia in adult mice is rarely covered. The purpose of this study was to investigate the potential neuroprotective effects of EPO on axons in mice after cerebral ischemia. Methods: A total of 30 adult male C57 BL/6 mice were treated with EPO (5000IU/kg) or vehicle after transient middle cerebral artery occlusion (MCAO). The mortality rate of each experimental group was calculated. Neurological function was assessed by Rota-rod test. Frozen sections from each mouse brain at 14days after reperfusion were used to evaluate the fluorescent intensity of myelin basic protein (MBP) and neurofilament 200 (NF-200). Immunofluorescence staining and Western blotting were used to assess the protein level of beta-amyloid precursor protein (beta-APP) and glial fibrillary acidic protein (GFAP), a marker of mature astrocytes. The protein levels of the myelin-derived growth inhibitory proteins, neurite growth inhibitor-A (Nogo-A), myelin-associated glycoprotein (MAG) and oligodendrocyte-myelin glycoprotein (OMG) were also examined by Western blot after MCAO. Results: The survival rate of the vehicle group 14 days after cerebral ischemia-reperfusion was 50%, which increased to 80% after EPO treatment at the start of reperfusion. EPO improved neurobehavioral outcomes at days 3 and 7 after MCAO was compared with the vehicle group (P < 0.05). Furthermore, EPO ameliorated demyelination, demonstrated by upregulation of the MBP/NF-200 ratio. Meanwhile, increased levels of beta-APP, GFAP, Nogo-A, and MAG after MCAO were reduced by EPO treatment (P < 0.05). Conclusion: EPO treatment attenuates axonal injury and improves neurological function after cerebral ischemia in adult mice.	[Wang, Rongliang; Zhao, Haiping; Fan, Zhibin; Tao, Zhen; Yan, Feng; Luo, Yumin] Capital Med Univ, Cerebrovasc Dis Res Inst, Beijing, Peoples R China; [Wang, Rongliang; Zhao, Haiping; Fan, Zhibin; Tao, Zhen; Yan, Feng; Luo, Yumin] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Rongliang; Zhao, Haiping; Duan, Yunxia; Fan, Zhibin; Tao, Zhen; Yan, Feng; Luo, Yumin] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Wang, Rongliang; Zhao, Haiping; Duan, Yunxia; Fan, Zhibin; Tao, Zhen; Yan, Feng; Luo, Yumin] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Li, Jincheng] Zibo Cent Hosp, Dept Neurol, Zibo, Peoples R China; [Ju, Fei] Cent Hosp Beijing, Prison Adm Bur, Internal Med Dept, Beijing, Peoples R China		Luo, YM (corresponding author), Capital Med Univ, Cerebrovasc Dis Res Inst, Beijing, Peoples R China.; Luo, YM (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.; Luo, YM (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Luo, YM (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.	yumin111@ccmu.edu.cn	zhao, haiping/I-1306-2014	yan, feng/0000-0001-8663-6859	Natural Science Foundation in ChinaNational Natural Science Foundation of China (NSFC) [81471340, 81641054]	This work was supported by the Natural Science Foundation in China [grant numbers 81471340, 81641054].	Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chen YZ, 2013, BRAIN RES, V1495, P11, DOI 10.1016/j.brainres.2012.12.006; Feng NP, 2016, EXP THER MED, V11, P1595, DOI 10.3892/etm.2016.3089; Frisen J, 2016, ANNU REV CELL DEV BI, V32, P127, DOI 10.1146/annurev-cellbio-111315-124953; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Hong L, 2014, NEUROL RES, V36, P276, DOI 10.1179/1743132813Y.0000000288; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Lee ST, 2012, J NEUROCHEM, V120, P115, DOI 10.1111/j.1471-4159.2011.07534.x; Lynch AM, 2010, AGING DIS, V1, P262; Ma QF, 2016, AGING DIS, V7, P705, DOI 10.14336/AD.2016.0320; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Merelli A, 2015, INT J NEUROSCI, V125, P793, DOI 10.3109/00207454.2014.989321; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang RL, 2016, BRAIN CIRC, V1, P54; Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441; Yam PS, 2000, J CEREBR BLOOD F MET, V20, P772, DOI 10.1097/00004647-200005000-00003; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011016	25	11	11	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2017	39	6			SI		545	551		10.1080/01616412.2017.1316904			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV6BL	WOS:000401854500012	28413924				2022-02-06	
J	Ye, YQ; Zhang, PJ; Qian, YH; Yin, BX; Yan, MJ				Ye, Yongqi; Zhang, Pengju; Qian, Yuhang; Yin, Baoxin; Yan, Meijuan			The Effect of Pyrroloquinoline Quinone on the Expression of WISP1 in Traumatic Brain Injury	STEM CELLS INTERNATIONAL			English	Article							SIGNALING PATHWAY PROTEIN-1; INDUCED CARDIOMYOCYTE DEATH; BETA-CATENIN; ALZHEIMERS-DISEASE; GROWTH-FACTOR; AUTOPHAGY; CELLS; SURVIVAL; PQQ; NEUROPROTECTION	WISP1, as a member of the CCN4 protein family, has cell protective effects of promoting cell proliferation and inhibiting cell apoptosis. Although some studies have confirmed that WISP1 is concerned with colon cancer and lung cancer, there is little report about the influence of WISP1 in traumatic brain injury. Here, we found that the expression of WISP1 mRNA and protein decreased at 3 d and then increased at 5 d after traumatic brain injury (TBI). Meanwhile, immunofluorescence demonstrated that there was little colocation of WISP1 with GFAP, Iba1, and WISP1 colocalized with NeuN partly. WISP1 colocalized with LC3, but there was little of colocation about WISP1 with cleaved caspase-3. Subsequent study displayed that the expression of beta-catenin protein was identical to that of WISP1 after TBI. WISP1 was mainly located in cytoplasm of PC12 or SHSY5Y cells. Compared with the negative control group, WISP1 expression reduced obviously in SHSY5Y cells transfected with WISP1 si-RNA. CCK-8 assay showed that pyrroloquinoline quinone (PQQ) had little influence on viability of PC12 and SHSY5Y cells. These results suggested that WISP1 played a protective role after traumatic brain injury in rats, and this effect might be relative to autophagy caused by traumatic brain injury.	[Ye, Yongqi; Zhang, Pengju; Qian, Yuhang; Yin, Baoxin; Yan, Meijuan] Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, Peoples R China		Yan, MJ (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, Peoples R China.	ymz@ntu.edu.cn	yan, mei/AAA-1379-2022		National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31370803]; Application Study Program of Nantong City [BK2013004]; Early Pre-research Program of Nantong University [10ZY013]; Doctoral Program of Nantong University [12B035]	This work was supported by the National Natural Scientific Foundation of China (31370803), Application Study Program of Nantong City (BK2013004), Early Pre-research Program of Nantong University (10ZY013), and Doctoral Program of Nantong University (12B035).	Broe M, 2001, ACTA NEUROPATHOL, V101, P616; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Feeney A., 2014, GUT PATHOG, V6, P15; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Halperin-Sheinfeld M, 2012, AGING-US, V4, P436, DOI 10.18632/aging.100468; He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3; Heise RL, 2011, J BIOL CHEM, V286, P17435, DOI 10.1074/jbc.M110.137273; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohara H, 2011, BIOMATERIALS, V32, P5726, DOI 10.1016/j.biomaterials.2011.04.035; Cabezas IL, 2014, NEUROLOGIA, V29, P305, DOI 10.1016/j.nrl.2012.10.006; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Sanchez RM, 2000, J NEUROSCI, V20, P2409; Venkatachalam K, 2009, J BIOL CHEM, V284, P14414, DOI 10.1074/jbc.M809757200; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wang SH, 2013, CURR NEUROVASC RES, V10, P54, DOI 10.2174/156720213804805945; Wang SH, 2012, CURR NEUROVASC RES, V9, P91, DOI 10.2174/156720212800410858; Wang SH, 2012, CURR NEUROVASC RES, V9, P20, DOI 10.2174/156720212799297137; Wang YS, 2012, AM J TRANSL RES, V4, P44; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Xu LF, 2000, GENE DEV, V14, P585; Yamada E, 2012, DIABETES, V61, P272, DOI 10.2337/db11-1199; Young JK, 2002, J ANAT, V201, P85, DOI 10.1046/j.1469-7580.2002.00068.x; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111; Zhu BQ, 2004, CARDIOVASC DRUG THER, V18, P421, DOI 10.1007/s10557-004-6219-x	37	11	11	1	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-966X	1687-9678		STEM CELLS INT	Stem Cells Int.		2017	2017								4782820	10.1155/2017/4782820			16	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FE8KM	WOS:000408454000001	28883836	Green Published, gold, Green Submitted			2022-02-06	
J	Choi, BY; Kim, IY; Kim, JH; Lee, BE; Lee, SH; Kho, AR; Sohn, M; Suh, SW				Choi, Bo Young; Kim, In Yeol; Kim, Jin Hee; Lee, Bo Eun; Lee, Song Hee; Kho, A. Ra; Sohn, Min; Suh, Sang Won			ZINC PLUS CYCLO-(HIS-PRO) PROMOTES HIPPOCAMPAL NEUROGENESIS IN RATS	NEUROSCIENCE			English	Article						zinc; zinc plus cyclo-(His-Pro); neurogenesis; hippocampus	CYCLO HIS-PRO; TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; ADULT-RAT; VESICULAR ZINC; NEURONAL DEATH; CEREBRAL-ISCHEMIA; PANCREATIC-ISLETS; ARACHIDONIC-ACID; GRANULE CELLS	Zinc is a central actor in regulating stem cell proliferation and neurogenesis in the adult brain. High levels of vesicular zinc are found in the presynaptic terminals. It has been demonstrated that high levels of vesicular zinc are localized in the presynaptic terminals of the granule cells of the dentate gyrus (DG) and that neurogenesis occurs in the subgranular zone (SGZ). Furthermore, zinc chelation reduces hippocampal neurogenesis in pathological conditions such as hypoglycemia, epilepsy and traumatic brain injury. Here we test the effects of zinc plus cyclo-(His-Pro) (CHP) treatment on neurogenesis in the adult SGZ. In order to increase brain zinc, Sprague-Dawley (SD) rats, aged 5 weeks, were given zinc plus CHP (ZC, 27 mg/kg) orally available once per day for 2 weeks. BrdU was intraperitoneally injected 2 times per day for 4 consecutive days starting 1 week after initial ZC treatment. Neurogenesis was analyzed by BrdU, Ki67 and doublecortin (DCX) immunostaining. The number of progenitor cells and immature neurons were significantly increased in the DG following 2 weeks of ZC treatment. Hippocampal vesicular zinc content was evaluated with TSQ staining. Vesicular TSQ fluorescent intensity was seen to increase in the mossy fiber area at 2 weeks after ZC treatment. The present study demonstrates that zinc supplementation by ZC treatment increases hippocampal neurogenesis and levels of vesicular zinc. These findings provide evidence in support of the essential role of zinc in modulating hippocampal neurogenesis. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Choi, Bo Young; Kim, In Yeol; Kim, Jin Hee; Lee, Bo Eun; Lee, Song Hee; Kho, A. Ra; Suh, Sang Won] Hallym Univ, Dept Physiol, Coll Med, 1 Okcheon Dong,39 Hallymdaehak Gil, Chunchon 200702, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea		Suh, SW (corresponding author), Hallym Univ, Dept Physiol, Coll Med, 1 Okcheon Dong,39 Hallymdaehak Gil, Chunchon 200702, South Korea.	swsuh@hallym.ac.kr		SOHN, MIN/0000-0003-4021-2051; Choi, Bo Young/0000-0002-9579-3503	Hallym University Research Fund [HRF-201607-014]; Brain Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016M3C7A1913844]	We thank Dr. MK Song (VA Greater Los Angles Healthcare System, Los Angeles, CA) for generously donating the CHP with or without zinc and Mr. Min Chul Park (Hallym Clinical and Translational Science Institute, Chuncheon, Korea) for operating confocal microscope. This study was supported by a grant from the Hallym University Research Fund (HRF-201607-014). This work was also supported by Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3C7A1913844) to S.W.S.	BANKS WA, 1993, AM J PHYSIOL, V264, pE723, DOI 10.1152/ajpendo.1993.264.5.E723; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; Boroujeni ST, 2009, BIOL TRACE ELEM RES, V130, P48, DOI 10.1007/s12011-008-8312-7; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; BUELL SJ, 1977, EXP NEUROL, V55, P199, DOI 10.1016/0014-4886(77)90170-4; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Choi BY, 2014, METALLOMICS, V6, P1513, DOI 10.1039/c4mt00067f; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P706, DOI 10.1177/33.7.4008918; DUERRE JA, 1977, J NUTR, V107, P1082, DOI 10.1093/jn/107.6.1082; DVERGSTEN CL, 1983, BRAIN RES, V271, P217, DOI 10.1016/0006-8993(83)90284-6; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FOSMIRE GJ, 1975, PEDIATR RES, V9, P89, DOI 10.1203/00006450-197509020-00006; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; GOLUB MS, 1994, AM J CLIN NUTR, V60, P238, DOI 10.1093/ajcn/60.2.238; HALAS ES, 1986, PHYSIOL BEHAV, V37, P451, DOI 10.1016/0031-9384(86)90205-2; HALAS ES, 1983, PHYSIOL BEHAV, V30, P371, DOI 10.1016/0031-9384(83)90140-3; Hambidge KM, 2007, J NUTR, V137, P1101, DOI 10.1093/jn/137.4.1101; Hwang IK, 2003, DIABETES OBES METAB, V5, P317, DOI 10.1046/j.1463-1326.2003.00281.x; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Karami M, 2013, HEALTH PROMOT PERSPE, V3, P242, DOI 10.5681/hpp.2013.027; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048543; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Levenson CW, 2011, ADV NUTR, V2, P96, DOI 10.3945/an.110.000174; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; MILLAR MJ, 1961, J HISTOCHEM CYTOCHEM, V9, P111, DOI 10.1177/9.2.111; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MORI M, 1983, BIOCHEM BIOPH RES CO, V115, P281, DOI 10.1016/0006-291X(83)91001-X; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; Piechal A, 2016, BIOL TRACE ELEM RES, V172, P408, DOI 10.1007/s12011-015-0597-8; PRASAD C, 1982, PEPTIDES, V3, P591, DOI 10.1016/0196-9781(82)90129-2; Rosenthal MJ, 2001, LIFE SCI, V70, P337, DOI 10.1016/S0024-3205(01)01395-9; Salazar G, 2005, J CELL SCI, V118, P1911, DOI 10.1242/jcs.02319; SANDSTEAD HH, 1972, PEDIATR RES, V6, P119, DOI 10.1203/00006450-197202000-00005; Sandstead HH, 2000, J NUTR, V130, p496S, DOI 10.1093/jn/130.2.496S; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Song MK, 2009, BRIT J PHARMACOL, V158, P442, DOI 10.1111/j.1476-5381.2009.00201.x; Song MK, 2001, METABOLISM, V50, P53, DOI 10.1053/meta.2001.19427; Song MK, 1998, METABOLISM, V47, P39, DOI 10.1016/S0026-0495(98)90190-1; STEWART GR, 1984, BRAIN RES, V290, P43, DOI 10.1016/0006-8993(84)90734-0; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2005, DIABETES, V54, P500, DOI 10.2337/diabetes.54.2.500; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2001, NEUROREPORT, V12, P1523, DOI 10.1097/00001756-200105250-00044; Suh SW, 1999, J HISTOCHEM CYTOCHEM, V47, P969, DOI 10.1177/002215549904700715; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2000, BRAIN RES, V859, P352, DOI 10.1016/S0006-8993(00)02027-8; Tamano H, 2015, HIPPOCAMPUS; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; WU FYH, 1987, ANNU REV NUTR, V7, P251, DOI 10.1146/annurev.nu.07.070187.001343; YANAGISAWA T, 1980, J BIOL CHEM, V255, P290; YOSHINAGA T, 1974, ENDOKRINOLOGIE, V63, P53	71	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 17	2016	339						634	643		10.1016/j.neuroscience.2016.10.035			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED9CT	WOS:000389168500053	27773743				2022-02-06	
J	Doig, RLO; Bartlett, CA; Smith, NM; Hodgetts, SI; Dunlop, SA; Hool, L; Fitzgerald, M				Doig, Ryan L. O'Hare; Bartlett, Carole A.; Smith, Nicole M.; Hodgetts, Stuart I.; Dunlop, Sarah A.; Hool, Livia; Fitzgerald, Melinda			SPECIFIC COMBINATIONS OF ION CHANNEL INHIBITORS REDUCE EXCESSIVE Ca2+ INFLUX AS A CONSEQUENCE OF OXIDATIVE STRESS AND INCREASE NEURONAL AND GLIAL CELL VIABILITY IN VITRO	NEUROSCIENCE			English	Article						Ca2+ channel inhibitors; intracellular Ca2+ concentration; oligodendroglia; NG2-glia; Cell viability	CONFORMATIONALLY CONSTRAINED ANALOGS; SPINAL-CORD-INJURY; HYDROGEN-PEROXIDE; POTENT ANTAGONIST; CALCIUM-CHANNELS; SECONDARY DEGENERATION; BIOLOGICAL-ACTIVITY; WHITE-MATTER; BRAIN-INJURY; BLOOD-FLOW	Combinations of Ca2+ channel inhibitors have been proposed as an effective means to prevent excess Ca2+ flux and death of neurons and glia following neurotrauma in vivo. However, it is not yet known if beneficial outcomes such as improved viability have been due to direct effects on intracellular Ca2+ concentrations. Here, the effects of combinations of Lomerizine (Lom), 2,3-dioxo-7-(1H-imidazol-1-yl)6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl] acetic acid monohydrate (YM872), 3,5-dimethyl-1-adamantanamine (memantine (Mem)) and/or adenosine 5'-triphosphate periodate oxidized sodium salt (oxATP) to block voltage-gated Ca2+ channels, Ca2+ permeable (x-ami no-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, NMDA receptors and purinergic P2X(7) receptors (P2X(7)R) respectively, on Ca2+ concentration and viability of rat primary mixed cortical (MC) cultures exposed to hydrogen peroxide (H2O2) insult, were assessed. The contribution of ryanodine-sensitive intracellular stores to intracellular Ca2+ concentration was also assessed. Live cell calcium imaging revealed that a 30 min H2O2 insult induced a slow increase in intracellular Ca2+, in part from intracellular sources, associated with loss of cell viability by 6 h. Most combinations of inhibitors that included oxATP significantly decreased Ca2+ influx and increased cell viability when administered simultaneously with H2O2. However, reductions in intracellular Ca2+ concentration were not always linked to improved cell viability. Examination of the density of specific cell subpopulations demonstrated that most combinations of inhibitors that included oxATP preserved NG2+ non-oligodendroglial cells, but preservation of astrocytes and neurons required additional inhibitors. Olig(2+) oligodendroglia and ED-1(+) activated microglia/macrophages were not preserved by any of the inhibitor combinations. These data indicate that following H2O2 insult, limiting intracellular Ca2+ entry via P2X(7)R is generally associated with increased cell viability. Protection of NG2+ non-oligodendroglial cells by Ca2+ channel inhibitor combinations may contribute to observed beneficial outcomes in vivo. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Doig, Ryan L. O'Hare; Bartlett, Carole A.; Smith, Nicole M.; Hodgetts, Stuart I.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Doig, Ryan L. O'Hare; Bartlett, Carole A.; Smith, Nicole M.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Doig, Ryan L. O'Hare; Hodgetts, Stuart I.; Hool, Livia] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Smith, Nicole M.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Hool, Livia] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Smith, Nicole/L-2502-2013; Doig, Ryan O'Hare/AAG-7585-2019; Hool, Livia C/H-5059-2014; Fitzgerald, Melinda/C-4235-2011	Smith, Nicole/0000-0002-5519-8152; Hool, Livia C/0000-0001-7758-5252; Fitzgerald, Melinda/0000-0002-4823-8179; Dunlop, Sarah/0000-0002-1306-3962; Hodgetts, Stuart/0000-0002-3318-0410	Neurotrauma Research Program of Western Australia, an initiative of the Road Safety Council of Western Australia; Road Trauma Trust Account, Western Australia; NHMRCNational Health and Medical Research Council of Australia [APP1087114]	We acknowledge financial support from the Neurotrauma Research Program of Western Australia, an initiative of the Road Safety Council of Western Australia. This project is funded through the Road Trauma Trust Account, Western Australia, but does not reflect views or recommendations of the Road Safety Council. We thank Dr Robert Gasperini for his helpful advice on Ca<SUP>2+</SUP> imaging. MF is supported by an NHMRC Career Development Fellowship (APP1087114).	Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Back SA, 1998, J NEUROSCI, V18, P6241; Bal-Price A, 2002, GLIA, V40, P312, DOI 10.1002/glia.10124; Baraldi PG, 2003, J MED CHEM, V46, P1318, DOI 10.1021/jm021049d; Baraldi PG, 2002, ARZNEIMITTEL-FORSCH, V52, P273; Baraldi PG, 2000, BIOORG MED CHEM LETT, V10, P681, DOI 10.1016/S0960-894X(00)00083-4; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Block F, 1996, NEUROSCI LETT, V208, P41, DOI 10.1016/0304-3940(96)12545-3; Bolanos JP, 1997, J NEUROCHEM, V68, P2227; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.0.CO;2-L; Camello-Almaraz MC, 2006, J CELL PHYSIOL, V206, P487, DOI 10.1002/jcp.20498; Chaplin NL, 2015, CIRC RES; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; DYKENS JA, 1994, J NEUROCHEM, V63, P584; Ehrlich M, 1999, J THORAC CARDIOV SUR, V117, P285, DOI 10.1016/S0022-5223(99)70424-1; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Follett PL, 2000, J NEUROSCI, V20, P9235; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; GILL R, 1994, CEREBROVAS BRAIN MET, V6, P225; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Graham SH, 1996, J PHARMACOL EXP THER, V276, P1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Hara H, 1999, CLIN EXP PHARMACOL P, V26, P870, DOI 10.1046/j.1440-1681.1999.03154.x; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Herson PS, 1999, J BIOL CHEM, V274, P833, DOI 10.1074/jbc.274.2.833; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Huang CY, 2015, MOL NEUROBIOL, V51, P1038, DOI 10.1007/s12035-014-8767-9; Huang XJ, 2009, CELL MOL NEUROBIOL, V29, P1211, DOI 10.1007/s10571-009-9417-z; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; KANEKO M, 1989, AM J PHYSIOL, V256, pH368, DOI 10.1152/ajpheart.1989.256.2.H368; KATSETOS CD, 1993, J NEUROPATH EXP NEUR, V52, P655, DOI 10.1097/00005072-199311000-00013; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Klein KU, 2010, BEST PRACT RES-CLIN, V24, P535, DOI 10.1016/j.bpa.2010.10.008; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu XZ, 1997, J NEUROSCI, V17, P5395; Ma SW, 2012, NEUROTOXICOLOGY, V33, P59, DOI 10.1016/j.neuro.2011.11.003; Mandavilli BS, 2005, MOL BRAIN RES, V133, P215, DOI 10.1016/j.molbrainres.2004.10.033; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Matute C, 2006, TRENDS MOL MED, V12, P289, DOI 10.1016/j.molmed.2006.05.004; McAllister J, 2008, BIOCHEM PHARMACOL, V75, P956, DOI 10.1016/j.bcp.2007.10.019; Muralidharan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19067; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; NICOTERA P, 1994, MOL CELL BIOCHEM, V135, P89, DOI 10.1007/BF00925964; Nishida K, 2012, J NEUROCHEM, V122, P1118, DOI 10.1111/j.1471-4159.2012.07868.x; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; ROJANASAKUL Y, 1993, AM J RESP CELL MOL, V8, P377, DOI 10.1165/ajrcmb/8.4.377; ROVERI A, 1992, ARCH BIOCHEM BIOPHYS, V297, P265, DOI 10.1016/0003-9861(92)90671-I; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Spitzer NC, 2000, BIOESSAYS, V22, P811; Stack EC, 2006, BBA-MOL BASIS DIS, V1762, P373, DOI 10.1016/j.bbadis.2005.11.002; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takadera T, 2010, CELL MOL NEUROBIOL, V30, P193, DOI 10.1007/s10571-009-9442-y; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Tamaki Y, 2003, INVEST OPHTH VIS SCI, V44, P4864, DOI 10.1167/iovs.02-1173; Tanaka T, 2004, J AM SOC NEPHROL, V15, P2320, DOI 10.1097/01.ASN.0000138287.46849.82; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tuszynski MH, 2005, E SCHERING RES FDN W, V53, P1; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VANDENPOL AN, 1992, J NEUROSCI, V12, P2648; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Weishaupt N, 2010, J NEUROTRAUM, V27, P1387, DOI 10.1089/neu.2010.1346; WHITTEMORE ER, 1994, NEUROREPORT, V5, P1485, DOI 10.1097/00001756-199407000-00019; XUE D, 1994, J CEREBR BLOOD F MET, V14, P251, DOI 10.1038/jcbfm.1994.32; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070	87	11	11	1	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 17	2016	339						450	462		10.1016/j.neuroscience.2016.10.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED9CT	WOS:000389168500038	27725216	Green Submitted			2022-02-06	
J	Streijger, F; Lee, JHT; Manouchehri, N; Okon, EB; Tigchelaar, S; Anderson, LM; Dekaban, GA; Rudko, DA; Menon, RS; Iaci, JF; Button, DC; Vecchione, AM; Konovalov, A; Sarmiere, PD; Ung, C; Caggiano, AO; Kwon, BK				Streijger, Femke; Lee, Jae H. T.; Manouchehri, Neda; Okon, Elena B.; Tigchelaar, Seth; Anderson, Lisa M.; Dekaban, Greg A.; Rudko, David A.; Menon, Ravi S.; Iaci, Jennifer F.; Button, Donald C.; Vecchione, Andrea M.; Konovalov, Andrey; Sarmiere, Patrick D.; Ung, Chi; Caggiano, Anthony O.; Kwon, Brian K.			The Evaluation of Magnesium Chloride within a Polyethylene Glycol Formulation in a Porcine Model of Acute Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						AC105; magnesium; polyethylene glycol; porcine; spinal cord injury	TRAUMATIC BRAIN-INJURY; FAST-MAG; STROKE THERAPY; NEUROPROTECTIVE THERAPY; IMPACT TRAUMA; SULFATE; TRIAL; RAT; METHODOLOGY; PARAMETERS	A porcine model of spinal cord injury (SCI) was used to evaluate the neuroprotective effects of magnesium chloride (MgCl2) within a polyethylene glycol (PEG) formulation, called AC105 (Acorda Therapeutics Inc., Ardsley, NY). Specifically, we tested the hypothesis that AC105 would lead to greater tissue sparing at the injury site and improved behavioral outcome when delivered in a clinically realistic time window post-injury. Four hours after contusion/compression injury, Yucatan minipigs were randomized to receive a 30-min intravenous infusion of AC105, magnesium sulfate (MgSO4), or saline. Animals received 4 additional infusions of the same dose at 6-h intervals. Behavioral recovery was tested for 12 weeks using two-dimensional (2D) kinematics during weight-supported treadmill walking and the Porcine Injury Behavior Scale (PTIBS), a 10-point locomotion scale. Spinal cords were evaluated ex vivo by diffusion-weighted magnetic resonance imaging (MRI) and subjected to histological analysis. Treatment with AC105 or MgSO4 did not result in improvements in locomotor recovery on the PTIBS or in 2D kinematics on weight-supported treadmill walking. Diffusion weighted imaging (DWI) showed severe loss of tissue integrity at the impact site, with decreased fractional anisotropy and increased mean diffusivity; this was not improved with AC105 or MgSO4 treatment. Histological analysis revealed no significant increase in gray or white matter sparing with AC105 or MgSO4 treatment. Finally, AC105 did not result in higher Mg2+ levels in CSF than with the use of standard MgSO4. In summary, when testing AC105 in a porcine model of SCI, we were unable to reproduce the promising therapeutic benefits observed previously in less-severe rodent models of SCI.	[Streijger, Femke; Lee, Jae H. T.; Manouchehri, Neda; Okon, Elena B.; Tigchelaar, Seth; Anderson, Lisa M.; Kwon, Brian K.] Univ British Columbia, Blusson Spinal Cord Ctr, ICORD, Vancouver, BC, Canada; [Dekaban, Greg A.] Western Univ, Robarts Res Inst, London, ON, Canada; [Rudko, David A.] Montreal Neurol Hosp & Inst, Brain Imaging Ctr, Montreal, PQ, Canada; [Menon, Ravi S.] Univ Western Ontario, Ctr Funct & Metab Mapping, London, ON, Canada; [Iaci, Jennifer F.; Button, Donald C.; Vecchione, Andrea M.; Konovalov, Andrey; Sarmiere, Patrick D.; Ung, Chi; Caggiano, Anthony O.] Acorda Therapeut Inc, Ardsley, NY USA; [Kwon, Brian K.] Univ British Columbia, Blusson Spinal Cord Ctr, Vancouver Spine Surg Inst, Dept Orthoped, Vancouver, BC, Canada		Kwon, BK (corresponding author), Univ British Columbia, VGH, Dept Orthoped, Blusson Spinal Cord Ctr, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca	Dekaban, Gregory/L-1987-2013; Menon, Ravi/ABA-8654-2020; Menon, Ravi S/K-5500-2013	Dekaban, Gregory/0000-0002-3087-4660; Menon, Ravi/0000-0002-7916-0263; Menon, Ravi S/0000-0002-7916-0263; Tigchelaar, Seth/0000-0002-2207-9034; Rudko, David/0000-0002-1299-954X; Okon, Elena/0000-0001-8568-5771	Scientific Advisory Board for Acorda Therapeutics	Brian K. Kwon is a paid member of the Scientific Advisory Board for Acorda Therapeutics. Jennifer F. Iaci, Donald C. Button, Andrea M. Vecchione, Andrey Konovalov, Patrick D. Sarmiere, Chi Ung, and Anthony O. Caggiano are all paid full-time employees of Acorda Therapeutics. For all other authors, no competing financial interests exist.	Aslanyan S, 2007, STROKE, V38, P1269, DOI 10.1161/01.STR.0000259628.94421.09; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Brewer RP, 2001, CLIN NEUROPHARMACOL, V24, P341, DOI 10.1097/00002826-200111000-00005; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cheran S, 2011, J NEUROTRAUM, V28, P1881, DOI 10.1089/neu.2010.1741; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gok B, 2007, CHINESE J PHYSIOL, V50, P93; Gorelick PB, 2004, LANCET NEUROL, V3, P330, DOI 10.1016/S1474-4422(04)00762-8; Gowda RM, 2004, INT J CARDIOL, V96, P467, DOI 10.1016/j.ijcard.2003.04.067; Heath DL, 1999, J CLIN NEUROSCI, V6, P505, DOI 10.1016/S0967-5868(99)90011-5; Heath DL, 1999, MAGNESIUM RES, V12, P269; HEIPERTZ R, 1979, J NEUROL SCI, V40, P87, DOI 10.1016/0022-510X(79)90194-1; Ivancic PC, 2007, SPINE, V32, P2467, DOI 10.1097/BRS.0b013e3181573b67; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Klassen LM, 2004, MAGN RESON MED, V51, P881, DOI 10.1002/mrm.20094; Ko SH, 2001, ANESTHESIOLOGY, V95, P640, DOI 10.1097/00000542-200109000-00016; Koskinen EA, 2014, SPINAL CORD, V52, P202, DOI 10.1038/sc.2013.163; Koskinen E, 2013, J NEUROTRAUM, V30, P1587, DOI 10.1089/neu.2013.2943; Kwon BK, 2015, EXP NEUROL, V269, P154, DOI 10.1016/j.expneurol.2015.04.008; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; Lee JHT, 2010, SPINE, V35, P2041, DOI 10.1097/BRS.0b013e3181d2d6c5; Leeman L, 2008, AM FAM PHYSICIAN, V78, P93; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; LEMKE M, 1990, MOL CHEM NEUROPATHOL, V12, P147, DOI 10.1007/BF03159941; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Mendez DR, 2005, PEDIATR RES, V57, P347, DOI 10.1203/01.PDR.0000150803.36315.FF; Nevo U, 2001, MAGN RESON MED, V45, P1, DOI 10.1002/1522-2594(200101)45:1<1::AID-MRM1001>3.0.CO;2-I; PANJABI MM, 1995, J SPINAL DISORD, V8, P39; Popovich PG, 2012, EXP NEUROL, V233, P615, DOI 10.1016/j.expneurol.2010.11.016; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Saver JL, 2014, INT J STROKE, V9, P215, DOI 10.1111/ijs.12243; Saver JL, 2014, INT J STROKE, V9, P220, DOI 10.1111/ijs.12242; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Streijger F, 2015, J NEUROTRAUM, V32, P908, DOI 10.1089/neu.2014.3707; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; THURNAU GR, 1987, AM J OBSTET GYNECOL, V157, P1435, DOI 10.1016/S0002-9378(87)80239-9; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Wilcox RK, 2002, J BIOMECH, V35, P381, DOI 10.1016/S0021-9290(01)00180-4; Wiseman DB, 2009, J NEUROSURG-SPINE, V10, P308, DOI 10.3171/spi.2009.10.4.308; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	50	11	11	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2016	33	24					2202	2216		10.1089/neu.2016.4439			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF3RU	WOS:000390242900005	27125815				2022-02-06	
J	Brooks, BL; Holdnack, JA; Iverson, GL				Brooks, Brian L.; Holdnack, James A.; Iverson, Grant L.			To Change is Human: "Abnormal" Reliable Change Memory Scores are Common in Healthy Adults and Older Adults	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Test-retest; Psychometrics; Reliable change index; Mild cognitive impairment; Cognition; Multivariate	MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL ASSESSMENT; INTERPRETING CHANGE; CLINICAL-SAMPLES; BASE RATES; SHORT-FORM; RELIABILITY; PREVALENCE; CONCUSSION; CRITERIA	Objective: The rate at which people obtain reliably improved or declined cognitive test scores when retested, in the absence of a change in clinical condition, is largely unknown. The purpose of this study was to illustrate the prevalence of statistically reliable change scores on memory test batteries in healthy adults and older adults. Method: Participants included three adult and older adult test-retest samples from memory test batteries. Reliable change scores (reliable change index with 90% confidence interval and practice effects) were calculated for the indexes and subtests of each battery. Multivariate analyses involved calculating the frequencies of healthy people obtaining one or more reliably declined or one or more reliably improved scores when considering all change scores simultaneously within each battery. Results: Across all batteries, having one or more reliably changed index or subtest score on retest was common. With most batteries, having two or more reliably changed scores was uncommon. Those with higher intellectual abilities were more likely to have a change on retest; however, no significant differences in base rates were found based on education level, sex, or ethnic minority status. Those older adults who did not have any low memory scores were more likely to improve than decline on retest. Conclusions: Having a single reliably changed score on retest is common when interpreting a battery of memory measures. This has implications for determining cognitive decline and cognitive recovery, suggesting that multivariate interpretation is necessary.	[Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehab, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Holdnack, James A.] Pearson Clin Assessment, San Antonio, TX USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca			Neurosciences program at the Alberta Children's Hospital; Canadian Institutes of Health Research (CIHR) Embedded Clinician Researcher Salary Award; Mooney-Reed Charitable Foundation; TBI Endpoints Development Initiative	No grant funding was provided for this study. Salary support for this research was provided to Brian Brooks by the Neurosciences program at the Alberta Children's Hospital (Conny Betuzzi) and the Canadian Institutes of Health Research (CIHR) Embedded Clinician Researcher Salary Award. Grant Iverson acknowledges support from the Mooney-Reed Charitable Foundation and the TBI Endpoints Development Initiative (i.e., a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials).	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Brooks B. L., 2012, PEDIAT FORENSIC NEUR, P66; Brooks B.L., 2012, PEDIAT FORENSIC NEUR; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Brooks BL, 2012, APPL NEUROPSYCH-ADUL, V19, P61, DOI 10.1080/09084282.2012.651951; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P14, DOI 10.1093/arclin/acp100; Brooks BL, 2009, ARCH CLIN NEUROPSYCH, V24, P647, DOI 10.1093/arclin/acp061; Brooks BL, 2009, CAN PSYCHOL, V50, P196, DOI 10.1037/a0016066; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Crawford JR, 2008, BRIT J CLIN PSYCHOL, V47, P215, DOI 10.1348/014466507X258859; Crawford JR, 2010, BRIT J CLIN PSYCHOL, V49, P235, DOI 10.1348/014466509X455470; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Iverson G. L., 2012, PEDIAT FORENSIC NEUR, P89; Iverson G. L., 2012, NEUROPSYCHOLOGICAL A; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 1998, INT J GERIATR PSYCH, V13, P661, DOI 10.1002/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jak AJ, 2009, INT REV NEUROBIOL, V84, P81, DOI 10.1016/S0074-7742(09)00405-X; Kamphaus, 2003, REYNOLDS INTELLECTUA; L?ders H., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Salinsky MC, 2001, J INT NEUROPSYCH SOC, V7, P597, DOI 10.1017/S1355617701755075; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; Sawrie SM, 1999, J GERONTOL B-PSYCHOL, V54, pP116, DOI 10.1093/geronb/54B.2.P116; Schinka JA, 2010, AM J GERIAT PSYCHIAT, V18, P684, DOI 10.1097/JGP.0b013e3181e56d5a; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Sherman EMS, 2015, MEMORY VALIDITY PROF; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P83, DOI 10.1016/j.acn.2005.07.008	40	11	11	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2016	31	8					1026	1036		10.1093/arclin/acw079			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EJ1MM	WOS:000392974600018	27680088	Green Published, Bronze			2022-02-06	
J	Graff, DM; Caperell, KS				Graff, Danielle M.; Caperell, Kerry S.			Concussion Management in the Classroom	JOURNAL OF CHILD NEUROLOGY			English	Article						education; mild traumatic brain injury; recovery; intervention	FOR-DISEASE-CONTROL; SPORTS; KNOWLEDGE; HEADS; ATTITUDES; COACHES	There is a new emphasis on the team approach to pediatric concussion management, particularly in the classroom. However, it is expected that educators are unfamiliar with the Returning to Learning recommendations. The authors' primary objective was to assess and improve high school educators' knowledge regarding concussions and management interventions using an online education tool. A total of 247 high school educators completed a 12 question pretest to assess core knowledge of concussions and classroom management followed by a 20-minute online literature-based education module. Participants then completed an identical posttest. The improvement in core knowledge was statistically significant (P < .001). Initial areas of weakness were the description and identification of concussions. Questions regarding concussion classroom management also showed a statistically significant increase in scores (P < .001). This study identifies the deficits in the knowledge of educators regarding concussions and classroom management as well as the significant improvement after an online educational module.	[Graff, Danielle M.; Caperell, Kerry S.] Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA		Graff, DM (corresponding author), Univ Louisville, Dept Pediat, 571 S Floyd St,Ste 300, Louisville, KY 40202 USA.	dmgraf02@louisville.edu		Caperell, Kerry/0000-0002-1545-5417	Children's Hospital Foundation Grant, Louisville, Kentucky	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Children's Hospital Foundation Grant, Louisville, Kentucky.	Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; [Anonymous], 2011, CONC; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Centers for Disease Control and Prevention, 2015, HEADS UP; Centers for Disease Control and Prevention, 2013, TRAUMATIC BRAIN INJU; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Fraze S, 2003, J AGR ED, V44, P11; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Herring SA, 2011, MED SCI SPORTS EXERC, V43, P2412; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Northwest Center for Public Health Practice, 2012, EFFF AD LEARN TOOLK; Nulty D., 2008, ASSESS EVAL HIGH EDU, V33, P14; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Tracy M, 2012, J EMERG NURS, V38, P580, DOI 10.1016/j.jen.2012.08.004	22	11	11	1	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2016	31	14					1569	1574		10.1177/0883073816666205			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	EB7DG	WOS:000387545600008	27591004				2022-02-06	
J	Hart, T; Whyte, J; Poulsen, I; Kristensen, KS; Nordenbo, AM; Chervoneva, I; Vaccaro, MJ				Hart, Tessa; Whyte, John; Poulsen, Ingrid; Kristensen, Karin Spangsberg; Nordenbo, Annette M.; Chervoneva, Inna; Vaccaro, Monica J.			How Do Intensity and Duration of Rehabilitation Services Affect Outcomes From Severe Traumatic Brain Injury? A Natural Experiment Comparing Health Care Delivery Systems in 2 Developed Nations	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Health services research; Rehabilitation; Treatment outcome	SCHEDULED TELEPHONE INTERVENTION; LENGTH-OF-STAY; MODERATE; THERAPY; QUALITY; SCALE; LIFE	Objective: To determine the effects of inpatient and outpatient treatment intensity on functional and emotional well-being outcomes at 1 year after severe traumatic brain injury (TBI). Design: Prospective, quasiexperimental study comparing outcomes in a U.S. TBI treatment center with those in a Denmark (DK) center providing significantly greater intensity and duration of rehabilitation. Setting: Inpatient and outpatient TBI rehabilitation. Participants: Persons with severe TBI (N=274). Interventions: Inpatient rehabilitation interventions were counted daily by discipline. Outpatient treatments were estimated per discipline using a structured interview administered to patients, caregivers, or both, at 12 months. Main Outcome Measures: FEVI, Glasgow Outcome Scale Extended, Disability Rating Scale, Participation Assessment with Recombined Tools Objective, Perceived Quality of Life, Medical Outcomes Study 12-Item Short-Form Health Survey, Brief Symptom Inventory-18-item version. Results: Despite identical inclusion criteria, patient severity on admission was greater at the DK site. After adjustment for patient/injury characteristics, there were no site differences in either functional or emotional outcome at 12 months. Significantly more inpatient plus outpatient treatment was administered to DK patients than to those in the U.S. For functional but not emotional treatments, more severely impaired patients received higher doses. One-year outcomes were predicted by admission severity, age, employment, and other baseline characteristics. Conclusions: Contrary to expectation, DK patients who received significantly more rehabilitation services during the year after severe TBI did not differ in outcome from their less intensively treated U.S. counterparts, after adjusting for initial severity. The negative association of functional treatment dose with extent of early disability suggests that dose was driven by unmeasured factors reflecting need for services. Improved measures of injury-related factors driving treatment allocation are needed to model the independent effects of treatment on outcomes. (C) 2016 by the American Congress of Rehabilitation Medicine	[Hart, Tessa; Whyte, John; Vaccaro, Monica J.] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Hart, Tessa; Whyte, John] Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; [Poulsen, Ingrid; Kristensen, Karin Spangsberg; Nordenbo, Annette M.] Rigshosp, Res Unit Brain Injury Rehabil, Clin Neurorehabil, Copenhagen, Denmark; [Chervoneva, Inna] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pharmacol & Expt Therapeut, Div Biostat, Philadelphia, PA 19107 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.; Hart, T (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA.	thart@einstein.edu	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Whyte, John/0000-0002-4381-1474	Department of Education, National Institute on Disability and Rehabilitation Research [H133A070040, H133A120037]; Danish Nurses Association; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant nos H133A070040, H133A120037). However, these contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government. Also supported by the Danish Nurses Association and the Novo Nordisk Foundation. The funders had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication.	Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Granger CV, 1987, UNIFORM DATA SET MED; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Peiris CL, 2011, ARCH PHYS MED REHAB, V92, P1490, DOI 10.1016/j.apmr.2011.04.005; POKORNY AD, 1972, AM J PSYCHIAT, V129, P342, DOI 10.1176/ajp.129.3.342; Powell JM, 2002, ARCH PHYS MED REHAB, V83, P1235, DOI 10.1053/apmr.2002.34556; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; U.S. Census Bureau, 2000, DIS STAT; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	31	11	12	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2016	97	12					2045	2053		10.1016/j.apmr.2016.07.012			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EE7GM	WOS:000389783900003	27497825				2022-02-06	
J	Heinemann, AW; Miskovic, A; Semik, P; Wong, A; Dashner, J; Baum, C; Magasi, S; Hammel, J; Tulsky, DS; Garcia, SF; Jerousek, S; Lai, JS; Carlozzi, NE; Gray, DB				Heinemann, Allen W.; Miskovic, Ana; Semik, Patrick; Wong, Alex; Dashner, Jessica; Baum, Carolyn; Magasi, Susan; Hammel, Joy; Tulsky, David S.; Garcia, Sofia F.; Jerousek, Sara; Lai, Jin-Shei; Carlozzi, Noelle E.; Gray, David B.			Measuring Environmental Factors: Unique and Overlapping International Classification of Functioning, Disability and Health Coverage of 5 Instruments	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attitude; Environment; Rehabilitation	SPINAL-CORD-INJURY; MEASUREMENT ERROR; PARTICIPATION; BARRIERS; PEOPLE; FACILITATORS; STROKE	Objectives: To describe the unique and overlapping content of the newly developed Environmental Factors Item Banks (EFIB) and 7 legacy environmental factor instruments, and to evaluate the EFIB's construct validity by examining associations with legacy instruments. Design: Cross-sectional, observational cohort. Setting: Community. Participants: A sample of community-dwelling adults with stroke, spinal cord injury, and traumatic brain injury (N=568). Interventions: None. Main Outcome Measures: EFIB covering domains of the built and natural environment; systems, services, and policies; social environment; and access to information and technology; the Craig Hospital Inventory of Environmental Factors (CHIEF) short form; the Facilitators and Barriers Survey/Mobility (FABS/M) short form; the Home and Community Environment Instrument (HACE); the Measure of the Quality of the Environment (MQE) short form; and 3 of the Patient Reported Outcomes Measurement Information System's (PROMIS) Quality of Social Support measures. Results: The EFIB and legacy instruments assess most of the International Classification of Functioning, Disability and Health (ICF) environmental factors chapters, including chapter 1 (products and technology; 75 items corresponding to 11 codes), chapter 2 (natural environment and human-made changes; 31 items corresponding to 7 codes), chapter 3 (support and relationships; 74 items corresponding to 7 codes), chapter 4 (attitudes; 83 items corresponding to 8 codes), and chapter 5 (services, systems, and policies; 72 items corresponding to 16 codes). Construct validity is provided by moderate correlations between EFIB measures and the CHIEF, MQE barriers, HACE technology mobility, FABS/M community built features, and PROMIS item banks and by small correlations with other legacy instruments. Only 5 of the 66 legacy instrument correlation coefficients are moderate, suggesting they measure unique aspects of the environment, whereas all infra-EFIB correlations were at least moderate. Conclusions: The EFIB measures provide a brief and focused assessment of ICF environmental factor chapters. The pattern of correlations with legacy instruments provides initial evidence of construct validity. (C) 2016 by the American Congress of Rehabilitation Medicine	[Heinemann, Allen W.; Miskovic, Ana; Semik, Patrick; Jerousek, Sara] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, 345 E Super St, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestem Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 345 E Super St, Chicago, IL 60611 USA; [Wong, Alex; Dashner, Jessica; Baum, Carolyn; Gray, David B.] Washington Univ, Program Occupat Therapy, St Louis, MO 63130 USA; [Wong, Alex; Dashner, Jessica; Baum, Carolyn] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Baum, Carolyn] Washington Univ, Brown Sch Social Work, St Louis, MO 63130 USA; [Magasi, Susan; Hammel, Joy] Univ Illinois, Dept Occupat Therapy, Chicago, IL 60680 USA; [Hammel, Joy] Univ Illinois, Dept Disabil & Human Dev, Chicago, IL 60680 USA; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Garcia, Sofia F.] Northwestern Univ, Dept Med Social Sci, Chicago, IL 60208 USA; [Garcia, Sofia F.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60208 USA; [Carlozzi, Noelle E.] Univ Michigan, Ctr Clin Outcomes Dev & Applicat, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Heinemann, AW (corresponding author), Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, 345 E Super St, Chicago, IL 60611 USA.; Heinemann, AW (corresponding author), Northwestem Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 345 E Super St, Chicago, IL 60611 USA.	a-heinemann@northwestern.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant [H133B090024]; National Institute on Disability and Rehabilitation Research [H133F140037]; Craig H. Neilsen Foundation [290474]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant (grant no. H133B090024); the National Institute on Disability and Rehabilitation Research (grant no. H133F140037); and the Craig H. Neilsen Foundation (grant no. 290474)	Alvarelhao J, 2012, J REHABIL MED, V44, P1, DOI 10.2340/16501977-0905; ASIA, 1982, STAND NEUR CLASS SPI; Bond T., 2015, APPL RASCH MODEL; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Charles EP, 2005, PSYCHOL METHODS, V10, P206, DOI 10.1037/1082-989X.10.2.206; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Escorpizo Reuben, 2011, Am J Phys Med Rehabil, V90, pS66, DOI 10.1097/PHM.0b013e318230fbf9; Garcia SF, 2015, ARCH PHYS MED REHAB, V96, P596, DOI 10.1016/j.apmr.2014.06.019; Gray DB, 2008, DISABIL REHABIL, V30, P434, DOI 10.1080/09638280701625377; Hahn EA, 2016, ARCH PHYS MED REHAB, V97, P1284, DOI 10.1016/j.apmr.2016.01.027; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Heinemann AW, 2016, QUAL LIFE RES; Hollingsworth H, 2010, ARCH PHYS MED REHAB, V91, P1174, DOI 10.1016/j.apmr.2010.04.019; Keysor JJ, 2005, J REHABIL MED, V37, P37, DOI 10.1080/16501970410014830; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Lai JS, ARCH PHYS M IN PRESS; Levasseur Melanie, 2007, Can J Occup Ther, V74 Spec No., P233; Patient-Reported Outcomes Measurement Information System (PROMIS), 2015, EM SUPP; Patient-Reported Outcomes Measurement Information System (PROMIS), 2015, INSTR SUPP; Patient-Reported Outcomes Measurement Information System (PROMIS), 2015, INF SUPP; Reinhardt JD, 2011, DISABIL REHABIL, V33, P2151, DOI 10.3109/09638288.2011.573053; Rochette A, 2001, DISABIL REHABIL, V23, P559; Schmidt FL, 1999, INTELLIGENCE, V27, P183, DOI 10.1016/S0160-2896(99)00024-0; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; World Health Organization, 2007, INT CLASS FUNCT DIS	30	11	12	1	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2016	97	12					2113	2122		10.1016/j.apmr.2016.05.021			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EE7GM	WOS:000389783900011	27343347				2022-02-06	
J	Helmich, I; Berger, A; Lausberg, H				Helmich, Ingo; Berger, Alisa; Lausberg, Hedda			Neural Control of Posture in Individuals with Persisting Postconcussion Symptoms	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						PERSISTENT POSTCONCUSSION SYMPTOMS; FUNCTIONAL NEARINFRARED SPECTROSCOPY; BALANCE; POSTURAL CONTROL; FRONTAL CORTEX	NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; MOVEMENT-RELATED POTENTIALS; MILD HEAD-INJURY; PREFRONTAL CORTEX; CONCUSSION; OXYGENATION; BALANCE; RESOLUTION; MEMORY	Introduction: Postural instability has been shown to characterize individuals who suffered from long-term symptoms after mild traumatic brain injury. However, recordings of neural processes during postural control are difficult to realize with standard neuroimaging techniques. Thus, we used functional nearinfrared spectroscopy to investigate brain oxygenation of individuals with persistent postconcussion symptoms (pPCS) during postural control in altered environments. Methods: We compared brain oxygenation and postural sway during balance control in three groups: individuals suffering from pPCS, individuals with a history of mild traumatic brain injury but without pPCS, and healthy controls. Individuals were investigated during postural control tasks with six different conditions: i) eyes opened, ii) eyes closed, and iii) blurred visual input, each while standing a) on a stable and b) an unstable surface. Results: In all groups, during the eyes closed/unstable surface condition as compared with the other conditions, the postural sway increased as well as the brain oxygenation in frontal brain cortices. In the most difficult balance condition, as compared with the other two groups, subjects with pPCS applied more force over time to keep balance as measured by the force plate system with a significantly greater activation in frontopolar/orbitofrontal areas of the right hemisphere. Conclusions: As subjects with pPCS applied more force over time to control balance, we propose that with regard to cognitive processes, the increase of cerebral activation in these individuals indicates an increase of attention-demanding processes during postural control in altered environments.	[Helmich, Ingo; Berger, Alisa; Lausberg, Hedda] German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpark Mungersdorf 6, D-50933 Cologne, Germany		Helmich, I (corresponding author), German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpark Mungersdorf 6, D-50933 Cologne, Germany.	in.helmich@gmail.com			German Sports University, Cologne; Heinrich Hertz Foundation; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia [6/13]	The study was funded by the University research funding of the German Sports University, Cologne and by the Heinrich Hertz Foundation, Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia (B 41 Nr. 6/13). The authors disclose no conflicts of interest. The results of the present study do not constitute an endorsement by the American College of Sports Medicine.	Bhambhani Y, 2006, J REHABIL RES DEV, V43, P845, DOI 10.1682/JRRD.2005.09.0151; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Cope M, 1988, Adv Exp Med Biol, V222, P183; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Del Percio C, 2009, BRAIN RES BULL, V79, P193, DOI 10.1016/j.brainresbull.2009.02.001; Dudos NC, 2015, BRAIN RES, V1625, P159, DOI 10.1016/j.brainres.2015.08.043; Ferrari M, 2014, BRAIN TOPOGR, V27, P353, DOI 10.1007/s10548-013-0320-z; Golomer E, 2010, NEUROL RES, V32, P409, DOI 10.1179/174313209X382476; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Helmich I, 2015, J NEUROPSYCH CLIN N, V27, P287, DOI 10.1176/appi.neuropsych.14100276; Helmich I, 2015, INT J PSYCHOPHYSIOL, V96, P1, DOI 10.1016/j.ijpsycho.2015.03.001; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Lidvall H F, 1974, Acta Neurol Scand Suppl, V56, P3; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mallinson AI, 1998, AM J OTOL, V19, P814; Manor B, 2010, NEUROLOGY, V74, P458, DOI 10.1212/WNL.0b013e3181cef647; MATIN E, 1974, PSYCHOL BULL, V81, P899, DOI 10.1037/h0037368; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; NASHNER LM, 1982, J NEUROSCI, V2, P536; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Prime SL, 2011, PHILOS T R SOC B, V366, P540, DOI 10.1098/rstb.2010.0184; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Strangman G, 2003, NEUROIMAGE, V18, P865, DOI 10.1016/S1053-8119(03)00021-1; Taube W, 2015, CORTEX, V64, P102, DOI 10.1016/j.cortex.2014.09.022; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	39	11	11	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	DEC	2016	48	12					2362	2369		10.1249/MSS.0000000000001028			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EE4WF	WOS:000389605600003	27387294				2022-02-06	
J	Moore, M; Whiteside, LK; Dotolo, D; Wang, J; Ho, LN; Conley, B; Forrester, M; Fouts, SO; Vavilala, MS; Zatzick, DF				Moore, Megan; Whiteside, Lauren K.; Dotolo, Danae; Wang, Jin; Ho, Leyna; Conley, Bonnie; Forrester, Mollie; Fouts, Susan O.; Vavilala, Monica S.; Zatzick, Douglas F.			The Role of Social Work in Providing Mental Health Services and Care Coordination in an Urban Trauma Center Emergency Department	PSYCHIATRIC SERVICES			English	Article							BRAIN-INJURY; UNITED-STATES; DISORDERS; IMPLEMENTATION; INTERVENTION; COMORBIDITY; DEPRESSION; SETTINGS; TRENDS; PTSD	Objective: This study examined the role of emergency department (ED) social workers and identified predictors of receipt of social work services and length of ED stay. Methods: Comprehensive reviews were conducted of medical records of all patients (N= 49,354) treated in a level 1 trauma center ED from January 1, 2012, to March 31, 2013. Content analysis of chart notes was used to categorize the types of social work services provided. Poisson regression was used to assess associations between demographic and clinical characteristics, receipt of social work services, and length of ED stay. Results: Social work services were provided to 18,532 (38%) patients. Most were mental health services (54%), followed by care coordination (31%) and material support or other referrals (15%). Patients seen by social workers had complex presentations, involving mental disorder diagnoses (18%), substance use disorder diagnoses (29%), comorbid diagnoses (32%), and injuries (51%); a quarter of patients had multiple ED visits (26%). In adjusted regression analysis, females (relative risk [RR]= 1.15), patients not discharged home (RR= 1.44), and those with two or more comorbid diagnoses (RR= 1.80), injuries due to assault (RR= 1.37), and traumatic brain injury (RR= 1.20) were more likely to receive social work services. Such services were associated with an increased length of ED stay (RR= 1.34). Conclusions: Social workers provided services to patients with multifaceted needs resulting from complex presentations. Provision of social work services modestly increased length of ED stay. Triage algorithms are needed to target efficiencies, systematize provision of ED social work services, and improve access to services for all patients.	[Moore, Megan; Dotolo, Danae; Ho, Leyna] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Moore, Megan] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Whiteside, Lauren K.; Wang, Jin; Vavilala, Monica S.; Zatzick, Douglas F.] Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA; [Conley, Bonnie; Forrester, Mollie; Fouts, Susan O.] Univ Washington, Harborview Dept Social Work, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, Seattle, WA 98195 USA.; Moore, M (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	mm99@uw.edu		Whiteside, Lauren/0000-0002-0284-5336	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]	This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (grant KL2TR000421 to Dr. Moore).	Almgren G, 2012, SAFETY-NET HEALTH CARE SYSTEM: HEALTH CARE AT THE MARGINS, P1; American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Andrews CM, 2013, HEALTH SOC WORK, V38, P67, DOI 10.1093/hsw/hlt002; [Anonymous], 2010, MATR E COD GROUP; [Anonymous], 2010, GREATER SEATTLE DATA; Auerbach C, 2000, SOC WORK HEALTH CARE, V32, P9; Auerbach C, 2007, SOC WORK HEALTH CARE, V44, P17, DOI 10.1300/J010v44n04_02; Auerbach C, 2010, SOC WORK HEALTH CARE, V49, P314, DOI 10.1080/00981380903426772; Baillargeon J, 2008, PSYCHIAT SERV, V59, P808, DOI 10.1176/appi.ps.59.7.808; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cavanagh S, 1997, Nurse Res, V4, P5, DOI 10.7748/nr.4.3.5.s2; Council on Social Work Education, 2008, ED POL ACCR STAND; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Faul M XL, 2010, TRAUMATIC BRAIN INJU; Gordon JA, 2001, ACAD EMERG MED, V8, P54, DOI 10.1111/j.1553-2712.2001.tb00552.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hackman AL, 2006, PSYCHIAT SERV, V57, P563, DOI 10.1176/appi.ps.57.4.563; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kushel MB, 2006, J GEN INTERN MED, V21, P71, DOI 10.1111/j.1525-1497.2005.00278.x; Love J, 2014, PSYCHIAT SERV, V65, P918, DOI 10.1176/appi.ps.201300399; Mahajan P, 2005, ANN EMERG MED, V45, P245, DOI 10.1016/j.annemergmed.2004.06.008; Moore M, 2014, BRAIN INJURY, V28, P448, DOI 10.3109/02699052.2014.890746; Moore M, 2012, SOC WORK HEALTH CARE, V51, P140, DOI 10.1080/00981389.2011.610872; National Center for Health Statistics, 2008, NAT HOSP AMB MED CAR; National Center for Health Statistics, 2010, NAT HOSP AMB MED CAR; Pines JM, 2009, ACAD EMERG MED, V16, P403, DOI 10.1111/j.1553-2712.2009.00381.x; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Rasooly IR, 2014, J PEDIATR-US, V165, P618, DOI 10.1016/j.jpeds.2014.04.059; Rockett IRH, 2003, ANN EMERG MED, V41, P802, DOI 10.1067/mem.2003.189; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Shumway M, 2008, AM J EMERG MED, V26, P155, DOI 10.1016/j.ajem.2007.04.021; Smulowitz PB, 2011, ANN EMERG MED, V58, P225, DOI 10.1016/j.annemergmed.2011.02.020; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Van Eaton EG, 2014, J AM COLL SURGEONS, V219, P505, DOI 10.1016/j.jamcollsurg.2014.02.032; Wu LT, 2012, ANN EMERG MED, V60, P172, DOI 10.1016/j.annemergmed.2012.02.003; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	11	11	7	18	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	DEC 1	2016	67	12					1348	1354		10.1176/appi.ps.201500469			7	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	EF1ZE	WOS:000390122900016	27417898	Bronze			2022-02-06	
J	Bao, HJ; Yang, XF; Zhuang, Y; Huang, YX; Wang, T; Zhang, MY; Dai, DK; Wang, SX; Xiao, H; Huang, GP; Kuai, JX; Tao, LY				Bao, Haijun; Yang, Xiaofang; Zhuang, Ying; Huang, Yuxiu; Wang, Tao; Zhang, Mingyang; Dai, Dingkun; Wang, Shaoxian; Xiao, Hua; Huang, Gengping; Kuai, Jinxia; Tao, Luyang			The effects of poloxamer 188 on the autophagy induced by traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Poloxamer 188; Autophagy	CONTROLLED CORTICAL IMPACT; BARRIER DAMAGE; MICE; DEATH; CELLS	Poloxamer 188 (P188) has been reported to reseal plasma membranes and attenuate TBI-induced neuronal death by suppressing apoptosis. Recent studies also confirm increased autophagy after traumatic brain injury (TBI). The present study aimed to investigate the effects of plasmalemmal resealing by P188 on neuronal autophagy in TBI. Scratch test was performed in rat cell line PC-12 in vitro, followed by immunofluorescence analysis of LC3 24 h after PC-12 cell stretch-injury in vitro. CD1 mice were randomized into saline and P188-treatment groups (both undergoing intravenous injection of 4 mg/ml, 100 mu l via the caudal vein 30 min after TBI) as well as sham group. To analyze the effect of P188 on autophagy, the LC3 protein levels were assessed by western blotting 1 h, 6 h, 12 h, 24 h, and 48 h after TBI. The autophagy-associated protein levels of Beclin-1, BcI-2, and p62 were likewise determined. In vitro, the scratch test showed that the wound healing rate was significantly improved at 12 h and 24 h in P188 groups, and LC3 immunofluorescence analysis indicated that P188 induced extensive formation of LC3 puncta in PC-12 cells. In vivo, western blotting analyses revealed elevations of the LC3-II/LC3-I and Beclin-1/bcl-2 ratios as well as downregulation of p62 in the saline group, in contrast with the more significant increases of LC3-II/LC3-I and Beclin-1/bcl-2 ratios and the further downregulation of p62 in P188-treated group. These results revealed that plasma membranes were resealed after TBI, in which P188 aggravated autophagy in vivo. (C) 2016 Published by Elsevier Ireland Ltd.	[Bao, Haijun; Yang, Xiaofang; Zhuang, Ying; Huang, Yuxiu; Wang, Shaoxian; Xiao, Hua; Huang, Gengping] Xuzhou Med Univ, Dept Pathol, Xuzhou, Peoples R China; [Wang, Tao; Zhang, Mingyang] Soochow Univ, Dept Forens Med, Suzhou, Peoples R China; [Dai, Dingkun] Peoples Hosp Subei, Dept Forens Identificat, Yangzhou, Jiangsu, Peoples R China; [Kuai, Jinxia] Xuzhou Med Univ, Dept Forens Med, 209 Tongshan Rd, Xuzhou, Peoples R China		Kuai, JX; Tao, LY (corresponding author), Soochow Univ, Dept Forens Med, Suzhou, Peoples R China.; Kuai, JX; Tao, LY (corresponding author), Xuzhou Med Univ, Dept Forens Med, 209 Tongshan Rd, Xuzhou, Peoples R China.	55752663@163.com; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National High Technology Research Program of China (The 863 Program) [SS2015AA020503]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81302612, 81172911, 81301039]; Priority Academic Program Development of the Jiangsu Higher Education Institutions	The project was supported by the National High Technology Research Program of China (The 863 Program, SS2015AA020503), the National Science Foundation of China (No. 81302612, No. 81172911 and No. 81301039). We also appreciate the support from the Priority Academic Program Development of the Jiangsu Higher Education Institutions.	Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lee JM, 2015, BIOCHEM BIOPH RES CO, V461, P378, DOI 10.1016/j.bbrc.2015.04.042; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2015, J MOL NEUROSCI, V56, P988, DOI 10.1007/s12031-015-0568-8; Martindale JJ, 2014, J MOL CELL CARDIOL, V67, P26, DOI 10.1016/j.yjmcc.2013.12.008; Miller BF, 2014, J CEREBR BLOOD F MET, V34, P1347, DOI 10.1038/jcbfm.2014.89; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang T, 2015, J MOL NEUROSCI, V55, P240, DOI 10.1007/s12031-014-0313-8; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	20	11	11	1	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 10	2016	634						7	12		10.1016/j.neulet.2016.09.052			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC3UM	WOS:000388052300002	27693566	Bronze			2022-02-06	
J	Gohy, B; Ali, E; Van den Bergh, R; Schillberg, E; Nasim, M; Naimi, MM; Cherestal, S; Falipou, P; Weerts, E; Skelton, P; Van Overloop, C; Trelles, M				Gohy, Berangere; Ali, Engy; Van den Bergh, Rafael; Schillberg, Erin; Nasim, Masood; Naimi, Muhammad Mahmood; Cherestal, Sophia; Falipou, Pauline; Weerts, Eric; Skelton, Peter; Van Overloop, Catherine; Trelles, Miguel			Early physical and functional rehabilitation of trauma patients in the Medecins Sans Frontieres trauma centre in Kunduz, Afghanistan: luxury or necessity?	INTERNATIONAL HEALTH			English	Article						Function; MSF; Operational Research; Outcome measure; Rehabilitation; Trauma	MAJOR TRAUMA; MEDICAL REHABILITATION; NATURAL DISASTERS; INJURIES; DISABILITY; SERVICES; OUTCOMES; QUALITY; VICTIMS; AFRICA	Background: In Afghanistan, Medecins Sans Frontieres provided specialised trauma care in Kunduz Trauma Centre (KTC), including physiotherapy. In this study, we describe the development of an adapted functional score for patient outcome monitoring, and document the rehabilitation care provided and patient outcomes in relation to this functional score. Methods: A descriptive cohort study was done, including all patients admitted in the KTC inpatient department (IPD) between January and June 2015. The adapted functional score was collected at four points in time: admission and discharge from both IPD and outpatient department (OPD). Results: Out of the 1528 admitted patients, 92.3% (n = 1410) received at least one physiotherapy session. A total of 1022 patients sustained either lower limb fracture, upper limb fracture, traumatic brain injury or multiple injury. Among them, 966 patients received physiotherapy in IPD, of whom 596 (61.7%) received IPD sessions within 2 days of admission; 696 patients received physiotherapy in OPD. Functional independence increased over time; among patients having a functional score taken at admission and discharge from IPD, 32.2% (172/535) were independent at discharge, and among patients having a functional score at OPD admission and discharge, 79% (75/95) were independent at discharge. Conclusions: The provision of physiotherapy was feasible in this humanitarian setting, and the tailored functional score appeared to be relevant.	[Gohy, Berangere; Falipou, Pauline; Weerts, Eric; Skelton, Peter] Operat Ctr Lyon, Emergency Tech Unit, Handicap Int, Lyon, France; [Gohy, Berangere; Ali, Engy; Van den Bergh, Rafael] Operat Res Unit LuxOR, Med Dept, Med Sans Frontieres Operat Ctr Brussels, Luxembourg, Luxembourg; [Nasim, Masood] Med Sans Frontieres Operat Ctr Brussel, Afghanistan Mission, Kabul, Afghanistan; [Naimi, Muhammad Mahmood] Kunduz Trauma Ctr, Med Sans Frontieres Operat Ctr Brussels, Afghanistan Mission, Kabul, Afghanistan; [Cherestal, Sophia] Operat Ctr Brussels, Med Sans Frontieres, Port Au Prince, Haiti; [Van Overloop, Catherine] Med Sans Frontieres Operat Ctr Brussels, Operat Dept, Brussels, Belgium; [Trelles, Miguel] Operat Ctr Brussels, Med Dept, Med Sans Frontieres, Brussels, Belgium		Gohy, B (corresponding author), Operat Ctr Lyon, Emergency Tech Unit, Handicap Int, Lyon, France.	bgohy@handicap-international.org		Van den Bergh, Rafael/0000-0001-6277-8713			Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Armstrong Jo C, 2014, Confl Health, V8, P4, DOI 10.1186/1752-1505-8-4; Balogh ZJ, 2012, LANCET, V380, P1109, DOI 10.1016/S0140-6736(12)60991-X; Carthaigh NN, 2015, INT HEALTH, V7, P169, DOI 10.1093/inthealth/ihu086; Christian A, 2011, PAN AFR MED J, V10; Cohen ME, 2000, ARCH PHYS MED REHAB, V81, pS21, DOI 10.1053/apmr.2000.20620; Delauche MC, 2013, P IEEE INT C BOD SEN, P1; Giannou C., 2010, WAR SURG WORKING LTD; Goldberg KF, 2009, J MANIP PHYSIOL THER, V32, P781, DOI 10.1016/j.jmpt.2009.10.010; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Jandric S, 2001, Pediatr Rehabil, V4, P169, DOI 10.1080/13638490210121711; Khan F, 2015, ARCH PHYS MED REHAB, V96, P1709, DOI 10.1016/j.apmr.2015.02.007; Landry MD, 2010, DISABIL REHABIL, V32, P1616, DOI 10.3109/09638288.2010.500345; May-Teerink T, 1999, INT J REHABIL RES, V22, P311, DOI 10.1097/00004356-199912000-00008; McDonald W, 2007, ACUTE PAIN MANAGEMEN; McNair PJ, 2007, ARCH PHYS MED REHAB, V88, P993, DOI 10.1016/j.apmr.2007.05.008; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Rathore FA, 2012, ARCH PHYS MED REHAB, V93, P1875, DOI 10.1016/j.apmr.2012.05.018; Reinhardt JD, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7191; Schneider M, 2015, PREHOSP DISASTER MED, V30, P618, DOI 10.1017/S1049023X15005269; Smith J, 2015, INT J PUBLIC HEALTH, V60, P865, DOI 10.1007/s00038-015-0723-6; Teicher C, 2014, INJURY, V45, P1996, DOI 10.1016/j.injury.2014.10.003; Twomey M, 2012, INT EMERG NURS, V20, P142, DOI 10.1016/j.ienj.2011.08.002; WHO, MIN STAND REH EM MED; Wickford Jenny, 2010, THESIS; World Confederation for Physical Therapy (WCPT), 2016, WCPT REP ROL PHYS TH; Zhang X, 2012, J REHABIL MED, V44, P206, DOI 10.2340/16501977-0945; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0061922, 10.1371/journal.pone.0053931]	30	11	11	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1876-3413	1876-3405		INT HEALTH	Int. Health	NOV	2016	8	6					381	389		10.1093/inthealth/ihw039			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EU1NJ	WOS:000400786800005	27738078	Green Published, Green Submitted, hybrid			2022-02-06	
J	Hem, S; Albite, R; Loresi, M; Rasmussen, J; Ajler, P; Yampolsky, C; Chabot, JD; Gerszten, PC; Goldschmidt, E				Hem, Santiago; Albite, Romina; Loresi, Monica; Rasmussen, Jorge; Ajler, Pablo; Yampolsky, Claudio; Chabot, Joseph D.; Gerszten, Peter C.; Goldschmidt, Ezequiel			Pathological changes of the hippocampus and cognitive dysfunction following frontal lobe surgery in a rat model	ACTA NEUROCHIRURGICA			English	Article						Cerebral surgery; Hippocampus; Inflammation; Postoperative cognitive dysfunction	TRAUMATIC BRAIN-INJURY; ELDERLY-PATIENTS; RISK-FACTORS; CAROTID-ENDARTERECTOMY; INTRACRANIAL ANEURYSM; NEUROTROPHIC FACTOR; SPINE SURGERY; AGED RATS; MEMORY; ANESTHESIA	Postoperative cognitive dysfunction (POCD) is a known complication after intracranial surgery. Impaired hippocampal neurogenesis has been associated with cognitive dysfunction in animal models. In order to assess hippocampal changes after brain surgery, a frontal lobe corticectomy was performed in ten adult Wistar rats (group 4). Three different control groups (n = 10 each) included no treatment (G1), general anesthesia alone (G2), and craniectomy without dural opening (G3). Twenty-four hours after surgery, half of the animals were killed, and the mRNA levels for IL-6, TNF-alpha, and brain-derived growth factor (BDNF) in the contralateral hippocampus were assessed by qPCR. Seven days later, the remaining animals underwent anxiety and memory testing. Afterwards, the number of immature neurons in the hippocampal cortex was measured by doublecortin (DCX) staining. Twenty-four hours after surgery, mRNA levels of IL-6 and TNF-alpha increased and BDNF decreased in both surgical groups G3 and G4 (p = 0.012). Cognitive tests demonstrated an increase in anxiety levels and memory impairment in surgical groups compared with non-surgical animals. These changes correlated with an inhibition of hippocampal neurogenesis evidenced by a decreased number of new neurons (mean +/- SD for G1-4: 66.4 +/- 24; 57.6 +/- 22.2; 21.3 +/- 3.78; 5.7 +/- 1.05, p < 0.001, non-parametric ANOVA). Intracranial surgery was demonstrated to induce an inflammatory reaction within the hippocampus that compromised neurogenesis and impaired normal cognitive processing. Corticectomy had a greater effect than craniotomy alone, indicating a central trigger for hippocampal inflammatory changes. POCD after craniotomy may originate from a central inflammatory response resulting from surgical trauma to the brain parenchyma.	[Hem, Santiago; Rasmussen, Jorge; Ajler, Pablo; Yampolsky, Claudio; Goldschmidt, Ezequiel] Hosp Italiano Buenos Aires, Dept Neurosurg, Buenos Aires, DF, Argentina; [Albite, Romina; Loresi, Monica; Goldschmidt, Ezequiel] Hosp Italiano Buenos Aires, Inst Basic Sci & Expt Med, Buenos Aires, DF, Argentina; [Chabot, Joseph D.; Gerszten, Peter C.; Goldschmidt, Ezequiel] Univ Pittsburgh, Dept Neurosurg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA		Goldschmidt, E (corresponding author), Hosp Italiano Buenos Aires, Dept Neurosurg, Buenos Aires, DF, Argentina.; Goldschmidt, E (corresponding author), Hosp Italiano Buenos Aires, Inst Basic Sci & Expt Med, Buenos Aires, DF, Argentina.; Goldschmidt, E (corresponding author), Univ Pittsburgh, Dept Neurosurg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	goldschmidted@upmc.edu		Hem, Santiago Matias/0000-0002-8492-4619	Hospital Italiano de Buenos Aires	This work was supported by a grant from "Hospital Italiano de Buenos Aires".	Abildstrom H, 2000, ACTA ANAESTH SCAND, V44, P1246, DOI 10.1034/j.1399-6576.2000.441010.x; Bekinschtein P, 2014, NEUROPHARMACOLOGY, V76, P677, DOI 10.1016/j.neuropharm.2013.04.024; Biedler A, 1999, ANAESTHESIST, V48, P884, DOI 10.1007/s001010050802; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bramham CR, 2007, PROG BRAIN RES, V163, P453, DOI 10.1016/S0079-6123(07)63025-8; Canet J, 2003, ACTA ANAESTH SCAND, V47, P1204, DOI 10.1046/j.1399-6576.2003.00238.x; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Caza N, 2008, PROG BRAIN RES, V169, P409, DOI 10.1016/S0079-6123(07)00026-X; Chen K, 2015, MED SCI MONITOR, V21, P1402, DOI 10.12659/MSM.894384; Chida K, 2009, STROKE, V40, P448, DOI 10.1161/STROKEAHA.108.515775; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DiPatri AJ, 2009, CANCER TREAT RES, V150, P7, DOI 10.1007/b109924_2; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Lin GX, 2014, ACTA ANAESTH SCAND, V58, P668, DOI 10.1111/aas.12320; Lin Shun-Yan, 2014, Zhongguo Zhong Xi Yi Jie He Za Zhi, V34, P795; Lunn S, 1999, CEREBROVASC DIS, V9, P74, DOI 10.1159/000015901; Ma YZ, 2015, MOL MED REP, V12, P3095, DOI 10.3892/mmr.2015.3744; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Oomen CA, 2014, WIRES COGN SCI, V5, P573, DOI 10.1002/wcs.1304; Otawara Y, 2005, STROKE, V36, P142, DOI 10.1161/01.STR.0000149925.36914.4e; Parihar VK, 2014, TRANSL CANCER RES, V3, P124, DOI 10.3978/j.issn.2218-676X.2013.06.02; Radtke FM, 2012, J INT MED RES, V40, P612, DOI 10.1177/147323001204000223; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Riazi K, 2015, J NEUROSCI, V35, P4942, DOI 10.1523/JNEUROSCI.4485-14.2015; RICHARDSON JTE, 1991, ACTA NEUROL SCAND, V83, P110, DOI 10.1111/j.1600-0404.1991.tb04659.x; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Seo JS, 2014, J KOREAN NEUROSURG S, V56, P28, DOI 10.3340/jkns.2014.56.1.28; Shi CG, 2015, WORLD NEUROSURG, V84, P1466, DOI 10.1016/j.wneu.2015.05.057; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Strom C, 2014, Singapore Dent J, V35C, P23, DOI 10.1016/j.sdj.2014.11.003; Tao H, 2014, MED SCI MONITOR, V20, P1902, DOI [10.12659/MSM.892485, 10.12659/MSM.892271]; Vacas S, 2013, BRIT MED BULL, V106, P161, DOI 10.1093/bmb/ldt006; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Walker AK, 2014, PHARMACOL REV, V66, P80, DOI 10.1124/pr.113.008144; Wang L, 2015, J NEUROSCI, V35, P8384, DOI 10.1523/JNEUROSCI.4682-14.2015; Weber CF, 2009, WORLD J SURG, V33, P1526, DOI 10.1007/s00268-009-0047-x; Yang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078355; Zheng X, 2015, EXP THER MED, V9, P1443, DOI 10.3892/etm.2015.2241	48	11	14	1	10	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2016	158	11					2163	2171		10.1007/s00701-016-2938-6			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EA1OR	WOS:000386362200020	27631973				2022-02-06	
J	Pape, TLB; Herrold, AA; Smith, B; Babcock-Parziale, J; Harp, J; Shandera-Ochsner, A; Jenkins, S; Evans, CT; Schleenbaker, R; High, WM				Pape, Theresa Louise-Bender; Herrold, Amy A.; Smith, Bridget; Babcock-Parziale, Judith; Harp, Jordan; Shandera-Ochsner, Anne; Jenkins, Shonna; Evans, Charlesnika T.; Schleenbaker, Randal; High, Walter M.			Algorithm for Symptom Attribution and Classification Following Possible Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; depression; diagnostic accuracy; diagnostic criteria; mental health conditions; mild traumatic brain injury; mTBI; posttraumatic stress disorder; PTSD; Veteran	POSTTRAUMATIC-STRESS-DISORDER; MILITARY SERVICE MEMBERS; DEPRESSION INVENTORY-II; ADMINISTERED PTSD SCALE; CLOSED-HEAD INJURY; PSYCHOMETRIC PROPERTIES; CROSS-VALIDATION; VETERANS; HISTORY; HEALTH	Objective: To present a heuristic model of a symptom attribution and classification algorithm (SACA) for mild traumatic brain injury (mTBI). Setting: VA Polytrauma sites. Participants: 422 Veterans. Design: Cross-sectional. Main Measures: SACA, Comprehensive TBI Evaluation (CTBIE), Structured TBI Diagnostic Interview, Minnesota Multiphasic Personality Inventory (MMPI-2-RF), Letter Memory Test, Validity-10. Results: SACA and CTBIE diagnoses differ significantly (P < .01). The CTBIE, compared with SACA, attributes 16% to 500% more symptoms to mTBI, behavioral health (BH), mTBI + BH and symptom resolution. Altering SACA criteria indicate that (1) CTBIE determination of cognitive impairment yields 27% to 110% more mTBI, mTBI + BH and symptom resolution diagnoses, (2) ignoring timing of symptom onset yields 32% to 76% more mTBI, mTBI + BH and Other Condition diagnoses, (3) Proportion of sample having questionably valid profiles using structured TBI diagnostic interview and MMPI-2-RF and Letter Memory Test is 26% whereas with CTBIE item number 23 and Validity-10 is 6% to 26%, (4) MMPI-2-RF F-scale is the only measure identifying Veterans with posttraumatic amnesia for more than 24 hours as having questionably valid profiles. Conclusions: Symptom attribution-based diagnoses differ when using status quo versus the SACA. The MMPI-2-RF F-scale, compared with the Validity-10 and LetterMemory Test, may be more precise in identifying questionably valid profiles for mTBI + BH. The SACA provides a framework to inform clinical practice, resource allocation, and future research.	[Pape, Theresa Louise-Bender; Herrold, Amy A.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, 5000 South 5th Ave,MC151H,Bldg 1, Hines, IL 60141 USA; [Pape, Theresa Louise-Bender; Herrold, Amy A.; Smith, Bridget; Evans, Charlesnika T.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Ctr Innovat Complex Chron Healthcare, 5000 South 5th Ave,MC151H,Bldg 1, Hines, IL 60141 USA; [Herrold, Amy A.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Jenkins, Shonna; Schleenbaker, Randal; High, Walter M.] Dept Vet Affairs VA, Lexington VAMC C-306, Lexington, KY USA; [Jenkins, Shonna; Schleenbaker, Randal; High, Walter M.] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY 40506 USA; [Jenkins, Shonna; Schleenbaker, Randal; High, Walter M.] Univ Kentucky, Dept Neurosurg, Lexington, KY 40506 USA; [Harp, Jordan; Shandera-Ochsner, Anne; Jenkins, Shonna; Schleenbaker, Randal; High, Walter M.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Smith, Bridget; Evans, Charlesnika T.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Spinal Cord Injury QUERI, 5000 South 5th Ave,MC151H,Bldg 1, Hines, IL 60141 USA; [Smith, Bridget] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Smith, Bridget] Stanley Manne Childrens Res Inst, Dept Pediat, Child Hlth Res Program, Chicago, IL USA; [Evans, Charlesnika T.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Babcock-Parziale, Judith] Southern AZ VA Hlth Care Syst 3 124, Dept Vet Affairs VA, Tucson, AZ USA		Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, 5000 South 5th Ave,MC151H,Bldg 1, Hines, IL 60141 USA.	Theresa.Pape@va.gov		Bender Pape, Theresa/0000-0001-7738-5963	US Department of Veterans Affairs, Office of Research Development [HSRD SDR-08-377]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	This study was funded by US Department of Veterans Affairs, Office of Research & Development, HSR&D SDR-08-377.	Arbisi P. A., 2006, PSYCHOL SERV, V3, P249, DOI DOI 10.1037/1541-1559.3.4.249; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1988, MANUAL BECK ANXIETY; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Ben-Porath, 2008, MINNESOTA MULTIPHASI; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; French LM, 2009, J HEAD TRAUMA REHAB, V24, P1, DOI 10.1097/HTR.0b013e318197a14c; Gould CE, 2015, INT J GERIATR PSYCH, V30, P623, DOI 10.1002/gps.4193; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T, 2009, J REHABIL RES DEV, V46, pCP1; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mason LH, 2013, J PERS ASSESS, V95, P585, DOI 10.1080/00223891.2013.819512; Palmer GA, 2014, MIL MED, V179, P879, DOI 10.7205/MILMED-D-14-00048; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; Roth R. S., 2013, INT J PHYS MED REHAB, V1, P1, DOI [10.4172/2329-9096.1000105, DOI 10.4172/2329-9096.1000105]; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Government Accountability Office, 2008, GAO082762008; VA Employee Educational System Veterans Health Initiative, 2010, TRAUMATIC BRAIN INJU; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	45	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E10	E22		10.1097/HTR.0000000000000220			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800002	26828712				2022-02-06	
J	Zangbar, B; Khalil, M; Gruessner, A; Joseph, B; Friese, R; Kulvatunyou, N; Wynne, J; Latifi, R; Rhee, P; O'Keeffe, T				Zangbar, Bardiya; Khalil, Mazhar; Gruessner, Angelika; Joseph, Bellal; Friese, Randall; Kulvatunyou, Narong; Wynne, Julie; Latifi, Rifat; Rhee, Peter; O'Keeffe, Terence			Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis	WORLD JOURNAL OF SURGERY			English	Article							RISK-FACTORS; PHENYTOIN; PREVENTION; ADULTS; TRIAL	Early seizures after severe traumatic brain injury (TBI) have a reported incidence of up to 15 %. Prophylaxis for early seizures using 1 week of phenytoin is considered standard of care for seizure prevention. However, many centers have substituted the anticonvulsant levetiracetam without good data on the efficacy of this approach. Our hypothesis was that the treatment with levetiracetam is not effective in preventing early post-traumatic seizures. All trauma patients sustaining a TBI from January 2007 to December 2009 at an urban level-one trauma center were retrospectively analyzed. Seizures were identified from a prospectively gathered morbidity database and anticonvulsant use from the pharmacy database. Statistical comparisons were made by Chi square, t tests, and logistic regression modeling. Patients who received levetiracetam prophylaxis were matched 1:1 using propensity score matching with those who did not receive the drug. 5551 trauma patients suffered a TBI during the study period, with an overall seizure rate of 0.7 % (39/5551). Of the total population, 1795 were diagnosed with severe TBI (Head AIS score 3-5). Seizures were 25 times more likely in the severe TBI group than in the non-severe group [2.0 % (36/1795) vs. 0.08 % (3/3756); OR 25.6; 95 % CI 7.8-83.2; p < 0.0001]. Of the patients who had seizures after severe TBI, 25 % (9/36) received pharmacologic prophylaxis with levetiracetam, phenytoin, or fosphenytoin. In a matched cohort by propensity scores, no difference was seen in seizure rates between the levetiracetam group and no-prophylaxis group (1.9 vs. 3.4 %, p = 0.50). In this propensity score-matched cohort analysis, levetiracetam prophylaxis was ineffective in preventing seizures as the rate of seizures was similar whether patients did or did not receive the drug. The incidence of post-traumatic seizures in severe TBI patients was only 2.0 % in this study; therefore we question the benefit of routine prophylactic anticonvulsant therapy in patients with TBI.	[Zangbar, Bardiya; Khalil, Mazhar; Joseph, Bellal; Friese, Randall; Kulvatunyou, Narong; Wynne, Julie; Latifi, Rifat; Rhee, Peter; O'Keeffe, Terence] Univ Arizona, Dept Surg, Tucson, AZ 85721 USA; [Gruessner, Angelika] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA		O'Keeffe, T (corresponding author), Univ Arizona, Dept Surg, Tucson, AZ 85721 USA.	tokeeffe@surgery.arizona.edu		Latifi, Rifat/0000-0003-1091-3682			Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caballero G Christina, 2013, Hosp Pharm, V48, P757, DOI 10.1310/hpj4809-757; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; Frend V, 2007, CLIN NEUROPHARMACOL, V30, P362, DOI 10.1097/WNF.0b013e318059ae1c; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; Oluwole OSA, 2011, BRAIN INJURY, V25, P980, DOI 10.3109/02699052.2011.589798; Pieracci FM, 2012, J TRAUMA ACUTE CARE, V72, P276, DOI 10.1097/TA.0b013e31823df31f; Stratton SC, 2003, EPILEPSY RES, V53, P95, DOI 10.1016/S0920-1211(02)00254-1; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Teixeira PGR, 2013, J TRAUMA ACUTE CARE, V75, P717, DOI 10.1097/TA.0b013e31829d27b6; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	23	11	11	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2016	40	11					2667	2672		10.1007/s00268-016-3606-y			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EA5XP	WOS:000386698800017	27307089				2022-02-06	
J	Deselms, H; Maggio, N; Rubovitch, V; Chapman, J; Schreiber, S; Tweedie, D; Kim, DS; Greig, NH; Pick, CG				Deselms, Hanna; Maggio, Nicola; Rubovitch, Vardit; Chapman, Joab; Schreiber, Shaul; Tweedie, David; Kim, Dong Seok; Greig, Nigel H.; Pick, Chaim G.			Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Animal models of TBI; Exendin-4; N-Acetyl-L-cycteine; Salubrinal; Thrombin	GLUCAGON-LIKE PEPTIDE-1; PROTEASE-ACTIVATED RECEPTOR-1; ALPHA SYNTHESIS INHIBITOR; REVERSES BEHAVIORAL IMPAIRMENTS; AMYLOID-BETA-PEPTIDE; CLOSED-HEAD INJURY; TNF-ALPHA; COGNITIVE DEFICITS; NEURODEGENERATIVE DISEASES; SYNAPTIC PLASTICITY	Background: The need for effective pharmaceuticals within animal models of traumatic brain injury (TBI) continues to be paramount, as TBI remains the major cause of brain damage for children and young adults. While preventative measures may act to reduce the incidence of initial blunt trauma, well-tolerated drugs are needed to target the neurologically damaging internal cascade of molecular mechanisms that follow. Such processes, known collectively as the secondary injury phase, include inflammation, excitotoxicity, and apoptosis among other changes still subject to research. In this article positive treatment findings to mitigate this secondary injury in rodent TBI models will be overviewed, and include recent studies on Exendin-4, N-Acetyl-L-cycteine, Salubrinal and Thrombin. Conclusions: These studies provide representative examples of methodologies that can be combined with widely available in vivo rodent models to evaluate therapeutic approaches of translational relevance, as well as drug targets and biochemical cascades that may slow or accelerate the degenerative processes induced by TBI. They employ well-characterized tests such as the novel object recognition task for assessing cognitive deficits. The application of such methodologies provides both decision points and a gateway for implementation of further translational studies to establish the feasibility of clinical efficacy of potential therapeutic interventions. (C) 2016 Elsevier B.V. All rights reserved.	[Deselms, Hanna; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, Tel Aviv, Israel; [Maggio, Nicola; Chapman, Joab] Chaim Sheba Med Ctr, Dept Neurol, J Sagol Neurosci Ctr, Ramat Gan, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel; [Maggio, Nicola; Chapman, Joab] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Dept Psychiat, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Tweedie, David; Kim, Dong Seok; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA		Pick, CG (corresponding author), Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, Tel Aviv, Israel.	pickc@post.tau.ac.il	Schreiber, Shaul/E-5821-2010; Chapman, Joab/E-4598-2010	Schreiber, Shaul/0000-0002-2189-0693; 	Intramural Research Program of the National Institute on Aging, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Ari and Regine Aprijaskis Fund at Tel-Aviv University; Israel Science FoundationIsrael Science Foundation [108/09]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333, ZIAAG000311] Funding Source: NIH RePORTER	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09.	Almonte AG, 2007, NEUROBIOL LEARN MEM, V88, P295, DOI 10.1016/j.nlm.2007.04.004; Almonte AG, 2013, J NEUROCHEM, V124, P109, DOI 10.1111/jnc.12075; Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Ben Shimon M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00151; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bolouri H., 2015, BRAIN NEUROTRAUMA MO; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coughlin SR, 2001, THROMB HAEMOSTASIS, V86, P298; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Duarte AI, 2013, BBA-MOL BASIS DIS, V1832, P527, DOI 10.1016/j.bbadis.2013.01.008; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Filichia E, 2015, NEUROSCIENCE, V295, P1, DOI 10.1016/j.neuroscience.2015.03.018; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Greig NH, 2004, ACTA NEUROBIOL EXP, V64, P1; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Lippi G, 2012, J THROMB THROMBOLYS, V34, P367, DOI 10.1007/s11239-012-0748-0; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2014, HIPPOCAMPUS, V24, P1030, DOI 10.1002/hipo.22288; Maggio N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00046; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry Tracy Ann, 2005, Current Alzheimer Research, V2, P377, DOI 10.2174/1567205054367892; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Reiner O, 2014, ADV EXP MED BIOL, V800, P97, DOI 10.1007/978-94-007-7687-6_6; Rubovitch V, 2015, NEUROMOL MED, V17, P1; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Russo I, 2012, J NEUROCHEM, V122, P1181, DOI 10.1111/j.1471-4159.2012.07846.x; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Schuepbach RA, 2009, THROMB HAEMOSTASIS, V101, P724, DOI 10.1160/TH08-10-0632; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Siller-Matula JM, 2011, THROMB HAEMOSTASIS, V106, P1020, DOI 10.1160/TH10-11-0711; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Spiel AO, 2011, THROMB HAEMOSTASIS, V105, P655, DOI 10.1160/TH10-08-0530; Stiles TL, 2014, BBA-MOL BASIS DIS, V1842, P2561, DOI 10.1016/j.bbadis.2014.07.012; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu XX, 2003, J MED CHEM, V46, P5222, DOI 10.1021/jm030152f; Zhu XX, 2002, J MED CHEM, V45, P5090, DOI 10.1021/jm020044d; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	114	11	11	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2016	272				SI		69	76		10.1016/j.jneumeth.2016.02.002			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA6LF	WOS:000386740000008	26868733	Green Accepted			2022-02-06	
J	Pruitt, DT; Schmid, AN; Danaphongse, TT; Flanagan, KE; Morrison, RA; Kilgard, MP; Rennaker, RL; Hays, SA				Pruitt, David T.; Schmid, Ariel N.; Danaphongse, Tanya T.; Flanagan, Kate E.; Morrison, Robert A.; Kilgard, Michael P.; Rennaker, Robert L., II; Hays, Seth A.			Forelimb training drives transient map reorganization in ipsilateral motor cortex	BEHAVIOURAL BRAIN RESEARCH			English	Article						Motor training; Map plasticity; ipsilateral hemisphere	VAGUS NERVE-STIMULATION; ADULT SQUIRREL-MONKEYS; LONG-TERM POTENTIATION; TRAUMATIC BRAIN-INJURY; MOVEMENT REPRESENTATIONS; FUNCTIONAL RECOVERY; FINGER MOVEMENTS; PLASTICITY; RATS; STROKE	Skilled motor training results in reorganization of contralateral motor cortex movement representations. The ipsilateral motor cortex is believed to play a role in skilled motor control, but little is known about how training influences reorganization of ipsilateral motor representations of the trained limb. To determine whether training results in reorganization of ipsilateral motor cortex maps, rats were trained to perform the isometric pull task, an automated motor task that requires skilled forelimb use. After either 3 or 6 months of training, intracortical microstimulation (ICMS) mapping was performed to document motor representations of the trained forelimb in the hemisphere ipsilateral to that limb. Motor training for 3 months resulted in a robust expansion of right forelimb representation in the right motor cortex, demonstrating that skilled motor training drives map plasticity ipsilateral to the trained limb. After 6 months of training, the right forelimb representation in the right motor cortex was significantly smaller than the representation observed in rats trained for 3 months and similar to untrained controls, consistent with a normalization of motor cortex maps. Forelimb map area was not correlated with performance on the trained task, suggesting that task performance is maintained despite normalization of cortical maps. This study provides new insights into how the ipsilateral cortex changes in response to skilled learning and may inform rehabilitative strategies to enhance cortical plasticity to support recovery after brain injury. (C) 2016 Elsevier B.V. All rights reserved.	[Pruitt, David T.; Schmid, Ariel N.; Danaphongse, Tanya T.; Flanagan, Kate E.; Morrison, Robert A.; Kilgard, Michael P.; Rennaker, Robert L., II] Univ Texas Dallas, Sch Behav Brain Sci, 800 West Campbell Rd,GR41, Richardson, TX 75080 USA; [Rennaker, Robert L., II; Hays, Seth A.] Univ Texas Dallas, Erik Jonsson Sch Engn & Comp Sci, 800 West Campbell Rd, Richardson, TX 75080 USA; [Pruitt, David T.; Schmid, Ariel N.; Danaphongse, Tanya T.; Flanagan, Kate E.; Morrison, Robert A.; Kilgard, Michael P.; Rennaker, Robert L., II; Hays, Seth A.] Univ Texas Dallas, Texas Biomed Device Ctr, 800 West Campbell Rd, Richardson, TX 75080 USA		Pruitt, DT (corresponding author), Univ Texas Dallas, Sch Behav Brain Sci, 800 West Campbell Rd,GR41, Richardson, TX 75080 USA.	dtp110020@utdallas.edu	Hays, Seth/U-4701-2019; , David/ABG-7327-2020; Rennaker II, Robert/K-9049-2013	Hays, Seth/0000-0003-4225-241X; , David/0000-0001-8356-0887; Kilgard, Michael/0000-0002-6699-1818; Morrison, Robert/0000-0001-7524-4729; Rennaker II, Robert/0000-0003-1260-1973	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS085167]; NIH NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC010433]; Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [HR0011-15-2-0017]; Texas Biomedical Device Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094384, R01NS085167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC010433] Funding Source: NIH RePORTER	This study was supported by the following funding sources: NIH NINDS (R01 NS085167), NIH NIDCD (R01 DC010433), Defense Advanced Research Projects Agency (DARPA, HR0011-15-2-0017), and the Texas Biomedical Device Center.	Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009; Caramia MD, 2000, CLIN NEUROPHYSIOL, V111, P1990, DOI 10.1016/S1388-2457(00)00430-2; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Cramer SC, 1999, J NEUROPHYSIOL, V81, P383, DOI 10.1152/jn.1999.81.1.383; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Gonzalez CLR, 2004, EUR J NEUROSCI, V20, P3442, DOI 10.1111/j.1460-9568.2004.03751.x; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Hays SA, 2013, J NEUROSCI METH, V212, P329, DOI 10.1016/j.jneumeth.2012.11.007; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Hulsey DR, 2016, BRAIN STIMUL, V9, P174, DOI 10.1016/j.brs.2015.12.007; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Jones TA, 1999, J NEUROSCI, V19, P10153; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Kilgard MP, 2012, TRENDS NEUROSCI, V35, P715, DOI 10.1016/j.tins.2012.09.002; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Liepert J, 1999, EXP BRAIN RES, V125, P435, DOI 10.1007/s002210050700; Molina-Luna K, 2008, NEUROIMAGE, V40, P1748, DOI 10.1016/j.neuroimage.2007.11.018; Monfils MH, 2004, NEUROSCIENCE, V125, P329, DOI 10.1016/j.neuroscience.2004.01.048; Monfils MH, 2004, CEREB CORTEX, V14, P586, DOI 10.1093/cercor/bhh020; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Porter BA, 2012, CEREB CORTEX, V22, P2365, DOI 10.1093/cercor/bhr316; Pruitt D., 2015, J NEUROTRAUM; Pruitt D, 2014, BRAIN RES, V1582, P91, DOI 10.1016/j.brainres.2014.07.039; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Sawaki L, 2008, NEUROREHAB NEURAL RE, V22, P505, DOI 10.1177/1545968308317531; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Young NA, 2012, J NEUROPHYSIOL, V108, P1309, DOI 10.1152/jn.01045.2011	35	11	11	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 15	2016	313						10	16		10.1016/j.bbr.2016.07.005			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DU7SB	WOS:000382413800002	27392641	Green Accepted, Bronze			2022-02-06	
J	Adams, H; Kolias, AG; Hutchinson, PJ				Adams, Hadie; Kolias, Angelos G.; Hutchinson, Peter J.			The Role of Surgical Intervention in Traumatic Brain Injury	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Neurosurgery; Traumatic brain injury; Neurotrauma; Decompressive craniectomy; Neuromonitoring	ACUTE SUBDURAL HEMATOMAS; LONG-TERM DISABILITY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; TEMPORAL BONE; UNITED-STATES; POSTTRAUMATIC HYDROCEPHALUS; COMMUNICATING HYDROCEPHALUS; INTRACEREBRAL HEMORRHAGE	The general consensus to optimize the care for severe traumatic brain injury (TBI) patients is management at specialized neurotrauma centers with neurosurgical and neurocritical care support and the use of guidelines-based standardized protocols. Over the last decade, significant efforts have been made to define neurotrauma treatment guidelines. However, it is important to recognize the heterogeneity of TBI and that the "one-size-fits-all approach" may not always be appropriate for these patients. Knowledge synthesis activities in neurotrauma are important to define future research agendas. Clinical and research advances have influenced neurotrauma as it continues to mature into a distinct subspecialty of neurosurgery.	[Adams, Hadie; Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus, Cambridge CB2 0QQ, England		Adams, H (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	ha356@cam.ac.uk		Kolias, Angelos/0000-0003-3992-0587; Hutchinson, Peter/0000-0002-2796-1835	NIHRNational Institute for Health Research (NIHR); NIHR Cambridge BRC; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025, G0600986, G1002277, G0502030, G9439390] Funding Source: UKRI	P.J. Hutchinson is supported by an NIHR Research Professorship and the NIHR Cambridge BRC.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Ali B, 2002, EMERG MED J, V19, P552, DOI 10.1136/emj.19.6.552; American College of Surgeons, 2015, TQIP BEST PRACT MAN; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Bontke C F, 1991, Neurosurg Clin N Am, V2, P473; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Brodie HA, 1997, AM J OTOL, V18, P188; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58; Centers for Disease Control and Prevention, 2015, VACC IMM; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2015, TRAUM BRAIN INJ US E; Chambers IR, 1998, ACT NEUR S, V71, P42; CHANDLER JR, 1983, OTOLARYNG CLIN N AM, V16, P623; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 2000, HEAD INJURY; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Czosnyka Z, 2005, ACTA NEUROCHIR SUPPL, V95, P247; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P9, DOI 10.1016/j.clineuro.2012.08.021; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Ghajar J, 1995, New Horiz, V3, P395; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guyot LL, 2000, NEUROL RES, V22, P25; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Hayhurst C, 2009, J NEUROSURG, V111, P1179, DOI 10.3171/2008.12.JNS08628; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; LEECH PJ, 1973, LANCET, V1, P1013; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Low CYD, 2013, J CLIN NEUROSCI, V20, P867, DOI 10.1016/j.jocn.2012.06.007; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mathias T, 2016, OCHSNER J, V16, P136; Maxeiner H, 2007, NEUROSURGERY S, V61, P272; Maxelner H, 2007, NEUROSURGERY, V61, P267, DOI 10.1227/01.neu.0000279222.76375.d4; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MCGUIRT WF, 1995, LARYNGOSCOPE, V105, P359, DOI 10.1288/00005537-199504000-00003; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Mendizabal G R, 1992, Rev Laryngol Otol Rhinol (Bord), V113, P423; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Nyquist GG, 2013, J NEUROL SURG B S1, V74, pA046; Ommaya A, 1996, NEUROSURGERY; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; Paoletti P, 1983, J Neurosurg Sci, V27, P171; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Ratilal BO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004884.pub4; Rimmer J, 2014, J LARYNGOL OTOL, V128, P626, DOI 10.1017/S0022215114001431; Ropper A.H., 2014, ADAMS VICTORS PRINCI, V10th ed.; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Savva A, 2003, LARYNGOSCOPE, V113, P50, DOI 10.1097/00005537-200301000-00010; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; SHAPIRO SA, 1992, NEUROSURGERY, V30, P241, DOI 10.1227/00006123-199202000-00015; Singh I, 2008, NEUROSURG REV, V31, P319, DOI 10.1007/s10143-008-0137-5; SPETZLER RF, 1978, J NEUROSURG, V49, P393, DOI 10.3171/jns.1978.49.3.0393; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Tribl G, 2000, BRAIN INJURY, V14, P345; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	115	11	11	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					519	+		10.1016/j.nec.2016.05.007			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800013	27637401	Green Accepted			2022-02-06	
J	Jadischke, R; Viano, DC; McCarthy, J; King, AI				Jadischke, Ron; Viano, David C.; McCarthy, Joe; King, Albert I.			The Effects of Helmet Weight on Hybrid III Head and Neck Responses by Comparing Unhelmeted and Helmeted Impacts	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						football helmets; head mass; helmet mass; upper neck forces; Hybrid III dummy; concussion; brain stem	PROFESSIONAL FOOTBALL; CONCUSSION; PERFORMANCE	Most studies on football helmet performance focus on lowering head acceleration-related parameters to reduce concussions. This has resulted in an increase in helmet size and mass. The objective of this paper was to study the effect of helmet mass on head and upper neck responses. Two independent test series were conducted. In test series one, 90 pendulum impact tests were conducted with four different headform and helmet conditions: unhelmeted Hybrid III headform, Hybrid III headform with a football helmet shell, Hybrid III headform with helmet shell and facemask, and Hybrid III headform with the helmet and facemask with mass added to the shell (n = 90). The Hybrid III neck was used for all the conditions. For all the configurations combined, the shell only, shell and facemask, and weighted helmet conditions resulted in 36%, 43%, and 44% lower resultant head accelerations (p < 0.0001), respectively, when compared to the unhelmeted condition. Head delta-V reductions were 1.1%, 4.5%, and 4.4%, respectively. In contrast, the helmeted conditions resulted in 26%, 41%, and 49% higher resultant neck forces (p < 0.0001), respectively. The increased neck forces were dominated by neck tension. In test series two, testing was conducted with a pneumatic linear impactor (n = 178). Fourteen different helmet makes and models illustrate the same trend. The increased neck forces provide a possible explanation as to why there has not been a corresponding reduction in concussion rates despite improvements in helmets ability to reduce head accelerations.	[Jadischke, Ron; Viano, David C.; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Windsor, ON N9C 4E4, Canada; [Jadischke, Ron; McCarthy, Joe] McCarthy Engn Inc, Windsor, ON N9C 4E4, Canada; [Viano, David C.] ProBiomechanics LLC, Bloomfield Hills, MI 48304 USA		Jadischke, R (corresponding author), Wayne State Univ, Dept Biomed Engn, Windsor, ON N9C 4E4, Canada.; Jadischke, R (corresponding author), McCarthy Engn Inc, Windsor, ON N9C 4E4, Canada.	rjadischke@mccarthyengineering.ca; dviano@comcast.net; jmccarthy@mccarthyengineering.ca; king@eng.wayne.edu			Institute for Injury Research; McCarthy Engineering, Inc.	The authors would like to thank the staff of McCarthy Engineering for their assistance in various aspects of testing and preparation of this paper. Funding for this research has been received from the Institute for Injury Research and from McCarthy Engineering, Inc. Joe McCarthy is the President of McCarthy Engineering, Inc. and therefore has financial interest in the company. Ron Jadischke is an employee of McCarthy Engineering, Inc., and this work was performed as a research project related to his degree.	Bartsch A., 2011, J NEUROSURG, V116, P1; Breig, 1960, BIOMECHANICS CENTRAL; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; CNN, 2013, NFL CONC FAST FACTS; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Gurdjian E. S., 1967, MED SCI, V18, P45; Gurdjian E. S., 1966, 9 STAPP CAR CRASH C; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hardy W. N., 2007, 51 STAPP CAR CRASH C; HARDY WN, 2001, 45 STAPP CAR CRASH C; Hodgson V. R., 1979, 791023 SAE; Hodgson V. R., 1983, 831687 SAE; Hodgson V. R., 1969, 690796 SAE; HODGSON VR, 1966, J NEUROSURG, V25, P549, DOI 10.3171/jns.1966.25.5.0549; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kroeker SG, 2013, J BIOMECH, V46, P773, DOI 10.1016/j.jbiomech.2012.11.012; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; National Football League Health and Safety Committee, 2015, NFL SUP BOWL 48 HLTH; NOCSAE, 2012, STAND PERF SPEC NEWL; Ommaya A. K., 1966, STAPP CAR CRASH C; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Piziali R., 1998, 980362 SAE; Viano D. C., 1986, STAPP CAR CRASH C; Viano D. C., 2012, BRAIN INJURY MED; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Widmaier E.P., 2006, VANDERS HUMAN PHYSL	35	11	11	0	14	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT	2016	138	10							101008	10.1115/1.4034306			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DW9ML	WOS:000383984000008	27456840				2022-02-06	
J	Rabiu, TB; Komolafe, EO				Rabiu, Taopheeq Bamidele; Komolafe, Edward Oluwole			Neurosurgery in rural Nigeria: A prospective study	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Africa; Nigeria; rural neurosurgery; rural surgery	SUB-SAHARAN AFRICA; NEUROTRAUMA; EXPERIENCE; SURGERY; PATTERN; ACCESS	Background: Africa has very few neurosurgeons. These are almost exclusively in urban centers. Consequently, people in rural areas, most of the African population, have poor or no access to neurosurgical care. We have recently pioneered rural neurosurgery in Nigeria. Objectives: This report details our initial experiences and the profile of neurosurgical admissions in our center. Methods: A prospective observational study of all neurosurgical patients managed at a rural tertiary health institution in Nigeria from December 2010 to May 2012 was done. Simple descriptive data analysis was performed. Results: A total of 249 males (75.2%) and 82 females (24.8%) were managed. The median age was 37 years (range: Day of birth - 94 years). Trauma was the leading cause of presentation with 225 (68.0%) and 35 (10.6%) having sustained head and spinal injuries, respectively. Operative intervention was performed in 54 (16.3%). Twenty-four (7.2%) patients discharged against medical advice, mostly for economic reasons. Most patients (208, 63.4%) had satisfactory outcome while 30 (9.1%) died. Conclusion: Trauma is the leading cause of rural neurosurgical presentations. There is an urgent need to improve access to adequate neurosurgical care in the rural communities.	[Rabiu, Taopheeq Bamidele; Komolafe, Edward Oluwole] Fed Med Ctr, Div Neurol Surg, Dept Surg, Ido Ekiti, Nigeria; [Rabiu, Taopheeq Bamidele] Lautech Teaching Hosp, Div Neurol Surg, Dept Surg, Osogbo, Nigeria; [Komolafe, Edward Oluwole] Obafemi Awolowo Univ, Div Neurol Surg, Dept Surg, Teaching Hosp Complex, Ife, Nigeria		Rabiu, TB (corresponding author), Lautech Teaching Hosp, Div Neurol Surg, Dept Surg, Osogbo, Nigeria.	eshohealth@gmail.com		komolafe, edward/0000-0003-1261-3501			Adeleye Amos Olufemi, 2009, Congenital Anomalies, V49, P258, DOI 10.1111/j.1741-4520.2009.00241.x; Adeolu AA, 2013, WORLD NEUROSURG, V80, P251, DOI 10.1016/j.wneu.2012.11.063; Agius S, 2012, BRIT J NEUROSURG, V26, P212, DOI 10.3109/02688697.2011.609920; Agrawal Deepak, 2012, J Emerg Trauma Shock, V5, P7, DOI 10.4103/0974-2700.93099; Beavogi K, 2011, Zh Vopr Neirokhir Im N N Burdenko, V75, P38; Bellagio Essential Surgery Group, 2007, IMPR ACC SURG SUBS A; Bishop CV, 2006, ANZ J SURG, V76, P53, DOI 10.1111/j.1445-2197.2006.03642.x; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Dechambenoit G, 2010, WORLD NEUROSURG, V73, P251, DOI 10.1016/j.wneu.2010.02.046; deVilliers JC, 1996, SURG NEUROL, V46, P403, DOI 10.1016/S0090-3019(96)00041-9; El-Fiki M, 2010, WORLD NEUROSURG, V73, P254, DOI 10.1016/j.wneu.2010.02.012; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Emejulu JK, 2009, AJNS, V28; Idowu OE, 2008, ACTA NEUROCHIR, V150, P911, DOI 10.1007/s00701-008-0002-x; Ivers LC, 2008, WORLD J SURG, V32, P537, DOI 10.1007/s00268-008-9527-7; Park BE, 2010, WORLD NEUROSURG, V73, P276, DOI 10.1016/j.wneu.2010.02.016; Rabiu TB, 2012, CHILD NERV SYST, V28, P2115, DOI 10.1007/s00381-012-1879-5; Taira B, 2009, WORLD J SURG, V33, P893, DOI 10.1007/s00268-009-9981-x; United Nations, 2012, WORLD URB PROSP 2011; Vargas J, 2013, WORLD NEUROSURG, V80, pE91, DOI 10.1016/j.wneu.2012.01.033; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; World Health Organization, 2008, GLOB BURD DIS 2004 U, P39	22	11	11	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT-DEC	2016	7	4					485	488		10.4103/0976-3147.188624			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DW7BS	WOS:000383806800003	27695224	Green Published, gold			2022-02-06	
J	Ramtinfar, S; Chabok, SY; Chari, AJ; Reihanian, Z; Leili, EK; Alizadeh, A				Ramtinfar, Sara; Chabok, Shahrokh Yousefzadeh; Chari, Aliakbar Jafari; Reihanian, Zoheir; Leili, Ehsan Kazemnezhad; Alizadeh, Arsalan			Early detection of nonneurologic organ failure in patients with severe traumatic brain injury: Multiple organ dysfunction score or sequential organ failure assessment?	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Multiple organ dysfunction syndrome; organ failure; sequential organ failure assessment; traumatic brain injury	CRITICALLY-ILL; HEAD-INJURY; CARE; COMPLICATIONS; MANAGEMENT; SURVIVAL; IMPACT; SOFA	Objective: The aim of this study is to compare the discriminant function of multiple organ dysfunction score (MODS) and sequential organ failure assessment (SOFA) components in predicting the Intensive Care Unit (ICU) mortality and neurologic outcome. Materials and Methods: A descriptive-analytic study was conducted at a level I trauma center. Data were collected from patients with severe traumatic brain injury admitted to the neurosurgical ICU. Basic demographic data, SOFA and MOD scores were recorded daily for all patients. Odd's ratios (ORs) were calculated to determine the relationship of each component score to mortality, and area under receiver operating characteristic (AUROC) curve was used to compare the discriminative ability of two tools with respect to ICU mortality. Results: The most common organ failure observed was respiratory detected by SOFA of 26% and MODS of 13%, and the second common was cardiovascular detected by SOFA of 18% and MODS of 13%. No hepatic or renal failure occurred, and coagulation failure reported as 2.5% by SOFA and MODS. Cardiovascular failure defined by both tools had a correlation to ICU mortality and it was more significant for SOFA (OR = 6.9, CI = 3.6-13.3, P < 0.05 for SOFA; OR = 5, CI = 3-8.3, P < 0.05 for MODS; AUROC = 0.82 for SOFA; AUROC = 0.73 for MODS). The relationship of cardiovascular failure to dichotomized neurologic outcome was not significant statistically. ICU mortality was not associated with respiratory or coagulation failure. Conclusion: Cardiovascular failure defined by either tool significantly related to ICU mortality. Compared to MODS, SOFA-defined cardiovascular failure was a stronger predictor of death. ICU mortality was not affected by respiratory or coagulation failures.	[Ramtinfar, Sara; Chabok, Shahrokh Yousefzadeh; Chari, Aliakbar Jafari; Reihanian, Zoheir; Leili, Ehsan Kazemnezhad; Alizadeh, Arsalan] Guilan Univ Med Sci, Poursina Hosp, Dept Neurosurg, Guilan, Iran		Ramtinfar, S (corresponding author), Guilan Univ Med Sci, Poursina Hosp, Dept Neurosurg, Guilan, Iran.	dr.ramtinfar@yahoo.com	Reihanian, Zoheir/AAG-4217-2021	Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015			Berthiaume L, 2006, CRIT CARE CLIN, V22, P753, DOI 10.1016/j.ccc.2006.09.002; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Diringer MN, 2007, CURR OPIN CRIT CARE, V13, P156, DOI 10.1097/MCC.0b013e32807f2aa5; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; GADKARY CS, 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001048; Gonzalvo R, 2007, CRIT CARE, V11, DOI 10.1186/cc5930; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Khwannimit Bodin, 2007, Journal of the Medical Association of Thailand, V90, P1074; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Marshall J, 2012, CLIN TRIALS TREATMEN, P122; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Ulvik A, 2007, CRIT CARE, V11, DOI 10.1186/cc6111; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wang HL, 2008, AM J EMERG MED, V26, P711, DOI 10.1016/j.ajem.2007.10.031; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	28	11	13	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	OCT	2016	20	10					575	580		10.4103/0972-5229.192042			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EB8OM	WOS:000387650500003	27829712	Green Published, Bronze			2022-02-06	
J	Ryan, NP; Beauchamp, MH; Beare, R; Coleman, L; Ditchfield, M; Kean, M; Silk, TJ; Genc, S; Catroppa, C; Anderson, VA				Ryan, Nicholas P.; Beauchamp, Miriam H.; Beare, Richard; Coleman, Lee; Ditchfield, Michael; Kean, Michael; Silk, Timothy J.; Genc, Sila; Catroppa, Cathy; Anderson, Vicki A.			Uncovering cortico-striatal correlates of cognitive fatigue in pediatric acquired brain disorder: Evidence from traumatic brain injury	CORTEX			English	Article						Cognitive fatigue; Pediatrics; Brain injuries; Neurobiology; Magnetic resonance imaging	QUALITY-OF-LIFE; BASAL GANGLIA; POSTSTROKE FATIGUE; FRONTAL-CORTEX; MENTAL FATIGUE; CHILDREN; RELIABILITY; SURVIVORS; MODERATE; LESIONS	Cognitive fatigue is among the most profound and disabling sequelae of pediatric acquired brain disorders, however the neural correlates of these symptoms in children remains unexplored. One hypothesis suggests that cognitive fatigue may arise from dysfunction of cortico-striatal networks (CSNs) implicated in effort output and outcome valuation. Using pediatric traumatic brain injury (TBI) as a model, this study investigated (i) the sub-acute effect of brain injury on CSN volume; and (ii) potential relationships between cognitive fatigue and sub-acute volumetric abnormalities of the CSN. 3D T1 weighted magnetic resonance imaging sequences were acquired sub-acutely in 137 children (TBI: n = 103; typically developing - TD children: n = 34). 67 of the original 137 participants (49%) completed measures of cognitive fatigue and psychological functioning at 24-months post injury. Results showed that compared to TD controls and children with milder injuries, children with severe TBI showed volumetric reductions in the overall CSN package, as well as regional gray matter volumetric change in cortical and subcortical regions of the CSN. Significantly greater cognitive fatigue in the TBI patients was associated with volumetric reductions in the CSN and its putative hub regions, even after adjusting for injury severity, socioeconomic status (SES) and depression. In the first study to evaluate prospective neuroanatomical correlates of cognitive fatigue in pediatric acquired brain disorder, these findings suggest that post-injury cognitive fatigue is related to structural abnormalities of cortico-striatal brain networks implicated in effort output and outcome valuation. Morphometric magnetic resonance imaging (MRI) may have potential to unlock early prognostic markers that may assist to identify children at elevated risk for cognitive fatigue post-TBI. (C) 2016 Elsevier Ltd. All rights reserved.	[Ryan, Nicholas P.; Coleman, Lee; Ditchfield, Michael; Catroppa, Cathy; Anderson, Vicki A.] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [Beare, Richard; Kean, Michael; Silk, Timothy J.; Genc, Sila] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia; [Silk, Timothy J.; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Ryan, NP (corresponding author), Murdoch Childrens Res Inst, Child Neuropsychol, Flemington Rd, Parkville, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au	Silk, Tim/K-4295-2019; Catroppa, Cathy/AAX-9458-2021; Ryan, Nicholas/K-5445-2019	Catroppa, Cathy/0000-0002-9750-0436; Ryan, Nicholas/0000-0002-0878-8889; Silk, Tim/0000-0002-7290-512X; Beare, Richard/0000-0002-7530-5664; Genc, Sila/0000-0002-4624-7071	National Health and Medical Research Council Moving Ahead Seed Grant; Victoria Neurotrauma Initiative, Australia; Victorian Government Operational Infrastructure Support Program [CO6E1]	All phases of this study were supported in part by a National Health and Medical Research Council Moving Ahead Seed Grant (Nicholas Ryan, awarded 2014); a grant from the Victoria Neurotrauma Initiative, Australia; and the Victorian Government Operational Infrastructure Support Program (No. CO6E1).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Botvinick MM, 2009, PSYCHOL RES-PSYCH FO, V73, P835, DOI 10.1007/s00426-008-0197-8; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Crichton A, 2015, PEDIATRICS, V135, pE1015, DOI 10.1542/peds.2014-2440; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fowler A, 2008, EUR J PAEDIATR NEURO, V12, P484, DOI 10.1016/j.ejpn.2007.12.009; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Johannsdottir IMR, 2012, PEDIATR BLOOD CANCER, V58, P415, DOI 10.1002/pbc.23111; Johnson SL, 2008, J NEUROSCI NURS, V40, P72, DOI 10.1097/01376517-200804000-00005; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; McCarthy ML, 2007, J TRAUMA, V63, pS122, DOI 10.1097/TA.0b013e31815accdf; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Meeske K, 2004, CANCER, V101, P2116, DOI 10.1002/cncr.20609; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; O'Doherty JP, 2011, ANN NY ACAD SCI, V1239, P118, DOI 10.1111/j.1749-6632.2011.06290.x; O'Keeffe F, 2012, BRAIN INJURY, V26, P1072, DOI 10.3109/02699052.2012.661117; Overweg-Plandsoen WCG, 1999, EUR J PEDIATR, V158, P249, DOI 10.1007/s004310051061; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Salamone JD, 2003, J PHARMACOL EXP THER, V305, P1, DOI 10.1124/jpet.102.035063; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Sumpter R, 2011, BRAIN INJURY, V25, P1288, DOI 10.3109/02699052.2011.613090; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2; Varni JW, 2009, PEDIATR DIABETES, V10, P321, DOI 10.1111/j.1399-5448.2008.00482.x; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Walton ME, 2003, J NEUROSCI, V23, P6475; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	59	11	11	0	13	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	OCT	2016	83						222	230		10.1016/j.cortex.2016.07.020			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DZ1LG	WOS:000385599300020	27603573				2022-02-06	
J	Songara, A; Gupta, R; Jain, N; Rege, S; Masand, R				Songara, Abhishek; Gupta, Rakesh; Jain, Nilesh; Rege, Shrikant; Masand, Ravi			Early Cranioplasty in Patients With Posttraumatic Decompressive Craniectomy and Its Correlation with Changes in Cerebral Perfusion Parameters and Neurocognitive Outcome	WORLD NEUROSURGERY			English	Article						Cranioplasty; CT perfusion; Decompressive craniectomy; Neurocognition	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; CT; IMPROVEMENT; METABOLISM; IMPACT	BACKGROUND: Decompressive craniectomy is a life-saving procedure in many patients after traumatic brain injury. Delayed recovery in such patients can be attributed to various causes. Cranioplasty (CP) helps in early improvement of neurocognitive function along with better brain protection and cosmesis. The mechanism responsible for this functional improvement and the ideal time to perform cranial reconstruction is less understood. METHODS: We studied 16 patients who unde ent CP after decompressive craniectomy (DC) for traumatic brain injury. These patients were divided in 2 groups, early and late CP, depending on the interval between DC and CP. Three months was the cutoff time for early CP. Nemocognitive status was assessed by Glasgow Coma Scale, Glasgow Outcome Scale, and Mini-Mental State Examination scores prior to and after CP. Computed tomography (CT) perfusion was done to correlate the improvement in neurologic status and CT perfusion parameters. RESULTS: We observed that there was a positive influence of CP on neurologic and psychologic function in all of the patients. The neurocognitive improvement after CP was more remarkable in the early CP group. More complications were noted in patients in the late CP group. Brain perfusion after CP showed improvement in all parameters in both of the groups, both on the operated and contralateral side. CONCLUSIONS: Neurocognitive improvement is noted after CP in all of the patients. CP should be offered once the brain edema subsides, at the earliest. Improved cerebral perfusion may be the key factor for the improved functional outcome.	[Songara, Abhishek; Gupta, Rakesh; Jain, Nilesh; Rege, Shrikant] Sri Aurobindo Inst Med Sci, Dept Neurosurg, Indore, Madhya Pradesh, India; [Songara, Abhishek; Gupta, Rakesh; Jain, Nilesh; Rege, Shrikant] PG Inst, Indore, Madhya Pradesh, India; [Masand, Ravi] CHL Hosp, Dept Radiodiag, Indore, Madhya Pradesh, India		Songara, A (corresponding author), Sri Aurobindo Inst Med Sci, Dept Neurosurg, Indore, Madhya Pradesh, India.; Songara, A (corresponding author), PG Inst, Indore, Madhya Pradesh, India.	dr.abhineuro2011@gmail.com	Jain, Nilesh/K-1317-2019	Jain, Nilesh/0000-0003-2794-6237			Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chibbaro S, 2012, INDIAN J NEUROSURG, V1, P17; Chibbaro S, 2013, INDIAN J NEUROSURG, V2, P189, DOI 10.4103/2277-9167.118124; David H, 1994, NEUROSURGERY, V34, P729; Decaminada N, 2008, NEURORADIOL J, V21, P459, DOI 10.1177/197140090802100402; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Doss K, 2005, BENEFITS EARLY CRANI; Erdogan E, 2003, NEUROL INDIA, V51, P479; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gordon, 2013, THESIS; Griffiths PD, 2001, VASC MED, V6, P51; JENNETT B, 1975, LANCET, V1, P480; Mann C., 2013, THESIS; Pangilinan Jr PH, 2013, MEDSCAPE MED NEWS; Paredes I, 2015, J NEUROTRAUMA; Paredes Igor, 2011, Surg Neurol Int, V2, P88, DOI 10.4103/2152-7806.82370; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Sarubbo S, 2014, NEURORADIOLOGY, V56, P237, DOI 10.1007/s00234-014-1318-2; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Senapati SB, 2012, INDIAN J NEUROTRAUM, V9, P136, DOI 10.1016/j.ijnt.2012.10.006; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; TEASDALE G, 1974, LANCET, V2, P81; Van Aken J., 1998, EUR J ANAESTH, V15, P59; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Wiesmann M., CT PERFUSION BRAIN V; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yamaura A, 1977, No Shinkei Geka, V5, P345; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	31	11	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2016	94						303	308		10.1016/j.wneu.2016.07.003			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5EJ	WOS:000390353200040	27418533				2022-02-06	
J	Xu, J; Sisniega, A; Zbijewski, W; Dang, H; Stayman, JW; Mow, M; Wang, XH; Foos, DH; Koliatsos, VE; Aygun, N; Siewerdsen, JH				Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Mow, Michael; Wang, Xiaohui; Foos, David H.; Koliatsos, Vassillis E.; Aygun, Nafi; Siewerdsen, Jeffrey H.			Technical assessment of a prototype cone-beam CT system for imaging of acute intracranial hemorrhage	MEDICAL PHYSICS			English	Article						cone-beam CT; dose; image quality; head imaging; imaging performance	X-RAY CT; COMPUTED-TOMOGRAPHY; ARTIFACT-CORRECTION; AXONAL INJURY; NECK-SURGERY; HEAD; QUALITY; STROKE; MOBILE; ALGORITHM	Purpose: A cone-beam CT scanner has been developed for detection and monitoring of traumatic brain injury and acute intracranial hemorrhage (ICH) at the point of care. This work presents a technical assessment of imaging performance and dose for the scanner in phantom and cadaver studies as a prerequisite to clinical translation. Methods: The scanner incorporates a compact, rotating-anode x-ray source and a flat-panel detector (43x43 cm(2)) on a mobile U-arm gantry with source-axis distance = 550 mm and source-detector distance = 1000 mm. Central and peripheral doses were measured in 16 cm diameter CTDI phantoms using a 0.6 cm(3) Farmer ionization chamber for various scan techniques and as a function of longitudinal position, including out of field. Spatial resolution, contrast, noise, and image uniformity were assessed in quantitative and anthropomorphic head phantoms. Two reconstruction protocols were evaluated, including filtered backprojection (FBP) for high-resolution bone imaging and penalized weighted least squares (PWLS) reconstruction for low-contrast soft tissue (ICH) visualization. A fresh cadaver was imaged with and without simulated ICH using the scanner as well as a diagnostic multidetector CT (MDCT) scanner using a standard head protocol. Images were interpreted by a fellowship-trained neuroradiologist for imaging tasks of ICH detection, gray-white-CSF differentiation, detection of midline shift, and fracture detection. Results: The nominal scan protocol involved 720 projections acquired over a 360 degrees orbit at 100 kV and 216 mAs, giving a dose (weighted CTDI) of 22.8 mGy (similar to 1.2 mSv effective dose). Out-of-field dose decreased to <10% within 6 cm of the field edge (approximate to the thyroid position). Image uniformity demonstrated <1% variation between the edge of the field (near the cranium) and center of the image. The high-resolution FBP reconstruction protocol showed similar to 0.9 mm point spread function (PSF) full-width at half-maximum (FWHM). The smooth PWLS reconstruction protocol yielded similar to 1.2 mm PSF FWHM and contrast-to-noise ratio exceeding 5.7 in similar to 50 HU spherical ICH, resulting in conspicuous depiction of ICH down to similar to 2 mm (the smallest diameter investigated). Cadaver images demonstrated good differentiation of brain and CSF (sufficient, but inferior to MDCT, recognizing that the CBCT dose was one-third that of MDCT), excellent visualization of cranial sutures and fracture (potentially superior to MDCT), clear detection of midline shift, and conspicuous detection of ICH. Conclusions: Technical assessment of the prototype demonstrates dose characteristics and imaging performance consistent with point-of-care detection and monitoring of head injury-most notably, conspicuous detection of ICH-and supports translation of the system to clinical studies. (C) 2016 American Association of Physicists in Medicine.	[Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Mow, Michael; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Wang, Xiaohui; Foos, David H.] Carestream Hlth, Rochester, NY 14608 USA; [Koliatsos, Vassillis E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Aygun, Nafi; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21205 USA; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21205 USA; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21205 USA		Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu	Dang, Hao/U-4865-2018	Dang, Hao/0000-0001-5861-6535; Stayman, Joseph/0000-0003-4358-378X; Sisniega, Alejandro/0000-0003-2030-2711	Carestream Health	The research was supported by academic-industry research partnership with Carestream Health. The authors thank Dr. Nathan Packard, Joe Stagnito, Kevin Richard, and William Snyder (Carestream Health, Rochester NY, USA) for engineering related to the scanner prototype and control system and to Dr. Brian Whitaker and colleagues (Varian Imaging Products, Palo Alto CA, USA) for assistance with custom DG readout configurations. Thanks also to Mr. Ron Wade and colleagues at the Maryland Anatomy Board (University of Maryland, Baltimore MD, USA) for assistance with cadaver studies.	American Association of Physicists in Medicine (AAPM), 2011, SIZ SPEC DOS EST SSD; Badal A, 2009, IEEE T MED IMAGING, V28, P1894, DOI 10.1109/TMI.2009.2021615; Baro J., 1995, Nuclear Instruments & Methods in Physics Research, Section B (Beam Interactions with Materials and Atoms), VB100, P31, DOI 10.1016/0168-583X(95)00349-5; Beck M, 2009, EUR SPINE J, V18, P1469, DOI 10.1007/s00586-009-1050-5; Blaickner M, 2013, RADIAT PROT DOSIM, V155, P451, DOI 10.1093/rpd/nct033; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; Bruder N., 2016, OXFORD TXB NEUROCRIT, P197; Carlson AP, 2012, J NEUROIMAGING, V22, P408, DOI 10.1111/j.1552-6569.2011.00621.x; Carrino JA, 2014, RADIOLOGY, V270, P816, DOI 10.1148/radiol.13130225; Chen B, 2002, MED PHYS, V29, P755, DOI 10.1118/1.1461843; Chesnut RM, 2004, CRIT CARE CLIN, V20, P25, DOI 10.1016/S0749-0704(03)00090-3; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Dang H, 2016, PROC SPIE, V9783, DOI 10.1117/12.2216937; Dang H, 2015, PHYS MED BIOL, V60, P6153, DOI 10.1088/0031-9155/60/16/6153; Doddamani RS, 2012, INDIAN J NEUROTRAUM, V9, P33, DOI 10.1016/j.ijnt.2012.04.007; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fiebach JB, 2004, NEURORADIOLOGY, V46, P44, DOI 10.1007/s00234-003-1132-8; Gerlach R, 2008, NEUROSURGERY, V63, P272, DOI 10.1227/01.NEU.0000312362.63693.78; Gilberto G. R., 2016, NEUROIMAGING 1; Gross T, 2010, BRIT J SURG, V97, P118, DOI 10.1002/bjs.6842; Helm PA, 2015, IEEE T MED IMAGING, V34, P1738, DOI 10.1109/TMI.2015.2391200; Hernandez AM, 2014, MED PHYS, V41, DOI 10.1118/1.4866216; Huda W, 2001, MED PHYS, V28, P393, DOI 10.1118/1.1350435; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; JOSEPH PM, 1978, J COMPUT ASSIST TOMO, V2, P100, DOI 10.1097/00004728-197801000-00017; King E, 2013, HEAD NECK-J SCI SPEC, V35, P959, DOI 10.1002/hed.23060; Konstantinidis AC, 2012, NUCL INSTRUM METH A, V689, P12, DOI 10.1016/j.nima.2012.06.024; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lev MH, 2001, STROKE, V32, P2021, DOI 10.1161/hs0901.095680; Li T, 2006, PHYS MED BIOL, V51, P253, DOI 10.1088/0031-9155/51/2/005; Li YS, 2016, PROC SPIE, V9783, DOI 10.1117/12.2216838; Linfante I, 1999, STROKE, V30, P2263, DOI 10.1161/01.STR.30.11.2263; Long Y, 2010, IEEE T MED IMAGING, V29, P1839, DOI 10.1109/TMI.2010.2050898; Manninen PH, 1999, CAN J ANAESTH, V46, P7, DOI 10.1007/BF03012507; Miracle AC, 2009, AM J NEURORADIOL, V30, P1285, DOI 10.3174/ajnr.A1654; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murayama Y, 2011, NEUROSURGERY, V68, P1427, DOI 10.1227/NEU.0b013e31820b4f1c; Nael K, 2014, STROKE, V45, P1985, DOI 10.1161/STROKEAHA.114.005305; Navab N, 1996, P SOC PHOTO-OPT INS, V2708, P361, DOI 10.1117/12.237798; Ott Lora K, 2011, J Radiol Nurs, V30, P49; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Poludniowski G, 2009, PHYS MED BIOL, V54, P3847, DOI 10.1088/0031-9155/54/12/016; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Punnoose J, 2016, MED PHYS, V43, P4711, DOI 10.1118/1.4955438; Purdie TG, 2007, INT J RADIAT ONCOL, V68, P243, DOI 10.1016/j.ijrobp.2006.12.022; Rumboldt Z, 2009, AM J NEURORADIOL, V30, P1630, DOI 10.3174/ajnr.A1603; SAUER K, 1993, IEEE T SIGNAL PROCES, V41, P534, DOI 10.1109/78.193196; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Seeberger R, 2012, J CRANIO MAXILL SURG, V40, P731, DOI 10.1016/j.jcms.2012.01.008; Siewerdsen JH, 2011, NUCL INSTRUM METH A, V648, pS241, DOI 10.1016/j.nima.2010.11.088; Sisniega A, 2016, PROC SPIE, V9783, DOI 10.1117/12.2217243; Sisniega A, 2015, PHYS MED BIOL, V60, P1415, DOI 10.1088/0031-9155/60/4/1415; Sisniega A, 2013, MED PHYS, V40, DOI 10.1118/1.4801895; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Tyndall Donald A, 2008, Dent Clin North Am, V52, P825, DOI 10.1016/j.cden.2008.05.002; Valentin J., 2007, ANN ICRP, V103; Wallace MJ, 2009, J VASC INTERV RADIOL, V20, pS523, DOI 10.1016/j.jvir.2009.04.059; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Wang AS, 2013, PROC SPIE, V8668, DOI 10.1117/12.2008421; Waydhas C, 1999, CRIT CARE, V3, pR83, DOI 10.1186/cc362; Wilson JM, 2013, MED PHYS, V40, DOI 10.1118/1.4791645; Wintermark M, 2013, J AM COLL RADIOL, V10, P828, DOI [10.1016/j.jacr.2013.06.019, 10.3174/ajnr.A3690]; Xu J, 2016, PHYS MED BIOL, V61, P3180, DOI 10.1088/0031-9155/61/8/3180; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805; Xu J, 2016, PHYS MED BIOL, V61, P5973, DOI 10.1088/0031-9155/61/16/5973; Zbijewski W, 2014, Proc SPIE Int Soc Opt Eng, V9033, P903329; Zbijewski W., 2014, 3 INT C IM FORM XRAY, P401; Zbijewski W, 2007, IEEE NUCL SCI CONF R, P2985, DOI 10.1109/NSSMIC.2007.4436761; Zhao Z, 2014, MED PHYS, V41, DOI 10.1118/1.4875688; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P567, DOI 10.1080/15459620500324727	73	11	12	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	OCT	2016	43	10					5745	5757		10.1118/1.4963220			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DZ1DA	WOS:000385577900049	27782694	hybrid			2022-02-06	
J	Zimmermann, LL; Diaz-Arrastia, R; Vespa, PM				Zimmermann, Lara L.; Diaz-Arrastia, Ramon; Vespa, Paul M.			Seizures and the Role of Anticonvulsants After Traumatic Brain Injury	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Seizure; Nonconvulsive seizure; Posttraumatic seizure; Status epilepticus; Continuous electroencephalography; Metabolic crisis; Secondary brain injury	LATE POSTTRAUMATIC SEIZURES; PERCENT-ALPHA-VARIABILITY; INTENSIVE-CARE-UNIT; STATUS EPILEPTICUS; METABOLIC CRISIS; CONTINUOUS ELECTROENCEPHALOGRAPHY; ELECTROGRAPHIC SEIZURES; RISK-FACTORS; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE	Posttraumatic seizures are a common complication of traumatic brain injury. Post traumatic epilepsy accounts for 20% of symptomatic epilepsy in the general population and 5% of all epilepsy. Early posttraumatic seizures occur in more than 20% of patients in the intensive care unit and are associated with secondary brain injury and worse patient outcomes. Most posttraumatic seizures are nonconvulsive, and therefore continuous electroencephalography monitoring should be the standard of care for patients with moderate or severe brain injury. The literature shows that posttraumatic seizures result in secondary brain injury caused by increased intracranial pressure, cerebral edema and metabolic crisis.	[Zimmermann, Lara L.; Vespa, Paul M.] Ronald Reagan UCLA Med Ctr, Dept Neurosurg, 757 Westwood Plaza,Suite 6236, Los Angeles, CA 90095 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA		Zimmermann, LL (corresponding author), Ronald Reagan UCLA Med Ctr, Dept Neurosurg, 757 Westwood Plaza,Suite 6236, Los Angeles, CA 90095 USA.	Zimmermann.Lara.L@gmail.com		Diaz-Arrastia, Ramon/0000-0001-6051-3594			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Ding K., 2016, TRANSLATIONAL RES TR; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Kamel H, 2013, NEUROCRIT CARE, V19, P336, DOI 10.1007/s12028-012-9736-7; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2002, ACTA NEUROCHIR SUPPL, V81, P355; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Welch RD, 2015, EPILEPSIA, V56, P254, DOI 10.1111/epi.12905; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	50	11	11	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					499	+		10.1016/j.nec.2016.06.001			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800011	27637399				2022-02-06	
J	Hehar, H; Yu, K; Ma, I; Mychasiuk, R				Hehar, Harleen; Yu, Katrina; Ma, Irene; Mychasiuk, Richelle			PATERNAL AGE AND DIET: THE CONTRIBUTIONS OF A FATHER'S EXPERIENCE TO SUSCEPTIBILITY FOR POST-CONCUSSION SYMPTOMOLOGY	NEUROSCIENCE			English	Article						traumatic brain injury; development; epigenetics; High-Fat Diet; aging	TRAUMATIC BRAIN-INJURY; SLOW GROWTH PERIOD; POSTCONCUSSION SYNDROME; DOPAMINE TRANSPORTER; PPAR-ALPHA; RAT; EXPRESSION; NUTRITION; OUTCOMES; MODEL	In an attempt to improve current understanding of risk factors that influence individual susceptibility to poor outcomes following mild traumatic brain injury (mTBI) or concussion, this project investigated whether modifications to paternal experiences (Advanced Age (AA) or High-Fat Diet (HFD)) affected offspring susceptibility to behavioral symptomology and changes in gene expression following pediatric concussion in a rodent model. The study demonstrated that paternal treatment prior to conception altered behavioral outcomes and molecular characterization of offspring. Offspring of AA fathers demonstrated abnormal behavioral performance when compared to offspring of control fathers. Similarly, paternal HFD altered pathophysiological outcomes for offspring, contributing to the heterogeneity in post-concussion syndrome. Additionally, this study provided insight into the mechanisms that mediate non-genetic paternal inheritance. Paternal treatment and the mTBI significantly influenced expression of a majority of the genes under examination in the prefrontal cortex, hippocampus, and nucleus accumbens, with changes being dependent upon sex and the brain region examined. These epigenetic changes may have contributed to the differences in offspring susceptibility to concussion. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hehar, Harleen; Yu, Katrina; Ma, Irene; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Psychol, 2500 Univ Dr NW,AD030, Calgary, AB T2N 4N1, Canada.	rmmychas@ucalgary.ca			Alberta Children's Hospital Research Institute (ACHRI); Integrated Concussion Research Program (ICRP)	The authors would like to thank the Alberta Children's Hospital Research Institute (ACHRI) and the Integrated Concussion Research Program (ICRP) for their financial support.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bohacek J, 2013, NEUROPSYCHOPHARMACOL, V38, P220, DOI 10.1038/npp.2012.110; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hehar H., 2015, NONGENET INHERITANCE, V2, P23; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Helmeke C, 2009, NEUROSCIENCE, V163, P790, DOI 10.1016/j.neuroscience.2009.07.008; Inoue I, 2001, METABOLISM, V50, P3, DOI 10.1053/meta.2001.19415; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jenkins TG, 2011, ASIAN J ANDROL, V13, P76, DOI 10.1038/aja.2010.61; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Kirkwood M, 2008, CLIN NEUROPSYCHOL, V22; Levitan RD, 2004, BIOL PSYCHIAT, V56, P665, DOI 10.1016/j.biopsych.2004.08.013; Liu YS, 2011, AGEING RES REV, V10, P115, DOI 10.1016/j.arr.2010.09.004; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Lundstrom S, 2010, J CHILD PSYCHOL PSYC, V51, P850, DOI 10.1111/j.1469-7610.2010.02223.x; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Manaenko A, 2010, NEUROCHEM INT, V57, P844, DOI 10.1016/j.neuint.2010.09.001; Milekic M, 2014, MOL PSYCHIATR; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Mychasiuk R, 2013, NEUROSCIENCE, V241, P100, DOI 10.1016/j.neuroscience.2013.03.025; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Onyango IG, 2010, BBA-MOL BASIS DIS, V1802, P228, DOI 10.1016/j.bbadis.2009.07.014; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Sinclair KD, 2014, REPROD FERT DEVELOP, V26, P99, DOI 10.1071/RD13290; Smith RG, 2013, MOL PSYCHIATR, V18, P635, DOI 10.1038/mp.2012.88; Smith RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008456; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; U. S. Census Bureau, 2011, CENS REP DEL BOOM MO; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013	60	11	11	2	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 22	2016	332						61	75		10.1016/j.neuroscience.2016.06.039			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DT2SD	WOS:000381329800006	27365176				2022-02-06	
J	Bekerman, I; Sigal, T; Kimiagar, I; Vaiman, M				Bekerman, Inessa; Sigal, Tal; Kimiagar, Itzhak; Vaiman, Michael			Initial evaluation of the intracranial pressure in cases of traumatic brain injury without hemorrhage	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Optic nerve sheath diameter; CT scan; Traumatic head injury; Intracranial pressure; Brain swelling; Brain edema	NERVE SHEATH DIAMETER	Our objective was to apply the technique of measuring diameters of optic nerve sheath (ONSD) for the intracranial pressure assessment for the cases with traumatic head injury without hemorrhage. In a retrospective study, CT data of 720 adult patients were collected and analyzed. ONSDs were measured at the point where the ophthalmic artery crosses the optic nerve (anatomical landmark) together with the eyeball transverse diameter (ETD). The ONSD/ETD index was calculated. The correlation analysis was performed with gender, age, the Glasgow Coma Scale score, and the Glasgow Outcome Score. ONSD was enlarged in 82% cases (n = 591). Enlarged right/left ONSDs were 6.7 +/- 1.0/6.7 +/- 0.9 mm (cut-off value 5.5 mm). ONSD/ETD ratio was 0.28 +/- 0.05 against 0.19 +/- 0.02 in healthy adults (p = 0.02). We did not find correlation between ONSD/ETD ratio with initial Glasgow Coma Scale score but there was an inverse correlation between ONSD/ETD ratio and the Glasgow Outcome Score (r = -0.64). We conclude that in majority of cases with traumatic head injury without hemorrhage the ONSD is significantly enlarged indicating elevated intracranial pressure even if CT scans are negative. (C) 2016 Elsevier B.V. All rights reserved.	[Bekerman, Inessa; Sigal, Tal] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Radiol, IL-69978 Tel Aviv, Israel; [Kimiagar, Itzhak] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Vaiman, Michael] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Otolaryngol Head & Neck Surg, IL-69978 Tel Aviv, Israel		Vaiman, M (corresponding author), 33 Shapiro St, IL-59561 Bat Yam, Israel.	vaimed@yahoo.com					Andresen M, 2014, J NEUROSURG, V121, P797, DOI 10.3171/2014.2.JNS132209; Bekerman I., 2016, J CLIN NEUROSCI; Bekerman I, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/503645; Cartwright MS, 2015, MED HYPOTHESES, V85, P262, DOI 10.1016/j.mehy.2015.05.012; Chen H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0361-x; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Dietrich W, 2013, MED KLIN-INTENSIVMED, V108, P157, DOI 10.1007/s00063-013-0232-4; Giger-Tobler C, 2015, KLIN MONATSBL AUGENH, V232, P467, DOI 10.1055/s-0035-1545711; Graham D.I., 1996, NEUROTRAUMA, P43; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Vaiman M., 2016, J CLIN NEUROSCI; Vaiman M., 2016, J NEUROTRAUMA; Vaiman M, 2015, INT J OPHTHALMOL-CHI, V8, P1240, DOI 10.3980/j.issn.2222-3959.2015.06.30; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32	19	11	11	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2016	368						285	289		10.1016/j.jns.2016.07.023			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7SU	WOS:000382415700059	27538650				2022-02-06	
J	Castano-Leon, AM; Lora, D; Munarriz, PM; Cepeda, S; Paredes, I; de la Cruz, J; Lopez, PAG; Lagares, A				Castano-Leon, Ana M.; Lora, David; Munarriz, Pablo M.; Cepeda, Santiago; Paredes, Igor; de la Cruz, Javier; Gomez Lopez, Pedro A.; Lagares, Alfonso			Predicting Outcomes after Severe and Moderate Traumatic Brain Injury: An External Validation of Impact and Crash Prognostic Models in a Large Spanish Cohort	JOURNAL OF NEUROTRAUMA			English	Article						external validation; outcome prediction; prognostic model; traumatic brain injury	HEAD-INJURY; MORTALITY; SCORE	Prognostic models that were developed by the International Mission on Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) study group and the Corticosteroid Randomization After Signification Head injury (CRASH) collaborators are the most commonly used prognostic models for outcome after traumatic brain injury (TBI). Although they have been considered to be useful tools in clinical practice, a continuous process of external validation in recent cohorts of different populations is necessary. The objective of this study was to determine the external validity and compare the IMPACT and CRASH-refitted models for prediction of outcomes after moderate or severe TBI in a nonselected 1301-patient Spanish cohort. We studied discrimination, calibration, and overall fit as external validation measures. Excellent discrimination was indicated (area under the curve [AUC] 0.78-0.87) by the higher values in the validation than in the development sample for both models and outcomes. Calibration revealed that IMPACT models, in general, predict lower probabilities of both outcomes (mortality and disability). In contrast, CRASH-refitted models provided higher predicted probabilities than those observed. We can conclude that both models demonstrate an adequate performance in our representative traumatic brain Mediterranean population. Therefore, these models can be sensibly applied in our clinical practice so long as their limitations are observed during individual outcome prediction.	[Castano-Leon, Ana M.; Munarriz, Pablo M.; Cepeda, Santiago; Paredes, Igor; Gomez Lopez, Pedro A.; Lagares, Alfonso] Univ Complutense, Octubre Univ Hosp 12, I CIBERESP 12, Dept Neurosurg, Madrid, Spain; [Lora, David; de la Cruz, Javier] Univ Complutense, Octubre Univ Hosp 12, I CIBERESP 12, Clin Res Unit, Madrid, Spain		Castano-Leon, AM (corresponding author), Univ Complutense, Octubre Univ Hosp 12, Dept Neurosurg, Avda Cordoba SN, Madrid 28041, Spain.	ana.maria.castano.leon@gmail.com	Castano-Leon, Ana M/ABF-6322-2020; Munarriz, Pablo M/S-3398-2018; Paredes, Igor/AAW-6313-2021; Lagares, Alfonso/B-2969-2011; Cepeda, Santiago/AAE-3200-2021; Gomez, Pedro/N-5051-2019; Sansinenea, Igor Paredes/S-6281-2019	Castano-Leon, Ana M/0000-0002-7918-5049; Munarriz, Pablo M/0000-0002-9888-7046; Paredes, Igor/0000-0002-3846-4164; Lagares, Alfonso/0000-0003-3996-0554; Cepeda, Santiago/0000-0003-1667-8548; Gomez, Pedro/0000-0002-4185-5238; 			Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Edwards P, 2005, LANCET, V365, P1957; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Harrison D, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17030; JENNETT B, 1975, LANCET, V1, P480; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223	18	11	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1598	1606		10.1089/neu.2015.4182			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300005	26982260				2022-02-06	
J	de Andrade, D; Homel, R; Townsley, M				de Andrade, Dominique; Homel, Ross; Townsley, Michael			Trouble in paradise: The crime and health outcomes of the Surfers Paradise licensed venue lockout	DRUG AND ALCOHOL REVIEW			English	Article						alcohol; assaultive behaviour; lockout; intoxication; night-time economy	PUB CLOSING TIMES; NEWCASTLE; IMPACT; POLICY	Introduction and AimsThe lockout intervention has become embedded in Australian alcohol policy with little scientific evidence of its effectiveness in reducing violence and disorder. This paper reports an evaluation of the Queensland lockout pilot in Surfers Paradise. Patrons could not enter or re-enter licensed venues after 3am, while patrons inside at this time could stay until close. Design and MethodsUsing police and ambulance data, time series analyses examined the impact of tourism seasons and the lockout on rates of crime, violence, injury and intoxication. Additional analyses were also conducted to show spatial and temporal changes in crime over time. ResultsBoth police and ambulance data showed that the lockout introduction had no statistically significant impact on rates of crime, violence, head and neck injuries, and intoxication over the 2years following lockout. Hot spot maps indicated limited spatial shift of crime within Surfers Paradise following the lockout introduction, with evidence of a temporary intensification of crime in already established hot spots. We found a moderate statistically significant change in the 24h distribution of crime after the lockout implementation, suggesting temporal displacement of crime. DiscussionResults support the small existing body of evidence on lockouts that indicates they are largely ineffective in reducing crime and injuries in entertainment districts. ConclusionAs multi-pronged strategies that include a lockout gain in popularity, further investigation should focus on identifying the key drivers of successful interventions such as the Newcastle strategy, to better refine these interventions for replication and evaluation elsewhere. [De Andrade D, Homel R, Townsley M. Trouble in paradise: The crime and health outcomes of the Surfers Paradise licensed venue lockout. Drug Alcohol Rev 2016;35:564-572]	[de Andrade, Dominique; Homel, Ross; Townsley, Michael] Griffith Univ, Griffith Criminol Inst, Brisbane, Qld, Australia		de Andrade, D (corresponding author), Griffith Univ, Griffith Criminol Inst, Mt Gravatt Campus,176 Messines Ridge Rd, Mt Gravatt, Qld 4122, Australia.	d.deandrade@griffith.edu.au	de Andrade, Dominique/O-5652-2019	de Andrade, Dominique/0000-0003-2674-5740	Queensland Government; Australian Research CouncilAustralian Research Council [LP0561851]	This research was undertaken as part of a PhD project at the School of Criminology and Criminal Justice, Griffith University. This project stems from evidence-based recommendations made in the Queensland Government funded 'Keeping Surfers Safe' project. Funding for this project was provided by the Australian Research Council grant LP0561851 and the Queensland Government 'Growing the Smart State' PhD Scholarship. The authors gratefully acknowledge the Queensland Police Service and Queensland Ambulance Service for providing data. The authors also acknowledge statisticians Associate Professor Samantha Low-Choy and Dr Clair Alston in the Griffith Behavioural and Social Research College who provided advice on refining regression models.	Briscoe S, 2001, ALCOHOL STUDIES B, P1; Chainey S, 2005, MAPPING CRIME UNDERS, P15; Chainey SP, 2002, INNOVATIONS GIS, V9; Homel R, 2007, POLICING PREVENTION, V7, P35; Homel R, 1994, CRIME PREVENTION STU, V3, P1; Howard SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-848; Jones C., 2009, CRIME JUSTICE B, V23; KPMG, 2008, EV TEMP LAT NIGHT EN; Kypri K, 2015, DRUG ALCOHOL REV; Kypri K, 2015, ADDICTION, V110, P965, DOI 10.1111/add.12935; Kypri K, 2014, DRUG ALCOHOL REV, V33, P323, DOI 10.1111/dar.12123; Kypri K, 2011, ADDICTION, V106, P303, DOI 10.1111/j.1360-0443.2010.03125.x; Legislative Assembly of Queensland, 2010, INQ ALC REL VIOL REP; Mazerolle L, 2012, LAW POLICY, V34, P55, DOI 10.1111/j.1467-9930.2011.00353.x; Menendez P, 2015, CRIME JUSTICE B, V183; Miller P, 2014, CRIME PREV COMMUNITY, V16, P38, DOI 10.1057/cpcs.2013.12; Miller P, 2012, DRUG ALCOHOL REV, V31, P370, DOI 10.1111/j.1465-3362.2011.00375.x; Miller PG, 2012, DEALING ALCOHOL NIGH; Molloy M, 2004, OPERATION LINK SAFE; Palk GRM, 2010, POLICE PRACT RES, V11, P5, DOI 10.1080/15614260802586392; Shepherd Jonathan, 2007, Crim Behav Ment Health, V17, P250; Steenson T, 2013, KEY FEATURES LIQUOR; Surfers Paradise Alliance, 2014, EC IMP ASS NIGHT TIM; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135; Williamson D., 1999, ESRI ARCUSER MAG, P1	25	11	11	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-5236	1465-3362		DRUG ALCOHOL REV	Drug Alcohol Rev.	SEP	2016	35	5					564	572		10.1111/dar.12384			9	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	DX6XS	WOS:000384530000008	26913775	Bronze			2022-02-06	
J	Fuentes, MM; Apkon, S; Jimenez, N; Rivara, FP				Fuentes, Molly M.; Apkon, Susan; Jimenez, Nathalia; Rivara, Frederick P.			Association Between Facility Type During Pediatric Inpatient Rehabilitation and Functional Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Physiatrists	FEB 19, 2016	Sacramento, CA	Assoc Acad Physiatrists		Child; Hospitals; Rehabilitation; Treatment outcome	TRAUMATIC BRAIN-INJURY; OF-CARE INDICATORS; CHILDREN; INDEPENDENCE; ADOLESCENTS; MORTALITY; CENTERS; ADULT	Objective: To compare functional outcomes between children receiving inpatient rehabilitation at children's hospitals and those at other facilities. Design: Retrospective cohort study. Setting: Inpatient rehabilitation facilities. Participants: Children (N=28,793) aged 6 months to 18 years who received initial inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Total, cognitive, and motor developmental functional quotients (DFQs; which is the WeeFIM score divided by age adjusted norms and multiplied by 100) at discharge from inpatient rehabilitation and WeeFIM efficiency (the change in WeeFIM score from admission to discharge divided by the length of the rehabilitation stay), adjusting for age, sex, race, insurance, region, admission function, impairment type, discharge year, and length of stay. Results: A total of 12,732 children received rehabilitation at 25 children's hospitals and 16,061 at 36 other facilities (general hospitals or freestanding rehabilitation hospitals). Adjusting for clustering by facility, patients at children's hospitals had a lower cognitive DFQ at admission (difference between children's hospitals and other facility types, -3.8; 95% confidence interval [CI], -7.7 to -0.1), a shorter length of stay (median, 16d vs 22d; P<.001), and a higher WeeFIM efficiency (difference, 0.63; 95% CI, 0.25-1.00) than did children at other facility types. Rehabilitation in a children's hospital was independently associated with a higher discharge cognitive DFQ (regression coefficient, 2.3; 95% CI, 0.3-4.2) and more efficient rehabilitation admissions (regression coefficient, 0.3; 95% CI, 0.1-0.6). Conclusions: Children who receive inpatient rehabilitation at children's hospitals have more efficient inpatient rehabilitation admissions, a shorter median length of stay, and a slight improvement in cognitive function than do children at other facility types. (C) 2016 by the American Congress of Rehabilitation Medicine	[Fuentes, Molly M.; Apkon, Susan] Univ Washington, Dept Rehabil Med, 325 9th Ave,Box 359960, Seattle, WA 98104 USA; [Fuentes, Molly M.; Apkon, Susan; Jimenez, Nathalia; Rivara, Frederick P.] Seattle Childrens Hosp, Seattle, WA USA; [Fuentes, Molly M.; Jimenez, Nathalia; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Jimenez, Nathalia] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Fuentes, MM (corresponding author), Univ Washington, Dept Rehabil Med, 325 9th Ave,Box 359960, Seattle, WA 98104 USA.	mollyfue@uw.edu		Jimenez, Nathalia/0000-0002-6785-8330; Fuentes, Molly/0000-0001-8971-228X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822, K23HD078453] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822, K23 HD078453] Funding Source: Medline		Burke RE, 2015, JAMA INTERN MED, V175, P295, DOI 10.1001/jamainternmed.2014.6383; Chandra A, 2013, HEALTH AFFAIR, V32, P864, DOI 10.1377/hlthaff.2012.1262; Chen CC, 2005, AM J PHYS MED REHAB, V84, P671, DOI 10.1097/01.phm.0000176439.32318.36; Densmore JC, 2006, J PEDIATR SURG, V41, P92, DOI 10.1016/j.jpedsurg.2005.10.013; Donoghue AJ, 2006, PEDIATRICS, V118, P995, DOI 10.1542/peds.2006-0453; Jimenez N, 2015, ARCH PHYS MED REHAB, V96, P1255, DOI 10.1016/j.apmr.2015.02.019; Keehan SP, 2015, HEALTH AFFAIR, V34, P1407, DOI 10.1377/hlthaff.2015.0600; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Matsushima K, 2013, AM SURGEON, V79, P267; Msall ME, 1999, AM J MED GENET, V89, P62, DOI 10.1002/(SICI)1096-8628(19990625)89:2<62::AID-AJMG3>3.0.CO;2-T; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Oyetunji TA, 2011, AM J SURG, V201, P445, DOI 10.1016/j.amjsurg.2010.10.006; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Uniform Data System for Medical Rehabilitation, 2006, WEEFIM 2 CLIN GUID V; Wang NE, 2013, J TRAUMA ACUTE CARE, V75, P704, DOI 10.1097/TA.0b013e31829a0a65; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	20	11	11	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2016	97	9					1407	1412		10.1016/j.apmr.2016.02.026			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	DV1VP	WOS:000382710500002	27026580	Green Accepted			2022-02-06	
J	Matsushima, K; Inaba, K; Cho, JY; Mohammed, H; Herr, K; Leichtle, S; Zada, G; Demetriades, D				Matsushima, Kazuhide; Inaba, Kenji; Cho, Jayun; Mohammed, Hussan; Herr, Keith; Leichtle, Stefan; Zada, Gabriel; Demetriades, Demetrios			Therapeutic anticoagulation in patients with traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Therapeutic anticoagulation; Safety; Outcome	VENOUS THROMBOEMBOLISM; INTRACRANIAL HEMORRHAGE; WESTERN TRAUMA; PROPHYLAXIS; MANAGEMENT; SAFETY; CHEMOPROPHYLAXIS; MULTICENTER; THROMBOSIS; BENEFITS	Background: Therapeutic anticoagulation (TAC) is often required in trauma patients for various indications. However, it remains unknown whether TAC can be safely initiated in the postinjury period for patients with traumatic brain injury (TBI). The purpose of this study was to evaluate the safety of TAC in TBI patients. Materials and methods: We conducted a 7-y retrospective study. All TBI patients who received TAC within 60 d postinjury were included. In addition to patient and injury characteristics, detailed information regarding TAC was collected. The primary outcome was the incidence of neurologic deterioration or progression of hemorrhagic TBI on repeat head computed tomography (CT) after initiation of TAC. Univariate and multivariate analyses were used to identify factors associated with progression of hemorrhagic TBI after TAC. Results: A total of 3355 TBI patients were identified. Of those, 72 patients (2.1%) received TAC. Median age, 59; 76.4% male; median Injury Severity Score, 19; median admission Glasgow Coma Scale, 14; and median Rotterdam score on the initial head CT, 3. Although atrial fibrillation was the most common preinjury indication for TAC, venous thromboembolism was the most common postinjury indication. The median postinjury time of initiation of TAC was 9 d. Intravenous heparin infusion was the most commonly used agent for TAC (70.8%). None of our study patients developed any signs of neurologic deterioration due to TAC. Progression of hemorrhagic TBI on repeat head CT was observed in six patients. In a multiple logistic regression model, aged >= 65 y was significantly associated with progression of hemorrhagic TBI after TAC (odds ratio, 15.2; 95% confidence interval, 1.1-212.7; P = 0.04). Conclusions: This study shows preliminary data regarding TAC initiated in patients with TBI. Further prospective study is warranted to determine the risks and benefits of TAC in this specific group of patients. (C) 2016 Elsevier Inc. All rights reserved.	[Matsushima, Kazuhide; Inaba, Kenji; Cho, Jayun; Leichtle, Stefan; Demetriades, Demetrios] Univ Southern Calif, Dept Surg, Div Acute Care Surg, Los Angeles, CA USA; [Mohammed, Hussan; Herr, Keith] Univ Southern Calif, Dept Radiol, Los Angeles, CA USA; [Zada, Gabriel] Univ Southern Calif, Dept Neurosurg, Los Angeles, CA USA		Matsushima, K (corresponding author), Dept Surg, Div Acute Care Surg, 2051 Marengo St,Inpatient Tower C,Rm C5L100, Los Angeles, CA 90033 USA.	kazuhide.matsushima@med.usc.edu	INABA, KENJI/AAC-8532-2020; Leichtle, Stefan/U-7148-2019	Matsushima, Kazuhide/0000-0001-9625-5363			ACS TQIP, BEST PRACT MAN TRAUM; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; *BRAIN TRAUM FDN A, 2007, J NEUROTRAUMA S1, V24, pS32, DOI DOI 10.1089/NEU.2007.9991; Byrnes MC, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-25; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Cothren CC, 2004, ARCH SURG-CHICAGO, V139, P540, DOI 10.1001/archsurg.139.5.540; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Feliciano DV, 2011, J TRAUMA, V70, P1551, DOI 10.1097/TA.0b013e31821b5bdd; Golob JF, 2008, SURGERY, V144, P591, DOI 10.1016/j.surg.2008.06.022; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Lin M, AM SURG; Malhotra AK, 2000, ANN SURG, V231, P804, DOI 10.1097/00000658-200006000-00004; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Nickele CM, 2013, NEUROCRIT CARE, V18, P184, DOI 10.1007/s12028-012-9786-x; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Thorson CM, 2012, CRIT CARE MED, V40, P2967, DOI 10.1097/CCM.0b013e31825bcb60; Velmahos GC, 2010, ARCH SURG-CHICAGO, V145, P456, DOI 10.1001/archsurg.2010.58; Wells PS, 2014, JAMA-J AM MED ASSOC, V311, P717, DOI 10.1001/jama.2014.65; Whitlock RP, 2012, CHEST, V141, pE576S, DOI 10.1378/chest.11-2305; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	27	11	11	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2016	205	1					186	191		10.1016/j.jss.2016.06.042			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DW0VE	WOS:000383360300026	27621017				2022-02-06	
J	Oyesanya, TO; Thomas, MA; Brown, RL; Turkstra, LS				Oyesanya, Tolu O.; Thomas, Mitchell A.; Brown, Roger L.; Turkstra, Lyn S.			Nurses' Beliefs About Caring for Patients With Traumatic Brain Injury	WESTERN JOURNAL OF NURSING RESEARCH			English	Article						nursing; attitude; brain injuries; education; nursing	KNOWLEDGE; MISCONCEPTIONS; EDUCATION; PROFESSIONALS; EXPERIENCE; FRAMEWORK; SURVIVORS; TBI; PERCEPTIONS; RECOVERY	Patients with traumatic brain injury (TBI) and their families rely on health care providers, particularly nurses, to provide accurate information, yet inaccurate beliefs about TBI have been found among nurses. Although prior studies have assessed nurses' beliefs about TBI recovery and rehabilitation, none have assessed specific beliefs about the nursing role to care for these patients. The purpose of this study was to investigate nurses' beliefs and learning preferences about caring for patients with moderate-to-severe TBI. A cross-sectional survey was administered to 513 nurses at a Midwestern hospital between October and December 2014 (20.3% response rate). Latent class analysis was used. Findings showed that nurses had inaccurate beliefs about TBI relating to recovery and the nursing role, and had significant differences in learning preferences. These findings have implications for development of educational and training interventions specific to nurses to ensure that they have factual information about TBI and to clarify the nursing role.	[Oyesanya, Tolu O.; Thomas, Mitchell A.; Brown, Roger L.; Turkstra, Lyn S.] Univ Wisconsin, Madison, WI USA		Oyesanya, TO (corresponding author), Univ Wisconsin, Sch Nursing, 5130 Signe Skott Cooper Hall,701 Highland Ave, Madison, WI 53705 USA.	toyesanya@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Oyesanya, Tolu/0000-0001-8821-4510	University of Wisconsin-Madison, School of Nursing; National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Initiative for Maximizing Student Development [R25GM083252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the University of Wisconsin-Madison, School of Nursing and the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Initiative for Maximizing Student Development (principal investigator, M. Carnes) Grant R25GM083252.	American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; American Cancer Society, 2015, WHAT AR KEY STAT BRE; Baker M, 2012, NURS EDUC TODAY, V32, P71, DOI 10.1016/j.nedt.2011.01.011; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Blegen MA, 2001, J NURS ADMIN, V31, P33, DOI 10.1097/00005110-200101000-00007; Brain Injury Association of America, 2015, LIV BRAIN INJ; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Browndyke JN, 1998, ARCH CLIN NEUROPSYCH, V13, P133; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Clogg C. C., 1995, HDB STAT MODELING SO, P311, DOI [10.1007/978-1-4899-1292-3_6, DOI 10.1007/978-1-4899-1292-3_6, DOI 10.1007/978-1-4899-1292-3]; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Costello J, 1989, Nurse Educ Today, V9, P203, DOI 10.1016/0260-6917(89)90045-2; Couper MP, 2008, PUBLIC OPIN QUART, V72, P831, DOI 10.1093/poq/nfn066; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Defense and Veterans Brain Injury Center, 2014, WEB TRAUM BRAIN INJ; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Edwards Geraldine, 2006, Br J Nurs, V15, P1180; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Estabrooks CA, 2005, QUAL HEALTH RES, V15, P460, DOI 10.1177/1049732304273702; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Faul M, 2010, TRAUMATIC BRAIN INJU; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Gould D, 2007, NURS EDUC TODAY, V27, P26, DOI 10.1016/j.nedt.2006.02.006; Green REA, 2006, BRAIN COGNITION, V60, P199; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hintze J.L., 1987, NUMBER CRUNCHER STAT; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Jeffries PR, 2005, NURS EDUC PERSPECT, V26, P96; Keane M, 1991, Perspect Psychiatr Care, V27, P13, DOI 10.1111/j.1744-6163.1991.tb01557.x; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Long AF, 2002, J ADV NURS, V37, P70, DOI 10.1046/j.1365-2648.2002.02059.x; Long AF, 2002, NURS EDUC TODAY, V22, P136, DOI 10.1054/nedt.2001.0671; Lunney M, 2010, REHABIL NURS, V35, P161, DOI 10.1002/j.2048-7940.2010.tb00042.x; Mansour A., 2015, PSYCHOLOGY, V06, P323, DOI [10.4236/psych.2015.64033, DOI 10.4236/PSYCH.2015.64033]; MCDONALD RP, 1970, BRIT J MATH STAT PSY, V23, P1, DOI 10.1111/j.2044-8317.1970.tb00432.x; McHugh MD, 2010, RES NURS HEALTH, V33, P276, DOI 10.1002/nur.20388; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Michigan Department of Health and Human Services & Brain Injury Association of Michigan, 2015, MICH TRAUM BRAIN INJ; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Muthen L.K., 2010, MPLUS USERS GUIDE ST; NOVICK MR, 1967, PSYCHOMETRIKA, V32, P1, DOI 10.1007/BF02289400; Oyesanya T. O., 2016, CARING US PATI UNPUB; Oyesanya T. O., 2016, NURSES PERCEPT UNPUB; Peden-McAlpine, 2006, INT J NURSING ED SCH, V3, P17; Pryor J, 2002, J ADV NURS, V39, P249; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Ryan DL., 2009, AM NURSE TODAY, V4, P18; Saban KL, 2011, J WOMENS HEALTH, V20, P179, DOI 10.1089/jwh.2010.2334; Secomb J, 2008, J CLIN NURS, V17, P703, DOI 10.1111/j.1365-2702.2007.01954.x; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	65	11	11	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-9459	1552-8456		WESTERN J NURS RES	West. J. Nurs. Res.	SEP	2016	38	9					1114	1138		10.1177/0193945916636629			25	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DU9TL	WOS:000382560600003	26955844	Green Accepted			2022-02-06	
J	Schoneboom, BA; Perry, SM; Barnhill, WK; Giordano, NA; Nicely, KLW; Polomano, RC				Schoneboom, Bruce A.; Perry, Susan M.; Barnhill, William Keith; Giordano, Nicholas A.; Nicely, Kelly L. Wiltse; Polomano, Rosemary C.			Answering the call to address chronic pain in military service members and veterans: Progress in improving pain care and restoring health	NURSING OUTLOOK			English	Article						Chronic pain; Military; Veterans; Pain management; Advanced practice registered nurses	POSTTRAUMATIC-STRESS-DISORDER; CHRONIC NONCANCER PAIN; 5TH VITAL SIGN; LOW-BACK-PAIN; SELF-MANAGEMENT; OPIOID THERAPY; RATING-SCALE; EDUCATION; SYMPTOMS; IRAQ	Chronic noncancer pain (CNCP) in military and veteran populations mirrors the experience of chronic pain in America; however, these two populations have unique characteristics and comorbid conditions such as traumatic brain injuries, postconcussive syndrome, posttraumatic stress disorder, and behavioral health disorders that complicate the diagnosis and treatment of chronic pain. Military members and veterans may also be stigmatized about their conditions and experience problems with integration back into healthy lifestyles and society as a whole following deployments and after military service. The military and veteran health care systems have made chronic pain a priority and have made substantial strides in addressing this condition through advances in practice, education, research, and health policy. Despite this progress, significant challenges remain in responding to the wide-spread problem of chronic pain. The purpose of this article is to: (a) examine the state of CNCP in military and veteran populations; (b) discuss progress made in pain practice, education, research, and health policy; and (c) examine research, evidence-based practice guidelines, and expert consensus reports that are foundational to advancing pain care and improving health for military service members and veterans with CNCP. In addition, recommendations are proposed to address this widespread health problem through the expanded use of advanced practice registered nurses, the implementation of models of care, and use of national resources to educate health care providers, support practice, and promote effective pain care.	[Schoneboom, Bruce A.] Amer Assoc Nurse Anesthetists, Educ & Profess Dev, 222 South Prospect Ave, Park Ridge, IL 60068 USA; [Perry, Susan M.] Univ S Florida, Coll Nursing, Grad Acute Care Programs, CRNA Program, Tampa, FL USA; [Barnhill, William Keith] Univ Iowa, Sch Nursing, Iowa City, IA USA; [Giordano, Nicholas A.] Univ Penn, Sch Nursing, Nursing Innovat, Philadelphia, PA 19104 USA; [Nicely, Kelly L. Wiltse] Univ Penn, Sch Nursing, Anesthesia Program, Philadelphia, PA 19104 USA; [Polomano, Rosemary C.] Univ Penn, Sch Nursing, Perelman Sch Med, Philadelphia, PA 19104 USA		Schoneboom, BA (corresponding author), Amer Assoc Nurse Anesthetists, Educ & Profess Dev, 222 South Prospect Ave, Park Ridge, IL 60068 USA.	bschoneboom@aana.com	Schoneboom, Bruce/D-8769-2019	Schoneboom, Bruce/0000-0002-8571-8403			American Association of Nurse Anesthetists, 2014, CHRON PAIN MAN GUID; [Anonymous], 1986, Pain Suppl, V3, pS1; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P18; Arwood E, 2015, PAIN MED, V16, P291, DOI 10.1111/pme.12563; Bair MJ, 2015, JAMA INTERN MED, V175, P682, DOI 10.1001/jamainternmed.2015.97; Berry Melanie E, 2014, Glob Adv Health Med, V3, P28, DOI 10.7453/gahmj.2013.075; Boldt I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009177.pub2; Bosco MA, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/174728; Brown CA, 2013, SLEEP DISORD, V2013; Buchheit T, 2016, PAIN MED, V17, P149, DOI 10.1111/pme.12848; Buckenmaier CC, 2013, PAIN MED, V14, P110, DOI 10.1111/j.1526-4637.2012.01516.x; Buckenmaier C, 2012, PAIN MED, V13, P919, DOI 10.1111/j.1526-4637.2012.01382.x; Burgess DJ, 2013, CLIN J PAIN, V29, P118, DOI 10.1097/AJP.0b013e31826a86ae; Chapman CR, 2010, J PAIN, V11, P807, DOI 10.1016/j.jpain.2010.02.019; Cheatle MD, 2012, TRANSL BEHAV MED, V2, P47, DOI 10.1007/s13142-012-0113-z; Chiesa A, 2011, J ALTERN COMPLEM MED, V17, P83, DOI 10.1089/acm.2009.0546; Childs JD, 2014, SPINE J, V14, P571, DOI 10.1016/j.spinee.2013.03.019; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Cohen SP, 2012, SPINE J, V12, P833, DOI 10.1016/j.spinee.2011.10.010; Connolly SB, 2015, PAIN MED, V16, P943, DOI 10.1111/pme.12675; Conover C. J., 2015, EC BENEFITS LESS RES; Cook KF, 2014, PAIN MANAG, V4, P277, DOI [10.2217/PMT.14.25, 10.2217/pmt.14.25]; Crawford C, 2014, PAIN MED, V15, pS54, DOI 10.1111/pme.12410; Department of Veterans Affairs Office of Inspector General, 2014, 1400895163 DEP VET A; Dorflinger LM, 2014, PAIN MED, V15, P2046, DOI 10.1111/pme.12554; Dowell D., 2015, DRAFT CDC GUIDELINE; Edlund MJ, 2014, PAIN, V155, P2337, DOI 10.1016/j.pain.2014.08.033; Fishman SM, 2013, PAIN MED, V14, P971, DOI 10.1111/pme.12107; Fu LM, 2009, J ALTERN COMPLEM MED, V15, P133, DOI 10.1089/acm.2008.0135; Furlan A. D., 2010, COMPLEMENTARY AND AL; Gatchel RJ, 2009, MIL MED, V174, P270, DOI 10.7205/MILMED-D-03-1607; Gereau RW, 2014, J PAIN, V15, P1203, DOI 10.1016/j.jpain.2014.09.004; Gilman SC, 2014, ACAD MED, V89, P1113, DOI 10.1097/ACM.0000000000000312; Groessl EJ, 2012, J ALTERN COMPLEM MED, V18, P832, DOI 10.1089/acm.2010.0657; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Hauret KG, 2010, AM J PREV MED, V38, pS61, DOI 10.1016/j.amepre.2009.10.021; Helfand M, 2009, PAIN MED, V10, P1183, DOI 10.1111/j.1526-4637.2009.00718.x; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Institute of Medicine, 2011, RELIEVING PAIN IN AM; Jones M, 2015, J PROF NURS, V31, P402, DOI 10.1016/j.profnurs.2015.03.004; Katzman JG, 2016, MIL MED, V181, P227, DOI 10.7205/MILMED-D-15-00044; Katzman JG, 2014, J CONTIN EDUC HEALTH, V34, P68, DOI 10.1002/chp.21210; Kerns RD., 2011, FED PRACTITIONER, V28, P39; Knox J, 2011, SPINE, V36, P1492, DOI 10.1097/BRS.0b013e3181f40ddd; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lorenz KA, 2009, J AM BOARD FAM MED, V22, P291, DOI 10.3122/jabfm.2009.03.080162; Macea DD, 2010, J PAIN, V11, P917, DOI 10.1016/j.jpain.2010.06.005; Management of Chronic Multisymptom Illness Guideline Working Group, 2014, VA DOD CLIN PRACT GU; Management of Opioid Therapy for Chronic Pain Working Group, 2010, VA DOD CLIN PRACT GU; MASSIE ML, 2014, CLIN SCHOLARS REV, V7, P4; Matthias MS, 2015, PAIN MED, V16, P81, DOI 10.1111/pme.12571; Matthias MS, 2012, PAIN MED, V13, P1018, DOI 10.1111/j.1526-4637.2012.01433.x; McGeary DD, 2012, J APPL BIOBEHAV RES, V17, P215, DOI 10.1111/jabr.12001; Melnyk B.M., 2011, EVIDENCE BASED PRACT; Mezei L, 2011, J PAIN, V12, P1199, DOI 10.1016/j.jpain.2011.06.006; Morone NE, 2013, CLIN THER, V35, P1728, DOI 10.1016/j.clinthera.2013.10.001; Morrison-Beedy D, 2015, NURS OUTLOOK, V63, P512, DOI 10.1016/j.outlook.2015.05.004; Mularski RA, 2006, J GEN INTERN MED, V21, P607, DOI 10.1111/j.1525-1497.2006.00415.x; Mundell BF, 2013, HEALTH AFFAIR, V32, P1949, DOI 10.1377/hlthaff.2013.0586; Murphy J.L., 2012, FEDERAL PRACTITIO S4, p4S; Nassif TH, 2015, PAIN MED, V16, P2152, DOI 10.1111/pme.12866; Newhouse R. P., 2011, NURSING EC, V29, P230; Nworah U, 2012, NURS FORUM, V47, P91, DOI 10.1111/j.1744-6198.2012.00262.x; Office of the Secretary of Defense, 2015, IMPL COMPR POL PAIN; Outcalt SD, 2014, J REHABIL RES DEV, V51, P559, DOI 10.1682/JRRD.2013.06.0134; Pellico Linda H, 2014, Open Nurs J, V8, P25, DOI 10.2174/1874434601408010025; Plunkett A, 2012, PAIN MANAG, V2, P231, DOI [10.2217/pmt.12.18, 10.2217/PMT.12.18]; Polomano RC, 2013, PAIN MED, V14, P1088, DOI 10.1111/pme.12094; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Stojanovic M. P., 2016, PAIN MED, P1; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Tellier PP, 2013, PAIN RES MANAG, V18, P259, DOI 10.1155/2013/920961; Tighe P, 2015, PAIN MED, V16, P1806, DOI 10.1111/pme.12760; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726; Toblin RL, 2011, PAIN, V152, P1249, DOI 10.1016/j.pain.2010.12.036; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Veterans Health Administration Memorandum, 1999, PAIN 5 VITAL SIGN; Watson EC, 2014, J REHABIL RES DEV, V51, P503, DOI 10.1682/JRRD.2013.10.0221; Webster LR, 2016, POSTGRAD MED, V128, P76, DOI 10.1080/00325481.2016.1113841; Webster LR, 2010, J PAIN, V11, P602, DOI 10.1016/j.jpain.2010.02.008; Wiedemer NL, 2007, PAIN MED, V8, P573, DOI 10.1111/j.1526-4637.2006.00254.x; Zubkoff L, 2010, J GEN INTERN MED, V25, P900, DOI 10.1007/s11606-010-1301-5; [No title captured]	88	11	11	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0029-6554	1528-3968		NURS OUTLOOK	Nurs. Outlook	SEP-OCT	2016	64	5			SI		459	484		10.1016/j.outlook.2016.05.010			26	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DW6CE	WOS:000383733200010	27427406				2022-02-06	
J	Schwarzmaier, SM; de Chaumont, C; Balbi, M; Terpolilli, NA; Kleinschnitz, C; Gruber, A; Plesnila, N				Schwarzmaier, Susanne M.; de Chaumont, Ciaran; Balbi, Matilde; Terpolilli, Nicole A.; Kleinschnitz, Christoph; Gruber, Andras; Plesnila, Nikolaus			The Formation of Microthrombi in Parenchymal Microvessels after Traumatic Brain Injury Is Independent of Coagulation Factor XI	JOURNAL OF NEUROTRAUMA			English	Article						2-photon microscopy; anticoagulation; in vivo; microthrombi; traumatic brain injury	CEREBRAL-BLOOD-FLOW; VENOUS THROMBOEMBOLISM PROPHYLAXIS; THROMBUS FORMATION; INTRAVASCULAR COAGULATION; HEMODYNAMIC DEPRESSION; C1-INHIBITOR PROTECTS; PROVIDES PROTECTION; ISCHEMIA; ACTIVATION; ANTICOAGULATION	Microthrombus formation and bleeding worsen the outcome after traumatic brain injury (TBI). The aim of the current study was to characterize these processes in the brain parenchyma after experimental TBI and to determine the involvement of coagulation factor XI (FXI). C57BL/6 mice (n = 101) and FXI-deficient mice (n = 15) were subjected to controlled cortical impact (CCI). Wild-type mice received an inhibitory antibody against FXI (14E11) or control immunoglobulin G 24 h before or 30 or 120 min after CCI. Cerebral microcirculation was visualized in vivo by 2-photon microscopy 2-3 h post-trauma and histopathological outcome was assessed after 24 h. TBI induced hemorrhage and microthrombus formation in the brain parenchyma (p < 0.001). Inhibition of FXI activation or FXI deficiency did not reduce cerebral thrombogenesis, lesion volume, or hemispheric swelling. However, it also did not increase intracranial hemorrhage. Formation of microthrombosis in the brain parenchyma after TBI is independent of the intrinsic coagulation cascade since it was not reduced by inhibition of FXI. However, since targeting FXI has well-established antithrombotic effects in humans and experimental animals, inhibition of FXI could represent a reasonable strategy for the prevention of deep venous thrombosis in immobilized patients with TBI.	[Schwarzmaier, Susanne M.; de Chaumont, Ciaran; Balbi, Matilde; Plesnila, Nikolaus] RCSI, Dept Neurodegenerat, Dublin, Ireland; [Schwarzmaier, Susanne M.; Balbi, Matilde; Terpolilli, Nicole A.; Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res ISD, Feodor Lynen Str 17, D-81377 Munich, Germany; [Schwarzmaier, Susanne M.] Univ Munich, Med Ctr, Dept Anesthesiol, Munich, Germany; [Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Gruber, Andras] Oregon Hlth & Sci Univ, Sch Med, Knight Cardiovasc Inst, Dept Biomed Engn, Portland, OR 97201 USA; [Gruber, Andras] Oregon Hlth & Sci Univ, Sch Med, Knight Cardiovasc Inst, Dept Med, Portland, OR 97201 USA; [Plesnila, Nikolaus] SyNergy, Munich Cluster Syst Neurol, Munich, Germany		Plesnila, N (corresponding author), Univ Munich, Med Ctr, Inst Stroke & Dementia Res ISD, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Terpolilli, Nicole/AAG-3598-2021; Plesnila, Nikolaus/T-7522-2019; Balbi, Matilde/ABC-2246-2021	Gruber, Andras/0000-0001-6212-2247; Kleinschnitz, Christoph/0000-0002-1650-8875; Balbi, Matilde/0000-0003-4590-5447			Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00269; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Carlile M, 2010, J TRAUMA, V68, P916, DOI 10.1097/TA.0b013e3181b16d2d; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GRAHAM DI, 1971, LANCET, V1, P265; Guillen J, 2012, J AM ASSOC LAB ANIM, V51, P311; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Lafuente JV, 1999, J NEUROTRAUM, V16, P425, DOI 10.1089/neu.1999.16.425; Leung PY, 2012, TRANSL STROKE RES, V3, P381, DOI 10.1007/s12975-012-0186-5; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; Maeda T, 1997, ACT NEUR S, V70, P102; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Petruska DA, 2011, J AM COLL SURGEONS, V213, P809, DOI 10.1016/j.jamcollsurg.2011.08.015; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Quick A J, 1950, Can Med Assoc J, V63, P89; Quick AJ, 1939, P SOC EXP BIOL MED, V42, P788; QUICK AJ, 1949, BLOOD, V4, P1281, DOI 10.1182/blood.V4.12.1281.1281; Raychaudhuri R, 2014, EXPERT REV NEUROTHER, V14, P237, DOI 10.1586/14737175.2014.888652; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; RODMAN NF, 1958, AM J CLIN PATHOL, V29, P525; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; SMITH D R, 1969, Journal of Neurosurgery, V30, P664, DOI 10.3171/jns.1969.30.6.0664; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Tucker EI, 2008, J INFECT DIS, V198, P271, DOI 10.1086/589514; Tucker EI, 2012, BLOOD, V119, P4762, DOI 10.1182/blood-2011-10-386185; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	67	11	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1634	1644		10.1089/neu.2015.4173			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300009	26886854	Green Published			2022-02-06	
J	Rizoli, S; Petersen, A; Bulger, E; Coimbra, R; Kerby, JD; Minei, J; Morrison, L; Nathens, A; Schreiber, M; Manoel, ALD				Rizoli, Sandro; Petersen, Ashley; Bulger, Eileen; Coimbra, Raul; Kerby, Jeffrey D.; Minei, Joseph; Morrison, Laurie; Nathens, Avery; Schreiber, Martin; Manoel, Airton Leonardo de Oliveira		ROC Investigators	Early prediction of outcome after severe traumatic brain injury: a simple and practical model	BMC EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Recovery; Outcome measures; Prognostic models	PROGNOSTIC MODELS; IMPACT; VALIDATION; COHORT; SCALE; CRASH; COMA	Background: Traumatic brain injury (TBI) is a heterogeneous syndrome with a broad range of outcome. We developed a simple model for long-term outcome prognostication after severe TBI. Methods: Secondary data analysis of a large multicenter randomized trial. Patients were grouped according to 6-month extended Glasgow outcome scale (eGOS): poor-outcome (eGOS <= 4; severe disability or death) and acceptable outcome (eGOS > 4; no or moderate disability). A prediction decision tree was built using binary recursive partitioning to predict poor or acceptable 6-month outcome. Comparison to two previously published and validated models was made. Results: The decision tree included the predictors of head Abbreviated Injury Scale (AIS) severity, the Marshall computed tomography score, and pupillary reactivity. All patients with a head AIS severity of 5 were predicted to have a poor outcome. In patients with head AIS severity < 5, the model predicted an acceptable outcome for (1) those with Marshall score of 1, and (2) those with Marshall score above 1 but with reactive pupils at admission. The decision tree had a sensitivity of 72.3 % (95 % CI: 66.4-77.6 %) and specificity of 62.5 % (95 % CI: 54.9-69.6 %). The proportion correctly classified for the comparison models was similar to our model. Our model was more apt at correctly classifying those with poor outcome but more likely to misclassify those with acceptable outcome than the comparison models. Conclusion: Predicting long-term outcome early after TBI remains challenging and inexact. This model could be useful for research and quality improvement studies to provide an early assessment of injury severity, but is not sufficiently accurate to guide decision-making in the clinical setting.	[Rizoli, Sandro] St Michaels Hosp, Dept Trauma, Toronto, ON, Canada; [Petersen, Ashley] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bulger, Eileen] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Coimbra, Raul] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Kerby, Jeffrey D.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Minei, Joseph] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX USA; [Morrison, Laurie] Univ Toronto, Div Emergency Med, Toronto, ON, Canada; [Nathens, Avery] Sunnybrook Hlth Sci Ctr, Div Gen Surg, Toronto, ON M4N 3M5, Canada; [Schreiber, Martin] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Manoel, Airton Leonardo de Oliveira] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Neurosci Res Program, 30 Bond St, Toronto, ON M5B 1W8, Canada		Manoel, ALD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Neurosci Res Program, 30 Bond St, Toronto, ON M5B 1W8, Canada.	airtonleo.manoel@gmail.com	de Oliveira Manoel, Airton Leonardo/C-4724-2018; morrison, laurie J/A-6325-2012; Coimbra, Raul/AAP-3019-2020	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013; morrison, laurie J/0000-0001-8369-9774; Coimbra, Raul/0000-0002-3759-6851; Petersen, Ashley/0000-0001-7711-9657	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health, Defence Research and Development CanadaCanadian Institutes of Health Research (CIHR); Heart, Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; American Heart AssociationAmerican Heart Association; University of Washington Data Coordinating Center from the National Heart, Lung and Blood Institute [5U01 HL077863]; University of Iowa from the National Heart, Lung and Blood Institute [HL077865]; Medical College of Wisconsin from the National Heart, Lung and Blood Institute [HL077866]; University of Washington from the National Heart, Lung and Blood Institute [HL077867]; University of Pittsburgh from the National Heart, Lung and Blood Institute [HL077871]; St. Michael's Hospital from the National Heart, Lung and Blood Institute [HL077872]; Oregon Health and Science University from the National Heart, Lung and Blood Institute [HL077873]; University of Alabama at Birmingham from the National Heart, Lung and Blood Institute [HL077881]; Ottawa Hospital Research Institute from the National Heart, Lung and Blood Institute [HL077885]; University of Texas SW Medical Ctr/Dallas from the National Heart, Lung and Blood Institute [HL077887]; University of California San Diego from the National Heart, Lung and Blood Institute [HL077908]; U.S. Army Medical Research & Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077867, U01HL077866, U01HL077873, U01HL077863, U01HL077872, U01HL077887, U01HL077908, U01HL077871, U01HL077885, U01HL077881, U01HL077865] Funding Source: NIH RePORTER	The Resuscitation Outcomes Consortium is supported by a series of cooperative agreements to 10 regional clinical centers and one Data Coordinating Center (5U01 HL077863-University of Washington Data Coordinating Center, HL077865-University of Iowa, HL077866-Medical College of Wisconsin, HL077867-University of Washington, HL077871-University of Pittsburgh, HL077872-St. Michael's Hospital, HL077873-Oregon Health and Science University, HL077881-University of Alabama at Birmingham, HL077885-Ottawa Hospital Research Institute, HL077887-University of Texas SW Medical Ctr/Dallas, HL077908-University of California San Diego) from the National Heart, Lung and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, U.S. Army Medical Research & Material Command, The Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the Heart, Stroke Foundation of Canada and the American Heart Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung and Blood Institute or the National Institutes of Health.	Breiman L, 1984, CLASSIFICATION REGRE, pI41; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Thompson K, 2001, N C Med J, V62, P376; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	18	11	11	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	AUG 24	2016	16								32	10.1186/s12873-016-0098-x			9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	EM4IA	WOS:000395275500001	27553436	Green Published, gold			2022-02-06	
J	Goodus, MT; Kerr, NA; Talwar, R; Buziashvili, D; Fragale, JEC; Pang, KCH; Levison, SW				Goodus, Matthew T.; Kerr, Nadine A.; Talwar, Ruchika; Buziashvili, David; Fragale, Jennifer E. C.; Pang, Kevin C. H.; Levison, Steven W.			Leukemia Inhibitory Factor Haplodeficiency Desynchronizes Glial Reactivity and Exacerbates Damage and Functional Deficits after a Concussive Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						astrogliosis; cytokines; microglia; motor function; trauma	CILIARY NEUROTROPHIC FACTOR; CNTF-RECEPTOR-ALPHA; SPINAL-CORD; DIFFERENTIAL REGULATION; INFLAMMATORY MEDIATORS; AXON GROWTH; IGF-I; EXPRESSION; ASTROCYTES; OLIGODENDROCYTE	Reactions of both astrocytes and microglia to central nervous system injury can be beneficial or detrimental to recovery. To gain insights into the functional importance of gliosis, we developed a new model of adolescent closed-head injury (CHI) and interrogated the behavioral, physiological, and cellular outcomes after a concussive CHI in leukemia inhibitory factor (LIF) haplodeficient mice. These mice were chosen because LIF is important for astrocyte and microglial activation. Behaviorally, the LIF haplodeficient animals were equally impaired 4 h after the injury, but in the subsequent 2 weeks, the LIF haplodeficient mice acquired more severe motor and sensory deficits, compared with wild type mice. The prolonged accumulation of neurological impairment was accompanied by desynchronization of the gliotic response, increased cell death, axonal degeneration, diminished callosal compound action potential, and hypomyelination. Our results clearly show that LIF is an essential injury-induced cytokine that is required to prevent the propagation of secondary neurodegeneration.	[Goodus, Matthew T.; Kerr, Nadine A.; Talwar, Ruchika; Buziashvili, David; Fragale, Jennifer E. C.; Pang, Kevin C. H.; Levison, Steven W.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Fragale, Jennifer E. C.; Pang, Kevin C. H.] New Jersey Hlth Care Syst, Vet Affairs Med Ctr, E Orange, NJ USA		Levison, SW (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, Lab Regenerat Neurobiol, 205 South Orange Ave, Newark, NJ 07103 USA.	steve.levison@rutgers.edu	Goodus, Matthew T/O-4986-2016; Levison, Steven W./Q-6903-2019	Goodus, Matthew T/0000-0001-5022-8562; Levison, Steven W./0000-0002-1264-7309; Talwar, Ruchika/0000-0003-1971-8568			Barres BA, 1996, MOL CELL NEUROSCI, V8, P146, DOI 10.1006/mcne.1996.0053; Blesch A, 1999, J NEUROSCI, V19, P3556; Buono KD, 2012, DEV NEUROSCI-BASEL, V34, P449, DOI 10.1159/000345155; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; de Pablo F, 2000, NEUROREPORT, V11, P1365, DOI 10.1097/00001756-200004270-00043; Deverman BE, 2012, J NEUROSCI, V32, P2100, DOI 10.1523/JNEUROSCI.3803-11.2012; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gresle MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047379; Habecker BA, 2009, DEV NEUROBIOL, V69, P392, DOI 10.1002/dneu.20706; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Holmberg KH, 2006, BRAIN RES, V1075, P26, DOI 10.1016/j.brainres.2005.12.103; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; Ishibashi T, 2009, J NEUROSCI RES, V87, P3343, DOI 10.1002/jnr.22173; Kazanis I, 2004, EXP NEUROL, V186, P221, DOI 10.1016/j.expneurol.2003.12.004; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Kerr BJ, 2004, EXP NEUROL, V188, P391, DOI 10.1016/j.expneurol.2004.04.012; Labourdette G., 1995, P441; Lee MY, 1997, J NEUROSCI, V17, P1137; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Lepore AC, 2011, J NEUROSCI RES, V89, P1001, DOI 10.1002/jnr.22624; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Lin TN, 1998, MOL BRAIN RES, V55, P71, DOI 10.1016/S0169-328X(97)00367-7; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Murphy S., 1993, ASTROCYTES PHARM FUC; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Oyesiku NM, 1997, J NEUROBIOL, V32, P251, DOI 10.1002/(SICI)1097-4695(199703)32:3<251::AID-NEU1>3.0.CO;2-6; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Raivich G, 1999, ACTA NEUROCHIR SUPPL, V73, P21; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RUDGE JS, 1995, J NEUROSCI, V15, P6856; SAAD B, 1991, J CELL BIOL, V115, P473, DOI 10.1083/jcb.115.2.473; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SCHWARTZ JP, 1993, ANN NY ACAD SCI, V679, P226, DOI 10.1111/j.1749-6632.1993.tb18302.x; Sen E, 2011, ASN NEURO, V3, DOI 10.1042/AN20100029; Silberstein FC, 1996, J NEUROCHEM, V66, P1409; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sugiura S, 2000, EUR J NEUROSCI, V12, P457, DOI 10.1046/j.1460-9568.2000.00922.x; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Suzuki S, 2005, J CEREBR BLOOD F MET, V25, P685, DOI 10.1038/sj.jcbfm.9600061; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Wu WF, 2010, J CLIN NEUROSCI, V17, P92, DOI 10.1016/j.jocn.2009.03.039	61	11	11	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1522	1534		10.1089/neu.2015.4234			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900006	26541248				2022-02-06	
J	Devine, JM; Wong, B; Gervino, E; Pascual-Leone, A; Alexander, MP				Devine, Jennifer M.; Wong, Bonnie; Gervino, Ernest; Pascual-Leone, Alvaro; Alexander, Michael P.			Independent, Community-Based Aerobic Exercise Training for People With Moderate-to-Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Exercise; Rehabilitation	COGNITIVE PERFORMANCE; CONTROLLED-TRIAL; OLDER-ADULTS; QUALITY; PROGRAM; DISEASE; STROKE; RISK; LIFE	Objective: To determine whether people with moderate-to-severe traumatic brain injury (TBI) can adhere to a minimally supervised, community based, vigorous aerobic exercise program. Design: Prospective trial. Setting: Young Men's Christian Association (YMCA) facilities. Participants: Community-dwelling volunteers (N=10; 8 men, 2 women; age range, 22-49y) 6 to 15 months after moderate-to-severe TBI. Intervention: Participants received memberships to local YMCAs and brief orientations to exercise. They were then asked to independently complete >= 12 weeks of >= 3 training sessions per week, performed at 65% to 85% of maximum heart rate for >= 30 minutes per session. Participants could selfselect exercise modality, provided they met intensity and duration targets. Programmable heart rate monitors captured session intensity and duration. Main Outcome Measures: Independence with equipment and facility use and compliance with training goals (session frequency, duration, intensity, total weeks of training). Results: All participants achieved independence with equipment and facility use. All met at least 2 of 4 training goals; half met all 4 goals. Participants averaged (+/- SD) 3.3 +/- 0.7 sessions per week for 13 weeks (range, 6-24). Average SD session duration was 62 23 minutes, of which 51 22 minutes occurred at or above individuals' heart rate training targets. Conclusions: People in recovery from moderate-to-severe TBI can, with minimal guidance, perform vigorous, community-based exercise. This suggests that decentralized exercise may be logistically and economically sustainable after TBI, expanding its potential therapeutic utility and rendering longer-duration exercise studies more feasible. (C) 2016 by the American Congress of Rehabilitation Medicine	[Devine, Jennifer M.; Wong, Bonnie; Pascual-Leone, Alvaro; Alexander, Michael P.] Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Wong, Bonnie; Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Div Brain Stimulat & Cognit Training, Brain Fit Club, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Gervino, Ernest] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Cardiol, Boston, MA USA		Devine, JM (corresponding author), Integrated Rehab Consultants, 401 North Michigan Ave,Suite 1200, Chicago, IL 60611 USA.	drdevine@irehabconsultants.com	Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382	National Institutes of Health-Harvard Clinical and Translational Science Center/Harvard Catalyst [UL1 RR025758]; Center for Integrative Medicine and Technology; Sidney-Baer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER	Supported by the National Institutes of Health-Harvard Clinical and Translational Science Center/Harvard Catalyst (grant no. UL1 RR025758), the Center for Integrative Medicine and Technology, and the Sidney-Baer Foundation, and by Joseph Hamilburg through his generous donation to the Berenson-Allen Center for Noninvasive Brain Stimulation at Beth Israel Deaconess Medical Center in support of this work.	Baker LD, 2010, J ALZHEIMERS DIS, V22, P569, DOI 10.3233/JAD-2010-100768; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Fiocco AJ, 2013, CAN J DIABETES, V37, P214, DOI 10.1016/j.jcjd.2013.03.369; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Marzolini S, 2013, NEUROREHAB NEURAL RE, V27, P392, DOI 10.1177/1545968312465192; Pang MYC, 2013, CEREBROVASC DIS, V35, P7, DOI 10.1159/000346075	10	11	11	1	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1392	1397		10.1016/j.apmr.2016.04.015			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200022	27216223				2022-02-06	
J	Grieve, R; Sadique, Z; Gomes, M; Smith, M; Lecky, FE; Hutchinson, PJA; Menon, DK; Rowan, KM; Harrison, DA				Grieve, R.; Sadique, Z.; Gomes, M.; Smith, M.; Lecky, F. E.; Hutchinson, P. J. A.; Menon, D. K.; Rowan, K. M.; Harrison, D. A.		Risk Adjustment In Neurocritical C	An evaluation of the clinical and cost-effectiveness of alternative care locations for critically ill adult patients with acute traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Cost-effectiveness analysis; neurocritical care; traumatic brain injury	SEVERE HEAD-INJURY; INTENSIVE-CARE; GUIDELINES; MANAGEMENT; VALIDATION	Background: For critically ill adult patients with acute traumatic brain injury (TBI), we assessed the clinical and cost-effectiveness of: (a) Management in dedicated neurocritical care units versus combined neuro/general critical care units within neuroscience centres. (b) Early' transfer to a neuroscience centre versus no or late' transfer for those who present at a non-neuroscience centre.Methods: The Risk Adjustment In Neurocritical care (RAIN) Study included prospective admissions following acute TBI to 67 UK adult critical care units during 2009-11. Data were collected on baseline case-mix, mortality, resource use, and at six months, Glasgow Outcome Scale Extended (GOSE), and quality of life (QOL) (EuroQol 5D-3L). We report incremental effectiveness, costs and cost per Quality-Adjusted Life Year (QALY) of the alternative care locations, adjusting for baseline differences with validated risk prediction models. We tested the robustness of results in sensitivity analyses.Findings: Dedicated neurocritical care unit patients (N=1324) had similar six-month mortality, higher QOL (mean gain 0.048, 95% CI -0.002 to 0.099) and increased average costs compared with those managed in combined neuro/general units (N=1341), with a lifetime cost per QALY gained of 14,000. Early' transfer to a neuroscience centre (N=584) was associated with lower mortality (odds ratio 0.52, 0.34-0.80), higher QOL for survivors (mean gain 0.13, 0.032-0.225), but positive incremental costs (15,001 pound, 11,123 pound to 18,880) pound compared with late or no transfer' (N=263). The lifetime cost per QALY gained for early' transfer was 11,000 pound.Conclusions: For critically ill adult patients with acute TBI, within neuroscience centres management in dedicated neurocritical care units versus combined neuro/general units led to improved QoL and higher costs, on average, but these differences were not statistically significant. This study finds that early' transfer to a neuroscience centre is associated with reduced mortality, improvement in QOL and is cost-effective.	[Grieve, R.; Sadique, Z.; Gomes, M.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England; [Smith, M.] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, London, England; [Lecky, F. E.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Hutchinson, P. J. A.; Menon, D. K.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Rowan, K. M.; Harrison, D. A.] Intens Care Natl Audit & Res Ctr, Clin Trials Unit, London, England		Grieve, R (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	Richard.Grieve@lshtm.ac.uk	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Grieve, Richard/0000-0001-8899-1301; Gomes, Manuel/0000-0002-1428-1232; Rowan, Kathryn/0000-0001-8217-5602; Sadique, Zia/0000-0001-5814-0258	ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G00188X/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G106/1173, G0601025] Funding Source: UKRI; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G00188X/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [07/37/29, NF-SI-0512-10090, NIHR-RP-R3-12-013, 12/35/57, SRF-2013-06-016] Funding Source: researchfish; Department of HealthEuropean Commission [NIHR-RP-R3-12-013, 07/37/29, SRF-2013-06-016, 12/35/57] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G106/1173, G0601025] Funding Source: Medline		ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Department of Health, 2011, NHS REF COSTS 2010 2; Dolan P, 1999, 138 CHE U YORK; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; GENTLEMAN D, 1981, LANCET, V2, P853; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Harrison DA, 2015, J NEUROTRAUM, V32, P1522, DOI 10.1089/neu.2014.3628; Ibrahim MI, 2007, ASIAN J SURG, V30, P261, DOI 10.1016/S1015-9584(08)60036-6; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Latimer N., 2011, NICE DSU TECHNICAL S; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; NHS Information Standards Board, 2007, PAED CRIT CAR MIN DA; Office of National Statistics, 2011, INT LIF TABL 2008 20; Park CA, 2001, AM SURGEON, V67, P665; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Rubin D.B., 1987, MULTIPLE IMPUTATION; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teig M, 2010, J NEUROSURG ANESTH, V22, P357, DOI 10.1097/ANA.0b013e3181f0dada	30	11	11	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	2016	30	4					388	396		10.3109/02688697.2016.1161166			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DT3NG	WOS:000381387400004	27188663	Green Submitted, Green Accepted			2022-02-06	
J	Jiang, L; Wang, WH; Dong, XQ; Yu, WH; Du, Q; Yang, DB; Wang, H; Shen, YF				Jiang, L.; Wang, W. -H.; Dong, X. -Q.; Yu, W. -H.; Du, Q.; Yang, D. -B.; Wang, H.; Shen, Y. -F.			The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage	ACTA NEUROLOGICA SCANDINAVICA			English	Article						intracranial aneurysmal; pituitary adenylate cyclase-activating polypeptide; prognosis; severity; subarachnoid hemorrhage	VASOACTIVE-INTESTINAL-PEPTIDE; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; PACAP; APOPTOSIS; INFLAMMATION; MACROPHAGES; RECEPTORS; IMMUNITY; NEURONS	ObjectiveElevated circulating pituitary adenylate cyclase-activating polypeptide (PACAP) levels have been demonstrated to be associated with clinical outcomes of severe traumatic brain injury. The current study aimed to confirm whether elevated plasma PACAP levels are predictive of clinical outcomes of aneurysmal subarachnoid hemorrhage (aSAH). Materials and methodsOne hundred and eighteen aSAH patients and 118 controls were recruited. Plasma PACAP concentrations were determined using enzyme-linked immunosorbent assay. Patients were followed up until death or completion of 6 months after aSAH. An unfavorable outcome was defined as Glasgow Outcome Scale score of 1-3. ResultsThe admission PACAP levels were significantly elevated in all patients (296.6 119.7 pg/ml) compared with controls (77.1 +/- 17.9 pg/ml, P < 0.001). Plasma PACAP levels were independently associated with clinical severity indicated by World Federation of Neurological Surgeons (WFNS) score (t = 4.745, P < 0.001) and Fisher score (t = 4.239, P < 0.001) using a multivariate linear regression. PACAP was identified as an independent predictor for 6-month mortality [odds ratio (OR), 1.014; 95% confidence interval (CI), 1.005-1.030; P < 0.001] and 6-month unfavorable outcome (OR, 1.012; 95% CI, 1.006-1.028; P < 0.001) and 6-month overall survival (hazard ratio, 1.016; 95% CI, 1.008-1.023; P < 0.001) using a binary logistic regression analysis and a Cox's proportional hazard analysis, respectively. PACAP had similar predictive values compared with WFNS score and Fisher score according to the receiver operating characteristic curve analysis. ConclusionsHigher plasma PACAP levels are associated with clinical severity and long-term prognosis of aSAH patients, and PACAP has potential to be a good prognostic biomarker of aSAH.	[Jiang, L.; Dong, X. -Q.; Yu, W. -H.; Du, Q.; Yang, D. -B.; Wang, H.; Shen, Y. -F.] Nanjing Med Univ, Dept Neurosurg, Hangzhou Peoples Hosp 1, Affiliated Hangzhou Hosp, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Wang, W. -H.] Southeast Univ, Dept Neurosurg, Affiliated Zhongda Hosp, Nanjing, Jiangsu, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Dept Neurosurg, Hangzhou Peoples Hosp 1, Affiliated Hangzhou Hosp, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Zhejiang Province Medical and Health Project [2014KYA177]	This study was supported by a grant from Zhejiang Province Medical and Health Project (No. 2014KYA177).	Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Badjatia N, 2015, NEUROLOGY, V84, P680, DOI 10.1212/WNL.0000000000001259; Budohoski KP, 2015, NEUROCRIT CARE, V22, P65, DOI 10.1007/s12028-014-0032-6; Bukovics P, 2014, PEPTIDES, V60, P18, DOI 10.1016/j.peptides.2014.07.001; Cavallaro S, 1996, MOL PHARMACOL, V50, P60; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Delgado M, 1999, J IMMUNOL, V162, P2358; Delgado M, 2003, ANN NY ACAD SCI, V992, P141, DOI 10.1111/j.1749-6632.2003.tb03145.x; Delgado M, 2002, GLIA, V39, P148, DOI 10.1002/glia.10098; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; DRAKE CG, 1988, J NEUROSURG, V68, P985; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Hanafy KA, 2010, J CLIN NEUROSCI, V17, P22, DOI 10.1016/j.jocn.2009.09.003; Khurana VG, 2004, NEUROSURGERY, V55, P69, DOI 10.1227/01.NEU.0000126877.10254.4C; Lee EH, 2014, BMB REP, V47, P369, DOI 10.5483/BMBRep.2014.47.7.086; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Li M, 2007, PEPTIDES, V28, P1891, DOI 10.1016/j.peptides.2007.05.002; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Lv YH, 2015, NEUROL SCI, V36, P1203, DOI 10.1007/s10072-015-2073-9; Ma BQ, 2015, CLIN CHIM ACTA, V439, P102, DOI 10.1016/j.cca.2014.10.010; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591, DOI 10.1002/jlb.63.5.591; Mester L, 2011, J MOL NEUROSCI, V43, P35, DOI 10.1007/s12031-010-9427-9; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; Racz B, 2010, REGUL PEPTIDES, V160, P91, DOI 10.1016/j.regpep.2009.12.003; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Shioda S, 1998, ANN NY ACAD SCI, V865, P111, DOI 10.1111/j.1749-6632.1998.tb11169.x; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Szabadfi K, 2012, NEUROTOX RES, V21, P41, DOI 10.1007/s12640-011-9254-y; Szakaly P, 2010, TRANSPL P, V42, P2283, DOI 10.1016/j.transproceed.2010.05.012; Tanaka J, 1997, REGUL PEPTIDES, V72, P1, DOI 10.1016/S0167-0115(97)01038-0; Tsuchikawa D, 2012, J MOL NEUROSCI, V48, P508, DOI 10.1007/s12031-012-9817-2; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	42	11	11	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	AUG	2016	134	2					131	139		10.1111/ane.12522			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR5GB	WOS:000379930400006	26471292				2022-02-06	
J	Ng, LC; Petruzzi, LJ; Greene, MC; Mueser, KT; Borba, CPC; Henderson, DC				Ng, Lauren C.; Petruzzi, Liana J.; Greene, M. Claire; Mueser, Kim T.; Borba, Christina P. C.; Henderson, David C.			Posttraumatic Stress Disorder Symptoms and Social and Occupational Functioning of People With Schizophrenia	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Functioning; interpersonal; occupational; PTSD; schizophrenia	SEVERE MENTAL-ILLNESS; COGNITIVE-BEHAVIORAL TREATMENT; NATIONAL COMORBIDITY SURVEY; QUALITY-OF-LIFE; CHILDHOOD TRAUMA; SCHIZOAFFECTIVE DISORDER; PSYCHIATRIC-INPATIENTS; CLINICIAN PERSPECTIVES; 1ST-EPISODE PSYCHOSIS; SPECTRUM DISORDERS	This study sought to clarify the contribution of posttraumatic stress disorder (PTSD) to interpersonal and occupational functioning in people with schizophrenia. Self-report questionnaires and semistructured interviews were used to evaluate PTSD and brain injury, positive symptoms, depression, substance abuse, occupational and social functioning, and intelligence. Multiple regressions assessed the relationship between predictors and functional impairment. Posttraumatic stress disorder symptoms were present in 76% of participants, with 12% of participants meeting diagnostic criteria for PTSD. Participants with PTSD had higher rates of depression and more severe positive symptoms. Results of multiple regressions indicated that PTSD symptoms were the only significant predictor of patient-rated interpersonal and occupational functioning. Posttraumatic stress disorder symptoms were not associated with interviewer-rated interpersonal or occupational functioning or employment. While more research is needed, screening and treatment for exposure to traumatic events and PTSD symptoms might be indicated for individuals with schizophrenia. Availability of PTSD assessment and evidence-based treatments for people with schizophrenia is a crucial and often unmet health service need.	[Ng, Lauren C.; Petruzzi, Liana J.; Greene, M. Claire; Borba, Christina P. C.; Henderson, David C.] Massachusetts Gen Hosp, Dept Psychiat, Schizophrenia Clin & Res Program, Boston, MA 02114 USA; [Ng, Lauren C.; Borba, Christina P. C.; Henderson, David C.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Petruzzi, Liana J.] Univ Texas Austin, Sch Social Work, Austin, TX 78712 USA; [Greene, M. Claire] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mueser, Kim T.] Boston Univ, Ctr Psychiat Rehabil, Dept Occupat Therapy, Boston, MA 02215 USA; [Mueser, Kim T.] Boston Univ, Dept Psychol, Ctr Psychiat Rehabil, 64 Cummington St, Boston, MA 02215 USA; [Mueser, Kim T.] Boston Univ, Dept Psychiat, Ctr Psychiat Rehabil, Boston, MA 02215 USA		Ng, LC (corresponding author), Freedom Trail Clin, 25 Staniford St,2nd Floor, Boston, MA 02114 USA.	lng4@mgh.harvard.edu		Borba, Christina/0000-0003-3559-9351	National Institute of Mental Health at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH093310]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH100428, T32MH093310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA007292] Funding Source: NIH RePORTER	This work was supported by the National Institute of Mental Health at the National Institutes of Health (grant T32 MH093310).	Aas M, 2011, SCHIZOPHR RES, V129, P12, DOI 10.1016/j.schres.2011.03.017; Achim AM, 2011, SCHIZOPHRENIA BULL, V37, P811, DOI 10.1093/schbul/sbp148; Alvarez MJ, 2015, COMMUNITY MENT HLT J, V51, P54, DOI 10.1007/s10597-014-9755-2; Cascardi M, 1996, PSYCHIATR SERV, V47, P531; Chapleau KM, 2014, BRIT J CLIN PSYCHOL, V53, P157, DOI 10.1111/bjc.12033; Chernomas WM, 2013, ISSUES MENT HEALTH N, V34, P639, DOI 10.3109/01612840.2013.799721; Chessen CE, 2011, PSYCHIAT SERV, V62, P1201, DOI 10.1176/ps.62.10.pss6210_1201; Cohen CI, 2012, AM J GERIAT PSYCHIAT, V20, P408, DOI 10.1097/JGP.0b013e318211817e; Conus P, 2010, SCHIZOPHRENIA BULL, V36, P1105, DOI 10.1093/schbul/sbp009; CRAINE LS, 1988, HOSP COMMUNITY PSYCH, V39, P300; Cusack KJ, 2006, COMMUNITY MENT HLT J, V42, P487, DOI 10.1007/s10597-006-9049-4; de Bont PAJM, 2015, BRIT J PSYCHIAT, V206, P408, DOI 10.1192/bjp.bp.114.148486; de Bont PAJM, 2013, BEHAV THER, V44, P717, DOI 10.1016/j.beth.2013.07.002; Duke LA, 2010, J CLIN EXP NEUROPSYC, V32, P737, DOI 10.1080/13803390903512660; Eisen S V, 1986, Psychiatr Hosp, V17, P165; EISEN SV, 1994, HOSP COMMUNITY PSYCH, V45, P242; Fan XD, 2008, PSYCHIAT RES, V159, P140, DOI 10.1016/j.psychres.2007.10.012; Frueh BC, 2006, PSYCHIAT SERV, V57, P1027, DOI 10.1176/appi.ps.57.7.1027; Frueh BC, 2009, BEHAV MODIF, V33, P66, DOI 10.1177/0145445508322619; Frueh BC, 2009, J ANXIETY DISORD, V23, P665, DOI 10.1016/j.janxdis.2009.02.005; Frueh BC, 2002, COMMUNITY MENT HLT J, V38, P351, DOI 10.1023/A:1015909611028; Gairns S, 2015, EARLY INTERV PSYCHIA, V9, P12, DOI 10.1111/eip.12065; Goodman LA, 2001, J TRAUMA STRESS, V14, P615, DOI 10.1023/A:1013026318450; Grubaugh AL, 2011, CLIN PSYCHOL REV, V31, P883, DOI 10.1016/j.cpr.2011.04.003; Halasz I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00136; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hassan AN, 2015, SCHIZOPHR RES, V161, P496, DOI 10.1016/j.schres.2014.10.048; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lommen MJJ, 2009, COMMUNITY MENT HLT J, V45, P485, DOI 10.1007/s10597-009-9248-x; Lu WL, 2012, PSYCHIAT SERV, V63, P785, DOI 10.1176/appi.ps.201000458; Lu WL, 2011, SCHIZOPHR RES, V127, P66, DOI 10.1016/j.schres.2011.01.006; Lysaker PH, 2009, J NERV MENT DIS, V197, P311, DOI 10.1097/NMD.0b013e3181a2070e; Lysaker PH, 2004, J TRAUMA STRESS, V17, P435, DOI 10.1023/B:JOTS.0000048957.70768.b9; Lysakera PH, 2008, COMPR PSYCHIAT, V49, P330, DOI 10.1016/j.comppsych.2007.12.003; Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785; Mollica R.F., 2004, MEASURING TRAUMA MEA; Mueser KT, 2008, J CONSULT CLIN PSYCH, V76, P259, DOI 10.1037/0022-006X.76.2.259; Mueser KT, 2015, BRIT J PSYCHIAT, V206, P501, DOI 10.1192/bjp.bp.114.147926; Mueser KT, 2010, SCHIZOPHR RES, V116, P217, DOI 10.1016/j.schres.2009.10.025; Mueser KT, 2004, CNS SPECTRUMS, V9, P913, DOI 10.1017/S1092852900009779; Mueser KT, 2004, SCHIZOPHRENIA BULL, V30, P45, DOI 10.1093/oxfordjournals.schbul.a007067; Mueser KT, 1998, J CONSULT CLIN PSYCH, V66, P493, DOI 10.1037/0022-006X.66.3.493; Ramsay CE, 2011, PSYCHIAT RES, V188, P343, DOI 10.1016/j.psychres.2011.05.019; Read John, 2003, J Am Acad Psychoanal Dyn Psychiatry, V31, P247, DOI 10.1521/jaap.31.1.247.21938; Salyers MP, 2004, COMMUNITY MENT HLT J, V40, P17, DOI 10.1023/B:COMH.0000015215.45696.5f; Sautter FJ, 1999, J TRAUMA STRESS, V12, P73, DOI 10.1023/A:1024794232175; Schenkel LS, 2005, SCHIZOPHR RES, V76, P273, DOI 10.1016/j.schres.2005.03.003; Schneeberger AR, 2014, J TRAUMA DISSOCIATIO, V15, P494, DOI 10.1080/15299732.2014.903550; Silverstein SM, 2008, CLIN PSYCHOL REV, V28, P1108, DOI 10.1016/j.cpr.2008.03.004; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; StataCorp, 2011, STAT STAT SOFTW REL; Trappler B, 2007, PSYCHIAT QUART, V78, P317, DOI 10.1007/s11126-007-9049-8; Tucker WM, 2002, PSYCHIAT QUART, V73, P135, DOI 10.1023/A:1015007828262; van den Berg DPG, 2016, SCHIZOPHRENIA BULL, V42, P693, DOI 10.1093/schbul/sbv172; van den Berg DPG, 2015, JAMA PSYCHIAT, V72, P259, DOI 10.1001/jamapsychiatry.2014.2637; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Wechsler D., 1997, TECHNICAL MANUAL WEC	63	11	11	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	AUG	2016	204	8					590	598		10.1097/NMD.0000000000000523			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DS4PF	WOS:000380762300006	27105458	Green Accepted, Green Published			2022-02-06	
J	Pajoumand, M; Kufera, JA; Bonds, BW; Devabhakthuni, S; Boswell, S; Hesselton, K; Scalea, TM; Stein, DM				Pajoumand, Mehrnaz; Kufera, Joseph A.; Bonds, Brandon W.; Devabhakthuni, Sandeep; Boswell, Sharon; Hesselton, Kathleen; Scalea, Thomas M.; Stein, Deborah M.			Dexmedetomidine as an adjunct for sedation in patients with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Dexmedetomidine; intensive care unit (ICU); sedation; traumatic brain injury	CRITICALLY-ILL PATIENTS; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTENSIVE-CARE; PROPOFOL INFUSION; TERM SEDATION; MIDAZOLAM; AGONIST; SURGERY; SAFETY	BACKGROUND: In patients with traumatic brain injury (TBI), optimizing sedation is challenging because maintaining a clinical examination is important in being able to detect neurological deterioration. Propofol (PROP) is frequently used as a sedative in TBI since it has been shown to reduce the cerebral metabolic rate, but it may lead to PROP-related infusion syndrome and hemodynamic compromise. Dexmedetomidine (DEX) is a sedative that produces minimal respiratory depression with opioid-sparing effects. The purpose of this study was to determine whether sedation with DEX would be safe in patients with severe TBI. METHODS: This prospective observational single-center study was conducted from 2011 to 2013. Patients with severe TBI were treated according to standard of care per the Brain Trauma Foundation guidelines. Sedative agents were titrated using the Richmond Agitation Sedation Scale (RASS) while maintaining intracranial pressure of less than 20 mm Hg and cerebral perfusion pressure of greater than 60 mm Hg. The primary outcome measure was the mean time in target RASS (0 = alert and calm to -2 = light sedation). RESULTS: A total of 198 patients were enrolled in the study. Patient-days (1,028 in total) were stratified into four groups: DEX only (n = 222), DEX + PROP (n = 148), PROP only (n = 599), and NEITHER (n = 59). Regression analyses indicated a significant difference in target RASS between sedative agents (p = 0.001). The DEX-only group had the highest adjusted mean daily estimate of 16.0 hours in target RASS. Hypotension was significantly higher in both the DEX only (p = 0.01) and DEX + PROP (p = 0.01) groups than in the PROP-only group. CONCLUSIONS: Dexmedetomidine was found to be associated with significantly more hypotension. Therefore, larger studies are needed to identify the role of DEX in TBI. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Pajoumand, Mehrnaz] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Devabhakthuni, Sandeep] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Kufera, Joseph A.; Bonds, Brandon W.; Boswell, Sharon; Hesselton, Kathleen; Scalea, Thomas M.; Stein, Deborah M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Stein, DM (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Surg, 22 S Greene St, Baltimore, MD 21201 USA.	dstein@umm.edu		Stein, Deborah/0000-0003-3683-3963	Hospira, Inc.	M.P. and D.M.S. received an educational grant from Hospira, Inc. The other authors declare no conflicts of interest.	Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; BLOOR BC, 1992, ANESTHESIOLOGY, V77, P1134, DOI 10.1097/00000542-199212000-00014; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corbett SM, 2008, PHARMACOTHERAPY, V28, P250, DOI 10.1592/phco.28.2.250; Devabhakthuni S, 2011, J TRAUMA, V71, P1164, DOI 10.1097/TA.0b013e3182147670; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; FALE A, 1994, ANESTH ANALG, V79, P892; FARLING PA, 1989, ANAESTHESIA, V44, P222, DOI 10.1111/j.1365-2044.1989.tb11228.x; Fong JJ, 2008, CRIT CARE MED, V36, P2281, DOI 10.1097/CCM.0b013e318180c1eb; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Herr DL, 2003, J CARDIOTHOR VASC AN, V17, P576, DOI 10.1016/S1053-0770(03)00200-3; Herregods L, 1988, Anaesthesia, V43 Suppl, P107, DOI 10.1111/j.1365-2044.1988.tb09089.x; Ho KM, 2012, ANAESTH INTENS CARE, V40, P927, DOI 10.1177/0310057X1204000603; Ice CJ, 2016, ANESTH ANALG, V122, P462, DOI 10.1213/ANE.0000000000001125; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; KALLIO A, 1989, CLIN PHARMACOL THER, V46, P33, DOI 10.1038/clpt.1989.103; Keating GM, 2015, DRUGS, V75, P1119, DOI 10.1007/s40265-015-0419-5; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Ruokonen E, 2009, INTENS CARE MED, V35, P282, DOI 10.1007/s00134-008-1296-0; Shehabi Y, 2009, ANESTHESIOLOGY, V111, P1075, DOI 10.1097/ALN.0b013e3181b6a783; Srivastava U, 2014, INDIAN J CRIT CARE M, V18, P431, DOI 10.4103/0972-5229.136071; STEWART L, 1994, ACTA NEUROCHIR, P544; Talke P, 1997, ANESTH ANALG, V85, P1136, DOI 10.1097/00000539-199711000-00033; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; ZORNOW MH, 1992, ANESTH ANALG, V75, P232	36	11	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2016	81	2					345	351		10.1097/TA.0000000000001069			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DS5CE	WOS:000380797300020	27116413				2022-02-06	
J	Guo, SZ; Lok, J; Zhao, S; Leung, W; Som, AT; Hayakawa, K; Wang, QZ; Xing, CH; Wang, XY; Ji, XM; Zhou, YM; Lo, EH				Guo, Shuzhen; Lok, Josephine; Zhao, Song; Leung, Wendy; Som, Angel T.; Hayakawa, Kazuhide; Wang, Qingzhi; Xing, Changhong; Wang, Xiaoying; Ji, Xunming; Zhou, Yiming; Lo, Eng H.			Effects of Controlled Cortical Impact on the Mouse Brain Vasculome	JOURNAL OF NEUROTRAUMA			English	Article						extracellular matrix; inflammation; microvessels; neurovascular unit; traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; LONG PENTRAXIN PTX3; GENE-EXPRESSION; XANTHINE-OXIDASE; ACTIVIN-A; EXTRACELLULAR-MATRIX; CELL PROLIFERATION; CEREBRAL-CORTEX; BREAST-CANCER; SELF-RENEWAL	Perturbations in blood vessels play a critical role in the pathophysiology of brain injury and neurodegeneration. Here, we use a systematic genome-wide transcriptome screening approach to investigate the vasculome after brain trauma in mice. Mice were subjected to controlled cortical impact and brains were extracted for analysis at 24 h post-injury. The core of the traumatic lesion was removed and then cortical microvesels were isolated from nondirectly damaged ipsilateral cortex. Compared to contralateral cortex and normal cortex from sham-operated mice, we identified a wide spectrum of responses in the vasculome after trauma. Up-regulated pathways included those involved in regulation of inflammation and extracellular matrix processes. Decreased pathways included those involved in regulation of metabolism, mitochondrial function, and transport systems. These findings suggest that microvascular perturbations can be widespread and not necessarily localized to core areas of direct injury per se and may further provide a broader gene network context for existing knowledge regarding inflammation, metabolism, and blood-brain barrier alterations after brain trauma. Further efforts are warranted to map the vasculome with higher spatial and temporal resolution from acute to delayed phase post-trauma. Investigating the widespread network responses in the vasculome may reveal potential mechanisms, therapeutic targets, and biomarkers for traumatic brain injury.	[Guo, Shuzhen; Lok, Josephine; Leung, Wendy; Som, Angel T.; Hayakawa, Kazuhide; Wang, Qingzhi; Xing, Changhong; Wang, Xiaoying; Zhou, Yiming; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Radiol, Charlestown, MA USA; [Guo, Shuzhen; Lok, Josephine; Leung, Wendy; Som, Angel T.; Hayakawa, Kazuhide; Wang, Qingzhi; Xing, Changhong; Wang, Xiaoying; Zhou, Yiming; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Neurol, Charlestown, MA USA; [Lok, Josephine] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA USA; [Zhao, Song] Jilin Univ, Hosp 1, Dept Spine Surg, Changchun, Peoples R China; [Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Cerebrovasc Res Ctr, Dept Neurosurg, Beijing, Peoples R China		Lo, EH (corresponding author), Massachusetts Gen Hosp, Neuroprotect Res Lab, 149 13th St,Room 2401, Charlestown, MA 02129 USA.	lo@helix.mgh.harvard.edu	Ji, Xunming/AAN-3370-2021		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS093415, P01 NS055104] Funding Source: Medline		Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arai K, 2011, J CHILD NEUROL, V26, P1193, DOI 10.1177/0883073811408610; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Avraham HK, 2014, J PATHOL, V232, P369, DOI 10.1002/path.4304; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Bangsow T, 2008, J CEREBR BLOOD F MET, V28, P1249, DOI 10.1038/jcbfm.2008.19; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Bek EL, 2000, J CARDIOVASC PHARM, V36, pS135, DOI 10.1097/00005344-200036051-00043; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Cakir M, 2003, J CLIN ENDOCR METAB, V88, P1402, DOI 10.1210/jc.2002-020995; Cantu-Medellin N, 2013, REDOX BIOL, V1, P353, DOI 10.1016/j.redox.2013.05.002; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cheyuo C, 2012, BIOL CHEM, V393, P429, DOI 10.1515/hsz-2012-0103; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; Cook DR, 2011, J NEUROCHEM, V118, P1113, DOI 10.1111/j.1471-4159.2011.07383.x; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; Dai W, 2009, BRAIN RES, V1251, P287, DOI 10.1016/j.brainres.2008.11.034; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Denis CV, 2001, BLOOD, V97, P465, DOI 10.1182/blood.V97.2.465; Deverman BE, 2012, J NEUROSCI, V32, P2100, DOI 10.1523/JNEUROSCI.3803-11.2012; Dohgu S, 2011, MICROVASC RES, V81, P103, DOI 10.1016/j.mvr.2010.10.004; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Duparc T, 2011, ANTIOXID REDOX SIGN, V15, P1477, DOI 10.1089/ars.2010.3454; Ebrahimian TG, 2012, STEM CELLS, V30, P1436, DOI 10.1002/stem.1126; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fang HY, 2005, SURG NEUROL, V64, P511, DOI 10.1016/j.surneu.2005.03.018; Filipovich T, 2008, PEPTIDES, V29, P2250, DOI 10.1016/j.peptides.2008.09.002; Flynn KM, 2013, ANGIOGENESIS, V16, P689, DOI 10.1007/s10456-013-9346-9; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Greenlee MC, 2008, CURR DRUG TARGETS, V9, P130; Greenlee MC, 2009, INFLAMM RES, V58, P909, DOI 10.1007/s00011-009-0064-0; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Guo SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052665; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harhausen D, 2010, J IMMUNOL, V184, P6407, DOI 10.4049/jimmunol.0902342; Harris LG, 2012, ONCOGENE, V31, P3370, DOI 10.1038/onc.2011.496; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heuckeroth RO, 2003, NEURON, V40, P871, DOI 10.1016/S0896-6273(03)00763-3; Hilfiker-Kleiner D, 2004, CIRCULATION, V109, P2227, DOI 10.1161/01.CIR.0000127952.90508.9D; Hiyama TY, 2013, CELL METAB, V17, P507, DOI 10.1016/j.cmet.2013.02.018; Hubner G, 1999, HISTOL HISTOPATHOL, V14, P295, DOI 10.14670/HH-14.295; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Iruela-Arispe ML, 2003, ANN NY ACAD SCI, V995, P183, DOI 10.1111/j.1749-6632.2003.tb03221.x; Ivanciu L, 2007, ARTERIOSCL THROM VAS, V27, P310, DOI 10.1161/01.ATV.0000254147.89321.cf; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaneda H, 2011, BRIT J CANCER, V105, P1210, DOI 10.1038/bjc.2011.348; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051647; Kato J, 2005, ARTERIOSCL THROM VAS, V25, P2480, DOI 10.1161/01.ATV.0000184759.91369.f8; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Kirkiles-Smith NC, 2004, J IMMUNOL, V172, P1391, DOI 10.4049/jimmunol.172.3.1391; Kis B, 2003, HYPERTENS RES, V26, pS61, DOI 10.1291/hypres.26.S61; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leali D, 2012, ARTERIOSCL THROM VAS, V32, P696, DOI 10.1161/ATVBAHA.111.243998; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lennon FE, 2011, AM J CARDIOVASC DIS, V1, P200; Li JJ, 2015, SCIENCE, V347, P1066, DOI 10.1126/science.aaa8332; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Lo E.H., 2014, SPRINGER SERIES TRAN, V5; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mahboubi K, 2000, J IMMUNOL, V164, P3837, DOI 10.4049/jimmunol.164.7.3837; Malarstig A, 2011, J INTERN MED, V270, P229, DOI 10.1111/j.1365-2796.2011.02364.x; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Minami M, 1998, J CARDIOVASC PHARM, V31, pS467, DOI 10.1097/00005344-199800001-00133; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mochizuki Y, 2002, J CELL SCI, V115, P175; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ning MM, 2011, STROKE, V42, P37, DOI 10.1161/STROKEAHA.110.585703; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Risso FM, 2012, J MATERN-FETAL NEO M, V25, P70, DOI 10.3109/14767058.2012.664892; Rivera CG, 2011, ANN BIOMED ENG, V39, P2213, DOI 10.1007/s10439-011-0325-2; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Rozyczka J, 2004, BRAIN PATHOL, V14, P406; Samson WK, 1999, ANNU REV PHYSIOL, V61, P363, DOI 10.1146/annurev.physiol.61.1.363; SAMSON WK, 1991, BRAIN RES, V539, P347, DOI 10.1016/0006-8993(91)91643-F; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Sawane M, 2011, AM J PATHOL, V179, P2691, DOI 10.1016/j.ajpath.2011.08.024; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Schroder K, 2006, FREE RADICAL BIO MED, V41, P1353, DOI 10.1016/j.freeradbiomed.2006.03.026; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song L, 2003, IN VITRO CELL DEV-AN, V39, P313; Sonmez A, 2010, CLIN EXP HYPERTENS, V32, P179, DOI 10.3109/10641960903254505; Stahl A, 2012, BLOOD, V120, P2925, DOI 10.1182/blood-2012-04-422527; STRATTON CW, 1987, J ANTIMICROB CHEMOTH, V19, P21, DOI 10.1093/jac/19.1.21; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki Y, 2009, BLOOD, V114, P3352, DOI 10.1182/blood-2009-02-203919; Tang C, 2011, CELL PHYSIOL BIOCHEM, V27, P757, DOI 10.1159/000330084; Temmesfeld-Wollbruck B, 2007, THROMB HAEMOSTASIS, V98, P944, DOI 10.1160/TH07-02-0128; Teng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033444; Thier M, 1999, MOL BRAIN RES, V64, P80, DOI 10.1016/S0169-328X(98)00329-5; TOWNSEND SF, 1990, J BIOL CHEM, V265, P22117; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Tsuru M, 2013, STEM CELLS DEV, V22, P2057, DOI 10.1089/scd.2012.0695; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Vates GE, 2005, J NEUROSURG, V103, P136, DOI 10.3171/jns.2005.103.1.0136; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang G, 2008, INT J BIOCHEM CELL B, V40, P461, DOI 10.1016/j.biocel.2007.08.008; Wang H, 2001, STROKE, V32, P1020, DOI 10.1161/01.STR.32.4.1020; Wang XK, 2002, J NEUROCHEM, V83, P1172, DOI 10.1046/j.1471-4159.2002.01225.x; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White GE, 2011, J MOL HISTOL, V42, P137, DOI 10.1007/s10735-011-9317-7; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xu LL, 2003, CANCER RES, V63, P4299; Yin YL, 2013, EUR J CELL BIOL, V92, P150, DOI 10.1016/j.ejcb.2013.01.001; YOKOYAMA Y, 1990, AM J PHYSIOL, V258, pG564, DOI 10.1152/ajpgi.1990.258.4.G564; Yuan K, 2004, BLOOD, V104, P1025, DOI 10.1182/blood-2003-09-3334; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zacchigna S, 2008, CURR TOP DEV BIOL, V80, P1, DOI 10.1016/S0070-2153(07)80001-9; Zagzag D, 1999, EXP NEUROL, V159, P391, DOI 10.1006/exnr.1999.7162; Zagzag D, 1996, CANCER RES, V56, P182; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	148	11	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1303	1316		10.1089/neu.2015.4101			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100003	26528928	Green Published			2022-02-06	
J	Bolkvadze, T; Puhakka, N; Pitkanen, A				Bolkvadze, Tamuna; Puhakka, Noora; Pitkanen, Asla			Epileptogenesis after traumatic brain injury in Plaur-deficient mice	EPILEPSY & BEHAVIOR			English	Article						Controlled cortical impact; Epilepsy; Pentylenetetrazol; Seizure susceptibility; Traumatic brain injury; Urokinase-type plasminogen activator receptor	PLASMINOGEN-ACTIVATOR RECEPTOR; CONTROLLED CORTICAL IMPACT; TEMPORAL-LOBE EPILEPSY; LATE POSTTRAUMATIC SEIZURES; FEAR EXTINCTION; INTERNEURON DEVELOPMENT; ELECTRICAL-STIMULATION; ISCHEMIC-STROKE; RAT HIPPOCAMPUS; CORTEX	Binding of the extracellular matrix proteinase urokinase-type plasminogen activator (uPA) to its receptor, uPAR, regulates tissue remodeling during development and after injury in different organs, including the brain. Accordingly, mutations in the Plaur gene, which encodes uPAR, have been linked to language deficits, autism, and epilepsy, both in mouse and human. Whether uPAR deficiency modulates epileptogenesis and comorbidogenesis after brain injury, however, is unknown. To address this question, we induced traumatic brain injury (TBI) by controlled cortical impact (CCI) in 10 wild-type (Wt-CCI) and 16 Plaur-deficient (uPAR-CCI) mice. Sham-operated mice served as controls (10 Wt-sham 10 uPAR-sham). During the 4-month follow-up, the mice were neurophenotyped by assessing the somatomotor performance with the composite neuroscore test, emotional learning and memory with fear conditioning to tone and context, and epileptogenesis with videoelectroencephalography monitoring and the pentylenetetrazol (PTZ) seizure susceptibility test. At the end of the testing, the mice were perfused for histology to analyze cortical and hippocampal neuroclegeneration and mossy fiber sprouting. Fourteen percent (1/7) of the mice in the Wt-CCI and 0% in the uPAR-CCI groups developed spontaneous seizures (p > 0.05; chi-square). Both the Wt-CCI and uPAR-CCI groups showed increased seizure susceptibility in the PTZ test (p < 0.05), impaired recovery of motor function (p < 0.001), and neurodegeneration in the hippocampus and cortex (p < 0.05) compared with the corresponding sham-operated controls. Motor recovery and emotional learning showed a genotype effect, being more impaired in uPAR-CCI than in Wt-CCI mice (p < 0.05). The findings of the present study indicate that uPAR deficiency does not increase susceptibility to epileptogenesis after CCI injury but has an unfavorable comorbidity-modifying effect after TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Bolkvadze, Tamuna; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi			Academy of FinlandAcademy of FinlandEuropean Commission; COST Action ECMNETEuropean Cooperation in Science and Technology (COST) [BM1001]; ERA-NET Neuron [TBI Epilepsy]	This study was supported by the Academy of Finland, COST Action ECMNET [BM1001], ERA-NET Neuron [TBI Epilepsy]. We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bae MH, 2010, EXP NEUROL, V221, P129, DOI 10.1016/j.expneurol.2009.10.011; Beschorner R, 2000, NEUROPATH APPL NEURO, V26, P522, DOI 10.1046/j.0305-1846.2000.287.x; Bissonette GB, 2015, BIOL PSYCHIAT, V77, P454, DOI 10.1016/j.biopsych.2014.07.023; Bissonette GB, 2014, BEHAV BRAIN RES, V259, P143, DOI 10.1016/j.bbr.2013.10.051; Bolkvadze T, 2015, EPILEPSY BEHAV, V51, P19, DOI 10.1016/j.yebeh.2015.06.037; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cunningham O, 2009, GLIA, V57, P1802, DOI 10.1002/glia.20892; Eagleson KL, 2010, NEUROSCIENCE, V168, P797, DOI 10.1016/j.neuroscience.2010.03.066; Eagleson KL, 2005, J COMP NEUROL, V489, P449, DOI 10.1002/cne.20647; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; FREUND TF, 1992, BRAIN RES BULL, V28, P27, DOI 10.1016/0361-9230(92)90227-O; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Iyer AM, 2010, NEUROSCIENCE, V167, P929, DOI 10.1016/j.neuroscience.2010.02.047; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Lahtinen L, 2009, NEUROSCIENCE, V163, P316, DOI 10.1016/j.neuroscience.2009.06.019; Levitt P, 2005, EPILEPSIA, V46, P22, DOI 10.1111/j.1528-1167.2005.00305.x; Liu B, 2010, J NEUROSCI RES, V88, P2747, DOI 10.1002/jnr.22419; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Meng Y, 2014, PLOS ONE, V4, P23; Michelucci R, 2008, EPILEPSY RES, V80, P9, DOI 10.1016/j.eplepsyres.2008.03.014; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Miszczuk D., 2015, MOL NEUROBIOL; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Nagai N, 2008, NEUROSCI LETT, V432, P46, DOI 10.1016/j.neulet.2007.12.004; Nagai N, 2010, BRAIN RES, V1322, P109, DOI 10.1016/j.brainres.2010.01.077; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Paul R, 2005, J INFECT DIS, V191, P776, DOI 10.1086/427829; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Quirico-Santos T, 2013, BRAIN RES, V1538, P172, DOI 10.1016/j.brainres.2013.09.044; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rantala J, 2015, EPILEPSY BEHAV, V42, P117, DOI 10.1016/j.yebeh.2014.11.001; Reinthaler EM, 2014, EPILEPSIA, V55, pE89, DOI 10.1111/epi.12712; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Salmi M, 2013, BRAIN, V136, P2457, DOI 10.1093/brain/awt161; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; Wu F, 2014, J NEUROSCI, V34, P14219, DOI 10.1523/JNEUROSCI.5309-13.2014; Yu L, 2014, NEUROL INDIA, V62, P498, DOI 10.4103/0028-3886.144439	57	11	11	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUL	2016	60						187	196		10.1016/j.yebeh.2016.04.038			10	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	DO7WA	WOS:000377992500031	27208924				2022-02-06	
J	Feldman, JL; Freitas, AL				Feldman, Julia L.; Freitas, Antonio L.			An Investigation of the Reliability and Self-Regulatory Correlates of Conflict Adaptation	EXPERIMENTAL PSYCHOLOGY			English	Article						cognitive control; conflict adaptation; self-regulation; individual differences	COGNITIVE CONTROL ADJUSTMENTS; TRAUMATIC BRAIN-INJURY; EXECUTIVE CONTROL; FLANKER TASK; EVENT FILES; PERFORMANCE; IMPULSIVITY; MODEL; INDIVIDUALS; INTEGRATION	The study of the conflict-adaptation effect, in which encountering information-processing conflict attenuates the disruptive influence of information-processing conflicts encountered subsequently, is a burgeoning area of research. The present study investigated associations among performance measures on a Stroop-trajectory task (measuring Stroop interference and conflict adaptation), on a Wisconsin Card Sorting Task (WCST; measuring cognitive flexibility), and on self-reported measures of self-regulation (including impulsivity and tenacity). We found significant reliability of the conflict-adaptation effects across a two-week period, for response-time and accuracy. Variability in conflict adaptation was not associated significantly with any indicators of performance on the WCST or with most of the self-reported self-regulation measures. There was substantial covariance between Stroop interference for accuracy and conflict adaptation for accuracy. The lack of evidence of covariance across distinct aspects of cognitive control (conflict adaptation, WCST performance, self-reported self-control) may reflect the operation of relatively independent component processes.	[Feldman, Julia L.; Freitas, Antonio L.] SUNY Stony Brook, Stony Brook, NY 11794 USA		Feldman, JL (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11790 USA.	Julia.Feldman@stonybrook.edu					Abrahamse E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00179; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Billieux J, 2007, ADDICT BEHAV, V32, P1189, DOI 10.1016/j.addbeh.2006.08.007; Billieux J, 2008, PERS INDIV DIFFER, V44, P1432, DOI 10.1016/j.paid.2007.12.011; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Bugg JM, 2008, MEM COGNITION, V36, P1217, DOI 10.3758/MC.36.7.1217; Clawson A, 2013, PSYCHOPHYSIOLOGY, V50, P711, DOI 10.1111/psyp.12066; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; Clayson PE, 2012, PSYCHOPHYSIOLOGY, V49, P627, DOI 10.1111/j.1469-8986.2011.01345.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Desender K, 2014, PSYCHOL SCI, V25, P675, DOI 10.1177/0956797613511468; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Duncker K, 1945, PSYCHOL MONOGR, V58, P1; Duthoo W, 2014, PSYCHOL RES-PSYCH FO, V78, P483, DOI 10.1007/s00426-013-0498-4; Duthoo W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01001; Freitas AL, 2015, PSYCHOL RES-PSYCH FO, V79, P143, DOI 10.1007/s00426-014-0540-1; Freitas AL, 2009, PSYCHOPHYSIOLOGY, V46, P1226, DOI 10.1111/j.1469-8986.2009.00864.x; Funes MJ, 2010, COGN NEUROPSYCHOL, V27, P360, DOI 10.1080/02643294.2010.532618; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Kan IP, 2013, COGNITION, V129, P637, DOI 10.1016/j.cognition.2013.09.001; Keye D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00947; Keye D, 2009, PSYCHOL RES-PSYCH FO, V73, P762, DOI 10.1007/s00426-008-0188-9; Kim S, 2014, ACTA PSYCHOL, V149, P60, DOI 10.1016/j.actpsy.2014.03.004; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Larson MJ, 2013, BIOL PSYCHOL, V94, P408, DOI 10.1016/j.biopsycho.2013.08.006; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2009, PSYCHOL RES-PSYCH FO, V73, P794, DOI 10.1007/s00426-008-0191-1; Miyake A., 1999, MODELS WORKING MEMOR; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P993, DOI 10.1037/0278-7393.18.5.993; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Rustamov N, 2013, NEUROPSYCHOLOGIA, V51, P2976, DOI 10.1016/j.neuropsychologia.2013.10.025; Schmidt JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102337; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Stratta P, 2000, SCHIZOPHR RES, V44, P57, DOI 10.1016/S0920-9964(99)00142-5; Streeter CC, 2008, NEUROPSYCHOPHARMACOL, V33, P827, DOI 10.1038/sj.npp.1301465; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Verplanken B, 2007, J PERS SOC PSYCHOL, V92, P526, DOI 10.1037/0022-3514.92.3.526; WAGNER M, 1981, PERCEPT PSYCHOPHYS, V29, P359, DOI 10.3758/BF03207345; Weissman DH, 2014, J EXP PSYCHOL HUMAN, V40, P2022, DOI 10.1037/a0037454; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	56	11	11	0	10	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	MERKELSTR 3, D-37085 GOTTINGEN, GERMANY	1618-3169	2190-5142		EXP PSYCHOL	Exp. Psychol.	JUL	2016	63	4					237	247		10.1027/1618-3169/a000328			11	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	EA7DH	WOS:000386788400003	27750519				2022-02-06	
J	Fischer, TD; Red, SD; Chuang, AZ; Jones, EB; McCarthy, JJ; Patel, SS; Sereno, AB				Fischer, Tara D.; Red, Stuart D.; Chuang, Alice Z.; Jones, Elizabeth B.; McCarthy, James J.; Patel, Saumil S.; Sereno, Anne B.			Detection of Subtle Cognitive Changes after mTBI Using a Novel Tablet-Based Task	JOURNAL OF NEUROTRAUMA			English	Article						assessment tools; behavioral assessment; cognitive function; head trauma; outcome measures	TRAUMATIC BRAIN-INJURY; SACCADIC EYE-MOVEMENTS; KING-DEVICK TEST; POSTCONCUSSION SYNDROME; HAND COORDINATION; HEAD-INJURY; MILD; CONCUSSION; SYMPTOMS; DIAGNOSIS	This study examined the potential for novel tablet-based tasks, modeled after eye tracking techniques, to detect subtle sensorimotor and cognitive deficits after mild traumatic brain injury (mTBI). Specifically, we examined whether performance on these tablet-based tasks (Pro-point and Anti-point) was able to correctly categorize concussed versus non concussed participants, compared with performance on other standardized tests for concussion. Patients admitted to the emergency department with mTBI were tested on the Pro-point and Anti-point tasks, a current standard cognitive screening test (i.e., the Standard Assessment of Concussion [SAC]), and another eye movement-based tablet test, the King-Devick (R) (KD). Within hours after injury, mTBI patients showed significant slowing in response times, compared with both orthopedic and age-matched control groups, in the Pro-point task, demonstrating deficits in sensorimotor function. Mild TBI patients also showed significant slowing, compared with both control groups, on the Anti-point task, even when controlling for sensorimotor slowing, indicating deficits in cognitive function. Performance on the SAC test revealed similar deficits of cognitive function in the mTBI group, compared with the age-matched control group; however, the KD test showed no evidence of cognitive slowing in mTBI patients, compared with either control group. Further, measuring the sensitivity and specificity of these tasks to accurately predict mTBI with receiver operating characteristic analysis indicated that the Anti-point and Pro-point tasks reached excellent levels of accuracy and fared better than current standardized tools for assessment of concussion. Our findings suggest that these rapid tablet-based tasks are able to reliably detect and measure functional impairment in cognitive and sensorimotor control within hours after mTBI. These tasks may provide a more sensitive diagnostic measure for functional deficits that could prove key to earlier detection of concussion, evaluation of interventions, or even prediction of persistent symptoms.	[Fischer, Tara D.; Red, Stuart D.; Sereno, Anne B.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, 6431 Fannin St,MSB 7-330, Houston, TX 77030 USA; [Chuang, Alice Z.] Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Jones, Elizabeth B.; McCarthy, James J.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA; [Patel, Saumil S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA		Fischer, TD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, 6431 Fannin St,MSB 7-330, Houston, TX 77030 USA.	tara.fischer@uth.tmc.edu	Fischer, Tara/ABA-1727-2020	Fischer, Tara/0000-0002-6590-4401	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30 EY010608] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY010608] Funding Source: NIH RePORTER		Ariff G, 2002, J NEUROSCI, V22, P7721; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Carey DP, 2002, PROG BRAIN RES, V140, P311; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Devick S, 2016, SCAND J MED SCI SPOR, V26, P593, DOI 10.1111/sms.12691; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Faul M, 2010, TRAUMATIC BRAIN INJU; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Heck J., 2001, SPORTS MED UPDATE, V15, P46; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kaminski H. J., 2002, FOREWARD ANN N Y ACA, V956, pxiii; Kim N., 2013, PLOS ONE, V8; KOKEN PW, 1992, EXP BRAIN RES, V88, P657; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2001, J ATHL TRAINING, V36, P274; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mercier E, 2016, INJURY, V47, P985, DOI 10.1016/j.injury.2016.04.001; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Mounce LTA, 2013, J HEAD TRAUMA REHAB, V28, P397, DOI 10.1097/HTR.0b013e318252dd75; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Muri RM, 1999, EXP BRAIN RES, V128, P200, DOI 10.1007/s002210050836; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Piponnier J.C., 2015, 1 2 ORDER STIMULI RE; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg N.D., 2014, BRAIN INJURY, V5, P1; Squire LR, 2009, ENCY NEUROSCIENCE, P117; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Tate DF, 2012, BRAIN IMAGING BEHAV, V6, P103, DOI 10.1007/s11682-012-9185-0; Taylor KS, 2010, PAIN, V151, P582, DOI 10.1016/j.pain.2010.06.032; TEASDALE G, 1974, LANCET, V2, P81; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Zee D.S., 1999, NEUROLOGY EYE MOVEME, V3rd; Zhang M., 2013, PLOS ONE, V8	66	11	11	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2016	33	13					1237	+		10.1089/neu.2015.3990			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DP2QY	WOS:000378336200390	26398492	Green Published			2022-02-06	
J	Gaur, P; Chawla, A; Verma, K; Mukherjee, S; Lalvani, S; Malhotra, R; Mayer, C				Gaur, Piyush; Chawla, Anoop; Verma, Khyati; Mukherjee, Sudipto; Lalvani, Sanjeev; Malhotra, Rajesh; Mayer, Christian			Characterisation of human diaphragm at high strain rate loading	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Human soft tissues; Diaphragm; Impact; Strain rate dependence; Failure; Tensile characterisation	HUMAN AORTIC TISSUE; MECHANICAL-PROPERTIES; CANINE DIAPHRAGM; FINITE-ELEMENT; MUSCLE-TISSUE; BRAIN-TISSUE; BIOMECHANICAL RESPONSE; BIOLOGICAL TISSUES; TENSILE PROPERTIES; FAILURE PROPERTIES	Motor vehicle crashes (MVC's) commonly results in life threating thoracic and abdominal injuries. Finite element models are becoming an important tool in analyzing automotive related injuries to soft tissues. Establishment of accurate material models including tissue tolerance limits is critical for accurate injury evaluation. The diaphragm is the most important skeletal muscle for respiration having a bi-domed structure, separating the thoracic cavity from abdominal cavity. Traumatic rupture of the diaphragm is a potentially serious injury which presents in different forms depending upon the mechanisms of the causative trauma. A major step to gain insight into the mechanism of traumatic rupture of diaphragm is to understand the high rate failure properties of diaphragm tissue. Thus, the main objective of this study was to estimate the mechanical and failure properties of human diaphragm at strain rates associated with blunt thoracic and abdominal trauma. A total of 23 uniaxial tensile tests were performed at various strain rates ranging from 0.001-200 s(-1) in order to characterize the mechanical and failure properties on human diaphragm tissue. Each specimen was tested to failure at one of the four strain rates (0.001 s(-1), 65 s(-1), and 130 s(-1), 190 s(-1)) to investigate the effects of strain rate dependency. High speed video and markers placed on the grippers were used to measure the gripper to gripper displacement. Engineering stresses reported in the study is calculated from the ratio of force measured and initial cross sectional area whereas engineering strain is calculated from the ratio of the elongation to the undeformed length (gauge length) of the specimen. The results of this study showed that the diaphragm tissues is rate dependent with higher strain rate tests giving higher failure stress and higher failure strains. The failure stress for all tests ranged from 1.17 MPa to 4.1 MPa and failure strain ranged from 12.15% to 24.62%. (C) 2016 Elsevier Ltd. All rights reserved.	[Gaur, Piyush; Chawla, Anoop; Verma, Khyati; Mukherjee, Sudipto] Indian Inst Technol, Dept Mech Engn, New Delhi 110016, India; [Lalvani, Sanjeev; Malhotra, Rajesh] All India Inst Med Sci, New Delhi, India; [Mayer, Christian] Daimler AG, D-70546 Stuttgart, Germany		Chawla, A (corresponding author), Indian Inst Technol, Dept Mech Engn, New Delhi 110016, India.	gaurhcst@gmail.com; achawla@mech.iitd.ernet.in; khyativermajss@gmail.com; sudipto@mech.iitd.ernet.in; drsanjeevlalwani@gmail.com; rmalhotra62@hotmail.com; christian.c.mayer@daimler.com		mukherjee, sudipto/0000-0002-7175-1237; Gaur, Piyush/0000-0002-6826-6855; Chawla, Anoop/0000-0001-6398-0008	Mercedes Benz RD India	The work was supported by a Grant from Mercedes Benz R&D India.	Adegboye V O, 2002, Afr J Med Med Sci, V31, P149; Ahmad R, 2015, SURG SCI, V6, P133; Angelillo M, 1997, J APPL PHYSIOL, V83, P1486, DOI 10.1152/jappl.1997.83.5.1486; Angelillo M, 2000, J APPL PHYSIOL, V89, P15, DOI 10.1152/jappl.2000.89.1.15; Assari S., 2014, HIGH RATE FAILURE PR, P1; Augenstein J, 1999, P ANN C ASS, P139; Bartlett CS, 2003, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000053164.71678.14; Behr M., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P263, DOI 10.1080/10255840310001606080; Bir C, 2004, J BIOMECH, V37, P73, DOI 10.1016/S0021-9290(03)00238-0; Boriek AM, 2000, J APPL PHYSIOL, V89, P2187, DOI 10.1152/jappl.2000.89.6.2187; Boriek AM, 2005, AM J PHYSIOL-REG I, V288, pR1021, DOI 10.1152/ajpregu.00499.2003; Bosanquet D, 2009, RESP MED CME, V2, P1, DOI [10.1016/j.rmedc.2009.01.002, DOI 10.1016/J.RMEDC.2009.01.002]; BOULANGER BR, 1993, J TRAUMA, V35, P255, DOI 10.1097/00005373-199308000-00014; Brown B.J.B., 2014, J PHYS C SERIES, V500; Brunon A, 2011, J MECH BEHAV BIOMED, V4, P1572, DOI 10.1016/j.jmbbm.2010.12.016; Brunon A, 2010, J BIOMECH, V43, P2221, DOI 10.1016/j.jbiomech.2010.03.038; BUTLER DL, 1986, J BIOMECH, V19, P425, DOI 10.1016/0021-9290(86)90019-9; CAREW TE, 1968, CIRC RES, V23, P61, DOI 10.1161/01.RES.23.1.61; Carter FJ, 2001, MED IMAGE ANAL, V5, P231, DOI 10.1016/S1361-8415(01)00048-2; Cavanaugh J., 1996, P STAPP CAR, DOI [10.4271/962410, DOI 10.4271/962410]; Chawla A., 2006, DETERMINING STRAIN R, P173; Chawla A., 2005, DYNAMIC CHARACTERIZA; Choudhury N, 2009, CARDIOVASC PATHOL, V18, P83, DOI 10.1016/j.carpath.2008.01.001; Christensen MB, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0922-x; Chung J., 1999, 724 SAE; COOPER GJ, 1991, J BIOMECH, V24, P273, DOI 10.1016/0021-9290(91)90346-O; Covey CDC, 2002, J BONE JOINT SURG AM, V84A, P1221, DOI 10.2106/00004623-200207000-00022; DECRAEMER WF, 1980, J BIOMECH, V13, P463, DOI 10.1016/0021-9290(80)90338-3; Duprey A., 2008, MECH PROPERTIES AORT, P1; Edsberg LE, 1999, J REHABIL RES DEV, V36, P133; Egorov VI, 2002, J BIOMECH, V35, P1417, DOI 10.1016/S0021-9290(02)00084-2; Elhagediab A.M., 1998, P 16 INT TECHN C EXP, P327; Favre J.-P., 2005, POLYM MECH, V2, P242; Fung Y. C., 1977, Polymer Mechanics, V11, P726; Gallagher AJ, 2012, P INT RES COUNC BIOM, P494; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gao Z, 2010, MED IMAGE ANAL, V14, P126, DOI 10.1016/j.media.2009.11.002; Grimal Q, 2004, INT J IMPACT ENG, V30, P665, DOI 10.1016/j.ijimpeng.2003.08.002; Gundiah N, 2007, J BIOMECH, V40, P586, DOI 10.1016/j.jbiomech.2006.02.004; Hanna WC, 2008, ANN THORAC SURG, V85, P1044, DOI 10.1016/j.athoracsur.2007.10.084; HE CM, 1994, J VASC SURG, V20, P6, DOI 10.1016/0741-5214(94)90169-4; Holzapfel G.A., 2004, ENCY COMPUTATIONAL M, DOI DOI 10.1002/0470091355.ECM041; Holzapfel G.A., 2000, BIOMECHANICS SOFT TI, V7; Kara E, 2004, ANN ACAD MED SINGAP, V33, P649; Kemper Andrew R, 2010, Ann Adv Automot Med, V54, P15; Kemper AR, 2012, J BIOMECH, V45, P348, DOI 10.1016/j.jbiomech.2011.10.022; KIM MJ, 1976, J APPL PHYSIOL, V41, P369, DOI 10.1152/jappl.1976.41.3.369; Lake SP, 2009, J ORTHOP RES, V27, P1596, DOI 10.1002/jor.20938; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Manoogian SJ, 2008, J BIOMECH, V41, P3436, DOI 10.1016/j.jbiomech.2008.09.020; Mansour K A, 1997, Chest Surg Clin N Am, V7, P373; MARGULIES SS, 1994, J APPL PHYSIOL, V76, P2070, DOI 10.1152/jappl.1994.76.5.2070; Markogiannakis H, 2006, EMERG MED J, V23, P27, DOI 10.1136/emj.2004.022392; Mattucci SFE, 2012, J MECH BEHAV BIOMED, V10, P216, DOI 10.1016/j.jmbbm.2012.02.004; Mavrilas D, 2005, J BIOMECH, V38, P761, DOI 10.1016/j.jbiomech.2004.05.019; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231, DOI 10.1152/jappl.1966.21.4.1231; MCELWEE TB, 1984, AM SURGEON, V50, P143; Mihos P, 2003, INJURY, V34, P169, DOI 10.1016/S0020-1383(02)00369-8; Miller K, 2000, Med Sci Monit, V6, P158; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; MINNS RJ, 1973, J BIOMECH, V6, P153, DOI 10.1016/0021-9290(73)90084-5; Mohammadi H, 2009, MED ENG PHYS, V31, P1110, DOI 10.1016/j.medengphy.2009.07.012; MOHAN D, 1983, J BIOMECH, V16, P31, DOI 10.1016/0021-9290(83)90044-1; MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0; Murray C., 1996, GLOBAL BURDEN DIS; Murray JA, 1998, J AM COLL SURGEONS, V187, P626, DOI 10.1016/S1072-7515(98)00246-4; Ottenio M, 2015, J MECH BEHAV BIOMED, V41, P241, DOI 10.1016/j.jmbbm.2014.10.006; Ozpolat B, 2009, THORAC CARDIOV SURG, V57, P358, DOI 10.1055/s-0029-1185579; PATEL DJ, 1969, CIRC RES, V25, P765, DOI 10.1161/01.RES.25.6.765; Raghavan ML, 1996, ANN BIOMED ENG, V24, P573, DOI 10.1007/BF02684226; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Reber PU, 1998, J TRAUMA, V44, P183, DOI 10.1097/00005373-199801000-00026; Roberts JC, 2007, J BIOMECH, V40, P125, DOI 10.1016/j.jbiomech.2005.11.003; Robinson SL, 2001, BIOREMED SER, V6, P1; Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021; Scharff James R, 2007, Thorac Surg Clin, V17, P81, DOI 10.1016/j.thorsurg.2007.03.006; Sellier KG, 1994, WOUND BALLISTICS SCI; Snedeker JG, 2005, J BIOMECH, V38, P993, DOI 10.1016/j.jbiomech.2004.05.030; Snedeker JG, 2005, J BIOMECH, V38, P1011, DOI 10.1016/j.jbiomech.2004.05.036; Sokolis DP, 2007, ACTA PHYSIOL, V190, P277, DOI 10.1111/j.1748-1716.2006.01661.x; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; STRUMPF RK, 1993, AM J PHYSIOL, V265, pH469, DOI 10.1152/ajpheart.1993.265.2.H469; Takaza M, 2013, J MECH BEHAV BIOMED, V17, P209, DOI 10.1016/j.jmbbm.2012.09.001; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Thomas P., 1999, SAE TECHNICAL INJURY, V724; Thubrikar MJ, 2001, J MED ENG TECHNOL, V25, P133, DOI 10.1080/03091900110057806; Umale S, 2013, J MECH BEHAV BIOMED, V17, P22, DOI 10.1016/j.jmbbm.2012.07.010; Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015; Vorp DA, 2003, ANN THORAC SURG, V75, P1210, DOI 10.1016/S0003-4975(02)04711-2; Warhatkar H., 2009, EXPT STUDY VARIATION, DOI [10.4271/2009-01-0392., DOI 10.4271/2009-01-0392]; Yamada H, 1971, J ANAT 3, V108, P582; Yang ZH, 1996, J TRAUMA, V40, pS81, DOI 10.1097/00005373-199603001-00019; Yoganandan N, 2000, Annu Proc Assoc Adv Automot Med, V44, P17; Zhang W, 2007, BIOMATERIALS, V28, P1307, DOI 10.1016/j.biomaterials.2006.10.022	95	11	11	2	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUL	2016	60						603	616		10.1016/j.jmbbm.2016.02.031			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	DQ1OA	WOS:000378969100054	27062242				2022-02-06	
J	Gosteli, G; Yersin, B; Mabire, C; Pasquier, M; Albrecht, R; Carron, PN				Gosteli, Gael; Yersin, Bertrand; Mabire, Cedric; Pasquier, Mathieu; Albrecht, Roland; Carron, Pierre-Nicolas			Retrospective analysis of 616 air-rescue trauma cases related to the practice of extreme sports	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Emergency medical services; Extreme sports; Fall; Prehospital; Trauma	PARAGLIDING ACCIDENTS; INJURY PATTERNS; RISK-FACTORS; EPIDEMIOLOGY; MOUNTAIN; ALPS	Introduction: Extreme sports (ESs) are increasingly popular, and accidents due to ESs sometimes require helicopter emergency medical services (HEMSs). Little is known about their epidemiology, severity, specific injuries and required rescue operations. Aim: Our aims were to perform an epidemiological analysis, to identify specific injuries and to describe the characteristic of prehospital procedures in ES accidents requiring HEMSs. Methods: This is a retrospective study, reviewing all rescue missions dedicated to ESs provided by HEMS REGA Lausanne, from 1 January 1998 to 31 December 2008. ES were classified into three categories of practice, according to the type of risk at the time of the fall. Results: Among the 616 cases meeting inclusion criteria, 219 (36%) were clearly high-risk ES accidents; 69 (11%) and 328 (53%) were related to potential ES, but with respectively low or indeterminate risk at the time of the fall. In the high-risk ES group, the median age was 32 years and 80% were male. Mortality at 48 h was 11%, almost ten times higher than in the other two groups. The proportion of potentially life-threatening injuries (the National Advisory Committee for Aeronautics (NACA) score > 4) was 39% in the high-risk ES group and 13% in the other two groups. Thirty per cent of the cases in the high-risk ES group presented an Injury Severity Score (ISS) > 15, compared with 7% in the other groups. Thoracolumbar vertebral fractures were the most common injuries with 32% of all cases having at least one, involving the T12-L2 junction in 56% of cases. The other most frequent injuries were traumatic brain injuries (16%), rib fractures (9%), pneumothorax (8%) and femoral (7%), cervical (7%), ankle (5%) and pelvic (5%) fractures. Median time on site for rescue teams was higher in the confirmed high-risk ES group, with 50% of prehospital missions including at least one environmental difficulty. Conclusions: High-risk ESs led to high-energy accidents, characterized by a large proportion of severe injuries and axial traumas (spine, thorax, pelvis and proximal femur). We identified a considerable percentage of thoracolumbar vertebral fractures, mainly in the T12-L2 junction. HEMSs dedicated to high-risk ESs implied longer and more complex interventions. (C) 2016 Elsevier Ltd. All rights reserved.	[Gosteli, Gael; Yersin, Bertrand; Pasquier, Mathieu; Carron, Pierre-Nicolas] Univ Lausanne Hosp, Emergency Dept, CH-1011 Lausanne, Switzerland; [Mabire, Cedric] Univ Hlth Sci HESAV, Av Beaumont 21, CH-1011 Lausanne, Switzerland; [Albrecht, Roland] Swiss Air Rescue, CH-8058 Zurich, Switzerland		Gosteli, G (corresponding author), Univ Lausanne Hosp, Emergency Dept, CH-1011 Lausanne, Switzerland.	gael@gosteli.ch; bertrand.yersin@chuv.ch; cedric.mabire@hesav.ch; mathieu.pasquier@chuv.ch; Roland.Albrecht@rega.ch; pierre-nicolas.carron@chuv.ch	Mabire, Cedric/L-3893-2013	Mabire, Cedric/0000-0003-2666-8300			[Anonymous], 2013, STAT STAT SOFTW REL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Carmont MR, 2005, SCOT MED J, V50, P106, DOI 10.1177/003693300505000306; Corra S, 2012, EUR J EMERG MED, V19, P69, DOI 10.1097/MEJ.0b013e328347c1e9; Exadaktylos AK, 2003, EUR J EMERG MED, V10, P27, DOI 10.1097/00063110-200303000-00008; Ferrera PC, 1999, AM J EMERG MED, V17, P575, DOI 10.1016/S0735-6757(99)90199-7; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Gauler R, 2006, SPINE, V31, P1125, DOI 10.1097/01.brs.0000216502.39386.70; Hasler RM, 2012, INJURY, V43, P440, DOI 10.1016/j.injury.2011.06.193; Hasler RM, 2012, EUR J EMERG MED, V19, P73, DOI 10.1097/MEJ.0b013e328348b460; Hasler RM, 2010, BRIT J SPORT MED, V44, P816, DOI 10.1136/bjsm.2010.071357; Heggie TW, 2012, MED SPORT SCI, P58; Jones G, 2008, BRIT J SPORT MED, V42, P773, DOI 10.1136/bjsm.2007.037978; Kajtna T., 2004, KINESIOLOGY, V36, P24; Kupper T, 2013, ANN OCCUP HYG, V57, P1180, DOI 10.1093/annhyg/met031; Martha C, 2009, PSYCHOL SPORT EXERC, V10, P193, DOI 10.1016/j.psychsport.2008.07.004; Martha C, 2010, INT J SPORT EXERC PS, V8, P129, DOI 10.1080/1612197X.2010.9671938; Mei-Dan O, 2013, ADVENTURE EXTREME SP, P1; Mort A, 2011, CLIN J SPORT MED, V21, P530, DOI 10.1097/JSM.0b013e318234be97; Nelson NG, 2009, AM J PREV MED, V37, P195, DOI 10.1016/j.amepre.2009.04.025; PALMER C, 2002, AUSTR J ANTHR, V13, P323, DOI DOI 10.1111/J.1835-9310.2002.TB00213.X; Pasquier M, 2012, INJURY, V43, P1377, DOI 10.1016/j.injury.2011.06.196; Raveneau G., 2006, ETHNOLOGIE FRANCAISE, V36, P581, DOI [10.3917/ethn.064.0581, DOI 10.3917/ETHN.064.0581]; Rekand T, 2008, SPINAL CORD, V46, P412, DOI 10.1038/sj.sc.3102158; Ringburg AN, 2007, J TRAUMA, V63, P258, DOI 10.1097/01.ta.0000240449.23201.57; Selig HF, 2012, HIGH ALT MED BIOL, V13, P112, DOI 10.1089/ham.2011.1082; Soule B., 2008, MOVEMENT SPORT SCI, V63, P83, DOI DOI 10.3917/SM.063.0083; Tomazin I, 2003, HIGH ALT MED BIOL, V4, P479, DOI 10.1089/152702903322616236; Watson AE, 2004, PERCEPT MOTOR SKILL, V99, P83; Weiss M, 2001, ANAESTHESIST, V50, P150, DOI 10.1007/s001010170030; Williams R, 2007, WILD ENVIRON MED, V18, P102, DOI 10.1580/06-WEME-OR-037R1.1	31	11	11	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2016	47	7					1414	1420		10.1016/j.injury.2016.03.025			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DO8QL	WOS:000378048300008	27206845				2022-02-06	
J	Hachem, LD; Kourtis, G; Mylabathula, S; Tator, CH				Hachem, Laureen D.; Kourtis, George; Mylabathula, Swapna; Tator, Charles H.			Experience with Canada's First Policy on Concussion Education and Management in Schools	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Brain injury; Brain injury - traumatic; Education; Head trauma	RETURN; COACHES	Background: In response to the rising incidence of concussions among children and adolescents, the province of Ontario recently introduced the Ontario Policy/Program Memorandum on Concussions (PPM No. 158) requiring school boards to develop a concussion protocol. As this is the first policy of its kind in Canada, the impact of the PPM is not yet known. Methods: An electronic survey was sent to all high school principals in the Toronto District School Board 1 year after announcement of the PPM. Questions covered extent of student, parent, and staff concussion education along with concussion management protocols. Results: Of 109 high school principals contacted, 39 responded (36%). Almost all schools provided concussion education to students (92%), with most education delivered through physical education classes. Nearly all schools had return to play (92%) and return to learn (77%) protocols. Although 85% of schools educated staff on concussions, training was aimed at individuals involved in sports/physical education. Only 43.6% of schools delivered concussion education to parents, and many principals requested additional resources in this area. Conclusions: One year after announcement of the PPM, high schools in the Toronto District School Board implemented significant student concussion education programs and management protocols. Staff training and parent education required further development. A series of recommendations are provided to aid in future concussion policy development.	[Hachem, Laureen D.; Tator, Charles H.] Univ Hlth Network, Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Hachem, Laureen D.; Mylabathula, Swapna] Univ Toronto, Fac Med, Toronto, ON, Canada; [Kourtis, George] Toronto Dist Sch Board, Dept Hlth & Phys Educ, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada		Tator, CH (corresponding author), Univ Toronto, Div Neurosurg, Toronto Western Hosp, 399 Bathurst St Room 4W-422, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca			Determinants of Community Health II Course at the University of Toronto Faculty of Medicine	The authors thank the Determinants of Community Health II Course at the University of Toronto Faculty of Medicine for support in conducting this project.	[Anonymous], 2014, 158 ONT MIN ED; Billette J., 2011, INJURIES CANADA INSI; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; National Conference of State Legislatures, 2014, NAT C STAT LEG; Patel Dilip R, 2002, Adolesc Med, V13, P569; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	15	11	11	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JUL	2016	43	4					554	560		10.1017/cjn.2016.41			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ5KW	WOS:000379245100016	27142787	Bronze			2022-02-06	
J	Thackeray, JD; Wannemacher, J; Adler, BH; Lindberg, DM				Thackeray, Jonathan D.; Wannemacher, Jacob; Adler, Brent H.; Lindberg, Daniel M.			The classic metaphyseal lesion and traumatic injury	PEDIATRIC RADIOLOGY			English	Article						Child abuse; Children; Classic metaphyseal lesion; Fractures; Radiography	CHILD PHYSICAL ABUSE; SENTINEL INJURIES; CESAREAN-SECTION; HEAD TRAUMA; FRACTURES; INFANTS; PREVALENCE	It is widely accepted that the classic metaphyseal lesion (CML) is a traumatic lesion, strongly associated with abuse in infants. Nevertheless, various non-traumatic origins for CMLs continue to be suggested in medical and legal settings. No studies to date systematically describe the association of CMLs with other traumatic injuries. The primary objective of this study is to examine the association of CMLs with other traumatic injuries in a large data set of children evaluated for physical abuse. This was a retrospectively planned secondary analysis of data from a prospective, observational study of children < 120 months of age who underwent evaluation by a child abuse physician. For this secondary analysis, we identified all children a parts per thousand currency sign12 months of age with an identified CML and determined the number and type of additional injuries identified. Descriptive analysis was used to report frequency of additional traumatic injuries. Among 2,890 subjects, 119 (4.1%) were identified as having a CML. Of these, 100 (84.0%) had at least one additional (non-CML) fracture. Thirty-three (27.7%) had traumatic brain injury. Nearly half (43.7%) of children had cutaneous injuries. Oropharyngeal injuries were found in 12 (10.1%) children. Abdominal/thoracic injuries were also found in 12 (10.1%) children. In all, 95.8% of children with a CML had at least one additional injury; one in four children had three or more categories of injury. CMLs identified in young children are strongly associated with traumatic injuries. Identification of a CML in a young child should prompt a thorough evaluation for physical abuse.	[Thackeray, Jonathan D.] Nationwide Childrens Hosp, Div Child & Family Advocacy, 655 E Livingston Ave, Columbus, OH 43205 USA; [Wannemacher, Jacob] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Adler, Brent H.] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA; [Lindberg, Daniel M.] Univ Colorado, Sch Med, Dept Emergency Med, Denver, CO USA; [Lindberg, Daniel M.] Univ Colorado, Sch Med, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Denver, CO USA		Thackeray, JD (corresponding author), Nationwide Childrens Hosp, Div Child & Family Advocacy, 655 E Livingston Ave, Columbus, OH 43205 USA.	jonathan.thackeray@nationwidechildrens.org	Adler, Brent/AAV-5730-2020				Applegate KE, 2006, ACR PRACTICE GUIDELI, P253; Ayoub DM, 2014, AM J ROENTGENOL, V202, P185, DOI 10.2214/AJR.13.10540; Barber I, 2015, PEDIATR RADIOL, V45, P69, DOI 10.1007/s00247-014-3064-3; Burrell T, 2015, J FORENSIC LEG MED, V35, P51, DOI 10.1016/j.jflm.2015.07.005; CAFFEY J, 1957, BRIT J RADIOL, V30, P225, DOI 10.1259/0007-1285-30-353-225; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Grayev AM, 2001, PEDIATR RADIOL, V31, P559, DOI 10.1007/s002470100497; Harper NS, 2014, J PEDIAT, V165, pe1; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kleinman PK, 2008, PEDIATR RADIOL, V38, pS388, DOI 10.1007/s00247-008-0845-6; Kleinman PK, 2014, AM J ROENTGENOL, V202, pW603, DOI 10.2214/AJR.14.12532; Kleinman PK, 2011, AM J ROENTGENOL, V197, P1005, DOI 10.2214/AJR.11.6540; Kleinman PK, 2009, AM J ROENTGENOL, V192, P1266, DOI 10.2214/AJR.08.1619; KLEINMAN PK, 1986, AM J ROENTGENOL, V146, P895, DOI 10.2214/ajr.146.5.895; KLEINMAN PK, 1995, AM J ROENTGENOL, V165, P647, DOI 10.2214/ajr.165.3.7645487; Kleinman PK., 2015, DIAGNOSTIC IMAGING C; Lindberg DM, 2013, PEDIATR EMERG CARE, V29, P26, DOI 10.1097/PEC.0b013e31827b475e; Lindberg DM, 2012, PEDIATRICS, V130, P193, DOI 10.1542/peds.2012-0085; Lindberg DM, 2014, J PEDIAT, V164, pe1; Loder R T, 1991, J Orthop Trauma, V5, P428, DOI 10.1097/00005131-199112000-00007; Lysack JT, 2003, PEDIATR RADIOL, V33, P422, DOI 10.1007/s00247-003-0914-9; MERTEN DF, 1983, RADIOLOGY, V146, P377, DOI 10.1148/radiology.146.2.6849085; Meyer JS, 2011, J AM COLL RADIOL, V8, P87, DOI 10.1016/j.jacr.2010.09.008; O'Connell A, 2007, PEDIATR RADIOL, V37, P488, DOI 10.1007/s00247-007-0445-x; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Petska HW, 2014, PEDIATR CLIN N AM, V61, P923, DOI 10.1016/j.pcl.2014.06.007; Quigley AJ, 2014, PEDIATR RADIOL, V44, P82, DOI 10.1007/s00247-013-2802-2; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Sieswerda-Hoogendoorn T, 2014, J FORENSIC RADIOL IM, V2, P2, DOI 10.1016/j.jofri.2013.11.004; Thackeray JD, 2007, PEDIATR EMERG CARE, V23, P735, DOI 10.1097/PEC.0b013e3181568039; Thorpe EL, 2014, PEDIATR EMERG CARE, V30, P771, DOI 10.1097/PEC.0000000000000257	31	11	11	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	JUL	2016	46	8					1128	1133		10.1007/s00247-016-3568-0			6	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	DQ2MV	WOS:000379037300006	26902299				2022-02-06	
J	Wilkinson, AA; Simic, N; Frndova, H; Taylor, MJ; Choong, K; Fraser, D; Campbell, C; Dhanani, S; Kuehn, S; Beauchamp, MH; Farrell, C; Anderson, V; Guerguerian, AM; Dennis, M; Schachar, R; Hutchison, JS				Wilkinson, Amy A.; Simic, Nevena; Frndova, Helena; Taylor, Margot J.; Choong, Karen; Fraser, Douglas; Campbell, Craig; Dhanani, Sonny; Kuehn, Sally; Beauchamp, Miriam H.; Farrell, Catherine; Anderson, Vicki; Guerguerian, Anne-Marie; Dennis, Maureen; Schachar, Russell; Hutchison, Jamie S.		Attention Traumatic Brain Injury I; Canadian Critical Care Trials Grp; Canadian Critical Care Translation	Serum Biomarkers Help Predict Attention Problems in Critically Ill Children With Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						attention; pediatrics; serum biomarkers; traumatic brain injury	NEURON-SPECIFIC ENOLASE; DEFICIT HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; DEFICIT/HYPERACTIVITY DISORDER; RESPONSE-INHIBITION; BEHAVIOR; PREVALENCE; MORTALITY; SYMPTOMS; RECOVERY	Objective: To evaluate the association between acute serum biomarkers, and the changes in attention at 1 year following traumatic brain injury. Design and Setting: A prospective observational and laboratory study conducted in PICUs at five Canadian children's hospitals. Study Population and Measurements: Fifty-eight patients aged 5 to 17 years with traumatic brain injury were enrolled in the study. Nine brain-specific and inflammatory serum protein biomarkers were measured multiple times over the first week following injury. Attention was measured at "baseline" to represent pre-injury function and at 1 year following injury using the Conners Third Parent Rating Scale. Results: Compared with baseline, there were significantly more clinical symptoms of inattention at 1 year post injury. The Glasgow Coma Scale score, age at injury, baseline levels of inattention, and highest levels of serum biomarkers were used to estimate the probability of developing inattention. These independent variables were first evaluated individually followed by combinations of the best predictors using area under the receiver operating characteristic curve analyses. A combination of high baseline levels of inattention and high serum levels of the biomarker neuron-specific enolase was the best predictor for inattention. Glasgow Coma Scale and age at injury were not associated with inattention at 1 year post injury. Conclusions: Combining baseline assessment of attention with measurement of serum biomarkers shows promise as reliable, early predictors of long-term attention after childhood traumatic brain injury.	[Wilkinson, Amy A.; Simic, Nevena; Taylor, Margot J.; Guerguerian, Anne-Marie; Dennis, Maureen; Schachar, Russell; Hutchison, Jamie S.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Res Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Wilkinson, Amy A.; Simic, Nevena; Taylor, Margot J.; Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Simic, Nevena] Hamilton Hlth Sci Corp, Comprehens Pediat Epilepsy Program, Hamilton, ON, Canada; [Frndova, Helena; Guerguerian, Anne-Marie; Hutchison, Jamie S.] Hosp Sick Children, Dept Crit Care, Toronto, ON, Canada; [Taylor, Margot J.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada; [Choong, Karen] Childrens Hosp Hamilton, Dept Pediat, Div Pediat Intens Care, Hamilton, ON, Canada; [Fraser, Douglas] Childrens Hosp, London Hlth Sci Ctr, Div Pediat Crit Care Med, London, ON, Canada; [Fraser, Douglas; Campbell, Craig] Lawson Res Inst, London, ON, Canada; [Fraser, Douglas] Childrens Hosp, London Hlth Sci Ctr, Dept Pediat, London, ON, Canada; [Fraser, Douglas] Western Univ, Pediat, London, ON, Canada; [Campbell, Craig] Childrens Hosp, London Hlth Sci Ctr, Div Neurol, London, ON, Canada; [Campbell, Craig] Western Univ, Schulich Sch Med, Clin Neurol Sci & Epidemiol, London, ON, Canada; [Dhanani, Sonny] Childrens Hosp Eastern Ontario, Div Pediat Crit Care, Ottawa, ON, Canada; [Dhanani, Sonny] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Kuehn, Sally] Childrens Hosp Eastern Ontario, Mental Hlth Outpatient Serv, Ottawa, ON, Canada; [Kuehn, Sally] Smyth Med Ctr, Ottawa, ON, Canada; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Farrell, Catherine] CHU St Justine, Dept Pediat, Div Pediat Intens Care, Montreal, PQ, Canada; [Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Psychol Sci & Pediat, Melbourne, Vic, Australia; [Guerguerian, Anne-Marie; Hutchison, Jamie S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada		Wilkinson, AA; Hutchison, JS (corresponding author), Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Res Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Wilkinson, AA (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.; Hutchison, JS (corresponding author), Hosp Sick Children, Dept Crit Care, Toronto, ON, Canada.; Hutchison, JS (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	amy.wilkinson@sickkids.ca; jamie.hutchison@sickkids.ca	Choong, Karen/ABB-7867-2021; Hahn, Cecil/J-3372-2016	Choong, Karen/0000-0002-4608-4508; Hahn, Cecil/0000-0002-0887-8761; Doja, Asif/0000-0003-1457-071X	Ontario Neurotrauma Foundation (ONF) in Canada [2006-ABI-COMOR-440]; ONF in Canada; Victoria Neurotrauma Initiative in Australia [2010-VNI-DCP08-817]; Ontario Neuro-trauma Foundation [ONF] [2011-ABI-PHD-934]; ONF in Canada [2006-ABI-COMOR-440]; HAHSO Fund; Hospital for Sick Children Research Institute; Guilford Press; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); ONF [2011-ABI-PHD-934]; Ministry of Long Term Health of Ontario	Supported by a grant from the Ontario Neurotrauma Foundation (ONF; 2006-ABI-COMOR-440) in Canada and a collaborative grant from the ONF in Canada and the Victoria Neurotrauma Initiative (2010-VNI-DCP08-817) in Australia.; Ms. Wilkinson was awarded a graduate student scholarship (Ontario Neuro-trauma Foundation [ONF] #2011-ABI-PHD-934) for this work. Her institution received funding from the ONF, a grant from the ONF (2006-ABI-COMOR-440) in Canada, and a collaborative grant from the ONF in Canada and the Victoria Neurotrauma Initiative (2010-VNI-DCP08-817) in Australia. Dr. Choong disclosed payment to research assistant for data collection. Her institution received funding from HAHSO Fund. Dr. Dhanani's institution received funding from the Hospital for Sick Children Research Institute. Dr. Kuehn disclosed government work and that her contribution to the data collected was as an employee of the Children's Hospital of Eastern Ontario. Dr. Beauchamp received funding from Guilford Press royalties for a book unrelated to the manuscript. Her institution received funding from the Canadian Institutes of Health Research (grant funding unrelated to this project). Dr. Farrell is a member of the Board of Directors of the Canadian Critical Care Society but receives no financial compensation whatsoever. Dr. Guerguerian other support from the A graduate student scholarship (ONF #2011-ABI-PHD-934). Her institution received funding from the ONF, the Ministry of Long Term Health of Ontario (which contributes to paying Dr. Guerguerian's institution, Hospital for Sick Children), and the Canadian Institutes of Health Research (that sponsors work on traumatic brain injury for an operating grant unrelated to the work published in this manuscript). Dr. Schachar disclosed other support from the Canadian Institutes of Health Research. His institution received funding from the ONF. Dr. Hutchison's institution received finding from the ONF and from the ONF and Victoria Neurotrauma Initiative partnership grant. The remaining authors have disclosed that they do not have any potential conflicts of interest.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Conners CK, 2008, CONN MAN; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Fridriksson T, 2000, ACAD EMERG MED, V7, P816, DOI 10.1111/j.1553-2712.2000.tb02276.x; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; HATTORI T, 1994, BIOCHEM BIOPH RES CO, V202, P25, DOI 10.1006/bbrc.1994.1888; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, BRAIN INJURY, V12, P41; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Shahim P, 2013, PEDIATR NEUROL, V49, P31, DOI 10.1016/j.pediatrneurol.2013.02.015; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Weledji EP, 2014, ANN MED SURG, V3, P77, DOI 10.1016/j.amsu.2014.06.014; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	38	11	11	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2016	17	7					638	648		10.1097/PCC.0000000000000752			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pediatrics	DR0LV	WOS:000379599900010	27167007				2022-02-06	
J	Xu, BH; Tian, R; Wang, X; Zhan, SH; Wang, RZ; Guo, Y; Ge, W				Xu, Benhong; Tian, Rui; Wang, Xia; Zhan, Shaohua; Wang, Renzhi; Guo, Yi; Ge, Wei			Protein profile changes in the frontotemporal lobes in human severe traumatic brain injury	BRAIN RESEARCH			English	Article						Severe traumatic brain injury; TMT (tandem mass tags); Human; Proteomics	2,3-CYCLIC NUCLEOTIDE 3-PHOSPHODIESTERASE; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; HEAD-INJURY; IMMUNE-RESPONSE; SERUM; PROTEOMICS; COMPLEMENT; BIOMARKERS; OVEREXPRESSION	Severe traumatic brain injury (sTBI) is a serious public health issue with high morbidity and mortality rates. Previous proteomic studies on sTBI have mainly focused on human cerebrospinal fluid and serum, as well as on brain protein changes in murine models. However, human proteomic data in sTBI brain is still scarce. We used proteomic and bioinformatic strategies to investigate variations in protein expression levels in human brains after sTBI, using samples from the Department of Neurosurgery, Affiliated Hospital of Hebei University (Hebei, China). Our proteomic data identified 4031 proteins, of which 160 proteins were overexpressed and 5 proteins were downregulated. Bioinformatics analysis showed significant changes in biological pathways including glial cell differentiation, complement activation and apolipoprotein catalysis in the statin pathway. Western blot verification of protein changes in a subset of the available tissue samples showed results that were consistent with the proteomic data. This study is one of the first to investigate the whole proteome of human sTBI brains, and provide a characteristic signature and overall landscape of the sTBI brain proteome. (C) 2016 Elsevier B.V. All rights reserved.	[Xu, Benhong; Guo, Yi; Ge, Wei] Hebei Univ, Affiliated Hosp, Dept Neurosurg, Baoding 071000, Peoples R China; [Xu, Benhong; Wang, Xia; Zhan, Shaohua; Ge, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Xu, Benhong; Wang, Xia; Zhan, Shaohua; Ge, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Tian, Rui; Wang, Renzhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China; [Guo, Yi] Tsinghua Changgung Hosp, Dept Neurosurg, Beijing 102218, Peoples R China		Guo, Y; Ge, W (corresponding author), Hebei Univ, Affiliated Hosp, Dept Neurosurg, Baoding 071000, Peoples R China.	ghuoyi@gmail.com; wei.ge@chem.ox.ac.uk	Xu, Benhong/L-6500-2019; Xu, Benhong/ABG-4700-2021	Xu, Benhong/0000-0002-5331-3102; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373150]; Research Fund for Medical Science of Hebei University [2014B2001]; National High Technology Research and Development Program ("863" Program) of ChinaNational High Technology Research and Development Program of China [2013AA020106]	The authors thank all donors and their relatives for tissue samples. These tissues are archived at the Department of Neurosurgery, Affiliated Hospital of Hebei University (Hebei, China) and the Chinese Human Brain Bank (Beijing, China). This study was supported by the National Natural Science Foundation of China (81373150 to WG), the Research Fund for Medical Science of Hebei University (2014B2001 to Yi Guo), National High Technology Research and Development Program ("863" Program) of China (2013AA020106).	Angelis D.D., 1994, MULTIDISCIPLINARY AP, P49; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cho WCS, 2014, EXPERT REV PROTEOMIC, V11, P131, DOI 10.1586/14789450.2014.899908; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Davis A E, 2000, Crit Care Nurs Q, V23, P1; de Vries H, 2000, GLYCOCONJUGATE J, V17, P181, DOI 10.1023/A:1026533021994; Dove AQ, 1999, NAT BIOTECHNOL, V17, P233, DOI 10.1038/6972; DUJARDIN BCG, 1985, J IMMUNOL METHODS, V80, P227, DOI 10.1016/0022-1759(85)90024-9; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; GADDIS GM, 1994, ANN EMERG MED, V23, P75, DOI 10.1016/S0196-0644(94)70012-5; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; Gravel M, 1997, ALTSCHUL SY, V4, P75; Gravel M., 2012, CELL BIOL PATHOLOGY, V4, P75; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; James P, 1997, Q REV BIOPHYS, V30, P279, DOI 10.1017/S0033583597003399; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kulbe JR, 2015, EXP NEUROL; Kumar R., 2014, J HEAD TRAUMA REHABI; Lawrence D. W., 2015, BRAIN INJURY, P1; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lutz D., 2015, MOL NEUROBIOL, P1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; McDowell M., 2014, IMMUNOLOGICAL MECH T, P67; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Rodriguez M, 1996, NEUROLOGY, V46, P538, DOI 10.1212/WNL.46.2.538; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Stahel PF, 1997, LANCET, V349, P1886, DOI 10.1016/S0140-6736(05)63877-9; Stahel PF, 2007, INJURY, V38, P1409, DOI 10.1016/j.injury.2007.09.023; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Ternent T, 2014, PROTEOMICS, V14, P2233, DOI 10.1002/pmic.201400120; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang F., 2015, NEUROSCIENCE; Yin X, 1997, J NEUROSCI RES, V50, P238, DOI 10.1002/(SICI)1097-4547(19971015)50:2<238::AID-JNR12>3.0.CO;2-4; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	55	11	11	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 1	2016	1642						344	352		10.1016/j.brainres.2016.04.008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP7EI	WOS:000378661600039	27067185				2022-02-06	
J	Ng, CF; Ko, CH; Koon, CM; Chin, WC; Kwong, HCST; Lo, AWI; Wong, HL; Fung, KP; Lau, CBS; Lam, PK; Poon, WS; Leung, PC				Ng, Chun-Fai; Ko, Chun-Hay; Koon, Chi-Man; Chin, Wai-Ching; Kwong, Hiu Ching Sonya Themis; Lo, Anthony Wing-Ip; Wong, Hing-Lok; Fung, Kwok-Pui; Lau, Clara Bik-San; Lam, Ping-Kuen; Poon, Wai Sang; Leung, Ping-Chung			The aqueous extract of rhizome of Gastrodia elata Blume attenuates locomotor defect and inflammation after traumatic brain injury in rats	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Traumatic brain injury; Gastrodia elata Blume; Controlled cortical impact; Rotarod; Inflammation	CEREBRAL-ISCHEMIA; CELLS; CONSTITUENTS; MECHANISMS; GLUTAMATE; ALCOHOL; DAMAGE; SUPPRESSION; MICROGLIA; APOPTOSIS	Ethnopharmacological relevance: Traumatic brain injury (TBI) has an incident rate of 200-300 people per 100,000 annually in the developed countries. TBI has relatively high incidence at an early age and may cause long-term physical disability. Patients suffered from severe TBI Would have motor and neuropsychological malfunctions, affecting their daily activities. Traditionally, Gastrodia elata Blume is a Chinese Medicines which was used for the head diseases, while their efficiency on reducing brain damage was still largely unknown. In the present study, we aimed to examine the effect of water extract of G. elate Blume (GE) against TBI and elucidate its underlying mechanism. Materials and methods: Sprague-Dawley rats were treated with GE for 7 days, immediately after controlled cortical impact-induced TBI. Impaired neurobehavioral functioning was measured on day 3 and 6 after TBI. Histology of TBI was examined to assess the extent of inflammation, and the expressions of pro-inflammatory cytokines were examined by immunofluorescence study on day 7. Results: GE treatment significantly improved the impaired locomotor functions induced by TBI. GE treatment reduced inflammation and gliosis in the penumbral area. The increase in brain levels of pro inflammatory cytokines interleukin-6 and tumor necrosis factor-alpha observed in non-GE treated TBI rats were also reversed. Conclusions: GE treatment attenuated the locomotor deficit caused by TBI. The anti-inflammatory activity might be mediated by inhibition of pro-inflammatory cytokines responses in the TBI-brain. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Ng, Chun-Fai; Ko, Chun-Hay; Koon, Chi-Man; Wong, Hing-Lok; Fung, Kwok-Pui; Lau, Clara Bik-San; Leung, Ping-Chung] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China; [Ng, Chun-Fai; Ko, Chun-Hay; Koon, Chi-Man; Wong, Hing-Lok; Fung, Kwok-Pui; Lau, Clara Bik-San; Leung, Ping-Chung] Chinese Univ Hong Kong, State Key Lab Phytochem & Plant Resources West Ch, Shatin, Hong Kong, Peoples R China; [Chin, Wai-Ching; Kwong, Hiu Ching Sonya Themis; Lam, Ping-Kuen; Poon, Wai Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Chin, Wai-Ching; Kwong, Hiu Ching Sonya Themis; Lam, Ping-Kuen] Chinese Univ Hong Kong, Chow Tai Fook Cheng Yu Tung Surg Stem Cell Res Ct, Hong Kong, Hong Kong, Peoples R China; [Lo, Anthony Wing-Ip] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Fung, Kwok-Pui] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China		Ko, CH (corresponding author), Chinese Univ Hong Kong, Rm E302A,3-F,Sci Ctr East Block, Shatin, Hong Kong, Peoples R China.; Leung, PC (corresponding author), CUHK, Prince Wales Hosp, Hong Kong Jockey Club Sch Publ Hlth Bldg,5-F, Shatin, Hong Kong, Peoples R China.	ncf0000@hotmail.com; gohey@yahoo.com; johnnykoon@cuhk.edu.hk; donchin@surgery.cuhk.edu.hk; b114332@mailserv.cuhk.edu.hk; awilo@cuhk.edu.hk; vhlwong@yahoo.com; kpfung@cuhk.edu.hk; claralau@cuhk.edu.hk; lampingkuen@yahoo.com.hk; wpoon@surgery.cuhk.edu.hk; pingcleung@cuhk.edu.hk	Fung, Kwok Pui/R-9708-2018; Poon, Wai Sang/F-1558-2011; Lau, Clara Bik-San/AAF-3989-2020	Fung, Kwok Pui/0000-0001-6214-5123; Lau, Clara Bik-San/0000-0002-7409-1270	Food and Health Bureau, Hong Kong Special Administrative Region, Health and Health Service Research Fund [12134111]	This research was partly financially supported by the Food and Health Bureau, Hong Kong Special Administrative Region, Health and Health Service Research Fund (No. 12134111).	Arvin B, 1995, ANN NY ACAD SCI, V765, P62, DOI 10.1111/j.1749-6632.1995.tb16561.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bulpitt CJ, 2007, J ROY SOC MED, V100, P558, DOI 10.1258/jrsm.100.12.558; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen PJ, 2008, AM J CHINESE MED, V36, P95, DOI 10.1142/S0192415X08005618; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Dardiotis E, 2012, BRAIN INJURY PATHOGE, P23; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Hsieh CL, 2005, AM J CHINESE MED, V33, P599, DOI 10.1142/S0192415X0500320X; Hsieh CL, 2001, AM J CHINESE MED, V29, P331, DOI 10.1142/S0192415X01000356; Huang NK, 2004, LIFE SCI, V75, P1649, DOI 10.1016/j.lfs.2004.05.008; Huang ZB, 2006, ARCH PHARM RES, V29, P963, DOI 10.1007/BF02969279; Kim IS, 2011, MOLECULES, V16, P5349, DOI 10.3390/molecules16075349; Lee JY, 2006, ARCH PHARM RES, V29, P849, DOI 10.1007/BF02973905; Lee YS, 1999, ARCH PHARM RES, V22, P404, DOI 10.1007/BF02979066; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lim EJ, 2007, J PHARM PHARMACOL, V59, P1235, DOI 10.1211/jpp.59.9.0007; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ng C. F., 2013, EVID-BASED COMPL ALT, V2013, P12; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; REID TR, 1989, J BIOL CHEM, V264, P4583; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Shin EJ, 2011, CURR NEUROPHARMACOL, V9, P118, DOI 10.2174/157015911795016967; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu CR, 1996, PLANTA MED, V62, P317, DOI 10.1055/s-2006-957892; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu S., 2013, NEUROCHEM RES; Yu SJ, 2005, BIOL PHARM BULL, V28, P1016, DOI 10.1248/bpb.28.1016; Zeng XH, 2006, PLANTA MED, V72, P1359, DOI 10.1055/s-2006-951709	34	11	12	3	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	JUN 5	2016	185						87	95		10.1016/j.jep.2016.03.018			9	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	DM9OV	WOS:000376696500009	26979339				2022-02-06	
J	Cusimano, MD; Ilie, G; Mullen, SJ; Pauley, CR; Stulberg, JR; Topolovec-Vranic, J; Zhang, S				Cusimano, Michael D.; Ilie, Gabriela; Mullen, Sarah J.; Pauley, Christopher R.; Stulberg, Jennifer R.; Topolovec-Vranic, Jane; Zhang, Stanley			Aggression, Violence and Injury in Minor League Ice Hockey: Avenues for Prevention of Injury	PLOS ONE			English	Article							BODY-CHECKING; BRAIN-INJURY; CONCUSSION EDUCATION; BAYESIAN NETWORK; YOUTH HOCKEY; RISK-FACTORS; SPORT; PSYCHOLOGY; BEHAVIOR; PLAYERS	Background In North America, more than 800,000 youth are registered in organized ice hockey leagues. Despite the many benefits of involvement, young players are at significant risk for injury. Body-checking and aggressive play are associated with high frequency of game-related injury including concussion. We conducted a qualitative study to understand why youth ice hockey players engage in aggressive, injury-prone behaviours on the ice. Methods Semi-structured interviews were conducted with 61 minor ice hockey participants, including male and female players, parents, coaches, trainers, managers and a game official. Players were aged 13-15 playing on competitive body checking teams or on non-body checking teams. Interviews were manually transcribed, coded and analyzed for themes relating to aggressive play in minor ice hockey. Results Parents, coaches, teammates and the media exert a large influence on player behavior. Aggressive behavior is often reinforced by the player's social environment and justified by players to demonstrate loyalty to teammates and especially injured teammates by seeking revenge particularly in competitive, body-checking leagues. Among female and male players in non-body checking organizations, aggressive play is not reinforced by the social environment. These findings are discussed within the framework of social identity theory and social learning theory, in order to understand players' need to seek revenge and how the social environment reinforces aggressive behaviors. Conclusion This study provides a better understanding of the players' motivations and environmental influences around aggressive and violent play which may be conducive to injury. The findings can be used to help design interventions aimed at reducing aggression and related injuries sustained during ice hockey and sports with similar cultures and rules.	[Cusimano, Michael D.; Mullen, Sarah J.; Pauley, Christopher R.; Zhang, Stanley] St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Stulberg, Jennifer R.] Univ Toronto, Family & Community Med, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med, Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca	Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212	Canadian Institutes of Health Research Strategic Team Grant [TIR-103946]; Ontario Neurotrauma Foundation; St. Michael's Hospital Foundation	This research was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation (http://onf.org), as well as the St. Michael's Hospital Foundation (http://www.stmichaelsfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PL, 2014, REV PSICOL DEPORTE, V23, P395; Anderson E., 2010, SPORT THEORY AND SOC; [Anonymous], 2012, CULTURE; Arnold E, 2002, WHOSE PUCK IS IT ANY; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bawa H BM, 2004, SPORTS RELATED INJUR; Beddoes-Jones F., 2004, TRAINING JOURNAL, V16; Bortoli L, 2012, PSYCHOL SPORT EXERC, V13, P397, DOI 10.1016/j.psychsport.2012.01.001; Bronfenbrenner U., 1988, PERSONS CONTEXT DEVE, P25; Bruner MW, 2015, J APPL SPORT PSYCHOL, V27, P351, DOI 10.1080/10413200.2015.1010661; Bruner MW, 2013, GROUP DYN-THEOR RES, V17, P30, DOI 10.1037/a0030114; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Carron AV, 1982, JOURNAL OF SPORT PSY; Celozzi MJ, 1981, JOURNAL OF SPORT BEH; Chalabaev A, 2013, PSYCHOL SPORT EXERC, V14, P136, DOI 10.1016/j.psychsport.2012.10.005; Chapman J., 2006, MANAGE DECIS, V44, P1391, DOI DOI 10.1108/00251740610715713; Chicau Borrego C, 2012, J HUMAN KINETICS, V34, P119; Cohen J, 1977, STATISTICAL POWER AN; Cope CJ, 2011, INT J SPORT EXERC PS, V9, P19, DOI 10.1080/1612197X.2011.563124; Cusimano MD, 2012, CANADIAN MEDICAL ASS; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Cusimano Michael D, 2011, Open Med, V5, pe57; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ford DW, 2012, JOURNAL OF SPORT ADM, V4; Frederick EL, 2013, CONTRACT NO 1; Freedman J, 1970, AGGRESSION SOCIAL PS, P101; Fu T, 2015, CANADIAN JOURNAL OF, V42; Fuster-Parra P, 2015, HUM MOVEMENT SCI, V40, P98, DOI 10.1016/j.humov.2014.12.005; Fuster-Parra P, 2014, QUAL QUANT, V48, P1473, DOI 10.1007/s11135-013-9848-y; Gillis C., 2014, HOW PARENTS AND THEI; Gould D, 2006, BRIT J SPORT MED, V40, P632, DOI 10.1136/bjsm.2005.024927; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Hancock B, 1998, AN INTRODUCTION TO Q; Hardy J, 2005, SMALL GR RES, V36, P166, DOI 10.1177/1046496404266715; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Ilie G, 2014, JOURNAL OF NEUROTRAU; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Janis IL., 1997, GROUPTHINK; Jeffery-Tosoni S, 2015, J SPORT BEHAV, V38, P3; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kimmel M., 1987, THE LIFE OF A MANS S, P53; Kirker B, 2000, RES Q EXERCISE SPORT, V71, P373, DOI 10.1080/02701367.2000.10608920; Kleiber DA, 1981, JOURNAL OF SPORT PSY, V3; Lacey A, 2001, TRENT FOCUS FOR RESE; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Loughead TM, 2001, JOURNAL OF SPORT BEH; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Mageau GA, 2003, J SPORT SCI, V21, P883, DOI 10.1080/0264041031000140374; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; MARCOTTE G, 1993, ASTM STP, V1212, P103, DOI DOI 10.1520/STP13128S; Mugno D A, 1985, Can J Appl Sport Sci, V10, P26; NASH JE, 1981, YOUTH SOC, V13, P229, DOI 10.1177/0044118X8101300202; Patton M.Q., 1990, QUALITATIVE EVALUATI; Pediatrics AAo, 2000, PEDIATRICS PT 1, V105, P657; Perry JL, 2013, ATHLETIC INSIGHT, V5, P197; R M. The Bertuzzi Incident, 2004, GLOBE MAIL; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Rothe JP, 2000, UNDERTAKING QUALITAT; Rutten EA, 2007, J YOUTH ADOLESCENCE, V36, P255, DOI 10.1007/s10964-006-9085-y; Schwandt T. A., 2007, THE SAGE DICTIONARY; Shah C.P., 2003, PUBLIC HEALTH AND PR; Sheldon JP, 2001, RES Q EXERCISE SPORT, V72, P304, DOI 10.1080/02701367.2001.10608965; Shirazi M, 2015, CANADIAN JOURNAL OF, P42; Smith MD, 1979, CANADIAN JOURNAL OF, P105; Sports C., 2015, NHL HOCKEY INJURIES; Steinfeldt JA, PSYCHOLOGY OF MEN MA, V12, P324; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Surveillance Epidemiology Division CfCDPPHAoC, 2014, CHRONIC DISEASES AND, V34, P272; Tajfel H, 2004, THE SOCIAL IDENTITY; Taylor S J, 1981, Monogr Am Assoc Ment Defic, P71; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Traclet A, 2015, AGGRESSIVE BEHAV, V41, P123, DOI 10.1002/ab.21561; TUCKMAN BW, 1965, PSYCHOL BULL, V63, P384, DOI 10.1037/h0022100; Villani S, 2001, J AM ACAD CHILD PSY, V40, P392, DOI 10.1097/00004583-200104000-00007; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wiese-Bjornstal DM, 2014, REV PSICOL DEPORTE, V23, P411; Wojtys EM, 2015, SPORTS HEALTH, V7, P108, DOI 10.1177/1941738115572986	89	11	12	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156683	10.1371/journal.pone.0156683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	WOS:000377369700103	27258426	Green Published, gold, Green Submitted			2022-02-06	
J	Beard, DJ; Murtha, LA; McLeod, DD; Spratt, NJ				Beard, Daniel J.; Murtha, Lucy A.; McLeod, Damian D.; Spratt, Neil J.			Intracranial Pressure and Collateral Blood Flow	STROKE			English	Article						collaterals; intracranial pressure; stroke-in-progression	ACUTE ISCHEMIC-STROKE; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MINOR STROKE; CARDIAC-ARREST; HEAD-INJURY; RATS; CIRCULATION		[Beard, Daniel J.; Murtha, Lucy A.; McLeod, Damian D.; Spratt, Neil J.] Univ Newcastle, Sch Biomed Sci & Pharm, Univ Dr,MSB 502, Newcastle, NSW 2308, Australia; [Beard, Daniel J.; Murtha, Lucy A.; McLeod, Damian D.; Spratt, Neil J.] Univ Newcastle, Hunter Med Res Inst, Univ Dr,MSB 502, Newcastle, NSW 2308, Australia; [Spratt, Neil J.] John Hunter Hosp, Hunter New England Local Hlth Dist, Dept Neurol, Newcastle, NSW, Australia		Spratt, NJ (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Univ Dr,MSB 502, Newcastle, NSW 2308, Australia.	Neil.Spratt@hnehealth.nsw.gov.au	Beard, Daniel/AAP-1258-2020; Spratt, Neil J/K-4208-2012; MCLEOD, DAMIAN/G-7704-2013	Beard, Daniel/0000-0002-3720-7588; Spratt, Neil J/0000-0002-9023-6177; MCLEOD, DAMIAN/0000-0002-1297-8984; Murtha, Lucy/0000-0002-7396-6741	Australian National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia [APP1035465]	Dr Spratt was supported by an Australian National Health and Medical Research Council Career Development Fellowship APP1035465.	Akamatsu Y, 2015, J NEUROSCI, V35, P3851, DOI 10.1523/JNEUROSCI.3838-14.2015; Alexandrov AV, 2007, STROKE, V38, P3045, DOI 10.1161/STROKEAHA.107.482810; Ali Latisha K, 2007, Rev Neurol Dis, V4, P85; Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Asdaghi N, 2011, STROKE, V42, P2191, DOI 10.1161/STROKEAHA.110.611376; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Beard DJ, 2016, J CEREBR BLOOD F MET, V36, P917, DOI 10.1177/0271678X15625578; Beard DJ, 2015, J CEREBR BLOOD F MET, V35, P861, DOI 10.1038/jcbfm.2015.2; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brozici M, 2003, STROKE, V34, P2750, DOI 10.1161/01.STR.0000095791.85737.65; Campbell BCV, 2013, J CEREBR BLOOD F MET, V33, P1168, DOI 10.1038/jcbfm.2013.77; Chalothorn D, 2010, J MOL CELL CARDIOL, V49, P251, DOI 10.1016/j.yjmcc.2010.03.014; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Coutts SB, 2012, STROKE, V43, P1013, DOI 10.1161/STROKEAHA.111.637421; COYLE P, 1983, STROKE, V14, P605, DOI 10.1161/01.STR.14.4.605; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Davalos A, 2001, CURRENT REV CEREBROV, P169; Emery DJ, 2011, STROKE, V42, P1135, DOI 10.1161/STROKEAHA.110.607846; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hacke W, 2004, LANCET, V363, P768; Han JH, 2008, STROKE, V39, P1340, DOI 10.1161/STROKEAHA.107.500132; Heubner O, 1874, FC VOGEL, P170; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Kellie G., 1824, EDINBURGH MED CHIR S, V1, P84; Klassman L, 2011, J NEUROSCI NURS, V43, P94, DOI 10.1097/JNN.0b013e31820b5fcd; Kleindorfer D, 2004, STROKE, V35, pE27, DOI 10.1161/01.STR.0000109767.11426.17; KOTWICA Z, 1991, RES EXP MED, V191, P99, DOI 10.1007/BF02576664; Leng X, 2015, J NEUROL NEUROSUR PS; Liebeskind DS, 2014, STROKE, V45, P2036, DOI 10.1161/STROKEAHA.114.004781; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; McVerry F, 2012, AM J NEURORADIOL, V33, P576, DOI 10.3174/ajnr.A2794; Mistri AK, 2006, STROKE, V37, P1565, DOI 10.1161/01.STR.0000222002.57530.05; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; Monroe A, 1783, OBSERVATIONS STRUCTU; Murtha LA, 2014, INT J STROKE, V9, P553, DOI 10.1111/ijs.12181; Murtha LA, 2015, J CEREBR BLOOD F MET, V35, P592, DOI 10.1038/jcbfm.2014.230; Murtha LA, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-12; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Palamarchuk I, 2013, CEREBROVASC DIS, V36, P454, DOI 10.1159/000356093; PAPO I, 1979, NEUROSURGERY, V4, P504, DOI 10.1227/00006123-197906000-00002; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Pranevicius O, 2012, STROKE, V43, P575, DOI 10.1161/STROKEAHA.111.635037; Riva M, 2012, EXP NEUROL, V233, P815, DOI 10.1016/j.expneurol.2011.12.006; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; ROVAINEN CM, 1993, J CEREBR BLOOD F MET, V13, P359, DOI 10.1038/jcbfm.1993.49; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shin HK, 2008, STROKE, V39, P1548, DOI 10.1161/STROKEAHA.107.499483; Shipley RE, 1944, AM J PHYSIOL, V141, P0289; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Silasi G, 2009, CURR NEUROVASC RES, V6, P62, DOI 10.2174/156720209787466046; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Toriumi H, 2009, STROKE, V40, P3378, DOI 10.1161/STROKEAHA.109.558577; Urrutia VC, 2008, NEUROL CLIN, V26, P565, DOI 10.1016/j.ncl.2008.02.002; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Wang Z, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.125001; Winship IR, 2014, J CEREBR BLOOD F MET, V34, P61, DOI 10.1038/jcbfm.2013.162; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	65	11	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUN	2016	47	6					1695	1700		10.1161/STROKEAHA.115.011147			6	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	DN4MI	WOS:000377040800056	26786117	Bronze, Green Submitted			2022-02-06	
J	Csajbok, LZ; Nylen, K; Ost, M; Blennow, K; Zetterberg, H; Nellgard, P; Nellgard, B				Csajbok, L. Z.; Nylen, K.; Ost, M.; Blennow, K.; Zetterberg, H.; Nellgard, P.; Nellgard, B.			Apolipoprotein E polymorphism in aneurysmal subarachnoid haemorrhage in West Sweden	ACTA NEUROLOGICA SCANDINAVICA			English	Article						strokes; neurointensive care; quality of life; neurogenetics	TRAUMATIC BRAIN-INJURY; E GENOTYPE; INTRACEREBRAL HEMORRHAGE; ALZHEIMERS-DISEASE; ISCHEMIC-STROKE; ASSOCIATION; VASOSPASM; POPULATION; GENE; ALLELE	Background and purposeAneurysmal subarachnoid haemorrhage (aSAH) is associated with high morbidity and mortality despite novel treatments. Genetic variability may explain outcome differences. Apolipoprotein E (ApoE) is a glycoprotein with a major role in brain lipoprotein metabolism. It has three isoforms encoded by distinct alleles: APOE epsilon 2, APOE epsilon 3 and APOE epsilon 4. The APOE epsilon 4 allele is associated with Alzheimer's disease and worse outcome after traumatic brain injury and ischaemic stroke. This prospective blinded study explored the influence of the APOE epsilon 4 polymorphism on the risk of aSAH, risk of cerebral vasospasm (CVS) and 1-year neurological outcome. MethodsThe APO epsilon 4 polymorphism was analysed in 147 patients with aSAH. Allele and genotype frequencies were compared to those found in a gender- and area-matched control group of healthy individuals (n = 211). Early CVS was identified and treated according to neurointensive care unit (NICU) guidelines. Neurological deficit(s) at admittance and at 1-year follow-up visit was recorded. Neurological outcome was assessed by the National Institute of Health Stroke Scale, Barthel Index and the Extended Glasgow Outcome Scale. ResultsAPOE epsilon 4 and non-APOE epsilon 4 allele frequencies were similar in aSAH patients and healthy individuals. The presence of APOE epsilon 4 was not associated with the development of early CVS. We could not find an influence of the APOE polymorphism on 1-year neurological outcome between groups. Subgroup analyses of patients treated with surgical clipping vs endovascular coiling did not reveal any associations. ConclusionsThe APOE epsilon 4 polymorphism has no major influence on risk of aSAH, the occurrence of CVS or long-term neurological outcome after aSAH.	[Csajbok, L. Z.; Ost, M.; Nellgard, P.; Nellgard, B.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Anesthesiol & Intens Care Med, Gothenburg, Sweden; [Nylen, K.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neurol, Gothenburg, Sweden; [Blennow, K.; Zetterberg, H.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, H.] UCL Inst Neurol, Queen Sq, London, England		Csajbok, LZ (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Anesthesiol & Intens Care Med, Gothenburg, Sweden.	ludvigcsajbok@gmail.com	Ost, Martin/AAY-5827-2020		Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences; Hjarnfonden (Swedish National Brain Foundation); Medical Research Council, Sweden [14002]; LUA/ALF grants of W-Sweden; Mattsson's Foundation; Heart-Lung FoundationSwedish Heart-Lung Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation	The study was financially supported by Grants of Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences, Hjarnfonden (Swedish National Brain Foundation), The Medical Research Council, Sweden ( Grant # 14002), LUA/ALF grants of W-Sweden, Mattsson's Foundation, Heart-Lung Foundation, and the Knut and Alice Wallenberg Foundation.	Altman D.G., 1990, PRACTICAL STAT MED R; Bachmeier C, 2014, NEUROMOL MED, V16, P686, DOI 10.1007/s12017-014-8318-6; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Blennow K, 2000, J NEURAL TRANSM, V107, P1065, DOI 10.1007/s007020070052; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; DORSCH NWC, 1995, BRIT J NEUROSURG, V9, P403, DOI 10.1080/02688699550041403; Dunn LT, 2001, NEUROSURGERY, V48, P1006, DOI 10.1097/00006123-200105000-00007; EHNHOLM C, 1986, J LIPID RES, V27, P227; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Fontanella M, 2007, J NEUROSURG, V106, P245, DOI 10.3171/jns.2007.106.2.245; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gerdes LU, 2003, CLIN CHEM LAB MED, V41, P628, DOI 10.1515/CCLM.2003.094; Guo ZD, 2011, ACTA NEUROCHIR SUPPL, V110, P5, DOI 10.1007/978-3-7091-0356-2_1; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; Juvela S, 2009, J NEUROSURG, V110, P989, DOI 10.3171/2008.11.JNS081266; Koffijberg H, 2008, J NEUROL NEUROSUR PS, V79, P294, DOI 10.1136/jnnp.2007.123901; Kokubo Y, 2000, STROKE, V31, P1299, DOI 10.1161/01.STR.31.6.1299; Lanterna LA, 2007, NEUROLOGY, V69, P766, DOI 10.1212/01.wnl.0000267640.03300.6b; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; Lautner R, 2014, JAMA PSYCHIAT, V71, P1183, DOI 10.1001/jamapsychiatry.2014.1060; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Leung CHS, 2002, STROKE, V33, P548, DOI 10.1161/hs0202.102326; Levine JM, 2009, CURR TREAT OPTION NE, V11, P126, DOI 10.1007/s11940-009-0016-6; Lindekleiv HM, 2011, ACTA NEUROL SCAND, V123, P34, DOI 10.1111/j.1600-0404.2010.01336.x; Liu YW, 2002, J CEREBR BLOOD F MET, V22, P1336, DOI 10.1097/01.WCB.0000033200.58646.B3; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; MAHONEY F I, 1965, Md State Med J, V14, P61; Man P, 2015, WORLD NEUROSURG, V84, P933, DOI 10.1016/j.wneu.2015.05.070; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mazur-Kolecka B, 2003, NEUROBIOL AGING, V24, P355, DOI 10.1016/S0197-4580(02)00095-7; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; McColgan P, 2010, J NEUROSURG, V112, P714, DOI 10.3171/2009.8.JNS092; Mooney MA, 2015, WORLD NEUROSURG, V84, P1520, DOI 10.1016/j.wneu.2015.07.012; Morris PG, 2004, ACTA NEUROL SCAND, V109, P205, DOI 10.1034/j.1600-0404.2003.00206.x; Niskakangas T, 2001, STROKE, V32, P1181, DOI 10.1161/01.STR.32.5.1181; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Prince JA, 2004, NEUROLOGY, V62, P2116, DOI 10.1212/01.WNL.0000128088.08695.05; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sabri M, 2011, STROKE, V42, P1454, DOI 10.1161/STROKEAHA.110.604728; SAVELAND H, 1994, ACTA NEUROL SCAND, V90, P245; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; SIEST G, 1995, CLIN CHEM, V41, P1068; Sudlow C, 2006, STROKE, V37, P364, DOI 10.1161/01.STR.0000199065.12908.62; Tang J, 2003, SURG NEUROL, V60, P391, DOI 10.1016/S0090-3019(03)00323-9; Tomasello F, 2015, WORLD NEUROSURG, V84, P1207, DOI 10.1016/j.wneu.2015.06.049; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu HT, 2011, ACTA NEUROCHIR SUPPL, V110, P141, DOI 10.1007/978-3-7091-0353-1_24; Yin C, 2015, GENE, V563, P52, DOI 10.1016/j.gene.2015.03.009; Zetterberg M, 2008, AM J MED GENET B, V147B, P720, DOI 10.1002/ajmg.b.30668	54	11	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JUN	2016	133	6					466	474		10.1111/ane.12487			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DJ2OM	WOS:000374044400009	26374096				2022-02-06	
J	Leal-Noval, SR; Munoz-Serrano, A; Arellano-Orden, V; Cayuela, A; Munoz-Gomez, M; Recio, A; Alcantara, A; Amaya-Villar, R; Casado-Mendez, M; Murillo-Cabezas, F				Leal-Noval, Santiago R.; Munoz-Serrano, Angela; Arellano-Orden, Victoria; Cayuela, Aurelio; Munoz-Gomez, Manuel; Recio, Antonio; Alcantara, Antonio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Murillo-Cabezas, Francisco			Effects of Red Blood Cell Transfusion on Long-Term Disability of Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Anemia; Disability; Hemoglobin; Neurological; Transfusion; Traumatic brain injury	CEREBRAL OXYGENATION; HEMOGLOBIN CONCENTRATION; SUBARACHNOID HEMORRHAGE; ILL PATIENTS; MORTALITY; SHOCK	This 3-year prospective study examined the association between red blood cell transfusion (RBCT) and 1-year neurocognitive and disability levels in 309 patients with traumatic brain injury (TBI) admitted to the neurological intensive care unit (NICU). Using a telephone interview-based survey, functional outcomes were assessed by the Glasgow Outcome Scale (GOS), Rancho Los Amigos Levels of Cognitive Functioning Scale (RLCFS), and Disability Rating Scale (DRS) and dichotomized as favorable and unfavorable (dependent variable). The adjusted influence of RBCT on unfavorable results was assessed by conventional logistic regression, controlling for illness severity and propensity score (introduced as a continuous variable and by propensity score-matched patients). Overall, 164 (53 %) patients received a parts per thousand yen1 unit of RBCT during their NICU stay. One year postinjury, transfused patients exhibited significantly higher unfavorable GOS (46.0 vs. 22.0 %), RLCFS (37.4 vs. 15.4 %), and DRS (39.6 vs. 18.7 %) scores than nontransfused patients. Although transfused patients were more severely ill upon admission, their adjusted odds ratios (95 % confidence intervals) for unfavorable GOS, RLCFS, and DRS scores were 2.5 (1.2-5.1), 3.0 (1.4-6.3), and 2.3 (1.1-4.8), respectively. These odds ratios remained largely unmodified when the calculated propensity score was incorporated as an independent continuous variable into the multivariate analysis. Furthermore, in 76 pairs of propensity score-matched patients, the rate of an unfavorable RLCFS score at the 1-year (but not 6-month) follow-up was significantly higher in transfused than nontransfused patients [3.0 (1.1-8.2)]. Our results strongly suggest an independent association between RBCT and unfavorable long-term functional outcomes of patients with TBI.	[Leal-Noval, Santiago R.; Arellano-Orden, Victoria; Alcantara, Antonio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Murillo-Cabezas, Francisco] Hosp Univ Virgen del Rocio, Inst Biomed IBIS, Crit Care Div, Avda Manuel Siurot S-N, Seville 41013, Spain; [Munoz-Serrano, Angela] Hosp Univ Virgen del Rocio, Inst Biomed IBIS, Neuropsychol Div, Seville, Spain; [Cayuela, Aurelio] Hosp Valme, Stat & Design Div, Seville, Spain; [Munoz-Gomez, Manuel] Univ Malaga, Perioperat Transfus Med, E-29071 Malaga, Spain; [Recio, Antonio] Hosp Univ Virgen del Rocio, Transfus Serv, Seville, Spain		Leal-Noval, SR (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed IBIS, Crit Care Div, Avda Manuel Siurot S-N, Seville 41013, Spain.	srlealnoval@gmail.com	Cayuela, Aurelio/AAZ-1294-2020; Murillo-Cabezas, Francisco/AAO-3348-2021; Cayuela, Aurelio/C-6698-2012; Noval, Santiago/K-4515-2019; IBIS, NEUROCRITICOS/C-1805-2016	Cayuela, Aurelio/0000-0002-4936-9402; 	MAPFRE foundation (Mutualidad de la Agrupacion de Propietarios de Fincas Rusticas de Espana)	This study was partially supported by MAPFRE foundation (Mutualidad de la Agrupacion de Propietarios de Fincas Rusticas de Espana).	Centre for Disease Control and Prevention Traumatic Brain Injury in the United States, 2010, EM DEP VIS HOSP DEAT; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2013, BLOOD TRANSFUS-ITALY, V11, P585, DOI 10.2450/2013.0029-13; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Park DW, 2012, CRIT CARE MED, V40, P3140, DOI 10.1097/CCM.0b013e3182657b75; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2015, NEUROCRIT CARE, P1; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tan HY, 2015, CRIT CARE MED, V43, pE276, DOI 10.1097/CCM.0000000000001023; Vincent JL, 2008, ANESTHESIOLOGY, V108, P31, DOI 10.1097/01.anes.0000296070.75956.40; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	24	11	12	0	23	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2016	24	3					371	380		10.1007/s12028-015-0220-z			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN2ZP	WOS:000376932100007	26627227				2022-02-06	
J	Ning, JL; Mo, LW; Yi, B; Gu, JT; Lu, KZ; Zhou, YY; Lai, XN; Zhao, HL; Ma, DQ				Ning, Jiaolin; Mo, Liwen; Yi, Bin; Gu, Jianteng; Lu, Kaizhi; Zhou, Yaying; Lai, Xinan; Zhao, Hailin; Ma, Daqing			Therapeutic Whole-body Hypothermia Protects Remote Lung, Liver, and Kidney Injuries after Blast Limb Trauma in Rats	ANESTHESIOLOGY			English	Article							HYDROGEN-SULFIDE; MILD HYPOTHERMIA; HEMORRHAGIC-SHOCK; CARDIAC-ARREST; RESUSCITATION; DYSFUNCTION; SURVIVAL; BRAIN; INTERLEUKIN-10; PRESSURE	Background: Severe blast limb trauma (BLT) induces distant multiple-organ injuries. In the current study, the authors determined whether whole-body hypothermia (WH) and its optimal duration (if any) afford protection to the local limb damage and distant lung, liver, and kidney injuries after BLT in rats. Methods: Rats with BLT, created by using chartaceous electricity detonators, were randomly treated with WH for 30 min, 60 min, 3 h, and 6 h (n = 12/group). Rectal temperature and arterial blood pressure were monitored throughout. Blood and lung, liver, and kidney tissue samples were harvested for measuring tumor necrosis factor-a, interleukin-6 and interleukin-10, myeloperoxidase activity, hydrogen sulfide, and biomarkers of oxidative stress at 6 h after BLT. The pathologic lung injury and the water content of the lungs, liver, and kidneys and blast limb tissue were assessed. Results: Unlike WH for 30 min, WH for 60 min reduced lung water content, lung myeloperoxidase activity, and kidney myeloperoxidase activity by 10, 39, and 28% (all P < 0.05), respectively. WH for 3 h attenuated distant vital organs and local traumatic limb damage and reduced myeloperoxidase activity, hydrogen peroxide and malondialdehyde concentration, and tumor necrosis factor-a and interleukin-6 levels by up to 49% (all P < 0.01). Likewise, WH for 6 h also provided protection to such injured organs but increased blood loss from traumatic limb. Conclusions: Results of this study indicated that WH may provide protection for distant organs and local traumatic limb after blast trauma, which warrants further study.	[Ning, Jiaolin; Yi, Bin; Gu, Jianteng; Lu, Kaizhi; Zhou, Yaying] Third Mil Med Univ, Southwest Hosp, Dept Anesthesiol, 30 Gaotanyan St, Chongqing, Peoples R China; [Mo, Liwen] Peoples Liberat Army Chengdu Mil Area Command Gen, Dept Nephrol, Chengdu, Sichuan, Peoples R China; [Lai, Xinan] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma & Burns, Dept Traumat Surg,Surg Res Inst, Chongqing, Peoples R China; [Zhao, Hailin; Ma, Daqing] Fac Med, Dept Surg & Canc, Anaesthet Pain Med & Intens Care, London, England		Lu, KZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Anesthesiol, 30 Gaotanyan St, Chongqing, Peoples R China.	lukaizhi@163.net		Ma, Daqing/0000-0003-1235-0537; Ma, Daqing/0000-0002-0688-2097	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81470267]	This study was supported by the grant from National Natural Science Foundation of China (grant no. 81470267).	Ang SF, 2011, J IMMUNOL, V187, P4778, DOI 10.4049/jimmunol.1101559; Babaei-Karamshahlou M, 2012, EUR J PHARMACOL, V696, P130, DOI 10.1016/j.ejphar.2012.09.039; Badiei A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/848570; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Che DF, 2011, CRIT CARE MED, V39, P1423, DOI 10.1097/CCM.0b013e318212020a; Cuschieri J, 2007, ANTIOXID REDOX SIGN, V9, P1485, DOI 10.1089/ars.2007.1670; De Deyne CS, 2010, CURR OPIN ANESTHESIO, V23, P258, DOI 10.1097/ACO.0b013e328336ea44; EMIRBEKOV EZ, 1978, UKR BIOKHIM ZH+, V50, P296; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P1425, DOI 10.1097/TA.0000000000000224; Fu ZF, 2008, LIFE SCI, V82, P1196, DOI 10.1016/j.lfs.2008.04.005; Gong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035313; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Han Y, 2013, WORLD J EMERG MED, V4, P298, DOI [10.5847/wjem.j.1920-8642.2013.04.011, 10.5847/wjem.j.issn.1920-8642.2013.04.011]; Handrigan MT, 2005, SHOCK, V23, P337, DOI 10.1097/01.shk.0000156667.04628.1f; Heinius G, 2011, SHOCK, V36, P60, DOI 10.1097/SHK.0b013e3182116143; Henderson PW, 2010, PLAST RECONSTR SURG, V126, P1890, DOI 10.1097/PRS.0b013e3181f446bc; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Huang PS, 2006, CRIT CARE MED, V34, P1160, DOI 10.1097/01.CCM.0000207342.50559.0F; Jiang SY, 2013, J SURG RES, V179, P145, DOI 10.1016/j.jss.2012.09.024; Jin Z, 2015, J PHYSIOL PHARMACOL, V66, P169; Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015; Li T, 2012, ANESTHESIOLOGY, V116, P1288, DOI 10.1097/ALN.0b013e318256f09d; Lobb Ian, 2014, Can Urol Assoc J, V8, pE413, DOI 10.5489/cuaj.1694; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Marotta SE, 2011, THER HYPOTHERMIA TEM, V1, P57, DOI 10.1089/ther.2010.0005; Mathieu L, 2014, INT ORTHOP, V38, P2565, DOI 10.1007/s00264-014-2532-6; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; Ning JL, 2012, J TRAUMA ACUTE CARE, V73, P1537, DOI 10.1097/TA.0b013e318266013a; Ning JL, 2014, CRIT CARE MED, V42, pE68, DOI 10.1097/CCM.0b013e3182a84daa; Ning JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059100; Nishi K, 2012, J TRAUMA ACUTE CARE, V72, P130, DOI 10.1097/TA.0b013e31821e61d8; Nozari A, 2004, CRIT CARE MED, V32, P2110, DOI 10.1097/01.CCM.0000142700.19377.AE; Polfer EM, 2013, J BONE JOINT SURG AM, V95A, P2214, DOI 10.2106/JBJS.M.00212; Renga Barbara, 2011, Inflammation & Allergy Drug Targets, V10, P85; Sarcia PJ, 2003, SHOCK, V20, P41, DOI 10.1097/01.shk.0000071080.50028.f2; Schwarzl M, 2013, CRIT CARE MED, V41, pE401, DOI 10.1097/CCM.0b013e31829791da; Selewski DT, 2013, J PEDIATR-US, V162, P725, DOI 10.1016/j.jpeds.2012.10.002; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Talaei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022568; Testori C, 2012, RESUSCITATION, V83, P596, DOI 10.1016/j.resuscitation.2011.11.019; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; Wang KQ, 2013, CIRCULATION, V127, P2514, DOI 10.1161/CIRCULATIONAHA.113.001631; Wang XL, 2011, BIOSCIENCE REP, V31, P87, DOI 10.1042/BSR20100003; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wu XR, 2006, CIRCULATION, V113, P1974, DOI 10.1161/CIRCULATIONAHA.105.587204; Young MN, 2014, AM J CARDIOL, V114, P128, DOI 10.1016/j.amjcard.2014.04.012; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422; Zhao HL, 2015, ANESTHESIOLOGY, V122, P1312, DOI 10.1097/ALN.0000000000000664; Zhao HL, 2015, KIDNEY INT, V87, P738, DOI 10.1038/ki.2014.388; Zhao H, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/131834; Zhao HZ, 2014, J TRAUMA ACUTE CARE, V77, P464, DOI 10.1097/TA.0000000000000396; Zobel C, 2012, CRIT CARE MED, V40, P1715, DOI 10.1097/CCM.0b013e318246b820	53	11	15	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	JUN	2016	124	6					1360	1371		10.1097/ALN.0000000000001106			12	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	DO3NB	WOS:000377687200019	27028466				2022-02-06	
J	Ross, P; Ponsford, JL; Di Stefano, M; Charlton, J; Spitz, G				Ross, Pamela; Ponsford, Jennie L.; Di Stefano, Marilyn; Charlton, Judith; Spitz, Gershon			On the road again after traumatic brain injury: driver safety and behaviour following on-road assessment and rehabilitation	DISABILITY AND REHABILITATION			English	Article						Automobile driving; crash risk; head injury; occupational therapy	COMMUNITY INTEGRATION; DRIVING ASSESSMENT; ACCIDENT RATE; FITNESS; PREDICTORS; VALIDITY; RECOMMENDATIONS; AVOIDANCE; EXPOSURE; RETURN	Purpose: To examine pre- and post-injury self-reported driver behaviour and safety in individuals with traumatic brain injury (TBI) who returned to driving after occupational therapy driver assessment and on-road rehabilitation. Method: A self-report questionnaire, administered at an average of 4.5 years after completing an on-road driver assessment, documenting pre- and post-injury crash rates, near-crashes, frequency of driving, distances driven, driving conditions avoided and navigation skills, was completed by 106 participants, who had either passed the initial driver assessment (pass group n=74), or required driver rehabilitation, prior to subsequent assessments (rehabilitation group n=32). Results: No significant difference was found between pre- and post-injury crash rates. Compared to pre-injury, 36.8% of drivers reported limiting driving time, 40.6% drove more slowly, 41.5% reported greater difficulty with navigating and 20.0% reported more near-crashes. The rehabilitation group (with greater injury severity) was significantly more likely to drive less frequently, shorter distances, avoid: driving with passengers, busy traffic, night and freeway driving than the pass group. Conclusions: Many drivers with moderate/severe TBI who completed a driver assessment and rehabilitation program at least 3 months post-injury, reported modifying their driving behaviour, and did not report more crashes compared to pre-injury. On-road driver training and training in navigation may be important interventions in driver rehabilitation programs.Implications for RehabilitationDriver assessment and on-road retraining are important aspects of rehabilitation following traumatic brain injury.Many drivers with moderate/severe TBI, reported modifying their driving behaviour to compensate for ongoing impairment and continued to drive safely in the longer term.Navigational difficulties were commonly experienced following TBI, suggesting that training in navigation may be an important aspect of driver rehabilitation.	[Ross, Pamela] Epworth HealthCare, Occupat Therapy Dept, Melbourne, Vic, Australia; [Ponsford, Jennie L.; Spitz, Gershon] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Ponsford, Jennie L.; Spitz, Gershon] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Di Stefano, Marilyn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia; [Charlton, Judith] Monash Univ, Accid Res Ctr, Melbourne, Vic 3004, Australia		Ross, P (corresponding author), Epworth HealthCare, Occupat Therapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	pam.ross@epworth.org.au	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480; Charlton, Judith/0000-0002-5990-2151	RACV Sir Edmond Herring Memorial Scholarship	Pamela Ross was awarded an RACV Sir Edmond Herring Memorial Scholarship in 2009. The remaining authors report no declarations of interest.	Anstey KJ, 2009, TRAFFIC INJ PREV, V10, P84, DOI 10.1080/15389580802486399; Asimakopulos J, 2012, AUST OCCUP THER J, V59, P402, DOI 10.1111/j.1440-1630.2011.00963.x; Austroads, 2012, ASS FITN DRIV COMM P; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Charlton J, 2006, SELF REGULATORY PRAC; Charlton J., 2010, INFLUENCE CHRONIC IL; Classen S, 2014, OCCUP THER HEALTH CA, V28, P154, DOI 10.3109/07380577.2014.901590; Classen S, 2013, AM J OCCUP THER, V67, P108, DOI 10.5014/ajot.2013.005116; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Di Stefano M., 2006, DRIVER REHABILITATIO, P297, DOI [10.1016/B978-032302937-7.50019-8, DOI 10.1016/B978-032302937-7.50019-8]; Di Stefano M, 2010, AM J OCCUP THER, V64, P325, DOI 10.5014/ajot.64.2.325; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Finestone HM, 2011, TRAFFIC INJ PREV, V12, P327, DOI 10.1080/15389588.2011.581716; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; JONES R, 1983, AM J OCCUP THER, V37, P754, DOI 10.5014/ajot.37.11.754; Kay LG, 2009, ARCH PHYS MED REHAB, V90, P1514, DOI 10.1016/j.apmr.2009.03.011; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Liddle J, 2012, AUST OCCUP THER J, V59, P79, DOI 10.1111/j.1440-1630.2011.00978.x; Liddle J, 2011, DISABIL REHABIL, V33, P2574, DOI 10.3109/09638288.2011.582922; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Molnar L. J., 2013, INJURY PREV, V15, P262; Molnar LJ, 2013, ACCIDENT ANAL PREV, V57, P96, DOI 10.1016/j.aap.2013.04.010; Molnar LJ, 2008, TRAFFIC INJ PREV, V9, P314, DOI 10.1080/15389580801895319; Occupational Therapy Australia, 1998, COMP STAND OCC THER; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Roads C, 1999, POLA CRITERIA; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2009, HANDBOOK FOR THE ASSESSMENT OF DRIVING CAPACITY, P1; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90	54	11	11	0	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 7	2016	38	10					994	1005		10.3109/09638288.2015.1074293			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DG1HE	WOS:000371815900009	26312651				2022-02-06	
J	de Guise, E; Belanger, S; Tinawi, S; Anderson, K; LeBlanc, J; Lamoureux, J; Audrit, H; Feyz, M				de Guise, Elaine; Belanger, Sara; Tinawi, Simon; Anderson, Kirsten; LeBlanc, Joanne; Lamoureux, Julie; Audrit, Helene; Feyz, Mitra			Usefulness of the rivermead postconcussion symptoms questionnaire and the trail-making test for outcome prediction in patients with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						rivermead postconcussion symptoms questionnaire; rehabilitation; mild traumatic brain injury; Mayo-portland adaptability inventory-4; outcome	HEAD-INJURY; TEST-PERFORMANCE; RISK-FACTORS; CONCUSSION; MODERATE; MORTALITY; INDIVIDUALS; SERVICE	The aim of the study was to determine if the Rivermead Postconcussion Symptoms Questionnaire (RPQ) is a better tool for outcome prediction than an objective neuropsychological assessment following mild traumatic brain injury (mTBI). The study included 47 patients with mTBI referred to an outpatient rehabilitation clinic. The RPQ and a brief neuropsychological battery were performed in the first few days following the trauma. The outcome measure used was the Mayo-Portland Adaptability Inventory-4 (MPAI-4) which was completed within the first 3 months. The only variable associated with results on the MPAI-4 was the RPQ score (p<.001). The predictive outcome model including age, education, and the results of the Trail-Making Test-Parts A and B (TMT) had a pseudo-R-2 of .02. When the RPQ score was added, the pseudo-R-2 climbed to .19. This model indicates that the usefulness of the RPQ score and the TMT in predicting moderate-to-severe limitations, while controlling for confounders, is substantial as suggested by a significant increase in the model chi-square value, delta ((1df))=6.517, p<.001. The RPQ and the TMT provide clinicians with a brief and reliable tool for predicting outcome functioning and can help target the need for further intervention and rehabilitation following mTBI.	[de Guise, Elaine; Anderson, Kirsten; Audrit, Helene] Univ Montreal, Dept Psychol, Pavillon Marie Victorin,CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [de Guise, Elaine] Univ Montreal, Dept Neurol & Neurosurg, Montreal, PQ H3C 3J7, Canada; [Belanger, Sara; LeBlanc, Joanne; Feyz, Mitra] McGill Univ, Montreal Gen Hosp, Hlth Ctr, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [Tinawi, Simon] McGill Univ, Montreal Gen Hosp, Hlth Ctr, Dept Rehabil Med, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ H3C 3J7, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Pavillon Marie Victorin,CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	elaine.de.guise@umontreal.ca			Research Institute of the McGill University Health Centre	We thank the Research Institute of the McGill University Health Centre for its support. The authors report no declaration of interest.	Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Barco PP, 2014, AM J OCCUP THER, V68, P221, DOI 10.5014/ajot.2014.008938; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Brooks JBB, 2011, ARQ NEURO-PSIQUIAT, V69, P482, DOI 10.1590/S0004-282X2011000400014; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Brickenkamp R., 1981, TEST D2 AUFMERKSAMKE, V7th ed.; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Corrigan J., 2005, PROBLEMATIC SUBSTANC; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dhawan P, 2006, BCMJ, V9, P442; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Leininger S, 2014, J HEAD TRAUMA REHAB, V29, P109, DOI 10.1097/HTR.0b013e3182860506; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MALEC J, 2005, INTRO MAYO PORTLAND; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Paniak C, 2000, J MUSCULOSKELET PAIN, V8, P193, DOI 10.1300/J094v08n01_16; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; STERN B, 1985, SCAND J REHABIL MED, P31; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Wechsler D., 2008, WMS 3 MANUAL, V3rd; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	51	11	11	1	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 3	2016	23	3					213	222		10.1080/23279095.2015.1038747			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DH6KJ	WOS:000372899100009	26571267				2022-02-06	
J	Hamele, M; Stockmann, C; Cirulis, M; Riva-Cambrin, J; Metzger, R; Bennett, TD; Bratton, SL				Hamele, Mitchell; Stockmann, Chris; Cirulis, Meghan; Riva-Cambrin, Jay; Metzger, Ryan; Bennett, Tellen D.; Bratton, Susan L.			Ventilator-Associated Pneumonia in Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						pediatric; pneumonia; traumatic brain injury	INTENSIVE-CARE-UNIT; RISK-FACTORS; NOSOCOMIAL PNEUMONIA; ACQUIRED PNEUMONIA; CLINICAL-TRIAL; CHILDREN; HYPOTHERMIA; GUIDELINES; MANAGEMENT; INFECTION	Ventilator-associated pneumonia (VAP) is a common occurrence among intubated pediatric traumatic brain injury (TBI) patients. However, little is known about the epidemiology, risk factors, and microbiology of VAP in pediatric TBI. We reviewed a cohort of 119 pediatric moderate-to-severe TBI patients and identified 42 with VAP by positive protected bronchial brush specimens. Location of intubation, severity of injury, and antibiotic administration within 2 days after injury were not associated with VAP. Most treatments for elevated intracranial pressure were associated with increased risk of VAP; however, in a multi-variable analysis barbiturate coma (hazard ratio [HR], 3.2; 95% confidence interval [CI] 1.4-7.3), neuromuscular blockade (NMBA; HR, 3.4; 95% CI 1.6-7.3), and use of a cooling blanket for euthermia (HR 2.4; 95% CI 1.1-5.5) remained independently associated with VAP. Most VAP (55%) occurred prior to hospital Day 4 and only 7% developed VAP after Day 7. Methicillin-sensitive Staphylococcus aureus (34%), Haemophilus influenzae (22%), and Streptococcus pneumoniae (15%) were the most common organisms, comprising 71% of isolated pathogens (36% of infections were polymicrobial). Patients with VAP had significantly longer intensive care unit and hospital stays, as well as increased risk of chronic care needs after discharge, but not mortality. VAP is a common occurrence in pediatric TBI patients, and early empiric therapy for patients requiring barbiturate infusion, NMBA, or use of a cooling blanket could mitigate morbidity.	[Hamele, Mitchell; Stockmann, Chris; Cirulis, Meghan; Bratton, Susan L.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Riva-Cambrin, Jay] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA; [Metzger, Ryan] Univ Utah, Sch Med, Div Pediat Surg, Salt Lake City, UT USA; [Bennett, Tellen D.] Univ Colorado, Sch Med, Pediat Crit Care, Aurora, CO USA		Hamele, M (corresponding author), Univ Utah, Dept Pediat, US Army Med Corps, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	mitchell.hamele@hsc.utah.edu	Bratton, Susan L./O-2353-2013; Sherwin, Catherine Mary Turner/B-2888-2012	Bratton, Susan L./0000-0002-4605-8078; Sherwin, Catherine Mary Turner/0000-0002-0844-3207; Bennett, Tellen/0000-0003-1483-4236	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD074620] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER		Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Al-Dorzi HM, 2012, AM J INFECT CONTROL, V40, P794, DOI 10.1016/j.ajic.2011.10.004; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Almuneef M, 2004, INFECT CONT HOSP EP, V25, P753, DOI 10.1086/502472; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; Bigham MT, 2009, J PEDIATR-US, V154, P582, DOI 10.1016/j.jpeds.2008.10.019; Bradley JS, 2011, CLIN INFECT DIS, V53, P617, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Bradley JS, 2010, CLIN INFECT DIS, V51, pS136, DOI 10.1086/653063; Casado RJA, 2011, CRIT CARE MED, V39, P1968, DOI 10.1097/CCM.0b013e31821b840d; Centers for Disease Control and Prevention, 2006, TBI AG GROUP 14 15; Clark TG, 2003, BRIT J CANCER, V89, P781, DOI 10.1038/sj.bjc.6601117; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Decelle L, 2013, EUR J EMERG MED, V20, P61, DOI 10.1097/MEJ.0b013e3283501677; EBERHARDT KEW, 1992, INFECTION, V20, P12, DOI 10.1007/BF01704886; Elward AM, 2002, PEDIATRICS, V109, P758, DOI 10.1542/peds.109.5.758; Fayon MJ, 1997, AM J RESP CRIT CARE, V155, P162, DOI 10.1164/ajrccm.155.1.9001306; Gupta S, 2015, PEDIATR CRIT CARE ME, V16, pE65, DOI 10.1097/PCC.0000000000000338; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Labenne M, 1999, CRIT CARE MED, V27, P2537, DOI 10.1097/00003246-199911000-00035; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Patel CB, 2011, AM J SURG, V202, P66, DOI 10.1016/j.amjsurg.2010.10.010; Pelosi P, 2008, CHEST, V134, P101, DOI 10.1378/chest.07-2546; SATO M, 1989, RESUSCITATION, V17, P233, DOI 10.1016/0300-9572(89)90039-7; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Srinivasan R, 2009, PEDIATRICS, V123, P1108, DOI 10.1542/peds.2008-1211; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Taira BR, 2009, PEDIATR CRIT CARE ME, V10, P491, DOI 10.1097/PCC.0b013e3181a3108d; Therneau T, 2014, USING TIME DEPENDENT	34	11	14	2	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					832	839		10.1089/neu.2015.4004			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800005	26203702	Green Published			2022-02-06	
J	Honce, JM; Nyberg, E; Jones, I; Nagae, L				Honce, Justin M.; Nyberg, Eric; Jones, Isaac; Nagae, Lidia			Neuroimaging of Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; mTBI; Magnetic resonance imaging; Diffusion tensor imaging; Functional MRI; Spectroscopy	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; WHITE-MATTER INTEGRITY; SPORTS-RELATED CONCUSSION; DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; TECHNETIUM-99M-HMPAO SPECT; OUTCOME PREDICTION; CORPUS-CALLOSUM	In this review, we discuss the literature regarding concussion and mild traumatic brain injury. We focus on the role for neuroimaging in patients with suspected concussion and describe the recommended practices related to imaging in mTBI. This discussion first focuses on the exclusion of severe injuries and is followed by a discussion of the potential utility of various advanced imaging techniques in both research and clinical practice.	[Honce, Justin M.; Nyberg, Eric; Jones, Isaac; Nagae, Lidia] Univ Colorado, Sch Med, Dept Radiol, 12700 East 19th Ave,Mailstop C278, Aurora, CO 80045 USA		Honce, JM (corresponding author), Univ Colorado, Sch Med, Dept Radiol, 12700 East 19th Ave,Mailstop C278, Aurora, CO 80045 USA.	justin.honce@ucdenver.edu					[Anonymous], SPEC REP TRAUM BRAIN; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; CDC. CDC, TBI DAT STAT TRAUM B; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DESSY A, 2015, NEUROSURG QUART, V25, P423, DOI DOI 10.1097/WNQ.0000000000000085; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Holbourn AHS, 1943, LANCET, V2, P438; Iverson GL, 2000, BRAIN INJURY, V14, P1057; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JENKINS A, 1986, LANCET, V2, P445; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Katayama Y, 2009, J NEUROSURG S, V112, P889; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kuzma BB, 2000, SURG NEUROL, V53, P400; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Luther N, 2013, BRIT J SPORT MED, V47; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; National Research Council Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, 2006, HLTH RISKS EXP LOW L, VVII; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Russman A, 2015, NEUROLOGY, V84, pP7; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stippich C., 2015, CLIN FUNCTIONAL MRI; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veterans Affairs, DEP DEF CLIN PRACT G; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	111	11	11	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					411	+		10.1016/j.pmr.2016.01.002			19	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DN4RU	WOS:000377055700005	27154853				2022-02-06	
J	Kelleher, MS; Gao, GZ; Rolen, MF; Bokhari, SAJ				Kelleher, Michael S., Jr.; Gao, Guangzu; Rolen, Michael F.; Bokhari, S. A. Jamal			Completion CT of Chest, Abdomen, and Pelvis after Acute Head and Cervical Spine Trauma: Incidence of Acute Traumatic Findings in the Setting of Low-Velocity Trauma	RADIOLOGY			English	Article							COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; OBVIOUS SIGNS; BLUNT TRAUMA; INJURY; RADIOLOGY; TRENDS	Purpose: To determine the frequency of acute traumatic findings in computed tomographic (CT) chest abdomen pelvis (CAP) examinations in patients with acute traumatic head and/or cervical spine injury and no evidence suggesting bodily injury. Materials and Methods: After institutional review board approval with a waiver of informed consent was obtained, a HIPAA-compliant retrospective study was performed. A review of the electronic medical records and dictated reports identified patients who met the following criteria: CT-documented acute head and/or cervical spine trauma, CT CAP performed at least 20 minutes after initial brain and/or cervical spine CT, and no evidence of bodily injury at physical examination or on initial plain radiographs. The types of head and/or cervical injury, as well as mechanisms of injury in these patients, were analyzed. The frequency of acute traumatic injury in the CT CAP examinations was also determined, and 95% confidence intervals were calculated. Results: There were 115 patients who met the study criteria (average age, 67.3 years). Sixty-three (54.8%) patients were male. The average injury severity score was 9.3. No patients who met the criteria for this study were found to have an acute traumatic injury to the chest, abdomen, or pelvis. These 115 CT CAP examinations comprised 7.5% (115 of 1530) of all CT CAP examinations performed in the emergency department over the 15-month study period. Conclusion: CT CAP examinations rarely if ever reveal acute traumatic injury in patients who have experienced low-velocity trauma and have acute head and/or cervical spine trauma in the absence of evidence of bodily injury. (C)RSNA, 2015	[Kelleher, Michael S., Jr.; Gao, Guangzu; Rolen, Michael F.; Bokhari, S. A. Jamal] Yale Univ, Sch Med, Dept Radiol, 333 Cedar St, New Haven, CT 06510 USA		Kelleher, MS (corresponding author), Yale Univ, Sch Med, Dept Radiol, 333 Cedar St, New Haven, CT 06510 USA.	m.kelleher@yale.edu					Asha S, 2012, EMERG MED AUSTRALAS, V24, P43, DOI 10.1111/j.1742-6723.2011.01504.x; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Caputo ND, 2014, J TRAUMA ACUTE CARE, V77, P534, DOI 10.1097/TA.0000000000000414; FRIED AM, 1992, J COMPUT ASSIST TOMO, V16, P717, DOI 10.1097/00004728-199209000-00009; Gupta M, 2011, ANN EMERG MED, V58, P407, DOI 10.1016/j.annemergmed.2011.06.003; Heller MT, 2014, EMERG RADIOL, V21, P341, DOI 10.1007/s10140-014-1200-x; Horny M, 2014, J AM COLL RADIOL, V11, P692, DOI 10.1016/j.jacr.2014.01.019; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Mitchell AM, 2010, CLIN J AM SOC NEPHRO, V5, P4, DOI 10.2215/CJN.05200709; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Tien HC, 2007, J TRAUMA, V62, P151, DOI 10.1097/TA.0b013e31802d9700; Tyburski JG, 2006, ARCH SURG-CHICAGO, V141, P473; Wu SR, 2006, EMERG RADIOL, V13, P61, DOI 10.1007/s10140-006-0514-8	15	11	11	0	2	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	MAY	2016	279	2					395	399		10.1148/radiol.2015151509			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DP7YO	WOS:000378715300006	26694053	Bronze			2022-02-06	
J	Tommerdahl, M; Dennis, RG; Francisco, EM; Holden, JK; Nguyen, R; Favorov, OV				Tommerdahl, Mark; Dennis, Robert G.; Francisco, Eric M.; Holden, Jameson K.; Nguyen, Richard; Favorov, Oleg V.			Neurosensory Assessments of Concussion	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium	AUG 17-21, 2014	Fort Lauderdale, FL				STIMULUS-DRIVEN SYNCHRONIZATION; VIBROTACTILE ADAPTATION; SPATIAL LOCALIZATION; SENSORY PERCEPTION; STIMULATION; AUTISM; CAPACITY; DEPENDENCY; CHILDREN; DEVICE	The purpose of this research was to determine if cortical metrics-a unique set of sensory-based assessment tools-could be used to characterize and differentiate concussed individuals from nonconcussed individuals. Cortical metrics take advantage of the somatotopic relationship between skin and cortex, and the protocols are designed to evoke interactions between adjacent cortical regions to investigate fundamental mechanisms that mediate cortical-cortical interactions. Student athletes, aged 18 to 22 years, were recruited into the study through an athletic training center that made determinations of postconcussion return-to-play status. Sensory-based performance tasks utilizing vibrotactile stimuli applied to tips of the index and middle fingers were administered to test an individual's amplitude discrimination, temporal order judgment, and duration discrimination capacity in the presence and absence of illusion-inducing conditioning stimuli. Comparison of the performances in the presence and absence of conditioning stimuli demonstrated differences between concussed and nonconcussed individuals. Additionally, mathematically combining results from the measures yields a unique central nervous system (CNS) profile that describes an individual's information processing capacity. A comparison was made of CNS profiles of concussed vs. nonconcussed individuals and demonstrated with 99% confidence that the two populations are statistically distinct. The study established solid proof-of-concept that cortical metrics have significant potential as a quantitative biomarker of CNS status.	[Tommerdahl, Mark; Dennis, Robert G.; Favorov, Oleg V.] Univ North Carolina Chapel Hill, Dept Biomed Engn, CB 7575, Chapel Hill, NC 27599 USA; [Tommerdahl, Mark; Dennis, Robert G.; Francisco, Eric M.; Holden, Jameson K.; Nguyen, Richard] Cort Metr LLC, 87 Possum Trot, Semora, NC 27343 USA		Tommerdahl, M (corresponding author), Univ North Carolina Chapel Hill, Dept Biomed Engn, CB 7575, Chapel Hill, NC 27599 USA.			Favorov, Oleg V./0000-0002-8963-8339; Nguyen, Ruby/0000-0002-6598-8457			Arning K, 2009, NEUROTHERAPEUTICS, V6, P738, DOI 10.1016/j.nurt.2009.07.002; Folger SE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-87; Francisco E, 2008, EXP BRAIN RES, V191, P49, DOI 10.1007/s00221-008-1494-6; Francisco E, 2011, BRAIN RES, V1415, P76, DOI 10.1016/j.brainres.2011.07.043; Holden JK, 2012, J NEUROSCI METH, V204, P215, DOI 10.1016/j.jneumeth.2011.11.007; Lee KGH, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-89; Mardia K. V., 1980, MULTIVARIATE ANAL; Nelson AJ, 2012, CAN J NEUROL SCI, V39, P52, DOI 10.1017/S0317167100012683; Nguyen RH, 2013, BRAIN RES, V1498, P50, DOI 10.1016/j.brainres.2012.12.043; Nguyen RH, 2014, EXP BRAIN RES, V232, P3601, DOI 10.1007/s00221-014-4045-3; Puts NAJ, 2014, J NEUROPHYSIOL, V111, P1803, DOI 10.1152/jn.00890.2013; Puts NAJ, 2013, J NEUROSCI METH, V218, P39, DOI 10.1016/j.jneumeth.2013.04.012; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Simons SB, 2007, J NEUROPHYSIOL, V97, P2121, DOI 10.1152/jn.00513.2006; Simons SB, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-43; Tannan V, 2007, BRAIN RES, V1186, P164, DOI 10.1016/j.brainres.2007.10.024; Tannan V, 2007, J NEUROSCI METH, V164, P131, DOI 10.1016/j.jneumeth.2007.04.011; Tannan V, 2006, BRAIN RES, V1102, P109, DOI 10.1016/j.brainres.2006.05.037; Tannan V, 2008, AUTISM RES, V1, P223, DOI 10.1002/aur.34; Tommerdahl M, 2007, BRAIN RES, V1154, P116, DOI 10.1016/j.brainres.2007.04.032; Tommerdahl M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-19; Tommerdahl M, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-61; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zhang Z, 2011, CLIN J PAIN, V27, P755, DOI 10.1097/AJP.0b013e31821c98ec; Zhang Z, 2009, BRAIN RES, V1302, P97, DOI 10.1016/j.brainres.2009.09.037	26	11	11	1	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2016	181	5		S			45	50		10.7205/MILMED-D-15-00172			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	DW5LJ	WOS:000383686400009	27168552	Green Submitted, Bronze			2022-02-06	
J	Combs, HL; Jones, TA; Kozlowski, DA; Adkins, DL				Combs, Hannah L.; Jones, Theresa A.; Kozlowski, Dorothy A.; Adkins, DeAnna L.			Combinatorial Motor Training Results in Functional Reorganization of Remaining Motor Cortex after Controlled Cortical Impact in Rats	JOURNAL OF NEUROTRAUMA			English	Article						neuroplasticity; exercise; motor rehabilitation; constraint-induced movement therapy; functional recovery	TRAUMATIC BRAIN-INJURY; CORTICOSPINAL SYSTEM INTEGRITY; SENSORIMOTOR CORTEX; PREMOTOR CORTEX; INTRACORTICAL MICROSTIMULATION; VOLUNTARY EXERCISE; SUBCORTICAL STROKE; LESIONS; PLASTICITY; RECOVERY	Cortical reorganization subsequent to post-stroke motor rehabilitative training (RT) has been extensively examined in animal models and humans. However, similar studies focused on the effects of motor training after traumatic brain injury (TBI) are lacking. We previously reported that after a moderate/severe TBI in adult male rats, functional improvements in forelimb use were accomplished only with a combination of skilled forelimb reach training and aerobic exercise, with or without nonimpaired forelimb constraint. Thus, the current study was designed to examine the relationship between functional motor cortical map reorganization after experimental TBI and the behavioral improvements resulting from this combinatorial rehabilitative regime. Adult male rats were trained to proficiency on a skilled reaching task, received a unilateral controlled cortical impact (CCI) over the forelimb area of the caudal motor cortex (CMC). Three days post-CCI, animals began RT (n = 13) or no rehabilitative training (NoRT) control procedures (n = 13). The RT group participated in daily skilled reach training, voluntary aerobic exercise, and nonimpaired forelimb constraint. This RT regimen significantly improved impaired forelimb reaching success and normalized reaching strategies, consistent with previous findings. RT also enlarged the area of motor cortical wrist representation, derived by intracortical microstimulation, compared to NoRT. These findings indicate that sufficient RT can greatly improve motor function and improve the functional integrity of remaining motor cortex after a moderate/severe CCI. When compared with findings from stroke models, these findings also suggest that more intense RT may be needed to improve motor function and remodel the injured cortex after TBI.	[Combs, Hannah L.; Jones, Theresa A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Jones, Theresa A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Adkins, DeAnna L.] Med Univ S Carolina, Dept Neurosci, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Adkins, DeAnna L.] Med Univ S Carolina, Ctr Biomed Imaging, Charleston, SC 29425 USA; [Combs, Hannah L.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA		Adkins, DL (corresponding author), Med Univ S Carolina, Dept Neurosci, 173 Ashley Ave,CRI404D,MSC 510, Charleston, SC 29425 USA.	adkinsdl@musc.edu	Jones, Theresa A/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Adkins, DeAnna L/0000-0002-3063-5731	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065866] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109040] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065866] Funding Source: Medline		Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Adkins DL, 2005, NEUROSCI LETT, V380, P214, DOI 10.1016/j.neulet.2005.01.036; Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Allred RP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00379; Boychuk JA, 2011, NEUROREHAB NEURAL RE, V25, P88, DOI 10.1177/1545968310385126; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Deffeyes JE, 2015, J NEUROPHYSIOL, V113, P3893, DOI 10.1152/jn.00760.2014; Eshkol N., 1958, MOVEMENT NOTATION; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; Gharbawie OA, 2005, NEUROSCIENCE, V130, P601, DOI 10.1016/j.neuroscience.2004.10.010; Gharbawie OA, 2005, BEHAV BRAIN RES, V156, P125, DOI 10.1016/j.bbr.2004.05.015; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hsu JE, 2005, EUR J NEUROSCI, V22, P2069, DOI 10.1111/j.1460-9568.2005.04370.x; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jefferson S. C., 2015, NEUROREHABIL NEURAL; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jones T. A., 2010, BRAIN REPAIR STROKE; JONES TA, 1994, J NEUROSCI, V14, P2140; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; O'Bryant A. J., 2014, NEUROREHABIL NE 1219, V19; Piecharka DA, 2005, BRAIN RES BULL, V66, P203, DOI 10.1016/j.brainresbull.2005.04.013; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Tennant KA, 2015, NEUROREHAB NEURAL RE, V29, P193, DOI 10.1177/1545968314541329; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Teskey GC, 2002, CEREB CORTEX, V12, P98, DOI 10.1093/cercor/12.1.98; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; WHISHAW IQ, 1993, HIPPOCAMPUS, V3, P373, DOI 10.1002/hipo.450030311; WISE SP, 1979, NEUROSCIENCE, V4, P65, DOI 10.1016/0306-4522(79)90218-5	55	11	11	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2016	33	8					741	747		10.1089/neu.2015.4136			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DJ0ZM	WOS:000373932900004	26421759	Green Published			2022-02-06	
J	Zhu, R; Yang, TJ; Kobeissy, F; Mouhieddine, TH; Raad, M; Nokkari, A; Gold, MS; Wang, KK; Mechref, Y				Zhu, Rui; Yang, Tianjiao; Kobeissy, Firas; Mouhieddine, Tarek H.; Raad, Mohamad; Nokkari, Amaly; Gold, Mark S.; Wang, Kevin K.; Mechref, Yehia			The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GRAY-MATTER VOLUME; NEURONAL APOPTOSIS; MOUSE-BRAIN; DOPAMINERGIC-NEURONS; MEDIATED PROTEOLYSIS; PARKINSONS-DISEASE; MOLECULAR-BASES; CELL-LINE; FETUIN-A	Nowadays, drug abuse and addiction are serious public health problems in the USA. Methamphetamine (METH) is one of the most abused drugs and is known to cause brain damage after repeated exposure. In this paper, we conducted a neuroproteomic study to evaluate METH-induced brain protein dynamics, following a two-week chronic regimen of an escalating dose of METH exposure. Proteins were extracted from rat brain hippocampal and olfactory bulb tissues and subjected to liquid chromatography-mass spectrometry (LCMS/MS) analysis. Both shotgun and targeted proteomic analysis were performed. Protein quantification was initially based on comparing the spectral counts between METH exposed animals and their control counterparts. Quantitative differences were further confirmed through multiple reaction monitoring (MRM) LC-MS/MS experiments. According to the quantitative results, the expression of 18 proteins (11 in the hippocampus and 7 in the olfactory bulb) underwent a significant alteration as a result of exposing rats to METH. 13 of these proteins were up-regulated after METH exposure while 5 were down-regulated. The altered proteins belonging to different structural and functional families were involved in processes such as cell death, inflammation, oxidation, and apoptosis.	[Zhu, Rui; Yang, Tianjiao; Mechref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Kobeissy, Firas; Gold, Mark S.; Wang, Kevin K.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Mouhieddine, Tarek H.; Raad, Mohamad] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon; [Nokkari, Amaly] Amer Univ Beirut, Med Ctr, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon		Mechref, Y (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.; Wang, KK (corresponding author), Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA.	kwang@psychiatry.ufl.edu; yehia.mechref@ttu.edu	Kobeissy, Firas/E-7042-2017; Mechref, Yehia/I-5126-2013	Kobeissy, Firas/0000-0002-5008-6944; Mechref, Yehia/0000-0002-6661-6073; Raad, Mohamad/0000-0002-5446-3786; Mouhieddine, Tarek/0000-0002-1190-5978; Wang, Kevin/0000-0002-9343-6473	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM112490] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001427] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM112490] Funding Source: Medline		Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Akiyama K, 2008, PROG NEURO-PSYCHOPH, V32, P1957, DOI 10.1016/j.pnpbp.2008.09.021; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Choi HJ, 2002, MOL CELLS, V13, P221; Crochemore C, 2009, MUSCLE NERVE, V39, P548, DOI 10.1002/mus.21260; Daulatzai MA, 2015, J NEURAL TRANSM, V122, P1475, DOI 10.1007/s00702-015-1404-6; Davidson C, 2001, BRAIN RES REV, V36, P1, DOI 10.1016/S0165-0173(01)00054-6; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Deng XL, 2002, MOL PHARMACOL, V62, P993, DOI 10.1124/mol.62.5.993; Deng XL, 2002, NEUROPHARMACOLOGY, V42, P837, DOI 10.1016/S0028-3908(02)00034-5; DEVITO MJ, 1989, NEUROPHARMACOLOGY, V28, P1145, DOI 10.1016/0028-3908(89)90130-5; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Elsas J, 2013, DEV NEUROBIOL, V73, P354, DOI 10.1002/dneu.22064; Ernst T, 2000, NEUROLOGY, V54, P1344, DOI 10.1212/WNL.54.6.1344; Fan JW, 2011, CLIN CANCER RES, V17, P2908, DOI 10.1158/1078-0432.CCR-10-2552; Finnegan S, 2010, MOL VIS, V16, P7; Freese TE, 2000, J PSYCHOACTIVE DRUGS, V32, P177, DOI 10.1080/02791072.2000.10400226; Galinato MH, 2015, NEUROSCIENCE, V286, P97, DOI 10.1016/j.neuroscience.2014.11.042; Gluck MR, 2001, J NEUROCHEM, V79, P152, DOI 10.1046/j.1471-4159.2001.00549.x; Granado N, 2010, NEUROTOX RES, V18, P48, DOI 10.1007/s12640-009-9106-1; Groman SM, 2013, PSYCHOPHARMACOLOGY, V229, P527, DOI 10.1007/s00213-013-3159-9; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hanaya R, 2012, NEUROSCIENCE, V221, P12, DOI 10.1016/j.neuroscience.2012.06.058; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Ivanova M, 2014, ACTA NEUROBIOL EXP, V74, P317; IWANAMI A, 1994, ACTA PSYCHIAT SCAND, V89, P428, DOI 10.1111/j.1600-0447.1994.tb01541.x; Jayanthi S, 2014, BIOL PSYCHIAT, V76, P47, DOI 10.1016/j.biopsych.2013.09.034; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1749, DOI 10.1136/jnnp.2003.035287; Keller CM, 2011, PSYCHOPHARMACOLOGY, V215, P513, DOI 10.1007/s00213-011-2301-9; Keverne EB, 2005, NAT NEUROSCI, V8, P1637, DOI 10.1038/nn1205-1637; Kitanaka N, 2010, NEUROCHEM RES, V35, P749, DOI 10.1007/s11064-010-0132-4; Kobeissy FH, 2008, EXPERT REV PROTEOMIC, V5, P293, DOI 10.1586/14789450.5.2.293; Kobeissy FH, 2012, METHODS MOL BIOL, V829, P269, DOI 10.1007/978-1-61779-458-2_17; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Larsen KE, 2002, J NEUROSCI, V22, P8951; Lee DH, 2010, ANAT CELL BIOL, V43, P194, DOI 10.5115/acb.2010.43.3.194; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee KH, 2011, J NEUROSCI RES, V89, P96, DOI 10.1002/jnr.22525; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Moberg Paul J, 2003, Curr Psychiatry Rep, V5, P311, DOI 10.1007/s11920-003-0061-x; Molz S, 2008, NEUROCHEM RES, V33, P27, DOI 10.1007/s11064-007-9402-1; Morales AM, 2015, MOL PSYCHIATR, V20, P764, DOI 10.1038/mp.2015.47; Morales AM, 2012, DRUG ALCOHOL DEPEN, V125, P230, DOI 10.1016/j.drugalcdep.2012.02.017; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Negoias S, 2016, BRAIN IMAGING BEHAV, V10, P367, DOI 10.1007/s11682-015-9400-x; North A, 2013, SYNAPSE, V67, P245, DOI 10.1002/syn.21635; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; Orikabe L, 2011, SCHIZOPHR RES, V132, P183, DOI 10.1016/j.schres.2011.07.006; OTMAKHOVA NA, 1992, PHYSIOL BEHAV, V52, P441, DOI 10.1016/0031-9384(92)90329-Z; Ramkissoon A, 2013, FREE RADICAL BIO MED, V65, P620, DOI 10.1016/j.freeradbiomed.2013.07.043; Riddle EL, 2002, EUR J PHARMACOL, V435, P181, DOI 10.1016/S0014-2999(01)01592-8; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Romero L, 2006, BIOCHEM J, V400, P135, DOI 10.1042/BJ20060110; Ryoo K, 2004, J BIOL CHEM, V279, P43589, DOI 10.1074/jbc.M404359200; Sailasuta N, 2010, J CEREBR BLOOD F MET, V30, P950, DOI 10.1038/jcbfm.2009.261; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Schwartz DL, 2010, NEUROIMAGE, V50, P1392, DOI 10.1016/j.neuroimage.2010.01.056; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; Seo JY, 2009, J NEUROL SCI, V285, P88, DOI 10.1016/j.jns.2009.05.029; Sokolov BP, 2004, PHARMACOL BIOCHEM BE, V77, P319, DOI 10.1016/j.pbb.2003.11.006; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Stumm G, 1999, FASEB J, V13, P1065, DOI 10.1096/fasebj.13.9.1065; Sun KH, 2011, J NEUROCHEM, V118, P902, DOI 10.1111/j.1471-4159.2011.07343.x; Takaichi R, 2012, J NEUROSCI RES, V90, P21, DOI 10.1002/jnr.22740; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Thiriet N, 2001, MOL BRAIN RES, V90, P202, DOI 10.1016/S0169-328X(01)00093-6; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; THORNE BM, 1993, ANN NY ACAD SCI, V702, P131, DOI 10.1111/j.1749-6632.1993.tb17245.x; Tokunaga I, 2008, J MED INVESTIG, V55, P241, DOI 10.2152/jmi.55.241; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Urbina A, 2004, CLIN INFECT DIS, V38, P890, DOI 10.1086/381975; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486; Yamamoto H, 2006, ANN NY ACAD SCI, V1074, P97, DOI 10.1196/annals.1369.009; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Yuan TF, 2014, PROG NEURO-PSYCHOPH, V54, P26, DOI 10.1016/j.pnpbp.2014.05.013; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857; Zuloaga DG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00178	99	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0151034	10.1371/journal.pone.0151034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	WOS:000374291800003	27082425	gold, Green Submitted, Green Published			2022-02-06	
J	Bjorkman, A; Wijk, U; Antfolk, C; Bjorkman-Burtscher, I; Rosen, B				Bjorkman, Anders; Wijk, Ulrika; Antfolk, Christian; Bjorkman-Burtscher, Isabella; Rosen, Birgitta			SENSORY QUALITIES OF THE PHANTOM HAND MAP IN THE RESIDUAL FOREARM OF AMPUTEES	JOURNAL OF REHABILITATION MEDICINE			English	Article						sensory feedback; prosthesis; forearm amputees; referred sensations	UPPER-EXTREMITY AMPUTEES; CORTICAL REORGANIZATION; DISCRIMINATION TEST; NERVE INJURY; AMPUTATION; SENSIBILITY; SENSATION	Objective: Most amputees experience referred sensations, known as a phantom hand map, on the residual forearm, where touch on specific areas is perceived as touch on the amputated hand. The aim of this study was to evaluate the sensory qualities of the phantom hand map. Methods: In 10 traumatic forearm-amputees touch thresholds and discriminative touch of the phantom hand map were assessed and compared with corresponding areas on the contralateral forearm. The study assessed the localization of touch on the phantom hand map, and how distinct and similar to normal touch the referred feeling was. Results: Similar touch thresholds were seen in the phantom hand map and the control site. Tactile discrimination, requiring both detection of stimulus and interpretation, was significantly better in the phantom hand map. Conclusion: This explorative study suggests that the phantom hand map and the superior tactile discrimination seen in the phantom hand map are based on adaptations within the brain. Further studies investigating the neural basis for the phantom hand map are needed.	[Bjorkman, Anders; Wijk, Ulrika; Rosen, Birgitta] Skane Univ Hosp, Dept Hand Surg, SE-20502 Malmo, Sweden; [Antfolk, Christian] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Bjorkman-Burtscher, Isabella] Lund Univ, Dept Radiol, Clin Sci, Lund, Sweden; [Bjorkman-Burtscher, Isabella] Lund Univ, BioImaging Ctr, Lund, Sweden		Rosen, B (corresponding author), Skane Univ Hosp, Dept Hand Surg, SE-20502 Malmo, Sweden.	birgitta.rosen@med.lu.se	Bjorkman, Anders/AAR-5375-2020; Antfolk, Christian/B-2507-2013; Bjorkman-Burtscher, Isabella/AAC-8480-2020	Antfolk, Christian/0000-0001-6783-0461; Bjorkman-Burtscher, Isabella/0000-0002-9023-3363; Wijk, Ulrika/0000-0002-4140-7478	Stockholm Brain Institute; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Crawford Foundation; Promobilia Foundation; Skane County Council Research and Development Foundation	This study was supported by the Stockholm Brain Institute, the Swedish Research Council, the Crawford Foundation, the Promobilia Foundation and Skane County Council Research and Development Foundation. The authors thank Associate Professor Mats Geijer for evaluation of MR images.	Antfolk C, 2012, J REHABIL MED, V44, P702, DOI 10.2340/16501977-1001; Bell-Krotoski J, 1993, J Hand Ther, V6, P114; Bell-Krotoski JA, 2011, REHABILITATION HAND, V1, P132, DOI [10.1016/B978-0-323-05602-1.00011-8, DOI 10.1016/B978-0-323-05602-1.00011-8]; Bjorkman A, 2012, EUR J NEUROSCI, V36, P2098, DOI 10.1111/j.1460-9568.2012.08099.x; BRAUNE S, 1993, J NEUROL NEUROSUR PS, V56, P393, DOI 10.1136/jnnp.56.4.393; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; Grusser SM, 2004, EXP BRAIN RES, V154, P97, DOI 10.1007/s00221-003-1649-4; Grusser SM, 2001, NEUROSCI LETT, V302, P13, DOI 10.1016/S0304-3940(01)01606-8; Hunter JP, 2008, NEUROSCIENCE, V156, P939, DOI 10.1016/j.neuroscience.2008.07.053; Jerosch-Herold C, 2005, J HAND SURG-BRIT EUR, V30B, P252, DOI 10.1016/jshb.2004.12.006; JOHNSON KO, 1994, PROG PAIN RES MANAG, V3, P389; Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P418, DOI 10.1016/j.jhsb.2004.02.008; Lundborg G, 2004, NERVE INJURY REPAIR; MOBERG E, 1990, SCAND J REHABIL MED, V22, P127; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Ramachandran VS, 2000, ARCH NEUROL-CHICAGO, V57, P317, DOI 10.1001/archneur.57.3.317; Schmalzl L., 2011, FRONT HUM NEUROSCI, V5, P1, DOI DOI 10.3389/FNHUM.2011.00001; van Gils W, 2013, ARCH PHYS MED REHAB, V94, P2179, DOI 10.1016/j.apmr.2013.05.025; WEINSTEIN SIDNEY, 1968, P195; Wolfe S, 2011, GREENS OPERATIVE HAN; Wu CWH, 2002, SOMATOSENS MOT RES, V19, P153, DOI 10.1080/08990220220133261	23	11	13	3	11	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2016	48	4					365	370		10.2340/16501977-2074			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DH0EU	WOS:000372456100007	26999267	Green Submitted, gold			2022-02-06	
J	Bomyea, J; Lang, AJ; Delano-Wood, L; Jak, A; Hanson, KL; Sorg, S; Clark, AL; Schiehser, DM				Bomyea, Jessica; Lang, Ariel J.; Delano-Wood, Lisa; Jak, Amy; Hanson, Karen L.; Sorg, Scott; Clark, Alexandra L.; Schiehser, Dawn M.			Neuropsychiatric Predictors of Post-Injury Headache After Mild-Moderate Traumatic Brain Injury in Veterans	HEADACHE			English	Article						traumatic brain injury; headache; post-traumatic headache; post-injury headache	POSTTRAUMATIC-STRESS-DISORDER; MILITARY PERSONNEL; SLEEP DISTURBANCES; CHRONIC PAIN; POSTCONCUSSION SYNDROME; PSYCHOMETRIC PROPERTIES; US SOLDIERS; FATIGUE; PREVALENCE; COMPLAINTS	ObjectivesTo determine differences in neuropsychiatric complaints between Veterans with mild to moderate traumatic brain injury (TBI), with and without headache, compared with Veteran controls, and to identify neuropsychiatric predictors of headache severity. BackgroundMild to moderate TBI is a common occurrence in Veterans, and is frequently associated with complaints of headache. Neuropsychiatric complaints are also common among individuals who have sustained head injury, although the relationship between these factors and headache after injury is unclear. Research is needed to comprehensively determine differences between individuals with mild to moderate traumatic brain injury who differ with respect to headache, and which injury, psychological, or sleep and fatigue factors predict headache severity. MethodsA cross-sectional study compared 85 Veterans in three groups (positive for TBI and headache, positive for TBI without significant headache, and a control group) on a set of injury characteristics and neuropsychiatric variables. Correlates of headache severity were examined, and a regression model was used to identify significant independent predictors of headache severity. ResultsIndividuals with mild to moderate TBI and headache endorsed significantly greater neuropsychiatric symptoms than participants in the other groups ((2)(p)=.23-.36) Neuropsychiatric complaints, as well as presence of posttraumatic amnesia, were correlated with headache in the subsample with TBI (rs=.44-.57). When entering all predictors into a regression model, only fatigue represented a significant independent predictor of headache severity (=.59, R-2= .35). ConclusionsRather than being a global risk factor, mild to moderate TBI was associated with poorer mental health outcomes, particularly for those who endorse headache. Findings underscore the possibility that Veterans with history of TBI who present with complaints of headache may represent a particularly vulnerable subgroup. Additionally, our findings suggest that clinical outcomes may be improved in those with neurotrauma by incorporating a focus on fatigue in treatment.	[Bomyea, Jessica; Delano-Wood, Lisa; Jak, Amy; Hanson, Karen L.; Sorg, Scott; Clark, Alexandra L.; Schiehser, Dawn M.] Vet Affairs San Diego Healthcare Syst, Res & Psychol Serv, San Diego, CA USA; [Bomyea, Jessica; Lang, Ariel J.; Delano-Wood, Lisa; Jak, Amy; Schiehser, Dawn M.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Bomyea, Jessica; Lang, Ariel J.; Delano-Wood, Lisa; Jak, Amy; Hanson, Karen L.; Clark, Alexandra L.; Schiehser, Dawn M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Clark, Alexandra L.] Univ Calif San Diego, SDSU, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA		Schiehser, DM (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	dschiehser@ucsd.edu			Veteran's AdministrationUS Department of Veterans Affairs [CDA-2-065-10S, CX000842-01A2, 829-CD-MH-13858]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; Office of Academic Affiliations, Department of Veterans Affairs: VA Advanced Fellowship Program in Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation	Dr. Schiehser: CDA-2-065-10S, Veteran's Administration; Dr. Delano-Wood: W81XWH-10-2-0169, Department of Defense; CX000842-01A2 and 829-CD-MH-13858, Veteran's Administration. This material is based upon work supported by the Office of Academic Affiliations, Department of Veterans Affairs: VA Advanced Fellowship Program in Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; [Anonymous], 2009, J REHABIL RES DEV, V46, pCP1; Asmundson GJG, 2006, COGN BEHAV PRACT, V13, P8, DOI 10.1016/j.cbpra.2005.03.001; Association AP, 2000, DIAGN STAT MAN MENT; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; BECK AT, 1991, J ANXIETY DISORD, V5, P213, DOI 10.1016/0887-6185(91)90002-B; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Fishbain DA, 2003, PAIN MED, V4, P51, DOI 10.1046/j.1526-4637.2003.03008.x; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lu W, 2014, NEUROREHABILITATION, V35, P245, DOI 10.3233/NRE-141117; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Maizels M, 2004, HEADACHE, V44, P983, DOI 10.1111/j.1526-4610.2004.04192.x; Mastaglia FL, 2012, NEUROMUSCULAR DISORD, V22, pS178, DOI 10.1016/j.nmd.2012.10.003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nestvold K, 2005, ACTA NEUROL SCAND, V112, P13, DOI 10.1111/j.1600-0404.2005.00344.x; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Peres MFP, 2002, CEPHALALGIA, V22, P720, DOI 10.1046/j.1468-2982.2002.00426.x; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rains JC, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-014-0520-2; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Riechers Ronald G 2nd, 2015, Handb Clin Neurol, V128, P567, DOI 10.1016/B978-0-444-63521-1.00036-4; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Russo A, 2014, NEUROL SCI, V35, pS153, DOI 10.1007/s10072-014-1758-9; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Spierings ELH, 1997, HEADACHE, V37, P549, DOI 10.1046/j.1526-4610.1997.3709549.x; Stark CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-014-0468-6; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Vancleef LMG, 2008, J ANXIETY DISORD, V22, P401, DOI 10.1016/j.janxdis.2007.05.006; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Weathers WF, 1993, ANN C INT SOC TRAUM; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	68	11	11	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	APR	2016	56	4					699	710		10.1111/head.12799			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DK1TB	WOS:000374696100007	27028095				2022-02-06	
J	Clark, JM; Hoshizaki, TB				Clark, J. Michio; Hoshizaki, T. Blaine			The Ability of Men's Lacrosse Helmets to Reduce the Dynamic Impact Response for Different Striking Techniques in Women's Field Lacrosse	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; women's field lacrosse; biomechanics of brain injury; injury prevention	TRAUMATIC BRAIN-INJURY; VIDEO INCIDENT ANALYSIS; HIGH-SCHOOL LACROSSE; PROFESSIONAL FOOTBALL; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; HEAD-INJURIES; EYE INJURIES; RECONSTRUCTION; CONCUSSION	Background: Women's field lacrosse is described as a noncontact game relying primarily on rules to decrease the risk of head injuries. Despite not allowing head contact, however, concussions continue to be reported in women's field lacrosse. Purpose: To assess the ability of men's lacrosse helmets to decrease linear and angular acceleration for different striking techniques in women's field lacrosse. Study Design: Controlled laboratory study. Methods: A helmeted and unhelmeted Hybrid III 50th Percentile headform was attached to a Hybrid III neckform and were subjected to impacts by 8 striking techniques. Eleven athletic females completed 5 slashing techniques, while physical reconstruction equipment was used to simulate falls and shoulder and ball impacts to the head. Three trials were conducted for each condition, and peak resultant linear and angular accelerations of the headform were measured. Results: Falls produced the highest linear and angular acceleration, followed by ball and high-velocity stick impacts. Low-velocity stick impacts were found to produce the lowest linear and angular accelerations. Men's lacrosse helmets significantly decreased linear and angular accelerations in all conditions, while unhelmeted impacts were associated with high accelerations. Conclusion: If women's field lacrosse is played within the rules, only falls were found to produce high linear and angular acceleration. However, ball and high-velocity stick impacts were found to produce high linear and angular accelerations. These linear and angular accelerations were found to be within the ranges reported for concussion. When the game is not played within the rules, men's lacrosse helmets provide an effective method of reducing linear and angular accelerations. Thus, women's field lacrosse may be able to reduce the occurrence of high linear and angular acceleration impacts by having governing bodies improving rules, implementing the use of helmets, or both. Clinical Relevance: Identifying striking techniques that produce high linear and angular acceleration specific to women's lacrosse and measuring the capacity of a men's lacrosse helmet to reduce linear and angular acceleration.	[Clark, J. Michio; Hoshizaki, T. Blaine] Univ Ottawa, 200 Lees Ave,A 106, Ottawa, ON K1S 5S9, Canada; [Clark, J. Michio; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, 200 Lees Ave,A 106, Ottawa, ON K1S 5S9, Canada		Clark, JM (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, 200 Lees Ave,A 106, Ottawa, ON K1S 5S9, Canada.	jclar136@uottawa.ca					Auer C, 2001, INT SOC BIOM 18 C JU; Bartosh T. J., 2014, BMJ-BRIT MED J, V4, P1; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Coulson NR, 2009, J ASTM INT, V6, P1; Crisco JJ, 2005, J APPL BIOMECH, V21, P383, DOI 10.1123/jab.21.4.383; Crisco JJ, 2009, J APPL BIOMECH, V25, P184, DOI 10.1123/jab.25.2.184; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly MC, 2009, INT J CRASHWORTHINES, V14, P503, DOI 10.1080/13588260902826554; Doorly M.C., 2007, THESIS U COLL DUBLIN; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Goldenberg Michael S., 1995, Journal of Athletic Training, V30, P37; Hall C, 2013, RES SPORTS MED, V21, P229, DOI 10.1080/15438627.2013.792085; Harmer PA, 1993, SPORT HLTH, V11, P14; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Karton C, 2014, ASTM STP, P23; Krustrup P, 2005, MED SCI SPORT EXER, V37, P1242, DOI 10.1249/01.mss.0000170062.73981.94; LAPIDUS CS, 1992, J TRAUMA, V32, P555, DOI 10.1097/00005373-199205000-00003; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mohr M, 2008, J STRENGTH COND RES, V22, P341, DOI 10.1519/JSC.0b013e318165fef6; Newman J, 2000, P IRCOBI; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2014, IRCOBI C; Post A, 2013, P 1 INT C HELM PERF; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Rousseau P., 2009, J ASTM INT, V6, P1; Rousseau P, 2014, MECH CONCUSSION SPOR; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	43	11	12	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2016	44	4					1047	1055		10.1177/0363546515623272			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DI7FX	WOS:000373665800035	26831628				2022-02-06	
J	Gerstenecker, A; Niccolai, L; Marson, D; Triebel, KL				Gerstenecker, Adam; Niccolai, Lindsay; Marson, Daniel; Triebel, Kristen L.			Enhancing Medical Decision-Making Evaluations: Introduction of Normative Data for the Capacity to Consent to Treatment Instrument	ASSESSMENT			English	Article						capacity; medical decision making; CCTI; normative study; psychometric	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; WAIS-R; COMPETENCE; EDUCATION; AGE; CONSISTENCY; JUDGMENTS; NORMS	A number of measures have been developed to assess medical decision-making capacity (MDC) in adults. However, their clinical utility is limited by a lack of available normative data. In the current study, we introduce age-independent and age-adjusted normative data for a measure of MDC: the Capacity to Consent to Treatment Instrument. The sample consisted of 308 cognitively normal, community-dwelling adults ranging in age from 19 to 86 years. For age-adjusted norms, individual raw scores were first converted to age-corrected scaled scores based on position within a cumulative frequency distribution and then grouped according to empirically supported age ranges. For age-independent norms, the same method was utilized but without age-corrections being applied or participants being grouped into age ranges. This study has the potential to enhance MDC evaluations by allowing clinicians to compare a patient's performance on the Capacity to Consent to Treatment Instrument with that of adults regardless of age as well as to same age peers. Tables containing normative corrections are supplementary material available online at http://asm.sagepub.com/supplemental.	[Gerstenecker, Adam; Niccolai, Lindsay; Marson, Daniel; Triebel, Kristen L.] Univ Alabama Birmingham, Birmingham, AL USA		Triebel, KL (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650, Birmingham, AL 35294 USA.	ktriebel@uab.edu	triebel, kristen/A-6569-2019	triebel, kristen/0000-0001-9161-7847	NIH/NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000166]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R01 AG021927]; NIH/National Institute on Child Health and Human Development [1R01HD053074]; University of Alabama at Birmingham, Department of Neurology; Mentored Research Scholar Grants in Applied and Clinical Research from the American Cancer Society [MRSG-14-204-01-PCSM]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000166, UL1TR001417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021927] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the NIH/NCATS (KL2 TR000166; Triebel), NIH/NIA (1R01 AG021927; Marson, PI), NIH/National Institute on Child Health and Human Development (1R01HD053074; Marson, PI), and by funds from the University of Alabama at Birmingham, Department of Neurology. Kristen Triebel, PsyD, was also supported by a Mentored Research Scholar Grants in Applied and Clinical Research, MRSG-14-204-01-PCSM from the American Cancer Society.	Bambara JK, 2007, EPILEPSY BEHAV, V10, P63, DOI 10.1016/j.yebeh.2006.10.003; Duff K, 2003, CLIN NEUROPSYCHOL, V17, P351, DOI 10.1076/clin.17.3.351.18082; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Edelstein B., 1999, HOPEMONT CAPACITY AS; Gerstenecker A, 2014, J NEURO-ONCOL, V120, P179, DOI 10.1007/s11060-014-1543-x; Grisso T, 1997, PSYCHIATR SERV, V48, P1415; Grisso T., 2003, EVALUATING COMPETENC; Grisso T., 1998, ASSESSING COMPETENCE; Hermann H, 2015, J MED ETHICS, V41, P739, DOI 10.1136/medethics-2014-102263; Huthwaite JS, 2006, BEHAV SCI LAW, V24, P453, DOI 10.1002/bsl.701; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; Kurland, 1992, CLIN NEUROPSYCHOL, V6, P31, DOI [10.1080/13854049208401878, DOI 10.1080/13854049208401878]; MALEC JF, 1993, NEUROPSYCHOLOGY ALZH, P81; Marson DC, 2000, J AM GERIATR SOC, V48, P911, DOI 10.1111/j.1532-5415.2000.tb06887.x; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Marson DC, 1997, J AM GERIATR SOC, V45, P453, DOI 10.1111/j.1532-5415.1997.tb05170.x; Martin RC, 2008, MOVEMENT DISORD, V23, P1867, DOI 10.1002/mds.22170; Moye J, 2006, CLIN PSYCHOL REV, V26, P1054, DOI 10.1016/j.cpr.2005.04.013; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; PAUKER JD, 1988, J CLIN PSYCHOL, V44, P930, DOI 10.1002/1097-4679(198811)44:6<930::AID-JCLP2270440613>3.0.CO;2-H; Smith GE, 1997, ASSESSMENT, V4, P79, DOI 10.1177/107319119700400111; TEPPER AM, 1984, LAW HUMAN BEHAV, V8, P205, DOI 10.1007/BF01044693; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Trachsel M, 2015, AM J ALZHEIMERS DIS, V30, P360, DOI 10.1177/1533317514539377; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce	30	11	11	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	APR	2016	23	2					232	239		10.1177/1073191115599053			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DG8CO	WOS:000372310200008	26282778	Green Accepted			2022-02-06	
J	Southerland, LT; Stephens, JA; Robinson, S; Falk, J; Phieffer, L; Rosenthal, JA; Caterino, JM				Southerland, Lauren T.; Stephens, Julie A.; Robinson, Shari; Falk, James; Phieffer, Laura; Rosenthal, Joseph A.; Caterino, Jeffrey M.			Head Trauma from Falling Increases Subsequent Emergency Department Visits More Than Other Fall-Related Injuries in Older Adults	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						older adults; falls; head trauma; emergency department	FUNCTIONAL DECLINE; CARE; INDIVIDUALS	ObjectivesTo determine whether fall-related injuries affect return to the ED after the initial visit. DesignRetrospective chart review. SettingAcademic Level 1 trauma center ED. ParticipantsIndividuals aged 65 and older evaluated for a fall from standing height or less and discharged (N=263, average age 77, 70% female). MeasurementsAfter institutional review board approval, electronic medical record data were queried. Univariate and multivariable logistic regression models were used to determine factors associated with risk of returning to the ED within 90days. ResultsInjuries included fractures (45%, n=117); head trauma (22%, n=58); abrasions, lacerations, or contusions (34%, n=88); and none (22%, n=57). Emergency care was frequently required, with 13 (5%, 95% confidence interval (CI)=2.3-7.6%) returning within 72hours, 35 (13%, 95% CI=9.2-17%] within 30days, and 57 (22%, 95% CI=17-27%) within 90days. Univariately, the odds of returning to the ED within 90days was more than two times as high for those with head trauma as for those without (odds ratio=2.66). This remained significant in the multivariable model, which controlled for Charlson Comorbidity Index, fractures, soft tissue injuries, and ED observation unit use. ConclusionMore than one-third of older adults with minor head trauma from a fall will need to return to the ED in the following 90days. These individuals should receive close attention from primary care providers. The link between minor head trauma and ED recidivism is a new finding.	[Southerland, Lauren T.; Robinson, Shari; Falk, James; Caterino, Jeffrey M.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Phieffer, Laura] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA; [Rosenthal, Joseph A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Stephens, Julie A.] Ohio State Univ, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA		Southerland, LT (corresponding author), 750 Prior Hall,376 W 10th Ave, Columbus, OH 43210 USA.	Lauren.Southerland@osumc.edu		Southerland, Lauren/0000-0002-3561-8332	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG038351]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG038351] Funding Source: NIH RePORTER	Dr. Caterino's work on this project was supported by the National Institute on Aging Grant K23AG038351.	Bell AJ, 2000, MED J AUSTRALIA, V173, P179, DOI 10.5694/j.1326-5377.2000.tb125596.x; Betz ME, 2014, J AM GERIATR SOC, V62, P1317, DOI 10.1111/jgs.12877; Buurman BM, 2011, EUR J EMERG MED, V18, P215, DOI 10.1097/MEJ.0b013e328344597e; Carpenter CR, 2015, ACAD EMERG MED, V22, P1, DOI 10.1111/acem.12569; Carpenter CR, 2014, ACAD EMERG MED, V21, P1069, DOI 10.1111/acem.12488; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Close JCT, 2012, EMERG MED J, V29, P742, DOI 10.1136/emermed-2011-200380; Hall EC, 2014, J TRAUMA ACUTE CARE, V76, P859, DOI 10.1097/TA.0000000000000148; Hasegawa K, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-40; Hirshson CI, 2013, NEUROREHABILITATION, V32, P225, DOI 10.3233/NRE-130840; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Keegan THM, 2004, AM J EPIDEMIOL, V159, P192, DOI 10.1093/aje/kwh026; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nance ML, 2013, NATL TRAUMA DATA BAS; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Salter AE, 2006, OSTEOPOROSIS INT, V17, P672, DOI 10.1007/s00198-005-0032-7; Sirois MJ, 2013, J AM GERIATR SOC, V61, P1661, DOI 10.1111/jgs.12482; Southerland Lauren T, 2014, Am J Emerg Med, V32, P1089, DOI 10.1016/j.ajem.2014.05.005; Tirrell G, 2015, ACAD EMERG MED, V22, P461, DOI 10.1111/acem.12634; Wang Han-Yi, 2007, Chang Gung Med J, V30, P437; Wang H, 2014, BMC CANCER, V14, DOI [10.1186/1471-2407-14-37, 10.1186/s12879-014-0609-x]; Wilber ST, 2010, ACAD EMERG MED, V17, P679, DOI 10.1111/j.1553-2712.2010.00799.x	23	11	11	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2016	64	4					870	874		10.1111/jgs.14041			5	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DK1WO	WOS:000374705900020	27100582	Green Accepted			2022-02-06	
J	Shih, FY; Chang, HH; Wang, HC; Lee, TH; Lin, YJ; Lin, WC; Chen, WF; Ho, JT; Lu, CH				Shih, Fu-Yuan; Chang, Hsin-Huan; Wang, Hung-Chen; Lee, Tsung-Han; Lin, Yu-Jun; Lin, Wei-Che; Chen, Wu-Fu; Ho, Jih-Tsun; Lu, Cheng-Hsien			Risk factors for delayed neuro-surgical intervention in patients with acute mild traumatic brain injury and intracranial hemorrhage	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Risk factor; Mild traumatic brain injury; Surgical intervention	MINIMAL HEAD-INJURY; COMPUTED-TOMOGRAPHY; CT; COAGULOPATHY	Background: Mild traumatic brain injury (TBI) patients with initial traumatic intracranial hemorrhage (tICH) and without immediate neuro-surgical intervention require close monitoring of their neurologic status. Progressive hemorrhage and neurologic deterioration may need delayed neuro-surgical intervention. This study aimed to determine the potential risk factors of delayed neuro-surgical intervention in mild TBI patients with tICH on admission. Methods: Three hundred and forty patients with mild TBI and tICH who did not need immediate neuro-surgical intervention on admission were evaluated retrospectively. Their demographic information, clinical evaluation, laboratory data, and brain CT was reviewed. Delayed neuro-surgical intervention was defined as failure of non-operative management after initial evaluation. Risk factors of delayed neuro-surgical intervention on admission were analyzed. Results: Delayed neuro-surgical intervention in mild TBI with tICH on initial brain CT accounted for 3.8 % (13/340) of all episodes. Higher WBC concentration, higher initial ISS, epidural hemorrhage (EDH), higher volume of EDH, midline shift, and skull fracture were risk factors of delayed neuro-surgical intervention. The volume of EDH and skull fracture is independent risk factors. One cubic centimeter (cm3) increase in EDH on initial brain CT increased the risk of delayed neurosurgical intervention by 16 % (p = 0.011; OR: 1.190, 95 % CI: 1.041-1.362). Conclusions: Mild TBI patients with larger volume of EDH have higher risk of delayed neuro-surgical interventions after neurosurgeon assessment. Longer and closer neurological function monitor and repeated brain image is required for those patients had initial larger EDH. A large-scale, multi-centric trial with a bigger study population should be performed to validate the findings.	[Shih, Fu-Yuan; Chang, Hsin-Huan; Wang, Hung-Chen; Lee, Tsung-Han; Lin, Yu-Jun; Chen, Wu-Fu; Ho, Jih-Tsun] Chang Gung Univ, Coll Med, Dept Neurosurg, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Dept Neurol, Kaohsiung, Taiwan; [Lin, Wei-Che] Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan; [Lin, Wei-Che] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan		Wang, HC (corresponding author), Chang Gung Univ, Coll Med, Dept Neurosurg, Kaohsiung, Taiwan.; Lu, CH (corresponding author), Chang Gung Univ, Coll Med, Dept Neurol, Kaohsiung, Taiwan.	m82whc@gmail.com					ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Bordignon KC, 2002, ARQ NEURO-PSIQUIAT, V60, P204, DOI 10.1590/S0004-282X2002000200004; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chen H, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/134905; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; Gurkanlar D, 2009, TURK NEUROSURG, V19, P211; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Lozance K, 1998, J CLIN NEUROSCI, V5, P394, DOI 10.1016/S0967-5868(98)90269-7; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Radulovic D, 2006, ZBL NEUROCHIR, V67, P76, DOI 10.1055/s-2006-933359; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	26	11	11	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	MAR 31	2016	11								13	10.1186/s13017-016-0069-2			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	DI1OW	WOS:000373266400001	27034712	Green Published, gold			2022-02-06	
J	Thelin, EP; Frostell, A; Mulder, J; Mitsios, N; Damberg, P; Aski, SN; Risling, M; Svensson, M; Morganti-Kossmann, MC; Bellander, BM				Thelin, Eric Peter; Frostell, Arvid; Mulder, Jan; Mitsios, Nicholas; Damberg, Peter; Aski, Sahar Nikkhou; Risling, Marten; Svensson, Mikael; Morganti-Kossmann, Maria Cristina; Bellander, Bo-Michael			Lesion Size Is Exacerbated in Hypoxic Rats Whereas Hypoxia-Inducible Factor-1 Alpha and Vascular Endothelial Growth Factor Increase in Injured Normoxic Rats: A Prospective Cohort Study of Secondary Hypoxia in Focal Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; hypoxia; hypoxia-inducible factor 1; vascular endothelial growth factor A; S100B; edema; neuronal death; secondary insults	CORTICAL IMPACT INJURY; CLOSED-HEAD INJURY; FLUID-PERCUSSION; EDEMA FORMATION; NEURONAL DEGENERATION; POSTTRAUMATIC HYPOXIA; RECEPTOR EXPRESSION; CEREBRAL CONTUSION; GENDER-DIFFERENCES; GENE-EXPRESSION	Background: Hypoxia following traumatic brain injury (TBI) is a severe insult shown to exacerbate the pathophysiology, resulting in worse outcome. The aim of this study was to investigate the effects of a hypoxic insult in a focal TBI model by monitoring brain edema, lesion volume, serum biomarker levels, immune cell infiltration, as well as the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF). Materials and methods: Female Sprague-Dawley rats (n = 73, including sham and naive) were used. The rats were intubated and mechanically ventilated. A controlled cortical impact device created a 3-mm deep lesion in the right parietal hemisphere. Post-injury, rats inhaled either normoxic (22% O-2) or hypoxic (11 % O-2) mixtures for 30 min. The rats were sacrificed at 1, 3, 7, 14, and 28 days post-injury. Serum was collected for S100B measurements using ELISA. Ex vivo magnetic resonance imaging (MRI) was performed to determine lesion size and edema volume. Immunofluorescence was employed to analyze neuronal death, changes in cerebral macrophage- and neutrophil infiltration, microglia proliferation, apoptosis, complement activation (C5b9), IgG extravasation, HIF-1 alpha, and VEGF. Results: The hypoxic group had significantly increased blood levels of lactate and decreased pO(2) (p < 0.0001). On MRI post-traumatic hypoxia resulted in larger lesion areas (p = 0.0173), and NeuN staining revealed greater neuronal loss (p = 0.0253). HIF-1 alpha. and VEGF expression was significantly increased in normoxic but not in hypoxic animals (p < 0.05). A trend was seen for serum levels of S100B to be higher in the hypoxic group at 1 day after trauma (p = 0.0868). No differences were observed between the groups in cytotoxic and vascular edema, IgG extravasation, neutrophils and macrophage aggregation, microglia proliferation, or C5b-9 expression. Conclusion: Hypoxia following focal TBI exacerbated the lesion size and neuronal loss. Moreover, there was a tendency to higher levels of S100B in the hypoxic group early after injury, indicating a potential validity as a biomarker of injury severity. In the normoxic group, the expression of HIF-1 alpha and VEGF was found elevated, possibly indicative of neuro-protective responses occurring in this less severely injured group. Further studies are warranted to better define the pathophysiology of post-TBI hypoxia.	[Thelin, Eric Peter; Frostell, Arvid; Damberg, Peter; Aski, Sahar Nikkhou; Svensson, Mikael; Morganti-Kossmann, Maria Cristina; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Mulder, Jan; Mitsios, Nicholas] Karolinska Inst, Dept Neurosci, Sci Life Lab, Stockholm, Sweden; [Damberg, Peter; Aski, Sahar Nikkhou] Karolinska Univ Sjukhuset Solna, Karolinska Expt Res & Imaging Ctr, Stockholm, Sweden; [Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Svensson, Mikael; Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Morganti-Kossmann, Maria Cristina] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Morganti-Kossmann, Maria Cristina] Univ Arizona, Coll Med Phoenix, Phoenix Childrens Hosp, Dept Child Hlth,Barrow Neurol Inst, Phoenix, AZ USA		Thelin, EP (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	eric.thelin@ki.se	Svensson, Mikael/F-8662-2012; Mulder, Jan/G-3909-2011; Thelin, Eric Peter/K-2144-2012; Mulder, Jan/AAG-9761-2021	Svensson, Mikael/0000-0003-1179-7003; Mulder, Jan/0000-0003-3717-5018; Thelin, Eric Peter/0000-0002-2338-4364; Mitsios, Nicholas/0000-0001-6243-4953; Morganti-Kossmann, Cristina/0000-0002-0807-2063	Stockholm CountyStockholm County Council; Karolinska InstitutetKarolinska Institutet; SENSUS Region MellanSverige; Swedish Armed Forces	The authors wish to thank Stockholm County, Karolinska Institutet, SENSUS Region MellanSverige and Swedish Armed Forces for funding and resources. We would also like to thank Sarah Hellewell (Department of Surgery, Monash University, Melbourne, VIC, Australia) for help with setting up the hypoxic model.	Agostoe DV, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00047; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Barzo P, 1997, ACT NEUR S, V70, P243; Barzo P, 1997, ACT NEUR S, V70, P119; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Beharier O, 2012, J MATERN-FETAL NEO M, V25, P1523, DOI 10.3109/14767058.2012.664200; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1997, J NEUROSCI, V17, P9172; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DIAMOND L, 1977, J APPL PHYSIOL, V43, P942, DOI 10.1152/jappl.1977.43.6.942; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gandhi C, 2012, BLOOD, V119, P2385, DOI 10.1182/blood-2011-09-376202; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gudjonsson SV, 1932, J PHYSIOL-LONDON, V74, P73, DOI 10.1113/jphysiol.1932.sp002830; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Ladeby R, 2005, GLIA, V50, P121, DOI 10.1002/glia.20159; Lawrence MS, 1996, J CEREBR BLOOD F MET, V16, P181, DOI 10.1097/00004647-199603000-00001; Leonardo CC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-34; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li L, 2007, BRAIN RES, V1180, P133, DOI 10.1016/j.brainres.2007.08.059; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maeda T, 2003, ACT NEUR S, V86, P329; Marmarou A, 2003, ACT NEUR S, V86, P7; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; R Development Core Team, 2008, R LANG ENV STAT COMP; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RStudio I, 2015, SHIN EAS WEB APPL R; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Singh N, 2012, CELL MOL NEUROBIOL, V32, P491, DOI 10.1007/s10571-012-9803-9; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Soares HD, 1995, J NEUROSCI, V15, P8223; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Stroop R, 1998, ACT NEUR S, V71, P303; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yu R, 2001, Chin J Traumatol, V4, P218; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	107	11	12	0	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 7	2016	7								23	10.3389/fneur.2016.00023			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF7WU	WOS:000371569200001	27014178	Green Published, gold			2022-02-06	
J	Adeleye, AO				Adeleye, Amos O.			Clinical and Radiologic Outcome of a Less Invasive, Low-Cost Surgical Technique of Osteoplastic Decompressive Craniectomy	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						decompressive craniectomy; hinge decompressive craniectomy; low-resource practice; surgical technique; outcome study	TRAUMATIC BRAIN-INJURY; HINGE CRANIOTOMY; HEAD-INJURY; BONE FLAP; CLASSIFICATION	Background Decompressive craniectomy (DC) has many technical details with significant constraining logistic/economic considerations in low-resource practice areas. We present a less invasive, cost-saving, and evidence-based technique of DC evolving in our practice. Methods Earlier, we reported a technique of hinge decompressive craniectomy (hDC), in which the frontotemporoparietal skull flap is hinged on the temporal muscle. In this article we describe further refinements of this temporal muscle hDC : The scalp flap is raised in a galeal-skeletonizing plane preserving the subgaleal fascia on the pericranium, ready for use for duraplasty after durotomy. We performed a descriptive analysis of the clinical outcome of this surgical technique in a prospective consecutive cohort of patients with traumatic brain injury (TBI). The primary and secondary clinical outcome measures were in-hospital mortality and survival, respectively, and the immediate as well as long-term surgical wound issues. Results There were 40 cases, 38men (95%) and 2 women over a 40-month period with amild (n = 8), moderate (n = 17), or severe TBI (n = 15). As assessed by the computed tomography Rotterdam score, life-threatening significant brain injury was present in 90%. Poor clinical outcome occurred in about a third of cases (32.5%) mainly in the severe TBI group (77% of poor outcome) and not in the mild TBI group. Surgical site complications occurred in four patients (10%) Conclusions The presented modified temporal muscle hDC technique offers significant economic advantages over the traditional surgical method of DC without added complications. Analysis of the clinical data in a consecutive prospective cohort of patients with potentially fatal TBI who underwent this surgical procedure showed a good outcome in at least two thirds.	[Adeleye, Amos O.] Univ Ibadan, Dept Surg, Div Neurol Surg, Ibadan, Nigeria; [Adeleye, Amos O.] UCH, Ibadan, Nigeria		Adeleye, AO (corresponding author), Univ Coll Hosp, Dept Neurol Surg, PMB 5116, Ibadan 200001, Nigeria.	femdoy@yahoo.com					Adeleye A, 2014, E CENT AFRICA J SURG, V19, P67; Adeleye A Olufemi, 2011, Surg Neurol Int, V2, P150, DOI 10.4103/2152-7806.86227; Adeleye AO, 2013, NEUROSURG QUART, V23, P127, DOI 10.1097/WNQ.0b013e318266c44a; Adeleye AO, 2010, INDIAN J NEUROTRAUM, V7, P41, DOI 10.1016/S0973-0508(10)80010-3; Baldo S, 2010, WORLD NEUROSURG, V73, P552, DOI 10.1016/j.wneu.2010.02.018; Bhaskar IP, 2011, ANZ J SURG, V81, P137, DOI 10.1111/j.1445-2197.2010.05584.x; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; Ito H, 2011, ACTA NEUROCHIR, V153, P2251, DOI 10.1007/s00701-011-1077-3; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kersh AM, 2012, MED J CAIRO U, V80, P143; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Missori P, 2008, SURG NEUROL, V70, P437, DOI 10.1016/j.surneu.2007.03.029; Miyake S, 2006, NEUROL MED-CHIR, V46, P104, DOI 10.2176/nmc.46.104; Mracek J, 2011, ACTA NEUROCHIR, V153, P2259, DOI 10.1007/s00701-011-1132-0; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965	27	11	11	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAR	2016	77	2					167	175		10.1055/s-0035-1566115			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DF1CE	WOS:000371075200012	26731715				2022-02-06	
J	Goldberg, HS; Paterno, MD; Grundmeier, RW; Rocha, BH; Hoffman, JM; Tham, E; Swietlik, M; Schaeffer, MH; Pabbathi, D; Deakyne, SJ; Kuppermann, N; Dayan, PS				Goldberg, Howard S.; Paterno, Marilyn D.; Grundmeier, Robert W.; Rocha, Beatriz H.; Hoffman, Jeffrey M.; Tham, Eric; Swietlik, Marguerite; Schaeffer, Molly H.; Pabbathi, Deepika; Deakyne, Sara J.; Kuppermann, Nathan; Dayan, Peter S.			Use of a remote clinical decision support service for a multicenter trial to implement prediction rules for children with minor blunt head trauma	INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS			English	Article						Clinical decision support; Clinical trial; Interoperability; Service-oriented architecture; Traumatic brain injury; Standards	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; MANAGEMENT; CHILDHOOD; SCANS; RISK	Objective: To evaluate the architecture, integration requirements, and execution characteristics of a remote clinical decision support (CDS) service used in a multicenter clinical trial. The trial tested the efficacy of implementing brain injury prediction rules for children with minor blunt head trauma. Materials and Methods: We integrated the Epic electronic health record (EHR) with the Enterprise Clinical Rules Service (ECRS), a web-based CDS service, at two emergency departments. Patterns of CDS review included either a delayed, near-real-time review, where the physician viewed CDS recommendations generated by the nursing assessment, or a real-time review, where the physician viewed recommendations generated by their own documentation. A backstopping, vendor-based CDS triggered with zero delay when no recommendation was available in the EHR from the web-service. We assessed the execution characteristics of the integrated system and the source of the generated recommendations viewed by physicians. Results: The ECRS mean execution time was 0.74 +/- 0.72 s. Overall execution time was substantially different at the two sites, with mean total transaction times of 19.67 and 3.99 s. Of 1930 analyzed transactions from the two sites, 60% (310/521) of all physician documentation-initiated recommendations and 99% (1390/1409) of all nurse documentation-initiated recommendations originated from the remote web service. Discussion: The remote CDS system was the source of recommendations in more than half of the real-time cases and virtually all the near-real-time cases. Comparisons are limited by allowable variation in user workflow and resolution of the EHR clock. Conclusion: With maturation and adoption of standards for CDS services, remote CDS shows promise to decrease time-to-trial for multicenter evaluations of candidate decision support interventions. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Goldberg, Howard S.; Paterno, Marilyn D.; Rocha, Beatriz H.] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Goldberg, Howard S.; Paterno, Marilyn D.; Rocha, Beatriz H.] Harvard Univ, Sch Med, Boston, MA USA; [Schaeffer, Molly H.; Pabbathi, Deepika] Partners HealthCare Syst, Informat Syst, Boston, MA USA; [Grundmeier, Robert W.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Grundmeier, Robert W.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hoffman, Jeffrey M.] Nationwide Childrens Hosp, Dept Pediat, Sect Emergency Med, Columbus, OH USA; [Hoffman, Jeffrey M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Tham, Eric] Seattle Childrens Res Inst, Res Informat, Seattle, WA USA; [Tham, Eric; Swietlik, Marguerite] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [Swietlik, Marguerite] Univ Colorado, Denver, CO 80202 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Dayan, Peter S.] Columbia Univ, Coll Phys & Surg, Div Pediat Emergency Med, Pediat, New York, NY USA; [Deakyne, Sara J.] Childrens Hosp Colorado, Res Informat, Aurora, CO USA		Goldberg, HS (corresponding author), Partners Healthcare Syst, 93 Worcester St, Wellesley, MA 02481 USA.	hgoldberg@partners.org		Goldberg, Howard/0000-0001-9285-6866	Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality	The authors acknowledge the work of the Clinical Decision Support Consortium (CDSC), led by Dr. Blackford Middleton and supported under a contract with the Agency for Healthcare Research and Quality (AHRQ), in the development of the four layer knowledge specification methodology and ECRS. We also acknowledge the efforts of Sirina Lu at Nationwide Children's Hospital, Richard Boyer at Partners HealthCare System, John Bear, Nola McDougall, and Mike Schmit at Children's Hospital Colorado, Vickie Schum at Cincinnati Children's Hospital Medical Center, and Alan Cole at University of California, Davis Medical Center for their operational support of the clinical trial.	Boxwala AA, 2011, J AM MED INFORM ASSN, V18, pI132, DOI 10.1136/amiajnl-2011-000334; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catley C., 2004, Software Engineering Notes, V29, P130; Deakyne SJ, 2015, APPL CLIN INFORM, V6, P521, DOI 10.4338/ACI-2015-02-RA-0019; Dixon BE, 2013, ARTIF INTELL MED, V59, P45, DOI 10.1016/j.artmed.2013.03.004; Dixon BE, 2013, STUD HEALTH TECHNOL, V192, P1268; Dolin RH, 2006, J AM MED INFORM ASSN, V13, P30, DOI 10.1197/jamia.M1888; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M, 2010, TRAUMATIC BRAIN INJU; Frush DP, 2008, PEDIATR RADIOL, V38, pS629, DOI 10.1007/s00247-008-1006-7; Goldberg Howard S, 2006, AMIA Annu Symp Proc, P294; Goldberg HS, 2014, J AM MED INFORM ASSN, V21, pE55, DOI 10.1136/amiajnl-2013-001990; Kawamoto Kensaku, 2010, Open Med Inform J, V4, P245, DOI 10.2174/1874431101004010245; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee J, 2010, STUD HEALTH TECHNOL, V160, P811, DOI 10.3233/978-1-60750-588-4-811; Lobach DF, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9922-3; Lobach DF, 2007, STUD HEALTH TECHNOL, V129, P861; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Phillips-Wren GE, 2004, OMEGA-INT J MANAGE S, V32, P323, DOI 10.1016/j.omega.2004.01.003; Rao R., 2010, IBM DEV WORKS; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Stantchev V, 2009, 2009 THIRD INTERNATIONAL CONFERENCE ON ADVANCED ENGINEERING COMPUTING AND APPLICATIONS IN SCIENCES (ADVCOMP 2009), P187, DOI 10.1109/ADVCOMP.2009.36; Tekli JM, 2012, IEEE T SERV COMPUT, V5, P387, DOI 10.1109/TSC.2011.11; Willis JM, 2013, STUD HEALTH TECHNOL, V183, P116, DOI 10.3233/978-1-61499-203-5-116; Wright A, 2015, INT J MED INFORM, V84, P901, DOI 10.1016/j.ijmedinf.2015.08.008; Wright A, 2008, J BIOMED INFORM, V41, P982, DOI 10.1016/j.jbi.2008.03.009; Zhang Mingyuan, 2013, AMIA Annu Symp Proc, V2013, P1558	29	11	11	3	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1386-5056	1872-8243		INT J MED INFORM	Int. J. Med. Inform.	MAR	2016	87						101	110		10.1016/j.ijmedinf.2015.12.002			10	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	DB8MD	WOS:000368769900012	26806717				2022-02-06	
J	Heverly-Fitt, S; Rubin, KH; Dennis, M; Taylor, HG; Stancin, T; Gerhardt, CA; Vannatta, K; Bigler, ED; Yeates, KO				Heverly-Fitt, Sara; Rubin, Kenneth H.; Dennis, Maureen; Taylor, H. Gerry; Stancin, Terry; Gerhardt, Cynthia A.; Vannatta, Kathryn; Bigler, Erin D.; Yeates, Keith Owen			Investigating a Proposed Model of Social Competence in Children With Traumatic Brain Injuries	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						psychosocial functioning; school functioning; social skills and development	PROBLEM-SOLVING SKILLS; EXECUTIVE FUNCTIONS; PEER REJECTION; SPINA-BIFIDA; CHILDHOOD; ADJUSTMENT; MEDIATOR; FRIENDSHIP; SYMPTOMS; OUTCOMES	Objective The goal of the current study was to test a proposed model of social competence for children who have suffered a traumatic brain injury (TBI). We hypothesized that both peer and teacher reports of social behavior would mediate the relation between intraindividual characteristics (e.g., executive function) and peer acceptance. Methods Participants were 52 children with TBI (M age = 10.29; M time after injury: 2.46 years). Severity of TBI ranged from complicated mild to severe. Classroom and laboratory measures were used to assess executive function, social behavior, and peer acceptance. Results Analyses revealed that peer reports of social behavior were a better mediator than teacher reports of the associations between executive function, social behaviors, and peer acceptance. Discussion The results underscore the importance of including peer reports of social behavior when developing interventions designed to improve the social, emotional, and behavioral outcomes of children with TBI.	[Heverly-Fitt, Sara; Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Gerhardt, Cynthia A.; Vannatta, Kathryn] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Gerhardt, Cynthia A.; Vannatta, Kathryn] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol Sci, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada		Heverly-Fitt, S (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, 3304 Benjamin Bldg, College Pk, MD 20742 USA.	sfitt@umd.edu	Rubin, Kenneth H/M-5276-2018; Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human Development at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 R01 HD048946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development at the National Institutes of Health (grant number 5 R01 HD048946 to K.O.Y).	Anderson P., 2008, EXECUTIVE FUNCTIONS; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; ASHER SR, 1979, DEV PSYCHOL, V15, P443, DOI 10.1037/0012-1649.15.4.443; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Holbein CE, 2015, J PEDIATR PSYCHOL, V40, P320, DOI 10.1093/jpepsy/jsu101; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Laird RD, 2001, DEV PSYCHOPATHOL, V13, P337, DOI 10.1017/S0954579401002085; Lennon JM, 2015, J PEDIATR PSYCHOL, V40, P336, DOI 10.1093/jpepsy/jsu075; Manly T, 1999, TEA CH TEST EVERYDAY; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reijntjes A, 2006, INFANT CHILD DEV, V15, P89, DOI 10.1002/icd.435; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rubin K. H., 2015, HDB CHILD PSYCHOL DE, V4, P175, DOI [10.1002/9781118963418.childpsy405, DOI 10.1002/9781118963418.CHILDPSY405]; Rubin K.H., 1992, HDB SOCIAL DEV, P283, DOI [10.1007/978-1-4899-0694-6_12, DOI 10.1007/978-1-4899-0694-6]; Rubin KH, 2006, J ABNORM CHILD PSYCH, V34, P143, DOI 10.1007/s10802-005-9017-4; Spangler T, 2009, SOC DEV, V18, P833, DOI 10.1111/j.1467-9507.2008.00517.x; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531	29	11	11	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	MAR	2016	41	2					235	243		10.1093/jpepsy/jsv085			9	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	DJ4QY	WOS:000374193600007	26374864	Green Published			2022-02-06	
J	Lu, XCM; Shear, DA; Deng-Bryant, Y; Leung, LY; Wei, G; Chen, ZY; Tortella, FC				Lu, Xi-Chun May; Shear, Deborah A.; Deng-Bryant, Ying; Leung, Lai Yee; Wei, Guo; Chen, Zhiyong; Tortella, Frank C.			Comprehensive Evaluation of Neuroprotection Achieved by Extended Selective Brain Cooling Therapy in a Rat Model of Penetrating Ballistic-Like Brain Injury	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article							NONDISRUPTIVE AXONAL INJURY; MODERATE HYPOTHERMIA; INTRACEREBRAL HEMORRHAGE; MILD HYPOTHERMIA; SEIZURES; TRAUMA; NORMOTHERMIA; COAGULOPATHY; INFLAMMATION; ISCHEMIA	Brain hypothermia has been considered as a promising alternative to whole-body hypothermia in treating acute neurological disease, for example, traumatic brain injury. Previously, we demonstrated that 2-hours selective brain cooling (SBC) effectively mitigated acute (<= 24 hours postinjury) neurophysiological dysfunction induced by a penetrating ballistic-like brain injury (PBBI) in rats. This study evaluated neuroprotective effects of extended SBC (4 or 8 hours in duration) on sub-acute secondary injuries between 3 and 21 days postinjury (DPI). SBC (34 degrees C) was achieved via extraluminal cooling of rats' bilateral common carotid arteries (CCA). Depending on the experimental design, SBC was introduced either immediately or with a 2- or 4-hour delay after PBBI and maintained for 4 or 8 hours. Neuroprotective effects of SBC were evaluated by measuring brain lesion volume, axonal injury, neuroinflammation, motor and cognitive functions, and post-traumatic seizures. Compared to untreated PBBI animals, 4 or 8 hours SBC treatment initiated immediately following PBBI produced comparable neuroprotective benefits against PBBI-induced early histopathology at 3 DPI as evidenced by significant reductions in brain lesion volume, axonal pathology (beta-amyloid precursor protein staining), neuroinflammation (glial fibrillary acetic protein stained-activated astrocytes and rat major histocompatibility complex class I stained activated microglial cell), and post-traumatic nonconvulsive seizures. In the later phase of the injury (7-21 DPI), significant improvement on motor function (rotarod test) was observed under most SBC protocols, including the 2-hour delay in SBC initiation. However, SBC treatment failed to improve cognitive performance (Morris water maze test) measured 13-17 DPI. The protective effects of SBC on delayed axonal injury (silver staining) were evident out to 14 DPI. In conclusion, the CCA cooling method of SBC produced neuroprotection measured across multiple domains that were evident days/weeks beyond the cooling duration and in the absence of overt adverse effects. These proof-of-concept results suggest that SBC may provide an attractive neuroprotective approach for clinical considerations.	[Lu, Xi-Chun May; Shear, Deborah A.; Deng-Bryant, Ying; Leung, Lai Yee; Wei, Guo; Chen, Zhiyong; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, 503 Robert Grant Ave, Silver Spring, MD USA		Lu, XCM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, 503 Robert Grant Ave, Silver Spring, MD USA.	xi-chun.m.lu.civ@mail.mil			U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program	This work was supported by funding provided by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. We would like to thank Ms. Xiaofang Yang for her excellent technical support on these experiments.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Bernard SA, 2008, RESUSCITATION, V76, P311, DOI 10.1016/j.resuscitation.2007.07.017; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Clark DL, 2009, EXP NEUROL, V220, P391, DOI 10.1016/j.expneurol.2009.10.002; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Cobb Anne M, 2008, J Trauma Nurs, V15, P192, DOI 10.1097/01.JTN.0000343326.93204.0b; Corry JJ, 2008, NEUROCRIT CARE, V9, P189, DOI 10.1007/s12028-008-9092-9; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; Fingas M, 2007, EXP NEUROL, V208, P277, DOI 10.1016/j.expneurol.2007.08.018; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Grande PO, 2009, ACTA ANAESTH SCAND, V53, P1233, DOI 10.1111/j.1399-6576.2009.02074.x; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; Hemmen TM, 2007, STROKE, V38, P794, DOI 10.1161/01.STR.0000247920.15708.fa; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Holzer M, 2008, EUR J ANAESTH, V25, P31, DOI 10.1017/S0265021507003274; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Lu XCM, 2015, J NEUROTRAUM, V32, P1621, DOI 10.1089/neu.2014.3766; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Maeda T, 1999, BRAIN RES, V818, P228, DOI 10.1016/S0006-8993(98)01269-4; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Milhaud D, 2005, J NEUROSURG ANESTH, V17, P49; Misgav Mudi, 2011, Harefuah, V150, P99; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Schmitt FC, 2006, NEUROBIOL DIS, V23, P689, DOI 10.1016/j.nbd.2006.05.008; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Tortella FC, 2015, SHOCK, V44, P17, DOI 10.1097/SHK.0000000000000380; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wei G, 2008, J NEUROTRAUM, V25, P549, DOI 10.1089/neu.2007.0498; Wei G, 2011, THER HYPOTHERMIA TEM, V1, P33, DOI 10.1089/ther.2010.0007; Yao CP, 2011, J NEUROTRAUM, V28, P1237, DOI 10.1089/neu.2010.1678	51	11	11	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2016	6	1					30	39		10.1089/ther.2015.0017			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD5NV	WOS:000369971800007	26684246	Green Published			2022-02-06	
J	Nadal-Nicolas, FM; Rodriguez-Villagra, E; Bravo-Osuna, I; Sobrado-Calvo, P; Molina-Martinez, I; Villegas-Perez, MP; Vidal-Sanz, M; Agudo-Barriuso, M; Herrero-Vanrell, R				Nadal-Nicolas, Francisco M.; Rodriguez-Villagra, Esther; Bravo-Osuna, Irene; Sobrado-Calvo, Paloma; Molina-Martinez, Irene; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta; Herrero-Vanrell, Rocio			Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						NSAIDS; neuroprotection; PLGA; microspheres; ketorolac; Brn3	SPINAL-CORD-INJURY; OPTIC-NERVE TRANSECTION; QUANTITATIVE IN-VIVO; ALBINO SWISS MICE; ADULT-RATS; NEUROTROPHIC FACTOR; OCULAR INFLAMMATION; TRANSIENT ISCHEMIA; DELIVERY SYSTEMS; DOWN-REGULATION	PURPOSE. To assess the neuroprotective effects of ketorolac administration, in solution or delivered from biodegradable microspheres, on the survival of axotomized retinal ganglion cells (RGCs). METHODS. Retinas were treated intravitreally with a single injection of tromethamine ketorolac solution and/or with ketorolac-loaded poly(D,L-lactide-co-glycolide) (PLGA) microspheres. Ketorolac treatments were administered either 1 week before optic nerve crush (pre-ONC) or right after the ONC (simultaneous). In all cases, animals were euthanized 7 days after the ONC. As control, nonloaded microspheres or vehicle (balanced salt solution, BSS) were administered in parallel groups. All retinas were dissected as flat mounts; RGCs were immunodetected with brain-specific homeobox/POU domain protein 3A (Brn3a), and their number was automatically quantified. RESULTS. The percentage of Brn3a(+) RGCs was 36% to 41% in all control groups (ONC with or without BSS or nonloaded microparticles). Ketorolac solution administered pre-ONC resulted in 63% survival of RGCs, while simultaneous administration promoted a 53% survival. Ketorolac-loaded microspheres were not as efficient as ketorolac solution (43% and 42% of RGC survival pre-ONC or simultaneous, respectively). The combination of ketorolac solution and ketorolac-loaded microspheres did not have an additive effect (54% and 55% survival preONC and simultaneous delivery, respectively). CONCLUSIONS. Treatment with the nonsteroidal anti-inflammatory drug ketorolac delays RGC death triggered by a traumatic axonal insult. Pretreatment seems to elicit a better output than simultaneous administration of ketorolac solution. This may be taken into account when performing procedures resulting in RGC axonal injury.	[Nadal-Nicolas, Francisco M.; Sobrado-Calvo, Paloma; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Hosp Clin Univ Virgen de la Arrixaca IMIB ARRIXAC, Inst Murciano Invest Biosanitaria, Murcia, Spain; [Nadal-Nicolas, Francisco M.; Sobrado-Calvo, Paloma; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Univ Murcia, Dept Oftalmol, Murcia, Spain; [Rodriguez-Villagra, Esther; Bravo-Osuna, Irene; Molina-Martinez, Irene; Herrero-Vanrell, Rocio] Univ Complutense Madrid, Fac Farm, Dept Farm & Tecnol Farmaceut, Pza Ramon y Cajal S-N, E-28040 Madrid, Spain; [Rodriguez-Villagra, Esther; Bravo-Osuna, Irene; Molina-Martinez, Irene; Herrero-Vanrell, Rocio] IdISSC, Fdn Invest, HCSC, Madrid, Spain; [Bravo-Osuna, Irene; Molina-Martinez, Irene; Herrero-Vanrell, Rocio] Univ Complutense Madrid, Inst Univ Farm Ind, Madrid, Spain		Herrero-Vanrell, R (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Farm & Tecnol Farmaceut, Pza Ramon y Cajal S-N, E-28040 Madrid, Spain.; Agudo-Barriuso, M (corresponding author), IMIB ARRIXACA, Grp Oftalmol Expt, Edificio LAIB Planta 5,Carretera Buenavista S-N, El Palmar 30120, Spain.	martabar@um.es; rociohv@farm.ucm.es	Herrero-Vanrell, Rocio/G-6849-2017; Vidal-Sanz, Manuel/J-6989-2016; Agudo-Barriuso, Marta/B-7100-2016; Martinez, Irene Teresa Molina/G-4970-2017; Bravo-Osuna, Irene/M-3469-2015	Herrero-Vanrell, Rocio/0000-0001-9764-7975; Vidal-Sanz, Manuel/0000-0002-9216-1615; Agudo-Barriuso, Marta/0000-0002-8566-9277; Martinez, Irene Teresa Molina/0000-0002-9157-571X; Bravo-Osuna, Irene/0000-0003-3133-7872; Nadal-Nicolas, Francisco M./0000-0003-4121-514X	Spanish Ministry of Education and ScienceSpanish Government [SAF-2012-38328]; ISCIII-FEDER [PI13/00643, PI13/01266]; ISCIII-FEDER Red Tematica de Investigacion Cooperativa en Oftalmologia RETICS (Oftared) [RD12/0034/0003, RD12/0034/0014]; Complutense Research Group UCM [920415-GR3/14]; Spanish Ministry of Economy and Competitiveness MICINN-MAT [2013-43127R]	Supported by Spanish Ministry of Education and Science SAF-2012-38328; ISCIII-FEDER "Una manera de hacer Europa" PI13/00643, PI13/01266; ISCIII-FEDER Red Tematica de Investigacion Cooperativa en Oftalmologia RETICS (Oftared) RD12/0034/0003 and RD12/0034/0014, Complutense Research Group UCM 920415-GR3/14 and Spanish Ministry of Economy and Competitiveness MICINN-MAT 2013-43127R.	Agudo M, 2008, MOL VIS, V14, P1050; Agudo-Barriuso M, 2013, INVEST OPHTH VIS SCI, V54, P4249, DOI 10.1167/iovs.12-11451; Al Dhibi HA, 2013, WORLD J DIABETES, V4, P295, DOI 10.4239/wjd.v4.i6.295; Lopez-Villodres JA, 2012, EUR J PHARM SCI, V45, P624, DOI 10.1016/j.ejps.2012.01.001; Bagriyanik HA, 2008, ADV THER, V25, P152, DOI 10.1007/s12325-008-0018-x; Baranano DE, 2009, BRIT J OPHTHALMOL, V93, P1387, DOI 10.1136/bjo.2009.157297; Barcia E, 2009, EXP EYE RES, V89, P238, DOI 10.1016/j.exer.2009.03.012; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berthelot JM, 2013, JOINT BONE SPINE, V80, P363, DOI 10.1016/j.jbspin.2012.12.001; Brown J, 2007, OPHTHALMOLOGY, V114, P1876, DOI 10.1016/j.ophtha.2007.04.035; Bucolo C, 2014, J PHARM PHARMACOL, V66, P954, DOI 10.1111/jphp.12224; Checa-Casalengua P, 2011, J CONTROL RELEASE, V156, P92, DOI 10.1016/j.jconrel.2011.06.023; Conti SM, 2006, CURR OPIN OPHTHALMOL, V17, P235, DOI 10.1097/01.icu.0000193107.00089.ee; Cuenca N, 2010, EXP EYE RES, V91, P273, DOI 10.1016/j.exer.2010.05.020; Diem R, 2003, J NEUROSCI, V23, P6993, DOI 10.1523/JNEUROSCI.23-18-06993.2003; Dimitriu C, 2008, INVEST OPHTH VIS SCI, V49, P5003, DOI 10.1167/iovs.08-1869; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Guy WM, 2014, JAMA OPHTHALMOL, V132, P567, DOI 10.1001/jamaophthalmol.2014.82; Heiduschka P, 2006, GRAEF ARCH CLIN EXP, V244, P1512, DOI 10.1007/s00417-005-0164-7; Herrero-Vanrell R., 2010, RETINAL PHARMACOTHER, DOI [10.1016/b978-1-4377-0603-1.00014-4, DOI 10.1016/B978-1-4377-0603-1.00014-4]; Herrero-Vanrell R, 2014, PROG RETIN EYE RES, V42, P27, DOI 10.1016/j.preteyeres.2014.04.002; Jehle T, 2008, GRAEF ARCH CLIN EXP, V246, P1255, DOI 10.1007/s00417-007-0746-7; Jiang S, 2004, INT J IMMUNOPATH PH, V17, P353, DOI 10.1177/039463200401700315; Ju WK, 2003, EXP EYE RES, V77, P137, DOI 10.1016/S0014-4835(03)00128-3; Ju WK, 2002, J COMP NEUROL, V452, P392, DOI 10.1002/cne.10400; Kapin MA, 2003, INFLAMMATION, V27, P281, DOI 10.1023/A:1026024409826; Klegeris A, 2002, NEUROBIOL AGING, V23, P787, DOI 10.1016/S0197-4580(02)00021-0; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; Madura T, 2011, J PLAST RECONSTR AES, V64, P1641, DOI 10.1016/j.bjps.2011.07.014; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Margalit E, 2006, INVEST OPHTH VIS SCI, V47, P2093, DOI 10.1167/iovs.05-0764; Martinez-Sancho C, 2004, J CONTROL RELEASE, V99, P41, DOI 10.1016/j.jconrel.2004.06.004; Mihalcea Oana, 2008, Oftalmologia, V52, P36; MIN DI, 1991, PHARMACOTHERAPY, V11, pS119; Montero JA, 2009, CURR DIABETES REV, V5, P26, DOI 10.2174/157339909787314211; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P4309, DOI 10.1167/iovs.15-16963; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Park EM, 2005, NEUROSCIENCE, V132, P625, DOI 10.1016/j.neuroscience.2005.01.021; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Prodanov D, 1998, ARCH PHYSIOL BIOCHEM, V106, P355, DOI 10.1076/apab.106.5.355.4361; Redondo-Castro E, 2014, EXP NEUROL, V252, P95, DOI 10.1016/j.expneurol.2013.11.008; Rodrigues EB, 2016, DEV OPHTHALMOL, V55, P212, DOI 10.1159/000431197; Rovere G, 2015, INVEST OPHTH VIS SCI, V56, P4487, DOI 10.1167/iovs.15-17145; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Sharma J, 2003, CURR EYE RES, V27, P309, DOI 10.1076/ceyr.27.5.309.17222; Sharp KG, 2013, EXP NEUROL, V248, P321, DOI 10.1016/j.expneurol.2013.06.023; Steinsapir KD, 2000, RESTOR NEUROL NEUROS, V17, P157; Turan-Vural E, 2014, INT OPHTHALMOL, V34, P525, DOI 10.1007/s10792-013-9847-y; Valiente-Soriano FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121134; Valiente-Soriano FJ, 2015, INVEST OPHTH VIS SCI, V56, P1924, DOI 10.1167/iovs.15-16454; Vidal-Sanz M, 2015, PROG BRAIN RES, V220, P1, DOI 10.1016/bs.pbr.2015.04.008; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wang AG, 2002, EXP EYE RES, V74, P651, DOI 10.1006/exer.2002.1190; Wang MZ, 2012, RETINA-J RET VIT DIS, V32, P2158, DOI 10.1097/IAE.0b013e3182576d1d; Wang QW, 2013, OPHTHALMOLOGICA, V229, P187, DOI 10.1159/000346847; Wang XX, 2009, J NEUROTRAUM, V26, P81, DOI 10.1089/neu.2007.0464; Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003; Yasukawa Tsutomu, 2011, Recent Pat Drug Deliv Formul, V5, P1, DOI 10.2174/187221111794109529; ZIMMER A, 1995, ADV DRUG DELIVER REV, V16, P61, DOI 10.1016/0169-409X(95)00017-2	68	11	11	1	14	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	MAR	2016	57	3					1183	1192		10.1167/iovs.15-18213			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	DK4BE	WOS:000374860600055	26975030	gold			2022-02-06	
J	Pabon, MM; Acosta, S; Guedes, VA; Tajiri, N; Kaneko, Y; Borlongan, CV				Pabon, Mibel M.; Acosta, Sandra; Guedes, Vivian A.; Tajiri, Naoki; Kaneko, Yuji; Borlongan, Cesar V.			Brain Region-Specific Histopathological Effects of Varying Trajectories of Controlled Cortical Impact Injury Model of Traumatic Brain Injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Cerebellum; Cortex; Inflammation; Neurogenesis; Olfactory bulb; Trauma	FLUID PERCUSSION INJURY; HEAD-INJURY; COGNITIVE PERFORMANCE; ANIMAL-MODELS; UNITED-STATES; ADULT RATS; NEUROGENESIS; BLAST; HIPPOCAMPUS; DEFICITS	AimsTraumatic brain injury (TBI) occurs when the head is impacted by an external force causing either a closed or penetrating head injury through a direct or accelerating impact. In laboratory research, most of the TBI animal models focus on a specific region to cause brain injury, but traumatic injuries in patients do not always impact the same brain regions. The aim of this study was to examine the histopathological effects of different angles of mechanical injury by manipulating the trajectory of the controlled cortical impact injury (CCI) model in adult Sprague-Dawley rats. MethodsThe CCI model was manipulated as follows: conventional targeting of the frontal cortex, farthest right angle targeting the frontal cortex, closest right angle targeting the frontal cortex, olfactory bulb injury, and cerebellar injury. Three days after TBI, brains were harvested to analyze cortical and hippocampal cell loss, neuroinflammatory response, and neurogenesis via immunohistochemistry. ResultsResults revealed cell death in the M1 region of the cortex across all groups, and in the CA3 area from olfactory bulb injury group. This observed cell death involved upregulation of inflammation as evidenced by rampant MHCII overexpression in cortex, but largely spared Ki-67/nestin neurogenesis in the hippocampus during this acute phase of TBI. ConclusionThese results indicate a trajectory-dependent injury characterized by exacerbation of inflammation and different levels of impaired cell proliferation and neurogenesis. Such multiple brain areas showing varying levels of cell death after region-specific CCI model may closely mimic the clinical manifestations of TBI.	[Pabon, Mibel M.; Acosta, Sandra; Guedes, Vivian A.; Tajiri, Naoki; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Coll Med, Tampa, FL 33612 USA		Borlongan, CV (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Kaneko, Yuji/J-6447-2012	Borlongan, Cesar/0000-0002-2966-9782; de Alvarenga Guedes, Vivian/0000-0001-8478-2465	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Byrd Alzheimer's Research Grant; National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	Financial support for this study was provided by the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience funds, the University of South Florida and Veterans Administration Reintegration Funds, University of South Florida Byrd Alzheimer's Research Grant, and the University of South Florida Neuroscience Collaborative Program. CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, and James and Esther King Foundation for Biomedical Research Program.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carey ME, 1990, J NEUROTRAUM, V7, P13, DOI 10.1089/neu.1990.7.13; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Thais MERD, 2012, CNS NEUROSCI THER, V18, P606, DOI 10.1111/j.1755-5949.2012.00346.x; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Ohab JJ, 2008, NEUROSCIENTIST, V14, P369, DOI 10.1177/1073858407309545; OTTO T, 1991, BEHAV NEUROSCI, V105, P111, DOI 10.1037/0735-7044.105.1.111; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Steuer E, 2014, J NEUROTRAUM, V31, P1277, DOI 10.1089/neu.2013.3296; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tajiri N, 2014, BRAIN RES, V1559, P65, DOI 10.1016/j.brainres.2014.02.041; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Vanderwolf CH, 2001, BEHAV BRAIN RES, V127, P25, DOI 10.1016/S0166-4328(01)00354-0; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zanier ER, 2013, CNS NEUROSCI THER, V19, P695, DOI 10.1111/cns.12128; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; Zhao SS, 2013, CNS NEUROSCI THER, V19, P194, DOI 10.1111/cns.12058	59	11	11	1	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	MAR	2016	22	3					200	211		10.1111/cns.12485			12	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DF6UF	WOS:000371491700006	26775604	hybrid, Green Published			2022-02-06	
J	Rahmani, A; Hatefi, M; Dastjerdi, MM; Zare, M; Imani, A; Shirazi, D				Rahmani, Asghar; Hatefi, Masoud; Dastjerdi, Masoud Moghadas; Zare, Mahsa; Imani, Asad; Shirazi, Davood			Correlation Between Serum Homocysteine Levels and Outcome of Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						CT scan; Glasgow Coma Scale; Homocysteine; Outcome; Prognosis; Traumatic brain injury	HEAD-INJURY; CEREBROSPINAL-FLUID; RISK	OBJECTIVE: To examine the relationship between homocysteine (Hcy) plasma levels and the outcome of patients with traumatic brain injury (TBI). METHODS: In a prospective case-control study, demographic, clinical, and Glasgow Coma Scale score data were collected. Outcome was evaluated according to the Glasgow Outcome Scale score at the time of discharge from the hospital and 6 months after hospitalization. Plasma levels of Hcy were measured using high-performance liquid chromatography. Computed tomography scan of the brain was performed within the first 24 hours of hospitalization. RESULTS: The case group comprised 150 patients with TBI (men, 54.7%; mean age, 55.90 years +/- 12.31), and a control group comprised 150 healthy individuals (men, 52%; mean age, 49.56 years +/- 15.64) were studied. The mean +/- SD plasma Hcy level in the TBI group (20.91 mmol/L +/- 15.56) was significantly higher than plasma Hcy level in the control group (7.45 mmol/L +/- 13.54, P = 0.000). There was a significant relationship between Hcy plasma levels and Glasgow Coma Scale score and computed tomography findings classified by the Marshall score. (P = 0.001 and P = 0.028, respectively). Also, there was a significant difference in mean Hcy plasma between patients who died as a result of TBI and patients who were still alive at the end of the study period according to Glasgow Outcome Scale score (P = 0.000 and P = 0.054, respectively). CONCLUSIONS: There was a significant correlation in this study between plasma Hcy levels and severity of trauma and prognosis in patients with TBI.	[Shirazi, Davood] Ilam Univ Med Sci, Gen Med, Student Res Comm, Ilam, Iran; [Rahmani, Asghar] Ilam Univ Med Sci, Student Res Comm, Ilam, Iran; [Hatefi, Masoud] Ilam Univ Med Sci, Dept Neurosurg, Sch Med, Ilam, Iran; [Dastjerdi, Masoud Moghadas] Esfahan Univ Med Sci, Dept Emergency Med, Sch Med, Esfahan, Iran; [Zare, Mahsa] Int Shiraz Univ Med Sci, Dept Pharmacol, Sch Pharmacol, Shiraz, Iran; [Imani, Asad] Shahid Beheshti Univ Med Sci, Dept Nursing & Midwifery, Med & Surg Nursing Educ, Tehran, Iran		Rahmani, A (corresponding author), Ilam Univ Med Sci, Student Res Comm, Ilam, Iran.	asrahmani1991@yahoo.com	asadollahi, khairollah/A-8011-2011; Imani, Asad/G-9021-2019	asadollahi, khairollah/0000-0001-7701-1558; Imani, Asad/0000-0002-6748-2986; Hatafi, Masoud/0000-0002-1529-2419	School of Medicine, Ilam University of Medical Sciences	This study was supported by the School of Medicine, Ilam University of Medical Sciences.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; BAKAY RAE, 1986, NEUROSURGERY, V18, P376, DOI 10.1227/00006123-198603000-00026; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Cristofori L, 2005, CLIN BIOCHEM, V38, P97, DOI 10.1016/j.clinbiochem.2004.09.013; da Cunha MJ, 2012, INT J DEV NEUROSCI, V30, P69, DOI 10.1016/j.ijdevneu.2012.01.001; Dayal S, 2004, STROKE, V35, P1957, DOI 10.1161/01.STR.0000131749.81508.18; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Longstreth WT, 2004, ARCH NEUROL-CHICAGO, V61, P67, DOI 10.1001/archneur.61.1.67; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Matsui T, 2001, STROKE, V32, P1116, DOI 10.1161/01.STR.32.5.1116; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Postea O, 2006, ARTERIOSCL THROM VAS, V26, P508, DOI 10.1161/01.ATV.0000201039.21705.dc; Sachdev P, 2004, J NEUROL SCI, V226, P25, DOI 10.1016/j.jns.2004.09.006; Sachdev P, 2004, ARCH NEUROL-CHICAGO, V61, P1369, DOI 10.1001/archneur.61.9.1369; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Streck EL, 2003, NEUROCHEM INT, V43, P597, DOI 10.1016/S0197-0186(02)00230-9; [The American Association of Neurological Surgeons The Brain Trauma Foundation], 2000, J NEUROTRAUM, V17, P463; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Verkhratsky A, 2006, J CELL MOL MED, V10, P826, DOI 10.1111/j.1582-4934.2006.tb00527.x; Wang L, 2005, ANN CLIN LAB SCI, V35, P79; Zieminska E, 2003, NEUROCHEM INT, V43, P481, DOI 10.1016/S0197-0186(03)00038-X	28	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2016	87						507	515		10.1016/j.wneu.2015.09.016			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3HR	WOS:000373390200070	26386458				2022-02-06	
J	Wiegand, J; Hickson, L; Merz, TM				Wiegand, Jan; Hickson, Liz; Merz, Tobias M.			Indicators of external ventricular drainage-related infections-a retrospective observational study	ACTA NEUROCHIRURGICA			English	Article						EVD infection; Diagnostic parameters; Markers of inflammation; CSF analysis	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID; INTRACEREBRAL HEMORRHAGE; EARLY-DIAGNOSIS; RISK-FACTORS; EPIDEMIOLOGY; PROCALCITONIN; MANAGEMENT	External ventricular drainage (EVD) is frequently used in different groups of patients in neurocritical care. Despite the frequent use of EVD, no consensus regarding the diagnosis of EVD-related infection currently exists, and diagnosis is commonly based on criteria for the diagnosis of non-EVD-related CNS infections. This study evaluates the diagnostic accuracy of clinical and laboratory parameters for the prediction of EVD-related infection in patients with proven EVD-related infection. In two tertiary care centers, data on EVD insertions were matched with a microbiologic database of cultured microorganisms and positive Gram stains of cerebrospinal fluid (CSF) to identify patients with EVD-related infections. Available clinical data and results of blood tests and CSF analysis were retrospectively collected. Predefined potential clinical and laboratory predictors of EVD-related infection were compared between three time points: at the time EVD insertion and 48 h before and at the time of occurrence of EVD-related infection. Thirty-nine patients with EVD-associated infection defined by positive CSF culture or positive CSF Gram stains and concomitant clinical signs of infection were identified. At the time of infection, a significantly higher incidence of abnormal temperature, high respiratory rate, and a slightly but significantly higher incidence of decreased mental state were observed. The assessed blood and CSF parameters did not significantly differ between the different assessment time points. Our analysis of 39 patients with culture positive EVD-related infection showed that commonly used clinical and laboratory parameters are not reliable infection predictors.	[Wiegand, Jan; Merz, Tobias M.] Univ Hosp Bern, Dept Intens Care Med, CH-3010 Bern, Switzerland; [Wiegand, Jan; Merz, Tobias M.] Univ Bern, CH-3010 Bern, Switzerland; [Hickson, Liz] Royal N Shore Hosp, Dept Intens Care Med, St Leonards, NSW 2065, Australia		Merz, TM (corresponding author), Univ Hosp Bern, Dept Intens Care Med, CH-3010 Bern, Switzerland.; Merz, TM (corresponding author), Univ Bern, CH-3010 Bern, Switzerland.	tobias.merz@insel.ch	Merz, Tobias/AAE-8323-2020				AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Berger C, 2002, CRIT CARE MED, V30, P1778, DOI 10.1097/00003246-200208000-00017; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; BRODERICK JP, 1993, J NEUROSURG, V78, P188, DOI 10.3171/jns.1993.78.2.0188; CLARK WC, 1989, NEUROSURGERY, V25, P20; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gordon M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0567-0; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hillier SL, 1997, BRAIN INJURY, V11, P649; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Khan SH, 1998, ACT NEUR S, V71, P50; Lai L, 2012, J CLIN NEUROSCI, V19, P733, DOI 10.1016/j.jocn.2011.09.001; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Lopez-Cortes LF, 2000, CRIT CARE MED, V28, P215, DOI 10.1097/00003246-200001000-00035; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Nathan BR, 2002, CURR CLIN TOPICS INF, V22, P155; Neuman MI, 2008, PEDIATR INFECT DIS J, V27, P309, DOI 10.1097/INF.0b013e31815f53ba; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; STENAGER E, 1986, ACTA NEUROCHIR, V83, P20, DOI 10.1007/BF01420503; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; van Mourik MSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051509; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169	36	11	12	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2016	158	3					595	601		10.1007/s00701-016-2709-4			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD6ZX	WOS:000370074500033	26811299	Green Published			2022-02-06	
J	Jin, HB; Li, WL; Dong, CZ; Ma, L; Wu, J; Zhao, WQ				Jin, Hongbo; Li, Wenling; Dong, Changzheng; Ma, Li; Wu, Jiang; Zhao, Wenqing			Effects of Different Doses of Levetiracetam on Aquaporin 4 Expression in Rats with Brain Edema Following Fluid Percussion Injury	MEDICAL SCIENCE MONITOR			English	Article						Aquaporin 4; Brain Edema; Real-Time Polymerase Chain Reaction	CEREBRAL EDEMA; MODEL; AQP4; TBI; INHIBITION; ASTROCYTES; HIF1-ALPHA	Background: This study was designed to investigate the effects of different doses of levetiracetam on aquaporin 4 (AQP4) expression in rats after fluid percussion injury. Material/Methods: Sprague-Dawley rats were randomly divided into 4 groups: sham operation group, traumatic brain injury group, low-dose levetiracetam group, and high-dose levetiracetam group. Brain edema models were established by fluid percussion injury, and intervened by the administration of levetiracetam. Samples from the 4 groups were collected at 2, 6, 12, and 24 h, and at 3 and 7 days after injury. Histological observation was performed using hematoxylin-eosin staining and immunohistochemical staining. AQP4 and AQP4 mRNA expression was detected using Western blot assay and RT-PCR. Brain water content was measured by the dry-wet method. Results: Compared with the traumatic brain injury group, brain water content, AQP4 expression, and AQP4 mRNA expression were lower in the levetiracetam groups at each time point and the differences were statistically significant (P<0.05). The intervention effects of high-dose levetiracetam were more apparent. Conclusions: Levetiracetam can lessen brain edema from fluid percussion injury by down-regulating AQP4 and AQP4 mRNA expression. There is a dose-effect relationship in the preventive effect of levetiracetam within a certain extent.	[Jin, Hongbo; Zhao, Wenqing] Hebei Med Univ, Fac Grad Studies, Shijiazhuang, Hebei, Peoples R China; [Li, Wenling; Dong, Changzheng; Wu, Jiang; Zhao, Wenqing] Hebei Gen Hosp, Dept Funct Neurosurg, Shijiazhuang, Hebei, Peoples R China; [Ma, Li] Second Hosp Shijiazhuang, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China		Zhao, WQ (corresponding author), Hebei Med Univ, Fac Grad Studies, Shijiazhuang, Hebei, Peoples R China.; Zhao, WQ (corresponding author), Hebei Gen Hosp, Dept Funct Neurosurg, Shijiazhuang, Hebei, Peoples R China.	wenqingzhaohebei@sina.com			Natural Science Foundation Project of Hebei Province [H2014307060]; Department of Science and Technology of Hebei Province [13277767D]	This work was supported by the Natural Science Foundation Project of Hebei Province (no. H2014307060) and the Department of Science and Technology of Hebei Province (no. 13277767D)	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Amorini AM, 2003, ACT NEUR S, V86, P261; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Benge JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00195; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; Filippidis AS, 2014, J NEUROTRAUM, V31, P1258, DOI 10.1089/neu.2013.3063; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Iliff JJ, 2014, J NEUROSCI, V34, P16180; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P390; Kitchen P, 2015, J BIOL CHEM, V290, P16873, DOI 10.1074/jbc.M115.646034; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lo Pizzo M, 2013, NEUROL SCI, V34, P1309, DOI 10.1007/s10072-012-1233-4; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ramakrishnan Vivek, 2015, Surg Neurol Int, V6, P8, DOI 10.4103/2152-7806.149613; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; Sviri GE, 2015, J NEUROSURG; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wu WC, 2014, BRIT J NEUROSURG, V28, P739, DOI 10.3109/02688697.2014.915007; Zou HC, 2015, BRAIN INJURY, V29, P78, DOI 10.3109/02699052.2014.955528; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	35	11	12	0	2	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	FEB 29	2016	22						678	686		10.12659/MSM.897201			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DF0KK	WOS:000371027700002	26927633	Green Published			2022-02-06	
J	Haran, FJ; Dretsch, MN; Slaboda, JC; Johnson, DE; Adam, OR; Tsao, JW				Haran, F. Jay; Dretsch, Michael N.; Slaboda, Jill C.; Johnson, Dagny E.; Adam, Octavian R.; Tsao, Jack W.			Comparison of baseline-referenced versus norm-referenced analytical approaches for in-theatre assessment of mild traumatic brain injury neurocognitive impairment	BRAIN INJURY			English	Article						normative; baseline; neurocognitive; ANAMA; military; mTBI	SPORTS-RELATED CONCUSSION; ASSOCIATION POSITION STATEMENT; ASSESSMENT METRICS ANAM; NEUROPSYCHOLOGICAL ASSESSMENT; CLINICAL-SIGNIFICANCE; TEST-PERFORMANCE; NORMATIVE DATA; MANAGEMENT; UTILITY; ENVIRONMENT	Primary objective: To examine differences between the baseline-referenced and norm-referenced approaches for determining decrements in Automated Neuropsychological Assessment Metrics Version 4 TBI-MIL (ANAM) performance following mild traumatic brain injury (mTBI). Research design: ANAM data were reviewed for 616 US Service members, with 528 of this sample having experienced an mTBI and 88 were controls. Methods and procedures: Post-injury change scores were calculated for each sub-test: (1) normative change score = in-theater score - normative mean and (2) baseline change score = in-theater score - pre-deployment baseline. Reliable change cut-scores were applied to the change and the resulting frequency distributions were compared using McNemar tests. Receiver operator curves (ROC) using both samples (i.e. mTBI and control) were calculated for the change scores for each approach to determine the discriminate ability of the ANAM. Main outcomes and results: There were no statistical differences, p < 0.05 (Bonferonni-Holm corrected), between the approaches. When the area under the curve for the ROCs were averaged across sub-tests, there were no significant differences between either the norm-referenced (0.65) or baseline-referenced (0.66) approaches, p > 0.05. Conclusions: Overall, the findings suggest there is no clear advantage of using the baseline-referenced approach over norm-referenced approach.	[Haran, F. Jay] Naval Submarine Med Res Lab, Groton, CT USA; [Dretsch, Michael N.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Slaboda, Jill C.] Geneva Fdn, Tacoma, WA USA; [Johnson, Dagny E.] Eyak Dev Corp, Arlington, VA USA; [Adam, Octavian R.] Naval Med Ctr Portsmouth, Portsmouth, VA USA; [Tsao, Jack W.] US Navy, Bur Med & Surg, Arlington, VA USA		Haran, FJ (corresponding author), Naval Submarine Med Res Lab, Warfighter Performance Dept, Naval Submarine Base New London Box 900, Groton, CT 06349 USA.	francis.j.haran.mil@mail.mil			US Navy Bureau of Medicine and Surgery Project [255]	This report was supported by the US Navy Bureau of Medicine and Surgery Project #255. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense or the U.S. Government. Approved for public release; distribution is unlimited. This study protocol was reviewed by the Navy Experimental Diving Unit Institutional Review Board and determined to not qualify as human subject research in compliance with all applicable Federal regulations governing the protection of human subjects. LT Haran and MAJ Dretsch are military service members. This work was prepared as part of their official duties. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	[Anonymous], 2013, 649013 DODI; Attix DK, 2009, CLIN NEUROPSYCHOL, V23, P21, DOI 10.1080/13854040801945078; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Barth JT, 1989, MILD HEAD INJURY, P257; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Chelune GJ, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P123; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Coldren RL, 2011, MIL MED, V176, pIV; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Defense and Veterans Brain Injury Center, 2014, DOD WORLD WID NUMB T; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Dretsch M, 2015, APPL NEUROPSYCH-ADUL, V22, P304, DOI 10.1080/23279095.2014.926454; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Graham R, 2014, CONCUSSION RECOGNITI, P125; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Haran FJ, 2015, J HEAD TRAUMA R 0819; Heaton R.K., 2003, CLIN INTERPRETATION; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kendall PC, 1999, J CONSULT CLIN PSYCH, V67, P285, DOI 10.1037/0022-006X.67.3.285; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; MURPHY JM, 1987, ARCH GEN PSYCHIAT, V44, P550; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289	50	11	11	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					280	286		10.3109/02699052.2015.1118766			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900005	26909463				2022-02-06	
J	Kiiski, H; Tenhunen, J; Ala-Peijari, M; Huhtala, H; Hamalainen, M; Langsjo, J; Moilanen, E; Narkilahti, S; Ohman, J; Peltola, J				Kiiski, Heikki; Tenhunen, Jyrki; Ala-Peijari, Marika; Huhtala, Heini; Hamalainen, Mari; Langsjo, Jaakko; Moilanen, Eeva; Narkilahti, Susanna; Ohman, Juha; Peltola, Jukka			Increased plasma UCH-L1 after aneurysmal subarachnoid hemorrhage is associated with unfavorable neurological outcome	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Aneurysmal subarachnoid hemorrhage; Biomarkers; UCH-L1; Neurological outcome; Secondary brain injury	TRAUMATIC BRAIN-INJURY; C-TERMINAL HYDROLASE; DELAYED CEREBRAL-ISCHEMIA; L1 UCH-L1; BIOMARKERS; VASOSPASM; UTILITY	Objective: Aneurysmal subarachnoid hemorrhage (aSAH) is a common cause of long-term disability and death. After primary hemorrhage, secondary brain injury is the main cause of mortality and morbidity. Despite extensive research, reliable prognostic biomarkers are lacking. We measured ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) levels in aSAH patients to evaluate its prognostic potential. This is the first time that plasma UCH-L1 has been studied as a potential prognostic biomarker in patients with aSAH. Methods: In this prospective population-based study, UCH-L1 levels were measured in aSAH patients (n = 47) for up to five days. UCH-L1 was measured at 0, 12 and 24 h after the admission to the intensive care unit (ICU) and daily thereafter until the patient was transferred from the ICU. Only patients whose UCH-L1 was measured within 24 h from aSAH were included in the study. The patients' neurological outcome was evaluated with the modified Rankin Scale (mRS) at six months after aSAH. Results: UCH-L1 levels during the first 24 h after aSAH were not significantly different between the groups with favorable (mRS 0-2) and unfavorable (mRS 3-6) neurological outcome. In 22 patients, UCH-L1 levels were obtained for up to five days. In this subgroup, UCH-L1 measured at day five showed significant elevation from baseline levels in patients with unfavorable outcome (p = 0.026). Elevated UCH-L1 levels at day five were higher in patients with unfavorable outcome than in patients with favorable outcome (p = 0.001). Conclusions: Elevated UCH-L1 levels during the five-day follow-up were associated with unfavorable neurological outcome. Repetitive measurements of UCH-L1 concentrations with an emphasis on change relative to the individual baseline could be the optimal approach for future clinical studies. (C) 2015 Elsevier B.V. All rights reserved.	[Kiiski, Heikki; Tenhunen, Jyrki; Ala-Peijari, Marika; Langsjo, Jaakko] Tampere Univ Hosp, Dept Intens Care, Crit Care Med Res Grp, Tampere, Finland; [Kiiski, Heikki; Narkilahti, Susanna] Univ Tampere, NeuroGrp, BioMediTech, FIN-33101 Tampere, Finland; [Tenhunen, Jyrki] Uppsala Univ, Dept Surg Sci, Div Anesthesiol & Intens Care, Uppsala, Sweden; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Hamalainen, Mari; Moilanen, Eeva] Univ Tampere, Tampere Univ Hosp, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Ohman, Juha; Peltola, Jukka] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland		Kiiski, H (corresponding author), Tampere Univ Hosp, Dept Intens Care, Tampere 2000, Finland.	heikki.kiiski@fimnet.fi		Hamalainen, Mari/0000-0002-6409-3758; Kiiski, Heikki/0000-0002-5235-1772; Ohman, Juha/0000-0002-6592-1367	Academy of FinlandAcademy of FinlandEuropean Commission [123233, 139345]; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital	The study was financially supported by Academy of Finland (Grants 123233, 139345) and the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital.	Bishop P, 2014, J BIOL CHEM, V289, P36140, DOI 10.1074/jbc.M114.557124; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; Dupont S, 2013, NEUROL RES, V35, P107, DOI 10.1179/1743132812Y.0000000122; Hong CM, 2014, BIOMARKERS, V19, P95, DOI 10.3109/1354750X.2014.881418; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sarrafzadeh AS, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00134; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Zacharia BE, 2010, NEUROSURG CLIN N AM, V21, P221, DOI 10.1016/j.nec.2009.10.002	19	11	11	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	FEB 15	2016	361						144	149		10.1016/j.jns.2015.12.046			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD7HD	WOS:000370093400028	26810533				2022-02-06	
J	Munakomi, S				Munakomi, Sunil			A comparative study between Marshall and Rotterdam CT scores in predicting early deaths in patients with traumatic brain injury in a major tertiary care hospital in Nepal	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Brain injuries; Tomography computed; Prognosis; Marshall score; Rotterdam score		Purpose: CT plays a crucial role in the early assessment of patients with traumatic brain injury (TBI). Marshall and Rotterdam are the mostly used scoring systems, in which CT findings are grouped differently. We sought to determine the values of the scoring system and initial CT findings in predicting the death at hospital discharge (early death) in patients with TBI. Methods: There were consecutive 634 traumatic neurosurgical patients with mild-to-severe TBI admitted to the emergency department of College of Medical Sciences. Their initial CT and status at hospital discharge (dead or alive) were reviewed, and both CT scores were calculated. We examined whether each score is related to early death; compared the two scoring systems' performance in predicting early death, and identified the CT findings that are independent predictors for early death. Results: Both imaging score (Marshall) and clinical score (Rotterdam) can be used to reliably predict mortality in patients with acute traumatic brain injury with high prognostic accuracy. Other specific CT characteristics that can be used to predict early mortality are traumatic subarachnoid hemorrhage, midline shift and status of the peri-mesencephalic cisterns. Conclusions: Marshall CT classification has strong predictive power, but greater discrimination can be obtained if the individual CT parameters underlying the CT classification are included in a prognostic model as in Rotterdam score. Consequently, for prognostic purposes, we recommend the use of individual characteristics rather than the CT classification. Performance of CT models for predicting outcome in TBI can be significantly improved by including more details of variables and by adding other variables to the models. (c) 2015 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Munakomi, Sunil] Coll Med Sci, Dept Neurosurg, Bharatpur, Nepal		Munakomi, S (corresponding author), Coll Med Sci, Dept Neurosurg, Bharatpur, Nepal.	sunilmunakomi@gmail.com	Munakomi, Sunil/I-6888-2019	Munakomi, Sunil/0000-0001-6079-3792			Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Castellan N. J, 1988, NONPARAMETRIC STAT B; Chesnut R M, 2000, Clin Neurosurg, V46, P185; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Havill J H, 2001, Crit Care Resusc, V3, P15; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Kakarieka A, 1995, Neurologia, V10, P159; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LIU HM, 1995, J TRAUMA, V38, P330, DOI 10.1097/00005373-199503000-00003; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Okten Ali Ihsan, 2006, Ulus Travma Acil Cerrahi Derg, V12, P107; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Pillai SV, 2003, NEUROL INDIA, V51, P345; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, 1974, LANCET, V2, P81; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; [No title captured]	36	11	11	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	FEB	2016	19	1					25	27		10.1016/j.cjtee.2015.12.005			3	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1OQ	WOS:000442099200006	27033268	gold, Green Published			2022-02-06	
J	Qu, WR; Liu, NK; Xie, XM; Li, R; Xu, XM				Qu, Wenrui; Liu, Nai-kui; Xie, Xin-min (Simon); Li, Rui; Xu, Xiao-ming			Automated monitoring of early neurobehavioral changes in mice following traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; controlled cortical impact; automated behavior; motor activity; anxiety; exploratory activity; sleep; neural regeneration	CONTROLLED CORTICAL IMPACT; BEHAVIORAL DEFICITS; SLEEP DISORDERS; HEAD-INJURY; MODEL; MODERATE; MILD; MOUSE; MOTOR; NEURONS	Traumatic brain injury often causes a variety of behavioral and emotional impairments that can develop into chronic disorders. Therefore, there is a need to shift towards identifying early symptoms that can aid in the prediction of traumatic brain injury outcomes and behavioral endpoints in patients with traumatic brain injury after early interventions. In this study, we used the SmartCage system, an automated quantitative approach to assess behavior alterations in mice during an early phase of traumatic brain injury in their home cages. Female C57BL/6 adult mice were subjected to moderate controlled cortical impact (CCI) injury. The mice then received a battery of behavioral assessments including neurological score, locomotor activity, sleep/wake states, and anxiety-like behaviors on days 1, 2, and 7 after CCI. Histological analysis was performed on day 7 after the last assessment. Spontaneous activities on days 1 and 2 after injury were significantly decreased in the CCI group. The average percentage of sleep time spent in both dark and light cycles were significantly higher in the CCI group than in the sham group. For anxiety-like behaviors, the time spent in a light compartment and the number of transitions between the dark/light compartments were all significantly reduced in the CCI group than in the sham group. In addition, the mice suffering from CCI exhibited a preference of staying in the dark compartment of a dark/light cage. The CCI mice showed reduced neurological score and histological abnormalities, which are well correlated to the automated behavioral assessments. Our findings demonstrate that the automated SmartCage system provides sensitive and objective measures for early behavior changes in mice following traumatic brain injury.	[Qu, Wenrui; Li, Rui] Jilin Univ, Hosp 2, Orthopaed Hosp, Hand & Foot Surg & Reparat & Reconstruct Surg Ctr, Changchun 130023, Jilin Province, Peoples R China; [Qu, Wenrui; Liu, Nai-kui; Xu, Xiao-ming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Qu, Wenrui; Xu, Xiao-ming] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Qu, Wenrui; Liu, Nai-kui; Xu, Xiao-ming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Qu, Wenrui; Liu, Nai-kui; Xu, Xiao-ming] Goodman Campbell Brain & Spine, Indianapolis, IN USA; [Xie, Xin-min (Simon)] AfaSci Res Labs, Redwood City, CA USA		Li, R (corresponding author), Jilin Univ, Hosp 2, Orthopaed Hosp, Hand & Foot Surg & Reparat & Reconstruct Surg Ctr, Changchun 130023, Jilin Province, Peoples R China.; Xu, XM (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA.; Xu, XM (corresponding author), Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA.; Xu, XM (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.; Xu, XM (corresponding author), Goodman Campbell Brain & Spine, Indianapolis, IN USA.	13304321102@qq.com; xu26@iupui.edu	Rui, Li/P-6743-2018; 吉大二院手足重建, 瞿文瑞/AAL-9639-2020	Rui, Li/0000-0002-9922-4308; Qu, Wenrui/0000-0002-0178-3698	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS073636, NS059622]; DOD CDMRPUnited States Department of Defense [W81XWH-12-1-0562]; DVA [1I01BX002356-01A1]; Craig H Neilsen Foundation [296749]; Indiana Spinal Cord and Brain Injury Research Foundation; Mari Hulman George Endowment Funds; State of Indiana (ISDH) [A70-2-079609, A70-9-079138, A70-5-0791033]; China Scholarship CouncilChina Scholarship Council [CSC-201306170108]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073636, R01NS059622] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002356] Funding Source: NIH RePORTER; VAUS Department of Veterans Affairs [1I01BX002356-01A1] Funding Source: Federal RePORTER	This work was supported by NIH NS073636 (RS/XMX), NS059622, DOD CDMRP W81XWH-12-1-0562, DVA 1I01BX002356-01A1, Craig H Neilsen Foundation 296749, Indiana Spinal Cord and Brain Injury Research Foundation and Mari Hulman George Endowment Funds (XMX), and by the State of Indiana (ISDH, Grant # A70-2-079609, A70-9-079138 and A70-5-0791033; NKL). This work was also supported by a grant from China Scholarship Council (CSC-201306170108) to WQ.	Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Hopkins KJ, 2000, BRAIN RES, V864, P69, DOI 10.1016/S0006-8993(00)02137-5; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kas MJH, 2008, BEHAV NEUROSCI, V122, P769, DOI 10.1037/0735-7044.122.4.769; Khroyan TV, 2012, CLIN EXP PHARMACOL P, V39, P614, DOI 10.1111/j.1440-1681.2012.05719.x; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schumacher T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035613; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Tang XD, 2002, BEHAV BRAIN RES, V136, P555, DOI 10.1016/S0166-4328(02)00228-0; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xie X., 2012, ANIMAL MODELS ACUTE, V1, P205, DOI [DOI 10.1007/978-1-61779-576-3_13., 10.1007/978-1-61779-576-3_13.]; Xiong XX, 2013, STROKE, V44, P764, DOI 10.1161/STROKEAHA.112.681700; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	51	11	11	1	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2016	11	2					248	256		10.4103/1673-5374.177732			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DI0XZ	WOS:000373221900025	27073377	gold, Green Published			2022-02-06	
J	Shura, RD; Rowland, JA; Miskey, HM				Shura, Robert D.; Rowland, Jared A.; Miskey, Holly M.			Auditory Consonant Trigrams: A Psychometric Update	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Auditory Consonant Trigrams; ACT; Psychometric; Reliability; Validity	TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSIVE DISORDER; UNITED-STATES; MEMORY; TESTS; RELIABILITY; PERFORMANCE; PREVALENCE; ATTENTION; VETERANS	The Auditory Consonant Trigrams (ACT) test was developed to evaluate immediate memory in the absence of rehearsal. There are few psychometric studies of the measure and a lack of normative data using samples from the United States or Veterans. ACT data were examined for 184 participants who passed the Word Memory Test, denied a history of moderate to severe traumatic brain injury (TBI), and consented for research purposes only. Reliability and construct validity were examined and normative data developed using a healthy subsample. Cronbach's alpha for the ACT total score was 0.79. Regression analyses suggested that years of education, estimated premorbid IQ, psychomotor speed, working memory, and impulsivity had the strongest relationships with performance on the ACT. Performance was unrelated to posttraumatic stress disorder and remote mild TBI, but the presence of major depressive disorder was associated with lower total scores. These results demonstrate the ACT has adequate psychometric properties.	[Shura, Robert D.; Rowland, Jared A.; Miskey, Holly M.] WG Bill Hefner Vet Affairs Med Ctr, MA MIRECC, Salisbury, NC 28144 USA; [Shura, Robert D.; Rowland, Jared A.; Miskey, Holly M.] Wake Forest Sch Med, Dept Psychiat & Behav Sci, Winston Salem, NC 27157 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA		Shura, RD (corresponding author), Hefner VAMC, 11M-2 MH BS,1601 Brenner Ave, Salisbury, NC 28144 USA.	robert.shura2@va.gov	Shura, Robert D/J-6749-2019; Rowland, Jared A./AAN-3030-2021	Rowland, Jared A./0000-0002-3655-3411; Miskey, Holly/0000-0002-5139-4586; Shura, Robert/0000-0002-9505-0080	W.G. "Bill" Hefner Veterans Affairs Medical Center; Mid-Atlantic Mental Illness Research Education and Clinical Center; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs	This research was supported by resources of the W.G. "Bill" Hefner Veterans Affairs Medical Center, the Mid-Atlantic Mental Illness Research Education and Clinical Center, and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anil AE, 2003, CLIN NEUROPSYCHOL, V17, P159, DOI 10.1076/clin.17.2.159.16510; Boone KB, 1998, ARCH CLIN NEUROPSYCH, V13, P585, DOI 10.1016/S0887-6177(97)00074-7; BOONE KB, 1990, DEV NEUROPSYCHOL, V6, P215, DOI 10.1080/87565649009540462; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Conners C.K., 2004, CONNERS CONTINUOUS P; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P255, DOI 10.1080/713755575; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dige N, 2005, INT J NEUROSCI, V115, P169, DOI 10.1080/00207450590519058; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; First M., 1997, STRUCTURED CLIN INTE; Folmer RL, 2011, J REHABIL RES DEV, V48, P503, DOI 10.1682/JRRD.2010.07.0138; Golden CJ., 2002, STROOP COLOR WORD TE; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Grigsby J, 1996, BEHAV DYSCONTROL SCA; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Mertens VB, 2006, ARCH CLIN NEUROPSYCH, V21, P733, DOI 10.1016/j.acn.2006.08.005; Oral E, 2012, BRAIN RES BULL, V88, P454, DOI 10.1016/j.brainresbull.2012.03.005; Ozakbas S, 2004, MULT SCLER, V10, P686, DOI 10.1191/1352458504ms1111oa; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; *PSYCH CORP, 2001, WECHSL TEST AD READ; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reitan R, 1985, HALSTEAD REITAN NEUR; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Shura RD, 2014, ARCH CLIN NEUROPSYCH, V29, P409, DOI 10.1093/arclin/acu022; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	37	11	11	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2016	31	1					47	57		10.1093/arclin/acv083			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DD8QQ	WOS:000370192400008	26645315	hybrid			2022-02-06	
J	Tasissa, AF; Hautefeuille, M; Fitek, JH; Radovitzky, RA				Tasissa, Abiy F.; Hautefeuille, Martin; Fitek, John H.; Radovitzky, Raul A.			On the formation of Friedlander waves in a compressed-gas-driven shock tube	PROCEEDINGS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Article						blast waves; shock tubes; Friedlander waves	TRAUMATIC BRAIN-INJURY; BLAST; MODELS	Compressed-gas-driven shock tubes have become popular as a laboratory-scale replacement for field blast tests. The well-known initial structure of the Riemann problem eventually evolves into a shock structure thought to resemble a Friedlander wave, although this remains to be demonstrated theoretically. In this paper, we develop a semi-analytical model to predict the key characteristics of pseudo blast waves forming in a shock tube: location where the wave first forms, peak over-pressure, decay time and impulse. The approach is based on combining the solutions of the two different types of wave interactions that arise in the shock tube after the family of rarefaction waves in the Riemann solution interacts with the closed end of the tube. The results of the analytical model are verified against numerical simulations obtained with a finite volume method. The model furnishes a rational approach to relate shock tube parameters to desired blast wave characteristics, and thus constitutes a useful tool for the design of shock tubes for blast testing.	[Tasissa, Abiy F.; Hautefeuille, Martin; Radovitzky, Raul A.] MIT, Dept Aeronaut & Astronaut, Inst Solider Nanotechnol, Cambridge, MA 02139 USA; [Fitek, John H.] US Army Natick Soldier Res, Ctr Dev & Engn, Natick, MA 01760 USA		Radovitzky, RA (corresponding author), MIT, Dept Aeronaut & Astronaut, Inst Solider Nanotechnol, Cambridge, MA 02139 USA.	rapa@mit.edu	Radovitzky, Raul A/A-5353-2009	Radovitzky, Raul A/0000-0001-6339-2708; Tasissa, Abiy/0000-0003-4033-7735	US Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL); US Army Research Office through Institute for Soldier Nanotechnologies [W911NF-13-D-0001]	This work was supported by the US Army Research Laboratory and the US Army Research Office through the Institute for Soldier Nanotechnologies, under contract no. W911NF-13-D-0001.	Anderson J., 2003, MODERN COMPRESSIBLE; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Courant R., 1999, SUPERSONIC FLOW SHOC; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Dal Cengio Leonardi A., 2011, THESIS; Deiterding R, 2006, ENG COMPUT-GERMANY, V22, P325, DOI 10.1007/s00366-006-0043-9; DEWEY JM, 1964, PROC R SOC LON SER-A, V279, P366, DOI 10.1098/rspa.1964.0110; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P322, DOI 10.1098/rspa.1946.0046; Gliner E. B., 1964, DIFFERENTIAL EQUATIO; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Kleinschmit NN, 2011, THESIS; Landau L. D., 1987, FLUID MECH-SOV RES; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; LIEPMANN HW, 2002, ELEMENTS GAS DYNAMIC; Nakagawa A, 2011, J NEUROTRAUM, V28, P1335, DOI [10.1089/neu.2009.1146, DOI 10.1089/NEU.2009.1146]; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Orde, 2004, COLLECTED PAPERS; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Raizer Y.P., 2012, PHYS SHOCK WAVES HIG; Riemann B., 1860, ABHANDLUNGEN KONIGLI, V8, P43; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; TAUB AH, 1946, ANN MATH, V47, P811, DOI 10.2307/1969238; Whitham G.B., 1974, LINEAR NONLINEAR WAV; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	27	11	11	0	9	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-5021	1471-2946		P ROY SOC A-MATH PHY	Proc. R. Soc. A-Math. Phys. Eng. Sci.	FEB 1	2016	472	2186							20150611	10.1098/rspa.2015.0611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO3ZC	WOS:000377720300008	27118888	Green Published, Bronze			2022-02-06	
J	Russmann, V; Goc, J; Boes, K; Ongerth, T; Salvamoser, JD; Siegl, C; Potschka, H				Russmann, Vera; Goc, Joanna; Boes, Katharina; Ongerth, Tanja; Salvamoser, Josephine D.; Siegl, Claudia; Potschka, Heidrun			Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Status epilepticus; Epileptogenesis; Minocycline; Learning; Microglia; Neuroinflammation	TEMPORAL-LOBE EPILEPSY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; LITHIUM-PILOCARPINE MODEL; TRAUMATIC BRAIN-INJURY; MEMORY DEFICITS; HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; MOUSE MODEL; NEURODEGENERATIVE DISEASES; ELECTRICAL-STIMULATION	The tetracycline antibiotic minocycline can exert strong anti-inflammatory, antioxidant, and antiapoptotic effects. There is cumulating evidence that epileptogenic brain insults trigger neuroinflammation and anti-inflammatory concepts can modulate the process of epileptogenesis. Based on the mechanisms of action discussed for minocycline, the compound is of interest for intervention studies as it can prevent the polarization of microglia into a pro-inflammatory state. Here, we assessed the efficacy of sub-chronic minocycline administration initiated immediately following an electrically-induced status epilepticus in rats. The treatment did not affect the development of spontaneous seizures. However, minocycline attenuated behavioral long-term consequences of status epilepticus with a reduction in hyperactivity and hyperlocomotion. Furthermore, the compound limited the spatial learning deficits observed in the post-status epilepticus model. The typical status epilepticus-induced neuronal cell loss was evident in the hippocampus and the piriform cortex. Minocycline exposure selectively protected neurons in the piriform cortex and the hilus, but not in the hippocampal pyramidal layer. In conclusion, the data argue against an antiepileptogenic effect of minocycline in adult rats. However, the findings suggest a disease-modifying impact of the tetracycline affecting the development of behavioral co-morbidities, as well as long-term consequences on spatial learning. In addition, minocycline administration resulted in a selective neuroprotective effect. Although strong anti-inflammatory effects have been proposed for minocycline, we could not verify these effects in our experimental model. Considering the multitude of mechanisms claimed to contribute to minocycline's effects, it is of interest to further explore the exact mechanisms underlying the beneficial effects in future studies. (C) 2015 Elsevier B.V. All rights reserved.	[Russmann, Vera; Goc, Joanna; Boes, Katharina; Ongerth, Tanja; Salvamoser, Josephine D.; Siegl, Claudia; Potschka, Heidrun] Univ Munich, Inst Pharmacol Toxicol & Pharm, D-80539 Munich, Germany		Potschka, H (corresponding author), Univ Munich, Inst Pharmacol Toxicol & Pharm, Koeniginstr 16, D-80539 Munich, Germany.	potschka@pharmtox.vetmed.uni-muenchen.de		Potschka, Heidrun/0000-0003-1506-0252	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG PO-681/5-2]	This research was supported by a Grant of the Deutsche Forschungsgemeinschaft (DFG PO-681/5-2). The authors thank Olga Cabezas, Marion Fisch, Sieglinde Fischlein, Barbara Kohler, Regina Rentsch and Angela Vicidomini for their technical assistance.	Abraham J, 2012, NEUROBIOL DIS, V46, P425, DOI 10.1016/j.nbd.2012.02.006; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Andre V, 2003, EPILEPSIA, V44, P893, DOI 10.1046/j.1528-1157.2003.61802.x; Anisman H, 2002, J NEUROSCI, V22, P7809; Bankstahl JP, 2014, EPILEPSY RES, V108, P802, DOI 10.1016/j.eplepsyres.2014.01.025; Baram TZ, 2012, EPILEPSY CURR, V12, P7, DOI 10.5698/1535-7511-12.4s.7; Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Brandt C, 2003, EPILEPSY RES, V55, P83, DOI 10.1016/S0920-1211(03)00114-1; Brandt C, 2003, NEUROSCIENCE, V118, P727, DOI 10.1016/S0306-4522(03)00027-7; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Cornaggia CM, 2006, EPILEPSIA, V47, P34, DOI 10.1111/j.1528-1167.2006.00685.x; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Fujikawa DG, 1996, BRAIN RES, V725, P11, DOI 10.1016/0006-8993(96)00203-X; Garrido-Mesa N, 2013, PHARMACOL RES, V67, P18, DOI 10.1016/j.phrs.2012.10.006; Gilby KL, 2007, BEHAV NEUROSCI, V121, P370, DOI 10.1037/0735-7044.121.2.370; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kohman RA, 2013, BEHAV BRAIN RES, V242, P17, DOI 10.1016/j.bbr.2012.12.032; Kwon YS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-30; Laufs H, 2011, NEUROLOGY, V77, P904, DOI 10.1212/WNL.0b013e31822c90f2; Li CY, 2013, REV NEUROSCIENCE, V24, P553, DOI 10.1515/revneuro-2013-0040; Li LY, 2013, J MOL NEUROSCI, V50, P109, DOI 10.1007/s12031-012-9879-1; Licko T, 2013, EPILEPSIA, V54, P1176, DOI 10.1111/epi.12196; Loscher W, 1996, PROG NEUROBIOL, V50, P427, DOI 10.1016/S0301-0082(96)00036-6; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; McIntyre DC, 2007, EPILEPSIA, V48, P30, DOI 10.1111/j.1528-1167.2007.01398.x; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Nasr SMB, 2013, SEIZURE-EUR J EPILEP, V22, P670, DOI 10.1016/j.seizure.2013.05.005; Noe FM, 2013, NEUROBIOL DIS, V59, P183, DOI 10.1016/j.nbd.2013.07.015; Pang T, 2012, BBA-GEN SUBJECTS, V1820, P503, DOI 10.1016/j.bbagen.2012.01.011; Paribello C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-91; Pekcec A, 2008, J NEUROCHEM, V105, P389, DOI 10.1111/j.1471-4159.2007.05172.x; Pineda E, 2014, EPILEPSY BEHAV, V31, P267, DOI 10.1016/j.yebeh.2013.10.004; PIREDDA S, 1985, NATURE, V317, P623, DOI 10.1038/317623a0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ravizza T, 2013, NEUROPEDIATRICS, V44, P330, DOI 10.1055/s-0033-1358601; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Roch C, 2002, EPILEPSIA, V43, P325, DOI 10.1046/j.1528-1157.2002.11301.x; Russmann V, 2013, NEUROSCI LETT, V556, P170, DOI 10.1016/j.neulet.2013.10.003; Seeger N, 2011, EPILEPSIA, V52, P2333, DOI 10.1111/j.1528-1167.2011.03302.x; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Tyler AL, 2012, J NEUROSCI, V32, P11365, DOI 10.1523/JNEUROSCI.1516-12.2012; Vezzani A, 2014, NEUROPHARMACOLOGY; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Volk HA, 2004, NEUROSCIENCE, V123, P751, DOI 10.1016/j.neuroscience.2003.10.012; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang DD, 2012, EPILEPSY BEHAV, V24, P314, DOI 10.1016/j.yebeh.2012.03.035; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Xu D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00195; Yang F, 2010, J NEUROSCI RES, V88, P519, DOI 10.1002/jnr.22224; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zaccara G, 2009, ACTA NEUROL SCAND, V120, P1, DOI 10.1111/j.1600-0404.2008.01146.x; Zibell G, 2009, NEUROPHARMACOLOGY, V56, P849, DOI 10.1016/j.neuropharm.2009.01.009	62	11	11	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JAN 15	2016	771						29	39		10.1016/j.ejphar.2015.12.002			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DA9CO	WOS:000368105100004	26681545				2022-02-06	
J	Peach, RK; Coelho, CA				Peach, Richard K.; Coelho, Carl A.			Linking inter- and intra-sentential processes for narrative production following traumatic brain injury: Implications for a model of discourse processing	NEUROPSYCHOLOGIA			English	Article						Traumatic brain injury; Cognition; Language; Executive functions; Discourse; Sentence planning	EXECUTIVE FUNCTIONS; LANGUAGE; IMPAIRMENT; ADULTS; STORY; COHERENCE; COHESION; PATTERNS; MODERATE; CHILDREN	Some suggest that traumatic brain injury (TBI) produces dissociation between the macrolinguistic and microlinguistic levels of discourse production. This assumption is based primarily on studies that have found preserved intersentential cohesion and/or intra-sentential processing in narratives produced by these individuals. However, few studies exist, if any, that have investigated the relationship between these processes in TBI speakers who do demonstrate such microlinguistic impairments. This study investigated the relationship between impairments of intersentential cohesion and intra-sentential processing in the discourse of 15 speakers with severe TBI. The results demonstrated a significant relationship between the production of cohesive ties and instances of intra-sentential impairment that suggests that utilization of resources for adequate cohesion appears to negatively affect intra-sentential processing following TBI. We propose that macrolinguistic and microlinguistic processes are not independent of one another, as has been proposed, but share cognitive resources that support the planning and production of both local (microlinguistic) and long-distance (macrolinguistic) relationships expressed through discourse. (C) 2015 Elsevier Ltd. All rights reserved.	[Peach, Richard K.] Rush Univ, Med Ctr, Dept Commun Disorders & Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA; [Peach, Richard K.] Rush Univ, Med Ctr, Dept Neurol Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA; [Peach, Richard K.] Rush Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA; [Coelho, Carl A.] Univ Connecticut, Dept Speech Language & Hearing Sci, Unit 1085, Storrs, CT 06269 USA		Peach, RK (corresponding author), Rush Univ, Med Ctr, Dept Commun Disorders & Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA.; Peach, RK (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA.; Peach, RK (corresponding author), Rush Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1018B Armour Acad Ctr,600 South Paulina St, Chicago, IL 60612 USA.	richard_k_peach@rush.edu; carl.coelho@uconn.edu			Department of Communication Disorders and Sciences, College of Health Sciences, Rush University	The Department of Communication Disorders and Sciences, College of Health Sciences, Rush University provided financial support for the conduct of this research and the preparation of this article. The funding source had no role in the study design, the collection, analysis or interpretation of data, in the writing of the report, or in the decision to submit this article for publication.	ADORNETTI I., 2014, WAYS PROTOLANGUAGE, V3, P9; Armstrong E, 2000, APHASIOLOGY, V14, P875, DOI 10.1080/02687030050127685; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Boersma P., 2012, PRAAT DOING PHONETIC; Boyle M, 2011, APHASIOLOGY, V25, P1308, DOI 10.1080/02687038.2011.596185; Bublitz W., 2011, DISCURSIVE PRAGMATIC, P37; Cannizzaro M, 2012, COGNITION ACQUIRED L, P227; CHRISTIANSEN JA, 1995, BRAIN LANG, V51, P291, DOI 10.1006/brln.1995.1062; Coelho C. A., 2007, BRAIN INJURY MED, P895; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Ferreira VS, 2002, J EXP PSYCHOL LEARN, V28, P1187, DOI 10.1037//0278-7393.28.6.1187; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS EX; GROSJEAN F, 1979, PHONETICA, V36, P98, DOI 10.1159/000259950; Halliday M. K., 1976, COHESION ENGLISH; Harley T., 2014, PSYCHOL LANGUAGE DAT; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Jennett B, 1981, MANAGEMENT HEAD INJU; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kertesz A., 1982, W APHASIA BATTERY; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Levelt W.J.M., 1989, SPEAKING INTENTION A; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Liles BZ, 1998, ANAL DISCOURSE COMMU, P65; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Meister, 2013, 2013 WORKSH COMP MOD, DOI [10.4230/OASIcs.CMN.2013.61, DOI 10.4230/OASICS.CMN.2013.61]; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Miller J. F., 2008, SYSTEMATIC ANALYSIS; Navarro-Ruiz MI, 2001, CLIN LINGUIST PHONET, V15, P63, DOI 10.3109/02699200109167632; Peach R. K., 1990, ANN CONV AM SPEECH L; Peach R. K., 1986, ANN CONV AM SPEECH L; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Rispoli M, 2008, J SPEECH LANG HEAR R, V51, P953, DOI 10.1044/1092-4388(2008/070); Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thordardottir ET, 2002, BRAIN COGNITION, V48, P587, DOI 10.1006/brcg.2001.1422; Zimmermann N, 2015, BRAIN INJURY, V29, P1071, DOI 10.3109/02699052.2015.1015613	48	11	11	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JAN 8	2016	80						157	164		10.1016/j.neuropsychologia.2015.11.015			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DC1CB	WOS:000368953300016	26593882				2022-02-06	
J	Baky, NAA; Fadda, L; Al-Rasheed, NM; Al-Rasheed, NM; Mohamed, A; Yacoub, H				Baky, Nayira Ahmed Abdel; Fadda, Laila; Al-Rasheed, Nouf M.; Al-Rasheed, Nawal M.; Mohamed, Azza; Yacoub, Hazar			Neuroprotective effect of carnosine and cyclosporine-A against inflammation, apoptosis, and oxidative brain damage after closed head injury in immature rats	TOXICOLOGY MECHANISMS AND METHODS			English	Article						lipid peroxidation; oxidative damage; traumatic brain injury; Calcium-adenosine triphosphatase; sFasL	MITOCHONDRIAL PERMEABILITY TRANSITION; CENTRAL-NERVOUS-SYSTEM; DNA-DAMAGE; CELL-DEATH; CALCIUM ACCUMULATION; MOLECULAR-MECHANISMS; COMET ASSAY; FAS LIGAND; IN-VITRO; HISTIDINE	Context: Traumatic brain injury in the pediatric population can have a great economic and emotional impact on both the child's family and society. Objective: The present study aimed to compare the effects of carnosine (CAR) and/or cyclosporine A (CyA) on oxidative brain damage after closed head injury (CHI) in immature rats. Materials and methods: Thirty-day-old rat pups were divided into five groups: non-traumatic control group, trauma group underwent CHI, trauma group injected with CAR (200 mg/kg, i.p.) following CHI for 7 d, trauma group injected with CyA (20 mg/kg, i.p.) given 15 min and 24 h after CHI, and trauma group treated with CAR and CyA. At the end of the treatment, rats were sacrificed; blood and brains were collected for assessing different biochemical parameters. Results: Trauma significantly increased brain level of malondialdehyde, nitric oxide, glucose, calcium, inflammatory mediators. Brain DNA damage was confirmed by comet assay and the significant increase in brain caspase-3 activity. Moreover, the serum level of Fas ligand in traumatized animals was significantly elevated. Concomitant decrease in brain-reduced glutathione (GSH) and calcium-adenosine triphosphatase activity was observed in the traumatized-untreated group. Treatment of traumatized animals with CAR and/or CyA ameliorated all the biochemical changes induced by CHI with marked protective effect in the combination group. Discussion and conclusion: CAR and CyA exerted a synergistic neuroprotective effect against CHI through blocking the induction of lipid peroxidation, reducing inflammatory, and oxidative stress biomarkers, preserving brain GSH content, and reducing the alterations in brain apoptotic biomarkers in traumatized animals.	[Baky, Nayira Ahmed Abdel; Fadda, Laila; Al-Rasheed, Nouf M.; Al-Rasheed, Nawal M.; Yacoub, Hazar] King Saud Univ, Dept Pharmacol, Riyadh, Saudi Arabia; [Mohamed, Azza] King Abdulaziz Univ, Fac Sci Girls, Dept Biochem, Jeddah 21413, Saudi Arabia		Baky, NAA (corresponding author), King Saud Univ, Dept Pharmacol, Riyadh, Saudi Arabia.	nayiraabdelbaky@yahoo.com	Baky, Nayira Abdel/AAF-4768-2021; mohamed, azza Mostafa/I-5066-2012	Abdel Baky, Nayira/0000-0003-2519-2558; Mohamed, Azza/0000-0002-8580-2824	Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud UniversityKing Saud University	This research was supported by a grant from the Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud University.	Aldini G, 2002, BIOCHEM BIOPH RES CO, V298, P699, DOI 10.1016/S0006-291X(02)02545-7; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BABIZHAYEV MA, 1994, BIOCHEM J, V304, P509, DOI 10.1042/bj3040509; Badjatia N, 2012, STROKE, V43, P691, DOI 10.1161/STROKEAHA.111.636035; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Boldyrev A, 1999, NEUROSCIENCE, V94, P571, DOI 10.1016/S0306-4522(99)00273-0; Boldyrev A, 2004, COMP BIOCHEM PHYS B, V137, P81, DOI 10.1016/j.cbpc.2003.10.008; BOLDYREV AA, 1988, COMP BIOCHEM PHYS B, V89, P245, DOI 10.1016/0305-0491(88)90218-0; Bullock R, 2002, J NEUROTRAUM, V17, P449; Chen G, 2013, AM J MED SCI, V345, P369, DOI 10.1097/MAJ.0b013e318271c031; CHURCHILL TA, 1995, ARCH BIOCHEM BIOPHYS, V320, P43, DOI 10.1006/abbi.1995.1340; Dagci T, 2009, PHYSIOL RES, V58, P427, DOI 10.33549/physiolres.931388; Dobrota D, 2005, NEUROCHEM RES, V30, P1283, DOI 10.1007/s11064-005-8799-7; El-Ansary A, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-9; Ellman GL, 1959, ARCH BIOCHEM BIOPHYS, V17, P214; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; Fleisher-Berkovich S, 2009, PEPTIDES, V30, P1306, DOI 10.1016/j.peptides.2009.04.003; Fontana M, 2002, CELL MOL LIFE SCI, V59, P546, DOI 10.1007/s00018-002-8446-2; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Hyland P, 2000, MECH AGEING DEV, V121, P203; Jung JY, 2008, ARCH ORAL BIOL, V53, P1042, DOI 10.1016/j.archoralbio.2008.03.008; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kassubek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030926; Khama-Murad AK, 2011, REGUL PEPTIDES, V167, P65, DOI 10.1016/j.regpep.2010.11.007; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Li NL, 2004, WORLD J GASTROENTERO, V10, P3151; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Matsukura T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P817; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; McIntosh TK, 1996, LAB INVEST, V74, P315; Millar DJ, 1993, CALCIUM SENSITISING, P117; Mirzayan MJ, 2008, NEUROL RES, V30, P476, DOI 10.1179/174313208X276916; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakai A, 2004, PEDIATR NEUROL, V30, P247, DOI 10.1016/j.pediatrneurol.2003.09.006; Niu LJ, 2012, NEUROSCIENCE, V213, P19, DOI 10.1016/j.neuroscience.2012.03.057; Ori Y, 2012, BIOMED PHARMACOTHER, V66, P409, DOI 10.1016/j.biopha.2012.06.001; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Pops-Wagner A, 2013, OXID MED CELL LONGEV, V2013, P1; PRAJDA N, 1975, FEBS LETT, V59, P245, DOI 10.1016/0014-5793(75)80385-1; Qian NS, 2010, LIFE SCI, V87, P64, DOI 10.1016/j.lfs.2010.05.014; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sasaki YF, 1997, MUTAT RES-GEN TOX EN, V391, P215, DOI 10.1016/S1383-5718(97)00073-9; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Simon FR, 1996, J BIOL CHEM, V271, P24967, DOI 10.1074/jbc.271.40.24967; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Soliman K, 2001, COMP BIOCHEM PHYS B, V129, P157, DOI 10.1016/S1096-4959(01)00332-3; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stvolinskii SL, 2003, B EXP BIOL MED+, V135, P130, DOI 10.1023/A:1023855428130; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tanaka M, 1996, NAT MED, V2, P317, DOI 10.1038/nm0396-317; Tang SC, 2007, J NEUROCHEM, V101, P729, DOI 10.1111/j.1471-4159.2006.04412.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vaculova A, 2008, METHOD ENZYMOL, V442, P157, DOI 10.1016/S0076-6879(08)01408-0; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang JP, 2013, BRAIN RES, V1507, P125, DOI 10.1016/j.brainres.2013.02.032; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; WILLIS JB, 1961, ANAL CHEM, V33, P556, DOI 10.1021/ac60172a021; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1; Zhang XM, 2011, EUR J PHARMACOL, V667, P202, DOI 10.1016/j.ejphar.2011.06.003; Zhang ZY, 2015, CELL MOL NEUROBIOL, V35, P147, DOI 10.1007/s10571-014-0106-1	93	11	14	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1537-6516	1537-6524		TOXICOL MECH METHOD	Toxicol. Mech. Methods	JAN 2	2016	26	1					1	10		10.3109/15376516.2015.1070224			10	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	DG5EJ	WOS:000372097800001	26275125				2022-02-06	
J	Allen, S; Stewart, SH; Cusimano, M; Asbridge, M				Allen, Stefan; Stewart, Sherry Heather; Cusimano, Michael; Asbridge, Mark			Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population	SUBSTANCE USE & MISUSE			English	Article						TBI; alcohol; illicit drug; Canada; cocaine; marijuana; cannabis; heroin; smoking; coping	SPINAL-CORD-INJURY; UNITED-STATES; ALCOHOL; ABUSE; DISORDERS	Background: The literature has opposing views regarding the magnitude of the association between substance use and TBI. Most studies have examined clinical samples which are not representative of the entire head injured population. Clinical samples provide very limited insight into TBI patients whom do not seek care. Objectives: This paper examines the associations between TBI and substance use/misuse. Its primary aim is to test whether or not individuals with a past-year TBI have higher rates of substance use/misuse than Canadians without a TBI or back and/or spine injury controls drawing on self-report population level data. Methods: Using the 2009-2010 Canadian Community Health Survey, a nationally representative cross-sectional survey of Canadians 12years and older, this paper assessed substance use (i.e., illicit drug use; drinking and binge drinking; current smoking) among those with a TBI, as compared to two control groups: (1) individuals with a back or spinal injury (BSI); and (2) healthy noninjured controls. Multivariate regressions (logistic and multinomial), both unadjusted and adjusting for a range of injury and sociodemographic covariates, were used in hypothesis testing. Results: Those with a past-year TBI demonstrated significantly elevated rates of illicit drug use relative to non-injured Canadians. Relative to the BSI group those with a TBI were less likely to drink alcohol, did not differ in binge drinking, cigarette smoking and illicit drug use. Conclusion: Health care professionals working with the TBI population should integrate screening, brief intervention, and referral programming as a means to reduce future harm related to substance misuse.	[Allen, Stefan; Stewart, Sherry Heather; Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Stewart, Sherry Heather] Dalhousie Univ, Dept Psychol, Halifax, NS, Canada; [Cusimano, Michael] St Michaels Hosp, Toronto, ON, Canada		Allen, S (corresponding author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Clin Res Ctr, Room 407,5790 Univ Ave, Halifax, NS B3H 1V7, Canada.	stefan.allen@dal.ca	Cusimano, Michael/X-4059-2019	Stewart, Sherry/0000-0003-3350-2712	Canadian Institutes of Health Research (CIHR) Team Grant: Strategic Teams in Applied Injury Research [103946]	This research was supported by a Canadian Institutes of Health Research (CIHR) Team Grant: Strategic Teams in Applied Injury Research: #103946.	Alegria M, 2000, ARCH GEN PSYCHIAT, V57, P383, DOI 10.1001/archpsyc.57.4.383; Azizian Allen, 2009, Handb Exp Pharmacol, P113, DOI 10.1007/978-3-540-69248-5_5; Blum K, 2012, J PSYCHOACTIVE DRUGS, V44, P134, DOI 10.1080/02791072.2012.685407; Bulamu NB, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0372-8; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; Hosseinpoor AR, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-52; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LAWSON GW, 1989, ALCOHOLISM SUBSTANCE; Leo P, 2016, TRANSLATIONAL RES TR; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sinha R, 2013, CURR OPIN NEUROBIOL, V23, P649, DOI 10.1016/j.conb.2013.05.001; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Tan CH, 2015, MMWR-MORBID MORTAL W, V64, P1042, DOI 10.15585/mmwr.mm6437a3; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397	27	11	12	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2016	51	12					1577	1586		10.1080/10826084.2016.1188955			10	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	DV2KZ	WOS:000382750700005	27484302				2022-02-06	
J	Basamh, M; Robert, A; Lamoureux, J; Saluja, RS; Marcoux, J				Basamh, Mohammed; Robert, Antony; Lamoureux, Julie; Saluja, Rajeet Singh; Marcoux, Judith			Epidural Hematoma Treated Conservatively: When to Expect the Worst	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; epidural hematoma; non-surgical treatment; injury progression	CRANIAL COMPUTED-TOMOGRAPHY; EXTRADURAL HEMATOMAS; BRAIN-INJURY; HEAD-INJURY; COAGULATION DISORDERS; MANAGEMENT; CT; COAGULOPATHY; TRAUMA; PROGRESSION	Background: The Brain Trauma Foundation's 2006 surgical guidelines have objectively defined the epidural hematoma (EDH) patients who can be treated conservatively. Since then, the literature has not provided adequate clues to identify patients who are at higher risk for EDH progression (EDHP) and conversion to surgical therapy. The goal of our study was to identify those patients. Methods: We carried a retrospective review over a 5-year period of all EDH who were initially triaged for conservative management. Demographic data, injury severity and history, neurological status, use of anticoagulants or anti-platelets, radiological parameters, conversion to surgery and its timing, and Glasgow Outcome Scale were analyzed. Bivariate association and further logistic regression were used to point out the significant predictors of EDHP and conversion to surgery. Results: 125 patients (75% of all EDH) were included. The mean age was 39.1 years. The brain injury was mild in 62.4% of our sample and severe in 14.4%. Only 11.2% of the patients required surgery. Statistical comparison showed that younger age (p< 0.0001) and coagulopathy (p=0.009) were the only significant factors for conversion to surgery. There was no difference in outcomes between patients who had EDHP and those who did not. Conclusions: Most traumatic EDH are not surgical at presentation. The rate of conversion to surgery is low. Significant predictors of EDHP are coagulopathy and younger age. These patients need closer observation because of a higher risk of EDHP. Outcome of surgical conversion was similar to successful conservative management.	[Basamh, Mohammed] King Abdulaziz Univ Hosp, Div Neurosurg, Jeddah, Saudi Arabia; [Robert, Antony] McGill Univ, Emergency Med, Montreal, PQ H3G 1A4, Canada; [Saluja, Rajeet Singh; Marcoux, Judith] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Neurosurg, 1650 Cedar Ave,Room L7-516, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Baptist Hlth South Florida, Miami, FL USA		Marcoux, J (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Neurosurg, 1650 Cedar Ave,Room L7-516, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca		Basamh, Mohammed/0000-0002-6191-2674			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Bezircioglu H, 1996, J TRAUMA, V41, P696, DOI 10.1097/00005373-199610000-00016; Bhau KS, 2010, INDIAN J SURG, V72, P124, DOI 10.1007/s12262-010-0036-1; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; CUCCINIELLO B, 1993, ACTA NEUROCHIR, V120, P47, DOI 10.1007/BF02001469; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; DOMENICUCCI M, 1995, NEUROSURG REV, V18, P109, DOI 10.1007/BF00417668; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; GUPTA SK, 1992, CLIN NEUROL NEUROSUR, V94, P127, DOI 10.1016/0303-8467(92)90069-F; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Mayr R, 2012, ARCH ORTHOP TRAUM SU, V132, P1445, DOI 10.1007/s00402-012-1559-7; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; Salama MM, 2010, EGYPTIAN J NEUROL SU, V25, P185; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	39	11	14	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2016	43	1					74	81		10.1017/cjn.2015.232			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB5FW	WOS:000368541000010	26786639	hybrid			2022-02-06	
J	Bryson-Campbell, M; Shaw, L; O'Brien, J; Holmes, J				Bryson-Campbell, Mikelle; Shaw, Lynn; O'Brien, James; Holmes, Jeff			Exploring the transformation in occupational identity: Perspectives from brain injury survivors	JOURNAL OF OCCUPATIONAL SCIENCE			English	Article						occupational identity; brain injury; grounded theory; adaptation	SELF; ADAPTATION; TRANSITION; PEOPLE	Background and Purpose: When life disruptions occur, people's occupational identity shifts to reflect their changed abilities and health. There may also be changes in the range of occupations judged as meaningful. The purpose of this study was to clarify the nature of the process that underpins shifts in occupational identity following a traumatic brain injury (TBI). Data Collection and Analysis: Participants were adults with TBI recruited from a centre for brain injury survivors. Interview data were analyzed through an objectivist grounded theory approach to uncover emergent categories. Findings: The nine participants suggested that the shift in occupational identity was impacted by occupational choices, re-engagement in occupations, and the development of competence. The shift was marked by Facing the Reality of Limitations and Challenges (returning to previous occupations, reflecting on changed abilities or performance), Grappling with Negative Labels (encountering labels and walls, discontinuing occupations), and Disconnecting from One Sub-Group within Society and into Another (shifting vocational or occupational repertoires). Conclusion: The results are discussed in relation to the influence of contextual factors, occupational adaptation, and the implications for occupational science.	[Bryson-Campbell, Mikelle; Shaw, Lynn; Holmes, Jeff] Western Univ, London, ON, Canada; [Shaw, Lynn] Pacific Coast Univ, Port Alberni, BC, Canada; [O'Brien, James] St Marys Univ, Halifax, NS, Canada		Bryson-Campbell, M (corresponding author), Western Univ, London, ON, Canada.	mbrysoncampbellresearch@gmail.com	O'Brien, James/V-3967-2019	O'Brien, James/0000-0003-4491-8852; Shaw, Lynn/0000-0001-7317-3891			Braveman Brent, 2006, Work, V27, P267; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-1561, 10.3233/WOR-2012-01561]; Christiansen CH, 1999, AM J OCCUP THER, V53, P547, DOI 10.5014/ajot.53.6.547; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Cotton GS, 2012, OCCUP THER HEALTH CA, V26, P270, DOI 10.3109/07380577.2012.726759; Howie L, 2004, AM J OCCUP THER, V58, P446, DOI 10.5014/ajot.58.4.446; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Martin LM, 2011, OCCUP THER INT, V18, P152, DOI 10.1002/oti.318; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Plano Clark, 2018, DESIGNING CONDUCTING; Rudman DL, 2002, J OCCUP SCI, V9, P12, DOI DOI 10.1080/14427591.2002.9686489; Soeker M., 2014, TRAUMATIC BRAIN INJU, P373; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Statistics Canada, 2010, DEF FULL PART TIM WO; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Unruh Anita M, 2004, Can J Occup Ther, V71, P290; Unruh Anita M, 2002, Can J Occup Ther, V69, P5; Vrkljan B H, 2001, Can J Occup Ther, V68, P237; Vrkljan BH, 2007, J OCCUP SCI, V14, P30, DOI 10.1080/14427591.2007.9686581; Wilson LH, 2010, J OCCUP SCI, V17, P47, DOI 10.1080/14427591.2010.9686672	23	11	11	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1442-7591			J OCCUP SCI	J. Occup. Sci.		2016	23	2					208	216		10.1080/14427591.2015.1131188			9	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	EB9EJ	WOS:000387694900007					2022-02-06	
S	Hellewell, SC; Ziebell, JM; Lifshitz, J; Morganti-Kossmann, MC		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Hellewell, Sarah C.; Ziebell, Jenna M.; Lifshitz, Jonathan; Morganti-Kossmann, M. Cristina			Impact Acceleration Model of Diffuse Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Diffuse traumatic brain injury; Traumatic axonal injury; Neuronal pathology; Rat model	AXONAL INJURY; FUNCTIONAL DEFICITS; IMMATURE RAT; CYCLOSPORINE-A; MESSENGER-RNA; UP-REGULATION; MOTOR; EDEMA; NEUROINFLAMMATION; PERFORMANCE	The impact acceleration (I/A) model of traumatic brain injury (TBI) was developed to reliably induce diffuse traumatic axonal injury in rats in the absence of skull fractures and parenchymal focal lesions. This model replicates a pathophysiology that is commonly observed in humans with diffuse axonal injury (DAI) caused by acceleration-deceleration forces. Such injuries are typical consequences of motor vehicle accidents and falls, which do not necessarily require a direct impact to the closed skull. There are several desirable characteristics of the I/A model, including the extensive axonal injury produced in the absence of a focal contusion, the suitability for secondary insult modeling, and the adaptability for mild/moderate injury through alteration of height and/or weight. Furthermore, the trauma device is inexpensive and readily manufactured in any laboratory, and the induction of injury is rapid (similar to 45 min per animal from weighing to post-injury recovery) allowing multiple animal experiments per day. In this chapter, we describe in detail the methodology and materials required to produce the rat model of I/A in the laboratory. We also review current adaptations to the model to alter injury severity, discuss frequent complications and technical issues encountered using this model, and provide recommendations to ensure technically sound injury induction.	[Hellewell, Sarah C.] Univ Alberta, Canadian Mil & Vet Clin Rehabil Res Program, Fac Rehabil Med, Edmonton, AB, Canada; [Ziebell, Jenna M.; Lifshitz, Jonathan; Morganti-Kossmann, M. Cristina] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ziebell, Jenna M.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Lifshitz, Jonathan] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA; [Morganti-Kossmann, M. Cristina] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Morganti-Kossmann, M. Cristina] Australian New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Morganti-Kossmann, M. Cristina] Arizona State Univ, Dept Psychol, Neurosci Program, Tempe, AZ 85287 USA		Hellewell, SC (corresponding author), Univ Alberta, Canadian Mil & Vet Clin Rehabil Res Program, Fac Rehabil Med, Edmonton, AB, Canada.		Ziebell, Jenna/Y-4496-2019	Hellewell, Sarah/0000-0002-2179-2209; Morganti-Kossmann, Cristina/0000-0002-0807-2063; Ziebell, Jenna/0000-0003-2497-4347			Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Stibick DL, 2001, J NEUROTRAUM, V18, P303, DOI 10.1089/08977150151070955; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Zhang LY, 2011, J NEUROSCI METH, V198, P93, DOI 10.1016/j.jneumeth.2011.03.024	32	11	11	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						253	266		10.1007/978-1-4939-3816-2_15	10.1007/978-1-4939-3816-2		14	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500017	27604723				2022-02-06	
J	Littlefield, PD; Pinto, RL; Burrows, HL; Brungart, DS				Littlefield, Philip D.; Pinto, Robin L.; Burrows, Holly L.; Brungart, Douglas S.			The Vestibular Effects of Repeated Low-Level Blasts	JOURNAL OF NEUROTRAUMA			English	Article						military injury; peripheral nerve injury; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSITION UPBEAT NYSTAGMUS; NORMATIVE DATA; EXPOSURE; ENCEPHALOPATHY; PREGABALIN; VERTIGO; IRAQ	The objective of this study was to use a prospective cohort of United States Marine Corps (USMC) instructors to identify any acute or long-term vestibular dysfunction following repeated blast exposures during explosive breaching training. They were assessed in clinic and on location during training at the USMC Methods of Entry School, Quantico, VA. Subjects received comprehensive baseline vestibular assessments and these were repeated in order to identify longitudinal changes. They also received shorter assessments immediately following blast exposure in order to identify acute findings. The main outcome measures were the Neurobehavioral Symptom Inventory, vestibular Visual Analog Scale (VAS) of subjective vestibular function, videonystagmography (VNG), vestibular evoked myogenic potentials (VEMP), rotary chair (including the unilateral centrifugation test), computerized dynamic posturography, and computerized dynamic visual acuity. A total of 11 breachers and 4 engineers were followed for up to 17 months. No acute effects or longitudinal deteriorations were identified, but there were some interesting baseline group differences. Upbeat positional nystagmus was common, and correlated (p<0.005) with a history of mild traumatic brain injury (mTBI). Several instructors had abnormally short low-frequency phase leads on rotary chair testing. This study evaluated breaching instructors over a longer test period than any other study, and the results suggest that this population appears to be safe from a vestibular standpoint at the current exposure levels. Upbeat positional nystagmus correlated with a history of mTBI in this population, and this has not been described elsewhere. The data trends also suggest that this nystagmus could be an acute blast effect. However, the reasons for the abnormally short phase leads seen in rotary chair testing are unclear at this time. Further investigation seems warranted.	[Littlefield, Philip D.] Walter Reed Natl Mil Med Ctr, Dept Otolaryngol, Bethesda, MD USA; [Pinto, Robin L.; Burrows, Holly L.; Brungart, Douglas S.] Walter Reed Natl Mil Med Ctr, Audiol & Speech Pathol Ctr, Bethesda, MD USA		Littlefield, PD (corresponding author), Tripler Army Med Ctr, Dept Otolaryngol, 1 Jarrett White Rd, Honolulu, HI 96859 USA.	philip.d.littlefield.mil@mail.mil			U.S. Army Medical Research and Materiel Command, Intramural War Supplemental Program [W81XWH-09-2-0192]; Congressionally Directed Medical Research Program Intramural Traumatic Brain Injury Investigator-Initiated Research Award (Ahroon) [FY07]	No competing financial interests exist. This research was performed in collaboration with the U.S. Army Aeromedical Research Lab, Fort Rucker, AL. William A. Ahroon, PhD, was the principal investigator of the overall grant supporting it. The grant was through the U.S. Army Medical Research and Materiel Command, Intramural War Supplemental Program, Award Number W81XWH-09-2-0192. This was from the Congressionally Directed Medical Research Program FY07 Intramural Traumatic Brain Injury Investigator-Initiated Research Award (Ahroon). The funding period was September 29, 2009 to May 28, 2014.	Adamec I, 2012, J CLIN NEUROSCI, V19, P161, DOI 10.1016/j.jocn.2011.05.028; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Bertholon P, 2006, ANN OTO RHINOL LARYN, V115, P587, DOI 10.1177/000348940611500804; Beyea JA, 2010, LARYNGOSCOPE, V120, P208, DOI 10.1002/lary.20730; Bockbrader HN, 2010, CLIN PHARMACOKINET, V49, P661, DOI 10.2165/11536200-000000000-00000; Choi JY, 2014, J NEUROL SCI, V337, P243, DOI 10.1016/j.jns.2013.12.007; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Deutschlander A, 2008, NEUROIMAGE, V41, P479, DOI 10.1016/j.neuroimage.2008.03.001; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Geisler C, 2000, ORL-J OTO-RHIN-LARYN, V62, P266, DOI 10.1159/000027757; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Herdman SJ, 2007, ARCH OTOLARYNGOL, V133, P383, DOI 10.1001/archotol.133.4.383; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kim JS., 2006, J CLIN NEUROL, V2, P58; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maes L, 2008, J VESTIBUL RES-EQUIL, V18, P197; Mallinson AI, 2005, OTOL NEUROTOL, V26, P686, DOI 10.1097/01.mao.0000169639.48193.fb; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pierrot-Deseilligny C, 2005, BRAIN, V128, P1237, DOI 10.1093/brain/awh532; Polensek SH, 2010, AUDIOL NEURO-OTOL, V15, P241, DOI 10.1159/000255440; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; SIBONY PA, 1987, ANN NEUROL, V21, P53, DOI 10.1002/ana.410210110; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; St Onge Paul, 2011, US Army Med Dep J, P97; Sunami K, 2004, ACTA OTO-LARYNGOL, V124, P35, DOI 10.1080/03655230410018408; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351; Ward BK, 2008, J VESTIBUL RES-EQUIL, V18, P187	37	11	11	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					71	81		10.1089/neu.2014.3824			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200009	25790248				2022-02-06	
S	Markowitsch, HJ; Staniloiu, A		Hallett, M; Stone, J; Carson, A		Markowitsch, H. J.; Staniloiu, A.			Functional (dissociative) retrograde amnesia	FUNCTIONAL NEUROLOGIC DISORDERS	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; PERSISTENT ANTEROGRADE AMNESIA; POSTTRAUMATIC-STRESS-DISORDER; MNESTIC BLOCK SYNDROME; CLOSED-HEAD INJURY; AUTOBIOGRAPHICAL MEMORY; EPISODIC MEMORY; DIFFUSION-TENSOR; PSYCHOGENIC AMNESIA	Retrograde amnesia is described as condition which can occur after direct brain damage, but which occurs more frequently as a result of a psychiatric illness. In order to understand the amnesic condition, content-based divisions of memory are defined. The measurement of retrograde memory is discussed and the dichotomy between "organic" and "psychogenic" retrograde amnesia is questioned. Briefly, brain damage-related etiologies of retrograde amnesia are mentioned. The major portion of the review is devoted to dissociative amnesia (also named psychogenic or functional amnesia) and to the discussion of an overlap between psychogenic and "brain organic" forms of amnesia. The "inability of access hypothesis" is proposed to account for most of both the organic and psychogenic (dissociative) patients with primarily retrograde amnesia. Questions such as why recovery from retrograde amnesia can occur in retrograde (dissociative) amnesia, and why long-term new learning of episodic-autobiographic episodes is possible, are addressed. It is concluded that research on retrograde amnesia research is still in its infancy, as the neural correlates of memory storage are still unknown. It is argued that the recollection of episodic-autobiographic episodes most likely involves frontotemporal regions of the right hemisphere, a region which appears to be hypometabolic in patients with dissociative amnesia.	[Markowitsch, H. J.] Univ Bielefeld, Dept Physiol Psychol, Bielefeld, Germany; [Staniloiu, A.] Sunnybrook Med Ctr, Dept Psychiat, Toronto, ON, Canada		Markowitsch, HJ (corresponding author), Univ Bielefeld, Physiol Psychol, POB 100131, D-33501 Bielefeld, Germany.	hjmarkowitsch@uni-bielefeld.de					Aldenhoff J, 1997, NERVENARZT, V68, P379, DOI 10.1007/s001150050139; Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1968, DIAGN STAT MAN MENT; Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson ND, 2011, J COGNITIVE NEUROSCI, V23, P3804, DOI 10.1162/jocn_a_00050; Anderson SD, 2004, ARCH PHYS MED REHAB, V85, P862, DOI 10.1016/j.apmr.2004.03.001; [Anonymous], 1935, LANCET, V26, P953; Arrigo JM, 1997, CURR DIR PSYCHOL SCI, V6, P148, DOI 10.1111/1467-8721.ep10772916; Arzy S, 2011, EUR J NEUROL, V18, P1422, DOI 10.1111/j.1468-1331.2011.03423.x; Back T, 1998, NERVENARZT, V69, P909, DOI 10.1007/s001150050363; BANCAUD J, 1994, BRAIN, V117, P71, DOI 10.1093/brain/117.1.71; Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; Bartsch T, 2013, NAT REV NEUROL, V9, P86, DOI 10.1038/nrneurol.2012.264; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bass C, 2007, J ROY SOC MED, V100, P81, DOI 10.1258/jrsm.100.2.81; Bell V, 2011, J NEUROL NEUROSUR PS, V82, P332, DOI 10.1136/jnnp.2009.199158; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bennett AR, 1878, BRAIN, V1, P114; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; Bergstrom ZM, 2013, BIOL PSYCHOL, V94, P1, DOI 10.1016/j.biopsycho.2013.04.012; Boedeker J, 1896, ARCH PSYCHIAT NERVEN, V29, P647; Bogousslavsky J, 2011, FRONT NEUROL NEUROSC, V29, P137, DOI 10.1159/000321783; Boone K.B., 2013, CLIN PRACTICE FORENS; Brand M, 2010, CURR ISS MEM, P239; Brand M, 2009, PSYCHIAT RES-NEUROIM, V174, P32, DOI 10.1016/j.pscychresns.2009.03.008; Brandt J, 2006, SEMIN NEUROL, V26, P331, DOI 10.1055/s-2006-945519; Bremner J Douglas, 2005, J Trauma Dissociation, V6, P51, DOI 10.1300/J229v06n02_06; Bremner JD, 2010, PSYCHOL BULL, V136, P1, DOI 10.1037/a0018021; Breuer J., 1895, STUDIEN HYSTERIE; Brown AS, 2002, PSYCHON B REV, V9, P403, DOI 10.3758/BF03196300; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Bumke O, 1924, LEHRBUCH GEISTESKRAN; Butler CR, 2011, BEHAV NEUROL, V24, P299, DOI [10.3233/BEN-2011-0340, 10.1155/2011/602965]; Calabrese P, 1996, J NEUROL NEUROSUR PS, V61, P304, DOI 10.1136/jnnp.61.3.304; Campbell BC, 2009, FRONT EVOL NEUROSCI, V4, P1; Carlesimo GA, 2011, NEUROPSYCHOLOGIA, V49, P777, DOI 10.1016/j.neuropsychologia.2011.01.026; Chadda R K, 2002, Indian J Psychiatry, V44, P283; Charcot JM., 1892, REV MED, V12, P81; CIMINO CR, 1991, BRAIN COGNITION, V15, P106, DOI 10.1016/0278-2626(91)90019-5; Clark A, 1998, ANALYSIS, V58, P7, DOI 10.1111/1467-8284.00096; Clark A, 2008, SUPERSIZING THEMIND; Coons PM, 1992, DISSOCIATION, V5, P73; Cox RE, 2003, MEMORY, V11, P307, DOI 10.1080/09658210244000108; Craver CF, 2014, CORTEX, V59, P153, DOI 10.1016/j.cortex.2013.11.001; Craver CF, 2014, NEUROPSYCHOLOGIA, V57, P191, DOI 10.1016/j.neuropsychologia.2014.03.004; Dalenberg CJ, 2012, PSYCHOL BULL, V138, P550, DOI 10.1037/a0027447; DallaBarba G, 1997, CORTEX, V33, P143, DOI 10.1016/S0010-9452(97)80010-X; Damasio A., 1999, FEELING WHAT HAPPENS; DAMASIO AR, 1990, BEHAV BRAIN RES, V40, P193, DOI 10.1016/0166-4328(90)90076-Q; DAMASIO AR, 1990, TRENDS NEUROSCI, V13, P95, DOI 10.1016/0166-2236(90)90184-C; Damasio AR, 1991, FRONTAL LOBE FUNCTIO, P217; de Kloet ER, 2005, NEUROSCI BIOBEHAV R, V29, P271, DOI 10.1016/j.neubiorev.2004.10.008; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 2007, TRAUMATIC DISSOCIATI, P139; Deacon T., 1989, INTEGRATING THEORY P, P1, DOI DOI 10.4324/9780429489464-1; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DEELMAN BG, 1990, TRAUMATIC BRAIN INJU; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; DERENZI E, 1994, CORTEX, V30, P3, DOI 10.1016/S0010-9452(13)80322-X; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; DERENZI E, 1993, CORTEX, V29, P449, DOI 10.1016/S0010-9452(13)80253-5; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; Detre GJ, 2013, NEUROPSYCHOLOGIA, V51, P2371, DOI 10.1016/j.neuropsychologia.2013.02.017; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; DOTY RW, 1970, ELECTROPHYSIOLOGY CE, P97; Dove G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00242; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Engelhardt E, 2013, ARQ NEURO-PSIQUIAT, V71, P487, DOI 10.1590/0004-282X20130067; Exner S., 1894, ENTWURF PHYSL ERKLAR; Fast K, 2001, Neurocase, V7, P269, DOI 10.1076/neur.7.4.269.16252; Feuchtwanger E., 1923, FUNKTIONEN STIRNHIRN; Fink GR, 1996, J NEUROSCI, V16, P4275; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FLECHSIG P, 1896, LOKALISATION GEISTIG; Flechsig P, 1896, GEHIRN UND SEELE; Fradera A, 2009, ENCY NEUROSCIENCE, V5, P751; Fraser LM, 2008, J ECT, V24, P10, DOI 10.1097/YCT.0b013e3181616c26; FREUD S, 1910, PSYCHOANALYSE FUNF V; Freud S., 1954, ORIGINS PSYCHOANALYS, P1887; Freud S, 1901, MON PSYCHIATR NEUROL, V10, P1; Freud Sigmund, 1901, MONATSSCHRIFT PSYCHI, V4, P436; Fujiwara E, 2006, NEUROBIOLOGISCHE KOR, P186; Fujiwara E., 2006, BINDING HUMAN MEMORY, P379; Fujiwara E, 2008, CORTEX, V44, P29, DOI 10.1016/j.cortex.2005.09.001; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Ganser, 1903, ARCH PSYCHIAT NERVEN, V38, P34, DOI 10.1007/BF02173461; Ganser SJ, 1898, ARCH PSYCHIATRIE NER, V30:, P633, DOI 10.1007/BF02036039; Goh WD, 2012, MEM COGNITION, V40, P28, DOI 10.3758/s13421-011-0133-9; Gold JJ, 2006, LEARN MEMORY, V13, P699, DOI 10.1101/lm.357406; GOLDBERG E, 1982, CORTEX, V18, P459, DOI 10.1016/S0010-9452(82)80042-7; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; Govindan RM, 2010, CEREB CORTEX, V20, P561, DOI 10.1093/cercor/bhp122; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Gregory E, 2014, FRONT HUM NEUROSCI, V8, P1; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; GROSSI D, 1988, CORTEX, V24, P457, DOI 10.1016/S0010-9452(88)80009-1; Grunthal E, 1930, MON PSYCHIATR NEUROL, V74, P354; Grunthal E, 1954, SCHWEIZ ARCH NEUROL, V74, P179; GRUNTHAL E, 1956, Monatsschr Psychiatr Neurol, V132, P309; Grunthal E, 1933, MONATSZEITSCHRIFT PS, V77, P374; Hanslmayr S, 2012, J NEUROSCI, V32, P14742, DOI 10.1523/JNEUROSCI.1777-12.2012; Harris CB, 2010, CURR ISS MEM, P253; Heim C, 2008, BIOL PSYCHIAT, V63, P398, DOI 10.1016/j.biopsych.2007.07.002; Heine R, 1911, VIERTELJAHRESSCHRIFT, V42, P51; Hennig-Fast K, 2008, NEUROPSYCHOLOGIA, V46, P2993, DOI 10.1016/j.neuropsychologia.2008.06.014; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Hihn H, 2006, J ECT, V22, P189, DOI 10.1097/01.yct.0000235512.75568.43; HODGES JR, 1993, BRAIN, V116, P921, DOI 10.1093/brain/116.4.921; Hokkanen L, 1996, ARCH NEUROL-CHICAGO, V53, P972, DOI 10.1001/archneur.1996.00550100038013; Hokkanen L, 1996, J NEUROL NEUROSUR PS, V61, P478, DOI 10.1136/jnnp.61.5.478; HOKKANEN L, 1995, PSYCHOL MED, V25, P203, DOI 10.1017/S0033291700028245; HOREL JA, 1978, BRAIN, V101, P403, DOI 10.1093/brain/101.3.403; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Huss M., 1852, CHRONISCHE ALKOHOLSK; Iglesias A, 2009, AM J CLIN HYPN, V52, P123, DOI 10.1080/00029157.2009.10401703; Igwe Monday N, 2013, J Med Case Rep, V7, P143, DOI 10.1186/1752-1947-7-143; Insausti R, 2013, P NATL ACAD SCI USA, V110, pE1953, DOI 10.1073/pnas.1306244110; Janet P., 1907, MAJOR SYMPTOMS HYSTE; Janet P., 1893, REV GENERALE SCI, V4, P167; Jenkins KG, 2009, CURR OPIN NEUROL, V22, P601, DOI 10.1097/WCO.0b013e32833299bb; Jetten J, 2010, J CLIN EXP NEUROPSYC, V32, P408, DOI 10.1080/13803390903140603; JOHN ER, 1975, ACTA NEUROBIOL EXP, V35, P417; JOHN ER, 1972, SCIENCE, V177, P850, DOI 10.1126/science.177.4052.850; Jokeit H, 1997, NEUROLOGY, V49, P481, DOI 10.1212/WNL.49.2.481; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; KAPUR N, 1989, CORTEX, V25, P387, DOI 10.1016/S0010-9452(89)80053-X; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kapur N, 1996, J COGNITIVE NEUROSCI, V8, P416, DOI 10.1162/jocn.1996.8.5.416; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kessler J, 1997, J CLIN EXP NEUROPSYC, V19, P604, DOI 10.1080/01688639708403746; Kier EL, 2004, AM J NEURORADIOL, V25, P677; KIERSCH TA, 1962, AM J PSYCHIAT, V119, P57, DOI 10.1176/ajp.119.1.57; Kihlstrom JF, 2013, CORTEX, V49, P393, DOI 10.1016/j.cortex.2012.04.018; Kikuchi H, 2010, J COGNITIVE NEUROSCI, V22, P602, DOI 10.1162/jocn.2009.21212; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Klein SB, 2015, WIRES COGN SCI, V6, P1, DOI 10.1002/wcs.1333; Kleist K., 1934, GEHIRNPATHOLOGIE; Kleist K, 1918, ALLG Z PSYCHIATR PS, V74, P432; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Kopelman MD, 2003, HIPPOCAMPUS, V13, P879, DOI 10.1002/hipo.10140; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Krarup F, 1924, Z GESAMTE NEUROL PSY, V90, P638, DOI 10.1007/BF02901336; Kritchevsky M, 2004, LEARN MEMORY, V11, P213, DOI 10.1101/lm.71404; KRITCHEVSKY M, 1993, NEUROLOGY, V43, P326, DOI 10.1212/WNL.43.2.326; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; Kruse Kuno, 2010, MANN SEIN GEDACHTNIS; Kuehnel S, 2008, BRAIN IMAGING BEHAV, V2, P163, DOI 10.1007/s11682-008-9026-3; Kunii Y, 2012, PSYCHIAT CLIN NEUROS, V66, P623, DOI 10.1111/j.1440-1819.2012.02408.x; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lah S, 2006, EPILEPSIA, V47, P615, DOI 10.1111/j.1528-1167.2006.00476.x; Lah S, 2008, EPILEPSY BEHAV, V13, P391, DOI 10.1016/j.yebeh.2008.05.002; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lee SS, 2011, PSYCHIAT INVEST, V8, P377, DOI 10.4306/pi.2011.8.4.377; Lennox WG, 1943, AM J PSYCHIAT, V99, P732, DOI 10.1176/ajp.99.5.732; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Levine B, 2009, NEUROPSYCHOLOGIA, V47, P2188, DOI 10.1016/j.neuropsychologia.2008.12.026; Llewellyn S, 2013, BEHAV BRAIN SCI, V36, P634, DOI 10.1017/S0140525X1300160X; Loftus EF, 2006, ANNU REV CLIN PSYCHO, V2, P469, DOI 10.1146/annurev.clinpsy.2.022305.095315; LUCCHELLI F, 1995, BRAIN, V118, P167, DOI 10.1093/brain/118.1.167; Lundholm H, 1931, J ABNORM SOC PSYCH, V26, P355; Lupien S.J., 2000, ENCY STRESS, V2, P693; Lupien SJ, 2005, PSYCHONEUROENDOCRINO, V30, P225, DOI 10.1016/j.psyneuen.2004.08.003; Lupien SJ, 2011, P NATL ACAD SCI USA, V108, P14324, DOI 10.1073/pnas.1105371108; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mace JH, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00183; Mace JH, 2013, MEMORY, V21, P324, DOI 10.1080/09658211.2012.726359; Mace JH, 2010, MEMORY, V18, P845, DOI 10.1080/09658211.2010.514271; Magnin E, 2014, NEUROCASE, V20, P27, DOI 10.1080/13554794.2012.732081; Maldonado J.R., 2008, AM PSYCHIAT PUBLISHI, V5th ed., P665; Marinkovic K, 2011, COGN AFFECT BEHAV NE, V11, P113, DOI 10.3758/s13415-010-0017-7; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch HJ, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 2: H-O, P131; Markowitsch H J, 1992, Rehabilitation (Stuttg), V31, P11; Markowitsch H.J., 1992, INTELLECTUAL FUNCTIO; Markowitsch H. J., 2012, BRAIN DAMAGE CAUSES, P41; Markowitsch H.J., 1988, INFORMATION PROCESSI, P125; Markowitsch HJ, 2013, CORTEX, V49, P1494, DOI 10.1016/j.cortex.2012.05.020; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Markowitsch HJ, 2011, CORTEX, V47, P1248, DOI 10.1016/j.cortex.2011.06.013; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Markowitsch HJ, 2011, CONSCIOUS COGN, V20, P16, DOI 10.1016/j.concog.2010.09.005; Markowitsch HJ, 2010, CURR ISS MEM, P23; Markowitsch Hans J, 2008, Handb Clin Neurol, V88, P155, DOI 10.1016/S0072-9752(07)88007-9; MARKOWITSCH HJ, 1985, INT J NEUROSCI, V27, P191, DOI 10.3109/00207458509149767; Markowitsch HJ, 1999, CORTEX, V35, P243, DOI 10.1016/S0010-9452(08)70797-4; Markowitsch HJ, 2000, NEUROPSY NEUROPSY BE, V13, P60; Markowitsch HJ, 1997, EUR J NEUROL, V4, P178, DOI 10.1111/j.1468-1331.1997.tb00324.x; Markowitsch HJ, 1999, NEUROCASE, V5, P189, DOI 10.1093/neucas/5.3.189; Markowitsch HJ, 1999, CORTEX, V35, P219, DOI 10.1016/S0010-9452(08)70795-0; Markowitsch HJ, 1998, NEUROL PSYCHIAT BR, V6, P73; Markowitsch HJ, 1997, NEUROCASE, V3, P445, DOI 10.1093/neucas/3.6.445; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P627, DOI 10.1080/01688639308402586; MARKOWITSCH HJ, 1978, BEHAV BIOL, V22, P411, DOI 10.1016/S0091-6773(78)92531-2; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; Markowitsch HJ, 1996, NEUROCASE, V2, P357; MARKOWITSCH HJ, 1984, INT J NEUROSCI, V25, P145, DOI 10.3109/00207458408985596; MARKOWITSCH HJ, 1986, INT J NEUROSCI, V29, P1; Markowitsch HJ, 1997, NEUROL PSYCHIAT BR, V5, P71; Markowitsch HJ, 2002, CORTEX, V38, P651, DOI 10.1016/S0010-9452(08)70030-3; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Markowitsch HJ, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P319; MARKOWITSCH HJ, 1992, J NEUROL NEUROSUR PS, V55, P507, DOI 10.1136/jnnp.55.6.507; Markowitsch HJ, 2000, BEHAV NEUROL, V12, P181, DOI 10.1155/2000/303651; Markowitsch HJ, 1996, BEHAV NEUROL, V9, P45, DOI 10.3233/BEN-1996-9201; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; Markowitsch HJ, 1999, MEMORY, V7, P561, DOI 10.1080/096582199387751; Markowitsch HJ, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P193; Markowitsch HJ, 1999, CURR OPIN PSYCHIATR, V12, P331, DOI 10.1097/00001504-199905000-00014; Markowitsch HJ, 1996, NEUROL PSYCHIAT BR, V4, P1; Markowitsch HJ, 2012, BRAIN INJURY, V26, P198; Markowitsch HJ, 2009, PSYCHOANALYSE, V13, P246; Markowitsch HJ, 2006, BIOL PSYCHIAT PSYCHO, V8, P50; Markowitsch HJ, 1999, NEUROLOGIE PRAXIS KL, V1, P60; MARKOWITSCH HJ, 1990, TRANSIENT GLOBAL AMN, P181; Markowitsch HJ, OXFORD HDB IN PRESS; Markowitsch HJ, 2013, MEMORY SELF NEUROSCI; Markowitsch HJ, 1990, TRANSIENT GLOBAL AMN, P4; Matthies, 1908, ALLG Z PSYCHIATR PS, V65, P188; Maudsley Henry, 1870, BODY MIND INQUIRY TH; Mayes A., 1988, HUMAN ORGANIC MEMORY; McKay G. C. M., 2009, ADV PSYCHIAT TREAT, V15, P152, DOI [10.1192/apt.bp.105.001586, DOI 10.1192/APT.BP.105.001586]; Meijneke Ruud W H, 2014, Ned Tijdschr Geneeskd, V158, pA6962; Mesulam M.-M., 2000, PRINC BEHAV COGN NEU, V2, P1, DOI [DOI 10.1017/9781108164320.002, 10.1017/9781108164320.002]; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Metcalfe J., 2005, MISSING LINK COGNITI, P4, DOI DOI 10.1093/ACPROF:OSO/9780195161564.003.0001; Miller LA, 2001, NEUROPSYCHOLOGIA, V39, P1037, DOI 10.1016/S0028-3932(01)00041-0; Milton F, 2010, BRAIN, V133, P1368, DOI 10.1093/brain/awq055; Mishra NK, 2011, EUR NEUROL, V66, P229, DOI 10.1159/000330953; Moriguchi Y, 2009, HUM BRAIN MAPP, V30, P2063, DOI 10.1002/hbm.20653; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Mortati K, 2012, PATIENT DISTINCT DIS; Naef M, 1897, Z HYPNOTISMUS, V6, P321; Nairne JS, 2002, MEMORY, V10, P389, DOI 10.1080/09658210244000216; Noulhiane M, 2007, BRAIN, V130, P3184, DOI 10.1093/brain/awm258; O'Brien DJ, 2011, NAT REV NEUROSCI, V12, P302, DOI 10.1038/nrn2889-c1; O'Neill A, 2000, PSYCHOTHER PSYCHOSOM, V69, P108, DOI 10.1159/000012374; OBrien JT, 1997, BRIT J PSYCHIAT, V170, P199, DOI 10.1192/S0007125000146513; Osnato M, 1930, AM J PSYCHIAT, V9, P643; Ouellet J, 2008, BEHAV NEUROL, V20, P27, DOI [10.1155/2008/520328, 10.3233/BEN-2008-0213]; Parkin AJ, 1996, ACTA NEUROL BELG, V96, P43; PAUL M, 1899, ARCH PSYCHIAT NERVEN, V32, P251; Paz-Alonso PM, 2013, J NEUROSCI, V33, P5017, DOI 10.1523/JNEUROSCI.3459-12.2013; Paz-Alonso PM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.024.2009; Peckl Petra, 2007, Praxis (Bern 1994), V96, P2075, DOI 10.1024/1661-8157.96.51.2075; Peper M, 2001, J Hist Neurosci, V10, P58, DOI 10.1076/jhin.10.1.58.5628; Pfeifer R., 2007, BODY SHAPES WAY WE T; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Pietrini P, 2003, AM J PSYCHIAT, V160, P1907, DOI 10.1176/appi.ajp.160.11.1907; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Pommerenke K, 2012, NEUROL REHAB, V18, P106; Pribram KH., 1971, LANGUAGES BRAIN EXPT; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Quesada AA, 2012, PSYCHONEUROENDOCRINO, V37, P125, DOI 10.1016/j.psyneuen.2011.05.013; Quirin M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00902; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2013, ACTA NEUROBIOL EXP, V73, P463; Quiroga RQ, 2012, NAT REV NEUROSCI, V13, P587, DOI 10.1038/nrn3251; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rathbone CJ, 2015, NEUROCASE, V21, P727, DOI 10.1080/13554794.2014.977923; Rathbone CJ, 2009, NEUROCASE, V15, P405, DOI 10.1080/13554790902849164; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Reinhold N, 2006, CURR MED IMAGING, V2, P35, DOI 10.2174/157340506775541668; Reinhold N, 2008, Z NEUROPSYCHOL, V19, P15; Reinhold N, 2007, J NEUROPSYCHOL, V1, P53, DOI 10.1348/174866407X180819; Reinhold N, 2009, NEUROPSYCHOLOGIA, V47, P2197, DOI 10.1016/j.neuropsychologia.2009.01.037; Reinvang I, 1998, NEUROPSYCHOLOGIA, V36, P1335, DOI 10.1016/S0028-3932(98)00021-9; Ribot T., 1882, DIS MEMORY; Risius UM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00024; Roberts I, 2013, AM J PSYCHIAT, V170, P1398, DOI 10.1176/appi.ajp.2013.12121632; Roediger HL, 2010, CURR ISS MEM, P1; ROMANCAMPOS G, 1980, CORTEX, V16, P509, DOI 10.1016/S0010-9452(80)80053-0; Rosenbaum RS, 2014, NEUROPSYCHOLOGIA, V65, P82, DOI 10.1016/j.neuropsychologia.2014.09.047; Rosenbaum RS, 2009, NEUROPSYCHOLOGIA, V47, P2181, DOI 10.1016/j.neuropsychologia.2008.11.028; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Russell WR, 1935, LANCET, V2, P762; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Sackeim HA, 2007, NEUROPSYCHOPHARMACOL, V32, P244, DOI 10.1038/sj.npp.1301180; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SARTER M, 1984, J COMP NEUROL, V224, P445, DOI 10.1002/cne.902240312; Savage GH, 1878, BRAIN, V1, P265; Schacter D. L., 1991, AWARENESS DEFICIT BR, P258; SCHACTER DL, 1989, HDB NEUROPSYCHOLOGY, V3, P209; Schlesinger H, 1916, MUENCHNER MED WOCHEN, V1, P18; Schneider K., 1928, HDB GEISTESKRANKHEIT, V1, P508; SCHOENFELD TA, 1977, PHYSIOL BEHAV, V18, P951, DOI 10.1016/0031-9384(77)90206-2; Schore AN, 2005, PEDIATR REV, V26, P204, DOI 10.1542/pir.26-6-204; Schore AN, 2002, AUST NZ J PSYCHIAT, V36, P9, DOI 10.1046/j.1440-1614.2002.00996.x; Schulte-Ruther M, 2011, SOC NEUROSCI, V6, P1; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354; Sehm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026538; Seidl U., 2006, WARUM MENSCHEN SICH, P286; Semon R, 1904, MNEME ALS ERHALTENDE; Serra L, 2007, BEHAV NEUROL, V18, P53, DOI 10.1155/2007/193140; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silver JM, 1997, NEUROCASE, V3, P151, DOI 10.1080/13554799708404048; Smith CN, 2010, NEUROPSYCHOLOGIA, V48, P2833, DOI 10.1016/j.neuropsychologia.2010.05.025; Soper AC, 2011, EPILEPSY BEHAV, V20, P709, DOI 10.1016/j.yebeh.2011.01.026; Souques A., 1892, REV MED, V13, P367; Spiegel D, 2013, ANNU REV CLIN PSYCHO, V9, P299, DOI 10.1146/annurev-clinpsy-050212-185531; Spiegel D, 2011, DEPRESS ANXIETY, V28, P824, DOI 10.1002/da.20874; Spinnler, 1998, COGNITIVE NEUROPSYCH, V3, P91, DOI https://doi.org/10.1080/135468098396189; Squire L.R., 1982, HUMAN MEMORY AMNESIA, P275; Staniloiu A, 2015, INT ENCY SOCIAL BEHA, V1, P651; Staniloiu A, 2011, ADV BRAIN IMAGING, P11; Staniloiu A, 2012, FUNCTIONAL IMPAIRMEN, P87; Staniloiu A, 2012, J LIT THEORY, V6, P103, DOI 10.1515/jlt-2011-0012; Staniloiu A, 2014, LANCET PSYCHIAT, V1, P226, DOI 10.1016/S2215-0366(14)70279-2; Staniloiu A, 2012, BRAIN SCI, V2, P101, DOI 10.3390/brainsci2020101; Staniloiu A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00342; Staniloiu A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00403; Staniloiu A, 2012, BEHAV BRAIN SCI, V35, P164, DOI 10.1017/S0140525X11001543; Staniloiu A, 2010, CONSCIOUS COGN, V19, P778, DOI 10.1016/j.concog.2010.06.024; Staniloiu A, 2010, Z PSYCHOL, V218, P96, DOI 10.1027/0044-3409/a000017; Staniloiu Angelica, 2009, Cogn Neuropsychiatry, V14, P180, DOI 10.1080/13546800902931036; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Storring GE, 1936, ARCH GESAMTE PSYCHOL, V95, P436; Storring GE, 1931, ARCH GESAMTE PSYCHOL, V81, P257; Stone J, 2006, BRIT J PSYCHIAT, V188, P204, DOI 10.1192/bjp.188.3.204; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; Stracciari A, 2008, BEHAV NEUROL, V20, P113, DOI [10.1155/2008/376159, 10.3233/BEN-2008-0222]; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; STUSS DT, 1988, BRAIN COGNITION, V8, P21, DOI 10.1016/0278-2626(88)90036-X; STUSS DT, 1982, COMA PHYSIOPATHOLOGY, P193; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Syz H, 1937, J GEN PSYCHOL, V17, P355, DOI 10.1080/00221309.1937.9918005; Teramoto S, 2005, PEDIATR INT, V47, P469, DOI 10.1111/j.1442-200x.2005.02095.x; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; Thomas-Anterion C, 2014, NEUROPHYSIOL CLIN, V44, P355, DOI 10.1016/j.neucli.2014.08.003; Thomas-Anterion C, 2010, J NEUROL NEUROSUR PS, V81, P468, DOI 10.1136/jnnp.2008.163808; Toussi A, 2014, GEN HOSP PSYCHIAT, V36, P225, DOI 10.1016/j.genhosppsych.2013.10.007; Tramoni E, 2009, NEUROPSYCHOLOGIA, V47, P611, DOI 10.1016/j.neuropsychologia.2008.11.012; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; TREADWAY M, 1992, HDB EMOTION MEMORY R, P389; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Tulving E., 1983, ELEMENTS EPISODIC ME; Valentino K, 2009, J CHILD PSYCHOL PSYC, V50, P1029, DOI 10.1111/j.1469-7610.2009.02072.x; van der Kruijs SJM, 2014, J NEUROL NEUROSUR PS, V85, P174, DOI 10.1136/jnnp-2012-302905; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; van Schie K, 2013, COGNITION EMOTION, V27, P1122, DOI 10.1080/02699931.2013.765387; Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vermetten E., 2007, TRAUMATIC DISSOCIATI; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Viskontas IV, 2002, NEUROPSYCHOLOGY, V16, P472, DOI 10.1037//0894-4105.16.4.472; von Monakow C., 1914, LOKALISATION GROSSHI; VONCRAMON DY, 1993, NEUROPSYCHOLOGIA, V31, P1159, DOI 10.1016/0028-3932(93)90065-8; Wabnitz P, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21452; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; Watkins E, 2000, PSYCHOL MED, V30, P911, DOI 10.1017/S0033291799002263; Weusten L H, 2013, Tijdschr Psychiatr, V55, P281; WHO, 1992, CLASS MENT BEH DIS C; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278; Wilson BA, 2015, IDENTITY UNKNOWN; Wingenfeld K, 2014, HIPPOCAMPUS CLIN NEU, P1; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013; WOLPAW JR, 1971, LANCET, V2, P356; Yamadori A, 2001, TOHOKU J EXP MED, V193, P57, DOI 10.1620/tjem.193.57; YONEDA Y, 1992, EUR NEUROL, V32, P340, DOI 10.1159/000116857; [No title captured]; [No title captured]; [No title captured]	371	11	11	2	11	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-801849-1; 978-0-12-801772-2	HAND CLINIC			2016	139						419	445		10.1016/B978-0-12-801772-2.00036-9			27	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BH3HD	WOS:000399651400037	27719861				2022-02-06	
J	Merzo, A; Lenell, S; Nyholm, L; Enblad, P; Lewen, A				Merzo, Abraham; Lenell, Samuel; Nyholm, Lena; Enblad, Per; Lewen, Anders			Promising clinical outcome of elderly with TBI after modern neurointensive care	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Outcome; Elderly; Neurointensive care; Secondary injury	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; HEAD-INJURY; FOLLOW-UP; AGE; EPIDEMIOLOGY; PATIENT; COMA; HEMATOMAS; LEVEL	The increasing number of elderly patients with traumatic brain injury (TBI) leads to specific neurointensive care (NIC) challenges. Therefore, elderly subjects with TBI need to be further studied. In this study we evaluated the demographics, management and outcome of elderly TBI patients receiving modern NIC. Patients referred to our NIC unit between 2008 and 2010 were included. Patients were divided in two age groups, elderly (E) a parts per thousand yen65 years and younger (Y) 64-15 years. Parameters studied were the dominant finding on CT scans, neurological motor skills and consciousness, type of monitoring, neurosurgical procedures/treatments and Glasgow Outcome Scale Extended score at 6 months after injury. Sixty-two E (22 %) and 222 Y (78 %) patients were included. Falls were more common in E (81 %) and vehicle accidents were more common in Y patients (37 %). Acute subdural hematoma was significantly more common in E (50 % of cases) compared to Y patients (18 %). Intracranial pressure was monitored in 44 % of E and 57 % of Y patients. Evacuation of significant mass lesions was performed more common in the E group. The NIC mortality was similar in both groups (4-6 %). Favorable outcome was observed in 72 % of Y and 51 % of E patients. At the time of follow-up 25 % of E and 7 % of Y patients had died. The outcome of elderly patients with TBI was significantly worse than in younger patients, as expected. However, as much as 51 % of the elderly patients showed a favorable outcome after NIC. We believe that these results encourage modern NIC in elderly patients with TBI. We need to study how secondary brain injury mechanisms differ in the older patients and to identify specific outcome predictors for elderly patients with TBI.	[Merzo, Abraham; Lenell, Samuel; Nyholm, Lena; Enblad, Per; Lewen, Anders] Uppsala Univ, Dept Neurosci, Neurosurg, SE-75185 Uppsala, Sweden		Lewen, A (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, SE-75185 Uppsala, Sweden.	anders.lewen@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Lenell, Samuel/0000-0001-8914-5086	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Selanders Foundation	We would like to acknowledge Uppsala Clinical Research Center (Uppsala University) for the help with the TBI register. The study was supported by The Swedish Research Council and The Selanders Foundation.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ely EW, 1999, ANN INTERN MED, V131, P96, DOI 10.7326/0003-4819-131-2-199907200-00004; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Hermans G, 2008, CRIT CARE, V12, DOI 10.1186/cc7100; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Karni A, 2001, AM SURGEON, V67, P1098; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Lenell S, 2015, ACTA NEUROCHIR, V157, P417, DOI 10.1007/s00701-014-2329-9; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nguyen Dung V, 2012, Front Endocrinol (Lausanne), V3, P170, DOI 10.3389/fendo.2012.00170; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Statistics Sweden (SCB), 2009, SCB DEM REP; Stefan Mihaela, 2011, Hosp Pract (1995), V39, P41, DOI 10.3810/hp.2011.02.373; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	42	11	11	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2016	158	1					125	133		10.1007/s00701-015-2639-6			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CZ2ZY	WOS:000366975000016	26577639				2022-02-06	
J	Migliorini, C; Enticott, J; Callaway, L; Moore, S; Willer, B				Migliorini, Christine; Enticott, Joanne; Callaway, Libby; Moore, Sophie; Willer, Barry			Community integration questionnaire: Outcomes of people with traumatic brain injury and high support needs compared with multiple matched controls	BRAIN INJURY			English	Article						Brain injuries; community assessment; reference values; rehabilitation (community-based); community integration; community living; community participation; social participation; TBI (Traumatic Brain Injury)	LONG-TERM OUTCOMES	Objectives: To determine level of community integration in adults with traumatic brain injury and high support needs (TBI-HSN) compared with multiple matched controls.Setting: Community setting, Victoria, Australia.Participants: Adults with TBI-HSN living in the community (n = 61). Australian normative data (n = 1973) was used for matching purposes (1:4).Design: Matched analysis from people with and without TBI. Matching aimed to reduce variability expected from age, gender, metropolitan/rural residence and co-resident status.Main measures: Community Integration Questionnaire (CIQ): total and sub-scales of Home Integration, Social Integration and Productivity.Results: Matched analysis showed large effects favouring the general population, e.g. CIQ total scores were significantly different, F(1, 304) = 5.8, p < 0.0001. Conditional relative risk showed community-dwelling participants with TBI were 540-times more likely to report a poor CIQ total score compared to the general population.Conclusion: Normative CIQ data has enabled meaningful comparisons of the community integration of adults with chronic TBI to the general population in Australia. Evidence makes clear with numeric precision that individuals with TBI and high support needs are much less integrated than their non-TBI counterparts despite living in the community for many years.	[Migliorini, Christine; Callaway, Libby; Moore, Sophie] Monash Univ, Dept Occupat Therapy, Melbourne, Vic, Australia; [Migliorini, Christine; Callaway, Libby] Summer Fdn, Melbourne, Vic, Australia; [Enticott, Joanne] Southern Synergy, Melbourne, Vic, Australia; [Enticott, Joanne] Southern Clin Sch, Dept Psychiat, Melbourne, Vic, Australia; [Enticott, Joanne] Monash Univ, Sch Primary Hlth Care, Melbourne, Vic, Australia; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Buffalo, NY USA		Migliorini, C (corresponding author), Monash Univ, Dept Occupat Therapy, Peninsula Campus,McMahons Rd, Frankston, Vic 3199, Australia.	christine.migliorini@monash.edu	enticott, joanne C/I-1587-2014	enticott, joanne C/0000-0002-4480-5690	Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research	The authors report no conflicts of interest. This project was funded by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research.	[Anonymous], 2015, STAND OUTC MEAS; Beane Freeman LE, 2009, JNCI-J NATL CANCER I, V101, P751, DOI 10.1093/jnci/djp096; Breslow NE, 1980, ANAL CASE CONTROL ST; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Callaway L, AUST OCCUP THER J; Callaway L., 2014, COMMUNITY INTEGRATIO; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Cummings P, 2004, STATA J, V4, P274, DOI 10.1177/1536867X0400400305; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers M., 1998, TOP SPINAL CORD INJ, V4, P1, DOI DOI 10.1310/BJJA-2018-45KL-0VTL; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Glenn ND., 2007, BLACKWELL ENCY SOCIO; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Reisenwitz TH., 2009, MARK MANAG J, V19, P91; Rigby AS, 2000, DISABIL REHABIL, V22, P259, DOI 10.1080/096382800296719; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schieman S., 2007, BLACKWELL ENCY SOCIO; Settersten RA, 2010, FUTURE CHILD, V20, P19; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Sloan S, 2012, BRAIN IMPAIR, V13, P24, DOI 10.1017/BrImp.2012.5; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; [Statewide Rehabilitation Clinical Network South Australia Health], 2012, ACQ BRAIN INJ MOD RE; Tate R., 2011, MANUAL CARE NEEDS SC; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; von Lehn D., 2007, BLACKWELL ENCY SOCIO; Waldschmidt A., 2007, BLACKWELL ENCY SOCIO; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299	35	11	11	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1201	1207		10.1080/02699052.2016.1175666			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300005	27314287				2022-02-06	
J	Padegimas, EM; Stepan, JG; Stoker, GE; Polites, GM; Brophy, RH				Padegimas, Eric M.; Stepan, Jeffrey G.; Stoker, Geoffrey E.; Polites, Gregory M.; Brophy, Robert H.			Epidemiology and Severity of Sports and Recreation Injuries Presenting to a Tertiary Adult Emergency Department	PHYSICIAN AND SPORTSMEDICINE			English	Article						Sports injuries; emergency department; ATV injuries; concussion; hospital admissions	TERRAIN VEHICLE ACCIDENTS; RETAIL CLINICS; UNITED-STATES; VISITS; YOUNG; CARE; COSTS	Objective: This study aims to evaluate all sports and recreation injuries that present to an emergency department, identify the activity and injury patterns associated with hospital admission, and determine injuries that could be better treated in alternative care settings. Methods: This is a retrospective review of all sports injuries that presented to the emergency department of a high volume, urban, tertiary referral center from 1/1/2010 to 12/31/2011. These were identified by a sports term search algorithm applied to all emergency department records. The main outcome measured was hospital admission status after sports injury. Univariate and multivariate regression analysis was performed to identify risk factors for hospital admission in the sports injury population. Results: 1,101 of the 191,259 encounters (0.6%) had 1,210 sports injuries. 84 were admitted (7.6%). Basketball injuries were most prevalent (31.6%). All-terrain vehicle (ATV) related injuries was most often admitted (46.4%). Logistic regression identified ATV riding (95% CI 6.15-23.37, p < 0.001) and age over 50years-old (4.09-17.40, p < 0.001) as independent risk factors for admission while basketball (0.101-0.985, p=0.047) and black race (0.17-0.77, p=0.008) were independently protective. Isolated sprains/strains and soft tissue injuries (4/649, 0.6%) rarely required admission. Conclusions: The 7.6% admission rate is higher than previously reported, likely because the study institution is a tertiary referral center. ATV riding is associated with higher severity injuries that are more likely to require hospital admission. Most sports injuries that present to an emergency department, specifically isolated soft tissue injuries of the extremities, may be more efficiently treated in a non-emergent setting.	[Padegimas, Eric M.; Stepan, Jeffrey G.; Stoker, Geoffrey E.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA; [Polites, Gregory M.] Washington Univ, Barnes Jewish Hosp, Sch Med St Louis, Dept Emergency Med, St Louis, MO USA; [Brophy, Robert H.] Washington Univ, Barnes Jewish Hosp, Sch Med St Louis, Dept Orthopaed Surg, St Louis, MO USA; [Padegimas, Eric M.] Thomas Jefferson Univ Hosp, Rothman Inst, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Stepan, Jeffrey G.] Hosp Special Surg, Dept Orthopaed Surg, New York, NY 10021 USA; [Stoker, Geoffrey E.] Tufts Med Ctr, Dept Orthopaed Surg, Boston, MA USA		Padegimas, EM (corresponding author), Thomas Jefferson Univ Hosp, Dept Orthopaed Surg, 1025 Walnut St,Room 516 Coll, Philadelphia, PA 19107 USA.	padegimase@gmail.com	Brophy, Robert H/AAX-8562-2021	Brophy, Robert H/0000-0002-2912-8265; Stepan, Jeffrey/0000-0002-6595-9752			[Anonymous], 2013, 2013 PART REP PHYS A; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Burt CW, 2001, ANN EMERG MED, V37, P301, DOI 10.1067/mem.2001.111707; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P736; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; GANOS D, 1988, AM SURGEON, V54, P429; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hanseen J, 2013, NAT C STAT LEG DEC D; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; KRANE BD, 1988, AM SURGEON, V54, P471; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; MARGOLIS JL, 1988, J TRAUMA, V28, P395, DOI 10.1097/00005373-198803000-00017; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Merkel DL, 2012, INT J SPORTS PHYS TH, V7, P242; Monroe KW, 2011, CLIN PEDIATR, V50, P17, DOI 10.1177/0009922810378735; Nalliah RP, 2014, PEDIATR EMERG CARE, V30, P511, DOI 10.1097/PEC.0000000000000180; Obama M, LETS MOVE; Pollard KA, 2011, CLIN PEDIATR, V50, P844, DOI 10.1177/0009922811406262; Sabo D, 2008, GO OUT PLAY YOUTH SP; Shults RA, 2005, PEDIATRICS, V116, pE608, DOI 10.1542/peds.2005-0937; Testerman George M, 2009, Tenn Med, V102, P45; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283; TRAGER GW, 1986, ANN EMERG MED, V15, P1293, DOI 10.1016/S0196-0644(86)80612-6; Weinick RM, 2010, HEALTH AFFAIR, V29, P1630, DOI 10.1377/hlthaff.2009.0748; Yanchar NL, 2006, INJURY PREV, V12, P30, DOI 10.1136/ip.2005.008466	29	11	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2016	44	3					263	268		10.1080/00913847.2016.1171683			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	DW3AW	WOS:000383515400010	27014859				2022-02-06	
J	Pearce, B; Cartwright, J; Cocks, N; Whitworth, A				Pearce, Bronte; Cartwright, Jade; Cocks, Naomi; Whitworth, Anne			Inhibitory control and traumatic brain injury: The association between executive control processes and social communication deficits	BRAIN INJURY			English	Article						TBI; disinhibition; executive functioning	MONTREAL COGNITIVE ASSESSMENT; ABILITY; QUESTIONNAIRE; IMPULSIVITY; VALIDITY; INSIGHTS; CONSENT; SKILLS	Primary objective: To further examine the proposed relationship between executive impairments in inhibitory control and social communication difficulties reflecting poor inhibition following TBI. Method: Inhibitory control was assessed in 14 adults with TBI on the Hayling Sentence Completion Test (HSCT). Errors on Part B (failed inhibition) and Part B-Part A response latencies (delayed inhibition) were examined. A relative, friend or frequent communication partner of each participant with TBI completed the La Trobe Communication Questionnaire (LCQ) on the communication difficulties of the person with TBI. The Inhibitory Control Factor (ICF) score of the LCQ based on seven items relating to poor inhibition was specifically analysed against performance on the HSCT. Results: Multiple regression analysis indicated that 58% (51% adjusted) of the variance in LCQ ICF scores was accounted for by measures on the HSCT. Only B-A response latencies on the HSCT explained a significant proportion of the variability in LCQ ICF scores. Conclusions: Reduced inhibition speed may more strongly contribute to disinhibited communication behaviours than failures in inhibition. These findings contribute to understanding of the cognitive processes underlying social communication and have the potential to support and inform the use and development of management practices for individuals following TBI.	[Pearce, Bronte; Cartwright, Jade; Cocks, Naomi; Whitworth, Anne] Curtin Univ, Dept Psychol & Speech Pathol, Perth, WA, Australia		Pearce, B (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Bentley, WA, Australia.	bronte.pearce@graduate.curtin.edu.au	Whitworth, Anne/AAX-4888-2020	Whitworth, Anne/0000-0002-4653-0782; Cartwright, Jade/0000-0002-6381-6184; Cocks, Naomi/0000-0002-1744-6979	School of Psychology and Speech Pathology at Curtin University, Perth, Western Australia	This research was supported in part by a grant from the School of Psychology and Speech Pathology at Curtin University, Perth, Western Australia. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Boersma P, 2014, PRAAT DOING PHONETIC; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Damico JS, 1986, COMMUNICATION SKILLS, P165; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dunn LB, 2002, AM J GERIAT PSYCHIAT, V10, P142, DOI 10.1176/appi.ajgp.10.2.142; Faul F, 2009, G POWER 3 COMPUTER S; Fonseca Rochele Paz, 2012, Psychol. Neurosci., V5, P183, DOI 10.3922/j.psns.2012.2.08; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Helps Y, 2008, AIHW INJURY RES STAT, V45; Karlawish J, 2013, NEUROLOGY, V81, P801, DOI 10.1212/WNL.0b013e3182a05ba5; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; McDonald S, 2014, SOCIAL COMMUNICATION; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Spreen O., 1969, NEUROSENSORY CTR COM; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tabachnick B.G., 2001, USING MULTIVARIATE S; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746	35	11	11	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1708	1717		10.1080/02699052.2016.1202450			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800026	27996329				2022-02-06	
J	Rushby, JA; McDonald, S; Fisher, AC; Kornfeld, EJ; De Blasio, FM; Parks, N; Piguet, O				Rushby, Jacqueline A.; McDonald, Skye; Fisher, Alana C.; Kornfeld, Emma J.; De Blasio, Frances M.; Parks, Nicklas; Piguet, Olivier			Brain volume loss contributes to arousal and empathy dysregulation following severe traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Brain volume loss; Limbic system; Physiological arousal; Empathy; Severe traumatic brain injury	FALSE DISCOVERY RATE; NEURAL BASIS; MODERATE; VETERANS; BEHAVIOR; DEFICITS; FMRI	Severe traumatic brain injury (TBI) often leads to deficits in physiological arousal and empathy, which are thought to be linked. This study examined whether injury-related brain volume loss in key limbic system structures is associated with these deficits. Twenty-four adults with TBI and 24 matched Controls underwent MRI scans to establish grey matter volumes in the amygdala, thalamus, and hippocampus. EEG and skin conductance levels were recorded to index basal physiological arousal. Self-report emotional empathy levels were also assessed. The TBI group had reduced brain volumes, topographic alpha differences, and lower emotional empathy compared to Controls. Regional brain volumes were differentially correlated to arousal and self-report empathy. Importantly, lower volume in pertinent brain structures correlated with lower empathy, for participants with and without TBI. Overall we provide new insights into empathic processes after TBI and their relationship to brain volume loss. (C) 2016 The Authors. Published by Elsevier Inc.	[Rushby, Jacqueline A.; McDonald, Skye; Fisher, Alana C.; Kornfeld, Emma J.; De Blasio, Frances M.; Parks, Nicklas] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Piguet, Olivier] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Piguet, Olivier] UNSW, Sch Med Sci, Sydney, NSW 2052, Australia; [Piguet, Olivier] Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2052, Australia		Rushby, JA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	j.rushby@unsw.edu.au	De Blasio, Frances M./D-9158-2019; Fisher, Alana/T-1869-2019; Rushby, Jacqueline/D-1820-2010; Piguet, Olivier/C-9658-2011	De Blasio, Frances M./0000-0003-1442-9820; Kornfeld, Emma/0000-0002-8877-3686; Rushby, Jacqueline/0000-0002-5018-638X; Fisher, Alana/0000-0002-6027-659X; Piguet, Olivier/0000-0002-6696-1440			Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barry RJ, 2005, CLIN NEUROPHYSIOL, V116, P2693, DOI 10.1016/j.clinph.2005.08.008; Barry RJ, 2008, BIOL PSYCHOL, V77, P304, DOI 10.1016/j.biopsycho.2007.11.002; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Beadle JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00069; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; D'Orazio DM, 2004, SEX ABUSE-J RES TR, V16, P173, DOI 10.1023/B:SEBU.0000023169.51421.76; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Detari L, 2000, BEHAV BRAIN RES, V115, P159, DOI 10.1016/S0166-4328(00)00256-4; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Fisher AC, 2015, CLIN NEUROPHYSIOL, V126, P314, DOI 10.1016/j.clinph.2014.05.033; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mehrabian A., 2000, MANUAL BALANCED EMOT; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Perry RJ, 2001, NEUROCASE, V7, P145, DOI 10.1076/neur.7.2.145.16267; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P460, DOI 10.1016/j.ijpsycho.2013.05.009; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P466, DOI 10.1016/j.ijpsycho.2013.06.013; Schnell K, 2011, NEUROIMAGE, V54, P1743, DOI 10.1016/j.neuroimage.2010.08.024; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tabachnick BG., 2012, USING MULTIVARIATE S; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326	47	11	12	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	12						607	614		10.1016/j.nicl.2016.09.017			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EF3AI	WOS:000390196400069	27709066	gold, Green Published			2022-02-06	
J	Salois, G; Smith, JS				Salois, Garrick; Smith, Jeffrey S.			Housing Complexity Alters GFAP-Immunoreactive Astrocyte Morphology in the Rat Dentate Gyrus	NEURAL PLASTICITY			English	Article							TRAUMATIC BRAIN-INJURY; COMBINING ENRICHED ENVIRONMENT; LONG-TERM POTENTIATION; REACTIVE ASTROCYTES; D-SERINE; TARGETING ASTROCYTES; HIPPOCAMPAL-NEURONS; ENDOTHELIAL-CELLS; UP-REGULATION; MODEL	Rats used in research are typically housed singly in cages with limited sensory stimulation. There is substantial evidence that housing rats in these conditions lead to numerous neuroanatomical and behavioral abnormalities. Alternatively, rats can be housed in an enriched environment in which rats are housed in groups and given room for exercise and exploration. Enriched environments result in considerable neuroplasticity in the rodent brain. In the dentate gyrus of the hippocampus, enriched environments evoke especially profound neural changes, including increases in the number of neurons and the number of dendritic spines. However, whether changes in astrocytes, a type of glia increasingly implicated in mediating neuroplasticity, are concurrent with these neural changes remains to be investigated. In order to assess morphological changes among astrocytes of the rat dentate gyrus, piSeeDB was used to optically clear 250 mu m sections of tissue labeled using GFAP immunohistochemistry. Confocal imaging and image analysis were then used to measure astrocyte morphology. Astrocytes from animals housed in EE demonstrated a reduced distance between filament branch points. Furthermore, the most complex astrocytes were significantly more complex among animals housed in EE compared to standard environments.	[Salois, Garrick; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475	Saginaw Valley State University Student Research and Creativity Institute	This research was supported by a Saginaw Valley State University Student Research and Creativity Institute grant to Garrick Salois. The authors would like to thank Zack Bowers, Jake Dunkerson, Sarah Fluharty, Katalin Geeck, Ivy Hiatt, Justin Jacqmain, Evan Nudi, Nick Sanislo, and Madeleine Searles for their assistance throughout the study.	Alberdi E, 2013, AGING CELL, V12, P292, DOI 10.1111/acel.12054; Aronica E, 2000, EUR J NEUROSCI, V12, P2333, DOI 10.1046/j.1460-9568.2000.00131.x; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Bae SK, 2013, J AM CHEM SOC, V135, P9915, DOI 10.1021/ja404004v; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Bordey A, 1998, EPILEPSY RES, V32, P286, DOI 10.1016/S0920-1211(98)00059-X; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Delekate A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6422; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; Dunkerson J, 2014, RESTOR NEUROL NEUROS, V32, P675, DOI 10.3233/RNN-140408; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Foster TC, 2000, BRAIN RES, V871, P39, DOI 10.1016/S0006-8993(00)02379-9; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gleave JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072039; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; Gross AN, 2012, BEHAV BRAIN RES, V234, P61, DOI 10.1016/j.bbr.2012.06.007; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.0.CO;2-B; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hinterkeuser S, 2000, EUR J NEUROSCI, V12, P2087, DOI 10.1046/j.1460-9568.2000.00104.x; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Jacqmain J, 2014, BEHAV BRAIN RES, V275, P201, DOI 10.1016/j.bbr.2014.08.056; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Jones TA, 1996, NEUROBIOL LEARN MEM, V65, P48, DOI 10.1006/nlme.1996.0005; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Kim JH, 2001, EXP MOL PATHOL, V70, P345, DOI 10.1006/exmp.2001.2372; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; Landers MS, 2011, NEUROSCIENCE, V199, P143, DOI 10.1016/j.neuroscience.2011.10.040; Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112; Martineau M, 2013, J NEUROSCI, V33, P3413, DOI 10.1523/JNEUROSCI.3497-12.2013; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; Nudi ET, 2015, J NEUROTRAUM, V32, P1117, DOI 10.1089/neu.2014.3618; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P1092, DOI 10.1037/h0042758; Schroder W, 2000, EPILEPSIA, V41, pS181, DOI 10.1111/j.1528-1157.2000.tb01578.x; Schroeter ML, 1999, FEBS LETT, V449, P241, DOI 10.1016/S0014-5793(99)00451-2; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Sherwood CC, 2006, P NATL ACAD SCI USA, V103, P13606, DOI 10.1073/pnas.0605843103; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SIREVAAG AM, 1991, BRAIN RES, V540, P273, DOI 10.1016/0006-8993(91)90517-Y; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wagner DC, 2013, ACTA NEUROBIOL EXP, V73, P79; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004	76	11	11	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2016	2016								3928726	10.1155/2016/3928726			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH7TA	WOS:000372995500001	26989515	Green Submitted, gold, Green Published			2022-02-06	
J	Shakir, A; Aksoy, D; Mlynash, M; Harris, OA; Albers, GW; Hirsch, KG				Shakir, Afaaf; Aksoy, Didem; Mlynash, Michael; Harris, Odette A.; Albers, Gregory W.; Hirsch, Karen G.			Prognostic Value of Quantitative Diffusion-Weighted MRI in Patients with Traumatic Brain Injury	JOURNAL OF NEUROIMAGING			English	Article						Traumatic brain injury; MRI; diffusion-weighted imaging; prognosis	AXONAL INJURY	BACKGROUND AND PURPOSEData about the predictive value of quantitative diffusion-weighted MRI in traumatic brain injury (TBI) patients is lacking. This study aimed to determine if specific apparent diffusion coefficient (ADC) thresholds could be determined that correlate with outcome in moderate-severe TBI. METHODSThis retrospective observational study investigated patients with moderate-severe TBI. MRIs obtained post-injury days 1-13 were analyzed. MRIs were obtained on a 1.5T scanner; 20-23 contiguous diffusion-weighted imaging (DWI) sections with a spin-echo echo planar imaging DWI 256x256 reconstructed matrix; field of view 24x24 cm; slice thickness/gap of 5/1.5 or 5/2.5 mm. The ADC value of each brain tissue voxel was determined. The percentage of voxels below different ADC thresholds was calculated and correlated with outcome. A good outcome was defined as discharge to home or a rehabilitation facility. RESULTSSeventy-six patients were analyzed. Thirty-five patients (46%) had a good outcome. The timing of MRI scans did not differ between groups, but the mean age did (4218 years vs. 56 +/- 19 years, p<.01, good vs. poor outcome). Patients with poor outcome had significantly higher percentage of brain volume with ADC < 400x10(-6) mm(2)/second (.85 +/-.67% vs. .60 +/-.29%, poor vs. good outcome, p<.05). Using a ROC curve analysis and Youden's index, an ADC <400x10(-6) mm(2)/second in .49% of brain was 85% sensitive and 46% specific for poor outcome (p<.05). CONCLUSIONSQuantitative MRI offers additional prognostic information in acute TBI. A whole brain tissue ADC threshold of <400x10(-6) mm(2)/second in .49% of brain may be a novel prognostic biomarker.	[Shakir, Afaaf] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Aksoy, Didem] Stanford Univ, Sch Med, Dept Radiol, Stanford Stroke Ctr, Stanford, CA 94305 USA; [Mlynash, Michael; Albers, Gregory W.] Stanford Univ, Sch Med, Dept Neurol, Stanford Stroke Ctr, Stanford, CA 94305 USA; [Harris, Odette A.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Hirsch, Karen G.] Stanford Univ, Sch Med, Dept Neurol, Neurocrit Care, Stanford, CA 94305 USA		Hirsch, KG (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Neurocrit Care, 780 Welch Rd,Suite 350, Stanford, CA 94305 USA.	khirsch@stanford.edu		Shakir, Afaaf/0000-0002-9445-9992			Aggarwal C. C., 2015, DATA MINING TXB; Ahlhelm F, 2004, MED SCI MONITOR, V10, pMT121; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dyke JP, 2007, AM J NEURORADIOL, V28, P1232, DOI 10.3174/ajnr.A0551; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Hermida RC, 2001, HYPERTENSION, V38, P746, DOI 10.1161/01.HYP.38.3.746; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Mlynash M, 2010, STROKE, V41, P1665, DOI 10.1161/STROKEAHA.110.582452; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Nair DG, 2005, BRAIN RES REV, V50, P229, DOI 10.1016/j.brainresrev.2005.07.001; Olivot JM, 2011, REV NEUROL-FRANCE, V167, P873, DOI 10.1016/j.neurol.2011.10.002; Olivot Jean-Marc, 2010, Curr Treat Options Cardiovasc Med, V12, P230, DOI 10.1007/s11936-010-0072-y; Purushotham A, 2015, INT J STROKE, V10, P348, DOI 10.1111/ijs.12068; Tavazzi E, 2007, NEUROIMAGE, V36, P746, DOI 10.1016/j.neuroimage.2007.03.056; Thomas RGR, 2013, J STROKE CEREBROVASC, V22, P906, DOI 10.1016/j.jstrokecerebrovasdis.2012.09.018; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wu CY, 2012, J CHIN MED ASSOC, V75, P75, DOI 10.1016/j.jcma.2011.12.011; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232	26	11	13	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	JAN-FEB	2016	26	1					103	108		10.1111/jon.12286			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DA7VI	WOS:000368012400014	26296810				2022-02-06	
J	Soeker, S				Soeker, Shaheed			A pilot study on the operationalization of the Model of Occupational Self Efficacy: A model for the reintegration of persons with brain injuries to their worker roles	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Occupational therapy; Model of Occupational Self Efficacy; case study methodology and traumatic brain injury	SOUTH-AFRICA; QUALITATIVE RESEARCH; RETURN; REHABILITATION; INDIVIDUALS; EMPLOYMENT	BACKGROUND: Traumatic brain injury causes functional limitations that can cause people to struggle to reintegrate in the workplace despite participating in work rehabilitation programmes. OBJECTIVE: The aim of the study was to explore, and describe the experiences of individuals with Traumatic Brain Injury regarding returning to work through the use of the model of occupational self-efficacy. PARTICIPANTS: In the study 10 individuals who were diagnosed with a mild to moderate brain injury participated in the study. METHODS: The research study was positioned within the qualitative paradigm specifically utilizing case study methodology. In order to gather data from the participants, individual interviews and participant observation techniques were used. RESULTS: Two themes emerged from the findings of the study theme one reflected the barriers related to the use of the model (i.e. Theme one: Effective participation in the model is affected by financial assistance). The second theme related to the enabling factors related to the use of the model (i.e. Theme two: A sense of normality). CONCLUSION: The findings of this study indicated that the Model of Occupational Self Efficacy (MOS) is a useful model to use in retraining the work skills of individual's who sustained a traumatic brain injury. The participants in this study could maintain employment in the open labour market for a period of at least 12 months and it improved their ability to accept their brain injury as well as adapt to their worker roles. The MOS also provides a framework for facilitating community integration.	[Soeker, Shaheed] Univ Western Cape, Occupat Therapy Dept, ZA-7535 Bellville, Western Cape, South Africa		Soeker, S (corresponding author), Univ Western Cape, Occupat Therapy Dept, ZA-7535 Bellville, Western Cape, South Africa.	msoeker@uwc.ac.za					Bobat S, 2003, EMPLOYMENT EQUITY DI; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Denzin N. K., 2005, SAGE HDB QUALITATIVE, V3rd; DUFFY ME, 1993, PRACTICAL RES PLANNI; Faul M, 2010, TRAUMATIC BRAIN INJU; Friesen Margaret N., 2001, Work, V17, P11; Green J, 2007, AUST NZ J PUBL HEAL, V31, P545, DOI 10.1111/j.1753-6405.2007.00141.x; Gutman SA, 2001, OCCUPATIONAL THERAPY; Holzberg Emily, 2001, Work, V16, P245; Huang Yueng-Hsiang, 2004, Work, V23, P225; Jennette B, 1981, MANAGEMENT HEAD INJU; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Keough Jeremy L., 2001, Work, V16, P101; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; Maxwell J.A., 2008, HDB EMERGENT METHODS; Mouton J., 2001, PRACTICE SOCIAL RES; Moyers P., 2005, OCCUPATIONAL THERAPY; National Health Laboratory Services, TRAUM BRAIN INJ HEAD; Patton M.Q., 1990, QUALITATIVE EVALUATI; RASKIN SA, 2000, NEUROPSYCHOLOGICAL M; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Salminen A.L., 2006, AUST OCCUP THER J, V53, DOI [10.1111/j.1440-1630.2006.00540.x, DOI 10.1111/J.1440-1630.2006.00540.X, https://doi.org/10.1111/j.1440-1630.2006.00540.x]; Seale C., 2011, RES SOC CULTURE; Soeker MS, 2013, WORK, V44, P201, DOI 10.3233/WOR-2012-1411; Soeker MS, 2012, WORK, V43, P313, DOI 10.3233/WOR-2012-1412; Soeker MS, 2012, WORK, V43, P171, DOI 10.3233/WOR-2012-1413; Soeker MS, 2012, WORK, V42, P589, DOI 10.3233/WOR-2012-1414; Stroupe KT, 2013, J REHABILITATION RES, V50; Tipton-Burton M, 2005, PEDRETTIS OCCUPATION; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; van Niekerk Lana, 2008, S. Afr. j. occup. ther., V38, P9; Vuadens P, 2006, RETURN WORK TRAUMATI; Watson RM, 2004, S AFRICAN J OCCUPATI, V34, P11; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Yin R. K., 1994, CASE STUDY RES DESIG, V2nd	37	11	11	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2016	53	3					523	534		10.3233/WOR-152229			12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DI0TG	WOS:000373209500008	26835857				2022-02-06	
J	Tham, E; Swietlik, M; Deakyne, S; Hoffman, JM; Grundmeier, RW; Paterno, MD; Rocha, BH; Schaeffer, MH; Pabbathi, D; Alessandrini, E; Ballard, D; Goldberg, HS; Kuppermann, N; Dayan, PS				Tham, Eric; Swietlik, Marguerite; Deakyne, Sara; Hoffman, Jeffrey M.; Grundmeier, Robert W.; Paterno, Marilyn D.; Rocha, Beatriz H.; Schaeffer, Molly H.; Pabbathi, Deepika; Alessandrini, Evaline; Ballard, Dustin; Goldberg, Howard S.; Kuppermann, Nathan; Dayan, Peter S.		Pediat Emergency Care Appl Res Net	Clinical Decision Support for a Multicenter Trial of Pediatric Head Trauma Development, Implementation, and Lessons Learned	APPLIED CLINICAL INFORMATICS			English	Article						Clinical decision support; clinical trial; blunt head trauma; traumatic brain injury; implementation; children	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CANCER; CHILDREN; RISKS; CHILDHOOD; SCANS; CT	Introduction: For children who present to emergency departments (EDs) due to blunt head trauma, ED clinicians must decide who requires computed tomography (CT) scanning to evaluate for traumatic brain injury (TBI). The Pediatric Emergency Care Applied Research Network (PECARN) derived and validated two age-based prediction rules to identify children at very low risk of clinically-important traumatic brain injuries (ciTBIs) who do not typically require CT scans. In this case report, we describe the strategy used to implement the PECARN TBI prediction rules via electronic health record (EHR) clinical decision support (CDS) as the intervention in a multicenter clinical trial. Methods: Thirteen EDs participated in this trial. The 10 sites receiving the CDS intervention used the Epic (R) EHR. All sites implementing EHR-based CDS built the rules by using the vendor's CDS engine. Based on a sociotechnical analysis, we designed the CDS so that recommendations could be displayed immediately after any provider entered prediction rule data. One central site developed and tested the intervention package to be exported to other sites. The intervention package included a clinical trial alert, an electronic data collection form, the CDS rules and the format for recommendations. Results: The original PECARN head trauma prediction rules were derived from physician documentation while this pragmatic trial led each site to customize their workflows and allow multiple different providers to complete the head trauma assessments. These differences in workflows led to varying completion rates across sites as well as differences in the types of providers completing the electronic data form. Site variation in internal change management processes made it challenging to maintain the same rigor across all sites. This led to downstream effects when data reports were developed. Conclusions: The process of a centralized build and export of a CDS system in one commercial EHR system successfully supported a multicenter clinical trial.	[Tham, Eric; Swietlik, Marguerite; Deakyne, Sara] Childrens Hosp Colorado, Aurora, CO USA; [Tham, Eric] Univ Colorado, Denver, CO 80202 USA; [Hoffman, Jeffrey M.] Nationwide Childrens Hosp, Sect Emergency Med, Dept Pediat, Columbus, OH USA; [Hoffman, Jeffrey M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Grundmeier, Robert W.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Grundmeier, Robert W.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Paterno, Marilyn D.; Rocha, Beatriz H.; Goldberg, Howard S.] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Paterno, Marilyn D.; Rocha, Beatriz H.; Goldberg, Howard S.] Harvard Med Sch, Boston, MA USA; [Schaeffer, Molly H.; Pabbathi, Deepika] Partners HealthCare Syst, Informat Syst, Boston, MA USA; [Alessandrini, Evaline] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Ballard, Dustin] Kaiser Permanente, San Rafael Med Ctr, Oakland, CA USA; [Ballard, Dustin] Kaiser Permanente, Div Res, Oakland, CA USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Div Pediat Emergency Med, Pediat, 630 W 168th St, New York, NY 10032 USA		Tham, E (corresponding author), Seattle Childrens Res Inst, MS CW8-4,2001 Eighth Ave,Suite 400, Seattle, WA 98121 USA.	eric.tham@seattlechildrens.org			American Recovery and Reinvestment Act-Office of the Secretary (ARRA OS) [S02MC19289-01-00]; Health Resources and Services Administration (HRSA)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); Emergency Medical Services for Children (EMSC) Program [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, U03MC22685]; Maternal and Child Health Bureau (MCHB)	American Recovery and Reinvestment Act-Office of the Secretary (ARRA OS): Grant # S02MC19289-01-00. PECARN is supported by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Program through the following cooperative agreements: U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, and U03MC22685.	Boxwala AA, 2011, J AM MED INFORM ASSN, V18, pI132, DOI 10.1136/amiajnl-2011-000334; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Centers for Disease Control and Prevention, 2014, RAT TBI REL EM DEP V; Deakyne SJ, 2015, APPL CLIN INFORM, V6, P521, DOI 10.4338/ACI-2015-02-RA-0019; Goldberg HS, 2014, J AM MED INFORM ASSN, V21, pE55, DOI 10.1136/amiajnl-2013-001990; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005	13	11	11	1	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1869-0327			APPL CLIN INFORM	Appl. Clin. Inform.		2016	7	2					534	542		10.4338/ACI-2015-10-CR-0144			9	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	DS5IN	WOS:000380815000018	27437059	Green Published, Bronze			2022-02-06	
S	Van, KC; Lyeth, BG		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Van, Ken C.; Lyeth, Bruce G.			Lateral (Parasagittal) Fluid Percussion Model of Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Fluid percussion; Craniectomy; Endotracheal intubation; Trephination; Mechanical ventilation	CEREBRAL-BLOOD-FLOW; HIPPOCAMPAL CELL LOSS; ACUTE LUNG INJURY; MODERATE HYPOTHERMIA; IMPACT ACCELERATION; INTRACRANIAL-PRESSURE; ANESTHETIC AGENTS; HEAD-INJURY; DAMAGE; TEMPERATURE	Fluid percussion was first conceptualized in the 1940s and has evolved into one of the leading laboratory methods for studying experimental traumatic brain injury (TBI). Over the decades, fluid percussion has been used in numerous species and today is predominantly applied to the rat. The fluid percussion technique rapidly injects a small volume of fluid, such as isotonic saline, through a circular craniotomy onto the intact dura overlying the brain cortex. In brief, the methods involve surgical production of a circular craniotomy, attachment of a fluid-filled conduit between the dura overlying the cortex and the outlet port of the fluid percussion device. A fluid pulse is then generated by the free-fall of a pendulum striking a piston on the fluid-filled cylinder of the device. The fluid enters the cranium, producing a compression and displacement of the brain parenchyma resulting in a sharp, high magnitude elevation of intracranial pressure that is propagated diffusely through the brain. This results in an immediate and transient period of traumatic unconsciousness as well as a combination of focal and diffuse damage to the brain, which is evident upon histological and behavioral analysis. Numerous studies have demonstrated that the rat fluid percussion model reproduces a wide range of pathological features associated with human TBI.	[Van, Ken C.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA		Van, KC (corresponding author), Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA.			Lyeth, Bruce/0000-0003-4811-1474			Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Bahloul M, 2006, AM J CRIT CARE, V15, P462; BAIN J. A., 1967, CAN ANAESTH SOC J, V14, P69, DOI 10.1007/BF03003626; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; CHRISTENSEN MS, 1967, BRIT J ANAESTH, V39, P927, DOI 10.1093/bja/39.12.927; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COSTA DL, 1986, LAB ANIM SCI, V36, P256; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hartl R, 1997, ACT NEUR S, V70, P240; HASEGAWA Y, 1994, J CEREBR BLOOD F MET, V14, P383, DOI 10.1038/jcbfm.1994.49; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; JENNETT WB, 1969, LANCET, V1, P61; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Koerner IP, 2006, CURR OPIN ANESTHESIO, V19, P481, DOI 10.1097/01.aco.0000245271.84539.4c; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Matchett GA, 2009, NEUROL RES, V31, P128, DOI 10.1179/174313209X393546; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; RINK A, 1995, AM J PATHOL, V147, P1575; Rivard AL, 2006, J INVEST SURG, V19, P267, DOI 10.1080/08941930600778297; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; SINSON G, 1995, J NEUROCHEM, V65, P2209; SMITH AL, 1972, ANESTHESIOLOGY, V36, P378, DOI 10.1097/00000542-197204000-00015; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P38; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P7; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P27; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; THET LA, 1983, LAB ANIM SCI, V33, P368; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	64	11	11	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						231	251		10.1007/978-1-4939-3816-2_14	10.1007/978-1-4939-3816-2		21	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500016	27604722				2022-02-06	
J	von der Brelie, C; Stojanovski, I; Meier, U; Lemcke, J				von der Brelie, Christian; Stojanovski, Igor; Meier, Ullrich; Lemcke, Johannes			Open Traumatic Brain Injury Is a Strong Predictor for Aseptic Bone Necrosis after Cranioplasty Surgery: A Retrospective Analysis of 219 Patients	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						traumatic brain injury; decompressive craniectomy; cranioplasty; surgical complication	DECOMPRESSIVE CRANIECTOMY; CLINICAL ARTICLE; HEMORRHAGIC STROKE; RISK-FACTORS; COMPLICATIONS; HEMICRANIECTOMY; INFARCTION	Objective To investigate whether independent predictors of complications after cranioplasty are identifiable. Methods Parameters that could predict the occurrence of complications were analyzed retrospectively. The end point of the study was the explantation of the bone flap. Results A total of 219 patients with a mean age of 42.8 years (standard deviation: 17.89) were included. History of trauma and especially open traumatic brain injury (TBI) were associated with a higher complication rate (p = 0.01 and p = 0.02, respectively). Multivariate testing showed that fragmented bone flap resulted in a more frequent occurrence of bone flap necrosis (p = 0.014). The risk of complications following cranioplasty was higher if a ventriculoperitoneal (VP) shunt was placed at the same time (p = 0.01). Longer duration of the cranioplasty procedure was significantly associated with a higher postoperative complication rate (p = 0.001). Subsequent rehabilitation is more frequent if patients develop a complication. Conclusions To avoid complications after cranial vault reconstruction, indications for simultaneous VP shunt implantation should be carefully evaluated. The implantation of traumatically fragmented bone flaps should be avoided. Patients after open TBI should either primarily be treated with an allogenic graft or they should be carefully followed up because they are prone to develop aseptic necrosis.	[von der Brelie, Christian; Stojanovski, Igor; Meier, Ullrich; Lemcke, Johannes] Unfallkrankenhaus Berlin, Dept Neurosurg, Warenerstr 7, D-12683 Berlin, Germany; [von der Brelie, Christian] Univ Kiel, Med Ctr, Dept Neurosurg, Kiel, Germany		von der Brelie, C (corresponding author), Unfallkrankenhaus Berlin, Dept Neurosurg, Warenerstr 7, D-12683 Berlin, Germany.; von der Brelie, C (corresponding author), Univ Kiel, Med Ctr, Dept Neurosurg, Kiel, Germany.	cvdb@gmx.net		Lemcke, Johannes/0000-0002-8073-1625			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Colohan Austin R T, 2005, Clin Neurosurg, V52, P19; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Marion DW, 2006, NEUROSURGERY, V58, P655; Mracek J, 2015, ACTA NEUROCHIR, V157, P501, DOI 10.1007/s00701-014-2333-0; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37	18	11	11	0	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	JAN	2016	77	1					19	24		10.1055/s-0035-1558410			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DB4ZT	WOS:000368522900004	26238941				2022-02-06	
J	Wang, YC; Fang, F; Wu, YK; Ai, XL; Lan, T; Liang, RC; Zhang, Y; Trishul, NM; He, M; You, C; Yu, C; Tan, H				Wang, Yan-Chao; Fang, Fang; Wu, Ying-Ke; Ai, Xiao-Lin; Lan, Ting; Liang, Rui-Chao; Zhang, Yu; Trishul, Narasimha Murthy; He, Min; You, Chao; Yu, Chuan; Tan, Hong			Waterborne biodegradable polyurethane 3-dimensional porous scaffold for rat cerebral tissue regeneration	RSC ADVANCES			English	Article							HYALURONIC-ACID HYDROGELS; NERVE REGENERATION; BRAIN; MODEL; FABRICATION; PROTEINS; REPAIR; NANOFIBERS; FIBERS; GROWTH	Rehabilitation from traumatic brain injury (TBI) is a significant challenge for neurosurgeons as no effective strategies for cerebral tissue reconstruction can be adopted in clinical applications. To explore an appropriate method for cerebral tissue regeneration, we developed a type of waterborne biodegradable polyurethane (WBPU) 3-dimentional (3D) porous scaffold. Two types of WBPU (WBPU17 and WBPU25) 3D scaffolds were prepared based on different molar content of poly ethylene glycol (PEG) within the scaffolds. The porosity of WBPU17 and WBPU25 scaffolds was 83.29% +/- 0.53% and 86.72% +/- 0.78%, respectively. The mean pore size of the WBPU17 and WBPU25 scaffolds was 20.10 mm and 22.18 mu m, respectively. No pronounced cytotoxicity was noticed for the rat glial cells when treated with degradation liquid of the WBPU17 and WBPU25 scaffold. Moreover, both the WBPU17 and WBPU25 scaffold treated groups showed stronger expression of neuronal growth associated protein (GAP43) and synaptophysin, indicating better nerve regeneration in the experiment groups compared to none in the scaffold control group in the rat TBI model. In addition, functional recovery also displayed a satisfactory result in the WBPU17 and WBPU25 scaffold treated groups. Overall, the WBPU25 scaffold had better performance than of the WBPU17 scaffold. The results of our experiments proved that the WBPU 3D porous scaffold, especially the WBPU25 scaffold, is a promising therapeutic implant for both cerebral tissue regeneration and neural functional recovery in TBI.	[Wang, Yan-Chao; Fang, Fang; Ai, Xiao-Lin; Liang, Rui-Chao; Trishul, Narasimha Murthy; He, Min; You, Chao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Wu, Ying-Ke; Tan, Hong] Sichuan Univ, State Key Lab Polymer Mat Engn, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China; [Lan, Ting] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Yu] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Dept Neurosurg, Chengdu 610081, Sichuan, Peoples R China; [Yu, Chuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Yu, Chuan] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China		Wang, YC (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China.	merrisn@hotmail.com; hongtan@scu.edu.cn	Yu, Chuan/AAC-1440-2019	Yanchao, Wang/0000-0001-7893-2412	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100925, 81472361, 51273124, 51273126]; National Science Fund for Distinguished Young Scholars of ChinaNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [51425305]	We would like to thank the financial support by the National Natural Science Foundation of China (contract/grant number: 81100925, 81472361, 51273124, 51273126) and the National Science Fund for Distinguished Young Scholars of China (contract/grant number: 51425305).	Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Algarrahi K, 2015, BIOMATERIALS, V53, P149, DOI 10.1016/j.biomaterials.2015.02.092; Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; Chen G.-E., 2015, KOREAN J CHEM ENG, P1; Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Gauthier-Kemper A, 2014, MOL BIOL CELL, V25, P3284, DOI 10.1091/mbc.E13-12-0737; George P., 2007, QINGCHUAN ZHUGE TRAN, V32; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Granseth B, 2007, J PHYSIOL-LONDON, V585, P681, DOI 10.1113/jphysiol.2007.139022; Hausner T, 2007, ACTA NEUROCHIR SUPPL, V100, P69; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hou XE, 2000, NEUROCHEM RES, V25, P1275, DOI 10.1023/A:1007600313865; Janik H, 2015, MAT SCI ENG C-MATER, V48, P586, DOI 10.1016/j.msec.2014.12.037; Jiang X, 2010, J BIOMAT SCI-POLYM E, V21, P1637, DOI 10.1163/092050609X12525750021270; Kim JI, 2014, MAT SCI ENG C-MATER, V44, P52, DOI 10.1016/j.msec.2014.07.062; Machado LS, 2009, STROKE, V40, P3028, DOI 10.1161/STROKEAHA.109.556852; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Maitz M.F., 2015, BIOSURFACE BIOTRIBOL, V1, P161; MEBERG PJ, 1993, P NATL ACAD SCI USA, V90, P12050, DOI 10.1073/pnas.90.24.12050; Niemeier Janet P, 2015, N C Med J, V76, P105; Niu YQ, 2014, BIOMATERIALS, V35, P4266, DOI 10.1016/j.biomaterials.2014.02.013; Pang XM, 2014, J PHARMACOL TOX MET, V69, P217, DOI 10.1016/j.vascn.2014.01.001; Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Piontek J, 2002, J NEUROSCI RES, V67, P471, DOI 10.1002/jnr.10094; Piper LC, 2015, JAMA SURG, V150, P1013, DOI 10.1001/jamasurg.2015.1838; Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rosskothen-Kuhl N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092624; Saracino GAA, 2013, CHEM SOC REV, V42, P225, DOI 10.1039/c2cs35065c; Shin OH, 2014, COMPR PHYSIOL, V4, P149, DOI 10.1002/cphy.c130021; Stevenson AT, 2015, BIOMATERIALS, V54, P168, DOI 10.1016/j.biomaterials.2015.03.020; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522; Wang ZG, 2011, POLYM CHEM-UK, V2, P601, DOI 10.1039/c0py00235f; Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11; Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j; Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154	45	11	13	0	47	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2016	6	5					3840	3849		10.1039/c5ra20181k			10	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	DC8ZF	WOS:000369508800054					2022-02-06	
J	Watts, AD; Shuttleworth-Edwards, AB				Watts, Ann D.; Shuttleworth-Edwards, Ann B.			Neuropsychology in South Africa: confronting the challenges of specialist practice in a culturally diverse developing country	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychological education; neuropsychological training; cross-cultural; multicultural; South Africa	SPEAKING UNSKILLED WORKERS; TRAUMATIC BRAIN-INJURY; NORMATIVE INDICATIONS; PERFORMANCE; PSYCHOLOGY; CHILDREN	Objective: This was an invited paper on the history and current status of neuropsychology in South Africa. Method: Information was gathered from literature searches, personal communication, and the authors' experiences while occupying relevant professional and academic positions for over 30years. Results: Since its origins in the 1950s, the development of neuropsychology in South Africa has faced numerous challenges, against a background of extreme sociocultural and socioeconomic disparity in the country that is on-going. The creation of the South African Clinical Neuropsychological Society in the 1980s, a credentialing and training body, gave impetus to the discipline. In the absence of a neuropsychology category within the South African professional framework, university instruction has been ad hoc with vastly different levels of competency depending on the institution involved. The small number of practitioners and/or academics involved in neuropsychology includes mainly masters, and some doctoral level psychologists registered in clinical, counseling or educational categories. A prime emphasis of neuropsychological research has been local norming of psychometric tests to facilitate valid assessment practices in the country. South Africa is on the cusp of achieving a hard-won neuropsychology professional register. It is anticipated that this development will provide impetus to the discipline by promoting training programs, the creation of neuropsychology posts, wider service delivery, and increased research funding. Conclusions: Despite significant challenges in a culturally diverse, developing country, neuropsychology has evolved sufficiently to warrant the creation of a separate category in the professional framework. This development will facilitate training, research, and services in the country.	[Watts, Ann D.] Entabeni Hosp, Durban, South Africa; [Shuttleworth-Edwards, Ann B.] Rhodes Univ, Dept Psychol, Grahamstown, South Africa		Watts, AD (corresponding author), Entabeni Hosp, Durban, South Africa.	anndwatts@iafrica.com					Aderemi TJ, 2013, J CHILD ADOLESC MENT, V25, P161, DOI 10.2989/17280583.2013.823867; Andrews K, 2012, J PSYCHOL AFR, V22, P333, DOI 10.1080/14330237.2012.10820538; Christensen AL, 1979, LURIAS NEUROPSYCHOLO; Claassen N., 2001, STANDARDIZATION WAIS; Cockcroft K, 2011, J CHILD ADOLESC MENT, V23, P107, DOI 10.2989/17280583.2011.634545; COLVIN M, 1994, NEUROBEHAVIORAL METHODS AND EFFECTS IN OCCUPATIONAL AND ENVIRONMENTAL HEALTH, P181; Cooper S., 1990, PSYCHOL APARTHEID, P1; Cooper S, 2014, AM PSYCHOL, V69, P837, DOI 10.1037/a0037569; de Kock J. H., S AFRICAN J IN PRESS; de la Rey C, 2004, S AFR J PSYCHOL, V34, P544, DOI 10.1177/008124630403400403; de Villiers J. C., 1987, P 2 S AFR SPORTS MED, P164; Department of Public Service and Administration South Africa, 2014, SAL SCAL TRANSL KEYS; Duncan A, 2015, MULT SCLER J, V21, P776, DOI 10.1177/1352458514549400; Duncan N., 2004, CRITICAL PSYCHOL, P360; Ferrett HL, 2014, METAB BRAIN DIS, V29, P395, DOI 10.1007/s11011-014-9495-6; Ferrett HL, 2010, DRUG ALCOHOL DEPEN, V110, P8, DOI 10.1016/j.drugalcdep.2010.01.019; Fike L, 2012, J PSYCHOL AFR, V22, P323, DOI 10.1080/14330237.2012.10820537; Foxcroft C., 2004, S AFRICAN J IND PSYC, V30, P8, DOI DOI 10.4102/SAJIP.V30I4.171; Foxcroft CD, 1997, EUR J PSYCHOL ASSESS, V13, P229, DOI 10.1027/1015-5759.13.3.229; Gouse H, 2013, ARCH CLIN NEUROPSYCH, V28, P38, DOI 10.1093/arclin/acs100; Hoffman M., 1996, SA J RADIOL, V1, P30; Hoffmann M, 1998, J Stroke Cerebrovasc Dis, V7, P24, DOI 10.1016/S1052-3057(98)80018-9; John V., 2015, SAS SCH SYSTEM OUT C, P10; Joska JA, 2011, AIDS PATIENT CARE ST, V25, P95, DOI 10.1089/apc.2010.0292; Laher S, 2014, S AFR J PSYCHOL, V44, P303, DOI 10.1177/0081246314533634; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; Louw J., 1987, S AFRICAN J PSYCHOL, V17, P33, DOI 10.1177/008124638701700201; Luria A.R., 1973, WORKING BRAIN INTRO; Mani Z., 2011, GROCOTTS MAIL, P1; Murdoch B D, 1997, Adler Mus Bull, V23, P3; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nell V, 1999, S AFR J PSYCHOL, V29, P128, DOI 10.1177/008124639902900305; NELL V, 1993, ENVIRON RES, V63, P301, DOI 10.1006/enrs.1993.1150; Nell V., 1997, 9747 U S AFR HLTH PS; Nell V., 1992, 922 U S AFR HLTH PSY; Nell V., 2000, CROSS CULTURAL NEURO; Pileggi LA, 2015, LATERALITY, V20, P154, DOI 10.1080/1357650X.2014.948449; Pillay YG, 1996, S AFR J PSYCHOL, V26, P76, DOI 10.1177/008124639602600202; Pretorius C, 2015, SEIZURE-EUR J EPILEP, V30, P32, DOI 10.1016/j.seizure.2015.05.008; Richter L. M., 1991, MCCARTHY SCALES CHIL; Rushton JP, 2000, INTELLIGENCE, V28, P251, DOI 10.1016/S0160-2896(00)00035-0; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Edwards A., 2016, MINORITY CROSSCULTUR, P72; Shuttleworth-Edwards AB, 2016, CLIN NEUROPSYCHOL, V30, P975, DOI 10.1080/13854046.2016.1204011; Shuttleworth-Edwards A. B., 2013, PSYCHOL ASSESSMENT S, P33; Shuttleworth-Edwards A. B., 2013, PSYCHOL ASSESSMENT S, P17; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards A, 2014, J PSYCHOL AFR, V24, P492, DOI 10.1080/14330237.2014.997032; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Shuttleworth-Edwards AB, 2014, PROG NEUROL SURG, V28, P213, DOI 10.1159/000358785; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; ShuttleworthJordan AB, 1996, S AFR J PSYCHOL, V26, P96, DOI 10.1177/008124639602600205; Skuy M, 2001, PERS INDIV DIFFER, V30, P1413, DOI 10.1016/S0191-8869(00)00123-9; Statistics South Africa, 2015, MID POP EST; Stats SA (Statistics South Africa), 2014, GEN HOUS SURV 2014; TOLLMAN S G, 1990, South African Journal of Psychology, V20, P20; Tollman S. G., 1993, S AFRICAN LAW J, V110, P357; Tollman S. G., 1983, AFRIKAANSE VERTALING; TOLLMAN SG, 1991, J CLIN EXP NEUROPSYC, V13, P438; VILJOEN G, 1994, S AFR J PSYCHOL, V24, P145, DOI 10.1177/008124639402400306; Walsh K. W., 1985, UNDERSTANDING BRAIN; Watts A. D., 2008, INTERIORS HIST PSYCH, P358; Wechsler D., 2014, WAIS 4 WECHSLER ADUL; [No title captured]	64	11	11	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	8					1305	1324		10.1080/13854046.2016.1212098			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EA8NR	WOS:000386893100012	27650491				2022-02-06	
J	Katzman, BM; Perszyk, RE; Yuan, HJ; Tahirovic, YA; Sotimehin, AE; Traynelis, SF; Liotta, DC				Katzman, Brooke M.; Perszyk, Riley E.; Yuan, Hongjie; Tahirovic, Yesim Altas; Sotimehin, Ayodeji E.; Traynelis, Stephen F.; Liotta, Dennis C.			A novel class of negative allosteric modulators of NMDA receptor function	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						GluN2; Glutamate; Noncompetitive antagonist; N-Methyl-D-aspartate; Neuroprotection	ANTAGONISTS	NMDA receptors mediate a slow Ca2+-permeable component of excitatory synaptic transmission, and are involved in numerous normal brain functions including learning and memory. NMDA receptor over-activation can lead to cell death and abnormal excitation in ischemia associated with stroke, traumatic brain injury, and epilepsy. We have explored a series of novel noncompetitive allosteric modulators of NMDA receptor function characterized by an iminothiazolidinone ring. Saturating concentrations of these compounds inhibit NMDA receptors to varying maximal extents, raising the possibility that they may attenuate over-activation in pathological situations while preserving some minimal receptor function, which may limit side-effects. The best in class compounds have sub-micromolar IC50 values and show modest preference for GluN2C- and GluN2D-containing receptors. (C) 2015 Elsevier Ltd. All rights reserved.	[Katzman, Brooke M.; Tahirovic, Yesim Altas; Liotta, Dennis C.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Perszyk, Riley E.; Yuan, Hongjie; Sotimehin, Ayodeji E.; Traynelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA		Liotta, DC (corresponding author), Emory Univ, Dept Chem, 1521 Dickey Dr, Atlanta, GA 30322 USA.	dliotta@emory.edu		Perszyk, Riley/0000-0001-8283-7709	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS065371]; Michael J. Fox Foundation; NeurOp Inc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065371] Funding Source: NIH RePORTER	This work was supported by the NIH (NS065371, SFT) and the Michael J. Fox Foundation. Some of the authors are Board members (DCL) or paid consultants (SFT) of NeurOp Inc, a company developing glutamate receptor modulators for therapeutic use.	Acker TM, 2013, J MED CHEM, V56, P6434, DOI 10.1021/jm400652r; Acker TM, 2011, MOL PHARMACOL, V80, P782, DOI 10.1124/mol.111.073239; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Costa BM, 2012, NEUROPHARMACOLOGY, V62, P1730, DOI 10.1016/j.neuropharm.2011.11.019; Freel RMS, 2013, J MED CHEM, V56, P5351, DOI 10.1021/jm400177t; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Hansen KB, 2013, MOL PHARMACOL, V84, P114, DOI 10.1124/mol.113.085803; Hansen KB, 2010, J PHARMACOL EXP THER, V333, P650, DOI 10.1124/jpet.110.166256; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Koller M, 2010, EXPERT OPIN THER PAT, V20, P1683, DOI 10.1517/13543776.2010.533656; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Mosley CA, 2010, J MED CHEM, V53, P5476, DOI 10.1021/jm100027p; Mullasseril P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1085; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Santangelo RM, 2012, EXPERT OPIN THER PAT, V22, P1337, DOI 10.1517/13543776.2012.728587; Shi MX, 2009, BIOORG MED CHEM LETT, V19, P6337, DOI 10.1016/j.bmcl.2009.09.085; SOHDA T, 1984, CHEM PHARM BULL, V32, P4460; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zimmerman SS, 2014, J MED CHEM, V57, P2334, DOI 10.1021/jm401695d	23	11	13	0	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	DEC 1	2015	25	23					5583	5588		10.1016/j.bmcl.2015.10.046			6	Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy; Chemistry	CV8KV	WOS:000364535400025	26525866	Green Accepted			2022-02-06	
J	Liu, S; Liu, Y; Deng, SK; Guo, AS; Wang, XB; Shen, GY				Liu, Su; Liu, Ying; Deng, Shukun; Guo, Aisong; Wang, Xiubing; Shen, Guangyu			Beneficial effects of hyperbaric oxygen on edema in rat hippocampus following traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Diffusion-weighted imaging; Hyperbaric oxygen	THERAPY; ACTIVATION; CONTUSIONS; MODEL	Hyperbaric oxygen (HBO) therapy helps alleviate secondary injury following brain trauma [traumatic brain injury (TBI)], although the mechanisms remain unclear. In this study, we assessed recovery of post-TBI spatial learning and memory in rats using the Morris water maze (MWM) and measured changes in apparent diffusion coefficient in the hippocampus by diffusion-weighted imaging (DWI) to evaluate possible therapeutic effects of HBO on TBI-associated brain edema. DWIs were obtained 8, 24, 48 h, 7 days, and 14 days post-TBI. Daily HBO therapy significantly improved post-TBI MWM performance and reduced edema in the ipsilateral hippocampus, suggesting that the therapeutic efficacy of HBO is mediated, at least in part, by a reduction in brain edema.	[Liu, Su; Guo, Aisong; Shen, Guangyu] Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong 226001, Peoples R China; [Liu, Ying] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong 226001, Peoples R China; [Wang, Xiubing] Nantong Univ, Affiliated Hosp, Dept Imaging, Nantong 226001, Peoples R China; [Deng, Shukun] Wuxi Peoples Hosp, Dept Rehabil Med, Wuxi 214023, Peoples R China		Shen, GY (corresponding author), Nantong Univ, Affiliated Hosp, Dept Rehabil Med, 20 Xisi Rd, Nantong 226001, Peoples R China.	sgyrm@163.com			Science and Technology Plan Projects of Nantong [HS13967TDFY0348]	We are thankful for the excellent technical assistance of Zhijun Zhang and Yulin Dong. This study was supported by the Science and Technology Plan Projects of Nantong (Grant No. HS13967TDFY0348).	Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Bennett MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004609.pub3; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Huisman TAGM, 2001, RADIOLOGE, V41, P1038, DOI 10.1007/s001170170003; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Masel BE, 2011, ARCH PHYS MED REHAB, V92, P1519, DOI 10.1016/j.apmr.2011.06.011; McNair ND, 1999, NURS CLIN N AM, V34, P637; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Prieto-Valderrey F, 2013, MED INTENSIVA, V37, P375, DOI 10.1016/j.medin.2012.07.002; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Voigt C, 2008, ACTA NEUROCHIR SUPPL, V102, P441, DOI 10.1007/978-3-211-85578-2_86; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Wei XE, 2014, NEUROL SCI, V35, P295, DOI 10.1007/s10072-013-1514-6; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	32	11	12	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	DEC	2015	233	12					3359	3365		10.1007/s00221-015-4405-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW7UJ	WOS:000365204600003	26267487				2022-02-06	
J	Mao, HJ; Unnikrishnan, G; Rakesh, V; Reifman, J				Mao, Haojie; Unnikrishnan, Ginu; Rakesh, Vineet; Reifman, Jaques			Untangling the Effect of Head Acceleration on Brain Responses to Blast Waves	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						blast-induced traumatic brain injury; head acceleration; brain pressure; finite-element model	INJURY; RAT; MECHANISM; IMPACT; MODEL	Multiple injury-causing mechanisms, such as wave propagation, skull flexure, cavitation, and head acceleration, have been proposed to explain blast-induced traumatic brain injury (bTBI). An accurate, quantitative description of the individual contribution of each of these mechanisms may be necessary to develop preventive strategies against bTBI. However, to date, despite numerous experimental and computational studies of bTBI, this question remains elusive. In this study, using a two-dimensional (2D) rat head model, we quantified the contribution of head acceleration to the biomechanical response of brain tissues when exposed to blast waves in a shock tube. We compared brain pressure at the coup, middle, and contre-coup regions between a 2D rat head model capable of simulating all mechanisms (i.e., the all-effects model) and an acceleration-only model. From our simulations, we determined that head acceleration contributed 36-45% of the maximum brain pressure at the coup region, had a negligible effect on the pressure at the middle region, and was responsible for the low pressure at the contre-coup region. Our findings also demonstrate that the current practice of measuring rat brain pressures close to the center of the brain would record only two-thirds of the maximum pressure observed at the coup region. Therefore, to accurately capture the effects of acceleration in experiments, we recommend placing a pressure sensor near the coup region, especially when investigating the acceleration mechanism using different experimental setups.	[Mao, Haojie; Unnikrishnan, Ginu; Rakesh, Vineet; Reifman, Jaques] US Army Med Res & Mat Command, US Dept Def, Software Applicat Inst, Telemed & Adv Technol Res Ctr,Biotechnol High Per, Ft Detrick, MD 21702 USA		Reifman, J (corresponding author), US Army Med Res & Mat Command, US Dept Def, Software Applicat Inst, Telemed & Adv Technol Res Ctr,Biotechnol High Per, 504 Scott St, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234	U.S. Army Network Science Initiative; U.S. Department of Defense High Performance Computing Modernization ProgramUnited States Department of Defense; Defense Health Agency; NIH GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10 RR23017]; U.S. Army Medical Research and Materiel Command, Fort Detrick, MDU.S. Army Medical Research & Materiel Command (USAMRMC); NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023017] Funding Source: NIH RePORTER	This research was supported by the U.S. Army Network Science Initiative, U.S. Army Medical Research and Materiel Command, Fort Detrick, MD, the U.S. Department of Defense High Performance Computing Modernization Program, and the Defense Health Agency. The rat head MRI images were acquired at the University of Utah Small Animal Imaging Facility on an instrument funded by NIH Grant No. S10 RR23017. The opinions and assertions contained herein are the private views of the authors and do not reflect the views of the U.S. Army or of the U.S. Department of Defense.	Abdullah O., 2014, COMMUNICATION; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; Bird SM, 2007, INT J EPIDEMIOL, V36, P841, DOI 10.1093/ije/dym103; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Chavko M, 2011, NATO S SURV BLAST IN; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Leggieri M. J., 2011, NATO S SURV BLAST IN; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2011, J MECH MED BIOL, V11, P1199, DOI 10.1142/S021951941100423X; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	39	11	11	0	14	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2015	137	12							124502	10.1115/1.4031765			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CW8SR	WOS:000365270000012	26458125	Green Published			2022-02-06	
J	Hong, CT; Wong, CS; Ma, HP; Wu, D; Huang, YH; Wu, CC; Lin, CM; Su, YK; Liao, KH; Ou, JC; Hu, CJ				Hong, Chien-Tai; Wong, Chung-Shun; Ma, Hon-Ping; Wu, Dean; Huang, Yao-Hsien; Wu, Chung-Che; Lin, Chien-Min; Su, Yu-Kai; Liao, Kuo-Hsing; Ou, Ju-Chi; Hu, Chaur-Jong			PERIOD3 polymorphism is associated with sleep quality recovery after a mild traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article							LENGTH POLYMORPHISM; DIURNAL PREFERENCE; PHASE SYNDROME; INVENTORY; PER3; GENE; DEPRESSION; DISORDERS; INSOMNIA; INDEX	Background and aim: Mild traumatic brain injury (mTBI) causes transient sleep disorders and circadian dysrhythmia. One of the clock genes, PERIOD3 (PER3), regulates the circadian rhythm and contains a genetic polymorphism, namely a variable-number tandem repeat in the coding area with either four or five repeats. PER3(5) carriers are inclined to have a morning preference and associated with higher risk of bipolar disorder and diabetes. This study investigated the effects of PER3 polymorphism on sleep quality changes after mTBI. Materials and methods: From May 2012 to May 2014, a total of 96 mTBI patients completed the baseline (1 week after mTBI) and follow-up (6 weeks after mTBI) assessments, including the Pittsburgh Sleep Quality Index (PSQI) and anxiety and depression questionnaires. Statistics were analyzed using the Mann-Whitney U test, Wilcox signed-rank test or chi-squared test. Results: Among the 96 patients, 24 were heterozygous PER3(5) carriers (PER3(4/5)), and the rest of 72 were PER3(5) noncarriers (PER3(4/4)). The subscale of PSQI questionnaire results indicated that the PER3(5) allele was associated with significant sleep duration shortening, but improvement in overall sleep quality. Furthermore, analyzing patients with sleep disturbance at the baseline (PSQI >5) revealed that only the PER3(5) noncarriers exhibited a significant improvement in overall PSQI scores. Conclusion: PER3(5) carriers exhibited sleep duration shortening and improved daytime function 6 weeks after mTBI compared with the baseline values. On the other hand, among poor sleepers, PER3(5) carriers did not embrace a significant improvement of overall PSQI scores as noncarriers. The underlying mechanisms and clinical significances must be investigated further. (C) 2015 Elsevier B.V. All rights reserved.	[Hong, Chien-Tai; Wu, Dean; Huang, Yao-Hsien; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Wong, Chung-Shun; Ma, Hon-Ping; Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei, Taiwan; [Wong, Chung-Shun] Taipei Med Univ, Grad Inst Clin Med, New Taipei, Taiwan; [Ma, Hon-Ping] Taipei Med Univ, Dept Emergency Med, Sch Med, Coll Med, New Taipei, Taiwan; [Ma, Hon-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, New Taipei, Taiwan; [Wu, Dean; Huang, Yao-Hsien; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Sleep Ctr, New Taipei, Taiwan; [Wu, Dean; Hu, Chaur-Jong] Taipei Med Univ, Dept Neurol, Sch Med, Coll Med, New Taipei, Taiwan; [Wu, Chung-Che] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Lin, Chien-Min; Su, Yu-Kai] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, New Taipei, Taiwan		Ou, JC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei, Taiwan.	juchi@tmu.edu.tw; chaurjongh@tmu.edu.tw		Wong, Chung-Shun/0000-0003-3347-3843	Center of Excellence for Clinical Trial and Research in Neuroscience [DOH 101-TD-B-111-003]; Shuang-Ho Hospital [103TMU-SHH-24]; Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [98-2321-B-038-003-MY3]	This study was supported by the Center of Excellence for Clinical Trial and Research in Neuroscience DOH 101-TD-B-111-003, Shuang-Ho Hospital 103TMU-SHH-24 and Ministry of Science and Technology Grant 98-2321-B-038-003-MY3.	Alexander M, 2015, ONCOL REP, V33, P935, DOI 10.3892/or.2014.3667; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; An HJ, 2014, INT J CLIN EXP MED, V7, P3770; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Karthikeyan R, 2014, NEUROPSYCH DIS TREAT, V10, P2325, DOI 10.2147/NDT.S73765; Karthikeyan R, 2014, HORM MOL BIOL CLIN I, V18, P145, DOI 10.1515/hmbci-2013-0049; Landgraf D, 2012, PFLUG ARCH EUR J PHY, V463, P3, DOI 10.1007/s00424-011-1003-9; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Viola AU, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.024; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; ZHENG YP, 1988, COMPR PSYCHIAT, V29, P484, DOI 10.1016/0010-440X(88)90063-6	26	11	12	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	NOV 15	2015	358	1-2					385	389		10.1016/j.jns.2015.09.376			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW5PZ	WOS:000365050200063	26440425				2022-02-06	
J	Woods, DL; Wyma, JM; Yund, EW; Herron, TJ				Woods, David L.; Wyma, John M.; Yund, E. William; Herron, Timothy J.			The Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury on High-Precision Measures of Simple Visual Reaction Time	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						aging; motor; head injury; reliability; effort; feigning; computer; timing errors	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; TEST-RETEST RELIABILITY; RELIABLE DIGIT SPAN; CLOSED-HEAD-INJURY; PROCESSING SPEED; COMPUTERIZED MEASURES; COGNITIVE IMPAIRMENT; IRAQ-WAR; PERFORMANCE; VALIDITY	Simple reaction time (SRT), the latency to respond to a stimulus, has been widely used as a basic measure of processing speed. In the current experiments, we examined clinically relevant properties of a new SRT test that presents visual stimuli to the left or right hemifield at varying stimulus onset asynchronies (SOAs). Experiment 1 examined test-retest reliability in 48 participants who underwent three test sessions at weekly intervals. In the first test, log transformed (log SRT) z-scores, corrected for the influence of age and computer-use, were well predicted by regression functions derived from a normative population of 189 control participants. Test-retest reliability of log-SRT z-scores was measured with an intraclass correlation coefficient (ICC = 0.83) and equaled or exceeded those of other SRT tests and other widely used tests of processing speed that are administered manually. No significant learning effects were observed across test sessions. Experiment 2 investigated the same participants when instructed to malinger during a fourth testing session: 94% showed abnormal log-SRT z-scores, with 83% producing log SRT z-scores exceeding a cutoff of 3.0, a degree of abnormality never seen in full-effort conditions. Thus, a log-SRT z-score cutoff of 3.0 had a sensitivity (83%) and specificity (100%) that equaled or exceeded that of existing symptom validity tests. We argue that even expert malingerers, fully informed of the malingering-detection metric, would be unable to successfully feign impairments on the SRT test because of the precise control of SRT latencies that would be required. Experiment 3 investigated 26 patients with traumatic brain injury (TBI) tested more than 1 year post-injury. The 22 patients with mild TBI showed insignificantly faster SRTs than controls, but a small group of four patients with severe TBI showed slowed SRTs. Simple visual reaction time is a reliable measure of processing speed that is sensitive to the effects of malingering and TBI.	[Woods, David L.; Wyma, John M.; Yund, E. William; Herron, Timothy J.] Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, UC Davis Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, UC Davis Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, UC Davis Ctr Mind & Brain, Davis, CA 95616 USA		Woods, DL (corresponding author), Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	Clinical Sciences Research and Development Service of the United States (U.S.) Department of Veterans Affairs [CX000583, CX001000]; Veterans AffairsUS Department of Veterans Affairs [I01CX000583, I01CX001000] Funding Source: NIH RePORTER	This work was supported by Merit Review Grants CX000583 and CX001000 to DLW from the Clinical Sciences Research and Development Service of the United States (U.S.) Department of Veterans Affairs. The content is solely the responsibility of the authors and does not necessarily represent the official views of Department of Veterans Affairs or the U.S. Government. We would like to thank Ben Edwards, Oren Poliva, Masood Younus, Nabeel Rahman, and Kerry Hubei who gathered data used in this report, and Robert Hink who developed the MySQL database.	Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Camicioli RM, 2008, NEUROSCI LETT, V441, P77, DOI 10.1016/j.neulet.2008.06.004; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; DERME P, 1992, NEUROPSYCHOLOGIA, V30, P989, DOI 10.1016/0028-3932(92)90050-V; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fong KNK, 2009, NEUROREHABILITATION, V24, P165, DOI 10.3233/NRE-2009-0465; Garaizar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085108; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kertzman S, 2006, ISRAEL J PSYCHIAT, V43, P112; Kertzman S, 2014, COMPR PSYCHIAT, V55, P1587, DOI 10.1016/j.comppsych.2014.05.004; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Papapetropoulos S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/760196; Plant RR, 2013, COGN AFFECT BEHAV NE, V13, P598, DOI 10.3758/s13415-013-0166-6; Plant RR, 2009, BEHAV RES METHODS, V41, P598, DOI 10.3758/BRM.41.3.598; Plant RR, 2003, BEHAV RES METH INS C, V35, P276, DOI 10.3758/BF03202553; Puopolo C, 2013, NEUROSCI BIOBEHAV R, V37, P2638, DOI 10.1016/j.neubiorev.2013.08.013; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Sakong J, 2007, NEUROTOXICOLOGY, V28, P235, DOI 10.1016/j.neuro.2006.03.004; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Ylioja SG, 2009, ARCH CLIN NEUROPSYCH, V24, P729, DOI 10.1093/arclin/acp078	68	11	12	0	17	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 9	2015	9								540	10.3389/fnhum.2015.00540			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CY7AL	WOS:000366560100001	26617505	Green Published, gold			2022-02-06	
J	Bowman, TG; Breedlove, KM; Breedlove, EL; Dodge, TM; Nauman, EA				Bowman, Thomas G.; Breedlove, Katherine M.; Breedlove, Evan L.; Dodge, Thomas M.; Nauman, Eric A.			Impact attenuation properties of new and used lacrosse helmets	JOURNAL OF BIOMECHANICS			English	Article						Gadd Severity Index; Head impact; Protective equipment; Drop test; Helmet evaluation	COLLEGIATE FOOTBALL PLAYERS; INJURY SURVEILLANCE SYSTEM; HIGH-SCHOOL FOOTBALL; DESCRIPTIVE EPIDEMIOLOGY; AMERICAN FOOTBALL; HEAD IMPACTS; CONCUSSIONS; BOYS	The National Operating Committee on Standards for Athletic Equipment (NOCSAE) has developed impact attenuation thresholds that protective helmets worn in sport must meet to be commercially available in an attempt to prevent injury. It remains unknown how normal helmet use in athletic activity alters the force attenuation ability of lacrosse helmets. We tested 3 new and 3 randomly selected used helmets from 2 popular lacrosse models (Cascade Pro7, Cascade CPXR). All used helmets had been worn for 3 collegiate seasons prior to testing and had never been refurbished. Helmets were drop-tested using 3 prescribed impact velocities at 6 locations according to the NOCSAE lacrosse helmet standard, and we compared the Gadd Severity Index (GSI) scores between new and used helmets using a repeated measure ANOVA with location as the repeated variable and data separated by impact velocity. All 12 helmets passed the NOCSAE GSI threshold for all testing conditions; however 1 used helmet shell cracked resulting in a failed test. We found a significant main effect for helmet age at the low (F-5,F-50 = 2.98, P = .02), medium (F-5,F-50 = 3.71, P = .006), and high (F-5,F-50 = 2.70, P = .03) velocities. We suspect that helmet use can degrade materials under some conditions, but improve performance in others due to changes in helmet composition from use. The clinical implications of the differences in GSI scores noted remain unclear. Because one helmet shell cracked resulting in a failed test, used helmets should be regularly inspected for cracks or other signs of mechanical fatigue that may weaken helmet integrity. (C) 2015 Elsevier Ltd. All rights reserved.	[Bowman, Thomas G.] Lynchburg Coll, Dept Athlet Training, Lynchburg, VA 24501 USA; [Breedlove, Katherine M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Dodge, Thomas M.] Springfield Coll, Dept Exercise Sci & Sport Studies, Springfield, MA 01109 USA; [Nauman, Eric A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Bowman, TG (corresponding author), Lynchburg Coll, Dept Athlet Training, Lynchburg, VA 24501 USA.	Bowman.t@lynchburg.edu	Bowman, Tom/AAU-6473-2020; Bowman, Thomas/AAA-3036-2020	Bowman, Thomas/0000-0002-0034-2946	Indiana State Department of Health Spinal Cord and Brain Injury Research Fund; Indiana Clinical and Translational Sciences Institute; Purdue's Office of the Vice President for Research; Lynchburg College	This work was supported in part by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Research Fund, a Core Facility Grant from the Indiana Clinical and Translational Sciences Institute, Purdue's Office of the Vice President for Research, and a faculty development grant from Lynchburg College. We would like to thank the Lynchburg College men's lacrosse program for donating the used helmets tested in the current study. In addition, we thank Jay Hertel, PhD, ATC, FNATA, FACSM for his assistance with the statistical approach to data analysis.	Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cascade Lacrosse, HELM SAF BOOKL; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P221; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Higgins M.J., 2015, J ATHL TRAINING, V50; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Koehling E.M., 2015, J ATHL TRAINING, V50; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; NCAA, 2015 16 NCAA MENS LA; NOCSAE, 2012, 04111M12 NOCSAE ND; NOCSAE, 2011, 04204M11A NOCSAE ND; NOCSAE, NOCS BOARD APPR 1 HE; NOCSAE, 2013, 00111M13 NOCSAE ND; NOCSAE, 2006, 08104M04 NOCSAE ND; O'Day K.M., 2015, J ATHL TRAINING, V50; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vollavanh L.R., 2015, J ATHL TRAINING, V50	31	11	12	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 5	2015	48	14					3782	3787		10.1016/j.jbiomech.2015.08.026			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CX9YZ	WOS:000366064000007	26429768				2022-02-06	
J	Rabago, CA; Dingwell, JB; Wilken, JM				Rabago, Christopher A.; Dingwell, Jonathan B.; Wilken, Jason M.			Reliability and Minimum Detectable Change of Temporal-Spatial, Kinematic, and Dynamic Stability Measures during Perturbed Gait	PLOS ONE			English	Article							TRANSTIBIAL AMPUTATION WALKING; TRAUMATIC BRAIN-INJURY; DUAL-TASK PERFORMANCE; DESTABILIZING ENVIRONMENTS; TREADMILL WALKING; YOUNG-ADULTS; RETEST RELIABILITY; DIVIDED ATTENTION; COGNITIVE TASK; HEALTHY-YOUNG	Temporal-spatial, kinematic variability, and dynamic stability measures collected during perturbation-based assessment paradigms are often used to identify dysfunction associated with gait instability. However, it remains unclear which measures are most reliable for detecting and tracking responses to perturbations. This study systematically determined the between-session reliability and minimum detectable change values of temporal-spatial, kinematic variability, and dynamic stability measures during three types of perturbed gait. Twenty young healthy adults completed two identical testing sessions two weeks apart, comprised of an unperturbed and three perturbed (cognitive, physical, and visual) walking conditions in a virtual reality environment. Within each session, perturbation responses were compared to unperturbed walking using paired t-tests. Between-session reliability and minimum detectable change values were also calculated for each measure and condition. All temporal-spatial, kinematic variability and dynamic stability measures demonstrated fair to excellent between-session reliability. Minimal detectable change values, normalized to mean values ranged from 1-50%. Step width mean and variability measures demonstrated the greatest response to perturbations with excellent between-session reliability and low minimum detectable change values. Orbital stability measures demonstrated specificity to perturbation direction and sensitivity with excellent between-session reliability and low minimum detectable change values. We observed substantially greater between-session reliability and lower minimum detectable change values for local stability measures than previously described which may be the result of averaging across trials within a session and using velocity versus acceleration data for reconstruction of state spaces. Across all perturbation types, temporal-spatial, orbital and local measures were the most reliable measures with the lowest minimum detectable change values, supporting their use for tracking changes over multiple testing sessions. The between-session reliability and minimum detectable change values reported here provide an objective means for interpreting changes in temporal-spatial, kinematic variability, and dynamic stability measures during perturbed walking which may assist in identifying instability.	[Rabago, Christopher A.; Wilken, Jason M.] Brooke Army Med Ctr, Dept Orthopaed & Rehabil, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA; [Rabago, Christopher A.; Wilken, Jason M.] Dept Def & Vet Affairs Extrem Trauma, Jbsa Ft Sam Houston, TX USA; [Rabago, Christopher A.; Wilken, Jason M.] Amputat Ctr Excellence, Jbsa Ft Sam Houston, TX USA; [Dingwell, Jonathan B.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA		Rabago, CA (corresponding author), Brooke Army Med Ctr, Dept Orthopaed & Rehabil, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA.	Christopher.A.Rabago.civ@mail.mil	Wilken, Jason/ABA-3309-2021	Wilken, Jason/0000-0002-5556-7667; Dingwell, Jonathan/0000-0001-6990-4153; Rabago, Christopher/0000-0002-4484-0613	Medical Research and Materiel Command's Military Operational Medicine Research Program [W81XWH-09-P-0874]	Support provided by Medical Research and Materiel Command's Military Operational Medicine Research Program, http://mrmc.amedd.army.mil, Grant W81XWH-09-P-0874 (to JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Arellano CJ, 2009, MED SCI SPORT EXER, V41, P620, DOI 10.1249/MSS.0b013e31818a0ea4; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Beltran EJ, 2014, J BIOMECH, V47, P1138, DOI 10.1016/j.jbiomech.2013.12.011; Beurskens R, 2014, J BIOMECH, V47, P3072, DOI 10.1016/j.jbiomech.2014.06.041; Beurskens R, 2014, J BIOMECH, V47, P1675, DOI 10.1016/j.jbiomech.2014.02.033; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Oliveira ASC, 2012, GAIT POSTURE, V36, P301, DOI 10.1016/j.gaitpost.2012.03.016; Cohen J., 2013, STAT POWER ANAL BEHA; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Dingwell J.B., 2006, WILEY ENCY BIOMEDICA; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-12; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Gates DH, 2009, J BIOMECH, V42, P1345, DOI 10.1016/j.jbiomech.2009.03.015; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Grabiner Mark D, 2005, J Neuroeng Rehabil, V2, P25, DOI 10.1186/1743-0003-2-25; Granata KP, 2008, J ELECTROMYOGR KINES, V18, P172, DOI 10.1016/j.jelekin.2007.06.008; Hak L, 2012, GAIT POSTURE, V36, P260, DOI 10.1016/j.gaitpost.2012.03.005; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; HOLM S, 1979, SCAND J STAT, V6, P65; Hurmuzlu Y, 1996, J BIOMECH ENG-T ASME, V118, P405, DOI 10.1115/1.2796024; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kim H, 2012, J BIOMECH, V45, P1850, DOI 10.1016/j.jbiomech.2012.05.003; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mayer-Kress G., 1986, DIMENSIONS ENTROPIES, P82, DOI [10.1007/978-3-642-71001-8_11, DOI 10.1007/978-3-642-71001-8_11]; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; McAndrew PM, 2010, J BIOMECH, V43, P1470, DOI 10.1016/j.jbiomech.2010.02.003; McFadyen BJ, 2007, EXP BRAIN RES, V179, P235, DOI 10.1007/s00221-006-0784-0; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Melnyk BM, 2005, EVIDENCE BASED PRACT; Mersmann F, 2013, GAIT POSTURE, V37, P373, DOI 10.1016/j.gaitpost.2012.08.005; Nayfeh AH., 2008, APPL NONLINEAR DYNAM; Nnodim JO, 2013, GAIT POSTURE, V37, P61, DOI 10.1016/j.gaitpost.2012.06.002; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; O'Connor SM, 2012, J NEUROPHYSIOL, V107, P2549, DOI 10.1152/jn.00866.2011; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Plummer-D'Amato P, 2008, GAIT POSTURE, V27, P683, DOI 10.1016/j.gaitpost.2007.09.001; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Regnaux JP, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-19; Reynard P, 2014, J BIOMECH, V47, P74, DOI 10.1016/j.jbiomech.2013.10.011; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Sheehan RC, 2015, GAIT POSTURE, V41, P795, DOI 10.1016/j.gaitpost.2015.02.008; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinitksi EH, 2012, J BIOMECH, V45, P2084, DOI 10.1016/j.jbiomech.2012.05.039; Stolze H, 1998, GAIT POSTURE, V7, P125, DOI 10.1016/S0966-6362(97)00043-X; Szturm T, 2013, GAIT POSTURE, V38, P596, DOI 10.1016/j.gaitpost.2013.02.004; Terrier P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-94; Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12; Terry K, 2012, J BIOMECH, V45, P1979, DOI 10.1016/j.jbiomech.2012.05.006; van Schooten KS, 2014, GAIT POSTURE, V39, P695, DOI 10.1016/j.gaitpost.2013.09.020; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	71	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142083	10.1371/journal.pone.0142083			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	WOS:000364298400130	26535580	Green Published, gold			2022-02-06	
J	Topolovec-Vranic, J; Zhang, S; Wong, H; Lam, E; Jing, RW; Russell, K; Cusimano, MD				Topolovec-Vranic, Jane; Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Russell, Kelly; Cusimano, Michael D.		Canadian Brain Injury Violence Res	Recognizing the Symptoms of Mental Illness following Concussions in the Sports Community: A Need for Improvement	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PUBLIC KNOWLEDGE; FOOTBALL PLAYERS; SEX-DIFFERENCES; HEAD-INJURY; POPULATION; PROFESSIONALS; ADOLESCENTS; ENGLAND; RISK	Objective To evaluate the awareness of concussion-related symptoms amongst members of the sports community in Canada. Methods A cross-sectional national electronic survey was conducted. Youth athletes, parents, coaches and medical professionals across Canada were recruited through mailing lists from sports-related opt-in marketing databases. Participants were asked to identify, from a list of options, the symptoms of a concussion. The proportion of identified symptoms (categorized as physical, cognitive, mental health-related and overall) as well as participant factors associated with symptom recognition were analyzed. Results The survey elicited 6,937 responses. Most of the respondents (92.1%) completed the English language survey, were male (57.7%), 35-54 years of age (61.7%), with post-secondary education (58.2%), or high reported yearly household income (>$80,000; 53.0%). There were respondents from all provinces and territories with the majority of respondents from Ontario (35.2%) or British Columbia (19.1%). While participants identified most of the physical (mean = 84.2% of symptoms) and cognitive (mean = 91.2% of symptoms), they on average only identified 53.5% of the mental health-related symptoms of concussions. Respondents who were older, with higher education and household income, or resided in the Northwest Territories or Alberta identified significantly more of the mental health-related symptoms listed. Interpretation While Canadian youth athletes, parents, coaches and medical professionals are able to identify most of the physical and cognitive symptoms associated with concussion, identification of mental health-related symptoms of concussion is still lagging.	[Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Russell, Kelly] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013; Meijer, Anna/K-5118-2016	Topolovec-Vranic, Jane/0000-0001-7695-4212; Russell, Kelly/0000-0002-9159-9201; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Public Health Agency of Canada	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation, and Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Author, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058868, DOI 10.1371/J0URNAL.P0NE.0058868]; Babul S, 2014, BRIT J SPORT MED, V48, P563, DOI [10.1136/bjsports-2014-093494.11, DOI 10.1136/BJSP0RTS-2014-093494.11]; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Blake T, 2014, BRIT J SPORT MED, V48, P570, DOI [10.1136/bjsports-2014-093494.28, DOI 10.1136/BJSP0RTS-2014-093494.28]; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hogg R. V., 2005, INTRO MATH STAT; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun C, 2014, BRIT J SPORT MED, V48, P623, DOI [10.1136/bjsports-2014-093494.171, DOI 10.1136/BJSP0RTS-2014-093494.171]; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitaker S, 2012, FAM PRACT, V29, P168, DOI 10.1093/fampra/cmr079; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	40	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141699	10.1371/journal.pone.0141699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	WOS:000364298400078	26536016	Green Submitted, Green Published, gold			2022-02-06	
J	Meyers, JE; English, J; Miller, RM; Lee, AJ				Meyers, John E.; English, James; Miller, Ronald M.; Lee, Amy Junghyun			Normative Data for the Neurobehavioral Symptom Inventory	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						adulthood; cognition; ethnic-minority studies; neuropsychology	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; MIGRAINE; VETERANS	The demographically diverse populations served by large health care systems (Veterans Affairs, Department of Defense, Medicare, Medicaid) are routinely screened with the Neurobehavioral Symptom Inventory (NSI). The extent to which a patient's report of symptoms either initially and/or across time is affected by demographic variablesgender, ethnicity, age, or educationhas not been investigated despite widespread use of the NSI. In practice, the effectiveness of this tool might be improved with demographically based norms. A large data set of normal community-dwelling individuals was collected using the NSI. Emphasis was made to collect data from individuals of diverse ethnic backgrounds. It was hypothesized that ethnic/cultural backgrounds would have an impact on NSI scores. The results provide normative data for the NSI applicable to a wide variety of individuals of various ages and ethnic backgrounds. An analysis of variance indicated there was no significant difference in NSI responses based on ethnic/cultural background; however, age and gender were found to contribute significantly to the variance associated with symptom endorsement. The NSI appears to be a reliable measure of self-report postconcussive symptoms. Age is a variable associated with differential symptom endorsement on the NSI. Follow-up studies are needed to provide a measure of the sensitivity and specificity of this measure.	[Meyers, John E.] Meyers Neuropsychol Serv, Mililani, HI 96789 USA; [Miller, Ronald M.; Lee, Amy Junghyun] Brigham Young Univ Hawaii, Dept Psychol, Laie, HI USA		Meyers, JE (corresponding author), Meyers Neuropsychol Serv, 94-553 Alapoai St,162, Mililani, HI 96789 USA.	jmeyersneuro@yahoo.com		Lee, Amy Junghyun/0000-0001-7745-7058			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIPTON RB, 1992, ARCH INTERN MED, V152, P1273, DOI 10.1001/archinte.152.6.1273; McCaffrey R. J., 2003, PRACTITIONERS GUIDE; MERIKANGAS KR, 1990, ARCH GEN PSYCHIAT, V47, P849; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; RASMUSSEN BK, 1992, ARCH NEUROL-CHICAGO, V49, P914, DOI 10.1001/archneur.1992.00530330036012; StataCorp, 2013, STAT 13 BAS REF MAN; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Census Bureau, 2015, STAT COUNT QUICKF; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	16	11	11	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2015	22	6					427	434		10.1080/23279095.2014.968919			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CS6VM	WOS:000362221000005	25874907				2022-02-06	
J	Kamourieh, S; Braga, RM; Leech, R; Newbould, RD; Malhotra, P; Wise, RJS				Kamourieh, Salwa; Braga, Rodrigo M.; Leech, Robert; Newbould, Rexford D.; Malhotra, Paresh; Wise, Richard J. S.			Neural Systems Involved When Attending to a Speaker	CEREBRAL CORTEX			English	Article						attention; cognitive control; functional mRI; right anterior insula; speech	INDEPENDENT COMPONENT ANALYSIS; POSTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; SELECTIVE ATTENTION; AUDITORY FMRI; NETWORKS; CONNECTIVITY; ARCHITECTURE; SPEECH; ROBUST	Remembering what a speaker said depends on attention. During conversational speech, the emphasis is on working memory, but listening to a lecture encourages episodic memory encoding. With simultaneous interference from background speech, the need for auditory vigilance increases. We recreated these context-dependent demands on auditory attention in 2 ways. The first was to require participants to attend to one speaker in either the absence or presence of a distracting background speaker. The second was to alter the task demand, requiring either an immediate or delayed recall of the content of the attended speech. Across 2 fMRI studies, common activated regions associated with segregating attended from unattended speech were the right anterior insula and adjacent frontal operculum (aI/FOp), the left planum temporale, and the precuneus. In contrast, activity in a ventral right frontoparietal system was dependent on both the task demand and the presence of a competing speaker. Additional multivariate analyses identified other domain-general frontoparietal systems, where activity increased during attentive listening but was modulated little by the need for speech stream segregation in the presence of 2 speakers. These results make predictions about impairments in attentive listening in different communicative contexts following focal or diffuse brain pathology.	[Kamourieh, Salwa; Braga, Rodrigo M.; Leech, Robert; Newbould, Rexford D.; Malhotra, Paresh; Wise, Richard J. S.] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Div Brain Sci, London W12 0NN, England; [Newbould, Rexford D.] Imanova Ctr Imaging Sci, London W12 0NN, England		Kamourieh, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Div Brain Sci, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	salwa.kamourieh@imperial.ac.uk	Malhotra, Paresh/A-5227-2009; Leech, Robert/AAE-8254-2019	Malhotra, Paresh/0000-0002-1897-0780; Leech, Robert/0000-0002-5801-6318	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1100423]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K014129/1, G1100423] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K014129/1] Funding Source: researchfish	This work was supported by the Medical Research Council (G1100423). Funding to pay the Open Access publication charges for this article was provided by the Medical Research Council.	Algazi VR, 2001, J ACOUST SOC AM, V109, P1110, DOI 10.1121/1.1349185; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Boccia M, 2014, NEUROPSYCHOL REV, V24, P236, DOI 10.1007/s11065-014-9247-8; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brungart DS, 2001, J ACOUST SOC AM, V109, P1101, DOI 10.1121/1.1345696; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Darwin CJ, 2008, PHILOS T R SOC B, V363, P1011, DOI 10.1098/rstb.2007.2156; Darwin CJ, 2000, J ACOUST SOC AM, V107, P970, DOI 10.1121/1.428278; Darwin CJ, 2000, J ACOUST SOC AM, V108, P335, DOI 10.1121/1.429468; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Feng AS, 2000, ANNU REV PSYCHOL, V51, P699, DOI 10.1146/annurev.psych.51.1.699; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geranmayeh F, 2014, BRAIN, V137, P2632, DOI 10.1093/brain/awu163; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Robertson IH, 2014, NEUROBIOL AGING, V35, P1375, DOI 10.1016/j.neurobiolaging.2013.11.028; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Schwarzbauer C, 2006, NEUROIMAGE, V29, P774, DOI 10.1016/j.neuroimage.2005.08.025; Shallice T, 2008, FRONT NEUROSCI-SWITZ, V2, P79, DOI 10.3389/neuro.01.013.2008; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Woolgar A, 2013, J COGNITIVE NEUROSCI, V25, P1542, DOI 10.1162/jocn_a_00432; Woolgar A, 2011, J NEUROSCI, V31, P14592, DOI 10.1523/JNEUROSCI.2616-11.2011; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044; Zundorf IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064259	58	11	11	1	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	NOV	2015	25	11					4284	4298		10.1093/cercor/bhu325			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CY5QW	WOS:000366463300023	25596592	Green Published, Green Submitted, hybrid			2022-02-06	
J	Stepkowski, TM; Wasyk, I; Grzelak, A; Kruszewski, M				Stepkowski, Tomasz Maciej; Wasyk, Iwona; Grzelak, Agnieszka; Kruszewski, Marcin			6-OHDA-Induced Changes in Parkinson's Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Parkinson's disease; Gene expression; 6-hydroxydopamine; LUHMES cells; PGAM5	TRAUMATIC BRAIN-INJURY; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; MOTOR BEHAVIOR; TETANUS TOXIN; SH-SY5Y CELLS; NEUROPROTECTION; PROTEIN; DJ-1; APOPTOSIS	LUHMES cells, a recently established line of immortalized embryonic mesencephalic cells, are the novel in vitro model for studying Parkinson's disease (PD) and dopaminergic neuron biology. Phosphoglyceromutase 5 (PGAM5) is a mitochondrial protein involved in mitophagy, mitochondria dynamics, and other processes important for PD pathogenesis. We tested the impact of lentiviral overexpression of PGAM5 protein in LUHMES cells on their differentiation and expression of 84 PD-related genes. LUHMES cells were transduced with PGAM5 or mock and treated with 100 mu M 6-hydroxydopamine (6-OHDA), a model PD neurotoxin. Real-Time PCR analysis revealed that the treatment with 6-OHDA-induced changes in expression of 44 PD-related genes. PGAM5 transduction alone did not cause alternations in PD-related genes expression, nor it affected changes in gene expression mediated by 6-OHDA. The 6-OHDA-induced PD-related gene expression profile of LUHMES cells is presented for the first time and widely discussed.	[Stepkowski, Tomasz Maciej; Wasyk, Iwona; Kruszewski, Marcin] Inst Nucl Chem & Technol, Ctr Radiobiol & Biol Dosimetry, PL-03195 Warsaw, Poland; [Grzelak, Agnieszka] Univ Lodz, Dept Mol Biophys, PL-90237 Lodz, Poland; [Kruszewski, Marcin] Inst Rural Hlth, Dept Mol Biol & Translat Res, PL-20090 Lublin, Poland; [Kruszewski, Marcin] Univ Informat Technol & Management, Fac Med, Dept Med Biol & Translat Res, PL-35225 Rzeszow, Poland		Stepkowski, TM (corresponding author), Inst Nucl Chem & Technol, Ctr Radiobiol & Biol Dosimetry, Dorodna 16, PL-03195 Warsaw, Poland.	t.stepkowski@ichtj.waw.pl	Kruszewski, Marcin/S-6095-2018	Kruszewski, Marcin/0000-0003-4554-8566; Grzelak, Agnieszka/0000-0002-9695-6693; Stepkowski, Tomasz/0000-0002-8454-4421	Polish Ministry of Science and Higher EducationMinistry of Science and Higher Education, Poland [IP2011052071]; statutory grant for Institute of Nuclear Chemistry and Technology	This study was founded by IUVENTUS PLUS young researcher grant IP2011052071 from Polish Ministry of Science and Higher Education (T.M.S, A.G) and statutory grant for Institute of Nuclear Chemistry and Technology (I.W. and M.K.).	Binz T, 2010, TOXINS, V2, P665, DOI 10.3390/toxins2040665; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonifati Vincenzo, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS23, DOI 10.1016/S1353-8020(13)70009-9; Cao TT, 2005, J NEUROCHEM, V95, P406, DOI 10.1111/j.1471-4159.2005.03377.x; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cuadrado A, 2009, EXPERT OPIN THER TAR, V13, P319, DOI [10.1517/13543780802716501, 10.1517/13543780802716501 ]; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ferecsko AS, 2015, BRAIN STRUCT FUNCT, V220, P1013, DOI 10.1007/s00429-013-0697-1; Golden JP, 2013, J NEUROSCI, V 33, P17095, DOI 10.1523/JNEUROSCI.0890-13.2013; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; Mendieta L, 2012, NEUROSCI RES, V74, P156, DOI 10.1016/j.neures.2012.08.006; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Raptis A, 2005, J CHEM NEUROANAT, V30, P201, DOI 10.1016/j.jchemneu.2005.08.002; Reijneveld JC, 1997, J NEUROL NEUROSUR PS, V63, P258, DOI 10.1136/jnnp.63.2.258; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Shin OH, 2014, COMPR PHYSIOL, V4, P149, DOI 10.1002/cphy.c130021; Stepkowski TM, 2011, FREE RADICAL BIO MED, V50, P1186, DOI 10.1016/j.freeradbiomed.2011.01.033; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tanaka K, 2010, ACTA NEUROL SCAND, V122, P377, DOI 10.1111/j.1600-0404.2010.01327.x; Temburni MK, 2004, J NEUROSCI, V24, P6776, DOI 10.1523/JNEUROSCI.1826-04.2004; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wu H, 2014, AUTOPHAGY, V10, P1712, DOI 10.4161/auto.29568; Xu Y, 2013, CANCER RES, V73, P4406, DOI 10.1158/0008-5472.CAN-12-4297; Yamamoto H, 2012, MICROBIOL IMMUNOL, V56, P245, DOI 10.1111/j.1348-0421.2012.00434.x; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871; ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N	49	11	11	1	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2015	35	8					1137	1147		10.1007/s10571-015-0207-5			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CT5WR	WOS:000362882300007	25986246	Green Published, hybrid			2022-02-06	
J	Sun, ZX; Zu, HC; Yuan, D; Sun, YX; Zhang, K; Cui, ZQ; Wang, J				Sun, Zhenxing; Zu, Huancong; Yuan, Dan; Sun, Yaxing; Zhang, Kai; Cui, Zhiqiang; Wang, Jin			Predictors of prognosis in patients with temporal lobe epilepsy after anterior temporal lobectomy	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						anterior temporal lobectomy; mesial temporal lobe epilepsy; predictor; prognosis	SURGICAL-TREATMENT; MULTIVARIATE-ANALYSIS; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; HIPPOCAMPAL SCLEROSIS; INTRACTABLE EPILEPSY; SEIZURE RECURRENCE; SURGERY; RESECTION; MRI; EXTENT	The aim of this study was to evaluate the predictive value of prognostic factors for the surgical outcome of patients with mesial temporal lobe epilepsy (MTLE) using Engel seizure classification. The clinical data of 121 patients with MTLE who underwent anterior temporal lobectomy (ATL) and received a 1-year minimum follow-up were collected between January 2005 and December 2008. Patients were divided into seizure and seizure-free groups according to the Engel seizure classification. Univariate analysis and multivariate logistic regression analysis were used to analyze the potential predictive and prognostic factors, including medical history, clinical features of seizures, magnetic resonance imaging (MRI) and video-electroencephalogram (EEG) monitoring results. Univariate analysis indicated no statistically significant differences in gender, age at seizure onset, age at surgery, history of traumatic brain injury, perinatal anoxia, intracranial infection, family history of seizure, auras or site of surgery between the two groups; however, significant differences were detected in pre-surgical seizure duration, history of febrile seizures, seizure types, MRI and video-EEG results. Multivariate logistic regression analysis demonstrated that a pre-surgical seizure duration of <10 years, history of positive febrile seizures, simple complex partial seizure, positive MRI results and unilateral local video-EEG spikes may be considered as predictors of a good prognosis. These results indicate that remission may be achieved in patients with MTLE via the collection of accurate clinical information and adequate pre-surgical evaluation.	[Sun, Zhenxing; Zu, Huancong; Cui, Zhiqiang] Tsinghua Univ, Yuquan Hosp, Dept Neurosurg, Beijing 100084, Peoples R China; [Yuan, Dan] Capital Med Univ, Luhe Teaching Hosp, Dept Neurol, Beijing 101149, Peoples R China; [Sun, Yaxing] Second Municipal Hosp Zaozhuang, Dept Psychiat, Zaozhuang 277100, Shandong, Peoples R China; [Zhang, Kai] Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing 101149, Peoples R China; [Wang, Jin] Tsinghua Univ, Med Ctr, Changgung Hosp, Dept Neurosurg, Beijing 100084, Peoples R China		Wang, J (corresponding author), Tsinghua Univ, Med Ctr, Changgung Hosp, Dept Neurosurg, 168 Litang Rd, Beijing 100084, Peoples R China.	wja01068@btch.edu.cn					Antel SB, 2002, NEUROLOGY, V58, P1505, DOI 10.1212/WNL.58.10.1505; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; BEHRENS E, 1994, ACTA NEUROCHIR, V128, P84, DOI 10.1007/BF01400656; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; BLUME WT, 1994, J EPILEPSY, V7, P203, DOI 10.1016/0896-6974(94)90031-0; Bote RP, 2008, SEMIN ULTRASOUND CT, V29, P2, DOI 10.1053/j.sult.2007.11.005; Camacho DLA, 2007, SEMIN ULTRASOUND CT, V28, P424, DOI 10.1053/j.sult.2007.09.005; Clusmann H, 2004, J NEUROL NEUROSUR PS, V75, P1589, DOI 10.1136/jnnp.2003.024208; Clusmann H, 2002, J NEUROSURG, V97, P1131, DOI 10.3171/jns.2002.97.5.1131; Clusmann H, 2008, SEMIN ULTRASOUND CT, V29, P60, DOI 10.1053/j.sult.2007.11.004; Engel J, 1999, ARCH NEUROL-CHICAGO, V56, P1338, DOI 10.1001/archneur.56.11.1338; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; FALCONER MA, 1968, ARCH NEUROL-CHICAGO, V19, P353, DOI 10.1001/archneur.1968.00480040019001; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; Gilliam F, 1997, EPILEPSIA, V38, P1315, DOI 10.1111/j.1528-1157.1997.tb00069.x; GULDVOG B, 1994, EPILEPSIA, V35, P566, DOI 10.1111/j.1528-1157.1994.tb02476.x; Hennessy MJ, 2001, ACTA NEUROL SCAND, V103, P344, DOI 10.1034/j.1600-0404.2001.103006344.x; Ho SS, 1996, EPILEPSIA, V37, P788, DOI 10.1111/j.1528-1157.1996.tb00653.x; Holmes MD, 2000, SEIZURE-EUR J EPILEP, V9, P407, DOI 10.1053/seiz.2000.0423; Janszky J, 2003, EPILEPSY RES, V55, P1, DOI 10.1016/S0920-1211(03)00087-1; Jeong SW, 1999, EPILEPSIA, V40, P1735, DOI 10.1111/j.1528-1157.1999.tb01591.x; McIntosh AM, 2001, EPILEPSIA, V42, P1288, DOI 10.1046/j.1528-1157.2001.02001.x; McIntosh AM, 2005, ANN NEUROL, V57, P283, DOI 10.1002/ana.20372; Pavlidou E, 2008, BRAIN DEV-JPN, V30, P7, DOI 10.1016/j.braindev.2007.05.001; Pillai JJ, 2007, SEMIN ULTRASOUND CT, V28, P437, DOI 10.1053/j.sult.2007.09.006; Radhakrishnan K, 1998, NEUROLOGY, V51, P465, DOI 10.1212/WNL.51.2.465; Schramm J, 2008, EPILEPSIA, V49, P1296, DOI 10.1111/j.1528-1167.2008.01604.x; Schulz R, 2000, EPILEPSIA, V41, P564, DOI 10.1111/j.1528-1157.2000.tb00210.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Specht U, 1997, J NEUROL NEUROSUR PS, V62, P501, DOI 10.1136/jnnp.62.5.501; Spencer SS, 2003, NEUROLOGY, V61, P1680, DOI 10.1212/01.WNL.0000098937.35486.A3; SPERLING MR, 1994, NEUROLOGY, V44, P2325, DOI 10.1212/WNL.44.12.2325; Tanriverdi T, 2008, J NEUROSURG, V108, P517, DOI 10.3171/JNS/2008/108/3/0517; Tezer FI, 2008, SEIZURE-EUR J EPILEP, V17, P549, DOI 10.1016/j.seizure.2008.02.003; Vinton AB, 2007, BRAIN, V130, P548, DOI 10.1093/brain/awl232; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2004, EPILEPSIA, V45, P32; Wieser HG, 2004, SEIZURE-EUR J EPILEP, V13, P534, DOI 10.1016/j.seizure.2003.12.010; ZENTNER J, 1995, J NEUROL NEUROSUR PS, V58, P666, DOI 10.1136/jnnp.58.6.666	39	11	11	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	NOV	2015	10	5					1896	1902		10.3892/etm.2015.2753			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CW3JW	WOS:000364889600043	26640569	Green Published, gold			2022-02-06	
J	Vadivelu, S; Esernio-Jenssen, D; Rekate, HL; Narayan, RK; Mittler, MA; Schneider, SJ				Vadivelu, Sudhakar; Esernio-Jenssen, Debra; Rekate, Harold L.; Narayan, Raj K.; Mittler, Mark A.; Schneider, Steven J.			Delay in Arrival to Care in Perpetrator-Identified Nonaccidental Head Trauma: Observations and Outcomes	WORLD NEUROSURGERY			English	Article						Child abuse; Decompressive craniectomy; Hypoxic - ischemic stroke; Inflicted head injury; Shaken baby; Traumatic brain injury	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; CHILDREN; INFANTS; ADMISSIONS; SHAKING; ABUSE	BACKGROUND: Children who sustained nonaccidental head trauma (NAHT) are at severe risk for mortality within the first 24 hours after presentation. OBJECTIVE: Extent of delay in seeking medical attention may be related to patient outcome. METHODS: A 10-year, single-institution, retrospective review of 48 cases treated at a large tertiary Children's Hospital reported to the New York State Central Registrar by the child protection team was conducted. The perpetrator was identified in 28 cases on the basis of confession or conviction. The medical and legal records allowed for identification of time of injury and the interval between injury and arrival to the hospital; this information was categorized as follows: < 6 hours (without delay); 6-12 hours (moderate delay); and > 12 hours (severe delay). The King's Outcome Scale for Childhood Head Injury (KOSCHI) score was recorded for each case. RESULTS: All children were 3 years of age or younger (2.1-34 months) and predominantly male (68%; 19/28). On arrival, 61% of patients (17/28) presented with moderate or severe delay. A low arrival Glasgow Coma Scale (GCS) score (P < 0.0001) and extracranial injuries (P < 0.0061) correlated with worse clinical patient outcomes. Patients with an arrival GCS score < 7 predominantly arrived without delay or with moderate delay. Patients presenting without delay or with severe delay were more likely to have a higher KOSCHI outcome score on discharge (P < 0.0426). Four of the 6 patients who died presented after moderate delay. CONCLUSION: Patients presenting to medical care 6-12 hours after NAHT (moderate delay) appeared to have worse outcomes than those presenting earlier or later.	[Vadivelu, Sudhakar; Rekate, Harold L.; Narayan, Raj K.; Mittler, Mark A.; Schneider, Steven J.] Cohen Childrens Med Ctr, Hofstra North Shore Long Isl Jewish Sch Med, Cushing Neurosci Inst, Manhasset, NY 11021 USA; [Vadivelu, Sudhakar; Rekate, Harold L.; Narayan, Raj K.; Mittler, Mark A.; Schneider, Steven J.] Cohen Childrens Med Ctr, Hofstra North Shore Long Isl Jewish Sch Med, Dept Neurosurg, Manhasset, NY USA; [Vadivelu, Sudhakar; Rekate, Harold L.; Narayan, Raj K.; Mittler, Mark A.; Schneider, Steven J.] North Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA; [Esernio-Jenssen, Debra] Univ Florida, Sch Med, Dept Pediat, Shands Childrens Hosp, Gainesville, FL USA		Vadivelu, S (corresponding author), Cohen Childrens Med Ctr, Hofstra North Shore Long Isl Jewish Sch Med, Cushing Neurosci Inst, Manhasset, NY 11021 USA.	sudhakar.vadivelu@cchmc.org		Vadivelu, Sudhakar/0000-0003-1419-5673			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Amlie-Lefond C, 2009, LANCET NEUROL, V8, P530, DOI 10.1016/S1474-4422(09)70106-1; CAFFEY J, 1974, PEDIATRICS, V54, P396; Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Duhaime AC, 2007, PROG BRAIN RES, V161, P293, DOI 10.1016/S0079-6123(06)61020-0; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Golden N, 2005, J CLIN NEUROSCI, V12, P235, DOI 10.1016/j.jocn.2004.11.001; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; McDonald J W, 1993, NIDA Res Monogr, V133, P185; Oluigbo CO, 2012, J NEUROSURG-PEDIATR, V9, P125, DOI 10.3171/2011.11.PEDS09449; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Rafay MF, 2009, STROKE, V40, P58, DOI 10.1161/STROKEAHA.108.519066; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STARLING SP, 1995, PEDIATRICS, V95, P259; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9	21	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2015	84	5					1340	1346		10.1016/j.wneu.2015.06.023			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CV8KM	WOS:000364533900031	26118721				2022-02-06	
J	Yamal, JM; Benoit, JS; Doshi, P; Rubin, ML; Tilley, BC; Hannay, HJ; Robertson, CS				Yamal, Jose-Miguel; Benoit, Julia S.; Doshi, Pratik; Rubin, Maria Laura; Tilley, Barbara C.; Hannay, H. Julia; Robertson, Claudia S.			Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Blood transfusion complications; adult; leukoreduced red blood cells; traumatic brain injury	DURATION; LEUKOREDUCTION; THRESHOLD; ADULTS	BACKGROUND The effect of red blood cell (RBC) storage on oxygenation in critically ill patients is still unknown. The objective of this study was to determine the association of RBC storage with oxygenation, long-term neurologic recovery, and death after traumatic brain injury. METHODS We used data from a 2 x 2 factorial randomized controlled trial of administration of erythropoietin or placebo and of assignment to transfusion threshold of less than 7g/dL or less than 10 g/dL in neurosurgical intensive care units in two US Level 1 trauma centers. Patients had severe traumatic brain injury with closed head injury, were unable to follow commands, and were enrolled within 6 hours of injury. Blood oxygenation 1 hour after the transfusion as measured by jugular venous oxygen saturation (n = 59) was the primary outcome. Secondary outcomes were brain tissue oxygenation (n = 77), 6-month Glasgow Outcome Scale (GOS) score (n = 122) collected using a structured interview and dichotomized into favorable (good recovery or moderate disability) or unfavorable outcome (severe disability, vegetative state, or dead), and mortality (n = 125). RBC age was defined as the maximum age of RBCs over all units in one transfusion per patient. For long-term outcomes, RBC age was defined as the mean age over all units given. RESULTS We failed to detect an association of RBC age with jugular venous oxygen saturation (linear regression = 1.59; 95% confidence interval [CI], -2.99 to 6.18; p = 0.49), brain tissue oxygenation (linear regression = 0.20; 95% CI, -0.23 to 0.63; p = 0.36), GOS score (odds ratio, 1.37; 95% CI, 0.53-3.57; p = 0.52), and mortality (hazard ratio, 1.35; 95% CI, 0.61-2.98; p = 0.46). CONCLUSION Limitations of this study include the fact that the RBC ages were not randomized, although this was a prospective study. We conclude that older blood does not seem to have adverse effects in severe traumatic brain injury. LEVEL OF EVIDENCE Prognostic study, level III.	[Yamal, Jose-Miguel; Rubin, Maria Laura; Tilley, Barbara C.] Univ Texas Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA; [Benoit, Julia S.] Univ Houston, Dept Vis Sci, Houston, TX USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Doshi, Pratik] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med & Internal Med, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Yamal, JM (corresponding author), Univ Texas Hlth Sci Ctr Houston, 1200 Pressler,RAS W928, Houston, TX 77030 USA.	Jose-Miguel.Yamal@uth.tmc.edu			National Institute of Neurological Disorders and Stroke, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS38660]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (grant no. P01NS38660).	del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS97, DOI 10.1097/TA.0b013e318298b0a4; Kiraly LN, 2009, J TRAUMA, V67, P29, DOI 10.1097/TA.0b013e3181af6a8c; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; Phelan HA, 2010, J TRAUMA, V69, P330, DOI 10.1097/TA.0b013e3181e0b253; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Weinberg JA, 2008, J TRAUMA, V65, P794, DOI 10.1097/TA.0b013e318184aa11; Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687; Weinberg JA, 2010, J TRAUMA, V69, P1427, DOI 10.1097/TA.0b013e3181fa0019; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752	14	11	11	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2015	79	5					843	849		10.1097/TA.0000000000000834			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CV3XX	WOS:000364201100022	26496111	Green Accepted			2022-02-06	
J	Yang, XJ; Yao, ZD; He, DM; Cai, YH; Dong, MJ; Yang, C				Yang, Xiujuan; Yao, Zhengduo; He, Dongmei; Cai, Yihua; Dong, Minjun; Yang, Chi			Does Soft Tissue Injury Affect Intracapsular Condylar Fracture Healing?	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							RESONANCE-IMAGING ASSESSMENT; TEMPOROMANDIBULAR-JOINT; EXPERIENCE	Purpose: The soft tissue healing patterns of mandibular intracapsular condylar fracture (ICF) after closed treatment have not been well characterized. The purpose of the present study was to classify the injury and healing patterns in adult patients using magnetic resonance imaging (MRI) evaluation. Patients and Methods: The present study represents a retrospective review of MRI examinations performed on patients treated with closed reduction of an ICF from 2010 to 2013. The MRI scans used for comparison were taken at 1 week and at least 3 months after the injury. These studies were used to identify the common patterns of hard and soft tissue derangements. The predictor variable was the type of soft tissue injuries, categorized as anteromedial displacement of both the disc and the fractured bony fragment, anteromedial displacement of the bony fragment with the disc remaining over the residual ramus, tear of the retrodiscal tissue or capsule, and joint effusion. The outcome variables were the MRI comparisons of the disc position, healing status of the retrodiscal tissue and capsule, and resolution of joint effusions. Results: Twelve patients, all with ICFs, were included in the present study. Immediately after injury, all 17 fractures (100%) showed anteromedial displacement of both the disc and the fractured condylar fragment, and 10 fractures (58.8%) showed anteromedial displacement of the condylar fragment with the disc remaining over the residual condyle. Also, 11 (64.7%) showed evidence of perforation of the retrodiscal tissue, and 7 (41.2%) showed tears in the capsule. Finally, all 17 (100%) exhibited joint effusions. At 3 months after injury, all 17 fractures (100%) continued to exhibit displacement of both the disc and the condylar segments. Also, 15 fractures (88.2%) showed elongation of the disc and thickening of the retrodiscal tissue, 2 fractures (11.8%) had developed osteoid hyperplasia and meniscal perforation, and 6 fractures (35.3%) showed resolution of previous joint effusions. Finally, 17 fractures (100%) showed reactive bone formation at the condylar head. Conclusions: ICFs treated with closed reduction consistently result in a specific pattern of temporomandibular joint pathologic features. These pathologic features are characterized by anteromedial displacement of the articular disc, elongation and thickening of the retrodiscal tissue, and reactive bone formation at the condylar head. The presence of a portion of the disc between the residual condyle and the fossa prevented the development of osteoarthritis and ankylosis. Perforation of the bilaminar tissue and contact between the residual condyle and the fossa promoted osteoarthritic changes and ankylosis. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Yang, Xiujuan; Yao, Zhengduo; He, Dongmei; Cai, Yihua; Yang, Chi] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Surg, Key Lab Stomatol,Sch Med, Shanghai 200011, Peoples R China; [Dong, Minjun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Radiol, Shanghai 200011, Peoples R China		He, DM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Oral & Maxillofacial Surg, Shanghai Peoples Hosp 9, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	dongmeihe119@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472117]; Combined Medicine and Engineering Project of Shanghai Jiao Tong University [YG2014MS05]	This work was supported by the National Natural Science Foundation of China (grant 81472117) and the Combined Medicine and Engineering Project of Shanghai Jiao Tong University (grant YG2014MS05).	Chen MJ, 2010, J ORAL MAXIL SURG, V68, P2189, DOI 10.1016/j.joms.2009.09.063; Choi BH, 1997, INT J ORAL MAX SURG, V26, P344, DOI 10.1016/S0901-5027(97)80794-1; Dwivedi AND, 2012, J ORAL MAXIL SURG, V70, P2829, DOI 10.1016/j.joms.2012.08.026; Emshoff R, 2007, J ORAL MAXIL SURG, V65, P1550, DOI 10.1016/j.joms.2006.10.068; Ferretti C, 2005, INT J ORAL MAX SURG, V34, P376, DOI 10.1016/j.ijom.2004.09.003; Gerhard S, 2007, INT J ORAL MAX SURG, V36, P214, DOI 10.1016/j.ijom.2006.09.013; HE D, 2014, J ORAL MAXILLOFAC SU, V72, P763; He DM, 2013, BRIT J ORAL MAX SURG, V51, P58, DOI 10.1016/j.bjoms.2012.02.005; He DM, 2009, J ORAL MAXIL SURG, V67, P1672, DOI 10.1016/j.joms.2009.02.012; SULLIVAN SM, 1995, J ORAL MAXIL SURG, V53, P763, DOI 10.1016/0278-2391(95)90326-7; Takahashi T, 2004, CRANIO, V22, P124, DOI 10.1179/crn.2004.016; Takaku S, 1996, J CRANIO MAXILL SURG, V24, P173, DOI 10.1016/S1010-5182(96)80052-7; Wang P, 2009, AM J NEURORADIOL, V30, P59, DOI 10.3174/ajnr.A1313; Yu YH, 2013, BRIT J ORAL MAX SURG, V51, P133, DOI 10.1016/j.bjoms.2012.03.019	14	11	13	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	NOV	2015	73	11					2169	2180		10.1016/j.joms.2015.05.030			12	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	CW9VW	WOS:000365347300016	26079691				2022-02-06	
J	Zhang, XL; Shuttleworth, CW; Moskal, JR; Stanton, PK				Zhang, Xiao-lei; Shuttleworth, C. William; Moskal, Joseph R.; Stanton, Patric K.			Suppression of spreading depolarization and stabilization of dendritic spines by GLYX-13, an NMDA receptor glycine-site functional partial agonist	EXPERIMENTAL NEUROLOGY			English	Article						CA1; Hippocampus; Migraine; Schaffer collateral; Spreading depression	INTRINSIC OPTICAL SIGNALS; PERIINFARCT DEPOLARIZATIONS; ANOXIC DEPOLARIZATION; HIPPOCAMPAL SLICE; LIGHT-SCATTERING; RAT HIPPOCAMPUS; DEPRESSION; MIGRAINE; ISCHEMIA; BLOCKADE	Cortical spreading depolarization (SD) is a slow self-propagating wave of mass cellular depolarization in brain tissue, thought to be the underlying cause of migraine scintillating scotoma and aura, and associated with stroke, traumatic brain injury, and termination of status epilepticus. The N-methyl-D-aspartate subtype of glutamate receptor (NMDAR), which gates influx of calcium and is an important trigger of long-term synaptic plasticity, is also a contributor to the initiation and propagation of SD. The current study tested the potential of pharmacological modulation of NMDAR activity through the obligatory co-agonist binding site, to suppress the initiation of SD, and modulate the effects of SD on dendritic spine morphology, in in vitro hippocampal slices. A novel NMDAR functional glycine site partial agonist, GLYX-13, sometimes completely prevented the induction of SD and consistently slowed its rate of propagation. The passage of SD through the hippocampal CA1 region produced a rapid retraction of dendritic spines which reversed after neuronal depolarization had recovered. GLYX-13 improved the rate and extent of return of dendritic spines to their original sizes and locations following SD, suggesting that NMDAR modulators can protect synaptic connections in the brain from structural alterations elicited by SD. These data indicate that NMDAR modulation to renormalize activity may be an effective new treatment strategy for suppression or amelioration of the contribution of SD to short and long-term symptoms of migraine attacks, as well as the effects of SD on tissue damaged by stroke or traumatic brain injury. (C) 2015 Elsevier Inc. All rights reserved.	[Zhang, Xiao-lei; Stanton, Patric K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Shuttleworth, C. William] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Moskal, Joseph R.] Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Dept Biomed Engn, Falk Ctr Mol Therapeut, Evanston, IL 60208 USA; [Stanton, Patric K.] New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA		Stanton, PK (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	patric_stanton@nymc.edu	Moskal, Joseph/B-7628-2009	Stanton, Patric/0000-0002-2294-0613	Naurex Inc.; Migraine Research Foundation	This study was supported by Naurex Inc. and the Migraine Research Foundation. This work is dedicated to the memories of John M. Sarvey, Lewis N. Stanton, Sr., Eleanor F. Stanton and Gary L Stanton.	Aiba I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075739; Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; AMEMORI T, 1990, BRAIN RES, V519, P351, DOI 10.1016/0006-8993(90)90101-G; Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; Ashina M, 2013, CEPHALALGIA, V33, P540, DOI 10.1177/0333102412475234; Ayata C, 2010, HEADACHE, V50, P725, DOI 10.1111/j.1526-4610.2010.01647.x; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Burgdorf J., 2009, NEUROBIOL AGING, V32, P698; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Costa C, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-62; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Dreier Jens P, 2015, Acta Neurochir Suppl, V120, P137, DOI 10.1007/978-3-319-04981-6_23; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Edvinsson L, 2012, PHARMACOL THERAPEUT, V136, P319, DOI 10.1016/j.pharmthera.2012.08.011; Eikermann-Haerter K, 2010, CURR NEUROL NEUROSCI, V10, P167, DOI 10.1007/s11910-010-0099-1; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Faria LC, 2004, J NEUROPHYSIOL, V92, P2610, DOI 10.1152/jn.00466.2004; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; Jourdain P, 2002, J NEUROSCI, V22, P3108, DOI 10.1523/JNEUROSCI.22-08-03108.2002; Lapilover EG, 2012, NEUROBIOL DIS, V48, P495, DOI 10.1016/j.nbd.2012.06.024; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; MARTINSF.H, 1966, J NEUROPHYSIOL, V29, P715, DOI 10.1152/jn.1966.29.4.715; Moskal JR, 2014, EXPERT OPIN INV DRUG, V23, P243, DOI 10.1517/13543784.2014.852536; Moskal JR, 2005, NEUROPHARMACOLOGY, V49, P1077, DOI 10.1016/j.neuropharm.2005.06.006; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; O'Farrell AM, 2000, NEUROREPORT, V11, P2121, DOI 10.1097/00001756-200007140-00013; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Peeters M, 2007, J PHARMACOL EXP THER, V321, P564, DOI 10.1124/jpet.106.117101; Pomper JK, 2006, J NEUROPHYSIOL, V95, P355, DOI 10.1152/jn.00186.2005; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; SNOW RW, 1983, J NEUROPHYSIOL, V50, P561, DOI 10.1152/jn.1983.50.3.561; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tao L, 2002, BRAIN RES, V952, P290, DOI 10.1016/S0006-8993(02)03254-7; Tso AR, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0318-1; Velisek L, 2007, ANN NEUROL, V61, P109, DOI 10.1002/ana.21082; Vilagi I, 2001, BRAIN RES, V898, P288, DOI 10.1016/S0006-8993(01)02196-5; Zhang XL, 2008, NEUROPHARMACOLOGY, V55, P1238, DOI 10.1016/j.neuropharm.2008.08.018; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	59	11	12	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						312	321		10.1016/j.expneurol.2015.07.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW7BB	WOS:000365151800029	26244282				2022-02-06	
J	Thiagarajan, P; Ciuffreda, KJ				Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Short-term persistence of oculomotor rehabilitative changes in mild traumatic brain injury (mTBI): A pilot study of clinical effects	BRAIN INJURY			English	Article						Acquired brain injury; clinical effects; eye movements; oculomotor rehabilitation; oculomotor system; traumatic brain injury; vision rehabilitation; vision therapy	CONVERGENCE; PLASTICITY; PREVALENCE	Primary objective: In our earlier published studies, oculomotor therapy (OMT) was performed in 15 individuals with mild traumatic brain injury (mTBI) and over 90% of the clinical oculomotor parameters abnormal at baseline significantly improved immediately following the OMT. There was no placebo (P) effect on any of the parameters. The purpose of the present pilot study was to assess the short-term persistence of the previously obtained positive OMT findings.Research design: Upon completion of the OMT, clinical oculomotor parameters were re-assessed at 3-month and 6-month periods. No subsequent training was performed during this 6-month period.Methods and procedures: Clinical measures were repeated in eight of the 15 subjects who subsequently completed both the 3-month and 6-month follow-up assessments. All measures were assessed using conventional clinical testing methods.Main outcomes and results: Eight of the 13 (62%) clinical oculomotor parameters exhibited either persistence of, or delayed, improvement at the 3 and 6 month follow-up intervals.Conclusions: Findings demonstrate both the presence and persistence of oculomotor-based changes, suggestive of neural plasticity even in the adult, compromised brain. Further studies are warranted to confirm and extend the present pilot findings.	[Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			US Army DoD TATRC [W81XWH-12-1-0240, 11258003]	This study was sponsored by the US Army DoD TATRC (Proposal #: 11258003), Grant #: W81XWH-12-1-0240.	Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Candler R., 1944, BR ORTHOPTIC J, V2, P56; Ciuffreda K. J., 2007, OPTOMETRY, V78, P55; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Department ofVeterans Affairs/DepartmentofDefense (VA/ DoD), 2009, CLIN PRACT GUID MAN; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiebig F, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00064; Gearing RE, 2013, DEPRESS ANXIETY, V30, P800, DOI 10.1002/da.22118; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hokoda S C, 1985, J Am Optom Assoc, V56, P560; KERKHOFF G, 1994, BRAIN INJURY, V8, P15, DOI 10.3109/02699059409150955; KROHEL GB, 1986, ANN OPHTHALMOL, V18, P101; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Porcar E, 1997, OPTOMETRY VISION SCI, V74, P111, DOI 10.1097/00006324-199702000-00023; Savion-Lemieux T, 2005, EXP BRAIN RES, V161, P423, DOI 10.1007/s00221-004-2085-9; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Thiagarajan P., 2012, THESIS; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Wesner AC, 2014, BEHAV COGNTIVE PSYCH, V10, P1; Wick B., 2008, CLIN MANAGEMENT BINO	31	11	11	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1475	1479		10.3109/02699052.2015.1070905			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200012	26308101				2022-02-06	
J	Aikins, RD; Golub, A; Bennett, AS				Aikins, Ross D.; Golub, Andrew; Bennett, Alexander S.			Readjustment of Urban Veterans: A Mental Health and Substance Use Profile of Iraq and Afghanistan Veterans in Higher Education	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article						veterans; alcohol and other drugs (AOD) use; traumatic brain injury (TBI); mental health; posttraumatic stress disorder (PTSD)	STUDENT SERVICE MEMBERS/VETERANS; DRUG-USERS; POSTTRAUMATIC-STRESS; UNITED-STATES; RECRUITMENT; ALCOHOL; EQUITY; ACCESS; RISK; SEX	Objective: To identify the prevalence of substance use and mental health problems among veterans and student service members/veterans (SSM/V) returning from Iraq and Afghanistan to New York City's low-income neighborhoods. Participants: A sample of 122 veterans attending college and 116 veterans not enrolled recruited using respondent-driven sampling. Methods: Logistic regression analysis of variation in characteristics of those veterans attending college; linear regression examining effects of college attendance on life satisfaction. Results: Having a traumatic brain injury or disability was positively associated with college attendance. Being married, employed, or in college was predictive of overall life satisfaction. SSM/V were significantly less likely to screen positive for depression or drug use disorder. African American veterans were significantly less likely to attend college than white or Hispanic veterans. Conclusion: Substance use and some mental health disorders do not preclude inner-city veterans from entering higher education. This study contributes to the sparse literature on African American veterans and SSM/V.	[Aikins, Ross D.] Univ Penn, Grad Sch Educ, Philadelphia, PA 19104 USA; [Aikins, Ross D.; Golub, Andrew; Bennett, Alexander S.] Natl Dev & Res Inst Inc, New York, NY USA		Aikins, RD (corresponding author), Univ Penn, Grad Sch Educ, Philadelphia, PA 19104 USA.				National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA020178]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA020178] Funding Source: NIH RePORTER	This research was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism (R01 AA020178). Points of view expressed in this paper do not necessarily represent the official position of the US Government, National Institute of Alcohol Abuse and Alcoholism, or National Development and Research Institutes, Inc.	Abdul-Quader AS, 2006, AIDS BEHAV, V9, P403; Ackerman R., 2009, NEW DIRECTIONS STUDE, V126, P5, DOI [https://doi.org/10.1002/ss.311, DOI 10.1002/SS.311]; American Council on Education, 2009, SERV THOS WHO SERV H; Barry AE, 2014, J STUD AFF RES PRACT, V51, P30, DOI 10.1515/jsarp-2014-0003; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; Barry AE, 2012, DRUG-EDUC PREV POLIC, V19, P415, DOI 10.3109/09687637.2011.647123; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bowen H.R, 1997, INVESTMENT LEARNING; Bray R, 2009, DEP DEFENSE SURVEY H; Briere J., 2006, PRINCIPLES TRAUMA TH; Chiarelli P. W., 2010, ARMY HLTH PROMOTION; Church TE., 2009, J POSTSECOND ED DISA, V22, P224; Congressional Budget Office, 2012, VET HLTH ADM TREAT P; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Edens EL, 2011, AM J ADDICTION, V20, P412, DOI 10.1111/j.1521-0391.2011.00166.x; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Emmons M., 2006, OAKLAND TRIBUNE 1226; Evans N.J., 1998, STUDENT DEV COLL THE, V1st ed; Figley C. R., 1980, STRANGERS HOME VIETN, pxxi; Gaultney JF, 2010, J AM COLL HEALTH, V59, P91, DOI 10.1080/07448481.2010.483708; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Grossman PD, 2009, J POSTSECOND EDUC DI, V22, P4; Grucza RA, 2009, J AM ACAD CHILD PSY, V48, P692, DOI 10.1097/CHI.0b013e3181a2b32f; Harper SR, 2009, J HIGH EDUC-UK, V80, P389, DOI 10.1353/jhe.0.0052; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2013, RESPONDENT DRIVEN SA; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Iguchi MY, 2009, J URBAN HEALTH, V86, pS5, DOI 10.1007/s11524-009-9365-4; Jeffri J., 2003, CHANGING BEAT STUDY, VVol. 3, P48; Johnson CV, 2009, AM J PUBLIC HEALTH, V99, pS187, DOI 10.2105/AJPH.2007.127464; Johnston L.D., 2012, MONITORING FUTURE NA, V2; Johnston LD, 2013, MONITORING FUTURE NA; Karen D, 2002, SOCIOL EDUC, V75, P191, DOI 10.2307/3090265; Karney B. R., 2008, INVISIBLE WOUNDS PRE; Kim Y., 2009, SOLDIER STUDENT EASI; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lansky A, 2007, PUBLIC HEALTH REP, V122, P48, DOI 10.1177/00333549071220S108; Livingston WG, 2011, J STUD AFF RES PRACT, V48, P315, DOI 10.2202/1949-6605.6292; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Matthews D., 2014, STRONGER NATION HIGH; McBain L., 2012, SOLDIER STUDENT 2 AS; Mikelson JD, 2013, CALLED SERVE HDB STU, P140; National Institute on Drug Abuse, 2012, SUBS AB MIL VET THEI; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Perna LW, 2006, RES HIGH EDUC, V47, P197, DOI 10.1007/s11162-005-8886-2; Perna LW, 2014, ATTAINMENT AGENDA: STATE POLICY LEADERSHIP IN HIGHER EDUCATION, P1; RADFORD AW, 2009, MILITARY SERVICE MEM; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Rubalcaba JA., 2014, EFFECTS POST 9 11 GI; Rudd MD, 2011, PROF PSYCHOL-RES PR, V42, P354, DOI 10.1037/a0025164; Rumann CB, 2010, J HIGH EDUC, V81, P431, DOI 10.1353/jhe.0.0103; Rusch ML, 2009, J URBAN HEALTH, V86, P760, DOI 10.1007/s11524-009-9377-0; Schuetze HG, 2002, HIGH EDUC, V44, P309, DOI 10.1023/A:1019898114335; Shahmanesh M, 2009, AM J PUBLIC HEALTH, V99, P1239, DOI 10.2105/AJPH.2008.149930; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; US Army Office of the Chief of Public Affairs, 2010, HLTH PROM RISK RED S; US Department of Defense, 2009, ENH POSTD HLTH ASS P; US Department of Defense, 2011, DEF ACT NONTR ED SUP; US Department of Veterans Affairs, 2007, WOM VET PAST PRES FU; Wang JC, 2007, ADDICT BEHAV, V32, P924, DOI 10.1016/j.addbeh.2006.06.031; Wattana W, 2007, DRUG ALCOHOL DEPEN, V90, P228, DOI 10.1016/j.drugalcdep.2007.03.013; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Whiteman SD, 2013, J COUNS PSYCHOL, V60, P265, DOI 10.1037/a0031650; Widome R, 2011, AM J HEALTH BEHAV, V35, P387, DOI 10.5993/AJHB.35.4.1; [No title captured]; [No title captured]	71	11	11	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health	OCT 3	2015	63	7			SI		482	494		10.1080/07448481.2015.1068173			13	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	CR5NJ	WOS:000361389500004	26367215	Green Accepted			2022-02-06	
J	Crago, EA; Sherwood, PR; Bender, C; Balzer, J; Ren, DX; Poloyac, SM				Crago, Elizabeth A.; Sherwood, Paula R.; Bender, Catherine; Balzer, Jeffrey; Ren, Dianxu; Poloyac, Samuel M.			Plasma Estrogen Levels Are Associated With Severity of Injury and Outcomes After Aneurysmal Subarachnoid Hemorrhage	BIOLOGICAL RESEARCH FOR NURSING			English	Article						subarachnoid hemorrhage; delayed cerebral ischemia; estrogen; outcomes	DELAYED CEREBRAL-ISCHEMIA; TANDEM MASS-SPECTROMETRY; ENDOTHELIN-RECEPTOR ANTAGONISTS; TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR-I; HORMONE-LEVELS; STROKE; ESTRADIOL; VASOSPASM; SERUM	Background: Biochemical mediators alter cerebral perfusion and have been implicated in delayed cerebral ischemia (DCI) and poor outcomes after aneurysmal subarachnoid hemorrhage (aSAH). Estrogens (estrone [E1] and estradiol [E2]) are mediators with neuroprotective properties that could play a role in DCI. This study explored associations between plasma estrogen levels and outcomes following aSAH. Methods: Plasma samples from 1-4, 4-6, and 7-10 days after hemorrhage from 99 adult aSAH patients were analyzed for estrogen levels using liquid chromatography tandem mass spectrometry. DCI was operationalized as radiographic/ultrasonic evidence of impaired cerebral blood flow accompanied by neurological deterioration. Outcomes were assessed using the Modified Rankin Scale at 3 and 12 months after hemorrhage. Statistical analysis included correlation, regression, and group-based trajectory. Results: Higher E1 and E2 levels were associated with higher Hunt and Hess grade (E1, p = .01; E2, p = .03), the presence of DCI (E1, p = .02; E2, p = .02), and poor 3-month outcomes (E1, p = .002; E2, p = .002). Trajectory analysis identified distinct populations over time for E1 (61% E1 high) and E2 (68% E2 high). Patients in higher trajectory groups had higher Fisher grades (E1, p = .008; E2, p = .01), more frequent DCI (E1, p = .04; E2, p = .08), and worse 3-month outcomes (E1, p = .01; E2, p = .004) than low groups. Conclusions: These results provide the first clinical evidence that plasma E1 and E2 concentrations are associated with severity of injury and outcomes after aSAH.	[Crago, Elizabeth A.; Sherwood, Paula R.; Bender, Catherine; Balzer, Jeffrey; Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Balzer, Jeffrey] Univ Pittsburgh, Med Ctr, Neurol Surg, Pittsburgh, PA 15261 USA; [Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharmaceut Sci, Pittsburgh, PA 15261 USA		Crago, EA (corresponding author), Univ Pittsburgh, Sch Nursing, Acute & Tertiary Care, 320B Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15261 USA.	ecrago@pitt.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NR004339]; Neuroscience Nursing Foundation, Nightingale Scholarship of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL074316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004339] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: NIH RO1 NR004339; Neuroscience Nursing Foundation, Nightingale Scholarship of Pennsylvania.	Aberg D, 2011, J CLIN ENDOCR METAB, V96, pE1055, DOI 10.1210/jc.2010-2802; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Auriat A, 2005, J CEREBR BLOOD F MET, V25, P247, DOI 10.1038/sj.jcbfm.9600026; Azcoitia I, 2011, TRENDS ENDOCRIN MET, V22, P467, DOI 10.1016/j.tem.2011.08.002; Rauschemberger MB, 2011, MOL CELL ENDOCRINOL, V339, P136, DOI 10.1016/j.mce.2011.04.009; Bendel S, 2010, CRIT CARE, V14, DOI 10.1186/cc8988; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Cahill J, 2009, STROKE, V40, pS86, DOI 10.1161/STROKEAHA.108.533315; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Crago EA, 2011, STROKE, V42, P1872, DOI 10.1161/STROKEAHA.110.605816; de Rooij NK, 2013, STROKE, V44, P43, DOI 10.1161/STROKEAHA.112.674291; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hurn PD, 2003, STROKE, V34, P338, DOI 10.1161/01.STR.0000054051.88378.25; Johnsen SP, 2005, J CLIN ENDOCR METAB, V90, P5937, DOI 10.1210/jc.2004-2088; Kauffmann RM, 2011, J AM COLL SURGEONS, V212, P703, DOI 10.1016/j.jamcollsurg.2010.12.017; Lerchbaum E, 2011, EXP CLIN ENDOCR DIAB, V119, P490, DOI 10.1055/s-0031-1284370; Lin CL, 2009, J NEUROSURG, V110, P457, DOI 10.3171/2008.6.17622; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; Ma JP, 2012, CRIT CARE, V16, DOI 10.1186/cc11686; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Nelson RE, 2004, CLIN CHEM, V50, P373, DOI 10.1373/clinchem.2003.025478; Pappa T, 2012, EUR J NEUROL, V19, P1300, DOI 10.1111/j.1468-1331.2012.03714.x; Rothman MS, 2011, STEROIDS, V76, P177, DOI 10.1016/j.steroids.2010.10.010; Sealy-Jefferson S, 2012, GENDER MED, V9, P121, DOI 10.1016/j.genm.2012.02.002; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Selles J, 2005, STEROIDS, V70, P251, DOI 10.1016/j.steroids.2004.10.012; Spratt DI, 2006, AM J PHYSIOL-ENDOC M, V291, pE631, DOI 10.1152/ajpendo.00467.2005; Vergouwen MDI, 2012, STROKE, V43, P2671, DOI 10.1161/STROKEAHA.112.666693; Vergouwen MDI, 2009, STROKE, V40, pE39, DOI 10.1161/STROKEAHA.108.537985; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Xu X, 2007, ANAL CHEM, V79, P7813, DOI 10.1021/ac070494j; Yi KD, 2011, BRAIN RES, V1379, P61, DOI 10.1016/j.brainres.2010.11.058; Zhang WR, 2009, J CEREBR BLOOD F MET, V29, P1475, DOI 10.1038/jcbfm.2009.65; Zubkov AY, 2009, NEUROL RES, V31, P626, DOI 10.1179/174313209X382331	40	11	11	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	OCT	2015	17	5					558	566		10.1177/1099800414561632			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	CQ9BV	WOS:000360906800011	25548393	Green Accepted			2022-02-06	
J	Fei, F; Li, J; Rao, W; Liu, WB; Chen, XY; Su, N; Wang, YS; Fei, Z				Fei, Fei; Li, Juan; Rao, Wei; Liu, Wenbo; Chen, Xiaoyan; Su, Ning; Wang, Yusheng; Fei, Zhou			Upregulation of Homer1a Promoted Retinal Ganglion Cell Survival After Retinal Ischemia and Reperfusion via Interacting with Erk Pathway	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Homer1a; Erk signaling; Retinal ischemia and reperfusion; Retinal ganglion cells	METABOTROPIC GLUTAMATE RECEPTORS; SPINAL DORSAL-HORN; OPTIC-NERVE HEAD; NECROSIS-FACTOR-ALPHA; MEDIATED EXCITOTOXICITY; ENDOPLASMIC-RETICULUM; VESL/HOMER PROTEINS; INDUCED APOPTOSIS; NEUROPATHIC PAIN; GENE-EXPRESSION	Retinal ischemia and reperfusion (I/R) is extensively involved in ocular diseases, causing retinal ganglion cell (RGCs) death resulting in visual impairment and blindness. Homer1a is considered as an endogenous neuroprotective protein in traumatic brain injury. However, the roles of Homer1a in RGCs I/R injury have not been elucidated. The present study investigated the changes in expression and effect of Homer1a in RGCs both in vitro and in vivo after I/R injury using Western blot, TUNEL assay, gene interference and overexpression, and gene knockout procedures. The levels of Homer1a and phosphorylated Erk (p-Erk) increased in RGCs and retinas after I/R injury. Upregulation of Homer1a in RGCs after I/R injury decreased the level of p-Erk, and mitigated RGCs apoptosis. Conversely, downregulation of Homer1a increased the level of p-Erk, and augmented RGCs apoptosis. Furthermore, inhibition of the p-ERK reduced RGCs apoptosis, and increased the expression of Homer 1a after I/R injury. Finally, the retinas of Homer1a KO mice treated with I/R injury had significantly less dendrites and RGCs, compared with Homer1a WT mice. These findings demonstrated that Homer1a may contribute to RGCs survival after I/R injury by interacting with Erk pathway.	[Fei, Fei; Wang, Yusheng] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 71032, Peoples R China; [Li, Juan; Rao, Wei; Liu, Wenbo; Chen, Xiaoyan; Su, Ning; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China		Wang, YS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 71032, Peoples R China.	wangys003@126.com; feizhou@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430043, 30930093]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Science and Technology Project of Shaanxi [2013KTCQ03-01]	We express our thanks to Professors Bo Xiao and Paul Worley for providing the Homer1a KO mice. This study was supported by the National Natural Science Foundation of China (Nos. 81430043 and 30930093), the National Science and Technology Major Project of China (2013ZX 09J13109-02C), the National Science and Technology Pillar Program of China (No. 2012BAI11B02), and the Science and Technology Project of Shaanxi (No. 2013KTCQ03-01).	Bek S, 2009, NEUROLOGIST, V15, P147, DOI 10.1097/NRL.0b013e3181870408; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Colucciello M, 2004, POSTGRAD MED, V116, P57, DOI 10.3810/pgm.2004.07.1558; Curran MP, 2009, DRUG AGING, V26, P169, DOI 10.2165/0002512-200926020-00008; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Duncan RS, 2005, EXP BIOL MED, V230, P527, DOI 10.1177/153537020523000803; Dvoriantchikova G, 2014, EXP EYE RES, V123, P1, DOI 10.1016/j.exer.2014.04.009; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Galan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101349; Gao S, 2014, MOL VIS, V20, P1374; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; Hwang SY, 2003, CELL CALCIUM, V34, P177, DOI 10.1016/S0143-4160(03)00082-4; Ivanov D, 2006, FEBS LETT, V580, P331, DOI 10.1016/j.febslet.2005.12.017; Joo CK, 1999, INVEST OPHTH VIS SCI, V40, P713; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kaja S, 2014, VISION RES, V94, P16, DOI 10.1016/j.visres.2013.10.018; Kammermeier PJ, 2007, P NATL ACAD SCI USA, V104, P6055, DOI 10.1073/pnas.0608991104; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Liu B, 2001, ARCH OPHTHALMOL-CHIC, V119, P240; Luo JM, 2007, EUR J NEUROSCI, V26, P828, DOI 10.1111/j.1460-9568.2007.05718.x; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Menard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028666; Miletic G, 2005, NEUROSCI LETT, V386, P189, DOI 10.1016/j.neulet.2005.06.007; Miletic G, 2009, ANESTH ANALG, V109, P2000, DOI 10.1213/ANE.0b013e3181beea9b; Miyabe T, 2006, NEUROSCI LETT, V398, P296, DOI 10.1016/j.neulet.2006.01.011; Obara I, 2013, PAIN, V154, P1932, DOI 10.1016/j.pain.2013.03.035; Park YH, 2015, EXP EYE RES, V132, P136, DOI 10.1016/j.exer.2015.01.026; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Roth S, 2003, INVEST OPHTH VIS SCI, V44, P5383, DOI 10.1167/iovs.03-0451; Schwartz M, 2003, EUR J OPHTHALMOL, V13, pS27; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Soloviev MM, 2000, J MOL BIOL, V295, P1185; Sun J, 1998, FEBS LETT, V437, P304, DOI 10.1016/S0014-5793(98)01256-3; Tanaka M, 2006, FEBS LETT, V580, P6145, DOI 10.1016/j.febslet.2006.10.013; Tappe-Theodor A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-38; Tezel G, 1999, ARCH OPHTHALMOL-CHIC, V117, P917; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Wagner KV, 2013, J NEUROSCI, V33, P3857, DOI 10.1523/JNEUROSCI.4333-12.2013; Westhoff JH, 2003, CELL CALCIUM, V34, P261, DOI 10.1016/S0143-4160(03)00112-X; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666, DOI 10.1001/archopht.118.5.666; Yao YX, 2011, ANESTH ANALG, V113, P1501, DOI 10.1213/ANE.0b013e31822c0b98; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zhang ZZ, 2011, NEUROSCI LETT, V504, P88, DOI 10.1016/j.neulet.2011.09.003	52	11	13	1	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2015	35	7					1039	1048		10.1007/s10571-015-0198-2			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CR6VP	WOS:000361486300013	25924704				2022-02-06	
J	Horng, LY; Hsu, PL; Chen, LW; Tseng, WZ; Hsu, KT; Wu, CL; Wu, RT				Horng, Lin-Yea; Hsu, Pei-Lun; Chen, Li-Wen; Tseng, Wang-Zou; Hsu, Kai-Tin; Wu, Chia-Ling; Wu, Rong-Tsun			Activating mitochondrial function and haemoglobin expression with EH-201, an inducer of erythropoietin in neuronal cells, reverses memory impairment	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							ALZHEIMERS-DISEASE; SLEEP-DEPRIVATION; TETRAHYDROXYSTILBENE GLUCOSIDE; IN-VITRO; HIPPOCAMPAL; 2,3,5,4'-TETRAHYDROXYSTILBENE-2-O-BETA-D-GLUCOSIDE; PHARMACOKINETICS; INJURY; ALPHA; BLOOD	Background and PurposeMemory impairment can be progressive in neurodegenerative diseases, and physiological ageing or brain injury, mitochondrial dysfunction and oxidative stress are critical components of these issues. An early clinical study has demonstrated cognitive improvement during erythropoietin treatment in patients with chronic renal failure. As erythropoietin cannot freely cross the blood-brain barrier, we tested EH-201 (2,3,5,4-tetrahydroxystilbene-2-O--d-glucoside, also known as TSG), a low MW inducer of erythropoietin, for its therapeutic effects on memory impairment in models of neurodegenerative diseases, physiological ageing or brain injury. Experimental ApproachThe effects of EH-201 were investigated in astrocytes and PC12 neuronal-like cells. In vivo, we used sleep-deprived (SD) mice as a stress model, amyloid- (A)-injected mice as a physiological ageing model and kainic acid (KA)-injected mice as a brain damage model to assess the therapeutic effects of EH-201. Key ResultsEH-201 induced expression of erythropoietin, PPAR- coactivator 1 (PGC-1) and haemoglobin in astrocytes and PC12 neuronal-like cells. In vivo, EH-201 treatment restored memory impairment, as assessed by the passive avoidance test, in SD, A and KA mouse models. In the hippocampus of mice given EH-201 in their diet, levels of erythropoietin, PGC-1 and haemoglobin were increased Conclusions and ImplicationsThe induction of endogenous erythropoietin in neuronal cells by inducers such as EH-201 might be a therapeutic strategy for memory impairment in neurodegenerative disease, physiological ageing or traumatic brain injury.	[Horng, Lin-Yea; Chen, Li-Wen; Tseng, Wang-Zou; Hsu, Kai-Tin; Wu, Rong-Tsun] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Horng, Lin-Yea; Hsu, Pei-Lun; Wu, Chia-Ling; Wu, Rong-Tsun] Natl Yang Ming Univ, Res Ctr Drug Discovery, Taipei 112, Taiwan; [Wu, Rong-Tsun] Kaohsiung Med Univ, Inst Nat Prod, Res Ctr Nat Prod & Drug Dev, Kaohsiung, Taiwan		Wu, RT (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Res Ctr Drug Discovery, 155,Sec 2,Linong St, Taipei 112, Taiwan.	rtwu@ym.edu.tw			Ministry of Education, Republic of China (Taiwan)Ministry of Education, Taiwan; Aim for the Top University PlanMinistry of Education, Taiwan; Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST 103-2320-B-010-016]	We are grateful for a grant from the Ministry of Education, Republic of China (Taiwan), Aim for the Top University Plan and Ministry of Science and Technology, grant MOST 103-2320-B-010-016.	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Andreazza AC, 2010, J PSYCHIATR RES, V44, P775, DOI 10.1016/j.jpsychires.2010.01.015; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Carraway MS, 2010, CIRC RES, V106, P1722, DOI 10.1161/CIRCRESAHA.109.214353; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Chou YC, 2003, NEUROCHEM INT, V43, P197, DOI 10.1016/S0197-0186(03)00003-2; Craik FIM, 2012, NEUROSCI BIOBEHAV R, V36, P1729, DOI 10.1016/j.neubiorev.2011.11.007; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; D'Almeida V, 1998, NEUROREPORT, V9, P2853, DOI 10.1097/00001756-199808240-00031; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Ehrenreich H, 2007, MOL PSYCHIATR, V12, P206, DOI 10.1038/sj.mp.4001907; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; El-Kordi A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-37; GOLDWASSER E, 1975, FED PROC, V34, P2285; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Han X, 2012, ATHEROSCLEROSIS, V225, P76, DOI 10.1016/j.atherosclerosis.2012.08.011; HARMAN D, 1992, ANN NY ACAD SCI, V673, P126, DOI 10.1111/j.1749-6632.1992.tb27444.x; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Hsu PL, 2013, BRIT J PHARMACOL, V169, P1461, DOI 10.1111/bph.12197; Huang CH, 2007, J ETHNOPHARMACOL, V114, P199, DOI 10.1016/j.jep.2007.07.034; HUBER SJ, 1987, CORTEX, V23, P275, DOI 10.1016/S0010-9452(87)80037-0; Ismail Z, 2009, DEMENT GERIATR COGN, V27, P254, DOI 10.1159/000203889; JARVIK ME, 1967, PSYCHOL REP, V21, P221, DOI 10.2466/pr0.1967.21.1.221; Juul SE, 1999, PEDIATR DEVEL PATHOL, V2, P148, DOI 10.1007/s100249900103; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lund A, 2014, EUR J CLIN INVEST, V44, P1230, DOI 10.1111/eci.12357; Lv GY, 2011, J ETHNOPHARMACOL, V137, P449, DOI 10.1016/j.jep.2011.05.049; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marden MC, 1995, TRANSFUS CLIN BIOL, V2, P473, DOI 10.1016/S1246-7820(05)80074-6; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Miyata S, 2010, NEUROSCI LETT, V469, P229, DOI 10.1016/j.neulet.2009.12.001; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Moslehi J, 2010, CIRCULATION, V122, P1004, DOI 10.1161/CIRCULATIONAHA.109.922427; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Park SH, 2011, BIOCHEM BIOPH RES CO, V408, P602, DOI 10.1016/j.bbrc.2011.04.068; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Shaskey DJ, 2000, SPORTS MED, V29, P27, DOI 10.2165/00007256-200029010-00003; Sifringer M, 2010, BRAIN BEHAV IMMUN, V24, P792, DOI 10.1016/j.bbi.2009.08.010; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun FL, 2011, EUR J PHARMACOL, V660, P283, DOI 10.1016/j.ejphar.2011.03.046; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van der Kooij MA, 2008, BRAIN RES REV, V59, P22, DOI 10.1016/j.brainresrev.2008.04.007; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Vgontzas AN, 1999, ANNU REV MED, V50, P387; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Wang R, 2007, NEUROSCIENCE, V149, P739, DOI 10.1016/j.neuroscience.2007.07.065; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Widmer CC, 2010, ANTIOXID REDOX SIGN, V12, P185, DOI 10.1089/ars.2009.2826; Zhang L, 2006, BEHAV BRAIN RES, V173, P246, DOI 10.1016/j.bbr.2006.06.034; Zhang XM, 2011, CURR NEUROPHARMACOL, V9, P388, DOI 10.2174/157015911795596540; Zhao YY, 2013, J SEP SCI, V36, P863, DOI 10.1002/jssc.201200668	75	11	11	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	OCT	2015	172	19					4741	4756		10.1111/bph.13248			16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CQ9FM	WOS:000360918200011	26177968	hybrid, Green Published			2022-02-06	
J	Yu, M; Xue, YX; Liang, WD; Zhang, YP; Zhang, ZQ				Yu, Min; Xue, Yixue; Liang, Weidi; Zhang, Yupeng; Zhang, Zhiqiang			Protection mechanism of early hyperbaric oxygen therapy in rats with permanent cerebral ischemia	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Hyperbaric oxygen therapy; Cerebrovascular protection; Cerebral ischemic rats	TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; ALPHA; NEUROPROTECTION; INFARCTION; MICE; PKC	[Purpose] The purpose of this study was to investigate whether early hyperbaric oxygen is useful in rats with permanent cerebral ischemia, and whether its mechanism relates to the inhibition of the tumor necrosis factor-alpha-protein kinase C-alpha pathway. [Subjects] Healthy, male Sprague-Dawley rats (N = 108) were the subjects. [Methods] After middle cerebral artery occlusion models were successfully made, rats were randomly divided into sham-operated, cerebral ischemia, and hyperbaric oxygen groups. At 4 and 12 hours after modeling, the volume of cerebral infarction was determined by triphenyltetrazolium chloride staining, and brain water content was measured using the dry and wet method. The expression of tumor necrosis factor-alpha and protein kinase C-alpha in the ischemic penumbra tissue was measured using Western blot analysis. [Results] The data showed that at 4 and 12 hours after modeling, cerebral infarct volume and brain water content decreased in the hyperbaric oxygen group, and expression of tumor necrosis factor-alpha and phospho-protein kinase C-alpha in the ischemic penumbra tissue also decreased. [Conclusion] Our study demonstrates that early hyperbaric oxygen therapy has protective effects on brain tissue after cerebral ischemia, possibly via inhibition of tumor necrosis factor-alpha and phospho-protein kinase C-alpha.	[Yu, Min; Liang, Weidi; Zhang, Yupeng; Zhang, Zhiqiang] China Med Univ, Shengjing Hosp, Dept Rehabil, Shenyang 110022, Liaoning, Peoples R China; [Xue, Yixue] China Med Univ, Coll Basic Med Sci, Dept Neurobiol, Shenyang 110022, Liaoning, Peoples R China		Zhang, ZQ (corresponding author), China Med Univ, Shengjing Hosp, Dept Rehabil, 39 Huaxiang Rd, Shenyang 110022, Liaoning, Peoples R China.	zhangzq@sj-hospital.org					Badr AE, 2001, AM J PHYSIOL-REG I, V280, pR766, DOI 10.1152/ajpregu.2001.280.3.R766; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; CORKILL G, 1985, SURG NEUROL, V24, P206, DOI 10.1016/0090-3019(85)90186-7; Dong Y, 2015, J PHYS THER SCI, V27, P1295, DOI 10.1589/jpts.27.1295; Gong C, 1998, BRAIN RES, V801, P1, DOI 10.1016/S0006-8993(98)00489-2; Lee JY, 2000, J BIOL CHEM, V275, P29290, DOI 10.1074/jbc.M000170200; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lou M, 2007, NEUROSCIENCE, V146, P555, DOI 10.1016/j.neuroscience.2007.01.046; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Michalski D, 2011, ACTA NEUROL SCAND, V123, P85, DOI 10.1111/j.1600-0404.2010.01363.x; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; REITAN JA, 1990, STROKE, V21, P119, DOI 10.1161/01.STR.21.1.119; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Schabitz WR, 2004, STROKE, V35, P1175, DOI 10.1161/01.STR.0000125868.86298.8e; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; TAKAGI K, 1993, J CEREBR BLOOD F MET, V13, P575, DOI 10.1038/jcbfm.1993.75	19	11	15	0	3	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	OCT	2015	27	10					3271	3274		10.1589/jpts.27.3271			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	CW6UH	WOS:000365133000056	26644690	Green Published, gold, Green Submitted			2022-02-06	
J	Morrow, BM; Argent, AC; Kling, S				Morrow, Brenda M.; Argent, Andrew C.; Kling, Sharon			Informed consent in paediatric critical care research - a South African perspective	BMC MEDICAL ETHICS			English	Article							RANDOMIZED CONTROLLED-TRIALS; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; CLINICAL-TRIALS; RESUSCITATION RESEARCH; EMERGENCY RESEARCH; VOLUNTARY CONSENT; DEFERRED CONSENT; ILL CHILDREN; PATIENT COMPREHENSION	Background: Medical care of critically ill and injured infants and children globally should be based on best research evidence to ensure safe, efficacious treatment. In South Africa and other low and middle-income countries, research is needed to optimise care and ensure rational, equitable allocation of scare paediatric critical care resources. Ethical oversight is essential for safe, appropriate research conduct. Informed consent by the parent or legal guardian is usually required for child research participation, but obtaining consent may be challenging in paediatric critical care research. Local regulations may also impede important research if overly restrictive. By narratively synthesising and contextualising the results of a comprehensive literature review, this paper describes ethical principles and regulations; potential barriers to obtaining prospective informed consent; and consent options in the context of paediatric critical care research in South Africa. Discussion: Voluntary prospective informed consent from a parent or legal guardian is a statutory requirement for child research participation in South Africa. However, parents of critically ill or injured children might be incapable of or unwilling to provide the level of consent required to uphold the ethical principle of autonomy. In emergency care research it may not be practical to obtain consent when urgent action is required. Therapeutic misconceptions and sociocultural and language issues are also barriers to obtaining valid consent. Alternative consent options for paediatric critical care research include a waiver or deferred consent for minimal risk and/or emergency research, whilst prospective informed consent is appropriate for randomised trials of novel therapies or devices. Summary: We propose that parents or legal guardians of critically ill or injured children should only be approached to consent for their child's participation in clinical research when it is ethically justifiable and in the best interests of both child participant and parent. Where appropriate, alternatives to prospective informed consent should be considered to ensure that important paediatric critical care research can be undertaken in South Africa, whilst being cognisant of research risk. This document could provide a basis for debate on consent options in paediatric critical care research and contribute to efforts to advocate for South African law reform.	[Morrow, Brenda M.; Kling, Sharon] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Ctr Med Eth & Law, ZA-8000 Cape Town, South Africa; [Argent, Andrew C.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, ZA-7700 Cape Town, South Africa; [Argent, Andrew C.] Red Cross War Mem Childrens Hosp, Paediat Intens Care Unit, ZA-7700 Cape Town, South Africa; [Kling, Sharon] Univ Stellenbosch, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-8000 Cape Town, South Africa		Morrow, BM (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Ctr Med Eth & Law, POB 241, ZA-8000 Cape Town, South Africa.	Brenda.morrow@uct.ac.za	Morrow, Brenda/AAI-3819-2020; Argent, Andrew/J-1605-2019	Morrow, Brenda/0000-0001-5193-918X; Argent, Andrew/0000-0001-9333-2036; Kling, Sharon/0000-0002-4498-1811	Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC); Office of AIDS Research, OD; National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25 TW 008981]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R25TW008981] Funding Source: NIH RePORTER	Research reported in this publication was supported by the Fogarty International Center and Office of AIDS Research, OD and National Institute of Allergy and Infectious Diseases and the National Institutes of Health under Award Number R25 TW 008981 to the ARESA Project.	Adde M., 2013, CANC CONTROL, P27; [Anonymous], 1979, BELM REP ETH PRINC G; Appelbaum Paul S., 2002, American Journal of Bioethics, V2, P22, DOI 10.1162/152651602317533596; Argent AC, 2014, PEDIATR CRIT CARE ME, V15, P7, DOI 10.1097/PCC.0000000000000029; Baines P, 2008, J MED ETHICS, V34, P141, DOI 10.1136/jme.2006.018747; Baren JM, 2005, ACAD EMERG MED, V12, P1071, DOI 10.1197/j.aem.2005.06.020; Bernard GR, 2004, AM J RESP CRIT CARE, V170, P1375, DOI 10.1164/rccm.200406-726ST; Bhagwanjee S, 2007, SAMJ S AFR MED J, V97, P1311; Bland M, 1997, BRIT MED J, V314, P1477; Board R, 2000, Am J Crit Care, V9, P106; Board R, 2002, HEART LUNG, V31, P53, DOI 10.1067/mhl.2002.121246; Board Rhonda, 2003, J Pediatr Nurs, V18, P195, DOI 10.1053/jpdn.2003.38; Brierley J, 2011, J MED ETHICS, V37, P429, DOI 10.1136/jme.2010.040667; Brierley J, 2010, ARCH DIS CHILD, V95, P863, DOI 10.1136/adc.2009.179762; Brierley J, 2009, ARCH DIS CHILD, V94, P651, DOI 10.1136/adc.2008.155317; Brody H, 2013, HASTINGS CENT REP, V43, P41, DOI 10.1002/hast.199; Bull S, 2011, AM J BIOETHICS, V11, P27, DOI 10.1080/15265161.2011.585272; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Cameron Melissa A, 2011, IRB, V33, P6; Childress JF, 1985, GENETICS LAW 3; Crow K, 2000, J NURS ADMIN, V30, P148, DOI 10.1097/00005110-200003000-00007; *DEP HLTH, 2004, ETH HLTH RES PRINC S; Desai S, 2005, A FOCUS ON GENDER; Durand-Zaleski IS, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.023473; Eberly T W, 1985, CCQ, V8, P57; Eltorki M, 2013, ACAD EMERG MED, V20, P822, DOI 10.1111/acem.12180; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; FREEDMAN B, 1993, HASTINGS CENT REP, V23, P13, DOI 10.2307/3562813; Freer Y, 2009, PEDIATRICS, V123, P1301, DOI 10.1542/peds.2007-3860; Gamble T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035982, 10.1371/journal.pone.0039429]; Gefenas E, 2007, SCI ENG ETHICS, V13, P281, DOI 10.1007/s11948-007-9029-2; Halila R, 2007, SCI ENG ETHICS, V13, P305, DOI 10.1007/s11948-007-9026-5; Hayes J S, 2000, Int J Trauma Nurs, V6, P88, DOI 10.1067/mtn.2000.107881; Hoffman TM, 2007, PEDIATR CARDIOL, V28, P167, DOI 10.1007/s00246-006-0020-5; Huckabay L M, 1999, Dimens Crit Care Nurs, V18, P36, DOI 10.1097/00003465-199903000-00009; Human Sciences Research Council, 2012, GUID RES MIN; IJSSELMUIDEN CB, 1992, NEW ENGL J MED, V326, P830, DOI 10.1056/NEJM199203193261212; Iserson K V, 1995, J Emerg Med, V13, P563, DOI 10.1016/0736-4679(95)80021-2; Jansen TC, 2007, INTENS CARE MED, V33, P894, DOI 10.1007/s00134-007-0580-8; Jansen TC, 2010, INTENS CARE MED, V36, P1962, DOI 10.1007/s00134-010-1988-0; Jansen TG, 2009, CRIT CARE MED, V37, pS65, DOI 10.1097/CCM.0b013e3181920851; Joffe Steven, 2014, IRB, V36, P16; Johnson-Greene D, 2010, J HEAD TRAUMA REHAB, V25, P145, DOI 10.1097/HTR.0b013e3181d8287d; Kanthimathinathan HK, 2014, ARCH DIS CHILD, V99, P1043, DOI 10.1136/archdischild-2013-304871; KASPER JW, 1988, HEART LUNG, V17, P574; Knox Christina A, 2007, J Pediatr Nurs, V22, P310, DOI 10.1016/j.pedn.2007.02.004; Koogler Tracy, 2012, Virtual Mentor, V14, P797, DOI 10.1001/virtualmentor.2012.14.10.pfor1-1210; LaMontagne L L, 1994, Clin Nurs Res, V3, P104, DOI 10.1177/105477389400300204; Lantos JD, 1999, J PEDIATR-US, V134, P130, DOI 10.1016/S0022-3476(99)70400-2; Lema V M, 2009, East Afr Med J, V86, P133; Magnus D, 2013, NEW ENGL J MED, V368, P1864, DOI 10.1056/NEJMp1305086; Maitland K, 2012, LANCET, V379, P613, DOI 10.1016/S0140-6736(12)60260-8; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Maitland K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-90; Majdalani MN, 2014, INT J NURS STUD, V51, P217, DOI 10.1016/j.ijnurstu.2013.06.001; Manning DJ, 2000, J MED ETHICS, V26, P249, DOI 10.1136/jme.26.4.249; Mason S, 1997, ARCH DIS CHILD-FETAL, V76, pF143, DOI 10.1136/fn.76.3.F143; McRae AD, 2005, ACAD EMERG MED, V12, P1104, DOI 10.1197/j.aem.2005.04.005; McRae AD, 2002, CRIT CARE MED, V30, P1146, DOI 10.1097/00003246-200205000-00032; Menon K, 2014, J MED ETHICS, V40, P123, DOI 10.1136/medethics-2012-101075; Menon K, 2012, INTENS CARE MED, V38, P153, DOI 10.1007/s00134-011-2412-0; Miles M S, 1989, Matern Child Nurs J, V18, P181; Miles M S, 1989, Matern Child Nurs J, V18, P199; Miller FG, 2007, HASTINGS CENT REP, V37, P24, DOI 10.1353/hcr.2007.0044; Miller VA, 2011, J PEDIATR PSYCHOL, V36, P1102, DOI 10.1093/jpepsy/jsr033; Miller VA, 2011, MED DECIS MAKING, V31, P730, DOI 10.1177/0272989X11398666; Molyneux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054894; Morris AD, 2000, CRIT CARE MED, V28, P1152, DOI 10.1097/00003246-200004000-00039; Morris MC, 2007, CRIT CARE MED, V35, P940, DOI 10.1097/01.CCM.0000257333.95528.B8; Morris MC, 2006, CRIT CARE MED, V34, P2567, DOI 10.1097/01.CCM.0000239115.76603.55; Morris MC, 2004, PEDIATRICS, V114, P776, DOI 10.1542/peds.2004-0482; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Neill Sarah J, 2005, J Child Health Care, V9, P46, DOI 10.1177/1367493505049646; Nelson RM, 2011, AM J BIOETHICS, V11, P6, DOI 10.1080/15265161.2011.583318; Nichol G, 2006, RESUSCITATION, V70, P360, DOI 10.1016/j.resuscitation.2006.01.020; Nienaber A, 2013, SAJP-S AFR J PSYCHI, V19, P19, DOI 10.7196/SAJP.386; Nijhawan LP, 2013, J ADV PHARM TECHNOL, V4, P134, DOI 10.4103/2231-4040.116779; Nuffield Council of Bioethics, 2015, CHILDR CLIN RES ETH; Oduro AR, 2008, BMC MED ETHICS; Preziosi MP, 1997, NEW ENGL J MED, V336, P370, DOI 10.1056/NEJM199701303360511; Raymond TT, 2010, PEDIATRICS, V125, pE866, DOI 10.1542/peds.2009-2427; Rischbieth A, 2005, Crit Care Resusc, V7, P310; Roberts R, 2003, JAMA-J AM MED ASSOC, V290, P905, DOI 10.1001/jama.290.7.905; Sachdeva T, 2013, PEDIATRICS, V132, pE1302, DOI 10.1542/peds.2013-1700; SCHULTZ AL, 1975, WESTERN J MED, V123, P76; Shaul RZ, 2005, CRIT CARE, V9, P123, DOI 10.1186/cc3037; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Sibley A, 2012, J MED ETHICS, V38, P3, DOI 10.1136/medethics-2011-100317; Silverman H, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-8; Silverman HJ, 2006, INTENS CARE MED, V32, P1697, DOI 10.1007/s00134-006-0305-4; Silverman HJ, 2005, CRIT CARE MED, V33, P867, DOI 10.1097/01.CCM.0000159201.08203.10; South African Department of Health, 2006, GUID GOOD PRACT COND; Strode A, 2014, S AFR J HIV MED, V15, P46, DOI [10.7196/sajhivmed.1014, 10.7196/SAJHIVMED.1014]; Strode A, 2010, SAMJ S AFR MED J, V100, P247, DOI 10.7196/SAMJ.3609; Sturdivant L, 2009, CRIT CARE NURS Q, V32, P149, DOI 10.1097/CNQ.0b013e3181a27f6d; TANKANOW RM, 1992, AM J HOSP PHARM, V49, P633, DOI 10.1093/ajhp/49.3.633; Tindana P, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-15; Truog RD, 1999, CRIT CARE, V3, pR29, DOI 10.1186/cc347; Truog RD, 2008, INTENS CARE MED, V34, P198, DOI 10.1007/s00134-007-0917-3; UK Medical Research Council, 2004, MRC ETH GUID MED RES MRC ETH GUID MED RES; van As AB, 2006, SAMJ S AFR MED J, V96, P874; Vukoja M, 2014, GLOB HEART, V9, P337, DOI 10.1016/j.gheart.2014.08.002; Weijer C, 2004, CRIT CARE, V8, P85, DOI 10.1186/cc2822; Wendler D, 2012, AM J BIOETHICS, V12, P23, DOI 10.1080/15265161.2011.634482; Wendler DS, 2006, J MED ETHICS, V32, P229, DOI 10.1136/jme.2004.011114; Wertheimer A, 2012, J MED PHILOS, V37, P226, DOI 10.1093/jmp/jhs016; Woods S, 2013, BIOETHICS, V27, P243, DOI 10.1111/j.1467-8519.2011.01945.x; Woolfall K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067352; World Medical Association, 2013, WMA DECL HELS ETH PR; Young Daniel R, 1990, IRB, V12, P1, DOI 10.2307/3564107; Yuval R, 2003, CARDIOLOGY, V99, P68, DOI 10.1159/000069729; Yuval R, 2000, ARCH INTERN MED, V160, P1142, DOI 10.1001/archinte.160.8.1142; Zawistowski CA, 2003, CRIT CARE MED, V31, pS407, DOI 10.1097/01.CCM.0000065274.46402.DB	114	11	11	0	18	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6939			BMC MED ETHICS	BMC Med. Ethics	SEP 9	2015	16									10.1186/s12910-015-0052-6			13	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	CR4CR	WOS:000361279900001	26354389	Green Published, gold			2022-02-06	
J	Anderson, GD; Peterson, TC; Haar, CV; Farin, FM; Bammler, TK; MacDonald, JW; Kantor, ED; Hoane, MR				Anderson, Gail D.; Peterson, Todd C.; Haar, Cole Vonder; Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.; Kantor, Eric D.; Hoane, Michael R.			Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model	AAPS JOURNAL			English	Article						anakinra; erythropoietin; hepatic metabolism; traumatic brain injury	NF-KAPPA-B; GENE-EXPRESSION; HEAD-INJURY; FUNCTIONAL RECOVERY; MESSENGER-RNA; NEUROPROTECTION; PHARMACOKINETICS; INFLAMMATION; INTERLEUKIN-10; INHIBITOR	In contrast to considerable data demonstrating a decrease in cytochrome P450 (CYP) activity in inflammation and infection, clinically, traumatic brain injury (TBI) results in an increase in CYP and UDP glucuronosyltransferase (UGT) activity. The objective of this study was to determine the effects of TBI alone and with treatment with erythropoietin (EPO) or anakinra on the gene expression of hepatic inflammatory proteins, drug-metabolizing enzymes, and transporters in a cortical contusion impact (CCI) injury model. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24 h, 72 h, and 7 days post-CCI. Plasma cytokine and liver protein concentrations of CYP2D4, CYP3A1, EPHX1, and UGT2B7 were determined. There was no effect of TBI, TBI+EPO, or TBI+ anakinra on gene expression of the inflammatory factors shown to be associated with decreased expression of hepatic metabolic enzymes in models of infection and inflammation. IL-6 plasma concentrations were increased in TBI animals and decreased with EPO and anakinra treatment. There was no significant effect of TBI and/or anakinra on gene expression of enzymes or transporters known to be involved in drug disposition. TBI+ EPO treatment decreased the gene expression of Cyp2d4 at 72 h with a corresponding decrease in CYP2D4 protein at 72 h and 7 days. CYP3A1 protein was decreased at 24 h. In conclusion, EPO treatment may result in a significant decrease in the metabolism of Cyp-metabolized drugs. In contrast to clinical TBI, there was not a significant effect of experimental TBI on CYP or UGT metabolic enzymes.	[Anderson, Gail D.; Kantor, Eric D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Peterson, Todd C.; Haar, Cole Vonder; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Carbondale, IL 62901 USA; [Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Seattle, WA 98195 USA.	gaila@washington.edu		Vonder Haar, Cole/0000-0001-7949-2068; Hoane, Michael/0000-0001-7779-2657	National Institutes of Health/National Institute of Child, Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; NIEHS Center for Ecogenetics & Environmental Health [P30ES007033]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER	The research was supported by a grant from the National Institutes of Health/National Institute of Child, Health and Development (R01 HD061944-01) and by the NIEHS Center for Ecogenetics & Environmental Health (P30ES007033).	Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; Anderson GD, 2007, CLIN PHARMACOKINET, V46, P307, DOI 10.2165/00003088-200746040-00004; Anderson GD, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00129; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; ANDERSON GD, 1994, BRIT J CLIN PHARMACO, V37, P559, DOI 10.1111/j.1365-2125.1994.tb04304.x; Anderson GD, 1998, BRIT J CLIN PHARMACO, V45, P101, DOI 10.1046/j.1365-2125.1998.00652.x; ASADULLAH K, 1995, CRIT CARE MED, V23, P1976, DOI 10.1097/00003246-199512000-00006; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Boogaerts M, 2006, CURR MED RES OPIN S4, V22, pS15, DOI DOI 10.1185/030079906X159588; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; CHEN YL, 1994, CLIN PHARMACOL THER, V55, P649, DOI 10.1038/clpt.1994.82; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Falany CN, 1995, ANN NY ACAD SCI, V774, P59, DOI 10.1111/j.1749-6632.1995.tb17372.x; FAN L, 1995, MOL BRAIN RES, V30, P125; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Gorski JC, 2000, CLIN PHARMACOL THER, V67, P32, DOI 10.1067/mcp.2000.103860; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Harbrecht BG, 2005, CRIT CARE MED, V33, P541, DOI 10.1097/01.ccm.0000155989.54344.E0; Harris TR, 2013, GENE, V526, P61, DOI 10.1016/j.gene.2013.05.008; Hiroi T, 1998, BBA-GEN SUBJECTS, V1380, P305, DOI 10.1016/S0304-4165(97)00157-8; Huhn RD, 1996, BLOOD, V87, P699, DOI 10.1182/blood.V87.2.699.bloodjournal872699; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Ishii Y, 2012, BIOL PHARM BULL, V35, P1811, DOI 10.1248/bpb.b12-00568; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147; Kovacs EJ, 2004, MECH AGEING DEV, V125, P121, DOI 10.1016/j.mad.2003.11.007; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Poloyac SM, 2001, DRUG METAB DISPOS, V29, P296; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; RENTON KW, 1976, BIOCHEM BIOPH RES CO, V73, P343, DOI 10.1016/0006-291X(76)90713-0; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Seekamp A, 2002, EUR J TRAUMA, V28, P83; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TOLER SM, 1993, DRUG METAB DISPOS, V21, P1064; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283	55	11	12	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1550-7416			AAPS J	AAPS J.	SEP	2015	17	5					1255	1267		10.1208/s12248-015-9792-y			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CQ1NN	WOS:000360364500020	26068867	Green Published, Bronze			2022-02-06	
J	Avantaggiato, P; Molteni, E; Formica, F; Gigli, GL; Valente, M; Lorenzut, S; de Biase, S; Arcieri, S; Locatelli, F; Strazzer, S				Avantaggiato, Paolo; Molteni, Erika; Formica, Francesca; Gigli, Gian Luigi; Valente, Mariarosaria; Lorenzut, Simone; de Biase, Stefano; Arcieri, Salvatore; Locatelli, Federica; Strazzer, Sandra			Polysomnographic Sleep Patterns in Children and Adolescents in Unresponsive Wakefulness Syndrome	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury prognosis; electroencephalography; encephalopathy; pediatric brain injury; pediatric brain tumor; persistent vegetative state; polysomnography; unresponsive wakefulness syndrome	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; VEGETATIVE STATE; PROGNOSTIC VALUE; EVOKED-POTENTIALS; CONSCIOUSNESS; RECOVERY; SPINDLES; CYCLE	Objectives: We aimed (i) to search for qualitative sleep patterns for pediatric unresponsive wakefulness syndrome (SPPUWS) in prolonged polysomnographic (PSG) recordings in children and adolescents with subacute severe disorders of consciousness due to an acquired brain damage; (ii) to investigate the clinical relevance of SPPUWS and of possible neurophysiological markers (rapid eye movement sleep and sleep spindles) in PSG recordings of pediatric patients with unresponsive wakefulness syndrome (UWS). Methods: We performed a PSG study in 27 children with UWS due to acquired brain damage in the subacute phase. Patients received a full neurological examination and a clinical assessment with standardized scales. In addition, outcome was assessed after 36 months. Results: We identified 6 PSG patterns (SPPUWS) corresponding to increasing neuroelectrical complexity. The presence of an organized sleep pattern, as well as rapid eye movement sleep and sleep spindles, in the subacute stage appeared highly predictive of a more favorable outcome. Correlation was found between SPPUWS and recovery, as assessed by several clinical and rehabilitation scales. Conclusions: Polysomnography can be used as a prognostic tool, as it can help determine the capability to recover from a pediatric UWS and predict outcome well before the confirmation provided by suitable clinical scales.	[Avantaggiato, Paolo; Molteni, Erika; Formica, Francesca; Arcieri, Salvatore; Locatelli, Federica; Strazzer, Sandra] Sci Inst Eugenio Medea, Acquired Brain Injury Unit, Bosisio Parini, Lecco, Italy; [Gigli, Gian Luigi; Valente, Mariarosaria] Univ Udine, Sch Med, Dept Expt & Clin Med, I-33100 Udine, Italy; [Lorenzut, Simone; de Biase, Stefano] Santa Maria della Misericordia Univ Hosp, Neurol Unit, Udine, Italy; [Lorenzut, Simone; de Biase, Stefano] Santa Maria della Misericordia Univ Hosp, Ctr Sleep Med, Udine, Italy		Molteni, E (corresponding author), Sci Inst E Medea, Acquired Brain Injury Unit, Via Don Luigi Monza 20, I-23842 Bosisio Parini, Lecco, Italy.	erika.molteni@gmail.com	Valente, Mariarosaria/AAC-4798-2022; Strazzer, Sandra/AAH-5712-2019; AVANTAGGIATO, PAOLO/AAA-6387-2020; FEDERICA, LOCATELLI/AAA-5601-2020; Gigli, Gian Luigi/AAC-4781-2022; formica, francesca/AAA-6043-2020; Molteni, Erika/P-4564-2016	Strazzer, Sandra/0000-0001-8414-6565; AVANTAGGIATO, PAOLO/0000-0002-6076-6812; FEDERICA, LOCATELLI/0000-0002-8243-5483; Molteni, Erika/0000-0001-7773-8140; GIGLI, Gian Luigi/0000-0003-3526-1414; VALENTE, Mariarosaria/0000-0001-6077-1315; formica, francesca/0000-0002-4423-8200	Italian Department of Health	This study was supported by the Italian Department of Health (Ricerca Corrente 2008-2009, Bando Ricerca Finalizzata 2008). The authors acknowledge Drs Katia Colombo, Valentina Pastore, and Federica Villa for their flawless assistance in the clinical scale administration.	American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; Aneja S., 2005, Indian Journal of Pediatrics, V72, P687, DOI 10.1007/BF02724078; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Cabello B, 2007, CURR OPIN CRIT CARE, V13, P20, DOI 10.1097/MCC.0b013e3280121adc; Cheliout-Heraut F, 2001, NEUROPHYSIOL CLIN, V31, P283, DOI 10.1016/S0987-7053(01)00270-2; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; Cologan V, 2010, SLEEP MED REV, V14, P97, DOI 10.1016/j.smrv.2009.04.003; Constant I, 2012, PEDIATR ANESTH, V22, P539, DOI 10.1111/j.1460-9592.2012.03883.x; COONS S, 1984, DEV MED CHILD NEUROL, V26, P169; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; D'Aleo G, 1994, Funct Neurol, V9, P189; DALEO G, 1994, ITAL J NEUROL SCI, V15, P347, DOI 10.1007/BF02339931; de Biase S, 2014, SLEEP MED, V15, P393, DOI 10.1016/j.sleep.2013.09.026; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Evans BM, 2003, NEUROPHYSIOL CLIN, V33, P1, DOI 10.1016/S0987-7053(03)00002-9; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Fingelkurts AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025967; Fingelkurts AA, 2013, NEUROREHAB NEURAL RE, V27, P345, DOI 10.1177/1545968312469836; Flannery J, 1993, Appl Nurs Res, V6, P167; Fukudome Y, 1996, AM J PHYSIOL-REG I, V270, pR1109, DOI 10.1152/ajpregu.1996.270.5.R1109; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIUBILEI F, 1995, J NEUROL NEUROSUR PS, V58, P484, DOI 10.1136/jnnp.58.4.484; GORDON CR, 1993, ELECTROEN CLIN NEURO, V86, P132, DOI 10.1016/0013-4694(93)90085-A; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Himanen SL, 2000, SLEEP MED REV, V4, P149, DOI 10.1053/smrv.1999.0086; HULIHAN JF, 1994, NEUROLOGY, V44, P758, DOI 10.1212/WNL.44.4.758; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1981, MANAGEMENT HEAD INJU, P317; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KOHYAMA J, 1986, BRAIN DEV-JPN, V8, P583, DOI 10.1016/S0387-7604(86)80003-1; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Laureys S, 2008, NAT CLIN PRACT NEURO, V4, P544, DOI 10.1038/ncpneuro0887; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Oksenberg A, 2000, SLEEP, V23, P953; Oksenberg A, 2001, SLEEP, V24, P703, DOI 10.1093/sleep/24.6.703; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pattoneri Paolo, 1800, J Clin Hypertens (Greenwich), V7, P734, DOI 10.1111/j.1524-6175.2005.04780.x; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rechtschaffen A., 1968, MANUAL STANDARDIZED; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Royal College of Physicians, 2003, PERM VEG STAT GUID D; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Scher MS, 2005, PEDIATR RES, V57, P879, DOI 10.1203/01.PDR.0000157678.84132.A8; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Villa F, 2015, J CHILD NEUROL, V30, P1125, DOI 10.1177/0883073814553798; Watson PL, 2013, CRIT CARE MED, V41, P1958, DOI 10.1097/CCM.0b013e31828a3f75; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	59	11	14	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					334	346		10.1097/HTR.0000000000000122			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400011	25699626				2022-02-06	
J	Dobryakova, E; Boukrina, O; Wylie, GR				Dobryakova, Ekaterina; Boukrina, Olga; Wylie, Glenn R.			Investigation of Information Flow During a Novel Working Memory Task in Individuals with Traumatic Brain Injury	BRAIN CONNECTIVITY			English	Article						attention; capacity; effective connectivity; fMRI; fronto-parietal network; manipulation; TBI; working memory		Working memory (WM) is often compromised after traumatic brain injury (TBI). A number of functional and effective connectivity studies investigated the interaction between brain regions during WM task performance. However, previously used WM tasks did not allow differentiation of WM subprocesses such as capacity and manipulation. We used a novel WM paradigm, CapMan, to investigate effective connectivity associated with the capacity and manipulation subprocesses of WM in individuals with TBI relative to healthy controls (HCs). CapMan allows independent investigation of brain regions associated with capacity and manipulation, while minimizing the influence of other WM-related subprocesses. Areas of the fronto-parietal WM network, previously identified in healthy individuals as engaged in capacity and manipulation during CapMan, were analyzed with the Independent Multiple-sample Greedy Equivalence Search (IMaGES) method to investigate the differences in information flow between healthy individuals and individuals with TBI. We predicted that diffuse axonal injury that often occurs after TBI might lead to changes in task-based effective connectivity and result in hyper-connectivity between the regions engaged in task performance. In accordance with this hypothesis, TBI participants showed greater inter-hemispheric connectivity and less coherent information flow from posterior to anterior brain regions compared with HC participants. Thus, this study provides much needed evidence about the potential mechanism of neurocognitive impairments in individuals affected by TBI.	[Dobryakova, Ekaterina; Wylie, Glenn R.] Kessler Fdn, W Orange, NJ USA; [Dobryakova, Ekaterina; Wylie, Glenn R.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Boukrina, Olga] Rutgers New Jersey Med Sch, Dept Psychol, Newark, NJ USA; [Wylie, Glenn R.] War Related Illness & Injury Study Ctr, Dept Vet Affairs, E Orange, NJ USA		Wylie, GR (corresponding author), Kessler Fdn, Neuropsychol & Neurosci Lab, 300 Execut Dr,Suite 70, W Orange, NJ 07052 USA.	gwylie@kesslerfoundation.org	Boukrina, Olga/Y-7162-2019; Dobryakova, Ekaterina/ABD-2853-2021	Boukrina, Olga/0000-0003-4298-2893; Dobryakova, Ekaterina/0000-0002-6005-2115	Kessler Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R42NS050007-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R42NS050007] Funding Source: NIH RePORTER	This project was supported by grants from the Kessler Foundation and from the National Institutes of Health (1R42NS050007-02 to Dr. Randall Barbour).	Anteraper SA, 2013, BRAIN CONNECT, V3, P302, DOI 10.1089/brain.2012.0113; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bledowski C, 2010, BEHAV BRAIN RES, V214, P172, DOI 10.1016/j.bbr.2010.05.041; Boukrina O, 2014, HUM BRAIN MAPP, V35, P2543, DOI 10.1002/hbm.22348; Boukrina O, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00518; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dobryakova E, 2014, BRAIN IMAGING BEHAV, V8, P475, DOI 10.1007/s11682-013-9282-8; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Hanson C, 2013, BRAIN CONNECT, V3, P578, DOI 10.1089/brain.2013.0161; Hillary FG, 2014, BRAIN IMAGING BEHAV, V8, P435, DOI 10.1007/s11682-012-9205-0; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Jolles DD, 2010, NEUROIMAGE, V52, P658, DOI 10.1016/j.neuroimage.2010.04.028; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Koch K, 2006, BRAIN RES, V1107, P140, DOI 10.1016/j.brainres.2006.06.003; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhn S, 2013, HUM BRAIN MAPP, V34, P1530, DOI 10.1002/hbm.22007; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levy R, 1997, J NEUROSCI, V17, P3870; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mumford JA, 2014, NEUROIMAGE, V86, P573, DOI 10.1016/j.neuroimage.2013.10.020; Narayanan NS, 2005, NEUROPSYCHOLOGY, V19, P223, DOI 10.1037/0894-4105.19.2.223; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Ramsey JD, 2014, NEUROIMAGE, V84, P986, DOI 10.1016/j.neuroimage.2013.09.062; Ramsey JD, 2011, NEUROIMAGE, V58, P838, DOI 10.1016/j.neuroimage.2011.06.068; Satterthwaite TD, 2012, NEUROIMAGE, V61, P723, DOI 10.1016/j.neuroimage.2012.03.060; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y	43	11	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	SEP	2015	5	7			SI		433	441		10.1089/brain.2014.0283			9	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VG7GK	WOS:000448203700004	25490432	Green Published			2022-02-06	
J	Johanssen, T; Suphantarida, N; Donnelly, PS; Liu, XM; Petrou, S; Hill, AF; Barnham, KJ				Johanssen, Timothy; Suphantarida, Nuttawat; Donnelly, Paul S.; Liu, Xiang M.; Petrou, Steven; Hill, Andrew F.; Barnham, Kevin J.			PBT2 inhibits glutamate-induced excitotoxicity in neurons through metal-mediated preconditioning	NEUROBIOLOGY OF DISEASE			English	Article						Excitotoxicity; Zinc; Calcium flux; Huntington's disease (HD); Alzheimer's disease (AD)	A-BETA OLIGOMERS; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; PRION PROTEIN; UP-REGULATION; NMDA; ACTIVATION; MODEL; NEUROPROTECTION	Excitotoxicity is the pathological process by which neuronal death occurs as a result of excessive stimulation of receptors at the excitatory synapse such as the NMDA receptor (NMDAR). Excitotoxicity has been implicated in the acute neurological damage from ischemia and traumatic brain injury and in the chronic neurodegeneration in Alzheimer's disease (AD) and Huntington's disease (HD). As a result NMDAR antagonists have become an attractive therapeutic strategy for the potential treatment of multiple neurodegenerative diseases. However NMDAR signaling is dichotomous in nature, with excessive increases in neuronal intracellular calcium through excessive NMDAR activity being lethal but moderate increases to intracellular calcium levels during normal synaptic function providing neuroprotection. Subsequently indiscriminant inhibition of this receptor is best avoided as was concluded from previous clinical trials of NMDAR antagonists. We show that the metal chaperone, PBT2, currently in clinical trials for HD, is able to protect against glutamate-induced excitotoxicity mediated through NMDARs. This was achieved by PBT2 inducing Zn2+-dependent increases in intracellular Ca2+ levels resulting in preconditioning of neurons and inhibition of Ca2+-induced neurotoxic signaling cascade involving calpain-activated cleavage of calcineurin. Our study demonstrates that modulating intracellular Ca2+ levels by a zinc ionophore is a valid therapeutic strategy to protect against the effects of excitotoxicity thought to underlie both acute and chronic neurodegenerative diseases. (C) 2015 Elsevier Inc. All rights reserved.	[Johanssen, Timothy] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Johanssen, Timothy; Suphantarida, Nuttawat; Liu, Xiang M.; Petrou, Steven; Barnham, Kevin J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Johanssen, Timothy; Donnelly, Paul S.; Liu, Xiang M.; Hill, Andrew F.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Suphantarida, Nuttawat; Petrou, Steven] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3010, Australia; [Suphantarida, Nuttawat; Petrou, Steven] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3010, Australia; [Donnelly, Paul S.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia		Johanssen, T (corresponding author), Univ Melbourne, Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	jot@unimelb.edu.au; kbarnham@unimelb.edu.au	Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Petrou, Steven/0000-0002-4960-6375	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [628946, APP1002373, APP1031193, 628952, 100505]; Victorian Government through the Operational Infrastructure Scheme; National Health & Medical Research CouncilNational Health and Medical Research Council of Australia; Commonwealth Scientific & Industrial Research Organisation of Australia	This work was supported by the National Health and Medical Research Council of Australia (Program Grant 628946 to AFH, KJB: Senior Research Fellowship APP1002373 to KJB, Project Grant APP1031193 to KJB, PSD Program Grant 628952 and Senior Research Fellowship 100505 to SP) and by the Victorian Government through the Operational Infrastructure Scheme. T.J. received PhD scholarships from the National Health & Medical Research Council and Commonwealth Scientific & Industrial Research Organisation of Australia.	AbdelHamid KM, 1997, NEUROSCIENCE, V81, P673, DOI 10.1016/S0306-4522(97)00162-0; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2014, AGING CELL, V13, P351, DOI 10.1111/acel.12178; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bamham K.J., 2003, J BIOL CHEM, V278, P42959; Bickler PE, 2004, NEUROSCIENCE, V127, P673, DOI 10.1016/j.neuroscience.2004.05.035; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOTTOMLEY GA, 1994, AUST J CHEM, V47, P143, DOI 10.1071/CH9940143; Bradley CA, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00013; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Corona C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.57; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Dugan L.L., 1999, BASIC NEUROCHEMISTRY, V6th; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; FERRANTE RJ, 1993, EXP NEUROL, V119, P46, DOI 10.1006/exnr.1993.1006; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Katsura K, 2001, NEUROL RES, V23, P751, DOI 10.1179/016164101101199126; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lee JY, 2008, J NEUROSCI, V28, P10919, DOI 10.1523/JNEUROSCI.3421-08.2008; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; McKay S, 2013, NEUROPHARMACOLOGY, V74, P119, DOI 10.1016/j.neuropharm.2013.01.024; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Rocha M, 1999, BRAIN RES, V827, P79, DOI 10.1016/S0006-8993(99)01307-4; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vogler EC, 2014, CURR PHARM DESIGN, V20, P2520, DOI 10.2174/13816128113199990510; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zhang H, 2008, NEUROBIOL DIS, V31, P80, DOI 10.1016/j.nbd.2008.03.010	51	11	11	0	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2015	81				SI		176	185		10.1016/j.nbd.2015.02.008			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CV9LC	WOS:000364607700018	25697105				2022-02-06	
J	Kallakuri, S; Bandaru, S; Zakaria, N; Shen, YM; Kou, ZF; Zhang, LY; Haacke, EM; Cavanaugh, JM				Kallakuri, Srinivasu; Bandaru, Sharath; Zakaria, Nisrine; Shen, Yimin; Kou, Zhifeng; Zhang, Liying; Haacke, Ewart Mark; Cavanaugh, John M.			Traumatic Brain Injury by a Closed Head Injury Device Induces Cerebral Blood Flow Changes and Microhemorrhages	JOURNAL OF CLINICAL IMAGING SCIENCE			English	Article						Arterial spin labeling; cerebral blood flow; hemorrhages; marmarou model; Prussian blue; susceptibility-weighted imaging; traumatic brain injury	DIFFUSE AXONAL INJURY; MODEL; RATS; PATHOPHYSIOLOGY; SATURATION; CAFFEINE; DAMAGE	Objectives: Traumatic brain injury is a poly-pathology characterized by changes in the cerebral blood flow, inflammation, diffuse axonal, cellular, and vascular injuries. However, studies related to understanding the temporal changes in the cerebral blood flow following traumatic brain injury extending to sub-acute periods are limited. In addition, knowledge related to microhemorrhages, such as their detection, localization, and temporal progression, is important in the evaluation of traumatic brain injury. Materials and Methods: Cerebral blood flow changes and microhemorrhages in male Sprague Dawley rats at 4 h, 24 h, 3 days, and 7 days were assessed following a closed head injury induced by the Marmarou impact acceleration device (2 m height, 450 g brass weight). Cerebral blood flow was measured by arterial spin labeling. Microhemorrhages were assessed by susceptibility-weighted imaging and Prussian blue histology. Results: Traumatic brain injury rats showed reduced regional and global cerebral blood flow at 4 h and 7 days post-injury. Injured rats showed hemorrhagic lesions in the cortex, corpus callosum, hippocampus, and brainstem in susceptibility-weighted imaging. Injured rats also showed Prussian blue reaction products in both the white and gray matter regions up to 7 days after the injury. These lesions were observed in various areas of the cortex, corpus callosum, hippocampus, thalamus, and midbrain. Conclusions: These results suggest that changes in cerebral blood flow and hemorrhagic lesions can persist for sub-acute periods after the initial traumatic insult in an animal model. In addition, microhemorrhages otherwise not seen by susceptibility-weighted imaging are present in diverse regions of the brain. The combination of altered cerebral blood flow and microhemorrhages can potentially be a source of secondary injury changes following traumatic brain injury and may need to be taken into consideration in the long-term care of these cases.	[Kallakuri, Srinivasu; Bandaru, Sharath; Zakaria, Nisrine; Kou, Zhifeng; Zhang, Liying; Haacke, Ewart Mark; Cavanaugh, John M.] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA; [Shen, Yimin; Kou, Zhifeng; Haacke, Ewart Mark] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA		Kallakuri, S (corresponding author), Dept Biomed Engn, 818 W Hancock, Detroit, MI 48201 USA.	skallakuri@wayne.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 EB006508]; OVPR	This study was supported by grants from NIH RO1 EB006508 and OVPR (WSU).	ADAMS J, 1986, HDB BEHAV TERATOLOGY, P67; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Bouma G J, 1995, New Horiz, V3, P384; Bullock R., 1997, HEAD INJURY, P89; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Cossa FM, 1999, ITAL J NEUROL SCI, V20, P145, DOI 10.1007/s100720050024; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grossman RI, 2003, NEURORADIOLOGY; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kennedy DO, 2011, BIOL PSYCHOL, V86, P298, DOI 10.1016/j.biopsycho.2010.12.010; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P194; Ngai AC, 2001, AM J PHYSIOL-HEART C, V280, pH2329, DOI 10.1152/ajpheart.2001.280.5.H2329; Paxinos G., 2007, RAT BRAIN STEREOTAXI, P1; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Reichenbach JR, 2000, J COMPUT ASSIST TOMO, V24, P949, DOI 10.1097/00004728-200011000-00023; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; Sedlacik J, 2008, NEUROIMAGE, V40, P11, DOI 10.1016/j.neuroimage.2007.11.046; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	46	11	11	0	4	SCIENTIFIC SCHOLAR LLC	PITTSFORD	50, WOODGREEN DR, PITTSFORD, NY 14534 USA	2156-7514	2156-5597		J CLIN IMAG SCI	J. Clin. Imag. Sci.	SEP	2015	5									10.4103/2156-7514.166354			11	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	V4U0G	WOS:000219262100002	26605126	Green Published			2022-02-06	
J	Lamprecht, MR; Morrison, B				Lamprecht, Michael R.; Morrison, Barclay, III			A Combination Therapy of 17 beta-Estradiol and Memantine Is More Neuroprotective Than Monotherapies in an Organotypic Brain Slice Culture Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; E2; memantine; electrophysiology; combination therapies	LONG-TERM POTENTIATION; INDUCED CELL-DEATH; IN-VITRO MODELS; HEAD-INJURY; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL CULTURE; ESTRADIOL PROTECTS; CEREBRAL-ISCHEMIA; CLINICAL-TRIALS; ESTROGEN	Combination therapies are a promising therapeutic option for traumatic brain injury (TBI) owing to the clinical failure of monotherapy treatments, such as progesterone. Organotypic hippocampal slice cultures (OHSCs) from Sprague-Dawley rats were subjected to an in vitro TBI, and the neuroprotective effects of 17 beta-estradiol (E2) or memantine (MEM) monotherapies were quantified. Several combination treatments at different concentrations of both drugs were tested, with 100 pM of E2 and 10 mu M of MEM statistically and significantly reducing cell death over either monotherapy when administered immediately after injury. This combination was also significantly neuroprotective when administered 1 h postinjury, possibly supporting future in vivo studies. Further, we hypothesized that this synergy could be the result of MEM blocking a potentially deleterious effect of E2, specifically E2 enhancement of N-methyl-d-aspartate (NMDA) currents. Evoked electrophysiological responses in OHSCs were potentiated by E2 treatment, whereas this potentiation was significantly reduced by MEM. In conclusion, a combination therapy of E2 and memantine was significantly more neuroprotective than both monotherapy treatments, and this synergy may be the result of MEM blocking a deleterious E2-mediated enhancement of NMDA receptors.	[Lamprecht, Michael R.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF); Multi-disciplinary University Research Initiative from the Army Research Office [W911MF-10-1-05026]	This work was supported by a National Science Foundation Graduate Research Fellowship (MRL) and a Multi-disciplinary University Research Initiative from the Army Research Office (W911MF-10-1-05026). The authors thank Benjamin S. Elkin and Gwen B. Effgen for their help with experimental design and insightful comments.	BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bjornstrom Linda, 2004, Nucl Recept, V2, P3, DOI 10.1186/1478-1336-2-3; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cimarosti H, 2005, NEUROCHEM RES, V30, P191, DOI 10.1007/s11064-004-2441-y; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Frankiewicz T, 1996, BRIT J PHARMACOL, V117, P689, DOI 10.1111/j.1476-5381.1996.tb15245.x; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; KOEK W, 1988, J PHARMACOL EXP THER, V245, P969; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Lamprecht MR, 2014, BRAIN RES, V1563, P131, DOI 10.1016/j.brainres.2014.03.037; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; Liu SB, 2013, BRAIN RES BULL, V93, P27, DOI 10.1016/j.brainresbull.2012.10.004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mathys ML, 2013, ANN PHARMACOTHER, V47, DOI 10.1345/aph.1R522; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nilsson S, 2002, CRIT REV EUKAR GENE, V12, P237, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.10; Numakawa Y, 2007, ENDOCRINOLOGY, V148, P627, DOI 10.1210/en.2006-1210; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Schneider Lon S, 2013, Continuum (Minneap Minn), V19, P339, DOI 10.1212/01.CON.0000429180.60095.d0; Simpkins JW, 2008, ALZHEIMERS DEMENT, V4, pS131, DOI 10.1016/j.jalz.2007.10.009; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Strom JO, 2011, INT J MOL SCI, V12, P1533, DOI 10.3390/ijms12031533; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; TASKER RC, 1992, J NEUROSCI, V12, P4298; Vornov J. J., 1994, STROKE, V2, P464; VORNOV JJ, 1994, STROKE, V25, P457, DOI 10.1161/01.STR.25.2.457; Wigginton JG, 2010, CRIT CARE MED, V38, pS620, DOI 10.1097/CCM.0b013e3181f243a9; Xia MN, 2007, APPL OPTICS, V46, P8315, DOI 10.1364/AO.46.008315; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3	54	11	11	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1361	1368		10.1089/neu.2015.3912			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500009	25752651				2022-02-06	
J	Peterson, RL; Connery, AK; Baker, DA; Kirkwood, MW				Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			Preinjury Emotional-Behavioral Functioning of Children With Lingering Problems After Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SYMPTOM VALIDITY TEST; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; ANXIETY DISORDERS; COGNITIVE RESERVE; ABDOMINAL-PAIN; PREDICTORS; PERFORMANCE; CHILDHOOD; OUTCOMES	This study aimed to characterize preinjury emotional-behavioral functioning in pediatric patients with lingering problems after mild traumatic brain injury (TBI). The clinical case series design included 278 patients 8-17 years old. Parents retrospectively rated children's preinjury emotional-behavioral functioning on a broadband questionnaire. The rate of clinically significant preinjury anxiety was elevated compared with national norms. The number of previous TBIs was associated with clinically significant preinjury externalizing problems, suggesting a link between externalizing disorders and mild TBI exposure. Premorbid emotional-behavioral difficulties may play an important role in the establishment or maintenance of lingering symptoms after pediatric mild TBI.	[Peterson, Robin L.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA		Peterson, RL (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA.	robin.peterson@childrenscolorado.org					Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; BIJUR PE, 1990, PEDIATRICS, V86, P337; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Dorn LD, 2003, J AM ACAD CHILD PSY, V42, P66, DOI 10.1097/00004583-200301000-00012; Ensign J, 2012, ARCH CLIN NEUROPSYCH, V27, P277, DOI 10.1093/arclin/acs030; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; HINSHAW SP, 1992, PSYCHOL BULL, V111, P127, DOI 10.1037/0033-2909.111.1.127; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Legerstee JS, 2010, EUR CHILD ADOLES PSY, V19, P143, DOI 10.1007/s00787-009-0051-6; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Pine DS, 1996, J CHILD ADOL PSYCHOP, V6, P153, DOI 10.1089/cap.1996.6.153; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Vervoort T, 2006, J PEDIATR PSYCHOL, V31, P674, DOI 10.1093/jpepsy/jsj059; Wechsler D., 2011, WECHSLER ABBREVIATED; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; White KS, 2006, J PEDIATR PSYCHOL, V31, P582, DOI 10.1093/jpepsy/jsj050; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	40	11	11	0	2	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2015	27	4					280	286		10.1176/appi.neuropsych.14120373			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DM0ON	WOS:000376045400005	26258490	Bronze			2022-02-06	
J	Pu, BF; Xue, YH; Wang, QM; Hua, CH; Li, XY				Pu, Benfang; Xue, Yonghua; Wang, Qingming; Hua, Chunhui; Li, Xinyuan			Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						dextromethorphan; neuroprotection; traumatic brain injury; inflammatory; excitotoxicity; rats	TUMOR-NECROSIS-FACTOR; GLUTAMATE TRANSPORTER; PARKINSONS-DISEASE; HEAD-INJURY; RAT; CYTOKINES; NEURONS; MICE; IL-6; INFLAMMATION	Traumatic brain injury (TBI) is caused by primary and secondary injury mechanisms. TBI induces a certain amount of inflammatory responses and glutamate excitotoxicity that are believed to participate in the pathogenesis of secondary injury. The non-narcotic anti-tussive drug dextromethorphan (DM) has been reported to have a high safety profile in humans and its neuroprotective against a variety of disorders, including cerebral ischemia, epilepsy and acute brain injury. However, few studies have explored the underlying mechanisms of the neuroprotective effects of DM in animals in the setting of TBI. The aim of the present study was to investigate the neuroprotective effects of DM on TBI and to determine the underlying mechanisms. Rats were subjected to a controlled cortical impact (CCI) injury and randomly divided into three groups: Sham-operated, TBI and DM treatment groups. The DM treatment group was administered DM (30 mg/kg of body weight, intraperitoneally) immediately after injury. It was identified that DM treatment following TBI significantly reduced brain edema and neurological deficits, as well as increased neuronal survival. These effects correlated with a decrease of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta) and IL-6 protein expression and an increase of glutamate/aspartate transporter and glutamate transporter-1 in the cortex of the brain. These results provided in vivo evidence that DM exerts neuroprotective effects via reducing inflammation and excitotoxicity induced following TBI. The present study has shed light on the potential use of DM as a neuroprotective agent in the treatment of cerebral injuries.	[Pu, Benfang; Xue, Yonghua; Wang, Qingming; Hua, Chunhui; Li, Xinyuan] Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Neurosurg, Shanghai 200333, Peoples R China		Li, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Neurosurg, 1111 Xianxia Rd, Shanghai 200333, Peoples R China.	leexinyuan24k@163.com					Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; CARPENTER CL, 1988, BRAIN RES, V439, P372, DOI 10.1016/0006-8993(88)91497-7; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Duhaime AC, 1996, J NEUROTRAUM, V13, P79, DOI 10.1089/neu.1996.13.79; Feng S, 2014, BIOL TRACE ELEM RES, V159, P332, DOI 10.1007/s12011-014-9977-8; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Klette KL, 1997, BRAIN RES, V756, P231, DOI 10.1016/S0006-8993(97)00142-X; Liu YX, 2003, J PHARMACOL EXP THER, V305, P212, DOI 10.1124/jpet.102.043166; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	29	11	11	1	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	SEP	2015	12	3					3704	3710		10.3892/mmr.2015.3830			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CP5OW	WOS:000359933900068	26004757	Bronze			2022-02-06	
J	Williams, G; Banky, M; Olver, J				Williams, Gavin; Banky, Megan; Olver, John			Distribution of Lower Limb Spasticity Does Not Influence Mobility Outcome Following Traumatic Brain Injury: An Observational Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; gait; mobility limitation; muscle spasticity; running; walking	JOINT POWER-GENERATION; ASSESSMENT-TOOL HIMAT; TOXIN TYPE-A; BOTULINUM TOXIN; CONTROLLED-TRIAL; DOUBLE-BLIND; GAIT; STROKE; LEVEL; FOOT	Objective: To examine the association between lower limb spasticity and mobility limitations following traumatic brain injury (TBI) and determine the influence of spasticity distribution on mobility outcomes following TBI. Setting: A large metropolitan rehabilitation hospital. Participants: Ninety-three ambulant people with TBI who were attending physiotherapy for mobility limitations. Design: Cross-sectional cohort study. Main Measures: The High-Level Mobility Assessment Tool, gait velocity, and the Tardieu scale. Results: Lower limb spasticity was common following TBI, with a distal distribution being the most prevalent. Participants with spasticity had significantly greater initial mobility limitations than participants without spasticity. However, the distribution of lower limb spasticity and the presence of unilateral or bilateral spasticity had no additional impact on mobility outcomes. There was no significant difference in mobility outcomes at the 6-month follow-up for people with spasticity, indicating that individuals have equivalent ability to improve their mobility over time despite the presence of spasticity. Conclusion: Following TBI, people with lower limb spasticity have significantly greater mobility limitations than those without spasticity, yet the presence and distribution of spasticity does not appear to impact mobility outcomes. There is long-term potential to improve mobility despite the presence of spasticity.	[Williams, Gavin] Univ Melbourne, Physiotherapy Dept, Melbourne, Vic 3010, Australia; [Williams, Gavin; Banky, Megan; Olver, John] Epworth Med Fdn, Physiotherapy Dept Rehabil, 89 Bridge Rd, Melbourne, Vic 3121, Australia		Banky, M (corresponding author), Epworth Med Fdn, Physiotherapy Dept Rehabil, 89 Bridge Rd, Melbourne, Vic 3121, Australia.	megan.banky@epworth.org.au		Williams, Gavin/0000-0003-2758-7473; Olver, John/0000-0001-7069-1191			Ada L, 1998, J NEUROL NEUROSUR PS, V64, P628, DOI 10.1136/jnnp.64.5.628; Ade-Hall R, 2000, COCHRANE DB SYST REV, V1; Amatya B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009974.pub2; Baguley I, 2000, BRAIN INJURY, V14, P505; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; Burbaud P, 1996, J NEUROL NEUROSUR PS, V61, P265, DOI 10.1136/jnnp.61.3.265; Davids JR, 1998, DEV MED CHILD NEUROL, V40, P528; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Goulart FR, 1999, CLIN NEUROPHYSIOL, V110, P1634, DOI 10.1016/S1388-2457(99)00109-1; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; JENNETT B, 1975, LANCET, V1, P480; Johnson CA, 2004, ARCH PHYS MED REHAB, V85, P902, DOI 10.1016/j.apmr.2003.08.081; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Olver J, 2010, EUR J NEUROL, V17, P57, DOI 10.1111/j.1468-1331.2010.03128.x; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Reiter F, 1998, ARCH PHYS MED REHAB, V79, P532, DOI 10.1016/S0003-9993(98)90068-5; Requiao LF, 2005, J ELECTROMYOGR KINES, V15, P393, DOI 10.1016/j.jelekin.2004.12.004; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; ROEBROECK ME, 1994, CLIN BIOMECH, V9, P235, DOI 10.1016/0268-0033(94)90004-3; Ross SA, 2007, ARCH PHYS MED REHAB, V88, P1114, DOI 10.1016/j.apmr.2007.06.011; Shakespeare D T, 2001, Cochrane Database Syst Rev, pCD001332, DOI 10.1002/14651858.CD001332; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Sosnoff JJ, 2011, J NEUROL PHYS THER, V35, P129, DOI 10.1097/NPT.0b013e31822a8c40; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1	44	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					E49	E57		10.1097/HTR.0000000000000094			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400006	25310296				2022-02-06	
J	Jerath, R; Crawford, MW; Barnes, VA				Jerath, Ravinder; Crawford, Molly W.; Barnes, Vernon A.			A unified 3D default space consciousness model combining neurological and physiological processes that underlie conscious experience	FRONTIERS IN PSYCHOLOGY			English	Article						consciousness; 3D default space; sensory memory space; global workspace theory; integrated information theory; thalamus; corticothalamic feedback loops; meditation	THALAMIC RETICULAR NUCLEUS; TRAUMATIC BRAIN-INJURY; SLOW EEG FLUCTUATIONS; NEURONS IN-VIVO; VISUAL-PERCEPTION; PREFRONTAL CORTEX; BAND OSCILLATIONS; NETWORK DYNAMICS; CEREBRAL-CORTEX; BASIC EMOTIONS	The Global Workspace Theory and Information Integration Theory are two of the most currently accepted consciousness models; however, these models do not address many aspects of conscious experience. We compare these models to our previously proposed consciousness model in which the thalamus fills-in processed sensory information from corticothalamic feedback loops within a proposed 3D default space, resulting in the recreation of the internal and external worlds within the mind. This 3D default space is composed of all cells of the body, which communicate via gap junctions and electrical potentials to create this unified space. We use 3D illustrations to explain how both visual and non-visual sensory information may be filled-in within this dynamic space, creating a unified seamless conscious experience. This neural sensory memory space is likely generated by baseline neural oscillatory activity from the default mode network, other salient networks, brainstem, and reticular activating system.	[Jerath, Ravinder; Crawford, Molly W.] Augusta Womens Ctr, Augusta, GA 30904 USA; [Barnes, Vernon A.] Georgia Regents Univ, Georgia Prevent Inst, Dept Pediat, Augusta, GA USA		Jerath, R (corresponding author), Augusta Womens Ctr, 2100 Cent Ave,Suite 7, Augusta, GA 30904 USA.	rj605r@aol.com					Aggleton JP, 2015, NEUROSCI BIOBEHAV R, V54, P131, DOI 10.1016/j.neubiorev.2014.08.013; Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Baars B. J., 1997, THEATRE CONSCIOUSNES; Baars B. J., 2003, SCI CON REV, V2; Baars BJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00200; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; BEAUCHEMIN KM, 1995, J AFFECT DISORDERS, V35, P41, DOI 10.1016/0165-0327(95)00036-M; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Bjornstad B, 2003, MAYO CLIN PROC, V78, P347, DOI 10.4065/78.3.347; BLOCH S, 1991, INT J PSYCHOPHYSIOL, V11, P141, DOI 10.1016/0167-8760(91)90006-J; Bogacz R., 2014, ENCY COMPUTATIONAL N, P1; BOGOUSSLAVSKY J, 1988, J NEUROL NEUROSUR PS, V51, P116, DOI 10.1136/jnnp.51.1.116; Bosman CA, 2014, EUR J NEUROSCI, V39, P1982, DOI 10.1111/ejn.12606; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Bruce BB, 2004, STEREOT FUNCT NEUROS, V82, P186, DOI 10.1159/000082207; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P254, DOI 10.1162/jocn.1997.9.2.254; Cartwright R, 2006, PSYCHIAT RES, V141, P261, DOI 10.1016/j.psychres.2005.05.013; Chalmers D.J., 1995, J CONSCIOUSNESS STUD, V2, P200, DOI 10.1093/acprof:oso/9780195311105.003.0001; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; Courtiol E, 2014, J NEUROPHYSIOL, V111, P1274, DOI 10.1152/jn.00741.2013; Crabtree JW, 1999, CELL MOL LIFE SCI, V56, P683, DOI 10.1007/s000180050462; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; D'Agostino A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00680; Damasio A., 1999, FEELING WHAT HAPPENS; Damasio A.R., 1995, DESCARTES ERROR; Danielson NB, 2011, BEHAV NEUROL, V24, P55, DOI [10.1155/2011/912720, 10.3233/BEN-2011-0310]; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Dentico D, 2014, NEUROIMAGE, V100, P237, DOI 10.1016/j.neuroimage.2014.05.081; deOcariz MDS, 1996, STROKE, V27, P1530; Di Rocco C, 2002, CHILD NERV SYST, V18, P440, DOI 10.1007/s00381-002-0609-9; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; Earl B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00697; Edelman DB, 2005, CONSCIOUS COGN, V14, P169, DOI 10.1016/j.concog.2004.09.001; Edelman Gerald, 2004, WIDER SKY PHENOMENAL; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Faivre N, 2014, PSYCHOL SCI, V25, P2006, DOI 10.1177/0956797614547916; Farb NAS, 2013, CEREB CORTEX, V23, P114, DOI 10.1093/cercor/bhr385; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; FENDRICH R, 1992, SCIENCE, V258, P1489, DOI 10.1126/science.1439839; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; FOULKES D, 1999, CHILDRENS DREAMING D; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Garcia-Rill E, 2007, SLEEP, V30, P1405, DOI 10.1093/sleep/30.11.1405; Garcia-Rill E, 2013, SLEEP MED REV, V17, P227, DOI 10.1016/j.smrv.2012.06.002; Gelabert-Gonzalez M, 2007, REV NEUROLOGIA, V45, P599, DOI 10.33588/rn.4510.2007354; Gray A., 1982, NEUROPSYCHOLOGY ANXI; Guntekin B, 2010, NEUROSCI LETT, V483, P173, DOI 10.1016/j.neulet.2010.08.002; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; HEILMAN KM, 1987, HDB PHYSL 1, V5, P461; Hiltunen T, 2014, J NEUROSCI, V34, P356, DOI 10.1523/JNEUROSCI.0276-13.2014; Hohwy J, 2009, CONSCIOUS COGN, V18, P428, DOI 10.1016/j.concog.2009.02.006; HOLDEN C, 1979, SCIENCE, V204, P1066, DOI 10.1126/science.377485; Holzinger B, 2006, DREAMING, V16, P88, DOI DOI 10.1037/1053-0797.16.2.88; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Horowitz TS, 2004, J VISION, V4, P585, DOI 10.1167/4.7.6; Jerath R, 2014, J BIOL REG HOMEOS AG, V28, P545; Jerath R., 2009, Journal of Complementary & Integrative Medicine, V6, P31, DOI 10.2202/1553-3840.1299; Jerath R., 2015, ADV MIND BODY MED; Jerath R, 2006, MED HYPOTHESES, V67, P566, DOI 10.1016/j.mehy.2006.02.042; Jerath R, 2015, MED HYPOTHESES, V85, P153, DOI 10.1016/j.mehy.2015.04.025; Jerath R, 2015, APPL PSYCHOPHYS BIOF, V40, P107, DOI 10.1007/s10484-015-9279-8; Jerath R, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00248; Jerath R, 2015, MED HYPOTHESES, V84, P31, DOI 10.1016/j.mehy.2014.11.010; Jerath R, 2014, CONSCIOUS COGN, V28, P81, DOI 10.1016/j.concog.2014.06.008; Jerath R, 2014, SLEEP MED, V15, P279, DOI 10.1016/j.sleep.2013.10.017; Jerath R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00131; KAHAN TL, 1994, CONSCIOUS COGN, V3, P246, DOI 10.1006/ccog.1994.1014; Kay LM, 2007, TRENDS NEUROSCI, V30, P47, DOI 10.1016/j.tins.2006.11.007; Kempton MJ, 2011, HUM BRAIN MAPP, V32, P71, DOI 10.1002/hbm.20999; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Lam YW, 2011, J NEUROSCI, V31, P6791, DOI 10.1523/JNEUROSCI.3073-10.2011; Lambertz M, 1998, J AUTONOM NERV SYST, V68, P58, DOI 10.1016/S0165-1838(97)00126-4; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Low P, 2012, F CRICK MEM C CAMBR; Lusignan FA, 2009, SCHIZOPHR RES, V112, P164, DOI 10.1016/j.schres.2009.03.032; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; MacDonald KD, 1998, J NEUROPHYSIOL, V79, P474, DOI 10.1152/jn.1998.79.1.474; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; Malhotra R, 2001, AM J PHYSIOL-CELL PH, V281, pC1596, DOI 10.1152/ajpcell.2001.281.5.C1596; Marchetti G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00880; Masaoka Y, 2000, NEUROSCI LETT, V283, P21, DOI 10.1016/S0304-3940(00)00895-8; McAlonan K, 2000, J NEUROSCI, V20, P8897; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; Merker B, 2007, BEHAV BRAIN SCI, V30, P63, DOI 10.1017/S0140525X07000891; Merker B, 2012, ADV CONSC RES, V88, P37; Merker B, 2013, UNITY OF MIND, BRAIN AND WORLD: CURRENT PERSPECTIVES ON A SCIENCE OF CONSCIOUSNESS, P7; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Mrazek MD, 2013, PSYCHOL SCI, V24, P776, DOI 10.1177/0956797612459659; Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Nguyen DK, 1998, CAN J NEUROL SCI, V25, P5, DOI 10.1017/S0317167100033424; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Northoff G, 2013, NEUROSCI BIOBEHAV R, V37, P726, DOI 10.1016/j.neubiorev.2012.12.004; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pendfield W., 1954, EPILEPSY FUNCTIONAL; Pergola G, 2013, NEUROIMAGE, V74, P195, DOI 10.1016/j.neuroimage.2013.02.017; Persaud N, 2008, CONSCIOUS COGN, V17, P1050, DOI 10.1016/j.concog.2007.10.002; Pierson D J, 2000, Respir Care, V45, P39; Pierson D. J., 2000, RESP CARE, V45, P51; Plankar M, 2013, PROG BIOPHYS MOL BIO, V111, P8, DOI 10.1016/j.pbiomolbio.2012.08.006; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; PRICE JL, 1983, J COMP NEUROL, V215, P63, DOI 10.1002/cne.902150106; PRICE JL, 1985, CHEM SENSES, V10, P239, DOI 10.1093/chemse/10.2.239; Purves D., 2001, NEUROSCIENCE, P618; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rainville P, 2006, INT J PSYCHOPHYSIOL, V61, P5, DOI 10.1016/j.ijpsycho.2005.10.024; Rajput DK, 2010, J PEDIATR NEUROSCI, V5, P45, DOI 10.4103/1817-1745.66672; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, PROG BRAIN RES, V150, P473, DOI 10.1016/S0079-6123(05)50033-5; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Schmid MC, 2010, NATURE, V466, P373, DOI 10.1038/nature09179; Sela L, 2009, J NEUROSCI, V29, P12059, DOI 10.1523/JNEUROSCI.2114-09.2009; Shah SA, 2010, EUR J NEUROSCI, V32, P1135, DOI 10.1111/j.1460-9568.2010.07420.x; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Sherman SM, 2001, EXPLORING THALAMUS; Shewmon DA, 1999, DEV MED CHILD NEUROL, V41, P364, DOI 10.1017/S0012162299000821; Shimojo S, 2001, SCIENCE, V293, P1677, DOI 10.1126/science.1060161; Somjen George G., 1995, P319; Sperandio I, 2012, J VISION, V12, DOI 10.1167/12.2.18; Spillmann L, 2006, VISION RES, V46, P4252, DOI 10.1016/j.visres.2006.08.033; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1992, NEUROLOGY, V42, P9; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STOGNER SW, 1992, ANN PHARMACOTHER, V26, P1554, DOI 10.1177/106002809202601214; Striedter GF, 2002, BRAIN RES BULL, V57, P239, DOI 10.1016/S0361-9230(01)00692-X; SZELIES B, 1991, ARCH NEUROL-CHICAGO, V48, P178, DOI 10.1001/archneur.1991.00530140072019; Tagliazucchi E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00256; Tagliazucchi E, 2013, NEUROIMAGE, V70, P327, DOI 10.1016/j.neuroimage.2012.12.073; Tham WWP, 2009, BRAIN RES REV, V62, P109, DOI 10.1016/j.brainresrev.2009.09.007; Thiagarajan TC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000278; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Timofeev I, 2012, JASPERS BASIC MECH E; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; TONONI G, 2000, UNIVERSE CONSCIOUSNE; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; Trehub A, 2007, CONSCIOUS COGN, V16, P310, DOI 10.1016/j.concog.2006.06.004; Tyll Sascha, 2011, Commun Integr Biol, V4, P378, DOI 10.4161/cib.4.4.15222; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Urbano FJ, 2007, P NATL ACAD SCI USA, V104, P12554, DOI 10.1073/pnas.0705087104; Valderrama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033477; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; vanDomburg PHMF, 1996, J NEUROL SCI, V139, P58, DOI 10.1016/S0022-510X(96)00026-3; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Verkhratsky A., 2013, GLIAL PHYSL PATHOPHY; Vimal RLP, 2013, UNITY OF MIND, BRAIN AND WORLD: CURRENT PERSPECTIVES ON A SCIENCE OF CONSCIOUSNESS, P149; Voss U, 2009, SLEEP, V32, P1191, DOI 10.1093/sleep/32.9.1191; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Ward LM, 2013, WIRES COGN SCI, V4, P609, DOI 10.1002/wcs.1256; WHISHAW IQ, 1990, CEREBRAL CORTEX RAT, P239; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Windt JM, 2011, CONSCIOUS COGN, V20, P1091, DOI 10.1016/j.concog.2010.09.010; Wojtecki L, 2014, CORTEX, V60, P94, DOI 10.1016/j.cortex.2014.09.007; Yassa MA, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00107; Yuan H, 2013, NEUROIMAGE, V79, P81, DOI 10.1016/j.neuroimage.2013.04.068; Yuan H, 2012, NEUROIMAGE, V60, P2062, DOI 10.1016/j.neuroimage.2012.02.031; Zaidi Q, 2012, CURR BIOL, V22, P220, DOI 10.1016/j.cub.2011.12.021	185	11	11	0	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	AUG 27	2015	6								1204	10.3389/fpsyg.2015.01204			25	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	CQ2AG	WOS:000360401100001	26379573	Green Published, gold			2022-02-06	
J	Beom, J; Oh, BM; Choi, KH; Kim, W; Song, YJ; You, DS; Kim, SJ; Han, TR				Beom, Jaewon; Oh, Byung-Mo; Choi, Kyoung Hyo; Kim, Won; Song, Young Jin; You, Dae Sang; Kim, Sang Jun; Han, Tai Ryoon			Effect of Electrical Stimulation of the Suprahyoid Muscles in Brain-Injured Patients with Dysphagia	DYSPHAGIA			English	Article						Deglutition; Deglutition disorders; Electrical stimulation therapy; Brain injuries	THERAPY; STROKE; REST	The purpose of this study is to determine whether neuromuscular electrical stimulation of the suprahyoid muscle is effective compared to that of the infrahyoid muscle in brain-injured patients with dysphagia. A total of 132 patients with stroke, traumatic brain injury, or brain tumor in 2 university hospitals were allocated to 2 groups: those who received electrical stimulation therapy (EST) on the suprahyoid muscles (SM group, n = 66) and those who received EST with one pair of electrodes on the suprahyoid muscle and the other pair on the infrahyoid muscle (SI group, n = 66). Patients received 11.2 +/- 3.4 sessions of electrical stimulation in the SM group and 11.9 +/- 3.4 sessions in the SI group. The functional dysphagia scale (FDS), swallow function score (SFS), supraglottic penetration, and subglottic aspiration were measured using videofluoroscopic swallowing study. FDS scores decreased from 42.0 +/- 19.1 to 32.3 +/- 17.8 in the SM group and from 44.8 +/- 17.4 to 32.9 +/- 18.8 in the SI group by per-protocol (PP) analysis, and those decreased from 41.2 +/- 20.9 to 34.5 +/- 20.3 in the SM group and from 44.3 +/- 19.1 to 35.7 +/- 20.5 in the SI group by intention-to-treat (ITT) analysis, after electrical stimulation (p < 0.001 for each). SFSs increased from 3.3 +/- 1.8 to 4.2 +/- 1.6 in the SM group and from 2.8 +/- 1.8 to 4.0 +/- 1.8 in the SI group by PP analysis, and those increased from 3.3 +/- 1.6 to 3.9 +/- 1.6 in the SM group and from 2.8 +/- 1.9 to 3.6 +/- 2.0 in the SI group by ITT analysis, after electrical stimulation (p < 0.001, respectively). However, changes in FDS scores, SFSs, penetration, and aspiration were comparable between the SM and the SI groups. The results suggest that both SM and SI therapies induced similar improvements in swallowing function in brain-injured patients.	[Beom, Jaewon] Chungnam Natl Univ Hosp, Dept Rehabil Med, Taejon, South Korea; [Oh, Byung-Mo; Han, Tai Ryoon] Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul Natl Univ Hosp, Seoul, South Korea; [Choi, Kyoung Hyo; Kim, Won; Song, Young Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Seoul, South Korea; [You, Dae Sang] Cheongshim Int Med Ctr, Gapyeong Gun, Gyeonggi Do, South Korea; [Kim, Sang Jun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Rehabil Med, Seoul, South Korea; [Beom, Jaewon] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Han, Tai Ryoon] Gangwon Rehabil Hosp, Dept Rehabil Med, Chuncheon Si 200939, Gangwon Do, South Korea		Han, TR (corresponding author), Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul, South Korea.	powe5@naver.com; keepwiz@gmail.com; kyounghyochoi@gmail.com; duocl79@gmail.com; irisot@hanmail.net; ydsang@hanmail.net; guitarren@hanmail.net; tairyoon@snu.ac.kr			Cyber-medic Corp., Iksan, Republic of Korea	This study was supported by Cyber-medic Corp., Iksan, Republic of Korea.	Beom J, 2011, ANN REHABIL MED-ARM, V35, P322, DOI 10.5535/arm.2011.35.3.322; Blumenfeld L, 2006, OTOLARYNG HEAD NECK, V135, P754, DOI 10.1016/j.otohns.2006.04.016; Burnett TA, 2003, J APPL PHYSIOL, V94, P128, DOI 10.1152/japplphysiol.00406.2002; Carnaby-Mann GD, 2008, ANN OTO RHINOL LARYN, V117, P279, DOI 10.1177/000348940811700407; Carnaby-Mann GD, 2007, ARCH OTOLARYNGOL, V133, P564, DOI 10.1001/archotol.133.6.564; Freed M L, 2001, Respir Care, V46, P466; Gow D, 2004, CLIN NEUROPHYSIOL, V115, P2382, DOI 10.1016/j.clinph.2004.05.017; Humbert IA, 2006, J APPL PHYSIOL, V101, P1657, DOI 10.1152/japplphysiol.00348.2006; Kim DY, 2008, ANN REHABIL MED-ARM, V32, P9; Kim SJ, 2009, NEUROMODULATION, V12, P134, DOI 10.1111/j.1525-1403.2009.00200.x; Leelamanit V, 2002, LARYNGOSCOPE, V112, P2204, DOI 10.1097/00005537-200212000-00015; Lim KB, 2009, J REHABIL MED, V41, P174, DOI 10.2340/16501977-0317; Ludlow CL, 2007, DYSPHAGIA, V22, P1, DOI 10.1007/s00455-006-9029-4; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Nam HS, 2013, DYSPHAGIA, V28, P548, DOI 10.1007/s00455-013-9465-x; Paik NJ, 2005, ANN REHABIL MED-ARM, V29, P43; Park JW, 2012, DYSPHAGIA, V27, P521, DOI 10.1007/s00455-012-9403-3; Park JW, 2009, DYSPHAGIA, V24, P296, DOI 10.1007/s00455-008-9205-9; Wijting Y., 2003, VITALSTIM THERAPY TR, P103	19	11	12	0	20	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	AUG	2015	30	4					423	429		10.1007/s00455-015-9617-2			7	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	CN1OZ	WOS:000358190800005	25917017				2022-02-06	
J	Duchnick, JJ; Ropacki, S; Yutsis, M; Petska, K; Pawlowski, C				Duchnick, Jennifer J.; Ropacki, Susan; Yutsis, Maya; Petska, Kelly; Pawlowski, Carey			Polytrauma Transitional Rehabilitation Programs: Comprehensive Rehabilitation for Community Integration After Brain Injury	PSYCHOLOGICAL SERVICES			English	Article						brain injury; interdisciplinary rehabilitation; neurobehavioral functioning; polytrauma; veterans	POSTTRAUMATIC-STRESS-DISORDER; PROLONGED EXPOSURE; VETERANS; THERAPY; PARTICIPATION; DEPRESSION; IMPAIRMENT; SURVIVORS; OUTCOMES	When the U.S. Congress passed the Veterans Health Programs Improvement Act of 2004 and the Consolidated Appropriations Act in 2005, Veterans Affairs (VA) traumatic brain injury centers responded by establishing and developing the polytrauma rehabilitation centers and polytrauma transitional rehabilitation programs (PTRPs) across 4 sites in Minneapolis, Minnesota, Palo Alto, California, Richmond, Virginia, and Tampa, Florida, in 2007. The 5th PTRP was opened in 2011 in San Antonio, Texas. This article presents the context of establishing these programs within a VA system, describes aspects of programmatic design, and shares characteristics and outcomes of individuals served by the first 4 national centers. PTRPs provide specialized, interdisciplinary brain injury rehabilitation to active-duty service members and veterans with complex rehabilitation needs. A total of 286 individuals participated in the first 4 PTRPs during the first 3 years. Admission and discharge data were collected as part of routine care, and data review focused on describing the demographic, injury, and neurobehavioral functioning outcomes across 4 sites. Mayo-Portland Adaptability Inventory Abilities, Adjustment, and Participation subscales and total scale T-scores served as primary functioning outcome measures. Mean scores are presented. Statistical analysis found a significant change in total scale T-score from admission to discharge, consistent with improved patient functional ability. Challenges associated with the development and implementation of programs are discussed. Elements of programming may be applicable for other health care organizations that seek to improve rehabilitation care delivery.	[Duchnick, Jennifer J.] James A Haley Vet Affairs Med Ctr, Mental Hlth & Behav Sci Serv, Tampa, FL 33612 USA; [Ropacki, Susan; Yutsis, Maya] VA Palo Alto Hlth Care Syst, Polytrauma Transit Rehabil Program, Polytrauma Syst Care, Palo Alto, CA USA; [Petska, Kelly] Minneapolis VA Hlth Care Syst, Phys Med & Rehabil Serv, Minneapolis, MN USA; [Pawlowski, Carey] VA Palo Alto Hlth Care Syst, Polytrauma Transit Rehabil Program, Palo Alto, CA USA		Duchnick, JJ (corresponding author), James A Haley Vet Affairs Med Ctr, Mental Hlth & Behav Sci Serv 116B, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	jen_duchnick@yahoo.com		Duchnick, Jennifer/0000-0002-2050-9272			Beck Lucille, 2010, COMMUNICATION   0505; Benedict SM, 2010, TRAUMATIC BRAIN INJU; Bertisch HC, 2013, REHABIL PSYCHOL, V58, P429, DOI 10.1037/a0034554; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Department of Veterans Affairs, 2012, PHYS MED REH SERV TR; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Haskins E.C., 2012, COGNITIVE REHABILITA; Institute of Medicine, 2011, COGN REH THER TRAUM; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Micklewright JL, 2011, ARCH PHYS MED REHAB, V92, P1974, DOI 10.1016/j.apmr.2011.07.199; Monson CM, 2005, FEDERAL PRACTITIONER, V22, P75; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2012, J CONSULT CLIN PSYCH, V80, P201, DOI 10.1037/a0026602; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Williams J. M., 1990, HEAD INJURY FAMILY M; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362	27	11	11	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	AUG	2015	12	3					313	321		10.1037/ser0000034			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CN8KN	WOS:000358689300014	25938856				2022-02-06	
J	Gradus, JL; Wisco, BE; Luciano, MT; Iverson, KM; Marx, BP; Street, AE				Gradus, Jaimie L.; Wisco, Blair E.; Luciano, Matthew T.; Iverson, Katherine M.; Marx, Brian P.; Street, Amy E.			Traumatic Brain Injury and Suicidal Ideation Among US Operation Enduring Freedom and Operation Iraqi Freedom Veterans	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SERVICES	Traumatic brain injury (TBI) is associated with suicidal behavior among veterans, and gender differences in the strength of associations may exist. Almost all research has been limited to Veterans Health Administration (VHA) patients, and it is unclear if findings generalize to veterans who do not use VHA services. We examined gender- and VHA-user-specific associations between TBI related to deployment and postdeployment suicidal ideation in a U.S. national sample of 1,041 female and 880 male Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) veterans. Path analysis was used to estimate TBI and suicidal ideation association, and examine PTSD and depression symptomatology in these associations. TBI was associated with suicidal ideation among male VHA users, OR = 3.64, 95% CI [2.21, 6.01]; and male and female nonusers, OR = 2.24, 95% CI [1.14, 4.44] and OR = 2.65, 95% CI [1.26, 5.58], respectively, in unadjusted analyses. This association was explained by depression symptoms among male and female nonusers. Among male VHA users an association between TBI and suicidal ideation remained when accounting for depression symptoms, OR = 2.50, 95% CI [1.33, 4.71]. Our findings offered evidence of an association between TBI and suicidal ideation among male OEF/OIF VHA users. Resumen LCT e Ideacion Suicida en Veteranos OEF/OIF La Lesion cerebral traumatica (TBI) se asocia con la conducta suicida entre los veteranos, y puede haber diferencias de genero en la fuerza de las asociaciones. Casi toda la investigacion esta limitada a pacientes de la Administracion de Salud de Veteranos (VHA), y no esta claro si los hallazgos se generalizan a los veteranos que no son usuarios de VHA. Evaluamos asociaciones especificas de genero - y usuarios de VHA- en TBI relacionado a ideacion suicida en el despliegue militar y post despliegue militar en una muestra nacional de 1041 mujeres y 880 varones veteranos de OEF y OIF. Se utilizo analisis de pautas para estimar asociacion de TBI e ideacion suicida, y evaluar sintomatologia de TEPT y depresion en estas asociaciones. TBI se asocio con ideacion suicida en varones usuarios VHA (OR: 3.64, 95% CI:[2.21, 6.01]) y en varones y mujeres no usuarios (OR: 2.24, 95% CI:[1.14, 4.44] y OR:2.65, 95% CI:[1.26, 5.58], respectivamente) en analisis no ajustados. Esta asociacion fue explicada por sintomas depresivos entre varones y mujeres no usuarias. Entre los usuarios masculinos VHA una asociacion se mantiene entre TBI e ideacion suicida cuando se incluyen los sintomas depresivos (OR: 2.50, 95% CI:[1.33, 4.71]). Nuestros hallazgos ofrecen evidencia de una asociacion entre TBI e ideacion suicida entre varones OEF/OIF usuarios de VHA. Traditional and Simplified Chinese Abstracts by AsianSTSS ?? : ????????(OEF)??????????(OIF)???????????????? ??: ??????(TBI)????????????,????????????????????????????????????(VHA)???,?????????????????VHA??????????????????????????(OEF)??????????(OIF)???????(1,041????880???),???????TBI???????????,?????VHA??????????????????TBI????????,????????PTSD?????????????????,TBI??????VHA?????? (OR = 3.64, 95% CI = [2.21, 6.01]) ,???VHA???????????? (??? OR = 2.24, 95% CI = [1.14, 4.44] ? OR = 2.65, 95% CI = [1.26, 5.58]) ,?????????VHA???????????????VHA???,????????,TBI????????? (OR = 2.50, 95% CI = [1.33, 4.71])??????OEF/OIF?VHA???TBI????????????? ?? : ????????(OEF)??????????(OIF)???????????????? ??: ??????(TBI)????????????,????????????????????????????????????(VHA)???,?????????????????VHA??????????????????????????(OEF)??????????(OIF)???????(1,041????880???),???????TBI???????????,?????VHA??????????????????TBI????????,????????PTSD????????????????,TBI??????VHA?????? (OR = 3.64, 95% CI = [2.21, 6.01]) ,???VHA???????????? (??? OR = 2.24, 95% CI = [1.14, 4.44] ? OR = 2.65, 95% CI = [1.26, 5.58]) ,?????????VHA???????????????VHA???,????????,TBI????????? (OR = 2.50, 95% CI = [1.33, 4.71])??????OEF/OIF?VHA???TBI?????????????	[Gradus, Jaimie L.; Luciano, Matthew T.; Iverson, Katherine M.; Marx, Brian P.; Street, Amy E.] VA Boston HCS, Natl Ctr PTSD, Womens Hlth Sci Div, Boston, MA 02130 USA; [Gradus, Jaimie L.; Iverson, Katherine M.; Marx, Brian P.; Street, Amy E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Gradus, Jaimie L.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Wisco, Blair E.] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA		Gradus, JL (corresponding author), VA Boston HCS, 150 South Huntington Ave, Boston, MA 02130 USA.	Jaimie.gradus@va.gov	Luciano, Matthew/K-1216-2019; Marx, Brian/AAK-5072-2020	Street, Amy/0000-0003-4554-9075; Gradus, Jaimie/0000-0003-1459-5327	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (HSR&D) Services as part of her HSR&D Career Development Award [CDA 10-029]	Dr. Iverson's contribution to this work was supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (HSR&D) Services as part of her HSR&D Career Development Award (CDA 10-029). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arlinghaus K. A., 2005, TBI QUICK SCR UNPUB; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Dillman DA., 2007, MAIL INTERNET SURVEY; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2013, AN VA HLTH CAR UT OP; Hayes, 2018, INTRO MEDIATION MODE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Linehan MM, 1996, SUICIDAL BEHAV UNPUB; Miller EA, 2012, SOC WORK PUBLIC HLTH, V27, P379, DOI 10.1080/19371910903176197; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Radloff L. S., 1977, APPLIED PSYCHOL MEAS, V1, P358, DOI DOI 10.1177/014662167700100306; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	18	11	11	0	23	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2015	28	4					361	365		10.1002/jts.22021			5	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	CP5HR	WOS:000359912400013	26179483				2022-02-06	
J	Lang, EW; Kasprowicz, M; Smielewski, P; Pickard, J; Czosnyka, M				Lang, Erhard W.; Kasprowicz, Magdalena; Smielewski, Peter; Pickard, John; Czosnyka, Marek			Changes in Cerebral Partial Oxygen Pressure and Cerebrovascular Reactivity During Intracranial Pressure Plateau Waves	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Cerebral hemodynamics; Cerebral autoregulation; Intracranial pressure plateau waves; Cerebral oxygenation; Cerebral partial pressure of oxygen	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; TISSUE OXYGEN; PERFUSION-PRESSURE; HEAD-INJURY; ARTERIAL-PRESSURE; AUTOREGULATION; HYPERTENSION; MODEL; HYDROCEPHALUS	Plateau waves in intracranial pressure (ICP) are frequently recorded in neuro intensive care and are not yet fully understood. To further investigate this phenomenon, we analyzed partial pressure of cerebral oxygen (pbtO(2)) and a moving correlation coefficient between ICP and mean arterial blood pressure (ABP), called PRx, along with the cerebral oxygen reactivity index (ORx), which is a moving correlation coefficient between cerebral perfusion pressure (CPP) and pbtO(2) in an observational study. We analyzed 55 plateau waves in 20 patients after severe traumatic brain injury. We calculated ABP, ABP pulse amplitude (ampABP), ICP, CPP, pbtO(2), heart rate (HR), ICP pulse amplitude (ampICP), PRx, and ORx, before, during, and after each plateau wave. The analysis of variance with Bonferroni post hoc test was used to compare the differences in the variables before, during, and after the plateau wave. We considered all plateau waves, even in the same patient, independent because they are separated by long intervals. We found increases for ICP and ampICP according to our operational definitions for plateau waves. PRx increased significantly (p = 0.00026), CPP (p < 0.00001) and pbtO(2) (p = 0.00007) decreased significantly during the plateau waves. ABP, ampABP, and HR remained unchanged. PRx during the plateau was higher than before the onset of wave in 40 cases (73 %) with no differences in baseline parameters for those with negative and positive Delta PRx (difference during and after). ORx showed an increase during and a decrease after the plateau waves, however, not statistically significant. PbtO(2) overshoot after the wave occurred in 35 times (64 %), the mean difference was 4.9 +/- A 4.6 Hg (mean +/- A SD), and we found no difference in baseline parameters between those who overshoot and those who did not overshoot. Arterial blood pressure remains stable in ICP plateau waves, while cerebral autoregulatory indices show distinct changes, which indicate cerebrovascular reactivity impairment at the top of the wave. PbtO(2) decreases during the waves and may show a slight overshoot after normalization. We assume that this might be due to different latencies of the cerebral blood flow and oxygen level control mechanisms. Other factors may include baseline conditions, such as pre-plateau wave cerebrovascular reactivity or pbtO(2) levels, which differ between studies.	[Lang, Erhard W.] Red Cross Hosp, Neurosurg Associates, D-34121 Kassel, Germany; [Kasprowicz, Magdalena] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Smielewski, Peter; Pickard, John; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England		Lang, EW (corresponding author), Red Cross Hosp, Neurosurg Associates, Bergmannstr 30, D-34121 Kassel, Germany.	keeflang@online.de	Viani, Rafael/V-1196-2018	Kasprowicz, Magdalena/0000-0002-2271-7737; Smielewski, Peter/0000-0001-5096-3938; czosnyka, marek/0000-0003-2446-8006	Polish Ministry of Science and Higher EducationMinistry of Science and Higher Education, Poland; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	Magdalena Kasprowicz is the recipient of a scholarship funded by the Polish Ministry of Science and Higher Education. All authors thank the Neurocritical Care Unit staff members at Addenbrooke's Hospital, UK, for their active involvement and support during the study.	ALBERTI E, 1978, J NEUROL, V217, P173, DOI 10.1007/BF00312958; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Carhuapoma JR, 2002, J NEUROSURG ANESTH, V14, P299, DOI 10.1097/00008506-200210000-00005; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1997, NEUROSURGERY, V41, P7; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; DAHLERUP B, 1985, CHILD NERV SYST, V1, P49, DOI 10.1007/BF00706731; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Fuentes J M, 1979, Anesth Analg (Paris), V36, P429; GJERRIS F, 1985, ANN NEUROL, V17, P158, DOI 10.1002/ana.410170209; HANDA Y, 1990, Neurologia Medico-Chirurgica, V30, P301, DOI 10.2176/nmc.30.301; HANSEN K, 1987, ACTA NEUROCHIR, V86, P93, DOI 10.1007/BF01402291; HAYASHI M, 1991, BRAIN, V114, P2693, DOI 10.1093/brain/114.6.2693; HAYASHI M, 1985, J NEUROSURG, V63, P556, DOI 10.3171/jns.1985.63.4.0556; HAYASHI M, 1987, J NEUROSURG, V67, P97, DOI 10.3171/jns.1987.67.1.0097; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; HAYASHI M, 1978, SURG NEUROL, V9, P343; Hayward R, 2005, J NEUROSURG, V102, P16, DOI 10.3171/ped.2005.102.1.0016; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Imberti R, 2005, J NEUROSURG, V102, P455, DOI 10.3171/jns.2005.102.3.0455; Imberti R, 2000, J NEUROSURG ANESTH, V12, P124, DOI 10.1097/00008506-200004000-00011; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2013, NEUROCRIT CARE, V19, P69, DOI 10.1007/s12028-013-9857-7; JENSEN F, 1979, ACTA NEUROCHIR, V46, P243, DOI 10.1007/BF01430586; JOHNSTON IH, 1975, J NEUROL NEUROSUR PS, V38, P1076, DOI 10.1136/jnnp.38.11.1076; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Kogure Y, 1989, No To Shinkei, V41, P283; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Lang E.W., 2013, OPEN CRIT CARE MED J, V6, P1, DOI [10.2174/1874828701306010001, DOI 10.2174/1874828701306010001]; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lazaridis C, 2014, J CRIT CARE, V29, P303, DOI 10.1016/j.jcrc.2013.12.002; Lewis PM, 2014, NEUROCRIT CARE; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MATSUDA M, 1979, J NEUROSURG, V50, P483, DOI 10.3171/jns.1979.50.4.0483; MATSUURA S, 1986, JPN J PHYSIOL, V36, P857, DOI 10.2170/jjphysiol.36.857; Nordstrom CH, 1993, LAKARTIDNINGEN, V90, P31; Oshorov A. V., 2013, Anesteziologiya i Reanimatologiya, P44; Radolovich DK, 2010, ANESTH ANALG, V110, P165, DOI 10.1213/ANE.0b013e3181c0722f; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Sandler AL, 2013, J NEUROSURG-PEDIATR, V11, P653, DOI 10.3171/2013.2.PEDS12404; Shahsavari S, 2011, IEEE ENG MED BIO, P3792, DOI 10.1109/IEMBS.2011.6090768; Stevens SA, 2008, IEEE T BIO-MED ENG, V55, P388, DOI 10.1109/TBME.2007.900552; SUTTON LN, 1986, NEUROSURGERY, V18, P756, DOI 10.1227/00006123-198606000-00013; TAKAYASU M, 1989, J NEUROSURG, V71, P711, DOI 10.3171/jns.1989.71.5.0711; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Torbey MT, 2004, CEPHALALGIA, V24, P495, DOI 10.1111/j.1468-2982.2004.00688.x; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; Ursino M, 2009, IEEE ENG MED BIOL, V28, P63, DOI 10.1109/MEMB.2009.934622; Varsos GV, 2013, NEUROCRIT CARE, V18, P341, DOI 10.1007/s12028-013-9830-5; WALD A, 1977, ANN NEUROL, V1, P486, DOI 10.1002/ana.410010515; Watling CJ, 2002, J NEUROSURG, V97, P224, DOI 10.3171/jns.2002.97.1.0224; WAYENBERG JL, 1995, SLEEP, V18, P223, DOI 10.1093/sleep/18.4.223; YASUNAMI T, 1987, ACTA NEUROL SCAND, V76, P94, DOI 10.1111/j.1600-0404.1987.tb03552.x	63	11	11	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2015	23	1					85	91		10.1007/s12028-014-0074-9			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CN8FJ	WOS:000358674600013	25501688				2022-02-06	
J	Mayer, SW; Stewart, JR; Fadell, MF; Kestel, L; Novais, EN				Mayer, Stephanie W.; Stewart, Jaime R.; Fadell, Michael F.; Kestel, Lauryn; Novais, Eduardo N.			MRI as a reliable and accurate method for assessment of posterior hip dislocation in children and adolescents without the risk of radiation exposure	PEDIATRIC RADIOLOGY			English	Article						Acetabular fracture; Children; Computed tomography; Hip; Labrum; Posterior hip dislocation; Magnetic resonance imaging	TRAUMATIC DISLOCATION; COMPUTED-TOMOGRAPHY; FRACTURE-DISLOCATIONS; ACETABULAR FRACTURE; STABILITY; WALL; ENTRAPMENT; CHILDHOOD	Posterior hip dislocation in children and adolescents may involve the non-ossified posterior acetabular wall. Plain radiographs and computed tomography (CT) have been shown to underestimate injury to the unossified acetabulum as well as associated soft-tissue structures. The purpose of this study was to describe findings on radiographs, CT and magnetic resonance imaging (MRI) after posterior hip dislocation in a series of adolescents and to report the intraoperative findings, which are considered the gold standard. Measurements of the posterior wall length using MRI and CT scans were also performed. After institutional review board approval, 40 patients who sustained a traumatic posterior dislocation of the hip between September 2007 and April 2014 were identified. Inclusion criteria were (1) age younger than 16 years old and (2) availability of MRI obtained following closed reduction of the hip. Eight male patients and one female patient with an average age of 13.2 years (range: 10.1-16.2 years) underwent hip MRI following posterior dislocation. Seven of the nine patients also underwent evaluation by CT. Plain radiographs, CT scans and MRI were evaluated in all patients by a single pediatric radiologist blinded to surgical findings for joint space asymmetry, posterior wall fracture, femoral head fracture, labrum tear, complete or partial ligamentum teres rupture and presence of intra-articular fragments. Six patients underwent surgical treatment and the intraoperative findings were compared with the imaging findings. CT identified all bone injuries but underestimated the involvement of posterior wall fractures. Assessment of the posterior wall size and fracture displacement was possible with MRI. All surgically confirmed soft-tissue injuries, including avulsion of the posterior labrum, were identified preoperatively on MRI. The measurement of posterior wall length was not statistically different using CT and MRI. Intraoperative pathological findings at the time of open surgical treatment were universally recognized on MRI but not on CT scans. MRI should be considered for evaluation of the hip following closed reduction for the treatment of a posterior dislocation in children and adolescents as it reliably allows assessment of intra-articular pathology without the risk of radiation exposure.	[Mayer, Stephanie W.; Kestel, Lauryn; Novais, Eduardo N.] Childrens Hosp Colorado, Dept Orthopaed Surg, Aurora, CO 80045 USA; [Mayer, Stephanie W.; Kestel, Lauryn; Novais, Eduardo N.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Stewart, Jaime R.; Fadell, Michael F.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Radiol, Aurora, CO 80045 USA		Novais, EN (corresponding author), Childrens Hosp Colorado, Dept Orthopaed Surg, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	eduardo.novais@childrenscolorado.org					American Association of Physicists in Medicine, 2008, 96 AAPM; American Association of Physicists in Medicine (AAPM), 2011, COLL OUP PARK REP AA; CALKINS MS, 1988, CLIN ORTHOP RELAT R, P152; Chun KA, 2004, SKELETAL RADIOL, V33, P728, DOI 10.1007/s00256-004-0800-z; Elder G, 2004, CAN J SURG, V47, P290; Fabricant PD, 2013, J BONE JOINT SURG AM, V95A, P230, DOI [10.2106/JBJS.L.00592, 10.2106/JBJS.L.00772]; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Hearty T, 2011, J ORTHOP TRAUMA, V25, pE68, DOI 10.1097/BOT.0b013e3181f9a7ba; KEITH JE, 1988, J BONE JOINT SURG AM, V70A, P711, DOI 10.2106/00004623-198870050-00011; Manner HM, 2012, J PEDIATR ORTHOP B, V21, P574, DOI 10.1097/BPB.0b013e328357bf04; Moed BR, 2009, J ORTHOP TRAUMA, V23, P7, DOI 10.1097/BOT.0b013e31818f9a5c; Moed BR, 2003, J BONE JOINT SURG AM, V85A, P512, DOI 10.2106/00004623-200303000-00018; Nepple Jeffrey J, 2011, Iowa Orthop J, V31, P187; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; Potter HG, 1998, J BONE JOINT SURG AM, V80A, P1276, DOI 10.2106/00004623-199809000-00005; Rubel IF, 2002, PEDIATR RADIOL, V32, P435, DOI 10.1007/s00247-001-0634-y; SHEA KP, 1986, J PEDIATR ORTHOPED, V6, P215, DOI 10.1097/01241398-198603000-00017; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; VAILAS JC, 1989, J TRAUMA, V29, P1494, DOI 10.1097/00005373-198911000-00007; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; Vialle R, 2004, PEDIATR RADIOL, V34, P970, DOI 10.1007/s00247-004-1299-0	21	11	11	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	AUG	2015	45	9					1355	1362		10.1007/s00247-015-3317-9			8	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	CO6UN	WOS:000359292100010	25801904				2022-02-06	
J	Shunmugavel, A; Khan, M; Hughes, FM; Purves, JT; Singh, A; Singh, I				Shunmugavel, Anandakumar; Khan, Mushfiquddin; Hughes, Francis M.; Purves, J. Todd; Singh, Avtar; Singh, Inderjit			S-Nitrosoglutathione protects the spinal bladder: Novel therapeutic approach to post-spinal cord injury bladder remodeling	NEUROUROLOGY AND URODYNAMICS			English	Article						bladder dysfunction; GSNO; ICAM-1; inflammation; iNOS; spinal cord injury	EXTERNAL URETHRAL SPHINCTER; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; URINARY-BLADDER; RAT MODEL; OXIDATIVE INJURY; EXPRESSION; NEUROREPAIR; DYSFUNCTION; DISRUPTION	AimsBladder and renal dysfunction are secondary events of the inflammatory processes induced by spinal cord injury (SCI). S-Nitrosoglutathione (GSNO), an endogenous nitrosylating agent is pleiotropic and has anti-inflammatory property. Hence, GSNO ameliorates inflammatory sequelae observed in bladder and renal tissues after SCI. Thus, we postulate that GSNO will improve the recovery of micturition dysfunction by quenching the bladder tissue inflammation associated with SCI. MethodsContusion-based mild SCI was induced in female Sprague-Dawley rats. Sham operated rats served as the controls. SCI rats were gavaged daily with GSNO (50 mu g/kg) or vehicle. Bladder function was assessed by urodynamics at 2 and 14 days following SCI. Urine protein concentration and osmolality were measured. Bladder and kidney tissues were analyzed by histology and immunofluorescence for a variety of endpoints related to inflammation. ResultsTwo days after SCI, urodynamics demonstrated a hyperreflexive bladder with overflow and no clear micturition events. By Day 14, vehicle animals regained a semblance of a voiding cycle but with no definite intercontraction intervals. GSNO-treated SCI-rats showed nearly normal cystometrograms. Vehicle-treated SCI rats had increased bladder wet weight, proteinuria, and urine osmolality at Day 14, which was reversed by GSNO treatment. In addition, the SCI-induced increase in immune cell infiltration, collagen deposition, iNOS, and ICAM-1 expression and apoptosis were attenuated by GSNO. ConclusionsThese results indicate that oral administration of GSNO hastens the recovery of bladder function after mild contusion-induced SCI through dampening the inflammation sequelae. These findings also suggest that GSNO-mediated redox modulation may be a novel therapeutic target for the treatment of mild SCI-induced renal and bladder dysfunction. Neurourol. Urodynam. 34:519-526, 2015. (c) 2014 Wiley Periodicals, Inc.	[Shunmugavel, Anandakumar; Khan, Mushfiquddin; Singh, Inderjit] Med Univ S Carolina, Charles P Darby Childrens Res Inst, Dept Pediat, Charleston, SC 29425 USA; [Hughes, Francis M.; Purves, J. Todd] Med Univ S Carolina, Charles P Darby Childrens Res Inst, Dept Urol, Charleston, SC 29425 USA; [Purves, J. Todd] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Pathol & Lab Med Serv, Charleston, SC 29425 USA; [Singh, Avtar] Med Univ S Carolina, Pathol & Lab Med Serv, Ralph H Johnson Vet Adm Med Ctr, Charleston, SC 29425 USA		Singh, I (corresponding author), Med Univ S Carolina, Darby Childrens Res Inst, 173 Ashley Ave, Charleston, SC 29425 USA.	saklaks@gmail.com	Hughes, Francis M/G-8036-2017	Hughes, Francis/0000-0003-3776-3653	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-72511]; Extramural Research Facilities Program of the National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [CO6 RR0015455]; Spinal Research Foundation VA; Heather Perkins Trew Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072511] Funding Source: NIH RePORTER	Grant sponsor: NIH; Grant number: NS-72511; Grant sponsor: Extramural Research Facilities Program of the National Center for Research Resources; Grant number: CO6 RR0015455; Grant sponsor: The Spinal Research Foundation VA; Grant sponsor: Heather Perkins Trew Foundation	Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; BRENT L, 1975, INVEST UROL, V12, P494; Burnett AL, 1997, NAT MED, V3, P571, DOI 10.1038/nm0597-571; Cameron AP, 2012, J UROLOGY, V187, P391, DOI 10.1016/j.juro.2011.10.020; Caremel R, 2010, EUR UROL, V58, P616, DOI 10.1016/j.eururo.2010.07.026; Chen SS, 2009, J FORMOS MED ASSOC, V108, P627, DOI 10.1016/S0929-6646(09)60383-1; Chikawa T, 2001, J NEUROTRAUM, V18, P93, DOI 10.1089/089771501750055802; Chou PCT, 2011, J MAGN RESON IMAGING, V33, P1301, DOI 10.1002/jmri.22574; David BT, 2010, EXP NEUROL, V226, P128, DOI 10.1016/j.expneurol.2010.08.014; Deveaud CM, 1998, J UROLOGY, V160, P1518, DOI 10.1016/S0022-5347(01)62606-5; Dorsher PT, 2012, ADV UROL, V2012, DOI 10.1155/2012/816274; Duan SJ, 2007, CELL MOL IMMUNOL, V4, P353; Duan SJ, 2009, APOPTOSIS, V14, P236, DOI 10.1007/s10495-008-0288-4; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Green M, 2004, UROLOGY, V63, P688, DOI 10.1016/j.urology.2003.11.022; Hamarat M, 2010, CHINESE J PHYSIOL, V53, P145, DOI 10.4077/CJP.2010.AMK035; Heise RL, 2012, BIOMECH MODEL MECHAN, V11, P131, DOI 10.1007/s10237-011-0298-y; Hess MJ, 2008, SPINAL CORD, V46, P622, DOI 10.1038/sc.2008.25; Horst M, 2012, J UROLOGY, P747; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; KRUSE MN, 1990, BRAIN RES, V532, P182, DOI 10.1016/0006-8993(90)91758-9; Lee HJ, 2012, CELL TRANSPLANT, V21, P959, DOI 10.3727/096368911X627516; Li QJ, 2012, AM J PHYSIOL-GASTR L, V303, pG103, DOI 10.1152/ajpgi.00381.2011; Manack A, 2011, NEUROUROL URODYNAM, V30, P395, DOI 10.1002/nau.21003; Marson L, 1997, J COMP NEUROL, V389, P584; MATTIASSON A, 1982, J UROLOGY, V128, P1340, DOI 10.1016/S0022-5347(17)53503-X; MIMATA H, 1993, UROL INT, V51, P89, DOI 10.1159/000282520; Moore Courtenay K, 2006, Curr Urol Rep, V7, P447, DOI 10.1007/s11934-006-0052-7; Murray CI, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013441; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; Ozawa H, 1999, J UROLOGY, V162, P2211, DOI 10.1016/S0022-5347(05)68161-X; Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010; Sakakima H, 2012, RESTOR NEUROL NEUROS, V30, P383, DOI 10.3233/RNN-2012-110209; Sasatomi K, 2008, UROLOGY, V72, P696, DOI 10.1016/j.urology.2007.12.002; Shunmugavel A, 2012, J NEUROIMMUNE PHARM, P274; Shunmugavel Anandakumar, 2012, Neurosci Med, V3, P294; Shunmugavel A, 2012, J SEX MED, V9, P148, DOI 10.1111/j.1743-6109.2011.02526.x; Shunmugavel A, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-17; STASKIN DR, 1991, UROL CLIN N AM, V18, P309; Steinbicker AU, 2011, NITRIC OXIDE-BIOL CH, V25, P294, DOI 10.1016/j.niox.2011.05.006; Watanabe T, 1996, UROL CLIN N AM, V23, P459, DOI 10.1016/S0094-0143(05)70325-6; Wognum S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005852; Yu YM, 2004, NEUROREPORT, V15, P2103, DOI 10.1097/00001756-200409150-00021	45	11	11	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34	6					519	526		10.1002/nau.22619			8	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	CM3UF	WOS:000357609500005	24853799	Green Accepted			2022-02-06	
J	Wang, XY; Ba, YC; Xiong, LL; Li, XL; Zou, Y; Zhu, YC; Zhou, XF; Wang, TH; Wang, F; Tian, HL; Li, JT				Wang, Xu-Yang; Ba, Ying-Chun; Xiong, Liu-Lin; Li, Xiao-li; Zou, Yu; Zhu, Ye-Chun; Zhou, Xin-Fu; Wang, Ting-Hua; Wang, Fang; Tian, Heng-Li; Li, Jin-Tao			Endogenous TGF beta 1 Plays a Crucial Role in Functional Recovery After Traumatic Brain Injury Associated with Smad3 Signal in Rats	NEUROCHEMICAL RESEARCH			English	Article						TGF beta 1; Traumatic brain injury; RNA interference; Neural protection	GROWTH-FACTOR-BETA; CILIARY NEUROTROPHIC FACTOR; DORSAL-ROOT GANGLION; SPINAL-CORD-INJURY; NEURONS IN-VITRO; NEURAL PLASTICITY; NT-3 EXPRESSION; NERVOUS-SYSTEM; GLIAL SCAR; ADULT RATS	Transforming growth factor-beta 1 (TGF beta 1) has a diverse role in astrogliosis and neuronal survival, but the underlying mechanism remains to be elucidated, especially in traumatic brain injury (TBI). Here, we show that the expression of TGF beta 1 was increased in the pericontusional region, accompanied with astrogliosis and neuronal loss in TBI rats. Moreover, TGF beta 1 knockdown not only reduced the number of neurons and inhibited astrogliosis but also resulted in a significant neurological dysfunction in rats with TBI. Subsequently, Smad3, a key downstream signal of TGF beta 1, was involved in pericontusional region after TBI. These findings therefore indicate that TGF beta 1 is involved in neuroprotection and astrogliosis, via activation of down stream Smad3 signal in the brain after injury.	[Wang, Xu-Yang; Li, Xiao-li; Tian, Heng-Li] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China; [Ba, Ying-Chun; Zhu, Ye-Chun; Zhou, Xin-Fu; Wang, Ting-Hua; Wang, Fang; Li, Jin-Tao] Kunming Med Univ, Inst Neurosci, Kunming 650031, Peoples R China; [Ba, Ying-Chun; Zhu, Ye-Chun; Zhou, Xin-Fu; Wang, Ting-Hua; Wang, Fang; Li, Jin-Tao] Kunming Med Univ, Dept Biochem, Kunming 650031, Peoples R China; [Xiong, Liu-Lin; Zou, Yu; Wang, Ting-Hua] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Dept Anesthesiol,Inst Neurol Dis, Chengdu 610041, Peoples R China; [Zhou, Xin-Fu] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Div Hlth Sci, Adelaide, SA 5001, Australia		Wang, F (corresponding author), Kunming Med Univ, Inst Neurosci, Kunming 650031, Peoples R China.	fangwang00@sina.com; tianhengli1964@yahoo.com.cn; lijintaokm@163.com	zhou, xin-fu/F-4119-2013; Zhou, Xiaofang/C-6169-2013	zhou, xin-fu/0000-0002-8687-0175; Zhou, Xiaofang/0000-0001-6343-1455	natural science foundation of Yunnan provinceNatural Science Foundation of Yunnan Province [2013FB119]; natural science foundation of Zhejiang provinceNatural Science Foundation of Zhejiang Province [Y2090864]	This research was supported by natural science foundation of Yunnan province (No. 2013FB119), and natural science foundation of Zhejiang province (No. Y2090864).	ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Anesti AM, 2008, NUCLEIC ACIDS RES, V36, P1; Bain JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009567; Bashir S, 2010, PM&R, V2, pS253, DOI 10.1016/j.pmrj.2010.10.015; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Chen J, 2007, NEUROSCI RES, V59, P399, DOI 10.1016/j.neures.2007.08.006; Chin J, 2002, J NEUROSCI, V22; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Harbeck-Seu A, 2011, CURR OPIN ANESTHESIO, V24, P144, DOI 10.1097/ACO.0b013e328344587f; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195; Kaiser O, 2013, NEUROPHARMACOLOGY, V75, P416, DOI 10.1016/j.neuropharm.2013.08.008; Kandasamy M, 2014, J CELL MOL MED, V18, P1444, DOI 10.1111/jcmm.12298; Khodosevich K, 2013, NEURON, V79, P1136, DOI 10.1016/j.neuron.2013.07.011; Kirsch M, 1998, GLIA, V23, P239, DOI 10.1002/(SICI)1098-1136(199807)23:3<239::AID-GLIA6>3.0.CO;2-#; Kopp MA, 2010, GLIA, V58, P1748, DOI 10.1002/glia.21045; Li XL, 2007, NEUROPEPTIDES, V41, P135, DOI 10.1016/j.npep.2007.02.001; Liu F, 2009, NEUROSCI LETT, V450, P158, DOI 10.1016/j.neulet.2008.09.066; Liu J, 2009, NEUROSCI LETT, V466, P1, DOI 10.1016/j.neulet.2009.09.020; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694; Qin DX, 2006, NEUROSCI LETT, V410, P222, DOI 10.1016/j.neulet.2006.10.006; RUDGE JS, 1994, EUR J NEUROSCI, V6, P218, DOI 10.1111/j.1460-9568.1994.tb00264.x; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Wang TH, 2008, NEUROCHEM RES, V33, P1, DOI 10.1007/s11064-007-9398-6; Wang XY, 2009, J MOL NEUROSCI, V37, P97, DOI 10.1007/s12031-008-9095-1; Warraich Z, 2010, PM&R, V2, pS208, DOI 10.1016/j.pmrj.2010.10.016; Welser JV, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-89; Zhang HT, 2007, J HISTOCHEM CYTOCHEM, V55, P1, DOI 10.1369/jhc.6A6952.2006; Zhang Rong-jun, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P348; Zhang W, 2010, GROWTH FACTORS, V28, P351, DOI 10.3109/08977194.2010.485571; Zhou HL, 2008, NEUROPEPTIDES, V42, P95, DOI 10.1016/j.npep.2007.09.007; Zhou J, 2008, TRAUMA SURG, V9, P106; Zhou X, 2009, NEUROPEPTIDES, V43, P363, DOI 10.1016/j.npep.2009.07.001	44	11	11	0	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2015	40	8					1671	1680		10.1007/s11064-015-1634-x			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP2TF	WOS:000359729300013	26253398				2022-02-06	
J	Yumoto, T; Sato, K; Ugawa, T; Ichiba, S; Ujike, Y				Yumoto, Tetsuya; Sato, Keiji; Ugawa, Toyomu; Ichiba, Shingo; Ujike, Yoshihito			Prevalence, Risk Factors, and Short-term Consequences of Traumatic Brain Injury-associated Hyponatremia	ACTA MEDICA OKAYAMA			English	Article						traumatic brain injury; hyponatremia; cranial fracture; fluid intake	INAPPROPRIATE SECRETION; ANTIDIURETIC-HORMONE; CLASSIFICATION	Hyponatremia, a common electrolyte disorder associated with traumatic brain injuries (TBIs), has high mortality and morbidity rates. The aim of this study was to identify the risk factors for hyponatremia associated with TBI. We retrospectively analyzed the cases of TBI patients who were admitted to the emergency intensive care unit at Okayama University Hospital between October 2011 and September 2014. A total of 82 TBI patients were enrolled. The incidences of hyponatremia (serum sodium level of < 135mEq/L) and severe hyponatremia (serum sodium level of < 130mEq/L) within the first 14 days after admission were 51 % (n = 42) and 20 % (n = 16), respectively. After admission, hyponatremia took a median period of 7 days to develop and lasted for a median of 3 days. Multivariate analysis demonstrated that higher fluid intake from days 1 to 3 and the presence of cranial fractures were risk factors for hyponatremia. The 58 patients with hyponatremia experienced fewer ventilator-free days, longer intensive care unit stays, and less favorable outcomes compared to the 24 patients without hyponatremia; however, these differences were not significant. Further studies are needed to determine the optimal management strategy for TBI-associated hyponatremia in the intensive care unit setting.	[Yumoto, Tetsuya; Sato, Keiji; Ugawa, Toyomu; Ichiba, Shingo; Ujike, Yoshihito] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency & Crit Care Med, Okayama 7008558, Japan		Yumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency & Crit Care Med, Okayama 7008558, Japan.	tyumoto@cc.okayama-u.ac.jp	Ichiba, Shingo/AAI-1607-2019				Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Bennani SL, 2003, REV MED INTERNE, V24, P224, DOI 10.1016/S0248-8663(02)00811-1; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Brimioulle S, 2008, INTENS CARE MED, V34, P125, DOI 10.1007/s00134-007-0905-7; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Chitsazian Z, 2013, ARCH TRAUMA RES, V2, P91, DOI 10.5812/atr.9877; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; Friedman B, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.06.001; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kirkman MA, 2013, NEUROCRIT CARE, V18, P406, DOI 10.1007/s12028-012-9805-y; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Padhi R, 2014, INDIAN J CRIT CARE M, V18, P83, DOI 10.4103/0972-5229.126077; PERUZZI WT, 1994, CRIT CARE MED, V22, P252, DOI 10.1097/00003246-199402000-00016; Potts MB, 2011, NEUROSURGERY, V69, P268, DOI 10.1227/NEU.0b013e318218c78f; Rabinstein AA, 2003, NEUROLOGIST, V9, P290, DOI 10.1097/01.nrl.0000095258.07720.89; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zada G, 2007, J NEUROSURG, V106, P66, DOI 10.3171/jns.2007.106.1.66	27	11	17	0	2	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	AUG	2015	69	4					213	218					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CX2IA	WOS:000365519100004	26289912				2022-02-06	
J	Evans, TM; Jaramillo, CA; Sataranatarajan, K; Watts, L; Sabia, M; Qi, W; Van Remmen, H				Evans, T. M.; Jaramillo, C. A.; Sataranatarajan, K.; Watts, L.; Sabia, M.; Qi, W.; Van Remmen, H.			THE EFFECT OF MILD TRAUMATIC BRAIN INJURY ON PERIPHERAL NERVOUS SYSTEM PATHOLOGY IN WILD-TYPE MICE AND THE G93A MUTANT MOUSE MODEL OF MOTOR NEURON DISEASE	NEUROSCIENCE			English	Article						TBI; amyotrophic lateral sclerosis; mouse model; oxidative stress; spinal cord	AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD-INJURY; OXIDATIVE STRESS; SKELETAL-MUSCLE; HEAD-INJURY; ANTIOXIDANT THERAPIES; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; TRANSGENIC MODEL; HIGH-SCHOOL	Traumatic brain injury (TBI) is associated with a risk of neurodegenerative disease. Some suggest a link between TBI and motor neuron disease (MND), including amyotrophic lateral sclerosis (ALS). To investigate the potential mechanisms linking TBI to MND, we measured motor function and neuropathology following mild-TBI in wild-type and a transgenic model of ALS, G93A mutant mice. Mild-TBI did not alter the lifespan of G93A mice or age of onset; however, rotarod performance was impaired in G93A verses wild-type mice. Grip strength was reduced only in G93A mice after mild-TBI. Increased electromyography (EMG) abnormalities and markers of denervation (AchR, Runx1) indicate that mild-TBI may result in peripheral effects that are exaggerated in G93A mice. Markers of inflammation (cell edema, astrogliosis and microgliosis) were detected at 24 and 72 h in the brain and spinal cord in wild-type and G93A mice. Levels of F2-isoprostanes, a marker of oxidative stress, were increased in the spinal cord 24 h post mild-TBI in wild-type mice but were not affected by TBI in G93A mice. In summary, our data demonstrate that mild-TBI induces inflammation and oxidative stress and negatively impacts muscle denervation and motor performance, suggesting mild-TBI can potentiate motor neuron pathology and influence the development of MND in mice. Published by Elsevier Ltd. on behalf of IBRO.	[Evans, T. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Watts, L.; Van Remmen, H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Watts, L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Res, Imaging Inst, San Antonio, TX 78229 USA; [Jaramillo, C. A.] Polytrauma Rehabil Ctr, San Antonio, TX USA; [Jaramillo, C. A.; Sabia, M.; Qi, W.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Jaramillo, C. A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, San Antonio, TX 78229 USA; [Sataranatarajan, K.; Van Remmen, H.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Sataranatarajan, K.; Van Remmen, H.] Oklahoma City VA Med Ctr, Oklahoma City, OK USA		Van Remmen, H (corresponding author), Oklahoma Med Res Fdn, Free Rad Biol & Aging Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	EvansTM@uthscsa.edu; jaramilloc3@uthscsa.edu; Kavithalakshmi-Sataranatarajan@omrf.org; wattsl@uthscsa.edu; sabia@uthscsa.edu; Qi@uthscsa.edu; holly-vanremmen@omrf.org	Watts, Lora Talley/A-2724-2012	Watts, Lora Talley/0000-0002-2337-1504; Evans, Teresa/0000-0002-3860-2205	independent National Research Service Award, National Institute for Neurological Diseases and Stroke [1F31NS080508-01]; Hartford Foundation/American Federation for Aging Research Scholars in Geriatric Medicine Program; VA Merit Review grantUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS080508] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000517] Funding Source: NIH RePORTER	This research was funded in part by an independent National Research Service Award, National Institute for Neurological Diseases and Stroke (1F31NS080508-01; Evans TM) and the Hartford Foundation/American Federation for Aging Research Scholars in Geriatric Medicine Program (Jaramillo CA) and a VA Merit Review grant to Dr. Van Remmen. We also acknowledge the assistance of Vivian Diaz and the Nathan Shock Center in animal care and maintenance and collection of body weight and body composition data. We would also like to acknowledge the help and guidance of Shane Sprague and the Neurosurgery Department Brain Injury Core for their support in establishing our TBI procedures.	Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; CHIO A, 1991, NEUROEPIDEMIOLOGY, V10, P174, DOI 10.1159/000110267; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Evans Teresa M, 2014, Transl Proteom, V3, P10; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; GALLAGHER JP, 1987, ACTA NEUROL SCAND, V75, P145, DOI 10.1111/j.1600-0404.1987.tb07909.x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, PATHOL BIOL, V44, P51; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.0.CO;2-H; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Ishido M, 2004, ACTA PHYSIOL SCAND, V180, P281, DOI 10.1046/j.0001-6772.2003.01238.x; Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kansagara D., 2013, COMPLICATIONS MILD T; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KURTZKE JF, 1980, NEUROLOGY, V30, P453, DOI 10.1212/WNL.30.5.453; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Martin PT, 2009, AM J PHYSIOL-CELL PH, V296, pC476, DOI 10.1152/ajpcell.00456.2008; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Milatovic D, 2011, METHODS MOL BIOL, V758, P195, DOI 10.1007/978-1-61779-170-3_13; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schmidt S, 2008, NEUROEPIDEMIOLOGY, V30, P191, DOI 10.1159/000126911; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; SPAANS F, 1982, J NEUROL SCI, V57, P291, DOI 10.1016/0022-510X(82)90036-3; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Winkler EA, 2014, P NATL ACAD SCI US; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135	54	11	12	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 9	2015	298						410	423		10.1016/j.neuroscience.2015.04.041			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI5GT	WOS:000354783300032	25921732	Green Accepted			2022-02-06	
J	Palermo, S; Cauda, F; Costa, T; Duca, S; Gallino, G; Geminiani, G; Keller, R; Amanzio, M				Palermo, S.; Cauda, F.; Costa, T.; Duca, S.; Gallino, G.; Geminiani, G.; Keller, R.; Amanzio, M.			Unawareness of bipolar disorder: the role of the cingulate cortex	NEUROCASE			English	Article						fMRI; awareness deficit; remitted bipolar disorder patients; anterior cingulate cortex; response inhibition	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RATING-SCALE; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; EUTHYMIC PATIENTS; SOCIAL COGNITION; SELF-AWARENESS; I DISORDER; INSIGHT	Reduced awareness of illness is a well-known phenomenon that has been understudied in remitted patients with bipolar disorder. In particular, the relationship between reduced awareness and executive dysfunction is an intriguing question that has yet to be resolved. The aim of the current study is to analyze the link between reduced awareness, brain dysfunction, and concomitant cognitive-behavioral disturbances from a neurocognitive perspective. In previous studies, we demonstrated the role of the anterior cingulate cortex (ACC) in the unawareness of distinct pathologies that exhibit overlapping symptoms in the context of overlapping circuit-specific dysfunction. Given the clinical importance of the results obtained, the present study considers six aware and four unaware remitted bipolar disorder patients. Cingulate functionality was assessed with functional magnetic resonance imaging while patients performed a go/no-go task. Patients were also studied on an overall cognitive task battery and with behavioral assessment of mood changes in terms of apathy and disinhibited behavior. Unaware patients showed frontoparietal hypo-perfusion, with a significant reduction of task-sensitive activity in the bilateral superior and middle frontal gyrus, putamen, insular, and ACCs.	[Palermo, S.; Cauda, F.; Costa, T.] Univ Turin, Dept Psychol, Turin, Italy; [Cauda, F.; Costa, T.; Duca, S.; Geminiani, G.] Koelliker Hosp, CCS fMRI, Turin, Italy; [Gallino, G.] ASL TO1, Natl Hlth Syst, Dept Mental Hlth, Turin, Italy; [Geminiani, G.; Amanzio, M.] Dept Psychol, Turin, Italy; [Geminiani, G.; Amanzio, M.] NIT, Turin, Italy; [Geminiani, G.; Amanzio, M.] Natl Inst Neurosci, Turin, Italy; [Keller, R.] ASL TO2, Natl Hlth Syst, Dept Mental Hlth, Turin, Italy		Amanzio, M (corresponding author), Dept Psychol, Turin, Italy.	martina.amanzio@unito.it	Cauda, Franco/G-5021-2010; Palermo, Sara/M-7102-2013; Amanzio, Martina/A-9085-2010; Keller, Roberto/AAC-6353-2022	Cauda, Franco/0000-0003-1526-8475; Palermo, Sara/0000-0002-1451-3793; Amanzio, Martina/0000-0002-2504-032X; Keller, Roberto/0000-0002-6873-9827; BRISCHETTO COSTA, Tommaso/0000-0002-0822-862X			Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; AMADOR XF, 1993, AM J PSYCHIAT, V150, P873; Amador XF, 2004, INSIGHT PSYCHOSIS AW; Amador XF, 1990, SCALE ASSESS UNAWARE; Amanzio M, 2008, BRAIN LANG, V107, P1, DOI 10.1016/j.bandl.2007.08.003; Amanzio M, 2013, J INT NEUROPSYCH SOC, V19, P63, DOI 10.1017/S1355617712000896; Amanzio M, 2011, BRAIN, V134, P1061, DOI 10.1093/brain/awr020; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BEWICK KC, 1995, NEUROREHABILITATION, V5, P367, DOI 10.3233/NRE-1995-5411; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brooks JO, 2010, BIPOLAR DISORD, V12, P866, DOI 10.1111/j.1399-5618.2010.00881.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Colombo L, 2002, GIORNALE ITALIANO PS, DOI DOI 10.1421/1249; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; D'Agata F, 2011, NATURE PRECEDINGS; Dell'Osso L, 2000, COMPR PSYCHIAT, V41, P242, DOI 10.1053/comp.2000.7432; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Dias VV, 2008, ACTA PSYCHIAT SCAND, V117, P28, DOI 10.1111/j.1600-0447.2007.01110.x; Dias VV, 2008, J AFFECT DISORDERS, V110, P75, DOI 10.1016/j.jad.2008.01.010; Dimitrov M, 1999, BRAIN COGNITION, V41, P213, DOI 10.1006/brcg.1999.1121; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P324, DOI 10.1006/ccog.2000.0449; First M.B., 1996, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goldstein RZ, 2001, NEUROREPORT, V12, P2595, DOI 10.1097/00001756-200108080-00060; Guy W., 1976, CLIN GLOBAL IMPRESSI; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Jovanovski D, 2007, J NERV MENT DIS, V195, P165, DOI 10.1097/01.nmd.0000253765.05357.c7; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; Koren D, 2004, SCHIZOPHR RES, V70, P195, DOI 10.1016/j.schres.2004.02.004; Koren D, 2006, SCHIZOPHRENIA BULL, V32, P310, DOI 10.1093/schbul/sbj035; Laicardi C, 1997, WAIS R CONTRIBUTO TA; LEYS D, 1989, REV NEUROL-FRANCE, V145, P443; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Nelson H.E., 1982, NATL ADULT READING T; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Palermo S, 2014, NEUROCASE, V20, P540, DOI 10.1080/13554794.2013.826686; Pavuluri MN, 2012, BEHAV BRAIN RES, V226, P493, DOI 10.1016/j.bbr.2011.10.003; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Posner MI., 1994, IMAGES MIND; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Roncone R, 1999, ACTA PSYCHIAT SCAND, V100, P229, DOI 10.1111/j.1600-0447.1999.tb10850.x; Samame C, 2012, ACTA PSYCHIAT SCAND, V125, P266, DOI 10.1111/j.1600-0447.2011.01808.x; Sartori G., 1995, PROFESSIONE PSICOLOG, V4, P1; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SPINNLER H, 1987, ITALIAN J NEUROLOGIC, V6; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Strakowski SM, 2005, AM J PSYCHIAT, V162, P1697, DOI 10.1176/appi.ajp.162.9.1697; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Trevisi M, 2012, PSYCHOPATHOLOGY, V45, P235, DOI 10.1159/000329998; Varga M, 2006, J AFFECT DISORDERS, V91, P1, DOI 10.1016/j.jad.2005.09.002; Ventura J., 1993, INT J METHODS PSYCHI, V3, P227; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vuilleumier P, 2004, CORTEX, V40, P9, DOI 10.1016/S0010-9452(08)70918-3; Wechsler D., 1981, WAIS R SCALA INTELLI; Wechsler D., 1945, WECHSLER MEMORY SCAL; Yen CF, 2002, J NERV MENT DIS, V190, P847, DOI 10.1097/00005053-200212000-00008; Yen CF, 2008, J AFFECT DISORDERS, V108, P121, DOI 10.1016/j.jad.2007.10.004; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	74	11	11	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	JUL 4	2015	21	4					438	447		10.1080/13554794.2014.917682			10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	CG6IN	WOS:000353403300005	24837443				2022-02-06	
J	Arduini, M; Mancini, F; Farsetti, P; Piperno, A; Ippolito, E				Arduini, M.; Mancini, F.; Farsetti, P.; Piperno, A.; Ippolito, E.			A new classification of peri-articular heterotopic ossification of the hip associated with neurological injury 3D CT SCAN ASSESSMENT AND INTRA-OPERATIVE FINDINGS	BONE & JOINT JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; RESECTION	In this paper we propose a new classification of neurogenic peri-articular heterotopic ossification (HO) of the hip based on three-dimensional (3D) CT, with the aim of improving pre-operative planning for its excision. A total of 55 patients (73 hips) with clinically significant HO after either traumatic brain or spinal cord injury were assessed by 3D-CT scanning, and the results compared with the intra-operative findings. At operation, the gross pathological anatomy of the HO as identified by 3D-CT imaging was confirmed as affecting the peri-articular hip muscles to a greater or lesser extent. We identified seven patterns of involvement: four basic (anterior, medial, posterior and lateral) and three mixed (anteromedial, posterolateral and circumferential). Excellent intra-and inter-observer agreement, with kappa values > 0.8, confirmed the reproducibility of the classification system. We describe the different surgical approaches used to excise the HO which were guided by the 3D-CT findings. Resection was always successful. 3D-CT imaging, complemented in some cases by angiography, allows the surgeon to define the 3D anatomy of the HO accurately and to plan its surgical excision with precision.	[Arduini, M.; Mancini, F.; Farsetti, P.; Ippolito, E.] Univ Roma Tor Vergata, I-00133 Rome, Italy; [Piperno, A.] Univ Roma Tor Vergata, Orthopaed Surg, I-00133 Rome, Italy		Ippolito, E (corresponding author), Univ Roma Tor Vergata, Viale Oxford 81, I-00133 Rome, Italy.	ippolito@med.uniroma2.it					BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Fujimura K, 2001, BRIT J ORAL MAX SURG, V39, P294, DOI 10.1054/bjom.2001.0647; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Ippolito E, 1999, J BONE JOINT SURG AM, V81A, P783, DOI 10.2106/00004623-199906000-00005; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Mavrogenis AF, 2012, J ORTHOP TRAUMATOL, V13, P69, DOI 10.1007/s10195-012-0193-z; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955; Wright J G, 1994, J Arthroplasty, V9, P549, DOI 10.1016/0883-5403(94)90104-X	17	11	12	1	5	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	JUL	2015	97B	7					899	904		10.1302/0301-620X.97B7.35031			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	CM2FL	WOS:000357495200007	26130343				2022-02-06	
J	Chen, PY; Tsai, PS; Chen, NH; Chaung, LP; Lee, CC; Chen, CC; Chiu, HT; Lu, YJ; Wei, KC; Chiu, HY				Chen, Pin-Yuan; Tsai, Pei-Shan; Chen, Ning-Hung; Chaung, Li-Pang; Lee, Cheng-Chi; Chen, Ching-Chang; Chiu, Hsiao-Ting; Lu, Yu-Jen; Wei, Kuo-Chen; Chiu, Hsiao-Yean			Trajectories of Sleep and Its Predictors in the First Year Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CIRCADIAN-RHYTHMS; INVENTORY-II; DISTURBANCES; INSOMNIA; PREVALENCE; ACTIGRAPHY; PAIN; METAANALYSIS; COMPLAINTS; DISORDERS	Objectives: To examine how sleep patterns change over the first year following traumatic brain injury (TBI) and to determine whether specific demographic and disease characteristics predict the trajectories of sleep. Design: Prospective study. Participants: Fifty-three patients with first-ever mild to severe TBI. Main Measurements: Sleep measured by actigraphy for 7 consecutive days in the first, third, sixth, and twelfth months following TBI: Chinese versions of Beck Anxiety Inventory and Beck Depression Inventory-II (CBDI-II) measured at the same time points. Data were analyzed with a linear mixed model. Results: Sleep efficiency (the ratio of sleep time to the total time spent in bed) showed a significant upward trend during the study period. Scores on the Chinese version of the Beck Anxiety Inventory and the CBDI-II as well as the use of analgesics significantly predicted the slope of change in sleep efficiency over time. Conclusions: Poor sleep efficiency is a common symptom in the first year among patients with first-ever TBI. Healthcare providers should consider both mental health and pain issues when dealing with sleep complaints in patients with TBI.	[Tsai, Pei-Shan; Chiu, Hsiao-Ting; Chiu, Hsiao-Yean] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei 110, Taiwan; [Chaung, Li-Pang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Sleep Ctr, Taoyuan, Taiwan; [Lee, Cheng-Chi; Lu, Yu-Jen; Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Taoyuan, Taiwan; Taoyuan Gen Hosp, Minist Hlth & Welf, Sinwu Branch, Dept Phys Med & Rehabil, Taoyuan, Taiwan		Chiu, HY (corresponding author), Taipei Med Univ, Grad Inst Nursing, Coll Nursing, 250 Wu Hsing St, Taipei 110, Taiwan.	happyone680315@hotmail.com		Wei, Kuochen/0000-0003-3505-2196	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2314-B-182A-047-MY2]	This research was supported by a grant (NSC 99-2314-B-182A-047-MY2) from the Ministry of Science and Technology, Taiwan.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, 1993, BECK ANXIETY INVENTO; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chan DW, 1991, PSYCHOL ASSESSMENT, V3, P616, DOI DOI 10.1037/1040-3590.3.4.616; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Che HH, 2006, FORMOSAN J MED, V10, P447, DOI DOI 10.6320/FJM.2006.10(4).05; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Lavigne GJ, 2011, CURR RHEUMATOL REP, V13, P535, DOI 10.1007/s11926-011-0209-3; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; West B.T., 2007, LINEAR MIXED MODELS; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	32	11	11	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					E50	E55		10.1097/HTR.0000000000000086			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JB	WOS:000357944800006	25119653				2022-02-06	
J	Chen, XD; Sun, J; Lu, C; Ba, HJ; Chen, MH; Lin, JH; Cai, JY				Chen, Xian-Dong; Sun, Jun; Lu, Chuan; Ba, Hua-Jun; Chen, Mao-Hua; Lin, Jian-Hu; Cai, Jian-Yong			The prognostic value of plasma soluble CD40 ligand levels following aneurysmal subarachnoid hemorrhage	THROMBOSIS RESEARCH			English	Article						Soluble CD40 ligand; Intracranial aneurysmal; Subarachnoid hemorrhage; Prognosis; Severity	VASCULAR ENDOTHELIAL-CELLS; ACUTE CORONARY SYNDROMES; TISSUE FACTOR; ACTIVATED PLATELETS; MYOCARDIAL-INFARCTION; ELEVATED LEVELS; SERUM SCD40L; DISEASE; STROKE; ATHEROSCLEROSIS	Background: Increased circulating soluble CD40 ligand (sCD40L) levels have been reported to be associated with severity and mortality of severe traumatic brain injury. The current study tested the hypothesis that elevated plasma sCD40L levels are predictive of clinical outcomes of aneurysmal subarachnoid hemorrhage (aSAH). Methods: Plasma sCD40L concentrations of 120 aSAH patients and 120 healthy volunteers were measured using enzyme-linked immunosorbent assay. An unfavorable outcome was defined as Glasgow Outcome Scale score of 1-3. Results: Plasma sCD40L levels were significantly elevated in aSAH patients compared with healthy controls; plasma sCD40L levels were highly associated with clinical severity reflected by World Federation of Neurological Surgeons (WFNS) score and Fisher score; sCD40L emerged as an independent predictor of 6-month mortality and unfavorable outcome and 6-month overall survival; although a combined logistic-regression model did not demonstrate the additive benefit of sCD40L to WFNS score and Fisher score, sCD40L possessed similar predictive value to WFNS score and Fisher score based on receiver operating characteristic curves. Conclusions: Higher plasma sCD40L levels on presentation are associated with clinical severity and have potential to be a good prognostic biomarker of aSAH. (C) 2015 Elsevier Ltd. All rights reserved.	[Chen, Xian-Dong; Sun, Jun; Lu, Chuan; Ba, Hua-Jun; Chen, Mao-Hua; Lin, Jian-Hu; Cai, Jian-Yong] Cent Hosp Wenzhou City, Dept Neurosurg, Wenzhou 325000, Peoples R China		Cai, JY (corresponding author), Cent Hosp Wenzhou City, Dept Neurosurg, 32 Dajian Lane, Wenzhou 325000, Peoples R China.	minleihu@163.com			Wenzhou Science and Technology Research Fund Project [Y20130263]	This study was supported by a grant from Wenzhou Science and Technology Research Fund Project (No. Y20130263).	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Burger D, 2004, J IMMUNOL, V173, P1292, DOI 10.4049/jimmunol.173.2.1292; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Clodi K, 1998, BRIT J HAEMATOL, V103, P270, DOI 10.1046/j.1365-2141.1998.01031.x; Danese S, 2003, GUT, V52, P1435, DOI 10.1136/gut.52.10.1435; Davi G, 2009, J ATHEROSCLER THROMB, V16, P707; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dhar R, 2008, NEUROCRIT CARE, V8, P404, DOI 10.1007/s12028-008-9054-2; DRAKE CG, 1988, J NEUROSURG, V68, P985; Erturan I, 2014, INT J DERMATOL, V53, P503, DOI 10.1111/ijd.12397; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Ferro D, 2007, ARTERIOSCL THROM VAS, V27, P2763, DOI 10.1161/ATVBAHA.107.152777; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Frossard JL, 2006, WORLD J GASTROENTERO, V12, P1613, DOI 10.3748/wjg.v12.i10.1613; Garlichs CD, 2003, STROKE, V34, P1412, DOI 10.1161/01.STR.0000074032.64049.47; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Hanafy KA, 2010, J CLIN NEUROSCI, V17, P22, DOI 10.1016/j.jocn.2009.09.003; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102; Ho TC, 2015, CLIN CHIM ACTA, V438, P236, DOI 10.1016/j.cca.2014.08.030; Ichiyama T, 2005, J NEUROL SCI, V239, P53, DOI 10.1016/j.jns.2005.07.010; Khurana VG, 2004, NEUROSURGERY, V55, P69, DOI 10.1227/01.NEU.0000126877.10254.4C; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Ludwiczek O, 2003, INT J COLORECTAL DIS, V18, P142, DOI 10.1007/s00384-002-0425-4; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373, DOI 10.1002/jlb.63.3.373; Nagasawa M, 2005, EUR J HAEMATOL, V74, P54, DOI 10.1111/j.1600-0609.2004.00342.x; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Pusuroglu H, 2014, CORONARY ARTERY DIS, V25, P558, DOI 10.1097/MCA.0000000000000142; Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025	41	11	11	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	JUL	2015	136	1					24	29		10.1016/j.thromres.2015.03.025			6	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	CS2KK	WOS:000361899300007	25944664				2022-02-06	
J	Laouchedi, M; Galanaud, D; Delmaire, C; Fernandez-Vidal, S; Messe, A; Mesmoudi, S; Boumghar, FO; Pelegrini-Issac, M; Puybasset, L; Benali, H; Perlbarg, V				Laouchedi, M.; Galanaud, D.; Delmaire, C.; Fernandez-Vidal, S.; Messe, A.; Mesmoudi, S.; Boumghar, F. Oulebsir; Pelegrini-Issac, M.; Puybasset, L.; Benali, H.; Perlbarg, V.			Deafferentation in thalamic and pontine areas in severe traumatic brain injury	JOURNAL OF NEURORADIOLOGY			English	Article						Traumatic brain injury; Diffusion MRI; Tractography; Thalamus; Pons	DIFFUSION TENSOR; MRI; TRACTOGRAPHY; STEM; DISABILITY; RECOVERY; ATLAS	Purpose: Severe traumatic brain injury (TBI) is characterized mainly by diffuse axonal injuries (DAI). The cortico-subcortical disconnections induced by such fiber disruption play a central role in consciousness recovery. We hypothesized that these cortico-subcortical deafferentations inferred from diffusion MRI data could differentiate between TBI patients with favorable or unfavorable (death, vegetative state, or minimally conscious state) outcome one year after injury. Methods: Cortico-subcortical fiber density maps were derived by using probabilistic tractography from diffusion tensor imaging data acquired in 24 severe TBI patients and 9 healthy controls. These maps were compared between patients and controls as well as between patients with favorable (FO) and unfavorable (UFO) 1-year outcome to identify the thalamo-cortical and ponto-thalamo-cortical pathways involved in the maintenance of consciousness. Results: Thalamo-cortical and ponto-thalamo-cortical fiber density was significantly lower in TBI patients than in healthy controls. Comparing FO and UFO TBI patients showed thalamo-cortical deafferentation associated with unfavorable outcome for projections from ventral posterior and intermediate thalamic nuclei to the associative frontal, sensorimotor and associative temporal cortices. Specific ponto-thalamic deafferentation in projections from the upper dorsal pons (including the reticular formation) was also associated with unfavorable outcome. Conclusion: Fiber density of cortico-subcortical pathways as measured from diffusion MRI tractography is a relevant candidate biomarker for early prediction of one-year favorable outcome in severe TBI. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Laouchedi, M.; Messe, A.; Mesmoudi, S.; Pelegrini-Issac, M.; Puybasset, L.; Benali, H.; Perlbarg, V.] Univ Paris 06, UMCR2, CHU Pitie Salpetriere, Sorbonne Univ,Inserm U1146,CNRS UMR7371,Lab Image, F-75634 Paris, France; [Laouchedi, M.; Boumghar, F. Oulebsir] USTHB, LRPE, ParlMed Team, Algiers, Algeria; [Galanaud, D.] Hop La Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France; [Delmaire, C.] CHRU Lille, Dept Neuroradiol, F-59037 Lille, France; [Fernandez-Vidal, S.] INSERM, Paris, France; [Fernandez-Vidal, S.] Univ Paris 06, UMR S 975, CNRS, UMR 7225,Ctr Rech,Inst Cerveau & Moelle Epiniere, Paris, France; [Fernandez-Vidal, S.] Ctr Neuroimagerie Rech, Inst Cerveau & Moelle Epiniere, Paris, France; [Mesmoudi, S.] Univ Paris 01, MATRICE Project, F-75231 Paris 05, France; [Puybasset, L.] Hop La Pitie Salpetriere, AP HP, Surg Neurointens Care Unit, Paris, France		Perlbarg, V (corresponding author), Univ Paris 06, UMCR2, CHU Pitie Salpetriere, Sorbonne Univ,Inserm U1146,CNRS UMR7371,Lab Image, 91 Blvd Hop, F-75634 Paris, France.	Vincent.Perlbarg@imed.jussieu.fr	Messe, Arnaud/I-1738-2019	Messe, Arnaud/0000-0001-9081-3088; Pelegrini-Issac, Melanie/0000-0003-3260-5795	French Ministry of Health (Projet Hospitalier de Recherche Clinique registration) [P051061]; Assistance publique-Hopitaux de Paris; project "Projet de recherche CNEPRU, equipe Parlmed, ParlMed Team, LRPE, USTHB, Algiers, Algeria" [J0200220100070]; program "Investissements d' avenir"French National Research Agency (ANR) [ANR-10-IAIHU-06]	This study was funded by a grant from the French Ministry of Health (Projet Hospitalier de Recherche Clinique registration #P051061 [2005]) and from departmental funds from the Assistance publique-Hopitaux de Paris. This work has also received support from the project "Projet de recherche CNEPRU J0200220100070, equipe Parlmed, ParlMed Team, LRPE, USTHB, Algiers, Algeria". Finally, The research leading to these results has also received funding from the program "Investissements d' avenir" ANR-10-IAIHU-06.	Bardinet E, 2009, J NEUROSURG, V110, P208, DOI 10.3171/2008.3.17469; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; BOGEN JE, 1995, CONSCIOUS COGN, V4, P52, DOI 10.1006/ccog.1995.1003; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Du H, 2014, J NEURORADI IN PRESS; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Galanaud D, 2010, E MEMOIRES ACAD NATL, V10, P038; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kremer S, 2010, J NEURORADIOLOGY, V37, P301, DOI 10.1016/j.neurad.2009.12.008; LEBIHAN D, 1987, J NEURORADIOLOGY, V14, P295; Llinas R, 2001, ANN NY ACAD SCI, V929, P166; Loevblad KO, 2008, J NEURORADIOLOGY, V35, P197, DOI 10.1016/j.neurad.2008.01.002; Lovblad KO, 2004, NEURORADIOLOGY, V46, P175, DOI 10.1007/s00234-003-1133-7; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Rao JS, 2013, J NEURORADIOLOGY, V40, P181, DOI 10.1016/j.neurad.2012.08.008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schiff ND, 2000, J CLIN NEUROPHYSIOL, V17, P438, DOI 10.1097/00004691-200009000-00002; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Yen K, 2006, AM J NEURORADIOL, V27, P70; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	43	11	11	0	7	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	JUL	2015	42	4					202	211		10.1016/j.neurad.2014.03.001			10	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CN0NA	WOS:000358109400003	24997478				2022-02-06	
J	Nardone, R; Holler, Y; Thomschewski, A; Bathke, AC; Ellis, AR; Golaszewski, SM; Brigo, F; Trinka, E				Nardone, R.; Hoeller, Y.; Thomschewski, A.; Bathke, A. C.; Ellis, A. R.; Golaszewski, S. M.; Brigo, F.; Trinka, E.			Assessment of corticospinal excitability after traumatic spinal cord injury using MEP recruitment curves: a preliminary TMS study	SPINAL CORD			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERVAL INTRACORTICAL INHIBITION; HUMAN MOTOR CORTEX; SILENT PERIOD; CORTICAL REORGANIZATION; INTRATHECAL BACLOFEN; FACILITATION; BRAIN; MODULATION; MUSCLES	Study design: Transcranial magnetic stimulation study. Objectives: To further investigate the corticospinal excitability changes after spinal cord injury (SCI), as assessed by means of transcranial magnetic stimulation (TMS). Setting: Merano (Italy) and Salzburg (Austria). Methods: We studied resting motor threshold (RMT), motor evoked potential (MEP) amplitude and recruitment curve in five subjects with good recovery after traumatic incomplete cervical SCI. Results: RMT did not differ significantly between patients and controls, whereas the slope of MEP recruitment curve was significantly increased in the patients. Conclusion: This abnormal finding may represent an adaptive response after SCI. The impaired ability of the motor cortex to generate proper voluntary movement may be compensated by increasing spinal excitability. The easily performed measurement of MEP recruitment curve may provide a useful additional tool to improve the assessment and monitoring of motor cortical function in subjects with SCI. Increasing our knowledge of the corticospinal excitability changes in the functional recovery after SCI may also support the development of effective therapeutic strategies.	[Nardone, R.; Hoeller, Y.; Thomschewski, A.; Golaszewski, S. M.; Trinka, E.] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria; [Nardone, R.; Hoeller, Y.; Thomschewski, A.; Golaszewski, S. M.; Trinka, E.] Ctr Cognit Neurosci, Salzburg, Austria; [Nardone, R.; Brigo, F.] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Nardone, R.; Hoeller, Y.; Thomschewski, A.; Trinka, E.] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr, Salzburg, Austria; [Bathke, A. C.] Paris Lodron Univ, Dept Math, Salzburg, Austria; [Bathke, A. C.; Ellis, A. R.] Univ Kentucky, Dept Stat, Lexington, KY USA; [Brigo, F.] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Clin Neurol, I-37100 Verona, Italy		Nardone, R (corresponding author), Franz Tappeiner Hosp, Dept Neurol, Via Rossini 5, I-39012 Merano, BZ, Italy.	raffaele.nardone@asbmeran-o.it	Holler, Yvonne/I-8928-2017; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; Brigo, Francesco/H-6513-2013	Holler, Yvonne/0000-0002-1727-8557; Thomschewski, Aljoscha/0000-0002-1811-5469; Nardone, Raffaele/0000-0001-5243-6760; Brigo, Francesco/0000-0003-0928-1577			Bathke AC, 2008, COMPUT STAT DATA AN, V52, P4951, DOI 10.1016/j.csda.2008.04.006; Boroojerdi B, 2001, CLIN NEUROPHYSIOL, V112, P931, DOI 10.1016/S1388-2457(01)00523-5; BURKE D, 1993, J PHYSIOL-LONDON, V470, P383, DOI 10.1113/jphysiol.1993.sp019864; Butler JE, 2007, J PHYSIOL-LONDON, V584, P651, DOI 10.1113/jphysiol.2007.134205; Chen R, 1998, J NEUROSCI, V18, P3443; Davey NJ, 1998, J NEUROL NEUROSUR PS, V65, P80, DOI 10.1136/jnnp.65.1.80; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Garry MI, 2009, EXP BRAIN RES, V193, P267, DOI 10.1007/s00221-008-1620-5; Geertsen SS, 2010, J PHYSIOL-LONDON, V588, P2391, DOI 10.1113/jphysiol.2010.190678; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kimiskidis VK, 2005, EXP BRAIN RES, V163, P21, DOI 10.1007/s00221-004-2134-4; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KOFLER M, 1992, NEUROLOGY, V42, P864, DOI 10.1212/WNL.42.4.864; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Kumru H, 2012, CLIN NEUROPHYSIOL, V123, P45, DOI 10.1016/j.clinph.2011.06.036; Lotze M, 2006, RESTOR NEUROL NEUROS, V24, P97; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; MURRAY NMF, 1999, ELECTRODIAGNOSIS CLI, P549; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P777, DOI 10.1113/jphysiol.1995.sp020703; Ortu E, 2008, J PHYSIOL-LONDON, V586, P5147, DOI 10.1113/jphysiol.2008.158956; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Roy FD, 2011, CLIN NEUROPHYSIOL, V122, P1387, DOI 10.1016/j.clinph.2010.11.020; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Saturno E, 2008, NEUROL RES, V30, P1084, DOI 10.1179/174313208X332968; Schneider C, 2004, J APPL PHYSIOL, V97, P2220, DOI 10.1152/japplphysiol.00542.2004; Shimizu T, 2000, NEUROSCI LETT, V286, P199, DOI 10.1016/S0304-3940(00)01125-3; Smith HC, 2000, SPINAL CORD, V38, P292, DOI 10.1038/sj.sc.3100994; Smith HC, 2000, J NEUROL NEUROSUR PS, V68, P516, DOI 10.1136/jnnp.68.4.516; Stetkarova I, 2013, CLIN NEUROPHYSIOL, V124, P339, DOI 10.1016/j.clinph.2012.07.005; Wagle-Shukla A, 2009, J PHYSIOL-LONDON, V587, P5665, DOI 10.1113/jphysiol.2009.181446; Willerslev-Olsen M, 2011, EXP BRAIN RES, V213, P465, DOI 10.1007/s00221-011-2798-5; Zanette G, 2004, CLIN NEUROPHYSIOL, V115, P1264, DOI 10.1016/j.clinph.2003.12.033; Ziemann U, 1998, J NEUROSCI, V18, P1115; Ziemann Ulf, 2013, Handb Clin Neurol, V116, P387, DOI 10.1016/B978-0-444-53497-2.00032-2	44	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JUL	2015	53	7					534	538		10.1038/sc.2015.12			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CM3IT	WOS:000357576200007	25665538	Bronze			2022-02-06	
J	Sannuel, N; Jacob, R; Eilon, Y; Mashiach, T; Shavit, I				Sannuel, Nir; Jacob, Ron; Eilon, Yael; Mashiach, Tania; Shavit, Itai			Falls in young children with minor head injury: A prospective analysis of injury mechanisms	BRAIN INJURY			English	Article						Children; fall; head injury; mechanism of injury; paediatric; trauma	CLINICAL-PREDICTION RULES; DECISION RULE	Background: Fall is a common mechanism of injury (MOI) in young children and an important risk factor for traumatic brain injury (TBI). Most children who fall have a minor head injury (MHO, defined as a blunt head trauma that occurred in a patient who is conscious and responsive. Objective: To seek a possible association between MOI and injury severity. Methods: A single centre cohort study was conducted. Data were collected on patients aged 0-2 years with MHI. Clinically-significant TBI (csTBI), defined as head injury resulting in death, intubation or neurosurgery, was the primary outcome measure. Traumatic finding on CT scan (TFCT) was the secondary outcome measure. Results: Five hundred and ninety-five patients were analysed. Eight types of falls were identified: from ground-level, down stairs, from a bed, from a changing table, from furniture, from adult-hold, from a playground-device and from a stroller/baby-carriage. One patient (0.16%) had csTBI. Thirty-one (5.2%) underwent CT scans, TFCT was diagnosed in 17 (2.8%) patients; 10 (1.7%) linear skull-fractures, two (0.3%) depressed skull-fractures and five (0.8%) intracranial haemorrhages. Regression analysis did not reveal a statistically significant association between any of the MOI and the presence of TFCT. Conclusions: The risk for csTBI was low and no association was found between MOI and injury severity.	[Sannuel, Nir; Shavit, Itai] Technion Israel Inst Technol, Pediat Emergency Dept, Haifa, Israel; [Jacob, Ron] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Sannuel, Nir; Jacob, Ron; Shavit, Itai] Rambam Hlth Care Campus, Dept Pediat, IL-31096 Haifa, Israel; [Eilon, Yael; Mashiach, Tania] Rambam Hlth Care Campus, Unit Med Stat, IL-31096 Haifa, Israel		Shavit, I (corresponding author), Rambam Hlth Care Campus, Meyer Childrens Hosp, Pediat Emergency Dept, POB 9602, IL-31096 Haifa, Israel.	i_shavit@rambam.health.gov.il			'Safe Kids Israel'	A research grant was provided by 'Safe Kids Israel'. The sponsors had no role in study design, conduct, data collection, analysis and report. The corresponding author had access to all the data and takes full responsibility for the decision to submit for publication.	Beterem - Safe Kids Israel, 2014, BET SAF KIDS ISR; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Israel Ministry of Health, 2014, MAN MIN HEAD INJ PED; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004	12	11	11	1	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					946	950		10.3109/02699052.2015.1017005			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800021	25955119				2022-02-06	
J	Schwarzmaier, SM; Gallozzi, M; Plesnila, N				Schwarzmaier, Susanne M.; Gallozzi, Micaela; Plesnila, Nikolaus			Identification of the Vascular Source of Vasogenic Brain Edema following Traumatic Brain Injury Using In Vivo 2-Photon Microscopy in Mice	JOURNAL OF NEUROTRAUMA			English	Article						2-photon microscopy; blood brain barrier; in vivo; traumatic brain injury; vasogenic brain edema	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; SEVERE HEAD-INJURY; BARRIER BREAKDOWN; FLUORESCENCE MICROSCOPY; CELLULAR EDEMA; COLD-INJURY; PERMEABILITY; PRESSURE; VOLUME	Vasogenic brain edema due to vascular leakage is one of the most important factors determining the clinical outcome of patients following acute brain injury. To date, performing a detailed in vivo quantification of vascular leakage has not been possible. Here, we used in vivo 2-photon microscopy (2-PM) to determine the spatial (3D) and temporal development of vasogenic brain edema following traumatic brain injury (TBI) in mice; in addition, we identified the vessel types involved in vascular leakage. Thirteen male Tie2-GFP mice (6-8 weeks old) were subjected to controlled cortical impact (CCI) or a sham operation; subsequently, a cranial window was prepared adjacent to the injury site, and tetramethylrhodamine-dextran (TMRM, 40mg/kg, MW 40,000) was injected intravenously to visualize blood plasma leakage. Parenchymal fluorescence intensity was monitored in three regions for 2-4h post-CCI, reaching from the surface of the brain to a depth of 300m, and TMRM leakage was measured as an increase in TMRM fluorescence intensity outside the vessel lumen and in the parenchyma. In the CCI group, vascular leakage was detected in all investigated regions as early as 2.5h post-injury. This leakage increased over time and was more pronounced proximal to the primary contusion. Both arterioles and venules contributed similarly to brain edema formation and their contribution was independent of vessel size; however, capillaries were the major contributor to leakage. In summary, using 2-PM to perform in vivo 3D deep-brain imaging, we found that TBI induces vascular leakage from capillaries, venules, and arterioles. Thus, all three vessel types are involved in trauma-induced brain edema and should be considered when developing novel therapies for preventing vasogenic brain edema.	[Schwarzmaier, Susanne M.; Gallozzi, Micaela; Plesnila, Nikolaus] Royal Coll Surgeons Ireland, Dept Neurodegenerat, Dublin 2, Ireland; [Schwarzmaier, Susanne M.] Univ Munich, Med Ctr, Dept Anesthesiol, D-81377 Munich, Germany; [Schwarzmaier, Susanne M.; Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res ISD, D-81377 Munich, Germany; [Plesnila, Nikolaus] Munich Cluster Symptoms Neurol Synergy, Munich, Germany		Plesnila, N (corresponding author), Univ Munich, Med Ctr, Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019				Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P119; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Chae SS, 2010, CLIN CANCER RES, V16, P3618, DOI 10.1158/1078-0432.CCR-09-3073; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Frederix K, 2007, BRAIN RES, V1185, P239, DOI 10.1016/j.brainres.2007.07.103; Ge SJ, 2005, J NEUROSCI RES, V79, P421, DOI 10.1002/jnr.20313; GIACOMELLI F, 1970, AM J PATHOL, V59, P133; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Grande PO, 2012, J NEUROSURG ANESTH, V24, P407, DOI 10.1097/01.ana.0000419730.29492.8b; Grape S, 2012, J NEUROSURG ANESTH, V24, P402, DOI 10.1097/01.ana.0000419729.52363.64; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guerin CJ, 2001, NEUROSCIENCE, V103, P873, DOI 10.1016/S0306-4522(01)00015-X; Guillen J, 2012, J AM ASSOC LAB ANIM, V51, P311; Hartl R, 1997, ACT NEUR S, V70, P240; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kempski O, 2001, SEMIN NEPHROL, V21, P303, DOI 10.1053/snep.2001.21665; Kenne E, 2011, THROMB HAEMOSTASIS, V105, P783, DOI 10.1160/TH10-10-0635; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Klohs J, 2009, J NEUROSCI METH, V180, P126, DOI 10.1016/j.jneumeth.2009.03.002; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Maeda T, 2003, ACT NEUR S, V86, P329; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayhan WG, 2001, MICROCIRCULATION, V8, P89, DOI 10.1038/sj.mn.7300154; MAYHAN WG, 1985, AM J PHYSIOL, V248, pH712, DOI 10.1152/ajpheart.1985.248.5.H712; MAYHAN WG, 1986, CIRC RES, V59, P216, DOI 10.1161/01.RES.59.2.216; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; NAGY Z, 1984, LAB INVEST, V50, P313; Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009; Raymond SB, 2007, J CEREBR BLOOD F MET, V27, P393, DOI 10.1038/sj.jcbfm.9600336; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Reyes-Aldasoro CC, 2008, MICROCIRCULATION, V15, P65, DOI 10.1080/10739680701436350; Ricard C, 2009, J SYNCHROTRON RADIAT, V16, P477, DOI 10.1107/S0909049509015428; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verant P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2870083; WAHL M, 1985, INT J MICROCIRC, V4, P3; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	70	11	11	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					990	1000		10.1089/neu.2014.3775			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200008	25585052				2022-02-06	
J	Tholance, Y; Barcelos, GK; Dailler, F; Renaud, B; Marinesco, S; Perret-Liaudet, A				Tholance, Yannick; Barcelos, Gleicy Keli; Dailler, Frederic; Renaud, Bernard; Marinesco, Stephane; Perret-Liaudet, Armand			Biochemical neuromonitoring of poor-grade aneurysmal subarachnoid hemorrhage: comparative analysis of metabolic events detected by cerebral microdialysis and by retrograde jugular vein catheterization	NEUROLOGICAL RESEARCH			English	Article						Aneurysmal subarachnoid hemorrhage; Cerebral microdialysis; Retrograde jugular vein catheterization; Brain energy metabolism; Hyperglycolysis; Metabolic ratio	TRAUMATIC BRAIN-INJURY; LACTATE; ISCHEMIA; GLUCOSE; OXYGEN; PRESSURE; CRISIS	Objectives: In severe aneurysmal subarachnoid hemorrhage (aSAH), pathological changes in cerebral energy metabolism can be detected either by local measurements using cerebral microdialysis (cMD) together with brain tissue oxygen probe or by global measurements of arterio-jugular difference performed with retrograde jugular vein catheter. Our main objective was to compare the two methods of detection and assess whether combining biomarkers from both procedures could improve outcome prediction, which has never been studied before. Methods: This study included 400 sets of paired arterial and jugular venous samples and 3138 brain microdialyzates obtained from 18 poor-grade aSAH patients. Using Glasgow outcome scale (GOS), neurochemical data from unfavorable (GOS 1-3) and favorable (GOS 4-5) outcome groups were compared. Results: The lactate/pyruvate ratio was found as the most sensitive marker for predicting unfavorable outcome (90%), although not specific. In contrast, hypoxic lactate events and those of metabolic ratio (MR) < 3.44, most frequently observed in the unfavorable outcome group than in the favorable one (13.9 vs 0.9% and 33.3 vs 3.75% respectively), were shown to be more specific biomarkers (86%) to predict unfavorable outcome, but less sensitive (< 70%). The combination of these three biomarkers improved the accuracy of outcome prediction (sensitivity 90% and specificity 71%). Discussion: Both retrograde jugular venous catheterization (RJVC) and cMD contribute to monitor poor-grade aSAH patients. In this preliminary study, we show that these two techniques are complementary and their combination increases the accuracy of outcome prediction.	[Tholance, Yannick; Renaud, Bernard; Perret-Liaudet, Armand] Hosp Civils Lyon, Dept Biochem & Mol Biol, Neurochem Unit, Neurobiol Lab, F-69677 Lyon, France; [Tholance, Yannick; Marinesco, Stephane] Univ Lyon, CNRS, Lyon Neurosci Res Ctr, WAKING Team, Lyon, France; [Barcelos, Gleicy Keli; Perret-Liaudet, Armand] Univ Lyon, CNRS, Lyon Neurosci Res Ctr, BioRaN Team, Lyon, France; [Barcelos, Gleicy Keli] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland; [Dailler, Frederic] Hosp Civils Lyon, Neurol Hosp, Neurointens Care Unit, Lyon, France; [Renaud, Bernard; Marinesco, Stephane] Univ Lyon, CNRS, Lyon Neurosci Res Ctr, AniRA Neurochem Technol Platform, Lyon, France		Tholance, Y (corresponding author), Hosp Civils Lyon, Ctr Biol & Pathol Est, Unite Neurochim, Neurobiol Lab,Dept Biochim & Biol Mol, 59 Blvd Pinel, F-69677 Lyon, France.	yannick-tholance@hotmail.fr	Marinesco, Stephane/M-6694-2017	Marinesco, Stephane/0000-0003-2712-6263; tholance, yannick/0000-0002-1826-3031			Artru F, 1998, NEUROL RES, V20, pS48; Barcelos GK, 2013, NEUROCRIT CARE, V18, P234, DOI 10.1007/s12028-012-9810-1; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Coppadoro A, 2011, MINERVA ANESTESIOL, V77, P74; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Holzschuh M, 1998, ACT NEUR S, V71, P170; JENNETT B, 1975, LANCET, V1, P480; Naval NS, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.03.006; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oertel MF, 2007, J CLIN NEUROSCI, V14, P948, DOI 10.1016/j.jocn.2006.11.002; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Tholance Y, 2011, CLIN CHIM ACTA, V412, P647, DOI 10.1016/j.cca.2010.12.025; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Washington CW, 2011, NEUROCRIT CARE, V15, P312, DOI 10.1007/s12028-011-9594-8	23	11	12	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2015	37	7					578	587		10.1179/1743132815Y.0000000012			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CJ7FI	WOS:000355659500003	25668478				2022-02-06	
J	Tian, X; An, L; Gao, LY; Bai, JP; Wang, J; Meng, WH; Ren, TS; Zhao, QC				Tian, Xing; An, Li; Gao, Ling-Yue; Bai, Jun-Peng; Wang, Jian; Meng, Wei-Hong; Ren, Tian-Shu; Zhao, Qing-Chun			Compound MQA, a Caffeoylquinic Acid Derivative, Protects Against NMDA-Induced Neurotoxicity and Potential Mechanisms In Vitro	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Apoptosis; Caffeoylquinic acid; Excitotoxicity; Neuroprotection; N-methyl-D-aspartate (NMDA)	TRAUMATIC BRAIN-INJURY; CELL-DEATH; CEREBRAL ISCHEMIA/REPERFUSION; DEPENDENT NEURODEGENERATION; APOPTOTIC MECHANISMS; MOLECULAR-MECHANISMS; RECEPTOR SUBUNITS; SH-SY5Y CELLS; UP-REGULATION; NEUROPROTECTION	Aims: Compound MQA (1,5-O-dicaffeoyl-3-O-[4-malic acid methyl ester]-quinic acid) is a natural derivative of caffeoylquinic acid isolated from Arctium lappa L. roots. However, we know little about the effects of MQA on the central nervous system. This study aims to investigate the neuroprotective effects and underlying mechanisms of MQA against the neurotoxicity of N-methyl-D-aspartate (NMDA). Methods and Results: Pretreatment with MQA attenuated the loss of cell viability after SH-SY5Y cells treated with 1 mM NMDA for 30 min by MTT assay. Hoechst 33342 and Annexin V-PI double staining showed that MQA inhibited NMDA-induced apoptosis. In addition to preventing Ca2+ influx, the potential mechanisms are associated with increases in the Bcl-2/Bax ratio, attenuation of cytochrome c release, caspase-3, caspase-9 activities, and expressions. Also, MQA inhibited NMDA-induced phosphorylation of ERK1/2, p38, and JNK1/2. Furthermore, deactivation of CREB, AKT, and GSK-3 beta, upregulation of GluN2B-containing NMDA receptors (NMDARs), and downregulation of GluN2A-containing NMDARs were significantly reversed by MQA treatment. Computational docking simulation indicates that MQA possesses a well affinity for NMDARs. Conclusion: The protective effects of MQA against NMDA-induced cell injury may be mediated by blocking NMDARs. The potential mechanisms are related with mitochondrial apoptosis, ERK-CREB, AKT/GSK-3 beta, p38, and JNK1/2 pathway.	[Tian, Xing; Meng, Wei-Hong; Ren, Tian-Shu; Zhao, Qing-Chun] Shenyang Mil Area Command, Gen Hosp, Dept Pharm, Shenyang 110840, Peoples R China; [Tian, Xing; An, Li; Gao, Ling-Yue; Bai, Jun-Peng; Wang, Jian] Shenyang Pharmaceut Univ, Dept Life Sci & Biochem, Shenyang, Peoples R China		Zhao, QC (corresponding author), Shenyang Mil Area Command, Gen Hosp, Dept Pharm, Shenyang 110840, Peoples R China.	zhaoqingchun1967@163.com			Key National Science & Technology Specific Project of China [2014ZX09J14101-05C]	This project was supported by Key National Science & Technology Specific Project of China (2014ZX09J14101-05C).	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; [白俊鹏 Bai Junpeng], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P163; Camins A, 2008, METHOD FIND EXP CLIN, V30, P43, DOI 10.1358/mf.2008.30.1.1090962; Centeno C, 2007, CELL DEATH DIFFER, V14, P240, DOI 10.1038/sj.cdd.4401988; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; Fan J, 2012, NEUROBIOL DIS, V45, P999, DOI 10.1016/j.nbd.2011.12.019; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Han J, 2010, NEUROSCIENCE, V169, P1039, DOI 10.1016/j.neuroscience.2010.05.049; Hovelso N, 2012, CURR NEUROPHARMACOL, V10, P12, DOI 10.2174/157015912799362805; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kim S, 2011, J PHARM PHARMACOL, V63, P1358, DOI 10.1111/j.2042-7158.2011.01342.x; Kim Y, 2012, PAIN, V153, P1022, DOI 10.1016/j.pain.2012.02.003; Kwon SH, 2011, FOOD CHEM TOXICOL, V49, P1011, DOI 10.1016/j.fct.2011.01.008; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Li XB, 2012, CNS NEUROSCI THER, V18, P927, DOI 10.1111/cns.12003; Liang K, 2014, J NEUROL SCI, V344, P100, DOI 10.1016/j.jns.2014.06.033; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Loftis JM, 2003, PHARMACOL THERAPEUT, V97, P55, DOI 10.1016/S0163-7258(02)00302-9; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; McElnea EM, 2011, MOL VIS, V17, P1182; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Meng HW, 2007, INT J DEV NEUROSCI, V25, P509, DOI 10.1016/j.ijdevneu.2007.09.010; Miyamae Y, 2012, BIOORGAN MED CHEM, V20, P5844, DOI 10.1016/j.bmc.2012.08.001; Ndountse LT, 2008, TOXICOLOGY, V249, P251, DOI 10.1016/j.tox.2008.05.011; Ooi KL, 2011, J ETHNOPHARMACOL, V135, P685, DOI 10.1016/j.jep.2011.04.001; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Petroni D, 2013, ENVIRON TOXICOL, V28, P700, DOI 10.1002/tox.20765; Sun BZ, 2011, BIOCHEM BIOPH RES CO, V409, P808, DOI 10.1016/j.bbrc.2011.05.095; Tan JW, 2013, NEUROCHEM RES, V38, P512, DOI 10.1007/s11064-012-0943-6; vonsEngelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhao JG, 2014, FOOD CHEM, V161, P22, DOI 10.1016/j.foodchem.2014.03.079; Zhou F, 2014, J NEUROSCI RES, V92, P808, DOI 10.1002/jnr.23354; Zuo W, 2015, CNS NEUROSCI THER, V21, P280, DOI 10.1111/cns.12364	45	11	13	0	19	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUL	2015	21	7					575	584		10.1111/cns.12408			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CL1LF	WOS:000356704000006	26096046	Green Published			2022-02-06	
J	Li, JX; Yang, F; Guo, J; Zhang, RR; Xing, XF; Qin, XY				Li, Jianxiong; Yang, Fei; Guo, Jia; Zhang, Rongrong; Xing, Xiangfeng; Qin, Xinyue			17-AAG post-treatment ameliorates memory impairment and hippocampal CA1 neuronal autophagic death induced by transient global cerebral ischemia	BRAIN RESEARCH			English	Article						GCI; Hsp70; 17-AAG; Inflammatory response; Autophagy; Functional recovery	INFLAMMATORY MECHANISMS; HSP70; OVEREXPRESSION; ACTIVATION; INJURY; DAMAGE; ROLES; MODEL	Neuro-inflammation plays an important role in global cerebral ischemia (GC). The 72-kDa heat shock protein (Hsp70) has been reported to be involved in the inflammatory response of many central nervous system diseases. Preclinical findings implicate that 17-allylamino-demethoxygeldanamycin (17-AAG), an anticancer drug in clinical, provide neuroprotection actions in a rat model of traumatic brain injury, and the beneficial effects of 17-AAG were specifically due to up-regulation of Hsp70. However, no experiments have tested whether 17-AAG has beneficial or harmful effects in the setting of GCI. The present study was designed to determine the hypothesis that administration of 17-AAG could attenuate cerebral infarction and improve neuronal survival, thereby ameliorating memory impairment in a rat model of GCI. Furthermore, to test whether any neuroprotective effect of 17-AAG was associated with inflammatory response and neuronal autophagy, we examined the expression of multiplex inflammatory cytokine levels as well as autophagy-associate protein in hippocampal CA1 of rat brain. Our results showed that post-GCI administration of 17-AAG significantly protected rats against GCI induced brain injury, and 17-AAG is also an effective antagonist of the inflammatory response and thereby ameliorates hippocampal CA1 neuronal autophagic death. We therefore believe that the present study provides novel clues in understanding the mechanisms by which 17-AAG exerts its neuroprotective activity in GCI. All data reveal that 17-AAG might be a potential neuroprotective agent for ischemic stroke. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Jianxiong; Guo, Jia; Zhang, Rongrong; Xing, Xiangfeng; Qin, Xinyue] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China; [Yang, Fei] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China		Qin, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, 1 Youyi Rd, Chongqin 400016, Peoples R China.	xinyueqin24k@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271307]; National Key Clinical Specialties Construction Program of China	This study was supported by the General Program of National Natural Science Foundation of China (81271307), and National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bejarano Eloy, 2010, Proc Am Thorac Soc, V7, P29, DOI 10.1513/pats.200909-102JS; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Dutta RK, 2012, INT J BIOCHEM CELL B, V44, P942, DOI 10.1016/j.biocel.2012.02.021; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Lee SH, 2004, STROKE, V35, P2195, DOI 10.1161/01.STR.0000136150.73891.14; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Nesbit Gary M, 2004, J Vasc Interv Radiol, V15, pS103; Ortega L, 2014, NEUROPEPTIDES, V48, P221, DOI 10.1016/j.npep.2014.04.006; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sato S., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P167; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; Tsuchiya D, 2003, NEUROSURGERY, V53, P1179, DOI 10.1227/01.NEU.0000090341.38659.CF; Wang RM, 2013, HIPPOCAMPUS, V23, P634, DOI 10.1002/hipo.22126; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3; Zhang HL, 2011, NEUROSCIENCE, V176, P381, DOI 10.1016/j.neuroscience.2010.12.029; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357; Zheng Z., 2005, FRONT BIOSCI J VIRTU, V11, P699	36	11	13	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 12	2015	1610						80	88		10.1016/j.brainres.2015.03.051			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CJ7XT	WOS:000355714400009	25858486				2022-02-06	
J	Ma, LS; Steinberg, JL; Keyser-Marcus, L; Ramesh, D; Narayana, PA; Merchant, RE; Moeller, FG; Cifu, DX				Ma, Liangsuo; Steinberg, Joel L.; Keyser-Marcus, Lori; Ramesh, Divya; Narayana, Ponnada A.; Merchant, Randall E.; Moeller, F. Gerard; Cifu, David X.			Altered white matter in cocaine-dependent subjects with traumatic brain injury: A diffusion tensor imaging study	DRUG AND ALCOHOL DEPENDENCE			English	Article						Diffusion tensor imaging; Cocaine dependence; Traumatic brain injury; TBSS	MEAN DIFFUSIVITY; FRACTIONAL ANISOTROPY; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM; SUBSTANCE-ABUSE; INTEGRITY; ABNORMALITIES; EIGENVALUES; INFERENCE; EXPOSURE	Background: Diffusion tensor imaging (DTI) is a useful technique for non-invasively investigating the microstructural organization of white matter (WM), and the most consistent DTI finding regarding cocaine-related WM alterations is in the corpus callosum (CC). WM injury has also been observed in subjects with traumatic brain injury (TB!), including in the CC. Methods: We used DTI to test if the WM microstructure is relatively more impaired in cocaine-dependent subjects who had suffered a mild TBI (mTBI). Fractional anisotropy (FA), which reflects the degree of alignment of cellular structures within fiber tracts and their structural integrity, was compared across cocaine-dependent subjects with mTBI (COCTBI group, n = 9), matched cocaine-dependent subjects without TBI (COC group, n=12), and matched healthy controls (CTL group, n=12). Results: The COCTBI group had significantly lower FA in the genu, body, and splenium of CC, than the CTL group whenever the education was controlled or not. The COC group had significantly lower FA in the left and right anterior corona radiata than the CTL group only when the education was controlled. There was no significant difference in FA between the COC and COCTBI groups. Conclusion: Cocaine dependence (or mTBI) related WM impairments in the CC were not detectable in this small subject sample. The significant finding in the CC suggests that the concurrence of cocaine dependence and mTBI might result in more severe damage to the CC, which could even be detected in small sample size. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ma, Liangsuo; Steinberg, Joel L.; Keyser-Marcus, Lori; Ramesh, Divya; Moeller, F. Gerard] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA 23219 USA; [Ma, Liangsuo] Virginia Commonwealth Univ, Dept Radiol, Richmond, VA 23219 USA; [Steinberg, Joel L.; Keyser-Marcus, Lori; Ramesh, Divya; Moeller, F. Gerard] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23219 USA; [Ramesh, Divya; Moeller, F. Gerard] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23219 USA; [Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Merchant, Randall E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23219 USA; [Merchant, Randall E.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23219 USA; [Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23219 USA		Ma, LS (corresponding author), Virginia Commonwealth Univ, Dept Radiol, Inst Drug & Alcohol Studies, 203 E Cary St Suite 202, Richmond, VA 23219 USA.	lma@vcu.edu		Cifu, David/0000-0003-1600-9387; Keyser-Marcus, Lori/0000-0001-6014-2500	National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA034131, U54 DA038999, P50 DA009262]; MCRR Shared Instrumentation Grant [1 S10 RR019186-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR019186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA034131, U54DA038999, P50DA009262] Funding Source: NIH RePORTER	This work is financially supported by National Institute on Drug Abuse (NIDA) Grants no. R01 DA034131 (LM), U54 DA038999 (FGM/JLS), P50 DA009262 (FGM/JLS), and MCRR Shared Instrumentation Grant no. 1 S10 RR019186-01 (PAN). We thank Zahra N. Kamdar, Vipulkumar S. (Vips) Patel, and Edward A. Zuniga for their excellent technical support. We also thank the anonymous reviewers for their constructive comments which have resulted in significant improvement of this article.	Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bell RP, 2011, DRUG ALCOHOL DEPEN, V114, P159, DOI 10.1016/j.drugalcdep.2010.10.001; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; First M., 1995, STRUCTURED CLIN INTE, V9, P92; First M.B., 1996, STRUCTURED CLIN INTE; Hanlon CA, 2013, NEUROSCI BIOBEHAV R, V37, P2037, DOI 10.1016/j.neubiorev.2013.04.007; Hasan KM, 2006, MAGN RESON MED, V56, P130, DOI 10.1002/mrm.20935; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Lebel C, 2013, PSYCHIAT RES-NEUROIM, V213, P161, DOI 10.1016/j.pscychresns.2013.04.002; Li ZH, 2013, PSYCHIAT RES-NEUROIM, V213, P47, DOI 10.1016/j.pscychresns.2012.12.005; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moeller FG, 2007, PSYCHIAT RES-NEUROIM, V154, P253, DOI 10.1016/j.pscychresns.2006.11.004; Moeller FG, 2010, PSYCHIAT RES-NEUROIM, V181, P174, DOI 10.1016/j.pscychresns.2009.11.003; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S, 2005, MRI ATLAS HUMAN WHIT; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Narayana PA, 2014, PSYCHIAT RES-NEUROIM, V221, P220, DOI 10.1016/j.pscychresns.2014.01.005; Narayana PA, 2009, PSYCHIAT RES-NEUROIM, V171, P242, DOI 10.1016/j.pscychresns.2008.04.004; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Salimi-Khorshidi G, 2011, NEUROIMAGE, V54, P2006, DOI 10.1016/j.neuroimage.2010.09.088; Schmitz Joy M, 2012, Front Psychiatry, V3, P77, DOI 10.3389/fpsyt.2012.00077; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Taber KH, 2002, J NEUROPSYCH CLIN N, V14, P1, DOI 10.1176/appi.neuropsych.14.1.1; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Xu JS, 2010, NEUROPSYCHOPHARMACOL, V35, P1541, DOI 10.1038/npp.2010.25	46	11	11	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	JUN 1	2015	151						128	134		10.1016/j.drugalcdep.2015.03.015			7	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	CL1WX	WOS:000356736700015	25841982	Green Accepted			2022-02-06	
J	Terry, DP; Adams, TE; Ferrara, MS; Miller, LS				Terry, Douglas P.; Adams, T. Eric; Ferrara, Michael S.; Miller, L. Stephen			FMRI Hypoactivation During Verbal Learning and Memory in Former High School Football Players with Multiple Concussions	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Childhood brain insult; Head injury; traumatic brain injury; Learning and memory; Neuroimaging (functional); Language and language disorders	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; WORKING-MEMORY; NEUROCOGNITIVE PERFORMANCE; PREFRONTAL ACTIVATION; COLLEGIATE; LONG; DIAGNOSIS; RECOVERY; RISK	Multiple concussions before the age of 18 may be associated with late-life memory deficits. This study examined neural activation associated with verbal encoding and memory retrieval in former athletes ages 40-65 who received at least two concussions ( median = 3; range = 2-15) playing high school football and a group of former high school football players with no reported history of concussions matched on age, education, and pre-morbid IQ. Functional magnetic resonance imaging data collected during a modified verbal paired associates paradigm indicated that those with concussive histories had hypoactivation in left hemispheric language regions, including the inferior/middle frontal gyri and angular gyrus compared with controls. However, concussive history was not associated with worse memory functioning on neuropsychological tests or worse behavioral performance during the paradigm, suggesting that multiple early-life concussions may be associated with subtle changes in the verbal encoding system that limits one from accessing higher-order semantic networks, but this difference does not translate into measurable cognitive performance deficits.	[Terry, Douglas P.; Adams, T. Eric; Miller, L. Stephen] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Ferrara, Michael S.] Univ New Hampshire, Coll Hlth & Human Serv, Durham, NH 03824 USA; [Miller, L. Stephen] Univ Georgia, Biomed & Hlth Sci Inst, BioImaging Res Ctr, Athens, GA 30602 USA		Terry, DP (corresponding author), Univ Georgia, 110 Hooper St,Psychol Bldg,Room 163, Athens, GA 30602 USA.	dpterry@uga.edu			John and Mary Franklin Foundation; BioImaging Research Center at the University of Georgia; Department of Kinesiology at the University of Georgia	This work was supported by the John and Mary Franklin Foundation, the BioImaging Research Center at the University of Georgia, and Department of Kinesiology at the University of Georgia.	Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bonner-Jackson A, 2007, BIOL PSYCHIAT, V61, P1141, DOI 10.1016/j.biopsych.2006.07.006; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Braskie MN, 2009, HUM BRAIN MAPP, V30, P3981, DOI 10.1002/hbm.20823; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Cohen NJ., 1993, MEMORY AMNESIA HIPPO; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dobbins IG, 2005, CEREB CORTEX, V15, P1768, DOI 10.1093/cercor/bhi054; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Fowler KS, 2002, J INT NEUROPSYCH SOC, V8, P58, DOI 10.1017/S1355617701020069; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gioia G, 2006, ACUTE CONCUSSION EVA; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Green P, 2004, GREENS MED SYMPTOM V; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jacques PLS, 2012, NEUROBIOL AGING, V33, P1298, DOI 10.1016/j.neurobiolaging.2010.11.007; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kendler KS, 2008, PSYCHOL MED, V38, P1001, DOI 10.1017/S0033291707001821; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Marvel CL, 2010, NEUROPSYCHOL REV, V20, P271, DOI 10.1007/s11065-010-9137-7; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Mitchell KJ, 2000, PSYCHOL AGING, V15, P527, DOI 10.1037//0882-7974.15.3.527; Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Park H, 2013, NEUROPSYCHOLOGIA, V51, P448, DOI 10.1016/j.neuropsychologia.2012.11.025; Pedersen HA, 2014, AM J ALZHEIMERS DIS, V29, P201, DOI 10.1177/1533317513517036; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; RAUSCH R, 1993, ARCH NEUROL-CHICAGO, V50, P812, DOI 10.1001/archneur.1993.00540080023008; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wechsler D., 2009, WECHSLER MEMORY SCAL; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	90	11	11	0	39	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2015	30	4					341	355		10.1093/arclin/acv020			15	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CJ6VF	WOS:000355632300006	25903375	Bronze, Green Published			2022-02-06	
J	Brazinova, A; Mauritz, W; Majdan, M; Rehorcikova, V; Leitgeb, J				Brazinova, Alexandra; Mauritz, Walter; Majdan, Marek; Rehorcikova, Veronika; Leitgeb, Johannes			Fatal traumatic brain injury in older adults in Austria 1980-2012: an analysis of 33 years	AGE AND AGEING			English	Article						traumatic brain injury deaths; epidemiology; mortality rate; age; sex; older people	PHYSICAL-ACTIVITY; EPIDEMIOLOGY; CONSEQUENCES; SURVEILLANCE; POPULATION; MORTALITY	Background: traumatic brain injury (TBI) is a significant public health problem. Developed countries report a significant increase of TBI in older adults in the past decades. The objective of this study was to investigate the changes in TBI-related mortality in older Austrians (65 years or older) between 1980 and 2012 (33 years) and to identify possible causes for these changes. Methods: data from Statistics Austria on mortality in Austria between 1980 and 2012 were screened and data on TBI-related mortality in adults aged 65 and older were extracted and analysed, based on the diagnostic codes of the International Classification of Diseases, 10th and 9th revision. Mortality rates were calculated for 5-year age groups; standardized mortality rates were calculated for the total. Mechanism of injury was analysed for all events, both sexes and individual age groups. Results: between 1980 and 2012, 16,204 people aged 65 or older died from TBI in Austria; 61% of these were male. Fatal TBI cases and mortality rates increased in the oldest age groups (80 years or older). Half of the fatal TBI cases were caused by falls, 22% by traffic accidents and 17% by suicides. Rate of fall-related fatal TBI increased and rate of traffic accident-related fatal TBI decreased with age. Conclusion: preventive measures introduced in the past decades in the developed countries have contributed to a decrease in traffic injuries. However, falls in the older population are on the rise, mainly due to ageing of the population, throughout the reported period. It is important to take preventive measures to stop the epidemics of fall-related TBIs and fatalities in older adults.	[Brazinova, Alexandra; Majdan, Marek; Rehorcikova, Veronika] Trnava Univ, Fac Hlth Sci & SocialWork, Dept Publ Hlth, Trnava 91843, Slovakia; [Brazinova, Alexandra; Mauritz, Walter; Majdan, Marek; Rehorcikova, Veronika] Int Neurotrauma Res Org, A-1080 Vienna, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Anaesthesiol & Intens Care Med, Vienna, Austria; [Leitgeb, Johannes] Univ Vienna, Dept Traumatol, Vienna, Austria		Brazinova, A (corresponding author), Trnava Univ, Fac Hlth Sci & SocialWork, Dept Publ Hlth, Trnava 91843, Slovakia.	abrazinova@igeh.org	Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X			Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Cefalu CA, 2011, CLIN GERIATR MED, V27, P491, DOI 10.1016/j.cger.2011.07.001; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Faul M, 2010, TRAUMATIC BRAIN INJU; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Ip EH, 2013, J GERONTOL A-BIOL, V68, P426, DOI 10.1093/gerona/gls186; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rodriguez SR, 2006, PUBLIC HEALTH REP, V121, P282, DOI 10.1177/003335490612100310; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x	17	11	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0002-0729	1468-2834		AGE AGEING	Age Ageing	MAY	2015	44	3					502	506		10.1093/ageing/afu194			5	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	CJ6SE	WOS:000355623100027	25520311	Bronze			2022-02-06	
J	Zuckerman, SL; Lee, YM; Odom, MJ; Forbes, JA; Solomon, GS; Sills, AK				Zuckerman, S. L.; Lee, Y. M.; Odom, M. J.; Forbes, J. A.; Solomon, G. S.; Sills, A. K.			Sports-Related Concussion in Helmeted vs. Unhelmeted Athletes: Who Fares Worse?	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sports; helmet; unhelmeted; protective headgear; mild traumatic brain injury; imPACT	AMERICAN FOOTBALL HELMETS; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; HEAD ACCELERATIONS; IMPACT PERFORMANCE; NORMATIVE DATA; BRAIN-INJURY; PLAYERS; SOCCER; RISK	In the management of sports-related concussion, little is known about the effect of wearing or not wearing a helmet (i.e., helmet status) on the acute outcomes of concussed athletes. We endeavored to assess acute neurocognitive and symptom changes after SRC in helmeted vs. unhelmeted athletes. In a retrospective study, 1025 athletes from 2 regional databases sustained a SRC. Athletes were matched by age, gender, number of prior concussions, and days to post-concussion test, yielding a final cohort of 138 athletes. For each group of 69, differences in post-concussion neurocognitive and symptom scores were compared using group mean differences as well as reliable change index (RCI) scores set at the 80% confidence interval. With gender, prior concussions, and days to post-concussion test similar in each group, using group mean change scores and RCI methodology, we found no significant differences between the helmeted and unhelmeted groups in 4 neurocognitive tests and one total symptom score. In a cohort of carefully matched athletes from 2 regional concussion centers, helmet status was unrelated to neurocognitive scores and total symptoms in athletes after suffering a SRC. These findings suggest that acute outcomes in helmeted vs. unhelmeted sports are quite similar.	[Zuckerman, S. L.; Odom, M. J.; Solomon, G. S.; Sills, A. K.] Vanderbilt Univ, Med Ctr, Neurosurg, Nashville, TN 37212 USA; [Lee, Y. M.] Vanderbilt Univ, Med Ctr, Sch Med, Nashville, TN 37212 USA; [Forbes, J. A.] David Grant Med Ctr, Neurosurg, Travis AFB, CA USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Neurosurg, 1211 Med Ctr Dr, Nashville, TN 37212 USA.	zuckerman.scott@gmail.com	Solomon, Gary/K-9011-2019				Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Bartsch A, 2013, J NEUROSURG, V119, P803, DOI 10.3171/2012.12.JNS122174; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; CW G, 1971, P 15 STAPP CAR CRASH; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fedor A, 2013, OBESITY FACTS, V6, P185, DOI 10.1159/000351138; Finklestein EA., 2006, INCIDENCE EC BURDEN; Forbes JA, 2012, NEUROSURG FOCUS, V33, P11; Gay T, 2004, PHYS FOOTBALL DISCOV, P212; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Hinton-Bayre AD, 2012, CLIN J SPORT MED, V22, P105, DOI 10.1097/JSM.0b013e318248a526; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Karton C, 2014, BRIT J SPORT MED, V48, P46, DOI 10.1136/bjsports-2012-091583; Kernan CL, 2012, EPILEPSIA, V53, P2156, DOI 10.1111/j.1528-1167.2012.03706.x; Kis M, 2013, CLIN J SPORT MED, V23, P470, DOI 10.1097/JSM.0b013e318295a80f; Kumar Sri, 2012, Biomed Sci Instrum, V48, P239; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Marar M, AM J SPORTS MED; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P669; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; Meehan WP, 2013, J PEDIATR-US, V163, P726, DOI 10.1016/j.jpeds.2013.03.073; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Ranson C, 2013, BRIT J SPORT MED, V47, P644, DOI 10.1136/bjsports-2012-091898; Rowson S, 2013, J NEUROSURG, V119, P805, DOI 10.3171/2013.3.JNS121735; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Somers Jeffrey T, 2011, Stapp Car Crash J, V55, P49; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	65	11	11	0	26	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	MAY	2015	36	5					419	425		10.1055/s-0034-1395587			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CH3HX	WOS:000353922000012	25664998				2022-02-06	
J	Feng, Z; Zhong, YJ; Wang, L; Wei, TQ				Feng, Zhen; Zhong, Ying-jun; Wang, Liang; Wei, Tian-qi			Resuscitation therapy for traumatic brain injury-induced coma in rats: mechanisms of median nerve electrical stimulation	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; coma; median nerve electrical stimulation; wake-promoting; orexin-A; OX1R; NSFC grants; neural regeneration	OREXIN; HOMEOSTASIS; EXPERIENCE; CELLS	In this study, rats were put into traumatic brain injury-induced coma and treated with median nerve electrical stimulation. We explored the wake-promoting effect, and possible mechanisms, of median nerve electrical stimulation. Electrical stimulation upregulated the expression levels of orexin-A and its receptor OX1R in the rat prefrontal cortex. Orexin-A expression gradually increased with increasing stimulation, while OX1R expression reached a peak at 12 hours and then decreased. In addition, after the OX1R antagonist, SB334867, was injected into the brain of rats after traumatic brain injury, fewer rats were restored to consciousness, and orexin-A and OXIR expression in the prefrontal cortex was downregulated. Our findings indicate that median nerve electrical stimulation induced an up-regulation of orexin-A and OX1R expression in the prefrontal cortex of traumatic brain injury-induced coma rats, which may be a potential mechanism involved in the wake-promoting effects of median nerve electrical stimulation.	[Feng, Zhen; Zhong, Ying-jun; Wang, Liang; Wei, Tian-qi] Nanchang Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanchang, Jiangxi Provinc, Peoples R China		Feng, Z (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanchang, Jiangxi Provinc, Peoples R China.	fengzhenly@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260295]; Natural Science Foundation of Jiangxi Province of ChinaNatural Science Foundation of Jiangxi Province [20132BAB205063]	This study was funded by grants from the National Natural Science Foundation of China, No. 81260295, and the Natural Science Foundation of Jiangxi Province of China, No. 20132BAB205063.	Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Belle MDC, 2014, J NEUROSCI, V34, P3607, DOI 10.1523/JNEUROSCI.3388-13.2014; Brevig HN, 2010, SLEEP, V33, P1285, DOI 10.1093/sleep/33.10.1285; Butler MP, 2012, EUR J NEUROSCI, V36, P2556, DOI 10.1111/j.1460-9568.2012.08166.x; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Dall'Aglio C, 2011, REGUL PEPTIDES, V172, P51, DOI 10.1016/j.regpep.2011.08.007; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; [冯士军 Feng Shijun], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P23; Gao XB, 2010, ACTA PHYSIOL, V198, P251, DOI 10.1111/j.1748-1716.2009.02047.x; Garosi L, 2011, J FELINE MED SURG, V13, P815, DOI 10.1016/j.jfms.2011.09.003; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Kaminski T, 2010, ANIM REPROD SCI, V117, P111, DOI 10.1016/j.anireprosci.2009.03.007; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Kukkonen JP, 2014, BRIT J PHARMACOL, V171, P314, DOI 10.1111/bph.12324; Mihara Y, 2011, J MOL NEUROSCI, V43, P162, DOI 10.1007/s12031-010-9438-6; Okazaki Y, 2008, NEUROSCI RES, V61, P129, DOI 10.1016/j.neures.2008.01.016; Ramanjaneya M, 2009, J ENDOCRINOL, V202, P249, DOI 10.1677/JOE-08-0536; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; STEPHENS JR, 1994, EPILEPSIA, V35, P164, DOI 10.1111/j.1528-1157.1994.tb02928.x; [王成 Wang Cheng], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P4469; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Xia JX, 2005, NEUROREPORT, V16, P783, DOI 10.1097/00001756-200505120-00025; Yeterian EH, 2012, CORTEX, V48, P58, DOI 10.1016/j.cortex.2011.03.004; Zawilska JB, 2013, PHARMACOL REP, V65, P513, DOI 10.1016/S1734-1140(13)71027-2	26	11	21	4	12	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2015	10	4					594	598		10.4103/1673-5374.155433			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CH6OP	WOS:000354156200022	26170820	gold, Green Published			2022-02-06	
J	Tulsky, DS; Kisala, PA; Lai, JS; Carlozzi, N; Hammel, J; Heinemann, AW				Tulsky, David S.; Kisala, Pamela A.; Lai, Jin-Shei; Carlozzi, Noelle; Hammel, Joy; Heinemann, Allen W.			Developing an Item Bank to Measure Economic Quality of Life for Individuals With Disabilities	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Economics; Outcome assessment (health care); Psychometrics; Quality of life; Rehabilitation	TRAUMATIC BRAIN-INJURY; DATA-COLLECTION INSTRUMENT; RESPONSE THEORY; HEAD-INJURY; CANCER; CHILDREN; HEALTH; VALIDATION; ISSUES; BARRIERS	Objective: To develop and evaluate the psychometric properties of an item set measuring economic quality of life (QOL) for use by individuals with disabilities. Design: Survey. Setting: Community settings. Participants: Individuals with disabilities completed individual interviews (n=64), participated in focus groups (n=172), and completed cognitive interviews (n=15). Inclusion criteria included the following: traumatic brain injury, spinal cord injury, or stroke; age >= 18 years; and ability to read and speak English. We calibrated the items with 305 former rehabilitation inpatients. Interventions: None. Main Outcome Measure: Economic QOL. Results: Confirmatory factor analysis showed acceptable fit indices (comparative fit index=.939, root mean square error of approximation=.089) for the 37 items. However, 3 items demonstrated local item dependence. Dropping 9 items improved fit and obviated local dependence. Rasch analysis of the remaining 28 items yielded a person reliability of .92, suggesting that these items discriminate about 4 economic QOL levels. Conclusions: We developed a 28-item bank that measures economic aspects of QOL. Preliminary confirmatory factor analysis and Rasch analysis results support the psychometric properties of this new measure. It fills a gap in health-related QOL measurement by describing the economic barriers and facilitators of community participation. Future development will make the item bank available as a computer adaptive test. (C) 2015 by the American Congress of Rehabilitation Medicine	[Tulsky, David S.; Kisala, Pamela A.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Tulsky, David S.] Kessler Fdn Res Ctr, W Orange, NJ USA; [Lai, Jin-Shei; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Carlozzi, Noelle] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Hammel, Joy] Univ Illinois, Chicago, IL USA; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA		Tulsky, DS (corresponding author), NYU, Langone Med Ctr, Ctr Ambulatory Care, Dept Rehabil Me,Rusk Inst Rehabil, 240 E 38th St,17th Fl, New York, NY 10016 USA.	David.Tulsky@nyumc.org	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509	National Institute on Disability and Rehabilitation Research [H133B090024, H133A030807, H133G070138]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HD054659]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD054569] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research (grant nos. H133B090024, H133A030807, and H133G070138) and the National Institutes of Health (grant no. 5R01HD054659).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Alfano CM, 2006, ONCOLOGY-BASEL, V70, P190, DOI 10.1159/000094320; Bach C A, 1993, Rehabil Nurs, V18, P364; Bae DS, 2008, J PEDIATR ORTHOPED, V28, P584, DOI 10.1097/BPO.0b013e31817bb88b; Barry C., 1998, SOCIOLOGICAL RES ONL, P3; Baum N.T., 2006, FAMILY QUALITY LIFE; BECKER M, 1993, QUAL LIFE RES, V2, P239, DOI 10.1007/BF00434796; Becker MA, 1999, WISCONSIN QUALITY LI; Bergmark BA, 2008, SPINAL CORD, V46, P684, DOI 10.1038/sc.2008.15; Bradburn NM, 1969, STRUCTURE PSYCHOL WE; Brown M.W., 1993, SOCIOL METHOD RES, P136; Campbell A., 1981, SENSE WELL BEING AM; Campbell A.-Ph. E. Converse-W. L., 1976, QUALITY AM LIFE PERC; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D F, 1990, Oncology (Williston Park), V4, P29; CELLA DF, 1993, CANCER INVEST, V11, P327, DOI 10.3109/07357909309024860; Costa P, 2001, EUR UROL, V39, P107, DOI 10.1159/000052421; Dedini RD, 2008, J PEDIATR ORTHOPED, V28, P259, DOI 10.1097/BPO.0b013e3181652135; Fajardo NR, 2003, AM J GASTROENTEROL, V98, P128; Hambleton RK, 1989, PRINCIPLES SELECTED, P147; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huberman A.M., 1994, DATA MANAGEMENT ANAL; Huppert JD, 2001, SCHIZOPHR RES, V51, P171, DOI 10.1016/S0920-9964(99)00151-6; Isaacs B. J., 2007, J POLICY PRACT INTEL, V4, P177, DOI DOI 10.1111/J.1741-1130.2007.00116.X; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Krueger R. A., 2000, FOCUS GROUPS PRACTIC, V3rd; Kuznets S., 1946, NATL PRODUCT 1869; Lai JS, 2007, J PEDIAT HEMATOL ONC, V29, P471, DOI 10.1097/MPH.0b013e318095057a; Lai JS, 2006, QUAL LIFE RES, V15, P1179, DOI 10.1007/s11136-006-0060-6; Lai JS, 2007, CHILD NERV SYST, V23, P47, DOI 10.1007/s00381-006-0176-6; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Lai JS, 2011, J PEDIATR PSYCHOL, V36, P766, DOI 10.1093/jpepsy/jsr005; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lew SQ, 2005, SEMIN DIALYSIS, V18, P119, DOI 10.1111/j.1525-139X.2005.18215.x; Linacre J.M., 2014, WINSTEPS RASCH MEASU; Manns PJ, 2001, QUAL HEALTH RES, V11, P795, DOI 10.1177/104973201129119541; McCarthy ML, 2002, DEV MED CHILD NEUROL, V44, P468; MISHLER EG, 1990, HARVARD EDUC REV, V60, P415, DOI 10.17763/haer.60.4.n4405243p6635752; Muthen B. O., 2001, MPLUS USERS GUIDE; National Institute on Aging National Institutes of Health, 2007, 075757 US DEP HLTH H; National Spinal Cord Injury Statistical Center, 2011, SPIN CORD INJ FACTS; Nelson N D, 2003, J Palliat Med, V6, P417, DOI 10.1089/109662103322144736; PROMIS, 2012, INSTR DEV PSYCH EV S; Reed J, 1997, J ADV NURS, V26, P765, DOI 10.1046/j.1365-2648.1997.00395.x; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Smith R M, 2000, J Appl Meas, V1, P199; Smith T. W., 2011, GEN SOCIAL SURVEYS 1; Steinberg L, 1996, PSYCHOL METHODS, V1, P81, DOI 10.1037/1082-989X.1.1.81; Todd A, 2012, REHABIL NURS, V37, P74, DOI 10.1002/RNJ.00013; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024; Tulslcy D, 2005, PHYS MED REHABILITAT, P1193; U. S. Bureau of Labor Statistics, 2014, TABL A 6 EMPL STAT C; White GW, 2004, ARCH PHYS MED REHAB, V85, pS3, DOI 10.1016/j.apmr.2003.08.109; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willis GBJRTP, 1999, COGNITIVE INTERVIEWI; World Health Organization, 2008, INT CLASS FUNCT DIS; Wren TAL, 2007, J PEDIATR ORTHOPED, V27, P233, DOI 10.1097/01.bpb.0000242436.65940.1a; YOUNG NL, 1995, J PEDIATR ORTHOPED, V15, P244	62	11	12	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4					604	613		10.1016/j.apmr.2014.02.030			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CE9RC	WOS:000352180100005	24736400	Green Accepted			2022-02-06	
J	Anthony, CA; Peterson, AR				Anthony, Christopher A.; Peterson, Andrew R.			Utilization of a Text-Messaging Robot to Assess Intraday Variation in Concussion Symptom Severity Scores	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						Concussion Symptom Severity Score; CSSS; SCAT2; SCAT3; concussion	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; ZURICH; SCALE	Objective: To determine the amount of within-day variation of Concussion Symptom Severity Scores (CSSSs) in athletes with a clinically diagnosed concussion. Design: This prospective cohort study used a text-messaging robot to survey concussed athletes using the CSSS 5-times daily while they remained symptomatic. Setting: Academic sports concussion clinic at a large tertiary care medical center. Participants: Fourteen 14- to 22-year-old athletes with clinically diagnosed concussions were enrolled. All were injured in sport, still in season, English speaking, and used a cellular telephone to text message on a regular basis. Assessment of Risk Factors: This study did not collect any demographic or other information about the subjects. The only data collected were the individual responses to the questions in the Post Concussion Symptom Score (PCSS). The only aim of this study was to evaluate the variability in responses to the CSSS, which is calculated from the PCSS. Main Outcome Measurements: The primary outcome measure was a repeatability coefficient from a random-effects model. Concussion Symptom Severity Score, mean daily CSSS, and standard deviation of CSSS differences from the mean were also calculated. Results: Mean follow-up was 23.9 days. A total of 24 180 text messages were received from subjects. Eight hundred four complete surveys were analyzed. Repeatability coefficient was 623.1. Conclusions: When surveyed frequently by a text-messaging robot, concussed athletes report poorly repeatable Sport Concussion Assessment Tool 2 (SCAT2) Symptom Severity Scores.	[Anthony, Christopher A.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Peterson, Andrew R.] Inst Orthopaed Sports Med & Rehabil, Iowa City, IA USA; [Peterson, Andrew R.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA		Peterson, AR (corresponding author), Univ Iowa Hosp & Clin, Dept Pediat, 200 Hawkins Dr,2607 JCP, Iowa City, IA 52242 USA.	andrew-r-peterson@uiowa.edu		Peterson, Andrew/0000-0003-4555-7366	University of Iowa Department of Pediatrics	Supported by the University of Iowa Department of Pediatrics.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320	10	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2015	25	2					149	152		10.1097/JSM.0000000000000115			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CD3RP	WOS:000350998200012	24905538				2022-02-06	
J	Khaitin, AM; Rudkovskii, MV; Uzdensky, AB				Khaitin, Andrej M.; Rudkovskii, Mikhail V.; Uzdensky, Anatoly B.			The method of isolation of the crayfish abdominal stretch receptor maintaining a connection of the sensory neuron to the ventral nerve cord ganglion	INVERTEBRATE NEUROSCIENCE			English	Article						Crayfish stretch receptor; Axotomy; Neuron; Glial cells; Cell death	TRAUMATIC BRAIN-INJURY; MECHANOTRANSDUCTION; ULTRASTRUCTURE; DEGENERATION; APOPTOSIS; SURVIVAL; NECROSIS; DISEASE; CELLS; FIELD	The crayfish stretch receptor consisting of the single mechanoreceptor neurons enveloped by satellite glial cells is the simplest functioning neuroglial preparation. However, during isolation, its axons are usually transected that eliminates afferent regulation and induces complex axotomy-related signaling responses in neurons and satellite glia. We developed new microsurgical method of crayfish stretch receptor isolation, which preserves connections of sensory neurons to the ventral nerve cord ganglion. The stretch receptor may either remain on the abdominal carapace, or be completely isolated. In both cases, it may be either intact, or axotomized. The integrity of axons was confirmed by firing recording from proximal and distal axon points. Normal, necrotic and apoptotic cells were visualized using double fluorochroming with Hoechst 33342 and propidium iodide. The isolated mechanoreceptor neurons maintain regular firing during 8-10 or more hours. Glial cells surrounding non-axotomized neurons demonstrate lower necrosis and apoptosis levels than the axotomized ones. Unlike the existing method, in which the sensory neurons were axotomized, the present method preserves links between the sensory neurons and the ganglion and makes possible to avoid consequences of axotomy in neurons and satellite glia. The present neuroglial preparation may be used as a simple but informative model object in studies of axotomy-induced degeneration and survival of peripheral neurons, the role of glia in neuron injury, the signaling mechanisms of neuroglial interactions, and the effects of diverse physical and chemical factors on neuronal and glial cells.	[Khaitin, Andrej M.; Rudkovskii, Mikhail V.; Uzdensky, Anatoly B.] Southern Fed Univ, Acad Biol & Biotechnol, Rostov Na Donu 344090, Russia		Uzdensky, AB (corresponding author), Southern Fed Univ, Acad Biol & Biotechnol, 194-1 Stachky Ave, Rostov Na Donu 344090, Russia.	andrej.wojt@gmail.com; mit_ru@mail.ru; auzd@yandex.ru	Uzdensky, A. B./E-2900-2014; Rudkovskii, Mikhail/P-1793-2016; Khaitin, Andrey/L-3082-2016	Uzdensky, A. B./0000-0002-0344-434X; Rudkovskii, Mikhail/0000-0001-9366-9747; Khaitin, Andrey/0000-0003-0413-7656	Russian Scientific FoundationRussian Science Foundation (RSF) [14-15-00068]; Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [14-04-00741]	The work was supported by grants Russian Scientific Foundation (Grant 14-15-00068) and Russian Foundation for Basic Research (Grant 14-04-00741).	ALEXANDROWICZ JS, 1951, Q J MICROSC SCI, V92, P163; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; EYZAGUIRRE C, 1955, J GEN PHYSIOL, V39, P87, DOI 10.1085/jgp.39.1.87; Fedorenko GM, 2009, CELL TISSUE RES, V337, P477, DOI 10.1007/s00441-009-0825-7; FLOREY E, 1955, J GEN PHYSIOL, V39, P69, DOI 10.1085/jgp.39.1.69; Fomichev NI, 1986, CRAYFISH METHODS STU; Giacobini E, 1969, Neurosci Res (N Y), V2, P111; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Ilyinsky OB, 1975, PHYSL SENSORY SYSTEM; Komandirov MA, 2011, J MOL NEUROSCI, V45, P229, DOI 10.1007/s12031-011-9499-1; KUFFLER SW, 1955, J GEN PHYSIOL, V39, P155, DOI 10.1085/jgp.39.1.155; Leksrisawat Bonnie, 2010, J Vis Exp, DOI 10.3791/2323; Lin JH, 1999, ACTA PHYSIOL SCAND, V166, P65, DOI 10.1046/j.1365-201X.1999.00525.x; Lobanov AV, 2009, J MOL NEUROSCI, V39, P308, DOI 10.1007/s12031-009-9199-2; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; MCKAY HA, 2002, EXP BRAIN RES, V142, P308; Nicotera P, 1998, TOXICOL LETT, V103, P139; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Purali N, 2005, J COMP NEUROL, V488, P369, DOI 10.1002/cne.20590; Richardson PM, 2009, NEUROSURGERY, V65, pA74, DOI 10.1227/01.NEU.0000352378.26755.C3; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Rodriguez-Muela N, 2012, AUTOPHAGY, V8, P286, DOI 10.4161/auto.8.2.18982; Rydqvist B, 2007, PHYSIOL BEHAV, V92, P21, DOI 10.1016/j.physbeh.2007.05.055; TAOCHENG JH, 1981, J COMP NEUROL, V200, P1, DOI 10.1002/cne.902000102; Trump BF, 1996, BBA-MOL CELL RES, V1313, P173, DOI 10.1016/0167-4889(96)00086-9; UZDENSKY A, 1993, P SOC PHOTO-OPT INS, V1882, P254, DOI 10.1117/12.147682; Uzdensky AB, 1997, ELECTRO MAGNETOBIOL, V16, P267, DOI 10.3109/15368379709015658; Uzdensky AB, 2011, NEURONAL CELL APOPTO, P79; Uzdensky A, 2007, J NEUROSCI RES, V85, P860, DOI 10.1002/jnr.21190	30	11	11	1	16	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1354-2516	1439-1104		INVERTEBR NEUROSCI	Invertebr. Neurosci.	MAR	2015	15	1							176	10.1007/s10158-014-0176-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI7XM	WOS:000354979400003	25374161				2022-02-06	
J	Li, W; Bai, YA; Li, YJ; Liu, KG; Wang, MD; Xu, GZ; Shang, HL; Li, YF				Li, Wen; Bai, Yin-An; Li, Ya-Jun; Liu, Kai-Ge; Wang, Mao-De; Xu, Gang-Zhu; Shang, Hong-Li; Li, Yan-Feng			Magnesium Sulfate for Acute Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Magnesium sulfate; acute traumatic brain injury; outcome; meta-analysis	FLUID PERCUSSION INJURY; SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; COGNITIVE DYSFUNCTION; CEREBROSPINAL-FLUID; IONIZED MAGNESIUM; RATS; SAFETY; SERUM; NEUROPROTECTION	Background: The purpose of this systematic review was to evaluate the effect of magnesium sulfate in the treatment of acute traumatic brain injury. Materials and Methods: A systematic search of ClinicalTrials.gov, the Cochrane Library database, EMBASE, MEDLINE, Web of Science, and the World Health Organization trial registry, plus manual searches of gray literature, was undertaken in April 2013. Two reviewers independently extracted the data with a predefined data extraction form. RevMan 5 software was used to synthesize data and calculate the risk ratio for mortality with the 95% confidence interval. For the Glasgow Outcome Scale and posttreatment Glasgow Coma Scale data, the weighted mean difference was calculated with the 95% confidence interval. Results: A total of 8 randomized controlled trials with a total of 786 patients were included. Meta-analysis showed that there was no significant difference between the groups for mortality. The Glasgow Outcome Scale of the treatment group was higher than that of the control group, although the significance was borderline. The Glasgow Coma Scale score change posttreatment was significantly higher than that of the control. Conclusions: The present meta-analysis of existing randomized controlled trials does not identify a significant beneficial effect in the mortality of traumatic brain injury patients; however, it suggests that magnesium sulfate shows a tendency to improve the Glasgow Outcome Scale and Glasgow Coma Scale scores, which is a promising result for traumatic brain injury therapy. Further effort is necessary to explore which subgroup of traumatic brain injury patients could benefit from magnesium sulfate.	[Li, Wen; Bai, Yin-An; Li, Ya-Jun; Liu, Kai-Ge; Xu, Gang-Zhu; Shang, Hong-Li; Li, Yan-Feng] Xian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Xian 710077, Shaanxi, Peoples R China; [Wang, Mao-De] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Neurosurg, Xian, Shaanxi, Peoples R China		Xu, GZ (corresponding author), Xian Med Univ, Affiliated Hosp 1, Dept Neurosurg, 48 Fenghao West Rd, Xian 710077, Shaanxi, Peoples R China.	xgz917@126.com					Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arango MF, 2008, COCHRANE DATABASE SY, P14; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Boet R, 2000, NEUROSURGERY, V47, P602, DOI 10.1097/00006123-200009000-00014; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Canavero S, 2003, SURG NEUROL, V60, P165, DOI 10.1016/S0090-3019(03)00159-9; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Dhandapani SS, 2008, INDIAN J NEUROTRAUM, V5, P27, DOI 10.1016/S0973-0508(08)80025-1; Enomoto T, 2005, J NEUROTRAUM, V22, P783, DOI 10.1089/neu.2005.22.783; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; [何百祥 He Baixiang], 2010, [中国急救医学, Chinese Journal of Critical Care Medicine], V30, P406; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, J CLIN NEUROSCI, V6, P505, DOI 10.1016/S0967-5868(99)90011-5; Heath DL, 1999, MAGNESIUM RES, V12, P269; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoane MR, 2000, BRAIN RES BULL, V53, P175, DOI 10.1016/S0361-9230(00)00327-0; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JENNETT B, 1975, LANCET, V1, P480; Kahraman S, 2003, CLIN CHIM ACTA, V334, P211, DOI 10.1016/S0009-8981(03)00235-3; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Miller John W, 2007, Epilepsy Curr, V7, P133, DOI 10.1111/j.1535-7511.2007.00201.x; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; Naidu S, 1996, BRIT J OBSTET GYNAEC, V103, P111, DOI 10.1111/j.1471-0528.1996.tb09660.x; Natale JE, 2007, PEDIATR CRIT CARE ME, V8, P1, DOI 10.1097/01.pcc.0000256620.55512.5f; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Patel HC, 1999, HOSP MED, V60, P497, DOI 10.12968/hosp.1999.60.7.1155; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; SADEH M, 1989, STROKE, V20, P1273, DOI 10.1161/01.STR.20.9.1273; Sakamoto T, 2005, J TRAUMA, V58, P1103, DOI 10.1097/01.TA.0000169950.51735.C4; Salehpour F, 2012, J PARAMED SCI, V3, P2008; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Tamai Hideaki, 2007, Masui, V56, P203; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; VINK R, 1988, J BIOL CHEM, V263, P757; Yanagawa Youichi, 2011, J Emerg Trauma Shock, V4, P355, DOI 10.4103/0974-2700.83863; [张赛 ZHANG Sai], 2006, [中华神经外科杂志, Chinese Journal of Neurosurgery], V22, P76; Zhou GS, 2001, CHINESE J TRAUMATOLO, V17, P161; Zhou GS, 2004, CHIN J CLIN REHABIL, V8, P1356	58	11	13	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2015	26	2					393	398		10.1097/SCS.0000000000001339			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CD2FX	WOS:000350891600062	25723660				2022-02-06	
J	Friess, SH; Bruins, B; Kilbaugh, TJ; Smith, C; Margulies, SS				Friess, Stuart H.; Bruins, Benjamin; Kilbaugh, Todd J.; Smith, Colin; Margulies, Susan S.			Differing Effects when Using Phenylephrine and Norepinephrine To Augment Cerebral Blood Flow after Traumatic Brain Injury in the Immature Brain	JOURNAL OF NEUROTRAUMA			English	Article						TBI; PE; CPP; CBF; NE	PERFUSION-PRESSURE AUGMENTATION; CLOSED-HEAD INJURY; CEREBROVASCULAR RESPONSE; AXONAL INJURY; ISOFLURANE; AUTOREGULATION; OXYGENATION; HYPOTENSION; DOPAMINE; CHILDREN	Low cerebral blood flow (CBF) states have been demonstrated in children early after traumatic brain injury (TBI), and have been correlated with poorer outcomes. Cerebral perfusion pressure (CPP) support following severe TBI is commonly implemented to correct cerebral hypoperfusion, but the efficacy of various vasopressors has not been determined. Sixteen 4-week-old female swine underwent nonimpact inertial brain injury in the sagittal plane. Intraparenchymal monitors were placed to measure intracranial pressure (ICP), CBF, brain tissue oxygen tension (PbtO(2)), and cerebral microdialysis 30 min to 6 h post-injury. One hour after injury, animals were randomized to receive either phenylephrine (PE) or norepinephrine (NE) infusions titrated to a CPP >70 mm Hg for 5 h. Animals were euthanized 6 h post-TBI, and brains were fixed and stained to assess regions of cell and axonal injury. After initiation of CPP augmentation with NE or PE infusions, there were no differences in ICP between the groups or over time. Animals receiving NE had higher PbtO(2) than those receiving PE (29.6 +/- 10.2 vs. 19.6 +/- 6.4 torr at 6 h post-injury, p<0.05). CBF increased similarly in both the NE and PE groups. CPP support with PE resulted in a greater reduction in metabolic crisis than with NE (lactate/pyruvate ratio 16.7 +/- 2.4 vs. 42.7 +/- 10.2 at 6 h post-injury, p<0.05). Augmentation of CPP to 70 mm Hg with PE resulted in significantly smaller cell injury volumes at 6 h post-injury than CPP support with NE (0.4% vs. 1.4%, p<0.05). Despite similar increases in CBF, CPP support with NE resulted in greater brain tissue oxygenation and hypoxic-ischemic injury than CPP support with PE. Future clinical studies comparing the effectiveness of various vasopressors for CPP support are warranted.	[Friess, Stuart H.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bruins, Benjamin; Kilbaugh, Todd J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Smith, Colin] Western Gen Hosp, Dept Neuropathol, Edinburgh EH4 2XU, Midlothian, Scotland; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Friess, SH (corresponding author), Washington Univ, Sch Med, Div Crit Care Med, Dept Pediat, Campus Box 8028,5th Floor MPRB,660 S Euclid Ave, St Louis, MO 63110 USA.	Friess_S@kids.wustl.edu		Kilbaugh, Todd/0000-0002-4959-3092; Smith, Colin/0000-0002-4507-5132	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08-NS064051, R01-NS39679, U01-NS069545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, K08NS064051, U01NS069545] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants K08-NS064051 (S.H.F.) R01-NS39679 (S.S.M.), and U01-NS069545 (S.S.M. and T.J.K.)	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead W. M., 2011, J NEUROTRAUMA; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; CUCCHIARA RF, 1974, ANESTHESIOLOGY, V40, P571, DOI 10.1097/00000542-197406000-00011; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Diringer MN, 2007, CURR OPIN CRIT CARE, V13, P156, DOI 10.1097/MCC.0b013e32807f2aa5; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2012, CRIT CARE MED, V40, P2400, DOI 10.1097/CCM.0b013e31825333e6; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Fu WM, 1998, NEUROBIOL DIS, V5, P229, DOI 10.1006/nbdi.1998.0192; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; IMURA H, 1971, J CLIN INVEST, V50, P1069, DOI 10.1172/JCI106578; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Smith JH, 2005, ACTA ANAESTH SCAND, V49, P23, DOI 10.1111/j.1399-6576.2004.00535.x; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Straub SG, 2012, AM J PHYSIOL-CELL PH, V302, pC1687, DOI 10.1152/ajpcell.00282.2011; Todd MM, 1996, J NEUROSURG ANESTH, V8, P296, DOI 10.1097/00008506-199610000-00007; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113	39	11	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2015	32	4					237	243		10.1089/neu.2014.3468			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB0KN	WOS:000349314900004	25072522	Green Submitted, Green Published			2022-02-06	
J	Schmitter-Edgecombe, M; Robertson, K				Schmitter-Edgecombe, Maureen; Robertson, Kayela			Recovery of visual search following moderate to severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Preattentive processes; Parallel and serial search; Outcome; Closed head injury; Attention	CLOSED-HEAD-INJURY; FEATURE-INTEGRATION-THEORY; SUPERIOR PARIETAL CORTEX; SELECTIVE ATTENTION; PRACTICAL SCALE; PERFORMANCE; PARALLEL; IMPLICIT; CONJUNCTION; ORIENTATION	Introduction: Deficits in attentional abilities can significantly impact rehabilitation and recovery from traumatic brain injury (TBI). This study investigated the nature and recovery of preattentive (parallel) and attentive (serial) visual search abilities after TBI. Method: Participants were 40 individuals with moderate to severe TBI who were tested following emergence from posttraumatic amnesia and approximately 8 months post injury, as well as 40 age- and education-matched controls. Preattentive (automatic) and attentive (controlled) visual search situations were created by manipulating the saliency of the target item amongst distractor items in visual displays. The relationship between preattentive and attentive visual search rates and follow-up community integration were also explored. Results: The results revealed intact parallel (automatic) processing skills in the TBI group both postacutely and at follow-up. In contrast, when attentional demands on visual search were increased by reducing the saliency of the target, the TBI group demonstrated poorer performances than the control group both postacutely and 8 months post injury. Neither preattentive nor attentive visual search slope values correlated with follow-up community integration. Conclusions: These results suggest that utilizing intact preattentive visual search skills during rehabilitation may help to reduce high mental workload situations, thereby improving the rehabilitation process. For example, making commonly used objects more salient in the environment should increase reliance or more automatic visual search processes and reduce visual search time for individuals with TBI.	[Schmitter-Edgecombe, Maureen; Robertson, Kayela] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	This study was supported by the National Institute of Neurological Disorders and Stroke [grant number R01 NS47690]. The authors have no financial interests or benefits to disclose.	Anderson EJ, 2007, EXP BRAIN RES, V180, P289, DOI 10.1007/s00221-007-0860-0; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Benton AL, 1994, MULTILINGUAL APHASIA; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; *CEDR CORP, 1999, SUPERLAB PRO BET VER; Chan LKH, 2009, J EXP PSYCHOL HUMAN, V35, P119, DOI 10.1037/0096-1523.35.1.119; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Donner TH, 2002, NEUROIMAGE, V15, P16, DOI 10.1006/nimg.2001.0951; Egeth H. E., 2012, PERCEPTION CONSCIOUS, P164; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Folstein M., 2003, TELEPHONE INTERVIEW; Hatta T, 2012, PSYCHOLOGIA, V55, P246, DOI 10.2117/psysoc.2012.246; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; Hommel B, 2004, DEV PSYCHOL, V40, P545, DOI 10.1037/0012-1649.40.4.545; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; Li L, 2010, BRAIN RES, V1344, P173, DOI 10.1016/j.brainres.2010.05.016; Madden DJ, 2007, CURR DIR PSYCHOL SCI, V16, P70, DOI 10.1111/j.1467-8721.2007.00478.x; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Millis S R, 1994, Int J Neurosci, V79, P165; Muller HJ, 2010, ACTA PSYCHOL, V135, P117, DOI 10.1016/j.actpsy.2010.05.004; Muller-Oehring EM, 2013, NEUROPSYCHOLOGY, V27, P48, DOI 10.1037/a0030921; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Palmer EM, 2011, ATTEN PERCEPT PSYCHO, V73, P2413, DOI 10.3758/s13414-011-0199-2; PALMER J, 1993, J EXP PSYCHOL HUMAN, V19, P108, DOI 10.1037/0096-1523.19.1.108; Parks EL, 2013, BRAIN CONNECT, V3, P317, DOI 10.1089/brain.2012.0139; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; PLUDE DJ, 1989, PSYCHOL AGING, V4, P98, DOI 10.1037/0882-7974.4.1.98; Potter LM, 2012, ACTA PSYCHOL, V140, P208, DOI 10.1016/j.actpsy.2012.05.001; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ries M, 2005, NEUROPSYCHOLOGY, V19, P476, DOI 10.1037/0894-4105.19.4.476; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; Smilek D, 2007, PERCEPT PSYCHOPHYS, V69, P1105, DOI 10.3758/BF03193948; Smith A., 1991, SYMBOL DIGIT MODALIT; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sung K, 2008, J EXP PSYCHOL HUMAN, V34, P1372, DOI 10.1037/a0011852; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsotsos JK, 2008, BRAIN RES, V1225, P119, DOI 10.1016/j.brainres.2008.05.038; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Wagenmakers EJ, 2012, MEM COGNITION, V40, P145, DOI 10.3758/s13421-011-0158-0; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wilkinson DT, 2002, NEUROIMAGE, V15, P611, DOI 10.1006/nimg.2001.0993; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfe JM, 2010, VISION RES, V50, P1304, DOI 10.1016/j.visres.2009.11.002; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1990, J EXP PSYCHOL HUMAN, V16, P879, DOI 10.1037/0096-1523.16.4.879; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135	67	11	12	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB 7	2015	37	2					162	177		10.1080/13803395.2014.998170			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CC9IP	WOS:000350682700005	25671675	Green Accepted			2022-02-06	
J	Barnes, SM; Russell, LM; Hostetter, TA; Forster, JE; Devore, MD; Brenner, LA				Barnes, Sean M.; Russell, Leah M.; Hostetter, Trisha A.; Forster, Jeri E.; Devore, Maria D.; Brenner, Lisa A.			Characteristics of Traumatic Brain Injuries Sustained Among Veterans Seeking Homeless Services	JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED			English	Article						Traumatic brain injuries; homeless; Veterans	PEOPLE; HEALTH	This hypothesis-generating research describes the characteristics of traumatic brain injuries (TBIs) sustained among 229 Veterans seeking homeless services. Nearly all participants (83%) had sustained at least one TBI prior to their first episode of homelessness. Among participants with a TBI, assaults, transportation-related accidents, and falls were the most common causes of these injuries. Thirty percent of individuals sustained injuries with severity levels that would be expected to be associated with ongoing TBI-related deficits. Forty-three percent of the Veterans sustained at least one brain injury following their first episode of homelessness. Median lifetime number of TBIs was three. The severity of TBIs was similar among Veterans who sustained injuries before or after their first incident of homelessness. Findings suggest that future research should directly examine the potential bi-directional relationship between TBI and homelessness, as well as the impact of TBI-related deficits on Veterans' ability to benefit from homeless services and/or maintain stable housing.	[Barnes, Sean M.; Russell, Leah M.; Hostetter, Trisha A.; Forster, Jeri E.; Devore, Maria D.; Brenner, Lisa A.] Vet Integrated Serv Network 19 Mental Illness Res, Denver, CO USA		Barnes, SM (corresponding author), Denver VA Med Ctr, MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	Sean.Barnes2@va.gov	Brenner, Lisa A./AAG-2442-2019		National Center on Homelessness	The authors are associated with the Veterans Integrated Service Network 19 Mental Illness Research, Education, and Clinical Center, Denver, CO. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. We wish to thank the National Center on Homelessness for their support of this project. Correspondence should be sent to Sean M. Barnes, Denver VA Medical Center, MIRECC, 1055 Clermont Street, Denver, CO 80220 (e-mail: Sean.Barnes2@va.gov).	[Anonymous], 2002, SAS STAT COMP PROGR; Borges G, 2006, B WORLD HEALTH ORGAN, V84, P453, DOI 10.2471/BLT.05.027466; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Burt MR, 2001, HOUS POLICY DEBATE, V12, P737, DOI 10.1080/10511482.2001.9521428; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Metraux S, 2013, AM J PUBLIC HEALTH, V103, pS255, DOI 10.2105/AJPH.2013.301432; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; US Department of Veterans Affairs, 2010, STRAT PLAN FY2010 20; van den Bree MBM, 2009, J ADOLESCENT HEALTH, V45, P571, DOI 10.1016/j.jadohealth.2009.03.027; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737	26	11	11	0	1	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	1049-2089	1548-6869		J HEALTH CARE POOR U	J. Health Care Poor Underserved	FEB	2015	26	1					92	105		10.1353/hpu.2015.0010			14	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CC7BO	WOS:000350522900011	25702730				2022-02-06	
J	Berger, RP; Fromkin, J; Rubin, P; Snyder, J; Richichi, R; Kochanek, P				Berger, Rachel P.; Fromkin, Janet; Rubin, Pam; Snyder, John; Richichi, Rudolph; Kochanek, Patrick			Serum D-Dimer Concentrations Are Increased after Pediatric Traumatic Brain Injury	JOURNAL OF PEDIATRICS			English	Article							ABUSIVE HEAD TRAUMA; SICKLE-CELL-DISEASE; YOUNG-CHILDREN; COAGULATION; FRAGMENT; MARKERS; WELL; POPULATION; BIOMARKERS; CRISIS	Objective To determine whether D-dimer would be increased in children with traumatic brain injury (TBI), specifically mild abusive head trauma. Study design D-dimer was measured using multiplex bead technology in 195 children <4 years old (n = 93 controls without TBI, n = 102 cases with TBI) using previously collected serum. D-dimer was then measured prospectively in a clinical setting in 44 children (n = 24 controls, n = 20 cases). Receiver operator curves were generated for prospective data. Results In both the retrospective and prospective cohorts, median (25th-75th percentile) D-dimer was significantly higher in cases vs controls. A receiver operator curve demonstrated an area under the curve of 0.91 (95% CI 0.83-0.99) in the prospective cohort. At a cut-off of 0.59 mu g/L, the sensitivity and specificity for identification of a case was 90% and 75%, respectively. Conclusions Our data suggest that serum D-dimer may be able to be used to identify which young children at risk for abusive head trauma might benefit from a head computed tomography or other additional evaluation. Additional data are needed to better identify the clinical scenarios that may result in false positive or false negative D-dimer concentrations.	[Berger, Rachel P.; Kochanek, Patrick] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Berger, Rachel P.; Fromkin, Janet; Rubin, Pam] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Snyder, John] UPMC Hillman Canc Ctr, Pittsburgh, PA USA; [Richichi, Rudolph] Stat Anal & Measurement Consultants Inc, Lanexa, VA USA		Berger, RP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	rachel.berger@chp.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD055986, 1K23HD43843]; General Clinical Resource Center of Children's Hospital of Pittsburgh of UPMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055986] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER	Funded by the National Institutes of Health (R01HD055986 AND 1K23HD43843 [to R.B.]) and the General Clinical Resource Center of Children's Hospital of Pittsburgh of UPMC. The authors declare no conflicts of interest.	Barnes DM, 2008, BIOMARK INSIGHTS, V3, P93; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, CLIN PEDIATR EMERG M, V7, P186, DOI 10.1016/j.cpem.2006.06.001; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; BOISCLAIR MD, 1990, BRIT J HAEMATOL, V74, P471, DOI 10.1111/j.1365-2141.1990.tb06337.x; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; Chen JP, 1999, THROMB RES, V94, P175, DOI 10.1016/S0049-3848(98)00211-4; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Corwin MT, 2009, AM J ROENTGENOL, V192, P1319, DOI 10.2214/AJR.08.1346; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; DEVINE DV, 1986, BLOOD, V68, P317; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; FRANCIS RB, 1989, HAEMOSTASIS, V19, P105; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Letson M, 2013, PED AC SOC ANN M; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Natorska J, 2011, THROMB HAEMOSTASIS, V105, P254, DOI 10.1160/TH10-09-0612; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Shah N, 2012, THROMB RES, V130, pE241, DOI 10.1016/j.thromres.2012.08.307; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; Swanson CA, 2010, J TRAUMA, V68, P1072, DOI 10.1097/TA.0b013e3181d7a6f2	30	11	13	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2015	166	2					383	388		10.1016/j.jpeds.2014.10.036			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AZ8XY	WOS:000348496200038	25454315	Green Accepted			2022-02-06	
J	Miyake, S; Muramatsu, R; Hamaguchi, M; Yamashita, T				Miyake, S.; Muramatsu, R.; Hamaguchi, M.; Yamashita, T.			Prolyl hydroxylase regulates axonal rewiring and motor recovery after traumatic brain injury	CELL DEATH & DISEASE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACTOR-RESPONSIVE GENE; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; GUIDANCE; HYPOXIA; NEURONS; RHO; REGENERATION; HIF-1-ALPHA	Prolyl 4-hydroxylases (PHDs; PHD1, PHD2, and PHD3) are a component of cellular oxygen sensors that regulate the adaptive response depending on the oxygen concentration stabilized by hypoxia/stress-regulated genes transcription. In normoxic condition, PHD2 is required to stabilize hypoxia inducible factors. Silencing of PHD2 leads to the activation of intracellular signaling including RhoA and Rho-associated protein kinase (ROCK), which are key regulators of neurite growth. In this study, we determined that genetic or pharmacological inhibition of PHD2 in cultured cortical neurons prevents neurite elongation through a ROCK-dependent mechanism. We then explored the role of PHDs in axonal reorganization following a traumatic brain injury in adult mice. Unilateral destruction of motor cortex resulted in behavioral deficits due to disruption of the corticospinal tract (CST), a part of the descending motor pathway. In the spinal cord, sprouting of fibers from the intact side of the CST into the denervated side is thought to contribute to the recovery process following an injury. Intracortical infusion of PHD inhibitors into the intact side of the motor cortex abrogated spontaneous formation of CST collaterals and functional recovery after damage to the sensorimotor cortex. These findings suggest PHDs have an important role in the formation of compensatory axonal networks following an injury and may represent a new molecular target for the central nervous system disorders.	[Miyake, S.; Muramatsu, R.; Hamaguchi, M.; Yamashita, T.] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Miyake, S.; Muramatsu, R.; Hamaguchi, M.; Yamashita, T.] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan; [Muramatsu, R.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo, Japan		Muramatsu, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka, Japan.	muramatsu@molneu.med.osaka-uac.jp; yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Sciences (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [24650197]; JSPSMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [25710006, 25221309]	The authors are grateful to Dr Shusaku Omoto, Dr Sachiko Lee, Dr Masaki Ueno, Dr Meiko Hagihara, and Dr Takahide Itokazu for helpful comments. This work was supported by a by a Grant-in-Aid for Exploratory Research (24650197) from the Japan Society for the Promotion of Sciences (JSPS) to RM, by a Grant-in-Aid for Young Scientists (A) (25710006) from the JSPS to RM, and by a Grant-in-Aid for Scientific Research (S) (25221309) from JSPS to TY. We are grateful to the Osaka University Program for the Support of Networking among Present and Future Researchers.	Acker T, 2004, J EXP BIOL, V207, P3171, DOI 10.1242/Jeb.01075; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bernstein BW, 2003, J NEUROSCI, V23, P1; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Cioffi CL, 2003, BIOCHEM BIOPH RES CO, V303, P947, DOI 10.1016/S0006-291X(03)00453-4; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Kubo T, 2007, CURR PHARM DESIGN, V13, P2493; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Moschella MC, 1999, GENE EXPRESSION, V8, P59; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Pronichev I V, 1998, Neurosci Behav Physiol, V28, P80, DOI 10.1007/BF02461916; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Sumimoto S, 2015, BRAIN RES, V1594, P46, DOI 10.1016/j.brainres.2014.07.048; Sumimoto S, 2014, BIOCHEM BIOPH RES CO, V450, P593, DOI 10.1016/j.bbrc.2014.06.012; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Uesugi N, 2009, BIOCHEM BIOPH RES CO, V383, P509, DOI 10.1016/j.bbrc.2009.04.085; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985; WAX SD, 1994, J BIOL CHEM, V269, P13041; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	41	11	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	FEB	2015	6								e1638	10.1038/cddis.2015.5			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CC7VF	WOS:000350575800012	25675298	Green Published, gold			2022-02-06	
J	Vandresen, S; Severino, PC; Constantino, LC; Martins, WC; Molz, S; Dal-Cim, T; Bertoldo, DB; Silva, FRMB; Tasca, CI				Vandresen-Filho, S.; Severino, P. C.; Constantino, L. C.; Martins, W. C.; Molz, S.; Dal-Cim, T.; Bertoldo, D. B.; Silva, F. R. M. B.; Tasca, C. I.			N-Methyl-D-aspartate Preconditioning Prevents Quinolinic Acid-Induced Deregulation of Glutamate and Calcium Homeostasis in Mice Hippocampus	NEUROTOXICITY RESEARCH			English	Article						NMDA preconditioning; Excitotoxicity; Calcium homeostasis; Glutamate release; Hippocampus	CEREBELLAR GRANULE CELLS; GATED CA2+ CHANNELS; NMDA RECEPTOR; INDUCED SEIZURES; NEURODEGENERATIVE DISORDERS; SUBLETHAL ISCHEMIA; CEREBRAL-ISCHEMIA; BRAIN-INJURY; RAT-BRAIN; DEATH	The search for new therapeutic strategies through modulation of glutamatergic transmission using effective neuroprotective agents is essential. Glutamatergic excitotoxicity is a major factor common to neurodegenerative diseases and in acute events such as cerebral ischemia, traumatic brain injury and epilepsy. We have previously demonstrated that N-methyl-d-aspartate (NMDA) preconditioning in mice showed 50 % of protection against seizures and full protection against damage to neuronal tissue induced by quinolinic acid (QA). In this study, cellular and molecular mechanisms involved on NMDA preconditioning and neuroprotection were investigated in mice treated with NMDA 24 h before QA insult. Calcium uptake and d-aspartate release from hippocampal slices obtained from mice treated with NMDA plus QA and not displaying seizures (protected mice) were similar to control (saline) or NMDA preconditioned mice. Increased calcium uptake and glutamate release is evidenced in unprotected (convulsed) mice as well as QA control, demonstrating that calcium and glutamate are involved in NMDA-induced preconditioning. Increased glutamate release evoked by QA was blocked by MK-801, whereas increased calcium uptake was abolished by voltage-dependent calcium channels inhibitors, but not MK-801. NMDA preconditioning is effective in normalizing the deregulation of glutamate transport and calcium homeostasis evoked by QA due to aberrant NMDA receptors activation that culminates in seizures and hippocampal cells damage.	[Vandresen-Filho, S.; Severino, P. C.; Constantino, L. C.; Martins, W. C.; Molz, S.; Dal-Cim, T.; Bertoldo, D. B.; Tasca, C. I.] Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Lab Neuroquim 4, BR-88040900 Florianopolis, SC, Brazil; [Vandresen-Filho, S.] Univ Fed Mato Grosso, Fac Med, Dept Ciencias Basicas Saude, BR-78060900 Cuiaba, MT, Brazil; [Molz, S.] Univ Contestado, Curso Farm, BR-89460000 Canoinhas, SC, Brazil; [Silva, F. R. M. B.] Univ Fed Santa Catarina, Lab Hormonios & Transducao Sinais, Dept Bioquim, Ctr Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil		Vandresen, S (corresponding author), Univ Fed Mato Grosso, Fac Med, Dept Ciencias Basicas Saude, BR-78060900 Cuiaba, MT, Brazil.	samuelvandresen@yahoo.com.br	Tasca, Carla Ines/AAB-8287-2019; Silva, Fatima Regina Mena Barreto/S-7939-2019; Constantino, Leandra/H-8505-2018; Constantino, Leandra/AAF-2838-2021	Tasca, Carla Ines/0000-0002-3414-6150; Constantino, Leandra/0000-0003-0523-4351; 	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [01.06.0842-00]; INCT (Instituto Nacional de Ciencia e Tecnologia) for Excitotoxicity and Neuroprotection; FAPESC (Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina) - Project NENASC/PRONEX; PRODOC/CAPES post-doctoral scholarship	Research supported by grants from the Brazilian funding agencies, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) - Projects IBN-Net # 01.06.0842-00 and INCT (Instituto Nacional de Ciencia e Tecnologia) for Excitotoxicity and Neuroprotection and FAPESC (Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina) - Project NENASC/PRONEX to C.I.T. CAPES, CNPq-Uni e FAPESC-Uni to F.R.M.B.S. C.I.T. is recipient of CNPq productivity fellowship and P.C.S. was recipient of PRODOC/CAPES post-doctoral scholarship.	Arthur PG, 2004, BRAIN RES, V1017, P146, DOI 10.1016/j.brainres.2004.05.031; Atlas D, 2013, ANNU REV BIOCHEM, V82, P607, DOI 10.1146/annurev-biochem-080411-121438; Bigdeli MR, 2009, J STROKE CEREBROVASC, V18, P336, DOI 10.1016/j.jstrokecerebrovasdis.2008.12.005; Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Boeck CR, 2004, EPILEPSIA, V45, P745, DOI 10.1111/j.0013-9580.2004.65203.x; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Cruz SL, 2003, BEHAV BRAIN RES, V140, P195, DOI 10.1016/S0166-4328(02)00323-6; Dickie BGM, 1996, NEUROSCIENCE, V72, P731, DOI 10.1016/0306-4522(95)00611-7; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Herculano BD, 2011, BEHAV BRAIN RES, V219, P92, DOI 10.1016/j.bbr.2010.12.025; HEYES MP, 1990, ANN NEUROL, V27, P666, DOI 10.1002/ana.410270614; Horiguchi T, 2003, STROKE, V34, P1015, DOI 10.1161/01.STR.0000063404.27912.5B; Hou XY, 2002, BRAIN RES, V955, P123, DOI 10.1016/S0006-8993(02)03376-0; Kaufman AM, 2012, J NEUROSCI, V32, P3992, DOI 10.1523/JNEUROSCI.4129-11.2012; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Li J, 2001, NEUROSCI LETT, V304, P29, DOI 10.1016/S0304-3940(01)01742-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Marganella C, 2005, EUR J PHARMACOL, V518, P111, DOI 10.1016/j.ejphar.2005.06.022; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Miyazaki H, 1999, LIFE SCI, V64, P869, DOI 10.1016/S0024-3205(99)00011-9; Molz S, 2005, NEUROCHEM RES, V30, P83, DOI 10.1007/s11064-004-9689-0; Molz S, 2008, NEUROCHEM RES, V33, P27, DOI 10.1007/s11064-007-9402-1; Molz S, 2011, J NEUROSCI RES, V89, P1400, DOI 10.1002/jnr.22681; Pal S, 2000, CELL CALCIUM, V28, P181, DOI 10.1054/ceca.2000.0146; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pringle AK, 1999, BRAIN RES, V845, P152, DOI 10.1016/S0006-8993(99)01916-2; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Schmidt AP, 2000, BRAIN RES, V864, P40, DOI 10.1016/S0006-8993(00)02106-5; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Stone TW, 2000, AMINO ACIDS, V19, P275, DOI 10.1007/s007260070059; Sugawara T, 2001, STROKE, V32, P2388, DOI 10.1161/hs1001.097109; Tauskela JS, 2012, J NEUROCHEM, V122, P470, DOI 10.1111/j.1471-4159.2012.07791.x; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Tavares RG, 2000, NEUROREPORT, V11, P249, DOI 10.1097/00001756-200002070-00005; Tavares RG, 2002, NEUROCHEM INT, V40, P621, DOI 10.1016/S0197-0186(01)00133-4; Valentim LM, 2003, NEUROSCIENCE, V118, P379, DOI 10.1016/S0306-4522(02)00919-3; Vandresen S, 2007, BRAIN RES, V1184, P38, DOI 10.1016/j.brainres.2007.09.091; Vandresen S, 2013, NEUROTOX RES, V24, P55, DOI 10.1007/s12640-012-9359-y; Vandresen S, 2013, NEUROCHEM INT, V62, P948, DOI 10.1016/j.neuint.2013.03.002; Yamada T, 2006, NEUROCHEM RES, V31, P49, DOI 10.1007/s11064-005-9077-4; Zanatta L, 2011, BIOCHEMISTRY-US, V50, P10284, DOI 10.1021/bi201113n; Zhang L, 2007, ARTERIOSCL THROM VAS, V27, P2470, DOI 10.1161/ATVBAHA.107.150748	55	11	12	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	FEB	2015	27	2					118	128		10.1007/s12640-014-9496-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ4OC	WOS:000348200900003	25367806				2022-02-06	
J	Romero, K; Lobaugh, NJ; Black, SE; Ehrlich, L; Feinstein, A				Romero, Kristoffer; Lobaugh, Nancy J.; Black, Sandra E.; Ehrlich, Lisa; Feinstein, Anthony			Old wine in new bottles: Validating the clinical utility of SPECT in predicting cognitive performance in mild traumatic brain injury	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Mild TBI; SPECT; Partial least squares; Executive function; Stroop test	CEREBRAL-BLOOD-FLOW; ANTERIOR CINGULATE CORTEX; PHOTON EMISSION CT; DIFFUSION-TENSOR; TECHNETIUM-99M-HMPAO SPECT; DEFAULT NETWORK; HMPAO SPECT; TC-99M ECD; SYMPTOMS; BIOMARKERS	The neural underpinnings of cognitive dysfunction in mild traumatic brain injury (TBI) are not fully understood. Consequently, patient prognosis using existing clinical imaging is somewhat imprecise. Single photon emission computed tomography (SPECT) is a frequently employed investigation in this population, notwithstanding uncertainty over the clinical utility of the data obtained. In this study, subjects with mild TBI underwent Tc-99m-ECD SPECT scanning, and were administered a brief battery of cognitive tests and self-report symptom scales of concussion and emotional distress. Testing took place 2 weeks (n = 84) and 1 year (n = 49) post-injury. Multivariate analysis (i.e., partial least squares analysis) revealed that frontal perfusion in right superior frontal and middle frontal gyri predicted poorer performance on the Stroop test, an index of executive function, both at initial and follow-up testing. Conversely, SPECT scans categorized as normal or abnormal by radiologists did not differentiate cognitively impaired from intact subjects. These results demonstrate the clinical utility of SPECT in mild TBI, but only when data are subjected to blood flow quantification analysis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Romero, Kristoffer; Black, Sandra E.; Ehrlich, Lisa; Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Lobaugh, Nancy J.] Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; [Black, Sandra E.] LC Campbell Cognit Neurol Res Unit, Toronto, ON M4N 3M5, Canada; [Black, Sandra E.] Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON M4N 3M5, Canada		Romero, K (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	Kris.romero@utoronto.ca		Romero, Kristoffer/0000-0002-3055-7112	Canadian Institute for Health ResearchCanadian Institutes of Health Research (CIHR) [36535]	This work was supported by a grant from the Canadian Institute for Health Research (36535) to A. Feinstein.	Altrocchi PH, 1996, NEUROLOGY, V46, P278; Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Audenaert K., 2003, MED SCI MONITOR, V9, P112; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Brinkmann BH, 2012, J CEREBR BLOOD F MET, V32, P190, DOI 10.1038/jcbfm.2011.123; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Champod AS, 2010, J NEUROSCI, V30, P3849, DOI 10.1523/JNEUROSCI.0097-10.2010; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ettenhofer ML, 2013, J INT NEUROPSYCH SOC, V19, P977, DOI 10.1017/S1355617713000763; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Harrison BJ, 2005, NEUROIMAGE, V24, P181, DOI 10.1016/j.neuroimage.2004.08.033; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; ICHISE M, 1994, J NUCL MED, V35, P217; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Ishizu K, 1996, J NUCL MED, V37, P1600; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Jacobs A, 1996, J NUCL MED, V37, P1605; Juni JE, 2009, J NUCL MED TECHNOL, V37, P191, DOI 10.2967/jnmt.109.067850; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kapucu OL, 2009, EUR J NUCL MED MOL I, V36, P2093, DOI 10.1007/s00259-009-1266-y; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lapshin H, 2013, MULT SCLER J, V19, P1905, DOI 10.1177/1352458513488841; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Lobaugh NJ, 2000, J NUCL MED, V41, P45; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nestor PG, 2002, SCHIZOPHR RES, V53, P57, DOI 10.1016/S0920-9964(00)00171-7; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pollock JM, 2009, MAGN RESON IMAGING C, V17, P315, DOI 10.1016/j.mric.2009.01.008; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tippett WJ, 2008, J INT NEUROPSYCH SOC, V14, P1034, DOI 10.1017/S1355617708081241; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Umile EM, 1998, BRAIN INJURY, V12, P577; VALLABHAJOSULA S, 1989, J NUCL MED, V30, P599; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	76	11	11	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	JAN 30	2015	231	1					15	24		10.1016/j.pscychresns.2014.11.003			10	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CA3YM	WOS:000348841100003	25466236				2022-02-06	
J	Clevenger, AC; Kilbaugh, T; Margulies, SS				Clevenger, Amy C.; Kilbaugh, Todd; Margulies, Susan S.			Carotid Artery Blood Flow Decreases after Rapid Head Rotation in Piglets	JOURNAL OF NEUROTRAUMA			English	Article						brain; flow; traumatic; carotid	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; CEREBROVASCULAR RESPONSE; AXONAL INJURY; NEONATAL PIG; SWINE MODEL; CHILDREN; AUTOREGULATION; ANESTHESIA	Modification of cerebral perfusion pressure and cerebral blood flow (CBF) are crucial components of the therapies designed to reduce secondary damage after traumatic brain injury (TBI). Previously we documented a robust decrease in CBF after rapid sagittal head rotation in our well-validated animal model of diffuse TBI. Mechanisms responsible for this immediate (<10 min) and sustained (similar to 24 h) reduction in CBF have not been explored. Because the carotid arteries are a major source of CBF, we hypothesized that blood flow through the carotid arteries (Q) and vessel diameter (D) would decrease after rapid nonimpact head rotation without cervical spine injury. Four-week-old (toddler) female piglets underwent rapid (<20 msec) sagittal head rotation without impact, previously shown to produce diffuse TBI with reductions in CBF. Ultrasonographic images of the bilateral carotid arteries were recorded at baseline (pre-injury), as well as immediately after head rotation and 15, 30, 45, and 60 min after injury. Diameter (D) and waveform velocity (V) were used to calculate blood flow (Q) through the carotid arteries using the equation Q=(0.25)pi(DV)-V-2. D, V, and Q were normalized to the pre-injury baseline values to obtain a relative change after injury in right and left carotid arteries. Three-way analysis of variance and post-hoc Tukey-Kramer analyses were used to assess statistical significance of injury, time, and side. The relative change in carotid artery diameter and flow was significantly decreased in injured animals in comparison with uninjured sham controls (pp=0.0093, respectively) and did not vary with side (p>0.39). The average carotid blood velocity did not differ between sham and injured animals (p=0.91). These data suggest that a reduction in global CBF after rapid sagittal head rotation may be partially mediated by a reduction in carotid artery flow, via vasoconstriction.	[Clevenger, Amy C.; Kilbaugh, Todd] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu		Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS039679]; Children's Hospital of Philadelphia Critical Care Endowed Chair Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, U01NS069545] Funding Source: NIH RePORTER	This research was funded by NIH R01NS039679 and the Children's Hospital of Philadelphia Critical Care Endowed Chair Fund. The authors are grateful to Jill Ralston, Sarah Sullivan, Melissa Byro, Ashley Bebee, Lorre Atlan, Stephanie Pasquesi, and Samer Jaber for their time and technical assistance. The authors also thank Joseph Coll from Siemans Medical Solutions USA, Inc (Malvern, PA) and Susan Schultz in the University of Pennsylvania Ultrasound Laboratory for their technical expertise and training for the ultrasound imaging.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Aristokleous N, 2011, IEEE T INF TECHNOL B, V15, P148, DOI 10.1109/TITB.2010.2091417; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Dagal A, 2009, CURR OPIN ANESTHESIO, V22, P547, DOI 10.1097/ACO.0b013e32833020be; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Eichler F, 2001, EUR J PEDIATR, V160, P633, DOI 10.1007/s004310100806; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Esposito E, 2014, PHARMACOL RES, V86, P26, DOI 10.1016/j.phrs.2014.05.009; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M, 2010, TRAUMATIC BRAIN INJU; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gao C, 2009, AUTON NEUROSCI-BASIC, V147, P70, DOI 10.1016/j.autneu.2009.01.010; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rhondali O, 2013, PEDIATR ANESTH, V23, P946, DOI 10.1111/pan.12166; Sakaguchi M, 2003, NEUROLOGY, V61, P845, DOI 10.1212/01.WNL.0000078081.12097.AE; Seric V, 2000, COLLEGIUM ANTROPOL, V24, P197; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Ter Minassian A, 2002, CRIT CARE MED, V30, P1616, DOI 10.1097/00003246-200207000-00036; Tewari A., 2014, J ANAESTHESIOL CLIN, V30, P160, DOI [10.4103/0970-9185.130001, DOI 10.4103/0970-9185.130001]; Walsh JT, 2014, IMMUNOLOGY, V141, P340, DOI 10.1111/imm.12187; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wilson TD, 2003, BRAIN RES, V961, P261, DOI 10.1016/S0006-8993(02)03965-3; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814	53	11	11	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2015	32	2					120	126		10.1089/neu.2014.3570			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AY6QM	WOS:000347690700007	25133889	Green Published			2022-02-06	
J	Midorikawa, A; Kawamura, M				Midorikawa, Akira; Kawamura, Mitsuru			The emergence of artistic ability following traumatic brain injury	NEUROCASE			English	Article						painting style; emergence of artistic ability; temporal lobe; painting; traumatic brain injury	FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; CREATIVITY; ART; NEUROPSYCHOLOGY	In this study, the case of a patient who developed artistic ability following a traumatic brain injury is reported. The subject was a 49-year-old male who suffered brain injury at the age of 44 due to an accidental fall. At age 48, he began drawing with great enthusiasm and quickly developed a personal style with his own biomorphic iconography. At first, his drawing was restricted to realistic reproductions of photographs of buildings, but his style of drawing changed and became more personal and expressionistic over the following 6 months.	[Midorikawa, Akira] Chuo Univ, Fac Letters, Dept Psychol, Tokyo 1920393, Japan; [Midorikawa, Akira; Kawamura, Mitsuru] Showa Univ, Sch Med, Dept Neurol, Tokyo 142, Japan		Midorikawa, A (corresponding author), Chuo Univ, Fac Letters, Dept Psychol, Tokyo 1920393, Japan.	green@tamacc.chuo-u.ac.jp	Midorikawa, Akira/F-7382-2015	Midorikawa, Akira/0000-0003-3340-4741	Chuo University Grant for Special Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22730587, 23591283]; Tamagawa University Center of Excellence under the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26119528] Funding Source: KAKEN	AM was supported by a Chuo University Grant for Special Research, and AM and MK were supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, 22730587(AM), 23591283(MK)). MK was supported by the Tamagawa University Center of Excellence under the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Bogousslavsky J, 2005, EUR NEUROL, V54, P103, DOI 10.1159/000088645; Chakravarty A, 2011, ANN INDIAN ACAD NEUR, V14, P291, DOI 10.4103/0972-2327.91953; Chatterjee A, 2006, INT REV NEUROBIOL, V74, P39, DOI 10.1016/S0074-7742(06)74003-X; Crutch SJ, 2006, INT REV NEUROBIOL, V74, P147, DOI 10.1016/S0074-7742(06)74012-0; Lythgoe MFX, 2005, NEUROLOGY, V64, P397, DOI 10.1212/01.WNL.0000150526.09499.3E; Mell JC, 2003, NEUROLOGY, V60, P1707, DOI 10.1212/01.WNL.0000064164.02891.12; Midorikawa A, 2008, EUR NEUROL, V60, P224, DOI 10.1159/000151697; Miller BL, 2000, BRIT J PSYCHIAT, V176, P458, DOI 10.1192/bjp.176.5.458; Miller BL, 2004, ARCH NEUROL-CHICAGO, V61, P842, DOI 10.1001/archneur.61.6.842; Miller BL, 1998, NEUROLOGY, V51, P978, DOI 10.1212/WNL.51.4.978; Okada M., 1991, J YOKOHAMA NATL U ED, V31, P45; Pollak Thomas A, 2007, Front Neurol Neurosci, V22, P75, DOI 10.1159/000102873; Schott GD, 2012, BRAIN, V135, P1947, DOI 10.1093/brain/awr314; Seeley WW, 2008, BRAIN, V131, P39, DOI 10.1093/brain/awm270; Tanabe H, 1996, INT CONGR SER, V1108, P141; Thomas-Anterion C, 2010, PAIN, V150, P121, DOI 10.1016/j.pain.2010.04.010; Walker RH, 2006, MOVEMENT DISORD, V21, P285, DOI 10.1002/mds.20758; Zaidel DW, 2005, BRAIN DAM B, P1	18	11	11	0	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	JAN 2	2015	21	1					90	94		10.1080/13554794.2013.873058			5	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	AR5AB	WOS:000343596300011	24417345	Green Published, hybrid			2022-02-06	
J	Bernard, SA; Smith, K; Porter, R; Jones, C; Gailey, A; Cresswell, B; Cudini, D; Hill, S; Moore, B; St Clair, T				Bernard, S. A.; Smith, K.; Porter, R.; Jones, C.; Gailey, A.; Cresswell, B.; Cudini, D.; Hill, S.; Moore, B.; St Clair, T.			Paramedic rapid sequence intubation in patients with non-traumatic coma	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; STATUS EPILEPTICUS; SUCCESS RATES; METAANALYSIS; KETAMINE	Introduction Pre-hospital intubation by paramedics is widely used in comatose patients prior to transportation to hospital, but the optimal technique for intubation is uncertain. One approach is paramedic rapid sequence intubation (RSI), which may improve outcomes in adult patients with traumatic brain injury. However, many patients present to emergency medical services with coma of non-traumatic cause and the role of paramedic RSI in these patients remains uncertain. Methods The electronic Victorian Ambulance Clinical Information System was searched for the term 'suxamethonium' between 2008 and 2011. We reviewed the patient care records and included patients with suspected non-traumatic coma who were treated and transported by road-based paramedics. Demographics, intubation conditions, vital signs (before and after drug administration) and complications were recorded. Younger patients (<60 years) were compared with older patients. Results There were 1152 paramedic RSI attempts of which 551 were for non-traumatic coma. The success rate for intubation was 97.5%. There was a significant drop in blood pressure in younger patients (<60 years) with the mean systolic blood pressure decreasing by 16 mm Hg (95% CI 11 to 21). In older patients, the systolic blood pressure also decreased significantly by 20 mm Hg (95% CI 17 to 24). Four patients suffered brief cardiac arrest during pre-hospital care, all of whom were successfully resuscitated and transported to hospital. Conclusions Paramedic RSI in patients with non-traumatic coma has a high procedural success rate. Further studies are required to determine whether this procedure improves outcomes.	[Bernard, S. A.; Smith, K.; Jones, C.; Gailey, A.; Cresswell, B.; Cudini, D.; Hill, S.; Moore, B.; St Clair, T.] Ambulance Victoria, Doncaster, Vic, Australia; [Bernard, S. A.; Smith, K.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bernard, S. A.; Porter, R.] Alfred Hosp, Intens Care Unit, Melbourne, Vic 3004, Australia		Bernard, SA (corresponding author), Alfred Hosp, Intens Care Unit, Commercial Rd, Melbourne, Vic 3004, Australia.	s.bernard@alfred.org.au		StClair, Toby/0000-0002-3398-1242; Smith, Karen/0000-0002-9057-0685			Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Bernard Stephen, 2002, Emerg Med (Fremantle), V14, P406, DOI 10.1046/j.1442-2026.2002.00382.x; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Harris T, 2011, EMERG MED J, V28, P225, DOI 10.1136/emj.2009.088302; Hiestand B, 2011, PREHOSP EMERG CARE, V15, P457, DOI 10.3109/10903127.2011.569853; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Kramer AH, 2012, NEUROCRIT CARE, V16, P299, DOI 10.1007/s12028-011-9668-7; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Nielsen K, 2012, EMERG MED J, V29, P887, DOI 10.1136/emermed-2011-200119; Sibley A, 2011, EMERG MED J, V28, P521, DOI 10.1136/emj.2009.088237; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494	15	11	11	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2015	32	1					60	64		10.1136/emermed-2013-202930			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AW5UU	WOS:000346340000015	24473409				2022-02-06	
S	Briones, TL		Conley, YP		Briones, Teresita L.			Animal Models of Traumatic Brain Injury Is There an Optimal Model That Parallels Human Brain Injury?	ANNUAL REVIEW OF NURSING RESEARCH, VOL 33: TRAUMATIC BRAIN INJURY	Annual Review of Nursing Research-Series		English	Article; Book Chapter							CONTROLLED CORTICAL IMPACT; LATERAL FLUID-PERCUSSION; CLOSED-HEAD INJURY; CEREBRAL-BLOOD-FLOW; MEDIATED FUNCTIONAL IMPROVEMENT; AMYLOID PRECURSOR PROTEIN; CNS LESION VOLUME; ENVIRONMENTAL ENRICHMENT; RAT MODEL; SENSORIMOTOR CORTEX	Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in the younger population worldwide. Survivors of TBI often experience long-term disability in the form of cognitive, sensorimotor, and affective impairments. Despite the high prevalence in, and cost of TBI to, both individuals and society, some of its underlying pathophysiology is not completely understood. Animal models have been developed over the past few decades to closely replicate the different facets of TBI in humans to better understand the underlying pathophysiology and behavioral impairments and assess potential therapies that can promote neuroprotection. However, no effective treatment for TBI has been established to date in the clinical setting, despite promising results generated in preclinical studies in the use of neuroprotective strategies. The failure to translate results from preclinical studies to the clinical setting underscores a compelling need to revisit the current state of knowledge in the use of animal models in TBI.	[Briones, Teresita L.] Wayne State Univ, Coll Nursing, Detroit, MI 48202 USA		Briones, TL (corresponding author), Wayne State Univ, Coll Nursing, Detroit, MI 48202 USA.						Abisambra JF, 2014, J ALZHEIMERS DIS, V40, P495, DOI 10.3233/JAD-131019; AFHS Center, 2013, DOD TBI STAT 2000 20; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Benzinger T. L., 2009, J NEUROTRAUM, V26, P2233; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Blanchet S, 2000, EUR J NEUROL, V7, P473, DOI 10.1046/j.1468-1331.2000.00107.x; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Briones T L, 2000, Biol Res Nurs, V1, P276, DOI 10.1177/109980040000100404; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carballosa G. M. M., 2013, J NEUROTRAUM, V30, P119, DOI DOI 10.1089/neu.2012.2499; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colombel C, 2002, BRAIN RES, V950, P231, DOI 10.1016/S0006-8993(02)03043-3; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; Darwish H, 2014, BRAIN INJURY, V28, P211, DOI 10.3109/02699052.2013.862737; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Ding YH, 2006, CURR NEUROVASC RES, V3, P263, DOI 10.2174/156720206778792911; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Godsil BP, 2013, EUR NEUROPSYCHOPHARM, V23, P1165, DOI 10.1016/j.euroneuro.2012.10.018; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iqbal K, 2006, J ALZHEIMERS DIS, V9, P219; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Jacqmain J, 2014, BEHAV BRAIN RES, V275, P201, DOI 10.1016/j.bbr.2014.08.056; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kim HS, 1998, NEUROREPORT, V9, P533; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Koo HM, 2013, J PHYS THER SCI, V25, P1103, DOI 10.1589/jpts.25.1103; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Maegele M, 2015, PHYSIOL RES, V64, P129, DOI 10.33549/physiolres.932664; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Malkki H, 2014, NAT REV NEUROL, V10, P243, DOI [10.1038/nrneurol.2014.63, 10.1038/nrneurol.2014.209, 10.1038/nrneurol.2013.267, 10.1038/nrneurol.2014.61, 10.1038/nrneurol.2014.21, 10.1038/nrneurol.2013.250, 10.1038/nrneurol.2014.142, 10.1038/nrneurol.2014.168]; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Moritz KE, 2014, RESTOR NEUROL NEUROS, V32, P701, DOI 10.3233/RNN-140414; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PARE WP, 1994, PHYSIOL BEHAV, V55, P433, DOI 10.1016/0031-9384(94)90097-3; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Popa-Wagner A, 1998, STROKE, V29, P2196, DOI 10.1161/01.STR.29.10.2196; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; RINK A, 1995, AM J PATHOL, V147, P1575; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Rosenzweig M. R., 1978, STUDIES DEV BEHAV NE, V4, P429; ROSENZWEIG MR, 1968, PHYSIOL BEHAV, V3, P819, DOI 10.1016/0031-9384(68)90161-3; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Sclafani A, 2006, PHYSIOL BEHAV, V87, P734, DOI 10.1016/j.physbeh.2006.01.017; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Seo TB, 2010, NEUROSCI LETT, V481, P178, DOI 10.1016/j.neulet.2010.06.087; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sun D., 2013, FRONT AGING NEUROSCI, V5; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tam SKE, 2014, J EXP PSYCHOL-ANIM L, V40, P106, DOI 10.1037/xan0000003; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wiebking C, 2014, NEUROIMAGE, V86, P10, DOI 10.1016/j.neuroimage.2013.04.042; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	203	11	11	0	4	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2922-2; 978-0-8261-7162-7	ANNU REV NURS RES-SE			2015	33						31	73		10.1891/0739-6686.33.31			43	Nursing	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Nursing	BI5YI	WOS:000412973800004	25946383				2022-02-06	
J	Cohen, A; Lerner-Yardeni, J; Meridor, D; Kasher, R; Nathan, I; Parola, AH				Cohen, Aviv; Lerner-Yardeni, Jenny; Meridor, David; Kasher, Roni; Nathan, Ilana; Parola, Abraham H.			Humanin Derivatives Inhibit Necrotic Cell Death in Neurons	MOLECULAR MEDICINE			English	Article							RESCUE FACTOR HUMANIN; ALZHEIMERS-DISEASE; INTRACELLULAR ATP; IN-VITRO; MECHANISMS; APOPTOSIS; NEUROPROTECTION; COLIVELIN; BAX; RECEPTOR-LIKE-1	Humanin and its derivatives are peptides known for their protective antiapoptotic effects against Alzheimer's disease. Herein, we identify a novel function of the humanin-derivative AGA(C8R)-HNG17 (namely, protection against cellular necrosis). Necrosis is one of the main modes of cell death, which was until recently considered an unmoderated process. However, recent findings suggest the opposite. We have found that AGA(C8R)-HNG17 confers protection against necrosis in the neuronal cell lines PC-12 and NSC-34, where necrosis is induced in a glucose-free medium by either chemohypoxia or by a shift from apoptosis to necrosis. Our studies in traumatic brain injury models in mice, where necrosis is the main mode of neuronal cell death, have shown that AGA(C8R)-HNG17 has a protective effect. This result is demonstrated by a decrease in a neuronal severity score and by a reduction in brain edema, as measured by magnetic resonance imaging (MRI). An insight into the peptide's antinecrotic mechanism was attained through measurements of cellular ATP levels in PC-12 cells under necrotic conditions, showing that the peptide mitigates a necrosis-associated decrease in ATP levels. Further, we demonstrate the peptide's direct enhancement of the activity of ATP synthase activity, isolated from rat-liver mitochondria, suggesting that AGA(C8R)-HNG17 targets the mitochondria and regulates cellular ATP levels. Thus, AGA(C8R)-HNG17 has potential use for the development of drug therapies for necrosis-related diseases, for example, traumatic brain injury, stroke, myocardial infarction, and other conditions for which no efficient drug-based treatment is currently available. Finally, this study provides new insight into the mechanisms underlying the antinecrotic mode of action of AGA(C8R)-HNG17.	[Cohen, Aviv; Lerner-Yardeni, Jenny; Meridor, David; Parola, Abraham H.] Ben Gurion Univ Negev, Dept Chem, Fac Nat Sci, Beer Sheva, Israel; [Kasher, Roni] Ben Gurion Univ Negev, Dept Desalinat & Water Treatment, Zuckerberg Inst Water Res, Blaustein Inst Desert Res, Midreshet Sede Boqer, Israel; [Nathan, Ilana] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel; [Nathan, Ilana] Soroka Univ, Med Ctr, Inst Hematol, Beer Sheva, Israel		Kasher, R (corresponding author), Ben Gurion Univ Negev, Dept Desalinat & Water Treatment, Zuckerberg Inst Water Res, Blaustein Inst Desert Res, IL-8499000 Ben Gurion, Israel.	kahser@bgu.ac.il; nathan@bgu.ac.il; aparola@bgu.ac.il		Parola, Abraham H./0000-0002-3953-5454	Kamin Program from the Chief Scientist of the Ministry of Economy of Israel; James-Frank Center for Laser-Matter Interaction; Edmund Safra Foundation for Functional Bio-polymer; New-York University Shanghai (NYUSH) research grant; Lyonel Israels' Chair Fund	The authors thank Mark M Karpasas and Lina Saveliev from the Analytical Research Services Unit, Ben-Gurion University of the Negev, for mass spectrometric analysis of the peptides, and Svetlana Lublinsky from the Brain Imaging Center, Ben-Gurion University of the Negev, for magnetic resonance imaging of the mice. The financial support of the Kamin Program from the Chief Scientist of the Ministry of Economy of Israel (to AH Parola, I Nathan, and R Kasher), the James-Frank Center for Laser-Matter Interaction (to A H Parola), the Edmund Safra Foundation for Functional Bio-polymer, the New-York University Shanghai (NYUSH) research grant (to AH Parola) and the Lyonel Israels' Chair Fund (I Nathan) are gratefully acknowledged.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; ALISON MR, 1994, GUT, V35, P577, DOI 10.1136/gut.35.5.577; Arakawa T, 2008, CURR MED CHEM, V15, P2086, DOI 10.2174/092986708785747616; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chiba T, 2006, BIOCHEM BIOPH RES CO, V343, P793, DOI 10.1016/j.bbrc.2006.02.184; Chiba T, 2005, J NEUROSCI, V25, P10252, DOI 10.1523/JNEUROSCI.3348-05.2005; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Eguchi Y, 1997, CANCER RES, V57, P1835; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hallak M, 2008, APOPTOSIS, V13, P147, DOI 10.1007/s10495-007-0156-7; Hallak M, 2009, BRIT J HAEMATOL, V147, P459, DOI 10.1111/j.1365-2141.2009.07867.x; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Jin H, 2010, NEUROCHEM INT, V56, P417, DOI 10.1016/j.neuint.2009.11.015; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li L, 2005, TOXICOL SCI, V86, P116, DOI 10.1093/toxsci/kfi164; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Matsuoka M, 2006, CNS DRUG REV, V12, P113, DOI 10.1111/j.1527-3458.2006.00113.x; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Nicotera P, 1998, TOXICOL LETT, V103, P139; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Prabhakaran K, 2004, J SURG RES, V116, P288, DOI 10.1016/j.jss.2003.08.008; Prabhakaran K, 2002, J PHARMACOL EXP THER, V303, P510, DOI 10.1124/jpet.102.039453; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Shapira MG, 2014, MOL MED, V20, P417, DOI 10.2119/molmed.2014.00054; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Terashita K, 2003, J NEUROCHEM, V85, P1521, DOI 10.1046/j.1471-4159.2003.01797.x; Tsesin N, 2014, CHEM PHYS LIPIDS, V183, P159, DOI 10.1016/j.chemphyslip.2014.06.007; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zelig U, 2009, BIOPHYS J, V97, P2107, DOI 10.1016/j.bpj.2009.07.026; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037	51	11	11	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1076-1551	1528-3658		MOL MED	Mol. Med.		2015	21						505	514		10.2119/molmed.2015.00073			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX5WC	WOS:000365772200004	26062019	Green Published, gold			2022-02-06	
J	Gerace, E; Pellegrini-Giampietro, DE; Moroni, F; Mannaioni, G				Gerace, Elisabetta; Pellegrini-Giampietro, Domenico E.; Moroni, Flavio; Mannaioni, Guido			Poly(ADP-Ribose) Polymerase 1 (PARP-1) Activation and Ca2+ Permeable alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors; cell death; Dementia; Neuroprotection; Poly(ADP-ribose) polymerases; stroke	APOPTOSIS-INDUCING FACTOR; FOCAL CEREBRAL-ISCHEMIA; NEURONAL DEATH; CELL-DEATH; RECEPTOR ANTAGONISTS; RAT HIPPOCAMPUS; 1-AMINOINDAN-1,5-DICARBOXYLIC ACID; MICROGLIAL ACTIVATION; SYNAPTIC PLASTICITY; GLOBAL-ISCHEMIA	A significant number of laboratories observed that poly (ADP-ribose) polymerase (PARP) inhibitors, administered a few hours after ischemic or traumatic brain injury, may drastically reduce the subsequent neurological damage. It has also been shown that PARP inhibitors, administered for 24 hours to rats with permanent middle cerebral artery occlusion (MCAO), may reduce the number of dying neurons for a long period after surgery, thus suggesting that these agents could reduce the delayed brain damage and the neurological and cognitive impairment (dementia) frequently observed a few months after a stroke. In organotypic hippocampal slices exposed to N-methyl-N'-nitro-N'-nitrosoguanidine (MNNG), an alkylating agent able to activate PARP, a selective and delayed degeneration of the CA1 pyramidal cells which was anatomically similar to that observed after a short period of oxygen and glucose deprivation (OGD) has been described. Biochemical and electrophysiological approaches showed that MNNG exposure caused an increased expression and function of the calcium permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) channels in the CA1 but not in the CA3 hippocampal region. PARP inhibitors prevented this increase and reduced CA1 cell death. The AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f] quinoxaline-2,3-dione or the selective Ca2+ permeable AMPA channel blocker 1-Naphthyl acetyl spermine (NASPM), also reduced the MNNG-induced CA1 pyramidal cell death. Since activation of PARP-1 facilitate the expression of Ca2+ permeable channels and the subsequent delayed cell death, PARP inhibitors administered a few hours after a stroke may not only reduce the early post-ischemic brain damage but also the late neuronal death frequently occurring after severe stroke.	[Gerace, Elisabetta; Pellegrini-Giampietro, Domenico E.] Univ Florence, Sect Clin Pharmacol & Oncol, Dept Hlth Sci, I-50121 Florence, Italy; [Moroni, Flavio; Mannaioni, Guido] Univ Florence, Dept Neurosci, Pharmacol Sect, I-50139 Florence, Italy		Moroni, F (corresponding author), Pharmacol Sect, Dept Neurosci, Viale Pieraccini 6, I-50139 Florence, Italy.	flavio.moroni@unifi.it		Pellegrini-Giampietro, Domenico E./0000-0002-3920-2297	University of Florence; Ente Cassa di Risparmio di Firenze GrantsFondazione Cassa Risparmio Firenze	This work was supported by University of Florence; and Ente Cassa di Risparmio di Firenze Grants to F.M. and G.M.	Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bhakar AL, 2002, J NEUROSCI, V22, P8466; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; COSI C, 1994, J NEUROSCI RES, V39, P38, DOI 10.1002/jnr.490390106; Cozzi A, 2006, J CEREBR BLOOD F MET, V26, P684, DOI 10.1038/sj.jcbfm.9600222; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fatokun AA, 2013, BRIT J PHARMACOL, V169, P1263, DOI 10.1111/bph.12201; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Gerace E, 2014, NEUROBIOL DIS, V70, P43, DOI 10.1016/j.nbd.2014.05.023; Gerace E, 2012, EUR J NEUROSCI, V36, P1993, DOI 10.1111/j.1460-9568.2012.08116.x; Giovannelli L, 2002, J CEREBR BLOOD F MET, V22, P697, DOI 10.1097/00004647-200206000-00008; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Hamby AM, 2007, STROKE, V38, P632, DOI 10.1161/01.STR.0000250742.61241.79; HEURTEAUX C, 1994, BRAIN RES, V659, P67, DOI 10.1016/0006-8993(94)90864-8; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Koh SH, 2005, TOXICOLOGY, V214, P131, DOI 10.1016/j.tox.2005.06.023; Koh SH, 2004, EUR J NEUROSCI, V20, P1461, DOI 10.1111/j.1460-9568.2004.03632.x; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; LOMBARDI G, 1994, EUR J PHARMACOL, V271, P489, DOI 10.1016/0014-2999(94)90810-9; LOMBARDI G, 1992, NEUROSCI LETT, V134, P171, DOI 10.1016/0304-3940(92)90509-6; Lu P, 2014, J NEUROSCI, V34, P15975, DOI 10.1523/JNEUROSCI.2499-14.2014; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; MELDRUM B, 1985, CLIN SCI, V68, P113, DOI 10.1042/cs0680113; Meli E, 2004, MOL CELL NEUROSCI, V25, P172, DOI 10.1016/j.mcn.2003.09.016; Moroni F, 2012, BRIT J PHARMACOL, V165, P1487, DOI 10.1111/j.1476-5381.2011.01666.x; Moroni F, 2009, BRIT J PHARMACOL, V157, P854, DOI 10.1111/j.1476-5381.2009.00232.x; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Moroni F, 2009, FEBS J, V276, P36, DOI 10.1111/j.1742-4658.2008.06768.x; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Oguro K, 1999, J NEUROSCI, V19, P9218; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; OTSUKA A, 1991, IMMUNOPHARM IMMUNOT, V13, P263, DOI 10.3109/08923979109019705; Pellegrini-Giampietro DE, 1999, EUR J NEUROSCI, V11, P3637, DOI 10.1046/j.1460-9568.1999.00786.x; Pellegrini-Giampietro DE, 1999, NEUROPHARMACOLOGY, V38, P1607, DOI 10.1016/S0028-3908(99)00097-0; PELLEGRINIGIAMPIETRO DE, 1994, NEUROSCIENCE, V63, P701, DOI 10.1016/0306-4522(94)90516-9; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y; Scartabelli T, 2008, NEUROPHARMACOLOGY, V55, P509, DOI 10.1016/j.neuropharm.2008.06.019; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SCHWARCZ R, 1985, LANCET, V2, P140; Scobie KN, 2014, P NATL ACAD SCI USA, V111, P2005, DOI 10.1073/pnas.1319703111; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TSUBOKAWA H, 1994, J NEUROPHYSIOL, V71, P1190, DOI 10.1152/jn.1994.71.3.1190; Tymianski M, 2014, NAT REV NEUROL, V10, P66, DOI 10.1038/nrneurol.2013.271; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Virgo L, 1996, NEUROREPORT, V7, P2507, DOI 10.1097/00001756-199611040-00021; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Weiss JH, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00042; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zhang YH, 2005, J CEREBR BLOOD F MET, V25, P868, DOI 10.1038/sj.jcbfm.9600081; Zingarelli B, 1998, CIRC RES, V83, P85, DOI 10.1161/01.RES.83.1.85	99	11	12	0	4	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	5					636	646		10.2174/1871527314666150430162841			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CI8DM	WOS:000354999100009	25924998				2022-02-06	
J	Goldberg, A; Curtis, CL; Kleim, JA				Goldberg, Allon; Curtis, Catherine L.; Kleim, Jeffrey A.			Linking Genes to Neurological Clinical Practice: The Genomic Basis for Neurorehabilitation	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						epigenetics; genetics; neural plasticity; personalized medicine; polymorphisms	TRAUMATIC BRAIN-INJURY; BDNF VAL66MET POLYMORPHISM; CENTRAL-NERVOUS-SYSTEM; RARE CODING VARIATION; THAN-T POLYMORPHISMS; CAG REPEAT LENGTH; ISCHEMIC-STROKE; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; NEUROTROPHIC FACTOR	Large-scale genomics projects such as the Human Genome Project and the International HapMap Project promise significant advances in the ability to diagnose and treat many conditions, including those with a neurological basis. A major focus of research has emerged in the neurological sciences to elucidate the molecular and genetic basis of various neurological diseases. Indeed, genetic factors are implicated in susceptibility for many neurological disorders, with family history studies providing strong evidence of familial risk for conditions such as stroke, Parkinson's, Alzheimer's, and Huntington's diseases. Heritability studies also suggest a strong genetic contribution to the risk for neurological diseases. Genome-wide association studies are also uncovering novel genetic variants associated with neurological disorders. Whole-genome and exome sequencing are likely to provide novel insights into the genetic basis of neurological disorders. Genetic factors are similarly associated with clinical phenotypes such as symptom severity and progression as well as response to treatment. Specifically, disease progression and functional restoration depend, in part, on the capacity for neural plasticity within residual neural tissues. Furthermore, such plasticity may be influenced in part by the presence of polymorphisms in several genes known to orchestrate neural plasticity including brain-derived neurotrophic factor (BDNF) and Apolipoprotein E. (APOE). It is important for neurorehabilitation therapist practicing in the "genomic era" to be aware of the potential influence of genetic factors during clinical encounters, as advances in molecular sciences are revealing information of critical relevance to the clinical rehabilitation management of individuals with neurological conditions. Video Abstract available (See Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A88) for more insights from the authors.	[Goldberg, Allon] Univ Michigan, Sch Hlth Profess & Studies, Phys Therapy Dept, Flint, MI 48502 USA; [Curtis, Catherine L.] New York Med Coll, Inst Publ Hlth, Sch Hlth Sci & Practice, Dept Phys Therapy, Valhalla, NY 10595 USA; [Kleim, Jeffrey A.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA		Goldberg, A (corresponding author), Univ Michigan, Sch Hlth Profess & Studies, Phys Therapy Dept, 303 East Kearsley St, Flint, MI 48502 USA.	allong@umich.edu					Abul-Husn NS, 2014, PHARMACOGEN PERS MED, V7, P227, DOI 10.2147/PGPM.S48887; Adams Stacie D, 2013, N C Med J, V74, P494; Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Agundez JAG, 2013, EXPERT OPIN DRUG MET, V9, P859, DOI 10.1517/17425255.2013.789018; Vilatela MEA, 2012, ARCH MED RES, V43, P622, DOI 10.1016/j.arcmed.2012.10.017; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bagnato S, 2012, J NEUROTRAUM, V29, P2050, DOI 10.1089/neu.2011.2184; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Battie MC, 2008, J APPL PHYSIOL, V104, P379, DOI 10.1152/japplphysiol.01009.2007; Beaudet A, 1995, METABOLIC MOL BASES, P53; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Binia A, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0421-7; Birkenmeier RL, 2010, NEUROREHAB NEURAL RE, V24, P620, DOI 10.1177/1545968310361957; Blix A, 2014, CLIN J ONCOL NURS, V18, P437, DOI 10.1188/14.CJON.437-441; Bloss CS, 2012, GENET EPIDEMIOL, V36, P66, DOI 10.1002/gepi.20664; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; Bouchard C, 2011, EXERC SPORT SCI REV, V39, P212, DOI 10.1097/JES.0b013e31822643f6; Chang WH, 2014, BRAIN STIMUL, V7, P553, DOI 10.1016/j.brs.2014.03.008; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; CRAUFURD D, 1993, J MED GENET, V30, P1008, DOI 10.1136/jmg.30.12.1008; de Lau LML, 2014, PARKINSONISM RELAT D, V20, P613, DOI 10.1016/j.parkreldis.2014.02.030; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Devan WJ, 2013, STROKE, V44, P1578, DOI 10.1161/STROKEAHA.111.000089; Falcone GJ, 2014, LANCET NEUROL, V13, P405, DOI 10.1016/S1474-4422(14)70029-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freburger JK, 2011, ARCH PHYS MED REHAB, V92, P1220, DOI 10.1016/j.apmr.2011.03.019; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; George AL, 2008, J AM SOC NEPHROL, V19, P1840, DOI 10.1681/ASN.2008050524; Goldberg A, 2005, J PHYS THER ED, V19, P8; Goldberg A, 2010, J NEUROL SCI, V298, P91, DOI 10.1016/j.jns.2010.08.002; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gromadzka G, 2007, ACTA NEUROL SCAND, V116, P392, DOI 10.1111/j.1600-0404.2007.00880.x; Guo SW, 2001, HUM HERED, V51, P121, DOI 10.1159/000053333; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Hakim AJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P275, DOI 10.1002/art.10395; Hallowell N, 2015, J MED ETHICS, V41, P317, DOI 10.1136/medethics-2013-101996; Han Guangchun, 2014, Genomics Proteomics & Bioinformatics, V12, P156, DOI 10.1016/j.gpb.2014.07.002; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Houston JP, 2012, J CLIN PSYCHIAT, V73, P878, DOI 10.4088/JCP.10m06744; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hudson KL, 2011, NEW ENGL J MED, V365, P1033, DOI 10.1056/NEJMra1010517; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Jarvis JN, 2014, ARTHRITIS RHEUMATOL, V66, pS227, DOI 10.1002/art.38600; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kilarski LL, 2014, NEUROLOGY, V83, P678, DOI 10.1212/WNL.0000000000000707; Kim DS, 2014, J LIPID RES, V55, P1173, DOI 10.1194/jlr.P049247; Kim JM, 2008, NEUROBIOL AGING, V29, P789, DOI 10.1016/j.neurobiolaging.2006.11.021; Kim JS, 2003, J NEUROL SCI, V206, P31, DOI 10.1016/S0022-510X(02)00361-1; Kim WS, 2013, ANN REHABIL MED-ARM, V37, P311, DOI 10.5535/arm.2013.37.3.311; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Knowles JW, 2012, CIRC-CARDIOVASC GENE, V5, P368, DOI 10.1161/CIRCGENETICS.112.962746; Kohen R, 2008, ARCH GEN PSYCHIAT, V65, P1296, DOI 10.1001/archpsyc.65.11.1296; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Lazaros L, 2010, EUR J NEUROL, V17, P757, DOI 10.1111/j.1468-1331.2009.02860.x; Le Q, 2014, AM J PHYS MED REHAB, V93, P422, DOI 10.1097/PHM.0000000000000027; Lesage Suzanne, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS66, DOI 10.1016/S1353-8020(11)70022-0; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lisabeth LD, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-20; Loprinzi PD, 2013, BRAIN RES, V1539, P95, DOI 10.1016/j.brainres.2013.10.004; Lovati C, 2010, INT J MOL EPIDEMIOL, V1, P193; Lundy MG, 2014, J GENET COUNS, V23, P618, DOI 10.1007/s10897-014-9692-9; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mang CS, 2013, PHYS THER, V93, P1707, DOI 10.2522/ptj.20130053; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marder K, 2002, NEUROLOGY, V59, P1622, DOI 10.1212/01.WNL.0000035627.16789.23; Markus HS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-113; Markus HS, 2011, HUM MOL GENET, V20, pR124, DOI 10.1093/hmg/ddr345; Markus HS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000225; Martinez-Levy Gabriela A., 2014, Yale Journal of Biology and Medicine, V87, P173; McHughen SA, 2011, EXP BRAIN RES, V213, P415, DOI 10.1007/s00221-011-2791-z; Mirowsha-Guzel D, 2014, TOP STROKE REHABIL, V21, pS33, DOI 10.1310/tsr21S1-S33; Mirowska-Guzel D, 2013, NEUROREHABILITATION, V32, P573, DOI 10.3233/NRE-130879; Morgan JC, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/426976; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Ortega-Alonso A, 2006, J GERONTOL A-BIOL, V61, P1082, DOI 10.1093/gerona/61.10.1082; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Pal R, 2014, MOL NEUROBIOL, V49, P1181, DOI 10.1007/s12035-013-8590-8; Pam A., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P349; Payami H, 2014, NEUROTHERAPEUTICS, V11, P111, DOI 10.1007/s13311-013-0237-y; Pearson-Fuhrhop KM, 2009, TOP STROKE REHABIL, V16, P282, DOI 10.1310/tsr1604-282; Pedersen NL, 2004, ANN NEUROL, V55, P180, DOI 10.1002/ana.10999; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rahimzadeh V, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0238-6; Ravina B, 2008, MOVEMENT DISORD, V23, P1223, DOI 10.1002/mds.21988; Reistetter TA, 2014, ARCH PHYS MED REHAB, V95, P29, DOI 10.1016/j.apmr.2013.07.018; Rich EC, 2004, J GEN INTERN MED, V19, P273, DOI 10.1111/j.1525-1497.2004.30401.x; Richardson K, 2005, BRIT J EDUC PSYCHOL, V75, P339, DOI 10.1348/000709904X24690; Rinaldi C, 2012, CAN J NEUROL SCI, V39, P48, DOI 10.1017/S0317167100012671; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rosen AR, 2007, NEUROGENETICS, V8, P263, DOI 10.1007/s10048-007-0100-6; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Schweizer S, 2013, J CEREBR BLOOD F MET, V33, P1335, DOI 10.1038/jcbfm.2013.93; Seshadri S, 2010, CIRCULATION, V121, P1304, DOI 10.1161/CIRCULATIONAHA.109.854240; Sharma P, 2013, J NEUROL NEUROSUR PS, V84, P1302, DOI 10.1136/jnnp-2012-304834; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Stankovic S, 2010, CRIT REV CL LAB SCI, V47, P72, DOI 10.3109/10408361003791520; Stoykov ME, 2015, J NEUROL PHYS THER, V39, P33, DOI 10.1097/NPT.0000000000000065; Taylor JG, 2001, TRENDS MOL MED, V7, P507, DOI 10.1016/S1471-4914(01)02183-9; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Treger I, 2003, ARCH PHYS MED REHAB, V84, P973, DOI 10.1016/S0003-9993(03)00043-1; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Vassy JL, 2013, J COMMUN GENET, V4, P263, DOI 10.1007/s12687-013-0140-6; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Weydt P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-1; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Xu Q, 2010, NEUROLOGY, V75, P341, DOI 10.1212/WNL.0b013e3181ea1597; Yin KJ, 2015, METAB BRAIN DIS, V30, P401, DOI 10.1007/s11011-013-9468-1; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhang JL, 2013, NEUROREHABILITATION, V32, P391, DOI 10.3233/NRE-130860; Zhao J, 2013, BRAIN RES, V1537, P312, DOI 10.1016/j.brainres.2013.08.061; Zhou BS, 2014, INT J MOL SCI, V15, P8931, DOI 10.3390/ijms15058931; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhou ZM, 2011, CLIN CHEM LAB MED, V49, P185, DOI 10.1515/CCLM.2011.039	138	11	11	1	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JAN	2015	39	1					52	61		10.1097/NPT.0000000000000066			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AX2GX	WOS:000346762600008	25415554				2022-02-06	
J	Gordon, RG; Rigon, A; Duff, MC				Gordon, Rupa Gupta; Rigon, Arianna; Duff, Melissa C.			Conversational synchrony in the communicative interactions of individuals with traumatic brain injury	BRAIN INJURY			English	Article						Communication accommodation; discourse; interpersonal co-ordination; speech convergence; traumatic brain injury	HEAD-INJURY; DISCOURSE; PARTNERS	Primary objective: To assess conversational synchrony in moderate-to-severe traumatic brain injury (TBI). Conversational synchrony, assessed by the similarity and co-ordination of words and words per turn, allows for effective and efficient communication and enhances the development of rapport. Research design: Eighteen participants with TBI (seven females) and 19 healthy comparison participants (CP; eight females) engaged in a 10-minute conversation with an unfamiliar partner. Methods and procedures: Conversational synchrony was assessed in these conversations by measuring the degree to which the participants' productions of words and words per turn became more similar to one another over the course of the session. Main outcomes and results: Significantly more sessions with participants with TBI (11/18 for words, 9/18 for words per turn) compared to CP sessions (5/19 for words, 4/19 for words per turns) did not display conversational synchrony. Likewise, synchrony was significantly correlated with subjective ratings of the interaction from raters who were blind to participant status and the study hypotheses. Conclusions: These results suggest that TBI can disrupt conversational synchrony and can, in turn, negatively impact social perceptions. The relationship between impaired conversational synchrony and other social communicative deficits in TBI warrants further study.	[Gordon, Rupa Gupta] Augustana Coll, Dept Psychol, Rock Isl, IL 61201 USA; [Gordon, Rupa Gupta; Duff, Melissa C.] Univ Iowa, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA; [Rigon, Arianna; Duff, Melissa C.] Univ Iowa, Neurosci Training Program, Iowa City, IA USA; [Duff, Melissa C.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA		Gordon, RG (corresponding author), Augustana Coll, Dept Psychol, 639 38th St, Rock Isl, IL 61201 USA.	rupagordon@augustana.edu			NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [RO1 DC011755]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011755] Funding Source: NIH RePORTER	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was supported by NIDCD RO1 DC011755 to Melissa C. Duff.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Body R, 2007, APHASIOLOGY, V21, P394, DOI 10.1080/02687030600911450; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CAPPELLA JN, 1981, HUM COMMUN RES, V7, P117, DOI 10.1111/j.1468-2958.1981.tb00564.x; Cappella JN, 1997, J PERS SOC PSYCHOL, V72, P119, DOI 10.1037/0022-3514.72.1.119; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cherney L. R., 1998, ANAL DISCOURSE COMMU; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Duff MC, 2008, BRAIN LANG, V106, P41, DOI 10.1016/j.bandl.2007.10.004; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Duff MC, 2011, APHASIOLOGY, V25, P675, DOI 10.1080/02687038.2010.536841; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Giles H., 1991, CONTEXTS ACCOMODATIO; Gordon RG, 2014, NEUROPSYCHOLOGY, V28, P624, DOI 10.1037/neu0000073; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hengst JA, 2007, TOP LANG DISORD, V27, P37, DOI 10.1097/00011363-200701000-00005; Hollan J., 2000, ACM Transactions on Computer-Human Interaction, V7, P174, DOI 10.1145/353485.353487; Hutchins E, 1995, COGNITION WILD; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Rime B, 1991, FUNDAMENTALS NONVERB, P401; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Snow P, 1997, BRAIN INJURY, V11, P409; Stone V.E., 2011, OXFORD HDB SOCIAL NE, P455; STREET RL, 1984, HUM COMMUN RES, V11, P139, DOI 10.1111/j.1468-2958.1984.tb00043.x; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]	34	11	11	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	11					1300	1308		10.3109/02699052.2015.1042408			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR4MF	WOS:000361306100004	26083049	Green Accepted			2022-02-06	
J	Harris, P; Whitty, JA; Kendall, E; Ratcliffe, J; Wilson, A; Littlejohns, P; Scuffham, PA				Harris, Paul; Whitty, Jennifer A.; Kendall, Elizabeth; Ratcliffe, Julie; Wilson, Andrew; Littlejohns, Peter; Scuffham, Paul A.			The Australian public's preferences for emergency care alternatives and the influence of the presenting context: a discrete choice experiment	BMJ OPEN			English	Article							PATIENT PREFERENCES; CONJOINT-ANALYSIS; ACCESS BLOCK; HEALTH; DEPARTMENTS; AMBULANCE; MODELS; IMPACT	Objectives: The current study seeks to quantify the Australian public's preferences for emergency care alternatives and determine if preferences differ depending on presenting circumstances. Setting: Increasing presentations to emergency departments have led to overcrowding, long waiting times and suboptimal health system performance. Accordingly, new service models involving the provision of care in alternative settings and delivered by other practitioners continue to be developed. Participants: A stratified sample of Australian adults (n=1838), 1382 from Queensland and 456 from South Australia, completed the survey. This included 951 females and 887 males from the 2045 people who met the screening criteria out of the 4354 people who accepted the survey invitation. Interventions: A discrete choice experiment was used to elicit preferences in the context of one of four hypothetical scenarios: a possible concussion, a rash/asthma-related problem involving oneself or one's child and an anxiety-related presentation. Mixed logit regression was used to analyse the dependent variable choice and identify the relative importance of care attributes and the propensity to access care in each context. Results: Results indicated a preference for treatment by an emergency physician in hospital for possible concussion and treatment by a doctor in ambulatory settings for rash/asthma-related and anxiety-related problems. Participants were consistently willing to wait longer before making trade-offs in the context of the rash/asthma-related scenario compared with when the same problem affected their child. Results suggest a clear preference for lower costs, shorter wait times and strong emphasis on quality care; however, significant preference heterogeneity was observed. Conclusions: This study has increased awareness that the public's emergency care choices will differ depending on the presenting context. It has further demonstrated the importance of service quality as a determinant of healthcare choices. The findings have also provided insights into the Australian public's reactions to emergency care reforms.	[Harris, Paul] Griffith Univ, Menzies Hlth Inst Queensland, Sch Med, Populat & Social Hlth Res Program, Meadowbrook, Qld 4131, Australia; [Whitty, Jennifer A.] Univ Queensland, Sch Pharm, Fac Hlth & Behav Sci, St Lucia, Qld, Australia; [Kendall, Elizabeth] Griffith Univ, Menzies Hlth Inst Queensland, Ctr Natl Res Disabil & Rehabil, Populat & Social Hlth Res Program, Meadowbrook, Qld 4131, Australia; [Ratcliffe, Julie] Flinders Univ S Australia, Sch Med, Flinders Hlth Econ Grp, Adelaide, SA 5001, Australia; [Wilson, Andrew] Univ Sydney, Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia; [Littlejohns, Peter] Kings Coll London, Sch Med, Div Hlth & Social Care Res, London WC2R 2LS, England; [Scuffham, Paul A.] Griffith Univ, Menzies Hlth Inst Queensland, Ctr Appl Hlth Econ, Populat & Social Hlth Res Program, Meadowbrook, Qld 4131, Australia		Harris, P (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Sch Med, Populat & Social Hlth Res Program, Meadowbrook, Qld 4131, Australia.	p.harris@griffith.edu.au	Scuffham, Paul/B-3066-2014; Whitty, Jennifer A/N-6434-2013; Harris, Paul/AAX-3758-2020; Scuffham, Paul/AAS-8084-2021; Ratcliffe, Julie/G-3169-2017	Scuffham, Paul/0000-0001-5931-642X; Whitty, Jennifer A/0000-0002-5886-1933; Scuffham, Paul/0000-0001-5931-642X; Ratcliffe, Julie/0000-0001-7365-1988; Kendall, Elizabeth/0000-0003-2399-1460; Harris, Paul/0000-0002-7198-9616	Australian Research Council Linkage ProjectAustralian Research Council [LP100200446]	This work was supported through an Australian Research Council Linkage Project, grant number LP100200446. Additional financial contributions were received from state health authorities in Queensland and South Australia.	Agresti A., 2007, INTRO CATEGORICAL DA, V2nd; Ang JB, 2010, APPL ECON LETT, V17, P639, DOI 10.1080/00036840802297868; Arendts G, 2011, EMERG MED J, V28, P1051, DOI 10.1136/emj.2010.099929; Australasian College for Emergency Medicine, 2013, POL AUSTR TRIAG SCAL; Australian Bureau of Statistics, 2012, 2011 CENS QUICKST; Australian Bureau of Statistics, 2009, HLTH SERV PAT EXP AU; Australian Institute of Health and Welfare (AIHW), 2013, HLTH WORKF; Bech M, 2011, HEALTH ECON, V20, P273, DOI 10.1002/hec.1587; Bell J, 2011, INT J ENV RES PUB HE, V8, P1222, DOI 10.3390/ijerph8041222; Blake DF, 2014, EMERG MED AUSTRALAS, V26, P145, DOI 10.1111/1742-6723.12223; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Bryan Stirling, 2004, Eur J Health Econ, V5, P199, DOI 10.1007/s10198-004-0241-6; Burke Gail, 2014, ABC NEWS; Chan CL, 2013, HEALTH POLICY, V110, P271, DOI 10.1016/j.healthpol.2012.12.003; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; Cunningham PJ, 2006, HEALTH AFFAIR, V25, pW324, DOI 10.1377/hlthaff.25.w324; Daly A, 2012, TRANSPORT RES B-METH, V46, P333, DOI 10.1016/j.trb.2011.10.008; Fatovich DM, 2005, EMERG MED J, V22, P351, DOI 10.1136/emj.2004.018002; FitzGerald G, 2010, EMERG MED AUSTRALAS, V22, P384, DOI 10.1111/j.1742-6723.2010.01329.x; Forero R, 2010, EMERG MED AUSTRALAS, V22, P119, DOI 10.1111/j.1742-6723.2010.01270.x; Fry MM, 2011, AUSTRALAS EMERG NURS, V14, P217, DOI 10.1016/j.aenj.2011.09.001; Gerard K, 2004, EMERG MED J, V21, P692, DOI 10.1136/emj.2002.003707; Green J, 2014, AUST HEALTH REV, V38, P65, DOI 10.1071/AH13065; Grouse AI, 2014, EMERG MED AUSTRALAS, V26, P164, DOI 10.1111/1742-6723.12204; HADORN DC, 1991, SOC SCI MED, V32, P773, DOI 10.1016/0277-9536(91)90303-T; Hawthorne G, 2013, AUST NZ J PUBL HEAL, V37, P7, DOI 10.1111/1753-6405.12004; Hensher D.A., 2005, APPL CHOICE ANAL PRI; Hess S, 2012, EXCEL ED; Hjelmgren J, 2007, HEALTH POLICY, V83, P314, DOI 10.1016/j.healthpol.2007.02.006; Hostetler MA, 2007, PEDIATR EMERG CARE, V23, P507, DOI 10.1097/01.pec.0000280518.36408.74; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Kahneman D., 2012, THINKING FAST SLOW; Kim BBJ, 2014, INT J HEALTH CARE Q, V27, P336, DOI 10.1108/IJHCQA-11-2012-0117; Knox I, 2008, SUBMISSION NATL HLTH; Kobayashi M, 2013, INT J HEALTH CARE Q, V26, P341, DOI 10.1108/09526861311319564; KRUG SE, 1999, CLIN PEDIAT EMERGENC, V1, P35; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2007, SOC SCI MED, V64, P1738, DOI 10.1016/j.socscimed.2006.12.007; Leung GM, 2001, ACAD EMERG MED, V8, P894, DOI 10.1111/j.1553-2712.2001.tb01151.x; Lowe RJ, 2012, CHILD SOC, V26, P269, DOI 10.1111/j.1099-0860.2010.00344.x; Mason S, 2012, ANN EMERG MED, V59, P341, DOI 10.1016/j.annemergmed.2011.08.017; Medew J., 2014, SYDNEY MORN HERALD; Morgans A, 2011, AUST HEALTH REV, V35, P284, DOI 10.1071/AH10922; Moskop JC, 2009, ANN EMERG MED, V53, P605, DOI 10.1016/j.annemergmed.2008.09.019; Nagree Y, 2013, EMERG MED AUSTRALAS, V25, P487, DOI 10.1111/1742-6723.12163; Nagree Y, 2012, EMERG MED AUSTRALAS, V24, P123, DOI 10.1111/j.1742-6723.2012.01547.x; O'Hara R, 2012, EMERG MED J, V29, P327, DOI 10.1136/emj.2010.104190; Pallant J., 2013, SPSS SURVIVAL GUIDE; Payne K, 2011, VALUE HEALTH, V14, P121, DOI 10.1016/j.jval.2010.10.007; Queensland Health, 2012, HLTH QUEENSL 2012 AD; Richardson G, 2009, VALUE HEALTH, V12, P331, DOI 10.1111/j.1524-4733.2008.00419.x; Rose JM, NGENE V 1 1 1; Rubin G, 2006, BRIT J GEN PRACT, V56, P743; San Miguel F, 2002, J ECON BEHAV ORGAN, V48, P1, DOI 10.1016/S0167-2681(01)00220-7; Scott A, 2003, SOC SCI MED, V56, P803, DOI 10.1016/S0277-9536(02)00079-5; Scuffham PA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005437; Skinner CA, 2007, MED J AUSTRALIA, V187, P634, DOI 10.5694/j.1326-5377.2007.tb01452.x; Smith R, 2010, A UNIVERSAL CHILD; Thompson Patricia A, 2008, Nursing, V38, P59, DOI 10.1097/01.NURSE.0000314801.45844.f4; Tsai JCH, 2010, J FORMOS MED ASSOC, V109, P533, DOI 10.1016/S0929-6646(10)60088-5; White JM, 2011, ANN SURG, V253, P1184, DOI [10.1097/SLA.0b013e31820752e3, 10.2165/11537150-000000000-00000]	61	11	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	4							e006820	10.1136/bmjopen-2014-006820			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE9DI	WOS:000352143400004	25841233	Green Published, Green Accepted, gold			2022-02-06	
J	Hasturk, AE; Yilmaz, ER; Turkoglu, E; Kertmen, H; Horasanli, B; Hayirli, N; Erguder, IB; Evirgen, O				Hasturk, Askin Esen; Yilmaz, Erdal Resit; Turkoglu, Erhan; Kertmen, Hayri; Horasanli, Bahriye; Hayirli, Nazli; Erguder, Imge Berrin; Evirgen, Oya			Therapeutic evaluation of interleukin 1-beta antagonist Anakinra against traumatic brain injury in rats	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Antioxidant; anakinra; interleukin-1; neuroprotection; traumatic brain injury	LIPID-PEROXIDATION; NEUROPROTECTION; EXPRESSION; DISEASE	BACKGROUND: The aim of this study was to evaluate the therapeutic efficiency of Anakinra, an IL-1 beta antagonist with anti-inflammatory effects, in an experimental model of traumatic brain injury (TBI). METHODS: Fifty-four rats underwent TBI after a weighted object was dropped onto a metal disc secured to their skulls. Animals were randomized into 3 main groups: control (n=18), TBI + saline (n=18; six animals per time-point) with samples obtained at the first, sixth and twenty-fourth h postoperatively, and TBI + Anakinra (n=18; six animals per time-point) with brain samples obtained at the first, sixth and twenty-fourth h postoperatively. Brain tissue and blood serum were extracted for the analysis of IL-1 beta, malondialdehyde, glutathione peroxidase, superoxide dismutase, and catalase levels. Tissue sections were evaluated histopathologically under a light microscope. RESULTS: After trauma, tissue and serum IL-1 beta levels were significantly elevated and after Anakinra administration, these levels substantially decreased. Glutathione peroxidase, superoxide dismutase, and catalase activity decreased following TBI and Anakinra administration proved effective in increasing the activity of these antioxidant enzymes. Histopathological analysis confirmed that Anakinra might protect the brain tissue and nerve cells from injury. CONCLUSION: Results demonstrate that Anakinra reduces the development of inflammation and tissue injury events associated with TBI.	[Hasturk, Askin Esen] Onkol Egitim & Arastirma Hastanesi, Beyin & Sinir Cerrahisi Bolumu, TR-06200 Ankara, Turkey; [Yilmaz, Erdal Resit; Turkoglu, Erhan; Kertmen, Hayri] Diskapi Yildirim Beyazit Training & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Horasanli, Bahriye] Baskent Univ, Fac Med, Dept Neurol, TR-06490 Ankara, Turkey; [Hayirli, Nazli; Evirgen, Oya] Ankara Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey; [Erguder, Imge Berrin] Ankara Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey		Hasturk, AE (corresponding author), Onkol Egitim & Arastirma Hastanesi, Beyin & Sinir Cerrahisi Bolumu, TR-06200 Ankara, Turkey.	aehasturk@yahoo.com	Ozyol, Nazli Hayirli/ABG-6396-2021; Turkoglu, Erhan/AAB-6395-2020; Erguder, Imge/AAZ-5673-2020; Hayirli Ozyol, Nazli/ABG-6379-2021; HASTURK, ASKIN ESEN/AAE-5065-2019; Evirgen, Oya/AAH-7582-2020	Evirgen, Oya/0000-0001-6456-1083; Horasanli, Bahriye/0000-0003-3142-1011; /0000-0003-0628-9223			AEBI H, 1974, EUR J BIOCHEM, V48, P137, DOI 10.1111/j.1432-1033.1974.tb03751.x; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Courcoul A, 2014, JOINT BONE SPINE, V81, P175, DOI 10.1016/j.jbspin.2013.06.013; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Marini H, 2004, EXP NEUROL, V188, P178, DOI 10.1016/j.expneurol.2004.03.023; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mena H, 2004, ACTA NEUROPATHOL, V108, P524, DOI 10.1007/s00401-004-0918-z; Nandi P, 2008, CURR OPIN RHEUMATOL, V20, P251, DOI 10.1097/BOR.0b013e3282fb7caa; Nishio S, 1997, ACT NEUR S, V70, P84; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Song C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-59; SUN Y, 1988, CLIN CHEM, V34, P497; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3	22	11	11	1	7	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JAN	2015	21	1					1	8		10.5505/tjtes.2015.57894			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CE1AX	WOS:000351544800001	25779705	Bronze			2022-02-06	
J	Jonsson, LS; Svedin, CG; Hyden, M				Jonsson, Linda S.; Svedin, Carl Goran; Hyden, Margareta			Young women selling sex online - narratives on regulating feelings	ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS			English	Article						adolescent; women; affect regulation; selling sex; prostitution; online	SELF-INJURY; PROSTITUTION; ADOLESCENTS; ABUSE; PREVALENCE; BEHAVIORS; JUVENILE; HEALTH; RISK	The current study concerns young women's life stories of their experiences selling sex online before the age of 18. The aim was to gain an understanding of young women's perceptions of the reasons they started, continued, and stopped selling sex. The study included interviews with 15 young women between the ages of 15 and 25 (M=18.9). Thematic analysis was used to identify similarities and differences in the narratives. Three themes and eight subthemes were identified in relation to different stages in their lives in the sex trade. The themes were organized into three parts, each with its own storyline: "Entering - adverse life experiences"; traumatic events: feeling different and being excluded. "Immersion - using the body as a tool for regulating feelings"; being seen: being touched: being in control: affect regulation and self-harming. "Exiting - change or die"; living close to death: the process of quitting. The informants all had stable social lives in the sense that they had roofs over their heads, food to eat, and no substance-abuse issues. None had a third party who arranged the sexual contacts and none were currently trafficked. They described how their experiences of traumatic events and of feeling different and excluded had led them into the sex trade. Selling sex functioned as a way to be seen, to handle traumatic events, and to regulate feelings. Professionals working with young people who sell sex online need to understand the complex web of mixed feelings and emotional needs that can play a role in selling sex. Young people selling sex might need guidance in relationship building as well as help processing traumatic experiences and ending self-harming behavior. Further studies are needed on the functions of online sex selling and on the exit process for young people, in order to prevent entrance and facilitate exiting.	[Jonsson, Linda S.; Svedin, Carl Goran] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Child & Adolescent Psychiat, Linkoping, Sweden; [Hyden, Margareta] Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden		Jonsson, LS (corresponding author), Linkoping Univ, Dept Child & Adolescent Psyciatry, Fac Hlth Sci, SE-58185 Linkoping, Sweden.	linda.s.jonsson@liu.se			Swedish National Board for Health and Welfare; Crime Victim Fund in Sweden	The study was made possible by grants from the Swedish National Board for Health and Welfare and the Crime Victim Fund in Sweden.	BAGLEY C, 1987, CANADIAN J COMMUNITY, V6, P5, DOI DOI 10.7870/CJCMH-1987-0001; Baker LM, 2010, VIOLENCE AGAINST WOM, V16, P579, DOI 10.1177/1077801210367643; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cooper A., 1998, CYBERPSYCHOL BEHAV, V1, P187, DOI [10.1089/pb.1998.1.187, DOI 10.1089/CPB.1998.1.187]; Coy M., 2009, RAPE CHALLENGING CON, P184; Coy M, 2012, 0ROSTITUTION HARM GE; Cunningham S, 2011, J URBAN ECON, V69, P273, DOI 10.1016/j.jue.2010.12.001; Dahlstrom O, 2015, PSYCHOL ASS IN PRESS; Edwards JM, 2006, SEX TRANSM INFECT, V82, P354, DOI 10.1136/sti.2006.020693; FINKELHOR D, 1985, AM J ORTHOPSYCHIAT, V55, P530, DOI 10.1111/j.1939-0025.1985.tb02703.x; Finkelhor D., 2004, JUVENILE JUSTICE B; Fredlund C, 2013, J CHILD SEX ABUS, V22, P312, DOI 10.1080/10538712.2013.743950; Gleiser K.A., 2003, J TRAUMA DISSOCIATIO, V4, P27, DOI [10.1300/J229v04n02_03, DOI 10.1300/J229V04N02_03]; Goffman E., 2009, JAGET MASKERNA STUDI; Goffman E., 2014, STIGMA AVVIKANDES RO, V4 ed; Government Offices of Sweden [homepage on the Internet], 1962, SWED PEN COD, P700; Gringeri C, 2012, QUALITATIVE SOCIAL W, V12, P654; Hyden M, 2014, QUAL SOC WORK, V13, P795, DOI 10.1177/1473325013506247; Johnson RJ, 2006, ADOLESCENCE, V41, P221; Jonsson L, 2012, ONLINE AR JAG NAGON, P38; Jonsson L.S., 2014, CYBERPSYCHOLOGY, V8, P4, DOI [10.5817/CP2014-1-4, DOI 10.5817/CP2014-1-4]; Kaestle CE, 2012, PREV SCI, V13, P314, DOI 10.1007/s11121-011-0268-8; Kidd SA, 2002, ADOLESCENCE, V37, P411; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; Lavoie F, 2010, ARCH SEX BEHAV, V39, P1147, DOI 10.1007/s10508-010-9605-4; Lloyd-Richardson EE, 2007, PSYCHOL MED, V37, P1183, DOI 10.1017/S003329170700027X; Mansson SA, 1999, INT J SOC WELF, V8, P67, DOI 10.1111/1468-2397.00063; Martin L, 2010, VIOLENCE AGAINST WOM, V16, P1252, DOI 10.1177/1077801210386771; Nadon SM, 1998, J INTERPERS VIOLENCE, V13, P206, DOI 10.1177/088626098013002003; Nock MK, 2005, J ABNORM PSYCHOL, V114, P140, DOI 10.1037/0021-843X.114.1.140; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pearche JJ, 2003, ITS SOMEONE TAKING P; Pedersen W, 2003, SOC SCI MED, V56, P135, DOI 10.1016/S0277-9536(02)00015-1; Polit DF, 2008, NURSING RES GENERATI; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Rathsman K., 2001, INCEST ATT BO STULEN; Roe-Sepowitz DE, 2012, VIOLENCE AGAINST WOM, V18, P562, DOI 10.1177/1077801212453140; Roy E, 2000, INT J STD AIDS, V11, P241, DOI 10.1258/0956462001915778; SILBERT MH, 1982, YOUTH SOC, V13, P471, DOI 10.1177/0044118X82013004005; Stroebel SS, 2013, J CHILD SEX ABUS, V22, P255, DOI 10.1080/10538712.2013.743952; Svedin CG, 2007, ARCH SEX BEHAV, V36, P21, DOI 10.1007/s10508-006-9083-x; Svensson F, 2013, NORD J PSYCHIAT, V67, P81, DOI 10.3109/08039488.2012.679968; Tyler K A, 2001, Violence Vict, V16, P441; United Nations, 2004, UN CONV TRANSN ORG C; United Nations, 1989, **NON-TRADITIONAL**; United Nations [homepage on the Internet], 2000, OPT PROT CONV RIGHT; van de Walle R, 2012, J SEX RES, V49, P547, DOI 10.1080/00224499.2011.618955; Weiner, 2001, COMMERCIAL SEXUAL EX; Wheaton B., 1997, STRESS ADVERSITY LIF, P1, DOI [10.1017/CBO9780511527623.001, DOI 10.1017/CBO9780511527623.001]; Wilson HW, 2010, J RES ADOLESCENCE, V20, P210, DOI 10.1111/j.1532-7795.2009.00624.x	50	11	11	1	12	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-318X			ADOLESC HEALTH MED T	ADOLESC. HEALTH MED. THER.		2015	6						17	27		10.2147/AHMT.S77324			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V06EF	WOS:000213922800003	25733944	gold, Green Submitted, Green Published			2022-02-06	
J	Kaldoja, ML; Saard, M; Lange, K; Raud, T; Teeveer, OK; Kolk, A				Kaldoja, Mari-Liis; Saard, Marianne; Lange, Kirsi; Raud, Triin; Teeveer, Ott-Kaarel; Kolk, Anneli			Neuropsychological benefits of computer-assisted cognitive rehabilitation (using FORAMENRehab program) in children with mild traumatic brain injury or partial epilepsy: A pilot study	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Pediatric rehabilitation; computer-assisted cognitive rehabilitation; attention impairment; epilepsy; mild traumatic brain injury; FORAMENRehab		INTRODUCTION: The number of children with different cognitive difficulties is constantly increasing. Still, too few evidence-based pediatric neurocognitive rehabilitation programs exist. The main aim of the study was to assess the efficiency and usability of computer-assisted FORAMENRehab program for training specific components of attention in children with mild traumatic brain injury (mTBI) and partial epilepsy (PE). The second aim was to specify short-and long-term effects of the intervention. METHODS: Eight children between the ages of 9-12 years with attention impairment (3 with PE and 5 with mTBI) and 18 healthy controls participated. FORAMENRehab Attention software, adapted by the authors, was used for intervention. Strict intervention protocol consisting of patients completing 10 sessions over a 6-week-period to train four components of attention (sustaining, focusing, dividing, tracking) was designed and applied. Follow-up assessments were conducted after the end of the last training and 1.63 years later. RESULTS: After the intervention patients' sustained and complex attention improved. Long-term follow-up revealed continuing positive rehabilitation effects. 100% compliance suggested that the used method is attractive for children. CONCLUSIONS: These preliminary results of the pilot study give reason to presume that the method is effective in attention impairment remediation. However, more thorough research is needed.	[Kaldoja, Mari-Liis] Tallinn Childrens Hosp, Psychiat Clin, Tallinn, Estonia; [Kaldoja, Mari-Liis; Saard, Marianne; Raud, Triin] Univ Tartu, Inst Psychol, Tartu, Estonia; [Kaldoja, Mari-Liis] Tallinn Univ, Inst Psychol, Tallinn, Estonia; [Saard, Marianne; Kolk, Anneli] Tartu Univ Hosp, Childrens Clin, Dept Neurol & Neurorehabil, N Lunini 6, EE-51014 Tartu, Estonia; [Saard, Marianne; Lange, Kirsi; Kolk, Anneli] Univ Tartu, Dept Pediat, Fac Med, Tartu, Estonia; [Teeveer, Ott-Kaarel] Univ Tartu, Fac Sci & Technol, Tartu, Estonia		Kolk, A (corresponding author), Tartu Univ Hosp, Childrens Clin, Dept Neurol & Neurorehabil, N Lunini 6, EE-51014 Tartu, Estonia.	anneli.kolk@kliinikum.ee		Kaldoja, Mari-Liis/0000-0002-7471-5813	Estonian Science Foundation [GARLA 9016]; Estonian Ministry of Education and ResearchMinistry of Education and Research, Estonia [TARLA 2695]	We gratefully acknowledge the assistance of Triinu Muur and Evelin Visk while training the children. We also express our special thanks to the patients and their parents for their kind cooperation. This study was supported by the Estonian Science Foundation (GARLA 9016) and by the Estonian Ministry of Education and Research TARLA 2695.	Aldenkamp AP, 2000, CHILD NEUROPSYCHOL, V6, P209, DOI 10.1076/chin.6.3.209.3153; Anderson N. D., 2010, HDB CLIN NEUROPSYCHO, V2nd, P50, DOI [10.1093/acprof:oso/9780199234110.003.04, DOI 10.1093/ACPROF:OSO/9780199234110.003.04]; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Baglietto MG, 2001, DEV MED CHILD NEUROL, V43, P407, DOI 10.1017/S0012162201000755; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Beilmann A, 1999, BRAIN DEV-JPN, V21, P166, DOI 10.1016/S0387-7604(98)00096-5; BENNETTLEVY J, 1984, ACTA NEUROL SCAND, V69, P79, DOI 10.1111/j.1600-0404.1984.tb05671.x; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; Danckaerts M, 2010, EUR CHILD ADOLES PSY, V19, P83, DOI 10.1007/s00787-009-0046-3; Engle JA, 2010, NEUROPSYCHOLOGIA, V48, P38, DOI 10.1016/j.neuropsychologia.2009.08.005; Fastenau PS, 2008, J LEARN DISABIL-US, V41, P195, DOI 10.1177/0022219408317548; Gulgonen S, 2000, EPILEPSIA, V41, P405, DOI 10.1111/j.1528-1157.2000.tb00181.x; Guzeva V I, 2009, Neurosci Behav Physiol, V39, P885, DOI 10.1007/s11055-009-9205-8; Hermann B, 2006, BRAIN, V129, P2609, DOI 10.1093/brain/awl196; Kaldoja ML, 2008, COGNITIVE NEUROSCIEN, V3, P81; Kolk A, 2004, EPILEPSIA, V45, P202; Kolk A, 2001, BRAIN DEV-JPN, V23, P88, DOI 10.1016/S0387-7604(01)00180-2; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lee Jaime, 2012, PERSPECT NEUROPHYSIO, V22, P90, DOI [10.1044/nnsld22.3.90, DOI 10.1044/NNSLD22.3.90]; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Massa R, 2001, NEUROLOGY, V57, P1071, DOI 10.1212/WNL.57.6.1071; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Mayes SD, 2000, J LEARN DISABIL-US, V33, P417, DOI 10.1177/002221940003300502; Metz-Lutz MN, 1999, DEV NEUROSCI-BASEL, V21, P182, DOI 10.1159/000017397; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Nixon, 2001, CHILD ADOL MENT H-UK, V6, P172, DOI [10.1017/s1360641701002738, DOI 10.1017/S1360641701002738]; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; PICCIRILLI M, 1994, EPILEPSIA, V35, P1091, DOI 10.1111/j.1528-1157.1994.tb02560.x; Prigatano G.P., 2000, BRIEF OVERVIEW 4 PRI, P115, DOI DOI 10.1007/978-1-4757-5569-5_7; Rabiner DL, 2010, J ABNORM CHILD PSYCH, V38, P131, DOI 10.1007/s10802-009-9353-x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Semrud-Clikeman M, 1999, EPILEPSIA, V40, P211, DOI 10.1111/j.1528-1157.1999.tb02077.x; Shalev L, 2007, CHILD NEUROPSYCHOL, V13, P382, DOI 10.1080/09297040600770787; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Sohlberg McKay Moore, 2005, Seminars in Speech and Language, V26, P268, DOI 10.1055/s-2005-922105; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van't Hooft I, 2003, ACTA PAEDIATR, V92, P935, DOI 10.1080/08035250310004586; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; Warschausky S, 1999, J HEAD TRAUMA REHAB, V14, P373, DOI 10.1097/00001199-199908000-00006; [No title captured]	53	11	12	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					271	283		10.3233/PRM-150346			13	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7LK	WOS:000448290900002	26684068				2022-02-06	
J	Li, Z; Tian, FX; Shao, Z; Shen, XM; Qi, X; Li, HY; Wang, Z; Chen, G				Li, Zhen; Tian, Fengxuan; Shao, Zhong; Shen, Xuming; Qi, Xin; Li, Haiying; Wang, Zhong; Chen, Gang			Expression and clinical significance of non-phagocytic cell oxidase 2 and 4 after human traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury (TBI); NOX2; NOX4	GENERATING NADPH-OXIDASE; NAD(P)H OXIDASE; INHIBITION	The goal of this study was to examine NOX2 and NOX4 expression in clinical samples of patients with traumatic brain injury (TBI), and to explore the correlation of NOX2 and NOX4 expression with the severity of injury, duration of injury, and prognosis. Brain samples of 20 TBI patients within 1 cm of the contusion site were collected and grouped based on duration of injury, Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS), and immunofluorescence staining were performed to examine the expression levels of NOX2 and NOX4 in the neurons and astrocytes. We found that the expression level of NOX2 in neurons and positive rate of NOX2 expression in astrocytes peaked at 12-24 and 6-12 h after injury, respectively. The expression level of NOX4 in neurons peaked at 24-48 h, and the positive rate of NOX4 expression gradually increased with prolonged injury. We also found that the higher the GCS score, the lower the expression levels of NOX2 and NOX4 in neurons was, while higher the GCS score, the lower the positive rate of NOX4 expression in astrocytes was and the higher the GOS grade, the lower the positive rate of expression in astrocytes was. In conclusion, NOX2 and NOX4 expressions significantly increase at an early stage after TBI, and abnormal expressions of NOX2 and NOX4 are correlated to patient prognosis to certain extent.	[Li, Zhen; Qi, Xin] Yangzhou Univ, Dept Neurosurg, Jingjiang Peoples Hosp, Yangzhou 214500, Jiangsu, Peoples R China; [Tian, Fengxuan] Qinghai Prov Peoples Hosp, Dept Neurosurg, Xining 810000, Qinghai, Peoples R China; [Shao, Zhong; Li, Haiying; Wang, Zhong; Chen, Gang] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China; [Shen, Xuming] Taicang Peoples Hosp, Dept Neurosurg, Suzhou 215400, Jiangsu, Peoples R China		Chen, G (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China.	Jeanne88@163.com; nju_neurosurgery@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171105, 81271300, 81371279]; Jiangsu Province's Outstanding Medical Academic Leader program [LJ201139]; National Key Technology RAMP;D program for the 12th Five-year plan of the People's Republic of China [2011BAI08B05, 2011BAI08B06, 2014BAZ04810]; Scientific Department of Jiangsu Province [BL2014045]; Suzhou Government [LCZX201301, SZS201413, SYS201332]	This work was supported by grants from the National Natural Science Foundation of China (No. 81171105, 81271300, and 81371279), Jiangsu Province's Outstanding Medical Academic Leader program (No. LJ201139), the National Key Technology R&D program for the 12th Five-year plan of the People's Republic of China (2011BAI08B05, 2011BAI08B06, and 2014BAZ04810), and grants from Scientific Department of Jiangsu Province (No. BL2014045) and Suzhou Government (No. LCZX201301, SZS201413 and SYS201332).	Anantharam V, 2007, NEUROTOXICOLOGY, V28, P988, DOI 10.1016/j.neuro.2007.08.008; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Babior B M, 1995, Curr Opin Hematol, V2, P55; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Ben-Ami R, 2003, AM J PHYSIOL-HEART C, V285, pH2663, DOI 10.1152/ajpheart.00128.2003; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Everse J, 2009, NEUROBIOL AGING, V30, P1011, DOI 10.1016/j.neurobiolaging.2007.10.007; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI 10.1089/ARS.2009.2587; Genovese T, 2011, BRAIN RES, V1372, P92, DOI 10.1016/j.brainres.2010.11.088; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Kamsler A, 2004, MOL NEUROBIOL, V29, P167, DOI 10.1385/MN:29:2:167; Kusaka I, 2004, AM J PHYSIOL-HEART C, V286, pH2442, DOI 10.1152/ajpheart.01169.2003; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	29	11	11	0	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JAN	2015	36	1					61	71		10.1007/s10072-014-1909-z			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AY0LE	WOS:000347287200008	25079350				2022-02-06	
J	Maegele, M; Stuermer, EK; Hoeffgen, A; Uhlenkueken, U; Mautes, A; Schaefer, N; Lippert-Gruener, M; Schaefer, U; Hoehn, M				Maegele, Marc; Stuermer, Ewa K.; Hoeffgen, Alexander; Uhlenkueken, Ulla; Mautes, Angelika; Schaefer, Nadine; Lippert-Gruener, Marcela; Schaefer, Ute; Hoehn, Mathias			Multimodal MR imaging of acute and subacute experimental traumatic brain injury: Time course and correlation with cerebral energy metabolites	ACTA RADIOLOGICA OPEN			English	Article						Traumatic brain injury; vasogenic edema; cytotoxic edema; ATP imaging; magnetic resonance imaging (MRI); transient reduction of energy metabolism	LASER-DOPPLER FLOWMETRY; EARLY-ONSET STIMULATION; CORTICAL IMPACT INJURY; ENRICHED ENVIRONMENT; RATS; DIFFUSION; EDEMA; SPECTROSCOPY; DYSFUNCTION; NEUROMOTOR	Background: Traumatic brain injury (TBI) is one of the leading causes of death and permanent disability world-wide. The predominant cause of death after TBI is brain edema which can be quantified by non-invasive diffusion-weighted magnetic resonance imaging (DWI). Purpose: To provide a better understanding of the early onset, time course, spatial development, and type of brain edema after TBI and to correlate MRI data and the cerebral energy state reflected by the metabolite adenosine triphosphate (ATP). Material and Methods: The spontaneous development of lateral fluid percussion-induced TBI was investigated in the acute (6 h), subacute (48 h), and chronic (7 days) phase in rats by MRI of quantitative T2 and apparent diffusion coefficient (ADC) mapping as well as perfusion was combined with ATP-specific bioluminescence imaging and histology. Results: An induced TBI led to moderate to mild brain damages, reflected by transient, pronounced development of vasogenic edema and perfusion reduction. Heterogeneous ADC patterns indicated a parallel, but mixed expression of vasogenic and cytotoxic edema. Cortical ATP levels were reduced in the acute and subacute phase by 13% and 27%, respectively, but were completely normalized at 7 days after injury. Conclusion: The partial ATP reduction was interpreted to be partially caused by a loss of neurons in parallel with transient dilution of the regional ATP concentration by pronounced vasogenic edema. The normalization of energy metabolism after 7 days was likely due to infiltrating glia and not to recovery. The MRI combined with metabolite measurement further improves the understanding and evaluation of brain damages after TBI.	[Maegele, Marc] Univ Witten Herdecke, Dept Traumatol Orthoped Surg & Sporttraumatol, CMMC, D-51109 Cologne, Germany; [Maegele, Marc; Stuermer, Ewa K.; Schaefer, Nadine] Univ Witten Herdecke, Inst Res Operat Med, D-51109 Cologne, Germany; [Hoeffgen, Alexander] Hosp Gummerbach, Dept Anaesthesiol & Intens Care Med, Gummersbach, Germany; [Uhlenkueken, Ulla; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany; [Mautes, Angelika] Univ Saarland, Inst Neurosurg Res, Dept Neurosurg, Homburg, Germany; [Lippert-Gruener, Marcela] Univ Cologne, Ctr Neurosurg, D-50931 Cologne, Germany; [Schaefer, Ute] Med Univ Graz, Dept Neurosurg, FE Expt Neurotraumatol, Graz, Austria; [Hoehn, Mathias] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands		Stuermer, EK (corresponding author), Univ Witten Herdecke, Inst Res Operat Med, Fac Hlth, Sch Med, D-51109 Cologne, Germany.	ewa.stuermer@uni.wh.de					Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Hoehn-Berlage M, 1995, J CEREB BLOOD FLOW M, V15, pS62; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kerskens CM, 1996, NMR BIOMED, V9, P20, DOI 10.1002/(SICI)1099-1492(199602)9:1<20::AID-NBM381>3.3.CO;2-I; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; KIMURA M, 1994, STROKE, V25, P2227, DOI 10.1161/01.STR.25.11.2227; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; OKADA Y, 1992, J NEUROSURG, V77, P917, DOI 10.3171/jns.1992.77.6.0917; PASCHEN W, 1990, PROG HISTOCHEM CYTOC, V20, P1; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wegener S, 2006, J CEREBR BLOOD F MET, V26, P38, DOI 10.1038/sj.jcbfm.9600166; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	32	11	11	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2058-4601			ACTA RADIOL OPEN	Acta Radiol. Open	JAN	2015	4	1								10.1177/2047981614555142			10	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	CX9BL	WOS:000365999600003	25610615	Green Published, gold			2022-02-06	
J	Nguyen, HS; Doan, N; Gelsomino, M; Shabani, S; Mueller, W; Zaidat, OO				Nguyen, Ha Son; Doan, Ninh; Gelsomino, Michael; Shabani, Saman; Mueller, Wade; Zaidat, Osama O.			Coincidence of an anterior cerebral artery aneurysm and a glioblastoma: case report and review of literature	INTERNATIONAL MEDICAL CASE REPORTS JOURNAL			English	Article						intracranial aneurysm; glioblastoma; traumatic brain injury		Background: The association between glioblastoma and intracranial aneurysm is rare. Treatment guidelines do not exist, and operative mortality and morbidity are significantly high. To our knowledge, no prior cases have employed endovascular therapy for the treatment of these intratumor intracranial aneurysms followed by tumor resection. Case presentation: A 74-year-old male, history of a left A2 aneurysm, presented after a motor vehicle accident at low speeds. Imaging was concerning for a possible traumatic brain contusion, an aneurysmal hemorrhage given history of left A2 aneurysm, or a hemorrhage from an underlying tumor given profound edema. The patient was discussed at the brain tumor board, where the plan was to address the aneurysm followed by resection of the mass versus close monitoring with subsequent imaging. The high risk of rehemorrhage, given the real possibility of an aneurysmal hemorrhage, motivated prompt treatment of the aneurysm. The patient was taken to the angiography suite; an anterosuperiorly projecting azygous A2 aneurysm, measuring 4.5 mm x 5.5 mm with a neck width at 3.5 mm and a small daughter sac, was completely obliterated with primary coiling. The following day, he underwent a left craniotomy along a forehead skin crease for mass excision. Final pathology revealed glioblastoma. The patient recovered well from both procedures, with a baseline neurological exam. The patient subsequently underwent hypofractionated radiation and temodar. Conclusion: To our knowledge, no prior cases have employed endovascular therapy for the treatment of these intracranial aneurysms. We emphasize that efforts to introduce less invasive elements may improve the overall outcomes in this rare patient population.	[Nguyen, Ha Son; Doan, Ninh; Gelsomino, Michael; Shabani, Saman; Mueller, Wade] Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Nguyen, HS (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA.	hsnguyen@mcw.edu		Nguyen, Ha/0000-0002-3515-278X			Ali Rushna, 2015, Surg Neurol Int, V6, P66, DOI 10.4103/2152-7806.155759; ANDREWS BT, 1985, NEUROSURGERY, V17, P645, DOI 10.1227/00006123-198510000-00019; Aoki N, 1999, ACTA NEUROCHIR, V141, P1005, DOI 10.1007/s007010050408; Cheng WY, 2004, MINIM INVAS NEUROSUR, V47, P181, DOI 10.1055/s-2004-818378; COWEN RL, 1970, RADIOLOGY, V97, P577, DOI 10.1148/97.3.577; DECHIARA A, 1986, NEUROCHIRURGIA, V29, P58; GLASS B, 1955, ARCH NEURO PSYCHIATR, V73, P369, DOI 10.1001/archneurpsyc.1955.02330100001001; GOKALP HZ, 1980, ACTA NEUROCHIR, V53, P267, DOI 10.1007/BF02074799; Hashiguchi A, 2007, CLIN NEUROL NEUROSUR, V109, P302, DOI 10.1016/j.clineuro.2006.12.002; HONDA M, 1980, Neurological Surgery, V8, P1065; Inamasu J, 2009, NEUROL MED-CHIR, V49, P427, DOI 10.2176/nmc.49.427; Kim YJ, 2008, J KOREAN NEUROSURG S, V44, P405, DOI 10.3340/jkns.2008.44.6.405; KONDZIOLKA D, 1987, J NEUROSURG, V67, P852, DOI 10.3171/jns.1987.67.6.0852; Lakicevic G, 2014, J NEUROL SURG REP, V75, pE117, DOI 10.1055/s-0034-1376198; LICATA C, 1986, ACTA NEUROCHIR, V82, P28, DOI 10.1007/BF01456316; LOCKSLEY HB, 1966, J NEUROSURG, V24, P1034, DOI 10.3171/jns.1966.24.6.1034; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Nanney AD, 2014, WORLD NEUROSURG, V81, P511, DOI 10.1016/j.wneu.2013.10.044; OKAMURA T, 1981, Neurologia Medico-Chirurgica, V21, P601; Paoletti P, 1983, J Neurosurg Sci, V27, P211; PIA HW, 1973, ACTA NEUROCHIR, V27, P189, DOI 10.1007/BF01401881; TAYLOR PE, 1961, NEUROLOGY, V11, P225, DOI 10.1212/WNL.11.3.225; WAKAI S, 1982, NEUROSURGERY, V10, P437, DOI 10.1227/00006123-198204000-00004; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yamada H, 1989, Neurol Med Chir (Tokyo), V29, P846, DOI 10.2176/nmc.29.846; Yoon WS, 2011, J KOREAN NEUROSURG S, V50, P457, DOI 10.3340/jkns.2011.50.5.457	27	11	11	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-142X			INT MED CASE REP J	INT. MED. CASE REP. J.		2015	8						295	299		10.2147/IMCRJ.S93271			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V26QT	WOS:000215307400062	26648761	Green Published, Green Submitted, gold			2022-02-06	
J	Silberg, T; Tal-Jacobi, D; Levav, M; Brezner, A; Rassovsky, Y				Silberg, Tamar; Tal-Jacobi, Dana; Levav, Miriam; Brezner, Amichai; Rassovsky, Yuri			Parents and teachers reporting on a child's emotional and behavioural problems following severe traumatic brain injury (TBI): The moderating effect of time	BRAIN INJURY			English	Article						Assessment; behaviour; caregiver; paediatric; traumatic brain injury	CROSS-INFORMANT CORRELATIONS; MULTIPLE INFORMANTS; ADJUSTMENT; SYMPTOMS; OUTCOMES; TERM	Background: Gathering information from parents and teachers following paediatric traumatic brain injury (TBI) has substantial clinical value for diagnostic decisions. Yet, a multi-informant approach has rarely been addressed when evaluating children at the chronic stage post-injury. In the current study, the goals were to examine (1) differences between parents' and teachers' reports on a child's emotional and behavioural problems and (2) the effect of time elapsed since injury on each rater's report. Methods: A sample of 42 parents and 42 teachers of children following severe TBI completed two standard rating scales. Receiver Operating Characteristic (ROC) curves were used to determine whether time elapsed since injury reliably distinguished children falling above and below clinical levels. Results: Emotional-behavioural scores of children following severe TBI fell within normal range, according to both teachers and parents. Significant differences were found between parents' reports relatively close to the time of injury and 2 years post-injury. However, no such differences were observed in teachers' ratings. Conclusions: Parents and teachers of children following severe TBI differ in their reports on a child's emotional and behavioural problems. The present study not only underscores the importance of multiple informants, but also highlights, for the first time, the possibility that informants' perceptions may vary across time.	[Silberg, Tamar; Tal-Jacobi, Dana; Rassovsky, Yuri] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Silberg, Tamar; Levav, Miriam; Brezner, Amichai] Edmond & Lily Safra Childrens Hosp, Tel Hashomer Med Ctr, Dept Pediat Rehabil, Ramat Gan, Israel		Silberg, T (corresponding author), Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel.	tamarsilberg@gmail.com		Rassovsky, Yuri/0000-0002-6362-9944			Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2006, CURR DIR PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2006.00414.x; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2001, BRAIN DAM B, P125; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Armstrong-Betts AE, 2011, THESIS; Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; Barlow JH, 2006, CHILD CARE HLTH DEV, V32, P19, DOI 10.1111/j.1365-2214.2006.00591.x; Biederman J, 1998, J PEDIATR-US, V133, P544, DOI 10.1016/S0022-3476(98)70065-4; Brenner LA, 2007, J HEAD TRAUMA REHAB, V22, P56, DOI 10.1097/00001199-200701000-00007; De Los Reyes A, 2013, ANNU REV CLIN PSYCHO, V9, P123, DOI 10.1146/annurev-clinpsy-050212-185617; De Los Reyes A, 2010, J YOUTH ADOLESCENCE, V39, P1417, DOI 10.1007/s10964-009-9496-7; Dirks MA, 2012, J CHILD PSYCHOL PSYC, V53, P558, DOI 10.1111/j.1469-7610.2012.02537.x; Enders C. K., 2010, APPL MISSING DATA AN; Friedman D, 2007, J PEDIATR PSYCHOL, V32, P512, DOI 10.1093/jpepsy/jsl051; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; KOLKO DJ, 1993, J CHILD PSYCHOL PSYC, V34, P991, DOI 10.1111/j.1469-7610.1993.tb01103.x; LAVIGNE JV, 1992, J PEDIATR PSYCHOL, V17, P133, DOI 10.1093/jpepsy/17.2.133; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Mares D, 2007, CAN J PSYCHIAT, V52, P527, DOI 10.1177/070674370705200811; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Nelson JM, 2011, PSYCHOL SCHOOLS, V48, P371, DOI 10.1002/pits.20560; Pintea S, 2009, J COGN BEHAV PSYCHOT, V9, P49; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Randazzo KV, 2003, J AM ACAD CHILD PSY, V42, P1343, DOI 10.1097/01.chi.0000085753.71002.da; Ravelli A, 2001, RHEUMATOLOGY, V40, P914, DOI 10.1093/rheumatology/40.8.914; Smith SR, 2007, J PSYCHOEDUC ASSESS, V25, P139, DOI 10.1177/0734282906296233; Snow AL, 2005, HEALTH SERV RES, V40, P1676, DOI 10.1111/j.1475-6773.2005.00447.x; STANGER C, 1993, J CLIN CHILD PSYCHOL, V22, P107, DOI 10.1207/s15374424jccp2201_11; Streiner DL, 2007, CAN J PSYCHIAT, V52, P121, DOI 10.1177/070674370705200210; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Treutler CM, 2003, J ABNORM CHILD PSYCH, V31, P13, DOI 10.1023/A:1021765114434; Waaland PK, 1990, COMMUNITY REINTEGRAT; Williams J, 1991, FAMILY CULTURE CHILD; World Health Organization, 2007, INT CLASS FUNCT DIS; ZILBER N, 1994, ISRAEL J PSYCHIAT, V31, P5	45	11	11	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	4					481	489		10.3109/02699052.2014.984758			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF8JE	WOS:000352803300010	25496044				2022-02-06	
J	Silver, JM				Silver, Jonathan M.			Invalid symptom reporting and performance: What are we missing?	NEUROREHABILITATION			English	Article						Concussion; validity; effort; stereotype threat; injustice; malingering	TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; ILLNESS PERCEPTIONS; PERCEIVED INJUSTICE; TEST FAILURE; HEAD-INJURY; FOLLOW-UP; VALIDITY; RECOVERY; PAIN	BACKGROUND: In the evaluation of neurorehabilitation patients involved in compensation or litigation, it is often assumed that poor performance or exaggerated symptoms reflects an intentional attempt to game the system. PURPOSE: The purpose of this article is to review multiple issues that can contribute to invalid symptom reporting and performance. CONCLUSIONS: Multiple factors relevant to normal behavior, including observations from social psychology and behavioral economics, are important in the context of invalid symptom reporting and performance. These factors, which include pre-injury traits and beliefs (e.g., beliefs about prognosis and symptoms after TBI), factors at the time of initial treatment (e.g., expectations of recovery, nocebo effects, stereotype threat), and thoughts and feelings during evaluations (e.g., anger, resentment, injustice), may be important explanations. To best serve our patients, further research is needed to illuminate these relative effects on performance compared to "not trying."	[Silver, Jonathan M.] NYU, Sch Med, New York, NY 10028 USA		Silver, JM (corresponding author), NYU, Sch Med, Psychiat, 40 East 83rd St,Suite 1E, New York, NY 10028 USA.	jonsilver@gmail.com					American Association of Justice, 2015, PROM ACC SAF; Ariely, 2009, PREDICTABLY IRRATION; Ariely D., 2010, UPSIDE IRRATIONALITY; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bertisch HC, 2013, REHABIL PSYCHOL, V58, P429, DOI 10.1037/a0034554; Bigler E. D., 2014, BRAIN INJURY, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Cragar DE, 2006, CLIN NEUROPSYCHOL, V20, P552, DOI 10.1080/13854040590947380; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Fresson M, 2014, ARCH CLIN NEUROPSYCH, V29; Gino F, 2013, J ECON BEHAV ORGAN, V93, P285, DOI 10.1016/j.jebo.2013.04.005; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; HarrisPoll, 2000, PUBL PERC BRAIN HEAD; Ho B., 2011, DOES SORRY WORK IMPA; Hou R, 2011, J NEUROL NEUROSUR PS, V83, P217; Job V, 2013, P NATL ACAD SCI USA, V110, P14837, DOI 10.1073/pnas.1313475110; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Koren D, 1999, AM J PSYCHIAT, V156, P367; Lahmann C, 2015, J NEUROL NEUROSUR PS, V86, P302, DOI 10.1136/jnnp-2014-307601; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Lazare A, 2006, JAMA-J AM MED ASSOC, V296, P1401, DOI 10.1001/jama.296.11.1401; Lineweaver TT, 2014, AM J PSYCHIAT, V171, P201, DOI 10.1176/appi.ajp.2013.12121590; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MacDonald N, 2009, CAN MED ASSOC J, V180, P11, DOI 10.1503/cmaj.081997; Marcopulos BA, 2014, CLIN NEUROPSYCHOL, V28, P633, DOI 10.1080/13854046.2014.896416; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCullough ME, 2014, P NATL ACAD SCI USA, V111, P11211, DOI 10.1073/pnas.1405072111; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Murrie DC, 2013, PSYCHOL SCI, V24, P1889, DOI 10.1177/0956797613481812; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Provance AJ, 2014, SPORTS HEALTH, V6, P410, DOI 10.1177/1941738114544444; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rief W, 2005, PSYCHONEUROENDOCRINO, V30, P996, DOI 10.1016/j.psyneuen.2005.03.018; Ross JS, 2012, AM J PUBLIC HEALTH, V102, P72, DOI 10.2105/AJPH.2011.300187; Scott W, 2013, PAIN, V154, P1691, DOI 10.1016/j.pain.2013.05.015; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; STAAL MA, 2004, NASATM2004212824; Steele Claude M., 2010, WHISTLING VIVALDI OT; Steinbrook R, 2009, NEW ENGL J MED, V360, P2160, DOI 10.1056/NEJMp0810200; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Sullivan MJL, 2012, CLIN J PAIN, V28, P484, DOI 10.1097/AJP.0b013e3182527d13; Sullivan MJL, 2009, PAIN, V145, P325, DOI 10.1016/j.pain.2009.06.031; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; TENNEN H, 1990, PSYCHOL BULL, V108, P209, DOI 10.1037/0033-2909.108.2.209; Thompson J, 2014, REHABIL PSYCHOL, V59, P376, DOI 10.1037/rep0000012; Vanderploeg RD, 2014, PSYCHOL INJ LAW, V7, P245, DOI 10.1007/s12207-014-9201-3; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P375	62	11	11	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	4					463	469		10.3233/NRE-151234			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CN8YP	WOS:000358732300008	26409494				2022-02-06	
J	Steel, J; Ferguson, A; Spencer, E; Togher, L				Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth; Togher, Leanne			Language and cognitive communication during post-traumatic amnesia: A critical synthesis	NEUROREHABILITATION			English	Article						Post-traumatic amnesia; traumatic brain injury; cognitive-communication; speech pathology; aphasia; assessment; acute; recovery	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; MINIMALLY CONSCIOUS STATE; OF-THE-LITERATURE; INCOG RECOMMENDATIONS; VERBAL IMPAIRMENT; ACUTE CONFUSION; REALITY ORIENTATION; ACUTE-CARE; RECOVERY	BACKGROUND: There is minimal speech pathology literature on communication presentation during post-traumatic amnesia (PTA) and the early recovery period after traumatic brain injury. While a body of research reports on other cognitive and behavioural functions during PTA, language and/or cognitive communication are not routinely the primary focus of current research literature. OBJECTIVE: This critical synthesis provides an overview of research to date on communication during PTA to inform speech pathology assessment practice and to assist with information provision to the multidisciplinary team and family members. METHODS: A search was conducted of studies reporting on language, cognition, and cognitive communication during the acute, inpatient and early recovery period after TBI. These were examined for relevance to speech pathology practice during PTA and acute confusional state. RESULTS: Historic and recent literature has described types of language and communication impairment during PTA and early recovery after TBI. Recently, aspects of communication impairment during PTA have been found relevant for outcome prediction. Few studies were found originating from speech pathology on communication during PTA. CONCLUSIONS: Communication disruption forms a key feature of PTA. Existing literature indicates that speech pathology monitoring of communication during PTA may be of benefit as part of multidisciplinary team management during early recovery.	[Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth] Univ Newcastle, Speech Pathol, Newcastle, NSW 2300, Australia; [Togher, Leanne] Univ Sydney, Speech Pathol, Sydney, NSW 2006, Australia; [Steel, Joanne; Ferguson, Alison; Togher, Leanne] NHMRC Clin Ctr Res Excellence Aphasia Rehabil, Brisbane, Qld, Australia		Steel, J (corresponding author), Univ Newcastle, Sch Humanities & Social Sci, Sch Off, 1st Floor,McMullin Bldg, Callaghan Campus, NSW 2308, Australia.	Joanne.Steel@uon.edu.au	Steel, Joanne/M-2585-2018; Steel, Joanne/AAA-2744-2022; Togher, Leanne/AAC-7083-2019	Steel, Joanne/0000-0002-5478-5865; Steel, Joanne/0000-0002-5478-5865; Togher, Leanne/0000-0002-4518-6748			Ahmed S, 2000, BRAIN INJURY, V14, P765; American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; De Guise E, 2005, BRAIN INJURY, V19, P263, DOI 10.1080/02699050400004971; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; Hagen C, 1980, RANCHO LEVELS COGNIT; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HALPERN H, 1973, J SPEECH HEAR DISORD, V38, P162, DOI 10.1044/jshd.3802.162; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Jakabek D. D., 2012, THESIS; Joanette Y, 2004, PROTOCOLE MONTREAL E; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Katz R, 2002, J MED SPEECH-LANG PA, V10, pix; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McGhee H, 2006, BRAIN INJURY, V20, P1307, DOI 10.1080/02699050601081851; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nilipour R, 1993, PERSIAN APHASIA TEST; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; O'Halloran R, 2007, J MED SPEECH-LANG PA, V15, P39; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Paterson A., 1942, LANCET, V240, P717; Pfaff A., 1996, THESIS; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Porch B.E., 1967, PORCH INDEX COMMUNIC; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snow P., 2013, TRAUMATIC BRAIN INJU; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C., 1943, LANCET, V241, P7, DOI DOI 10.1016/S0140-6736(00)70687-8; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra L., 2003, TECHNICAL REPORT; Valitchka L, 2013, SEMIN SPEECH LANG, V34, P142, DOI 10.1055/s-0033-1358371; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; WEINSTEIN EA, 1963, NEUROPSYCHOLOGIA, V1, P79, DOI 10.1016/0028-3932(63)90001-0; WEINSTEIN EA, 1968, ARCH GEN PSYCHIAT, V18, P348; WEINSTEIN EA, 1971, J PSYCHIATR RES, V8, P439, DOI 10.1016/0022-3956(71)90036-7; WEINSTEIN EA, 1952, AMA ARCH NEUROL PSY, V67, P72, DOI 10.1001/archneurpsyc.1952.02320130078008; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Zangwill O., 1945, BRIT J PSYCHIAT, V91, P322, DOI DOI 10.1192/BJP.91.384.322; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	85	11	11	0	14	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	2					221	234		10.3233/NRE-151255			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV9HB	WOS:000364597200007	26484514	Green Submitted			2022-02-06	
J	Velazquez, A; Ortega, M; Rojas, S; Gonzalez-Olivan, FJ; Rodriguez-Baeza, A				Velazquez, Antonio; Ortega, Marisa; Rojas, Santiago; Javier Gonzalez-Olivan, Francisco; Rodriguez-Baeza, Alfonso			Widespread microglial activation in patients deceased from traumatic brain injury	BRAIN INJURY			English	Article						Human; microglial activation; traumatic brain injury; Ricinus communis lectin	PARENCHYMAL MICROGLIA/MACROPHAGES; REGIONAL VULNERABILITY; PARKINSONS-DISEASE; EXPRESSION; INFLAMMATION; MONOCYTES; CELLS; MICE; CNS; STIMULATION	Primary objective: The role of microglial activation in traumatic brain injury (TBI) has been extensively described in established animal models. In contrast, very few studies have analysed this process in human patients, the majority being focused on the local reaction in the contused parenchyma. In this work, the main objective was the analysis of microglial activation in brain regions distant from the primary lesion. Research design: Morphological changes of microglia were evaluated in the cerebral cortex of patients deceased from TBI in comparison with control subjects. Methods and procedures: Cortical samples from five cases with TBI and 10 controls were evaluated using Ricinus communis lectin histochemistry and conventional Hematoxylin- eosin staining. Main outcomes and results: It was observed that microglial cells from patients with TBI presented shorter and thicker cellular projections compared with controls. Moreover, the percentage of histological area reactive to lectin was statistically higher in samples from subjects with TBI. These signs of microglial activation were observed in all of the analysed cortical areas, thus indicating a generalized effect on the whole cerebral cortex. The results are consistent with previous imaging PET studies performed in living patients with the C-11-PK11195 radiotracer. Conclusions: The findings indicate that TBI induces a widespread activation of brain microglia which affects all cortical areas, including those distant from the contusion site.	[Velazquez, Antonio; Ortega, Marisa; Rojas, Santiago; Rodriguez-Baeza, Alfonso] Univ Autonoma Barcelona, Fac Med, Dept Ciencias Morfol, E-08193 Barcelona, Spain; [Ortega, Marisa; Javier Gonzalez-Olivan, Francisco] Inst Med Legal Cataluna, Barcelona, Spain		Rodriguez-Baeza, A (corresponding author), Univ Autonoma Barcelona, Fac Med, Unit Human Anat, E-08193 Barcelona, Spain.	alfonso.rodriguez@uab.es	sanchez, marisa ortega/AAB-2253-2019; Rodriguez Baeza, Alfonso/L-8284-2014	sanchez, marisa ortega/0000-0003-0764-1452; Rodriguez Baeza, Alfonso/0000-0002-9181-5613	Fondo de Investigaciones Sanitarias Instituto Carlos IIIInstituto de Salud Carlos III [01/0008-01]	The study is financially supported by Fondo de Investigaciones Sanitarias Instituto Carlos III (01/0008-01).	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Beschorner R, 2002, J NEUROIMMUNOL, V126, P107, DOI 10.1016/S0165-5728(02)00046-2; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Ito S, 2007, EXP GERONTOL, V42, P532, DOI 10.1016/j.exger.2006.11.012; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Nakajima K, 2007, NEUROCHEM INT, V50, P807, DOI 10.1016/j.neuint.2007.02.006; Oehmichen M., 2009, Legal Medicine, V11, P118, DOI 10.1016/j.legalmed.2008.11.003; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Shavali S, 2006, NEUROCHEM RES, V31, P85, DOI 10.1007/s11064-005-9233-x; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Voss EV, 2012, NEUROBIOL DIS, V45, P519, DOI 10.1016/j.nbd.2011.09.008	30	11	12	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1126	1133		10.3109/02699052.2015.1018325			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000013	26067626				2022-02-06	
J	Wolf, H; Frantal, S; Pajenda, G; Leitgeb, J; Sarahrudi, K; Hajdu, S				Wolf, Harald; Frantal, Sophie; Pajenda, Gholam; Leitgeb, Johannes; Sarahrudi, Kambiz; Hajdu, Stefan			Analysis of S100 Calcium Binding Protein B Serum Levels in Different Types of Traumatic Intracranial Lesions	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; traumatic brain injury; brain edema	BRAIN-INJURY; HEAD; MILD; FRACTURE; FAMILY	The objective of this study was to determine whether the type of intracranial traumatic lesions, the number of simultaneous traumatic lesions, and the occurrence of skull and facial bone fractures have an influence on S100 calcium binding protein B (S100B) serum levels. Patients with blunt traumatic brain injury were prospectively enrolled into this cohort study over a period of 13 months. Venous blood samples were obtained prior to emergency cranial CT scan in all patients within 3 h after injury. The patients were then assigned into six groups: 1) concussion, 2) epidural hematoma, 3) subdural hematoma, 4) subarachnoid hemorrhage, 5) brain contusions, and 6) brain edema. The study included 1696 head trauma patients with a mean age of 57.7 +/- 25.3 years, and 126 patients (8%) had 182 traumatic lesions on CT. Significant differences in S100B serum levels were found between cerebral edema and the other four bleeding groups: epidural p=0.0002, subdural p<0.0001, subarachnoid p=0.0001, brain contusions p=0.0003, and concussion p<0.0001. Significant differences in S100B values between patients with one or two intracranial lesions (p=0.014) or with three (p<0.0001) simultaneous intracranial lesions were found. In patients with intracranial traumatic lesions, skull fractures, as well as skull and facial bone fractures occurring together, were identified as significant additional factors for the increase in serum S100B levels (p<0.0001). Older age was also associated with elevated S100B serum levels (p<0.0001). Our data show that peak S100B serum levels were found in patients with cerebral edema and brain contusions.	[Wolf, Harald; Pajenda, Gholam; Leitgeb, Johannes; Sarahrudi, Kambiz; Hajdu, Stefan] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Frantal, Sophie] Med Univ Vienna, Dept Med Stat, Vienna, Austria		Wolf, H (corresponding author), Vienna Gen Hosp, Dept Trauma Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	Harald.Wolf@meduniwien.ac.at					Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vajtr D, 2012, Soud Lek, V57, P7; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	19	11	11	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2015	32	1					23	27		10.1089/neu.2013.3202			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AX4JX	WOS:000346900100004	25068442				2022-02-06	
J	Yaggie, M; Stevens, L; Miller, S; Abbott, A; Woodruff, C; Getchis, M; Stevens, S; Sherlin, L; Keller, B; Daiss, S				Yaggie, Matthew; Stevens, Larry; Miller, Seth; Abbott, Angela; Woodruff, Chad; Getchis, Mike; Stevens, Sean; Sherlin, Leslie; Keller, Brandon; Daiss, Suzanne			Electroencephalography Coherence, Memory Vividness, and Emotional Valence Effects of Bilateral Eye Movements During Unpleasant Memory Recall and Subsequent Free Association: Implications for Eye Movement Desensitization and Reprocessing	JOURNAL OF EMDR PRACTICE AND RESEARCH			English	Article						eye movement desensitization and reprocessing (EMDR); electroencephalography (EEG); coherence; bilateral stimulation; posttraumatic stress disorder (PTSD); traumatic brain injury (TBI)		This study examined the effects of bilateral stimulation during unpleasant memory recall followed by free association, similar to Phase 4 of EMDR therapy. Forty-six female nonpatients were randomly assigned to one of three conditions: bilateral eye movements (BEMs), eye fixation with background movements (BDM), or eye fixation (Dot) control, each while recalling a moderately unpleasant memory and each followed by free association to the memory. Electroencephalography recordings were conducted on these participants during the 1-minute free association of the original memory after each of five administrations of the conditions. Results revealed only trend increases in Beta interhemispheric coherence following BEMs. However, statistically significant increases in Right Frontal Theta and Beta intrahemispheric coherences were found following BEMs, with similar trend increases for Left Frontal Theta and Beta and for Right Frontal Gamma. Cortical electrode maps are presented for these Beta coherence effects. Ratings of imagery vividness and emotional valence were collected after each set of eye movements plus free associations and showed a significant decrease across all conditions. Results are discussed within the context of a proposed integrated 2-stage cortical coherence model. Suggestions are made for future research, including investigation of possible implications for treatment of traumatic brain injury.	[Yaggie, Matthew; Stevens, Larry; Miller, Seth; Abbott, Angela; Woodruff, Chad; Getchis, Mike; Stevens, Sean; Sherlin, Leslie; Keller, Brandon; Daiss, Suzanne] No Arizona Univ, Dept Psychol Sci, NAU Box 15106, Flagstaff, AZ 86011 USA		Stevens, L (corresponding author), No Arizona Univ, Dept Psychol Sci, NAU Box 15106, Flagstaff, AZ 86011 USA.	Larry.Stevens@nau.edu					AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; Andrade J, 1997, BRIT J CLIN PSYCHOL, V36, P209, DOI 10.1111/j.2044-8260.1997.tb01408.x; Armstrong MS, 1996, J BEHAV THER EXP PSY, V27, P21, DOI 10.1016/0005-7916(95)00056-9; Bergmann U., 2000, TRAUMATOLOGY, V6, P175, DOI [10.1177/153476560000600303, DOI 10.1177/153476560000600303]; Bergmann U., 1998, TRAUMATOLOGY, V4, P1, DOI [10.1177/153476569800400102, DOI 10.1177/153476569800400102]; Bergmann U, 2008, J EMDR PRACT RES, V2, P300, DOI 10.1891/1933-3196.2.4.300; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Brown R. E., 1994, INTRO NEUROENDOCRINO; Carlson EB., 1993, DISSOCIATION, V6, P16; Christman SD, 2004, BRAIN COGNITION, V56, P313, DOI 10.1016/j.bandc.2004.08.005; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corrigan F. M., 2002, CONT HYPNOSIS, V19, P8, DOI [10.1002/ch.235,1, DOI 10.1002/CH.235,1]; de Barenne DD, 1942, AM J OBSTET GYNECOL, V44, P687, DOI 10.1016/S0002-9378(42)90438-1; Denny N., 1995, TRAUMATOLOGY, V1, P1; DYCK MJ, 1993, J BEHAV THER EXP PSY, V24, P201, DOI 10.1016/0005-7916(93)90022-O; Electro Cap System [Apparatus], 1983, EAT; EureKa! [Software], 2000, EURAKA; EyeScan 2000S Light Bar [Apparatus], 1994, LIGHT BAR; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Frederick J. A., 2001, Journal of Neurotherapy, V4, P39, DOI 10.1300/J184v04n04_07; Gunter RW, 2008, BEHAV RES THER, V46, P913, DOI 10.1016/j.brat.2008.04.006; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KAPLAN BJ, 1990, PSYCHOPHYSIOLOGY, V27, P445, DOI 10.1111/j.1469-8986.1990.tb02341.x; Keller B, 2014, J EMDR PRACT RES, V8, P113, DOI 10.1891/1933-3196.8.3.113; Kennedy J. E., 2007, J REHABILITATION RES, V44, P1; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knott VJ, 2002, EXP CLIN PSYCHOPHARM, V10, P435, DOI 10.1037//1064-1297.10.4.435; Lee CW, 2008, J ANXIETY DISORD, V22, P801, DOI 10.1016/j.janxdis.2007.08.007; Macculloch MJ, 1996, BRIT J PSYCHIAT, V169, P571, DOI 10.1192/bjp.169.5.571; Maxfield L, 2008, J EMDR PRACT RES, V2, P247, DOI 10.1891/1933-3196.2.4.247; MHyT [Software], 2000, MHYT; Mitsar [Apparatus], 2000, MITSAR; Nieuwenhuis S, 2013, BRAIN COGNITION, V81, P52, DOI 10.1016/j.bandc.2012.10.003; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pagani M, 2013, J EMDR PRACT RES, V7, P29, DOI 10.1891/1933-3196.7.1.29; Pagani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045753; Propper RE, 2007, J NERV MENT DIS, V195, P785, DOI 10.1097/NMD.0b013e318142cf73; Propper RE, 2008, J EMDR PRACT RES, V2, P269, DOI 10.1891/1933-3196.2.4.269; Rasolkhani-Kalhorn T., 2006, TRAUMATOLOGY, V12, P9, DOI DOI 10.1177/153476560601200102; Samara Z., 2011, FRONT PSYCHIATRY, V2, P4, DOI DOI 10.3389/FPSYT.2011.00004; Servan-Schreiber D., 2000, PSYCHIAT TIMES, V17, P36; Shapiro F., 1989, J TRAUMATIC STRESS, V2, P199, DOI [DOI 10.1002/JTS.2490020207, 10.1002/jts.2490020207]; SOLISORTIZ S, 1994, INT J NEUROSCI, V76, P279, DOI 10.3109/00207459408986010; Stevens L, 2004, AM J CLIN HYPN, V46, P323, DOI 10.1080/00029157.2004.10403616; Stickgold R, 2002, J CLIN PSYCHOL, V58, P61, DOI 10.1002/jclp.1129; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; van den Hout M, 2001, BRIT J CLIN PSYCHOL, V40, P121; van den Hout M.A., 2012, J EXP PSYCHOPATHOL, V3, P724, DOI [10.5127/jep.028212, DOI 10.5127/JEP.028212]; van den Hout MA, 2014, COGNITION EMOTION, V28, P717, DOI 10.1080/02699931.2013.848785; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weiss S, 2003, BRAIN LANG, V85, P325, DOI 10.1016/S0093-934X(03)00067-1; WinEEG [Software], 2000, WINEEG	54	11	11	0	6	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, NEW YORK, NY 10036 USA	1933-3196	1933-320X		J EMDR PRACT RES	J. EMDR Pract. Res.		2015	9	2					78	97		10.1891/1933-3196.9.2.78			20	Psychology, Clinical; Psychology	Emerging Sources Citation Index (ESCI)	Psychology	VD4AN	WOS:000436712400006					2022-02-06	
J	Zou, HC; Hurwitz, M; Fowler, L; Wagner, AK				Zou, Huichao; Hurwitz, Max; Fowler, Lorraine; Wagner, Amy K.			Abbreviated levetiracetam treatment effects on behavioural and histological outcomes after experimental TBI	BRAIN INJURY			English	Article						Levetiracetam; neuroprotection; traumatic brain injury; treatment guidelines	TRAUMATIC BRAIN-INJURY; ANTIEPILEPTIC DRUG LEVETIRACETAM; CORTICAL IMPACT INJURY; POSTTRAUMATIC EPILEPSY; MODEL; PHENYTOIN; ASSOCIATIONS; PROPHYLAXIS; PREVENTION; GLUTAMATE	Objective: Long-term prophylactic treatment with levetiracetam (LEV) has multiple neuroprotective effects in a traumatic brain injury (TBI) rat model. Although a rational time-frame of seizure prophylactic treatment with LEV for after TBI is not well established, clinical prophylaxis with LEV often includes treatment duration similar to clinical treatment guidelines with Phenytoin. Thus, this study investigated the effects of abbreviated LEV treatment on behavioural function and histological evidence of neuroprotection. Research design: Pre-clinical trial of abbreviated LEV dosing in an experimental model of TBI Methods: After either controlled cortical impact (CCI) injury or sham surgery, rats received three 50mgkg(-1) doses over 24 hours or vehicle. After injury/sham surgery, beam performance, spatial learning, contusion volume size and hippocampal neuron survival were assessed. Results: Abbreviated LEV did not improve motor or cognitive performance after TBI. Further, abbreviated LEV did not improve hippocampal neuron sparing or contusion volumes compared with vehicle controls. Conclusions: Together with previous work assessing daily LEV treatment, these results suggest that longer-term therapy may be required to confer beneficial effects within these domains. These findings may guide (1) future experimental studies assessing minimal effective dosing for neuroprotection and anti-epileptogenesis and (2) treatment guideline updates for seizure prophylaxis post-TBI.	[Zou, Huichao; Hurwitz, Max; Fowler, Lorraine; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Zou, Huichao; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Canham, Lorraine/0000-0002-9444-4125	University of Pittsburgh Department of Physical Medicine and Rehabilitation	This work was supported by the University of Pittsburgh Department of Physical Medicine and Rehabilitation. We would like to thank Mary Synnott for help with figure production.	Aguirre-Moreno A, 2013, INT J MED MUSHROOMS, V15, P555, DOI 10.1615/IntJMedMushr.v15.i6.40; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Belcastro V, 2011, BRAIN DEV-JPN, V33, P289, DOI 10.1016/j.braindev.2010.06.008; Benge JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00195; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Cuomo O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080852; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; De Smedt T, 2007, CNS DRUG REV, V13, P43, DOI 10.1111/j.1527-3458.2007.00004.x; De Smedt T, 2007, CNS DRUG REV, V13, P57, DOI 10.1111/j.1527-3458.2007.00005.x; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Fonkem E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00153; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kumar R., 2014, J HEAD TRAUMA REHABI; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Nakamura Hidefumi, 2013, Brain Nerve, V65, P1083; Nowack A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029560; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Ravizza T, 2008, NEUROBIOL DIS, V31, P327, DOI 10.1016/j.nbd.2008.05.007; Smith GR, 2014, J MOL NEUROSCI, V52, P446, DOI 10.1007/s12031-013-0180-8; Steinhoff BJ, 2012, EPILEPTIC DISORD, V14, P379, DOI 10.1684/epd.2012.0544; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Tanaka S, 2013, EPILEPTIC DISORD, V15, P132, DOI 10.1684/epd.2013.0576; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Tong X, 2001, BRIT J PHARMACOL, V133, P867, DOI 10.1038/sj.bjp.0704141; Vezzani A, 1999, J NEUROSCI, V19, P5054; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2013, NEUROBIOL LEARN MEM, V106, P71, DOI 10.1016/j.nlm.2013.07.006; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007; Zweckberger K, 2011, NEUROL RES, V33, P875, DOI 10.1179/1743132811Y.0000000017	45	11	11	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					78	85		10.3109/02699052.2014.955528			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000010	25255156				2022-02-06	
J	Case, ME				Case, Mary E.			Distinguishing accidental from inflicted head trauma at autopsy	PEDIATRIC RADIOLOGY			English	Article						Non-accidental injury; Head injury; Postmortem; Mechanism of injury; Child	SHAKEN BABY SYNDROME; DIFFUSE AXONAL INJURY; PERIMACULAR RETINAL FOLDS; YOUNG-CHILDREN; CARDIOPULMONARY-RESUSCITATION; BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; NONACCIDENTAL INJURY; SUBDURAL HEMATOMAS; EARLY INFANCY	This article will discuss accidental and inflicted head injuries in infants and young children and how forensic pathologists distinguish between these types of injuries. The article begins with a consideration of the special and unique features of the anatomy and development of the child's head and neck and then relates these features to the mechanisms of traumatic brain injury and how these unique features influence the mechanisms of injury. The article very specifically notes that accidental head injuries in young children that occur in and around the home are focal head injuries in distinction to inflicted head injuries, which are diffuse brain injuries. The article discusses the mechanisms by which traumatic brain injury causes loss of consciousness and relates those mechanisms to the differences in the clinical features that occur in both accidental and inflicted head injury. The article discusses and illustrates the pathological findings in accidental head injuries consisting of the crushing head injuries and the head injuries sustained in short falls including epidural hemorrhage and focal subdural hemorrhage. The article discusses and illustrates the pathological findings that occur in inflicted head trauma, including subdural and subarachnoid hemorrhages and retinal and optic nerve sheath hemorrhages.	St Louis Univ, Hlth Sci Ctr, St Louis, MO 63104 USA		Case, ME (corresponding author), St Louis Univ, Hlth Sci Ctr, 1402 S Grand Blvd, St Louis, MO 63104 USA.	mcase@stlouisco.com					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Bacopoulou F, 2006, ARCH DIS CHILD, V91, P919, DOI 10.1136/adc.2006.081836; BUDENZ DL, 1994, OPHTHALMOLOGY, V101, P559; Cantu RC, 2000, NEUROLOGIC ATHLETIC, P2; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; CHADWICK DL, 1993, J TRAUMA, V35, P968, DOI 10.1097/00005373-199312000-00031; Denton S, 2003, AM J FOREN MED PATH, V24, P371, DOI 10.1097/01.paf.0000097851.18478.16; Di Maio VJ, 2001, FORENSIC PATHOLOGY, V2, P338; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Douherty W, 1931, JAMA-J AM MED ASSOC, V97, P308; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, PEDIATR NEUROSURG, V25, P116, DOI 10.1159/000121108; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; ELNER SG, 1990, ARCH OPHTHALMOL-CHIC, V108, P1094, DOI 10.1001/archopht.1990.01070100050033; FRASER SG, 1995, EYE, V9, P659, DOI 10.1038/eye.1995.165; Gago LC, 2003, RETINA-J RET VIT DIS, V23, P724, DOI 10.1097/00006982-200310000-00027; Gean AD, 1994, HEAD TRAUMA; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Gilliland MGF, 2007, AM J FOREN MED PATH, V28, P323, DOI 10.1097/PAF.0b013e31815b4c00; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; GILLILAND MGF, 1993, AM J FOREN MED PATH, V14, P187, DOI 10.1097/00000433-199309000-00003; GOETTING MG, 1990, PEDIATRICS, V85, P585; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GREENWALD MJ, 1986, OPHTHALMOLOGY, V93, P618; Pham H, 2013, AM J FOREN MED PATH, V34, P122, DOI 10.1097/PAF.0b013e31828c38f9; HELFER RE, 1977, PEDIATRICS, V60, P533; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; JOHNSON DL, 1993, NEUROSURGERY, V33, P231; KANTER RK, 1986, J PEDIATR-US, V108, P430, DOI 10.1016/S0022-3476(86)80890-3; King WJ, 2003, CAN MED ASSOC J, V168, P155; KLEINMAN PK, 1990, AM J ROENTGENOL, V155, P703, DOI 10.2214/ajr.155.4.2119097; KRAMER K, 1993, CLIN PEDIATR, V32, P366, DOI 10.1177/000992289303200610; KRAVITZ H, 1969, PEDIATRICS, V44, P869; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; LEVIN A, 1986, PEDIATR EMERG CARE, V2, P269; LEVIN AV, 2000, RECENT ADV PAEDIAT, V18, P151; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; LYONS TJ, 1993, PEDIATRICS, V92, P125; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCCLELLAND CQ, 1980, CHILD BRAIN, V7, P225; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mishra P, 2008, HAEMOPHILIA, V14, P952, DOI 10.1111/j.1365-2516.2008.01814.x; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Ommaya AK, 2003, BRIT J NEUROSURG, V17, P201, DOI 10.1080/0268869031000110825; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Prahlow JA, 1998, AM J FOREN MED PATH, V19, P391, DOI 10.1097/00000433-199812000-00019; Prasad MR, 1999, J CHILD NEUROL, V14, P496, DOI 10.1177/088307389901400803; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; Salehi-Had H, 2006, PEDIATRICS, V117, pE1039, DOI 10.1542/peds.2005-0811; Schloff S, 2002, OPHTHALMOLOGY, V109, P1472, DOI 10.1016/S0161-6420(02)01086-2; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SMITH WL, 1992, PEDIATRICS, V89, P332; Stalhammar D, 1986, Acta Neurochir Suppl (Wien), V36, P33; Suzuki K, 1999, CHILD NERV SYST, V15, P292, DOI 10.1007/s003810050397; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; WEISSGOLD DJ, 1995, SURV OPHTHALMOL, V39, P509; Wilbur LS, 1994, APSAC ADVISOR, V7, P16; Wilkins RH, 1985, BIOMECHANICS HEAD IN, P1531; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; Winston, 1998, CHILD MALTREATMENT, V3, P116, DOI [DOI 10.1177/1077559598003002006, 10.1177/1077559598003002006]; Yason D, 1986, ARCH NEUROL-CHICAGO, V18, P370	78	11	11	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	DEC	2014	44			4	SI		632	640		10.1007/s00247-014-3061-6			9	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	AW4KG	WOS:000346249400013	25501735				2022-02-06	
J	Jeon, YH; Kim, DM; Kim, SH; Kim, SW				Jeon, Yong Hyun; Kim, Dong Min; Kim, Sung Hoon; Kim, Seok Won			Serious Penetrating Craniocerebral Injury Caused by a Nail Gun	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Head; Injury; Penetrating	INTRACRANIAL PENETRATION; TRAUMA; BODY; WOOD	Penetrating cerebral injuries caused by foreign bodies occur rarely due to the substantial mechanical protection offered by the skull. Throughout most of history, the brain, residing in a "closed box" of bone, has not been vulnerable to external aggression. Recently, we encountered a serious penetrating craniocerebral injury caused by a nail gun. Total excision of the offending nail via emergency craniotomy was performed, but the patient's neurologic status was not improved in spite of aggressive rehabilitative treatment. Here, we report on this troublesome case in light of a review of the relevant literature.	[Jeon, Yong Hyun] Chosun Univ, Coll Med, Dept Anat, Kwangju 501717, South Korea; [Kim, Dong Min] Chosun Univ, Coll Med, Dept Internal Med, Kwangju 501717, South Korea; [Kim, Sung Hoon] Yonsei Univ, Coll Med, Wonju Christian Hosp, Dept Rehabil Med, Wonju, South Korea; [Kim, Seok Won] Chosun Univ, Coll Med, Dept Neurosurg, Kwangju 501717, South Korea		Kim, SH (corresponding author), Chosun Univ, Sch Med, Dept Neurosurg, 365 Pilmun Daero, Kwangju 501717, South Korea.	chosunns@chosun.ac.kr	Jeon, Yong hyun/N-6910-2019	Jeon, Yong hyun/0000-0003-3161-7698; kim, sunghoon/0000-0002-1570-3230; Kim, Dong-Min/0000-0001-6373-0922			BAKAY L, 1977, ACTA NEUROCHIR, V39, P219, DOI 10.1007/BF01406732; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Gokcek C, 2007, TURK NEUROSURG, V17, P121; GREENE KA, 1993, SURG NEUROL, V40, P499, DOI 10.1016/0090-3019(93)90054-5; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; KAISER MC, 1983, NEURORADIOLOGY, V24, P229, DOI 10.1007/BF00399777; KELLY AJ, 1992, SURG NEUROL, V38, P471, DOI 10.1016/0090-3019(92)90118-7; Lee JI, 2011, J KOREAN NEUROSURG S, V50, P532, DOI 10.3340/jkns.2011.50.6.532; MILLER CF, 1977, SURG NEUROL, V7, P95; MINER ME, 1986, NEUROSURGERY, V19, P952, DOI 10.1227/00006123-198612000-00009; Offiah C, 2009, CLIN RADIOL, V64, P1146, DOI 10.1016/j.crad.2009.06.004; Sani S, 2005, J NEUROSURG, V103, P567, DOI 10.3171/jns.2005.103.3.0567; Winder MJ, 2008, J CLIN NEUROSCI, V15, P18, DOI 10.1016/j.jocn.2007.06.020; YAMAMOTO I, 1985, SURG NEUROL, V23, P396, DOI 10.1016/0090-3019(85)90215-0	14	11	11	0	4	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	DEC	2014	56	6					537	539		10.3340/jkns.2014.56.6.537			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AY7JD	WOS:000347735800018	25628820	Green Submitted, Green Published, gold			2022-02-06	
J	Juengst, SB; Arenth, PM; Raina, KD; McCue, M; Skidmore, ER				Juengst, Shannon B.; Arenth, Patricia M.; Raina, Ketki D.; McCue, Michael; Skidmore, Elizabeth R.			Affective State and Community Integration After Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Community Integration; Affect	QUALITY-OF-LIFE; PSYCHOSOCIAL ADJUSTMENT; EXECUTIVE FUNCTION; NEGATIVE AFFECT; FOLLOW-UP; DEPRESSION; SATISFACTION; INDIVIDUALS; PREDICTORS; VALIDITY	Previous studies investigating the relationship between affective state and community integration have focused primarily on the influence of depression and anxiety. In addition, they have focused on frequency of participation in various activities, failing to address an individual's subjective satisfaction with participation. The purpose of this study was to examine how affective state contributes to frequency of participation and satisfaction with participation after traumatic brain injury among participants with and without a current major depressive episode. Sixty-four community-dwelling participants with a history of complicated mild-to-severe traumatic brain injury participated in this cross-sectional cohort study. High positive affect contributed significantly to frequency of participation ( = 0.401, P = 0.001), and both high positive affect and low negative affect significantly contributed to better satisfaction with participation (F-2,F-61 = 13.63, P < 0.001). Further investigation to assess the direction of these relationships may better inform effective targets for intervention. These findings highlight the importance of assessing affective state after traumatic brain injury and incorporating a subjective measure of participation when considering community integration outcomes.	[Juengst, Shannon B.; Raina, Ketki D.; Skidmore, Elizabeth R.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA USA; [Juengst, Shannon B.; Arenth, Patricia M.; Skidmore, Elizabeth R.] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [McCue, Michael] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Pittsburgh, PA USA		Juengst, SB (corresponding author), 3471 Fifth Ave,Kaufmann Med Bldg,Suite 202, Pittsburgh, PA 15213 USA.		Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	School of Health and Rehabilitation Science Research Development Fund, School and Health of Rehabilitation Science, University of Pittsburgh; NIH NCMRR/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K12 HD 055931]; United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-1-0920]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931] Funding Source: NIH RePORTER	Supported in part by funding received from the School of Health and Rehabilitation Science Research Development Fund, School and Health of Rehabilitation Science, University of Pittsburgh; by the NIH NCMRR/NINDS K12 HD 055931; and by the United States Army Medical Research and Material Command under Award No. W81XWH-10-1-0920.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Conrad N, 2010, CLIN REHABIL, V24, P431, DOI 10.1177/0269215509358930; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dijkers M, 2009, ARCH PHYS MED REHAB, V90, pe39, DOI DOI 10.1016/j.apmr.2009.08.123; Dumont Claire, 2005, Can J Occup Ther, V72, P222; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hoofien D, 2001, BRAIN INJURY, V15, P189; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mount Sinai School of Medicine Department of Rehabilitation Medicine, 2007, PART OS INT MAN; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Payne R.L., 2003, EMOTIONS WORK THEORY; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	42	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2014	93	12					1086	1094		10.1097/PHM.0000000000000163			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AU0TS	WOS:000345338100011	25133618	Green Accepted			2022-02-06	
J	Kica, J; Rosenman, KD				Kica, Joanna; Rosenman, Kenneth D.			Surveillance for work-related skull fractures in Michigan	JOURNAL OF SAFETY RESEARCH			English	Article						Occupational injuries; Traumatic brain injury (TBI); Enforcement inspections; Public health surveillance; Injury prevention		Objectives: The objective was to develop a multisource surveillance system for work-related skull fractures. Methods: Records on work-related skull fractures were obtained from Michigan's 134 hospitals, Michigan's Workers' Compensation Agency and death certificates. Cases from the three sources were matched to eliminate duplicates from more than one source. Workplaces where the most severe injuries occurred were referred to OSHA for an enforcement inspection. Results: There were 318 work related skull fractures, not including facial fractures, between 2010 and 2012. In 2012, after the inclusion of facial fractures, 316 fractures were identified of which 218 (69%) were facial fractures. The Bureau of Labor Statistic's (BLS) 2012 estimate of skull fractures in Michigan, which includes facial fractures, was 170, which was 53.8% of those identified from our review of medical records. The inclusion of facial fractures in the surveillance system increased the percentage of women identified from 15.4% to 31.2%, decreased severity (hospitalization went from 48.7% to 10.6% and loss of consciousness went from 56.5% to 17.8%), decreased falls from 48.2% to 27.6%, and increased assaults from 5.0% to 202%, shifted the most common industry from construction (13.3%) to health care and social assistance (15.0%) and the highest incidence rate from males 65+ (6.8 per 100,000) to young men, 20-24 years (9.6 per 100,000). Workplace inspections resulted in 45 violations and $62,750 in penalties. Conclusions: The Michigan multisource surveillance system of workplace injuries had two major advantages over the existing national system: (a) workplace investigations were initiated hazards identified and safety changes implemented at the facilities where the injuries occurred; and (b) a more accurate count was derived, with 86% more work-related skull fractures identified than BLS's employer based estimate. Practical Applications: A more comprehensive system to identify and target interventions for workplace injuries was implemented using hospital and emergency department medical records. (C) 2014 National Safety Council and Elsevier Ltd. All rights reserved.	[Kica, Joanna; Rosenman, Kenneth D.] Michigan State Univ, Dept Med, Div Occupat & Environm Med, E Lansing, MI 48824 USA		Kica, J (corresponding author), Michigan State Univ, Dept Med, Div Occupat & Environm Med, 909 Fee Rd,Rm 118, E Lansing, MI 48824 USA.	Joanna.Kica@hc.msu.edu; rosenman@msu.edu			NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [U60OH008466] Funding Source: NIH RePORTER; NIOSH CDC HHS [5U60 OH008466] Funding Source: Medline		Bureau of Labor Statistics & U.S. Department of Labor, 2014, OCC INJ ILLN FAT INJ; Centers for Disease Control and Prevention (CDC), 2010, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention [CDC], 2012, STAT INJ IND INSTR P; Exadaktylos AK, 2002, OCCUP MED-OXFORD, V52, P45, DOI 10.1093/occmed/52.1.45; Executive Office of the President US Office of Management and Budget, 2002, N AM IND CLASS SYST; Finkelstein E., 2006, INCIDENCE EC BURDEN; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; IIZUKA T, 1990, J CRANIO MAXILL SURG, V18, P255, DOI 10.1016/S1010-5182(05)80426-3; Kica J, 2012, J OCCUP ENVIRON MED, V54, P642, DOI 10.1097/JOM.0b013e31824ed31a; Kim H, 2006, NEUROREHABILITATION, V21, P269; Largo TW, 2013, J OCCUP ENVIRON MED, V55, P280, DOI 10.1097/JOM.0b013e31827945be; Lee K. H., 2010, ASIAN J ORAL MAXILLO, V22, P138; Michigan Administrative Code, 1979, R325301306 MICH ADM; Michigan State University Occupational and Environmental Medicine, 2011, 1 MICH STAT U OCC EN; Michigan State University Occupational and Environmental Medicine (e), 2014, MICH FAT ASS CONTR E; Public Health Services and Health Care Financing Administration, 1980, INT CLASS DIS 9 REV; Roccia F, 2013, ORAL MAXILLOFAC SURG, V17, P181, DOI 10.1007/s10006-012-0336-7; U.S. Census Bureau, 2014, CURR POP SURV CPS; Wei Chia, 2012, Minn Med, V95, P55; World Health Organization, 2004, ICD 10 INT STAT CLAS	20	11	11	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	DEC	2014	51						49	56		10.1016/j.jsr.2014.09.003			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AU6PA	WOS:000345723400007	25453176				2022-02-06	
J	Lewis, PM; Smielewski, P; Rosenfeld, JV; Pickard, JD; Czosnyka, M				Lewis, Philip M.; Smielewski, Peter; Rosenfeld, Jeffrey V.; Pickard, John D.; Czosnyka, Marek			A Continuous Correlation Between Intracranial Pressure and Cerebral Blood Flow Velocity Reflects Cerebral Autoregulation Impairment During Intracranial Pressure Plateau Waves	NEUROCRITICAL CARE			English	Article						Intracranial pressure; Cerebral perfusion pressure; Cerebral blood volume; Cerebral autoregulation; Transcranial Doppler; Near-infrared spectroscopy	SPONTANEOUS OSCILLATIONS; VENOUS OUTFLOW; HYPERTENSION; VOLUME; FLUCTUATIONS; REACTIVITY; ELEVATION; SYSTEM	In the healthy brain, small oscillations in intracranial pressure (ICP) occur synchronously with those in cerebral blood volume (CBV), cerebrovascular resistance, and consequently cerebral blood flow velocity (CBFV). Previous work has shown that the usual synchrony between ICP and CBFV is lost during intracranial hypertension. Moreover, a continuously computed measure of the ICP/CBFV association (Fix index) was a more sensitive predictor of outcome after traumatic brain injury (TBI) than a measure of autoregulation (Mx index). In the current study we computed Fix during ICP plateau waves, to observe its behavior during a defined period of cerebrovascular vasodilatation. Twenty-nine recordings of arterial blood pressure (ABP), ICP, and CBFV taken during ICP plateau waves were obtained from the Addenbrooke's hospital TBI database. Raw data was filtered prior to computing Mx and Fix according to previously published methods. Analyzed data was segmented into three phases (pre, peak, and post), and a median value of each parameter was stored for analysis. ICP increased from a median of 22-44 mmHg before falling to 19 mmHg. Both Mx and Fix responded to the increase in ICP, with Mx trending toward +1, while Fix trended toward -1. Mx and Fix correlated significantly (Spearman's R = -0.89, p < 0.000001), however, Fix spanned a greater range than Mx. A plot of Mx and Fix against CPP showed a plateau (Mx) or trough (Fix) consistent with a zone of "optimal CPP". The Fix index can identify complete loss of cerebral autoregulation as the point at which the normally positive CBF/CBV correlation is reversed. Both CBF and CBV can be monitored noninvasively using near-infrared spectroscopy (NIRS), suggesting that a noninvasive method of monitoring autoregulation using only NIRS may be possible.	[Lewis, Philip M.; Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3003, Australia; [Lewis, Philip M.; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Smielewski, Peter; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England		Lewis, PM (corresponding author), Alfred Hosp, Dept Neurosurg, 1st Floor,Old Baker Bldg,Commercial Rd, Melbourne, Vic 3003, Australia.	p.lewis@alfred.org.au		czosnyka, marek/0000-0003-2446-8006; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B, G1000183B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001354, G0001237] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G0600986, G9439390] Funding Source: UKRI		Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; Anile C, 2009, CHILD NERV SYST, V25, P325, DOI 10.1007/s00381-008-0749-7; AUER LM, 1983, ACTA NEUROCHIR, V68, P93, DOI 10.1007/BF01406205; Avezaat CJJ, 2009, CHILD NERV SYST, V25, P339, DOI 10.1007/s00381-008-0756-8; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; Bhuiyan MR, 2012, J CLIN NEUROSCI, V19, P1255, DOI 10.1016/j.jocn.2012.02.001; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; BRIERLEY JB, 1969, BRAIN RES, V13, P68, DOI 10.1016/0006-8993(69)90144-9; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; DIEHL RR, 1991, NEUROSCI LETT, V127, P5, DOI 10.1016/0304-3940(91)90880-3; DROSTE DW, 1994, ACTA NEUROL SCAND, V90, P99; GOH D, 1992, DEV MED CHILD NEUROL, V34, P676; GRUBB RL, 1975, J NEUROSURG, V43, P385, DOI 10.3171/jns.1975.43.4.0385; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; JOHNSTON IH, 1974, J NEUROL NEUROSUR PS, V37, P392, DOI 10.1136/jnnp.37.4.392; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2008, ACTA NEUROCHIR, V150, P139, DOI 10.1007/s00701-007-1447-z; Lewis PM, 2007, NEUROL RES, V29, P260, DOI 10.1179/174313206X153987; Lewis Philip M, 2012, Acta Neurochir Suppl, V114, P147, DOI 10.1007/978-3-7091-0956-4_27; Lewis PM, 2008, ACTA NEUROCHIR WIEN, V150, P46; LUCE JM, 1982, J APPL PHYSIOL, V53, P1496, DOI 10.1152/jappl.1982.53.6.1496; LUNDAR T, 1990, ACTA NEUROCHIR, V102, P85, DOI 10.1007/BF01405419; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Miller J D, 1972, Prog Brain Res, V35, P411; NAKAGAWA Y, 1974, J NEUROSURG, V41, P427, DOI 10.3171/jns.1974.41.4.0427; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; Reinhard M, 2005, STROKE, V36, P1684, DOI 10.1161/01.STR.0000173183.36331.ee; RISBERG J, 1969, EXP BRAIN RES, V8, P321; RISBERG J, 1969, J NEUROSURG, V31, P303, DOI 10.3171/jns.1969.31.3.0303; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Rosner MJ, 1986, INTRACRANIAL PRESSUR; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; Vignes JR, 2007, J NEUROSURG, V107, P1205, DOI 10.3171/JNS-07/12/1205; WAGNER EM, 1985, ANN BIOMED ENG, V13, P311, DOI 10.1007/BF02584249; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Wolff HG, 1928, ARCH NEURO PSYCHIATR, V20, P1035, DOI 10.1001/archneurpsyc.1928.02210170142002; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	49	11	11	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2014	21	3					514	525		10.1007/s12028-014-9994-7			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AT2TY	WOS:000344790100018	24865272				2022-02-06	
J	McKinlay, A				McKinlay, Audrey			Long-Term Outcomes of Traumatic Brain Injury in Early Childhood	AUSTRALIAN PSYCHOLOGIST			English	Article						brain injury; concussion; early childhood; mTBI	MILD HEAD-INJURY; NEUROPSYCHOLOGICAL FUNCTION; ADOLESCENTS 6; BIRTH COHORT; YOUNG-ADULTS; CHILDREN; PLASTICITY; CONCUSSION; PREDICTORS; VULNERABILITY	Mild traumatic brain injury (mTBI) is a leading cause of injury among children, with approximately 15% of children experiencing a TBI prior to 15 years of age. Acutely, mTBI has been associated with a range of cognitive, physical, emotional and behavioural impairments. However, few studies have examined outcomes beyond five years post injury, long before the developmental process is complete and the full extent of any deficits may manifest. Our group had the unique opportunity to use data from a longitudinal birth cohort of 1265 children (Christchurch Health and Development Study) to examine the long term outcomes of early injury (0-5 years). Information about these children, including mTBI events, had been collected at birth, 4 months and at yearly intervals until age 16, and again at ages 18, 21 and 25 years. We found that even after statistical control for a wide range of child and family confounds, children who had been hospitalized for an mTBI had increased inattention/hyperactivity and conduct as rated by mothers and teachers over ages 7-13 years. Increased rates of psychiatric disorders were over 14-16 years for those injured in the preschool, including symptoms consistent with Attention Deficit/Hyperactivity Disorder (ADHD), Odds Ratio=4.6, Conduct Disorder (CD), Odds Ratio=5.6 and Substance Abuse (Odds Ratio=9.1). Over ages 21-25 ongoing behaviour problems were assessed using self-reported arrests, violent offenses and property offenses. Compared to non-injured individuals, mTBI groups were more likely to be arrested, involved in property, and violent offences. We controlled for a wide range of factors and there was still clear evidence of ongoing problems for individuals who had experienced a mTBI compared to their non injured counterparts. These findings provide compelling evidence of long term psychosocial and psychiatric outcomes following mTBI.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [McKinlay, Audrey] Univ Canterbury, Christchurch 1, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 2001, RECOVERY EARLY BRAIN; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; COSTEFF H, 1988, BRAIN DEV-JPN, V10, P371, DOI 10.1016/S0387-7604(88)80095-0; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Horowitz I, 1983, Int Rehabil Med, V5, P32; JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kraus J. F., 1995, EPIDEMIOLOGICAL FEAT; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A., 2012, MILD TRAUMATIC BRAIN, P361; McKinlay A., 2013, NEUROTRAUMA LETT; McKinlay A, 2003, BRAIN INJ S1, V17, P39; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McKinlay A, 2012, NEUROREHABILITATION, V30, P183, DOI 10.3233/NRE-2012-0743; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; Meekes J, 2006, PEDIATRICS, V117, P2330, DOI 10.1542/peds.2006-0083; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127	40	11	11	2	50	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	DEC	2014	49	6					323	327		10.1111/ap.12084			5	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AU1DO	WOS:000345361500001					2022-02-06	
J	Suehiro, E; Koizumi, H; Fujiyama, Y; Yoneda, H; Suzuki, M				Suehiro, Eiichi; Koizumi, Hiroyasu; Fujiyama, Yuichi; Yoneda, Hiroshi; Suzuki, Michiyasu			Predictors of deterioration indicating a requirement for surgery in mild to moderate traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Mild traumatic brain injury; Moderate traumatic brain injury; Exacerbation; Coagulopathy; Talk and deteriorate	COAGULOPATHY; THROMBELASTOGRAPHY; DISORDERS	Objectives: Careful course observation is necessary for cases of mild to moderate traumatic brain injury even when disturbed consciousness is mild on admission. This is because delayed enlargement of hematoma and progression of cerebral swelling may occur and result in an emergency craniotomy. Here, we investigated coagulopathy and abnormal fibrinolysis as a predictive factor of "deterioration requiring surgery" in mild to moderate traumatic brain injury. Patients and methods: Sixty-one patients with mild to moderate (Glasgow Coma Scale (GCS) score 9-15) traumatic brain injury were admitted betweenJune 2009 and October 2010. There were 54 subjects in the study, excluding those treated with oral antiplatelet agents and anticoagulants. Patients were classified into those with deterioration requiring surgery [op(+)] or those without deterioration requiring surgery [01)H]. This was based on whether surgical treatment was performed for hematoma expansion, and exacerbated consciousness level within 3 days after admission. Age, GCS score on admission and blood test findings (platelet count, PT-INR, APTT, fibrinogen, FDP, and n-dimer) on admission were compared. Results: The op(+) and op(-) groups comprised 7 (13.0%) and 47 patients (87.0%), respectively. Platelet counts (24.8 vs 18.5 x 10(4)/mu l) were decreased, and PT-INR (1.0 vs 1.2) was higher in the op(+) group. Specially, APTT (28.6 vs 39.1 s), FDP (28.9 vs 112.9 mu g/ml), and n-dimer (17.3 vs 69.6 mu g/ml) values were significantly higher in the op(+) group. Conclusions: Coagulopathy and abnormal fibrinolysis, which are measurable in routine medical practice, is associated with deterioration requiring surgery in mild to moderate traumatic brain injury, indicating that careful course observation is necessary. (C) 2014 Elsevier B.V. All rights reserved.	[Suehiro, Eiichi; Koizumi, Hiroyasu; Fujiyama, Yuichi; Yoneda, Hiroshi; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp	Suehiro, Eiichi/I-5852-2019				Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Japanese Guidelines Committee on the Management of Severe Head Injury the Japan Society of Neurotraumatology, 2012, NEUROL MED CHIR TOKY, V52, P1; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Kushimoto S, 2010, JPN J THROMB HEMOST, V21, P578; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Salehpour F, 2011, J CRIT CARE, V26, P352, DOI 10.1016/j.jcrc.2010.12.005; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tan JE, 2004, ANN ACAD MED SINGAP, V33, P489; Theusinger OM, 2009, CURR OPIN ANESTHESIO, V22, P305, DOI 10.1097/ACO.0b013e3283212c7c; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	20	11	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						97	100		10.1016/j.clineuro.2014.10.007			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800020	25459251				2022-02-06	
J	Tan, LB; Chew, FS; Tse, KM; Tan, VBC; Lee, HP				Tan, Long Bin; Chew, Fatt Siong; Tse, Kwong Ming; Tan, Vincent Beng Chye; Lee, Heow Pueh			Impact of complex blast waves on the human head: a computational study	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						concomitant blast; biological head; coupled Eulerian-Lagrangian (CEL); traumatic brain injury (TBI); intracranial pressure (ICP); fluid-structure interaction (FSI)	TRAUMATIC BRAIN-INJURY; INDUCED NEUROTRAUMA; MITIGATION; SIMULATION	Head injuries due to complex blasts are not well examined because of limited published articles on the subject. Previous studies have analyzed head injuries due to impact from a single planar blast wave. Complex or concomitant blasts refer to impacts usually caused by more than a single blast source, whereby the blast waves may impact the head simultaneously or consecutively, depending on the locations and distances of the blast sources from the subject, their blast intensities, the sequence of detonations, as well as the effect of blast wave reflections from rigid walls. It is expected that such scenarios will result in more serious head injuries as compared to impact from a single blast wave due to the larger effective duration of the blast.In this paper, the utilization of a head-helmet model for blast impact analyses in Abaqus(TM) (Dassault Systemes, Singapore) is demonstrated. The model is validated against studies published in the literature. Results show that the skull is capable of transmitting the blast impact to cause high intracranial pressures (ICPs). In addition, the pressure wave from a frontal blast may enter through the sides of the helmet and wrap around the head to result in a second impact at the rear. This study recommended better protection at the sides and rear of the helmet through the use of foam pads so as to reduce wave entry into the helmet. The consecutive frontal blasts scenario resulted in higher ICPs compared with impact from a single frontal blast. This implied that blast impingement from an immediate subsequent pressure wave would increase severity of brain injury. For the unhelmeted head case, a peak ICP of 330kPa is registered at the parietal lobe which exceeds the 235kPa threshold for serious head injuries. The concurrent front and side blasts scenario yielded lower ICPs and skull stresses than the consecutive frontal blasts case. It is also revealed that the additional side blast would only significantly affect ICPs at the temporal and parietal lobes when compared with results from the single frontal blast case.By analyzing the pressure wave flow surrounding the head and correlating them with the consequential evolution of ICP and skull stress, the paper provides insights into the interaction mechanics between the concomitant blast waves and the biological head model. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tan, Long Bin; Chew, Fatt Siong; Tse, Kwong Ming; Tan, Vincent Beng Chye; Lee, Heow Pueh] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore		Tan, LB (corresponding author), Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.	mpetl@nus.edu.sg	Tan, Vincent/R-8040-2019; Lee, Heow Pueh/I-7834-2014; Tse, Kwong Ming/D-8669-2011	Tan, Vincent/0000-0003-1436-5337; Lee, Heow Pueh/0000-0002-4380-3888; Tse, Kwong Ming/0000-0002-8170-0775; Tan, Long Bin/0000-0002-3897-7365			Air Force Civil Engineer Support Agency, 2008, STRUCT RES EFF ACC E; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chan M., 1980, P 24 STAPP CAR CRASH, P347; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; CLAESSENS M, 1997, P 41 STAPP CAR CRASH, P315, DOI DOI 10.4271/973338; Dewey JM., 2010, 21 INT S MIL ASP BLA; Dionne J-P, N ATLANTIC TREATY OR; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Gibson P., 1994, BLAST OVERPRESSURE S; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P297, DOI 10.1108/15736101211269122; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Hyde DW, 1991, CONWEP CONVENTIONAL; Krave U, 2005, EUR J NEUROSCI, V21, P2876, DOI 10.1111/j.1460-9568.2005.04115.x; Lee HP, 2010, COMPUT METHOD BIOMEC, V13, P537, DOI 10.1080/10255840903337848; Levitz Jennifer, 2013, WALL STREET J; Lockhart P. A., 2010, MECH MECHATRONICS EN; Mihradi S, 2004, JSME INT J A-SOLID M, V47, P581, DOI 10.1299/jsmea.47.581; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott D, 2008, 61 ANN M APS DIV FLU, V53; Mott DR, 2012, 22 INT S MIL ASP BLA; Nahum AM, 1977, 21 STAPP CAR CRASH C, P339; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Petr K, 2012, J COMPUT NONLIN DYN, V7; Pincus JH, 2003, BEHAV NEUROLOGY; Richmond DR., 1968, ESTIMATE MANS TOLERA; Simmonds KE, 2009, SENSOR SYSTEMS MEASU; Smith PD, 2009, BLAST LOAD ASSESSMEN; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P94, DOI 10.1111/j.1600-0404.1975.tb05764.x; Stuhmiller JH, 2008, TXB MILITARY MED OFF; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tan LB, 2012, PERFORMANCE EVALUATI; Tan LB, 2011, DSO NAT LAB DMERI; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Teland JA, 2010, IFMBE PROC, V31, P350, DOI 10.1007/978-3-642-14515-5_90; Zhang L, 2009, US ARM MED RES MAT C; Zhang L, 2011, W81XWH0810678LYZ USA; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	48	11	12	3	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	DEC	2014	30	12					1476	1505		10.1002/cnm.2668			30	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	AW0PK	WOS:000345995000005	25132676				2022-02-06	
J	Jeong, S; Lei, BL; Wang, HC; Dawson, HN; James, ML				Jeong, Seongtae; Lei, Beilei; Wang, Haichen; Dawson, Hana N.; James, Michael L.			Intravenous immunoglobulin G improves neurobehavioral and histological outcomes after traumatic brain injury in mice	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury (TBI); Intravenous immunoglobulin (IVIG); Neuroinflammation; Blood-brain barrier (BBB); Murine model; Long-term outcome	CLOSED-HEAD INJURY; MICROGLIAL ACTIVATION; FUNCTIONAL RECOVERY; MURINE MODEL; INFLAMMATION; BARRIER; RATS; NEUROPROTECTION; PERMEABILITY; HEMORRHAGE	Intravenous immunoglobulin (WIG) may improve neuroinflammation after traumatic brain injury (TBI). MG administration after TBI improved rotarod latencies over the first 7 days (p = 0.039) and water maze latencies over 29-32 days (p = 0.027), decreased F4/80-positive cells at 2 (p = 0.001) and 7 days (p < 0.001), decreased Fluoro-jade B-positive cells (p = 0.020), increased NeuN-positive cells (p = 0.014), decreased IL-6 production at 4 (p = 0.032) and 24 h (p = 0.023), and decreased blood-brain barrier breakdown by IgG extravasation (p = 0.001) and brain edema (p = 0.006); however, TNF-alpha concentration was unchanged. MG administration was associated with long-term neurobehavioral and histological improvement through modulation of neuroinflammation and blood-brain barrier permeability in a murine TBI model. (C) 2014 Elsevier B.V. All rights reserved.	[Jeong, Seongtae; Lei, Beilei; Wang, Haichen; Dawson, Hana N.; James, Michael L.] Duke Univ, Multidisciplinary Neuroprotect Labs, Durham, NC USA; [Jeong, Seongtae] Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwangiu, South Korea; [Lei, Beilei; James, Michael L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Wang, Haichen; Dawson, Hana N.; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA		James, ML (corresponding author), DUMC 3094, Durham, NC 27710 USA.	michael.james@duke.edu	James, Michael L./AAJ-5592-2020; Jeong, Seongtae/AAZ-2067-2020	James, Michael L./0000-0002-8715-5210; 			Ahishali B, 2005, INT J NEUROSCI, V115, P151, DOI 10.1080/00207450590519030; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Aschermann S, 2010, CLIN EXP IMMUNOL, V160, P161, DOI 10.1111/j.1365-2249.2009.04081.x; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Dudesek A, 2006, J NEUROL, V253, P50, DOI 10.1007/s00415-006-5007-x; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Esen F, 2012, CRIT CARE MED, V40, P1214, DOI 10.1097/CCM.0b013e31823779ca; Felker GM, 2010, CIRC-HEART FAIL, V3, P314, DOI 10.1161/CIRCHEARTFAILURE.109.893222; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; HAHN RG, 1989, J UROLOGY, V142, P1102, DOI 10.1016/S0022-5347(17)39005-5; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hughes RAC, 2009, CLIN EXP IMMUNOL, V158, P34, DOI [10.1111/j.1365-2249.2009.04025.X, 10.1111/j.1365-2249.2009.04025.x]; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; Lapointe BM, 2004, BRAIN, V127, P2649, DOI 10.1093/brain/awh297; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; McIntosh TK, 1996, LAB INVEST, V74, P315; Misra N, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-1102-7; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; STALBERG HP, 1993, ACTA ANAESTH SCAND, V37, P281, DOI 10.1111/j.1399-6576.1993.tb03716.x; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Wang B, 2013, NEUROCRIT CARE, V19, P125, DOI 10.1007/s12028-012-9808-8; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	40	11	11	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	NOV 15	2014	276	1-2					112	118		10.1016/j.jneuroim.2014.08.626			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AU3CI	WOS:000345490000014	25241288				2022-02-06	
J	Chen, HI; Attiah, M; Baltuch, G; Smith, DH; Hamilton, RH; Lucas, TH				Chen, H. Isaac; Attiah, Mark; Baltuch, Gordon; Smith, Douglas H.; Hamilton, Roy H.; Lucas, Timothy H.			Harnessing Plasticity for the Treatment of Neurosurgical Disorders: An Overview	WORLD NEUROSURGERY			English	Article						Functional recovery; Network remodeling; Plasticity; Restorative neurosurgery; Stem cells; Stimulation; Tissue engineering	NEURAL STEM-CELLS; MOTOR CORTEX STIMULATION; GRADE-II GLIOMAS; CORTICAL ELECTRICAL-STIMULATION; EXPERIENCE-DEPENDENT PLASTICITY; DEEP-BRAIN-STIMULATION; DORSAL PREMOTOR CORTEX; RAT BARREL CORTEX; FUNCTIONAL RECOVERY; CORTICOSPINAL PROJECTIONS	Plasticity is fundamental to normal central nervous system function and its response to injury. Understanding this adaptive capacity is central to the development of novel surgical approaches to neurologic disease. These innovative interventions offer the promise of maximizing functional recovery for patients by harnessing targeted plasticity. Developing novel therapies will require the unprecedented integration of neuroscience, bioengineering, molecular biology, and physiology. Such synergistic approaches will create therapeutic options for patients previously outside of the scope of neurosurgery, such as those with permanent disability after traumatic brain injury or stroke. In this review, we synthesize the rapidly evolving field of plasticity and explore ways that neurosurgeons may enhance functional recovery in the future. We conclude that understanding plasticity is fundamental to modern neurosurgical education and practice.	[Chen, H. Isaac; Baltuch, Gordon; Smith, Douglas H.; Lucas, Timothy H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Hamilton, Roy H.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Attiah, Mark] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lucas, Timothy H.] Univ Penn, Ctr Neuroengn & Therapeut, Philadelphia, PA 19104 USA		Chen, HI (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	Isaac.Chen@uphs.upenn.edu					Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BARKER AT, 1985, LANCET, V1, P1106; BARTH TM, 1994, CEREB CORTEX, V4, P271, DOI 10.1093/cercor/4.3.271; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Benzagmout M, 2007, NEUROSURGERY, V61, P741, DOI 10.1227/01.NEU.0000298902.69473.77; Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Bestmann S, 2010, J NEUROSCI, V30, P11926, DOI 10.1523/JNEUROSCI.5642-09.2010; Beuter A, 2009, CHAOS, V19, DOI 10.1063/1.3127585; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boakye M, 2009, SURG NEUROL, V71, P5, DOI 10.1016/j.surneu.2008.09.007; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRASILNETO JP, 1993, BRAIN, V116, P511, DOI 10.1093/brain/116.3.511; BRASILNETO JP, 1992, NEUROLOGY, V42, P1302, DOI 10.1212/WNL.42.7.1302; Brown JA, 2008, NEUROSURGERY, V62, P853, DOI [10.1227/01.neu.0000316287.37618.78, 10.1227/01.NEU.0000197100.63931.04]; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carey LM, 2006, NEUROREHAB NEURAL RE, V20, P24, DOI 10.1177/1545968305283053; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Chen H Isaac, 2007, Curr Stem Cell Res Ther, V2, P13; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chrysikou EG, 2011, RESTOR NEUROL NEUROS, V29, P375, DOI 10.3233/RNN-2011-0610; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; Cramer SC, 2006, EXP BRAIN RES, V168, P25, DOI 10.1007/s00221-005-0082-2; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; De Benedictis A, 2011, NEUROSURGERY, V68, P1709, DOI 10.1227/NEU.0b013e3182124690; De Ribaupierre S, 2012, EPILEPSY RES TREAT, V2012; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DONOGHUE JP, 1988, J NEUROSCI, V8, P3221; DONOGHUE JP, 1987, P NATL ACAD SCI USA, V84, P1123, DOI 10.1073/pnas.84.4.1123; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Duffau H, 2001, J NEUROL NEUROSUR PS, V70, P506, DOI 10.1136/jnnp.70.4.506; Duffau H, 2000, ANN NEUROL, V47, P132, DOI 10.1002/1531-8249(200001)47:1<132::AID-ANA23>3.0.CO;2-0; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; DUM RP, 1991, J NEUROSCI, V11, P667; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; EbrahimiGaillard A, 1996, J COMP NEUROL, V365, P129, DOI 10.1002/(SICI)1096-9861(19960129)365:1<129::AID-CNE10>3.0.CO;2-L; Edwardson MA, 2013, EXP BRAIN RES, V224, P335, DOI 10.1007/s00221-012-3315-1; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Eysel UT, 1997, ADV NEUROL, V73, P195; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Frappe I, 1999, NEUROSCIENCE, V89, P409, DOI 10.1016/S0306-4522(98)00379-0; FRIES W, 1993, BRAIN, V116, P369, DOI 10.1093/brain/116.2.369; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Gaillard F, 2008, RESTOR NEUROL NEUROS, V26, P267; Garcia JO, 2011, J NEUROPHYSIOL, V106, P1734, DOI 10.1152/jn.00739.2010; Garraghty PE, 1996, J COMP NEUROL, V367, P319, DOI 10.1002/(SICI)1096-9861(19960401)367:2<319::AID-CNE12>3.0.CO;2-L; Garraghty PE, 2006, J COMP NEUROL, V497, P636, DOI 10.1002/cne.21018; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ghanbari Y, 2012, LECT NOTES COMPUT SC, V7512, P231, DOI 10.1007/978-3-642-33454-2_29; GIRMAN SV, 1990, BRAIN RES, V523, P78, DOI 10.1016/0006-8993(90)91637-V; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; Grafton ST, 2006, NEUROLOGY, V66, P1192, DOI 10.1212/01.wnl.0000214237.58321.c3; Gulati S, 2011, WORLD NEUROSURG, V76, P572, DOI 10.1016/j.wneu.2011.06.014; Hanajima R, 2001, J PHYSIOL-LONDON, V531, P849, DOI 10.1111/j.1469-7793.2001.0849h.x; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Harvey RL, 2009, NEUROREHAB NEURAL RE, V23, P32, DOI 10.1177/1545968308317532; HE SQ, 1995, J NEUROSCI, V15, P3284; HE SQ, 1993, J NEUROSCI, V13, P952; Hebb M, 2007, MOVEMENT DISORD, V22, P1958, DOI 10.1002/mds.21616; Heiss WD, 2006, BRAIN LANG, V98, P118, DOI 10.1016/j.bandl.2006.02.002; Hickmott PW, 2002, J NEUROPHYSIOL, V88, P1288, DOI 10.1152/jn.00994.2001; Hodge CJ, 2001, NEUROSURGERY, V48, P2, DOI 10.1097/00006123-200101000-00002; Huang M, 2008, TOP STROKE REHABIL, V15, P160, DOI 10.1310/tsr1502-160; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Johansson BB, 2004, RESTOR NEUROL NEUROS, V22, P163; JONES TA, 1994, J NEUROSCI, V14, P2140; Kaas JH, 2004, RESTOR NEUROL NEUROS, V22, P145; Karbe H, 1998, BRAIN LANG, V64, P215, DOI 10.1006/brln.1998.1961; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kelly-Hayes M, 1989, J NEUROL REHABIL, V3, P65; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Krainik A, 2004, NEUROLOGY, V62, P1323, DOI 10.1212/01.WNL.0000120547.83482.B1; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kury P, 2004, EUR J NEUROSCI, V19, P1708, DOI 10.1111/j.1460-9568.2004.03226.x; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; LENDREM W, 1985, J NEUROL NEUROSUR PS, V48, P743, DOI 10.1136/jnnp.48.8.743; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Levy R, 2008, J NEUROSURG, V108, P707, DOI 10.3171/JNS/2008/108/4/0707; Li L, 2011, JOVE-J VIS EXP, DOI 10.3791/2937; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lucas TH, 2013, J NEUROSCI, V33, P5261, DOI 10.1523/JNEUROSCI.4683-12.2013; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Martino J, 2009, ACTA NEUROCHIR, V151, P427, DOI 10.1007/s00701-009-0232-6; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Merrill EG, 1978, NEURONAL PLASTICITY, P94; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Miura K, 1999, J NEUROL, V246, P939, DOI 10.1007/s004150050486; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Napieralski JA, 1996, J COMP NEUROL, V373, P484; NICHOLAS ML, 1993, ARCH PHYS MED REHAB, V74, P830, DOI 10.1016/0003-9993(93)90009-Y; Nouri S, 2011, NEUROLOGY, V77, P1076, DOI 10.1212/WNL.0b013e31822e1482; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Ohyama M, 1996, STROKE, V27, P897, DOI 10.1161/01.STR.27.5.897; OJEMANN JG, 1995, J NEUROSURG, V82, P641, DOI 10.3171/jns.1995.82.4.0641; Pais-Vieira M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01319; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Pillai JJ, 2010, AM J NEURORADIOL, V31, P990, DOI 10.3174/ajnr.A1896; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plow EB, 2009, STROKE, V40, P1926, DOI 10.1161/STROKEAHA.108.540823; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Postman-Caucheteux WA, 2010, J COGNITIVE NEUROSCI, V22, P1299, DOI 10.1162/jocn.2009.21261; Qi HX, 2000, J NEUROPHYSIOL, V84, P2133, DOI 10.1152/jn.2000.84.4.2133; Redecker C, 2000, J NEUROSCI, V20, P5045; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Rickhag M, 2006, J NEUROCHEM, V96, P14, DOI 10.1111/j.1471-4159.2005.03508.x; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riley JD, 2011, STROKE, V42, P421, DOI 10.1161/STROKEAHA.110.599340; Robles SG, 2008, J NEUROSURG, V109, P615, DOI 10.3171/JNS/2008/109/10/0615; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; ROSSINI PM, 1994, BRAIN RES, V642, P169, DOI 10.1016/0006-8993(94)90919-9; Ruge D, 2011, BRAIN, V134, P2106, DOI 10.1093/brain/awr122; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Sanai N, 2012, ADV EXP MED BIOL, V746, P12, DOI 10.1007/978-1-4614-3146-6_2; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Santos-Torres J, 2009, J NEUROTRAUM, V26, P1593, DOI 10.1089/neu.2008.0702; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Smith DH, 2001, TISSUE ENG, V7, P131, DOI 10.1089/107632701300062714; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871; Thiel A, 2006, BRAIN LANG, V98, P57, DOI 10.1016/j.bandl.2006.01.007; Thiel A, 2001, ANN NEUROL, V50, P620, DOI 10.1002/ana.1253; Thompson CK, 2000, J COMMUN DISORD, V33, P357, DOI 10.1016/S0021-9924(00)00031-9; Thompson CK, 2010, NEUROPSYCHOLOGIA, V48, P3211, DOI 10.1016/j.neuropsychologia.2010.06.036; Ulmer JL, 2003, AM J NEURORADIOL, V24, P213; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Warburton E, 1999, J NEUROL NEUROSUR PS, V66, P155, DOI 10.1136/jnnp.66.2.155; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; WEILLER C, 1993, ANN NEUROL, V33, P181; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Winhuisen L, 2005, STROKE, V36, P1759, DOI 10.1161/01.STR.0000174487.81126.ef; Witte OW, 1997, ADV NEUROL, V73, P207; Zhou Q, 2010, BRAIN RES, V1311, P148, DOI 10.1016/j.brainres.2009.11.022	178	11	11	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2014	82	5					648	659		10.1016/j.wneu.2014.02.003			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX9XK	WOS:000347252300063	24518888				2022-02-06	
J	Cockerham, GC; Lemke, S; Rice, TA; Wang, G; Glynn-Milley, C; Zumhagen, L; Cockerham, KP				Cockerham, Glenn C.; Lemke, Sonne; Rice, Thomas A.; Wang, Gloria; Glynn-Milley, Catherine; Zumhagen, Lars; Cockerham, Kimberly P.			Closed-Globe Injuries of the Ocular Surface Associated with Combat Blast Exposure	OPHTHALMOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EYE INJURIES; CORNEAL; WAR; IRAQ	Purpose: To describe closed-globe conjunctival and corneal injuries and endothelial cell abnormalities associated with blast exposure and their relationships to other closed-globe injuries and blast-event characteristics. Design: Observational cross-sectional study. Participants: Veterans with a history of blast-related traumatic brain injury (TBI). Methods: History and ocular examination, including slit-lamp biomicroscopy, gonioscopy, specular microscopy. Main Outcome Measures: Type and location of blast injuries to the conjunctiva and cornea. Results: Ocular surface injuries were present in 25% (16 of 65) of blast-exposed veterans with TBI. Injuries included partial-thickness anterior stromal corneal scars (15 eyes), Descemet membrane ruptures (6 eyes), and conjunctival or corneal foreign bodies (7 eyes). Based on normative information from an age-matched comparison group, endothelial cell abnormalities were identified in 37% of participants. Eyes with ocular surface injury were more likely to have lower endothelial cell density, higher coefficient of variation of cell area, and lower percentage of hexagonal cells compared with eyes without injury. Presence of ocular surface injury or endothelial cell abnormalities was associated with elevated rates of other anterior and posterior segment injuries, as well as impairment of visual acuity. We found no relationship between ballistic eyewear use or severity level of TBI and presence of ocular surface injuries from blast. Conclusions: Independent of TBI severity or use of protective eyewear, ocular surface injuries and endothelial cell abnormalities were found in significant numbers of veterans with blast-related brain injury. Descemet membrane ruptures from blast exposure were described. Ocular surface trauma was associated with other ocular injuries throughout the globe. Potential mechanisms for the types and locations of ocular injuries seen were discussed. Any corneal or conjunctival injury in a blast survivor should prompt a thorough ocular trauma examination, including gonioscopy and specular microscopy, with appropriate follow-up for associated injuries. Longitudinal studies are required to determine long-term visual outcomes after blast exposure. (C) 2014 by the American Academy of Ophthalmology.	[Cockerham, Glenn C.; Rice, Thomas A.; Wang, Gloria; Glynn-Milley, Catherine; Cockerham, Kimberly P.] Vet Adm Palo Alto Hlth Care Syst, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.; Rice, Thomas A.; Wang, Gloria; Cockerham, Kimberly P.] Stanford Univ, Sch Med, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Lemke, Sonne] Vet Adm Palo Alto Hlth Care Syst, Program Evaluat & Resource Ctr, Palo Alto, CA 94304 USA; [Zumhagen, Lars] Univ Munster, Dept Ophthalmol, Munster, Germany		Cockerham, GC (corresponding author), Vet Adm Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	glenn.cockerham@va.gov	Cockerham, Kimberly/AAR-5917-2021		Department of Veterans Affairs, Washington, DCUS Department of Veterans Affairs [C5018-R]	Supported in part by the Department of Veterans Affairs, Washington, DC (Merit Review Award C5018-R). The sponsor had no role in the design or conduct of this research. The views expressed in this article are those of the authors and do not necessarily reflect the position or policies of the Department of Veterans Affairs or the United States government.	[Anonymous], 2007, LANCET, V370, P1879; Blanch RJ, 2011, EYE, V25, P218, DOI 10.1038/eye.2010.190; BLANTON FM, 1964, ARCH OPHTHALMOL-CHIC, V72, P39, DOI 10.1001/archopht.1964.00970020041010; Breeze J, 2011, BRIT J ORAL MAX SURG, V49, P602, DOI 10.1016/j.bjoms.2010.10.001; Chow VWS, 2013, CURR OPIN OPHTHALMOL, V24, P356, DOI 10.1097/ICU.0b013e3283622873; CIBIS GW, 1978, ARCH OPHTHALMOL-CHIC, V96, P485; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Colyer MH, 2008, OPHTHALMOLOGY, V115, P2087, DOI 10.1016/j.ophtha.2008.05.013; COOPER GJ, 1991, J BIOMECH, V24, P273, DOI 10.1016/0021-9290(91)90346-O; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Doughty MJ, 2000, CORNEA, V19, P148, DOI 10.1097/00003226-200003000-00006; Erdurman FC, 2011, EYE, V25, P1491, DOI 10.1038/eye.2011.212; Institute of Medicine Committee on Gulf War and Health, 2014, GULF WAR HLTH, V9, P125; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P163, DOI 10.1016/S0896-1549(02)00007-X; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; MALONEY WF, 1979, ARCH OPHTHALMOL-CHIC, V97, P1647; MIMOUNI F, 1986, J FR OPHTALMOL, V9, P641; Mines M, 2000, OPHTHALMOLOGY, V107, P837, DOI 10.1016/S0161-6420(00)00030-0; Ohno K, 1999, CORNEA, V18, P416, DOI 10.1097/00003226-199907000-00005; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pichler A., 1916, OPHTHALMOLOGICA, V36, P311; Pieramici DJ, 1997, AM J OPHTHALMOL, V123, P820, DOI 10.1016/S0002-9394(14)71132-8; ROBERSON MC, 1985, ANN OPHTHALMOL, V17, P457; ROPERHALL MJ, 1982, BRIT J OPHTHALMOL, V66, P518, DOI 10.1136/bjo.66.8.518; SLINGSBY JG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1041; Sobaci G, 2005, AM J OPHTHALMOL, V139, P937, DOI 10.1016/j.ajo.2004.11.009; STULTING RD, 1986, AM J OPHTHALMOL, V101, P156, DOI 10.1016/0002-9394(86)90586-6; Thach AB, 2000, OPHTHALMOLOGY, V107, P844, DOI 10.1016/S0161-6420(00)00029-4; Thach AB, 2008, OPHTHALMOLOGY, V115, P377, DOI 10.1016/j.ophtha.2007.04.032; Thomas R, 2009, J TRAUMA, V66, pS99, DOI 10.1097/TA.0b013e31819d8695; THOMPSON JR, 1993, BRIT J OPHTHALMOL, V77, P115, DOI 10.1136/bjo.77.2.115; Tumbocon Joseph Anthony J., 2002, International Ophthalmology Clinics, V42, P69; VANRIJ G, 1981, DOC OPHTHALMOL, V50, P315, DOI 10.1007/BF00158015; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Zhou HY, 2010, MED HYPOTHESES, V74, P37, DOI 10.1016/j.mehy.2009.08.015	36	11	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	NOV	2014	121	11					2165	2172		10.1016/j.ophtha.2014.06.009			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	AS8DM	WOS:000344480400021	25124272				2022-02-06	
J	Jouzdani, SR; Ebrahimi, A; Rezaee, M; Shishegar, M; Tavallaii, A; Kaka, G				Jouzdani, Saeid Rezaei; Ebrahimi, Ali; Rezaee, Maryam; Shishegar, Mehdi; Tavallaii, Abbas; Kaka, Gholamreza			Characteristics of posttraumatic headache following mild traumatic brain injury in military personnel in Iran	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Posttraumatic headache; Mild traumatic brain injury; Blast injury; Migraine; Affective disorders	US SOLDIERS; SUBCUTANEOUS SUMATRIPTAN; ACUTE MIGRAINE; PATHOGENESIS; AFGHANISTAN; CONCUSSION; SYMPTOMS; EPIDEMIOLOGY; RELIABILITY; PREVALENCE	The primary goal of this study was to evaluate the incidence and characteristics of posttraumatic headache attributed to mild brain injury in military personnel in Iran within a prospective and observational study design. A prospective observational descriptive study was conducted with a cohort of military personnel under military education during a 6-month period at the Military Education Center in Isfahan, Iran. 322 military personnel under education were selected randomly and were given a 13-item mild brain injury questionnaire accompanied with affective disorders and headache questionnaires and were reevaluated after a 3-month interval. A total of 30 (9.3 %) of the 322 military personnel met criteria for a mild brain injury. Among them, 18 personnel (60 %) reported having headaches during the 3-month reevaluation. PTHs defined as headaches beginning within 1 week after a head trauma were present in 5.6 % of military personnel under study during 6 months. In total, 67 % of posttraumatic headaches (PTH) were classified as migrainous or possible migrainous features. Patients with affective disorders such as posttraumatic stress disorder and depression were at a higher risk for developing PTH following mild brain injury (p < 0.05). PTH did not relate to demographic factors such as age or type of trauma. Posttraumatic headache attributed to mild brain injury is a common disorder in military personnel. Migrainous features are predominant among them in comparison with the general population. PTH is not related to a type of trauma, but has association with affective disorders.	[Jouzdani, Saeid Rezaei; Kaka, Gholamreza] Baqiyatallah Univ Med Sci, Neurosci Res Ctr, Tehran 1956837173, Iran; [Ebrahimi, Ali] Baqiyatallah Univ Med Sci, Plast Surg Ward, Tehran 1956837173, Iran; [Ebrahimi, Ali; Rezaee, Maryam] Baqiyatallah Univ Med Sci, Trauma Res Ctr, Tehran 1956837173, Iran; [Shishegar, Mehdi] Shariati Hosp, Esfahan, Isfahan, Iran; [Tavallaii, Abbas] Baqiyatallah Univ Med Sci, Behav Sci Res Ctr, Tehran 1956837173, Iran		Kaka, G (corresponding author), Baqiyatallah Univ Med Sci, Neurosci Res Ctr, Tehran 1956837173, Iran.	s.rezaei.jouzdani@gmail.com	Ebrahimi, Ali/L-8487-2017	tavallaii, abbass/0000-0002-0816-3408; ebrahimi, Ali/0000-0001-5948-9371			[Anonymous], 2004, CEPHALALGIA S1, V24, P9; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Craig K, 1999, EMOTIONS, P331; CROYLE RT, 1987, HEALTH PSYCHOL, V6, P239, DOI 10.1037/0278-6133.6.3.239; Department ofVeterans Affairs/DepartmentofDefense (VA/ DoD), 2009, CLIN PRACT GUID MAN; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; GAWEL MJ, 1993, HEADACHE, V33, P96, DOI 10.1111/j.1526-4610.1993.hed3302096.x; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kozminski M, 2010, J AM OSTEOPATH ASSOC, V110, P514; Lainez Miguel J A, 2010, Handb Clin Neurol, V97, P501, DOI 10.1016/S0072-9752(10)97046-2; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lanteri-Minet M, 2005, PAIN, V118, P319, DOI 10.1016/j.pain.2005.09.010; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PACKARD RC, 1993, HEADACHE, V33, P133, DOI 10.1111/j.1526-4610.1993.hed3303133.x; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; Saper JR, 2000, ARCH NEUROL-CHICAGO, V57, P1776, DOI 10.1001/archneur.57.12.1776; Saper JR, 2000, ARCH NEUROL-CHICAGO, V57, P1780; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; SHEFTELL FD, 1994, HEADACHE, V34, P67, DOI 10.1111/j.1526-4610.1994.hed3402067.x; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sprenger T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-71; Stewart WF, 1999, NEUROLOGY, V53, P988, DOI 10.1212/WNL.53.5.988; Stovner LJ, 2008, CEPHALALGIA, V28, P28, DOI 10.1111/j.1468-2982.2008.01615.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanielian T, 2008, WOUNDS WAR SUMMARY R; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Torelli P, 2006, NEUROL SCI, V27, pS73, DOI 10.1007/s10072-006-0574-2; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042	46	11	11	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	NOV	2014	19	6					422	428		10.1007/s12199-014-0409-3			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AT2CB	WOS:000344737600005	25216772	gold, Green Published			2022-02-06	
J	Overton, TL; Shafi, S; Cravens, GF; Gandhi, RR				Overton, Tiffany L.; Shafi, Shahid; Cravens, George F.; Gandhi, Rajesh R.			Can trauma surgeons manage mild traumatic brain injuries?	AMERICAN JOURNAL OF SURGERY			English	Article						Mild traumatic brain injury; Neurosurgical management; Neurosurgeon consultation; Policy implementation; Mild TBI management	NATIONAL-SURVEY; COVERAGE; CARE	BACKGROUND: Current practices suggest that patients with mild traumatic brain injuries (MTBI) receive neurosurgical consultations, while less than 1% require neurosurgical intervention. We implemented a policy of selective neurosurgical consultation with the hypothesis that trauma surgeons alone may manage such patients with no impact on patient outcomes. METHODS: Data from a level I trauma registry were analyzed. Patients with MTBI resulting in an intracranial hemorrhage of 1 cm or less and a Glasgow Coma Score of 13 or greater were included. Patients with additional intracranial injuries were excluded. Multivariate regression was used to determine the relationship between neurosurgical management and good neurologic outcomes, while controlling for injury severity, demographics, and comorbidities. RESULTS: Implementation of the neurosurgical policy significantly reduced the number of such consults (94% before vs 65% after, P < .002). Multivariate analysis revealed that neurosurgical consultation was not associated with neurologic outcomes of patients. CONCLUSIONS: Implementation of a selective neurosurgical consultation policy for patients with MTBI reduced neurosurgical consultations without any impact on patient outcomes, suggesting that trauma surgeons can effectively manage these patients. Published by Elsevier Inc.	[Overton, Tiffany L.] JPS Hlth Network, Trauma Serv, Ft Worth, TX 76104 USA; [Shafi, Shahid; Gandhi, Rajesh R.] JPS Hlth Network, Dept Surg, Ft Worth, TX 76104 USA; [Cravens, George F.] JPS Hlth Network, Dept Neurosurg, Ft Worth, TX 76104 USA		Overton, TL (corresponding author), JPS Hlth Network, Trauma Serv, 1500 S Main St, Ft Worth, TX 76104 USA.	toverton@jpshealth.org					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American College of Surgeons Committee on Trauma, 2012, ADV TRAUM LIF SUPP S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Center for Workforce Studies, 2012, 2012 PHYS SPEC DAT B; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Copes WS, 1998, P 33 ANN M ASS ADV A; Dunham CM, 1996, J TRAUMA, V41, P679, DOI 10.1097/00005373-199610000-00014; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Harbrecht BG, 2010, J TRAUMA, V68, P1367, DOI 10.1097/TA.0b013e3181d990da; Huynh T, 2006, AM SURGEON, V72, P1162; Institute HPR, 2010, SURG WORKF US PROF R; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Miller EC, 1993, NEUROSURGERY, V32, P9; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Valadka AB, 2010, J TRAUMA, V68, P1372; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454; ZUIDEMA GD, 1977, J NEUROSURG, V46, P135, DOI 10.3171/jns.1977.46.2.0135	22	11	11	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	NOV	2014	208	5					806	810		10.1016/j.amjsurg.2014.02.012			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AT4TO	WOS:000344935500019	24933668				2022-02-06	
J	Sovik, S; Skaga, NO; Hanoa, R; Eken, T				Sovik, Signe; Skaga, Nils Oddvar; Hanoa, Rolf; Eken, Torsten			Sudden survival improvement in critical neurotrauma: An exploratory analysis using a stratified statistical process control technique	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma system; Outcome monitoring; Variable Life-Adjusted Display; CUSUM technique; Quality of care	INJURY SEVERITY SCORE; LIFE-ADJUSTED DISPLAY; TRAUMA CENTER; MAJOR TRAUMA; CARDIAC-SURGERY; CARE; MORTALITY; REVISION; OUTCOMES; QUALITY	Background: Outcome after trauma depends on patient characteristics, quality of care, and random events. The TRISS model predicts probability of survival (Ps) adjusted for Injury Severity Score (ISS), Revised Trauma Score (RTS), mechanism of injury, and age. Quality of care is often evaluated by calculating the number of "excess" survivors, year by year. In contrast, the Variable Life-Adjusted Display (VLAD) technique allows rapid detection of altered survival. VLAD adjusts each death or survival by the patient's risk status and graphically displays accumulated number of unexpected survivors over time. We evaluated outcome changes and their time relation to trauma service improvements. Methods: Observational, retrospective study of the total 2001-2011 trauma population from a Level I trauma centre. Outcome was 30-day survival. Ps was calculated with the TRISS model, 2005 coefficients. VLAD graphs were created for the entire population and for subpopulations stratified by ISS level, ISS body region (Head/Neck, Face, Chest, Abdomen/Pelvic contents, Extremities/Pelvic girdle, External), and maximum Abbreviated Injury Scale (maxAIS) score in each region. Piecewise linear regression identified VLAD graph breakpoints. Results: 12,191 consecutive trauma patients (median age 35 years, 72% males, 91% blunt injury, 41% ISS >= 16) formed the dataset. Their VLAD graph indicated performance equal to TRISS predicted survival until a sudden improvement in late 2004. From then survival remained improved but unchanged through 2011. Total number of excess survivors was 141. Inspection of subgroup VLAD graphs showed that the increased survival mainly occurred in patients having at least one Head/Neck AIS 5 injury. The effect was present in both isolated and multitraumatised maxAIS 5 Head/Neck trauma. The remaining trauma population showed unchanged survival, superior to TRISS predicted, throughout the study period. Important general and neurotrauma-targeted improvements in our trauma service could underlie our findings: A formalised trauma service, damage control resuscitation protocols, structured training, increased helicopter transfer capacity, consultant-based neurosurgical assessment, a doubling of emergency neurosurgical procedures, and improved neurointensive care. Conclusions: Stratified VLAD enables continuous, high-resolution system analysis. We encourage trauma centres to explore their data and to monitor future system changes. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/3.0/).	[Sovik, Signe] Akershus Univ Hosp, Div Surg, Dept Anaesthesia & Intens Care, N-1478 Lorenskog, Norway; [Sovik, Signe] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway; [Skaga, Nils Oddvar; Eken, Torsten] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anaesthesiol, Oslo, Norway; [Hanoa, Rolf] Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Neurosurg, Oslo, Norway		Sovik, S (corresponding author), Akershus Univ Hosp, Div Surg, Dept Anaesthesia & Intens Care, N-1478 Lorenskog, Norway.	signe.sovik@medisin.uio.no; noskaga@online.no; uxroha@ous-hf.no; torsten.eken@medisin.uio.no	Sovik, Signe/O-4185-2016; Eken, Torsten/B-4994-2013	Sovik, Signe/0000-0003-4524-2268; Eken, Torsten/0000-0002-5943-4538	South-Eastern Norway Regional Health Authority	We thank trauma registrars Morten Hestnes and Hans Johansson for their continuing efforts at the Oslo University Hospital Trauma Registry. The study was funded by the authors' institutions and by the South-Eastern Norway Regional Health Authority.	American College of Surgeons, 2005, J AM COLL SURGEONS, P1; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Association for the Advancement of Automotive Medicine (AAAM), 1998, ABR INJ SCAL 1990 RE, V98, P1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Eken T, 2010, AM ASS SURG TRAUM 20; Flaatten H, 2005, QUAL SAF HEALTH CARE, V14, P270, DOI 10.1136/qshc.2004.013540; Gaarder C, 2005, INJURY, V36, P1288, DOI 10.1016/j.injury.2005.06.034; Groven S, 2011, J TRAUMA, V70, P569, DOI 10.1097/TA.0b013e31820d1a9b; Jones JM, 2014, ACTA ANAESTH SCAND, V58, P303, DOI 10.1111/aas.12256; Lossius HM, 2000, EUR J SURG, V166, P760, DOI 10.1080/110241500447371; Lovegrove J, 1997, LANCET, V350, P1128, DOI 10.1016/S0140-6736(97)06507-0; Moore L, 2013, J TRAUMA ACUTE CARE, V74, P1331, DOI 10.1097/TA.0b013e31828c4787; Moore L, 2011, CRIT CARE MED, V39, P2246, DOI 10.1097/CCM.0b013e3182227a59; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pagel C, 2013, HEART, V99, P1445, DOI 10.1136/heartjnl-2013-303671; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Skaga NO, 2007, J TRAUMA, V63, P972, DOI 10.1097/TA.0b013e31804a571c; WU AW, 1995, ANN INTERN MED, V122, P149, DOI 10.7326/0003-4819-122-2-199501150-00013	21	11	11	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2014	45	11					1722	1730		10.1016/j.injury.2014.05.038			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AR9ME	WOS:000343898000010	25059506	Green Published, hybrid			2022-02-06	
J	Xia, SF; Xie, ZX; Qiao, Y; Li, LR; Cheng, XR; Duan, XM; Tang, X; Shi, YH; Le, GW				Xia, Shu-Fang; Xie, Zhen-Xing; Qiao, Yi; Li, Li-Rong; Cheng, Xiang-Rong; Duan, Xiao-Mei; Tang, Xue; Shi, Yong-Hui; Le, Guo-Wei			Salvianolic acid B counteracts cognitive decline triggered by oxidative stress in mice fed with high-fat diets	JOURNAL OF FUNCTIONAL FOODS			English	Article						Salvianolic acid B; High fat diets; Cognition; Oxidative stress	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA(25-35) PEPTIDE; TRANSGENIC MICE; SATURATED-FAT; MOUSE MODEL; MEMORY; CELLS; MILTIORRHIZA	The present study was designed to find out the initial factor that triggered cognitive deficits induced by high-fat diets (HFD) and whether salvianolic acid B (Sal B) had beneficial role on cognition. Seven weeks' consumption of HFD resulted in higher food intake, dyslipidaemia, cognitive impairment and increasing hippocampal and frontal cortex oxidative stress (OS) without significant change in blood glucose and hippocampal inflammation. Microarray analysis data demonstrated that long-term potentiation (LTP) pathway was altered with down-regulation of genes against OS. Correlation analysis showed that hippocampal OS biomarkers had strong relations to Morris water maze performance. Sal B in drinking water (0.07 mg/ml) normalised the cognitive deficits through attenuating hippocampal redox status, altering LTP pathway and other biological pathways, up-regulating antioxidative genes expression. Thus, OS induced by HFD might be the initial factor that triggers cognitive impairment. Sal B was an efficient agent that exerted neuroprotective effects. (C) 2014 Elsevier Ltd. All rights reserved.	[Xia, Shu-Fang; Xie, Zhen-Xing; Qiao, Yi; Li, Li-Rong; Cheng, Xiang-Rong; Duan, Xiao-Mei; Tang, Xue; Shi, Yong-Hui; Le, Guo-Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China		Le, GW (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	lgw@jiangnan.edu.cn		Tang, Xue/0000-0002-3280-8392	12th Five-Year Plan for Science and Technology DevelopmentChinese Academy of Sciences [2012BAD33B05]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31460424]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK20140147]	The study was supported by the 12th Five-Year Plan for Science and Technology Development (No. 2012BAD33B05), National Natural Science Foundation of China (Grant No.31460424) and the Natural Science Foundation of Jiangsu Province, China (BK20140147).	Akassoglou K, 1997, J IMMUNOL, V158, P438; Artola A, 2005, EUR J NEUROSCI, V22, P169, DOI 10.1111/j.1460-9568.2005.04205.x; Bao Y, 2012, ATHEROSCLEROSIS, V223, P152, DOI 10.1016/j.atherosclerosis.2012.05.006; Bi XB, 2008, ACTA PHARMACOL SIN, V29, P169, DOI 10.1111/j.1745-7254.2008.00710.x; Bonatto F, 2005, BRAIN RES, V1042, P17, DOI 10.1016/j.brainres.2005.02.002; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Elias MF, 2005, NEUROBIOL AGING, V26, pS11, DOI 10.1016/j.neurobiolaging.2005.08.019; Gao DY, 2009, ARCH PHARM RES, V32, P773, DOI 10.1007/s12272-009-1517-2; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hu P, 2005, CHEM PHARM BULL, V53, P481, DOI 10.1248/cpb.53.481; Kim DH, 2011, NEUROPHARMACOLOGY, V61, P1432, DOI 10.1016/j.neuropharm.2011.08.038; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lee GT, 2003, J AM SOC NEPHROL, V14, P709, DOI 10.1097/01.ASN.0000051660.82593.19; Lee YW, 2013, EUR J PHARMACOL, V704, P70, DOI 10.1016/j.ejphar.2013.02.015; Lin YH, 2006, BIOCHEM BIOPH RES CO, V348, P593, DOI 10.1016/j.bbrc.2006.07.110; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Ren XF, 2012, METAB BRAIN DIS, V27, P7, DOI 10.1007/s11011-011-9267-5; Studzinski CM, 2009, J NEUROCHEM, V108, P860, DOI 10.1111/j.1471-4159.2008.05798.x; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Tian LL, 2008, INT J BIOCHEM CELL B, V40, P409, DOI 10.1016/j.biocel.2007.08.005; Tsai MK, 2010, TOXICOL APPL PHARM, V242, P155, DOI 10.1016/j.taap.2009.10.002; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang L, 2010, J BIOMOL SCREEN, V15, P239, DOI 10.1177/1087057109359686; Wang SX, 2010, NEUROCHEM RES, V35, P1029, DOI 10.1007/s11064-010-0151-1; Willis LM, 2009, AM J CLIN NUTR, V89, pS1602, DOI 10.3945/ajcn.2009.26736J; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu YJ, 1998, ARTERIOSCL THROM VAS, V18, P481, DOI 10.1161/01.ATV.18.3.481; Xu M, 2007, BIOMED CHROMATOGR, V21, P1052, DOI 10.1002/bmc.852; Yokozawa T, 1997, EXP TOXICOL PATHOL, V49, P343, DOI 10.1016/S0940-2993(97)80104-2; Zhang J, 2013, BEHAV BRAIN RES, V244, P70, DOI 10.1016/j.bbr.2013.01.037; Zhong Y, 2012, FOOD CHEM, V134, P742, DOI 10.1016/j.foodchem.2012.02.172; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhuang PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035636	52	11	12	1	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	NOV	2014	11						278	292		10.1016/j.jff.2014.10.010			15	Food Science & Technology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology; Nutrition & Dietetics	AX4EB	WOS:000346885500030					2022-02-06	
J	Yuan, SM				Yuan, Shi-Min			Biomarkers of cerebral injury in cardiac surgery	ANATOLIAN JOURNAL OF CARDIOLOGY			English	Article						cardiopulmonary bypass; cerebrospinal fluid; circulatory arrest; deep hypothermia induced; S-100 calcium-binding protein beta subunit; S100 proteins	CORONARY-ARTERY-BYPASS; NEURON-SPECIFIC ENOLASE; HYPOTHERMIC CIRCULATORY ARREST; TRAUMATIC BRAIN-INJURY; OFF-PUMP; CEREBROSPINAL-FLUID; S-100 PROTEIN; EXTRACORPOREAL-CIRCULATION; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE	The present study aims to reveal the changing patterns of cerebral biomarkers and the underlying predictive factors as a consequence of cardiac surgery. Literature retrieval of articles on S100 and S100B of recent 20 years were made in the MEDLINE database, Highwire Press and Google search. Quantitative data of S100 and S100B along with neuron-specific enolase were carefully screened, collected and statistically analyzed. The biomarkers appeared earlier and lasted longer in the cerebrospinal fluid than in the serum. All three biomarkers exhibited a similar kinetic trend in the bloodstream, reaching a peak value at the end of cardiopulmonary bypass (CPB). In adults, serum biomarkers may recover to normal earlier than in pediatrics undergoing a cardiac surgery. The patients undergoing off-pump surgery had the minimal elevations of cerebral biomarkers comparing to all other cardiac surgeries under CPB, low core temperature and/or hypothermic circulatory arrest. In patients with pre- or postoperative neurological disorders, the biomarkers in the serum elevated even before operation and persisted longer time than those without neurological disorders. The serum concentrations of the biomarkers showed direct correlation with CPB duration and core temperature. Cardiac operations may lead to cerebral damage and blood-brain barrier changes, as a consequence of CPB and low core temperature. The cerebral biomarkers including S100, S100B and neuron-specific enolase may precisely reflect the cerebral damages in cardiac surgery. Attention has to be paid to the attenuations of cerebral damage by modifying the surgical conditions of CPB and core temperature.	Fujian Med Univ, Teaching Hosp, Hosp Putian 1, Putian, Fujian Province, Peoples R China		Yuan, SM (corresponding author), Fujian Med Univ, Teaching Hosp, Hosp Putian 1, 389 Longdejing St, Putian, Fujian Province, Peoples R China.	shi_min_yuan@yahoo.com					Abdul-Khaliq H, 1999, J THORAC CARDIOV SUR, V117, P1027, DOI 10.1016/S0022-5223(99)70389-2; Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; Ando Y, 2008, GEN THORAC CARDIOVAS, V56, P295, DOI 10.1007/s11748-008-0239-6; Ascione R, 2005, CIRCULATION, V112, P3833, DOI 10.1161/CIRCULATIONAHA.105.557462; Ashraf S, 1998, ANN THORAC SURG, V66, P1958, DOI 10.1016/S0003-4975(98)00904-7; Ashraf S, 1999, EUR J CARDIO-THORAC, V16, P32, DOI 10.1016/S1010-7940(99)00136-0; Basile AM, 2001, EUR NEUROL, V45, P151, DOI 10.1159/000052114; Bhattacharya K, 1999, ANN THORAC SURG, V68, P1225, DOI 10.1016/S0003-4975(99)00536-6; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; Cavus E, 2009, PEDIATR ANESTH, V19, P770, DOI 10.1111/j.1460-9592.2009.03074.x; Challa VR, 1998, J NEUROPATH EXP NEUR, V57, P140, DOI 10.1097/00005072-199802000-00005; Chernov VI, 2006, EUR J CARDIO-THORAC, V29, P74, DOI 10.1016/j.ejcts.2005.10.001; Dabrowski W, 2007, MAGNESIUM RES, V20, P168; Dabrowski W, 2012, J CARDIOTHOR VASC AN, V26, P395, DOI 10.1053/j.jvca.2011.10.014; Dabrowski W, 2009, MAGNESIUM RES, V22, P21; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X; Goni-de-Cerio F, 2009, HISTOL HISTOPATHOL, V24, P1129, DOI 10.14670/HH-24.1129; Hassan T, 2012, NEUROSURG REV, V35, P421, DOI 10.1007/s10143-011-0368-8; Herrmann M, 1999, EUR J CARDIO-THORAC, V16, P513, DOI 10.1016/S1010-7940(99)00245-6; Herrmann M, 2000, STROKE, V31, P645, DOI 10.1161/01.STR.31.3.645; Hilker M, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-14; Ilcol YO, 2006, CLIN CHEM LAB MED, V44, P471, DOI 10.1515/CCLM.2006.074; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ishida K, 2003, J CARDIOTHOR VASC AN, V17, P4, DOI 10.1053/jcan.2003.2; Johnsson P, 2003, ANN THORAC SURG, V75, P162, DOI 10.1016/S0003-4975(02)04318-7; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Jonsson H, 2003, RESTOR NEUROL NEUROS, V21, P151; Jonsson H, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-24; Kanbak M, 2007, HEART SURG FORUM, V10, P17, DOI 10.1532/HSF98.20061076; Kuzumi E, 2000, BRIT J ANAESTH, V85, P936; Levy JH, 1999, J CARDIOTHOR VASC AN, V13, P36; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Mazzone A, 2003, PERFUSION-UK, V18, P3, DOI 10.1191/0267659103pf622oa; MISSLER U, 1995, EUR J CLIN CHEM CLIN, V33, P743; Motallebzadeh R, 2004, EUR J CARDIO-THORAC, V25, P409, DOI 10.1016/j.ejcts.2003.12.018; Murkin JM, 1999, J CARDIOTHOR VASC AN, V13, P12; Pelinka LE, 2004, INDIAN J CRIT CARE M, V8, P190; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Pokela M, 2000, SCAND CARDIOVASC J, V34, P570; Prough DS, 2002, PERFUSION OXYGENATIO; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Rasmussen LS, 1999, ACTA ANAESTH SCAND, V43, P495, DOI 10.1034/j.1399-6576.1999.430502.x; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Schoerkhuber W, 1999, STROKE, V30, P1598, DOI 10.1161/01.STR.30.8.1598; SOTANIEMI KA, 1980, J NEUROL NEUROSUR PS, V43, P127, DOI 10.1136/jnnp.43.2.127; Ueda Y, 2001, Nagoya J Med Sci, V64, P93; USUI A, 1994, J NEUROL SCI, V123, P134, DOI 10.1016/0022-510X(94)90215-1; Wandschneider W, 2000, ANN THORAC SURG, V70, P1577, DOI 10.1016/S0003-4975(00)01843-9; Zurek J., BIOMARKERS BRAIN INJ	50	11	12	0	0	TURKISH SOC CARDIOLOGY	BAHCELIEVLER	COBANCESME SANAYI CAD NO 11, NISH ISTANBUL A BLOK KAT 8 NO 47-48, YENIBOSNA, BAHCELIEVLER, ISTANBUL 34196, TURKEY	2149-2263	2149-2271		ANATOL J CARDIOL	Anat. J. Cardiol.	NOV	2014	14	7					638	645		10.5152/akd.2014.5321			8	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	AW2RN	WOS:000346136500015	25163078				2022-02-06	
J	Higashi, Y; Hoshijima, M; Yawata, T; Nobumoto, A; Tsuda, M; Shimizu, T; Saito, M; Ueba, T				Higashi, Youichirou; Hoshijima, Michihiro; Yawata, Toshio; Nobumoto, Atsuya; Tsuda, Masayuki; Shimizu, Takahiro; Saito, Motoaki; Ueba, Tetuya			Suppression of Oxidative Stress and 5-Lipoxygenase Activation by Edaravone Improves Depressive-Like Behavior after Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; depression; edaravone; 5-lipoxygenase	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; FREE-RADICAL SCAVENGER; CHRONIC MILD STRESS; COGNITIVE DEFICITS; HEAD-INJURY; EXPRESSION; ACID; DAMAGE; IMMUNOREACTIVITY	Brain concussions are a serious public concern and are associated with neuropsychiatric disorders, such as depression. Patients with concussion who suffer from depression often experience distress. Nevertheless, few pre-clinical studies have examined concussion-induced depression, and there is little information regarding its pharmacological management. Edaravone, a free radical scavenger, can exert neuroprotective effects in several animal models of neurological disorders. However, the effectiveness of edaravone in animal models of concussion-induced depression remains unclear. In this study, we examined whether edaravone could prevent concussion-induced depression. Mice were subjected to a weight-drop injury and intravenously administered edaravone (3.0 mg/kg) or vehicle immediately after impact. Serial magnetic resonance imaging showed no abnormalities of the cerebrum on diffusion T1- and T2-weighted images. We found that edaravone suppressed concussion-induced depressive-like behavior in the forced swim test, which was accompanied by inhibition of increased hippocampal and cortical oxidative stress (OS) and suppression of 5-lipoxygenase (5-LOX) translocation to the nuclear envelope in hippocampal astrocytes. Hippocampal OS in concussed mice was also prevented by the nicotinamide adenine dinucleotide phosphate oxidase inhibitor, apocynin, and administration of BWB70C, a 5-LOX inhibitor, immediately and 24 h after injury prevented depressive-like behaviors in concussed mice. Further, antidepressant effects of edaravone were observed in mice receiving 1.0 or 3.0 mg/kg of edaravone immediately after impact, but not at a lower dose of 0.1 mg/kg. This antidepressant effect persisted up to 1 h after impact, whereas edaravone treatment at 3 h after impact had no effect on concussion-induced depressive-like behavior. These results suggest that edaravone protects against concussion-induced depression, and this protection is mediated by suppression of OS and 5-LOX translocation.	[Higashi, Youichirou; Hoshijima, Michihiro; Yawata, Toshio; Ueba, Tetuya] Kochi Univ, Kochi Med Sch, Dept Neurosurg, Nankoku, Kochi 7838505, Japan; [Nobumoto, Atsuya; Tsuda, Masayuki] Kochi Univ, Kochi Med Sch, Inst Lab Anim Res, Nankoku, Kochi 7838505, Japan; [Shimizu, Takahiro; Saito, Motoaki] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi 7838505, Japan		Higashi, Y (corresponding author), Kochi Univ, Kochi Med Sch, Dept Neurosurg, Okoh Cho, Nankoku, Kochi 7838505, Japan.	higasi@kochi-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24592133]; General Insurance Association of Japan	This work was supported, in part, by Grants-in-Aid for Scientific Research ([C], No. 24592133) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and The General Insurance Association of Japan. The authors thank Mitsubishi Tanabe Pharma for providing the edaravone used in this study.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Allam F, 2013, J NUTR, V143, P835, DOI 10.3945/jn.113.174649; Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Banno M, 2005, NEUROPHARMACOLOGY, V48, P283, DOI 10.1016/j.neuropharm.2004.10.002; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Dzitoyeva S, 2008, J NEURAL TRANSM, V115, P823, DOI 10.1007/s00702-008-0034-7; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Erlemann KR, 2006, BIOCHEM BIOPH RES CO, V350, P151, DOI 10.1016/j.bbrc.2006.09.011; Erlemann KR, 2004, J BIOL CHEM, V279, P40376, DOI 10.1074/jbc.M401294200; Forster C, 1999, ACTA NEUROPATHOL, V97, P215, DOI 10.1007/s004010050977; Hartig W, 2013, BRAIN RES, V1498, P69, DOI 10.1016/j.brainres.2012.12.022; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Kamida T, 2009, NEUROSCI LETT, V461, P298, DOI 10.1016/j.neulet.2009.06.039; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Lammers CH, 1996, J NEUROCHEM, V66, P147; Lee SY, 2013, PROG NEURO-PSYCHOPH, V46, P224, DOI 10.1016/j.pnpbp.2012.09.008; Li CT, 2010, ACTA PHARMACOL SIN, V31, P137, DOI 10.1038/aps.2009.196; Li CT, 2009, J NEUROSCI RES, V87, P991, DOI 10.1002/jnr.21913; Li LF, 2013, EUR J PHARMACOL, V711, P42, DOI 10.1016/j.ejphar.2013.04.008; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Naritomi Hiroaki, 2010, Drugs R D, V10, P155, DOI 10.2165/11586550-000000000-00000; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Peng YL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-75; Perez-Nievas BG, 2007, PSYCHONEUROENDOCRINO, V32, P703, DOI 10.1016/j.psyneuen.2007.04.011; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Reddy CC, 2011, PM&R, V3, pS396, DOI 10.1016/j.pmrj.2011.07.012; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Seo JS, 2012, J NEUROSCI, V32, P9690, DOI 10.1523/JNEUROSCI.0794-12.2012; SHAPIRA Y, 1989, Neurological Research, V11, P169; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Uz T, 1998, FASEB J, V12, P439, DOI 10.1096/fasebj.12.6.439; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; YEADON M, 1993, AGENTS ACTIONS, V38, P8, DOI 10.1007/BF02027207; Zhang L, 2006, NEUROPATHOLOGY, V26, P99, DOI 10.1111/j.1440-1789.2006.00658.x; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhou QG, 2011, J NEUROSCI, V31, P7579, DOI 10.1523/JNEUROSCI.0004-11.2011; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	58	11	11	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1689	1699		10.1089/neu.2014.3331			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200002	24849726	Green Published			2022-02-06	
J	Navarro, JC; Pillai, S; Ponce, LL; Van, M; Goodman, JC; Robertson, CS				Navarro, Jovany Cruz; Pillai, Shibu; Ponce, Lucido L.; Van, Mai; Goodman, Jerry Clay; Robertson, Claudia S.			Endothelial nitric oxide synthase mediates the cerebrovascular effects of erythropoietin in traumatic brain injury	FRONTIERS IN IMMUNOLOGY			English	Article						erythropoietin; traumatic brain injury; nitric oxide; nitric oxide synthase; neuroprotection; cerebral blood flow	RECOMBINANT-HUMAN-ERYTHROPOIETIN; CEREBRAL-BLOOD-FLOW; DARBEPOETIN-ALPHA; L-ARGININE; RAT MODEL; NEUROPROTECTION; ISCHEMIA; HYPOXIA; NEURONS; INFLAMMATION	Background: Erythropoietin (Epo) improves post-traumatic cerebral blood flow (CBF), pressure autoregulation, and vascular reactivity to L-arginine. This study examines the dependence of these cerebral hemodynamic effects of Epo on nitric oxide generated by endothelial nitric oxide synthase (eNOS). Methods: Using laser Doppler flow imaging, CBF was monitored in wild-type (WT) and eNOS-deficient mice undergoing controlled cortical impact followed by administration of Epo (5000 U/kg) or normal saline. Results: Cerebral blood flow decreased in all groups post-injury with the greatest reductions occurring at the impact site. Epo administration resulted in significantly higher CBF in the pen-contusional sites in the WT mice [70.2 +/- 3.35% in Epo-treated compared to 53 +/- 3.3% of baseline in saline-treated mice (p<0.0001)], but no effect was seen in the eNOS-deficient mice. No CBF differences were found at the core impact site where CBF dropped to 20-25% of baseline in all groups. Conclusion: These differences between eNOS-deficient and WT mice indicate that the Epo mediated improvement in CBF in traumatic brain injury is eNOS dependent.	[Navarro, Jovany Cruz; Pillai, Shibu; Ponce, Lucido L.; Van, Mai; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, Jerry Clay] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Goodman, Jerry Clay] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA		Goodman, JC (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, MS BCM315,One Baylor Plaza, Houston, TX 77030 USA.	jgoodman@bcm.edu			NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-N538660]	Sources of Support: NIH NINDS P01-N538660.	Beleslin-Cokic BB, 2011, CYTOKINE, V54, P129, DOI 10.1016/j.cyto.2011.01.015; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cherian L, 2011, J PHARMACOL EXP THER, V337, P451, DOI 10.1124/jpet.110.176602; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Contaldo C, 2011, SHOCK, V35, P315, DOI 10.1097/SHK.0b013e3181fd0700; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Feldman Laurie, 2003, Environ Health Prev Med, V7, P239, DOI 10.1007/BF02908882; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Liao ZB, 2009, NEUROL INDIA, V57, P722, DOI 10.4103/0028-3886.59466; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marzo F, 2008, J THROMB THROMBOLYS, V26, P183, DOI 10.1007/s11239-008-0212-3; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Murphy AM, 2008, J NEUROSURG, V109, P1155, DOI 10.3171/JNS.2008.109.12.1155; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nedjat MR, 2013, NEUROSCIENCE, V238, P125, DOI 10.1016/j.neuroscience.2013.01.067; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; de Souza ACCP, 2012, AM J PHYSIOL-RENAL, V302, pF1045, DOI 10.1152/ajprenal.00148.2011; Prough DS, 2006, SHOCK, V26, P290, DOI 10.1097/01.shk.0000225405.66693.49; Rangel-Castilla L, 2010, NEUROL RES, V32, P1033, DOI 10.1179/016164110X12767786356598; Rezaeian F, 2010, LAB INVEST, V90, P40, DOI 10.1038/labinvest.2009.117; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; Samson ML, 2010, J PHARMACOL EXP THER, V333, P437, DOI 10.1124/jpet.110.165530; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1007/BF03206565; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sytkowski AJ, 2011, CELL MOL NEUROBIOL, V31, P931, DOI 10.1007/s10571-011-9695-0; Teng RF, 2011, BASIC RES CARDIOL, V106, P343, DOI 10.1007/s00395-011-0158-z; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Tobalem M, 2013, CRIT CARE MED, V41, P963, DOI 10.1097/CCM.0b013e318275cee7; Xu Y, 2011, NEUROSCIENCE, V181, P292, DOI 10.1016/j.neuroscience.2011.02.051; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang YY, 2014, INT J MOL SCI, V15, P10296, DOI 10.3390/ijms150610296	58	11	11	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	OCT 9	2014	5						1	7		10.3389/fimmu.2014.00494			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI1GM	WOS:000354491500001	25346735	Green Published, gold			2022-02-06	
